data_4ayk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4ayk _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -81.7 119.63 24.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.038 -1.039 . . . . 0.0 108.68 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -82.43 -11.5 58.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.68 151.03 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.81 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.4 p -94.81 -3.99 47.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.518 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 47.4 m-70 -129.2 144.02 51.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -133.39 158.5 42.88 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.39 -0.819 . . . . 0.0 109.91 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.42 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 75.3 p -128.71 150.02 50.45 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.18 159.41 42.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 0.0 109.578 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -150.7 130.5 13.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.0 109.74 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.21 122.54 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.309 -0.87 . . . . 0.0 108.858 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.83 -40.08 83.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.477 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -161.74 159.45 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.857 -1.152 . . . . 0.0 110.212 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -100.12 138.19 37.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -69.53 139.77 89.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 108.983 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -66.31 -12.13 34.33 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.601 0.893 . . . . 0.0 111.309 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.02 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.387 -0.821 . . . . 0.0 108.976 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -138.04 149.93 65.56 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.88 -170.97 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 120.795 0.997 . . . . 0.0 112.094 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' NH2' ' OD2' ' A' ' 31' ' ' ASP . 6.6 ptm180 -88.51 -31.81 18.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.11 -47.38 78.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.975 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.96 -43.96 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -0.976 . . . . 0.0 110.092 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 87.3 m-20 -59.28 -41.68 89.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.12 . . . . 0.0 109.267 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -60.06 -49.03 79.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.46 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.4 92.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.29 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.05 -40.05 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 0.0 109.725 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.16 -41.02 74.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.818 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.73 -39.74 92.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -46.18 86.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.074 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.884 -1.135 . . . . 0.0 109.261 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -60.01 -41.2 91.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 110.232 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -41.39 91.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.022 -1.049 . . . . 0.0 109.889 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -72.57 -42.29 64.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.335 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -69.93 -30.82 68.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 110.249 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.61 -31.99 68.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 111.168 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.3 m -110.03 9.99 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.084 -1.01 . . . . 0.0 111.009 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.43 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 70.4 p -143.25 148.28 43.88 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 120.925 -1.109 . . . . 0.0 109.292 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.78 10.5 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 120.64 0.894 . . . . 0.0 111.196 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.58 151.5 44.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.515 -0.741 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.4 p -129.8 140.91 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.64 157.7 27.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.571 -0.705 . . . . 0.0 109.38 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -154.59 125.74 7.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 109.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -78.38 133.53 37.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.373 -0.83 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.9 135.89 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.579 -0.701 . . . . 0.0 109.261 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -96.22 -2.0 47.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 109.994 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -146.35 156.39 43.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.966 -1.084 . . . . 0.0 109.587 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.98 164.52 34.05 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -80.45 131.48 35.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.291 . . . . 0.0 108.594 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.81 155.19 16.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.22 -0.925 . . . . 0.0 109.846 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' H ' ' HG1' ' A' ' 15' ' ' THR . 97.6 m-20 -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 109.602 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -120.01 113.06 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.44 -0.788 . . . . 0.0 109.062 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.03 133.6 44.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.113 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 61' ' ' ILE . 89.7 mt -116.04 130.03 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.557 -0.714 . . . . 0.0 109.334 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.1 p -150.15 155.17 39.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.39 137.67 41.18 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.78 160.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.264 -0.897 . . . . 0.0 111.264 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -130.51 143.47 50.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.318 0.58 . . . . 0.0 109.528 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.88 -142.74 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -76.49 130.14 37.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.482 -1.01 . . . . 0.0 110.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.583 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 3.2 p-80 -130.56 54.14 1.91 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 57.45 49.99 12.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 109.818 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 8.4 m-20 -142.79 162.0 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 0.0 109.033 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -90.46 9.66 28.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.631 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.7 71.62 64.25 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.997 -1.064 . . . . 0.0 110.668 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.47 149.92 56.92 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.201 1.268 . . . . 0.0 111.828 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -77.45 142.98 38.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.592 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -108.01 65.5 0.64 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.45 -0.781 . . . . 0.0 109.353 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.44 -167.54 54.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.97 -8.52 4.75 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.2 1.267 . . . . 0.0 112.079 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.14 176.48 42.18 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 -164.27 41.17 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.416 ' H ' HD21 ' A' ' 80' ' ' ASN . 3.0 p30 -75.27 159.65 31.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.219 -1.165 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.67 -18.18 21.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.363 -0.836 . . . . 0.0 109.851 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.34 169.41 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.965 . . . . 0.0 108.872 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.6 177.75 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.081 . . . . 0.0 109.799 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.3 177.91 7.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.325 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.67 154.65 21.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.512 -0.743 . . . . 0.0 109.281 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 86' ' ' GLN . 3.7 mp0 -58.59 149.99 59.04 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.182 -0.949 . . . . 0.0 108.802 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -60.72 107.42 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.575 0.85 . . . . 0.0 112.047 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.11 173.24 41.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.59 176.98 2.44 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.091 1.194 . . . . 0.0 112.121 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.11 -131.93 33.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.51 -12.72 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -1.062 . . . . 0.0 109.788 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.38 142.94 42.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.29 -21.49 37.49 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.52 153.35 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -1.17 . . . . 0.0 109.946 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.64 122.69 10.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 109.062 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -104.89 152.13 23.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.459 -0.776 . . . . 0.0 110.11 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 20.8 m-85 -119.91 139.64 52.1 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -66.55 119.81 12.33 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -98.51 2.3 47.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.55 -22.38 59.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.156 -0.965 . . . . 0.0 109.752 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -100.69 155.31 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.271 -0.893 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -85.21 128.07 34.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.031 -1.043 . . . . 0.0 109.251 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -89.6 145.86 24.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 109.785 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.1 p -129.87 166.41 20.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.576 -0.703 . . . . 0.0 109.708 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.41 30.3 6.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.555 -0.715 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 4.7 p30 -150.02 -164.24 1.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 31.76 0.43 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.422 ' HE ' HD22 ' A' ' 106' ' ' ASN . 44.7 mtt-85 -75.91 -157.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.602 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -39.78 -59.66 1.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 111.389 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -135.08 151.21 50.53 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 67.1 m-20 -103.59 115.04 29.77 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.13 -43.92 90.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.053 -1.029 . . . . 0.0 110.736 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -60.01 -42.32 94.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 0.0 110.239 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -59.91 -40.53 89.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.997 . . . . 0.0 109.796 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.82 -41.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.996 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.93 92.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.018 -1.051 . . . . 0.0 109.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.75 88.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 0.0 109.204 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -68.33 -44.7 74.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.414 -0.804 . . . . 0.0 109.72 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 74.7 mt-10 -60.03 -39.93 87.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 109.437 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.69 -40.01 90.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 108.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.87 -41.84 84.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.27 -39.95 93.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 108.701 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.6 m -70.19 -27.27 64.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.82 -1.53 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.171 -0.955 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.12 9.93 69.67 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.28 123.61 30.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.939 -1.33 . . . . 0.0 109.181 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.9 m -88.2 176.23 7.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.97 155.38 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -131.17 168.38 17.56 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.1 p -101.82 10.52 39.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.379 -0.826 . . . . 0.0 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.43 129.52 34.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.33 -40.02 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 110.641 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 0.19 77.54 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.985 -1.103 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 129.52 34.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.655 -1.497 . . . . 0.0 109.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.0 mt -69.21 -24.28 64.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -71.44 45.58 0.11 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 135' ' ' LEU . 5.4 t80 -70.03 129.78 90.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -48.57 -71.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.192 1.104 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.4 p -80.92 170.0 16.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 109.597 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.8 t80 . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 109.197 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.417 0.627 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -146.43 152.29 38.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.079 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.52 142.98 42.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 109.043 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 166.57 12.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.178 -0.951 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.371 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -59.9 -40.3 88.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.517 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -73.07 -40.05 65.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 0.0 109.522 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.05 -50.07 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.76 -39.87 93.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.988 -1.07 . . . . 0.0 109.866 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.45 -57.49 19.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.222 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.99 -40.08 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.793 -1.416 . . . . 0.0 110.007 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.1 mt-30 -66.09 -39.95 90.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.88 96.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.01 -50.06 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.895 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -99.56 -64.86 1.0 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.5 -179.11 38.78 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -89.97 149.87 22.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -1.197 . . . . 0.0 109.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.43 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 21.5 m . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HG2' HH11 ' A' ' 8' ' ' ARG . 43.7 mtt-85 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -82.41 120.44 25.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.061 -1.024 . . . . 0.0 109.591 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -83.87 -13.89 52.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 109.598 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.98 149.22 28.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.912 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -95.03 -3.9 47.49 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 67.0 m80 -125.3 134.49 52.23 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.9 151.48 50.42 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.872 . . . . 0.0 109.221 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -120.97 155.91 33.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 109.221 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -145.19 159.22 43.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -150.77 133.81 16.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.089 -1.007 . . . . 0.0 110.07 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.5 mt -90.84 120.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.96 -40.11 91.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.991 -1.068 . . . . 0.0 110.882 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.9 149.58 14.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.713 -1.242 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -95.22 132.85 39.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -71.05 143.23 88.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.691 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.72 -9.91 24.6 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.789 0.993 . . . . 0.0 112.625 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.97 -39.97 87.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.086 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -137.83 149.69 65.27 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.64 179.8 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.667 0.911 . . . . 0.0 111.916 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -86.58 -31.43 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.71 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -70.42 -40.07 74.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 110.499 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -40.82 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.546 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.02 -40.46 89.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.34 -45.04 94.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.342 -0.849 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.81 91.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.31 -40.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.695 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -69.92 -40.1 75.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.415 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -61.82 -40.01 93.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.292 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.63 91.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.035 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -60.47 -40.21 90.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.918 -1.114 . . . . 0.0 108.881 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -59.97 -41.47 92.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.792 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.32 -41.3 93.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.104 -0.997 . . . . 0.0 110.458 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -74.76 -42.11 58.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.985 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -68.71 -34.8 76.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 110.407 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.27 -32.24 69.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.269 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' HG ' ' A' ' 163' ' ' SER . 17.3 m -109.79 11.7 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.049 -1.032 . . . . 0.0 110.761 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.0 p -143.01 149.27 48.62 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.911 -1.118 . . . . 0.0 109.472 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -73.68 3.88 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.538 0.826 . . . . 0.0 111.723 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 157.88 37.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 109.657 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.505 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 74.6 p -133.41 151.77 51.85 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.19 154.36 46.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.536 -0.727 . . . . 0.0 109.619 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.2 m -154.01 131.15 11.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -77.87 135.59 37.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.765 . . . . 0.0 109.082 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.17 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.313 -0.867 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 t -99.1 11.66 38.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.482 -0.761 . . . . 0.0 109.835 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.07 153.7 42.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.076 -1.015 . . . . 0.0 109.183 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 168.32 1.44 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -82.05 147.49 29.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 109.011 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.35 160.01 14.78 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.15 -40.06 88.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.34 119.32 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.396 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.1 mtp -103.58 134.3 47.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.523 -0.736 . . . . 0.0 109.767 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -119.68 126.83 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 0.0 109.283 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.9 p -149.69 156.09 41.29 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -103.13 140.78 36.89 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -138.95 169.77 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 120.945 -1.097 . . . . 0.0 110.818 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -138.08 149.26 45.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.713 -0.617 . . . . 0.0 110.147 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.91 -146.52 2.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -70.07 129.97 40.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -1.08 . . . . 0.0 110.296 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.1 p-80 -137.98 55.82 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.699 -0.626 . . . . 0.0 109.39 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 85.0 mtm180 57.24 48.96 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 109.79 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -142.47 158.25 43.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.347 -0.845 . . . . 0.0 109.156 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -90.96 8.61 34.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -134.5 72.48 69.96 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.342 -0.849 . . . . 0.0 109.752 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.95 148.46 35.54 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.312 1.341 . . . . 0.0 112.682 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -76.4 146.19 38.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.776 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.57 75.2 1.53 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.153 -0.967 . . . . 0.0 110.123 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 -178.75 44.15 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.67 -6.4 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 120.746 0.964 . . . . 0.0 110.999 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.25 43.89 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.69 -173.74 47.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -73.28 151.13 41.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -1.146 . . . . 0.0 109.089 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt -90.91 -13.39 33.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.24 163.41 8.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 108.909 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.46 179.72 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.836 -1.165 . . . . 0.0 110.211 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.83 174.13 10.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.4 155.72 17.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.376 -0.827 . . . . 0.0 108.995 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -59.56 149.02 72.56 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.279 -0.888 . . . . 0.0 108.836 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.97 100.19 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 120.503 0.802 . . . . 0.0 111.842 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 171.75 35.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.94 -169.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.422 1.415 . . . . 0.0 112.144 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.2 -131.38 51.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.03 -9.99 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -1.014 . . . . 0.0 109.796 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.94 147.33 26.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -23.01 36.19 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 121.268 -1.136 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -67.45 154.89 40.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.352 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.1 123.08 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -105.15 147.54 27.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.368 -0.833 . . . . 0.0 110.283 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -119.72 133.96 55.42 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -66.9 122.33 17.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.143 -0.973 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -95.94 -2.62 46.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.032 -1.043 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -76.07 -13.85 60.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.959 -1.088 . . . . 0.0 109.238 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -93.84 152.68 18.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -0.811 . . . . 0.0 109.107 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -86.5 115.07 23.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 108.704 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -91.97 144.6 25.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 110.125 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 p -129.35 174.13 9.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.2 22.38 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.416 -0.803 . . . . 0.0 109.492 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.02 -166.4 2.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -0.921 . . . . 0.0 109.887 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.76 29.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.201 -0.937 . . . . 0.0 110.621 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 109' ' ' GLU . 45.6 mtt-85 -76.16 -159.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.025 . . . . 0.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 108' ' ' ARG . 77.8 mm-40 -32.16 -60.4 0.27 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.815 -0.553 . . . . 0.0 111.819 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -137.92 139.08 39.61 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.089 -1.007 . . . . 0.0 110.041 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.502 HD21 ' N ' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -105.9 119.53 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.354 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 111' ' ' ASN . 64.8 tp -67.25 -39.93 86.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 0.0 110.632 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -60.07 -42.68 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.603 -1.311 . . . . 0.0 110.325 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.45 -39.78 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.902 -1.124 . . . . 0.0 109.595 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.6 93.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.46 94.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.034 -1.042 . . . . 0.0 109.891 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.05 -47.31 68.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.97 -39.95 75.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 109.493 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.53 -39.52 91.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 108.798 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.11 90.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -62.69 -40.01 95.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -1.232 . . . . 0.0 109.369 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -70.93 -23.49 62.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.236 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.39 -3.82 58.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.161 -0.962 . . . . 0.0 109.044 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.65 16.79 72.29 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.918 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.57 129.17 34.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.876 -1.367 . . . . 0.0 108.95 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 m -88.06 168.66 12.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.038 . . . . 0.0 109.54 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.73 159.99 31.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.6 t -130.22 168.84 16.21 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -103.05 10.06 38.23 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.316 -0.865 . . . . 0.0 109.618 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.39 128.5 33.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.06 -1.025 . . . . 0.0 109.176 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 132' ' ' ILE . 96.7 mt -59.95 -40.09 81.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.586 -0.696 . . . . 0.0 110.55 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.57 1.61 65.98 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.601 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 136.48 34.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.614 -1.521 . . . . 0.0 109.61 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.1 -26.38 64.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.4 mmm -75.23 52.12 0.57 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.0 t80 -70.17 137.25 86.86 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.954 . . . . 0.0 109.087 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.91 4.63 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 CA-C-N 119.847 0.981 . . . . 0.0 112.184 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.8 p -160.18 176.17 12.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.172 -0.955 . . . . 0.0 109.354 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 120.835 -1.166 . . . . 0.0 109.452 -179.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -144.57 160.2 41.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.439 -0.788 . . . . 0.0 108.89 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.24 141.05 45.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 109.354 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.19 156.43 16.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -56.61 -39.04 72.89 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.056 -1.027 . . . . 0.0 108.801 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -55.33 -39.99 70.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.83 -40.02 63.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.174 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.86 -51.35 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.0 109.034 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.17 -40.17 96.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.775 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.07 -53.32 41.15 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.309 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.02 -39.69 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.912 -1.346 . . . . 0.0 109.567 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.9 mt-30 -67.18 -37.97 84.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 109.172 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.9 -50.19 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.793 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -95.31 -69.96 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.16 -0.963 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.61 -168.56 36.12 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 mtm-85 -87.8 150.28 23.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -1.087 . . . . 0.0 108.714 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.416 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 13.8 m . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 108.793 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -81.71 125.93 31.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.239 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.7 -16.8 53.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 0.0 109.145 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -82.47 147.44 28.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.2 p -96.08 -4.87 42.12 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -123.38 130.01 52.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.52 150.53 40.09 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -125.63 154.92 41.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.47 159.61 41.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.252 -0.905 . . . . 0.0 109.78 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -148.99 130.31 14.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.385 -0.822 . . . . 0.0 109.318 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.42 127.07 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 108.728 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.88 -40.04 83.61 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -162.91 155.33 18.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.976 -1.077 . . . . 0.0 109.976 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.63 136.32 40.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t -70.49 141.66 88.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.29 -12.65 31.45 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 CA-C-N 119.413 0.826 . . . . 0.0 111.697 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.2 -39.93 88.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 110.5 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -138.38 149.58 63.56 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.062 -1.024 . . . . 0.0 108.39 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.68 -175.93 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.52 0.814 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -85.69 -33.25 21.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.65 74.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.344 -0.847 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.97 -39.99 72.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.13 -42.68 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 109.495 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.6 -44.48 93.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.201 -0.937 . . . . 0.0 109.111 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.21 -46.41 89.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 34' ' ' ILE . 46.0 mm -72.34 -41.05 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.844 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 86.7 tt0 -70.05 -40.89 74.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.966 -1.084 . . . . 0.0 109.751 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -61.35 -35.81 78.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 108.809 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.68 92.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.223 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.2 m-85 -60.19 -40.62 90.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.768 -1.208 . . . . 0.0 109.707 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.479 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -60.69 -39.81 89.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.052 -1.03 . . . . 0.0 110.506 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.67 -46.15 89.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.881 -1.137 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.463 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.6 m95 -71.32 -40.28 70.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.606 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -67.14 -39.16 86.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 111.301 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -56.33 -29.9 61.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.44 11.76 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.867 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.1 p -144.8 150.06 45.17 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.968 -1.083 . . . . 0.0 109.007 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.66 2.22 4.86 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.569 0.846 . . . . 0.0 111.962 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.1 mt -70.74 147.89 48.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.0 p -125.53 149.81 47.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 96.8 m-85 -126.21 152.29 46.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 33.8 m -153.23 129.92 10.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.899 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -77.08 144.22 38.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.543 -0.723 . . . . 0.0 109.54 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.6 135.4 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 t -95.45 -9.46 32.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -144.23 158.32 43.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.66 172.87 49.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.01 160.88 25.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.592 -0.946 . . . . 0.0 108.958 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.94 52.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.03 -40.6 89.91 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 110.558 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.64 119.91 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.3 mtp -102.22 131.6 48.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -0.798 . . . . 0.0 109.481 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 61' ' ' ILE . 91.3 mt -111.62 131.72 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -145.54 160.1 42.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.092 -1.005 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -116.96 136.65 52.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.23 160.01 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.296 -0.877 . . . . 0.0 110.601 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -126.75 137.14 53.19 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.77 -149.51 1.63 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -66.5 130.29 42.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -1.085 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.522 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.2 p-80 -130.89 47.57 2.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.687 -0.633 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 64.6 mtp180 59.54 51.83 6.19 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.161 0.505 . . . . 0.0 109.912 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.522 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 7.5 m-20 -137.67 167.72 21.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.383 -0.823 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -90.69 8.8 32.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 m -137.0 71.88 55.07 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.802 . . . . 0.0 109.133 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.54 146.55 55.67 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 121.184 1.256 . . . . 0.0 111.697 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.68 148.69 36.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -106.27 70.75 0.85 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.438 -0.789 . . . . 0.0 109.423 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.11 -157.58 2.52 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.28 -19.53 17.08 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 118.571 1.185 . . . . 0.0 112.179 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.2 -177.47 41.9 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.56 -166.93 38.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -72.02 152.02 42.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -1.132 . . . . 0.0 109.845 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.68 -18.01 23.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.62 165.3 8.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -162.85 -179.31 6.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.48 166.47 22.64 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -95.8 159.71 14.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 109.937 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.25 150.95 39.43 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.534 -0.729 . . . . 0.0 109.241 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -62.02 104.82 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.501 0.801 . . . . 0.0 112.198 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 174.61 37.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.89 171.57 15.45 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.868 1.045 . . . . 0.0 112.318 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 -126.72 17.38 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -73.88 -13.22 15.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.338 -1.095 . . . . 0.0 109.258 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 144.0 45.48 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.58 18.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.97 126.08 28.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.301 . . . . 0.0 110.197 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.74 129.92 51.18 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -102.46 142.54 33.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.288 -0.883 . . . . 0.0 109.833 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -120.18 136.88 54.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.718 -0.614 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.19 121.15 17.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 109.652 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -97.79 -4.53 36.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.55 -16.02 59.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.02 -1.05 . . . . 0.0 109.135 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -93.24 158.24 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.9 ttm-85 -87.9 115.11 25.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 108.796 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.66 139.83 30.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.5 p -127.54 166.66 17.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.473 -0.767 . . . . 0.0 109.644 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -111.45 33.28 4.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -151.75 -165.97 2.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -84.89 32.01 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.95 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -76.14 -161.66 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.1 -59.23 3.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 111.59 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -121.31 132.25 54.68 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.099 -1.001 . . . . 0.0 111.143 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.13 124.27 49.45 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.98 -39.8 75.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -58.46 -45.33 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 111.224 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.2 -44.27 95.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.28 . . . . 0.0 110.526 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.48 -41.05 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.019 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.16 93.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.061 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.22 86.34 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.647 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 56.0 t60 -70.06 -41.59 73.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 110.072 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -58.25 -42.06 85.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.058 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.42 -40.09 93.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 108.942 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.29 -40.08 83.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.647 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 20.5 m-70 -66.12 -34.91 79.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -1.206 . . . . 0.0 109.106 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.0 t -69.09 -29.05 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.57 -4.99 57.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.5 19.14 57.41 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.073 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.25 130.11 34.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.823 -1.398 . . . . 0.0 109.094 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 m -86.98 167.47 14.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 109.106 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -63.88 159.75 19.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -128.05 166.82 17.69 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.615 -0.678 . . . . 0.0 109.418 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -107.75 9.1 29.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 11.7 t70 -81.73 129.24 34.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.09 -39.47 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -74.75 -3.22 66.82 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.048 -1.033 . . . . 0.0 111.475 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 137.21 33.54 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.714 -1.462 . . . . 0.0 110.428 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.53 -27.55 65.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 0.0 108.961 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.424 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.0 mtp -76.64 58.67 1.42 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.864 . . . . 0.0 109.865 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -71.83 132.15 85.24 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.33 -68.18 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.211 0 CA-C-N 120.198 1.106 . . . . 0.0 111.057 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.0 p -86.33 175.29 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.42 -0.8 . . . . 0.0 109.773 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 108.444 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.436 0.636 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.49 150.55 39.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 143.72 40.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.825 -1.172 . . . . 0.0 109.298 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.84 156.43 19.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.04 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.75 -40.06 86.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 151' ' ' ASP . 48.6 t0 -58.76 -40.34 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.75 -40.2 66.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.585 -1.322 . . . . 0.0 109.205 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.51 -48.13 88.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.923 -1.111 . . . . 0.0 110.473 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.94 38.17 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 121.037 -1.039 . . . . 0.0 111.619 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.28 -38.75 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.83 -1.394 . . . . 0.0 109.549 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -64.41 -39.95 94.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 108.57 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.99 97.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.0 109.293 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.38 -50.09 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.037 -1.039 . . . . 0.0 109.593 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -100.66 -67.79 0.84 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.352 -0.843 . . . . 0.0 109.144 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.29 -169.77 34.91 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.11 152.33 22.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.243 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.402 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.452 0.644 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -84.36 124.87 31.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.323 -0.861 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.71 -12.68 59.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.884 -1.135 . . . . 0.0 110.63 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 19.2 pt20 -86.86 155.96 20.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.88 -1.138 . . . . 0.0 109.428 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.419 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 63.6 p -96.58 -4.2 41.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.071 -1.018 . . . . 0.0 109.672 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.419 ' CD2' ' HG1' ' A' ' 12' ' ' THR . 40.3 m170 -117.75 130.94 56.62 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.95 154.21 33.37 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.3 p -128.92 153.17 47.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.272 -0.892 . . . . 0.0 108.698 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.16 162.07 37.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.079 -1.013 . . . . 0.0 109.49 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 17' ' ' ARG . 16.6 ttt-85 -146.98 136.77 23.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 0.0 110.395 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 86.1 mt -89.33 111.47 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.6 tp10 -64.58 -38.78 92.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.486 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 61.5 m-80 -156.64 146.49 20.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.099 . . . . 0.0 110.264 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.76 138.98 32.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -70.01 134.95 87.43 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.085 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -64.11 -13.73 39.44 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 120.017 1.042 . . . . 0.0 111.533 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.873 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.2 mt -134.75 149.57 71.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.69 -175.53 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 120.708 0.938 . . . . 0.0 111.978 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -88.16 -35.58 17.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.12 79.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.566 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.12 -39.98 68.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.204 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.6 t -68.9 -40.84 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.142 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -40.11 88.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 108.824 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -56.7 -50.38 72.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 109.426 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.51 92.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 110.333 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.0 mm -69.94 -39.09 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.083 -1.011 . . . . 0.0 109.762 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.29 -41.44 89.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -63.28 -39.92 95.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.962 -1.087 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.88 75.72 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.803 -1.185 . . . . 0.0 109.206 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 38.1 m-85 -60.97 -40.78 94.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 109.159 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 19.2 mm100 -60.27 -43.23 96.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.97 -41.42 91.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.964 -1.085 . . . . 0.0 110.28 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -74.28 -41.28 61.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.704 -1.247 . . . . 0.0 110.028 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.1 -30.41 69.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 6.2 m120 -58.82 -32.91 69.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.282 -0.886 . . . . 0.0 111.22 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.55 8.26 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.3 p -143.83 148.87 44.25 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.915 -1.116 . . . . 0.0 109.843 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.66 6.58 1.55 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.015 1.143 . . . . 0.0 111.655 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.7 mt -70.24 152.25 44.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.382 -0.823 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.0 p -130.31 150.92 51.33 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 95.3 m-85 -125.86 157.15 38.34 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.5 -0.75 . . . . 0.0 109.952 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 79.7 m -154.89 126.98 7.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.392 -0.817 . . . . 0.0 109.866 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 64.2 tttp -81.37 139.73 35.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 136.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.477 -0.764 . . . . 0.0 109.012 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -95.3 -0.75 52.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.116 -0.99 . . . . 0.0 109.148 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -149.36 159.21 44.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.391 -0.818 . . . . 0.0 109.419 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.25 164.69 36.58 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.41 139.24 39.65 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -1.166 . . . . 0.0 108.075 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.34 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 109.439 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 93.5 m-20 -60.17 -40.71 90.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.462 -0.774 . . . . 0.0 110.006 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.03 118.56 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.83 123.58 45.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 108.956 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 61' ' ' ILE . 90.6 mt -113.04 129.96 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.471 -0.768 . . . . 0.0 109.035 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -146.34 152.61 39.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 109.728 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.58 138.12 40.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.1 162.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.984 . . . . 0.0 110.818 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.11 152.63 51.92 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.39 -151.74 0.62 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.49 130.2 41.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.957 . . . . 0.0 110.392 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 17.3 p-80 -135.63 49.27 2.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.493 -0.754 . . . . 0.0 109.073 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 55.07 56.95 5.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.5 t0 -142.52 160.28 40.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.326 -0.859 . . . . 0.0 108.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 50.5 t30 -88.93 7.53 34.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.084 -1.01 . . . . 0.0 110.047 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 72.4 m -136.11 71.24 62.06 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.0 108.925 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 144.29 75.88 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 120.919 1.079 . . . . 0.0 111.9 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.52 147.97 37.42 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.405 -0.809 . . . . 0.0 109.432 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -128.72 77.1 1.76 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.557 -0.714 . . . . 0.0 109.659 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.19 -174.27 26.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.42 -5.15 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.105 1.203 . . . . 0.0 112.392 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.76 179.19 44.29 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.81 -165.94 49.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.45 151.05 42.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.967 . . . . 0.0 109.412 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.3 mt -91.08 -17.56 26.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.42 164.67 8.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.016 -1.053 . . . . 0.0 109.85 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -160.37 177.32 10.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.266 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.87 174.7 9.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.201 -0.937 . . . . 0.0 109.766 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -109.05 153.26 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.645 -0.659 . . . . 0.0 109.897 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.93 151.57 64.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -58.01 104.85 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 120.956 1.104 . . . . 0.0 112.196 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.22 171.41 37.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.81 173.06 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.466 1.444 . . . . 0.0 111.81 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 -127.72 29.44 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.451 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.19 -7.1 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.604 -0.939 . . . . 0.0 110.234 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.31 47.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.3 -21.52 28.03 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 121.246 -1.149 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.33 156.1 35.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -1.197 . . . . 0.0 110.69 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 121.51 11.49 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.6 142.89 29.61 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.211 -0.931 . . . . 0.0 110.88 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.512 ' CE2' ' OE1' ' A' ' 119' ' ' GLU . 26.6 m-85 -119.96 134.59 55.2 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.73 116.58 8.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.493 -0.755 . . . . 0.0 109.025 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -99.58 2.26 44.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.14 -14.85 60.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.57 161.86 13.32 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.5 117.82 26.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -93.1 149.5 21.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.749 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.409 ' HB ' HD22 ' A' ' 106' ' ' ASN . 56.8 p -127.56 166.58 17.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.62 31.41 6.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.621 -0.674 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.565 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.91 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.088 -1.007 . . . . 0.0 109.896 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 53.3 t80 -81.11 33.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.508 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 18.2 mmm180 -76.58 -165.91 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.071 -1.018 . . . . 0.0 110.351 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -59.66 -56.99 14.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 0.0 111.794 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -93.62 125.14 38.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 110.223 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -104.42 104.57 14.46 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -70.02 -39.99 75.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -59.63 -47.43 85.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.908 -1.12 . . . . 0.0 110.781 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 110.548 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 59.5 t -69.76 -41.54 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.876 -1.14 . . . . 0.0 109.608 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.6 86.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.04 92.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.077 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.637 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 5.6 t60 -68.32 -43.93 76.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 110.726 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.512 ' OE1' ' CE2' ' A' ' 97' ' ' PHE . 5.5 mp0 -59.51 -40.69 87.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.597 -1.315 . . . . 0.0 109.633 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.12 -39.99 92.09 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.971 -1.081 . . . . 0.0 108.45 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.06 -41.97 98.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.637 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 4.2 m-70 -64.2 -36.21 83.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.019 -1.283 . . . . 0.0 108.653 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.4 t -69.96 -22.79 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.346 -0.846 . . . . 0.0 108.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.82 -3.75 58.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.09 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.11 21.27 55.66 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 120.401 -0.905 . . . . 0.0 110.932 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.72 135.92 34.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.38 . . . . 0.0 109.684 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.1 m -88.74 166.87 13.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.375 -0.828 . . . . 0.0 110.145 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -68.01 161.94 25.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.5 t -125.7 160.96 28.37 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.41 -0.806 . . . . 0.0 109.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 82.5 p -99.99 9.39 42.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.7 t0 -83.3 130.18 35.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt -62.01 -40.42 87.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 111.12 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.14 65.87 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.959 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.34 130.09 35.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.746 -1.444 . . . . 0.0 109.498 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.12 -34.34 73.38 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.9 mmm -72.31 44.95 0.12 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.793 -0.567 . . . . 0.0 110.894 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -69.29 139.95 90.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.6 -55.84 3.61 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 120.216 1.113 . . . . 0.0 111.484 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 140' ' ' TYR . 9.3 t -100.34 176.12 5.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.408 ' N ' ' OG ' ' A' ' 139' ' ' SER . 65.0 t80 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 109.37 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.429 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 57.6 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.55 0.69 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -150.41 149.44 30.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.79 148.77 36.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.693 -1.254 . . . . 0.0 109.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.02 159.72 15.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.052 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 108.914 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -58.19 -40.0 80.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.257 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.23 -41.83 60.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.31 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.17 -49.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.852 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.813 -1.179 . . . . 0.0 109.259 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -57.89 16.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.95 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.55 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.86 -1.376 . . . . 0.0 110.08 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.74 -40.05 88.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.004 . . . . 0.0 109.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.32 96.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 109.674 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.87 -50.23 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.95 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.35 -64.25 1.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.271 -0.893 . . . . 0.0 109.752 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.03 170.9 30.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 162' ' ' ARG . 46.4 mtt-85 -90.24 138.01 31.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.0 109.373 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--N 1.303 -1.452 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.461 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -84.07 133.38 34.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 108.993 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.56 -36.6 60.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.043 -1.035 . . . . 0.0 110.377 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -80.01 155.29 27.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.02 -1.05 . . . . 0.0 109.657 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -95.18 -2.73 49.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -111.62 135.51 52.11 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.5 mt -134.48 159.92 39.63 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.211 -0.93 . . . . 0.0 109.515 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.2 p -130.91 152.9 49.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.615 -0.678 . . . . 0.0 109.24 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.49 158.41 43.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 54' ' ' GLU . 69.6 ttt180 -150.73 137.06 18.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 0.0 109.244 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.67 122.09 42.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.53 -40.11 95.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.618 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -160.01 158.43 30.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.293 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.54 133.98 44.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.366 -0.834 . . . . 0.0 109.28 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -70.99 143.66 89.2 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.95 -10.85 24.44 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 CA-C-N 119.728 0.938 . . . . 0.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.17 -40.04 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.893 . . . . 0.0 110.263 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.7 mt -139.54 150.12 62.42 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.46 -174.77 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 120.77 0.98 . . . . 0.0 112.331 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -89.45 -37.13 15.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.96 94.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -71.36 -37.43 71.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.879 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.7 -40.45 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -59.98 -41.68 92.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.557 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -60.45 -45.27 94.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.536 -0.727 . . . . 0.0 109.32 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.75 -44.98 93.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.157 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.33 -41.74 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.584 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.95 -39.7 75.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.014 -1.054 . . . . 0.0 109.927 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.99 -39.3 85.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.34 94.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 109.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.9 m-85 -60.95 -39.77 90.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.077 -1.014 . . . . 0.0 109.381 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.85 -39.89 86.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.08 -42.17 94.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -71.35 -42.92 67.9 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.353 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.8 t -69.86 -25.23 63.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.404 -0.81 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.083 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.6 m -109.33 10.88 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.164 -0.96 . . . . 0.0 110.873 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' LEU . 38.1 p -139.95 143.3 33.81 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.002 -1.061 . . . . 0.0 109.505 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.47 13.49 0.44 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.182 1.254 . . . . 0.0 111.746 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.5 mt -72.66 160.54 32.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 108.893 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 p -137.22 149.2 47.03 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.4 154.25 47.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.761 -0.587 . . . . 0.0 109.536 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -153.08 130.05 11.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 109.748 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -81.77 139.87 34.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.14 139.65 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.5 t -99.89 -6.32 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.368 -0.832 . . . . 0.0 110.238 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.5 mt-10 -144.48 156.79 44.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.157 -0.964 . . . . 0.0 108.772 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 169.9 39.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -84.63 139.44 32.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -1.204 . . . . 0.0 109.655 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.2 156.1 17.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.64 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.1 -39.59 86.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.869 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.94 118.6 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.323 -0.86 . . . . 0.0 109.437 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.7 mmm -100.38 133.77 44.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 108.949 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.1 130.72 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.568 -0.708 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.0 p -149.76 167.73 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.588 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.33 137.65 51.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.72 159.84 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.278 -0.889 . . . . 0.0 110.841 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -125.29 135.35 52.4 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.14 -130.65 4.53 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -81.02 129.82 34.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -1.101 . . . . 0.0 109.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 29.4 p-80 -136.44 51.21 2.01 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.41 54.99 5.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.771 -0.581 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.3 p-10 -141.01 170.21 16.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.047 -1.033 . . . . 0.0 109.457 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -91.92 9.64 32.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 t -140.52 74.95 27.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -71.27 139.09 34.41 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.533 1.488 . . . . 0.0 112.17 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.76 148.14 36.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.105 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -133.27 77.19 1.72 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.563 -0.711 . . . . 0.0 109.819 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.52 177.28 42.93 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.065 -1.022 . . . . 0.0 110.747 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -68.83 -23.04 35.73 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.501 1.467 . . . . 0.0 112.312 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.79 -177.56 51.08 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.64 -153.39 27.24 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.57 144.11 44.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.85 -19.93 19.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.43 170.66 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 0.0 109.429 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.57 179.33 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 109.976 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.97 170.0 17.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.71 154.5 19.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.699 . . . . 0.0 109.452 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -60.07 150.54 69.95 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.228 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.44 102.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.563 0.842 . . . . 0.0 111.957 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.18 171.24 33.38 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.83 169.83 15.39 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.033 1.155 . . . . 0.0 111.966 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.98 -123.18 14.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -77.81 -13.1 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.027 . . . . 0.0 109.587 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.08 140.54 44.69 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.59 -17.22 50.59 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -66.26 158.32 29.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.323 -1.104 . . . . 0.0 109.757 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 118.97 6.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.171 -0.956 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.36 145.87 28.34 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.5 -0.75 . . . . 0.0 110.832 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 24.6 m-85 -116.19 139.11 50.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.758 -0.589 . . . . 0.0 109.679 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.85 118.79 10.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 108.489 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -97.38 -1.03 45.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 109.769 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.29 -20.03 59.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.049 -1.032 . . . . 0.0 109.542 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -98.04 162.34 13.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.7 121.33 29.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.815 -1.178 . . . . 0.0 109.056 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -89.13 135.45 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 109.522 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 p -128.82 170.06 13.81 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.0 109.473 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -118.71 27.12 9.1 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.573 -0.705 . . . . 0.0 110.172 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.681 HD21 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.9 -167.02 2.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 0.0 110.538 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -59.97 10.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.312 -0.868 . . . . 0.0 111.6 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 106' ' ' ASN . 96.4 mtt180 -76.24 166.32 23.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.724 -1.235 . . . . 0.0 110.154 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 108' ' ' ARG . 41.3 mp0 -4.89 -76.9 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -131.74 150.98 51.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.204 -0.935 . . . . 0.0 110.416 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 82.5 m-20 -99.36 119.99 38.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 tp -65.3 -40.11 93.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.223 -0.923 . . . . 0.0 110.59 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -59.97 -42.18 93.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.6 t -70.12 -41.57 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.4 91.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.35 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.05 88.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.067 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 5.9 t60 -66.81 -45.78 77.26 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.355 -0.841 . . . . 0.0 109.643 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.3 mt-10 -59.72 -39.38 84.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 109.304 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.2 -39.64 90.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.998 . . . . 0.0 109.12 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.85 93.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 7.6 m-70 -67.7 -38.48 83.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 0.0 109.022 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.5 p -70.11 -22.54 63.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.62 -3.35 59.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 109.239 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.97 72.72 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.86 131.23 35.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.345 . . . . 0.0 109.122 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.3 m -88.49 171.34 10.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 109.897 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -66.77 160.02 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.434 -0.791 . . . . 0.0 109.761 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -124.6 168.04 13.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.0 109.137 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.8 p -104.93 3.64 31.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 109.479 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 120.69 26.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.961 . . . . 0.0 109.312 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 tt -55.95 -29.97 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.21 0.74 83.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.681 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.48 135.95 34.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.785 -1.42 . . . . 0.0 109.546 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.14 -27.41 65.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 0.0 108.653 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.8 mmm -79.02 40.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.713 . . . . 0.0 110.033 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -69.88 133.87 88.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 108.982 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -46.91 -67.5 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.805 0.966 . . . . 0.0 112.207 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.5 m -82.63 175.51 10.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.911 -1.118 . . . . 0.0 109.329 -179.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -142.28 160.89 39.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.159 -0.963 . . . . 0.0 109.137 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.42 131.74 42.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.029 . . . . 0.0 109.267 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.27 166.45 13.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.541 -0.724 . . . . 0.0 109.157 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.842 . . . . 0.0 108.856 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.35 -39.69 80.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.25 -42.78 59.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.957 -1.089 . . . . 0.0 109.516 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 153' ' ' ILE . 97.0 mt -63.15 -51.59 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.159 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.4 -39.84 92.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.797 -1.19 . . . . 0.0 110.233 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.44 49.22 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.231 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.19 -37.54 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.305 . . . . 0.0 109.999 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.1 mt-30 -67.59 -40.65 84.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.82 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.09 89.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.131 -0.98 . . . . 0.0 109.484 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.47 -51.04 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.08 . . . . 0.0 109.647 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -98.52 -67.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.097 -1.002 . . . . 0.0 109.953 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.88 -169.25 38.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -96.62 138.49 34.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -1.08 . . . . 0.0 109.243 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.022 -1.049 . . . . 0.0 108.969 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -82.75 120.05 25.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.173 -0.954 . . . . 0.0 109.12 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.71 -12.62 55.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.776 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -83.29 150.63 26.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.2 p -95.69 -4.22 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.226 -0.921 . . . . 0.0 108.975 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.55 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 54.3 m-70 -130.57 144.78 51.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -136.12 158.88 43.34 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.8 p -124.24 155.79 37.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.366 -0.834 . . . . 0.0 109.205 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.97 158.42 43.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.787 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.423 HH21 ' CE ' ' A' ' 60' ' ' MET . 44.0 ttp180 -149.88 130.4 13.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.488 -0.757 . . . . 0.0 109.809 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -90.17 115.77 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.85 -39.73 94.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.473 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -159.46 152.62 22.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.791 -1.193 . . . . 0.0 110.701 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -97.93 135.28 39.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -70.04 138.02 87.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.036 . . . . 0.0 109.869 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.31 -12.5 30.75 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 119.619 0.9 . . . . 0.0 111.818 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.16 -39.43 86.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 109.817 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.81 150.47 65.67 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.31 -171.77 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.385 0.723 . . . . 0.0 111.794 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -86.5 -37.36 18.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.24 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.87 -40.74 75.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.295 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -70.23 -42.65 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 108.909 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.105 . . . . 0.0 108.998 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 45.9 t60 -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.626 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.84 82.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.22 -39.78 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.32 -47.41 79.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.774 -1.203 . . . . 0.0 109.786 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 36.1 mttp -64.03 -33.64 76.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.788 -1.195 . . . . 0.0 110.075 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.77 -50.98 71.69 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.813 -1.179 . . . . 0.0 109.025 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.4 -40.0 95.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -59.98 -43.34 95.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.8 -44.35 94.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 0.0 110.505 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.56 -40.07 70.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 109.67 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.9 t -69.81 -38.52 76.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.68 -30.57 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.201 -0.937 . . . . 0.0 110.898 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.4 11.14 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.204 -0.935 . . . . 0.0 109.842 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.4 p -142.08 146.21 39.19 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.97 5.38 2.61 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 120.859 1.039 . . . . 0.0 111.577 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -71.73 162.18 29.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.437 -0.79 . . . . 0.0 109.11 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 24.4 p -137.8 150.78 47.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -125.0 155.73 39.22 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.525 -0.734 . . . . 0.0 109.615 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.9 m -153.77 132.39 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HZ2' ' CB ' ' A' ' 51' ' ' LYS . 8.2 ttpm? -77.57 140.75 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.624 -0.673 . . . . 0.0 110.247 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.85 130.56 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.519 -0.738 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -95.56 -3.39 46.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.31 151.0 35.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.126 -0.984 . . . . 0.0 109.469 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.17 168.54 44.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.89 140.28 35.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -1.168 . . . . 0.0 108.956 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.62 148.58 25.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.64 -43.74 93.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.17 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -111.48 110.56 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 109.555 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.423 ' CE ' HH21 ' A' ' 17' ' ' ARG . 85.8 mtp -102.46 124.81 48.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 61' ' ' ILE . 96.6 mt -110.11 129.97 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 0.0 109.109 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.8 p -146.75 156.25 43.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.084 -1.01 . . . . 0.0 110.222 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -107.02 135.46 48.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.77 159.99 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 55.0 mtt-85 -123.77 138.93 54.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 109.802 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.36 -139.34 1.24 Allowed Glycine 0 N--CA 1.498 2.802 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.87 122.43 19.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.967 . . . . 0.0 109.427 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -135.17 66.29 1.53 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.431 -0.793 . . . . 0.0 109.866 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 53.69 50.34 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.98 . . . . 0.0 108.61 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 13.9 t0 -141.93 157.83 44.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 109.231 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 27.7 m120 -93.78 8.79 39.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.213 -0.929 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -136.81 74.25 51.89 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.203 -0.936 . . . . 0.0 109.286 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.47 147.32 86.81 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.281 1.32 . . . . 0.0 111.991 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.41 136.91 38.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.068 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -103.23 67.42 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.379 -0.826 . . . . 0.0 109.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.11 -175.02 37.73 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -70.57 -10.67 28.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.061 1.174 . . . . 0.0 111.944 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.33 179.55 40.64 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.06 -146.68 21.32 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.38 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 82' ' ' ALA . 13.1 t-20 -73.77 131.89 42.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.47 -1.018 . . . . 0.0 110.292 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.45 -18.23 24.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.061 -1.024 . . . . 0.0 109.157 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.88 164.51 7.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.001 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -161.21 125.47 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.977 -1.077 . . . . 0.0 110.68 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.57 168.26 14.65 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.682 -0.636 . . . . 0.0 109.292 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.02 142.15 35.32 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.41 147.87 56.93 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.939 -1.101 . . . . 0.0 109.334 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.17 123.16 12.58 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.42 0.747 . . . . 0.0 111.65 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -179.34 175.69 47.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -73.95 163.31 37.22 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.857 1.038 . . . . 0.0 111.908 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 92' ' ' GLY . . . 74.05 -147.33 37.79 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 tt -50.14 -8.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -1.07 . . . . 0.0 110.19 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 90' ' ' GLY . . . -60.5 142.27 47.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.79 -16.11 55.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.86 159.62 30.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.395 -1.062 . . . . 0.0 110.125 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.56 124.38 22.6 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -106.02 130.15 54.0 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.394 -0.817 . . . . 0.0 110.443 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.557 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.5 m-85 -114.18 134.33 54.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.561 -0.712 . . . . 0.0 109.611 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 98' ' ' ASP . 57.5 t0 -63.34 119.09 9.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 109.608 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.411 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.9 tt0 -101.13 -1.45 33.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.586 -0.696 . . . . 0.0 109.267 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -75.96 -19.83 58.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -101.82 156.6 17.41 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.476 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 44.4 ttp180 -87.23 125.13 34.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.051 -1.031 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.06 149.85 22.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 0.0 109.86 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.7 p -131.69 169.97 15.43 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.366 -0.833 . . . . 0.0 109.175 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -111.63 23.93 13.34 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.428 -0.795 . . . . 0.0 110.039 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.596 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.99 -165.0 2.13 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.909 -1.12 . . . . 0.0 109.995 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.74 22.19 0.06 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.128 -0.982 . . . . 0.0 111.51 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.9 mtp180 -76.66 -163.65 0.35 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.646 -1.284 . . . . 0.0 110.059 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.6 mt-10 -25.2 -67.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -141.4 159.17 42.79 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.905 -1.122 . . . . 0.0 110.842 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 68.8 m-80 -107.45 110.93 23.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -41.48 92.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.372 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.91 -46.92 87.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.922 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.33 -39.73 88.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.825 -1.172 . . . . 0.0 110.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.45 -40.21 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.989 -1.069 . . . . 0.0 108.407 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -41.88 91.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.386 -0.822 . . . . 0.0 109.014 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.088 -1.008 . . . . 0.0 109.724 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.22 -51.81 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 109.183 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.557 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 57.9 mt-10 -58.48 -40.97 84.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -63.4 -39.91 95.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.071 -1.018 . . . . 0.0 109.213 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.39 -38.66 93.74 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -64.21 -35.94 82.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 108.698 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.5 m -69.55 -25.47 64.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 108.726 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.03 -0.68 56.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.31 13.6 70.6 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.842 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.6 128.96 34.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.488 . . . . 0.0 108.919 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.14 170.96 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.607 -0.683 . . . . 0.0 109.703 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.95 156.36 37.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.862 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.4 t -124.97 165.04 18.85 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.1 p -102.04 0.89 35.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.456 -0.777 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -78.33 128.13 33.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.9 tt -58.71 -29.28 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.0 110.497 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.82 3.28 84.14 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.474 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.87 128.92 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.941 -1.329 . . . . 0.0 109.775 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.3 mt -65.64 -31.79 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.453 -0.78 . . . . 0.0 109.146 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 36.4 mtp -74.42 47.76 0.31 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 135' ' ' LEU . 10.2 t80 -68.99 130.92 91.14 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.0 108.948 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -45.63 -68.17 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 CA-C-N 119.99 1.032 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.2 p -80.15 171.02 15.63 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.138 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.6 t80 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 108.881 179.732 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 25.4 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.503 0.668 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -148.45 150.9 34.29 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.3 mt -75.24 147.95 39.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 0.0 109.017 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.16 158.42 16.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 109.06 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -60.04 -40.42 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.735 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.8 t0 -58.98 -40.2 84.1 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -74.27 -39.99 62.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.42 -50.03 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.96 -39.95 96.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.91 21.61 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.771 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.06 -39.54 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.852 -1.381 . . . . 0.0 109.659 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 33.1 mt-30 -66.13 -37.53 85.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 108.972 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.28 96.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.27 -48.44 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 109.279 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.08 -67.79 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.98 -178.12 37.94 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -88.76 150.61 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.427 -1.043 . . . . 0.0 109.296 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.044 -1.035 . . . . 0.0 109.043 179.666 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -84.13 130.13 34.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -0.867 . . . . 0.0 108.846 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.51 -32.96 62.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.959 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -82.36 153.34 25.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 0.0 109.685 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -93.92 -4.09 50.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.228 -0.92 . . . . 0.0 108.669 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -108.33 130.63 55.19 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.3 mt -126.28 152.42 46.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.474 -0.766 . . . . 0.0 109.486 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 p -124.04 150.45 44.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.488 -0.758 . . . . 0.0 109.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -144.63 161.38 39.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 109.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -151.32 133.62 15.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.415 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.35 116.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.34 -39.34 92.27 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.727 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -159.82 147.39 16.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.655 -1.278 . . . . 0.0 110.508 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.15 134.19 41.54 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -71.45 145.83 90.87 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.793 -1.192 . . . . 0.0 108.572 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.27 -8.62 19.24 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 119.391 0.818 . . . . 0.0 112.015 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.88 -39.91 86.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 mt -135.88 153.16 76.93 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.26 -176.56 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.389 0.818 . . . . 0.0 111.001 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.0 -38.83 15.18 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.967 -1.083 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.25 93.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.16 -39.14 72.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.15 -39.51 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 44.3 t0 -59.71 -40.45 87.98 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.526 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -60.17 -45.46 93.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 109.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.35 92.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 109.205 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -71.82 -40.19 68.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.494 -0.754 . . . . 0.0 110.042 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.15 -39.64 78.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -61.89 -39.87 93.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.786 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.12 93.66 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.308 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -59.92 -39.02 84.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.005 -1.059 . . . . 0.0 108.779 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.492 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.71 -45.63 91.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 109.678 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.43 ' O ' ' OG1' ' A' ' 45' ' ' THR . 94.2 m95 -74.69 -45.29 45.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -65.1 -37.41 87.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.843 . . . . 0.0 110.822 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.34 -23.34 64.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.543 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.81 7.19 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.413 -0.804 . . . . 0.0 110.71 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.543 ' C ' ' HG ' ' A' ' 163' ' ' SER . 11.3 p -145.31 150.06 43.4 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.109 -0.994 . . . . 0.0 109.101 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -72.11 9.51 1.1 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.451 0.767 . . . . 0.0 111.684 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.12 150.0 42.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.307 -0.871 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.9 p -130.25 148.2 52.06 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.495 ' C ' ' HG1' ' A' ' 50' ' ' THR . 97.3 m-85 -128.02 153.44 46.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.699 -0.625 . . . . 0.0 109.891 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.495 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 87.0 m -155.28 133.05 11.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.199 -0.938 . . . . 0.0 110.017 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.22 144.59 40.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.16 135.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -98.69 -4.38 33.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.739 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -144.22 147.78 34.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.04 172.12 48.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -82.59 149.74 27.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 109.331 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.44 152.26 24.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.55 -0.719 . . . . 0.0 109.102 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.1 -44.84 94.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.342 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -114.05 112.21 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.755 0.788 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.5 mtp -99.06 131.17 45.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 61' ' ' ILE . 97.2 mt -108.69 129.19 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.6 p -153.12 159.81 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.4 140.24 46.15 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.86 167.62 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.37 -0.831 . . . . 0.0 111.055 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.43 138.98 40.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.0 109.601 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.23 -139.82 10.7 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -73.39 129.04 37.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -1.004 . . . . 0.0 110.095 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.4 p-80 -133.0 60.83 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.256 -0.902 . . . . 0.0 109.619 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 57.66 47.26 16.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.469 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 93.3 m-20 -141.73 163.73 32.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.58 -0.7 . . . . 0.0 109.454 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -96.0 9.59 40.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.316 -0.865 . . . . 0.0 109.776 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -134.04 73.0 71.33 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.341 -0.849 . . . . 0.0 109.599 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -64.31 158.97 45.99 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.986 1.124 . . . . 0.0 112.143 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.79 152.03 31.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -110.36 67.88 0.65 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.525 -0.735 . . . . 0.0 109.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.85 -170.99 31.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.27 -16.78 23.53 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.323 1.349 . . . . 0.0 112.701 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.32 -175.25 46.27 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.16 -150.54 27.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -77.27 144.17 38.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.432 -1.04 . . . . 0.0 109.485 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.76 -18.33 25.15 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.954 -1.091 . . . . 0.0 109.067 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.16 166.06 9.04 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.352 -0.842 . . . . 0.0 108.83 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 83' ' ' HIS . 2.8 p80 -162.5 114.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.962 -1.086 . . . . 0.0 110.346 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.61 173.46 9.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -109.23 160.8 15.82 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -58.11 148.33 61.84 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.021 -1.049 . . . . 0.0 109.242 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.61 103.66 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.773 0.982 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -169.01 169.57 41.94 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -173.32 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.141 1.227 . . . . 0.0 112.81 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.43 -126.41 42.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -82.44 -8.43 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -1.057 . . . . 0.0 110.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.1 138.76 48.59 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.63 63.23 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.198 -1.177 . . . . 0.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.94 130.15 41.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.962 -1.317 . . . . 0.0 110.491 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.89 116.15 31.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.165 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -100.86 132.71 46.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.072 -1.017 . . . . 0.0 109.834 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.51 131.26 55.53 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.392 -0.818 . . . . 0.0 109.902 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.6 127.27 31.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.395 -0.815 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.64 3.98 42.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.104 -0.997 . . . . 0.0 109.97 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.38 -20.04 60.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.022 -1.049 . . . . 0.0 109.334 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -101.91 157.36 16.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 108.804 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -86.35 125.77 33.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 108.625 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -91.11 140.35 29.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.1 p -129.23 163.27 25.98 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -108.66 31.31 5.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.466 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -148.55 -164.99 2.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 109.855 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.54 28.26 0.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -76.56 -163.56 0.34 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -43.63 -60.97 1.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 111.909 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.437 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.2 m-85 -125.73 135.49 52.13 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.617 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -103.1 117.16 33.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.98 -41.7 96.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.844 -1.16 . . . . 0.0 109.76 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.43 -49.58 77.0 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.728 -0.608 . . . . 0.0 112.458 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.714 ' NH2' ' HH ' ' A' ' 140' ' ' TYR . 18.0 ptt180 -59.73 -42.91 94.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.232 -1.542 . . . . 0.0 110.453 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.29 -39.79 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.094 -1.004 . . . . 0.0 109.426 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.92 86.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.345 -0.847 . . . . 0.0 109.089 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.44 90.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.026 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.588 ' ND1' ' SD ' ' A' ' 136' ' ' MET . 3.2 t60 -68.13 -42.45 80.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.907 -1.12 . . . . 0.0 110.223 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -57.71 -40.13 78.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 109.329 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.69 -39.92 90.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.994 -1.066 . . . . 0.0 109.177 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.28 -38.21 77.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' NE2' ' CE1' ' A' ' 118' ' ' HIS . 47.8 m-70 -66.61 -34.76 78.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.082 -1.246 . . . . 0.0 109.305 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -70.21 -23.97 63.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.12 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.96 -5.63 58.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 108.771 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.96 58.16 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.03 131.47 35.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.117 -1.226 . . . . 0.0 108.707 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.7 m -87.18 169.86 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.091 -1.005 . . . . 0.0 109.511 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.52 161.73 27.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.513 -0.742 . . . . 0.0 109.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.587 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 15.5 t -126.96 166.16 18.05 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -102.31 11.33 38.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.587 ' H ' ' HG ' ' A' ' 129' ' ' SER . 51.9 t0 -83.1 130.33 35.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 109.882 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.75 -39.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.722 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.63 73.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.367 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.98 132.52 34.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.548 . . . . 0.0 109.222 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.14 -24.13 64.05 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.588 ' SD ' ' ND1' ' A' ' 118' ' ' HIS . 59.5 mmm -72.44 48.84 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.767 -0.583 . . . . 0.0 110.153 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 139' ' ' SER . 13.7 t80 -71.39 137.16 83.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.861 -1.149 . . . . 0.0 109.198 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.63 18.81 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.037 1.049 . . . . 0.0 111.844 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 137' ' ' TYR . 22.2 t -166.5 176.67 7.19 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.714 ' HH ' ' NH2' ' A' ' 114' ' ' ARG . 66.9 t80 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 120.644 -1.285 . . . . 0.0 110.436 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -142.46 150.49 40.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 108.653 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.49 145.43 45.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.058 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.17 156.8 17.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.449 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.94 -39.9 87.12 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.24 -40.4 85.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.461 -0.775 . . . . 0.0 109.255 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.63 -41.14 65.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.53 -46.48 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.192 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.54 -40.22 93.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.89 -1.131 . . . . 0.0 110.431 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.64 -58.19 15.11 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.731 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.91 -41.29 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.114 -1.227 . . . . 0.0 110.344 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.33 -40.32 89.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.823 -1.173 . . . . 0.0 110.386 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.42 93.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.956 -1.09 . . . . 0.0 109.65 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 159' ' ' ILE . 96.8 mt -60.8 -50.31 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 108.969 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.98 -74.02 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.196 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.99 -176.07 35.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -83.86 151.94 24.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.063 . . . . 0.0 109.441 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.543 ' HG ' ' C ' ' A' ' 45' ' ' THR . 5.8 m . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -84.79 114.46 22.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.854 -1.154 . . . . 0.0 109.094 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.57 -9.87 48.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 109.505 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -80.94 150.76 28.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.757 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 p -96.6 -5.05 40.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -123.97 131.74 53.61 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.6 mt -132.88 149.73 52.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -125.29 154.65 41.4 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.302 -0.874 . . . . 0.0 109.446 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.89 159.53 42.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 109.311 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.409 HH11 ' HG2' ' A' ' 17' ' ' ARG . 37.7 ttt-85 -148.8 134.04 18.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -89.79 123.26 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.22 -0.925 . . . . 0.0 108.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -41.57 84.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.515 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -162.28 151.04 15.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.858 -1.151 . . . . 0.0 110.23 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -96.94 138.4 34.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.85 144.18 85.25 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 109.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.45 -12.02 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.614 0.876 . . . . 0.0 112.018 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.15 -40.34 89.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.077 -1.014 . . . . 0.0 110.196 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.0 mt -135.73 151.24 73.87 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -65.58 -177.51 0.72 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.468 0.846 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -85.85 -35.51 20.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -43.23 90.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.43 -39.58 77.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 0.0 110.401 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.0 -40.0 87.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.824 -1.172 . . . . 0.0 109.422 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.48 -46.45 90.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.61 95.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.155 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.95 -40.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.717 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.83 -40.3 75.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.045 -1.034 . . . . 0.0 109.974 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -61.0 -40.87 95.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.98 87.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.962 -1.086 . . . . 0.0 109.259 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 30.4 m-85 -60.0 -40.6 89.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.856 -1.152 . . . . 0.0 109.496 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -59.95 -40.47 89.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 110.363 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.0 -45.14 93.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.015 -1.053 . . . . 0.0 110.039 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 45' ' ' THR . 95.3 m95 -71.75 -39.89 69.71 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.462 -0.774 . . . . 0.0 109.502 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 t -68.58 -30.63 69.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -0.85 . . . . 0.0 109.766 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -59.81 -37.51 79.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -106.96 10.31 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.217 -0.927 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 76.2 p -138.33 149.32 62.76 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.03 -1.044 . . . . 0.0 108.597 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.41 7.3 2.68 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.335 0.798 . . . . 0.0 110.529 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.4 157.88 36.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.701 -0.624 . . . . 0.0 109.753 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -137.4 151.99 49.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -130.78 155.87 45.94 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -154.33 132.75 11.98 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -81.64 137.02 35.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.324 -0.86 . . . . 0.0 110.032 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.26 132.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.7 t -94.7 0.94 55.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.045 -1.034 . . . . 0.0 109.594 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.3 157.71 44.12 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.22 -0.925 . . . . 0.0 109.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.76 167.31 8.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.03 160.38 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.264 . . . . 0.0 108.705 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.7 158.6 27.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 109.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.35 -39.65 83.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.298 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.23 120.0 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 109.53 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.0 mtp -101.12 135.93 41.79 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.192 -0.942 . . . . 0.0 109.419 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.84 126.94 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -148.03 155.19 41.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.65 139.03 40.86 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.22 163.09 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.503 -0.748 . . . . 0.0 110.773 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 61.4 mtt-85 -131.25 132.69 44.79 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.378 0.609 . . . . 0.0 110.023 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.3 -135.97 7.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -71.54 125.92 28.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.3 p-80 -134.03 49.77 2.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.325 -0.859 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 69' ' ' ARG . 52.8 mtt-85 58.41 53.09 6.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.643 -0.66 . . . . 0.0 111.109 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.536 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.4 m-20 -139.35 163.29 32.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.358 -0.838 . . . . 0.0 108.898 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -90.06 9.3 28.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.6 m -139.67 71.61 36.86 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.349 -0.844 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.91 159.27 41.86 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.154 1.236 . . . . 0.0 112.142 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.64 147.21 37.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.616 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.94 62.33 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.482 -0.761 . . . . 0.0 109.117 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.73 -166.01 53.4 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -54.19 -22.36 25.59 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.304 1.336 . . . . 0.0 112.636 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.0 177.79 48.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.03 -165.18 26.56 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.684 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -75.07 150.41 38.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.288 -1.125 . . . . 0.0 109.94 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -91.45 -13.26 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.57 167.33 9.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.046 -1.034 . . . . 0.0 109.893 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.98 179.91 7.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -166.38 169.33 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -98.04 156.88 16.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -58.48 149.65 59.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.146 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.69 103.12 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 120.428 0.752 . . . . 0.0 111.792 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.29 172.88 37.62 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.22 177.32 6.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.321 1.347 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.54 -125.35 31.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.27 -9.54 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.193 . . . . 0.0 110.041 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.65 135.94 47.03 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.1 -16.83 59.58 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.491 -1.005 . . . . 0.0 110.709 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.64 121.76 15.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.913 -1.345 . . . . 0.0 110.636 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.17 131.81 45.9 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -112.74 135.0 53.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.501 -0.749 . . . . 0.0 109.294 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.8 m-85 -114.73 130.97 56.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.374 -0.829 . . . . 0.0 110.087 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.412 ' OD2' ' OE2' ' A' ' 101' ' ' GLU . 62.4 t0 -69.32 122.59 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -99.57 4.47 45.86 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.027 -1.046 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -73.5 -15.28 61.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.713 -1.242 . . . . 0.0 109.128 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 56.4 mp0 -102.64 152.66 20.93 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -85.71 119.4 26.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.93 -1.106 . . . . 0.0 108.777 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.53 150.28 24.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 p -129.82 163.09 27.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -113.9 34.86 4.37 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -150.18 -165.02 2.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.0 109.99 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.25 31.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.305 -0.872 . . . . 0.0 109.764 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.473 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.9 mmt-85 -76.82 -165.09 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -0.999 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.0 -58.25 9.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.731 . . . . 0.0 112.203 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -101.12 121.85 42.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.052 -1.03 . . . . 0.0 110.984 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 9.3 m120 -108.69 110.95 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.77 -44.67 96.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.11 -0.994 . . . . 0.0 111.122 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.081 . . . . 0.0 110.713 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -59.17 -46.68 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 109.738 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.12 -40.4 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.165 -0.96 . . . . 0.0 109.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.08 91.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.955 -1.091 . . . . 0.0 109.575 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.13 95.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.8 . . . . 0.0 109.813 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.407 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 48.6 t60 -69.77 -40.79 75.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.16 -40.14 88.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.812 -1.18 . . . . 0.0 109.075 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.19 -39.97 88.38 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.65 -42.4 67.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.407 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 61.9 m-70 -63.24 -39.33 94.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.241 -1.152 . . . . 0.0 108.549 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.8 p -70.14 -22.93 62.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.232 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.22 -2.63 58.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.144 -0.973 . . . . 0.0 109.385 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.41 73.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.22 131.42 35.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.03 -1.276 . . . . 0.0 108.804 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.0 m -88.1 170.56 10.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.03 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -66.07 158.66 27.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 108.705 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -129.88 158.72 38.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.42 -0.8 . . . . 0.0 109.224 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -102.94 13.83 33.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -84.13 130.91 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -42.91 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.66 0.32 65.57 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.235 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.69 139.2 32.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.676 -1.485 . . . . 0.0 108.928 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.74 -27.61 66.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 108.895 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.401 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 28.7 mtp -75.75 60.86 1.34 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 0.0 109.489 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.7 t80 -68.31 137.49 91.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.46 5.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.985 1.03 . . . . 0.0 112.1 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.544 ' H ' ' C ' ' A' ' 137' ' ' TYR . 57.6 p -158.78 173.75 16.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.965 -1.084 . . . . 0.0 109.501 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.512 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -141.29 150.28 42.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 0.0 109.61 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.7 139.66 45.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 168.88 10.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.99 -40.7 90.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.581 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.53 -40.44 87.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.505 -0.747 . . . . 0.0 109.748 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -75.24 -42.56 55.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 109.263 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.79 -50.63 74.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.451 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.22 -39.37 90.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.16 . . . . 0.0 110.02 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.38 -56.37 20.3 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.72 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.38 -40.85 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.8 mt-30 -65.22 -39.09 92.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.029 -1.044 . . . . 0.0 110.108 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.41 88.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.81 -1.182 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.37 -49.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.044 -1.035 . . . . 0.0 109.527 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -97.28 -67.6 0.84 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.474 -0.766 . . . . 0.0 109.833 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.87 179.66 39.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.72 134.29 34.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -1.115 . . . . 0.0 109.421 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.799 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -84.87 124.11 31.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.38 -0.825 . . . . 0.0 109.6 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -87.55 -6.78 58.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.82 150.44 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -95.09 -6.29 42.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.471 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 31.9 m-70 -130.03 139.8 50.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -132.8 157.98 43.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.535 -0.728 . . . . 0.0 109.332 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -127.99 153.56 46.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.94 158.42 43.63 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.225 -0.922 . . . . 0.0 109.922 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -146.99 134.61 21.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.014 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.86 112.35 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.2 tt0 -63.63 -39.82 95.32 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 0.0 110.392 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 83.1 m-20 -155.29 142.45 19.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.949 -1.094 . . . . 0.0 110.479 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.01 137.06 32.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -69.34 136.99 88.79 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -66.83 -9.37 24.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.691 0.925 . . . . 0.0 110.909 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.28 -40.11 89.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.762 -0.586 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -136.24 149.87 69.23 Favored Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -178.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.107 0 CA-C-N 119.353 0.805 . . . . 0.0 111.443 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -31.69 18.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.71 87.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.895 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.92 -40.01 65.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.792 . . . . 0.0 110.7 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.05 -44.32 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -58.58 -44.8 89.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.298 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -59.64 -41.94 91.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.047 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.2 82.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.875 -1.14 . . . . 0.0 109.729 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.1 -39.26 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 0.0 109.684 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.14 -39.68 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.067 -1.021 . . . . 0.0 109.432 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -63.3 -40.04 96.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.738 -1.226 . . . . 0.0 110.695 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.89 71.43 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.691 -1.255 . . . . 0.0 109.45 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 37.8 m-85 -60.31 -43.96 95.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.547 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -60.04 -42.76 95.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.93 -40.29 88.39 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.839 -1.163 . . . . 0.0 110.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.9 m95 -74.42 -40.21 62.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.479 -1.388 . . . . 0.0 109.28 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.56 -27.24 66.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.587 -0.696 . . . . 0.0 110.061 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -38.85 84.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 111.252 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -109.84 13.46 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.22 -0.925 . . . . 0.0 110.77 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 72.1 p -141.34 148.42 50.88 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.2 -0.938 . . . . 0.0 108.879 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.06 6.17 2.27 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 119.573 0.883 . . . . 0.0 111.982 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.28 151.72 42.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.159 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.0 p -131.75 149.19 52.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 96.7 m-85 -129.21 156.04 44.58 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.274 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.8 m -154.66 128.83 8.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.669 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -78.53 139.3 38.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.36 136.82 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 t -97.81 -2.92 39.9 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.051 -1.03 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -145.61 155.28 42.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.815 -1.178 . . . . 0.0 109.528 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.58 173.46 44.91 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.0 158.7 26.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -1.207 . . . . 0.0 109.391 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.02 152.22 41.15 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.46 -0.775 . . . . 0.0 109.134 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -60.03 -40.6 89.89 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -119.83 119.04 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mtp -101.28 127.66 47.79 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.858 . . . . 0.0 109.646 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -109.88 131.13 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.415 -0.803 . . . . 0.0 109.251 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.6 p -146.86 160.0 42.84 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.849 0.833 . . . . 0.0 110.091 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.26 139.28 47.93 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.26 167.25 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -139.3 144.78 38.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 0.0 110.248 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.85 -149.6 2.29 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -71.77 128.83 37.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.277 -1.131 . . . . 0.0 109.565 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 11.3 p-80 -130.83 60.19 1.65 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.379 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 53.36 54.67 9.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.944 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.7 p-10 -142.77 169.44 17.56 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.157 -0.964 . . . . 0.0 109.35 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.86 9.04 41.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.319 -0.863 . . . . 0.0 109.236 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -137.17 70.97 55.28 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 0.0 109.579 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.24 145.69 73.21 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 120.716 0.944 . . . . 0.0 111.496 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -74.74 144.7 43.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 72.67 0.84 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.02 -166.71 54.51 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -66.81 -10.14 27.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.186 1.257 . . . . 0.0 111.72 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.6 170.22 26.6 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.04 -151.11 19.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -73.58 142.58 46.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -1.081 . . . . 0.0 109.64 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.89 -16.23 26.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.072 -1.017 . . . . 0.0 109.23 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.62 171.48 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -163.27 121.12 1.93 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.802 -1.186 . . . . 0.0 109.76 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.53 162.02 21.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.723 -0.611 . . . . 0.0 109.854 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -107.76 146.64 31.9 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -59.78 146.05 82.22 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.948 -1.095 . . . . 0.0 108.616 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.65 125.75 20.04 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.849 0.982 . . . . 0.0 112.122 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.27 174.51 44.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.96 -177.55 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.115 1.21 . . . . 0.0 112.093 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.32 -128.88 48.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -78.91 -4.14 6.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.43 -1.041 . . . . 0.0 109.838 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.99 132.45 50.81 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.1 52.12 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -68.75 160.02 31.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.0 122.28 21.63 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -99.12 136.21 39.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.409 -0.807 . . . . 0.0 110.867 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.8 m-85 -116.16 131.41 56.95 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.43 121.83 17.15 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.077 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -100.15 -0.46 38.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.155 -0.965 . . . . 0.0 109.868 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -72.93 -15.67 61.57 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.962 -1.086 . . . . 0.0 109.877 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 159.96 15.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.38 -0.825 . . . . 0.0 108.871 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.409 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.3 ttp180 -89.25 122.23 32.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.085 -1.009 . . . . 0.0 109.596 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -89.22 151.7 22.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 110.106 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 59.1 p -125.95 160.32 30.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.507 -0.746 . . . . 0.0 109.56 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.99 29.27 7.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.533 -0.729 . . . . 0.0 109.987 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' ND2' ' CG ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -148.67 -165.02 2.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.486 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -81.04 30.81 0.32 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.945 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.492 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 17.0 mmm180 -75.65 -175.06 2.75 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.033 -1.042 . . . . 0.0 109.228 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 55.5 mp0 -47.4 -59.77 2.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.828 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 79.7 m-85 -83.62 152.5 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.86 -1.15 . . . . 0.0 110.92 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -140.89 90.24 2.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.99 -46.44 89.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.139 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -60.07 -45.77 91.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.0 109.985 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -59.4 -40.31 86.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.009 -1.057 . . . . 0.0 108.798 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.262 -0.899 . . . . 0.0 109.319 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.84 -40.56 84.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 109.144 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.63 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 109.085 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -68.69 -50.33 51.84 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.5 mt-10 -57.49 -41.96 81.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.877 -1.139 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.86 -37.88 88.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.896 -1.127 . . . . 0.0 109.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.59 92.28 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -64.79 -37.33 87.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.266 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -69.92 -22.68 63.17 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.48 -1.91 57.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.16 59.82 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.25 132.16 35.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.361 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.3 m -87.54 163.8 16.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.457 -0.777 . . . . 0.0 110.169 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -65.81 157.94 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.633 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.416 ' OG ' ' OD2' ' A' ' 151' ' ' ASP . 30.4 t -130.3 167.44 18.5 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -106.6 10.63 31.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.744 . . . . 0.0 109.148 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.67 120.12 24.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.87 -28.81 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.828 . . . . 0.0 110.798 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.56 -6.89 88.81 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.699 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.11 133.15 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.271 . . . . 0.0 109.868 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.72 -24.65 67.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 84.2 mmm -74.71 56.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.958 . . . . 0.0 109.33 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.447 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.5 t80 -70.11 137.42 87.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 108.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.33 7.23 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 120.098 1.071 . . . . 0.0 112.743 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.5 p -161.67 169.69 21.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 109' ' ' GLU . 49.3 t80 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.216 -0.927 . . . . 0.0 109.788 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -148.93 147.22 28.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 109.01 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.0 mt -78.55 133.85 37.31 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.14 166.33 13.03 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -60.78 -40.03 91.05 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.416 ' OD2' ' OG ' ' A' ' 129' ' ' SER . 57.9 t0 -59.69 -40.49 88.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.813 . . . . 0.0 109.056 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -74.29 -42.24 59.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.78 -49.15 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.126 -0.984 . . . . 0.0 109.314 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.27 -40.3 89.88 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.05 -55.73 28.66 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.107 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.0 tp -65.9 -39.18 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.237 . . . . 0.0 109.797 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.8 mt-30 -66.99 -39.35 87.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.0 . . . . 0.0 109.256 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.76 93.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.995 -1.065 . . . . 0.0 109.721 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.06 -47.87 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.0 110.348 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -101.23 -61.26 1.39 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.401 -0.812 . . . . 0.0 109.899 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.85 179.61 35.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 145.12 24.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -1.162 . . . . 0.0 109.683 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.578 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -84.15 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.961 -1.087 . . . . 0.0 109.519 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.61 -9.14 59.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -83.17 148.91 27.18 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 p -98.21 -5.71 32.78 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.502 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 68.2 m80 -127.72 122.51 33.08 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.87 153.98 23.7 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.176 -0.952 . . . . 0.0 109.889 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 p -130.93 157.46 42.89 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -144.26 162.52 36.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -144.42 124.53 13.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.238 -0.914 . . . . 0.0 110.055 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.415 HG22 HD12 ' A' ' 18' ' ' ILE . 93.1 mt -86.77 113.59 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 77.3 tt0 -62.68 -41.15 98.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.95 154.73 24.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -95.9 142.4 28.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -70.05 138.57 87.42 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.174 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.28 -13.07 38.29 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.739 0.959 . . . . 0.0 111.37 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.59 -40.42 91.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.0 149.39 68.31 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.65 -178.72 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.209 0.753 . . . . 0.0 112.038 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -86.04 -32.12 21.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.303 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.04 86.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.112 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -69.17 -38.96 78.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.76 -39.99 80.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.259 -0.9 . . . . 0.0 109.644 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.87 -40.53 84.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.194 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -60.27 -48.8 80.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.69 84.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.949 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.93 -40.6 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.171 -0.955 . . . . 0.0 109.851 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -69.89 -39.44 76.26 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 108.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.19 -39.81 93.95 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.39 90.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 109.736 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.9 -40.45 93.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.823 -1.173 . . . . 0.0 109.073 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.12 -41.45 92.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.13 -45.82 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.403 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 98.2 m95 -74.09 -42.83 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 t -63.55 -37.96 89.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.345 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -60.16 -23.57 64.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.552 -0.718 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.54 7.63 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.957 -1.09 . . . . 0.0 110.457 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 4.9 p -145.67 151.95 47.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -72.12 4.2 3.45 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.821 1.014 . . . . 0.0 112.097 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.21 152.0 44.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.0 109.775 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 44.9 p -127.08 150.13 49.61 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.03 158.29 34.1 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 110.489 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 m -153.89 127.91 8.96 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.967 0.889 . . . . 0.0 110.291 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.76 140.74 31.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.674 -0.641 . . . . 0.0 109.681 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 141.88 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.33 -0.856 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -95.02 -6.99 40.99 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.179 -0.951 . . . . 0.0 110.69 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -149.5 155.33 40.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.919 -1.113 . . . . 0.0 109.545 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.37 160.6 33.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.68 130.96 35.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -1.124 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.7 170.02 9.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.089 -1.007 . . . . 0.0 109.79 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.08 -40.08 88.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 109.712 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.92 120.42 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.517 -0.739 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.4 mmm -98.77 129.61 45.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.349 -0.844 . . . . 0.0 109.498 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -112.42 130.32 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -147.19 156.88 43.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.995 -1.065 . . . . 0.0 110.226 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.0 133.15 53.49 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.62 160.09 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 O-C-N 121.006 -1.059 . . . . 0.0 111.395 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -124.73 138.32 54.29 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.2 -146.2 4.12 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.86 130.86 42.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.792 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.501 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -131.25 43.54 3.07 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 55.69 58.18 4.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.685 . . . . 0.0 110.139 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.501 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 17.7 p-10 -141.17 171.58 13.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 0.0 109.126 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -91.25 10.65 26.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 109.73 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 t -141.0 71.67 28.35 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.103 -0.998 . . . . 0.0 109.903 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.37 141.98 32.69 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.108 1.206 . . . . 0.0 112.12 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.5 153.79 33.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.604 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.83 75.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.93 -164.55 17.2 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -55.86 -17.99 20.39 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.796 0.998 . . . . 0.0 111.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -179.02 49.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.1 -164.87 35.54 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -74.77 155.79 37.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.132 -1.216 . . . . 0.0 109.428 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 mt -93.09 -19.7 21.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.141 -0.975 . . . . 0.0 109.272 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.94 169.79 8.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.012 -1.055 . . . . 0.0 109.37 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -163.03 179.96 7.16 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.646 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.83 170.94 16.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.621 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -98.64 158.1 15.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.354 -0.841 . . . . 0.0 109.589 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -57.06 145.94 62.88 Favored Pre-proline 0 N--CA 1.485 1.311 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.16 104.22 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 120.371 0.714 . . . . 0.0 111.62 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.05 171.23 37.91 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.3 -175.63 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.039 1.159 . . . . 0.0 112.024 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.96 -127.09 40.19 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -80.05 -11.13 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.24 . . . . 0.0 109.252 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.92 142.36 46.34 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.09 -21.84 32.22 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.3 150.25 46.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.286 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.03 125.94 19.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 108.749 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -105.87 150.06 25.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.534 -0.729 . . . . 0.0 109.554 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.13 140.05 51.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.77 119.26 10.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.057 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -99.48 -3.32 33.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.361 -0.837 . . . . 0.0 109.354 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.26 -18.56 60.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.833 . . . . 0.0 109.677 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -98.15 159.78 14.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.24 -0.913 . . . . 0.0 108.905 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.8 ttm-85 -89.39 119.59 29.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.25 -0.906 . . . . 0.0 109.691 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.74 145.34 25.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.345 -0.847 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 69.6 p -122.49 160.97 24.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -108.41 30.43 6.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.56 -0.712 . . . . 0.0 109.102 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -148.64 -165.0 2.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.09 -1.006 . . . . 0.0 110.269 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -82.25 28.98 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -73.7 -169.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.134 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.81 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 111.656 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.47 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -87.14 153.51 21.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.972 -1.08 . . . . 0.0 110.547 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -143.7 97.59 3.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.187 -0.946 . . . . 0.0 108.55 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.51 -45.95 92.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.364 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.56 -39.85 85.38 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.84 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.422 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 1.9 tpm_? -60.0 -43.37 95.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.27 -39.63 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.785 . . . . 0.0 108.89 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.96 84.49 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.37 -0.831 . . . . 0.0 109.164 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.63 -46.66 62.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.85 -41.37 91.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.5 mt -63.77 -39.72 94.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.78 -40.38 80.12 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -66.36 -35.46 80.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 108.328 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.4 t -69.96 -25.32 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.26 -0.03 50.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 109.07 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.19 12.08 66.1 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.813 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.79 128.58 33.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.461 . . . . 0.0 108.979 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.2 m -88.34 170.12 11.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.428 -0.795 . . . . 0.0 109.671 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -66.12 149.0 50.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 t -124.67 161.49 26.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.3 p -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.51 127.37 32.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.047 . . . . 0.0 108.732 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.88 -40.08 81.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.527 -0.733 . . . . 0.0 110.212 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.26 1.41 70.54 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.616 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.01 139.96 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.716 -1.461 . . . . 0.0 109.695 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.02 -29.3 67.45 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 109.274 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 77.3 mmm -74.3 55.23 0.6 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.8 t80 -69.29 139.49 89.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.8 -3.9 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 CA-C-N 119.832 0.976 . . . . 0.0 112.543 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -162.84 170.91 17.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 109.311 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.6 t80 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 120.715 -1.24 . . . . 0.0 109.06 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.35 0.595 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -146.95 151.81 37.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.408 -0.807 . . . . 0.0 109.207 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.14 149.58 38.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.03 150.26 21.08 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -58.4 -40.08 81.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.835 -1.166 . . . . 0.0 109.035 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.84 -37.74 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.785 -1.197 . . . . 0.0 108.448 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -74.69 -39.93 61.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.99 -49.86 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.095 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.67 -39.78 95.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.963 . . . . 0.0 110.512 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.18 -51.02 47.56 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.93 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 tp -67.81 -38.9 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.401 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.4 mt-30 -65.68 -39.75 91.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.685 -1.259 . . . . 0.0 109.315 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.04 95.2 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.782 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.34 -49.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.84 -63.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.094 -1.004 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.09 -165.5 33.25 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 162' ' ' ARG . 35.3 mtt-85 -96.17 139.85 31.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.451 -1.029 . . . . 0.0 109.261 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.492 1.66 0 O-C-N 120.762 -1.211 . . . . 0.0 108.425 179.503 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.163 0.506 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -85.91 122.01 29.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 108.523 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.85 -12.58 55.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.159 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -82.97 152.44 25.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.705 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 p -96.6 -4.59 40.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.921 . . . . 0.0 109.112 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.499 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 77.2 m80 -125.35 135.41 52.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.69 158.35 43.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.39 -0.819 . . . . 0.0 109.537 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.7 p -128.43 154.08 46.42 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.48 159.97 41.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -149.45 130.35 14.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.084 -1.01 . . . . 0.0 110.176 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.408 HG22 HD12 ' A' ' 18' ' ' ILE . 92.8 mt -87.44 115.2 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.88 -40.11 91.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -160.09 151.87 20.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.075 . . . . 0.0 110.26 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -98.87 135.65 40.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.379 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 t -71.2 144.08 89.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.947 . . . . 0.0 108.987 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -66.03 -11.25 30.26 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.704 0.936 . . . . 0.0 112.035 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.13 -39.93 87.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 109.957 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -137.59 150.21 67.51 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.193 -0.942 . . . . 0.0 108.951 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.35 -177.34 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.706 0.937 . . . . 0.0 111.924 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -88.99 -37.04 15.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 0.0 109.938 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.44 83.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.95 -39.01 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 109.617 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.68 -39.95 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -41.59 92.75 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.075 -1.016 . . . . 0.0 109.077 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.59 -46.38 90.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.98 90.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 0.0 109.775 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.31 -40.16 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -39.92 75.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.997 . . . . 0.0 108.682 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.06 -39.97 91.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.31 84.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.938 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.11 -39.95 87.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.965 -1.085 . . . . 0.0 108.786 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.12 -40.28 89.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 110.093 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.12 -47.02 87.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.871 -1.143 . . . . 0.0 109.644 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.448 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.3 m95 -71.78 -41.72 67.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.21 -38.17 81.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.552 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.28 7.73 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 14.9 p -145.79 150.0 41.5 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.893 -1.13 . . . . 0.0 109.215 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.13 6.47 1.77 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.693 0.929 . . . . 0.0 111.899 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.93 154.06 42.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.13 -0.981 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.499 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.8 p -133.3 149.99 51.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.533 -0.73 . . . . 0.0 109.333 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.88 156.24 43.99 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.468 -0.77 . . . . 0.0 109.965 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 m -155.38 132.43 10.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.755 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -78.3 145.66 35.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.96 134.98 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.447 -0.783 . . . . 0.0 109.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -93.07 -0.93 56.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.037 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -152.89 158.63 42.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 109.666 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.6 168.11 30.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.88 149.33 29.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -1.175 . . . . 0.0 109.127 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 151.93 25.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.437 -0.79 . . . . 0.0 109.108 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.286 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -116.56 116.06 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.47 137.52 39.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.46 127.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.1 p -149.58 161.36 42.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 110.207 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.14 139.97 46.07 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.72 167.14 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.198 -0.939 . . . . 0.0 110.739 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.76 146.79 49.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.629 -0.67 . . . . 0.0 110.194 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.52 -150.19 0.87 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -60.07 136.88 58.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.087 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 25.1 p-80 -137.48 54.23 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.82 54.14 8.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.592 -0.693 . . . . 0.0 110.035 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.9 t0 -147.31 162.14 39.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.5 m120 -89.7 9.0 28.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 109.775 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.7 m -134.55 70.58 72.01 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.412 -0.805 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.5 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 120.879 1.053 . . . . 0.0 112.051 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -77.62 141.44 39.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -103.54 62.07 0.77 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.413 -0.804 . . . . 0.0 109.179 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.92 54.82 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -55.91 -14.11 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.023 1.149 . . . . 0.0 111.914 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.18 -178.54 50.83 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.28 -158.8 42.34 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 80' ' ' ASN . 48.0 p-10 -74.33 147.61 42.09 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -1.137 . . . . 0.0 109.478 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -94.66 -15.85 23.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.89 160.12 8.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.05 -1.031 . . . . 0.0 109.286 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.18 -178.7 6.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.286 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.39 168.17 20.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 109.869 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.75 164.46 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.38 -0.825 . . . . 0.0 109.94 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.07 149.88 72.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.838 . . . . 0.0 109.553 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.26 103.47 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 120.689 0.926 . . . . 0.0 111.806 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.03 166.01 38.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.14 -172.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.984 1.123 . . . . 0.0 111.647 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.99 -132.96 49.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -79.92 -10.26 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -1.043 . . . . 0.0 109.946 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.99 144.21 39.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -18.15 32.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -67.12 124.26 22.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.283 . . . . 0.0 109.995 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.89 128.33 53.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.522 -0.736 . . . . 0.0 109.329 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -110.98 135.56 51.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -116.52 137.36 52.23 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.493 -0.754 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.5 122.59 17.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -100.4 0.38 39.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -74.56 -18.66 60.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.904 -1.122 . . . . 0.0 109.93 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.31 162.29 13.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -0.83 . . . . 0.0 109.479 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -87.74 121.43 30.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 0.0 109.28 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.19 147.07 23.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.359 -0.838 . . . . 0.0 110.174 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.0 p -125.56 168.77 13.21 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.43 31.82 6.21 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.579 HD22 ' CZ ' ' A' ' 108' ' ' ARG . 4.7 p30 -149.85 -164.84 2.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.889 . . . . 0.0 109.953 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -86.4 29.22 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.33 -0.856 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.579 ' CZ ' HD22 ' A' ' 106' ' ' ASN . 97.0 mtt180 -76.11 -159.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -40.36 -59.94 1.2 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.53 -0.731 . . . . 0.0 111.53 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.437 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.1 m-85 -129.78 130.09 44.93 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.048 -1.032 . . . . 0.0 110.388 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -98.58 112.01 24.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.268 -0.895 . . . . 0.0 109.297 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 0.0 110.084 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.94 -42.54 94.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.176 -0.952 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 114' ' ' ARG . 29.5 ttt-85 -60.1 -40.05 88.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 109.332 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.07 -40.06 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.271 -0.893 . . . . 0.0 109.539 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.61 93.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 108.866 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.46 94.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.425 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 28.5 t60 -67.38 -44.4 79.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.776 . . . . 0.0 110.517 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.07 -39.99 87.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.971 -1.081 . . . . 0.0 108.855 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.46 -37.03 84.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.05 -40.89 75.68 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -63.1 -40.12 96.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -1.17 . . . . 0.0 108.634 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -71.61 -23.52 61.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.97 -3.14 58.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -0.941 . . . . 0.0 108.865 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.43 64.3 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.81 127.35 34.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.076 -1.249 . . . . 0.0 109.756 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -88.66 170.04 11.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.453 -0.779 . . . . 0.0 109.752 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -67.5 152.98 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.113 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.8 t -125.15 163.6 22.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.556 -0.715 . . . . 0.0 109.392 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -101.62 6.64 42.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.352 -0.843 . . . . 0.0 110.047 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.97 126.62 32.72 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.186 0.993 . . . . 0.0 109.867 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.3 pt -59.0 -30.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.394 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.46 -3.34 90.57 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.252 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.92 139.15 33.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.352 . . . . 0.0 109.142 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.349 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.425 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 34.8 mtp -75.65 58.6 1.08 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -70.39 134.82 86.67 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -45.74 -63.08 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 120.409 1.182 . . . . 0.0 110.857 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.9 p -94.17 177.01 6.1 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 t80 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.58 -1.325 . . . . 0.0 109.106 179.692 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -145.02 154.46 42.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 109.062 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.42 148.24 37.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.924 -1.11 . . . . 0.0 108.89 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.36 148.45 22.11 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -55.83 -38.35 69.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.194 -0.942 . . . . 0.0 108.686 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -53.97 -39.52 66.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.163 -0.96 . . . . 0.0 108.547 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -73.0 -40.01 65.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 109.029 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.47 -50.52 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -39.99 93.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.108 -0.995 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.71 -54.15 7.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.089 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.02 -39.91 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.863 -1.375 . . . . 0.0 110.147 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 109.247 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.94 -43.37 95.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.725 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.01 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.512 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 -60.68 1.48 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.58 -178.92 35.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -95.02 140.74 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -1.221 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.48 118.83 23.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.57 -9.98 59.55 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.317 -0.865 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.5 145.2 26.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.074 . . . . 0.0 110.16 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -92.13 -4.04 54.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.447 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.9 m-70 -129.92 139.78 51.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.21 161.09 34.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.886 0.85 . . . . 0.0 109.52 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.1 p -127.01 157.07 40.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -144.49 157.55 44.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.156 -0.965 . . . . 0.0 109.339 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -151.06 133.09 15.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.15 118.92 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.62 -40.27 80.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.964 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -161.67 150.9 16.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.644 -1.285 . . . . 0.0 110.955 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.18 133.66 38.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.706 . . . . 0.0 109.558 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 t -70.05 142.56 90.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.3 -8.94 24.39 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.38 0.814 . . . . 0.0 111.398 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.93 -39.59 86.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.3 mt -139.52 152.34 68.62 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.86 -176.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 CA-C-N 119.168 0.739 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -86.87 -34.69 19.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.969 -1.082 . . . . 0.0 109.302 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.89 86.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -69.37 -39.63 77.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -0.834 . . . . 0.0 109.6 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 -47.36 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.159 -0.963 . . . . 0.0 109.045 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -60.28 -40.53 90.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.484 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 85.7 t60 -59.19 -47.55 84.91 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.674 -0.642 . . . . 0.0 109.777 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.2 -39.18 81.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.484 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.18 -38.32 74.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.788 -1.195 . . . . 0.0 110.064 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.94 -42.15 97.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.987 -1.071 . . . . 0.0 110.262 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.484 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 36.9 mttm -64.6 -39.83 94.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.71 76.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -60.8 -43.36 98.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -60.09 -41.46 92.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.93 -43.61 94.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.729 -1.232 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.7 m95 -73.49 -42.33 61.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.905 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t -68.3 -35.39 77.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.041 -1.037 . . . . 0.0 110.517 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.81 -28.9 64.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.271 -0.893 . . . . 0.0 111.673 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.92 10.4 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.934 -1.104 . . . . 0.0 111.062 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -144.49 149.9 45.71 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.001 -1.062 . . . . 0.0 109.126 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.18 5.29 2.75 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 120.81 1.007 . . . . 0.0 112.181 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.81 155.44 40.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.905 -1.122 . . . . 0.0 109.268 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.447 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 6.5 p -131.55 142.33 49.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.394 -0.816 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.29 153.29 36.6 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.367 -0.833 . . . . 0.0 109.467 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.2 m -153.18 132.31 12.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.804 . . . . 0.0 109.861 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -77.44 139.39 39.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.7 136.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.631 -0.668 . . . . 0.0 109.452 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -96.62 -2.21 45.26 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 110.021 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -149.86 152.27 34.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.41 168.65 45.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -79.95 132.03 35.95 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.564 -0.963 . . . . 0.0 109.461 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.67 149.74 20.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 108.965 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.84 -39.86 86.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.39 -0.819 . . . . 0.0 109.118 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 59' ' ' ILE . 78.5 mt -118.22 119.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.7 mmm -101.14 128.95 46.99 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.13 -0.981 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.04 126.42 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.3 p -149.98 159.71 44.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.781 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.19 137.77 50.96 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.09 162.7 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.42 -0.8 . . . . 0.0 111.626 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -130.43 145.3 51.8 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.813 -0.554 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.18 -146.81 0.64 Allowed Glycine 0 N--CA 1.495 2.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.034 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -72.49 128.95 37.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.615 -0.933 . . . . 0.0 109.165 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.55 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 3.9 p-80 -128.18 54.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.558 -0.714 . . . . 0.0 109.855 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 69' ' ' ARG . 52.4 mtm-85 56.62 50.02 13.52 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.482 -0.762 . . . . 0.0 110.06 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -139.83 163.11 33.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -89.42 14.61 10.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.217 -0.927 . . . . 0.0 109.906 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -140.61 68.62 31.03 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.099 -1.0 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.62 148.22 65.49 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.656 1.571 . . . . 0.0 112.74 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -73.79 149.83 41.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.596 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -124.69 74.43 1.34 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.837 -0.539 . . . . 0.0 109.645 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.94 -174.93 48.2 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.9 -13.64 39.03 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 120.839 1.026 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -174.03 43.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.02 -159.21 31.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -73.73 135.36 43.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.284 -1.127 . . . . 0.0 109.42 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.88 -10.81 43.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.695 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.79 161.35 5.89 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -161.63 116.92 2.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.706 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.74 172.83 8.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -104.57 157.08 17.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.78 147.48 78.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 108.571 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.58 104.37 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.628 0.885 . . . . 0.0 112.587 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.07 170.91 33.85 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -69.82 165.42 31.08 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.226 1.284 . . . . 0.0 112.196 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.61 -121.68 15.48 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.061 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.41 -12.98 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -1.04 . . . . 0.0 109.846 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.04 44.71 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 -8.48 78.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -65.06 128.05 34.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.012 -1.287 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.77 115.57 29.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -98.46 135.79 39.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.283 -0.886 . . . . 0.0 109.244 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.29 134.32 54.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.98 117.2 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.015 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -97.36 -0.34 46.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.365 -0.834 . . . . 0.0 109.046 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -74.77 -20.87 59.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -100.76 159.21 15.37 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.281 -0.887 . . . . 0.0 108.965 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 102' ' ' ARG . 18.7 ttt-85 -87.14 123.4 32.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -89.29 145.17 25.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.653 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.9 p -129.79 169.24 15.39 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.356 -0.84 . . . . 0.0 109.633 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.23 28.81 8.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.592 -0.693 . . . . 0.0 110.159 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.571 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -152.0 -167.01 2.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.033 . . . . 0.0 109.952 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -71.12 22.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.358 -0.839 . . . . 0.0 110.686 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 106' ' ' ASN . 29.2 mmt180 -75.8 -160.39 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 108' ' ' ARG . 54.3 mp0 -31.77 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.0 -0.437 . . . . 0.0 111.987 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -129.04 151.07 50.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.319 -0.863 . . . . 0.0 110.758 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 75.8 m-20 -99.25 114.33 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.25 -41.14 92.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.481 -0.762 . . . . 0.0 110.145 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -59.83 -42.06 92.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.0 110.618 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.85 -39.87 86.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.842 -1.161 . . . . 0.0 109.678 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 53.6 t -71.69 -39.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.16 90.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.839 -1.163 . . . . 0.0 108.769 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.69 95.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.569 -0.707 . . . . 0.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -69.18 -50.02 51.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.708 . . . . 0.0 110.335 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -58.6 -40.04 82.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.706 -1.246 . . . . 0.0 109.986 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.7 -39.93 93.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.018 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.25 94.49 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -63.61 -37.77 88.6 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 108.971 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.1 p -69.68 -21.8 63.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.006 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.07 -1.29 57.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.302 -0.874 . . . . 0.0 109.431 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.06 16.92 66.23 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.043 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.64 131.29 34.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.838 -1.389 . . . . 0.0 109.382 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.8 m -88.72 169.1 11.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -67.87 157.47 34.81 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.484 -0.76 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -127.95 164.07 23.11 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.439 -0.788 . . . . 0.0 109.318 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.2 p -102.58 8.94 39.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 110.008 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -83.79 127.65 33.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -0.911 . . . . 0.0 109.291 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.06 -30.02 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 110.319 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.29 0.74 88.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.54 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.77 34.88 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.324 . . . . 0.0 110.463 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.11 -28.47 65.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 109.602 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 86.0 mmm -74.99 52.64 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -70.33 128.97 90.88 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.61 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -48.91 -66.98 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.114 0 CA-C-N 120.483 1.208 . . . . 0.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.5 m -89.64 176.28 6.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.042 -1.036 . . . . 0.0 108.877 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 48.4 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 -179.659 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -145.55 159.94 42.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.65 142.31 42.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.88 165.7 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.24 -38.62 87.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -58.69 -40.66 84.22 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -75.3 -41.01 57.96 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.16 -53.25 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.075 -1.015 . . . . 0.0 109.894 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.78 -39.97 95.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.22 -63.26 5.48 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.758 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.6 -40.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.888 -1.36 . . . . 0.0 110.26 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.9 mt-30 -64.37 -39.71 94.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.249 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.25 93.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.873 -1.142 . . . . 0.0 109.626 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -50.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.057 . . . . 0.0 109.119 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.5 -67.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.918 -1.114 . . . . 0.0 109.215 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.47 177.87 37.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -86.14 149.05 25.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.085 -1.244 . . . . 0.0 108.724 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 108.915 179.653 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -83.21 130.0 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.164 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -82.42 -13.79 56.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.277 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -83.78 151.53 25.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.011 -1.056 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 p -97.44 -7.32 31.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.21 -0.932 . . . . 0.0 108.662 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.585 ' CE1' ' HG1' ' A' ' 48' ' ' THR . 31.1 m-70 -121.51 122.28 39.37 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.02 156.35 20.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -126.73 152.74 46.42 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.76 159.51 42.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 108.949 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.3 ttm180 -150.29 130.72 13.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -87.38 120.02 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 108.544 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.98 -40.09 87.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -160.78 149.98 16.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.875 -1.14 . . . . 0.0 109.988 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.22 132.22 43.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -68.67 143.45 95.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.828 -1.17 . . . . 0.0 109.161 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.11 -6.23 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 120.657 0.905 . . . . 0.0 111.774 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.19 -40.18 89.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.765 . . . . 0.0 109.767 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.7 mt -138.84 150.03 64.02 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.307 -0.871 . . . . 0.0 108.724 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.01 178.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 CA-C-N 119.247 0.767 . . . . 0.0 111.501 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -87.94 -38.71 15.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.993 -1.067 . . . . 0.0 109.546 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.28 92.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.008 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.12 -39.71 75.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 110.095 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.28 -43.6 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.055 . . . . 0.0 109.299 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.77 -39.37 80.81 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.584 ' CE1' ' HZ2' ' A' ' 36' ' ' LYS . 68.1 t60 -57.24 -47.49 81.23 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.555 -0.715 . . . . 0.0 109.175 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.25 -0.906 . . . . 0.0 110.308 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.07 -39.46 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.725 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.89 -41.64 95.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.948 . . . . 0.0 109.901 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.584 ' HZ2' ' CE1' ' A' ' 32' ' ' HIS . 21.5 mttp -62.5 -38.0 88.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 109.955 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.7 84.76 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.701 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -61.39 -41.08 96.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.29 -42.2 95.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.171 -0.955 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -59.94 -43.45 94.98 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.878 -1.139 . . . . 0.0 110.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.73 -41.61 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.3 t -68.25 -36.19 79.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -60.0 -19.19 51.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 0.0 110.242 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.2 m -112.29 1.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 p -144.56 150.24 46.64 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.0 109.421 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.27 7.66 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.936 1.091 . . . . 0.0 112.122 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.41 151.78 42.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.117 -0.99 . . . . 0.0 109.839 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.585 ' HG1' ' CE1' ' A' ' 13' ' ' HIS . 64.5 p -129.79 149.97 51.3 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -128.26 153.63 46.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.483 -0.76 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.1 m -153.0 134.99 14.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.03 131.6 36.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.649 -0.657 . . . . 0.0 109.437 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 14.7 m -119.67 130.69 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -96.0 -8.78 32.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.128 -0.982 . . . . 0.0 108.994 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 99.2 mt-10 -143.81 152.12 40.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 95.64 179.53 36.29 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.18 133.48 35.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.848 -1.384 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 131.03 45.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -59.87 -43.73 94.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.93 120.08 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.573 -0.704 . . . . 0.0 109.814 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 mtt -99.87 130.36 46.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.153 -0.967 . . . . 0.0 109.873 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.73 126.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 p -150.73 160.79 43.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.14 139.8 41.0 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.12 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.344 -0.848 . . . . 0.0 111.08 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 66' ' ' GLY . 83.3 mtm180 -131.35 143.8 50.76 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.737 -0.602 . . . . 0.0 109.423 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 42.65 -147.4 0.68 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -67.12 130.72 44.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -1.024 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.54 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -133.85 56.16 1.86 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.434 -0.791 . . . . 0.0 109.522 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 mtm-85 58.69 49.29 10.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.807 -0.558 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.4 m-20 -142.76 165.69 26.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.216 -0.928 . . . . 0.0 109.641 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -92.99 9.14 36.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.336 -0.853 . . . . 0.0 109.417 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.7 m -133.93 71.57 73.71 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.28 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.2 152.01 80.26 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 120.868 1.045 . . . . 0.0 111.547 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -76.81 147.66 37.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -109.49 75.04 0.92 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.39 -160.67 9.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.82 -15.66 22.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.957 1.104 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.96 -179.56 45.78 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -164.62 37.31 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -75.32 147.38 40.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -1.065 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 mt -92.71 -18.85 22.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 110.296 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.28 161.6 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 0.0 109.681 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.2 -179.81 6.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.697 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.52 167.42 21.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.142 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -101.14 135.22 42.96 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.272 -0.893 . . . . 0.0 109.784 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -60.01 150.04 71.51 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -41.76 120.97 1.54 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 120.706 0.937 . . . . 0.0 112.037 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 -169.28 21.29 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -76.4 117.43 4.59 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.564 1.51 . . . . 0.0 113.519 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.3 -111.49 3.35 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.451 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.29 -13.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.992 . . . . 0.0 110.888 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.87 133.12 51.26 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.927 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.3 77.76 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 121.459 -1.024 . . . . 0.0 111.009 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.38 129.75 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.736 -1.449 . . . . 0.0 110.436 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.44 129.1 46.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.31 -0.869 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -115.17 132.9 56.46 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.496 -0.752 . . . . 0.0 109.122 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -118.01 131.93 56.43 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -64.83 126.09 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -100.3 0.63 40.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 110.059 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.44 -20.01 60.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.027 -1.046 . . . . 0.0 109.679 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.13 158.36 15.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 102' ' ' ARG . 23.5 ttt-85 -87.49 114.63 24.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -89.59 150.72 22.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.73 . . . . 0.0 109.993 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 30.3 p -126.3 164.38 21.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -108.53 32.1 5.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.073 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.459 HD21 ' C ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.43 -164.98 2.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -0.964 . . . . 0.0 110.379 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -84.83 28.34 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -76.67 -164.07 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 110.498 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -43.64 -59.96 1.97 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.555 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.467 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -116.29 121.85 43.21 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.178 -0.951 . . . . 0.0 109.804 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.99 116.06 31.15 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.09 -39.91 87.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.231 . . . . 0.0 109.976 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -59.91 -41.91 92.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 112.226 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -59.99 -41.3 91.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.313 -1.492 . . . . 0.0 109.97 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.4 -39.25 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.227 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.1 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.81 94.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.99 -1.069 . . . . 0.0 108.95 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.87 -49.27 54.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -58.97 -40.17 83.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 109.595 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.08 -39.81 95.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 109.742 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.22 -40.04 95.31 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -61.59 -39.16 90.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -1.196 . . . . 0.0 108.519 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.0 m -70.14 -26.22 63.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.767 . . . . 0.0 109.14 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.82 -3.94 57.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.577 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.22 60.54 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -80.82 129.05 34.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.227 . . . . 0.0 108.889 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -88.35 169.69 11.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.72 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -68.89 156.96 37.55 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 108.865 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -125.86 163.42 22.95 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -105.08 13.48 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.392 -0.818 . . . . 0.0 109.715 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.65 130.89 34.66 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.313 -0.867 . . . . 0.0 108.889 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -60.05 -38.37 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.039 -1.038 . . . . 0.0 110.313 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.12 1.53 79.83 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.246 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 128.62 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.626 -1.514 . . . . 0.0 109.471 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.9 mt -67.56 -26.31 66.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.223 -0.923 . . . . 0.0 108.858 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.2 mmm -72.37 46.29 0.14 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 135' ' ' LEU . 3.0 t80 -69.84 127.88 92.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 108.892 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.63 -64.86 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.557 1.235 . . . . 0.0 111.766 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -85.86 169.29 13.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.383 -0.823 . . . . 0.0 109.651 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 120.94 -1.1 . . . . 0.0 108.897 179.338 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.257 0.551 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -144.97 150.0 36.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.241 -0.912 . . . . 0.0 109.066 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.14 143.88 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 108.962 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.51 163.71 12.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.29 -0.881 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -60.05 -40.18 88.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.98 -1.075 . . . . 0.0 108.759 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.74 -40.04 86.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.834 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.87 -40.08 65.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.042 -1.036 . . . . 0.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.11 -50.16 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.877 . . . . 0.0 109.716 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.88 -40.02 91.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.183 -0.948 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.13 -54.05 41.19 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.343 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -68.59 -39.09 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.882 -1.363 . . . . 0.0 110.039 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -63.69 -39.47 94.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.86 95.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.87 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 0.0 109.919 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -95.86 -67.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.047 . . . . 0.0 109.346 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.21 -173.4 40.2 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.51 142.27 27.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 108.963 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.302 -1.475 0 O-C-N 121.132 -0.98 . . . . 0.0 109.387 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.96 122.44 27.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.021 -1.049 . . . . 0.0 108.344 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -83.04 -9.81 59.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -83.73 150.72 25.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.465 ' HG1' ' CE1' ' A' ' 13' ' ' HIS . 35.4 p -96.87 -3.15 42.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 63.9 m80 -127.97 138.61 52.68 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.9 mt -133.29 158.65 42.42 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -130.2 155.6 45.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.21 157.45 44.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 0.0 108.536 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.543 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.4 ttm180 -150.09 133.63 16.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.97 116.9 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.843 -1.16 . . . . 0.0 108.399 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' SD ' ' A' ' 60' ' ' MET . 99.0 mt-10 -68.25 -38.34 81.7 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.798 . . . . 0.0 111.06 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.72 HD21 ' H ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -154.56 139.75 17.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.0 109.847 -178.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.72 ' H ' HD21 ' A' ' 20' ' ' ASN . 95.4 m-85 -93.86 142.28 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.74 . . . . 0.0 109.345 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -74.13 136.56 75.96 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.95 -11.55 31.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.788 0.96 . . . . 0.0 111.841 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.815 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.5 mt -133.74 151.2 76.62 Favored Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.44 -178.76 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.396 0.82 . . . . 0.0 111.911 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -86.53 -33.57 20.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 109.922 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.04 92.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.048 -1.033 . . . . 0.0 110.402 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.97 -38.94 76.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.275 -0.89 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.08 -41.89 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.133 -0.979 . . . . 0.0 108.922 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -40.22 88.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.004 -1.06 . . . . 0.0 110.045 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 75.7 t60 -60.57 -45.3 94.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.53 81.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.946 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -69.86 -36.83 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -0.816 . . . . 0.0 109.842 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -64.72 -45.64 85.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 109.669 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 35.9 mttm -62.45 -36.95 84.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.992 -1.067 . . . . 0.0 110.256 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.21 -50.01 75.37 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.221 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -60.78 -41.28 95.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 109.364 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 97.8 mt-30 -61.76 -40.21 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.731 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.06 -40.09 88.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.96 . . . . 0.0 109.573 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -73.42 -43.47 60.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 110.347 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -69.26 -30.45 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 19.1 m120 -59.35 -31.96 69.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 8.58 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.146 -0.971 . . . . 0.0 110.894 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 12.4 p -147.74 150.52 36.6 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.732 -1.23 . . . . 0.0 109.732 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.49 5.68 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.117 1.211 . . . . 0.0 112.356 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.3 156.31 39.46 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.096 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 73.9 p -137.74 147.74 45.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 0.0 109.089 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.7 m-85 -128.56 158.19 39.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -154.96 139.2 16.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.57 135.68 37.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 29.4 m -129.44 131.61 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.524 -0.735 . . . . 0.0 109.771 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t -102.51 -2.65 28.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.098 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' C ' HH22 ' A' ' 17' ' ' ARG . 96.8 mt-10 -140.72 152.51 45.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 86.8 177.71 49.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -83.81 134.58 34.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.169 -1.195 . . . . 0.0 109.881 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.93 135.18 41.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.361 -0.837 . . . . 0.0 109.287 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.41 -41.69 94.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 59' ' ' ILE . 86.0 mt -120.07 116.52 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.559 -0.713 . . . . 0.0 110.232 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.471 ' SD ' ' OE2' ' A' ' 19' ' ' GLU . 34.9 mtt -103.33 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 61' ' ' ILE . 95.9 mt -121.75 127.96 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.628 -0.67 . . . . 0.0 109.201 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.8 p -145.34 153.44 41.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.09 141.06 36.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.1 170.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.005 -1.059 . . . . 0.0 110.733 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.01 139.85 50.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.394 0.616 . . . . 0.0 110.408 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.02 -144.08 0.64 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.6 t0 -62.84 136.66 57.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.672 -0.899 . . . . 0.0 110.042 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.41 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -139.89 52.98 1.68 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 69' ' ' ARG . 56.8 mtt-85 53.24 55.14 9.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 33.9 t0 -145.13 162.18 37.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.213 -0.929 . . . . 0.0 109.217 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 5.5 m120 -89.58 8.87 29.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.113 -0.992 . . . . 0.0 109.1 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -134.64 69.4 72.25 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.452 -0.78 . . . . 0.0 109.23 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -72.34 148.01 48.25 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.7 1.6 . . . . 0.0 112.581 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -78.13 137.03 37.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -0.826 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -104.71 66.49 0.78 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.95 -171.0 48.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.76 -9.47 1.21 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.775 0.983 . . . . 0.0 112.176 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 -178.15 46.61 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.52 -167.3 53.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.433 HD21 ' H ' ' A' ' 80' ' ' ASN . 2.4 p30 -72.76 156.92 38.43 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.165 -1.197 . . . . 0.0 109.666 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.67 -19.25 22.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.86 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.69 163.8 10.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.037 -1.04 . . . . 0.0 108.752 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.42 -175.52 5.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.104 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.44 172.37 13.47 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.144 -0.972 . . . . 0.0 109.643 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.83 158.96 15.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.348 -0.845 . . . . 0.0 109.409 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.91 149.13 81.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.49 103.64 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.496 0.798 . . . . 0.0 112.149 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.43 171.61 35.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.1 -177.95 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.971 1.114 . . . . 0.0 111.758 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.91 -127.49 43.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -78.44 -7.23 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.293 -1.122 . . . . 0.0 110.24 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 142.4 47.74 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -14.8 61.15 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -67.95 157.91 33.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -1.229 . . . . 0.0 109.9 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.83 118.18 8.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 109.851 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -98.54 144.68 27.59 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.124 -0.985 . . . . 0.0 110.698 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 19.1 m-85 -119.93 137.55 53.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.21 121.02 13.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -97.81 -2.72 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -76.09 -19.27 58.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.83 158.92 15.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.804 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -87.16 117.59 26.01 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.86 147.44 23.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.532 -0.73 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 81.5 p -130.08 161.07 31.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -108.06 31.06 5.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.736 . . . . 0.0 109.547 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.3 p30 -149.95 -164.99 2.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.945 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 43.1 t80 -80.87 32.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.082 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -76.01 -163.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.962 . . . . 0.0 109.918 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -49.69 -59.0 4.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.537 -0.727 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -110.42 129.89 55.67 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.994 -1.066 . . . . 0.0 110.949 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 98.1 m-20 -101.97 107.15 18.2 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.238 -0.914 . . . . 0.0 108.542 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.79 -41.48 87.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 111.055 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -59.9 -41.55 91.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.994 -1.067 . . . . 0.0 109.945 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.452 ' NH2' ' CE1' ' A' ' 140' ' ' TYR . 45.3 ttp180 -60.24 -40.28 89.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.45 -39.57 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.21 82.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 0.0 109.215 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.93 78.95 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 109.701 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.16 -49.85 53.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 78.6 mt-10 -59.83 -40.54 88.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.48 -38.7 90.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 108.897 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.26 -41.14 86.35 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -63.7 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.264 . . . . 0.0 108.635 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.0 m -70.48 -25.1 63.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.7 mt -83.13 -1.94 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.5 76.76 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.85 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.08 130.65 35.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.808 -1.407 . . . . 0.0 109.279 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.2 m -88.03 173.53 8.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.3 156.49 37.61 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.803 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -130.32 158.15 40.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -100.08 7.29 44.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.863 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -78.61 132.2 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.1 tt -60.4 -38.25 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 111.257 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.61 87.32 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.339 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 129.49 35.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.806 -1.409 . . . . 0.0 109.49 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.43 -26.58 65.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.033 -1.042 . . . . 0.0 109.065 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.1 mmm -73.89 50.06 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.578 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.498 ' C ' ' H ' ' A' ' 139' ' ' SER . 18.3 t80 -68.08 135.81 91.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.85 14.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 CA-C-N 120.289 1.139 . . . . 0.0 112.569 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 137' ' ' TYR . 79.5 p -163.98 172.52 13.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 109.76 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CE1' ' NH2' ' A' ' 114' ' ' ARG . 58.3 t80 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.392 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.541 0.686 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -147.0 143.46 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.42 136.44 40.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.61 166.44 12.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.04 -39.19 85.09 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.81 -42.34 93.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.346 -0.846 . . . . 0.0 108.995 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -72.22 -43.12 64.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.569 -0.707 . . . . 0.0 109.822 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -49.99 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.012 -1.055 . . . . 0.0 109.369 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.76 -39.29 93.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.4 -51.54 53.79 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.261 -0.899 . . . . 0.0 111.393 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.26 -38.48 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.676 -1.485 . . . . 0.0 109.547 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.9 mt-30 -65.77 -38.65 89.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.088 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.24 94.83 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 0.0 109.278 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.09 -51.21 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.51 -65.31 0.97 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.29 179.28 34.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -86.6 156.42 20.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -1.146 . . . . 0.0 108.639 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--N 1.3 -1.553 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.669 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -80.27 115.7 19.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.349 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.63 -10.41 57.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.85 . . . . 0.0 109.597 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.97 149.51 28.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.139 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.684 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 71.7 p -94.46 -3.69 49.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.684 ' CD2' ' HG1' ' A' ' 12' ' ' THR . 88.6 m-70 -127.37 139.32 52.94 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.5 mt -130.34 153.04 49.1 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.23 -0.919 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.9 p -126.23 154.41 43.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -142.4 160.0 41.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -148.46 129.99 14.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.219 -0.926 . . . . 0.0 109.801 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.72 118.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.88 -40.22 94.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -163.66 154.26 15.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.812 -1.18 . . . . 0.0 110.404 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -98.78 138.19 36.29 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.259 -0.901 . . . . 0.0 108.901 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.57 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 2.3 t -71.85 145.95 89.95 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.349 -0.845 . . . . 0.0 109.253 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.1 -14.62 45.21 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.442 0.836 . . . . 0.0 111.786 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.57 ' H ' ' HG1' ' A' ' 22' ' ' THR . 82.7 m-20 -60.29 -39.86 88.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -135.62 150.18 71.29 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.83 -173.34 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.493 0.855 . . . . 0.0 111.847 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -88.16 -37.45 16.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.842 . . . . 0.0 110.443 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.01 89.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.923 -1.111 . . . . 0.0 109.516 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.28 -39.8 74.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -47.09 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 109.931 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.7 t0 -60.02 -41.11 91.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.501 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -60.05 -45.72 91.92 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 0.0 109.13 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.03 83.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.21 -40.45 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.907 . . . . 0.0 110.077 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.9 tt0 -69.88 -38.79 76.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.52 -40.09 90.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.37 98.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.885 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' ' CD2' ' A' ' 49' ' ' PHE . 26.4 m-85 -60.0 -40.18 88.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.163 . . . . 0.0 109.72 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 4.1 mp0 -60.11 -40.02 88.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.839 -1.163 . . . . 0.0 109.633 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.1 -40.58 90.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.876 -1.14 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -74.91 -44.04 50.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.2 t -69.42 -34.8 75.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.241 -0.912 . . . . 0.0 110.493 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -56.91 -28.09 61.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 110.107 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.514 ' C ' ' HG ' ' A' ' 163' ' ' SER . 30.0 m -110.82 5.28 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.379 -0.826 . . . . 0.0 110.694 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 157' ' ' GLN . 41.9 p -141.42 146.14 40.94 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.58 7.81 0.87 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.813 1.009 . . . . 0.0 111.702 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.71 156.87 37.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.917 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 22.2 p -134.55 151.67 51.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CD2' ' CE1' ' A' ' 38' ' ' PHE . 96.1 m-85 -130.89 150.9 51.84 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.326 -0.858 . . . . 0.0 110.291 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -155.8 135.22 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.253 -0.904 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -77.04 146.57 37.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.71 135.36 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.56 -0.712 . . . . 0.0 109.155 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -97.54 -4.2 38.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 109.841 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.4 150.44 36.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.073 -1.017 . . . . 0.0 109.364 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.44 169.62 40.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 4.7 pm0 -81.3 152.93 27.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -1.174 . . . . 0.0 109.19 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.31 155.45 21.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.36 -0.837 . . . . 0.0 108.91 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.02 -40.28 88.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.687 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 59' ' ' ILE . 84.8 mt -120.36 116.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.375 -0.828 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp -99.97 134.4 42.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.867 . . . . 0.0 109.38 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.85 129.18 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.525 -0.734 . . . . 0.0 109.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.8 p -147.3 155.94 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.11 139.31 39.97 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.88 162.48 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.36 -0.838 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -129.1 134.56 48.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.725 -0.609 . . . . 0.0 109.886 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.94 -136.42 3.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -70.41 124.45 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.54 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -138.11 66.65 1.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.518 -0.739 . . . . 0.0 109.786 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.3 mtm-85 56.98 48.54 15.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.88 155.2 44.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 108.751 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.61 8.45 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.6 m -137.93 75.39 42.22 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.299 -0.876 . . . . 0.0 109.524 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.74 163.59 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.307 1.338 . . . . 0.0 112.533 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -78.73 151.8 31.89 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.655 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -104.69 67.85 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.71 -167.12 21.04 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -58.1 -15.24 22.08 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.233 1.288 . . . . 0.0 111.919 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.54 -179.95 47.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.11 -163.65 34.67 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 121.042 -1.27 . . . . 0.0 110.163 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -74.54 150.33 39.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.491 -1.005 . . . . 0.0 109.525 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.36 -11.91 36.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.087 -1.008 . . . . 0.0 109.816 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.82 174.98 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.005 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.62 121.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.96 -1.087 . . . . 0.0 110.38 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.01 170.47 11.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.692 -0.63 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -106.5 149.48 27.06 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -58.8 149.07 66.13 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.199 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.67 102.73 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.792 0.995 . . . . 0.0 112.135 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 179.24 36.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.78 -177.62 3.26 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.443 1.429 . . . . 0.0 112.787 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.07 -120.72 23.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.89 -13.58 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.482 -1.01 . . . . 0.0 110.388 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.87 146.06 39.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.28 -18.63 35.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.58 161.69 22.56 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -1.113 . . . . 0.0 109.692 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.4 122.93 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -102.8 134.05 46.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.03 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.59 131.35 56.72 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -63.8 118.79 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -100.25 0.78 40.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.249 -0.907 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -74.05 -16.06 61.05 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.44 156.32 18.03 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -84.72 117.45 23.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 108.977 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.14 148.56 25.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 26.7 p -128.2 165.31 20.7 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.494 -0.754 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -117.02 29.14 8.09 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.722 HD22 ' HE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -146.33 -161.42 1.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.199 -0.938 . . . . 0.0 109.739 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -83.01 31.69 0.43 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.722 ' HE ' HD22 ' A' ' 106' ' ' ASN . 65.8 mtm180 -76.34 -162.7 0.26 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.823 -1.173 . . . . 0.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.72 -56.99 14.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 111.866 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.48 ' O ' ' OG1' ' A' ' 104' ' ' THR . 94.2 m-85 -106.87 128.69 54.51 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.948 -1.095 . . . . 0.0 111.176 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -101.2 115.34 30.26 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.97 -40.03 75.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.982 . . . . 0.0 111.053 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -60.36 -44.58 95.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.774 -1.204 . . . . 0.0 111.249 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -59.95 -42.38 93.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.746 -1.221 . . . . 0.0 109.682 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.92 -40.92 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.073 -1.017 . . . . 0.0 108.771 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -42.56 94.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.104 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.7 93.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.647 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 7.2 t60 -69.65 -40.16 76.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.878 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.02 -40.88 90.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.044 -1.035 . . . . 0.0 108.886 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 123' ' ' SER . 91.1 mt -62.97 -40.01 96.42 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.74 -40.07 92.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 14.1 m-70 -64.28 -37.49 87.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.035 -1.274 . . . . 0.0 108.509 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 85.2 p -70.01 -24.29 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.035 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.24 1.2 49.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.58 15.76 77.25 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.5 128.0 32.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.899 -1.353 . . . . 0.0 109.016 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.3 m -87.59 174.32 8.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -69.17 159.82 32.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.626 -0.671 . . . . 0.0 110.466 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -125.24 162.32 24.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.609 -0.682 . . . . 0.0 109.576 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -99.79 1.27 42.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.308 -0.87 . . . . 0.0 109.324 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 48.7 t0 -82.14 116.15 21.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.195 0.998 . . . . 0.0 108.971 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.97 -24.66 30.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.329 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.22 -4.1 88.39 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.88 144.62 29.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -1.221 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 87.0 mt -61.01 -35.26 76.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 72.0 mmm -70.37 54.82 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 109.666 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.3 t80 -70.14 132.38 88.24 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -45.5 -57.11 2.31 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.392 1.176 . . . . 0.0 111.165 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -100.68 175.8 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.7 t80 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 120.836 -1.165 . . . . 0.0 110.475 -179.405 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.138 0.494 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -149.28 152.36 35.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.234 -0.917 . . . . 0.0 108.623 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.96 145.12 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.924 -1.11 . . . . 0.0 108.812 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.77 163.7 14.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.099 -1.001 . . . . 0.0 109.45 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 109.211 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -59.17 -40.69 86.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.802 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -72.54 -40.24 66.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 109.889 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.8 -49.81 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.127 -0.983 . . . . 0.0 109.602 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.88 -39.91 91.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.959 -1.088 . . . . 0.0 109.962 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.63 -54.09 24.46 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.974 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.67 -39.87 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.735 -1.45 . . . . 0.0 109.621 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 161' ' ' GLY . 15.9 mm-40 -67.85 -36.89 81.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.4 94.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.793 -1.192 . . . . 0.0 109.381 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.19 -49.79 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.209 -0.932 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.95 -61.33 1.38 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.203 -0.935 . . . . 0.0 110.092 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.42 -175.97 41.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 162' ' ' ARG . 52.5 mtt-85 -93.25 140.12 29.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -1.035 . . . . 0.0 109.551 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.514 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 30.1 m . . . . . 0 C--N 1.301 -1.54 0 C-N-CA 119.503 -0.879 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 8' ' ' ARG . 51.7 mtm-85 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.25 0.547 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -79.86 123.85 28.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.71 -9.93 58.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.088 -1.007 . . . . 0.0 110.517 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -85.77 148.08 26.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 109.973 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 p -95.8 -4.12 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.514 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 90.0 m-70 -121.58 129.34 52.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.21 155.56 43.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.493 -0.754 . . . . 0.0 109.869 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -128.33 151.41 49.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.411 -0.805 . . . . 0.0 109.6 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -142.2 160.58 39.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.358 -0.839 . . . . 0.0 109.803 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -150.69 134.37 16.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.301 -0.875 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.73 119.61 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.8 -39.77 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -160.21 155.35 24.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.377 -0.827 . . . . 0.0 109.519 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -100.22 131.19 46.3 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 t -70.55 141.41 87.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.806 -1.184 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -65.75 -6.22 13.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.578 0.885 . . . . 0.0 111.544 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -60.19 -40.17 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -140.49 151.32 63.52 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.35 179.51 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.475 0.848 . . . . 0.0 111.338 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -85.77 -35.78 20.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.158 -0.964 . . . . 0.0 109.357 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.32 75.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.027 -1.045 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.55 -40.05 70.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.771 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.11 -40.57 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.015 . . . . 0.0 109.623 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.57 -42.87 93.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 109.189 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.37 -42.34 95.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.812 . . . . 0.0 108.911 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.41 95.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -0.834 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.74 -40.09 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 108.643 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.06 -40.76 74.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -60.04 -35.04 74.24 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.271 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.32 -45.84 71.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -60.2 -40.32 89.65 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.869 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -60.08 -40.3 89.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 110.176 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.93 -43.03 95.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.505 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.408 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.2 m95 -73.2 -40.29 64.87 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 110.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.6 t -67.96 -35.25 78.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.723 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.71 -34.44 69.46 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 110.182 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.97 10.7 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.965 -1.084 . . . . 0.0 111.558 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.517 ' N ' ' HG ' ' A' ' 163' ' ' SER . 66.6 p -145.34 148.45 37.61 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 120.757 -1.214 . . . . 0.0 109.634 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.57 9.68 0.92 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.823 1.016 . . . . 0.0 112.187 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.35 158.22 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 109.457 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.514 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 67.5 p -136.22 149.87 48.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.21 157.04 43.57 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.414 -0.803 . . . . 0.0 110.241 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.09 126.69 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -74.46 138.97 43.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.178 -0.951 . . . . 0.0 108.923 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.58 135.06 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 t -97.99 -1.4 42.77 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.23 -0.919 . . . . 0.0 110.587 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.9 158.41 43.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.093 . . . . 0.0 109.259 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 173.17 46.27 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -79.02 137.89 37.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.241 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.47 139.82 32.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 108.939 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.18 -41.65 93.33 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.7 mt -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mtt -105.48 132.09 52.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.563 -0.711 . . . . 0.0 109.753 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.7 131.27 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.1 p -146.61 159.55 43.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -110.55 139.42 45.81 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.43 168.7 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.271 -0.893 . . . . 0.0 111.229 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 66' ' ' GLY . 80.8 mtm180 -131.94 140.53 49.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.799 -0.563 . . . . 0.0 109.655 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 41.55 -144.25 0.79 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.28 136.69 55.31 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.931 . . . . 0.0 108.957 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.616 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.5 p-80 -138.32 50.59 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 0.0 109.726 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 57.6 50.01 11.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.717 -0.614 . . . . 0.0 110.053 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.537 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 77.8 m-20 -137.05 167.57 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.31 -0.869 . . . . 0.0 109.24 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -88.94 10.0 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 108.998 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.5 m -138.11 73.19 45.33 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -72.0 146.35 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.837 1.025 . . . . 0.0 111.612 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.86 149.21 31.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.062 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -128.17 74.16 1.53 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.29 173.72 46.58 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -50.91 -12.21 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.304 1.336 . . . . 0.0 112.438 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.72 177.23 44.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -157.31 28.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.98 145.57 40.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -1.135 . . . . 0.0 109.531 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.12 -15.62 29.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 108.707 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.91 170.39 6.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 109.152 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -161.41 176.38 11.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.914 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.17 168.86 18.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.123 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -105.07 142.27 35.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.757 . . . . 0.0 109.732 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.73 149.01 81.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.03 -1.044 . . . . 0.0 109.062 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.92 109.86 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.701 0.934 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.34 -179.72 29.03 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.46 141.48 20.09 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 120.997 1.131 . . . . 0.0 112.812 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.99 -125.39 7.19 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.285 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.64 -9.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.84 -0.8 . . . . 0.0 110.203 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.31 139.76 48.17 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.74 -13.28 63.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -66.78 160.15 26.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.906 -1.35 . . . . 0.0 110.035 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.12 116.57 6.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -0.851 . . . . 0.0 109.058 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -98.77 153.29 18.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 21.0 m-85 -121.87 140.45 52.38 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -65.75 120.77 13.6 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -99.52 -7.54 25.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.637 -0.664 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -75.69 -12.61 60.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -105.07 149.92 25.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.194 -0.941 . . . . 0.0 108.788 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -83.33 122.09 28.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 109.493 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -89.22 152.56 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.54 -0.725 . . . . 0.0 110.026 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.8 p -120.96 169.49 10.42 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -109.68 27.39 9.62 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.548 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.04 -165.02 2.17 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.815 . . . . 0.0 110.209 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.1 t80 -84.54 33.87 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.917 0.865 . . . . 0.0 109.989 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.2 mmt-85 -76.76 -162.46 0.27 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.831 -1.168 . . . . 0.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -55.02 -57.65 10.86 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.697 -0.627 . . . . 0.0 110.995 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -97.27 118.75 34.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -109.2 106.13 15.87 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.05 -44.18 69.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.865 -0.522 . . . . 0.0 110.044 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -60.5 -47.38 86.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -60.07 -40.79 90.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -70.29 -39.26 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.149 -0.969 . . . . 0.0 108.763 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.9 -43.97 94.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.953 -1.092 . . . . 0.0 109.488 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.08 78.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.107 -0.995 . . . . 0.0 109.208 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 135' ' ' LEU . 3.8 t60 -69.95 -50.61 40.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.427 -0.795 . . . . 0.0 110.29 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.2 mt-10 -58.95 -41.5 87.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.914 -1.117 . . . . 0.0 109.153 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 123' ' ' SER . 85.8 mt -62.75 -40.44 97.27 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.948 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.48 -41.98 82.46 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -65.42 -34.42 78.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.034 -1.274 . . . . 0.0 108.452 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 37.3 p -68.42 -19.44 64.59 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.71 -2.63 58.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.65 20.36 56.38 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.47 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.9 137.64 35.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.507 -1.584 . . . . 0.0 108.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -87.0 164.37 16.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -67.27 151.83 46.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.7 t -124.83 168.76 12.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.694 -0.629 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.5 p -107.42 9.98 29.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.449 -0.782 . . . . 0.0 109.951 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.11 130.37 35.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.032 -1.042 . . . . 0.0 109.771 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.4 -40.7 84.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 111.36 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.38 -5.12 85.37 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 121.094 -1.003 . . . . 0.0 110.747 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.69 130.26 35.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.811 -1.405 . . . . 0.0 109.889 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.9 mt -63.33 -22.96 67.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.3 mmt -70.54 35.86 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.693 -0.629 . . . . 0.0 109.627 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.4 t80 -70.71 128.94 90.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.014 -1.053 . . . . 0.0 108.925 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -52.8 -66.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.844 1.337 . . . . 0.0 111.765 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.5 p -82.65 173.94 11.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.96 . . . . 0.0 110.405 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.963 178.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.8 t . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -143.6 157.46 44.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.068 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.6 145.03 43.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.037 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 161.53 14.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.247 -0.908 . . . . 0.0 109.633 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -60.14 -42.51 95.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -58.38 -41.03 83.9 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.571 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.37 -42.08 62.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.837 -1.164 . . . . 0.0 109.48 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.71 -49.97 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 108.772 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.18 -40.27 93.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 109.868 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.51 -55.34 29.46 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.484 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -67.56 -39.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.246 . . . . 0.0 110.561 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -67.56 -41.5 84.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.063 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.02 94.78 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.8 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.63 -0.669 . . . . 0.0 109.718 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.08 -66.84 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.8 -175.83 36.6 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -86.95 149.7 24.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -0.999 . . . . 0.0 109.231 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 45' ' ' THR . 29.3 m . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 0.0 110.41 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' NH1' ' HG3' ' A' ' 8' ' ' ARG . 40.6 mtm-85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -83.79 122.59 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.037 -1.039 . . . . 0.0 109.936 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 47.6 mp0 -75.15 -30.17 60.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.387 -0.82 . . . . 0.0 109.763 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -81.58 154.51 26.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 p -98.25 -4.5 35.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.897 . . . . 0.0 109.214 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.435 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 82.5 m-70 -111.58 131.58 55.15 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -134.19 157.99 44.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 p -124.2 155.63 38.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.346 -0.846 . . . . 0.0 108.824 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.47 158.64 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -154.31 134.98 13.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 18' ' ' ILE . 85.7 mt -88.23 123.74 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 0.0 108.831 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.46 -40.25 85.34 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.023 -1.048 . . . . 0.0 111.343 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -160.28 159.15 31.02 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.81 -1.182 . . . . 0.0 109.861 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -102.51 139.78 37.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 142.19 63.43 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.23 -11.7 32.41 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 CA-C-N 119.457 0.842 . . . . 0.0 112.188 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.26 -38.94 85.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.73 153.47 78.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -60.69 -179.95 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 CA-C-N 119.461 0.843 . . . . 0.0 111.428 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 33.3 ptt180 -87.91 -35.48 17.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.91 -37.57 79.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 110.258 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.82 -34.83 60.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.84 . . . . 0.0 111.034 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.17 -49.82 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.77 -1.207 . . . . 0.0 109.965 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 12.3 p-10 -60.03 -37.08 78.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.751 -1.218 . . . . 0.0 109.62 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -59.13 -48.6 81.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.908 -1.12 . . . . 0.0 109.406 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.68 91.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.055 -1.028 . . . . 0.0 109.612 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.5 mm -72.28 -31.02 37.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.324 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -66.65 -41.65 87.87 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.07 -28.78 65.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.857 -1.152 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.59 -48.18 80.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.913 -1.117 . . . . 0.0 109.007 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.6 m-85 -62.67 -40.43 97.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.686 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.12 -43.52 95.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.099 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.61 -43.95 93.57 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.82 -1.175 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.429 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.3 m95 -70.34 -40.8 73.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.275 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.4 t -69.5 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 110.579 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -59.72 -27.37 66.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.968 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.62 9.56 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 O-C-N 120.971 -1.081 . . . . 0.0 110.492 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 22.5 p -149.19 150.49 32.0 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.926 -1.109 . . . . 0.0 109.658 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -69.68 9.33 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.643 0.895 . . . . 0.0 111.533 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' THR . 78.9 mt -71.27 151.18 44.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.225 -0.922 . . . . 0.0 109.068 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.435 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 71.2 p -134.66 148.53 50.38 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 96.6 m-85 -129.9 155.45 46.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.8 m -154.69 134.52 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.455 -0.778 . . . . 0.0 109.534 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -77.34 145.93 37.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.16 132.81 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.642 -0.662 . . . . 0.0 109.733 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 t -96.74 -9.16 29.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -141.9 156.34 45.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 108.878 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.9 171.46 47.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.33 134.82 35.64 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.667 -0.902 . . . . 0.0 109.767 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.86 143.67 26.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.946 -1.096 . . . . 0.0 109.282 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -40.67 89.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.85 119.09 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.521 -0.737 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.9 mtt -103.38 135.86 44.21 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.021 -1.049 . . . . 0.0 109.807 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.45 130.87 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.3 p -149.98 156.1 41.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.752 -1.218 . . . . 0.0 110.708 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.6 138.44 45.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.37 164.46 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.228 -0.92 . . . . 0.0 111.304 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -134.3 145.54 49.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.81 -147.03 2.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -73.77 125.72 28.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.45 -1.03 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -127.62 53.69 1.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 69' ' ' ARG . 61.1 mtt-85 56.61 50.03 13.54 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -139.18 158.36 44.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.19 -0.944 . . . . 0.0 109.658 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -89.12 10.47 21.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 109.751 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -137.81 72.51 48.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.12 146.64 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 120.843 1.029 . . . . 0.0 112.26 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD2' ' OD2' ' A' ' 98' ' ' ASP . 90.5 m-85 -76.26 148.47 37.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.368 -0.833 . . . . 0.0 108.987 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -132.57 72.88 1.5 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.382 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.27 -170.21 42.64 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.01 -16.25 54.49 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.197 1.264 . . . . 0.0 111.727 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.15 49.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.66 -165.97 46.71 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.4 142.1 41.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.9 mt -90.79 -12.36 36.67 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.61 157.33 8.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.362 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.61 177.76 10.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.315 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.78 161.73 23.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -92.71 156.03 17.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.11 149.78 65.46 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.377 -0.827 . . . . 0.0 108.967 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -59.17 106.87 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.61 0.873 . . . . 0.0 111.984 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.2 176.93 38.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -69.2 173.06 11.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.318 1.345 . . . . 0.0 112.029 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.75 14.45 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -83.93 -11.79 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -1.066 . . . . 0.0 109.841 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 140.03 38.02 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.28 -20.33 34.36 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.77 128.75 37.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.028 -1.277 . . . . 0.0 110.717 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.34 24.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.773 . . . . 0.0 109.09 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -130.07 132.44 46.17 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.5 136.4 54.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.385 -0.822 . . . . 0.0 110.095 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 13.9 t0 -65.77 124.31 22.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.291 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -101.18 0.27 37.31 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 97.3 m-20 -75.68 -15.21 60.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.048 -1.032 . . . . 0.0 110.068 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -106.93 164.23 12.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -88.34 118.37 27.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.116 -0.99 . . . . 0.0 109.902 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.97 148.65 23.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.108 -0.995 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.5 p -124.94 173.53 8.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.529 -0.732 . . . . 0.0 109.666 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -112.34 23.63 13.42 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.401 0.62 . . . . 0.0 109.445 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -147.27 -165.0 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -87.87 20.88 2.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 109' ' ' GLU . 96.1 mtt180 -75.83 -165.73 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.283 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' ARG . 72.5 mm-40 -11.16 -69.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 123.023 0.529 . . . . 0.0 112.41 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.41 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.2 m-85 -131.8 128.83 39.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -89.9 108.7 19.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 108.627 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.18 -40.16 78.27 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.451 ' ND1' ' C ' ' A' ' 113' ' ' HIS . 17.8 t-80 -59.98 -46.45 89.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.788 -1.195 . . . . 0.0 110.067 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -60.22 -41.91 94.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.004 -1.06 . . . . 0.0 110.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.75 -41.13 79.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.853 -1.154 . . . . 0.0 108.85 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.92 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.82 91.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.617 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 33.8 t60 -70.31 -39.97 74.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.989 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -58.66 -40.01 82.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.177 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.0 -39.74 95.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.56 -42.05 65.64 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.617 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 7.7 m-70 -62.26 -36.63 82.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.987 -1.302 . . . . 0.0 108.411 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.9 t -69.22 -24.49 64.02 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.6 -4.87 58.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 0.0 109.436 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.03 15.97 58.48 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.91 129.1 34.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.016 -1.285 . . . . 0.0 109.716 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.499 ' O ' ' SD ' ' A' ' 136' ' ' MET . 68.5 m -87.79 165.52 15.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 109.276 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -66.04 160.6 23.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.093 . . . . 0.0 108.788 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -127.21 166.22 18.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.44 -0.788 . . . . 0.0 109.405 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.3 p -100.53 7.32 44.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.336 -0.853 . . . . 0.0 108.988 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -83.26 116.44 22.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.53 -27.86 41.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.577 -0.702 . . . . 0.0 110.422 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.96 -5.76 89.48 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.298 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.45 156.08 24.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.284 . . . . 0.0 109.79 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.6 -29.53 67.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.764 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 127' ' ' SER . 5.6 mtt -74.0 61.95 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.85 126.92 92.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -47.98 -71.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.485 1.209 . . . . 0.0 110.835 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.5 p -94.44 170.15 9.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 108.982 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.0 t80 . . . . . 0 C--N 1.298 -1.659 0 O-C-N 121.062 -1.024 . . . . 0.0 108.511 179.258 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.382 0.61 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -144.78 154.94 43.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.82 145.78 34.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.4 156.24 18.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 109.524 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.16 -39.74 87.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 109.039 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 56.8 t0 -57.93 -39.63 78.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.506 -0.746 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -76.34 -40.71 50.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.952 -1.092 . . . . 0.0 109.519 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.5 -50.12 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.256 -0.902 . . . . 0.0 109.265 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.02 -40.06 90.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.085 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.99 -51.63 38.29 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.75 -40.2 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.008 -1.289 . . . . 0.0 109.486 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.1 mt-30 -65.29 -39.68 92.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.289 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.15 92.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.056 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.72 -49.98 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.057 . . . . 0.0 109.819 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.827 -1.17 . . . . 0.0 109.574 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.23 -165.96 33.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.57 138.64 33.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -1.21 . . . . 0.0 109.849 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -81.3 120.93 25.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.0 109.017 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.74 -14.82 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.69 149.26 27.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.736 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -94.49 -4.61 47.82 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -129.15 141.33 51.21 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -131.99 159.91 37.38 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.2 -0.938 . . . . 0.0 109.883 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.5 p -127.9 155.1 44.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.454 -0.779 . . . . 0.0 109.51 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.58 157.97 43.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -148.49 137.67 21.82 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.236 -0.915 . . . . 0.0 110.066 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.15 119.96 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.5 tt0 -64.98 -39.98 94.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.078 . . . . 0.0 110.365 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.8 m-20 -158.62 151.15 21.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.981 -1.074 . . . . 0.0 109.784 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.13 134.11 40.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 108.978 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 7.7 t -70.1 135.84 87.12 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -66.54 -10.66 28.65 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.769 0.953 . . . . 0.0 111.848 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' H ' ' HG1' ' A' ' 22' ' ' THR . 93.8 m-20 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.12 149.99 74.24 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.83 -177.77 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 CA-C-N 119.485 0.852 . . . . 0.0 111.429 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -87.26 -29.9 21.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.021 -1.049 . . . . 0.0 109.757 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.87 88.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.9 -39.14 76.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.89 -40.9 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.418 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.95 -43.18 95.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.995 . . . . 0.0 109.011 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -59.99 -43.59 95.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.209 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.36 77.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -70.13 -40.06 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.377 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.09 -39.9 75.27 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 109.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.61 88.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -60.1 -39.79 87.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -59.34 -43.43 92.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.968 -1.082 . . . . 0.0 109.638 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.93 -44.36 97.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.416 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.984 -1.072 . . . . 0.0 110.322 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 t -69.81 -39.84 76.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.87 -18.09 54.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.168 -0.958 . . . . 0.0 111.115 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.02 4.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.15 -0.969 . . . . 0.0 109.775 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.657 ' N ' ' HG ' ' A' ' 163' ' ' SER . 6.5 p -146.44 151.18 42.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.231 -0.918 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -69.32 4.82 1.79 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.823 1.015 . . . . 0.0 111.7 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.85 150.16 46.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 p -129.85 149.37 51.61 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.476 ' C ' ' HG1' ' A' ' 50' ' ' THR . 96.8 m-85 -126.01 157.6 37.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.427 -0.796 . . . . 0.0 109.683 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.476 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 19.9 m -155.06 129.14 8.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.935 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -76.39 138.02 40.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 m -121.12 133.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.466 -0.771 . . . . 0.0 109.354 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -97.77 -0.07 45.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -143.26 150.17 38.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.182 -0.949 . . . . 0.0 109.658 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 165.07 30.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -81.58 137.81 35.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -1.1 . . . . 0.0 109.308 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.0 151.85 21.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.98 -42.91 95.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.858 . . . . 0.0 109.717 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -104.39 109.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.404 -0.81 . . . . 0.0 109.397 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtp -101.94 136.76 41.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.286 -0.884 . . . . 0.0 109.684 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.77 132.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.66 -0.65 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.5 p -147.02 150.46 35.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.24 140.45 38.37 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 109.254 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.7 168.82 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -131.88 138.47 48.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.672 -0.642 . . . . 0.0 109.372 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.65 -151.35 1.11 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.3 t0 -65.24 134.89 54.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.615 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.0 p-80 -132.55 51.26 2.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.725 . . . . 0.0 109.627 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 61.9 mtp180 57.38 53.31 7.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.642 -0.661 . . . . 0.0 110.627 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 92.5 m-20 -142.27 169.99 16.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -89.43 9.49 26.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -138.9 72.42 40.92 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.15 152.31 31.03 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.33 1.353 . . . . 0.0 112.017 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -77.81 137.46 38.43 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.268 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -102.23 68.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.0 109.478 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 178.42 39.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.25 -21.03 6.34 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.252 1.301 . . . . 0.0 112.325 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.63 -178.84 45.09 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.02 -153.35 24.52 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -76.81 142.28 40.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -1.118 . . . . 0.0 109.807 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.3 mt -91.53 -15.16 29.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.99 174.86 4.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 108.9 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 2.6 p80 -161.96 117.34 1.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.197 . . . . 0.0 110.428 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.0 171.11 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.12 148.64 70.6 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 0.0 109.353 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.59 108.21 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 120.598 0.865 . . . . 0.0 111.738 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.62 171.26 41.49 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.976 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -65.93 171.61 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.228 1.286 . . . . 0.0 111.548 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.84 -125.94 16.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.14 -6.79 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.363 -1.081 . . . . 0.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.53 141.59 48.0 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.72 -16.27 54.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.76 163.46 21.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -1.074 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.09 117.73 8.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -0.776 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -101.35 135.55 42.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.453 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.1 m-85 -116.85 129.05 55.83 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' GLU . 62.3 t0 -68.06 128.75 37.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.248 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 69.5 tt0 -100.01 2.53 43.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.278 -0.888 . . . . 0.0 109.418 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.13 -16.78 60.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 54.0 mp0 -94.44 155.62 16.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.075 -1.016 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -85.16 115.12 22.76 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.59 145.46 25.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.105 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.9 p -120.31 171.51 8.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.11 26.08 9.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -151.0 -166.98 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -90.7 32.69 0.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.286 -0.884 . . . . 0.0 110.52 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' GLU . 9.0 mtp-105 -75.57 -156.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.841 -1.162 . . . . 0.0 109.652 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -36.86 -59.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.714 -0.616 . . . . 0.0 111.379 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.0 m-85 -123.09 128.96 50.83 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.079 -1.013 . . . . 0.0 110.249 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -108.52 110.37 21.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.381 -0.825 . . . . 0.0 109.186 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.4 -41.12 96.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.184 -0.947 . . . . 0.0 110.41 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 110.362 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -59.94 -41.16 91.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.047 -1.033 . . . . 0.0 109.944 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.9 -40.19 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 109.541 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.18 94.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.948 . . . . 0.0 108.992 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.33 83.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.449 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 4.8 t60 -69.98 -48.31 58.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.955 . . . . 0.0 109.609 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 82.8 mt-10 -59.95 -40.01 87.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.6 mt -62.88 -39.8 95.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.257 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.65 -41.45 82.28 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.449 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 19.9 m-70 -64.87 -39.17 93.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.8 p -69.99 -21.4 63.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.587 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.93 -3.24 59.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 0.0 109.219 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 9.86 60.85 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.64 124.58 30.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.103 -1.234 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 65.4 m -87.96 171.08 10.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.287 -0.883 . . . . 0.0 109.723 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.5 153.0 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.8 t -126.61 168.93 13.65 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.0 109.391 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.3 p -102.85 9.53 38.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -0.813 . . . . 0.0 109.561 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -82.47 123.86 29.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.519 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.71 -31.46 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.374 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.62 -4.3 90.19 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.652 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.11 129.77 35.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.858 -1.377 . . . . 0.0 109.404 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.5 mt -64.92 -24.94 67.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 108.967 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.9 mmm -73.17 46.98 0.19 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.421 -0.799 . . . . 0.0 109.651 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.2 t80 -69.76 129.95 90.71 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -48.4 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 120.343 1.158 . . . . 0.0 111.78 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.5 p -86.62 171.9 10.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.143 -0.973 . . . . 0.0 109.524 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.269 0.557 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.47 157.16 44.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 108.913 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.85 149.93 37.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.104 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.88 158.57 15.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -60.01 -39.48 85.95 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 108.809 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -57.82 -41.44 82.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.957 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.23 -40.35 62.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.147 . . . . 0.0 110.081 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.36 -50.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.93 -40.12 92.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.57 -55.2 24.29 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.397 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.01 -39.99 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.839 -1.389 . . . . 0.0 109.815 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.8 mt-30 -64.92 -38.5 91.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.681 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.13 92.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.16 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.97 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -98.1 -72.77 0.64 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.42 -0.8 . . . . 0.0 109.564 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.21 -165.06 35.24 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -91.47 139.88 30.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.98 . . . . 0.0 109.694 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.657 ' HG ' ' N ' ' A' ' 45' ' ' THR . 16.6 m . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 109.094 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.51 117.52 21.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.724 -1.235 . . . . 0.0 108.64 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -82.93 -10.5 58.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -84.44 149.55 25.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -96.06 -4.42 43.02 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -126.76 141.24 51.89 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.7 mt -135.74 158.33 44.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -129.39 154.03 47.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -141.39 160.59 39.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.442 -0.786 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -147.17 132.54 18.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.163 -0.961 . . . . 0.0 110.095 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.68 120.62 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.07 -40.16 94.27 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.988 -1.07 . . . . 0.0 109.839 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -160.19 157.14 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.082 -1.011 . . . . 0.0 109.741 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.71 136.83 40.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 109.196 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 t -68.5 141.22 92.99 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.004 . . . . 0.0 109.0 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.72 -10.81 29.47 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 119.5 0.857 . . . . 0.0 112.146 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.0 mt -135.47 151.33 74.46 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.71 -178.7 0.57 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 120.64 0.894 . . . . 0.0 111.257 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -86.72 -35.94 18.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.184 -0.948 . . . . 0.0 110.046 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.11 73.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.97 -39.9 75.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.29 -42.26 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.88 -40.38 88.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.02 -1.05 . . . . 0.0 108.911 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.83 -48.69 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.579 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.4 92.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.585 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.22 -43.24 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 109.937 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.36 -39.76 77.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.205 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -61.15 -39.88 91.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.18 87.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 109.993 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.8 m-85 -60.13 -39.99 88.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.05 . . . . 0.0 109.316 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -59.96 -41.06 91.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.168 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.13 -41.11 91.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -72.3 -40.02 67.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.35 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.26 -37.23 77.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 0.0 110.089 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -57.85 -21.76 44.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.209 -0.932 . . . . 0.0 110.743 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.93 5.66 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.3 p -147.0 150.38 38.54 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 120.975 -1.078 . . . . 0.0 109.534 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.12 5.3 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.688 0.925 . . . . 0.0 110.997 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -70.86 160.3 33.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.462 -0.774 . . . . 0.0 110.073 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 p -139.36 153.83 47.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.5 m-85 -130.02 152.02 49.93 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.515 -0.741 . . . . 0.0 109.585 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.541 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 18.3 m -153.31 131.32 11.79 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.283 -0.886 . . . . 0.0 110.33 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -79.5 139.11 37.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.54 136.1 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.346 -0.846 . . . . 0.0 108.842 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -96.89 -8.59 30.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.126 -0.984 . . . . 0.0 110.011 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -145.51 159.97 42.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 109.586 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 172.22 44.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.16 146.27 31.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -1.222 . . . . 0.0 109.494 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.77 145.72 33.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.65 -0.656 . . . . 0.0 109.422 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -117.27 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.497 -0.752 . . . . 0.0 108.978 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.1 mmm -100.09 122.05 42.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.271 -0.893 . . . . 0.0 109.778 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -112.1 129.77 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.254 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.6 p -149.81 161.5 42.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.137 -0.977 . . . . 0.0 109.676 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -109.01 138.39 45.43 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.365 -0.835 . . . . 0.0 110.692 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -133.11 145.45 50.72 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.41 -140.54 4.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -77.74 134.6 38.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.366 -1.079 . . . . 0.0 110.184 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.6 p-80 -136.46 64.55 1.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.525 -0.734 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.456 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 18.8 mtt-85 54.48 47.48 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.411 -0.806 . . . . 0.0 110.091 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 91.7 m-20 -141.52 165.05 28.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -95.61 9.92 38.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.342 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 67.86 73.59 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.547 -0.721 . . . . 0.0 109.723 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.61 147.29 86.18 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.044 1.162 . . . . 0.0 112.488 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.65 145.44 34.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -138.25 79.92 1.77 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.64 173.37 36.57 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.41 -7.35 19.94 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.147 1.231 . . . . 0.0 111.676 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.88 174.44 47.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.45 -160.54 31.77 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -76.51 144.66 39.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -1.097 . . . . 0.0 109.586 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.93 -15.43 29.8 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.99 -1.069 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.89 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -0.965 . . . . 0.0 108.926 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.14 121.2 3.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.801 -1.187 . . . . 0.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.17 172.63 10.39 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.284 0.564 . . . . 0.0 109.693 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -113.58 147.86 37.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -59.91 149.01 75.1 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.34 112.46 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.811 1.008 . . . . 0.0 112.197 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.52 172.9 43.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -73.27 161.61 42.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.352 1.368 . . . . 0.0 112.29 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.63 -119.5 5.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.66 -11.39 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.171 . . . . 0.0 109.857 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.28 144.39 47.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.06 -15.55 48.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -67.36 162.11 23.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.89 120.46 12.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.275 -0.891 . . . . 0.0 109.099 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -104.75 134.13 48.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.271 -0.893 . . . . 0.0 110.785 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.93 130.91 57.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 56.5 t0 -67.19 123.91 21.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 99' ' ' GLU . 13.9 tp10 -102.11 0.32 34.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.508 -0.745 . . . . 0.0 109.622 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 96.5 m-20 -73.88 -19.56 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 108.886 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.51 155.7 17.7 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.1 ttt-85 -86.03 121.59 28.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.02 148.71 24.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.5 p -127.11 156.57 41.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.358 -0.839 . . . . 0.0 109.9 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -107.36 30.95 5.78 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -148.43 -164.99 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -84.31 33.87 0.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.57 -163.37 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.405 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -54.17 -59.32 4.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.398 -0.814 . . . . 0.0 111.935 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.36 130.01 54.84 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.138 -0.976 . . . . 0.0 110.755 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -102.82 117.85 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.21 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.11 -49.34 67.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -59.86 -40.29 88.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 111.508 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.01 -41.27 91.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.686 -1.259 . . . . 0.0 109.611 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.96 -40.01 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 108.645 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.99 89.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.533 -0.73 . . . . 0.0 109.35 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.41 93.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.198 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -69.98 -46.61 64.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -59.13 -40.51 85.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.005 -1.059 . . . . 0.0 109.556 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.62 -35.71 81.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 108.819 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.77 -40.46 96.66 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -66.93 -38.27 85.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.589 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.0 p -69.5 -23.13 63.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.237 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.89 -2.3 58.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.186 -0.946 . . . . 0.0 109.143 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.49 65.66 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.69 128.29 34.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.339 . . . . 0.0 108.714 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.74 173.8 8.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 109.954 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -67.15 158.51 31.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.419 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 23.1 t -127.75 156.67 42.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.54 -0.725 . . . . 0.0 109.59 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.4 p -100.98 8.4 43.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.539 -0.726 . . . . 0.0 109.708 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.419 ' H ' ' HG ' ' A' ' 129' ' ' SER . 54.6 t0 -81.0 130.04 34.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 109.257 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 132' ' ' ILE . 96.0 mt -59.98 -39.79 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.331 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.41 72.6 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.238 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.53 137.87 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.686 -1.479 . . . . 0.0 109.146 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.16 -25.17 66.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -0.807 . . . . 0.0 109.021 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 66.5 mmm -74.09 62.04 0.88 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.394 -0.816 . . . . 0.0 109.043 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.1 129.44 87.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 108.852 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -48.21 -59.9 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.404 1.18 . . . . 0.0 111.829 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.618 ' HG ' ' H ' ' A' ' 140' ' ' TYR . 14.1 t -102.98 173.25 6.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.618 ' H ' ' HG ' ' A' ' 139' ' ' SER . 74.1 t80 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 120.808 -1.183 . . . . 0.0 109.0 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.04 0.448 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -150.03 154.17 37.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 109.049 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.78 146.96 39.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 108.954 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.4 161.47 14.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.475 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.26 -39.92 88.49 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.0 -41.53 87.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -74.08 -40.09 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 153' ' ' ILE . 90.1 mt -64.14 -50.16 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.839 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.61 -39.87 89.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.12 -60.94 7.51 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.777 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.25 -39.93 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.341 . . . . 0.0 109.274 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.5 mt-30 -65.73 -38.09 88.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 109.035 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.95 95.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.69 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.2 -50.12 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.194 -0.941 . . . . 0.0 109.2 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -96.96 -71.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 109.578 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.94 -177.57 38.96 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.56 146.42 24.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.356 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 8' ' ' ARG . 36.6 mtt-85 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.262 0.554 . . . . 0.0 109.892 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.1 126.03 30.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.173 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.35 -12.99 53.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 110.103 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -81.66 153.62 26.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.6 p -97.42 -6.28 34.31 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.302 -0.874 . . . . 0.0 108.82 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 34.1 m170 -126.64 143.78 51.12 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.2 159.58 39.76 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.194 -0.941 . . . . 0.0 109.859 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.5 p -127.54 152.98 46.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -142.86 156.11 44.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.722 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -150.21 131.8 14.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 0.0 109.86 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.96 118.47 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.59 -40.05 95.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 0.0 110.735 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -162.5 153.15 17.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.953 -1.092 . . . . 0.0 109.901 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.62 136.53 38.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.86 139.58 88.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.002 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -66.92 -14.05 42.26 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.614 0.898 . . . . 0.0 111.588 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.14 -38.19 82.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.352 -0.842 . . . . 0.0 109.037 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -134.74 149.96 72.15 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.03 -176.96 0.69 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.643 0.896 . . . . 0.0 111.859 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -87.29 -35.34 18.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 109.613 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.1 82.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.09 -40.1 75.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.007 . . . . 0.0 109.773 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.35 -46.08 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.682 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -59.62 -39.99 86.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.782 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -59.93 -46.9 87.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.813 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.4 92.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.206 -0.934 . . . . 0.0 109.827 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.47 -36.87 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 108.657 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.06 -39.96 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.15 -39.91 88.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.82 -1.175 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.54 72.92 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.368 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -62.94 -40.21 96.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.037 -1.04 . . . . 0.0 110.196 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.19 -44.81 94.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.962 -1.086 . . . . 0.0 109.623 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.1 -44.12 95.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.247 -0.908 . . . . 0.0 111.016 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.439 ' O ' ' OG1' ' A' ' 45' ' ' THR . 88.0 m95 -70.12 -41.83 73.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.681 -1.262 . . . . 0.0 109.802 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t -69.86 -30.57 68.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 110.359 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.88 -34.36 73.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 111.152 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.01 11.02 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.103 -0.998 . . . . 0.0 111.168 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 65.0 p -140.91 148.15 51.09 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.898 -1.126 . . . . 0.0 109.367 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.69 9.12 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.572 0.848 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.88 156.42 37.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 30.5 p -135.39 149.86 49.76 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.4 156.66 40.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.316 -0.865 . . . . 0.0 109.962 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -154.39 131.19 10.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -77.02 143.74 39.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.454 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 134.51 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.2 t -97.25 -4.08 39.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.13 159.06 43.57 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.911 -1.118 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.03 173.07 34.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -81.06 151.15 28.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 108.898 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.33 153.54 23.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.382 -0.824 . . . . 0.0 109.206 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.85 -40.94 90.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.93 119.46 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.642 -0.661 . . . . 0.0 109.389 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.1 mtp -103.82 131.38 51.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.409 -0.807 . . . . 0.0 108.867 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 61' ' ' ILE . 86.6 mt -118.88 129.38 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -150.52 159.69 44.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.19 137.27 44.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.01 160.09 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 0.0 111.169 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -128.71 137.81 51.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.775 -0.578 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.25 -141.57 3.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.72 126.96 31.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -1.054 . . . . 0.0 109.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -133.65 55.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.616 -0.677 . . . . 0.0 109.345 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 54.98 52.27 12.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 109.761 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.4 161.28 37.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.99 9.43 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.775 . . . . 0.0 110.379 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.5 t -139.74 72.91 35.21 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 109.106 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.31 152.06 79.76 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.234 1.289 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -77.79 150.33 34.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -129.65 72.42 1.48 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.545 -0.722 . . . . 0.0 109.824 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.11 170.47 38.17 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.5 Cg_endo -65.2 -24.72 58.35 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.366 1.377 . . . . 0.0 112.046 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.62 -177.98 46.7 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.8 -137.68 14.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.554 ' ND2' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -76.02 122.15 23.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -1.009 . . . . 0.0 109.83 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' N ' HD21 ' A' ' 80' ' ' ASN . 63.7 mt -90.61 -17.52 26.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.009 -1.057 . . . . 0.0 109.993 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.554 ' H ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.07 160.42 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.88 179.99 8.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.946 -1.097 . . . . 0.0 110.269 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.52 173.32 12.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 109.765 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.25 146.87 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.426 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 3.9 mp0 -59.72 146.99 79.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.901 -1.125 . . . . 0.0 108.397 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -51.04 113.32 1.05 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 120.498 0.799 . . . . 0.0 112.646 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.43 -178.3 34.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.05 176.84 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.246 1.298 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.32 -121.55 24.58 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.216 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -78.8 -10.45 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.577 -0.955 . . . . 0.0 110.284 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.37 151.39 13.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.24 -19.17 32.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.06 157.0 36.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -1.098 . . . . 0.0 110.6 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 122.95 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -102.07 146.0 28.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.858 . . . . 0.0 110.667 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.548 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 16.1 m-85 -117.49 138.31 51.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.444 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 7.9 t70 -65.9 118.39 9.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.032 -1.042 . . . . 0.0 108.599 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -97.9 -1.44 42.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 110.052 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.39 -18.61 59.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 77' ' ' PRO . 95.9 mt-10 -97.63 158.1 15.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 109.202 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -86.53 115.14 23.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.97 -1.081 . . . . 0.0 109.703 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 93.3 m95 -90.12 148.5 22.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 20.1 p -127.97 159.4 35.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.437 -0.79 . . . . 0.0 109.115 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -113.73 30.26 7.38 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.613 HD21 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -147.58 -164.4 2.0 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.062 . . . . 0.0 110.722 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 90.7 t80 -73.72 25.68 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.703 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.517 ' CG ' HD22 ' A' ' 106' ' ' ASN . 26.9 mmt180 -76.1 -168.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.612 -1.305 . . . . 0.0 109.904 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.52 -57.74 10.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 112.208 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.482 ' O ' ' OG1' ' A' ' 104' ' ' THR . 88.5 m-85 -99.5 118.57 36.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.685 -1.26 . . . . 0.0 111.431 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.48 116.52 31.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.339 -0.851 . . . . 0.0 109.475 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 tp -63.53 -38.45 91.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.428 -0.795 . . . . 0.0 109.688 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -59.78 -39.96 86.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 111.16 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.4 -43.87 92.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.848 -1.157 . . . . 0.0 109.857 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.77 -39.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.062 -1.024 . . . . 0.0 109.525 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.9 92.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.79 93.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.837 . . . . 0.0 109.617 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.428 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 5.3 t60 -69.89 -46.3 65.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.846 . . . . 0.0 110.882 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.548 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 80.5 mt-10 -59.86 -40.46 88.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.748 -1.22 . . . . 0.0 109.329 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.258 -0.901 . . . . 0.0 108.572 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.27 78.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.428 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 36.7 m-70 -65.05 -37.89 89.05 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -1.191 . . . . 0.0 108.716 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.0 p -70.27 -24.74 63.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.52 -2.99 58.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.151 -0.968 . . . . 0.0 108.821 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.77 15.79 62.72 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -82.9 130.16 35.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 m -88.25 169.97 11.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -68.57 156.6 37.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.386 -0.821 . . . . 0.0 109.114 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.6 t -131.96 160.84 34.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.85 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.1 p -99.54 6.81 45.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.329 -0.857 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 59.8 t0 -79.91 131.09 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 96.6 mt -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.459 -0.775 . . . . 0.0 109.988 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.38 -2.74 68.74 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.183 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.95 131.69 34.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.75 -1.441 . . . . 0.0 109.8 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.01 -29.87 67.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.0 mmm -75.59 53.95 0.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.186 -0.947 . . . . 0.0 109.732 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.42 ' C ' ' H ' ' A' ' 139' ' ' SER . 9.6 t80 -70.2 140.27 87.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 4.03 1.01 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 119.949 1.017 . . . . 0.0 111.636 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -156.95 177.53 11.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.625 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.5 t80 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 120.838 -1.164 . . . . 0.0 110.001 -179.894 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.328 0.585 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -142.54 151.5 41.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.345 -0.847 . . . . 0.0 108.92 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.64 147.85 39.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.119 -0.988 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.94 153.27 19.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.03 -39.33 78.11 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -53.58 -39.98 65.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.145 -0.972 . . . . 0.0 108.484 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -72.76 -39.95 66.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.279 -0.888 . . . . 0.0 108.701 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.42 -50.2 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 0.0 108.769 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.6 -40.05 93.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.76 -55.75 13.37 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.756 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.11 -40.19 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.923 -1.34 . . . . 0.0 109.616 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -69.6 -38.83 77.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.25 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.57 94.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.112 -0.992 . . . . 0.0 109.38 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.56 -50.06 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.602 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.28 -173.52 40.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -89.06 148.25 23.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.894 -179.871 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.158 0.504 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -82.17 124.15 29.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.01 . . . . 0.0 108.852 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -84.31 -14.01 50.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -87.3 147.34 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 110.317 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.6 p -94.64 -4.72 47.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.221 -0.924 . . . . 0.0 108.808 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 66.9 m80 -120.69 133.3 55.36 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt -131.8 156.33 46.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.143 -0.973 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -128.58 155.64 44.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.421 -0.799 . . . . 0.0 109.511 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -147.01 161.33 41.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -149.0 133.96 18.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.403 -0.811 . . . . 0.0 109.973 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.8 mt -89.9 118.52 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 93.4 mt-10 -65.94 -41.32 91.44 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.074 -1.016 . . . . 0.0 109.842 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 70.8 m-20 -158.14 158.0 33.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.04 134.45 44.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -68.89 138.02 90.18 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.801 -1.187 . . . . 0.0 108.648 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -66.09 -8.2 19.4 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.659 0.914 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.98 -39.86 87.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 mt -136.89 148.19 62.13 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -58.47 -177.94 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.646 0.897 . . . . 0.0 111.576 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -86.47 -33.72 20.29 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 0.0 109.614 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.51 89.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.905 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.44 -39.55 74.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -0.929 . . . . 0.0 110.016 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.55 -40.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 108.962 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.41 -43.1 93.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.16 -45.06 94.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.258 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.26 88.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.4 -42.87 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.07 -40.68 74.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.855 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -61.01 -40.1 92.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 108.921 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.14 94.64 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.317 -0.864 . . . . 0.0 110.122 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -61.35 -40.17 93.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.766 -1.209 . . . . 0.0 109.398 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -60.56 -42.25 96.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -73.69 -42.51 61.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.037 . . . . 0.0 110.21 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -66.73 -37.97 85.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 110.35 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -57.8 -22.91 49.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.497 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.34 7.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -145.72 149.49 40.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.014 -1.054 . . . . 0.0 109.184 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.92 7.47 1.31 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.615 0.877 . . . . 0.0 111.79 178.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.05 154.98 41.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 43.9 p -133.85 150.05 51.37 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -125.74 159.43 32.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.7 m -154.41 126.63 7.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.38 136.87 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.95 135.11 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.466 -0.771 . . . . 0.0 109.172 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 t -98.21 -4.33 35.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 0.0 110.624 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -142.38 155.36 45.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.893 -1.129 . . . . 0.0 110.111 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 177.39 50.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -82.26 143.48 31.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 108.965 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.77 150.89 25.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.8 -40.38 88.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 108.978 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.4 mt -119.61 118.87 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.717 . . . . 0.0 109.259 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.1 mmm -99.62 130.77 45.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.863 . . . . 0.0 108.878 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.45 130.72 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 160.31 43.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.97 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.7 139.18 42.65 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.58 160.45 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.03 -1.043 . . . . 0.0 111.223 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -129.5 136.69 50.18 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.596 0.712 . . . . 0.0 110.118 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.15 -141.86 2.98 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.76 130.5 43.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -1.053 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -138.18 53.3 1.82 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 109.803 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 53.61 59.64 4.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 108.912 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.95 160.39 43.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.048 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -89.37 9.44 26.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.175 -0.953 . . . . 0.0 109.733 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -136.47 71.06 59.99 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 109.367 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -68.42 144.89 63.24 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.061 1.174 . . . . 0.0 112.018 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -76.93 143.78 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.05 70.33 0.9 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.314 -0.866 . . . . 0.0 108.717 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.27 -165.98 42.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.93 -13.23 8.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.17 1.246 . . . . 0.0 112.597 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.42 -177.98 39.99 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.42 -158.12 28.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.87 149.89 39.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.407 -1.054 . . . . 0.0 109.286 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.35 -20.58 19.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.05 -1.032 . . . . 0.0 109.596 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.96 168.62 5.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 108.582 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.29 122.91 1.31 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.541 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.78 168.48 13.46 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.408 0.623 . . . . 0.0 109.408 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.08 153.72 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -59.58 145.36 82.93 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.007 -1.058 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.31 101.44 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 120.441 0.76 . . . . 0.0 111.709 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.64 174.87 35.75 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.28 -179.81 3.42 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 120.878 1.052 . . . . 0.0 111.203 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.47 -127.16 39.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -73.8 -14.33 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.382 -1.069 . . . . 0.0 110.28 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.41 139.45 48.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -16.63 60.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -67.78 160.25 28.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.74 120.86 10.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.052 -1.03 . . . . 0.0 109.227 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -104.31 136.66 43.49 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.664 -0.648 . . . . 0.0 110.427 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -115.81 136.7 52.8 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.667 -0.645 . . . . 0.0 109.615 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.82 118.97 10.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.027 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -99.58 -0.6 40.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 108.778 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.36 -13.04 60.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -105.58 152.17 23.42 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -89.53 120.07 30.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.178 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -84.13 153.5 23.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 -179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.7 p -117.76 164.69 14.62 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.523 0.677 . . . . 0.0 109.621 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.88 28.88 5.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.03 -165.04 2.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.796 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.66 34.04 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.48 -0.762 . . . . 0.0 109.8 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -76.23 -164.32 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -47.72 -57.56 5.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.835 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.91 149.83 23.14 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.727 -1.233 . . . . 0.0 110.767 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -148.36 91.25 1.88 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.0 109.032 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -60.03 -39.83 87.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.195 -0.941 . . . . 0.0 110.818 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.15 -41.22 92.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.732 -1.23 . . . . 0.0 109.773 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.04 -43.0 95.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.955 -1.091 . . . . 0.0 109.759 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.9 t -69.85 -40.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.365 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.69 89.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 108.877 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -68.98 -42.77 76.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 109.847 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.139 -0.976 . . . . 0.0 108.765 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.3 -39.14 93.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.26 85.34 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -65.75 -35.57 81.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.239 . . . . 0.0 108.804 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.8 m -71.65 -28.72 63.95 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 109.892 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.66 -2.54 56.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.84 11.84 67.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -82.27 129.54 34.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.83 -1.394 . . . . 0.0 109.042 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.0 m -88.72 169.93 11.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.873 . . . . 0.0 109.228 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.42 158.97 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.466 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.8 t -124.46 164.65 19.27 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.1 p -99.35 9.67 42.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.032 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -84.84 127.17 34.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.9 -37.33 71.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.507 -0.746 . . . . 0.0 110.598 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.09 1.14 85.99 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 120.981 -1.075 . . . . 0.0 111.45 -178.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.88 138.74 33.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.517 -1.578 . . . . 0.0 109.406 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.52 -29.72 67.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.9 . . . . 0.0 109.679 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.56 54.52 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.517 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.6 t80 -71.29 136.69 84.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.871 -1.143 . . . . 0.0 108.643 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.17 9.25 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.908 1.003 . . . . 0.0 112.061 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 137' ' ' TYR . 36.6 t -164.29 175.89 9.65 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.6 t80 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.221 -179.991 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -146.94 149.7 33.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 108.997 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.05 142.69 43.72 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.0 164.28 13.15 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -59.81 -39.34 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -58.43 -40.96 83.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -74.5 -40.48 61.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.81 -50.24 81.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.132 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.25 -40.23 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.439 178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -56.66 -61.09 7.88 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.48 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.3 . . . . 0.0 110.26 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.2 mt-30 -63.76 -39.67 94.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.807 -1.183 . . . . 0.0 109.495 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.39 92.75 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.52 -49.01 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -99.48 -62.2 1.27 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.216 -0.928 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.74 -176.47 34.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 148.66 24.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.024 -1.28 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 -179.786 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -80.29 126.38 31.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 108.706 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.9 -10.06 59.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 109.724 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -79.58 150.09 31.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.9 p -96.74 -3.99 41.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.682 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 97.1 m-70 -129.52 138.69 51.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.48 159.97 37.83 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.15 -0.969 . . . . 0.0 110.776 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -126.2 154.04 43.82 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.59 0.709 . . . . 0.0 109.144 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.42 ' HH ' ' HB2' ' A' ' 51' ' ' LYS . 54.1 p90 -143.5 156.18 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 109.422 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.4 ttt-85 -149.57 132.25 15.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 109.432 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.3 mt -89.25 121.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.87 -39.67 93.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.114 -0.991 . . . . 0.0 110.226 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -161.55 156.7 23.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -102.02 139.45 37.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.63 -0.669 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -74.03 145.81 84.07 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.53 -11.8 33.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.919 1.079 . . . . 0.0 111.518 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' H ' ' HG1' ' A' ' 22' ' ' THR . 97.1 m-20 -60.1 -40.02 88.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.6 mt -139.06 151.6 68.23 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.186 -0.946 . . . . 0.0 108.523 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -62.94 -175.27 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 CA-C-N 119.392 0.819 . . . . 0.0 111.93 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.41 -38.85 13.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.18 84.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.53 -39.13 77.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.616 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.97 -42.01 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.02 . . . . 0.0 109.168 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -59.3 -40.48 86.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 108.781 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -60.01 -46.37 89.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.847 . . . . 0.0 109.362 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.0 -39.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.192 -0.942 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.57 -41.56 88.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -60.72 -40.62 92.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.942 -1.099 . . . . 0.0 110.415 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.46 85.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.944 -1.098 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.23 -40.51 96.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.947 -1.096 . . . . 0.0 109.368 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.58 -43.28 97.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.223 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.75 -42.75 93.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.96 . . . . 0.0 110.265 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.0 m95 -70.44 -40.5 73.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.889 -1.132 . . . . 0.0 109.734 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 t -69.77 -32.41 70.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.792 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.02 -33.38 68.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.113 -0.992 . . . . 0.0 111.089 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.44 10.98 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 110.461 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.9 p -146.55 150.36 40.06 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 120.883 -1.135 . . . . 0.0 109.654 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.49 1.44 4.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.744 0.962 . . . . 0.0 111.467 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.01 153.1 44.37 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.406 -0.809 . . . . 0.0 109.275 -179.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.682 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 16.8 p -133.13 149.94 52.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -128.2 149.52 50.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.446 -0.784 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -152.92 133.09 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HB2' ' HH ' ' A' ' 16' ' ' TYR . 62.7 tttp -75.64 144.47 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.732 . . . . 0.0 109.786 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.4 136.58 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t -95.76 -1.47 49.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -145.96 157.18 43.89 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.969 -1.082 . . . . 0.0 109.228 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.78 159.03 13.36 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.07 137.39 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.529 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.15 149.75 22.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.473 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.33 -40.96 92.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.511 -0.743 . . . . 0.0 109.253 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.26 111.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.9 134.93 43.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 61' ' ' ILE . 96.9 mt -119.59 131.39 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.7 p -149.52 160.66 43.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -0.96 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.81 138.56 46.01 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.3 165.57 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 110.798 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -139.7 153.41 47.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.564 -0.71 . . . . 0.0 110.001 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.81 -148.68 0.38 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.3 130.91 45.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -1.08 . . . . 0.0 108.86 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 9.1 p-80 -136.38 57.08 1.79 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.611 -0.681 . . . . 0.0 109.899 -178.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 53.82 53.71 10.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.131 -0.981 . . . . 0.0 109.932 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' SER . 12.0 t70 -144.75 159.28 43.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.7 m-20 -89.65 9.54 26.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.29 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 70.0 m -136.81 73.24 54.08 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.437 -0.789 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.05 155.82 58.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.04 1.16 . . . . 0.0 112.232 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.47 150.24 34.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.508 -0.745 . . . . 0.0 109.154 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.25 77.55 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.15 -172.42 11.56 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -55.8 -14.42 10.69 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.414 1.41 . . . . 0.0 112.417 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.0 178.21 41.96 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 -153.39 26.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.413 -1.051 . . . . 0.0 110.533 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.489 HD22 ' C ' ' A' ' 82' ' ' ALA . 9.0 t30 -72.62 136.68 45.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.946 -0.738 . . . . 0.0 110.25 -179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -94.3 -19.91 20.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.489 ' C ' HD22 ' A' ' 80' ' ' ASN . . . -168.5 159.06 9.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.925 -1.109 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.06 -179.85 7.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.396 -0.815 . . . . 0.0 109.814 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.47 167.78 19.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.237 -0.915 . . . . 0.0 109.429 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -97.83 153.54 18.23 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.978 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -58.64 149.32 63.05 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 104.59 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 120.723 0.949 . . . . 0.0 111.655 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.68 -179.76 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.87 1.047 . . . . 0.0 111.434 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.06 -123.1 31.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.58 -10.05 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.948 . . . . 0.0 110.218 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.26 139.78 47.45 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.001 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.62 -15.97 52.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 127.37 31.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.857 -1.378 . . . . 0.0 110.093 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.73 127.36 47.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -111.21 138.6 47.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.3 -0.875 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.99 134.44 55.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.671 -0.643 . . . . 0.0 109.652 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 46.2 t0 -67.88 120.09 13.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.57 1.28 43.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -74.56 -19.71 60.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.003 -1.061 . . . . 0.0 109.388 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.317 -0.864 . . . . 0.0 108.96 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -85.85 120.08 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 108.701 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.448 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 92.8 m95 -89.52 146.64 24.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.805 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.2 p -123.18 161.16 25.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.22 29.44 7.8 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.756 HD22 ' HE ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -149.03 -164.99 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -80.68 31.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.956 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.756 ' HE ' HD22 ' A' ' 106' ' ' ASN . 61.2 mtm180 -74.57 -166.62 0.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.739 -1.226 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -48.74 -58.49 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.661 -0.649 . . . . 0.0 111.704 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.438 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -107.52 129.8 54.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.971 -1.081 . . . . 0.0 110.975 -178.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -102.48 112.67 25.5 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.37 -41.4 76.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.31 -0.869 . . . . 0.0 111.207 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.74 -41.33 90.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.81 -1.181 . . . . 0.0 109.528 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.8 -43.45 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.464 -0.772 . . . . 0.0 110.257 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.93 -39.79 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.189 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.1 92.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.225 -0.922 . . . . 0.0 109.067 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.66 92.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.612 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.74 -49.2 66.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 108.892 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 42.5 mt-10 -59.75 -41.44 91.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.76 -37.36 86.31 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 108.231 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.52 -41.88 89.35 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -64.2 -35.91 82.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 108.388 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.6 m -69.03 -26.46 65.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.628 -0.67 . . . . 0.0 109.413 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.36 -4.3 59.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.61 61.62 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.22 128.53 34.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.069 -1.253 . . . . 0.0 109.457 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.7 m -88.6 173.0 8.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 109.701 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -68.29 157.03 36.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -0.854 . . . . 0.0 109.014 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 38.7 t -125.01 164.4 20.24 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 64.5 p -97.41 4.34 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 109.318 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.546 ' H ' ' HG ' ' A' ' 129' ' ' SER . 59.9 t0 -82.07 124.95 30.28 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.949 -1.095 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.3 -39.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 110.387 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 5.65 51.91 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.356 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 142.75 30.42 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.65 -1.5 . . . . 0.0 109.292 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.78 -39.48 85.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 109.44 179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 31.1 mtp -71.1 67.85 0.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.473 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.514 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.5 t80 -71.69 124.89 91.6 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.11 -1.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 CA-C-N 120.488 1.21 . . . . 0.0 113.008 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 137' ' ' TYR . 50.3 m -167.75 166.96 13.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.071 -1.018 . . . . 0.0 108.486 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.688 -1.258 . . . . 0.0 108.84 179.662 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 121.426 0.632 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -148.73 159.44 44.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.806 . . . . 0.0 109.093 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.72 144.49 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.014 -1.054 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 163.16 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.013 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.95 -40.18 88.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -59.63 -41.37 90.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.264 -0.898 . . . . 0.0 109.835 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.24 -40.32 64.75 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.089 -1.007 . . . . 0.0 109.408 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.94 -49.96 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -64.87 -39.76 94.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.559 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.92 -54.72 26.31 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.067 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.43 -38.56 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.996 -1.296 . . . . 0.0 109.377 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -68.05 -34.92 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.106 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.16 88.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.34 -50.56 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.099 -1.001 . . . . 0.0 108.911 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -97.84 -73.69 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.72 . . . . 0.0 109.255 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.49 -169.34 37.74 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.1 mtm-85 -92.28 144.61 25.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.287 . . . . 0.0 109.707 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.487 1.417 0 O-C-N 121.254 -0.904 . . . . 0.0 108.914 -179.834 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -83.8 127.28 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.953 -1.092 . . . . 0.0 108.408 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.18 -10.78 59.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.272 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.447 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 9.8 mp0 -85.79 149.49 25.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.755 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -94.46 -4.12 48.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 108.623 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.547 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 33.7 m-70 -128.88 141.53 51.25 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.9 mt -130.27 153.76 48.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.388 -0.82 . . . . 0.0 109.675 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 p -125.29 155.8 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -144.61 159.91 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -149.29 133.14 17.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 18' ' ' ILE . 88.1 mt -89.88 120.05 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -65.86 -40.09 91.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.069 -1.019 . . . . 0.0 110.04 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -159.95 155.34 25.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.017 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -99.69 136.83 39.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 t -67.7 139.21 93.64 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.15 -0.968 . . . . 0.0 108.628 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.55 -13.96 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 CA-C-N 119.561 0.879 . . . . 0.0 112.196 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.23 -40.21 89.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 110.393 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.84 149.37 70.41 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.14 -175.92 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 119.304 0.787 . . . . 0.0 111.831 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 15.9 ptm180 -87.38 -32.27 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -56.96 -44.86 83.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 110.15 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.05 -39.8 54.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.011 -1.056 . . . . 0.0 110.159 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.41 -49.51 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 111.179 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 42.3 p-10 -58.98 -39.24 81.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.67 -1.269 . . . . 0.0 109.402 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.4 t60 -59.82 -43.3 94.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 0.0 108.86 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.26 91.5 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.25 -42.63 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -69.99 -39.12 76.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.052 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.31 -40.12 89.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.95 90.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.601 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.5 m-85 -60.08 -40.14 88.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 109.025 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.03 -43.01 95.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.1 -43.95 95.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.703 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -71.2 -42.3 69.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.659 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.2 t -67.75 -32.53 73.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 110.834 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.22 -35.0 72.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 110.72 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.87 14.92 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.283 -0.885 . . . . 0.0 111.122 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 62.2 p -144.66 147.34 35.5 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.833 -1.167 . . . . 0.0 109.139 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.9 6.3 1.75 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.623 0.882 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -72.57 163.76 27.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.227 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.547 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 33.3 p -138.89 151.34 46.88 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.96 149.97 52.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.632 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -155.04 129.81 9.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -77.93 142.08 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.405 -0.81 . . . . 0.0 109.922 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.42 134.85 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -97.13 -4.99 38.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.94 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -142.76 151.04 40.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.096 -1.003 . . . . 0.0 109.747 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.63 169.53 42.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.06 146.44 30.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -1.154 . . . . 0.0 109.025 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.79 157.08 18.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.41 -0.806 . . . . 0.0 109.209 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.93 118.09 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.412 -0.805 . . . . 0.0 109.581 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -98.57 128.11 44.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -110.68 129.94 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.4 p -148.41 155.11 40.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.94 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -104.72 139.14 39.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.6 160.09 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.344 -0.847 . . . . 0.0 110.754 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.32 142.46 50.82 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.682 -0.636 . . . . 0.0 109.442 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.79 -140.99 5.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -78.65 128.08 32.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -1.035 . . . . 0.0 109.285 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.588 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.6 p-80 -126.04 56.9 1.4 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 109.872 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 31.1 mmt180 56.4 47.82 18.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.544 -0.723 . . . . 0.0 109.997 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.2 m-20 -138.83 162.89 33.66 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.387 -0.82 . . . . 0.0 108.877 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -89.97 8.76 30.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.942 . . . . 0.0 110.333 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -136.04 73.35 59.02 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -70.02 155.84 64.11 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.164 1.243 . . . . 0.0 112.188 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.91 150.36 32.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -121.94 75.02 1.18 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.546 -0.721 . . . . 0.0 109.438 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.14 -171.27 7.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -53.05 -8.97 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.26 1.307 . . . . 0.0 112.784 -179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.27 46.81 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.83 -171.22 55.09 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -73.83 151.41 40.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.298 -1.119 . . . . 0.0 109.234 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 mt -91.01 -12.53 35.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.984 -1.073 . . . . 0.0 109.72 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.37 163.3 12.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.42 -179.6 7.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -0.817 . . . . 0.0 109.033 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.21 168.98 18.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.99 156.66 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -59.09 150.04 64.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.58 101.38 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 CA-C-N 119.083 0.708 . . . . 0.0 111.398 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.42 175.88 35.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 179.85 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.801 1.001 . . . . 0.0 111.667 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.47 -130.55 40.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -78.83 -7.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -1.19 . . . . 0.0 109.245 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.01 137.35 49.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.21 -15.63 52.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -67.91 124.64 23.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.884 -1.362 . . . . 0.0 109.964 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.13 149.87 21.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -132.9 132.5 42.12 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.427 -0.795 . . . . 0.0 109.668 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.78 135.38 54.09 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.407 -0.808 . . . . 0.0 109.914 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.466 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 56.7 t0 -67.58 121.83 16.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 108.935 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -98.98 0.02 43.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.358 -0.839 . . . . 0.0 109.834 -179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.36 -17.97 60.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.793 -1.192 . . . . 0.0 109.508 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.85 157.82 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -84.42 118.72 24.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.026 -1.047 . . . . 0.0 109.381 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.466 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 97.8 m95 -88.24 147.2 24.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.365 -0.834 . . . . 0.0 109.818 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 16.7 p -129.51 157.21 42.66 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.83 31.49 5.97 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -145.91 -164.16 1.9 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -178.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.77 30.85 0.36 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 110.21 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 12.9 mmt-85 -76.28 -164.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.92 -56.84 17.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 111.313 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.466 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.6 m-85 -104.68 119.14 38.29 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.987 -1.07 . . . . 0.0 110.385 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 79.2 m-20 -96.33 112.2 24.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.331 -0.856 . . . . 0.0 110.665 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.962 -1.086 . . . . 0.0 109.71 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 135' ' ' LEU . 20.3 tpt180 -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 -179.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.03 -39.39 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.198 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.37 85.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.951 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 109.511 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -69.98 -48.26 58.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 109.737 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.4 -40.19 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.541 -1.349 . . . . 0.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.48 -31.64 72.94 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.94 -39.64 95.83 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -66.59 -34.49 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -1.082 . . . . 0.0 109.037 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -69.64 -23.24 63.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.225 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.92 -4.94 58.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 109.221 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.91 16.7 59.22 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.35 131.11 35.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.927 -1.337 . . . . 0.0 109.809 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.5 m -88.41 171.56 10.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.989 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -68.59 159.15 32.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.3 t -125.08 157.41 36.35 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.53 -0.731 . . . . 0.0 109.461 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -99.89 3.82 44.73 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.43 126.9 32.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 132' ' ' ILE . 87.9 mt -60.0 -39.99 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.66 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.37 -1.06 49.89 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.047 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.95 33.15 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.682 -1.481 . . . . 0.0 109.38 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.449 ' CD2' ' NH1' ' A' ' 114' ' ' ARG . 93.6 mt -66.47 -34.43 77.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.776 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 37.7 mtp -75.15 64.95 1.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.945 . . . . 0.0 110.297 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.8 t80 -72.63 137.51 80.39 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 108.859 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.83 7.09 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 119.926 1.009 . . . . 0.0 112.127 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 137' ' ' TYR . 31.1 p -159.0 174.67 14.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 108.704 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.795 -1.19 . . . . 0.0 110.118 -179.629 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.487 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 39.7 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.373 0.606 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 99.9 mm-40 -148.9 159.0 44.59 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.09 139.85 41.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.963 -1.086 . . . . 0.0 108.765 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.55 164.88 13.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -40.51 89.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.0 -40.08 79.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.187 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.9 -40.9 60.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 109.829 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 153' ' ' ILE . 96.2 mt -63.06 -50.01 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.103 -0.998 . . . . 0.0 109.57 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.63 -40.01 95.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 110.153 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.15 -55.28 24.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.429 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.35 -40.0 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.89 -1.359 . . . . 0.0 110.227 -178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.8 mt-30 -68.89 -40.1 79.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 0.0 110.085 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.73 94.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.035 -1.041 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.43 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -96.77 -67.82 0.83 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.194 -0.941 . . . . 0.0 109.855 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.1 179.43 38.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.83 148.5 23.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.112 -1.228 . . . . 0.0 109.098 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.623 -179.583 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 124' ' ' LEU . 23.9 mmm180 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.91 122.74 28.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.006 -1.059 . . . . 0.0 108.543 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 58.7 mp0 -84.28 -11.53 56.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 109.905 -179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.42 144.52 29.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 109.211 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -91.67 -3.27 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.551 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 88.4 m-70 -126.64 142.13 51.63 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.46 156.87 48.0 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.208 -0.933 . . . . 0.0 109.929 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -130.49 154.79 47.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -141.84 159.84 41.41 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -147.09 137.22 23.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.157 -0.964 . . . . 0.0 109.949 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -88.14 119.04 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.513 -0.742 . . . . 0.0 109.025 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -69.9 -39.81 75.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -163.41 150.58 12.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.822 -1.174 . . . . 0.0 110.806 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.81 130.8 44.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.669 -0.644 . . . . 0.0 109.629 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.43 ' OG1' ' OE2' ' A' ' 99' ' ' GLU . 3.5 t -75.39 145.83 80.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.2 -9.67 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 CA-C-N 119.452 0.84 . . . . 0.0 111.956 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.96 -40.19 88.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.165 -0.959 . . . . 0.0 109.517 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.8 mt -140.07 151.24 64.53 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 108.952 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.75 -175.07 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.805 1.004 . . . . 0.0 112.038 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -88.7 -36.91 15.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.614 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -44.0 91.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.413 -0.804 . . . . 0.0 109.519 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.04 -39.92 75.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.08 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.85 -40.72 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.672 -179.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -60.15 -40.36 89.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.984 -1.073 . . . . 0.0 108.949 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.86 -45.19 93.26 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.69 89.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 34' ' ' ILE . 48.3 mm -72.29 -43.1 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.08 -1.012 . . . . 0.0 109.597 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.53 -39.76 81.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.79 -39.81 90.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 110.25 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.77 83.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.961 -1.087 . . . . 0.0 110.166 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -60.18 -39.69 87.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.996 -1.065 . . . . 0.0 109.032 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.73 -40.18 87.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.925 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.97 -44.96 94.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.001 -1.062 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -75.12 -41.81 57.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.226 -0.921 . . . . 0.0 111.132 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -66.77 -38.42 86.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 110.119 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.24 -15.87 28.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 111.044 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.71 2.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.96 -1.088 . . . . 0.0 110.504 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.401 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 13.1 p -145.49 150.57 44.5 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.054 . . . . 0.0 108.899 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.93 8.15 0.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.673 0.915 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.15 153.42 41.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.551 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.2 p -130.34 147.47 52.05 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.27 154.65 45.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.655 . . . . 0.0 109.462 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 m -155.64 133.58 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.486 -0.758 . . . . 0.0 109.87 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.0 135.35 36.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.43 130.72 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.477 -0.765 . . . . 0.0 108.955 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -95.63 0.11 52.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.092 -1.005 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.14 152.78 41.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.35 179.46 51.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.359 -1.083 . . . . 0.0 110.505 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.42 136.95 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.05 -40.21 88.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.212 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -121.52 120.39 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.556 -0.715 . . . . 0.0 109.401 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.9 mtt -100.84 139.19 36.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.38 131.3 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.6 p -151.01 156.11 40.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.119 -0.988 . . . . 0.0 109.949 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -104.35 138.65 40.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.06 160.03 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 O-C-N 121.061 -1.024 . . . . 0.0 110.674 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' CB ' ' A' ' 65' ' ' ARG . 11.5 mtp-105 -129.16 139.79 51.78 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.336 0.589 . . . . 0.0 110.087 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.98 -137.43 2.79 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -73.58 128.43 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.978 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 21.8 p-80 -137.97 65.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 53.21 53.51 11.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -142.69 161.6 37.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 109.106 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.91 9.73 41.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.3 m -138.61 69.68 45.13 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.425 -0.797 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.7 156.05 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.034 1.156 . . . . 0.0 112.292 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -76.6 140.59 41.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -101.76 60.24 0.87 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.545 -0.722 . . . . 0.0 109.613 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.3 179.33 50.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -50.09 -12.22 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.336 1.357 . . . . 0.0 111.927 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -91.23 178.52 41.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.25 -153.97 25.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 47.4 p-10 -75.16 149.65 38.95 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.353 -1.086 . . . . 0.0 109.415 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.13 -18.02 23.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.649 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.16 167.38 7.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -160.1 173.59 15.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.961 -1.087 . . . . 0.0 109.66 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.41 164.31 22.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.124 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.08 152.24 18.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.179 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -59.71 151.18 63.87 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 109.289 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -53.22 104.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 120.718 0.945 . . . . 0.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.92 174.62 34.56 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.0 172.56 15.23 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.069 1.18 . . . . 0.0 111.699 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.02 -125.33 18.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.82 -10.95 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.567 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.36 148.98 28.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.42 -20.65 10.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.01 151.43 47.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.275 . . . . 0.0 109.236 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.58 123.63 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 0.0 108.78 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -100.89 143.07 31.48 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.635 0.731 . . . . 0.0 110.793 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.4 m-85 -113.85 131.29 56.31 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -65.78 118.45 9.64 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.852 -1.155 . . . . 0.0 108.778 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' OG1' ' A' ' 22' ' ' THR . 70.4 tt0 -99.13 0.74 44.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.18 -16.88 60.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.821 -1.174 . . . . 0.0 109.754 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -101.22 159.16 15.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 109.444 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -85.53 121.13 27.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.228 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.94 147.59 23.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.373 -0.83 . . . . 0.0 109.97 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.5 p -129.89 164.21 24.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.491 -0.756 . . . . 0.0 109.573 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -110.33 32.5 5.12 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -149.03 -164.94 2.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 109.371 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -88.72 25.12 1.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 110.019 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -76.71 -161.45 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 110.032 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.0 mt-10 -24.42 -68.7 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.457 ' O ' ' OG1' ' A' ' 104' ' ' THR . 67.1 m-85 -137.27 144.02 42.49 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.967 -1.083 . . . . 0.0 109.912 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -105.02 119.4 38.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.757 . . . . 0.0 109.4 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.88 -40.78 97.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.41 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -59.94 -41.57 92.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.084 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.55 -44.96 93.08 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.082 -1.012 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.03 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.27 92.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.03 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.53 84.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 108.884 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.78 -46.4 62.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.838 . . . . 0.0 109.943 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 64.3 mt-10 -59.89 -40.59 89.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.721 -1.237 . . . . 0.0 109.489 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' A' ' 123' ' ' SER . 81.3 mt -63.15 -38.4 91.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.278 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.92 86.88 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.19 -26.81 64.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.267 . . . . 0.0 109.302 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 83.6 p -71.06 -22.21 62.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.073 -1.017 . . . . 0.0 108.399 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 89.6 mt -85.57 -8.73 58.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.361 -0.837 . . . . 0.0 109.14 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.88 19.28 48.13 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.666 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.93 142.1 32.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.84 -1.388 . . . . 0.0 108.947 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.9 m -87.71 168.39 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.015 -1.053 . . . . 0.0 109.479 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -67.92 153.0 44.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.405 -0.809 . . . . 0.0 109.412 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.5 t -124.11 154.54 39.85 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.1 p -99.99 10.83 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.286 -0.884 . . . . 0.0 109.829 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.5 t0 -83.53 132.91 34.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.925 -1.109 . . . . 0.0 110.143 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 91.8 mt -60.24 -40.04 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.12 -5.72 81.38 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.546 -178.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.55 128.88 34.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.935 -1.333 . . . . 0.0 109.486 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.4 mt -64.31 -25.36 68.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.571 -0.706 . . . . 0.0 109.275 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 47.0 mmm -74.18 45.16 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.115 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.6 t80 -69.55 129.94 91.03 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 108.7 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -46.28 -62.52 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.192 1.104 . . . . 0.0 111.702 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 t -96.97 172.42 7.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 108.819 179.706 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.9 t . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.295 0.569 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -148.63 151.04 34.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 109.056 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.52 142.9 40.72 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.859 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 162.93 13.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 108.735 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -59.83 -40.39 88.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 0.0 109.434 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -58.9 -40.14 83.57 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.521 -0.737 . . . . 0.0 109.642 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.22 -40.87 64.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.095 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.22 -52.81 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.43 -40.13 96.33 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.854 -1.154 . . . . 0.0 110.096 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.8 -55.43 29.86 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.611 -178.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 tp -65.61 -39.96 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.977 -1.308 . . . . 0.0 110.582 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.6 mt-30 -65.64 -39.82 91.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.821 -1.175 . . . . 0.0 109.346 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.59 -44.6 89.87 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.65 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -49.97 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 109.646 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -93.28 -70.1 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.66 -178.66 39.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.94 142.58 27.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.401 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 69.2 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.824 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -83.12 119.83 25.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.976 -1.078 . . . . 0.0 108.5 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.6 -9.97 59.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 109.5 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -80.3 145.08 32.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.51 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 71.7 p -94.81 -8.87 36.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.51 ' CD2' ' HG1' ' A' ' 12' ' ' THR . 93.5 m-70 -123.22 119.86 31.44 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.08 165.41 12.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.499 -0.751 . . . . 0.0 109.253 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -129.58 155.46 45.77 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -144.13 159.21 43.03 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.144 -0.972 . . . . 0.0 109.078 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' O ' ' A' ' 53' ' ' SER . 70.7 ttt180 -148.76 131.19 15.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.061 -1.024 . . . . 0.0 110.608 -178.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.51 116.81 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.22 -42.96 99.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 110.268 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -162.15 160.85 27.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.0 110.19 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.58 136.64 40.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.602 -0.686 . . . . 0.0 109.333 179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.568 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -74.97 142.32 76.11 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.975 . . . . 0.0 108.97 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -61.11 -10.88 16.46 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 CA-C-N 119.527 0.867 . . . . 0.0 111.825 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.568 ' H ' ' HG1' ' A' ' 22' ' ' THR . 94.6 m-20 -59.89 -40.1 87.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.0 mt -139.04 151.17 67.4 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.69 -171.35 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 119.475 0.848 . . . . 0.0 111.914 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HG3' ' NH1' ' A' ' 27' ' ' ARG . 7.1 ptm180 -87.96 -35.43 17.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.57 94.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 109.978 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.02 -39.72 75.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.2 -43.24 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.924 -1.11 . . . . 0.0 109.286 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -59.93 -50.04 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.15 91.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.206 -0.933 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -70.01 -39.82 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 110.159 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.57 -41.23 93.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.019 -1.05 . . . . 0.0 109.844 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -62.42 -40.02 95.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.728 -1.233 . . . . 0.0 110.037 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.66 64.13 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -62.36 -42.51 99.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.842 -1.161 . . . . 0.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mm-40 -60.3 -42.09 94.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.132 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.61 -41.66 90.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 109.91 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 45' ' ' THR . 86.2 m95 -72.79 -40.48 65.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.84 -1.163 . . . . 0.0 109.644 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 t -69.37 -32.97 72.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 110.593 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 17.0 m120 -59.3 -26.1 64.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.234 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.86 7.9 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.238 -0.914 . . . . 0.0 110.668 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 10.5 p -145.95 150.56 42.83 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.883 -1.136 . . . . 0.0 109.644 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.62 2.73 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.912 1.075 . . . . 0.0 111.538 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.04 151.62 44.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.265 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.494 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.8 p -137.16 147.01 45.65 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -121.18 120.24 34.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.6 m -96.0 132.48 41.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.465 -0.772 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 128.48 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 108.871 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 129.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.427 -0.796 . . . . 0.0 108.859 179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.494 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 40.3 t -99.49 0.29 42.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.9 158.63 43.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.138 -0.976 . . . . 0.0 109.639 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.92 170.4 38.4 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -82.62 130.27 35.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -1.152 . . . . 0.0 109.206 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.67 155.11 17.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -59.98 -39.9 87.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.803 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 59' ' ' ILE . 84.9 mt -118.92 120.0 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.7 mmm -99.13 128.6 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.62 126.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.4 p -148.42 157.53 43.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.994 -1.066 . . . . 0.0 110.356 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -107.35 136.85 46.46 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.1 160.38 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.167 -0.958 . . . . 0.0 111.42 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 142.79 49.08 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.26 -147.65 2.59 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.52 128.74 37.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.436 -1.038 . . . . 0.0 109.745 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p-80 -135.97 58.68 1.74 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.43 -0.794 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' A' ' 69' ' ' ARG . 59.6 mtt-85 55.56 52.92 10.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.485 -0.76 . . . . 0.0 110.426 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.0 p-10 -144.17 160.96 40.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.05 -1.031 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -92.48 12.37 23.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.071 -1.018 . . . . 0.0 110.022 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.6 m -139.37 69.76 39.69 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 109.563 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -70.19 148.65 62.77 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.927 1.085 . . . . 0.0 112.153 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.01 150.03 37.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -125.14 73.97 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.424 -0.798 . . . . 0.0 109.506 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.78 167.41 42.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -54.42 -16.34 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.334 1.356 . . . . 0.0 111.984 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 175.63 40.23 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.99 -151.25 19.99 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.99 141.05 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -1.201 . . . . 0.0 109.475 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.6 mt -93.91 -19.69 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.044 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.53 160.54 11.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.903 -1.123 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -160.18 -179.81 8.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.55 167.69 21.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.509 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.65 149.33 21.35 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.09 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -59.96 149.39 73.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -46.88 115.82 1.43 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 120.533 0.822 . . . . 0.0 112.084 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.96 173.9 42.26 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.37 173.95 12.93 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-N 118.157 0.978 . . . . 0.0 111.419 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.19 -120.75 22.27 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.85 -7.35 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.173 -1.192 . . . . 0.0 110.214 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.24 134.25 52.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.5 -11.38 70.19 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.0 124.94 24.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.272 . . . . 0.0 110.068 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.74 126.12 45.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.474 -0.766 . . . . 0.0 109.606 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -107.96 136.85 46.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.563 -0.711 . . . . 0.0 109.627 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -117.33 130.73 56.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.657 -0.652 . . . . 0.0 109.241 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.32 121.55 15.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 109.48 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -100.41 3.75 43.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.381 -0.824 . . . . 0.0 110.17 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -73.73 -18.16 61.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 109.175 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.47 158.43 16.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 108.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -86.9 125.02 33.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.943 . . . . 0.0 109.52 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.49 147.17 23.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.356 -0.84 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.3 p -129.68 158.86 38.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.535 -0.728 . . . . 0.0 109.741 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.03 29.97 7.15 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.554 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 15.8 p30 -144.99 -160.5 1.14 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.832 . . . . 0.0 109.447 -178.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -87.97 15.41 7.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.198 -0.939 . . . . 0.0 110.531 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.5 mtt180 -76.47 -167.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.809 -1.182 . . . . 0.0 109.981 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 108' ' ' ARG . 93.9 mt-10 -4.51 -87.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.02 151.68 51.6 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 110.084 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 5.5 m120 -98.41 115.14 27.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.883 . . . . 0.0 109.391 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.45 -39.22 93.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.008 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -59.06 -42.42 90.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.973 -1.079 . . . . 0.0 109.542 -179.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.9 -39.6 85.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.978 -1.076 . . . . 0.0 109.181 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.51 -40.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.05 92.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.024 . . . . 0.0 109.184 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.4 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.995 -1.066 . . . . 0.0 108.716 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -70.38 -48.8 54.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.68 -42.72 93.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.666 -1.271 . . . . 0.0 110.028 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -39.8 93.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.098 . . . . 0.0 108.701 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.97 88.96 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -65.59 -37.47 86.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -1.191 . . . . 0.0 109.171 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -69.86 -20.77 63.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.211 -0.93 . . . . 0.0 108.554 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.25 -0.97 57.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.43 66.68 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.635 179.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.86 128.68 34.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.896 -1.356 . . . . 0.0 109.082 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -87.97 170.37 11.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.361 -0.837 . . . . 0.0 109.5 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -65.85 155.12 37.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.5 t -125.3 153.71 42.84 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.0 p -99.52 9.87 42.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -82.36 128.37 34.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 108.874 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.04 -40.13 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.22 -2.19 66.16 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.254 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.28 141.19 32.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.712 -1.463 . . . . 0.0 109.201 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.42 -27.84 65.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 29.9 mtp -74.19 52.08 0.45 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.846 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 139' ' ' SER . 22.2 t80 -70.45 137.6 86.23 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -53.32 -1.99 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 119.828 0.974 . . . . 0.0 112.498 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 137' ' ' TYR . 81.4 p -159.94 174.75 13.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.938 -1.101 . . . . 0.0 110.502 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 0.0 109.676 -179.811 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.408 0.623 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -146.9 156.95 43.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.3 mt -75.97 146.63 39.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.883 -1.136 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.46 153.31 19.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.401 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -57.04 -39.94 75.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -53.08 -40.15 63.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.918 -1.114 . . . . 0.0 108.945 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.76 -39.67 66.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.32 -48.03 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.62 -40.09 90.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.727 -1.233 . . . . 0.0 110.514 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -51.46 44.59 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.162 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.62 -40.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.874 -1.368 . . . . 0.0 109.767 -179.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.3 mt-30 -66.08 -39.97 90.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.09 95.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.032 -1.042 . . . . 0.0 109.814 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -50.13 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.33 -65.41 0.96 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.121 -0.987 . . . . 0.0 109.421 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.34 -170.21 33.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.04 142.87 27.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.111 -1.229 . . . . 0.0 109.303 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.012 -1.055 . . . . 0.0 109.002 179.816 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.08 120.91 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 108.82 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.0 -10.01 58.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.37 148.65 29.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.275 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -95.86 -6.07 40.18 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.083 -1.011 . . . . 0.0 108.866 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 15.0 m-70 -130.62 132.57 45.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.238 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -121.77 156.03 34.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.7 p -125.7 153.57 43.7 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -144.78 161.06 40.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.77 132.45 13.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.869 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.59 120.03 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -64.96 -40.01 94.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -160.37 150.39 18.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.898 -1.126 . . . . 0.0 109.768 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.25 140.33 30.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 99' ' ' GLU . 9.0 t -70.7 137.24 85.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 109.642 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.75 -14.59 45.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.815 0.97 . . . . 0.0 111.792 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.99 -40.1 88.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.2 mt -135.05 149.1 69.37 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.05 -174.01 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 120.545 0.83 . . . . 0.0 112.031 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.43 -36.16 16.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.872 . . . . 0.0 109.739 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.99 -41.18 77.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 108.89 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -39.98 75.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.435 -0.79 . . . . 0.0 109.628 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.04 -43.83 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.982 . . . . 0.0 109.021 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.98 -39.93 87.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.337 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.622 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 59.9 t60 -59.97 -50.05 75.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.75 89.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 110.763 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.8 mm -70.05 -38.43 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.123 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.38 -41.3 96.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.007 -1.058 . . . . 0.0 109.776 -178.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.622 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 32.7 mttp -64.76 -37.58 88.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 109.994 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.947 -1.096 . . . . 0.0 109.322 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.88 -41.44 97.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 109.02 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.07 -41.53 92.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.831 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.92 -41.8 92.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.018 -1.051 . . . . 0.0 109.621 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.2 m95 -74.57 -40.49 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.04 -1.037 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -69.86 -35.27 74.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.106 -0.996 . . . . 0.0 110.42 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.31 -31.4 65.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 110.435 -178.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -109.53 9.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.308 -0.87 . . . . 0.0 110.208 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 72.9 p -140.94 144.91 37.13 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.234 -0.916 . . . . 0.0 108.983 178.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.9 2.99 3.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.563 0.842 . . . . 0.0 111.226 178.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.21 153.61 42.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 62.6 p -130.39 143.1 50.56 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.16 151.68 37.89 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.515 -0.741 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.9 m -153.34 131.71 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.49 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -77.19 144.88 38.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.439 -0.788 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.53 135.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.496 -0.753 . . . . 0.0 109.072 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -95.36 -6.86 40.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -150.18 159.57 44.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.032 -1.042 . . . . 0.0 109.411 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.14 176.42 51.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -83.81 139.04 32.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -1.096 . . . . 0.0 109.495 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.58 143.79 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.319 -0.863 . . . . 0.0 109.138 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -59.95 -40.09 87.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.011 -1.056 . . . . 0.0 109.348 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.01 118.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.7 mtt -102.45 133.3 47.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.239 -0.913 . . . . 0.0 109.579 179.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.25 128.33 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.1 p -147.36 153.13 39.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -101.87 138.54 38.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.24 164.86 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.189 -0.944 . . . . 0.0 110.535 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 65' ' ' ARG . 42.8 mtm-85 -139.96 142.45 36.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.67 5.39 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -70.04 127.25 32.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -1.074 . . . . 0.0 109.71 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 19.4 p-80 -136.94 62.29 1.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 69' ' ' ARG . 4.2 mmt-85 56.17 49.99 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.74 . . . . 0.0 109.304 -179.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.0 t0 -142.55 148.13 37.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 51.6 p-10 -89.48 9.73 25.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.064 -1.023 . . . . 0.0 109.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -136.24 73.14 58.17 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.555 -0.716 . . . . 0.0 109.161 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.85 166.44 26.36 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.252 1.301 . . . . 0.0 112.207 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -77.95 149.33 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 10.6 t0 -101.88 65.38 1.0 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.278 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.46 170.11 46.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.7 -16.26 29.95 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 120.903 1.069 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.42 -175.78 43.28 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.05 17.21 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.159 -1.2 . . . . 0.0 110.102 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 82' ' ' ALA . 13.7 t-20 -73.83 123.8 24.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.452 -1.028 . . . . 0.0 109.591 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.36 -14.32 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.128 -0.983 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -169.01 158.45 8.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.911 -1.118 . . . . 0.0 109.737 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.14 -178.8 6.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.059 -1.025 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.2 178.49 8.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.92 -178.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -104.33 157.4 17.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.656 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -59.99 149.59 73.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.14 103.99 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.601 0.867 . . . . 0.0 112.286 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.92 168.11 34.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.68 -178.42 1.57 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.045 1.163 . . . . 0.0 111.737 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.18 -123.18 30.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 tt -79.99 -12.8 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.949 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.11 144.18 48.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.52 -16.4 53.67 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -66.9 157.36 33.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -1.215 . . . . 0.0 109.366 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.88 17.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.188 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -102.17 136.06 42.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.75 . . . . 0.0 109.59 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -114.14 129.65 56.62 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.76 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.19 117.8 9.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.181 -0.95 . . . . 0.0 109.126 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' HG1' ' A' ' 22' ' ' THR . 25.2 tt0 -97.7 1.89 49.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 0.0 109.306 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.76 -17.68 61.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 0.0 108.447 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -97.49 158.51 15.44 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.632 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -85.58 120.58 27.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.928 -1.108 . . . . 0.0 108.962 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -90.51 140.0 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 109.539 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.9 p -125.29 170.0 11.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.559 -0.713 . . . . 0.0 109.691 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.37 28.76 8.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.459 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -148.58 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.63 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -86.95 27.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 110.643 -178.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -75.84 -158.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.659 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ARG . 96.1 mt-10 -32.47 -62.99 0.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.976 -0.453 . . . . 0.0 111.732 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.4 m-85 -136.04 141.38 44.3 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.118 -0.989 . . . . 0.0 110.219 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -98.96 116.75 31.91 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.98 -43.84 94.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -59.99 -41.0 91.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.624 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -59.97 -43.3 95.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.029 -1.044 . . . . 0.0 110.109 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -69.99 -40.0 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.961 -1.087 . . . . 0.0 108.807 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.71 87.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.01 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.81 92.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.419 ' CD2' ' NE2' ' A' ' 122' ' ' HIS . 3.6 t-160 -69.01 -48.06 63.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 108.949 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.23 -42.59 91.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.903 -1.123 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.67 -40.01 95.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 109.46 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.98 84.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.419 ' NE2' ' CD2' ' A' ' 118' ' ' HIS . 24.3 m-70 -63.46 -36.97 85.52 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -1.1 . . . . 0.0 108.738 179.242 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.9 m -68.81 -26.54 65.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 109.127 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.58 -2.61 54.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 108.469 179.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.01 10.61 66.22 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.81 126.88 31.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.372 . . . . 0.0 109.178 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.7 m -88.07 174.26 8.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.798 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -67.08 157.14 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.4 t -131.37 159.68 37.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.0 p -101.72 11.8 38.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 56.8 t0 -80.1 132.93 36.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.007 -1.058 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 95.9 mt -60.04 -40.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.431 -0.793 . . . . 0.0 111.253 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.14 81.98 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.908 -1.12 . . . . 0.0 111.157 -178.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.93 136.82 34.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.656 -1.496 . . . . 0.0 109.776 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.02 -29.88 67.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.445 -0.784 . . . . 0.0 109.267 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mmm -71.43 51.0 0.17 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 -178.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.2 t80 -70.0 137.22 87.24 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -64.85 10.22 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 119.871 0.99 . . . . 0.0 111.7 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.2 t -160.02 175.65 12.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 108.833 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.9 t80 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 120.664 -1.273 . . . . 0.0 109.662 -179.817 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.536 0.684 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.27 160.19 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.42 147.62 45.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.848 -1.157 . . . . 0.0 109.308 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.38 149.56 21.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.12 -39.91 72.95 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -54.84 -39.84 68.98 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -73.93 -39.95 63.43 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -0.817 . . . . 0.0 109.33 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.4 mm -62.58 -51.23 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.391 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.13 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.405 -0.809 . . . . 0.0 110.955 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -51.42 38.17 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.259 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.59 -39.96 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.935 -1.332 . . . . 0.0 110.295 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.4 mt-30 -67.38 -39.94 85.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.309 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.77 94.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.892 -1.13 . . . . 0.0 108.976 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 159' ' ' ILE . 96.9 mt -60.02 -50.04 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 109.437 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -96.6 -73.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.45 -171.51 35.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 162' ' ' ARG . 38.1 mtt-85 -85.51 156.27 20.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -1.125 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 -179.693 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -82.16 129.99 34.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.26 -13.43 57.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.886 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -81.84 149.36 28.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 109.58 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.6 p -96.57 -7.47 34.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.936 . . . . 0.0 108.847 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.526 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 64.0 m-70 -130.03 144.2 51.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.17 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.9 mt -134.24 157.6 45.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.18 -0.95 . . . . 0.0 109.802 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.0 p -127.77 155.57 43.83 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -142.5 159.84 41.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 0.0 109.497 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -148.1 130.12 15.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 110.082 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.33 119.81 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 78.0 tt0 -66.89 -39.92 87.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.1 m-20 -157.55 150.03 22.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.979 -1.076 . . . . 0.0 110.082 -179.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.16 135.16 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 t -68.59 141.75 93.35 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.232 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.81 -12.66 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.674 0.916 . . . . 0.0 111.832 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -136.28 149.55 68.22 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 121.255 -0.903 . . . . 0.0 108.848 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -59.61 -179.99 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.214 0.755 . . . . 0.0 111.744 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -86.46 -33.01 20.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.12 81.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.84 -39.91 76.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.36 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.35 -42.83 81.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.03 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.05 87.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.405 ' O ' ' N ' ' A' ' 36' ' ' LYS . 86.3 t60 -60.02 -49.7 76.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.18 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.01 90.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.406 -0.809 . . . . 0.0 109.88 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.61 -44.59 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.292 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.23 -40.15 74.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.5 tttt -62.64 -39.68 94.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.07 90.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 31.1 m-85 -59.87 -40.31 88.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.112 . . . . 0.0 109.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.11 -40.67 90.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.0 -43.31 95.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.009 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.97 -41.76 64.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.183 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.5 t -70.14 -26.49 63.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.248 -0.907 . . . . 0.0 110.521 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -60.07 -36.03 76.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 110.852 -178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.92 13.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.061 -1.024 . . . . 0.0 110.403 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -141.2 146.81 44.55 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.997 -1.064 . . . . 0.0 109.257 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.19 5.57 2.62 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.579 0.853 . . . . 0.0 111.414 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.84 153.39 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 0.0 109.866 -179.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.526 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 38.2 p -130.91 148.01 52.62 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 98.1 m-85 -126.52 149.76 49.19 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.3 m -153.33 132.06 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 0.0 109.835 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -79.62 142.03 35.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.413 -0.804 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.55 135.85 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -96.67 -3.14 43.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 0.0 110.011 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.67 152.55 41.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.028 -1.045 . . . . 0.0 109.647 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.31 166.99 33.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -82.91 139.52 33.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -1.156 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.64 160.44 14.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 108.983 179.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.97 -39.76 86.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.178 -0.952 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.85 120.02 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.485 0.659 . . . . 0.0 109.932 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -99.86 122.13 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 61' ' ' ILE . 95.5 mt -110.01 129.98 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.417 -0.802 . . . . 0.0 109.052 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -149.05 153.94 38.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.025 -1.047 . . . . 0.0 110.295 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -104.37 138.04 41.38 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.0 170.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.112 -0.993 . . . . 0.0 111.101 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -134.43 143.57 47.63 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.667 -0.646 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.44 -146.68 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -67.17 128.69 37.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.994 . . . . 0.0 109.597 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.495 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -135.97 58.49 1.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.06 52.2 10.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.588 -0.695 . . . . 0.0 109.341 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.495 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 18.9 p-10 -142.43 160.02 41.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 109.072 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -91.14 10.04 28.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.279 -0.888 . . . . 0.0 109.705 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -137.07 74.34 49.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.326 -0.859 . . . . 0.0 109.845 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.53 148.85 48.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.081 1.188 . . . . 0.0 111.405 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -75.88 139.98 41.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.276 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.86 61.04 0.97 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 109.351 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 -176.72 53.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -55.07 -13.55 6.84 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.158 1.238 . . . . 0.0 112.079 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 170.32 34.62 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -150.63 19.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -77.89 142.04 38.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -1.108 . . . . 0.0 109.862 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.5 mt -89.89 -16.6 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.197 -0.94 . . . . 0.0 108.953 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.01 166.96 9.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.932 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.59 -178.44 6.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.839 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.16 170.55 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.396 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.21 153.87 19.56 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.4 -0.813 . . . . 0.0 109.532 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -60.72 151.1 73.53 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.423 -0.798 . . . . 0.0 109.337 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 108.45 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.726 0.951 . . . . 0.0 112.402 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.67 165.19 34.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.04 161.92 40.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.108 1.206 . . . . 0.0 111.997 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.54 -126.65 7.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.51 -13.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 109.8 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.46 141.29 47.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.06 -15.23 60.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.38 159.21 31.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -1.193 . . . . 0.0 109.708 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.99 122.85 12.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.301 -0.874 . . . . 0.0 109.171 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -104.68 148.32 26.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.0 110.465 -179.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.3 m-85 -115.22 135.51 54.1 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.246 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 19.7 t0 -67.19 116.67 8.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -95.76 -0.25 51.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -178.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 94.3 m-20 -75.72 -17.33 59.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.84 -1.163 . . . . 0.0 110.095 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -102.2 159.8 15.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -88.29 120.35 29.57 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.051 -1.03 . . . . 0.0 109.365 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -88.33 148.52 24.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 60.8 p -124.9 161.12 27.28 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.531 -0.731 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -112.8 31.46 6.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -148.18 -164.9 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -0.881 . . . . 0.0 109.976 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -79.93 30.64 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 106' ' ' ASN . 48.9 mtt-85 -76.63 -164.48 0.42 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 52.5 mp0 -60.04 -58.3 9.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 112.552 -177.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 70.4 m-85 -106.1 121.63 44.54 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.975 -1.078 . . . . 0.0 111.349 -177.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 4.6 m120 -104.19 117.28 33.87 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.14 -40.17 90.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -60.1 -41.32 92.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 114' ' ' ARG . 4.4 mmt-85 -60.15 -39.98 88.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.28 -41.12 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.064 -1.022 . . . . 0.0 109.826 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.11 95.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.93 87.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -69.2 -46.16 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 94.4 mt-10 -59.1 -40.21 84.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.763 -1.211 . . . . 0.0 109.889 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.28 -39.94 92.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.088 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.77 97.16 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -65.3 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.161 -1.199 . . . . 0.0 108.803 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.3 p -70.04 -24.31 63.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 108.813 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.89 -3.43 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.43 13.31 76.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.7 132.66 35.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.884 -1.363 . . . . 0.0 108.942 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -87.91 173.04 9.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 109.793 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.62 159.3 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -127.88 162.57 26.4 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.0 p -100.12 2.8 43.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.019 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -82.3 128.81 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.09 -31.58 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.476 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.14 -0.72 77.87 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.272 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.309 . . . . 0.0 109.346 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 137' ' ' TYR . 97.1 mt -67.68 -27.55 66.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.7 mmm -74.11 44.43 0.19 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.421 -0.8 . . . . 0.0 109.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.5 t80 -70.05 134.71 87.44 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -50.62 -62.11 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 120.055 1.055 . . . . 0.0 111.536 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -81.71 175.38 10.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.815 . . . . 0.0 109.135 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.4 t80 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 109.725 -179.883 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.432 0.634 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -140.57 150.74 44.03 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.11 147.44 40.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 109.012 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.1 162.98 14.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.07 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.98 -40.17 88.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 109.002 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.39 -40.78 87.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.44 -40.15 62.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.12 -52.25 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.226 -0.921 . . . . 0.0 109.166 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.59 -40.1 90.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.051 -1.031 . . . . 0.0 109.476 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.05 11.38 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.793 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.4 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.339 . . . . 0.0 109.798 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.3 mt-30 -67.2 -39.93 86.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 0.0 109.717 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.54 92.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.077 -1.014 . . . . 0.0 109.273 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.0 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.751 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -97.57 -69.98 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.14 -0.975 . . . . 0.0 109.325 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.59 -169.18 33.9 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -86.22 157.66 19.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -1.177 . . . . 0.0 109.838 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.25 -0.906 . . . . 0.0 108.921 179.515 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -84.48 120.03 25.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.004 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 55.3 mp0 -82.69 -9.87 59.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.99 155.76 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 0.0 110.299 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.438 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 79.4 p -98.92 -4.5 32.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 48.2 m80 -129.96 141.72 50.73 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.0 mt -133.39 156.06 48.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.251 -0.905 . . . . 0.0 109.27 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 153.98 45.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.398 -0.813 . . . . 0.0 109.185 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -146.16 162.25 38.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.323 -0.86 . . . . 0.0 109.206 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -147.92 129.88 15.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.37 120.15 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.35 -40.12 89.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 110.422 -178.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -163.27 154.84 17.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.877 -1.139 . . . . 0.0 110.478 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.36 136.4 40.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -70.79 143.05 88.93 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.106 -0.996 . . . . 0.0 109.36 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.85 -11.08 25.15 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.603 0.869 . . . . 0.0 111.749 179.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.0 -39.93 87.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.947 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.8 mt -139.55 150.58 64.04 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.371 -0.831 . . . . 0.0 109.044 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.94 -177.04 0.3 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.622 0.881 . . . . 0.0 112.015 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.6 ptt180 -87.03 -33.23 19.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.39 -39.98 81.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.63 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.24 -39.97 59.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -50.04 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.0 111.261 -178.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 29.6 p-10 -59.16 -39.03 81.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.76 -1.213 . . . . 0.0 108.948 -179.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.8 t60 -59.73 -49.17 78.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.185 179.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.14 87.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 110.165 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.09 -40.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.229 -0.919 . . . . 0.0 109.857 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.07 -39.75 86.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.23 -39.8 87.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 109.29 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.33 95.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.09 -1.006 . . . . 0.0 109.498 -179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -60.02 -39.94 87.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.864 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -60.0 -40.03 87.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.369 -0.832 . . . . 0.0 109.827 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.03 -42.96 95.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.055 -1.028 . . . . 0.0 109.709 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -71.65 -40.11 69.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 109.702 -179.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 t -69.79 -33.7 72.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.03 -23.06 63.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 111.06 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 m -112.74 3.33 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.166 -0.959 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 9.2 p -148.63 151.37 35.67 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.861 -1.149 . . . . 0.0 109.586 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.99 8.88 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.657 0.905 . . . . 0.0 111.975 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -70.15 150.01 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.543 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -137.26 153.75 50.27 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.452 -0.78 . . . . 0.0 109.033 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.01 158.93 38.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.492 -0.755 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -154.88 126.69 7.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.864 . . . . 0.0 109.984 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.82 143.92 37.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.333 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.76 139.53 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -95.28 -11.2 28.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.165 -0.959 . . . . 0.0 110.097 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -147.59 158.16 43.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.964 -1.085 . . . . 0.0 109.546 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.93 170.83 47.65 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.512 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 5.5 pm0 -80.0 163.96 23.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.41 151.86 51.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -0.752 . . . . 0.0 109.757 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.11 -39.87 87.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.483 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.67 119.85 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.704 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.1 mmm -100.59 128.73 46.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.2 mt -119.13 129.92 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.468 -0.77 . . . . 0.0 109.722 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.7 p -149.74 159.92 43.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.172 -0.955 . . . . 0.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.56 138.37 44.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.14 161.54 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.162 -0.961 . . . . 0.0 111.25 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.92 142.78 50.83 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.717 -0.614 . . . . 0.0 109.786 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.99 -143.52 1.45 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.1 t0 -71.33 130.73 42.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.984 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.416 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.8 p-80 -133.11 53.59 2.01 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.5 -0.75 . . . . 0.0 109.835 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 54.04 50.98 15.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 109.386 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 10.4 t70 -140.03 165.88 26.14 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 26.1 m120 -89.15 9.36 25.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.11 -0.994 . . . . 0.0 109.946 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -135.57 71.43 65.41 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.833 . . . . 0.0 109.635 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.76 141.1 70.57 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 120.937 1.091 . . . . 0.0 111.986 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -75.2 141.33 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -110.74 74.28 0.87 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.784 . . . . 0.0 109.312 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.26 -178.62 6.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.56 -18.78 4.16 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.186 1.257 . . . . 0.0 112.044 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.22 175.06 55.03 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -160.46 29.29 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -75.03 160.12 30.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -1.114 . . . . 0.0 109.681 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 mt -93.64 -20.97 19.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.24 -0.912 . . . . 0.0 109.774 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.59 174.75 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.043 -1.036 . . . . 0.0 109.724 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.04 175.81 10.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 108.943 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.4 167.7 21.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.629 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.78 148.9 24.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.483 -0.76 . . . . 0.0 109.106 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -59.99 149.81 72.3 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.059 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.28 120.58 8.44 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.781 0.987 . . . . 0.0 112.16 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.53 174.9 47.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.81 172.95 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.211 1.274 . . . . 0.0 112.105 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.35 -124.83 16.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.09 -9.13 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -1.043 . . . . 0.0 110.002 -179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.78 143.9 35.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.18 -18.25 46.34 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.07 152.84 45.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.118 -1.225 . . . . 0.0 109.914 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.27 121.42 10.14 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -102.92 141.5 35.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.42 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.8 m-85 -113.8 136.57 52.71 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -65.71 115.6 6.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -98.43 -1.04 42.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.496 -0.752 . . . . 0.0 109.442 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.14 -20.23 59.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.976 -1.078 . . . . 0.0 109.557 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.31 159.55 14.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 108.84 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -87.23 122.43 31.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.932 . . . . 0.0 109.682 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.18 150.01 22.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.892 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.8 p -127.56 159.64 33.99 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.542 -0.724 . . . . 0.0 109.347 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.39 29.47 7.52 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.532 -0.73 . . . . 0.0 109.587 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.623 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.82 -165.01 2.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.217 -0.927 . . . . 0.0 109.655 -179.802 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.72 34.73 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 0.0 110.644 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.517 ' CG ' HD22 ' A' ' 106' ' ' ASN . 26.1 mmt180 -76.85 -165.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.392 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.38 -56.59 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.589 -0.694 . . . . 0.0 111.432 -178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 104' ' ' THR . 91.5 m-85 -100.33 119.79 38.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.052 -1.03 . . . . 0.0 110.756 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -103.35 107.3 18.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.385 -0.822 . . . . 0.0 109.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.38 -44.16 97.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 110.09 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -59.91 -43.43 94.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 114' ' ' ARG . 13.7 ttt-85 -59.95 -43.32 95.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.892 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.96 -40.03 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.15 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.56 92.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.27 90.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.28 -45.87 68.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 71.4 mt-10 -59.84 -40.14 87.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.94 -1.1 . . . . 0.0 109.142 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.58 -40.05 90.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 108.894 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.79 -41.92 84.44 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -64.65 -38.98 92.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -1.201 . . . . 0.0 108.835 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.3 p -70.02 -21.47 63.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.344 -0.847 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.86 -0.61 56.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 108.966 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.93 8.93 78.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.2 127.36 32.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.032 -1.275 . . . . 0.0 108.791 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -88.05 175.46 7.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.327 -0.858 . . . . 0.0 109.687 -179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -67.53 159.88 28.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -133.25 163.63 28.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.538 -0.727 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -100.89 7.45 43.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.65 122.01 27.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 108.788 179.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.24 -30.82 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.48 -5.74 89.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.464 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.77 132.08 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.995 -1.297 . . . . 0.0 109.505 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -68.91 -24.64 64.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.1 mmm -73.21 38.63 0.09 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.791 -178.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.9 t80 -69.32 129.72 91.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.965 . . . . 0.0 108.671 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -47.59 -67.51 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.3 1.143 . . . . 0.0 111.863 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 98.0 p -81.88 169.42 16.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.949 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.401 0.619 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.91 154.26 46.04 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 63.4 mt -74.93 146.04 42.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.969 -1.082 . . . . 0.0 109.11 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.07 156.89 16.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 109.092 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.77 -38.89 79.5 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -55.08 -40.11 70.01 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.072 -1.018 . . . . 0.0 108.624 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.7 -39.96 69.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.23 -49.94 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.659 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.99 -39.98 91.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.837 -1.164 . . . . 0.0 110.339 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.74 -54.43 9.91 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.137 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -61.89 -40.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.299 . . . . 0.0 110.038 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -65.86 -40.04 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.941 -1.099 . . . . 0.0 109.387 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.926 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -50.07 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 110.51 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -100.47 -61.04 1.42 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.171 -0.955 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.7 -176.93 34.69 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -90.93 149.43 21.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.426 -1.043 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 108.685 179.682 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 8' ' ' ARG . 22.6 mtt-85 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -83.75 120.63 26.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.285 -0.885 . . . . 0.0 109.527 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.95 -10.11 58.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 109.109 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.94 150.11 30.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 -179.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -97.0 -4.89 38.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.523 -0.735 . . . . 0.0 109.442 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -130.01 139.99 50.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.78 157.61 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.403 -0.811 . . . . 0.0 109.654 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -127.0 155.19 43.59 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.619 -0.676 . . . . 0.0 109.188 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.98 157.91 43.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.009 -1.057 . . . . 0.0 109.266 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.41 HH21 ' CE ' ' A' ' 60' ' ' MET . 42.3 ttp180 -147.33 128.86 15.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.166 -0.959 . . . . 0.0 109.954 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.0 mt -85.41 123.71 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -62.3 -40.76 97.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -178.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -162.22 151.84 16.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.304 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -97.54 135.94 38.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.378 -0.827 . . . . 0.0 109.27 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.542 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 4.0 t -73.41 144.92 84.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.752 -179.349 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.89 -15.09 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 CA-C-N 119.203 0.751 . . . . 0.0 111.046 179.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.542 ' H ' ' HG1' ' A' ' 22' ' ' THR . 84.2 m-20 -61.49 -40.07 93.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.4 mt -135.13 150.32 72.58 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.009 -1.057 . . . . 0.0 109.337 -178.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.39 179.82 2.75 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 CA-C-N 119.158 0.735 . . . . 0.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -85.54 -36.13 20.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.924 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.78 84.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.21 -40.03 74.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.85 -44.33 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.443 -179.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.54 89.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 108.719 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.87 -47.87 84.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.312 -0.867 . . . . 0.0 109.499 179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.47 89.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.143 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.58 -40.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -70.26 -40.0 74.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.609 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.29 95.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 108.609 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CE1' ' CD1' ' A' ' 49' ' ' PHE . 33.8 m-85 -61.21 -39.59 90.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 109.881 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.9 -40.93 85.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.2 -41.24 92.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.034 -1.041 . . . . 0.0 109.317 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.444 ' O ' ' OG1' ' A' ' 45' ' ' THR . 94.5 m95 -72.39 -40.0 67.57 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.68 -28.47 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.442 -0.786 . . . . 0.0 110.254 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -59.85 -35.14 74.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 110.766 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.52 5.63 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.278 -0.889 . . . . 0.0 110.985 -178.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 45.3 p -140.03 148.63 55.61 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 120.897 -1.127 . . . . 0.0 108.625 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.73 6.4 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.407 1.404 . . . . 0.0 112.389 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.16 157.92 35.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.367 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 p -135.79 147.71 48.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.482 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 95.9 m-85 -128.72 148.7 50.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.725 -0.609 . . . . 0.0 109.65 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -154.35 134.92 13.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -76.06 146.58 39.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.25 135.17 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.369 -0.832 . . . . 0.0 108.978 179.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -97.54 -5.89 34.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 110.052 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -142.67 156.67 45.08 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.07 -1.019 . . . . 0.0 109.565 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 167.59 25.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -78.37 148.03 33.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.932 . . . . 0.0 109.272 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.59 148.38 30.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -0.776 . . . . 0.0 108.913 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.45 -40.35 90.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.34 118.89 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.41 ' CE ' HH21 ' A' ' 17' ' ' ARG . 89.7 mmm -101.2 122.19 43.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -111.79 130.05 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.625 -0.672 . . . . 0.0 109.524 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.6 p -147.39 155.5 42.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -105.28 140.2 38.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.57 160.29 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 121.901 0.858 . . . . 0.0 111.188 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.3 mtm-85 -131.96 135.44 46.58 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.72 -138.66 13.88 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -77.37 129.09 35.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.561 -0.964 . . . . 0.0 110.243 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 19.1 p-80 -131.58 47.46 2.53 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.409 -0.807 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 56.04 59.35 3.78 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.1 p-10 -142.72 163.1 33.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.066 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.53 9.19 30.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.172 -0.955 . . . . 0.0 109.233 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 t -140.08 69.51 34.95 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.414 -0.804 . . . . 0.0 109.012 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.67 148.68 42.22 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.364 1.376 . . . . 0.0 112.083 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -79.25 151.12 31.34 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -134.93 76.36 1.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.428 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.83 -179.18 39.73 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -70.73 -15.6 33.46 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.194 1.262 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.04 -174.89 50.5 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.04 -158.38 36.38 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -75.06 143.78 43.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -1.023 . . . . 0.0 109.25 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.32 -16.0 32.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 109.0 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.54 175.67 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.264 -0.898 . . . . 0.0 108.937 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -163.01 120.25 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.914 -1.116 . . . . 0.0 110.629 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.45 168.11 16.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -109.61 143.93 38.63 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -59.47 145.95 80.94 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -58.36 127.28 24.16 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 119.249 0.768 . . . . 0.0 112.306 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.27 178.12 43.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.57 -177.86 3.87 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.359 1.373 . . . . 0.0 112.524 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.75 -123.7 33.52 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.14 -13.74 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.49 -1.006 . . . . 0.0 109.782 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.01 138.77 38.21 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.249 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -13.93 63.5 Favored Glycine 0 N--CA 1.497 2.702 0 O-C-N 121.231 -1.158 . . . . 0.0 110.546 179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.79 162.81 25.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.955 -1.321 . . . . 0.0 109.768 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.5 120.76 11.55 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -105.15 133.45 49.9 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.241 -0.912 . . . . 0.0 110.272 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.508 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 43.8 m-85 -114.65 129.75 56.72 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -67.53 120.72 14.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 108.968 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -99.4 6.5 46.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.308 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.47 -20.16 60.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 0.0 109.737 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -104.23 160.07 15.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 102' ' ' ARG . 33.2 ttt-85 -84.11 119.16 24.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.138 -0.976 . . . . 0.0 110.147 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -88.8 148.95 23.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.497 -0.752 . . . . 0.0 109.269 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 41.6 p -123.23 167.96 13.06 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.476 -0.765 . . . . 0.0 109.306 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -104.66 23.82 12.75 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -148.98 -165.0 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.657 -0.652 . . . . 0.0 109.805 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -90.88 27.0 1.92 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.231 -0.918 . . . . 0.0 110.911 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.0 mtt-85 -76.47 -157.14 0.08 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.837 -1.165 . . . . 0.0 109.442 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 108' ' ' ARG . 64.4 mm-40 -24.31 -65.4 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.4 m-85 -130.12 132.05 45.95 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.978 -1.076 . . . . 0.0 109.786 -179.455 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -95.99 113.83 25.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.204 -0.935 . . . . 0.0 109.701 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.25 -40.27 77.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -59.63 -42.9 93.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.958 -1.089 . . . . 0.0 109.988 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 114' ' ' ARG . 25.3 ttt-85 -59.7 -41.52 90.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.27 -39.67 77.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.77 92.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.328 -0.858 . . . . 0.0 108.926 179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.16 85.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.0 109.162 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 4.3 t60 -69.72 -50.1 46.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 73.4 mt-10 -59.95 -40.1 87.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.962 -1.086 . . . . 0.0 110.278 -178.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.12 -39.88 94.04 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 108.828 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.52 95.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 12.2 m-70 -61.93 -38.73 89.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.067 -1.255 . . . . 0.0 107.778 178.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.5 m -69.65 -24.31 63.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.1 -0.27 51.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 108.852 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.99 13.97 65.5 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.361 -0.923 . . . . 0.0 110.889 178.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.56 124.58 30.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.088 -1.243 . . . . 0.0 108.887 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -88.67 167.28 13.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.998 -1.064 . . . . 0.0 109.1 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 122' ' ' HIS . 80.9 m80 -68.58 152.36 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 t -126.44 169.69 12.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.473 -0.767 . . . . 0.0 108.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.3 p -98.94 1.02 45.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.398 -0.814 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -79.06 119.3 21.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 132' ' ' ILE . 90.2 mt -60.04 -40.44 83.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.77 27.87 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.01 -1.057 . . . . 0.0 111.007 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.1 23.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.852 -1.381 . . . . 0.0 109.159 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.19 -23.89 64.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 108.885 178.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' MET . . . . . 0.564 ' SD ' ' N ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -74.52 62.24 1.0 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.57 -0.706 . . . . 0.0 109.911 -179.262 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.499 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.8 t80 -71.19 123.95 90.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -51.11 -2.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 CA-C-N 120.459 1.2 . . . . 0.0 113.546 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 137' ' ' TYR . 58.3 m -163.05 174.55 12.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 0.0 109.074 179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.2 t80 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.903 . . . . 0.0 108.92 179.626 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.315 0.578 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -142.58 157.87 44.26 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.54 145.92 47.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.018 -1.051 . . . . 0.0 108.868 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.07 162.91 13.68 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.21 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.14 -40.19 88.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.22 -41.67 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -71.68 -40.78 69.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.76 -49.78 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.781 . . . . 0.0 109.298 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.67 -39.91 88.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.894 -1.129 . . . . 0.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -52.72 34.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.32 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -1.212 . . . . 0.0 109.669 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.28 -39.65 92.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.198 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.79 92.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.389 -0.819 . . . . 0.0 110.033 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.97 -47.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.92 -1.112 . . . . 0.0 109.478 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.41 -64.91 1.01 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.299 -0.876 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.91 -169.82 35.94 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -92.11 145.44 24.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.023 -1.281 . . . . 0.0 108.7 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.223 -0.923 . . . . 0.0 109.962 -178.738 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -83.13 118.71 23.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -85.26 -10.65 56.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.287 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.73 150.9 25.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.323 -179.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.7 p -96.19 -3.8 43.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -128.85 141.67 51.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 160.05 39.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.244 -0.91 . . . . 0.0 109.784 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 p -127.94 157.18 41.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -146.1 159.94 42.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.416 -0.802 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -150.4 133.87 16.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.2 mt -89.49 118.57 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.4 mt-10 -66.8 -40.13 87.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.531 -178.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.2 m-20 -155.95 152.71 28.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.119 -0.988 . . . . 0.0 109.849 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -101.4 131.98 47.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 5.8 t -68.75 138.26 90.61 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.993 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.47 -8.95 18.5 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.596 0.891 . . . . 0.0 112.052 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 22' ' ' THR . 92.9 m-20 -60.1 -39.97 88.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.004 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -135.73 149.06 67.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.13 -175.44 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.63 0.886 . . . . 0.0 111.696 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -90.01 -37.23 14.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -45.85 85.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.823 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.54 -39.83 73.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.72 -45.58 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -59.95 -40.11 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.184 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -60.12 -42.52 94.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.74 90.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.46 -36.89 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -65.71 -42.03 91.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.739 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.6 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.836 -1.165 . . . . 0.0 109.82 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.95 75.66 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 39.4 m-85 -61.69 -40.96 96.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.918 -1.114 . . . . 0.0 108.78 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.24 -42.03 94.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 0.0 110.356 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.79 -40.6 88.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.067 . . . . 0.0 110.116 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -73.0 -40.04 65.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.822 -1.174 . . . . 0.0 109.186 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 t -70.04 -26.48 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 110.25 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.92 -35.97 76.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.377 -0.827 . . . . 0.0 110.68 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 m -108.54 10.26 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -141.05 147.25 46.93 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.301 -0.875 . . . . 0.0 109.306 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.78 6.29 2.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.9 1.067 . . . . 0.0 112.067 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.32 155.9 40.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.813 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.8 p -134.54 149.85 50.69 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 91.8 m-85 -125.98 155.13 41.88 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.468 -0.77 . . . . 0.0 109.433 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.416 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 19.5 m -151.65 137.25 17.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.329 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.36 137.02 37.82 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -121.57 134.34 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.362 -0.836 . . . . 0.0 109.16 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 t -97.47 -6.02 34.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.344 -0.848 . . . . 0.0 110.624 -179.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -144.19 153.32 41.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.83 165.57 33.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -81.09 147.3 30.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -1.17 . . . . 0.0 108.972 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.77 17.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.73 -38.66 82.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.196 -0.94 . . . . 0.0 108.946 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -116.4 118.3 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.673 0.749 . . . . 0.0 109.833 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.43 129.64 46.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.335 -0.853 . . . . 0.0 109.737 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.46 130.63 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.1 p -148.43 161.2 42.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.0 -1.062 . . . . 0.0 110.582 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.08 140.01 48.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 173.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.134 -0.979 . . . . 0.0 111.003 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -138.15 141.93 40.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.518 -0.739 . . . . 0.0 110.481 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.49 -140.09 2.24 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.57 130.33 40.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.425 -1.044 . . . . 0.0 109.421 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.516 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 12.1 p-80 -136.91 60.44 1.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.519 -0.738 . . . . 0.0 110.315 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 52.45 51.16 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.543 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 72' ' ' SER . 11.9 t70 -144.36 160.09 41.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.219 -0.926 . . . . 0.0 109.337 -179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -88.96 9.89 23.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 108.74 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 40.3 t -134.17 73.78 69.08 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.537 -0.727 . . . . 0.0 109.318 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.77 145.08 45.27 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.057 1.171 . . . . 0.0 111.88 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.2 142.56 45.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.103 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -102.42 65.63 0.95 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.299 -0.876 . . . . 0.0 109.665 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.3 -166.6 41.39 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.09 -20.02 17.65 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.226 1.284 . . . . 0.0 111.998 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.69 173.77 43.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.38 -163.73 26.53 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -73.9 152.31 40.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.419 -1.048 . . . . 0.0 109.974 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -91.86 -17.0 25.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.03 171.26 7.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.432 -0.793 . . . . 0.0 109.053 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.56 121.97 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.7 173.3 9.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.616 -0.678 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.65 158.54 17.96 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.591 -0.693 . . . . 0.0 109.241 179.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -58.82 145.8 77.6 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.135 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.09 96.5 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.776 0.984 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.91 173.49 36.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -65.1 -174.1 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.92 1.08 . . . . 0.0 111.705 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.38 -134.11 50.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.24 -12.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -1.124 . . . . 0.0 110.313 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.88 144.22 44.68 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.7 -12.67 66.43 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.38 160.83 28.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -1.156 . . . . 0.0 109.979 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.72 115.56 9.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -100.13 142.53 31.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -122.04 134.88 54.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.557 -0.715 . . . . 0.0 109.275 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.8 119.46 13.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -95.14 -0.27 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.83 -18.46 60.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 109.781 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 162.58 13.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.228 -0.92 . . . . 0.0 108.927 179.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -87.21 119.15 27.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -87.44 140.12 29.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.038 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 54.3 p -128.78 166.33 19.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.495 -0.753 . . . . 0.0 109.735 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.73 31.05 6.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.62 -0.675 . . . . 0.0 109.258 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.514 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -148.46 -162.73 1.62 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.956 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -81.11 34.24 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.423 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.481 ' CG ' HD22 ' A' ' 106' ' ' ASN . 10.6 mmt-85 -76.77 -166.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.129 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -50.27 -57.14 8.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.596 -0.69 . . . . 0.0 111.991 -178.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.451 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.3 m-85 -119.94 140.16 51.34 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.136 -0.977 . . . . 0.0 111.494 -177.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 21.4 m120 -108.32 118.49 36.9 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.99 -42.01 85.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.18 -0.95 . . . . 0.0 110.682 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -59.95 -42.09 93.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.054 -1.029 . . . . 0.0 110.935 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -59.84 -40.87 89.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 109.968 -178.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 62.6 t -70.33 -40.09 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 108.789 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.23 80.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.004 -1.06 . . . . 0.0 108.943 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.06 -35.01 79.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.956 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -69.99 -56.22 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.857 -1.152 . . . . 0.0 109.948 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 7.0 mp0 -57.73 -39.92 78.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.951 -1.093 . . . . 0.0 109.677 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.94 -39.74 90.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.276 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.86 95.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -63.47 -33.66 76.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -1.091 . . . . 0.0 108.8 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -68.83 -25.31 64.59 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.4 mt -84.58 -6.27 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 0.0 109.431 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.14 19.53 52.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.37 134.81 34.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.866 -1.373 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.8 m -87.55 168.29 13.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.4 159.14 32.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.453 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 33.9 t -132.35 157.82 43.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.072 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 10.15 41.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.312 -0.867 . . . . 0.0 109.883 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 129' ' ' SER . 61.7 t0 -82.04 128.51 34.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 109.293 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.76 -27.67 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 110.463 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.15 -4.79 88.04 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.413 -179.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.35 132.34 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.671 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.84 -27.46 65.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 109.421 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.6 mtp -75.72 45.39 0.32 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.826 -179.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -69.94 135.54 87.52 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -47.07 -68.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 119.861 0.986 . . . . 0.0 112.545 179.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -85.14 174.05 9.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.017 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.9 t80 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.921 179.748 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.118 0.485 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.88 153.98 41.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.259 -0.9 . . . . 0.0 109.478 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.06 149.46 39.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 108.71 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.76 161.32 14.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -60.03 -39.82 87.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -58.59 -40.34 82.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.482 -0.761 . . . . 0.0 109.706 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.55 -40.14 66.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.747 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.81 -49.69 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.67 -40.21 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.182 -0.949 . . . . 0.0 109.868 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -57.53 12.76 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.911 -178.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.15 -39.98 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.308 . . . . 0.0 109.941 -179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -63.13 -39.58 95.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.028 -1.045 . . . . 0.0 109.175 179.399 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.57 94.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.22 -52.06 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.743 -1.223 . . . . 0.0 109.392 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -96.1 -70.9 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.11 -170.07 39.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -92.98 141.72 28.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -1.156 . . . . 0.0 109.721 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.16 -39.95 88.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.965 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 61.7 p -91.78 142.0 28.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.37 -0.831 . . . . 0.0 108.912 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -83.21 102.56 11.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.991 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.02 86.36 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.096 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.462 ' O ' ' OG1' ' A' ' 3' ' ' THR . 10.3 m120 -150.19 66.61 7.95 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 120.41 -1.641 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -78.1 144.41 21.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.404 1.402 . . . . 0.0 112.246 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 -87.18 167.37 14.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -81.7 119.63 24.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.038 -1.039 . . . . 0.0 108.68 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -82.43 -11.5 58.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.68 151.03 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.81 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.4 p -94.81 -3.99 47.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.518 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 47.4 m-70 -129.2 144.02 51.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -133.39 158.5 42.88 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.39 -0.819 . . . . 0.0 109.91 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.42 ' HG1' ' H ' ' A' ' 58' ' ' ASP . 75.3 p -128.71 150.02 50.45 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.18 159.41 42.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 0.0 109.578 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -150.7 130.5 13.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.0 109.74 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.21 122.54 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.309 -0.87 . . . . 0.0 108.858 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.83 -40.08 83.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.477 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -161.74 159.45 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.857 -1.152 . . . . 0.0 110.212 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -100.12 138.19 37.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -69.53 139.77 89.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 108.983 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -66.31 -12.13 34.33 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.601 0.893 . . . . 0.0 111.309 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.02 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.387 -0.821 . . . . 0.0 108.976 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -138.04 149.93 65.56 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.88 -170.97 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 120.795 0.997 . . . . 0.0 112.094 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' NH2' ' OD2' ' A' ' 31' ' ' ASP . 6.6 ptm180 -88.51 -31.81 18.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.11 -47.38 78.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.975 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.96 -43.96 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -0.976 . . . . 0.0 110.092 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 87.3 m-20 -59.28 -41.68 89.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.12 . . . . 0.0 109.267 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -60.06 -49.03 79.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.46 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.4 92.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.29 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.05 -40.05 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 0.0 109.725 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.16 -41.02 74.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.818 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.73 -39.74 92.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -46.18 86.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.074 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.884 -1.135 . . . . 0.0 109.261 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -60.01 -41.2 91.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 110.232 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -41.39 91.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.022 -1.049 . . . . 0.0 109.889 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -72.57 -42.29 64.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.335 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -69.93 -30.82 68.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 110.249 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.61 -31.99 68.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 111.168 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.3 m -110.03 9.99 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.084 -1.01 . . . . 0.0 111.009 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.43 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 70.4 p -143.25 148.28 43.88 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 120.925 -1.109 . . . . 0.0 109.292 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.78 10.5 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 120.64 0.894 . . . . 0.0 111.196 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.58 151.5 44.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.515 -0.741 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.4 p -129.8 140.91 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.64 157.7 27.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.571 -0.705 . . . . 0.0 109.38 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -154.59 125.74 7.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 109.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -78.38 133.53 37.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.373 -0.83 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.9 135.89 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.579 -0.701 . . . . 0.0 109.261 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -96.22 -2.0 47.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 109.994 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -146.35 156.39 43.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.966 -1.084 . . . . 0.0 109.587 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.98 164.52 34.05 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -80.45 131.48 35.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.291 . . . . 0.0 108.594 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.81 155.19 16.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.22 -0.925 . . . . 0.0 109.846 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' H ' ' HG1' ' A' ' 15' ' ' THR . 97.6 m-20 -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 109.602 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -120.01 113.06 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.44 -0.788 . . . . 0.0 109.062 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.03 133.6 44.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.113 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.429 HD12 HG22 ' A' ' 61' ' ' ILE . 89.7 mt -116.04 130.03 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.557 -0.714 . . . . 0.0 109.334 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.1 p -150.15 155.17 39.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.39 137.67 41.18 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.78 160.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.264 -0.897 . . . . 0.0 111.264 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -130.51 143.47 50.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.318 0.58 . . . . 0.0 109.528 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.88 -142.74 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -76.49 130.14 37.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.482 -1.01 . . . . 0.0 110.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.583 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.2 p-80 -130.56 54.14 1.91 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 57.45 49.99 12.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 109.818 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 8.4 m-20 -142.79 162.0 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 0.0 109.033 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -90.46 9.66 28.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.631 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.7 71.62 64.25 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.997 -1.064 . . . . 0.0 110.668 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.47 149.92 56.92 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.201 1.268 . . . . 0.0 111.828 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -77.45 142.98 38.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.592 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -108.01 65.5 0.64 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.45 -0.781 . . . . 0.0 109.353 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.44 -167.54 54.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.97 -8.52 4.75 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.2 1.267 . . . . 0.0 112.079 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.14 176.48 42.18 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 -164.27 41.17 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.416 HD21 ' H ' ' A' ' 80' ' ' ASN . 3.0 p30 -75.27 159.65 31.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.219 -1.165 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.67 -18.18 21.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.363 -0.836 . . . . 0.0 109.851 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.34 169.41 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.965 . . . . 0.0 108.872 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.6 177.75 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.081 . . . . 0.0 109.799 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.3 177.91 7.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.325 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.67 154.65 21.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.512 -0.743 . . . . 0.0 109.281 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.7 mp0 -58.59 149.99 59.04 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.182 -0.949 . . . . 0.0 108.802 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -60.72 107.42 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.575 0.85 . . . . 0.0 112.047 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.11 173.24 41.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.59 176.98 2.44 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.091 1.194 . . . . 0.0 112.121 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.11 -131.93 33.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.51 -12.72 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -1.062 . . . . 0.0 109.788 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.38 142.94 42.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.29 -21.49 37.49 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.52 153.35 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -1.17 . . . . 0.0 109.946 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.64 122.69 10.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 109.062 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -104.89 152.13 23.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.459 -0.776 . . . . 0.0 110.11 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 20.8 m-85 -119.91 139.64 52.1 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -66.55 119.81 12.33 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -98.51 2.3 47.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.55 -22.38 59.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.156 -0.965 . . . . 0.0 109.752 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -100.69 155.31 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.271 -0.893 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -85.21 128.07 34.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.031 -1.043 . . . . 0.0 109.251 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -89.6 145.86 24.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 109.785 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.1 p -129.87 166.41 20.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.576 -0.703 . . . . 0.0 109.708 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.41 30.3 6.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.555 -0.715 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 4.7 p30 -150.02 -164.24 1.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 31.76 0.43 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.422 ' HE ' HD22 ' A' ' 106' ' ' ASN . 44.7 mtt-85 -75.91 -157.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.602 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -39.78 -59.66 1.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 111.389 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -135.08 151.21 50.53 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 67.1 m-20 -103.59 115.04 29.77 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.13 -43.92 90.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.053 -1.029 . . . . 0.0 110.736 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -60.01 -42.32 94.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 0.0 110.239 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.549 HH12 ' N ' ' A' ' 143' ' ' SER . 69.9 ttt180 -59.91 -40.53 89.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.997 . . . . 0.0 109.796 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.82 -41.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.996 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.93 92.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.018 -1.051 . . . . 0.0 109.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.75 88.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 0.0 109.204 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.452 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 6.5 t60 -68.33 -44.7 74.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.414 -0.804 . . . . 0.0 109.72 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 74.7 mt-10 -60.03 -39.93 87.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 109.437 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.69 -40.01 90.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 108.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.87 -41.84 84.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.27 -39.95 93.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 108.701 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.6 m -70.19 -27.27 64.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.82 -1.53 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.171 -0.955 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.12 9.93 69.67 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.28 123.61 30.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.939 -1.33 . . . . 0.0 109.181 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.9 m -88.2 176.23 7.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.97 155.38 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -131.17 168.38 17.56 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.1 p -101.82 10.52 39.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.379 -0.826 . . . . 0.0 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.43 129.52 34.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.33 -40.02 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 110.641 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 0.19 77.54 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.985 -1.103 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 129.52 34.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.655 -1.497 . . . . 0.0 109.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 137' ' ' TYR . 88.0 mt -69.21 -24.28 64.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -71.44 45.58 0.11 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.461 ' H ' ' C ' ' A' ' 135' ' ' LEU . 5.4 t80 -70.03 129.78 90.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.451 ' O ' ' HC2' ' A' ' 173' ' ' CGS . 21.5 Cg_exo -48.57 -71.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.192 1.104 . . . . 0.0 112.091 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.4 p -80.92 170.0 16.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 109.597 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.54 135.88 33.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 109.197 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.492 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.0 p -146.71 171.82 14.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.296 -0.878 . . . . 0.0 109.321 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -95.77 115.86 28.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.549 ' N ' HH12 ' A' ' 114' ' ' ARG . 70.0 p -104.18 166.75 10.2 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -68.05 -120.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -80.45 156.92 26.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 109.208 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.4 t -86.39 104.81 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.949 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -146.43 152.29 38.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.079 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.52 142.98 42.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 109.043 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 166.57 12.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.178 -0.951 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.371 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -59.9 -40.3 88.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.517 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -73.07 -40.05 65.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 0.0 109.522 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.05 -50.07 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.76 -39.87 93.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.988 -1.07 . . . . 0.0 109.866 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.45 -57.49 19.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.222 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -65.99 -40.08 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.793 -1.416 . . . . 0.0 110.007 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.1 mt-30 -66.09 -39.95 90.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.88 96.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.01 -50.06 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.895 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -99.56 -64.86 1.0 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.5 -179.11 38.78 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -89.97 149.87 22.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -1.197 . . . . 0.0 109.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 165' ' ' ASN . 21.5 m -73.38 89.67 1.63 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.5 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 95.5 mt-30 -76.57 33.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.729 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 23.6 m120 -154.46 72.75 6.13 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.46 54.35 4.88 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.517 1.478 . . . . 0.0 112.015 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 t -89.93 110.16 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.032 -1.042 . . . . 0.0 109.397 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -64.35 -60.42 8.63 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 111.143 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.319 0 CA-C-N 120.398 1.178 . . . . 0.0 112.347 179.592 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.452 ' O48' ' CD2' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.436 ' H1 ' ' H ' ' A' ' 2' ' ' LEU . 6.7 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.101 0.477 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.436 ' H ' ' H1 ' ' A' ' 1' ' ' VAL . 91.2 mt -56.66 -82.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.0 109.449 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 p -98.67 138.79 35.34 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.193 -0.942 . . . . 0.0 109.721 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.97 145.94 39.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.103 -0.998 . . . . 0.0 109.1 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 -145.16 33.85 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -81.37 149.2 64.82 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.263 -1.14 . . . . 0.0 109.113 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -61.28 157.25 41.25 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.623 0.882 . . . . 0.0 112.131 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 8' ' ' ARG . 43.7 mtt-85 -146.21 163.02 36.74 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.744 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -82.41 120.44 25.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.061 -1.024 . . . . 0.0 109.591 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -83.87 -13.89 52.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 109.598 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.98 149.22 28.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.912 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -95.03 -3.9 47.49 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CD2' ' HG1' ' A' ' 48' ' ' THR . 67.0 m80 -125.3 134.49 52.23 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.9 151.48 50.42 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.872 . . . . 0.0 109.221 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -120.97 155.91 33.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 109.221 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -145.19 159.22 43.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -150.77 133.81 16.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.089 -1.007 . . . . 0.0 110.07 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.5 mt -90.84 120.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.96 -40.11 91.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.991 -1.068 . . . . 0.0 110.882 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.9 149.58 14.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.713 -1.242 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -95.22 132.85 39.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -71.05 143.23 88.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.691 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.72 -9.91 24.6 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.789 0.993 . . . . 0.0 112.625 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.97 -39.97 87.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.086 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -137.83 149.69 65.27 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.64 179.8 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.667 0.911 . . . . 0.0 111.916 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -86.58 -31.43 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.71 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -70.42 -40.07 74.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 110.499 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -40.82 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.546 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.02 -40.46 89.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.34 -45.04 94.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.342 -0.849 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.81 91.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.31 -40.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.695 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -69.92 -40.1 75.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.415 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -61.82 -40.01 93.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.292 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.63 91.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.035 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -60.47 -40.21 90.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.918 -1.114 . . . . 0.0 108.881 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -59.97 -41.47 92.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.792 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.32 -41.3 93.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.104 -0.997 . . . . 0.0 110.458 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -74.76 -42.11 58.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.985 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -68.71 -34.8 76.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 110.407 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.27 -32.24 69.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.269 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.416 ' C ' ' HG ' ' A' ' 163' ' ' SER . 17.3 m -109.79 11.7 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.049 -1.032 . . . . 0.0 110.761 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.0 p -143.01 149.27 48.62 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.911 -1.118 . . . . 0.0 109.472 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -73.68 3.88 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.538 0.826 . . . . 0.0 111.723 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 157.88 37.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 109.657 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.505 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 74.6 p -133.41 151.77 51.85 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.19 154.36 46.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.536 -0.727 . . . . 0.0 109.619 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.2 m -154.01 131.15 11.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -77.87 135.59 37.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.765 . . . . 0.0 109.082 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.17 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.313 -0.867 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 t -99.1 11.66 38.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.482 -0.761 . . . . 0.0 109.835 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.07 153.7 42.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.076 -1.015 . . . . 0.0 109.183 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 168.32 1.44 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -82.05 147.49 29.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 109.011 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.35 160.01 14.78 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.15 -40.06 88.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.34 119.32 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.396 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.1 mtp -103.58 134.3 47.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.523 -0.736 . . . . 0.0 109.767 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -119.68 126.83 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 0.0 109.283 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.9 p -149.69 156.09 41.29 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -103.13 140.78 36.89 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.1 m -138.95 169.77 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 120.945 -1.097 . . . . 0.0 110.818 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -138.08 149.26 45.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.713 -0.617 . . . . 0.0 110.147 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.91 -146.52 2.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -70.07 129.97 40.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -1.08 . . . . 0.0 110.296 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.1 p-80 -137.98 55.82 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.699 -0.626 . . . . 0.0 109.39 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 85.0 mtm180 57.24 48.96 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 109.79 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -142.47 158.25 43.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.347 -0.845 . . . . 0.0 109.156 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -90.96 8.61 34.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -134.5 72.48 69.96 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.342 -0.849 . . . . 0.0 109.752 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.95 148.46 35.54 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.312 1.341 . . . . 0.0 112.682 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -76.4 146.19 38.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.776 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.57 75.2 1.53 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.153 -0.967 . . . . 0.0 110.123 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 -178.75 44.15 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.67 -6.4 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 120.746 0.964 . . . . 0.0 110.999 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.25 43.89 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.69 -173.74 47.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -73.28 151.13 41.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -1.146 . . . . 0.0 109.089 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt -90.91 -13.39 33.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.24 163.41 8.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 108.909 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.46 179.72 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.836 -1.165 . . . . 0.0 110.211 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.83 174.13 10.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.4 155.72 17.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.376 -0.827 . . . . 0.0 108.995 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -59.56 149.02 72.56 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.279 -0.888 . . . . 0.0 108.836 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.97 100.19 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 120.503 0.802 . . . . 0.0 111.842 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 171.75 35.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.94 -169.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.422 1.415 . . . . 0.0 112.144 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.2 -131.38 51.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.03 -9.99 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -1.014 . . . . 0.0 109.796 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.94 147.33 26.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -23.01 36.19 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 121.268 -1.136 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -67.45 154.89 40.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.352 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.1 123.08 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -105.15 147.54 27.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.368 -0.833 . . . . 0.0 110.283 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -119.72 133.96 55.42 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -66.9 122.33 17.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.143 -0.973 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -95.94 -2.62 46.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.032 -1.043 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -76.07 -13.85 60.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.959 -1.088 . . . . 0.0 109.238 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -93.84 152.68 18.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -0.811 . . . . 0.0 109.107 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -86.5 115.07 23.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 108.704 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -91.97 144.6 25.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 110.125 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 p -129.35 174.13 9.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.2 22.38 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.416 -0.803 . . . . 0.0 109.492 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.02 -166.4 2.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -0.921 . . . . 0.0 109.887 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.76 29.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.201 -0.937 . . . . 0.0 110.621 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 109' ' ' GLU . 45.6 mtt-85 -76.16 -159.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.025 . . . . 0.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 108' ' ' ARG . 77.8 mm-40 -32.16 -60.4 0.27 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.815 -0.553 . . . . 0.0 111.819 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -137.92 139.08 39.61 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.089 -1.007 . . . . 0.0 110.041 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.502 HD21 ' N ' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -105.9 119.53 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.354 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 111' ' ' ASN . 64.8 tp -67.25 -39.93 86.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 0.0 110.632 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -60.07 -42.68 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 141' ' ' THR . 60.7 mtp180 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.603 -1.311 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.45 -39.78 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.902 -1.124 . . . . 0.0 109.595 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.6 93.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.46 94.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.034 -1.042 . . . . 0.0 109.891 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.56 ' HD1' HOM3 ' A' ' 173' ' ' CGS . 3.5 t-160 -68.05 -47.31 68.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.97 -39.95 75.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 109.493 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.53 -39.52 91.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 108.798 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.11 90.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -62.69 -40.01 95.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -1.232 . . . . 0.0 109.369 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -70.93 -23.49 62.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.236 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.39 -3.82 58.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.161 -0.962 . . . . 0.0 109.044 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.65 16.79 72.29 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.918 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.57 129.17 34.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.876 -1.367 . . . . 0.0 108.95 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 m -88.06 168.66 12.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.038 . . . . 0.0 109.54 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.73 159.99 31.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.6 t -130.22 168.84 16.21 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -103.05 10.06 38.23 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.316 -0.865 . . . . 0.0 109.618 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.39 128.5 33.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.06 -1.025 . . . . 0.0 109.176 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 132' ' ' ILE . 96.7 mt -59.95 -40.09 81.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.586 -0.696 . . . . 0.0 110.55 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.57 1.61 65.98 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.601 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 136.48 34.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.614 -1.521 . . . . 0.0 109.61 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.1 -26.38 64.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.4 mmm -75.23 52.12 0.57 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.0 t80 -70.17 137.25 86.86 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.954 . . . . 0.0 109.087 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.91 4.63 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 CA-C-N 119.847 0.981 . . . . 0.0 112.184 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.8 p -160.18 176.17 12.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.172 -0.955 . . . . 0.0 109.354 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 64.4 t80 -87.34 128.35 35.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.835 -1.166 . . . . 0.0 109.452 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.532 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 35.0 p -153.55 -171.38 3.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.422 -0.799 . . . . 0.0 109.099 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -141.03 148.46 40.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 t -176.56 122.43 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.57 -167.69 0.16 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -82.32 169.77 16.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 0.0 109.605 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.18 108.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -0.977 . . . . 0.0 109.281 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -144.57 160.2 41.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.439 -0.788 . . . . 0.0 108.89 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.24 141.05 45.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 109.354 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.19 156.43 16.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -56.61 -39.04 72.89 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.056 -1.027 . . . . 0.0 108.801 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -55.33 -39.99 70.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.83 -40.02 63.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.174 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.86 -51.35 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.0 109.034 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.17 -40.17 96.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.775 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.07 -53.32 41.15 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.309 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -69.02 -39.69 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.912 -1.346 . . . . 0.0 109.567 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.9 mt-30 -67.18 -37.97 84.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 109.172 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.9 -50.19 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.793 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -95.31 -69.96 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.16 -0.963 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.61 -168.56 36.12 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 mtm-85 -87.8 150.28 23.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -1.087 . . . . 0.0 108.714 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 165' ' ' ASN . 13.8 m -71.13 90.92 0.89 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 108.793 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.07 34.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.68 -0.638 . . . . 0.0 109.769 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 163' ' ' SER . 17.2 m120 -152.35 73.91 7.48 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.15 -0.969 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.16 61.41 7.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.526 1.484 . . . . 0.0 111.806 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 m -84.2 135.31 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.875 -1.141 . . . . 0.0 109.358 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -115.28 149.8 43.36 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 C-N-CA 120.824 1.016 . . . . 0.0 112.269 179.779 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.56 HOM3 ' HD1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.02 133.22 47.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.322 -0.861 . . . . 0.0 109.224 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.8 p -94.72 129.68 41.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 109.326 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.56 131.38 38.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.185 -0.947 . . . . 0.0 109.967 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.03 -59.76 0.51 Allowed Glycine 0 N--CA 1.501 3.024 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -151.92 72.81 7.94 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.133 -1.216 . . . . 0.0 109.595 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -59.76 107.84 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 120.996 1.131 . . . . 0.0 111.929 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -86.47 169.15 13.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -81.71 125.93 31.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.239 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.7 -16.8 53.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 0.0 109.145 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -82.47 147.44 28.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.2 p -96.08 -4.87 42.12 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -123.38 130.01 52.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.52 150.53 40.09 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -125.63 154.92 41.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.47 159.61 41.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.252 -0.905 . . . . 0.0 109.78 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -148.99 130.31 14.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.385 -0.822 . . . . 0.0 109.318 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.42 127.07 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 108.728 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.88 -40.04 83.61 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -162.91 155.33 18.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.976 -1.077 . . . . 0.0 109.976 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.63 136.32 40.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t -70.49 141.66 88.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.29 -12.65 31.45 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 CA-C-N 119.413 0.826 . . . . 0.0 111.697 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.2 -39.93 88.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 110.5 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -138.38 149.58 63.56 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.062 -1.024 . . . . 0.0 108.39 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.68 -175.93 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.52 0.814 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -85.69 -33.25 21.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.65 74.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.344 -0.847 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.97 -39.99 72.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.13 -42.68 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 109.495 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.6 -44.48 93.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.201 -0.937 . . . . 0.0 109.111 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.21 -46.41 89.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 34' ' ' ILE . 46.0 mm -72.34 -41.05 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.844 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 86.7 tt0 -70.05 -40.89 74.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.966 -1.084 . . . . 0.0 109.751 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -61.35 -35.81 78.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 108.809 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.68 92.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.223 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.2 m-85 -60.19 -40.62 90.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.768 -1.208 . . . . 0.0 109.707 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.479 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -60.69 -39.81 89.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.052 -1.03 . . . . 0.0 110.506 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.67 -46.15 89.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.881 -1.137 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.463 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.6 m95 -71.32 -40.28 70.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.606 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -67.14 -39.16 86.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 111.301 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -56.33 -29.9 61.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.44 11.76 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.867 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.1 p -144.8 150.06 45.17 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.968 -1.083 . . . . 0.0 109.007 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.66 2.22 4.86 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.569 0.846 . . . . 0.0 111.962 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.1 mt -70.74 147.89 48.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.0 p -125.53 149.81 47.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 96.8 m-85 -126.21 152.29 46.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 33.8 m -153.23 129.92 10.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.899 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -77.08 144.22 38.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.543 -0.723 . . . . 0.0 109.54 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.6 135.4 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 t -95.45 -9.46 32.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -144.23 158.32 43.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.66 172.87 49.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.01 160.88 25.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.592 -0.946 . . . . 0.0 108.958 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.94 52.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.03 -40.6 89.91 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 110.558 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.64 119.91 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.3 mtp -102.22 131.6 48.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -0.798 . . . . 0.0 109.481 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 61' ' ' ILE . 91.3 mt -111.62 131.72 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -145.54 160.1 42.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.092 -1.005 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -116.96 136.65 52.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.23 160.01 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.296 -0.877 . . . . 0.0 110.601 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -126.75 137.14 53.19 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.77 -149.51 1.63 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -66.5 130.29 42.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -1.085 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.522 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.2 p-80 -130.89 47.57 2.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.687 -0.633 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 64.6 mtp180 59.54 51.83 6.19 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.161 0.505 . . . . 0.0 109.912 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.522 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 7.5 m-20 -137.67 167.72 21.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.383 -0.823 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -90.69 8.8 32.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 m -137.0 71.88 55.07 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.802 . . . . 0.0 109.133 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.54 146.55 55.67 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 121.184 1.256 . . . . 0.0 111.697 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.68 148.69 36.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -106.27 70.75 0.85 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.438 -0.789 . . . . 0.0 109.423 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.11 -157.58 2.52 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.28 -19.53 17.08 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 118.571 1.185 . . . . 0.0 112.179 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.2 -177.47 41.9 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.56 -166.93 38.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.786 ' ND2' HG13 ' A' ' 173' ' ' CGS . 19.3 m120 -72.02 152.02 42.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -1.132 . . . . 0.0 109.845 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.68 -18.01 23.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.62 165.3 8.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -162.85 -179.31 6.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.48 166.47 22.64 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -95.8 159.71 14.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 109.937 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.25 150.95 39.43 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.534 -0.729 . . . . 0.0 109.241 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -62.02 104.82 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.501 0.801 . . . . 0.0 112.198 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 174.61 37.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.89 171.57 15.45 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.868 1.045 . . . . 0.0 112.318 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 -126.72 17.38 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -73.88 -13.22 15.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.338 -1.095 . . . . 0.0 109.258 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 144.0 45.48 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.58 18.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.97 126.08 28.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.301 . . . . 0.0 110.197 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.74 129.92 51.18 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -102.46 142.54 33.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.288 -0.883 . . . . 0.0 109.833 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -120.18 136.88 54.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.718 -0.614 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.19 121.15 17.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 109.652 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -97.79 -4.53 36.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.55 -16.02 59.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.02 -1.05 . . . . 0.0 109.135 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -93.24 158.24 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.9 ttm-85 -87.9 115.11 25.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 108.796 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.66 139.83 30.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.5 p -127.54 166.66 17.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.473 -0.767 . . . . 0.0 109.644 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -111.45 33.28 4.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -151.75 -165.97 2.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -84.89 32.01 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.95 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -76.14 -161.66 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.1 -59.23 3.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 111.59 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -121.31 132.25 54.68 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.099 -1.001 . . . . 0.0 111.143 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.13 124.27 49.45 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.98 -39.8 75.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -58.46 -45.33 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 111.224 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 87.4 mtt180 -60.2 -44.27 95.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.28 . . . . 0.0 110.526 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.48 -41.05 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.019 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.16 93.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.061 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.22 86.34 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.448 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 56.0 t60 -70.06 -41.59 73.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 110.072 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -58.25 -42.06 85.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.058 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.42 -40.09 93.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 108.942 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.29 -40.08 83.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -66.12 -34.91 79.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -1.206 . . . . 0.0 109.106 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.0 t -69.09 -29.05 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.57 -4.99 57.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.5 19.14 57.41 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.073 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.25 130.11 34.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.823 -1.398 . . . . 0.0 109.094 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 m -86.98 167.47 14.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 109.106 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -63.88 159.75 19.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -128.05 166.82 17.69 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.615 -0.678 . . . . 0.0 109.418 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -107.75 9.1 29.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 11.7 t70 -81.73 129.24 34.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.09 -39.47 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -74.75 -3.22 66.82 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.048 -1.033 . . . . 0.0 111.475 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 137.21 33.54 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.714 -1.462 . . . . 0.0 110.428 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.53 -27.55 65.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 0.0 108.961 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.424 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.0 mtp -76.64 58.67 1.42 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.864 . . . . 0.0 109.865 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -71.83 132.15 85.24 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.33 -68.18 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.211 0 CA-C-N 120.198 1.106 . . . . 0.0 111.057 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.0 p -86.33 175.29 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.42 -0.8 . . . . 0.0 109.773 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.63 126.14 31.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 41.3 p -148.63 153.7 38.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.58 119.93 24.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 109.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.8 t -90.02 -73.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 109.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.444 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 154.64 -110.79 0.46 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -80.05 141.7 35.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 108.439 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.2 t -86.46 105.45 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 110.385 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.49 150.55 39.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 143.72 40.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.825 -1.172 . . . . 0.0 109.298 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.84 156.43 19.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.04 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.75 -40.06 86.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 48.6 t0 -58.76 -40.34 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.75 -40.2 66.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.585 -1.322 . . . . 0.0 109.205 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.51 -48.13 88.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.923 -1.111 . . . . 0.0 110.473 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.94 38.17 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 121.037 -1.039 . . . . 0.0 111.619 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.28 -38.75 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.83 -1.394 . . . . 0.0 109.549 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -64.41 -39.95 94.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 108.57 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.99 97.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.0 109.293 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.38 -50.09 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.037 -1.039 . . . . 0.0 109.593 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -100.66 -67.79 0.84 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.352 -0.843 . . . . 0.0 109.144 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.29 -169.77 34.91 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.11 152.33 22.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.243 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 m -73.12 76.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -95.24 88.48 5.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -155.02 83.19 3.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.331 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -79.44 51.89 4.06 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.837 1.025 . . . . 0.0 112.322 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.45 137.8 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -126.16 79.17 70.06 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 C-N-CA 120.833 1.022 . . . . 0.0 112.14 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.786 HG13 ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.15 -53.44 57.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 108.696 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.6 p -100.73 146.1 27.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.16 132.91 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 0.0 108.766 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.74 -143.25 42.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -85.15 145.11 42.32 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.121 -1.223 . . . . 0.0 108.326 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 106.75 1.42 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 CA-C-N 119.758 0.949 . . . . 0.0 112.138 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.118 -0.989 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -84.36 124.87 31.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.323 -0.861 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.71 -12.68 59.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.884 -1.135 . . . . 0.0 110.63 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 19.2 pt20 -86.86 155.96 20.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.88 -1.138 . . . . 0.0 109.428 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.419 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 63.6 p -96.58 -4.2 41.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.071 -1.018 . . . . 0.0 109.672 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.419 ' CD2' ' HG1' ' A' ' 12' ' ' THR . 40.3 m170 -117.75 130.94 56.62 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.2 mt -118.95 154.21 33.37 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.3 p -128.92 153.17 47.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.272 -0.892 . . . . 0.0 108.698 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.16 162.07 37.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.079 -1.013 . . . . 0.0 109.49 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 17' ' ' ARG . 16.6 ttt-85 -146.98 136.77 23.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 0.0 110.395 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 86.1 mt -89.33 111.47 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.6 tp10 -64.58 -38.78 92.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.486 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 61.5 m-80 -156.64 146.49 20.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.099 . . . . 0.0 110.264 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.76 138.98 32.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -70.01 134.95 87.43 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.085 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -64.11 -13.73 39.44 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 120.017 1.042 . . . . 0.0 111.533 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.873 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.2 mt -134.75 149.57 71.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.69 -175.53 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 120.708 0.938 . . . . 0.0 111.978 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -88.16 -35.58 17.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.12 79.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.566 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.12 -39.98 68.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.204 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.6 t -68.9 -40.84 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.142 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -40.11 88.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 108.824 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -56.7 -50.38 72.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 109.426 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.51 92.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 110.333 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.0 mm -69.94 -39.09 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.083 -1.011 . . . . 0.0 109.762 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.29 -41.44 89.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -63.28 -39.92 95.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.962 -1.087 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.88 75.72 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.803 -1.185 . . . . 0.0 109.206 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 38.1 m-85 -60.97 -40.78 94.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 109.159 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 19.2 mm100 -60.27 -43.23 96.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.97 -41.42 91.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.964 -1.085 . . . . 0.0 110.28 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -74.28 -41.28 61.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.704 -1.247 . . . . 0.0 110.028 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.1 -30.41 69.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 6.2 m120 -58.82 -32.91 69.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.282 -0.886 . . . . 0.0 111.22 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.55 8.26 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.3 p -143.83 148.87 44.25 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.915 -1.116 . . . . 0.0 109.843 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.66 6.58 1.55 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.015 1.143 . . . . 0.0 111.655 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.7 mt -70.24 152.25 44.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.382 -0.823 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.0 p -130.31 150.92 51.33 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 95.3 m-85 -125.86 157.15 38.34 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.5 -0.75 . . . . 0.0 109.952 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 79.7 m -154.89 126.98 7.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.392 -0.817 . . . . 0.0 109.866 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 64.2 tttp -81.37 139.73 35.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 136.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.477 -0.764 . . . . 0.0 109.012 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -95.3 -0.75 52.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.116 -0.99 . . . . 0.0 109.148 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -149.36 159.21 44.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.391 -0.818 . . . . 0.0 109.419 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.25 164.69 36.58 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.41 139.24 39.65 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -1.166 . . . . 0.0 108.075 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.34 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 109.439 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 93.5 m-20 -60.17 -40.71 90.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.462 -0.774 . . . . 0.0 110.006 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.03 118.56 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.83 123.58 45.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 108.956 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 61' ' ' ILE . 90.6 mt -113.04 129.96 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.471 -0.768 . . . . 0.0 109.035 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -146.34 152.61 39.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 109.728 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.58 138.12 40.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.1 162.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.984 . . . . 0.0 110.818 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.11 152.63 51.92 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.39 -151.74 0.62 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.49 130.2 41.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.957 . . . . 0.0 110.392 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 17.3 p-80 -135.63 49.27 2.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.493 -0.754 . . . . 0.0 109.073 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 55.07 56.95 5.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.5 t0 -142.52 160.28 40.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.326 -0.859 . . . . 0.0 108.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 50.5 t30 -88.93 7.53 34.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.084 -1.01 . . . . 0.0 110.047 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 72.4 m -136.11 71.24 62.06 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.0 108.925 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 144.29 75.88 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 120.919 1.079 . . . . 0.0 111.9 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.52 147.97 37.42 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.405 -0.809 . . . . 0.0 109.432 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -128.72 77.1 1.76 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.557 -0.714 . . . . 0.0 109.659 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.19 -174.27 26.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.42 -5.15 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.105 1.203 . . . . 0.0 112.392 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.76 179.19 44.29 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.81 -165.94 49.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' ND2' HG12 ' A' ' 173' ' ' CGS . 22.0 m120 -72.45 151.05 42.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.967 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.3 mt -91.08 -17.56 26.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.42 164.67 8.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.016 -1.053 . . . . 0.0 109.85 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -160.37 177.32 10.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.266 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.87 174.7 9.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.201 -0.937 . . . . 0.0 109.766 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -109.05 153.26 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.645 -0.659 . . . . 0.0 109.897 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.93 151.57 64.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -58.01 104.85 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 120.956 1.104 . . . . 0.0 112.196 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.22 171.41 37.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.81 173.06 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.466 1.444 . . . . 0.0 111.81 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 -127.72 29.44 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.451 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.19 -7.1 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.604 -0.939 . . . . 0.0 110.234 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.31 47.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.3 -21.52 28.03 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 121.246 -1.149 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.33 156.1 35.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -1.197 . . . . 0.0 110.69 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 121.51 11.49 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.6 142.89 29.61 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.211 -0.931 . . . . 0.0 110.88 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.512 ' CE2' ' OE1' ' A' ' 119' ' ' GLU . 26.6 m-85 -119.96 134.59 55.2 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.73 116.58 8.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.493 -0.755 . . . . 0.0 109.025 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -99.58 2.26 44.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.14 -14.85 60.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.57 161.86 13.32 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.5 117.82 26.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -93.1 149.5 21.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.749 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.409 ' HB ' HD22 ' A' ' 106' ' ' ASN . 56.8 p -127.56 166.58 17.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.62 31.41 6.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.621 -0.674 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.565 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.91 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.088 -1.007 . . . . 0.0 109.896 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 53.3 t80 -81.11 33.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.508 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 18.2 mmm180 -76.58 -165.91 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.071 -1.018 . . . . 0.0 110.351 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -59.66 -56.99 14.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 0.0 111.794 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -93.62 125.14 38.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 110.223 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -104.42 104.57 14.46 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -70.02 -39.99 75.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -59.63 -47.43 85.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.908 -1.12 . . . . 0.0 110.781 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 110.548 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 59.5 t -69.76 -41.54 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.876 -1.14 . . . . 0.0 109.608 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.6 86.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.04 92.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.077 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.515 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 5.6 t60 -68.32 -43.93 76.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 110.726 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.512 ' OE1' ' CE2' ' A' ' 97' ' ' PHE . 5.5 mp0 -59.51 -40.69 87.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.597 -1.315 . . . . 0.0 109.633 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.12 -39.99 92.09 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.971 -1.081 . . . . 0.0 108.45 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.06 -41.97 98.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -64.2 -36.21 83.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.019 -1.283 . . . . 0.0 108.653 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.4 t -69.96 -22.79 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.346 -0.846 . . . . 0.0 108.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.82 -3.75 58.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.09 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.11 21.27 55.66 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 120.401 -0.905 . . . . 0.0 110.932 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.72 135.92 34.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.38 . . . . 0.0 109.684 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.1 m -88.74 166.87 13.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.375 -0.828 . . . . 0.0 110.145 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -68.01 161.94 25.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.5 t -125.7 160.96 28.37 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.41 -0.806 . . . . 0.0 109.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 82.5 p -99.99 9.39 42.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.7 t0 -83.3 130.18 35.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt -62.01 -40.42 87.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 111.12 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.14 65.87 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.959 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.34 130.09 35.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.746 -1.444 . . . . 0.0 109.498 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.12 -34.34 73.38 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.9 mmm -72.31 44.95 0.12 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.793 -0.567 . . . . 0.0 110.894 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -69.29 139.95 90.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.6 -55.84 3.61 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 120.216 1.113 . . . . 0.0 111.484 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 140' ' ' TYR . 9.3 t -100.34 176.12 5.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.408 ' N ' ' OG ' ' A' ' 139' ' ' SER . 65.0 t80 -82.88 147.23 28.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 109.37 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -142.18 130.33 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.249 -0.907 . . . . 0.0 109.689 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.37 -40.22 93.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.961 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.7 p -73.28 162.84 28.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.635 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 121.85 124.48 3.04 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.4 t0 -83.17 158.07 22.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -1.134 . . . . 0.0 109.425 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.532 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 57.6 t -84.22 76.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.476 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -150.41 149.44 30.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.79 148.77 36.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.693 -1.254 . . . . 0.0 109.225 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.02 159.72 15.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.052 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 108.914 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -58.19 -40.0 80.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.257 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.23 -41.83 60.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.31 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.17 -49.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.852 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.813 -1.179 . . . . 0.0 109.259 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -57.89 16.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.95 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -64.55 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.86 -1.376 . . . . 0.0 110.08 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.74 -40.05 88.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.004 . . . . 0.0 109.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.32 96.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 109.674 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.87 -50.23 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.95 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.35 -64.25 1.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.271 -0.893 . . . . 0.0 109.752 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.03 170.9 30.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 162' ' ' ARG . 46.4 mtt-85 -90.24 138.01 31.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.0 109.373 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.8 m -74.81 87.52 2.25 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -92.25 116.65 29.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.47 -0.769 . . . . 0.0 109.885 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 167' ' ' VAL . 57.7 m-80 -158.21 146.14 13.8 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -78.69 19.22 0.88 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 119.847 0.981 . . . . 0.0 111.698 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 165' ' ' ASN . 7.6 p -94.58 131.13 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -69.97 149.45 96.38 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.176 -0.953 . . . . 0.0 108.917 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 C-N-CA 120.755 0.97 . . . . 0.0 112.025 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.515 ' O48' ' CD2' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 8.7 mp -60.05 -40.72 90.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.371 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.0 p -94.32 162.81 13.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.069 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -71.91 131.5 43.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.24 -0.913 . . . . 0.0 108.963 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.2 -152.21 50.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -84.59 147.99 50.77 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -1.172 . . . . 0.0 108.294 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.74 93.65 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.352 0.804 . . . . 0.0 112.088 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -144.84 155.46 43.49 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -84.07 133.38 34.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 108.993 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.56 -36.6 60.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.043 -1.035 . . . . 0.0 110.377 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -80.01 155.29 27.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.02 -1.05 . . . . 0.0 109.657 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -95.18 -2.73 49.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -111.62 135.51 52.11 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.5 mt -134.48 159.92 39.63 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.211 -0.93 . . . . 0.0 109.515 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.2 p -130.91 152.9 49.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.615 -0.678 . . . . 0.0 109.24 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.49 158.41 43.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 54' ' ' GLU . 69.6 ttt180 -150.73 137.06 18.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 0.0 109.244 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.67 122.09 42.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.53 -40.11 95.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.618 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -160.01 158.43 30.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.293 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.54 133.98 44.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.366 -0.834 . . . . 0.0 109.28 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -70.99 143.66 89.2 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.95 -10.85 24.44 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 CA-C-N 119.728 0.938 . . . . 0.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.17 -40.04 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.893 . . . . 0.0 110.263 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.7 mt -139.54 150.12 62.42 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -60.46 -174.77 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 120.77 0.98 . . . . 0.0 112.331 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -89.45 -37.13 15.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.96 94.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -71.36 -37.43 71.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.879 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.7 -40.45 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -59.98 -41.68 92.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.557 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -60.45 -45.27 94.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.536 -0.727 . . . . 0.0 109.32 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.75 -44.98 93.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.157 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.33 -41.74 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.584 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.95 -39.7 75.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.014 -1.054 . . . . 0.0 109.927 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.99 -39.3 85.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.34 94.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 109.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.9 m-85 -60.95 -39.77 90.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.077 -1.014 . . . . 0.0 109.381 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.85 -39.89 86.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.08 -42.17 94.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -71.35 -42.92 67.9 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.353 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.8 t -69.86 -25.23 63.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.404 -0.81 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.083 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.6 m -109.33 10.88 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.164 -0.96 . . . . 0.0 110.873 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' LEU . 38.1 p -139.95 143.3 33.81 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.002 -1.061 . . . . 0.0 109.505 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.47 13.49 0.44 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.182 1.254 . . . . 0.0 111.746 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' THR . 85.5 mt -72.66 160.54 32.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 108.893 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 p -137.22 149.2 47.03 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.4 154.25 47.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.761 -0.587 . . . . 0.0 109.536 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -153.08 130.05 11.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 109.748 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -81.77 139.87 34.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.14 139.65 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.5 t -99.89 -6.32 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.368 -0.832 . . . . 0.0 110.238 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.5 mt-10 -144.48 156.79 44.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.157 -0.964 . . . . 0.0 108.772 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 169.9 39.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -84.63 139.44 32.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -1.204 . . . . 0.0 109.655 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.2 156.1 17.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.64 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.1 -39.59 86.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.869 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.94 118.6 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.323 -0.86 . . . . 0.0 109.437 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.7 mmm -100.38 133.77 44.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 108.949 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.1 130.72 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.568 -0.708 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.0 p -149.76 167.73 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.588 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.33 137.65 51.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.72 159.84 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.278 -0.889 . . . . 0.0 110.841 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -125.29 135.35 52.4 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.14 -130.65 4.53 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -81.02 129.82 34.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -1.101 . . . . 0.0 109.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 29.4 p-80 -136.44 51.21 2.01 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.41 54.99 5.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.771 -0.581 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.3 p-10 -141.01 170.21 16.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.047 -1.033 . . . . 0.0 109.457 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -91.92 9.64 32.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 t -140.52 74.95 27.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -71.27 139.09 34.41 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.533 1.488 . . . . 0.0 112.17 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.76 148.14 36.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.105 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -133.27 77.19 1.72 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.563 -0.711 . . . . 0.0 109.819 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.52 177.28 42.93 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.065 -1.022 . . . . 0.0 110.747 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -68.83 -23.04 35.73 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.501 1.467 . . . . 0.0 112.312 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.79 -177.56 51.08 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.64 -153.39 27.24 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.57 144.11 44.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.85 -19.93 19.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.43 170.66 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 0.0 109.429 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.57 179.33 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 109.976 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.97 170.0 17.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.71 154.5 19.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.699 . . . . 0.0 109.452 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -60.07 150.54 69.95 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.228 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.44 102.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.563 0.842 . . . . 0.0 111.957 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.18 171.24 33.38 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.83 169.83 15.39 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.033 1.155 . . . . 0.0 111.966 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.98 -123.18 14.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -77.81 -13.1 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.027 . . . . 0.0 109.587 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.08 140.54 44.69 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.59 -17.22 50.59 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -66.26 158.32 29.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.323 -1.104 . . . . 0.0 109.757 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 118.97 6.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.171 -0.956 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.36 145.87 28.34 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.5 -0.75 . . . . 0.0 110.832 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 24.6 m-85 -116.19 139.11 50.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.758 -0.589 . . . . 0.0 109.679 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.85 118.79 10.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 108.489 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -97.38 -1.03 45.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 109.769 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.29 -20.03 59.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.049 -1.032 . . . . 0.0 109.542 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -98.04 162.34 13.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.7 121.33 29.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.815 -1.178 . . . . 0.0 109.056 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -89.13 135.45 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 109.522 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 p -128.82 170.06 13.81 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.0 109.473 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -118.71 27.12 9.1 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.573 -0.705 . . . . 0.0 110.172 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.681 HD21 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.9 -167.02 2.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 0.0 110.538 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -59.97 10.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.312 -0.868 . . . . 0.0 111.6 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 106' ' ' ASN . 96.4 mtt180 -76.24 166.32 23.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.724 -1.235 . . . . 0.0 110.154 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 108' ' ' ARG . 41.3 mp0 -4.89 -76.9 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -131.74 150.98 51.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.204 -0.935 . . . . 0.0 110.416 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 82.5 m-20 -99.36 119.99 38.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 tp -65.3 -40.11 93.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.223 -0.923 . . . . 0.0 110.59 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -59.97 -42.18 93.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.6 t -70.12 -41.57 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.4 91.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.35 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.05 88.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.067 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.454 ' CD2' ' H50' ' A' ' 173' ' ' CGS . 5.9 t60 -66.81 -45.78 77.26 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.355 -0.841 . . . . 0.0 109.643 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.3 mt-10 -59.72 -39.38 84.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 109.304 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.2 -39.64 90.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.998 . . . . 0.0 109.12 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.85 93.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -67.7 -38.48 83.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 0.0 109.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.5 p -70.11 -22.54 63.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.62 -3.35 59.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 109.239 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.97 72.72 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.86 131.23 35.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.345 . . . . 0.0 109.122 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.3 m -88.49 171.34 10.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 109.897 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -66.77 160.02 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.434 -0.791 . . . . 0.0 109.761 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -124.6 168.04 13.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.0 109.137 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.8 p -104.93 3.64 31.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 109.479 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 120.69 26.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.961 . . . . 0.0 109.312 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 tt -55.95 -29.97 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.21 0.74 83.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.681 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.48 135.95 34.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.785 -1.42 . . . . 0.0 109.546 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.14 -27.41 65.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 0.0 108.653 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.8 mmm -79.02 40.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.713 . . . . 0.0 110.033 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -69.88 133.87 88.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 108.982 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.451 ' O ' ' HC2' ' A' ' 173' ' ' CGS . 22.1 Cg_exo -46.91 -67.5 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.805 0.966 . . . . 0.0 112.207 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.5 m -82.63 175.51 10.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -89.64 129.07 36.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.911 -1.118 . . . . 0.0 109.329 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.8 p -150.18 155.3 39.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.968 . . . . 0.0 109.355 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -102.39 127.15 49.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.391 -0.818 . . . . 0.0 108.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.9 p -152.31 100.11 2.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.093 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.53 -166.42 51.23 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -84.79 170.55 13.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -1.128 . . . . 0.0 109.023 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.5 t -82.81 99.35 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -142.28 160.89 39.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.159 -0.963 . . . . 0.0 109.137 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.42 131.74 42.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.029 . . . . 0.0 109.267 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.27 166.45 13.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.541 -0.724 . . . . 0.0 109.157 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.842 . . . . 0.0 108.856 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.35 -39.69 80.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.25 -42.78 59.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.957 -1.089 . . . . 0.0 109.516 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 153' ' ' ILE . 97.0 mt -63.15 -51.59 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.159 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.4 -39.84 92.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.797 -1.19 . . . . 0.0 110.233 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.44 49.22 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.231 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.19 -37.54 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.305 . . . . 0.0 109.999 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.1 mt-30 -67.59 -40.65 84.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.82 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.09 89.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.131 -0.98 . . . . 0.0 109.484 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.47 -51.04 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.08 . . . . 0.0 109.647 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -98.52 -67.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.097 -1.002 . . . . 0.0 109.953 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.88 -169.25 38.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -96.62 138.49 34.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -1.08 . . . . 0.0 109.243 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 m -73.72 87.03 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.022 -1.049 . . . . 0.0 108.969 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -89.25 102.88 15.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 110.53 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -159.52 137.79 7.57 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.286 -0.884 . . . . 0.0 109.34 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.15 -29.99 4.65 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 119.982 1.029 . . . . 0.0 111.331 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.8 m -96.34 130.03 45.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.4 148.33 98.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.915 -1.116 . . . . 0.0 109.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 117.93 -0.946 . . . . 0.0 111.416 179.19 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.454 ' H50' ' CD2' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.92 -39.97 95.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 108.926 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.1 p -94.53 159.83 14.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.329 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.45 134.9 42.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.88 -154.9 34.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.23 139.92 52.69 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.199 -1.177 . . . . 0.0 109.024 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.35 130.97 19.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 119.739 0.943 . . . . 0.0 111.909 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -91.3 168.99 11.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.957 . . . . 0.0 108.819 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -82.75 120.05 25.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.173 -0.954 . . . . 0.0 109.12 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.71 -12.62 55.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.776 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -83.29 150.63 26.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.2 p -95.69 -4.22 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.226 -0.921 . . . . 0.0 108.975 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.55 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 54.3 m-70 -130.57 144.78 51.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -136.12 158.88 43.34 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.8 p -124.24 155.79 37.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.366 -0.834 . . . . 0.0 109.205 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.97 158.42 43.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.787 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.423 HH21 ' CE ' ' A' ' 60' ' ' MET . 44.0 ttp180 -149.88 130.4 13.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.488 -0.757 . . . . 0.0 109.809 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -90.17 115.77 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.85 -39.73 94.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.473 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -159.46 152.62 22.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.791 -1.193 . . . . 0.0 110.701 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -97.93 135.28 39.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -70.04 138.02 87.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.036 . . . . 0.0 109.869 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.31 -12.5 30.75 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 119.619 0.9 . . . . 0.0 111.818 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.16 -39.43 86.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 109.817 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.81 150.47 65.67 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.31 -171.77 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.385 0.723 . . . . 0.0 111.794 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -86.5 -37.36 18.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.24 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.87 -40.74 75.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.295 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -70.23 -42.65 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 108.909 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.105 . . . . 0.0 108.998 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 45.9 t60 -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.626 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.84 82.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.22 -39.78 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.32 -47.41 79.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.774 -1.203 . . . . 0.0 109.786 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 36.1 mttp -64.03 -33.64 76.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.788 -1.195 . . . . 0.0 110.075 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.77 -50.98 71.69 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.813 -1.179 . . . . 0.0 109.025 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.4 -40.0 95.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -59.98 -43.34 95.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.8 -44.35 94.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 0.0 110.505 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.56 -40.07 70.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 109.67 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.9 t -69.81 -38.52 76.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.68 -30.57 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.201 -0.937 . . . . 0.0 110.898 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.4 11.14 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.204 -0.935 . . . . 0.0 109.842 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.4 p -142.08 146.21 39.19 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.97 5.38 2.61 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 120.859 1.039 . . . . 0.0 111.577 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -71.73 162.18 29.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.437 -0.79 . . . . 0.0 109.11 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 24.4 p -137.8 150.78 47.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -125.0 155.73 39.22 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.525 -0.734 . . . . 0.0 109.615 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.9 m -153.77 132.39 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HZ2' ' CB ' ' A' ' 51' ' ' LYS . 8.2 ttpm? -77.57 140.75 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.624 -0.673 . . . . 0.0 110.247 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.85 130.56 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.519 -0.738 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -95.56 -3.39 46.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.31 151.0 35.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.126 -0.984 . . . . 0.0 109.469 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.17 168.54 44.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.89 140.28 35.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -1.168 . . . . 0.0 108.956 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.62 148.58 25.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.64 -43.74 93.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.17 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -111.48 110.56 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 109.555 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.423 ' CE ' HH21 ' A' ' 17' ' ' ARG . 85.8 mtp -102.46 124.81 48.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 61' ' ' ILE . 96.6 mt -110.11 129.97 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 0.0 109.109 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.8 p -146.75 156.25 43.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.084 -1.01 . . . . 0.0 110.222 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -107.02 135.46 48.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.77 159.99 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 55.0 mtt-85 -123.77 138.93 54.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 109.802 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.36 -139.34 1.24 Allowed Glycine 0 N--CA 1.498 2.802 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.87 122.43 19.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.967 . . . . 0.0 109.427 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -135.17 66.29 1.53 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.431 -0.793 . . . . 0.0 109.866 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 53.69 50.34 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.98 . . . . 0.0 108.61 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 13.9 t0 -141.93 157.83 44.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 109.231 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 27.7 m120 -93.78 8.79 39.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.213 -0.929 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -136.81 74.25 51.89 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.203 -0.936 . . . . 0.0 109.286 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.47 147.32 86.81 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.281 1.32 . . . . 0.0 111.991 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.41 136.91 38.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.068 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -103.23 67.42 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.379 -0.826 . . . . 0.0 109.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.11 -175.02 37.73 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -70.57 -10.67 28.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.061 1.174 . . . . 0.0 111.944 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.33 179.55 40.64 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.06 -146.68 21.32 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.38 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.593 ' ND2' HG23 ' A' ' 173' ' ' CGS . 13.1 t-20 -73.77 131.89 42.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.47 -1.018 . . . . 0.0 110.292 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.45 -18.23 24.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.061 -1.024 . . . . 0.0 109.157 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.88 164.51 7.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.001 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -161.21 125.47 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.977 -1.077 . . . . 0.0 110.68 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.57 168.26 14.65 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.682 -0.636 . . . . 0.0 109.292 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.02 142.15 35.32 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.41 147.87 56.93 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.939 -1.101 . . . . 0.0 109.334 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.17 123.16 12.58 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.42 0.747 . . . . 0.0 111.65 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -179.34 175.69 47.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -73.95 163.31 37.22 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.857 1.038 . . . . 0.0 111.908 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 92' ' ' GLY . . . 74.05 -147.33 37.79 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 tt -50.14 -8.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -1.07 . . . . 0.0 110.19 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 90' ' ' GLY . . . -60.5 142.27 47.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.79 -16.11 55.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.86 159.62 30.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.395 -1.062 . . . . 0.0 110.125 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.56 124.38 22.6 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -106.02 130.15 54.0 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.394 -0.817 . . . . 0.0 110.443 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.557 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.5 m-85 -114.18 134.33 54.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.561 -0.712 . . . . 0.0 109.611 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 98' ' ' ASP . 57.5 t0 -63.34 119.09 9.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 109.608 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.411 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.9 tt0 -101.13 -1.45 33.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.586 -0.696 . . . . 0.0 109.267 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -75.96 -19.83 58.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -101.82 156.6 17.41 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.476 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 44.4 ttp180 -87.23 125.13 34.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.051 -1.031 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.06 149.85 22.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 0.0 109.86 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.7 p -131.69 169.97 15.43 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.366 -0.833 . . . . 0.0 109.175 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -111.63 23.93 13.34 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.428 -0.795 . . . . 0.0 110.039 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.596 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.99 -165.0 2.13 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.909 -1.12 . . . . 0.0 109.995 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.74 22.19 0.06 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.128 -0.982 . . . . 0.0 111.51 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.9 mtp180 -76.66 -163.65 0.35 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.646 -1.284 . . . . 0.0 110.059 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.6 mt-10 -25.2 -67.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -141.4 159.17 42.79 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.905 -1.122 . . . . 0.0 110.842 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 68.8 m-80 -107.45 110.93 23.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -41.48 92.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.372 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.91 -46.92 87.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.922 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.33 -39.73 88.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.825 -1.172 . . . . 0.0 110.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.45 -40.21 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.989 -1.069 . . . . 0.0 108.407 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -41.88 91.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.386 -0.822 . . . . 0.0 109.014 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.088 -1.008 . . . . 0.0 109.724 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.5 t-160 -68.22 -51.81 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 109.183 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.557 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 57.9 mt-10 -58.48 -40.97 84.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -63.4 -39.91 95.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.071 -1.018 . . . . 0.0 109.213 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.39 -38.66 93.74 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -64.21 -35.94 82.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 108.698 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.5 m -69.55 -25.47 64.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 108.726 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.03 -0.68 56.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.31 13.6 70.6 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.842 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.6 128.96 34.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.488 . . . . 0.0 108.919 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.14 170.96 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.607 -0.683 . . . . 0.0 109.703 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.95 156.36 37.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.862 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.4 t -124.97 165.04 18.85 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.1 p -102.04 0.89 35.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.456 -0.777 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -78.33 128.13 33.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.9 tt -58.71 -29.28 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.0 110.497 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.82 3.28 84.14 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.474 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.87 128.92 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.941 -1.329 . . . . 0.0 109.775 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.3 mt -65.64 -31.79 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.453 -0.78 . . . . 0.0 109.146 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 36.4 mtp -74.42 47.76 0.31 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 135' ' ' LEU . 10.2 t80 -68.99 130.92 91.14 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.0 108.948 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -45.63 -68.17 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 CA-C-N 119.99 1.032 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.2 p -80.15 171.02 15.63 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.138 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -82.83 130.31 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 108.881 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 59.5 p -149.81 170.25 19.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -92.08 136.47 33.15 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.162 -0.962 . . . . 0.0 109.546 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 145' ' ' ASP . 79.5 p -101.09 1.07 38.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.388 -0.82 . . . . 0.0 109.746 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.72 -42.78 1.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 143' ' ' SER . 49.9 m-20 -152.45 149.79 28.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.079 -1.248 . . . . 0.0 109.165 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 25.4 t -86.57 100.24 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 109.645 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -148.45 150.9 34.29 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.3 mt -75.24 147.95 39.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 0.0 109.017 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.16 158.42 16.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 109.06 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -60.04 -40.42 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.735 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.8 t0 -58.98 -40.2 84.1 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -74.27 -39.99 62.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.42 -50.03 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.96 -39.95 96.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.91 21.61 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.771 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 tp -60.06 -39.54 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.852 -1.381 . . . . 0.0 109.659 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 33.1 mt-30 -66.13 -37.53 85.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 108.972 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.28 96.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.27 -48.44 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 109.279 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.08 -67.79 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.98 -178.12 37.94 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -88.76 150.61 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.427 -1.043 . . . . 0.0 109.296 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.2 m -74.2 85.38 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.044 -1.035 . . . . 0.0 109.043 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -96.77 111.36 23.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -157.21 74.51 4.34 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.82 40.95 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.622 1.548 . . . . 0.0 112.404 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.49 118.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 109.691 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -127.91 78.28 75.37 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 121.159 1.24 . . . . 0.0 112.135 179.693 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.593 HG23 ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.082 0.468 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.66 141.35 51.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.069 -1.02 . . . . 0.0 109.431 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.9 p -99.27 -138.87 0.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 109.675 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.636 ' C ' ' H ' ' A' ' 6' ' ' ASN . 86.2 tt0 -69.4 154.73 41.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.605 -0.685 . . . . 0.0 109.167 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.09 19.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.338 -0.851 . . . . 0.0 111.087 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.636 ' H ' ' C ' ' A' ' 4' ' ' GLU . 25.2 m120 -149.42 69.84 9.65 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.671 -1.488 . . . . 0.0 109.411 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -61.15 149.96 86.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.23 1.287 . . . . 0.0 112.636 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.4 159.05 43.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -0.793 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -84.13 130.13 34.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -0.867 . . . . 0.0 108.846 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.51 -32.96 62.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.959 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -82.36 153.34 25.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 0.0 109.685 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -93.92 -4.09 50.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.228 -0.92 . . . . 0.0 108.669 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -108.33 130.63 55.19 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.3 mt -126.28 152.42 46.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.474 -0.766 . . . . 0.0 109.486 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 p -124.04 150.45 44.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.488 -0.758 . . . . 0.0 109.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -144.63 161.38 39.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 109.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -151.32 133.62 15.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.415 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.35 116.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.34 -39.34 92.27 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.727 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -159.82 147.39 16.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.655 -1.278 . . . . 0.0 110.508 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.15 134.19 41.54 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -71.45 145.83 90.87 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.793 -1.192 . . . . 0.0 108.572 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.27 -8.62 19.24 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 119.391 0.818 . . . . 0.0 112.015 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.88 -39.91 86.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 mt -135.88 153.16 76.93 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.26 -176.56 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.389 0.818 . . . . 0.0 111.001 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.0 -38.83 15.18 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.967 -1.083 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.25 93.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.16 -39.14 72.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.15 -39.51 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 44.3 t0 -59.71 -40.45 87.98 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.526 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -60.17 -45.46 93.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 109.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.35 92.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 109.205 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -71.82 -40.19 68.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.494 -0.754 . . . . 0.0 110.042 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.15 -39.64 78.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -61.89 -39.87 93.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.786 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.12 93.66 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.308 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -59.92 -39.02 84.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.005 -1.059 . . . . 0.0 108.779 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.492 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.71 -45.63 91.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 109.678 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.43 ' O ' ' OG1' ' A' ' 45' ' ' THR . 94.2 m95 -74.69 -45.29 45.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -65.1 -37.41 87.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.843 . . . . 0.0 110.822 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.34 -23.34 64.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.543 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.81 7.19 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.413 -0.804 . . . . 0.0 110.71 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.543 ' C ' ' HG ' ' A' ' 163' ' ' SER . 11.3 p -145.31 150.06 43.4 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.109 -0.994 . . . . 0.0 109.101 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -72.11 9.51 1.1 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.451 0.767 . . . . 0.0 111.684 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.12 150.0 42.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.307 -0.871 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.9 p -130.25 148.2 52.06 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.495 ' C ' ' HG1' ' A' ' 50' ' ' THR . 97.3 m-85 -128.02 153.44 46.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.699 -0.625 . . . . 0.0 109.891 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.495 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 87.0 m -155.28 133.05 11.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.199 -0.938 . . . . 0.0 110.017 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.22 144.59 40.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.16 135.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -98.69 -4.38 33.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.739 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -144.22 147.78 34.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.04 172.12 48.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -82.59 149.74 27.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 109.331 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.44 152.26 24.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.55 -0.719 . . . . 0.0 109.102 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.1 -44.84 94.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.342 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -114.05 112.21 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.755 0.788 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.5 mtp -99.06 131.17 45.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.402 HG22 HD12 ' A' ' 61' ' ' ILE . 97.2 mt -108.69 129.19 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.6 p -153.12 159.81 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.4 140.24 46.15 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.86 167.62 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.37 -0.831 . . . . 0.0 111.055 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.43 138.98 40.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.0 109.601 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.23 -139.82 10.7 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -73.39 129.04 37.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -1.004 . . . . 0.0 110.095 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.4 p-80 -133.0 60.83 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.256 -0.902 . . . . 0.0 109.619 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 57.66 47.26 16.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.469 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 93.3 m-20 -141.73 163.73 32.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.58 -0.7 . . . . 0.0 109.454 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -96.0 9.59 40.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.316 -0.865 . . . . 0.0 109.776 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -134.04 73.0 71.33 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.341 -0.849 . . . . 0.0 109.599 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -64.31 158.97 45.99 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.986 1.124 . . . . 0.0 112.143 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.79 152.03 31.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -110.36 67.88 0.65 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.525 -0.735 . . . . 0.0 109.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.85 -170.99 31.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.27 -16.78 23.53 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.323 1.349 . . . . 0.0 112.701 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.32 -175.25 46.27 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.16 -150.54 27.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -77.27 144.17 38.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.432 -1.04 . . . . 0.0 109.485 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.76 -18.33 25.15 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.954 -1.091 . . . . 0.0 109.067 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.16 166.06 9.04 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.352 -0.842 . . . . 0.0 108.83 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 83' ' ' HIS . 2.8 p80 -162.5 114.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.962 -1.086 . . . . 0.0 110.346 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.61 173.46 9.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -109.23 160.8 15.82 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -58.11 148.33 61.84 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.021 -1.049 . . . . 0.0 109.242 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.61 103.66 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.773 0.982 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -169.01 169.57 41.94 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -173.32 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.141 1.227 . . . . 0.0 112.81 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.43 -126.41 42.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -82.44 -8.43 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -1.057 . . . . 0.0 110.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.1 138.76 48.59 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.63 63.23 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.198 -1.177 . . . . 0.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.94 130.15 41.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.962 -1.317 . . . . 0.0 110.491 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.89 116.15 31.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.165 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -100.86 132.71 46.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.072 -1.017 . . . . 0.0 109.834 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.51 131.26 55.53 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.392 -0.818 . . . . 0.0 109.902 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.6 127.27 31.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.395 -0.815 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.64 3.98 42.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.104 -0.997 . . . . 0.0 109.97 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.38 -20.04 60.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.022 -1.049 . . . . 0.0 109.334 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -101.91 157.36 16.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 108.804 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -86.35 125.77 33.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 108.625 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -91.11 140.35 29.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.1 p -129.23 163.27 25.98 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -108.66 31.31 5.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.466 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -148.55 -164.99 2.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 109.855 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.54 28.26 0.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -76.56 -163.56 0.34 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -43.63 -60.97 1.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 111.909 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.437 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.2 m-85 -125.73 135.49 52.13 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.617 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -103.1 117.16 33.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.98 -41.7 96.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.844 -1.16 . . . . 0.0 109.76 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.43 -49.58 77.0 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.728 -0.608 . . . . 0.0 112.458 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.714 ' NH2' ' HH ' ' A' ' 140' ' ' TYR . 18.0 ptt180 -59.73 -42.91 94.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.232 -1.542 . . . . 0.0 110.453 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.29 -39.79 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.094 -1.004 . . . . 0.0 109.426 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.92 86.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.345 -0.847 . . . . 0.0 109.089 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.44 90.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.026 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.588 ' ND1' ' SD ' ' A' ' 136' ' ' MET . 3.2 t60 -68.13 -42.45 80.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.907 -1.12 . . . . 0.0 110.223 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -57.71 -40.13 78.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 109.329 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.69 -39.92 90.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.994 -1.066 . . . . 0.0 109.177 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.28 -38.21 77.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -66.61 -34.76 78.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.082 -1.246 . . . . 0.0 109.305 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -70.21 -23.97 63.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.12 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.96 -5.63 58.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 108.771 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.96 58.16 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.03 131.47 35.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.117 -1.226 . . . . 0.0 108.707 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.7 m -87.18 169.86 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.091 -1.005 . . . . 0.0 109.511 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.52 161.73 27.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.513 -0.742 . . . . 0.0 109.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.587 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 15.5 t -126.96 166.16 18.05 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -102.31 11.33 38.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.587 ' H ' ' HG ' ' A' ' 129' ' ' SER . 51.9 t0 -83.1 130.33 35.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 109.882 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.75 -39.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.722 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.63 73.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.367 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.98 132.52 34.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.548 . . . . 0.0 109.222 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.14 -24.13 64.05 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.588 ' SD ' ' ND1' ' A' ' 118' ' ' HIS . 59.5 mmm -72.44 48.84 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.767 -0.583 . . . . 0.0 110.153 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 139' ' ' SER . 13.7 t80 -71.39 137.16 83.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.861 -1.149 . . . . 0.0 109.198 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.63 18.81 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.037 1.049 . . . . 0.0 111.844 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 137' ' ' TYR . 22.2 t -166.5 176.67 7.19 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.714 ' HH ' ' NH2' ' A' ' 114' ' ' ARG . 66.9 t80 -83.53 117.82 23.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.644 -1.285 . . . . 0.0 110.436 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.6 p -150.21 176.52 10.78 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.49 154.28 42.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -129.8 -24.39 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.48 -0.763 . . . . 0.0 109.309 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 166.61 -124.83 1.26 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -80.35 169.98 17.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -1.068 . . . . 0.0 109.163 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.76 103.75 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.023 -1.048 . . . . 0.0 109.261 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -142.46 150.49 40.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 108.653 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.49 145.43 45.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.058 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.17 156.8 17.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.449 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.94 -39.9 87.12 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.24 -40.4 85.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.461 -0.775 . . . . 0.0 109.255 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.63 -41.14 65.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.53 -46.48 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.192 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.54 -40.22 93.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.89 -1.131 . . . . 0.0 110.431 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.64 -58.19 15.11 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.731 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.91 -41.29 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.114 -1.227 . . . . 0.0 110.344 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.33 -40.32 89.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.823 -1.173 . . . . 0.0 110.386 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.42 93.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.956 -1.09 . . . . 0.0 109.65 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 159' ' ' ILE . 96.8 mt -60.8 -50.31 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 108.969 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.98 -74.02 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.196 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.99 -176.07 35.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -83.86 151.94 24.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.063 . . . . 0.0 109.441 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.543 ' HG ' ' C ' ' A' ' 45' ' ' THR . 5.8 m -73.35 82.51 1.41 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -99.53 125.85 45.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.433 -0.792 . . . . 0.0 110.124 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -152.36 143.47 15.81 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.171 -0.955 . . . . 0.0 108.88 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.77 108.42 2.09 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 119.624 0.902 . . . . 0.0 111.655 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.95 134.38 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.335 -0.853 . . . . 0.0 109.942 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -71.23 148.81 94.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 108.682 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.488 1.152 0 C-N-CA 120.699 0.933 . . . . 0.0 112.03 179.338 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.526 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.28 -40.09 92.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.5 p -91.62 152.65 20.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.632 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -73.42 142.94 46.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.91 -161.78 35.06 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.96 137.29 53.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.884 -1.363 . . . . 0.0 108.565 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -67.8 -178.45 1.63 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 CA-C-N 119.694 0.927 . . . . 0.0 111.676 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.62 160.83 39.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -84.79 114.46 22.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.854 -1.154 . . . . 0.0 109.094 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.57 -9.87 48.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 109.505 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -80.94 150.76 28.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.757 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 p -96.6 -5.05 40.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -123.97 131.74 53.61 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.6 mt -132.88 149.73 52.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -125.29 154.65 41.4 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.302 -0.874 . . . . 0.0 109.446 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.89 159.53 42.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 109.311 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.409 HH11 ' HG2' ' A' ' 17' ' ' ARG . 37.7 ttt-85 -148.8 134.04 18.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -89.79 123.26 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.22 -0.925 . . . . 0.0 108.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -41.57 84.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.515 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -162.28 151.04 15.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.858 -1.151 . . . . 0.0 110.23 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -96.94 138.4 34.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.85 144.18 85.25 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 109.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.45 -12.02 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.614 0.876 . . . . 0.0 112.018 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.15 -40.34 89.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.077 -1.014 . . . . 0.0 110.196 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.0 mt -135.73 151.24 73.87 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -65.58 -177.51 0.72 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.468 0.846 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -85.85 -35.51 20.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -43.23 90.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.43 -39.58 77.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 0.0 110.401 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.0 -40.0 87.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.824 -1.172 . . . . 0.0 109.422 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.48 -46.45 90.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.61 95.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.155 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.95 -40.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.717 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.83 -40.3 75.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.045 -1.034 . . . . 0.0 109.974 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -61.0 -40.87 95.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.98 87.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.962 -1.086 . . . . 0.0 109.259 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 30.4 m-85 -60.0 -40.6 89.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.856 -1.152 . . . . 0.0 109.496 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -59.95 -40.47 89.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 110.363 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.0 -45.14 93.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.015 -1.053 . . . . 0.0 110.039 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.412 ' O ' ' OG1' ' A' ' 45' ' ' THR . 95.3 m95 -71.75 -39.89 69.71 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.462 -0.774 . . . . 0.0 109.502 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 t -68.58 -30.63 69.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -0.85 . . . . 0.0 109.766 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -59.81 -37.51 79.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -106.96 10.31 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.217 -0.927 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 76.2 p -138.33 149.32 62.76 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.03 -1.044 . . . . 0.0 108.597 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.41 7.3 2.68 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.335 0.798 . . . . 0.0 110.529 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.4 157.88 36.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.701 -0.624 . . . . 0.0 109.753 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -137.4 151.99 49.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -130.78 155.87 45.94 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -154.33 132.75 11.98 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -81.64 137.02 35.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.324 -0.86 . . . . 0.0 110.032 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.26 132.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.7 t -94.7 0.94 55.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.045 -1.034 . . . . 0.0 109.594 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.3 157.71 44.12 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.22 -0.925 . . . . 0.0 109.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.76 167.31 8.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.03 160.38 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.264 . . . . 0.0 108.705 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.7 158.6 27.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 109.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.35 -39.65 83.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.298 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.23 120.0 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 109.53 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.0 mtp -101.12 135.93 41.79 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.192 -0.942 . . . . 0.0 109.419 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.84 126.94 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -148.03 155.19 41.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.65 139.03 40.86 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.22 163.09 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.503 -0.748 . . . . 0.0 110.773 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 61.4 mtt-85 -131.25 132.69 44.79 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.378 0.609 . . . . 0.0 110.023 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.3 -135.97 7.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -71.54 125.92 28.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.3 p-80 -134.03 49.77 2.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.325 -0.859 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 69' ' ' ARG . 52.8 mtt-85 58.41 53.09 6.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.643 -0.66 . . . . 0.0 111.109 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.536 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.4 m-20 -139.35 163.29 32.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.358 -0.838 . . . . 0.0 108.898 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -90.06 9.3 28.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.6 m -139.67 71.61 36.86 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.349 -0.844 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.91 159.27 41.86 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.154 1.236 . . . . 0.0 112.142 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.64 147.21 37.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.616 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.94 62.33 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.482 -0.761 . . . . 0.0 109.117 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.73 -166.01 53.4 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -54.19 -22.36 25.59 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.304 1.336 . . . . 0.0 112.636 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.0 177.79 48.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.03 -165.18 26.56 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.684 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -75.07 150.41 38.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.288 -1.125 . . . . 0.0 109.94 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -91.45 -13.26 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.57 167.33 9.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.046 -1.034 . . . . 0.0 109.893 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.98 179.91 7.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -166.38 169.33 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -98.04 156.88 16.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -58.48 149.65 59.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.146 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.69 103.12 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 120.428 0.752 . . . . 0.0 111.792 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.29 172.88 37.62 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.22 177.32 6.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.321 1.347 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.54 -125.35 31.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.27 -9.54 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.193 . . . . 0.0 110.041 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.65 135.94 47.03 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.1 -16.83 59.58 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.491 -1.005 . . . . 0.0 110.709 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.64 121.76 15.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.913 -1.345 . . . . 0.0 110.636 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.17 131.81 45.9 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -112.74 135.0 53.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.501 -0.749 . . . . 0.0 109.294 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.8 m-85 -114.73 130.97 56.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.374 -0.829 . . . . 0.0 110.087 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' OD2' ' OE2' ' A' ' 101' ' ' GLU . 62.4 t0 -69.32 122.59 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -99.57 4.47 45.86 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.027 -1.046 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -73.5 -15.28 61.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.713 -1.242 . . . . 0.0 109.128 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 56.4 mp0 -102.64 152.66 20.93 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -85.71 119.4 26.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.93 -1.106 . . . . 0.0 108.777 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.53 150.28 24.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 p -129.82 163.09 27.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -113.9 34.86 4.37 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -150.18 -165.02 2.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.0 109.99 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.25 31.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.305 -0.872 . . . . 0.0 109.764 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.473 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.9 mmt-85 -76.82 -165.09 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -0.999 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.0 -58.25 9.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.731 . . . . 0.0 112.203 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -101.12 121.85 42.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.052 -1.03 . . . . 0.0 110.984 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 9.3 m120 -108.69 110.95 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.77 -44.67 96.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.11 -0.994 . . . . 0.0 111.122 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.081 . . . . 0.0 110.713 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.678 ' NH1' HOM1 ' A' ' 173' ' ' CGS . 43.9 ttt-85 -59.17 -46.68 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 109.738 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.12 -40.4 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.165 -0.96 . . . . 0.0 109.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.08 91.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.955 -1.091 . . . . 0.0 109.575 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.13 95.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.8 . . . . 0.0 109.813 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.438 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 48.6 t60 -69.77 -40.79 75.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.16 -40.14 88.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.812 -1.18 . . . . 0.0 109.075 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.19 -39.97 88.38 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.65 -42.4 67.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -63.24 -39.33 94.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.241 -1.152 . . . . 0.0 108.549 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.8 p -70.14 -22.93 62.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.232 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.22 -2.63 58.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.144 -0.973 . . . . 0.0 109.385 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.41 73.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.22 131.42 35.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.03 -1.276 . . . . 0.0 108.804 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.0 m -88.1 170.56 10.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.03 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -66.07 158.66 27.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 108.705 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -129.88 158.72 38.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.42 -0.8 . . . . 0.0 109.224 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -102.94 13.83 33.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -84.13 130.91 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -42.91 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.66 0.32 65.57 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.235 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.69 139.2 32.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.676 -1.485 . . . . 0.0 108.928 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.74 -27.61 66.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 108.895 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.401 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 28.7 mtp -75.75 60.86 1.34 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 0.0 109.489 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.7 t80 -68.31 137.49 91.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.46 5.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.985 1.03 . . . . 0.0 112.1 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.544 ' H ' ' C ' ' A' ' 137' ' ' TYR . 57.6 p -158.78 173.75 16.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.965 -1.084 . . . . 0.0 109.501 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -85.9 134.8 33.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.4 p -151.05 170.26 19.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.398 -0.814 . . . . 0.0 109.093 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 37.9 p90 -96.87 123.17 40.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.8 m -107.04 147.43 29.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.327 -0.858 . . . . 0.0 109.747 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.88 -89.07 0.13 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -88.43 135.3 33.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -1.229 . . . . 0.0 108.984 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 t -88.23 104.29 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.851 -1.156 . . . . 0.0 109.436 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -141.29 150.28 42.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 0.0 109.61 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.7 139.66 45.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 168.88 10.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.99 -40.7 90.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.581 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.53 -40.44 87.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.505 -0.747 . . . . 0.0 109.748 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -75.24 -42.56 55.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 109.263 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.79 -50.63 74.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.451 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.22 -39.37 90.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.16 . . . . 0.0 110.02 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.38 -56.37 20.3 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.72 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.5 tp -64.38 -40.85 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.8 mt-30 -65.22 -39.09 92.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.029 -1.044 . . . . 0.0 110.108 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.41 88.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.81 -1.182 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.37 -49.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.044 -1.035 . . . . 0.0 109.527 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -97.28 -67.6 0.84 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.474 -0.766 . . . . 0.0 109.833 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.87 179.66 39.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.72 134.29 34.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -1.115 . . . . 0.0 109.421 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.5 m -76.73 80.79 3.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -99.08 79.61 2.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.354 -0.842 . . . . 0.0 109.964 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.681 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 3.7 m-80 -157.91 -37.03 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.034 -1.041 . . . . 0.0 111.924 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.681 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 17.2 Cg_endo -86.42 79.07 1.93 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.322 1.151 . . . . 0.0 112.682 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 167' ' ' VAL . 17.4 m -87.72 119.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.82 -1.175 . . . . 0.0 108.766 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -71.21 150.63 94.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.048 -1.032 . . . . 0.0 110.114 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 CA-C-O 117.932 -0.945 . . . . 0.0 112.128 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.678 HOM1 ' NH1' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.363 0.601 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.36 137.73 53.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.4 p -89.8 166.02 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -0.86 . . . . 0.0 109.315 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -75.09 131.74 40.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.021 -1.049 . . . . 0.0 109.024 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.96 -174.53 54.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -82.98 147.28 53.94 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 108.558 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.9 118.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.643 0.895 . . . . 0.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -144.94 156.96 44.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -84.87 124.11 31.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.38 -0.825 . . . . 0.0 109.6 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -87.55 -6.78 58.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.82 150.44 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -95.09 -6.29 42.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.471 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 31.9 m-70 -130.03 139.8 50.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -132.8 157.98 43.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.535 -0.728 . . . . 0.0 109.332 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -127.99 153.56 46.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.94 158.42 43.63 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.225 -0.922 . . . . 0.0 109.922 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -146.99 134.61 21.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.014 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.86 112.35 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.2 tt0 -63.63 -39.82 95.32 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 0.0 110.392 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 83.1 m-20 -155.29 142.45 19.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.949 -1.094 . . . . 0.0 110.479 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.01 137.06 32.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -69.34 136.99 88.79 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -66.83 -9.37 24.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.691 0.925 . . . . 0.0 110.909 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.28 -40.11 89.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.762 -0.586 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -136.24 149.87 69.23 Favored Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -178.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.107 0 CA-C-N 119.353 0.805 . . . . 0.0 111.443 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -31.69 18.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.71 87.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.895 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.92 -40.01 65.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.792 . . . . 0.0 110.7 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.05 -44.32 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -58.58 -44.8 89.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.298 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -59.64 -41.94 91.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.047 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.2 82.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.875 -1.14 . . . . 0.0 109.729 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.1 -39.26 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 0.0 109.684 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.14 -39.68 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.067 -1.021 . . . . 0.0 109.432 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -63.3 -40.04 96.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.738 -1.226 . . . . 0.0 110.695 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.89 71.43 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.691 -1.255 . . . . 0.0 109.45 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 37.8 m-85 -60.31 -43.96 95.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.547 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -60.04 -42.76 95.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.93 -40.29 88.39 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.839 -1.163 . . . . 0.0 110.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.438 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.9 m95 -74.42 -40.21 62.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.479 -1.388 . . . . 0.0 109.28 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.56 -27.24 66.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.587 -0.696 . . . . 0.0 110.061 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -38.85 84.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 111.252 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -109.84 13.46 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.22 -0.925 . . . . 0.0 110.77 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 72.1 p -141.34 148.42 50.88 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.2 -0.938 . . . . 0.0 108.879 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.06 6.17 2.27 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 119.573 0.883 . . . . 0.0 111.982 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.28 151.72 42.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.159 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 21.0 p -131.75 149.19 52.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 96.7 m-85 -129.21 156.04 44.58 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.274 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.8 m -154.66 128.83 8.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.669 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -78.53 139.3 38.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.36 136.82 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 t -97.81 -2.92 39.9 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.051 -1.03 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -145.61 155.28 42.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.815 -1.178 . . . . 0.0 109.528 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.58 173.46 44.91 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.0 158.7 26.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -1.207 . . . . 0.0 109.391 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.02 152.22 41.15 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.46 -0.775 . . . . 0.0 109.134 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -60.03 -40.6 89.89 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -119.83 119.04 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mtp -101.28 127.66 47.79 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.858 . . . . 0.0 109.646 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -109.88 131.13 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.415 -0.803 . . . . 0.0 109.251 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.6 p -146.86 160.0 42.84 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.849 0.833 . . . . 0.0 110.091 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.26 139.28 47.93 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.26 167.25 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -139.3 144.78 38.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 0.0 110.248 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.85 -149.6 2.29 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -71.77 128.83 37.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.277 -1.131 . . . . 0.0 109.565 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 11.3 p-80 -130.83 60.19 1.65 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.379 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 53.36 54.67 9.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.944 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.7 p-10 -142.77 169.44 17.56 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.157 -0.964 . . . . 0.0 109.35 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.86 9.04 41.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.319 -0.863 . . . . 0.0 109.236 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -137.17 70.97 55.28 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 0.0 109.579 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.24 145.69 73.21 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 120.716 0.944 . . . . 0.0 111.496 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -74.74 144.7 43.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 72.67 0.84 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.02 -166.71 54.51 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -66.81 -10.14 27.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.186 1.257 . . . . 0.0 111.72 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.6 170.22 26.6 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.04 -151.11 19.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -73.58 142.58 46.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -1.081 . . . . 0.0 109.64 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.89 -16.23 26.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.072 -1.017 . . . . 0.0 109.23 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.62 171.48 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -163.27 121.12 1.93 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.802 -1.186 . . . . 0.0 109.76 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.53 162.02 21.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.723 -0.611 . . . . 0.0 109.854 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -107.76 146.64 31.9 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -59.78 146.05 82.22 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.948 -1.095 . . . . 0.0 108.616 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.65 125.75 20.04 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.849 0.982 . . . . 0.0 112.122 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.27 174.51 44.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.96 -177.55 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.115 1.21 . . . . 0.0 112.093 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.32 -128.88 48.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -78.91 -4.14 6.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.43 -1.041 . . . . 0.0 109.838 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.99 132.45 50.81 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.1 52.12 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -68.75 160.02 31.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.0 122.28 21.63 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -99.12 136.21 39.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.409 -0.807 . . . . 0.0 110.867 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.8 m-85 -116.16 131.41 56.95 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.43 121.83 17.15 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.077 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -100.15 -0.46 38.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.155 -0.965 . . . . 0.0 109.868 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -72.93 -15.67 61.57 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.962 -1.086 . . . . 0.0 109.877 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 159.96 15.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.38 -0.825 . . . . 0.0 108.871 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.409 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.3 ttp180 -89.25 122.23 32.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.085 -1.009 . . . . 0.0 109.596 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -89.22 151.7 22.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 110.106 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 59.1 p -125.95 160.32 30.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.507 -0.746 . . . . 0.0 109.56 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.99 29.27 7.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.533 -0.729 . . . . 0.0 109.987 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' ND2' ' CG ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -148.67 -165.02 2.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.486 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -81.04 30.81 0.32 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.945 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.492 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 17.0 mmm180 -75.65 -175.06 2.75 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.033 -1.042 . . . . 0.0 109.228 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 55.5 mp0 -47.4 -59.77 2.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.828 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 79.7 m-85 -83.62 152.5 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.86 -1.15 . . . . 0.0 110.92 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -140.89 90.24 2.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.99 -46.44 89.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.139 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -60.07 -45.77 91.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.0 109.985 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HG2' HOM2 ' A' ' 173' ' ' CGS . 45.8 ttp180 -59.4 -40.31 86.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.009 -1.057 . . . . 0.0 108.798 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 HG21 HOM3 ' A' ' 173' ' ' CGS . 53.6 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.262 -0.899 . . . . 0.0 109.319 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.84 -40.56 84.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 109.144 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.63 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 109.085 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.7 t-160 -68.69 -50.33 51.84 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.5 mt-10 -57.49 -41.96 81.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.877 -1.139 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.86 -37.88 88.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.896 -1.127 . . . . 0.0 109.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.59 92.28 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -64.79 -37.33 87.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.266 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -69.92 -22.68 63.17 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.48 -1.91 57.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.16 59.82 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.25 132.16 35.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.361 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.3 m -87.54 163.8 16.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.457 -0.777 . . . . 0.0 110.169 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -65.81 157.94 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.633 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.416 ' OG ' ' OD2' ' A' ' 151' ' ' ASP . 30.4 t -130.3 167.44 18.5 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -106.6 10.63 31.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.744 . . . . 0.0 109.148 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.67 120.12 24.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.87 -28.81 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.828 . . . . 0.0 110.798 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.56 -6.89 88.81 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.699 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.11 133.15 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.271 . . . . 0.0 109.868 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.72 -24.65 67.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 84.2 mmm -74.71 56.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.958 . . . . 0.0 109.33 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.447 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.5 t80 -70.11 137.42 87.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 108.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.33 7.23 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 120.098 1.071 . . . . 0.0 112.743 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.447 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.5 p -161.67 169.69 21.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 109' ' ' GLU . 49.3 t80 -87.13 133.12 33.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.216 -0.927 . . . . 0.0 109.788 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.7 p -145.82 145.74 30.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -66.18 -28.11 68.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.017 -1.052 . . . . 0.0 109.55 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.6 m -77.06 142.12 39.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.958 . . . . 0.0 109.811 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.22 113.79 1.09 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 60.4 t0 -85.08 156.19 21.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -1.189 . . . . 0.0 109.108 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.565 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 93.7 t -84.41 83.41 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 109.713 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -148.93 147.22 28.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 109.01 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.0 mt -78.55 133.85 37.31 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.14 166.33 13.03 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -60.78 -40.03 91.05 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.416 ' OD2' ' OG ' ' A' ' 129' ' ' SER . 57.9 t0 -59.69 -40.49 88.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.813 . . . . 0.0 109.056 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -74.29 -42.24 59.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.78 -49.15 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.126 -0.984 . . . . 0.0 109.314 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.27 -40.3 89.88 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.05 -55.73 28.66 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.107 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.0 tp -65.9 -39.18 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.237 . . . . 0.0 109.797 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.8 mt-30 -66.99 -39.35 87.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.0 . . . . 0.0 109.256 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.76 93.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.995 -1.065 . . . . 0.0 109.721 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.06 -47.87 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.0 110.348 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -101.23 -61.26 1.39 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.401 -0.812 . . . . 0.0 109.899 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.85 179.61 35.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 145.12 24.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -1.162 . . . . 0.0 109.683 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m -73.05 88.74 1.42 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -92.17 103.0 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -152.36 155.94 33.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.286 -0.884 . . . . 0.0 109.119 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.29 72.02 6.47 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 120.699 0.933 . . . . 0.0 111.111 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.76 133.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.423 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -69.79 148.06 96.41 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 108.946 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 C-N-CA 120.763 0.975 . . . . 0.0 112.118 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.438 HOM2 ' HG2' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 2' ' ' LEU . 7.6 p . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.405 ' N ' ' CG1' ' A' ' 1' ' ' VAL . 33.4 tp -90.09 -3.86 57.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -85.66 127.14 34.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.79 -1.193 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -75.61 139.39 42.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.659 -0.651 . . . . 0.0 109.518 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.83 -60.09 0.47 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -153.46 72.34 6.8 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.166 -1.196 . . . . 0.0 109.945 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.87 106.78 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.918 1.079 . . . . 0.0 112.313 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -87.61 161.34 17.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.036 -1.04 . . . . 0.0 109.065 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -84.15 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.961 -1.087 . . . . 0.0 109.519 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.61 -9.14 59.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -83.17 148.91 27.18 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 p -98.21 -5.71 32.78 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.502 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 68.2 m80 -127.72 122.51 33.08 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.87 153.98 23.7 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.176 -0.952 . . . . 0.0 109.889 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 p -130.93 157.46 42.89 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -144.26 162.52 36.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -144.42 124.53 13.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.238 -0.914 . . . . 0.0 110.055 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.415 HG22 HD12 ' A' ' 18' ' ' ILE . 93.1 mt -86.77 113.59 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 77.3 tt0 -62.68 -41.15 98.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.95 154.73 24.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -95.9 142.4 28.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -70.05 138.57 87.42 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.174 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.28 -13.07 38.29 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.739 0.959 . . . . 0.0 111.37 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.59 -40.42 91.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.0 149.39 68.31 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.65 -178.72 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.209 0.753 . . . . 0.0 112.038 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -86.04 -32.12 21.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.303 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.04 86.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.112 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -69.17 -38.96 78.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.76 -39.99 80.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.259 -0.9 . . . . 0.0 109.644 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.87 -40.53 84.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.194 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -60.27 -48.8 80.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.69 84.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.949 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.93 -40.6 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.171 -0.955 . . . . 0.0 109.851 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -69.89 -39.44 76.26 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 108.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.19 -39.81 93.95 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.39 90.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 109.736 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.9 -40.45 93.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.823 -1.173 . . . . 0.0 109.073 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.12 -41.45 92.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.13 -45.82 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.403 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 98.2 m95 -74.09 -42.83 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 t -63.55 -37.96 89.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.345 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -60.16 -23.57 64.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.552 -0.718 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.54 7.63 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.957 -1.09 . . . . 0.0 110.457 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 4.9 p -145.67 151.95 47.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -72.12 4.2 3.45 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.821 1.014 . . . . 0.0 112.097 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.21 152.0 44.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.0 109.775 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 44.9 p -127.08 150.13 49.61 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.03 158.29 34.1 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 110.489 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 m -153.89 127.91 8.96 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.967 0.889 . . . . 0.0 110.291 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.76 140.74 31.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.674 -0.641 . . . . 0.0 109.681 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 141.88 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.33 -0.856 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -95.02 -6.99 40.99 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.179 -0.951 . . . . 0.0 110.69 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -149.5 155.33 40.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.919 -1.113 . . . . 0.0 109.545 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.37 160.6 33.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.68 130.96 35.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -1.124 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.7 170.02 9.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.089 -1.007 . . . . 0.0 109.79 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.08 -40.08 88.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 109.712 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.92 120.42 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.517 -0.739 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.4 mmm -98.77 129.61 45.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.349 -0.844 . . . . 0.0 109.498 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -112.42 130.32 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -147.19 156.88 43.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.995 -1.065 . . . . 0.0 110.226 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.0 133.15 53.49 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.62 160.09 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 O-C-N 121.006 -1.059 . . . . 0.0 111.395 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -124.73 138.32 54.29 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.2 -146.2 4.12 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.86 130.86 42.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.792 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.501 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -131.25 43.54 3.07 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 55.69 58.18 4.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.685 . . . . 0.0 110.139 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.501 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 17.7 p-10 -141.17 171.58 13.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 0.0 109.126 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -91.25 10.65 26.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 109.73 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 t -141.0 71.67 28.35 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.103 -0.998 . . . . 0.0 109.903 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.37 141.98 32.69 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.108 1.206 . . . . 0.0 112.12 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.5 153.79 33.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.604 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.83 75.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.93 -164.55 17.2 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -55.86 -17.99 20.39 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.796 0.998 . . . . 0.0 111.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -179.02 49.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.1 -164.87 35.54 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -74.77 155.79 37.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.132 -1.216 . . . . 0.0 109.428 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 mt -93.09 -19.7 21.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.141 -0.975 . . . . 0.0 109.272 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.94 169.79 8.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.012 -1.055 . . . . 0.0 109.37 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -163.03 179.96 7.16 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.646 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.83 170.94 16.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.621 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -98.64 158.1 15.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.354 -0.841 . . . . 0.0 109.589 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -57.06 145.94 62.88 Favored Pre-proline 0 N--CA 1.485 1.311 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.16 104.22 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 120.371 0.714 . . . . 0.0 111.62 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.05 171.23 37.91 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.3 -175.63 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.039 1.159 . . . . 0.0 112.024 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.96 -127.09 40.19 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -80.05 -11.13 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.24 . . . . 0.0 109.252 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.92 142.36 46.34 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.09 -21.84 32.22 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.3 150.25 46.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.286 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.03 125.94 19.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 108.749 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -105.87 150.06 25.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.534 -0.729 . . . . 0.0 109.554 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.13 140.05 51.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.77 119.26 10.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.057 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -99.48 -3.32 33.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.361 -0.837 . . . . 0.0 109.354 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.26 -18.56 60.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.833 . . . . 0.0 109.677 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -98.15 159.78 14.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.24 -0.913 . . . . 0.0 108.905 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.8 ttm-85 -89.39 119.59 29.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.25 -0.906 . . . . 0.0 109.691 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.74 145.34 25.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.345 -0.847 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 69.6 p -122.49 160.97 24.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -108.41 30.43 6.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.56 -0.712 . . . . 0.0 109.102 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -148.64 -165.0 2.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.09 -1.006 . . . . 0.0 110.269 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -82.25 28.98 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -73.7 -169.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.134 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.81 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 111.656 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.47 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -87.14 153.51 21.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.972 -1.08 . . . . 0.0 110.547 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -143.7 97.59 3.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.187 -0.946 . . . . 0.0 108.55 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.51 -45.95 92.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.364 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.56 -39.85 85.38 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.84 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.422 ' HG3' ' NH1' ' A' ' 114' ' ' ARG . 1.9 tpm_? -60.0 -43.37 95.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.27 -39.63 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.785 . . . . 0.0 108.89 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.96 84.49 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.37 -0.831 . . . . 0.0 109.164 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.548 ' CD2' ' H50' ' A' ' 173' ' ' CGS . 4.5 t60 -70.63 -46.66 62.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.85 -41.37 91.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.5 mt -63.77 -39.72 94.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.78 -40.38 80.12 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -66.36 -35.46 80.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 108.328 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.4 t -69.96 -25.32 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.26 -0.03 50.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 109.07 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.19 12.08 66.1 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.813 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.79 128.58 33.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.461 . . . . 0.0 108.979 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.2 m -88.34 170.12 11.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.428 -0.795 . . . . 0.0 109.671 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -66.12 149.0 50.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 t -124.67 161.49 26.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.3 p -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.51 127.37 32.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.047 . . . . 0.0 108.732 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.88 -40.08 81.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.527 -0.733 . . . . 0.0 110.212 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.26 1.41 70.54 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.616 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.01 139.96 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.716 -1.461 . . . . 0.0 109.695 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.02 -29.3 67.45 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 109.274 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 77.3 mmm -74.3 55.23 0.6 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.8 t80 -69.29 139.49 89.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.8 -3.9 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 CA-C-N 119.832 0.976 . . . . 0.0 112.543 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -162.84 170.91 17.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 109.311 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -84.95 101.58 12.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.715 -1.24 . . . . 0.0 109.06 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.1 p -155.12 8.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 109.598 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -98.01 123.99 42.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.174 -0.953 . . . . 0.0 110.041 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.4 m -119.94 135.22 54.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.509 -0.744 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.16 -159.04 32.09 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.618 -1.277 . . . . 0.0 109.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 49.4 t0 -81.06 152.2 28.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -1.003 . . . . 0.0 108.967 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.522 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 98.4 t -83.01 96.92 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 0.0 109.703 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -146.95 151.81 37.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.408 -0.807 . . . . 0.0 109.207 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.14 149.58 38.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.03 150.26 21.08 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -58.4 -40.08 81.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.835 -1.166 . . . . 0.0 109.035 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.84 -37.74 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.785 -1.197 . . . . 0.0 108.448 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -74.69 -39.93 61.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.99 -49.86 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.095 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.67 -39.78 95.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.963 . . . . 0.0 110.512 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.18 -51.02 47.56 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.93 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 tp -67.81 -38.9 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.401 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.4 mt-30 -65.68 -39.75 91.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.685 -1.259 . . . . 0.0 109.315 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.04 95.2 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.782 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.34 -49.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.84 -63.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.094 -1.004 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.09 -165.5 33.25 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 162' ' ' ARG . 35.3 mtt-85 -96.17 139.85 31.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.451 -1.029 . . . . 0.0 109.261 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.7 m -75.55 88.58 2.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.762 -1.211 . . . . 0.0 108.425 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.06 77.43 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 108.752 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -156.63 76.44 4.37 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 121.496 -0.752 . . . . 0.0 109.16 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -81.19 93.12 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.542 1.495 . . . . 0.0 112.453 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.6 t -149.43 124.5 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -67.69 149.67 98.18 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.175 -0.953 . . . . 0.0 108.77 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 117.91 -0.954 . . . . 0.0 111.99 -179.488 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.548 ' H50' ' CD2' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.5 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -76.98 138.24 39.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 109.647 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 80.2 p -94.05 129.73 40.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -81.21 104.91 12.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.85 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.75 78.56 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.022 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.42 ' O ' ' OG1' ' A' ' 3' ' ' THR . 76.2 m-20 -152.87 70.05 7.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 120.683 -1.48 . . . . 0.0 110.692 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -78.15 101.3 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.386 1.391 . . . . 0.0 111.803 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -145.8 154.16 41.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.031 -1.043 . . . . 0.0 109.696 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -85.91 122.01 29.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 108.523 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.85 -12.58 55.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.159 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -82.97 152.44 25.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.705 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 p -96.6 -4.59 40.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.921 . . . . 0.0 109.112 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.499 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 77.2 m80 -125.35 135.41 52.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.69 158.35 43.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.39 -0.819 . . . . 0.0 109.537 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.7 p -128.43 154.08 46.42 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.48 159.97 41.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -149.45 130.35 14.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.084 -1.01 . . . . 0.0 110.176 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.408 HG22 HD12 ' A' ' 18' ' ' ILE . 92.8 mt -87.44 115.2 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.88 -40.11 91.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -160.09 151.87 20.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.075 . . . . 0.0 110.26 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -98.87 135.65 40.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.379 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 t -71.2 144.08 89.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.947 . . . . 0.0 108.987 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -66.03 -11.25 30.26 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.704 0.936 . . . . 0.0 112.035 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.13 -39.93 87.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 109.957 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -137.59 150.21 67.51 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.193 -0.942 . . . . 0.0 108.951 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.35 -177.34 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.706 0.937 . . . . 0.0 111.924 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -88.99 -37.04 15.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 0.0 109.938 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.44 83.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.95 -39.01 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 109.617 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.68 -39.95 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -41.59 92.75 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.075 -1.016 . . . . 0.0 109.077 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.59 -46.38 90.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.98 90.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 0.0 109.775 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.31 -40.16 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -39.92 75.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.997 . . . . 0.0 108.682 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.06 -39.97 91.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.31 84.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.938 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.11 -39.95 87.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.965 -1.085 . . . . 0.0 108.786 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.12 -40.28 89.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 110.093 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.12 -47.02 87.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.871 -1.143 . . . . 0.0 109.644 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.448 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.3 m95 -71.78 -41.72 67.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.493 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.21 -38.17 81.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.552 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.28 7.73 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 14.9 p -145.79 150.0 41.5 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.893 -1.13 . . . . 0.0 109.215 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.13 6.47 1.77 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.693 0.929 . . . . 0.0 111.899 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.93 154.06 42.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.13 -0.981 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.499 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.8 p -133.3 149.99 51.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.533 -0.73 . . . . 0.0 109.333 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.88 156.24 43.99 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.468 -0.77 . . . . 0.0 109.965 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 m -155.38 132.43 10.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.755 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -78.3 145.66 35.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.96 134.98 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.447 -0.783 . . . . 0.0 109.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -93.07 -0.93 56.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.037 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -152.89 158.63 42.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 109.666 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.6 168.11 30.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.88 149.33 29.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -1.175 . . . . 0.0 109.127 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 151.93 25.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.437 -0.79 . . . . 0.0 109.108 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.286 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -116.56 116.06 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.47 137.52 39.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.46 127.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.1 p -149.58 161.36 42.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 110.207 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.14 139.97 46.07 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.72 167.14 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.198 -0.939 . . . . 0.0 110.739 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.76 146.79 49.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.629 -0.67 . . . . 0.0 110.194 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.52 -150.19 0.87 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -60.07 136.88 58.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.087 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 25.1 p-80 -137.48 54.23 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.82 54.14 8.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.592 -0.693 . . . . 0.0 110.035 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.9 t0 -147.31 162.14 39.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.5 m120 -89.7 9.0 28.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 109.775 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.7 m -134.55 70.58 72.01 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.412 -0.805 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.5 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 120.879 1.053 . . . . 0.0 112.051 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -77.62 141.44 39.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -103.54 62.07 0.77 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.413 -0.804 . . . . 0.0 109.179 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.92 54.82 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -55.91 -14.11 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.023 1.149 . . . . 0.0 111.914 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.18 -178.54 50.83 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.28 -158.8 42.34 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 80' ' ' ASN . 48.0 p-10 -74.33 147.61 42.09 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -1.137 . . . . 0.0 109.478 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -94.66 -15.85 23.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.89 160.12 8.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.05 -1.031 . . . . 0.0 109.286 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.18 -178.7 6.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.286 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.39 168.17 20.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 109.869 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.75 164.46 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.38 -0.825 . . . . 0.0 109.94 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.07 149.88 72.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.838 . . . . 0.0 109.553 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.26 103.47 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 120.689 0.926 . . . . 0.0 111.806 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.03 166.01 38.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.14 -172.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.984 1.123 . . . . 0.0 111.647 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.99 -132.96 49.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -79.92 -10.26 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -1.043 . . . . 0.0 109.946 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.99 144.21 39.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -18.15 32.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -67.12 124.26 22.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.283 . . . . 0.0 109.995 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.89 128.33 53.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.522 -0.736 . . . . 0.0 109.329 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -110.98 135.56 51.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -116.52 137.36 52.23 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.493 -0.754 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.5 122.59 17.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -100.4 0.38 39.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -74.56 -18.66 60.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.904 -1.122 . . . . 0.0 109.93 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.31 162.29 13.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -0.83 . . . . 0.0 109.479 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -87.74 121.43 30.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 0.0 109.28 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.19 147.07 23.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.359 -0.838 . . . . 0.0 110.174 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 49.0 p -125.56 168.77 13.21 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.43 31.82 6.21 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.579 HD22 ' CZ ' ' A' ' 108' ' ' ARG . 4.7 p30 -149.85 -164.84 2.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.889 . . . . 0.0 109.953 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -86.4 29.22 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.33 -0.856 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.579 ' CZ ' HD22 ' A' ' 106' ' ' ASN . 97.0 mtt180 -76.11 -159.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -40.36 -59.94 1.2 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.53 -0.731 . . . . 0.0 111.53 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.437 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.1 m-85 -129.78 130.09 44.93 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.048 -1.032 . . . . 0.0 110.388 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -98.58 112.01 24.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.268 -0.895 . . . . 0.0 109.297 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 0.0 110.084 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.94 -42.54 94.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.176 -0.952 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.454 HH21 ' HG ' ' A' ' 143' ' ' SER . 29.5 ttt-85 -60.1 -40.05 88.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 109.332 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.07 -40.06 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.271 -0.893 . . . . 0.0 109.539 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.61 93.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 108.866 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.46 94.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.526 ' ND1' HOM3 ' A' ' 173' ' ' CGS . 28.5 t60 -67.38 -44.4 79.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.776 . . . . 0.0 110.517 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.07 -39.99 87.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.971 -1.081 . . . . 0.0 108.855 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.46 -37.03 84.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.05 -40.89 75.68 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -63.1 -40.12 96.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -1.17 . . . . 0.0 108.634 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -71.61 -23.52 61.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.97 -3.14 58.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -0.941 . . . . 0.0 108.865 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.43 64.3 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.81 127.35 34.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.076 -1.249 . . . . 0.0 109.756 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -88.66 170.04 11.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.453 -0.779 . . . . 0.0 109.752 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -67.5 152.98 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.113 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.8 t -125.15 163.6 22.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.556 -0.715 . . . . 0.0 109.392 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -101.62 6.64 42.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.352 -0.843 . . . . 0.0 110.047 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.97 126.62 32.72 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.186 0.993 . . . . 0.0 109.867 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.3 pt -59.0 -30.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.394 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.46 -3.34 90.57 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.252 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.92 139.15 33.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.352 . . . . 0.0 109.142 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.349 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.425 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 34.8 mtp -75.65 58.6 1.08 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -70.39 134.82 86.67 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.416 ' O ' ' HC2' ' A' ' 173' ' ' CGS . 22.8 Cg_exo -45.74 -63.08 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 120.409 1.182 . . . . 0.0 110.857 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.9 p -94.17 177.01 6.1 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.484 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 69.6 t80 -84.94 139.23 31.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.58 -1.325 . . . . 0.0 109.106 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.8 p -146.78 167.22 24.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.56 124.94 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.449 -0.782 . . . . 0.0 109.597 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.454 ' HG ' HH21 ' A' ' 114' ' ' ARG . 49.2 m -106.93 -22.83 12.55 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.376 -0.827 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' O ' ' OD1' ' A' ' 145' ' ' ASP . . . 74.58 -16.51 3.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 143' ' ' SER . 71.0 m-20 -153.7 122.36 6.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.893 -1.357 . . . . 0.0 109.815 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.8 t -87.7 105.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -145.02 154.46 42.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 109.062 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.42 148.24 37.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.924 -1.11 . . . . 0.0 108.89 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.36 148.45 22.11 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -55.83 -38.35 69.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.194 -0.942 . . . . 0.0 108.686 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -53.97 -39.52 66.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.163 -0.96 . . . . 0.0 108.547 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -73.0 -40.01 65.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 109.029 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.47 -50.52 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -39.99 93.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.108 -0.995 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.71 -54.15 7.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.089 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.02 -39.91 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.863 -1.375 . . . . 0.0 110.147 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 109.247 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.94 -43.37 95.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.725 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.01 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.512 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 -60.68 1.48 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.58 -178.92 35.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -95.02 140.74 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -1.221 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 165' ' ' ASN . 75.0 m -74.82 90.16 2.36 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.44 76.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 163' ' ' SER . 52.6 m-20 -152.48 156.44 33.42 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.11 95.4 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.492 0.795 . . . . 0.0 111.783 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.2 t -85.81 137.84 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.253 -0.904 . . . . 0.0 109.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -71.3 148.03 93.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 108.894 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 117.98 -0.925 . . . . 0.0 111.974 179.628 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.526 HOM3 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.042 0.449 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.1 -49.52 77.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.054 -1.029 . . . . 0.0 108.955 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.2 p -95.3 157.18 16.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.455 -0.778 . . . . 0.0 110.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -72.95 138.72 46.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.23 -146.92 33.85 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -79.83 147.31 66.24 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.232 -1.158 . . . . 0.0 109.099 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.94 -175.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 120.688 0.926 . . . . 0.0 112.292 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -147.15 163.57 35.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.302 -0.874 . . . . 0.0 109.467 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.48 118.83 23.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.57 -9.98 59.55 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.317 -0.865 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.5 145.2 26.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.074 . . . . 0.0 110.16 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -92.13 -4.04 54.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.447 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.9 m-70 -129.92 139.78 51.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.21 161.09 34.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.886 0.85 . . . . 0.0 109.52 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.1 p -127.01 157.07 40.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -144.49 157.55 44.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.156 -0.965 . . . . 0.0 109.339 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -151.06 133.09 15.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.15 118.92 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.62 -40.27 80.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.964 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -161.67 150.9 16.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.644 -1.285 . . . . 0.0 110.955 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.18 133.66 38.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.706 . . . . 0.0 109.558 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 t -70.05 142.56 90.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.3 -8.94 24.39 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.38 0.814 . . . . 0.0 111.398 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.93 -39.59 86.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.3 mt -139.52 152.34 68.62 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.86 -176.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 CA-C-N 119.168 0.739 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -86.87 -34.69 19.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.969 -1.082 . . . . 0.0 109.302 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.89 86.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -69.37 -39.63 77.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -0.834 . . . . 0.0 109.6 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 -47.36 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.159 -0.963 . . . . 0.0 109.045 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -60.28 -40.53 90.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.484 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 85.7 t60 -59.19 -47.55 84.91 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.674 -0.642 . . . . 0.0 109.777 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.2 -39.18 81.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.484 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.18 -38.32 74.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.788 -1.195 . . . . 0.0 110.064 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.94 -42.15 97.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.987 -1.071 . . . . 0.0 110.262 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.484 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 36.9 mttm -64.6 -39.83 94.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.71 76.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -60.8 -43.36 98.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -60.09 -41.46 92.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.93 -43.61 94.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.729 -1.232 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.7 m95 -73.49 -42.33 61.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.905 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t -68.3 -35.39 77.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.041 -1.037 . . . . 0.0 110.517 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.81 -28.9 64.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.271 -0.893 . . . . 0.0 111.673 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.92 10.4 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.934 -1.104 . . . . 0.0 111.062 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -144.49 149.9 45.71 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.001 -1.062 . . . . 0.0 109.126 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.18 5.29 2.75 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 120.81 1.007 . . . . 0.0 112.181 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.81 155.44 40.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.905 -1.122 . . . . 0.0 109.268 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.447 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 6.5 p -131.55 142.33 49.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.394 -0.816 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.29 153.29 36.6 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.367 -0.833 . . . . 0.0 109.467 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.2 m -153.18 132.31 12.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.804 . . . . 0.0 109.861 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -77.44 139.39 39.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.7 136.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.631 -0.668 . . . . 0.0 109.452 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -96.62 -2.21 45.26 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 110.021 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -149.86 152.27 34.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.41 168.65 45.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -79.95 132.03 35.95 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.564 -0.963 . . . . 0.0 109.461 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.67 149.74 20.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 108.965 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.84 -39.86 86.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.39 -0.819 . . . . 0.0 109.118 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 59' ' ' ILE . 78.5 mt -118.22 119.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.7 mmm -101.14 128.95 46.99 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.13 -0.981 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.04 126.42 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.3 p -149.98 159.71 44.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.781 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.19 137.77 50.96 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.09 162.7 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.42 -0.8 . . . . 0.0 111.626 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -130.43 145.3 51.8 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.813 -0.554 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.18 -146.81 0.64 Allowed Glycine 0 N--CA 1.495 2.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.034 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -72.49 128.95 37.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.615 -0.933 . . . . 0.0 109.165 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.55 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.9 p-80 -128.18 54.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.558 -0.714 . . . . 0.0 109.855 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 69' ' ' ARG . 52.4 mtm-85 56.62 50.02 13.52 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.482 -0.762 . . . . 0.0 110.06 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -139.83 163.11 33.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -89.42 14.61 10.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.217 -0.927 . . . . 0.0 109.906 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -140.61 68.62 31.03 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.099 -1.0 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.62 148.22 65.49 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.656 1.571 . . . . 0.0 112.74 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -73.79 149.83 41.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.596 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -124.69 74.43 1.34 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.837 -0.539 . . . . 0.0 109.645 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.94 -174.93 48.2 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.9 -13.64 39.03 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 120.839 1.026 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -174.03 43.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.02 -159.21 31.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -73.73 135.36 43.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.284 -1.127 . . . . 0.0 109.42 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.88 -10.81 43.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.695 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 173' ' ' CGS . . . -171.79 161.35 5.89 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -161.63 116.92 2.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.706 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.74 172.83 8.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -104.57 157.08 17.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.78 147.48 78.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 108.571 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.58 104.37 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.628 0.885 . . . . 0.0 112.587 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.07 170.91 33.85 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -69.82 165.42 31.08 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.226 1.284 . . . . 0.0 112.196 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.61 -121.68 15.48 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.061 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.41 -12.98 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -1.04 . . . . 0.0 109.846 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.04 44.71 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 -8.48 78.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -65.06 128.05 34.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.012 -1.287 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.77 115.57 29.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -98.46 135.79 39.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.283 -0.886 . . . . 0.0 109.244 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.29 134.32 54.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.98 117.2 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.015 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -97.36 -0.34 46.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.365 -0.834 . . . . 0.0 109.046 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -74.77 -20.87 59.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -100.76 159.21 15.37 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.281 -0.887 . . . . 0.0 108.965 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 102' ' ' ARG . 18.7 ttt-85 -87.14 123.4 32.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -89.29 145.17 25.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.653 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.9 p -129.79 169.24 15.39 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.356 -0.84 . . . . 0.0 109.633 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.23 28.81 8.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.592 -0.693 . . . . 0.0 110.159 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.571 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -152.0 -167.01 2.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.033 . . . . 0.0 109.952 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -71.12 22.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.358 -0.839 . . . . 0.0 110.686 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.492 ' H ' ' C ' ' A' ' 106' ' ' ASN . 29.2 mmt180 -75.8 -160.39 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 108' ' ' ARG . 54.3 mp0 -31.77 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.0 -0.437 . . . . 0.0 111.987 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -129.04 151.07 50.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.319 -0.863 . . . . 0.0 110.758 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 75.8 m-20 -99.25 114.33 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.25 -41.14 92.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.481 -0.762 . . . . 0.0 110.145 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -59.83 -42.06 92.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.0 110.618 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.554 HH12 ' N ' ' A' ' 143' ' ' SER . 62.8 ttt180 -59.85 -39.87 86.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.842 -1.161 . . . . 0.0 109.678 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 53.6 t -71.69 -39.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.16 90.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.839 -1.163 . . . . 0.0 108.769 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.69 95.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.569 -0.707 . . . . 0.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.562 ' HD1' HOM2 ' A' ' 173' ' ' CGS . 3.8 t-160 -69.18 -50.02 51.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.708 . . . . 0.0 110.335 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -58.6 -40.04 82.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.706 -1.246 . . . . 0.0 109.986 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.7 -39.93 93.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.018 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.25 94.49 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -63.61 -37.77 88.6 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 108.971 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.1 p -69.68 -21.8 63.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.006 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.07 -1.29 57.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.302 -0.874 . . . . 0.0 109.431 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.06 16.92 66.23 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.043 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.64 131.29 34.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.838 -1.389 . . . . 0.0 109.382 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.8 m -88.72 169.1 11.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -67.87 157.47 34.81 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.484 -0.76 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -127.95 164.07 23.11 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.439 -0.788 . . . . 0.0 109.318 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.2 p -102.58 8.94 39.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 110.008 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -83.79 127.65 33.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -0.911 . . . . 0.0 109.291 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.06 -30.02 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 110.319 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.29 0.74 88.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.54 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.77 34.88 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.324 . . . . 0.0 110.463 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.11 -28.47 65.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 109.602 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 86.0 mmm -74.99 52.64 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CD2' ' OG1' ' A' ' 141' ' ' THR . 2.7 t80 -70.33 128.97 90.88 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.61 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -48.91 -66.98 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.114 0 CA-C-N 120.483 1.208 . . . . 0.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.5 m -89.64 176.28 6.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.042 -1.036 . . . . 0.0 108.877 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.531 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 48.4 t80 -85.83 128.3 34.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 75.1 p -149.69 161.84 41.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -79.13 125.53 29.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.554 ' N ' HH12 ' A' ' 114' ' ' ARG . 49.7 p -111.41 12.58 21.52 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.736 -0.603 . . . . 0.0 109.449 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.9 -125.78 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -79.98 146.55 31.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.044 -1.268 . . . . 0.0 108.798 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.69 107.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.351 -0.843 . . . . 0.0 109.852 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -145.55 159.94 42.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.65 142.31 42.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.88 165.7 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.24 -38.62 87.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -58.69 -40.66 84.22 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -75.3 -41.01 57.96 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.16 -53.25 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.075 -1.015 . . . . 0.0 109.894 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.78 -39.97 95.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.22 -63.26 5.48 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.758 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.6 -40.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.888 -1.36 . . . . 0.0 110.26 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.9 mt-30 -64.37 -39.71 94.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.249 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.25 93.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.873 -1.142 . . . . 0.0 109.626 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.08 -50.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.057 . . . . 0.0 109.119 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.5 -67.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.918 -1.114 . . . . 0.0 109.215 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.47 177.87 37.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -86.14 149.05 25.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.085 -1.244 . . . . 0.0 108.724 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.5 m -72.75 85.06 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 108.915 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -78.2 54.54 1.38 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.062 -1.024 . . . . 0.0 109.211 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -151.68 73.39 8.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -80.29 35.35 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.29 1.327 . . . . 0.0 111.783 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.0 121.08 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.487 -0.758 . . . . 0.0 109.285 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.17 147.17 79.49 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 0.0 108.637 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 118.162 -0.849 . . . . 0.0 112.356 -179.406 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.562 HOM2 ' HD1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.5 mt -100.49 130.49 46.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.188 -0.945 . . . . 0.0 109.525 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.4 p -99.74 124.78 45.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -78.31 129.1 34.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 0.0 109.713 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.1 -66.14 0.58 Allowed Glycine 0 N--CA 1.5 2.962 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -155.55 77.09 4.82 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.257 . . . . 0.0 110.236 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -48.05 125.96 12.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.129 1.219 . . . . 0.0 112.837 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -91.34 161.43 15.02 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.583 -0.698 . . . . 0.0 109.576 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -83.21 130.0 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.164 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -82.42 -13.79 56.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.277 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -83.78 151.53 25.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.011 -1.056 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 p -97.44 -7.32 31.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.21 -0.932 . . . . 0.0 108.662 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.585 ' CE1' ' HG1' ' A' ' 48' ' ' THR . 31.1 m-70 -121.51 122.28 39.37 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.02 156.35 20.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -126.73 152.74 46.42 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.76 159.51 42.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 108.949 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.3 ttm180 -150.29 130.72 13.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -87.38 120.02 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 108.544 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.98 -40.09 87.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -160.78 149.98 16.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.875 -1.14 . . . . 0.0 109.988 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.22 132.22 43.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -68.67 143.45 95.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.828 -1.17 . . . . 0.0 109.161 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.11 -6.23 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 120.657 0.905 . . . . 0.0 111.774 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.19 -40.18 89.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.765 . . . . 0.0 109.767 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.7 mt -138.84 150.03 64.02 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.307 -0.871 . . . . 0.0 108.724 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.01 178.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 CA-C-N 119.247 0.767 . . . . 0.0 111.501 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -87.94 -38.71 15.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.993 -1.067 . . . . 0.0 109.546 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.28 92.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.008 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.12 -39.71 75.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 110.095 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.28 -43.6 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.055 . . . . 0.0 109.299 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.77 -39.37 80.81 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.584 ' CE1' ' HZ2' ' A' ' 36' ' ' LYS . 68.1 t60 -57.24 -47.49 81.23 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.555 -0.715 . . . . 0.0 109.175 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.25 -0.906 . . . . 0.0 110.308 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.07 -39.46 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.725 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.89 -41.64 95.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.948 . . . . 0.0 109.901 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.584 ' HZ2' ' CE1' ' A' ' 32' ' ' HIS . 21.5 mttp -62.5 -38.0 88.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 109.955 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.7 84.76 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.701 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -61.39 -41.08 96.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.29 -42.2 95.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.171 -0.955 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -59.94 -43.45 94.98 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.878 -1.139 . . . . 0.0 110.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.73 -41.61 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.3 t -68.25 -36.19 79.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -60.0 -19.19 51.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 0.0 110.242 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.2 m -112.29 1.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 p -144.56 150.24 46.64 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.0 109.421 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.27 7.66 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.936 1.091 . . . . 0.0 112.122 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.41 151.78 42.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.117 -0.99 . . . . 0.0 109.839 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.585 ' HG1' ' CE1' ' A' ' 13' ' ' HIS . 64.5 p -129.79 149.97 51.3 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -128.26 153.63 46.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.483 -0.76 . . . . 0.0 109.405 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.1 m -153.0 134.99 14.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.03 131.6 36.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.649 -0.657 . . . . 0.0 109.437 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 14.7 m -119.67 130.69 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -96.0 -8.78 32.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.128 -0.982 . . . . 0.0 108.994 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 99.2 mt-10 -143.81 152.12 40.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 95.64 179.53 36.29 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.18 133.48 35.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.848 -1.384 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 131.03 45.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -59.87 -43.73 94.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.93 120.08 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.573 -0.704 . . . . 0.0 109.814 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 mtt -99.87 130.36 46.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.153 -0.967 . . . . 0.0 109.873 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.73 126.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 p -150.73 160.79 43.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.14 139.8 41.0 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.12 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.344 -0.848 . . . . 0.0 111.08 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 66' ' ' GLY . 83.3 mtm180 -131.35 143.8 50.76 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.737 -0.602 . . . . 0.0 109.423 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 42.65 -147.4 0.68 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -67.12 130.72 44.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -1.024 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.54 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -133.85 56.16 1.86 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.434 -0.791 . . . . 0.0 109.522 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 mtm-85 58.69 49.29 10.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.807 -0.558 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.4 m-20 -142.76 165.69 26.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.216 -0.928 . . . . 0.0 109.641 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -92.99 9.14 36.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.336 -0.853 . . . . 0.0 109.417 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.7 m -133.93 71.57 73.71 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.28 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.2 152.01 80.26 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 120.868 1.045 . . . . 0.0 111.547 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -76.81 147.66 37.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -109.49 75.04 0.92 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.39 -160.67 9.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.82 -15.66 22.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.957 1.104 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.96 -179.56 45.78 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -164.62 37.31 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' ND2' HG12 ' A' ' 173' ' ' CGS . 32.6 m120 -75.32 147.38 40.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -1.065 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 mt -92.71 -18.85 22.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 110.296 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.28 161.6 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 0.0 109.681 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.2 -179.81 6.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.697 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.52 167.42 21.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.142 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -101.14 135.22 42.96 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.272 -0.893 . . . . 0.0 109.784 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -60.01 150.04 71.51 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -41.76 120.97 1.54 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 120.706 0.937 . . . . 0.0 112.037 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 -169.28 21.29 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -76.4 117.43 4.59 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.564 1.51 . . . . 0.0 113.519 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.3 -111.49 3.35 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.451 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.29 -13.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.992 . . . . 0.0 110.888 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.87 133.12 51.26 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.927 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.3 77.76 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 121.459 -1.024 . . . . 0.0 111.009 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.38 129.75 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.736 -1.449 . . . . 0.0 110.436 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.44 129.1 46.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.31 -0.869 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -115.17 132.9 56.46 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.496 -0.752 . . . . 0.0 109.122 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -118.01 131.93 56.43 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -64.83 126.09 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -100.3 0.63 40.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 110.059 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.44 -20.01 60.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.027 -1.046 . . . . 0.0 109.679 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.13 158.36 15.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 102' ' ' ARG . 23.5 ttt-85 -87.49 114.63 24.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -89.59 150.72 22.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.73 . . . . 0.0 109.993 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 30.3 p -126.3 164.38 21.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -108.53 32.1 5.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.073 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.459 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.43 -164.98 2.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -0.964 . . . . 0.0 110.379 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -84.83 28.34 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -76.67 -164.07 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 110.498 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -43.64 -59.96 1.97 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.555 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.467 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -116.29 121.85 43.21 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.178 -0.951 . . . . 0.0 109.804 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.99 116.06 31.15 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.09 -39.91 87.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.231 . . . . 0.0 109.976 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -59.91 -41.91 92.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 112.226 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.4 ptt-85 -59.99 -41.3 91.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.313 -1.492 . . . . 0.0 109.97 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.4 -39.25 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.227 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.1 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.81 94.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.99 -1.069 . . . . 0.0 108.95 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.587 ' CE1' ' H50' ' A' ' 173' ' ' CGS . 3.6 t-160 -69.87 -49.27 54.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -58.97 -40.17 83.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 109.595 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.08 -39.81 95.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 109.742 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.22 -40.04 95.31 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -61.59 -39.16 90.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -1.196 . . . . 0.0 108.519 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.0 m -70.14 -26.22 63.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.767 . . . . 0.0 109.14 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.82 -3.94 57.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.577 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.22 60.54 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -80.82 129.05 34.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.227 . . . . 0.0 108.889 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -88.35 169.69 11.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.72 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -68.89 156.96 37.55 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 108.865 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -125.86 163.42 22.95 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -105.08 13.48 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.392 -0.818 . . . . 0.0 109.715 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -84.65 130.89 34.66 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.313 -0.867 . . . . 0.0 108.889 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.9 tt -60.05 -38.37 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.039 -1.038 . . . . 0.0 110.313 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.12 1.53 79.83 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.246 -178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 128.62 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.626 -1.514 . . . . 0.0 109.471 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.9 mt -67.56 -26.31 66.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.223 -0.923 . . . . 0.0 108.858 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.2 mmm -72.37 46.29 0.14 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 135' ' ' LEU . 3.0 t80 -69.84 127.88 92.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 108.892 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.63 -64.86 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.557 1.235 . . . . 0.0 111.766 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -85.86 169.29 13.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.383 -0.823 . . . . 0.0 109.651 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 66.3 t80 -85.61 136.54 33.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.94 -1.1 . . . . 0.0 108.897 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.1 p -147.6 167.39 24.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.281 -0.887 . . . . 0.0 108.878 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.22 137.83 55.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 108.719 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 85.5 p -139.91 155.15 47.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -92.04 -126.33 3.79 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -80.72 160.04 25.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.71 111.72 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.987 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -144.97 150.0 36.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.241 -0.912 . . . . 0.0 109.066 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.14 143.88 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 108.962 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.51 163.71 12.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.29 -0.881 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -60.05 -40.18 88.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.98 -1.075 . . . . 0.0 108.759 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.74 -40.04 86.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.834 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.87 -40.08 65.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.042 -1.036 . . . . 0.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.11 -50.16 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.877 . . . . 0.0 109.716 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.88 -40.02 91.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.183 -0.948 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.13 -54.05 41.19 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.343 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -68.59 -39.09 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.882 -1.363 . . . . 0.0 110.039 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -63.69 -39.47 94.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.86 95.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.87 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 0.0 109.919 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -95.86 -67.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.047 . . . . 0.0 109.346 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.21 -173.4 40.2 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.51 142.27 27.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 108.963 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.5 m -76.36 85.59 3.13 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.132 -0.98 . . . . 0.0 109.387 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -93.58 101.17 13.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.315 -0.866 . . . . 0.0 109.099 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -159.08 155.52 24.39 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.63 68.77 8.0 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 CA-C-N 119.546 0.874 . . . . 0.0 111.363 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 t -87.16 133.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 108.959 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -122.98 80.69 50.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.654 -0.654 . . . . 0.0 109.384 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 120.8 1.0 . . . . 0.0 111.882 -179.594 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.587 ' H50' ' CE1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.531 ' H3 ' ' CG ' ' A' ' 7' ' ' PRO . 7.2 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.3 -40.47 90.62 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.663 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.1 p -99.67 127.64 45.78 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.086 -1.009 . . . . 0.0 109.701 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.64 133.05 38.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.318 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.41 -87.1 0.21 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -152.18 76.66 7.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.928 . . . . 0.0 108.794 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.531 ' CG ' ' H3 ' ' A' ' 1' ' ' VAL . 23.6 Cg_exo -54.48 -166.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.246 1.297 . . . . 0.0 113.18 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -91.88 172.19 8.62 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.96 122.44 27.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.021 -1.049 . . . . 0.0 108.344 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -83.04 -9.81 59.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -83.73 150.72 25.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.465 ' HG1' ' CE1' ' A' ' 13' ' ' HIS . 35.4 p -96.87 -3.15 42.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 63.9 m80 -127.97 138.61 52.68 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.9 mt -133.29 158.65 42.42 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -130.2 155.6 45.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.21 157.45 44.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 0.0 108.536 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.4 ttm180 -150.09 133.63 16.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.97 116.9 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.843 -1.16 . . . . 0.0 108.399 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' SD ' ' A' ' 60' ' ' MET . 99.0 mt-10 -68.25 -38.34 81.7 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.798 . . . . 0.0 111.06 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.72 HD21 ' H ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -154.56 139.75 17.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.0 109.847 -178.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.72 ' H ' HD21 ' A' ' 20' ' ' ASN . 95.4 m-85 -93.86 142.28 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.74 . . . . 0.0 109.345 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -74.13 136.56 75.96 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.95 -11.55 31.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.788 0.96 . . . . 0.0 111.841 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.815 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.5 mt -133.74 151.2 76.62 Favored Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.44 -178.76 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.396 0.82 . . . . 0.0 111.911 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -86.53 -33.57 20.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 109.922 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.04 92.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.048 -1.033 . . . . 0.0 110.402 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.97 -38.94 76.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.275 -0.89 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.08 -41.89 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.133 -0.979 . . . . 0.0 108.922 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -40.22 88.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.004 -1.06 . . . . 0.0 110.045 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 75.7 t60 -60.57 -45.3 94.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.53 81.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.946 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -69.86 -36.83 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -0.816 . . . . 0.0 109.842 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -64.72 -45.64 85.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 109.669 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 35.9 mttm -62.45 -36.95 84.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.992 -1.067 . . . . 0.0 110.256 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.21 -50.01 75.37 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.221 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -60.78 -41.28 95.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 109.364 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 97.8 mt-30 -61.76 -40.21 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.731 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.06 -40.09 88.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.96 . . . . 0.0 109.573 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -73.42 -43.47 60.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 110.347 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -69.26 -30.45 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 19.1 m120 -59.35 -31.96 69.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 8.58 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.146 -0.971 . . . . 0.0 110.894 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 12.4 p -147.74 150.52 36.6 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.732 -1.23 . . . . 0.0 109.732 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.49 5.68 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.117 1.211 . . . . 0.0 112.356 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.3 156.31 39.46 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.096 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 73.9 p -137.74 147.74 45.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 0.0 109.089 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.7 m-85 -128.56 158.19 39.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -154.96 139.2 16.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.57 135.68 37.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 29.4 m -129.44 131.61 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.524 -0.735 . . . . 0.0 109.771 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t -102.51 -2.65 28.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.098 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' C ' HH22 ' A' ' 17' ' ' ARG . 96.8 mt-10 -140.72 152.51 45.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 86.8 177.71 49.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -83.81 134.58 34.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.169 -1.195 . . . . 0.0 109.881 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.93 135.18 41.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.361 -0.837 . . . . 0.0 109.287 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.41 -41.69 94.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 59' ' ' ILE . 86.0 mt -120.07 116.52 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.559 -0.713 . . . . 0.0 110.232 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.471 ' SD ' ' OE2' ' A' ' 19' ' ' GLU . 34.9 mtt -103.33 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 61' ' ' ILE . 95.9 mt -121.75 127.96 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.628 -0.67 . . . . 0.0 109.201 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.8 p -145.34 153.44 41.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.09 141.06 36.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.1 170.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.005 -1.059 . . . . 0.0 110.733 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.01 139.85 50.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.394 0.616 . . . . 0.0 110.408 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.02 -144.08 0.64 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.6 t0 -62.84 136.66 57.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.672 -0.899 . . . . 0.0 110.042 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.41 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -139.89 52.98 1.68 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 69' ' ' ARG . 56.8 mtt-85 53.24 55.14 9.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 33.9 t0 -145.13 162.18 37.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.213 -0.929 . . . . 0.0 109.217 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 5.5 m120 -89.58 8.87 29.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.113 -0.992 . . . . 0.0 109.1 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -134.64 69.4 72.25 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.452 -0.78 . . . . 0.0 109.23 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -72.34 148.01 48.25 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.7 1.6 . . . . 0.0 112.581 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -78.13 137.03 37.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -0.826 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -104.71 66.49 0.78 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.95 -171.0 48.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.76 -9.47 1.21 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.775 0.983 . . . . 0.0 112.176 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 -178.15 46.61 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.52 -167.3 53.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.433 HD21 ' H ' ' A' ' 80' ' ' ASN . 2.4 p30 -72.76 156.92 38.43 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.165 -1.197 . . . . 0.0 109.666 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.67 -19.25 22.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.86 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.69 163.8 10.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.037 -1.04 . . . . 0.0 108.752 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.42 -175.52 5.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.104 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.44 172.37 13.47 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.144 -0.972 . . . . 0.0 109.643 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.83 158.96 15.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.348 -0.845 . . . . 0.0 109.409 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.91 149.13 81.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.49 103.64 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.496 0.798 . . . . 0.0 112.149 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.43 171.61 35.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.1 -177.95 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.971 1.114 . . . . 0.0 111.758 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.91 -127.49 43.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -78.44 -7.23 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.293 -1.122 . . . . 0.0 110.24 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 142.4 47.74 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -14.8 61.15 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -67.95 157.91 33.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -1.229 . . . . 0.0 109.9 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.83 118.18 8.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 109.851 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -98.54 144.68 27.59 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.124 -0.985 . . . . 0.0 110.698 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 19.1 m-85 -119.93 137.55 53.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.21 121.02 13.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -97.81 -2.72 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -76.09 -19.27 58.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.83 158.92 15.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.804 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -87.16 117.59 26.01 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.86 147.44 23.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.532 -0.73 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 81.5 p -130.08 161.07 31.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -108.06 31.06 5.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.736 . . . . 0.0 109.547 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.3 p30 -149.95 -164.99 2.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.945 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 43.1 t80 -80.87 32.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.082 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -76.01 -163.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.962 . . . . 0.0 109.918 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -49.69 -59.0 4.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.537 -0.727 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.425 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -110.42 129.89 55.67 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.994 -1.066 . . . . 0.0 110.949 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 98.1 m-20 -101.97 107.15 18.2 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.238 -0.914 . . . . 0.0 108.542 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.79 -41.48 87.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 111.055 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -59.9 -41.55 91.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.994 -1.067 . . . . 0.0 109.945 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.452 ' NH2' ' CE1' ' A' ' 140' ' ' TYR . 45.3 ttp180 -60.24 -40.28 89.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.45 -39.57 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.21 82.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 0.0 109.215 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.93 78.95 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 109.701 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.4 ' ND1' ' O27' ' A' ' 173' ' ' CGS . 3.6 t-160 -69.16 -49.85 53.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 78.6 mt-10 -59.83 -40.54 88.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.48 -38.7 90.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 108.897 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.26 -41.14 86.35 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -63.7 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.264 . . . . 0.0 108.635 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.0 m -70.48 -25.1 63.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.7 mt -83.13 -1.94 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.5 76.76 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.85 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.08 130.65 35.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.808 -1.407 . . . . 0.0 109.279 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.2 m -88.03 173.53 8.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.3 156.49 37.61 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.803 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -130.32 158.15 40.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -100.08 7.29 44.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.863 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -78.61 132.2 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.1 tt -60.4 -38.25 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 111.257 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -79.8 -1.61 87.32 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.339 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 129.49 35.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.806 -1.409 . . . . 0.0 109.49 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.43 -26.58 65.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.033 -1.042 . . . . 0.0 109.065 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.1 mmm -73.89 50.06 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.578 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.498 ' C ' ' H ' ' A' ' 139' ' ' SER . 18.3 t80 -68.08 135.81 91.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.85 14.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 CA-C-N 120.289 1.139 . . . . 0.0 112.569 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 137' ' ' TYR . 79.5 p -163.98 172.52 13.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 109.76 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CE1' ' NH2' ' A' ' 114' ' ' ARG . 58.3 t80 -83.37 143.8 30.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.392 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.0 p -141.91 136.93 30.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.207 -0.933 . . . . 0.0 109.584 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -69.02 -29.51 67.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 t -98.83 129.44 45.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.025 -1.047 . . . . 0.0 109.928 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.24 112.27 0.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.78 156.24 25.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -1.181 . . . . 0.0 108.646 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 81.6 t -85.06 88.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -147.0 143.46 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.42 136.44 40.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.61 166.44 12.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.04 -39.19 85.09 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.81 -42.34 93.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.346 -0.846 . . . . 0.0 108.995 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -72.22 -43.12 64.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.569 -0.707 . . . . 0.0 109.822 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -49.99 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.012 -1.055 . . . . 0.0 109.369 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.76 -39.29 93.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.4 -51.54 53.79 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.261 -0.899 . . . . 0.0 111.393 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 8.9 tp -69.26 -38.48 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.676 -1.485 . . . . 0.0 109.547 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.9 mt-30 -65.77 -38.65 89.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.088 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.24 94.83 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 0.0 109.278 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.09 -51.21 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.51 -65.31 0.97 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.29 179.28 34.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -86.6 156.42 20.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -1.146 . . . . 0.0 108.639 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 m -74.89 84.43 2.21 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -81.26 34.53 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.656 -0.653 . . . . 0.0 109.837 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -154.16 75.53 5.96 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.805 . . . . 0.0 108.902 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -82.1 74.17 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.674 1.583 . . . . 0.0 111.541 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.09 131.73 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -126.04 80.15 68.26 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 120.912 1.075 . . . . 0.0 112.184 -179.042 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.4 ' O27' ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.342 0.591 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 3.1 mm? -78.01 158.74 29.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.2 p -89.63 156.2 18.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.196 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -72.18 136.71 46.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.48 -169.32 53.52 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -82.64 149.86 61.52 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.218 -1.166 . . . . 0.0 109.361 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.69 -168.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 120.493 0.796 . . . . 0.0 111.916 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -141.33 164.35 30.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.867 . . . . 0.0 108.722 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -80.27 115.7 19.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.349 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.63 -10.41 57.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.85 . . . . 0.0 109.597 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.97 149.51 28.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.139 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.684 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 71.7 p -94.46 -3.69 49.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.684 ' CD2' ' HG1' ' A' ' 12' ' ' THR . 88.6 m-70 -127.37 139.32 52.94 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.5 mt -130.34 153.04 49.1 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.23 -0.919 . . . . 0.0 108.961 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.9 p -126.23 154.41 43.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -142.4 160.0 41.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -148.46 129.99 14.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.219 -0.926 . . . . 0.0 109.801 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.72 118.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.88 -40.22 94.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -163.66 154.26 15.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.812 -1.18 . . . . 0.0 110.404 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -98.78 138.19 36.29 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.259 -0.901 . . . . 0.0 108.901 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.57 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 2.3 t -71.85 145.95 89.95 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.349 -0.845 . . . . 0.0 109.253 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.1 -14.62 45.21 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.442 0.836 . . . . 0.0 111.786 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.57 ' H ' ' HG1' ' A' ' 22' ' ' THR . 82.7 m-20 -60.29 -39.86 88.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -135.62 150.18 71.29 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -67.83 -173.34 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.493 0.855 . . . . 0.0 111.847 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -88.16 -37.45 16.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.842 . . . . 0.0 110.443 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.01 89.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.923 -1.111 . . . . 0.0 109.516 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.28 -39.8 74.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -47.09 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 109.931 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.7 t0 -60.02 -41.11 91.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.501 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -60.05 -45.72 91.92 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 0.0 109.13 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.03 83.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.21 -40.45 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.907 . . . . 0.0 110.077 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.9 tt0 -69.88 -38.79 76.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.52 -40.09 90.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.37 98.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.885 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' ' CD2' ' A' ' 49' ' ' PHE . 26.4 m-85 -60.0 -40.18 88.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.163 . . . . 0.0 109.72 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 4.1 mp0 -60.11 -40.02 88.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.839 -1.163 . . . . 0.0 109.633 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.1 -40.58 90.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.876 -1.14 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -74.91 -44.04 50.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.2 t -69.42 -34.8 75.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.241 -0.912 . . . . 0.0 110.493 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -56.91 -28.09 61.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 110.107 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.514 ' C ' ' HG ' ' A' ' 163' ' ' SER . 30.0 m -110.82 5.28 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.379 -0.826 . . . . 0.0 110.694 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.461 ' CG2' ' NE2' ' A' ' 157' ' ' GLN . 41.9 p -141.42 146.14 40.94 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.58 7.81 0.87 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.813 1.009 . . . . 0.0 111.702 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.71 156.87 37.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.917 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 22.2 p -134.55 151.67 51.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CD2' ' CE1' ' A' ' 38' ' ' PHE . 96.1 m-85 -130.89 150.9 51.84 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.326 -0.858 . . . . 0.0 110.291 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -155.8 135.22 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.253 -0.904 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -77.04 146.57 37.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.71 135.36 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.56 -0.712 . . . . 0.0 109.155 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -97.54 -4.2 38.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 109.841 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.4 150.44 36.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.073 -1.017 . . . . 0.0 109.364 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.44 169.62 40.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 4.7 pm0 -81.3 152.93 27.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -1.174 . . . . 0.0 109.19 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.31 155.45 21.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.36 -0.837 . . . . 0.0 108.91 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.02 -40.28 88.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.687 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 59' ' ' ILE . 84.8 mt -120.36 116.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.375 -0.828 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp -99.97 134.4 42.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.867 . . . . 0.0 109.38 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.85 129.18 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.525 -0.734 . . . . 0.0 109.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.8 p -147.3 155.94 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.11 139.31 39.97 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.88 162.48 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.36 -0.838 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -129.1 134.56 48.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.725 -0.609 . . . . 0.0 109.886 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.94 -136.42 3.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -70.41 124.45 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.54 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -138.11 66.65 1.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.518 -0.739 . . . . 0.0 109.786 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.3 mtm-85 56.98 48.54 15.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.88 155.2 44.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 108.751 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.61 8.45 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.6 m -137.93 75.39 42.22 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.299 -0.876 . . . . 0.0 109.524 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.74 163.59 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.307 1.338 . . . . 0.0 112.533 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -78.73 151.8 31.89 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.655 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -104.69 67.85 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.71 -167.12 21.04 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -58.1 -15.24 22.08 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.233 1.288 . . . . 0.0 111.919 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.54 -179.95 47.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.11 -163.65 34.67 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 121.042 -1.27 . . . . 0.0 110.163 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -74.54 150.33 39.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.491 -1.005 . . . . 0.0 109.525 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.36 -11.91 36.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.087 -1.008 . . . . 0.0 109.816 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.82 174.98 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.005 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.62 121.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.96 -1.087 . . . . 0.0 110.38 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.01 170.47 11.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.692 -0.63 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -106.5 149.48 27.06 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -58.8 149.07 66.13 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.199 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.67 102.73 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.792 0.995 . . . . 0.0 112.135 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 179.24 36.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.78 -177.62 3.26 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.443 1.429 . . . . 0.0 112.787 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.07 -120.72 23.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.89 -13.58 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.482 -1.01 . . . . 0.0 110.388 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.87 146.06 39.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.28 -18.63 35.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.58 161.69 22.56 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -1.113 . . . . 0.0 109.692 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.4 122.93 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -102.8 134.05 46.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.03 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.59 131.35 56.72 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -63.8 118.79 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -100.25 0.78 40.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.249 -0.907 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -74.05 -16.06 61.05 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.44 156.32 18.03 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -84.72 117.45 23.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 108.977 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.14 148.56 25.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 26.7 p -128.2 165.31 20.7 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.494 -0.754 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -117.02 29.14 8.09 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.722 HD22 ' HE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -146.33 -161.42 1.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.199 -0.938 . . . . 0.0 109.739 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -83.01 31.69 0.43 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.722 ' HE ' HD22 ' A' ' 106' ' ' ASN . 65.8 mtm180 -76.34 -162.7 0.26 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.823 -1.173 . . . . 0.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.72 -56.99 14.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 111.866 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.48 ' O ' ' OG1' ' A' ' 104' ' ' THR . 94.2 m-85 -106.87 128.69 54.51 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.948 -1.095 . . . . 0.0 111.176 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -101.2 115.34 30.26 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.97 -40.03 75.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.982 . . . . 0.0 111.053 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -60.36 -44.58 95.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.774 -1.204 . . . . 0.0 111.249 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -59.95 -42.38 93.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.746 -1.221 . . . . 0.0 109.682 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.92 -40.92 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.073 -1.017 . . . . 0.0 108.771 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -42.56 94.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.104 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.7 93.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.647 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.468 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 7.2 t60 -69.65 -40.16 76.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.878 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.02 -40.88 90.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.044 -1.035 . . . . 0.0 108.886 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 123' ' ' SER . 91.1 mt -62.97 -40.01 96.42 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.74 -40.07 92.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -64.28 -37.49 87.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.035 -1.274 . . . . 0.0 108.509 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 85.2 p -70.01 -24.29 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.035 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.24 1.2 49.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.58 15.76 77.25 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.5 128.0 32.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.899 -1.353 . . . . 0.0 109.016 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.3 m -87.59 174.32 8.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -69.17 159.82 32.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.626 -0.671 . . . . 0.0 110.466 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -125.24 162.32 24.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.609 -0.682 . . . . 0.0 109.576 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -99.79 1.27 42.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.308 -0.87 . . . . 0.0 109.324 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 48.7 t0 -82.14 116.15 21.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.195 0.998 . . . . 0.0 108.971 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.97 -24.66 30.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.329 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.22 -4.1 88.39 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.88 144.62 29.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -1.221 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 87.0 mt -61.01 -35.26 76.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 72.0 mmm -70.37 54.82 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 109.666 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.3 t80 -70.14 132.38 88.24 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -45.5 -57.11 2.31 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.392 1.176 . . . . 0.0 111.165 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -100.68 175.8 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.472 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 65.7 t80 -84.93 125.69 32.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.836 -1.165 . . . . 0.0 110.475 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.2 p -149.01 160.02 43.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.38 -0.825 . . . . 0.0 109.297 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 28.7 p90 -99.98 120.49 39.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.8 t -88.32 -75.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 108.624 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -173.74 -103.76 0.17 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 33.3 p-10 -86.7 156.91 19.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -1.17 . . . . 0.0 108.804 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.48 105.47 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -149.28 152.36 35.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.234 -0.917 . . . . 0.0 108.623 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.96 145.12 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.924 -1.11 . . . . 0.0 108.812 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.77 163.7 14.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.099 -1.001 . . . . 0.0 109.45 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 109.211 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -59.17 -40.69 86.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.802 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -72.54 -40.24 66.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 109.889 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.8 -49.81 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.127 -0.983 . . . . 0.0 109.602 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.88 -39.91 91.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.959 -1.088 . . . . 0.0 109.962 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.63 -54.09 24.46 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.974 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.6 tp -63.67 -39.87 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.735 -1.45 . . . . 0.0 109.621 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.552 ' O ' ' N ' ' A' ' 161' ' ' GLY . 15.9 mm-40 -67.85 -36.89 81.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.4 94.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.793 -1.192 . . . . 0.0 109.381 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.19 -49.79 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.209 -0.932 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.95 -61.33 1.38 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.203 -0.935 . . . . 0.0 110.092 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.42 -175.97 41.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 162' ' ' ARG . 52.5 mtt-85 -93.25 140.12 29.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -1.035 . . . . 0.0 109.551 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.59 ' C ' ' H ' ' A' ' 165' ' ' ASN . 30.1 m -69.83 92.7 0.7 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.503 -0.879 . . . . 0.0 108.656 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -63.19 34.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.625 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.59 ' H ' ' C ' ' A' ' 163' ' ' SER . 22.6 m120 -153.19 74.02 6.84 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.418 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -80.22 73.58 5.95 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.551 1.501 . . . . 0.0 112.217 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 58.9 t -89.99 121.97 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.39 -0.818 . . . . 0.0 108.991 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -67.4 151.48 97.11 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 108.977 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 120.805 1.003 . . . . 0.0 112.261 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.472 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 1.3 mm? -59.98 -48.61 81.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.88 -1.138 . . . . 0.0 108.326 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.4 p -101.07 133.03 46.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.459 -0.776 . . . . 0.0 109.096 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -78.75 117.13 19.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.121 -0.987 . . . . 0.0 109.242 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.1 -92.82 0.21 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -150.69 87.53 4.76 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.15 -1.206 . . . . 0.0 109.771 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -56.03 111.28 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.148 1.232 . . . . 0.0 113.235 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 8' ' ' ARG . 51.7 mtm-85 -94.86 164.76 12.78 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.739 -0.601 . . . . 0.0 110.363 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -79.86 123.85 28.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.71 -9.93 58.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.088 -1.007 . . . . 0.0 110.517 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -85.77 148.08 26.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 109.973 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 p -95.8 -4.12 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.514 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 90.0 m-70 -121.58 129.34 52.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.21 155.56 43.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.493 -0.754 . . . . 0.0 109.869 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -128.33 151.41 49.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.411 -0.805 . . . . 0.0 109.6 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -142.2 160.58 39.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.358 -0.839 . . . . 0.0 109.803 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -150.69 134.37 16.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.301 -0.875 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 81.7 mt -87.73 119.61 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.8 -39.77 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -160.21 155.35 24.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.377 -0.827 . . . . 0.0 109.519 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -100.22 131.19 46.3 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 t -70.55 141.41 87.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.806 -1.184 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -65.75 -6.22 13.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.578 0.885 . . . . 0.0 111.544 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -60.19 -40.17 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -140.49 151.32 63.52 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.35 179.51 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.475 0.848 . . . . 0.0 111.338 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -85.77 -35.78 20.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.158 -0.964 . . . . 0.0 109.357 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.32 75.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.027 -1.045 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.55 -40.05 70.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.771 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.11 -40.57 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.015 . . . . 0.0 109.623 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.57 -42.87 93.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 109.189 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.37 -42.34 95.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.812 . . . . 0.0 108.911 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.41 95.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -0.834 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.74 -40.09 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 108.643 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.06 -40.76 74.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -60.04 -35.04 74.24 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.271 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.32 -45.84 71.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -60.2 -40.32 89.65 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.869 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -60.08 -40.3 89.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 110.176 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.93 -43.03 95.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.505 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.408 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.2 m95 -73.2 -40.29 64.87 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 110.131 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.6 t -67.96 -35.25 78.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.723 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.71 -34.44 69.46 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 110.182 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.97 10.7 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.965 -1.084 . . . . 0.0 111.558 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.517 ' N ' ' HG ' ' A' ' 163' ' ' SER . 66.6 p -145.34 148.45 37.61 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 120.757 -1.214 . . . . 0.0 109.634 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.57 9.68 0.92 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.823 1.016 . . . . 0.0 112.187 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.35 158.22 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 109.457 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.514 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 67.5 p -136.22 149.87 48.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.21 157.04 43.57 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.414 -0.803 . . . . 0.0 110.241 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.09 126.69 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -74.46 138.97 43.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.178 -0.951 . . . . 0.0 108.923 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.58 135.06 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 t -97.99 -1.4 42.77 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.23 -0.919 . . . . 0.0 110.587 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.9 158.41 43.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.093 . . . . 0.0 109.259 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 173.17 46.27 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -79.02 137.89 37.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.241 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.47 139.82 32.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 108.939 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.18 -41.65 93.33 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.7 mt -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mtt -105.48 132.09 52.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.563 -0.711 . . . . 0.0 109.753 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.7 131.27 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.1 p -146.61 159.55 43.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -110.55 139.42 45.81 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.43 168.7 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.271 -0.893 . . . . 0.0 111.229 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 66' ' ' GLY . 80.8 mtm180 -131.94 140.53 49.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.799 -0.563 . . . . 0.0 109.655 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 41.55 -144.25 0.79 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.28 136.69 55.31 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.931 . . . . 0.0 108.957 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.616 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.5 p-80 -138.32 50.59 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 0.0 109.726 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 57.6 50.01 11.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.717 -0.614 . . . . 0.0 110.053 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 77.8 m-20 -137.05 167.57 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.31 -0.869 . . . . 0.0 109.24 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -88.94 10.0 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 108.998 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.5 m -138.11 73.19 45.33 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -72.0 146.35 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.837 1.025 . . . . 0.0 111.612 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.86 149.21 31.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.062 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -128.17 74.16 1.53 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.29 173.72 46.58 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -50.91 -12.21 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.304 1.336 . . . . 0.0 112.438 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.72 177.23 44.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -157.31 28.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.641 ' CG ' HG12 ' A' ' 173' ' ' CGS . 7.8 m120 -75.98 145.57 40.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -1.135 . . . . 0.0 109.531 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.12 -15.62 29.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 108.707 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.91 170.39 6.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 109.152 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -161.41 176.38 11.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.914 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.17 168.86 18.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.123 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -105.07 142.27 35.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.757 . . . . 0.0 109.732 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.73 149.01 81.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.03 -1.044 . . . . 0.0 109.062 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.92 109.86 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.701 0.934 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.34 -179.72 29.03 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.46 141.48 20.09 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 120.997 1.131 . . . . 0.0 112.812 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.99 -125.39 7.19 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.285 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.64 -9.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.84 -0.8 . . . . 0.0 110.203 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.31 139.76 48.17 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.74 -13.28 63.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -66.78 160.15 26.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.906 -1.35 . . . . 0.0 110.035 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.12 116.57 6.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -0.851 . . . . 0.0 109.058 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -98.77 153.29 18.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 21.0 m-85 -121.87 140.45 52.38 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -65.75 120.77 13.6 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -99.52 -7.54 25.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.637 -0.664 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -75.69 -12.61 60.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -105.07 149.92 25.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.194 -0.941 . . . . 0.0 108.788 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -83.33 122.09 28.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 109.493 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -89.22 152.56 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.54 -0.725 . . . . 0.0 110.026 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.8 p -120.96 169.49 10.42 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -109.68 27.39 9.62 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.548 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.04 -165.02 2.17 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.815 . . . . 0.0 110.209 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.1 t80 -84.54 33.87 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.917 0.865 . . . . 0.0 109.989 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.2 mmt-85 -76.76 -162.46 0.27 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.831 -1.168 . . . . 0.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -55.02 -57.65 10.86 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.697 -0.627 . . . . 0.0 110.995 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -97.27 118.75 34.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -109.2 106.13 15.87 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.05 -44.18 69.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.865 -0.522 . . . . 0.0 110.044 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -60.5 -47.38 86.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -60.07 -40.79 90.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -70.29 -39.26 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.149 -0.969 . . . . 0.0 108.763 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.9 -43.97 94.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.953 -1.092 . . . . 0.0 109.488 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.08 78.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.107 -0.995 . . . . 0.0 109.208 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.519 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.8 t60 -69.95 -50.61 40.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.427 -0.795 . . . . 0.0 110.29 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.2 mt-10 -58.95 -41.5 87.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.914 -1.117 . . . . 0.0 109.153 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 123' ' ' SER . 85.8 mt -62.75 -40.44 97.27 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.948 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.48 -41.98 82.46 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -65.42 -34.42 78.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.034 -1.274 . . . . 0.0 108.452 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 37.3 p -68.42 -19.44 64.59 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.71 -2.63 58.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.65 20.36 56.38 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.47 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.9 137.64 35.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.507 -1.584 . . . . 0.0 108.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -87.0 164.37 16.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -67.27 151.83 46.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.7 t -124.83 168.76 12.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.694 -0.629 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.5 p -107.42 9.98 29.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.449 -0.782 . . . . 0.0 109.951 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.11 130.37 35.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.032 -1.042 . . . . 0.0 109.771 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.4 -40.7 84.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 111.36 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.38 -5.12 85.37 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 121.094 -1.003 . . . . 0.0 110.747 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.69 130.26 35.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.811 -1.405 . . . . 0.0 109.889 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 137' ' ' TYR . 93.9 mt -63.33 -22.96 67.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.3 mmt -70.54 35.86 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.693 -0.629 . . . . 0.0 109.627 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.4 t80 -70.71 128.94 90.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.014 -1.053 . . . . 0.0 108.925 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -52.8 -66.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.844 1.337 . . . . 0.0 111.765 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.5 p -82.65 173.94 11.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.96 . . . . 0.0 110.405 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -81.2 130.54 35.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.963 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -152.01 -169.48 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 54.7 p90 -97.22 133.33 42.0 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 81.3 p -114.0 14.71 18.46 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.541 -0.724 . . . . 0.0 109.39 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.56 -119.34 13.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -83.72 153.93 23.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -1.233 . . . . 0.0 109.966 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.16 90.72 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 109.138 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -143.6 157.46 44.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.068 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.6 145.03 43.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.037 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 161.53 14.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.247 -0.908 . . . . 0.0 109.633 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -60.14 -42.51 95.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -58.38 -41.03 83.9 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.571 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.37 -42.08 62.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.837 -1.164 . . . . 0.0 109.48 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.71 -49.97 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 108.772 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.18 -40.27 93.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 109.868 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.51 -55.34 29.46 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.484 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -67.56 -39.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.246 . . . . 0.0 110.561 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -67.56 -41.5 84.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.063 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.02 94.78 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.8 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.63 -0.669 . . . . 0.0 109.718 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.08 -66.84 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.8 -175.83 36.6 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -86.95 149.7 24.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -0.999 . . . . 0.0 109.231 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 45' ' ' THR . 29.3 m -77.21 64.89 2.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 0.0 110.41 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -96.28 131.08 43.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 108.839 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.73 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 52.0 m-20 -156.69 -34.87 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.497 -0.752 . . . . 0.0 111.846 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.73 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 24.2 Cg_endo -87.09 86.15 0.78 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 CA-C-N 120.571 1.24 . . . . 0.0 112.002 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.85 117.89 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.182 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.646 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 0.1 OUTLIER -75.59 -35.04 1.69 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.074 -1.016 . . . . 0.0 111.236 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 5.5 Cg_exo . . . . . 0 N--CA 1.486 1.063 0 CA-C-N 119.72 0.936 . . . . 0.0 111.403 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.641 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.0 tp -152.41 66.05 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.216 -0.928 . . . . 0.0 109.268 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.1 p -93.73 -179.38 4.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 0.0 109.822 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -70.49 140.45 51.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.892 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.06 -142.91 38.65 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -80.97 146.11 58.53 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.163 -1.198 . . . . 0.0 108.305 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.39 162.75 13.92 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 120.748 0.965 . . . . 0.0 112.516 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' NH1' ' HG3' ' A' ' 8' ' ' ARG . 40.6 mtm-85 -148.39 156.48 42.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -83.79 122.59 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.037 -1.039 . . . . 0.0 109.936 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 47.6 mp0 -75.15 -30.17 60.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.387 -0.82 . . . . 0.0 109.763 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -81.58 154.51 26.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 p -98.25 -4.5 35.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.897 . . . . 0.0 109.214 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 82.5 m-70 -111.58 131.58 55.15 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -134.19 157.99 44.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 p -124.2 155.63 38.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.346 -0.846 . . . . 0.0 108.824 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.47 158.64 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -154.31 134.98 13.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 18' ' ' ILE . 85.7 mt -88.23 123.74 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 0.0 108.831 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.46 -40.25 85.34 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.023 -1.048 . . . . 0.0 111.343 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -160.28 159.15 31.02 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.81 -1.182 . . . . 0.0 109.861 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -102.51 139.78 37.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 142.19 63.43 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.23 -11.7 32.41 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 CA-C-N 119.457 0.842 . . . . 0.0 112.188 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.26 -38.94 85.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.3 mt -134.73 153.47 78.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -60.69 -179.95 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 CA-C-N 119.461 0.843 . . . . 0.0 111.428 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 33.3 ptt180 -87.91 -35.48 17.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.91 -37.57 79.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 110.258 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.82 -34.83 60.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.84 . . . . 0.0 111.034 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.17 -49.82 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.77 -1.207 . . . . 0.0 109.965 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 12.3 p-10 -60.03 -37.08 78.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.751 -1.218 . . . . 0.0 109.62 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -59.13 -48.6 81.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.908 -1.12 . . . . 0.0 109.406 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.68 91.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.055 -1.028 . . . . 0.0 109.612 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.5 mm -72.28 -31.02 37.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.324 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -66.65 -41.65 87.87 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.07 -28.78 65.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.857 -1.152 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.59 -48.18 80.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.913 -1.117 . . . . 0.0 109.007 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.6 m-85 -62.67 -40.43 97.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.686 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.12 -43.52 95.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.099 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.61 -43.95 93.57 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.82 -1.175 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.429 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.3 m95 -70.34 -40.8 73.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.275 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.4 t -69.5 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 110.579 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -59.72 -27.37 66.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.968 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.62 9.56 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 O-C-N 120.971 -1.081 . . . . 0.0 110.492 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 22.5 p -149.19 150.49 32.0 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.926 -1.109 . . . . 0.0 109.658 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -69.68 9.33 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.643 0.895 . . . . 0.0 111.533 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 45' ' ' THR . 78.9 mt -71.27 151.18 44.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.225 -0.922 . . . . 0.0 109.068 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.435 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 71.2 p -134.66 148.53 50.38 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 96.6 m-85 -129.9 155.45 46.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.8 m -154.69 134.52 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.455 -0.778 . . . . 0.0 109.534 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -77.34 145.93 37.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.16 132.81 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.642 -0.662 . . . . 0.0 109.733 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 t -96.74 -9.16 29.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -141.9 156.34 45.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 108.878 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.9 171.46 47.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.33 134.82 35.64 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.667 -0.902 . . . . 0.0 109.767 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.86 143.67 26.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.946 -1.096 . . . . 0.0 109.282 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -40.67 89.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.85 119.09 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.521 -0.737 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.9 mtt -103.38 135.86 44.21 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.021 -1.049 . . . . 0.0 109.807 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.45 130.87 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.3 p -149.98 156.1 41.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.752 -1.218 . . . . 0.0 110.708 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.6 138.44 45.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.37 164.46 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.228 -0.92 . . . . 0.0 111.304 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -134.3 145.54 49.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.81 -147.03 2.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -73.77 125.72 28.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.45 -1.03 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -127.62 53.69 1.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.406 ' HG2' HH11 ' A' ' 69' ' ' ARG . 61.1 mtt-85 56.61 50.03 13.54 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -139.18 158.36 44.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.19 -0.944 . . . . 0.0 109.658 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -89.12 10.47 21.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 109.751 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -137.81 72.51 48.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.12 146.64 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 120.843 1.029 . . . . 0.0 112.26 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD2' ' OD2' ' A' ' 98' ' ' ASP . 90.5 m-85 -76.26 148.47 37.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.368 -0.833 . . . . 0.0 108.987 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -132.57 72.88 1.5 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.382 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.27 -170.21 42.64 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.01 -16.25 54.49 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.197 1.264 . . . . 0.0 111.727 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.15 49.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.66 -165.97 46.71 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.822 ' ND2' HG12 ' A' ' 173' ' ' CGS . 97.1 m-20 -76.4 142.1 41.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.9 mt -90.79 -12.36 36.67 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.61 157.33 8.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.362 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.61 177.76 10.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.315 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.78 161.73 23.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -92.71 156.03 17.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.11 149.78 65.46 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.377 -0.827 . . . . 0.0 108.967 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -59.17 106.87 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.61 0.873 . . . . 0.0 111.984 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.2 176.93 38.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -69.2 173.06 11.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.318 1.345 . . . . 0.0 112.029 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.75 14.45 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -83.93 -11.79 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -1.066 . . . . 0.0 109.841 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 140.03 38.02 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.28 -20.33 34.36 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.77 128.75 37.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.028 -1.277 . . . . 0.0 110.717 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.34 24.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.773 . . . . 0.0 109.09 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -130.07 132.44 46.17 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.5 136.4 54.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.385 -0.822 . . . . 0.0 110.095 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 13.9 t0 -65.77 124.31 22.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.291 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -101.18 0.27 37.31 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 97.3 m-20 -75.68 -15.21 60.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.048 -1.032 . . . . 0.0 110.068 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -106.93 164.23 12.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -88.34 118.37 27.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.116 -0.99 . . . . 0.0 109.902 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.97 148.65 23.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.108 -0.995 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.5 p -124.94 173.53 8.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.529 -0.732 . . . . 0.0 109.666 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -112.34 23.63 13.42 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.401 0.62 . . . . 0.0 109.445 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' N ' ' ND2' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -147.27 -165.0 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -87.87 20.88 2.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 109' ' ' GLU . 96.1 mtt180 -75.83 -165.73 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.283 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' ARG . 72.5 mm-40 -11.16 -69.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 123.023 0.529 . . . . 0.0 112.41 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.41 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.2 m-85 -131.8 128.83 39.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -89.9 108.7 19.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 108.627 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.18 -40.16 78.27 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.451 ' ND1' ' C ' ' A' ' 113' ' ' HIS . 17.8 t-80 -59.98 -46.45 89.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.788 -1.195 . . . . 0.0 110.067 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -60.22 -41.91 94.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.004 -1.06 . . . . 0.0 110.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.75 -41.13 79.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.853 -1.154 . . . . 0.0 108.85 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.92 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.82 91.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.441 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 33.8 t60 -70.31 -39.97 74.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.989 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -58.66 -40.01 82.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.177 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.0 -39.74 95.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.56 -42.05 65.64 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -62.26 -36.63 82.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.987 -1.302 . . . . 0.0 108.411 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.9 t -69.22 -24.49 64.02 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.6 -4.87 58.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 0.0 109.436 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.03 15.97 58.48 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.91 129.1 34.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.016 -1.285 . . . . 0.0 109.716 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.499 ' O ' ' SD ' ' A' ' 136' ' ' MET . 68.5 m -87.79 165.52 15.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 109.276 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -66.04 160.6 23.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.093 . . . . 0.0 108.788 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -127.21 166.22 18.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.44 -0.788 . . . . 0.0 109.405 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.3 p -100.53 7.32 44.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.336 -0.853 . . . . 0.0 108.988 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -83.26 116.44 22.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.53 -27.86 41.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.577 -0.702 . . . . 0.0 110.422 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.96 -5.76 89.48 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.298 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.45 156.08 24.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.284 . . . . 0.0 109.79 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.6 -29.53 67.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.764 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 127' ' ' SER . 5.6 mtt -74.0 61.95 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.85 126.92 92.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -47.98 -71.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.485 1.209 . . . . 0.0 110.835 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.5 p -94.44 170.15 9.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 108.982 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -84.61 137.62 33.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.062 -1.024 . . . . 0.0 108.511 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.7 p -148.6 -141.91 0.12 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.119 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -57.83 139.28 54.47 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.994 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.8 m -101.2 120.18 39.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.256 -0.903 . . . . 0.0 109.088 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.47 -153.62 27.84 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 42.3 t0 -80.85 154.1 27.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -1.204 . . . . 0.0 109.726 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.543 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 51.8 t -84.82 98.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 109.681 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -144.78 154.94 43.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.82 145.78 34.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.4 156.24 18.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 109.524 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.16 -39.74 87.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 109.039 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 56.8 t0 -57.93 -39.63 78.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.506 -0.746 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -76.34 -40.71 50.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.952 -1.092 . . . . 0.0 109.519 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.5 -50.12 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.256 -0.902 . . . . 0.0 109.265 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.02 -40.06 90.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.085 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.99 -51.63 38.29 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.75 -40.2 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.008 -1.289 . . . . 0.0 109.486 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.1 mt-30 -65.29 -39.68 92.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.289 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.15 92.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.056 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.72 -49.98 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.057 . . . . 0.0 109.819 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.827 -1.17 . . . . 0.0 109.574 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.23 -165.96 33.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.57 138.64 33.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -1.21 . . . . 0.0 109.849 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.4 m -75.05 84.45 2.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.17 112.65 24.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.679 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 14.7 m120 -156.59 -35.01 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.003 -1.061 . . . . 0.0 112.66 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 8.0 Cg_endo -80.41 48.59 2.93 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 CA-C-N 120.88 1.35 . . . . 0.0 111.201 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.75 125.44 41.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.552 -0.718 . . . . 0.0 109.384 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.494 HE22 ' C ' ' A' ' 166' ' ' PRO . 24.2 mp0 -124.6 79.26 62.56 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 0.0 109.101 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.492 1.434 0 C-N-CA 120.783 0.989 . . . . 0.0 112.714 -179.719 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.822 HG12 ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 8.0 mp -60.86 -39.99 91.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.777 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.1 p -93.69 163.51 13.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -72.21 141.61 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.099 -1.0 . . . . 0.0 109.289 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.91 -161.85 43.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.77 138.41 46.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.122 -1.222 . . . . 0.0 108.631 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.35 -171.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 119.795 0.963 . . . . 0.0 112.144 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -144.37 161.25 39.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.366 -0.834 . . . . 0.0 108.784 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -81.3 120.93 25.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.0 109.017 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.74 -14.82 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.69 149.26 27.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.736 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -94.49 -4.61 47.82 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -129.15 141.33 51.21 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -131.99 159.91 37.38 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.2 -0.938 . . . . 0.0 109.883 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.5 p -127.9 155.1 44.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.454 -0.779 . . . . 0.0 109.51 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.58 157.97 43.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -148.49 137.67 21.82 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.236 -0.915 . . . . 0.0 110.066 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.15 119.96 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.5 tt0 -64.98 -39.98 94.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.078 . . . . 0.0 110.365 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.8 m-20 -158.62 151.15 21.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.981 -1.074 . . . . 0.0 109.784 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.13 134.11 40.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 108.978 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 7.7 t -70.1 135.84 87.12 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -66.54 -10.66 28.65 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.769 0.953 . . . . 0.0 111.848 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' H ' ' HG1' ' A' ' 22' ' ' THR . 93.8 m-20 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.12 149.99 74.24 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.83 -177.77 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 CA-C-N 119.485 0.852 . . . . 0.0 111.429 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -87.26 -29.9 21.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.021 -1.049 . . . . 0.0 109.757 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.87 88.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.9 -39.14 76.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.89 -40.9 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.418 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.95 -43.18 95.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.995 . . . . 0.0 109.011 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -59.99 -43.59 95.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.209 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.36 77.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -70.13 -40.06 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.377 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.09 -39.9 75.27 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 109.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.61 88.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -60.1 -39.79 87.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -59.34 -43.43 92.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.968 -1.082 . . . . 0.0 109.638 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.93 -44.36 97.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.416 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.984 -1.072 . . . . 0.0 110.322 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 t -69.81 -39.84 76.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.87 -18.09 54.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.168 -0.958 . . . . 0.0 111.115 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.02 4.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.15 -0.969 . . . . 0.0 109.775 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.657 ' N ' ' HG ' ' A' ' 163' ' ' SER . 6.5 p -146.44 151.18 42.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.231 -0.918 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -69.32 4.82 1.79 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.823 1.015 . . . . 0.0 111.7 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.85 150.16 46.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 p -129.85 149.37 51.61 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.476 ' C ' ' HG1' ' A' ' 50' ' ' THR . 96.8 m-85 -126.01 157.6 37.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.427 -0.796 . . . . 0.0 109.683 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 19.9 m -155.06 129.14 8.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.935 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -76.39 138.02 40.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 m -121.12 133.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.466 -0.771 . . . . 0.0 109.354 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -97.77 -0.07 45.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -143.26 150.17 38.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.182 -0.949 . . . . 0.0 109.658 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 165.07 30.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -81.58 137.81 35.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -1.1 . . . . 0.0 109.308 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.0 151.85 21.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.98 -42.91 95.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.858 . . . . 0.0 109.717 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -104.39 109.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.404 -0.81 . . . . 0.0 109.397 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtp -101.94 136.76 41.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.286 -0.884 . . . . 0.0 109.684 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.77 132.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.66 -0.65 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.5 p -147.02 150.46 35.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.24 140.45 38.37 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 109.254 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.7 168.82 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -131.88 138.47 48.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.672 -0.642 . . . . 0.0 109.372 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.65 -151.35 1.11 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.3 t0 -65.24 134.89 54.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.615 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.0 p-80 -132.55 51.26 2.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.725 . . . . 0.0 109.627 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 61.9 mtp180 57.38 53.31 7.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.642 -0.661 . . . . 0.0 110.627 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 92.5 m-20 -142.27 169.99 16.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -89.43 9.49 26.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -138.9 72.42 40.92 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.15 152.31 31.03 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.33 1.353 . . . . 0.0 112.017 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -77.81 137.46 38.43 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.268 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -102.23 68.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.0 109.478 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 178.42 39.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.25 -21.03 6.34 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.252 1.301 . . . . 0.0 112.325 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.63 -178.84 45.09 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.02 -153.35 24.52 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.725 ' OD1' HG12 ' A' ' 173' ' ' CGS . 96.4 m-20 -76.81 142.28 40.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -1.118 . . . . 0.0 109.807 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.3 mt -91.53 -15.16 29.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 173' ' ' CGS . . . -170.99 174.86 4.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 108.9 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 2.6 p80 -161.96 117.34 1.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.197 . . . . 0.0 110.428 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.0 171.11 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.12 148.64 70.6 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 0.0 109.353 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.59 108.21 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 120.598 0.865 . . . . 0.0 111.738 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.62 171.26 41.49 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.976 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -65.93 171.61 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.228 1.286 . . . . 0.0 111.548 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.84 -125.94 16.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.14 -6.79 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.363 -1.081 . . . . 0.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.53 141.59 48.0 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.72 -16.27 54.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.76 163.46 21.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -1.074 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.09 117.73 8.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -0.776 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -101.35 135.55 42.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.453 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.1 m-85 -116.85 129.05 55.83 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' GLU . 62.3 t0 -68.06 128.75 37.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.248 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 69.5 tt0 -100.01 2.53 43.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.278 -0.888 . . . . 0.0 109.418 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.13 -16.78 60.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 54.0 mp0 -94.44 155.62 16.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.075 -1.016 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -85.16 115.12 22.76 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.59 145.46 25.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.105 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.9 p -120.31 171.51 8.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.11 26.08 9.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -151.0 -166.98 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -90.7 32.69 0.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.286 -0.884 . . . . 0.0 110.52 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 109' ' ' GLU . 9.0 mtp-105 -75.57 -156.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.841 -1.162 . . . . 0.0 109.652 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -36.86 -59.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.714 -0.616 . . . . 0.0 111.379 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.0 m-85 -123.09 128.96 50.83 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.079 -1.013 . . . . 0.0 110.249 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -108.52 110.37 21.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.381 -0.825 . . . . 0.0 109.186 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.4 -41.12 96.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.184 -0.947 . . . . 0.0 110.41 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 110.362 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 141' ' ' THR . 70.4 ttt180 -59.94 -41.16 91.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.047 -1.033 . . . . 0.0 109.944 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' HA ' HOM2 ' A' ' 173' ' ' CGS . 92.5 t -69.9 -40.19 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 109.541 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.18 94.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.948 . . . . 0.0 108.992 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.33 83.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -69.98 -48.31 58.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.955 . . . . 0.0 109.609 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 82.8 mt-10 -59.95 -40.01 87.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.6 mt -62.88 -39.8 95.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.257 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.65 -41.45 82.28 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -64.87 -39.17 93.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.8 p -69.99 -21.4 63.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.587 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.93 -3.24 59.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 0.0 109.219 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 9.86 60.85 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.64 124.58 30.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.103 -1.234 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 65.4 m -87.96 171.08 10.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.287 -0.883 . . . . 0.0 109.723 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.5 153.0 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.8 t -126.61 168.93 13.65 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.0 109.391 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.3 p -102.85 9.53 38.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -0.813 . . . . 0.0 109.561 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -82.47 123.86 29.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.519 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.71 -31.46 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.374 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.62 -4.3 90.19 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.652 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.11 129.77 35.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.858 -1.377 . . . . 0.0 109.404 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 137' ' ' TYR . 84.5 mt -64.92 -24.94 67.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 108.967 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.9 mmm -73.17 46.98 0.19 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.421 -0.799 . . . . 0.0 109.651 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.2 t80 -69.76 129.95 90.71 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -48.4 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 120.343 1.158 . . . . 0.0 111.78 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.5 p -86.62 171.9 10.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -85.15 138.29 32.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.143 -0.973 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.529 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 80.8 p -147.55 165.1 31.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -74.37 135.94 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.0 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.421 ' CB ' ' NH1' ' A' ' 114' ' ' ARG . 14.0 t -127.83 140.13 52.22 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.521 -0.737 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.43 -101.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.51 139.46 31.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.144 -1.209 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.8 t -86.99 111.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -0.957 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.47 157.16 44.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 108.913 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.85 149.93 37.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.104 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.88 158.57 15.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -60.01 -39.48 85.95 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 108.809 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -57.82 -41.44 82.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.957 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.23 -40.35 62.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.147 . . . . 0.0 110.081 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.36 -50.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.93 -40.12 92.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.57 -55.2 24.29 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.397 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.01 -39.99 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.839 -1.389 . . . . 0.0 109.815 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.8 mt-30 -64.92 -38.5 91.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.681 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.13 92.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.16 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.97 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -98.1 -72.77 0.64 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.42 -0.8 . . . . 0.0 109.564 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.21 -165.06 35.24 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -91.47 139.88 30.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.98 . . . . 0.0 109.694 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.657 ' HG ' ' N ' ' A' ' 45' ' ' THR . 16.6 m -76.26 84.58 3.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 109.094 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -97.25 123.81 41.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.838 . . . . 0.0 109.333 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -152.5 150.17 24.37 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.88 103.6 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 120.677 0.918 . . . . 0.0 111.976 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.18 123.77 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 0.0 109.635 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.91 149.91 92.68 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.221 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.49 1.311 0 CA-C-O 117.957 -0.935 . . . . 0.0 111.92 179.592 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.725 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.51 -41.46 97.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.285 -0.884 . . . . 0.0 108.939 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 p -130.24 139.74 50.76 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.694 -0.629 . . . . 0.0 109.318 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -75.16 130.0 38.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.3 -138.84 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -82.78 146.04 51.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -1.092 . . . . 0.0 109.107 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.92 171.94 6.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.527 0.818 . . . . 0.0 111.802 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -87.57 -176.73 5.68 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.51 117.52 21.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.724 -1.235 . . . . 0.0 108.64 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -82.93 -10.5 58.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -84.44 149.55 25.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -96.06 -4.42 43.02 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -126.76 141.24 51.89 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.7 mt -135.74 158.33 44.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -129.39 154.03 47.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -141.39 160.59 39.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.442 -0.786 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -147.17 132.54 18.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.163 -0.961 . . . . 0.0 110.095 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.68 120.62 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.07 -40.16 94.27 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.988 -1.07 . . . . 0.0 109.839 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -160.19 157.14 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.082 -1.011 . . . . 0.0 109.741 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.71 136.83 40.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 109.196 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 t -68.5 141.22 92.99 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.004 . . . . 0.0 109.0 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.72 -10.81 29.47 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 119.5 0.857 . . . . 0.0 112.146 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.0 mt -135.47 151.33 74.46 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.71 -178.7 0.57 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 120.64 0.894 . . . . 0.0 111.257 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -86.72 -35.94 18.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.184 -0.948 . . . . 0.0 110.046 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.11 73.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.97 -39.9 75.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.29 -42.26 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.88 -40.38 88.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.02 -1.05 . . . . 0.0 108.911 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.83 -48.69 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.579 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.4 92.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.585 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.22 -43.24 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 109.937 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.36 -39.76 77.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.205 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -61.15 -39.88 91.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.18 87.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 109.993 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.8 m-85 -60.13 -39.99 88.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.05 . . . . 0.0 109.316 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -59.96 -41.06 91.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.168 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.13 -41.11 91.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -72.3 -40.02 67.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.35 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.26 -37.23 77.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 0.0 110.089 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -57.85 -21.76 44.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.209 -0.932 . . . . 0.0 110.743 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.93 5.66 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' LEU . 10.3 p -147.0 150.38 38.54 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 120.975 -1.078 . . . . 0.0 109.534 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.12 5.3 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.688 0.925 . . . . 0.0 110.997 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' THR . 90.5 mt -70.86 160.3 33.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.462 -0.774 . . . . 0.0 110.073 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 p -139.36 153.83 47.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.5 m-85 -130.02 152.02 49.93 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.515 -0.741 . . . . 0.0 109.585 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.541 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 18.3 m -153.31 131.32 11.79 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.283 -0.886 . . . . 0.0 110.33 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -79.5 139.11 37.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.54 136.1 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.346 -0.846 . . . . 0.0 108.842 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -96.89 -8.59 30.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.126 -0.984 . . . . 0.0 110.011 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -145.51 159.97 42.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 109.586 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 172.22 44.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.16 146.27 31.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -1.222 . . . . 0.0 109.494 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.77 145.72 33.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.65 -0.656 . . . . 0.0 109.422 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -117.27 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.497 -0.752 . . . . 0.0 108.978 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.1 mmm -100.09 122.05 42.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.271 -0.893 . . . . 0.0 109.778 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -112.1 129.77 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.254 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.6 p -149.81 161.5 42.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.137 -0.977 . . . . 0.0 109.676 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -109.01 138.39 45.43 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.365 -0.835 . . . . 0.0 110.692 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -133.11 145.45 50.72 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.41 -140.54 4.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -77.74 134.6 38.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.366 -1.079 . . . . 0.0 110.184 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.6 p-80 -136.46 64.55 1.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.525 -0.734 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.456 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 18.8 mtt-85 54.48 47.48 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.411 -0.806 . . . . 0.0 110.091 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 91.7 m-20 -141.52 165.05 28.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -95.61 9.92 38.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.342 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 67.86 73.59 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.547 -0.721 . . . . 0.0 109.723 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.61 147.29 86.18 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.044 1.162 . . . . 0.0 112.488 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.65 145.44 34.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -138.25 79.92 1.77 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.64 173.37 36.57 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.41 -7.35 19.94 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.147 1.231 . . . . 0.0 111.676 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.88 174.44 47.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.45 -160.54 31.77 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -76.51 144.66 39.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -1.097 . . . . 0.0 109.586 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.93 -15.43 29.8 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.99 -1.069 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.89 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -0.965 . . . . 0.0 108.926 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.14 121.2 3.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.801 -1.187 . . . . 0.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.17 172.63 10.39 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.284 0.564 . . . . 0.0 109.693 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -113.58 147.86 37.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -59.91 149.01 75.1 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.34 112.46 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.811 1.008 . . . . 0.0 112.197 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.52 172.9 43.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -73.27 161.61 42.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.352 1.368 . . . . 0.0 112.29 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.63 -119.5 5.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.66 -11.39 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.171 . . . . 0.0 109.857 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.28 144.39 47.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.06 -15.55 48.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -67.36 162.11 23.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.89 120.46 12.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.275 -0.891 . . . . 0.0 109.099 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -104.75 134.13 48.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.271 -0.893 . . . . 0.0 110.785 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.93 130.91 57.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 56.5 t0 -67.19 123.91 21.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 99' ' ' GLU . 13.9 tp10 -102.11 0.32 34.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.508 -0.745 . . . . 0.0 109.622 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 96.5 m-20 -73.88 -19.56 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 108.886 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.51 155.7 17.7 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.1 ttt-85 -86.03 121.59 28.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.02 148.71 24.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.5 p -127.11 156.57 41.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.358 -0.839 . . . . 0.0 109.9 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -107.36 30.95 5.78 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -148.43 -164.99 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -84.31 33.87 0.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.57 -163.37 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.405 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -54.17 -59.32 4.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.398 -0.814 . . . . 0.0 111.935 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.36 130.01 54.84 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.138 -0.976 . . . . 0.0 110.755 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -102.82 117.85 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.21 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.11 -49.34 67.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -59.86 -40.29 88.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 111.508 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 28.1 mmt180 -60.01 -41.27 91.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.686 -1.259 . . . . 0.0 109.611 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.96 -40.01 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 108.645 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.99 89.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.533 -0.73 . . . . 0.0 109.35 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.41 93.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.198 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.3 t-160 -69.98 -46.61 64.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -59.13 -40.51 85.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.005 -1.059 . . . . 0.0 109.556 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.62 -35.71 81.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 108.819 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.77 -40.46 96.66 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -66.93 -38.27 85.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.589 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.0 p -69.5 -23.13 63.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.237 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.89 -2.3 58.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.186 -0.946 . . . . 0.0 109.143 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.49 65.66 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.69 128.29 34.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.339 . . . . 0.0 108.714 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.74 173.8 8.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 109.954 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -67.15 158.51 31.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.419 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 23.1 t -127.75 156.67 42.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.54 -0.725 . . . . 0.0 109.59 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.4 p -100.98 8.4 43.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.539 -0.726 . . . . 0.0 109.708 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.419 ' H ' ' HG ' ' A' ' 129' ' ' SER . 54.6 t0 -81.0 130.04 34.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 109.257 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 132' ' ' ILE . 96.0 mt -59.98 -39.79 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.331 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.41 72.6 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.238 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.53 137.87 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.686 -1.479 . . . . 0.0 109.146 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.16 -25.17 66.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -0.807 . . . . 0.0 109.021 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 66.5 mmm -74.09 62.04 0.88 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.394 -0.816 . . . . 0.0 109.043 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.1 129.44 87.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 108.852 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -48.21 -59.9 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.404 1.18 . . . . 0.0 111.829 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.618 ' HG ' ' H ' ' A' ' 140' ' ' TYR . 14.1 t -102.98 173.25 6.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.618 ' H ' ' HG ' ' A' ' 139' ' ' SER . 74.1 t80 -85.77 138.81 31.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.808 -1.183 . . . . 0.0 109.0 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 p -154.03 -171.87 4.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 109.905 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 44.3 p90 -61.44 130.18 44.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.1 p -92.81 156.64 16.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.522 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . -104.82 -127.62 6.04 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' C ' ' NH2' ' A' ' 114' ' ' ARG . 36.6 p-10 -85.06 152.17 23.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.072 -1.252 . . . . 0.0 108.7 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.21 89.74 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.105 . . . . 0.0 109.927 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -150.03 154.17 37.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 109.049 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.78 146.96 39.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 108.954 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.4 161.47 14.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.475 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.26 -39.92 88.49 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.0 -41.53 87.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -74.08 -40.09 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 153' ' ' ILE . 90.1 mt -64.14 -50.16 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.839 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.61 -39.87 89.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.12 -60.94 7.51 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.777 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 tp -60.25 -39.93 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.341 . . . . 0.0 109.274 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.5 mt-30 -65.73 -38.09 88.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 109.035 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.95 95.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.69 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.2 -50.12 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.194 -0.941 . . . . 0.0 109.2 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -96.96 -71.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 109.578 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.94 -177.57 38.96 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.56 146.42 24.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.3 m -76.41 77.54 3.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.508 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 95.4 mm-40 -100.3 125.06 46.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.451 -0.78 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 28.4 m120 -154.5 75.48 5.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.022 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -83.29 52.57 3.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.368 1.379 . . . . 0.0 111.373 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.9 126.82 41.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 108.886 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -125.94 79.65 68.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 109.544 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo . . . . . 0 N--CA 1.491 1.333 0 CA-C-O 117.949 -0.938 . . . . 0.0 112.11 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.502 ' O32' ' HD ' ' A' ' 173' ' ' CGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.265 0.555 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 7.2 mp -60.05 -40.08 88.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 0.0 109.557 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.9 p -91.66 160.19 15.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 109.886 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -75.83 130.06 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.16 -168.28 44.53 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 149.77 70.3 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.143 -1.21 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.73 128.71 25.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 CA-C-N 119.33 0.796 . . . . 0.0 111.399 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' A' ' 8' ' ' ARG . 36.6 mtt-85 -91.55 166.1 13.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.1 126.03 30.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.173 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.35 -12.99 53.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 110.103 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -81.66 153.62 26.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.6 p -97.42 -6.28 34.31 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.302 -0.874 . . . . 0.0 108.82 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 34.1 m170 -126.64 143.78 51.12 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.2 159.58 39.76 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.194 -0.941 . . . . 0.0 109.859 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.5 p -127.54 152.98 46.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -142.86 156.11 44.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.722 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttt-85 -150.21 131.8 14.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 0.0 109.86 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.96 118.47 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.59 -40.05 95.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 0.0 110.735 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -162.5 153.15 17.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.953 -1.092 . . . . 0.0 109.901 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.62 136.53 38.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.86 139.58 88.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.002 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -66.92 -14.05 42.26 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.614 0.898 . . . . 0.0 111.588 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.14 -38.19 82.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.352 -0.842 . . . . 0.0 109.037 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -134.74 149.96 72.15 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.03 -176.96 0.69 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.643 0.896 . . . . 0.0 111.859 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -87.29 -35.34 18.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 109.613 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.1 82.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.09 -40.1 75.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.007 . . . . 0.0 109.773 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.35 -46.08 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.682 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -59.62 -39.99 86.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.782 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -59.93 -46.9 87.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.813 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.4 92.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.206 -0.934 . . . . 0.0 109.827 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.47 -36.87 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 108.657 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.06 -39.96 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.15 -39.91 88.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.82 -1.175 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.54 72.92 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.368 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -62.94 -40.21 96.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.037 -1.04 . . . . 0.0 110.196 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.19 -44.81 94.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.962 -1.086 . . . . 0.0 109.623 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.1 -44.12 95.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.247 -0.908 . . . . 0.0 111.016 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.439 ' O ' ' OG1' ' A' ' 45' ' ' THR . 88.0 m95 -70.12 -41.83 73.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.681 -1.262 . . . . 0.0 109.802 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t -69.86 -30.57 68.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 110.359 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.88 -34.36 73.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 111.152 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.01 11.02 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.103 -0.998 . . . . 0.0 111.168 -178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 65.0 p -140.91 148.15 51.09 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.898 -1.126 . . . . 0.0 109.367 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.69 9.12 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.572 0.848 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.88 156.42 37.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 30.5 p -135.39 149.86 49.76 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.4 156.66 40.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.316 -0.865 . . . . 0.0 109.962 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -154.39 131.19 10.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -77.02 143.74 39.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.454 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 134.51 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.2 t -97.25 -4.08 39.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.13 159.06 43.57 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.911 -1.118 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.03 173.07 34.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -81.06 151.15 28.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 108.898 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.33 153.54 23.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.382 -0.824 . . . . 0.0 109.206 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.85 -40.94 90.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.93 119.46 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.642 -0.661 . . . . 0.0 109.389 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.1 mtp -103.82 131.38 51.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.409 -0.807 . . . . 0.0 108.867 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 61' ' ' ILE . 86.6 mt -118.88 129.38 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -150.52 159.69 44.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.19 137.27 44.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.01 160.09 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 0.0 111.169 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -128.71 137.81 51.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.775 -0.578 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.25 -141.57 3.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.72 126.96 31.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -1.054 . . . . 0.0 109.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -133.65 55.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.616 -0.677 . . . . 0.0 109.345 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.9 mtt-85 54.98 52.27 12.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 109.761 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.4 161.28 37.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.99 9.43 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.775 . . . . 0.0 110.379 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.5 t -139.74 72.91 35.21 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 109.106 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.31 152.06 79.76 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.234 1.289 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -77.79 150.33 34.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -129.65 72.42 1.48 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.545 -0.722 . . . . 0.0 109.824 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.11 170.47 38.17 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.5 Cg_endo -65.2 -24.72 58.35 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.366 1.377 . . . . 0.0 112.046 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.62 -177.98 46.7 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.8 -137.68 14.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.554 ' ND2' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -76.02 122.15 23.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -1.009 . . . . 0.0 109.83 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' N ' HD21 ' A' ' 80' ' ' ASN . 63.7 mt -90.61 -17.52 26.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.009 -1.057 . . . . 0.0 109.993 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.631 ' O ' HG22 ' A' ' 173' ' ' CGS . . . -170.07 160.42 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.88 179.99 8.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.946 -1.097 . . . . 0.0 110.269 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.52 173.32 12.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 109.765 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.25 146.87 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.426 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 3.9 mp0 -59.72 146.99 79.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.901 -1.125 . . . . 0.0 108.397 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -51.04 113.32 1.05 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 120.498 0.799 . . . . 0.0 112.646 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.43 -178.3 34.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.05 176.84 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.246 1.298 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.32 -121.55 24.58 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.216 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -78.8 -10.45 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.577 -0.955 . . . . 0.0 110.284 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.37 151.39 13.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.24 -19.17 32.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.06 157.0 36.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -1.098 . . . . 0.0 110.6 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 122.95 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -102.07 146.0 28.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.858 . . . . 0.0 110.667 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.548 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 16.1 m-85 -117.49 138.31 51.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.444 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 7.9 t70 -65.9 118.39 9.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.032 -1.042 . . . . 0.0 108.599 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -97.9 -1.44 42.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 110.052 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.39 -18.61 59.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 77' ' ' PRO . 95.9 mt-10 -97.63 158.1 15.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 109.202 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -86.53 115.14 23.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.97 -1.081 . . . . 0.0 109.703 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 93.3 m95 -90.12 148.5 22.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 20.1 p -127.97 159.4 35.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.437 -0.79 . . . . 0.0 109.115 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -113.73 30.26 7.38 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.613 HD21 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -147.58 -164.4 2.0 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.062 . . . . 0.0 110.722 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 90.7 t80 -73.72 25.68 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.703 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.517 ' CG ' HD22 ' A' ' 106' ' ' ASN . 26.9 mmt180 -76.1 -168.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.612 -1.305 . . . . 0.0 109.904 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.52 -57.74 10.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 112.208 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.482 ' O ' ' OG1' ' A' ' 104' ' ' THR . 88.5 m-85 -99.5 118.57 36.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.685 -1.26 . . . . 0.0 111.431 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.48 116.52 31.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.339 -0.851 . . . . 0.0 109.475 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 tp -63.53 -38.45 91.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.428 -0.795 . . . . 0.0 109.688 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -59.78 -39.96 86.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 111.16 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -59.4 -43.87 92.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.848 -1.157 . . . . 0.0 109.857 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.77 -39.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.062 -1.024 . . . . 0.0 109.525 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.9 92.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.79 93.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.837 . . . . 0.0 109.617 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.759 ' ND1' HOM2 ' A' ' 173' ' ' CGS . 5.3 t60 -69.89 -46.3 65.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.846 . . . . 0.0 110.882 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.548 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 80.5 mt-10 -59.86 -40.46 88.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.748 -1.22 . . . . 0.0 109.329 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.258 -0.901 . . . . 0.0 108.572 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.27 78.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -65.05 -37.89 89.05 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -1.191 . . . . 0.0 108.716 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.0 p -70.27 -24.74 63.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.52 -2.99 58.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.151 -0.968 . . . . 0.0 108.821 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.77 15.79 62.72 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -82.9 130.16 35.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 m -88.25 169.97 11.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -68.57 156.6 37.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.386 -0.821 . . . . 0.0 109.114 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.6 t -131.96 160.84 34.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.85 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.1 p -99.54 6.81 45.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.329 -0.857 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 59.8 t0 -79.91 131.09 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 96.6 mt -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.459 -0.775 . . . . 0.0 109.988 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.38 -2.74 68.74 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.183 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.95 131.69 34.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.75 -1.441 . . . . 0.0 109.8 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.01 -29.87 67.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.0 mmm -75.59 53.95 0.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.186 -0.947 . . . . 0.0 109.732 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.42 ' C ' ' H ' ' A' ' 139' ' ' SER . 9.6 t80 -70.2 140.27 87.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 4.03 1.01 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 119.949 1.017 . . . . 0.0 111.636 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -156.95 177.53 11.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.625 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 84.5 t80 -90.71 135.73 33.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.838 -1.164 . . . . 0.0 110.001 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.2 p -149.74 169.3 21.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -76.66 123.25 25.86 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.259 -0.901 . . . . 0.0 109.046 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.1 m -118.93 132.42 56.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.748 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.48 -112.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 48.9 t0 -82.75 152.28 25.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.136 . . . . 0.0 108.974 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.551 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.8 t -86.37 107.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.427 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -142.54 151.5 41.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.345 -0.847 . . . . 0.0 108.92 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.64 147.85 39.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.119 -0.988 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.94 153.27 19.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.03 -39.33 78.11 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -53.58 -39.98 65.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.145 -0.972 . . . . 0.0 108.484 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -72.76 -39.95 66.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.279 -0.888 . . . . 0.0 108.701 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.42 -50.2 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 0.0 108.769 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.6 -40.05 93.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.76 -55.75 13.37 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.756 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.11 -40.19 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.923 -1.34 . . . . 0.0 109.616 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -69.6 -38.83 77.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.25 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.57 94.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.112 -0.992 . . . . 0.0 109.38 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.56 -50.06 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.602 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.28 -173.52 40.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -89.06 148.25 23.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m -73.96 88.72 1.87 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -82.51 33.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.515 -0.74 . . . . 0.0 109.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -153.45 72.61 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.338 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.32 68.32 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.552 1.501 . . . . 0.0 111.598 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -85.58 134.9 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -71.5 149.11 93.49 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 118.112 -0.87 . . . . 0.0 111.8 179.168 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.759 HOM2 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.461 ' N ' ' CD1' ' A' ' 2' ' ' LEU . 7.1 mp -60.82 -40.69 93.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 p -92.21 162.6 14.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.49 130.52 39.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.54 -169.06 54.68 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.22 148.39 67.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.896 -1.355 . . . . 0.0 109.194 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.63 152.81 71.3 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 120.635 0.89 . . . . 0.0 111.82 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -149.0 159.2 44.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -82.17 124.15 29.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.01 . . . . 0.0 108.852 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -84.31 -14.01 50.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -87.3 147.34 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 110.317 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.6 p -94.64 -4.72 47.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.221 -0.924 . . . . 0.0 108.808 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 66.9 m80 -120.69 133.3 55.36 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt -131.8 156.33 46.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.143 -0.973 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -128.58 155.64 44.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.421 -0.799 . . . . 0.0 109.511 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -147.01 161.33 41.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -149.0 133.96 18.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.403 -0.811 . . . . 0.0 109.973 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.8 mt -89.9 118.52 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 93.4 mt-10 -65.94 -41.32 91.44 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.074 -1.016 . . . . 0.0 109.842 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 70.8 m-20 -158.14 158.0 33.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.04 134.45 44.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -68.89 138.02 90.18 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.801 -1.187 . . . . 0.0 108.648 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -66.09 -8.2 19.4 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.659 0.914 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.98 -39.86 87.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 mt -136.89 148.19 62.13 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -58.47 -177.94 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.646 0.897 . . . . 0.0 111.576 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -86.47 -33.72 20.29 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 0.0 109.614 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.51 89.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.905 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.44 -39.55 74.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -0.929 . . . . 0.0 110.016 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.55 -40.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 108.962 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.41 -43.1 93.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.16 -45.06 94.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.258 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.26 88.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.4 -42.87 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.07 -40.68 74.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.855 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -61.01 -40.1 92.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 108.921 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.14 94.64 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.317 -0.864 . . . . 0.0 110.122 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -61.35 -40.17 93.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.766 -1.209 . . . . 0.0 109.398 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -60.56 -42.25 96.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -73.69 -42.51 61.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.037 . . . . 0.0 110.21 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -66.73 -37.97 85.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 110.35 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -57.8 -22.91 49.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.497 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.34 7.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -145.72 149.49 40.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.014 -1.054 . . . . 0.0 109.184 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.92 7.47 1.31 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.615 0.877 . . . . 0.0 111.79 178.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.05 154.98 41.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 43.9 p -133.85 150.05 51.37 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -125.74 159.43 32.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.7 m -154.41 126.63 7.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.38 136.87 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.95 135.11 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.466 -0.771 . . . . 0.0 109.172 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 t -98.21 -4.33 35.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 0.0 110.624 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -142.38 155.36 45.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.893 -1.129 . . . . 0.0 110.111 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 177.39 50.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -82.26 143.48 31.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 108.965 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.77 150.89 25.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.8 -40.38 88.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 108.978 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.4 mt -119.61 118.87 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.717 . . . . 0.0 109.259 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.1 mmm -99.62 130.77 45.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.863 . . . . 0.0 108.878 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.45 130.72 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 160.31 43.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.97 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.7 139.18 42.65 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.58 160.45 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.03 -1.043 . . . . 0.0 111.223 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -129.5 136.69 50.18 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.596 0.712 . . . . 0.0 110.118 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.15 -141.86 2.98 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.76 130.5 43.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -1.053 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -138.18 53.3 1.82 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 109.803 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 53.61 59.64 4.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 108.912 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.95 160.39 43.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.048 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -89.37 9.44 26.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.175 -0.953 . . . . 0.0 109.733 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -136.47 71.06 59.99 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 109.367 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -68.42 144.89 63.24 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.061 1.174 . . . . 0.0 112.018 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -76.93 143.78 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.05 70.33 0.9 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.314 -0.866 . . . . 0.0 108.717 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.27 -165.98 42.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.93 -13.23 8.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.17 1.246 . . . . 0.0 112.597 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.42 -177.98 39.99 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.42 -158.12 28.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.87 149.89 39.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.407 -1.054 . . . . 0.0 109.286 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.35 -20.58 19.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.05 -1.032 . . . . 0.0 109.596 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.96 168.62 5.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 108.582 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.29 122.91 1.31 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.541 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.78 168.48 13.46 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.408 0.623 . . . . 0.0 109.408 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.08 153.72 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -59.58 145.36 82.93 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.007 -1.058 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.31 101.44 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 120.441 0.76 . . . . 0.0 111.709 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.64 174.87 35.75 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.28 -179.81 3.42 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 120.878 1.052 . . . . 0.0 111.203 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.47 -127.16 39.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -73.8 -14.33 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.382 -1.069 . . . . 0.0 110.28 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.41 139.45 48.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -16.63 60.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -67.78 160.25 28.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.74 120.86 10.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.052 -1.03 . . . . 0.0 109.227 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -104.31 136.66 43.49 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.664 -0.648 . . . . 0.0 110.427 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -115.81 136.7 52.8 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.667 -0.645 . . . . 0.0 109.615 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.82 118.97 10.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.027 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -99.58 -0.6 40.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 108.778 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.36 -13.04 60.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -105.58 152.17 23.42 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -89.53 120.07 30.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.178 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -84.13 153.5 23.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 -179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.7 p -117.76 164.69 14.62 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.523 0.677 . . . . 0.0 109.621 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.88 28.88 5.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.03 -165.04 2.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.796 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.66 34.04 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.48 -0.762 . . . . 0.0 109.8 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -76.23 -164.32 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -47.72 -57.56 5.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.835 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.91 149.83 23.14 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.727 -1.233 . . . . 0.0 110.767 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -148.36 91.25 1.88 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.0 109.032 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -60.03 -39.83 87.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.195 -0.941 . . . . 0.0 110.818 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.15 -41.22 92.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.732 -1.23 . . . . 0.0 109.773 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.04 -43.0 95.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.955 -1.091 . . . . 0.0 109.759 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.9 t -69.85 -40.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.365 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.69 89.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 108.877 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.446 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 6.2 t60 -68.98 -42.77 76.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 109.847 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.139 -0.976 . . . . 0.0 108.765 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.3 -39.14 93.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.26 85.34 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -65.75 -35.57 81.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.239 . . . . 0.0 108.804 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.8 m -71.65 -28.72 63.95 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 109.892 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.66 -2.54 56.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.84 11.84 67.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -82.27 129.54 34.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.83 -1.394 . . . . 0.0 109.042 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.0 m -88.72 169.93 11.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.873 . . . . 0.0 109.228 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.42 158.97 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.466 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.8 t -124.46 164.65 19.27 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.1 p -99.35 9.67 42.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.032 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -84.84 127.17 34.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.9 -37.33 71.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.507 -0.746 . . . . 0.0 110.598 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.09 1.14 85.99 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 120.981 -1.075 . . . . 0.0 111.45 -178.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.88 138.74 33.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.517 -1.578 . . . . 0.0 109.406 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.52 -29.72 67.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.9 . . . . 0.0 109.679 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.56 54.52 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.517 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.6 t80 -71.29 136.69 84.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.871 -1.143 . . . . 0.0 108.643 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.17 9.25 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.908 1.003 . . . . 0.0 112.061 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.517 ' H ' ' C ' ' A' ' 137' ' ' TYR . 36.6 t -164.29 175.89 9.65 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE1' ' O ' ' A' ' 141' ' ' THR . 53.6 t80 -82.26 154.86 25.16 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.221 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.518 ' O ' ' CE1' ' A' ' 140' ' ' TYR . 60.1 p -150.05 -175.47 5.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.426 -0.796 . . . . 0.0 109.499 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -60.07 150.62 28.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 109.749 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.8 p -72.68 160.19 32.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.329 -0.857 . . . . 0.0 109.565 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.51 -152.51 6.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -83.65 132.96 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.92 -1.341 . . . . 0.0 109.584 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.82 98.64 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.807 . . . . 0.0 109.199 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -146.94 149.7 33.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 108.997 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.05 142.69 43.72 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.0 164.28 13.15 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -59.81 -39.34 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -58.43 -40.96 83.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -74.5 -40.48 61.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.81 -50.24 81.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.132 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.25 -40.23 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.439 178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -56.66 -61.09 7.88 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.48 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.3 . . . . 0.0 110.26 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.2 mt-30 -63.76 -39.67 94.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.807 -1.183 . . . . 0.0 109.495 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.39 92.75 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.52 -49.01 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -99.48 -62.2 1.27 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.216 -0.928 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.74 -176.47 34.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 148.66 24.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.024 -1.28 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.1 m -74.96 67.42 1.68 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.52 99.94 10.61 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -156.33 78.91 4.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -80.46 41.02 1.06 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 120.905 1.07 . . . . 0.0 111.482 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.7 m -85.75 135.62 24.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -74.62 149.34 86.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 N--CA 1.491 1.353 0 CA-C-O 118.014 -0.911 . . . . 0.0 112.466 -179.871 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.446 ' O48' ' CD2' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.524 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 2.7 mm? -62.6 -41.97 99.29 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 38.2 p -100.48 143.26 30.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 110.202 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -80.38 95.57 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.811 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 23.47 77.39 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.367 178.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' OG1' ' A' ' 3' ' ' THR . 7.9 m120 -154.37 69.45 6.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.56 -1.553 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -60.22 152.15 68.3 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.097 1.198 . . . . 0.0 111.789 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -142.44 150.81 41.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -80.29 126.38 31.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 108.706 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.9 -10.06 59.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 109.724 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -79.58 150.09 31.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.9 p -96.74 -3.99 41.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.682 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 97.1 m-70 -129.52 138.69 51.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.48 159.97 37.83 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.15 -0.969 . . . . 0.0 110.776 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -126.2 154.04 43.82 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.59 0.709 . . . . 0.0 109.144 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.42 ' HH ' ' HB2' ' A' ' 51' ' ' LYS . 54.1 p90 -143.5 156.18 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 109.422 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.4 ttt-85 -149.57 132.25 15.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 109.432 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.3 mt -89.25 121.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.87 -39.67 93.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.114 -0.991 . . . . 0.0 110.226 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -161.55 156.7 23.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -102.02 139.45 37.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.63 -0.669 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 1.7 t -74.03 145.81 84.07 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.53 -11.8 33.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.919 1.079 . . . . 0.0 111.518 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' H ' ' HG1' ' A' ' 22' ' ' THR . 97.1 m-20 -60.1 -40.02 88.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.6 mt -139.06 151.6 68.23 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.186 -0.946 . . . . 0.0 108.523 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -62.94 -175.27 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 CA-C-N 119.392 0.819 . . . . 0.0 111.93 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.41 -38.85 13.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.18 84.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.53 -39.13 77.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.616 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.97 -42.01 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.02 . . . . 0.0 109.168 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -59.3 -40.48 86.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 108.781 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -60.01 -46.37 89.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.847 . . . . 0.0 109.362 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.0 -39.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.192 -0.942 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.57 -41.56 88.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -60.72 -40.62 92.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.942 -1.099 . . . . 0.0 110.415 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.46 85.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.944 -1.098 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.23 -40.51 96.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.947 -1.096 . . . . 0.0 109.368 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.58 -43.28 97.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.223 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.75 -42.75 93.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.96 . . . . 0.0 110.265 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.443 ' O ' ' OG1' ' A' ' 45' ' ' THR . 91.0 m95 -70.44 -40.5 73.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.889 -1.132 . . . . 0.0 109.734 -179.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 t -69.77 -32.41 70.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.792 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.02 -33.38 68.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.113 -0.992 . . . . 0.0 111.089 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.44 10.98 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 110.461 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.9 p -146.55 150.36 40.06 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 120.883 -1.135 . . . . 0.0 109.654 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.49 1.44 4.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.744 0.962 . . . . 0.0 111.467 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.01 153.1 44.37 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.406 -0.809 . . . . 0.0 109.275 -179.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.682 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 16.8 p -133.13 149.94 52.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -128.2 149.52 50.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.446 -0.784 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -152.92 133.09 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HB2' ' HH ' ' A' ' 16' ' ' TYR . 62.7 tttp -75.64 144.47 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.732 . . . . 0.0 109.786 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.4 136.58 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t -95.76 -1.47 49.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -145.96 157.18 43.89 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.969 -1.082 . . . . 0.0 109.228 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.78 159.03 13.36 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.07 137.39 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.529 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.15 149.75 22.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.473 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.33 -40.96 92.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.511 -0.743 . . . . 0.0 109.253 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.26 111.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.9 134.93 43.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 61' ' ' ILE . 96.9 mt -119.59 131.39 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.7 p -149.52 160.66 43.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -0.96 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.81 138.56 46.01 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.3 165.57 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 110.798 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -139.7 153.41 47.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.564 -0.71 . . . . 0.0 110.001 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.81 -148.68 0.38 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.3 130.91 45.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -1.08 . . . . 0.0 108.86 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 9.1 p-80 -136.38 57.08 1.79 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.611 -0.681 . . . . 0.0 109.899 -178.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 53.82 53.71 10.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.131 -0.981 . . . . 0.0 109.932 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' SER . 12.0 t70 -144.75 159.28 43.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.7 m-20 -89.65 9.54 26.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.29 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 70.0 m -136.81 73.24 54.08 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.437 -0.789 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.05 155.82 58.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.04 1.16 . . . . 0.0 112.232 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.47 150.24 34.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.508 -0.745 . . . . 0.0 109.154 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.25 77.55 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.15 -172.42 11.56 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -55.8 -14.42 10.69 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.414 1.41 . . . . 0.0 112.417 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.0 178.21 41.96 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 -153.39 26.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.413 -1.051 . . . . 0.0 110.533 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.489 HD22 ' C ' ' A' ' 82' ' ' ALA . 9.0 t30 -72.62 136.68 45.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.946 -0.738 . . . . 0.0 110.25 -179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -94.3 -19.91 20.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.489 ' C ' HD22 ' A' ' 80' ' ' ASN . . . -168.5 159.06 9.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.925 -1.109 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.06 -179.85 7.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.396 -0.815 . . . . 0.0 109.814 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.47 167.78 19.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.237 -0.915 . . . . 0.0 109.429 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -97.83 153.54 18.23 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.978 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -58.64 149.32 63.05 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 104.59 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 120.723 0.949 . . . . 0.0 111.655 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.68 -179.76 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.87 1.047 . . . . 0.0 111.434 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.06 -123.1 31.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.58 -10.05 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.948 . . . . 0.0 110.218 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.26 139.78 47.45 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.001 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.62 -15.97 52.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 127.37 31.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.857 -1.378 . . . . 0.0 110.093 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.73 127.36 47.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -111.21 138.6 47.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.3 -0.875 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.99 134.44 55.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.671 -0.643 . . . . 0.0 109.652 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 46.2 t0 -67.88 120.09 13.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.57 1.28 43.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -74.56 -19.71 60.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.003 -1.061 . . . . 0.0 109.388 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.317 -0.864 . . . . 0.0 108.96 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -85.85 120.08 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 108.701 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.448 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 92.8 m95 -89.52 146.64 24.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.805 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.2 p -123.18 161.16 25.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.22 29.44 7.8 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.756 HD22 ' HE ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -149.03 -164.99 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -80.68 31.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.956 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.756 ' HE ' HD22 ' A' ' 106' ' ' ASN . 61.2 mtm180 -74.57 -166.62 0.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.739 -1.226 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -48.74 -58.49 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.661 -0.649 . . . . 0.0 111.704 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.438 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -107.52 129.8 54.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.971 -1.081 . . . . 0.0 110.975 -178.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -102.48 112.67 25.5 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.37 -41.4 76.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.31 -0.869 . . . . 0.0 111.207 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.74 -41.33 90.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.81 -1.181 . . . . 0.0 109.528 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.404 HH11 ' HB2' ' A' ' 143' ' ' SER . 71.7 ttt180 -59.8 -43.45 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.464 -0.772 . . . . 0.0 110.257 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.93 -39.79 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.189 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.1 92.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.225 -0.922 . . . . 0.0 109.067 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.66 92.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.612 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.484 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.6 t-160 -66.74 -49.2 66.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 108.892 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 42.5 mt-10 -59.75 -41.44 91.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.76 -37.36 86.31 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 108.231 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.52 -41.88 89.35 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -64.2 -35.91 82.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 108.388 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.6 m -69.03 -26.46 65.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.628 -0.67 . . . . 0.0 109.413 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.36 -4.3 59.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.61 61.62 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.22 128.53 34.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.069 -1.253 . . . . 0.0 109.457 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.7 m -88.6 173.0 8.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 109.701 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -68.29 157.03 36.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -0.854 . . . . 0.0 109.014 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 38.7 t -125.01 164.4 20.24 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 64.5 p -97.41 4.34 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 109.318 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.546 ' H ' ' HG ' ' A' ' 129' ' ' SER . 59.9 t0 -82.07 124.95 30.28 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.949 -1.095 . . . . 0.0 109.674 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.3 -39.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 110.387 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 5.65 51.91 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.356 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 142.75 30.42 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.65 -1.5 . . . . 0.0 109.292 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.0 mt -59.78 -39.48 85.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 109.44 179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 31.1 mtp -71.1 67.85 0.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.473 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.514 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.5 t80 -71.69 124.89 91.6 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.11 -1.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 CA-C-N 120.488 1.21 . . . . 0.0 113.008 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 137' ' ' TYR . 50.3 m -167.75 166.96 13.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.071 -1.018 . . . . 0.0 108.486 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.66 136.85 33.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.688 -1.258 . . . . 0.0 108.84 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -148.57 -162.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 108.863 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.45 131.9 51.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.137 -0.977 . . . . 0.0 109.159 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.404 ' HB2' HH11 ' A' ' 114' ' ' ARG . 39.5 t -105.34 125.93 51.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 109.949 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -102.45 -125.44 5.63 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -81.8 135.44 35.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.055 -1.262 . . . . 0.0 109.044 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t -89.62 108.43 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.969 -1.082 . . . . 0.0 109.458 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -148.73 159.44 44.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.806 . . . . 0.0 109.093 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.72 144.49 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.014 -1.054 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 163.16 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.013 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.95 -40.18 88.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -59.63 -41.37 90.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.264 -0.898 . . . . 0.0 109.835 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.24 -40.32 64.75 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.089 -1.007 . . . . 0.0 109.408 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.94 -49.96 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -64.87 -39.76 94.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.559 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.92 -54.72 26.31 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.067 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.43 -38.56 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.996 -1.296 . . . . 0.0 109.377 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -68.05 -34.92 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.106 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.16 88.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.34 -50.56 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.099 -1.001 . . . . 0.0 108.911 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -97.84 -73.69 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.72 . . . . 0.0 109.255 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.49 -169.34 37.74 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.1 mtm-85 -92.28 144.61 25.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.287 . . . . 0.0 109.707 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.8 m -73.63 85.11 1.6 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.254 -0.904 . . . . 0.0 108.914 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -94.94 34.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.31 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -147.4 72.05 11.85 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 0.0 109.947 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -83.17 49.11 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.62 1.547 . . . . 0.0 111.318 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.2 134.95 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.349 -0.844 . . . . 0.0 109.511 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -72.77 148.9 90.12 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 108.95 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 118.023 -0.907 . . . . 0.0 111.708 179.879 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.484 ' O48' ' CD2' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.303 0.573 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.89 -39.93 91.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.816 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.4 p -137.8 160.02 40.42 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.225 -0.922 . . . . 0.0 109.94 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' A' ' 6' ' ' ASN . 75.9 tt0 -73.03 169.5 16.85 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.49 20.35 0.05 OUTLIER Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.607 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.627 ' H ' ' C ' ' A' ' 4' ' ' GLU . 20.5 m120 -150.25 67.82 8.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.302 . . . . 0.0 108.772 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.0 160.76 32.41 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.357 1.371 . . . . 0.0 112.795 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -145.53 151.71 38.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.428 -0.795 . . . . 0.0 109.007 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -83.8 127.28 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.953 -1.092 . . . . 0.0 108.408 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.18 -10.78 59.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.272 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.447 ' CD ' ' N ' ' A' ' 11' ' ' GLN . 9.8 mp0 -85.79 149.49 25.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.755 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -94.46 -4.12 48.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 108.623 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.547 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 33.7 m-70 -128.88 141.53 51.25 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.9 mt -130.27 153.76 48.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.388 -0.82 . . . . 0.0 109.675 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 p -125.29 155.8 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -144.61 159.91 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -149.29 133.14 17.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 18' ' ' ILE . 88.1 mt -89.88 120.05 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -65.86 -40.09 91.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.069 -1.019 . . . . 0.0 110.04 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -159.95 155.34 25.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.017 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -99.69 136.83 39.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 t -67.7 139.21 93.64 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.15 -0.968 . . . . 0.0 108.628 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.55 -13.96 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 CA-C-N 119.561 0.879 . . . . 0.0 112.196 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.23 -40.21 89.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 110.393 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.84 149.37 70.41 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.14 -175.92 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 119.304 0.787 . . . . 0.0 111.831 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 15.9 ptm180 -87.38 -32.27 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -56.96 -44.86 83.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 110.15 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.05 -39.8 54.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.011 -1.056 . . . . 0.0 110.159 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.41 -49.51 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 111.179 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 42.3 p-10 -58.98 -39.24 81.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.67 -1.269 . . . . 0.0 109.402 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.4 t60 -59.82 -43.3 94.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 0.0 108.86 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.26 91.5 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.25 -42.63 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -69.99 -39.12 76.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.052 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.31 -40.12 89.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.95 90.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.601 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.5 m-85 -60.08 -40.14 88.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 109.025 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.03 -43.01 95.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.1 -43.95 95.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.703 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.452 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -71.2 -42.3 69.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.659 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.2 t -67.75 -32.53 73.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 110.834 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.22 -35.0 72.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 110.72 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.87 14.92 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.283 -0.885 . . . . 0.0 111.122 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 62.2 p -144.66 147.34 35.5 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.833 -1.167 . . . . 0.0 109.139 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.9 6.3 1.75 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.623 0.882 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -72.57 163.76 27.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.227 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.547 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 33.3 p -138.89 151.34 46.88 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.96 149.97 52.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.632 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -155.04 129.81 9.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -77.93 142.08 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.405 -0.81 . . . . 0.0 109.922 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.42 134.85 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -97.13 -4.99 38.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.94 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -142.76 151.04 40.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.096 -1.003 . . . . 0.0 109.747 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.63 169.53 42.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.06 146.44 30.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -1.154 . . . . 0.0 109.025 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.79 157.08 18.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.41 -0.806 . . . . 0.0 109.209 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.93 118.09 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.412 -0.805 . . . . 0.0 109.581 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -98.57 128.11 44.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -110.68 129.94 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.4 p -148.41 155.11 40.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.94 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -104.72 139.14 39.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.6 160.09 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.344 -0.847 . . . . 0.0 110.754 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.32 142.46 50.82 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.682 -0.636 . . . . 0.0 109.442 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.79 -140.99 5.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -78.65 128.08 32.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -1.035 . . . . 0.0 109.285 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.588 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.6 p-80 -126.04 56.9 1.4 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 109.872 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 31.1 mmt180 56.4 47.82 18.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.544 -0.723 . . . . 0.0 109.997 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.2 m-20 -138.83 162.89 33.66 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.387 -0.82 . . . . 0.0 108.877 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -89.97 8.76 30.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.942 . . . . 0.0 110.333 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -136.04 73.35 59.02 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -70.02 155.84 64.11 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.164 1.243 . . . . 0.0 112.188 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.91 150.36 32.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -121.94 75.02 1.18 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.546 -0.721 . . . . 0.0 109.438 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.14 -171.27 7.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -53.05 -8.97 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.26 1.307 . . . . 0.0 112.784 -179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.27 46.81 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.83 -171.22 55.09 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -73.83 151.41 40.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.298 -1.119 . . . . 0.0 109.234 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 mt -91.01 -12.53 35.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.984 -1.073 . . . . 0.0 109.72 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.37 163.3 12.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.42 -179.6 7.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -0.817 . . . . 0.0 109.033 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.21 168.98 18.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.99 156.66 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -59.09 150.04 64.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.58 101.38 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 CA-C-N 119.083 0.708 . . . . 0.0 111.398 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.42 175.88 35.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 179.85 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.801 1.001 . . . . 0.0 111.667 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.47 -130.55 40.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -78.83 -7.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -1.19 . . . . 0.0 109.245 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.01 137.35 49.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.21 -15.63 52.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -67.91 124.64 23.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.884 -1.362 . . . . 0.0 109.964 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.13 149.87 21.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -132.9 132.5 42.12 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.427 -0.795 . . . . 0.0 109.668 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.78 135.38 54.09 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.407 -0.808 . . . . 0.0 109.914 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.466 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 56.7 t0 -67.58 121.83 16.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 108.935 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -98.98 0.02 43.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.358 -0.839 . . . . 0.0 109.834 -179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.36 -17.97 60.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.793 -1.192 . . . . 0.0 109.508 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.85 157.82 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -84.42 118.72 24.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.026 -1.047 . . . . 0.0 109.381 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.466 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 97.8 m95 -88.24 147.2 24.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.365 -0.834 . . . . 0.0 109.818 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 16.7 p -129.51 157.21 42.66 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.83 31.49 5.97 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -145.91 -164.16 1.9 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -178.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.77 30.85 0.36 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 110.21 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 12.9 mmt-85 -76.28 -164.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.92 -56.84 17.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 111.313 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.466 ' O ' ' OG1' ' A' ' 104' ' ' THR . 98.6 m-85 -104.68 119.14 38.29 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.987 -1.07 . . . . 0.0 110.385 -178.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 79.2 m-20 -96.33 112.2 24.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.331 -0.856 . . . . 0.0 110.665 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.962 -1.086 . . . . 0.0 109.71 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 135' ' ' LEU . 20.3 tpt180 -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 -179.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.03 -39.39 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.198 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.37 85.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.951 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 109.511 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.788 ' HD1' HOM2 ' A' ' 173' ' ' CGS . 5.3 t-160 -69.98 -48.26 58.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.4 -40.19 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.541 -1.349 . . . . 0.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.48 -31.64 72.94 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.94 -39.64 95.83 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -66.59 -34.49 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -1.082 . . . . 0.0 109.037 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -69.64 -23.24 63.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.225 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.92 -4.94 58.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 109.221 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.91 16.7 59.22 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.35 131.11 35.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.927 -1.337 . . . . 0.0 109.809 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.5 m -88.41 171.56 10.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.989 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -68.59 159.15 32.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.3 t -125.08 157.41 36.35 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.53 -0.731 . . . . 0.0 109.461 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -99.89 3.82 44.73 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.43 126.9 32.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 132' ' ' ILE . 87.9 mt -60.0 -39.99 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.66 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.37 -1.06 49.89 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.047 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.95 33.15 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.682 -1.481 . . . . 0.0 109.38 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.449 ' CD2' ' NH1' ' A' ' 114' ' ' ARG . 93.6 mt -66.47 -34.43 77.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.776 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 37.7 mtp -75.15 64.95 1.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.945 . . . . 0.0 110.297 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.8 t80 -72.63 137.51 80.39 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 108.859 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.83 7.09 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 119.926 1.009 . . . . 0.0 112.127 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 137' ' ' TYR . 31.1 p -159.0 174.67 14.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 108.704 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.52 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 58.7 t80 -87.45 121.28 29.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.795 -1.19 . . . . 0.0 110.118 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -149.18 160.01 43.74 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 52.0 p90 -99.66 126.29 45.66 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.0 109.077 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.422 ' HG ' HH22 ' A' ' 114' ' ' ARG . 92.2 p -109.8 18.35 20.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.567 -0.708 . . . . 0.0 109.419 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.08 -116.42 4.21 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.97 140.39 36.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -1.138 . . . . 0.0 109.849 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.487 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 39.7 t -88.46 117.84 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 99.9 mm-40 -148.9 159.0 44.59 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.09 139.85 41.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.963 -1.086 . . . . 0.0 108.765 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.55 164.88 13.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -40.51 89.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.0 -40.08 79.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.187 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.9 -40.9 60.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 109.829 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 153' ' ' ILE . 96.2 mt -63.06 -50.01 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.103 -0.998 . . . . 0.0 109.57 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.63 -40.01 95.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 110.153 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.15 -55.28 24.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.429 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.7 tp -67.35 -40.0 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.89 -1.359 . . . . 0.0 110.227 -178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.8 mt-30 -68.89 -40.1 79.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 0.0 110.085 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.73 94.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.035 -1.041 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.43 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -96.77 -67.82 0.83 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.194 -0.941 . . . . 0.0 109.855 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.1 179.43 38.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.83 148.5 23.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.112 -1.228 . . . . 0.0 109.098 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.5 m -71.64 85.32 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.623 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.37 34.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.784 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -151.76 72.19 8.07 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -81.76 46.94 2.36 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.512 1.475 . . . . 0.0 111.835 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.4 m -86.24 141.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -72.45 149.48 91.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 117.962 -0.932 . . . . 0.0 112.19 179.471 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.788 HOM2 ' HD1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.288 0.566 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.09 -41.53 92.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 0.0 109.576 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.5 p -90.88 158.19 16.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -71.43 137.48 48.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.049 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.49 -154.72 51.78 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -82.21 148.55 60.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.255 . . . . 0.0 109.242 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.7 132.38 37.39 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.518 0.812 . . . . 0.0 111.638 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 124' ' ' LEU . 23.9 mmm180 -89.44 158.95 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.947 . . . . 0.0 108.692 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.91 122.74 28.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.006 -1.059 . . . . 0.0 108.543 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 58.7 mp0 -84.28 -11.53 56.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 109.905 -179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.42 144.52 29.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 109.211 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -91.67 -3.27 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.551 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 88.4 m-70 -126.64 142.13 51.63 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.46 156.87 48.0 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.208 -0.933 . . . . 0.0 109.929 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -130.49 154.79 47.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -141.84 159.84 41.41 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -147.09 137.22 23.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.157 -0.964 . . . . 0.0 109.949 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -88.14 119.04 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.513 -0.742 . . . . 0.0 109.025 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -69.9 -39.81 75.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -163.41 150.58 12.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.822 -1.174 . . . . 0.0 110.806 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.81 130.8 44.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.669 -0.644 . . . . 0.0 109.629 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 ' OG1' ' OE2' ' A' ' 99' ' ' GLU . 3.5 t -75.39 145.83 80.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.02 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.2 -9.67 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 CA-C-N 119.452 0.84 . . . . 0.0 111.956 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.96 -40.19 88.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.165 -0.959 . . . . 0.0 109.517 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.8 mt -140.07 151.24 64.53 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 108.952 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.75 -175.07 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.805 1.004 . . . . 0.0 112.038 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -88.7 -36.91 15.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.614 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -44.0 91.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.413 -0.804 . . . . 0.0 109.519 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.04 -39.92 75.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.08 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.8 t -69.85 -40.72 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.672 -179.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -60.15 -40.36 89.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.984 -1.073 . . . . 0.0 108.949 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.86 -45.19 93.26 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.69 89.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.426 HG21 HD12 ' A' ' 34' ' ' ILE . 48.3 mm -72.29 -43.1 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.08 -1.012 . . . . 0.0 109.597 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.53 -39.76 81.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.79 -39.81 90.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 110.25 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.77 83.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.961 -1.087 . . . . 0.0 110.166 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -60.18 -39.69 87.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.996 -1.065 . . . . 0.0 109.032 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.73 -40.18 87.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.925 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.97 -44.96 94.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.001 -1.062 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -75.12 -41.81 57.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.226 -0.921 . . . . 0.0 111.132 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -66.77 -38.42 86.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 110.119 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.24 -15.87 28.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 111.044 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.71 2.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.96 -1.088 . . . . 0.0 110.504 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.401 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 13.1 p -145.49 150.57 44.5 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.054 . . . . 0.0 108.899 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.93 8.15 0.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.673 0.915 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.15 153.42 41.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.551 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.2 p -130.34 147.47 52.05 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.27 154.65 45.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.655 . . . . 0.0 109.462 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 m -155.64 133.58 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.486 -0.758 . . . . 0.0 109.87 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.0 135.35 36.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.43 130.72 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.477 -0.765 . . . . 0.0 108.955 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -95.63 0.11 52.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.092 -1.005 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.14 152.78 41.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.35 179.46 51.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.359 -1.083 . . . . 0.0 110.505 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.42 136.95 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.05 -40.21 88.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.212 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -121.52 120.39 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.556 -0.715 . . . . 0.0 109.401 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.9 mtt -100.84 139.19 36.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.38 131.3 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.6 p -151.01 156.11 40.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.119 -0.988 . . . . 0.0 109.949 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -104.35 138.65 40.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.06 160.03 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 O-C-N 121.061 -1.024 . . . . 0.0 110.674 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' CB ' ' A' ' 65' ' ' ARG . 11.5 mtp-105 -129.16 139.79 51.78 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.336 0.589 . . . . 0.0 110.087 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.98 -137.43 2.79 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -73.58 128.43 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.978 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 21.8 p-80 -137.97 65.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 53.21 53.51 11.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -142.69 161.6 37.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 109.106 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.91 9.73 41.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.3 m -138.61 69.68 45.13 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.425 -0.797 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.7 156.05 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.034 1.156 . . . . 0.0 112.292 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -76.6 140.59 41.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -101.76 60.24 0.87 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.545 -0.722 . . . . 0.0 109.613 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 78' ' ' GLY . . . 78.3 179.33 50.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -50.09 -12.22 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.336 1.357 . . . . 0.0 111.927 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 76' ' ' GLY . . . -91.23 178.52 41.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.25 -153.97 25.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 47.4 p-10 -75.16 149.65 38.95 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.353 -1.086 . . . . 0.0 109.415 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.13 -18.02 23.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.649 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.16 167.38 7.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -160.1 173.59 15.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.961 -1.087 . . . . 0.0 109.66 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.41 164.31 22.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.124 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.08 152.24 18.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.179 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -59.71 151.18 63.87 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 109.289 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -53.22 104.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 120.718 0.945 . . . . 0.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.92 174.62 34.56 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.0 172.56 15.23 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.069 1.18 . . . . 0.0 111.699 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.02 -125.33 18.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.82 -10.95 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.567 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.36 148.98 28.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.42 -20.65 10.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.01 151.43 47.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.275 . . . . 0.0 109.236 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.58 123.63 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 0.0 108.78 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -100.89 143.07 31.48 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.635 0.731 . . . . 0.0 110.793 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.4 m-85 -113.85 131.29 56.31 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -65.78 118.45 9.64 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.852 -1.155 . . . . 0.0 108.778 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.43 ' OE2' ' OG1' ' A' ' 22' ' ' THR . 70.4 tt0 -99.13 0.74 44.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.18 -16.88 60.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.821 -1.174 . . . . 0.0 109.754 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -101.22 159.16 15.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 109.444 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -85.53 121.13 27.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.228 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.94 147.59 23.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.373 -0.83 . . . . 0.0 109.97 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 52.5 p -129.89 164.21 24.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.491 -0.756 . . . . 0.0 109.573 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -110.33 32.5 5.12 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -149.03 -164.94 2.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 109.371 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -88.72 25.12 1.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 110.019 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -76.71 -161.45 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 110.032 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.0 mt-10 -24.42 -68.7 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' O ' ' OG1' ' A' ' 104' ' ' THR . 67.1 m-85 -137.27 144.02 42.49 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.967 -1.083 . . . . 0.0 109.912 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -105.02 119.4 38.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.757 . . . . 0.0 109.4 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.88 -40.78 97.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.41 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -59.94 -41.57 92.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.084 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.55 -44.96 93.08 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.082 -1.012 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.03 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.27 92.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.03 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.53 84.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 108.884 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.428 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 4.3 t60 -70.78 -46.4 62.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.838 . . . . 0.0 109.943 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 64.3 mt-10 -59.89 -40.59 89.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.721 -1.237 . . . . 0.0 109.489 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' A' ' 123' ' ' SER . 81.3 mt -63.15 -38.4 91.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.278 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.92 86.88 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.19 -26.81 64.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.267 . . . . 0.0 109.302 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 120' ' ' LEU . 83.6 p -71.06 -22.21 62.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.073 -1.017 . . . . 0.0 108.399 179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 89.6 mt -85.57 -8.73 58.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.361 -0.837 . . . . 0.0 109.14 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.88 19.28 48.13 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.666 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.93 142.1 32.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.84 -1.388 . . . . 0.0 108.947 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.9 m -87.71 168.39 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.015 -1.053 . . . . 0.0 109.479 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -67.92 153.0 44.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.405 -0.809 . . . . 0.0 109.412 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.5 t -124.11 154.54 39.85 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.1 p -99.99 10.83 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.286 -0.884 . . . . 0.0 109.829 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.5 t0 -83.53 132.91 34.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.925 -1.109 . . . . 0.0 110.143 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 91.8 mt -60.24 -40.04 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.12 -5.72 81.38 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.546 -178.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.55 128.88 34.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.935 -1.333 . . . . 0.0 109.486 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.451 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.4 mt -64.31 -25.36 68.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.571 -0.706 . . . . 0.0 109.275 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 47.0 mmm -74.18 45.16 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.115 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.6 t80 -69.55 129.94 91.03 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 108.7 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.484 ' O ' ' HC1' ' A' ' 173' ' ' CGS . 17.9 Cg_exo -46.28 -62.52 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.192 1.104 . . . . 0.0 111.702 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 t -96.97 172.42 7.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -85.11 147.06 26.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 108.819 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -134.35 137.99 44.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.503 -0.748 . . . . 0.0 109.272 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -61.9 -44.09 97.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -80.17 163.76 23.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.188 -0.945 . . . . 0.0 110.474 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 114.99 119.6 3.33 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -82.79 165.53 19.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.122 . . . . 0.0 109.194 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.78 90.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -148.63 151.04 34.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 109.056 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.0 mt -76.52 142.9 40.72 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.859 179.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 162.93 13.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 108.735 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -59.83 -40.39 88.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 0.0 109.434 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -58.9 -40.14 83.57 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.521 -0.737 . . . . 0.0 109.642 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.22 -40.87 64.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.095 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.22 -52.81 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.43 -40.13 96.33 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.854 -1.154 . . . . 0.0 110.096 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.8 -55.43 29.86 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.611 -178.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.1 tp -65.61 -39.96 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.977 -1.308 . . . . 0.0 110.582 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.6 mt-30 -65.64 -39.82 91.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.821 -1.175 . . . . 0.0 109.346 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.59 -44.6 89.87 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.65 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -49.97 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 109.646 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -93.28 -70.1 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.66 -178.66 39.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.94 142.58 27.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.401 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 69.2 m -72.96 84.88 1.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.824 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -89.66 112.96 24.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -153.83 75.28 6.24 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.18 -0.95 . . . . 0.0 109.778 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -82.57 47.37 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.558 1.506 . . . . 0.0 112.151 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.37 131.91 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 0.0 110.072 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -70.06 148.36 96.03 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.213 -0.929 . . . . 0.0 108.66 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo . . . . . 0 N--CA 1.491 1.352 0 CA-C-O 118.082 -0.883 . . . . 0.0 112.352 179.892 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.484 ' HC1' ' O ' ' A' ' 138' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.76 123.0 41.51 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.208 -0.932 . . . . 0.0 109.021 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.9 p -94.23 148.03 22.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 110.041 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -74.19 139.56 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.483 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.45 -147.41 19.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -84.0 122.53 76.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -1.178 . . . . 0.0 108.989 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -69.92 106.13 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.058 1.057 . . . . 0.0 112.338 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -92.74 161.7 14.43 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -83.12 119.83 25.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.976 -1.078 . . . . 0.0 108.5 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.6 -9.97 59.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 109.5 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -80.3 145.08 32.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.51 ' HG1' ' CD2' ' A' ' 13' ' ' HIS . 71.7 p -94.81 -8.87 36.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.51 ' CD2' ' HG1' ' A' ' 12' ' ' THR . 93.5 m-70 -123.22 119.86 31.44 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.08 165.41 12.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.499 -0.751 . . . . 0.0 109.253 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -129.58 155.46 45.77 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -144.13 159.21 43.03 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.144 -0.972 . . . . 0.0 109.078 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' O ' ' A' ' 53' ' ' SER . 70.7 ttt180 -148.76 131.19 15.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.061 -1.024 . . . . 0.0 110.608 -178.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.51 116.81 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.22 -42.96 99.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 110.268 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -162.15 160.85 27.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.0 110.19 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.58 136.64 40.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.602 -0.686 . . . . 0.0 109.333 179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.568 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 2.0 t -74.97 142.32 76.11 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.975 . . . . 0.0 108.97 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -61.11 -10.88 16.46 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 CA-C-N 119.527 0.867 . . . . 0.0 111.825 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.568 ' H ' ' HG1' ' A' ' 22' ' ' THR . 94.6 m-20 -59.89 -40.1 87.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.0 mt -139.04 151.17 67.4 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.69 -171.35 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 119.475 0.848 . . . . 0.0 111.914 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HG3' ' NH1' ' A' ' 27' ' ' ARG . 7.1 ptm180 -87.96 -35.43 17.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.57 94.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 109.978 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.02 -39.72 75.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.2 -43.24 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.924 -1.11 . . . . 0.0 109.286 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -59.93 -50.04 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.15 91.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.206 -0.933 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -70.01 -39.82 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 110.159 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.57 -41.23 93.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.019 -1.05 . . . . 0.0 109.844 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -62.42 -40.02 95.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.728 -1.233 . . . . 0.0 110.037 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.66 64.13 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -62.36 -42.51 99.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.842 -1.161 . . . . 0.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mm-40 -60.3 -42.09 94.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.132 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.61 -41.66 90.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 109.91 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.447 ' O ' ' OG1' ' A' ' 45' ' ' THR . 86.2 m95 -72.79 -40.48 65.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.84 -1.163 . . . . 0.0 109.644 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 t -69.37 -32.97 72.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 110.593 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 17.0 m120 -59.3 -26.1 64.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.234 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.86 7.9 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.238 -0.914 . . . . 0.0 110.668 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 10.5 p -145.95 150.56 42.83 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.883 -1.136 . . . . 0.0 109.644 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.62 2.73 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.912 1.075 . . . . 0.0 111.538 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.04 151.62 44.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.265 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.494 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.8 p -137.16 147.01 45.65 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -121.18 120.24 34.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.6 m -96.0 132.48 41.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.465 -0.772 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 128.48 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 108.871 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.41 129.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.427 -0.796 . . . . 0.0 108.859 179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.494 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 40.3 t -99.49 0.29 42.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.9 158.63 43.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.138 -0.976 . . . . 0.0 109.639 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.92 170.4 38.4 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -82.62 130.27 35.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -1.152 . . . . 0.0 109.206 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.67 155.11 17.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -59.98 -39.9 87.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.803 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.423 HD12 HG22 ' A' ' 59' ' ' ILE . 84.9 mt -118.92 120.0 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.7 mmm -99.13 128.6 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.62 126.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.4 p -148.42 157.53 43.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.994 -1.066 . . . . 0.0 110.356 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -107.35 136.85 46.46 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.1 160.38 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.167 -0.958 . . . . 0.0 111.42 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 142.79 49.08 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.26 -147.65 2.59 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.52 128.74 37.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.436 -1.038 . . . . 0.0 109.745 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p-80 -135.97 58.68 1.74 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.43 -0.794 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' A' ' 69' ' ' ARG . 59.6 mtt-85 55.56 52.92 10.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.485 -0.76 . . . . 0.0 110.426 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.0 p-10 -144.17 160.96 40.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.05 -1.031 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -92.48 12.37 23.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.071 -1.018 . . . . 0.0 110.022 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.6 m -139.37 69.76 39.69 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 109.563 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -70.19 148.65 62.77 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.927 1.085 . . . . 0.0 112.153 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.01 150.03 37.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -125.14 73.97 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.424 -0.798 . . . . 0.0 109.506 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.78 167.41 42.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -54.42 -16.34 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.334 1.356 . . . . 0.0 111.984 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 175.63 40.23 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.99 -151.25 19.99 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.58 ' ND2' HG13 ' A' ' 173' ' ' CGS . 16.7 m120 -75.99 141.05 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -1.201 . . . . 0.0 109.475 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.6 mt -93.91 -19.69 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.044 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' O ' HG21 ' A' ' 173' ' ' CGS . . . -168.53 160.54 11.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.903 -1.123 . . . . 0.0 109.735 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -160.18 -179.81 8.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.55 167.69 21.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.509 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.65 149.33 21.35 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.09 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -59.96 149.39 73.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -46.88 115.82 1.43 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 120.533 0.822 . . . . 0.0 112.084 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.96 173.9 42.26 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.37 173.95 12.93 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-N 118.157 0.978 . . . . 0.0 111.419 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.19 -120.75 22.27 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.85 -7.35 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.173 -1.192 . . . . 0.0 110.214 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.24 134.25 52.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.5 -11.38 70.19 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.0 124.94 24.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.272 . . . . 0.0 110.068 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.74 126.12 45.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.474 -0.766 . . . . 0.0 109.606 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -107.96 136.85 46.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.563 -0.711 . . . . 0.0 109.627 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -117.33 130.73 56.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.657 -0.652 . . . . 0.0 109.241 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.32 121.55 15.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 109.48 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -100.41 3.75 43.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.381 -0.824 . . . . 0.0 110.17 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -73.73 -18.16 61.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 109.175 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.47 158.43 16.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 108.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -86.9 125.02 33.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.943 . . . . 0.0 109.52 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.49 147.17 23.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.356 -0.84 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.3 p -129.68 158.86 38.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.535 -0.728 . . . . 0.0 109.741 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.03 29.97 7.15 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.554 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 15.8 p30 -144.99 -160.5 1.14 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.832 . . . . 0.0 109.447 -178.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -87.97 15.41 7.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.198 -0.939 . . . . 0.0 110.531 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.5 mtt180 -76.47 -167.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.809 -1.182 . . . . 0.0 109.981 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 108' ' ' ARG . 93.9 mt-10 -4.51 -87.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.02 151.68 51.6 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 110.084 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 5.5 m120 -98.41 115.14 27.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.883 . . . . 0.0 109.391 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.45 -39.22 93.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.008 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -59.06 -42.42 90.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.973 -1.079 . . . . 0.0 109.542 -179.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.9 -39.6 85.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.978 -1.076 . . . . 0.0 109.181 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.51 -40.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.05 92.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.024 . . . . 0.0 109.184 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.4 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.995 -1.066 . . . . 0.0 108.716 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.403 ' HD1' ' C20' ' A' ' 173' ' ' CGS . 3.6 t-160 -70.38 -48.8 54.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.68 -42.72 93.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.666 -1.271 . . . . 0.0 110.028 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -39.8 93.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.098 . . . . 0.0 108.701 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.97 88.96 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -65.59 -37.47 86.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -1.191 . . . . 0.0 109.171 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -69.86 -20.77 63.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.211 -0.93 . . . . 0.0 108.554 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.25 -0.97 57.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.43 66.68 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.635 179.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.86 128.68 34.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.896 -1.356 . . . . 0.0 109.082 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -87.97 170.37 11.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.361 -0.837 . . . . 0.0 109.5 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -65.85 155.12 37.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.5 t -125.3 153.71 42.84 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.0 p -99.52 9.87 42.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -82.36 128.37 34.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 108.874 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.04 -40.13 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.22 -2.19 66.16 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.254 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.28 141.19 32.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.712 -1.463 . . . . 0.0 109.201 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.42 -27.84 65.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 29.9 mtp -74.19 52.08 0.45 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.846 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 139' ' ' SER . 22.2 t80 -70.45 137.6 86.23 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -53.32 -1.99 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 119.828 0.974 . . . . 0.0 112.498 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 137' ' ' TYR . 81.4 p -159.94 174.75 13.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.938 -1.101 . . . . 0.0 110.502 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -86.95 137.76 32.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 0.0 109.676 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.3 p -146.88 159.69 43.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -65.68 139.76 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.847 . . . . 0.0 109.327 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -138.37 144.13 40.14 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.286 -0.884 . . . . 0.0 109.883 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.51 -114.14 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.2 t0 -82.01 154.71 25.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -1.186 . . . . 0.0 109.026 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.52 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 86.0 t -89.6 108.02 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.101 -179.502 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -146.9 156.95 43.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.3 mt -75.97 146.63 39.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.883 -1.136 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.46 153.31 19.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.401 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -57.04 -39.94 75.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -53.08 -40.15 63.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.918 -1.114 . . . . 0.0 108.945 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.76 -39.67 66.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.32 -48.03 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.62 -40.09 90.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.727 -1.233 . . . . 0.0 110.514 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -51.46 44.59 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.162 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.3 tp -66.62 -40.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.874 -1.368 . . . . 0.0 109.767 -179.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.3 mt-30 -66.08 -39.97 90.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.09 95.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.032 -1.042 . . . . 0.0 109.814 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -50.13 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.33 -65.41 0.96 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.121 -0.987 . . . . 0.0 109.421 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.34 -170.21 33.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.676 ' NH2' HE22 ' A' ' 164' ' ' GLN . 84.8 mtm180 -91.04 142.87 27.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.111 -1.229 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.4 m -73.33 78.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.012 -1.055 . . . . 0.0 109.002 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.676 HE22 ' NH2' ' A' ' 162' ' ' ARG . 96.9 mt-30 -100.48 116.58 32.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -155.8 140.67 12.14 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -79.92 41.99 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.023 1.044 . . . . 0.0 112.008 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 88.8 t -90.51 120.23 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.403 -0.811 . . . . 0.0 109.861 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' PRO . 32.5 mt-30 -69.99 150.39 96.29 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 168' ' ' GLN . 20.8 Cg_exo . . . . . 0 N--CA 1.489 1.216 0 CA-C-O 117.958 -0.934 . . . . 0.0 112.227 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.608 HG21 ' O ' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.99 -44.24 94.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 p -145.61 -152.46 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 6' ' ' ASN . 83.3 tt0 -73.2 159.38 33.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.356 -0.84 . . . . 0.0 109.035 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.41 10.28 0.3 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 4' ' ' GLU . 15.9 m120 -145.38 72.61 14.32 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 108.731 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -69.05 -171.24 0.4 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.019 1.146 . . . . 0.0 112.483 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -141.52 170.01 16.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.08 120.91 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 108.82 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.0 -10.01 58.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.37 148.65 29.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.275 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -95.86 -6.07 40.18 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.083 -1.011 . . . . 0.0 108.866 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 15.0 m-70 -130.62 132.57 45.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.238 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -121.77 156.03 34.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 -179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.7 p -125.7 153.57 43.7 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -144.78 161.06 40.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.77 132.45 13.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.869 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.59 120.03 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -64.96 -40.01 94.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -160.37 150.39 18.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.898 -1.126 . . . . 0.0 109.768 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.25 140.33 30.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 99' ' ' GLU . 9.0 t -70.7 137.24 85.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 109.642 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.75 -14.59 45.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.815 0.97 . . . . 0.0 111.792 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.99 -40.1 88.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.2 mt -135.05 149.1 69.37 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.05 -174.01 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 120.545 0.83 . . . . 0.0 112.031 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.43 -36.16 16.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.872 . . . . 0.0 109.739 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.99 -41.18 77.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 108.89 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -39.98 75.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.435 -0.79 . . . . 0.0 109.628 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.04 -43.83 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.982 . . . . 0.0 109.021 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.98 -39.93 87.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.337 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.622 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 59.9 t60 -59.97 -50.05 75.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.75 89.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 110.763 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.8 mm -70.05 -38.43 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.123 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.38 -41.3 96.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.007 -1.058 . . . . 0.0 109.776 -178.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.622 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 32.7 mttp -64.76 -37.58 88.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 109.994 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.947 -1.096 . . . . 0.0 109.322 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.88 -41.44 97.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 109.02 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.07 -41.53 92.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.831 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.92 -41.8 92.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.018 -1.051 . . . . 0.0 109.621 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.424 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.2 m95 -74.57 -40.49 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.04 -1.037 . . . . 0.0 109.946 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -69.86 -35.27 74.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.106 -0.996 . . . . 0.0 110.42 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.31 -31.4 65.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 110.435 -178.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 34.3 m -109.53 9.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.308 -0.87 . . . . 0.0 110.208 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 72.9 p -140.94 144.91 37.13 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.234 -0.916 . . . . 0.0 108.983 178.719 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.9 2.99 3.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.563 0.842 . . . . 0.0 111.226 178.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.21 153.61 42.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 62.6 p -130.39 143.1 50.56 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -119.16 151.68 37.89 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.515 -0.741 . . . . 0.0 109.36 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.9 m -153.34 131.71 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.49 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -77.19 144.88 38.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.439 -0.788 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.53 135.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.496 -0.753 . . . . 0.0 109.072 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -95.36 -6.86 40.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -150.18 159.57 44.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.032 -1.042 . . . . 0.0 109.411 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.14 176.42 51.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -83.81 139.04 32.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -1.096 . . . . 0.0 109.495 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.58 143.79 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.319 -0.863 . . . . 0.0 109.138 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -59.95 -40.09 87.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.011 -1.056 . . . . 0.0 109.348 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.01 118.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.7 mtt -102.45 133.3 47.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.239 -0.913 . . . . 0.0 109.579 179.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.25 128.33 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.1 p -147.36 153.13 39.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -101.87 138.54 38.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.24 164.86 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.189 -0.944 . . . . 0.0 110.535 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 65' ' ' ARG . 42.8 mtm-85 -139.96 142.45 36.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.67 5.39 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -70.04 127.25 32.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -1.074 . . . . 0.0 109.71 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 19.4 p-80 -136.94 62.29 1.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 69' ' ' ARG . 4.2 mmt-85 56.17 49.99 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.74 . . . . 0.0 109.304 -179.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.0 t0 -142.55 148.13 37.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 51.6 p-10 -89.48 9.73 25.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.064 -1.023 . . . . 0.0 109.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -136.24 73.14 58.17 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.555 -0.716 . . . . 0.0 109.161 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.85 166.44 26.36 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.252 1.301 . . . . 0.0 112.207 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -77.95 149.33 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 10.6 t0 -101.88 65.38 1.0 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.278 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.46 170.11 46.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.7 -16.26 29.95 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 120.903 1.069 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.42 -175.78 43.28 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.05 17.21 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.159 -1.2 . . . . 0.0 110.102 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 82' ' ' ALA . 13.7 t-20 -73.83 123.8 24.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.452 -1.028 . . . . 0.0 109.591 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.36 -14.32 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.128 -0.983 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -169.01 158.45 8.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.911 -1.118 . . . . 0.0 109.737 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.14 -178.8 6.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.059 -1.025 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.2 178.49 8.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.92 -178.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -104.33 157.4 17.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.656 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -59.99 149.59 73.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.14 103.99 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.601 0.867 . . . . 0.0 112.286 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.92 168.11 34.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.68 -178.42 1.57 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.045 1.163 . . . . 0.0 111.737 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.18 -123.18 30.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 tt -79.99 -12.8 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.949 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.11 144.18 48.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.52 -16.4 53.67 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -66.9 157.36 33.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -1.215 . . . . 0.0 109.366 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.88 17.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.188 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -102.17 136.06 42.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.75 . . . . 0.0 109.59 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -114.14 129.65 56.62 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.76 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.19 117.8 9.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.181 -0.95 . . . . 0.0 109.126 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' CD ' ' HG1' ' A' ' 22' ' ' THR . 25.2 tt0 -97.7 1.89 49.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 0.0 109.306 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.76 -17.68 61.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 0.0 108.447 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -97.49 158.51 15.44 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.632 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -85.58 120.58 27.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.928 -1.108 . . . . 0.0 108.962 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -90.51 140.0 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 109.539 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.9 p -125.29 170.0 11.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.559 -0.713 . . . . 0.0 109.691 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.37 28.76 8.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.459 ' C ' HD21 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -148.58 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.63 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -86.95 27.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 110.643 -178.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -75.84 -158.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.659 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ARG . 96.1 mt-10 -32.47 -62.99 0.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.976 -0.453 . . . . 0.0 111.732 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 99.4 m-85 -136.04 141.38 44.3 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.118 -0.989 . . . . 0.0 110.219 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -98.96 116.75 31.91 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.98 -43.84 94.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -59.99 -41.0 91.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.624 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -59.97 -43.3 95.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.029 -1.044 . . . . 0.0 110.109 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -69.99 -40.0 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.961 -1.087 . . . . 0.0 108.807 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.71 87.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.01 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.81 92.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.622 ' HD1' HOM1 ' A' ' 173' ' ' CGS . 3.6 t-160 -69.01 -48.06 63.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 108.949 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.23 -42.59 91.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.903 -1.123 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.67 -40.01 95.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 109.46 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.98 84.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -63.46 -36.97 85.52 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -1.1 . . . . 0.0 108.738 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.9 m -68.81 -26.54 65.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 109.127 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.58 -2.61 54.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 108.469 179.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.01 10.61 66.22 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.81 126.88 31.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.372 . . . . 0.0 109.178 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.7 m -88.07 174.26 8.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.798 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -67.08 157.14 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.4 t -131.37 159.68 37.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.0 p -101.72 11.8 38.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 56.8 t0 -80.1 132.93 36.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.007 -1.058 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 95.9 mt -60.04 -40.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.431 -0.793 . . . . 0.0 111.253 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.14 81.98 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.908 -1.12 . . . . 0.0 111.157 -178.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.93 136.82 34.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.656 -1.496 . . . . 0.0 109.776 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.02 -29.88 67.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.445 -0.784 . . . . 0.0 109.267 179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mmm -71.43 51.0 0.17 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 -178.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.2 t80 -70.0 137.22 87.24 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -64.85 10.22 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 119.871 0.99 . . . . 0.0 111.7 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.2 t -160.02 175.65 12.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 108.833 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.529 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 65.9 t80 -86.55 119.95 27.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.664 -1.273 . . . . 0.0 109.662 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 69.5 p -150.09 164.0 36.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -134.23 149.88 51.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.38 -0.825 . . . . 0.0 109.166 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -147.32 -1.83 0.62 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.05 -148.58 12.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -80.6 164.92 22.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 108.994 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.41 110.03 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.081 -1.012 . . . . 0.0 109.605 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.27 160.19 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.42 147.62 45.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.848 -1.157 . . . . 0.0 109.308 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.38 149.56 21.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.12 -39.91 72.95 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -54.84 -39.84 68.98 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -73.93 -39.95 63.43 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -0.817 . . . . 0.0 109.33 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.4 mm -62.58 -51.23 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.391 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.13 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.405 -0.809 . . . . 0.0 110.955 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -51.42 38.17 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.259 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.9 tp -69.59 -39.96 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.935 -1.332 . . . . 0.0 110.295 -178.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.4 mt-30 -67.38 -39.94 85.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.309 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.77 94.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.892 -1.13 . . . . 0.0 108.976 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 159' ' ' ILE . 96.9 mt -60.02 -50.04 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 109.437 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -96.6 -73.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.45 -171.51 35.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 162' ' ' ARG . 38.1 mtt-85 -85.51 156.27 20.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -1.125 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.5 m -71.38 85.05 0.81 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -93.55 35.44 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.384 -0.823 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -146.4 112.67 4.37 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 168' ' ' GLN . 29.1 Cg_endo -77.72 135.96 14.83 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.024 1.044 . . . . 0.0 112.15 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.9 t -86.05 146.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.599 -0.688 . . . . 0.0 109.731 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 166' ' ' PRO . 25.8 mp0 -125.02 78.8 66.02 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.49 1.305 0 C-N-CA 120.793 0.995 . . . . 0.0 112.039 -179.462 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.622 HOM1 ' HD1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.16 -43.72 95.56 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.619 ' HG1' ' N ' ' A' ' 4' ' ' GLU . 11.4 p -142.26 -150.14 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.619 ' N ' ' HG1' ' A' ' 3' ' ' THR . 88.3 tt0 -72.66 153.4 41.23 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.209 -0.932 . . . . 0.0 109.002 179.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.34 7.08 0.24 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' A' ' 4' ' ' GLU . 72.2 m-80 -145.39 75.45 13.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.143 -1.21 . . . . 0.0 108.726 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -59.1 148.57 84.94 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.784 0.989 . . . . 0.0 111.642 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.47 160.02 41.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.313 -0.867 . . . . 0.0 109.017 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -82.16 129.99 34.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.26 -13.43 57.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.886 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -81.84 149.36 28.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 109.58 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.6 p -96.57 -7.47 34.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.936 . . . . 0.0 108.847 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.526 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 64.0 m-70 -130.03 144.2 51.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.17 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.9 mt -134.24 157.6 45.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.18 -0.95 . . . . 0.0 109.802 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.0 p -127.77 155.57 43.83 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -142.5 159.84 41.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 0.0 109.497 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -148.1 130.12 15.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 110.082 -179.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.33 119.81 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 78.0 tt0 -66.89 -39.92 87.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.1 m-20 -157.55 150.03 22.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.979 -1.076 . . . . 0.0 110.082 -179.43 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.16 135.16 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 t -68.59 141.75 93.35 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.232 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.81 -12.66 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.674 0.916 . . . . 0.0 111.832 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -136.28 149.55 68.22 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 121.255 -0.903 . . . . 0.0 108.848 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -59.61 -179.99 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.214 0.755 . . . . 0.0 111.744 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -86.46 -33.01 20.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.12 81.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.84 -39.91 76.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.36 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.35 -42.83 81.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.03 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.05 87.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.405 ' O ' ' N ' ' A' ' 36' ' ' LYS . 86.3 t60 -60.02 -49.7 76.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.18 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.01 90.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.406 -0.809 . . . . 0.0 109.88 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.61 -44.59 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.292 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.23 -40.15 74.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.5 tttt -62.64 -39.68 94.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.07 90.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 31.1 m-85 -59.87 -40.31 88.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.112 . . . . 0.0 109.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.11 -40.67 90.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.0 -43.31 95.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.009 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.97 -41.76 64.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.183 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.5 t -70.14 -26.49 63.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.248 -0.907 . . . . 0.0 110.521 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -60.07 -36.03 76.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 110.852 -178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.92 13.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.061 -1.024 . . . . 0.0 110.403 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -141.2 146.81 44.55 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.997 -1.064 . . . . 0.0 109.257 179.082 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.19 5.57 2.62 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.579 0.853 . . . . 0.0 111.414 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.84 153.39 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 0.0 109.866 -179.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.526 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 38.2 p -130.91 148.01 52.62 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 98.1 m-85 -126.52 149.76 49.19 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.3 m -153.33 132.06 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 0.0 109.835 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -79.62 142.03 35.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.413 -0.804 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.55 135.85 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -96.67 -3.14 43.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 0.0 110.011 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.67 152.55 41.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.028 -1.045 . . . . 0.0 109.647 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.31 166.99 33.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -82.91 139.52 33.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -1.156 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.64 160.44 14.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 108.983 179.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.97 -39.76 86.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.178 -0.952 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.85 120.02 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.485 0.659 . . . . 0.0 109.932 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -99.86 122.13 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 61' ' ' ILE . 95.5 mt -110.01 129.98 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.417 -0.802 . . . . 0.0 109.052 179.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -149.05 153.94 38.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.025 -1.047 . . . . 0.0 110.295 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -104.37 138.04 41.38 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.0 170.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.112 -0.993 . . . . 0.0 111.101 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -134.43 143.57 47.63 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.667 -0.646 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.44 -146.68 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -67.17 128.69 37.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.994 . . . . 0.0 109.597 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.495 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -135.97 58.49 1.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.06 52.2 10.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.588 -0.695 . . . . 0.0 109.341 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.495 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 18.9 p-10 -142.43 160.02 41.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 109.072 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -91.14 10.04 28.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.279 -0.888 . . . . 0.0 109.705 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -137.07 74.34 49.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.326 -0.859 . . . . 0.0 109.845 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.53 148.85 48.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.081 1.188 . . . . 0.0 111.405 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -75.88 139.98 41.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.276 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.86 61.04 0.97 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 109.351 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 -176.72 53.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -55.07 -13.55 6.84 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.158 1.238 . . . . 0.0 112.079 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 170.32 34.62 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -150.63 19.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.751 ' OD1' HG12 ' A' ' 173' ' ' CGS . 97.9 m-20 -77.89 142.04 38.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -1.108 . . . . 0.0 109.862 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.5 mt -89.89 -16.6 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.197 -0.94 . . . . 0.0 108.953 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.661 ' O ' HG21 ' A' ' 173' ' ' CGS . . . -170.01 166.96 9.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.932 179.841 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.59 -178.44 6.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.839 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.16 170.55 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.396 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.21 153.87 19.56 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.4 -0.813 . . . . 0.0 109.532 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -60.72 151.1 73.53 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.423 -0.798 . . . . 0.0 109.337 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 108.45 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.726 0.951 . . . . 0.0 112.402 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.67 165.19 34.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.04 161.92 40.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.108 1.206 . . . . 0.0 111.997 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.54 -126.65 7.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.51 -13.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 109.8 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.46 141.29 47.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.06 -15.23 60.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.38 159.21 31.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -1.193 . . . . 0.0 109.708 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.99 122.85 12.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.301 -0.874 . . . . 0.0 109.171 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -104.68 148.32 26.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.0 110.465 -179.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.3 m-85 -115.22 135.51 54.1 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.246 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 19.7 t0 -67.19 116.67 8.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -95.76 -0.25 51.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -178.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 94.3 m-20 -75.72 -17.33 59.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.84 -1.163 . . . . 0.0 110.095 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -102.2 159.8 15.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -88.29 120.35 29.57 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.051 -1.03 . . . . 0.0 109.365 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -88.33 148.52 24.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 60.8 p -124.9 161.12 27.28 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.531 -0.731 . . . . 0.0 109.742 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -112.8 31.46 6.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -148.18 -164.9 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -0.881 . . . . 0.0 109.976 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -79.93 30.64 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 106' ' ' ASN . 48.9 mtt-85 -76.63 -164.48 0.42 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 52.5 mp0 -60.04 -58.3 9.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 112.552 -177.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' O ' ' OG1' ' A' ' 104' ' ' THR . 70.4 m-85 -106.1 121.63 44.54 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.975 -1.078 . . . . 0.0 111.349 -177.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 4.6 m120 -104.19 117.28 33.87 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.14 -40.17 90.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -60.1 -41.32 92.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 114' ' ' ARG . 4.4 mmt-85 -60.15 -39.98 88.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.453 ' HA ' HOM1 ' A' ' 173' ' ' CGS . 88.0 t -70.28 -41.12 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.064 -1.022 . . . . 0.0 109.826 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.11 95.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.93 87.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.4 t-160 -69.2 -46.16 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 94.4 mt-10 -59.1 -40.21 84.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.763 -1.211 . . . . 0.0 109.889 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.28 -39.94 92.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.088 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.77 97.16 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -65.3 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.161 -1.199 . . . . 0.0 108.803 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.3 p -70.04 -24.31 63.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 108.813 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.89 -3.43 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.43 13.31 76.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.7 132.66 35.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.884 -1.363 . . . . 0.0 108.942 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -87.91 173.04 9.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 109.793 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.62 159.3 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -127.88 162.57 26.4 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.0 p -100.12 2.8 43.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.019 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -82.3 128.81 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.09 -31.58 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.476 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.14 -0.72 77.87 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.272 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.309 . . . . 0.0 109.346 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 137' ' ' TYR . 97.1 mt -67.68 -27.55 66.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.7 mmm -74.11 44.43 0.19 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.421 -0.8 . . . . 0.0 109.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.417 ' H ' ' C ' ' A' ' 135' ' ' LEU . 15.5 t80 -70.05 134.71 87.44 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 -179.576 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -50.62 -62.11 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 120.055 1.055 . . . . 0.0 111.536 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -81.71 175.38 10.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.815 . . . . 0.0 109.135 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.99 128.77 34.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 109.725 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.4 p -149.43 175.0 11.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.455 -0.778 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -130.75 149.74 52.25 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.42 -0.8 . . . . 0.0 109.606 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.2 p -126.13 23.13 7.15 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.626 -0.672 . . . . 0.0 109.229 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.67 -109.91 3.31 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 42.5 t0 -81.76 155.11 25.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.124 179.833 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.515 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 60.9 t -88.66 110.04 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -140.57 150.74 44.03 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.11 147.44 40.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 109.012 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.1 162.98 14.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.07 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.98 -40.17 88.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 109.002 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.39 -40.78 87.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.44 -40.15 62.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.12 -52.25 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.226 -0.921 . . . . 0.0 109.166 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.59 -40.1 90.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.051 -1.031 . . . . 0.0 109.476 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.05 11.38 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.793 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.4 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.339 . . . . 0.0 109.798 -179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.3 mt-30 -67.2 -39.93 86.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 0.0 109.717 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.54 92.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.077 -1.014 . . . . 0.0 109.273 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.0 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.751 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -97.57 -69.98 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.14 -0.975 . . . . 0.0 109.325 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.59 -169.18 33.9 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -86.22 157.66 19.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -1.177 . . . . 0.0 109.838 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 165' ' ' ASN . 37.3 m -73.72 80.94 1.56 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.25 -0.906 . . . . 0.0 108.921 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -80.87 35.14 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 163' ' ' SER . 68.2 m-80 -145.55 85.71 7.74 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.269 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.65 63.45 8.77 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.119 1.213 . . . . 0.0 111.83 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.4 p -150.3 131.57 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 109.283 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -71.17 150.32 94.54 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.965 . . . . 0.0 109.169 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 120.825 1.017 . . . . 0.0 111.868 179.974 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.751 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.62 138.88 33.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.331 -0.855 . . . . 0.0 109.091 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.8 p -92.62 160.15 15.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.252 -0.905 . . . . 0.0 109.461 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -71.95 137.71 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 108.799 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.33 -159.68 48.89 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -80.01 148.93 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.26 . . . . 0.0 108.79 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.99 -178.62 2.13 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.647 0.898 . . . . 0.0 112.027 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -145.03 156.95 44.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 108.824 179.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -84.48 120.03 25.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.004 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 55.3 mp0 -82.69 -9.87 59.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.99 155.76 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 0.0 110.299 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.438 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 79.4 p -98.92 -4.5 32.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.341 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 48.2 m80 -129.96 141.72 50.73 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.0 mt -133.39 156.06 48.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.251 -0.905 . . . . 0.0 109.27 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 153.98 45.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.398 -0.813 . . . . 0.0 109.185 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -146.16 162.25 38.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.323 -0.86 . . . . 0.0 109.206 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -147.92 129.88 15.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.37 120.15 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.35 -40.12 89.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 110.422 -178.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -163.27 154.84 17.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.877 -1.139 . . . . 0.0 110.478 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.36 136.4 40.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -70.79 143.05 88.93 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.106 -0.996 . . . . 0.0 109.36 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.85 -11.08 25.15 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.603 0.869 . . . . 0.0 111.749 179.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.0 -39.93 87.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.947 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.8 mt -139.55 150.58 64.04 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.371 -0.831 . . . . 0.0 109.044 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.94 -177.04 0.3 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.622 0.881 . . . . 0.0 112.015 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.6 ptt180 -87.03 -33.23 19.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.39 -39.98 81.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.63 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.24 -39.97 59.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -50.04 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.0 111.261 -178.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 29.6 p-10 -59.16 -39.03 81.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.76 -1.213 . . . . 0.0 108.948 -179.399 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.404 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.8 t60 -59.73 -49.17 78.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.185 179.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.14 87.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 110.165 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.09 -40.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.229 -0.919 . . . . 0.0 109.857 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.07 -39.75 86.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.23 -39.8 87.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 109.29 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.33 95.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.09 -1.006 . . . . 0.0 109.498 -179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -60.02 -39.94 87.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.864 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -60.0 -40.03 87.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.369 -0.832 . . . . 0.0 109.827 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.2 mt -60.03 -42.96 95.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.055 -1.028 . . . . 0.0 109.709 -179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -71.65 -40.11 69.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 109.702 -179.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 t -69.79 -33.7 72.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.03 -23.06 63.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 111.06 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 m -112.74 3.33 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.166 -0.959 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 9.2 p -148.63 151.37 35.67 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.861 -1.149 . . . . 0.0 109.586 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.99 8.88 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.657 0.905 . . . . 0.0 111.975 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' THR . 95.2 mt -70.15 150.01 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.543 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -137.26 153.75 50.27 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.452 -0.78 . . . . 0.0 109.033 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.01 158.93 38.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.492 -0.755 . . . . 0.0 110.109 -179.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -154.88 126.69 7.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.864 . . . . 0.0 109.984 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.82 143.92 37.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.333 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.76 139.53 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -95.28 -11.2 28.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.165 -0.959 . . . . 0.0 110.097 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -147.59 158.16 43.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.964 -1.085 . . . . 0.0 109.546 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.93 170.83 47.65 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.512 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 5.5 pm0 -80.0 163.96 23.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.41 151.86 51.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -0.752 . . . . 0.0 109.757 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.11 -39.87 87.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.483 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.67 119.85 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.704 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.1 mmm -100.59 128.73 46.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.2 mt -119.13 129.92 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.468 -0.77 . . . . 0.0 109.722 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.7 p -149.74 159.92 43.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.172 -0.955 . . . . 0.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.56 138.37 44.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.14 161.54 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.162 -0.961 . . . . 0.0 111.25 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.92 142.78 50.83 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.717 -0.614 . . . . 0.0 109.786 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.99 -143.52 1.45 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.1 t0 -71.33 130.73 42.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.984 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.416 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.8 p-80 -133.11 53.59 2.01 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.5 -0.75 . . . . 0.0 109.835 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 54.04 50.98 15.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 109.386 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 10.4 t70 -140.03 165.88 26.14 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 26.1 m120 -89.15 9.36 25.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.11 -0.994 . . . . 0.0 109.946 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -135.57 71.43 65.41 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.833 . . . . 0.0 109.635 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.76 141.1 70.57 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 120.937 1.091 . . . . 0.0 111.986 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -75.2 141.33 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -110.74 74.28 0.87 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.784 . . . . 0.0 109.312 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.26 -178.62 6.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.56 -18.78 4.16 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.186 1.257 . . . . 0.0 112.044 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.22 175.06 55.03 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -160.46 29.29 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -75.03 160.12 30.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -1.114 . . . . 0.0 109.681 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 mt -93.64 -20.97 19.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.24 -0.912 . . . . 0.0 109.774 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.59 174.75 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.043 -1.036 . . . . 0.0 109.724 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.04 175.81 10.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 108.943 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.4 167.7 21.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.629 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.78 148.9 24.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.483 -0.76 . . . . 0.0 109.106 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -59.99 149.81 72.3 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.059 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.28 120.58 8.44 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.781 0.987 . . . . 0.0 112.16 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.53 174.9 47.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.81 172.95 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.211 1.274 . . . . 0.0 112.105 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.35 -124.83 16.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.09 -9.13 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -1.043 . . . . 0.0 110.002 -179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.78 143.9 35.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.18 -18.25 46.34 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.07 152.84 45.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.118 -1.225 . . . . 0.0 109.914 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.27 121.42 10.14 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -102.92 141.5 35.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.42 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.8 m-85 -113.8 136.57 52.71 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -65.71 115.6 6.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -98.43 -1.04 42.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.496 -0.752 . . . . 0.0 109.442 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.14 -20.23 59.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.976 -1.078 . . . . 0.0 109.557 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.31 159.55 14.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 108.84 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -87.23 122.43 31.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.932 . . . . 0.0 109.682 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.18 150.01 22.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.892 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.8 p -127.56 159.64 33.99 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.542 -0.724 . . . . 0.0 109.347 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.39 29.47 7.52 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.532 -0.73 . . . . 0.0 109.587 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.623 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.82 -165.01 2.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.217 -0.927 . . . . 0.0 109.655 -179.802 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.72 34.73 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 0.0 110.644 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.517 ' CG ' HD22 ' A' ' 106' ' ' ASN . 26.1 mmt180 -76.85 -165.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.392 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.38 -56.59 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.589 -0.694 . . . . 0.0 111.432 -178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 104' ' ' THR . 91.5 m-85 -100.33 119.79 38.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.052 -1.03 . . . . 0.0 110.756 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -103.35 107.3 18.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.385 -0.822 . . . . 0.0 109.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.38 -44.16 97.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 110.09 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -59.91 -43.43 94.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.706 ' NH1' HOM2 ' A' ' 173' ' ' CGS . 13.7 ttt-85 -59.95 -43.32 95.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.892 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.96 -40.03 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.15 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.56 92.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.27 90.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.585 ' CD2' ' H50' ' A' ' 173' ' ' CGS . 5.8 t60 -69.28 -45.87 68.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 71.4 mt-10 -59.84 -40.14 87.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.94 -1.1 . . . . 0.0 109.142 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.58 -40.05 90.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 108.894 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.79 -41.92 84.44 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -64.65 -38.98 92.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -1.201 . . . . 0.0 108.835 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.3 p -70.02 -21.47 63.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.344 -0.847 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.86 -0.61 56.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 108.966 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.93 8.93 78.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.2 127.36 32.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.032 -1.275 . . . . 0.0 108.791 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -88.05 175.46 7.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.327 -0.858 . . . . 0.0 109.687 -179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -67.53 159.88 28.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -133.25 163.63 28.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.538 -0.727 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -100.89 7.45 43.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.65 122.01 27.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 108.788 179.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.24 -30.82 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.48 -5.74 89.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.464 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.77 132.08 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.995 -1.297 . . . . 0.0 109.505 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -68.91 -24.64 64.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.1 mmm -73.21 38.63 0.09 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.791 -178.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.474 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.9 t80 -69.32 129.72 91.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.965 . . . . 0.0 108.671 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -47.59 -67.51 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.3 1.143 . . . . 0.0 111.863 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 98.0 p -81.88 169.42 16.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -87.37 139.54 30.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.2 p -147.51 160.63 42.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -72.92 149.51 43.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.812 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.3 p -152.87 160.08 43.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.277 -0.89 . . . . 0.0 109.579 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.88 -122.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.43 158.85 23.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 109.626 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.4 t -86.97 108.59 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 109.849 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.91 154.26 46.04 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 63.4 mt -74.93 146.04 42.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.969 -1.082 . . . . 0.0 109.11 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.07 156.89 16.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 109.092 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.77 -38.89 79.5 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -55.08 -40.11 70.01 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.072 -1.018 . . . . 0.0 108.624 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.7 -39.96 69.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.23 -49.94 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.659 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.99 -39.98 91.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.837 -1.164 . . . . 0.0 110.339 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.74 -54.43 9.91 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.137 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.7 tp -61.89 -40.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.299 . . . . 0.0 110.038 -179.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -65.86 -40.04 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.941 -1.099 . . . . 0.0 109.387 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.926 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -50.07 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 110.51 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -100.47 -61.04 1.42 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.171 -0.955 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.7 -176.93 34.69 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -90.93 149.43 21.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.426 -1.043 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.1 m -73.7 83.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 108.685 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.37 34.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 0.0 109.431 -179.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -143.54 72.32 17.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 109.324 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.99 58.07 5.64 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.653 1.569 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 82.5 t -87.04 118.5 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.36 -179.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -76.63 148.69 80.08 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 118.018 -0.909 . . . . 0.0 112.057 179.877 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.706 HOM2 ' NH1' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.213 0.53 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.32 -40.2 89.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.05 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.5 p -96.5 139.69 32.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.805 . . . . 0.0 108.997 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.12 134.47 38.7 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.931 -1.106 . . . . 0.0 108.986 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.69 -94.96 0.65 Allowed Glycine 0 N--CA 1.502 3.097 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.462 ' ND2' ' OE1' ' A' ' 86' ' ' GLN . 68.5 m-80 -153.45 83.52 4.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.347 -1.09 . . . . 0.0 109.966 -179.257 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -52.22 161.25 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 120.85 1.033 . . . . 0.0 111.998 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 8' ' ' ARG . 22.6 mtt-85 -88.97 179.29 6.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.954 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -83.75 120.63 26.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.285 -0.885 . . . . 0.0 109.527 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.95 -10.11 58.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 109.109 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.94 150.11 30.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 -179.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -97.0 -4.89 38.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.523 -0.735 . . . . 0.0 109.442 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -130.01 139.99 50.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.78 157.61 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.403 -0.811 . . . . 0.0 109.654 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -127.0 155.19 43.59 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.619 -0.676 . . . . 0.0 109.188 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.98 157.91 43.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.009 -1.057 . . . . 0.0 109.266 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.41 HH21 ' CE ' ' A' ' 60' ' ' MET . 42.3 ttp180 -147.33 128.86 15.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.166 -0.959 . . . . 0.0 109.954 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.0 mt -85.41 123.71 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -62.3 -40.76 97.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -178.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -162.22 151.84 16.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.304 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -97.54 135.94 38.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.378 -0.827 . . . . 0.0 109.27 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.542 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 4.0 t -73.41 144.92 84.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.752 -179.349 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.89 -15.09 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 CA-C-N 119.203 0.751 . . . . 0.0 111.046 179.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.542 ' H ' ' HG1' ' A' ' 22' ' ' THR . 84.2 m-20 -61.49 -40.07 93.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.4 mt -135.13 150.32 72.58 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.009 -1.057 . . . . 0.0 109.337 -178.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.39 179.82 2.75 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 CA-C-N 119.158 0.735 . . . . 0.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -85.54 -36.13 20.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.924 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.78 84.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.21 -40.03 74.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.85 -44.33 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.443 -179.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.54 89.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 108.719 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.87 -47.87 84.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.312 -0.867 . . . . 0.0 109.499 179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.47 89.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.143 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.58 -40.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -70.26 -40.0 74.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.609 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.29 95.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 108.609 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CE1' ' CD1' ' A' ' 49' ' ' PHE . 33.8 m-85 -61.21 -39.59 90.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 109.881 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -58.9 -40.93 85.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.2 -41.24 92.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.034 -1.041 . . . . 0.0 109.317 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.444 ' O ' ' OG1' ' A' ' 45' ' ' THR . 94.5 m95 -72.39 -40.0 67.57 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.476 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.68 -28.47 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.442 -0.786 . . . . 0.0 110.254 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -59.85 -35.14 74.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 110.766 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.52 5.63 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.278 -0.889 . . . . 0.0 110.985 -178.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 45.3 p -140.03 148.63 55.61 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 120.897 -1.127 . . . . 0.0 108.625 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.73 6.4 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.407 1.404 . . . . 0.0 112.389 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.16 157.92 35.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.367 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 p -135.79 147.71 48.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.482 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 95.9 m-85 -128.72 148.7 50.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.725 -0.609 . . . . 0.0 109.65 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -154.35 134.92 13.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -76.06 146.58 39.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.25 135.17 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.369 -0.832 . . . . 0.0 108.978 179.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -97.54 -5.89 34.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 110.052 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -142.67 156.67 45.08 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.07 -1.019 . . . . 0.0 109.565 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 167.59 25.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -78.37 148.03 33.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.932 . . . . 0.0 109.272 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.59 148.38 30.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -0.776 . . . . 0.0 108.913 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.45 -40.35 90.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.34 118.89 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.41 ' CE ' HH21 ' A' ' 17' ' ' ARG . 89.7 mmm -101.2 122.19 43.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -111.79 130.05 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.625 -0.672 . . . . 0.0 109.524 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.6 p -147.39 155.5 42.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -105.28 140.2 38.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.57 160.29 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 121.901 0.858 . . . . 0.0 111.188 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.3 mtm-85 -131.96 135.44 46.58 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.72 -138.66 13.88 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -77.37 129.09 35.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.561 -0.964 . . . . 0.0 110.243 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 19.1 p-80 -131.58 47.46 2.53 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.409 -0.807 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 56.04 59.35 3.78 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.1 p-10 -142.72 163.1 33.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.066 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.53 9.19 30.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.172 -0.955 . . . . 0.0 109.233 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 t -140.08 69.51 34.95 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.414 -0.804 . . . . 0.0 109.012 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.67 148.68 42.22 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.364 1.376 . . . . 0.0 112.083 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -79.25 151.12 31.34 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -134.93 76.36 1.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.428 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.83 -179.18 39.73 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -70.73 -15.6 33.46 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.194 1.262 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.04 -174.89 50.5 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.04 -158.38 36.38 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.502 ' ND2' HG13 ' A' ' 173' ' ' CGS . 11.7 m120 -75.06 143.78 43.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -1.023 . . . . 0.0 109.25 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.32 -16.0 32.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 109.0 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.54 175.67 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.264 -0.898 . . . . 0.0 108.937 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -163.01 120.25 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.914 -1.116 . . . . 0.0 110.629 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.45 168.11 16.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -109.61 143.93 38.63 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.462 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 80.3 mt-30 -59.47 145.95 80.94 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -58.36 127.28 24.16 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 119.249 0.768 . . . . 0.0 112.306 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.27 178.12 43.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.57 -177.86 3.87 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.359 1.373 . . . . 0.0 112.524 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.75 -123.7 33.52 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.14 -13.74 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.49 -1.006 . . . . 0.0 109.782 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.01 138.77 38.21 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.249 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -13.93 63.5 Favored Glycine 0 N--CA 1.497 2.702 0 O-C-N 121.231 -1.158 . . . . 0.0 110.546 179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.79 162.81 25.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.955 -1.321 . . . . 0.0 109.768 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.5 120.76 11.55 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -105.15 133.45 49.9 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.241 -0.912 . . . . 0.0 110.272 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.508 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 43.8 m-85 -114.65 129.75 56.72 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -67.53 120.72 14.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 108.968 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -99.4 6.5 46.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.308 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.47 -20.16 60.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 0.0 109.737 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -104.23 160.07 15.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 102' ' ' ARG . 33.2 ttt-85 -84.11 119.16 24.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.138 -0.976 . . . . 0.0 110.147 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -88.8 148.95 23.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.497 -0.752 . . . . 0.0 109.269 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 41.6 p -123.23 167.96 13.06 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.476 -0.765 . . . . 0.0 109.306 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -104.66 23.82 12.75 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -148.98 -165.0 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.657 -0.652 . . . . 0.0 109.805 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -90.88 27.0 1.92 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.231 -0.918 . . . . 0.0 110.911 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.0 mtt-85 -76.47 -157.14 0.08 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.837 -1.165 . . . . 0.0 109.442 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 108' ' ' ARG . 64.4 mm-40 -24.31 -65.4 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.4 m-85 -130.12 132.05 45.95 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.978 -1.076 . . . . 0.0 109.786 -179.455 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -95.99 113.83 25.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.204 -0.935 . . . . 0.0 109.701 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.25 -40.27 77.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -59.63 -42.9 93.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.958 -1.089 . . . . 0.0 109.988 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.797 ' NH1' HOM3 ' A' ' 173' ' ' CGS . 25.3 ttt-85 -59.7 -41.52 90.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.27 -39.67 77.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.77 92.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.328 -0.858 . . . . 0.0 108.926 179.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.16 85.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.0 109.162 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.42 ' HD1' HOM2 ' A' ' 173' ' ' CGS . 4.3 t60 -69.72 -50.1 46.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 73.4 mt-10 -59.95 -40.1 87.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.962 -1.086 . . . . 0.0 110.278 -178.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.12 -39.88 94.04 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 108.828 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.52 95.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 128' ' ' HIS . 12.2 m-70 -61.93 -38.73 89.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.067 -1.255 . . . . 0.0 107.778 178.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.5 m -69.65 -24.31 63.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.1 -0.27 51.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 108.852 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.99 13.97 65.5 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.361 -0.923 . . . . 0.0 110.889 178.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.56 124.58 30.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.088 -1.243 . . . . 0.0 108.887 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -88.67 167.28 13.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.998 -1.064 . . . . 0.0 109.1 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 122' ' ' HIS . 80.9 m80 -68.58 152.36 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 t -126.44 169.69 12.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.473 -0.767 . . . . 0.0 108.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.3 p -98.94 1.02 45.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.398 -0.814 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -79.06 119.3 21.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 132' ' ' ILE . 90.2 mt -60.04 -40.44 83.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 -179.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.77 27.87 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.01 -1.057 . . . . 0.0 111.007 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.1 23.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.852 -1.381 . . . . 0.0 109.159 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.19 -23.89 64.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 108.885 178.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.564 ' SD ' ' N ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -74.52 62.24 1.0 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.57 -0.706 . . . . 0.0 109.911 -179.262 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.499 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.8 t80 -71.19 123.95 90.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -51.11 -2.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 CA-C-N 120.459 1.2 . . . . 0.0 113.546 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 137' ' ' TYR . 58.3 m -163.05 174.55 12.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 0.0 109.074 179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -86.43 129.68 34.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.903 . . . . 0.0 108.92 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.4 p -153.01 168.66 25.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.127 -0.983 . . . . 0.0 110.036 -179.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.07 125.81 25.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.612 -0.68 . . . . 0.0 110.077 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 144' ' ' GLY . 51.0 m -129.66 142.69 50.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.449 -0.782 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -63.76 -126.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.8 155.59 25.34 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.842 -1.387 . . . . 0.0 109.213 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.26 110.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.456 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -142.58 157.87 44.26 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.54 145.92 47.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.018 -1.051 . . . . 0.0 108.868 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.07 162.91 13.68 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.21 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.14 -40.19 88.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.22 -41.67 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -71.68 -40.78 69.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.76 -49.78 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.781 . . . . 0.0 109.298 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.67 -39.91 88.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.894 -1.129 . . . . 0.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -52.72 34.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.32 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -1.212 . . . . 0.0 109.669 -179.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.28 -39.65 92.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.198 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.79 92.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.389 -0.819 . . . . 0.0 110.033 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.97 -47.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.92 -1.112 . . . . 0.0 109.478 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.41 -64.91 1.01 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.299 -0.876 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.91 -169.82 35.94 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -92.11 145.44 24.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.023 -1.281 . . . . 0.0 108.7 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.2 m -71.42 87.39 0.87 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.223 -0.923 . . . . 0.0 109.962 -178.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.417 ' C ' ' ND2' ' A' ' 165' ' ' ASN . 76.8 mt-30 -86.96 93.4 9.33 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 164' ' ' GLN . 14.3 m-80 -155.35 96.63 2.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.684 -0.635 . . . . 0.0 109.785 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -80.04 57.45 6.51 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 CA-C-N 119.425 0.83 . . . . 0.0 111.807 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.2 t -142.83 130.57 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.58 ' NE2' ' N ' ' A' ' 168' ' ' GLN . 2.5 mp0 -67.35 148.39 98.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.861 -1.149 . . . . 0.0 108.759 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.492 1.408 0 CA-C-O 118.063 -0.891 . . . . 0.0 112.525 -179.509 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.797 HOM3 ' NH1' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.29 -42.9 96.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 108.857 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.3 p -96.35 124.53 40.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 109.565 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.51 116.66 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.323 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.18 -98.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -142.47 81.32 13.79 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.336 -1.097 . . . . 0.0 109.551 -179.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -73.28 -171.37 0.8 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.079 1.186 . . . . 0.0 112.582 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -90.15 -179.14 5.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.747 . . . . 0.0 109.291 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -83.13 118.71 23.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -85.26 -10.65 56.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.287 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.73 150.9 25.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.323 -179.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.7 p -96.19 -3.8 43.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -128.85 141.67 51.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 160.05 39.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.244 -0.91 . . . . 0.0 109.784 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 p -127.94 157.18 41.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -146.1 159.94 42.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.416 -0.802 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -150.4 133.87 16.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.2 mt -89.49 118.57 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.4 mt-10 -66.8 -40.13 87.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.531 -178.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.2 m-20 -155.95 152.71 28.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.119 -0.988 . . . . 0.0 109.849 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -101.4 131.98 47.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HG1' ' H ' ' A' ' 24' ' ' ASP . 5.8 t -68.75 138.26 90.61 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.993 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.47 -8.95 18.5 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.596 0.891 . . . . 0.0 112.052 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' H ' ' HG1' ' A' ' 22' ' ' THR . 92.9 m-20 -60.1 -39.97 88.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.004 179.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -135.73 149.06 67.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.13 -175.44 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.63 0.886 . . . . 0.0 111.696 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -90.01 -37.23 14.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -45.85 85.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.823 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.54 -39.83 73.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.72 -45.58 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -59.95 -40.11 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.184 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -60.12 -42.52 94.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.74 90.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.46 -36.89 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -65.71 -42.03 91.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.739 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.6 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.836 -1.165 . . . . 0.0 109.82 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.95 75.66 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 39.4 m-85 -61.69 -40.96 96.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.918 -1.114 . . . . 0.0 108.78 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.24 -42.03 94.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 0.0 110.356 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.79 -40.6 88.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.067 . . . . 0.0 110.116 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -73.0 -40.04 65.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.822 -1.174 . . . . 0.0 109.186 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 t -70.04 -26.48 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 110.25 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.92 -35.97 76.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.377 -0.827 . . . . 0.0 110.68 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 m -108.54 10.26 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 65.9 p -141.05 147.25 46.93 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.301 -0.875 . . . . 0.0 109.306 178.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.78 6.29 2.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.9 1.067 . . . . 0.0 112.067 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.32 155.9 40.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.813 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.8 p -134.54 149.85 50.69 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 91.8 m-85 -125.98 155.13 41.88 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.468 -0.77 . . . . 0.0 109.433 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.416 ' HG1' ' C ' ' A' ' 49' ' ' PHE . 19.5 m -151.65 137.25 17.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.329 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.36 137.02 37.82 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -121.57 134.34 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.362 -0.836 . . . . 0.0 109.16 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 t -97.47 -6.02 34.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.344 -0.848 . . . . 0.0 110.624 -179.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -144.19 153.32 41.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.83 165.57 33.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -81.09 147.3 30.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -1.17 . . . . 0.0 108.972 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.77 17.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.73 -38.66 82.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.196 -0.94 . . . . 0.0 108.946 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -116.4 118.3 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.673 0.749 . . . . 0.0 109.833 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.43 129.64 46.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.335 -0.853 . . . . 0.0 109.737 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.46 130.63 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.1 p -148.43 161.2 42.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.0 -1.062 . . . . 0.0 110.582 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.08 140.01 48.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 173.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.134 -0.979 . . . . 0.0 111.003 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -138.15 141.93 40.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.518 -0.739 . . . . 0.0 110.481 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.49 -140.09 2.24 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.57 130.33 40.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.425 -1.044 . . . . 0.0 109.421 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.516 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 12.1 p-80 -136.91 60.44 1.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.519 -0.738 . . . . 0.0 110.315 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 52.45 51.16 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.543 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 72' ' ' SER . 11.9 t70 -144.36 160.09 41.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.219 -0.926 . . . . 0.0 109.337 -179.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -88.96 9.89 23.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 108.74 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 40.3 t -134.17 73.78 69.08 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.537 -0.727 . . . . 0.0 109.318 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.77 145.08 45.27 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.057 1.171 . . . . 0.0 111.88 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.2 142.56 45.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.103 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -102.42 65.63 0.95 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.299 -0.876 . . . . 0.0 109.665 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.3 -166.6 41.39 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.09 -20.02 17.65 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.226 1.284 . . . . 0.0 111.998 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.69 173.77 43.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.38 -163.73 26.53 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -73.9 152.31 40.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.419 -1.048 . . . . 0.0 109.974 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -91.86 -17.0 25.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.03 171.26 7.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.432 -0.793 . . . . 0.0 109.053 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.56 121.97 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.7 173.3 9.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.616 -0.678 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.65 158.54 17.96 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.591 -0.693 . . . . 0.0 109.241 179.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -58.82 145.8 77.6 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.135 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.09 96.5 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.776 0.984 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.91 173.49 36.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.318 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -65.1 -174.1 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.92 1.08 . . . . 0.0 111.705 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.38 -134.11 50.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.24 -12.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -1.124 . . . . 0.0 110.313 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.88 144.22 44.68 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.7 -12.67 66.43 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.38 160.83 28.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -1.156 . . . . 0.0 109.979 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.72 115.56 9.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -100.13 142.53 31.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -122.04 134.88 54.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.557 -0.715 . . . . 0.0 109.275 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.8 119.46 13.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -95.14 -0.27 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.83 -18.46 60.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 109.781 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 162.58 13.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.228 -0.92 . . . . 0.0 108.927 179.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -87.21 119.15 27.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -87.44 140.12 29.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.038 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 54.3 p -128.78 166.33 19.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.495 -0.753 . . . . 0.0 109.735 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.73 31.05 6.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.62 -0.675 . . . . 0.0 109.258 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.514 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -148.46 -162.73 1.62 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.956 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -81.11 34.24 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.423 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.481 ' CG ' HD22 ' A' ' 106' ' ' ASN . 10.6 mmt-85 -76.77 -166.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.129 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -50.27 -57.14 8.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.596 -0.69 . . . . 0.0 111.991 -178.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.451 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.3 m-85 -119.94 140.16 51.34 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.136 -0.977 . . . . 0.0 111.494 -177.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 21.4 m120 -108.32 118.49 36.9 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.99 -42.01 85.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.18 -0.95 . . . . 0.0 110.682 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -59.95 -42.09 93.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.054 -1.029 . . . . 0.0 110.935 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 143' ' ' SER . 82.8 mtt180 -59.84 -40.87 89.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 109.968 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 62.6 t -70.33 -40.09 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 108.789 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.23 80.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.004 -1.06 . . . . 0.0 108.943 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.06 -35.01 79.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.956 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.456 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.5 t-160 -69.99 -56.22 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.857 -1.152 . . . . 0.0 109.948 -179.479 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 7.0 mp0 -57.73 -39.92 78.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.951 -1.093 . . . . 0.0 109.677 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.94 -39.74 90.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.276 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.86 95.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -63.47 -33.66 76.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -1.091 . . . . 0.0 108.8 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -68.83 -25.31 64.59 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.4 mt -84.58 -6.27 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 0.0 109.431 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.14 19.53 52.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.37 134.81 34.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.866 -1.373 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.8 m -87.55 168.29 13.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.4 159.14 32.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.453 ' HG ' ' H ' ' A' ' 131' ' ' ASP . 33.9 t -132.35 157.82 43.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.072 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 10.15 41.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.312 -0.867 . . . . 0.0 109.883 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 129' ' ' SER . 61.7 t0 -82.04 128.51 34.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 109.293 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.76 -27.67 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 110.463 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.15 -4.79 88.04 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.413 -179.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.35 132.34 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.671 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.84 -27.46 65.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 109.421 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.6 mtp -75.72 45.39 0.32 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.826 -179.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -69.94 135.54 87.52 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -47.07 -68.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 119.861 0.986 . . . . 0.0 112.545 179.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -85.14 174.05 9.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.017 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -84.59 136.62 33.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.921 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.7 p -145.76 159.46 43.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.182 -0.948 . . . . 0.0 109.444 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.13 127.37 32.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.502 ' H ' ' NH1' ' A' ' 114' ' ' ARG . 32.0 t -117.05 122.7 44.93 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.491 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.1 -95.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.71 141.51 31.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -1.133 . . . . 0.0 109.718 -179.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t -89.12 107.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.248 -0.907 . . . . 0.0 109.737 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.88 153.98 41.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.259 -0.9 . . . . 0.0 109.478 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.06 149.46 39.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 108.71 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.76 161.32 14.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -60.03 -39.82 87.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -58.59 -40.34 82.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.482 -0.761 . . . . 0.0 109.706 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.55 -40.14 66.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.747 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.81 -49.69 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.67 -40.21 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.182 -0.949 . . . . 0.0 109.868 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -57.53 12.76 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.911 -178.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.15 -39.98 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.308 . . . . 0.0 109.941 -179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -63.13 -39.58 95.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.028 -1.045 . . . . 0.0 109.175 179.399 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.57 94.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.22 -52.06 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.743 -1.223 . . . . 0.0 109.392 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -96.1 -70.9 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.11 -170.07 39.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -92.98 141.72 28.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -1.156 . . . . 0.0 109.721 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.7 m -75.11 85.29 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -98.41 91.85 5.39 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.23 -0.919 . . . . 0.0 109.635 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -157.5 153.17 22.55 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.069 -1.02 . . . . 0.0 109.257 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -79.03 91.58 1.19 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.584 0.887 . . . . 0.0 111.553 178.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.5 m -85.28 139.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 110.28 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.441 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 12.5 mm100 -63.28 -58.79 14.23 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 111.029 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 168' ' ' GLN . 1.1 Cg_endo . . . . . 0 N--CA 1.493 1.494 0 CA-C-N 120.255 1.127 . . . . 0.0 112.107 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' CGS . . . . . 0.537 HG11 ' C5 ' ' A' ' 173' ' ' CGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -81.7 119.63 24.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.038 -1.039 . . . . 0.0 108.68 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -82.43 -11.5 58.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.68 151.03 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.81 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.4 p -94.81 -3.99 47.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -129.2 144.02 51.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -133.39 158.5 42.88 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.39 -0.819 . . . . 0.0 109.91 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.3 p -128.71 150.02 50.45 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.18 159.41 42.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 0.0 109.578 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -150.7 130.5 13.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.0 109.74 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.21 122.54 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.309 -0.87 . . . . 0.0 108.858 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.83 -40.08 83.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.477 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -161.74 159.45 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.857 -1.152 . . . . 0.0 110.212 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -100.12 138.19 37.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -69.53 139.77 89.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 108.983 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -66.31 -12.13 34.33 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.601 0.893 . . . . 0.0 111.309 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.02 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.387 -0.821 . . . . 0.0 108.976 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -138.04 149.93 65.56 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.88 -170.97 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 120.795 0.997 . . . . 0.0 112.094 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' NH2' ' OD2' ' A' ' 31' ' ' ASP . 6.6 ptm180 -88.51 -31.81 18.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.11 -47.38 78.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.975 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.96 -43.96 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -0.976 . . . . 0.0 110.092 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 87.3 m-20 -59.28 -41.68 89.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.12 . . . . 0.0 109.267 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -60.06 -49.03 79.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.46 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.4 92.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.29 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.05 -40.05 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 0.0 109.725 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.16 -41.02 74.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.818 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.73 -39.74 92.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -46.18 86.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.074 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.884 -1.135 . . . . 0.0 109.261 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.412 HE21 ' HG2' ' A' ' 35' ' ' GLU . 80.3 mt-30 -60.01 -41.2 91.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 110.232 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -41.39 91.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.022 -1.049 . . . . 0.0 109.889 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -72.57 -42.29 64.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.335 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -69.93 -30.82 68.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 110.249 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.61 -31.99 68.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 111.168 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 33.3 m -110.03 9.99 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.084 -1.01 . . . . 0.0 111.009 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 70.4 p -143.25 148.28 43.88 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 120.925 -1.109 . . . . 0.0 109.292 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.78 10.5 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 120.64 0.894 . . . . 0.0 111.196 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.58 151.5 44.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.515 -0.741 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 p -129.8 140.91 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.64 157.7 27.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.571 -0.705 . . . . 0.0 109.38 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -154.59 125.74 7.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 109.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -78.38 133.53 37.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.373 -0.83 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.9 135.89 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.579 -0.701 . . . . 0.0 109.261 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -96.22 -2.0 47.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 109.994 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -146.35 156.39 43.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.966 -1.084 . . . . 0.0 109.587 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.98 164.52 34.05 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -80.45 131.48 35.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.291 . . . . 0.0 108.594 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.81 155.19 16.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.22 -0.925 . . . . 0.0 109.846 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 109.602 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -120.01 113.06 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.44 -0.788 . . . . 0.0 109.062 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.03 133.6 44.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.113 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.7 mt -116.04 130.03 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.557 -0.714 . . . . 0.0 109.334 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.1 p -150.15 155.17 39.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.39 137.67 41.18 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.78 160.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.264 -0.897 . . . . 0.0 111.264 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -130.51 143.47 50.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.318 0.58 . . . . 0.0 109.528 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.88 -142.74 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -76.49 130.14 37.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.482 -1.01 . . . . 0.0 110.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.583 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 3.2 p-80 -130.56 54.14 1.91 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 57.45 49.99 12.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 109.818 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 8.4 m-20 -142.79 162.0 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 0.0 109.033 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -90.46 9.66 28.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.631 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.7 71.62 64.25 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.997 -1.064 . . . . 0.0 110.668 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.47 149.92 56.92 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.201 1.268 . . . . 0.0 111.828 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -77.45 142.98 38.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.592 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -108.01 65.5 0.64 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.45 -0.781 . . . . 0.0 109.353 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.44 -167.54 54.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.97 -8.52 4.75 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.2 1.267 . . . . 0.0 112.079 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.14 176.48 42.18 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 -164.27 41.17 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -75.27 159.65 31.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.219 -1.165 . . . . 0.0 109.786 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.67 -18.18 21.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.363 -0.836 . . . . 0.0 109.851 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.34 169.41 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.965 . . . . 0.0 108.872 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.6 177.75 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.081 . . . . 0.0 109.799 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.3 177.91 7.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.325 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.67 154.65 21.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.512 -0.743 . . . . 0.0 109.281 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 86' ' ' GLN . 5.1 mp0 -58.59 149.99 59.04 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.182 -0.949 . . . . 0.0 108.802 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -60.72 107.42 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.575 0.85 . . . . 0.0 112.047 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.11 173.24 41.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.59 176.98 2.44 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.091 1.194 . . . . 0.0 112.121 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.11 -131.93 33.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.51 -12.72 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -1.062 . . . . 0.0 109.788 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.38 142.94 42.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.29 -21.49 37.49 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.52 153.35 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -1.17 . . . . 0.0 109.946 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.64 122.69 10.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 109.062 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -104.89 152.13 23.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.459 -0.776 . . . . 0.0 110.11 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 20.8 m-85 -119.91 139.64 52.1 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -66.55 119.81 12.33 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -98.51 2.3 47.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.55 -22.38 59.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.156 -0.965 . . . . 0.0 109.752 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -100.69 155.31 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.271 -0.893 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -85.21 128.07 34.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.031 -1.043 . . . . 0.0 109.251 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -89.6 145.86 24.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 109.785 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.1 p -129.87 166.41 20.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.576 -0.703 . . . . 0.0 109.708 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.41 30.3 6.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.555 -0.715 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 4.7 p30 -150.02 -164.24 1.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 31.76 0.43 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 108' ' ' ARG . 44.7 mtt-85 -75.91 -157.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.602 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -39.78 -59.66 1.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 111.389 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -135.08 151.21 50.53 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 67.1 m-20 -103.59 115.04 29.77 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.13 -43.92 90.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.053 -1.029 . . . . 0.0 110.736 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -60.01 -42.32 94.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 0.0 110.239 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -59.91 -40.53 89.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.997 . . . . 0.0 109.796 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.82 -41.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.996 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.93 92.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.018 -1.051 . . . . 0.0 109.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.75 88.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 0.0 109.204 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -68.33 -44.7 74.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.414 -0.804 . . . . 0.0 109.72 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 74.7 mt-10 -60.03 -39.93 87.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 109.437 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.69 -40.01 90.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 108.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.87 -41.84 84.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.27 -39.95 93.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 108.701 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.6 m -70.19 -27.27 64.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.82 -1.53 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.171 -0.955 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.12 9.93 69.67 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.28 123.61 30.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.939 -1.33 . . . . 0.0 109.181 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.9 m -88.2 176.23 7.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.97 155.38 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -131.17 168.38 17.56 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.1 p -101.82 10.52 39.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.379 -0.826 . . . . 0.0 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.43 129.52 34.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.33 -40.02 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 110.641 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 0.19 77.54 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.985 -1.103 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 129.52 34.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.655 -1.497 . . . . 0.0 109.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 137' ' ' TYR . 88.0 mt -69.21 -24.28 64.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -71.44 45.58 0.11 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 135' ' ' LEU . 5.4 t80 -70.03 129.78 90.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -48.57 -71.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.192 1.104 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.4 p -80.92 170.0 16.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 109.597 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.8 t80 . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 109.197 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.417 0.627 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -146.43 152.29 38.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.079 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.52 142.98 42.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 109.043 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 166.57 12.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.178 -0.951 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.371 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -59.9 -40.3 88.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.517 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -73.07 -40.05 65.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 0.0 109.522 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.05 -50.07 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.76 -39.87 93.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.988 -1.07 . . . . 0.0 109.866 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.45 -57.49 19.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.222 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -65.99 -40.08 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.793 -1.416 . . . . 0.0 110.007 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.09 -39.95 90.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.88 96.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.01 -50.06 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.895 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -99.56 -64.86 1.0 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.5 -179.11 38.78 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -89.97 149.87 22.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -1.197 . . . . 0.0 109.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.43 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 21.5 m . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 8' ' ' ARG . 43.7 mtt-85 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -82.41 120.44 25.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.061 -1.024 . . . . 0.0 109.591 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -83.87 -13.89 52.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 109.598 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.98 149.22 28.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.912 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -95.03 -3.9 47.49 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 67.0 m80 -125.3 134.49 52.23 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.9 151.48 50.42 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.872 . . . . 0.0 109.221 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -120.97 155.91 33.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 109.221 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -145.19 159.22 43.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -150.77 133.81 16.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.089 -1.007 . . . . 0.0 110.07 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.5 mt -90.84 120.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.96 -40.11 91.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.991 -1.068 . . . . 0.0 110.882 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.9 149.58 14.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.713 -1.242 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -95.22 132.85 39.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -71.05 143.23 88.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.691 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.72 -9.91 24.6 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.789 0.993 . . . . 0.0 112.625 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.97 -39.97 87.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.086 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -137.83 149.69 65.27 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.64 179.8 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.667 0.911 . . . . 0.0 111.916 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -86.58 -31.43 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.71 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -70.42 -40.07 74.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 110.499 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -40.82 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.546 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.02 -40.46 89.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.34 -45.04 94.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.342 -0.849 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.81 91.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.31 -40.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.695 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -69.92 -40.1 75.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.415 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -61.82 -40.01 93.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.292 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.63 91.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.035 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -60.47 -40.21 90.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.918 -1.114 . . . . 0.0 108.881 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -59.97 -41.47 92.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.792 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.32 -41.3 93.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.104 -0.997 . . . . 0.0 110.458 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -74.76 -42.11 58.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.985 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -68.71 -34.8 76.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 110.407 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.27 -32.24 69.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.269 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.616 HG23 HG23 ' A' ' 45' ' ' THR . 17.3 m -109.79 11.7 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.049 -1.032 . . . . 0.0 110.761 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 44' ' ' VAL . 52.0 p -143.01 149.27 48.62 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.911 -1.118 . . . . 0.0 109.472 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -73.68 3.88 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.538 0.826 . . . . 0.0 111.723 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 157.88 37.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 109.657 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.478 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.6 p -133.41 151.77 51.85 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.19 154.36 46.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.536 -0.727 . . . . 0.0 109.619 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.2 m -154.01 131.15 11.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -77.87 135.59 37.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.765 . . . . 0.0 109.082 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.17 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.313 -0.867 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 t -99.1 11.66 38.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.482 -0.761 . . . . 0.0 109.835 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.07 153.7 42.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.076 -1.015 . . . . 0.0 109.183 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 168.32 1.44 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -82.05 147.49 29.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 109.011 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.35 160.01 14.78 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.15 -40.06 88.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.34 119.32 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.396 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.1 mtp -103.58 134.3 47.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.523 -0.736 . . . . 0.0 109.767 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -119.68 126.83 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 0.0 109.283 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.9 p -149.69 156.09 41.29 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -103.13 140.78 36.89 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 68' ' ' HIS . 26.1 m -138.95 169.77 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 120.945 -1.097 . . . . 0.0 110.818 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -138.08 149.26 45.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.713 -0.617 . . . . 0.0 110.147 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.91 -146.52 2.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -70.07 129.97 40.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -1.08 . . . . 0.0 110.296 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.1 p-80 -137.98 55.82 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.699 -0.626 . . . . 0.0 109.39 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 85.0 mtm180 57.24 48.96 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 109.79 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -142.47 158.25 43.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.347 -0.845 . . . . 0.0 109.156 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.96 8.61 34.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -134.5 72.48 69.96 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.342 -0.849 . . . . 0.0 109.752 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.95 148.46 35.54 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.312 1.341 . . . . 0.0 112.682 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -76.4 146.19 38.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.776 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.57 75.2 1.53 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.153 -0.967 . . . . 0.0 110.123 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 -178.75 44.15 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.67 -6.4 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 120.746 0.964 . . . . 0.0 110.999 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.25 43.89 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.69 -173.74 47.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -73.28 151.13 41.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -1.146 . . . . 0.0 109.089 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt -90.91 -13.39 33.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.24 163.41 8.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 108.909 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -161.46 179.72 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.836 -1.165 . . . . 0.0 110.211 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.83 174.13 10.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.4 155.72 17.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.376 -0.827 . . . . 0.0 108.995 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -59.56 149.02 72.56 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.279 -0.888 . . . . 0.0 108.836 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.97 100.19 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 120.503 0.802 . . . . 0.0 111.842 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 171.75 35.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.94 -169.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.422 1.415 . . . . 0.0 112.144 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.2 -131.38 51.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.03 -9.99 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -1.014 . . . . 0.0 109.796 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.94 147.33 26.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -23.01 36.19 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 121.268 -1.136 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -67.45 154.89 40.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.352 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.1 123.08 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -105.15 147.54 27.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.368 -0.833 . . . . 0.0 110.283 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -119.72 133.96 55.42 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -66.9 122.33 17.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.143 -0.973 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -95.94 -2.62 46.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.032 -1.043 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -76.07 -13.85 60.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.959 -1.088 . . . . 0.0 109.238 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -93.84 152.68 18.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -0.811 . . . . 0.0 109.107 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -86.5 115.07 23.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 108.704 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -91.97 144.6 25.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 110.125 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 p -129.35 174.13 9.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.2 22.38 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.416 -0.803 . . . . 0.0 109.492 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.741 HD22 ' NE ' ' A' ' 108' ' ' ARG . 20.1 p30 -151.02 -166.4 2.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -0.921 . . . . 0.0 109.887 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.76 29.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.201 -0.937 . . . . 0.0 110.621 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.741 ' NE ' HD22 ' A' ' 106' ' ' ASN . 45.6 mtt-85 -76.16 -159.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.025 . . . . 0.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 108' ' ' ARG . 77.8 mm-40 -32.16 -60.4 0.27 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.815 -0.553 . . . . 0.0 111.819 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -137.92 139.08 39.61 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.089 -1.007 . . . . 0.0 110.041 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -105.9 119.53 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.354 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -67.25 -39.93 86.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.07 -42.68 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.603 -1.311 . . . . 0.0 110.325 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.45 -39.78 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.902 -1.124 . . . . 0.0 109.595 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.6 93.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.46 94.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.034 -1.042 . . . . 0.0 109.891 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.05 -47.31 68.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.97 -39.95 75.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 109.493 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.53 -39.52 91.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 108.798 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.11 90.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -62.69 -40.01 95.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -1.232 . . . . 0.0 109.369 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -70.93 -23.49 62.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.236 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.39 -3.82 58.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.161 -0.962 . . . . 0.0 109.044 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.65 16.79 72.29 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.918 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.57 129.17 34.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.876 -1.367 . . . . 0.0 108.95 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 m -88.06 168.66 12.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.038 . . . . 0.0 109.54 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.73 159.99 31.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.6 t -130.22 168.84 16.21 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -103.05 10.06 38.23 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.316 -0.865 . . . . 0.0 109.618 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.39 128.5 33.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.06 -1.025 . . . . 0.0 109.176 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -40.09 81.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.586 -0.696 . . . . 0.0 110.55 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.57 1.61 65.98 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.601 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 136.48 34.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.614 -1.521 . . . . 0.0 109.61 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.1 -26.38 64.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.4 mmm -75.23 52.12 0.57 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.0 t80 -70.17 137.25 86.86 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.954 . . . . 0.0 109.087 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.91 4.63 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 CA-C-N 119.847 0.981 . . . . 0.0 112.184 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.8 p -160.18 176.17 12.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.172 -0.955 . . . . 0.0 109.354 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 120.835 -1.166 . . . . 0.0 109.452 -179.855 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -144.57 160.2 41.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.439 -0.788 . . . . 0.0 108.89 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.24 141.05 45.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 109.354 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.19 156.43 16.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -56.61 -39.04 72.89 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.056 -1.027 . . . . 0.0 108.801 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -55.33 -39.99 70.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.83 -40.02 63.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.174 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.86 -51.35 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.0 109.034 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.17 -40.17 96.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.775 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.07 -53.32 41.15 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.309 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -69.02 -39.69 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.912 -1.346 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.18 -37.97 84.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 109.172 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.9 -50.19 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.793 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -95.31 -69.96 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.16 -0.963 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.61 -168.56 36.12 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 162' ' ' ARG . 30.6 mtm-85 -87.8 150.28 23.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -1.087 . . . . 0.0 108.714 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 108.793 -179.713 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -81.71 125.93 31.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.239 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.7 -16.8 53.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 0.0 109.145 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -82.47 147.44 28.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.2 p -96.08 -4.87 42.12 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -123.38 130.01 52.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.52 150.53 40.09 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -125.63 154.92 41.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.47 159.61 41.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.252 -0.905 . . . . 0.0 109.78 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -148.99 130.31 14.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.385 -0.822 . . . . 0.0 109.318 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.42 127.07 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 108.728 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.88 -40.04 83.61 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -162.91 155.33 18.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.976 -1.077 . . . . 0.0 109.976 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.63 136.32 40.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t -70.49 141.66 88.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.29 -12.65 31.45 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 CA-C-N 119.413 0.826 . . . . 0.0 111.697 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.2 -39.93 88.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 110.5 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -138.38 149.58 63.56 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.062 -1.024 . . . . 0.0 108.39 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.68 -175.93 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.52 0.814 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -85.69 -33.25 21.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.65 74.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.344 -0.847 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.97 -39.99 72.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.13 -42.68 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 109.495 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.6 -44.48 93.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.201 -0.937 . . . . 0.0 109.111 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.21 -46.41 89.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -72.34 -41.05 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.844 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 86.7 tt0 -70.05 -40.89 74.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.966 -1.084 . . . . 0.0 109.751 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -61.35 -35.81 78.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 108.809 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.68 92.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.223 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.2 m-85 -60.19 -40.62 90.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.768 -1.208 . . . . 0.0 109.707 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.479 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -60.69 -39.81 89.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.052 -1.03 . . . . 0.0 110.506 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.67 -46.15 89.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.881 -1.137 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.405 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.6 m95 -71.32 -40.28 70.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.606 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -67.14 -39.16 86.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 111.301 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -56.33 -29.9 61.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.44 11.76 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.867 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.1 p -144.8 150.06 45.17 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.968 -1.083 . . . . 0.0 109.007 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.66 2.22 4.86 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.569 0.846 . . . . 0.0 111.962 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.1 mt -70.74 147.89 48.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.0 p -125.53 149.81 47.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 96.8 m-85 -126.21 152.29 46.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.8 m -153.23 129.92 10.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.899 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -77.08 144.22 38.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.543 -0.723 . . . . 0.0 109.54 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.6 135.4 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 t -95.45 -9.46 32.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -144.23 158.32 43.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.66 172.87 49.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.01 160.88 25.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.592 -0.946 . . . . 0.0 108.958 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.94 52.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.03 -40.6 89.91 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 110.558 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.64 119.91 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.3 mtp -102.22 131.6 48.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -0.798 . . . . 0.0 109.481 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -111.62 131.72 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -145.54 160.1 42.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.092 -1.005 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -116.96 136.65 52.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.23 160.01 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.296 -0.877 . . . . 0.0 110.601 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -126.75 137.14 53.19 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.77 -149.51 1.63 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -66.5 130.29 42.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -1.085 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.522 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.2 p-80 -130.89 47.57 2.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.687 -0.633 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 64.6 mtp180 59.54 51.83 6.19 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.161 0.505 . . . . 0.0 109.912 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.522 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 7.5 m-20 -137.67 167.72 21.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.383 -0.823 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -90.69 8.8 32.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 m -137.0 71.88 55.07 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.802 . . . . 0.0 109.133 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.54 146.55 55.67 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 121.184 1.256 . . . . 0.0 111.697 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.68 148.69 36.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -106.27 70.75 0.85 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.438 -0.789 . . . . 0.0 109.423 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.11 -157.58 2.52 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.28 -19.53 17.08 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 118.571 1.185 . . . . 0.0 112.179 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.2 -177.47 41.9 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.56 -166.93 38.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -72.02 152.02 42.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -1.132 . . . . 0.0 109.845 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.68 -18.01 23.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.62 165.3 8.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -162.85 -179.31 6.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.48 166.47 22.64 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -95.8 159.71 14.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 109.937 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -57.25 150.95 39.43 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.534 -0.729 . . . . 0.0 109.241 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -62.02 104.82 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.501 0.801 . . . . 0.0 112.198 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 174.61 37.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.89 171.57 15.45 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.868 1.045 . . . . 0.0 112.318 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 -126.72 17.38 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -73.88 -13.22 15.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.338 -1.095 . . . . 0.0 109.258 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 144.0 45.48 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.58 18.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.97 126.08 28.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.301 . . . . 0.0 110.197 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.74 129.92 51.18 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -102.46 142.54 33.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.288 -0.883 . . . . 0.0 109.833 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -120.18 136.88 54.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.718 -0.614 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.19 121.15 17.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 109.652 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -97.79 -4.53 36.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.55 -16.02 59.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.02 -1.05 . . . . 0.0 109.135 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -93.24 158.24 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.9 ttm-85 -87.9 115.11 25.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 108.796 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.66 139.83 30.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.5 p -127.54 166.66 17.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.473 -0.767 . . . . 0.0 109.644 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -111.45 33.28 4.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -151.75 -165.97 2.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -84.89 32.01 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.95 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -76.14 -161.66 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.1 -59.23 3.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 111.59 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -121.31 132.25 54.68 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.099 -1.001 . . . . 0.0 111.143 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.13 124.27 49.45 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.98 -39.8 75.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -58.46 -45.33 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 111.224 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.2 -44.27 95.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.28 . . . . 0.0 110.526 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.48 -41.05 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.019 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.16 93.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.061 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.22 86.34 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.647 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 56.0 t60 -70.06 -41.59 73.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 110.072 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -58.25 -42.06 85.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.058 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.42 -40.09 93.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 108.942 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.29 -40.08 83.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.647 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 20.5 m-70 -66.12 -34.91 79.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -1.206 . . . . 0.0 109.106 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.0 t -69.09 -29.05 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.57 -4.99 57.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.5 19.14 57.41 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.073 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.25 130.11 34.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.823 -1.398 . . . . 0.0 109.094 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 m -86.98 167.47 14.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 109.106 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -63.88 159.75 19.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -128.05 166.82 17.69 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.615 -0.678 . . . . 0.0 109.418 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -107.75 9.1 29.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 11.7 t70 -81.73 129.24 34.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.09 -39.47 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -74.75 -3.22 66.82 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.048 -1.033 . . . . 0.0 111.475 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 137.21 33.54 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.714 -1.462 . . . . 0.0 110.428 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.53 -27.55 65.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 0.0 108.961 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -76.64 58.67 1.42 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.864 . . . . 0.0 109.865 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -71.83 132.15 85.24 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.33 -68.18 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.211 0 CA-C-N 120.198 1.106 . . . . 0.0 111.057 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.0 p -86.33 175.29 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.42 -0.8 . . . . 0.0 109.773 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 108.444 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.436 0.636 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.49 150.55 39.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 143.72 40.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.825 -1.172 . . . . 0.0 109.298 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.84 156.43 19.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.04 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.75 -40.06 86.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 151' ' ' ASP . 48.6 t0 -58.76 -40.34 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.75 -40.2 66.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.585 -1.322 . . . . 0.0 109.205 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.51 -48.13 88.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.923 -1.111 . . . . 0.0 110.473 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.94 38.17 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 121.037 -1.039 . . . . 0.0 111.619 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.28 -38.75 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.83 -1.394 . . . . 0.0 109.549 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -64.41 -39.95 94.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 108.57 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.99 97.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.0 109.293 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.38 -50.09 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.037 -1.039 . . . . 0.0 109.593 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -100.66 -67.79 0.84 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.352 -0.843 . . . . 0.0 109.144 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.29 -169.77 34.91 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.11 152.33 22.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.243 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.402 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.452 0.644 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -84.36 124.87 31.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.323 -0.861 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.71 -12.68 59.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.884 -1.135 . . . . 0.0 110.63 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 19.2 pt20 -86.86 155.96 20.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.88 -1.138 . . . . 0.0 109.428 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -96.58 -4.2 41.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.071 -1.018 . . . . 0.0 109.672 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -117.75 130.94 56.62 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 HE21 ' A' ' 11' ' ' GLN . 73.2 mt -118.95 154.21 33.37 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.3 p -128.92 153.17 47.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.272 -0.892 . . . . 0.0 108.698 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.16 162.07 37.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.079 -1.013 . . . . 0.0 109.49 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 17' ' ' ARG . 16.6 ttt-85 -146.98 136.77 23.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 0.0 110.395 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 86.1 mt -89.33 111.47 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.6 tp10 -64.58 -38.78 92.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.486 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 61.5 m-80 -156.64 146.49 20.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.099 . . . . 0.0 110.264 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.76 138.98 32.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR . 9.7 t -70.01 134.95 87.43 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.085 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -64.11 -13.73 39.44 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 120.017 1.042 . . . . 0.0 111.533 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.873 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.2 mt -134.75 149.57 71.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.69 -175.53 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 120.708 0.938 . . . . 0.0 111.978 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -88.16 -35.58 17.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.12 79.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.566 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.12 -39.98 68.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.204 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.6 t -68.9 -40.84 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.142 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -40.11 88.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 108.824 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -56.7 -50.38 72.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 109.426 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.51 92.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 110.333 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.0 mm -69.94 -39.09 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.083 -1.011 . . . . 0.0 109.762 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.29 -41.44 89.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -63.28 -39.92 95.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.962 -1.087 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.88 75.72 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.803 -1.185 . . . . 0.0 109.206 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 38.1 m-85 -60.97 -40.78 94.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 109.159 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 19.2 mm100 -60.27 -43.23 96.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.97 -41.42 91.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.964 -1.085 . . . . 0.0 110.28 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.5 m95 -74.28 -41.28 61.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.704 -1.247 . . . . 0.0 110.028 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.1 -30.41 69.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 85.0 m-20 -58.82 -32.91 69.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.282 -0.886 . . . . 0.0 111.22 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.55 8.26 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.3 p -143.83 148.87 44.25 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.915 -1.116 . . . . 0.0 109.843 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.66 6.58 1.55 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.015 1.143 . . . . 0.0 111.655 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.7 mt -70.24 152.25 44.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.382 -0.823 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -130.31 150.92 51.33 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 95.3 m-85 -125.86 157.15 38.34 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.5 -0.75 . . . . 0.0 109.952 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.7 m -154.89 126.98 7.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.392 -0.817 . . . . 0.0 109.866 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.585 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 64.2 tttp -81.37 139.73 35.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 136.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.477 -0.764 . . . . 0.0 109.012 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -95.3 -0.75 52.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.116 -0.99 . . . . 0.0 109.148 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -149.36 159.21 44.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.391 -0.818 . . . . 0.0 109.419 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.25 164.69 36.58 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.41 139.24 39.65 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -1.166 . . . . 0.0 108.075 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.34 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 109.439 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 93.5 m-20 -60.17 -40.71 90.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.462 -0.774 . . . . 0.0 110.006 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.03 118.56 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.83 123.58 45.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 108.956 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -113.04 129.96 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.471 -0.768 . . . . 0.0 109.035 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -146.34 152.61 39.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 109.728 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.58 138.12 40.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.1 162.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.984 . . . . 0.0 110.818 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.11 152.63 51.92 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.39 -151.74 0.62 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.49 130.2 41.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.957 . . . . 0.0 110.392 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 17.3 p-80 -135.63 49.27 2.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.493 -0.754 . . . . 0.0 109.073 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 55.07 56.95 5.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.5 t0 -142.52 160.28 40.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.326 -0.859 . . . . 0.0 108.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 50.5 t30 -88.93 7.53 34.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.084 -1.01 . . . . 0.0 110.047 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 72.4 m -136.11 71.24 62.06 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.0 108.925 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 144.29 75.88 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 120.919 1.079 . . . . 0.0 111.9 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.52 147.97 37.42 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.405 -0.809 . . . . 0.0 109.432 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -128.72 77.1 1.76 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.557 -0.714 . . . . 0.0 109.659 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.19 -174.27 26.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.42 -5.15 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.105 1.203 . . . . 0.0 112.392 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.76 179.19 44.29 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.81 -165.94 49.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.45 151.05 42.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.967 . . . . 0.0 109.412 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.3 mt -91.08 -17.56 26.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.42 164.67 8.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.016 -1.053 . . . . 0.0 109.85 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -160.37 177.32 10.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.266 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.87 174.7 9.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.201 -0.937 . . . . 0.0 109.766 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -109.05 153.26 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.645 -0.659 . . . . 0.0 109.897 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.93 151.57 64.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -58.01 104.85 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 120.956 1.104 . . . . 0.0 112.196 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.22 171.41 37.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.81 173.06 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.466 1.444 . . . . 0.0 111.81 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 -127.72 29.44 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.451 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.19 -7.1 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.604 -0.939 . . . . 0.0 110.234 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.31 47.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.3 -21.52 28.03 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 121.246 -1.149 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.33 156.1 35.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -1.197 . . . . 0.0 110.69 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 121.51 11.49 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.6 142.89 29.61 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.211 -0.931 . . . . 0.0 110.88 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.512 ' CE2' ' OE1' ' A' ' 119' ' ' GLU . 26.6 m-85 -119.96 134.59 55.2 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.73 116.58 8.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.493 -0.755 . . . . 0.0 109.025 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -99.58 2.26 44.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.14 -14.85 60.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.57 161.86 13.32 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.5 117.82 26.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -93.1 149.5 21.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.749 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.8 p -127.56 166.58 17.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.62 31.41 6.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.621 -0.674 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.466 HD22 ' HG3' ' A' ' 108' ' ' ARG . 14.4 p30 -149.91 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.088 -1.007 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 53.3 t80 -81.11 33.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.466 ' HG3' HD22 ' A' ' 106' ' ' ASN . 18.2 mmm180 -76.58 -165.91 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.071 -1.018 . . . . 0.0 110.351 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -59.66 -56.99 14.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 0.0 111.794 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -93.62 125.14 38.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 110.223 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -104.42 104.57 14.46 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -70.02 -39.99 75.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -59.63 -47.43 85.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.908 -1.12 . . . . 0.0 110.781 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 110.548 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 59.5 t -69.76 -41.54 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.876 -1.14 . . . . 0.0 109.608 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.6 86.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.04 92.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.077 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.755 ' HE2' ' CE1' ' A' ' 122' ' ' HIS . 5.6 t60 -68.32 -43.93 76.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 110.726 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.512 ' OE1' ' CE2' ' A' ' 97' ' ' PHE . 5.5 mp0 -59.51 -40.69 87.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.597 -1.315 . . . . 0.0 109.633 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.12 -39.99 92.09 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.971 -1.081 . . . . 0.0 108.45 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.06 -41.97 98.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.755 ' CE1' ' HE2' ' A' ' 118' ' ' HIS . 4.2 m-70 -64.2 -36.21 83.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.019 -1.283 . . . . 0.0 108.653 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.4 t -69.96 -22.79 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.346 -0.846 . . . . 0.0 108.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.82 -3.75 58.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.09 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.11 21.27 55.66 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 120.401 -0.905 . . . . 0.0 110.932 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.72 135.92 34.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.38 . . . . 0.0 109.684 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.1 m -88.74 166.87 13.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.375 -0.828 . . . . 0.0 110.145 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -68.01 161.94 25.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.5 t -125.7 160.96 28.37 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.41 -0.806 . . . . 0.0 109.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 82.5 p -99.99 9.39 42.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.7 t0 -83.3 130.18 35.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt -62.01 -40.42 87.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 111.12 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.14 65.87 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.959 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.34 130.09 35.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.746 -1.444 . . . . 0.0 109.498 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.12 -34.34 73.38 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.9 mmm -72.31 44.95 0.12 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.793 -0.567 . . . . 0.0 110.894 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -69.29 139.95 90.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.6 -55.84 3.61 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 120.216 1.113 . . . . 0.0 111.484 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 140' ' ' TYR . 9.3 t -100.34 176.12 5.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.408 ' N ' ' OG ' ' A' ' 139' ' ' SER . 65.0 t80 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 109.37 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.429 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 57.6 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.55 0.69 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -150.41 149.44 30.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.426 HD22 ' CH2' ' A' ' 41' ' ' TRP . 69.4 mt -76.79 148.77 36.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.693 -1.254 . . . . 0.0 109.225 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.02 159.72 15.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.052 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 108.914 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -58.19 -40.0 80.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.257 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.23 -41.83 60.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.31 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.17 -49.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.852 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.813 -1.179 . . . . 0.0 109.259 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -57.89 16.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.95 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -64.55 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.86 -1.376 . . . . 0.0 110.08 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.74 -40.05 88.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.004 . . . . 0.0 109.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.32 96.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 109.674 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.87 -50.23 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.95 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.35 -64.25 1.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.271 -0.893 . . . . 0.0 109.752 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.03 170.9 30.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 162' ' ' ARG . 46.4 mtt-85 -90.24 138.01 31.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.0 109.373 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--N 1.303 -1.452 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.461 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -84.07 133.38 34.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 108.993 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.56 -36.6 60.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.043 -1.035 . . . . 0.0 110.377 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.413 HE21 HD23 ' A' ' 14' ' ' LEU . 20.3 pt20 -80.01 155.29 27.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.02 -1.05 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -95.18 -2.73 49.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -111.62 135.51 52.11 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD23 HE21 ' A' ' 11' ' ' GLN . 68.5 mt -134.48 159.92 39.63 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.211 -0.93 . . . . 0.0 109.515 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.2 p -130.91 152.9 49.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.615 -0.678 . . . . 0.0 109.24 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.49 158.41 43.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.469 HH12 ' HA ' ' A' ' 54' ' ' GLU . 69.6 ttt180 -150.73 137.06 18.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 0.0 109.244 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.67 122.09 42.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.53 -40.11 95.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.618 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -160.01 158.43 30.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.293 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.54 133.98 44.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.366 -0.834 . . . . 0.0 109.28 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -70.99 143.66 89.2 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.95 -10.85 24.44 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 CA-C-N 119.728 0.938 . . . . 0.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.17 -40.04 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.893 . . . . 0.0 110.263 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.7 mt -139.54 150.12 62.42 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.4 Cg_endo -60.46 -174.77 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 120.77 0.98 . . . . 0.0 112.331 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -89.45 -37.13 15.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.96 94.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -71.36 -37.43 71.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.879 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' PRO . 51.7 t -69.7 -40.45 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -59.98 -41.68 92.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.557 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -60.45 -45.27 94.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.536 -0.727 . . . . 0.0 109.32 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.75 -44.98 93.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.157 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.33 -41.74 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.584 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.95 -39.7 75.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.014 -1.054 . . . . 0.0 109.927 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.99 -39.3 85.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.34 94.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 109.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.9 m-85 -60.95 -39.77 90.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.077 -1.014 . . . . 0.0 109.381 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.85 -39.89 86.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 40' ' ' LEU . 91.0 mt -60.08 -42.17 94.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -71.35 -42.92 67.9 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.353 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.8 t -69.86 -25.23 63.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.404 -0.81 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.083 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 45' ' ' THR . 19.6 m -109.33 10.88 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.164 -0.96 . . . . 0.0 110.873 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.639 HG23 HG23 ' A' ' 44' ' ' VAL . 38.1 p -139.95 143.3 33.81 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.002 -1.061 . . . . 0.0 109.505 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.47 13.49 0.44 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.182 1.254 . . . . 0.0 111.746 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.66 160.54 32.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 108.893 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 p -137.22 149.2 47.03 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.4 154.25 47.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.761 -0.587 . . . . 0.0 109.536 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -153.08 130.05 11.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 109.748 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -81.77 139.87 34.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.14 139.65 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.5 t -99.89 -6.32 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.368 -0.832 . . . . 0.0 110.238 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.5 mt-10 -144.48 156.79 44.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.157 -0.964 . . . . 0.0 108.772 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 169.9 39.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -84.63 139.44 32.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -1.204 . . . . 0.0 109.655 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.2 156.1 17.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.64 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.1 -39.59 86.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.869 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.94 118.6 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.323 -0.86 . . . . 0.0 109.437 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.7 mmm -100.38 133.77 44.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 108.949 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.1 130.72 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.568 -0.708 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.0 p -149.76 167.73 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.588 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.33 137.65 51.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.72 159.84 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.278 -0.889 . . . . 0.0 110.841 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -125.29 135.35 52.4 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.14 -130.65 4.53 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -81.02 129.82 34.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -1.101 . . . . 0.0 109.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 29.4 p-80 -136.44 51.21 2.01 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.41 54.99 5.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.771 -0.581 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.3 p-10 -141.01 170.21 16.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.047 -1.033 . . . . 0.0 109.457 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -91.92 9.64 32.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 t -140.52 74.95 27.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -71.27 139.09 34.41 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.533 1.488 . . . . 0.0 112.17 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.76 148.14 36.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.105 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -133.27 77.19 1.72 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.563 -0.711 . . . . 0.0 109.819 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.52 177.28 42.93 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.065 -1.022 . . . . 0.0 110.747 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -68.83 -23.04 35.73 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.501 1.467 . . . . 0.0 112.312 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.79 -177.56 51.08 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.64 -153.39 27.24 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.57 144.11 44.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.85 -19.93 19.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.43 170.66 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 0.0 109.429 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.57 179.33 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 109.976 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.97 170.0 17.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.71 154.5 19.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.699 . . . . 0.0 109.452 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -60.07 150.54 69.95 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.228 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.44 102.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.563 0.842 . . . . 0.0 111.957 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.18 171.24 33.38 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.83 169.83 15.39 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.033 1.155 . . . . 0.0 111.966 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.98 -123.18 14.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -77.81 -13.1 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.027 . . . . 0.0 109.587 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.08 140.54 44.69 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.59 -17.22 50.59 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -66.26 158.32 29.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.323 -1.104 . . . . 0.0 109.757 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 118.97 6.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.171 -0.956 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.36 145.87 28.34 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.5 -0.75 . . . . 0.0 110.832 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 24.6 m-85 -116.19 139.11 50.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.758 -0.589 . . . . 0.0 109.679 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.85 118.79 10.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 108.489 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -97.38 -1.03 45.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 109.769 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.29 -20.03 59.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.049 -1.032 . . . . 0.0 109.542 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -98.04 162.34 13.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.7 121.33 29.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.815 -1.178 . . . . 0.0 109.056 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -89.13 135.45 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 109.522 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 p -128.82 170.06 13.81 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.0 109.473 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.71 27.12 9.1 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.573 -0.705 . . . . 0.0 110.172 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.593 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 37.0 p-10 -151.9 -167.02 2.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 0.0 110.538 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -59.97 10.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.312 -0.868 . . . . 0.0 111.6 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.529 ' NE ' HD22 ' A' ' 106' ' ' ASN . 96.4 mtt180 -76.24 166.32 23.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.724 -1.235 . . . . 0.0 110.154 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 108' ' ' ARG . 41.3 mp0 -4.89 -76.9 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -131.74 150.98 51.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.204 -0.935 . . . . 0.0 110.416 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 30.1 m120 -99.36 119.99 38.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 tp -65.3 -40.11 93.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.223 -0.923 . . . . 0.0 110.59 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -59.97 -42.18 93.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.6 t -70.12 -41.57 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.4 91.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.35 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.05 88.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.067 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 5.9 t60 -66.81 -45.78 77.26 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.355 -0.841 . . . . 0.0 109.643 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.3 mt-10 -59.72 -39.38 84.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 109.304 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.2 -39.64 90.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.998 . . . . 0.0 109.12 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.85 93.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 7.6 m-70 -67.7 -38.48 83.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 0.0 109.022 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.5 p -70.11 -22.54 63.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.62 -3.35 59.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 109.239 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.97 72.72 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.86 131.23 35.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.345 . . . . 0.0 109.122 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.3 m -88.49 171.34 10.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 109.897 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -66.77 160.02 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.434 -0.791 . . . . 0.0 109.761 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -124.6 168.04 13.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.0 109.137 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.8 p -104.93 3.64 31.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 109.479 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 120.69 26.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.961 . . . . 0.0 109.312 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 tt -55.95 -29.97 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.21 0.74 83.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.681 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.48 135.95 34.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.785 -1.42 . . . . 0.0 109.546 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.14 -27.41 65.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 0.0 108.653 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.8 mmm -79.02 40.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.713 . . . . 0.0 110.033 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -69.88 133.87 88.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 108.982 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -46.91 -67.5 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.805 0.966 . . . . 0.0 112.207 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.5 m -82.63 175.51 10.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.911 -1.118 . . . . 0.0 109.329 -179.874 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -142.28 160.89 39.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.159 -0.963 . . . . 0.0 109.137 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.42 131.74 42.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.029 . . . . 0.0 109.267 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.27 166.45 13.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.541 -0.724 . . . . 0.0 109.157 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.842 . . . . 0.0 108.856 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.35 -39.69 80.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.25 -42.78 59.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.957 -1.089 . . . . 0.0 109.516 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.15 -51.59 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.159 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.4 -39.84 92.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.797 -1.19 . . . . 0.0 110.233 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.44 49.22 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.231 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.19 -37.54 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.305 . . . . 0.0 109.999 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.1 mt-30 -67.59 -40.65 84.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.82 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.09 89.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.131 -0.98 . . . . 0.0 109.484 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.47 -51.04 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.08 . . . . 0.0 109.647 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -98.52 -67.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.097 -1.002 . . . . 0.0 109.953 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.88 -169.25 38.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -96.62 138.49 34.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -1.08 . . . . 0.0 109.243 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.022 -1.049 . . . . 0.0 108.969 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH1' HD13 ' A' ' 159' ' ' ILE . 30.1 mmt180 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -82.75 120.05 25.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.173 -0.954 . . . . 0.0 109.12 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.71 -12.62 55.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.776 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -83.29 150.63 26.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.2 p -95.69 -4.22 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.226 -0.921 . . . . 0.0 108.975 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.55 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 54.3 m-70 -130.57 144.78 51.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -136.12 158.88 43.34 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.8 p -124.24 155.79 37.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.366 -0.834 . . . . 0.0 109.205 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.97 158.42 43.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.787 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.441 HH21 ' CE ' ' A' ' 60' ' ' MET . 44.0 ttp180 -149.88 130.4 13.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.488 -0.757 . . . . 0.0 109.809 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -90.17 115.77 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.85 -39.73 94.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.473 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -159.46 152.62 22.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.791 -1.193 . . . . 0.0 110.701 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -97.93 135.28 39.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -70.04 138.02 87.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.036 . . . . 0.0 109.869 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.31 -12.5 30.75 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 119.619 0.9 . . . . 0.0 111.818 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.16 -39.43 86.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 109.817 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 105' ' ' ASN . 93.9 mt -138.81 150.47 65.67 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.31 -171.77 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.385 0.723 . . . . 0.0 111.794 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -86.5 -37.36 18.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.24 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.87 -40.74 75.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.295 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -70.23 -42.65 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 108.909 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.105 . . . . 0.0 108.998 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.626 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.84 82.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.22 -39.78 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.32 -47.41 79.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.774 -1.203 . . . . 0.0 109.786 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -64.03 -33.64 76.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.788 -1.195 . . . . 0.0 110.075 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.77 -50.98 71.69 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.813 -1.179 . . . . 0.0 109.025 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.4 -40.0 95.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -59.98 -43.34 95.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.8 -44.35 94.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 0.0 110.505 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.56 -40.07 70.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 109.67 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.9 t -69.81 -38.52 76.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -54.68 -30.57 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.201 -0.937 . . . . 0.0 110.898 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 45' ' ' THR . 35.9 m -106.4 11.14 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.204 -0.935 . . . . 0.0 109.842 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 44' ' ' VAL . 81.4 p -142.08 146.21 39.19 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.97 5.38 2.61 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 120.859 1.039 . . . . 0.0 111.577 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -71.73 162.18 29.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.437 -0.79 . . . . 0.0 109.11 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 24.4 p -137.8 150.78 47.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -125.0 155.73 39.22 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.525 -0.734 . . . . 0.0 109.615 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.9 m -153.77 132.39 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -77.57 140.75 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.624 -0.673 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.85 130.56 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.519 -0.738 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -95.56 -3.39 46.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.31 151.0 35.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.126 -0.984 . . . . 0.0 109.469 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.17 168.54 44.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.89 140.28 35.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -1.168 . . . . 0.0 108.956 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.62 148.58 25.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.64 -43.74 93.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.17 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -111.48 110.56 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 109.555 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.441 ' CE ' HH21 ' A' ' 17' ' ' ARG . 85.8 mtp -102.46 124.81 48.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.11 129.97 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 0.0 109.109 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.8 p -146.75 156.25 43.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.084 -1.01 . . . . 0.0 110.222 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -107.02 135.46 48.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.77 159.99 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 55.0 mtt-85 -123.77 138.93 54.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 109.802 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.36 -139.34 1.24 Allowed Glycine 0 N--CA 1.498 2.802 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.87 122.43 19.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.967 . . . . 0.0 109.427 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -135.17 66.29 1.53 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.431 -0.793 . . . . 0.0 109.866 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 53.69 50.34 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.98 . . . . 0.0 108.61 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 13.9 t0 -141.93 157.83 44.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 109.231 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 27.7 m120 -93.78 8.79 39.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.213 -0.929 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -136.81 74.25 51.89 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.203 -0.936 . . . . 0.0 109.286 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.47 147.32 86.81 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.281 1.32 . . . . 0.0 111.991 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.41 136.91 38.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.068 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -103.23 67.42 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.379 -0.826 . . . . 0.0 109.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.11 -175.02 37.73 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -70.57 -10.67 28.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.061 1.174 . . . . 0.0 111.944 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.33 179.55 40.64 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.06 -146.68 21.32 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.38 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 82' ' ' ALA . 13.1 t-20 -73.77 131.89 42.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.47 -1.018 . . . . 0.0 110.292 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.45 -18.23 24.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.061 -1.024 . . . . 0.0 109.157 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.88 164.51 7.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.001 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -161.21 125.47 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.977 -1.077 . . . . 0.0 110.68 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.57 168.26 14.65 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.682 -0.636 . . . . 0.0 109.292 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.02 142.15 35.32 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.41 147.87 56.93 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.939 -1.101 . . . . 0.0 109.334 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.17 123.16 12.58 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.42 0.747 . . . . 0.0 111.65 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -179.34 175.69 47.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -73.95 163.31 37.22 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.857 1.038 . . . . 0.0 111.908 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' GLY . . . 74.05 -147.33 37.79 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 tt -50.14 -8.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -1.07 . . . . 0.0 110.19 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 90' ' ' GLY . . . -60.5 142.27 47.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.79 -16.11 55.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.86 159.62 30.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.395 -1.062 . . . . 0.0 110.125 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.56 124.38 22.6 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -106.02 130.15 54.0 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.394 -0.817 . . . . 0.0 110.443 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.557 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.5 m-85 -114.18 134.33 54.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.561 -0.712 . . . . 0.0 109.611 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 98' ' ' ASP . 57.5 t0 -63.34 119.09 9.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 109.608 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.411 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.9 tt0 -101.13 -1.45 33.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.586 -0.696 . . . . 0.0 109.267 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -75.96 -19.83 58.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -101.82 156.6 17.41 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.476 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 44.4 ttp180 -87.23 125.13 34.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.051 -1.031 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.06 149.85 22.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 0.0 109.86 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.7 p -131.69 169.97 15.43 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.366 -0.833 . . . . 0.0 109.175 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.45 HD21 HD13 ' A' ' 25' ' ' LEU . 82.7 m-20 -111.63 23.93 13.34 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.428 -0.795 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 35.1 p-10 -146.99 -165.0 2.13 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.909 -1.12 . . . . 0.0 109.995 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.74 22.19 0.06 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.128 -0.982 . . . . 0.0 111.51 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.9 mtp180 -76.66 -163.65 0.35 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.646 -1.284 . . . . 0.0 110.059 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.6 mt-10 -25.2 -67.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -141.4 159.17 42.79 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.905 -1.122 . . . . 0.0 110.842 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 68.8 m-80 -107.45 110.93 23.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -41.48 92.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.372 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.91 -46.92 87.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.922 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.33 -39.73 88.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.825 -1.172 . . . . 0.0 110.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.45 -40.21 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.989 -1.069 . . . . 0.0 108.407 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -41.88 91.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.386 -0.822 . . . . 0.0 109.014 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.088 -1.008 . . . . 0.0 109.724 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.22 -51.81 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 109.183 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.557 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 57.9 mt-10 -58.48 -40.97 84.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -63.4 -39.91 95.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.071 -1.018 . . . . 0.0 109.213 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.39 -38.66 93.74 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -64.21 -35.94 82.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 108.698 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.5 m -69.55 -25.47 64.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 108.726 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.03 -0.68 56.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.31 13.6 70.6 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.842 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.6 128.96 34.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.488 . . . . 0.0 108.919 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.14 170.96 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.607 -0.683 . . . . 0.0 109.703 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.95 156.36 37.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.862 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.4 t -124.97 165.04 18.85 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.1 p -102.04 0.89 35.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.456 -0.777 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -78.33 128.13 33.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.9 tt -58.71 -29.28 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.0 110.497 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.82 3.28 84.14 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.474 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.87 128.92 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.941 -1.329 . . . . 0.0 109.775 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 -31.79 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.453 -0.78 . . . . 0.0 109.146 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 36.4 mtp -74.42 47.76 0.31 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.99 130.92 91.14 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.0 108.948 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -45.63 -68.17 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 CA-C-N 119.99 1.032 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.2 p -80.15 171.02 15.63 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.138 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.6 t80 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 108.881 179.732 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 25.4 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.503 0.668 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -148.45 150.9 34.29 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.3 mt -75.24 147.95 39.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 0.0 109.017 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.16 158.42 16.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 109.06 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -60.04 -40.42 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.735 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.8 t0 -58.98 -40.2 84.1 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -74.27 -39.99 62.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.475 HG22 ' NE2' ' A' ' 157' ' ' GLN . 96.9 mt -63.42 -50.03 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.96 -39.95 96.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.91 21.61 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.771 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -60.06 -39.54 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.852 -1.381 . . . . 0.0 109.659 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 33.1 mt-30 -66.13 -37.53 85.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 108.972 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.28 96.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.443 HD13 ' NH1' ' A' ' 8' ' ' ARG . 96.8 mt -62.27 -48.44 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.08 -67.79 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.98 -178.12 37.94 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -88.76 150.61 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.427 -1.043 . . . . 0.0 109.296 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.044 -1.035 . . . . 0.0 109.043 179.666 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -84.13 130.13 34.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -0.867 . . . . 0.0 108.846 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.51 -32.96 62.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.959 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.36 153.34 25.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 0.0 109.685 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -93.92 -4.09 50.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.228 -0.92 . . . . 0.0 108.669 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -108.33 130.63 55.19 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.416 HD12 ' CE1' ' A' ' 49' ' ' PHE . 82.3 mt -126.28 152.42 46.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.474 -0.766 . . . . 0.0 109.486 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 p -124.04 150.45 44.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.488 -0.758 . . . . 0.0 109.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -144.63 161.38 39.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 109.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -151.32 133.62 15.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.415 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.35 116.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.34 -39.34 92.27 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.727 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -159.82 147.39 16.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.655 -1.278 . . . . 0.0 110.508 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.15 134.19 41.54 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -71.45 145.83 90.87 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.793 -1.192 . . . . 0.0 108.572 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.27 -8.62 19.24 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 119.391 0.818 . . . . 0.0 112.015 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.88 -39.91 86.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 mt -135.88 153.16 76.93 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.5 Cg_endo -66.26 -176.56 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.389 0.818 . . . . 0.0 111.001 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.0 -38.83 15.18 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.967 -1.083 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.25 93.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.16 -39.14 72.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 26' ' ' PRO . 54.3 t -67.15 -39.51 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 44.3 t0 -59.71 -40.45 87.98 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.526 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -60.17 -45.46 93.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 109.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.35 92.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 109.205 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -71.82 -40.19 68.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.494 -0.754 . . . . 0.0 110.042 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.15 -39.64 78.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -61.89 -39.87 93.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.786 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.12 93.66 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.308 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -59.92 -39.02 84.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.005 -1.059 . . . . 0.0 108.779 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.492 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.71 -45.63 91.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 109.678 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.2 m95 -74.69 -45.29 45.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -65.1 -37.41 87.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.843 . . . . 0.0 110.822 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.34 -23.34 64.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.543 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.81 7.19 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.413 -0.804 . . . . 0.0 110.71 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.42 ' N ' ' OG ' ' A' ' 163' ' ' SER . 11.3 p -145.31 150.06 43.4 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.109 -0.994 . . . . 0.0 109.101 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -72.11 9.51 1.1 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.451 0.767 . . . . 0.0 111.684 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.12 150.0 42.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.307 -0.871 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.9 p -130.25 148.2 52.06 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 14' ' ' LEU . 97.3 m-85 -128.02 153.44 46.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.699 -0.625 . . . . 0.0 109.891 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -155.28 133.05 11.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.199 -0.938 . . . . 0.0 110.017 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.22 144.59 40.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.16 135.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -98.69 -4.38 33.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.739 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -144.22 147.78 34.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.04 172.12 48.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -82.59 149.74 27.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 109.331 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.44 152.26 24.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.55 -0.719 . . . . 0.0 109.102 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.1 -44.84 94.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.342 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -114.05 112.21 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.755 0.788 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.5 mtp -99.06 131.17 45.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.69 129.19 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.6 p -153.12 159.81 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.4 140.24 46.15 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.86 167.62 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.37 -0.831 . . . . 0.0 111.055 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.43 138.98 40.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.0 109.601 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.23 -139.82 10.7 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -73.39 129.04 37.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -1.004 . . . . 0.0 110.095 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 3.4 p-80 -133.0 60.83 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.256 -0.902 . . . . 0.0 109.619 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 57.66 47.26 16.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.469 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 93.3 m-20 -141.73 163.73 32.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.58 -0.7 . . . . 0.0 109.454 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -96.0 9.59 40.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.316 -0.865 . . . . 0.0 109.776 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -134.04 73.0 71.33 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.341 -0.849 . . . . 0.0 109.599 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -64.31 158.97 45.99 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.986 1.124 . . . . 0.0 112.143 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.79 152.03 31.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -110.36 67.88 0.65 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.525 -0.735 . . . . 0.0 109.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.85 -170.99 31.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.27 -16.78 23.53 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.323 1.349 . . . . 0.0 112.701 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.32 -175.25 46.27 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.16 -150.54 27.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -77.27 144.17 38.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.432 -1.04 . . . . 0.0 109.485 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.76 -18.33 25.15 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.954 -1.091 . . . . 0.0 109.067 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.16 166.06 9.04 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.352 -0.842 . . . . 0.0 108.83 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 83' ' ' HIS . 2.8 p80 -162.5 114.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.962 -1.086 . . . . 0.0 110.346 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.61 173.46 9.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -109.23 160.8 15.82 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -58.11 148.33 61.84 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.021 -1.049 . . . . 0.0 109.242 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.61 103.66 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.773 0.982 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -169.01 169.57 41.94 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -173.32 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.141 1.227 . . . . 0.0 112.81 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.43 -126.41 42.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -82.44 -8.43 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -1.057 . . . . 0.0 110.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.1 138.76 48.59 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.63 63.23 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.198 -1.177 . . . . 0.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.94 130.15 41.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.962 -1.317 . . . . 0.0 110.491 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.89 116.15 31.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.165 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -100.86 132.71 46.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.072 -1.017 . . . . 0.0 109.834 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.51 131.26 55.53 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.392 -0.818 . . . . 0.0 109.902 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.6 127.27 31.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.395 -0.815 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.64 3.98 42.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.104 -0.997 . . . . 0.0 109.97 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.38 -20.04 60.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.022 -1.049 . . . . 0.0 109.334 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -101.91 157.36 16.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 108.804 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -86.35 125.77 33.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 108.625 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -91.11 140.35 29.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.1 p -129.23 163.27 25.98 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -108.66 31.31 5.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.466 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -148.55 -164.99 2.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 109.855 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.54 28.26 0.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -76.56 -163.56 0.34 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -43.63 -60.97 1.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 111.909 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.2 m-85 -125.73 135.49 52.13 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.617 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -103.1 117.16 33.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.98 -41.7 96.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.844 -1.16 . . . . 0.0 109.76 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.43 -49.58 77.0 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.728 -0.608 . . . . 0.0 112.458 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -59.73 -42.91 94.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.232 -1.542 . . . . 0.0 110.453 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.29 -39.79 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.094 -1.004 . . . . 0.0 109.426 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.92 86.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.345 -0.847 . . . . 0.0 109.089 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.44 90.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.026 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.588 ' ND1' ' SD ' ' A' ' 136' ' ' MET . 3.2 t60 -68.13 -42.45 80.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.907 -1.12 . . . . 0.0 110.223 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -57.71 -40.13 78.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 109.329 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.69 -39.92 90.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.994 -1.066 . . . . 0.0 109.177 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.28 -38.21 77.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' NE2' ' CE1' ' A' ' 118' ' ' HIS . 47.8 m-70 -66.61 -34.76 78.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.082 -1.246 . . . . 0.0 109.305 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -70.21 -23.97 63.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.12 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.96 -5.63 58.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 108.771 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.96 58.16 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.03 131.47 35.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.117 -1.226 . . . . 0.0 108.707 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.7 m -87.18 169.86 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.091 -1.005 . . . . 0.0 109.511 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.52 161.73 27.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.513 -0.742 . . . . 0.0 109.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.5 t -126.96 166.16 18.05 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -102.31 11.33 38.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 51.9 t0 -83.1 130.33 35.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 109.882 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.75 -39.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.722 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.63 73.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.367 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -83.98 132.52 34.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.548 . . . . 0.0 109.222 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.14 -24.13 64.05 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.588 ' SD ' ' ND1' ' A' ' 118' ' ' HIS . 59.5 mmm -72.44 48.84 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.767 -0.583 . . . . 0.0 110.153 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 139' ' ' SER . 13.7 t80 -71.39 137.16 83.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.861 -1.149 . . . . 0.0 109.198 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.63 18.81 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.037 1.049 . . . . 0.0 111.844 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 137' ' ' TYR . 22.2 t -166.5 176.67 7.19 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.9 t80 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 120.644 -1.285 . . . . 0.0 110.436 -179.16 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -142.46 150.49 40.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 108.653 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 41' ' ' TRP . 97.1 mt -73.49 145.43 45.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.058 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.17 156.8 17.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.449 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.94 -39.9 87.12 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.24 -40.4 85.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.461 -0.775 . . . . 0.0 109.255 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.63 -41.14 65.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.53 -46.48 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.192 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.54 -40.22 93.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.89 -1.131 . . . . 0.0 110.431 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.64 -58.19 15.11 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.731 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -63.91 -41.29 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.114 -1.227 . . . . 0.0 110.344 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -66.33 -40.32 89.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.823 -1.173 . . . . 0.0 110.386 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.42 93.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.956 -1.09 . . . . 0.0 109.65 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -50.31 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 108.969 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.98 -74.02 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.196 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.99 -176.07 35.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 162' ' ' ARG . 57.6 mtt-85 -83.86 151.94 24.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.063 . . . . 0.0 109.441 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 45' ' ' THR . 5.8 m . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 87' ' ' PRO . 99.0 m95 -84.79 114.46 22.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.854 -1.154 . . . . 0.0 109.094 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.57 -9.87 48.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 109.505 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -80.94 150.76 28.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.757 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 p -96.6 -5.05 40.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -123.97 131.74 53.61 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.6 mt -132.88 149.73 52.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -125.29 154.65 41.4 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.302 -0.874 . . . . 0.0 109.446 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.89 159.53 42.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 109.311 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 17' ' ' ARG . 37.7 ttt-85 -148.8 134.04 18.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -89.79 123.26 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.22 -0.925 . . . . 0.0 108.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -41.57 84.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.515 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -162.28 151.04 15.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.858 -1.151 . . . . 0.0 110.23 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -96.94 138.4 34.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.85 144.18 85.25 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 109.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.45 -12.02 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.614 0.876 . . . . 0.0 112.018 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.15 -40.34 89.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.077 -1.014 . . . . 0.0 110.196 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.0 mt -135.73 151.24 73.87 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -65.58 -177.51 0.72 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.468 0.846 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -85.85 -35.51 20.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -43.23 90.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.43 -39.58 77.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 0.0 110.401 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.0 -40.0 87.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.824 -1.172 . . . . 0.0 109.422 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.48 -46.45 90.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.61 95.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.155 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.95 -40.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.717 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.83 -40.3 75.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.045 -1.034 . . . . 0.0 109.974 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -61.0 -40.87 95.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.98 87.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.962 -1.086 . . . . 0.0 109.259 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 30.4 m-85 -60.0 -40.6 89.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.856 -1.152 . . . . 0.0 109.496 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -59.95 -40.47 89.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 110.363 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.0 -45.14 93.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.015 -1.053 . . . . 0.0 110.039 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -71.75 -39.89 69.71 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.462 -0.774 . . . . 0.0 109.502 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 t -68.58 -30.63 69.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -0.85 . . . . 0.0 109.766 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -59.81 -37.51 79.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -106.96 10.31 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.217 -0.927 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -138.33 149.32 62.76 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.03 -1.044 . . . . 0.0 108.597 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.41 7.3 2.68 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.335 0.798 . . . . 0.0 110.529 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.4 157.88 36.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.701 -0.624 . . . . 0.0 109.753 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -137.4 151.99 49.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -130.78 155.87 45.94 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -154.33 132.75 11.98 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -81.64 137.02 35.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.324 -0.86 . . . . 0.0 110.032 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.26 132.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.7 t -94.7 0.94 55.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.045 -1.034 . . . . 0.0 109.594 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.3 157.71 44.12 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.22 -0.925 . . . . 0.0 109.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.76 167.31 8.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.03 160.38 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.264 . . . . 0.0 108.705 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.7 158.6 27.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 109.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.35 -39.65 83.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.298 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.23 120.0 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 109.53 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.0 mtp -101.12 135.93 41.79 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.192 -0.942 . . . . 0.0 109.419 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.84 126.94 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -148.03 155.19 41.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.65 139.03 40.86 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.22 163.09 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.503 -0.748 . . . . 0.0 110.773 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 61.4 mtt-85 -131.25 132.69 44.79 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.378 0.609 . . . . 0.0 110.023 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.3 -135.97 7.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -71.54 125.92 28.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.3 p-80 -134.03 49.77 2.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.325 -0.859 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 69' ' ' ARG . 52.8 mtt-85 58.41 53.09 6.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.643 -0.66 . . . . 0.0 111.109 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.536 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.4 m-20 -139.35 163.29 32.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.358 -0.838 . . . . 0.0 108.898 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -90.06 9.3 28.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.6 m -139.67 71.61 36.86 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.349 -0.844 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.91 159.27 41.86 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.154 1.236 . . . . 0.0 112.142 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.64 147.21 37.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.616 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.94 62.33 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.482 -0.761 . . . . 0.0 109.117 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.73 -166.01 53.4 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -54.19 -22.36 25.59 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.304 1.336 . . . . 0.0 112.636 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.0 177.79 48.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.03 -165.18 26.56 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -75.07 150.41 38.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.288 -1.125 . . . . 0.0 109.94 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -91.45 -13.26 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.57 167.33 9.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.046 -1.034 . . . . 0.0 109.893 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.98 179.91 7.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -166.38 169.33 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -98.04 156.88 16.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -58.48 149.65 59.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.146 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.411 ' HB3' ' NE1' ' A' ' 9' ' ' TRP . 7.5 Cg_endo -58.69 103.12 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 120.428 0.752 . . . . 0.0 111.792 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.29 172.88 37.62 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.22 177.32 6.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.321 1.347 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.54 -125.35 31.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.27 -9.54 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.193 . . . . 0.0 110.041 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.65 135.94 47.03 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.1 -16.83 59.58 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.491 -1.005 . . . . 0.0 110.709 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.64 121.76 15.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.913 -1.345 . . . . 0.0 110.636 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.17 131.81 45.9 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -112.74 135.0 53.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.501 -0.749 . . . . 0.0 109.294 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.8 m-85 -114.73 130.97 56.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.374 -0.829 . . . . 0.0 110.087 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.412 ' OD2' ' OE2' ' A' ' 101' ' ' GLU . 62.4 t0 -69.32 122.59 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -99.57 4.47 45.86 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.027 -1.046 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -73.5 -15.28 61.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.713 -1.242 . . . . 0.0 109.128 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.475 ' N ' ' OE1' ' A' ' 101' ' ' GLU . 56.4 mp0 -102.64 152.66 20.93 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -85.71 119.4 26.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.93 -1.106 . . . . 0.0 108.777 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.53 150.28 24.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 p -129.82 163.09 27.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -113.9 34.86 4.37 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.473 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.6 p30 -150.18 -165.02 2.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.0 109.99 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.25 31.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.305 -0.872 . . . . 0.0 109.764 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.473 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.9 mmt-85 -76.82 -165.09 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -0.999 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.0 -58.25 9.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.731 . . . . 0.0 112.203 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -101.12 121.85 42.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.052 -1.03 . . . . 0.0 110.984 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.69 110.95 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.77 -44.67 96.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.11 -0.994 . . . . 0.0 111.122 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.081 . . . . 0.0 110.713 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -59.17 -46.68 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 109.738 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.12 -40.4 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.165 -0.96 . . . . 0.0 109.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.08 91.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.955 -1.091 . . . . 0.0 109.575 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.13 95.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.8 . . . . 0.0 109.813 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.407 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 48.6 t60 -69.77 -40.79 75.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.16 -40.14 88.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.812 -1.18 . . . . 0.0 109.075 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.19 -39.97 88.38 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.65 -42.4 67.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.407 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 61.9 m-70 -63.24 -39.33 94.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.241 -1.152 . . . . 0.0 108.549 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.8 p -70.14 -22.93 62.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.232 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.22 -2.63 58.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.144 -0.973 . . . . 0.0 109.385 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.41 73.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.22 131.42 35.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.03 -1.276 . . . . 0.0 108.804 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.0 m -88.1 170.56 10.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.03 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -66.07 158.66 27.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 108.705 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -129.88 158.72 38.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.42 -0.8 . . . . 0.0 109.224 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -102.94 13.83 33.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -84.13 130.91 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -42.91 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.66 0.32 65.57 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.235 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.69 139.2 32.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.676 -1.485 . . . . 0.0 108.928 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.74 -27.61 66.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 108.895 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.7 mtp -75.75 60.86 1.34 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 0.0 109.489 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.7 t80 -68.31 137.49 91.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.46 5.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.985 1.03 . . . . 0.0 112.1 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 137' ' ' TYR . 57.6 p -158.78 173.75 16.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.965 -1.084 . . . . 0.0 109.501 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.512 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -141.29 150.28 42.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 0.0 109.61 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.7 139.66 45.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 168.88 10.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.99 -40.7 90.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.581 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.53 -40.44 87.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.505 -0.747 . . . . 0.0 109.748 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -75.24 -42.56 55.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 109.263 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.79 -50.63 74.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.451 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.22 -39.37 90.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.16 . . . . 0.0 110.02 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.38 -56.37 20.3 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.72 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -64.38 -40.85 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.4 mt-30 -65.22 -39.09 92.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.029 -1.044 . . . . 0.0 110.108 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.41 88.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.81 -1.182 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.37 -49.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.044 -1.035 . . . . 0.0 109.527 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -97.28 -67.6 0.84 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.474 -0.766 . . . . 0.0 109.833 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.87 179.66 39.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.72 134.29 34.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -1.115 . . . . 0.0 109.421 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.799 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -84.87 124.11 31.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.38 -0.825 . . . . 0.0 109.6 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -87.55 -6.78 58.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.82 150.44 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -95.09 -6.29 42.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -130.03 139.8 50.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -132.8 157.98 43.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.535 -0.728 . . . . 0.0 109.332 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -127.99 153.56 46.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.94 158.42 43.63 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.225 -0.922 . . . . 0.0 109.922 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -146.99 134.61 21.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.014 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.86 112.35 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.2 tt0 -63.63 -39.82 95.32 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 0.0 110.392 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 83.1 m-20 -155.29 142.45 19.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.949 -1.094 . . . . 0.0 110.479 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.01 137.06 32.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -69.34 136.99 88.79 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -66.83 -9.37 24.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.691 0.925 . . . . 0.0 110.909 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.28 -40.11 89.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.762 -0.586 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -136.24 149.87 69.23 Favored Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -178.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.107 0 CA-C-N 119.353 0.805 . . . . 0.0 111.443 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -31.69 18.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.71 87.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.895 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.92 -40.01 65.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.792 . . . . 0.0 110.7 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.05 -44.32 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -58.58 -44.8 89.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.298 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -59.64 -41.94 91.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.047 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.2 82.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.875 -1.14 . . . . 0.0 109.729 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.1 -39.26 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 0.0 109.684 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.14 -39.68 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.067 -1.021 . . . . 0.0 109.432 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -63.3 -40.04 96.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.738 -1.226 . . . . 0.0 110.695 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.89 71.43 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.691 -1.255 . . . . 0.0 109.45 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 37.8 m-85 -60.31 -43.96 95.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.547 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -60.04 -42.76 95.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.93 -40.29 88.39 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.839 -1.163 . . . . 0.0 110.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -74.42 -40.21 62.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.479 -1.388 . . . . 0.0 109.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.56 -27.24 66.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.587 -0.696 . . . . 0.0 110.061 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -38.85 84.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 111.252 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 22.9 m -109.84 13.46 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.22 -0.925 . . . . 0.0 110.77 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 72.1 p -141.34 148.42 50.88 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.2 -0.938 . . . . 0.0 108.879 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.06 6.17 2.27 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 119.573 0.883 . . . . 0.0 111.982 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.28 151.72 42.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.159 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 p -131.75 149.19 52.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 96.7 m-85 -129.21 156.04 44.58 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.274 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.8 m -154.66 128.83 8.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.669 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -78.53 139.3 38.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.36 136.82 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 t -97.81 -2.92 39.9 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.051 -1.03 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -145.61 155.28 42.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.815 -1.178 . . . . 0.0 109.528 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.58 173.46 44.91 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.0 158.7 26.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -1.207 . . . . 0.0 109.391 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.02 152.22 41.15 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.46 -0.775 . . . . 0.0 109.134 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -60.03 -40.6 89.89 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -119.83 119.04 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mtp -101.28 127.66 47.79 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.858 . . . . 0.0 109.646 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -109.88 131.13 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.415 -0.803 . . . . 0.0 109.251 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.6 p -146.86 160.0 42.84 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.849 0.833 . . . . 0.0 110.091 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.26 139.28 47.93 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.26 167.25 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -139.3 144.78 38.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 0.0 110.248 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.85 -149.6 2.29 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -71.77 128.83 37.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.277 -1.131 . . . . 0.0 109.565 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 11.3 p-80 -130.83 60.19 1.65 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.379 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 53.36 54.67 9.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.944 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.7 p-10 -142.77 169.44 17.56 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.157 -0.964 . . . . 0.0 109.35 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.86 9.04 41.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.319 -0.863 . . . . 0.0 109.236 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -137.17 70.97 55.28 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 0.0 109.579 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.24 145.69 73.21 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 120.716 0.944 . . . . 0.0 111.496 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -74.74 144.7 43.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 72.67 0.84 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.02 -166.71 54.51 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -66.81 -10.14 27.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.186 1.257 . . . . 0.0 111.72 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.6 170.22 26.6 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.04 -151.11 19.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -73.58 142.58 46.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -1.081 . . . . 0.0 109.64 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.89 -16.23 26.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.072 -1.017 . . . . 0.0 109.23 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.62 171.48 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -163.27 121.12 1.93 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.802 -1.186 . . . . 0.0 109.76 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.53 162.02 21.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.723 -0.611 . . . . 0.0 109.854 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -107.76 146.64 31.9 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -59.78 146.05 82.22 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.948 -1.095 . . . . 0.0 108.616 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.65 125.75 20.04 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.849 0.982 . . . . 0.0 112.122 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.27 174.51 44.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.96 -177.55 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.115 1.21 . . . . 0.0 112.093 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.32 -128.88 48.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -78.91 -4.14 6.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.43 -1.041 . . . . 0.0 109.838 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.99 132.45 50.81 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.1 52.12 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -68.75 160.02 31.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.0 122.28 21.63 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -99.12 136.21 39.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.409 -0.807 . . . . 0.0 110.867 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.8 m-85 -116.16 131.41 56.95 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.43 121.83 17.15 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.077 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -100.15 -0.46 38.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.155 -0.965 . . . . 0.0 109.868 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -72.93 -15.67 61.57 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.962 -1.086 . . . . 0.0 109.877 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 159.96 15.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.38 -0.825 . . . . 0.0 108.871 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.409 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.3 ttp180 -89.25 122.23 32.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.085 -1.009 . . . . 0.0 109.596 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -89.22 151.7 22.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 110.106 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 59.1 p -125.95 160.32 30.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.507 -0.746 . . . . 0.0 109.56 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.99 29.27 7.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.533 -0.729 . . . . 0.0 109.987 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -148.67 -165.02 2.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.486 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -81.04 30.81 0.32 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.945 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.65 -175.06 2.75 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.033 -1.042 . . . . 0.0 109.228 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.607 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 55.5 mp0 -47.4 -59.77 2.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.828 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 79.7 m-85 -83.62 152.5 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.86 -1.15 . . . . 0.0 110.92 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -140.89 90.24 2.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.99 -46.44 89.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.139 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.07 -45.77 91.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.0 109.985 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -59.4 -40.31 86.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.009 -1.057 . . . . 0.0 108.798 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.262 -0.899 . . . . 0.0 109.319 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.84 -40.56 84.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 109.144 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.63 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 109.085 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -68.69 -50.33 51.84 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.5 mt-10 -57.49 -41.96 81.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.877 -1.139 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.86 -37.88 88.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.896 -1.127 . . . . 0.0 109.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.59 92.28 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -64.79 -37.33 87.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.266 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -69.92 -22.68 63.17 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.48 -1.91 57.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.16 59.82 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.25 132.16 35.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.361 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.3 m -87.54 163.8 16.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.457 -0.777 . . . . 0.0 110.169 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -65.81 157.94 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.633 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -130.3 167.44 18.5 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -106.6 10.63 31.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.744 . . . . 0.0 109.148 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.67 120.12 24.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.87 -28.81 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.828 . . . . 0.0 110.798 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.56 -6.89 88.81 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.699 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.11 133.15 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.271 . . . . 0.0 109.868 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.72 -24.65 67.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 84.2 mmm -74.71 56.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.958 . . . . 0.0 109.33 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.5 t80 -70.11 137.42 87.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 108.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.33 7.23 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 120.098 1.071 . . . . 0.0 112.743 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.5 p -161.67 169.69 21.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 109' ' ' GLU . 49.3 t80 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.216 -0.927 . . . . 0.0 109.788 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -148.93 147.22 28.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 109.01 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.0 mt -78.55 133.85 37.31 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.14 166.33 13.03 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -60.78 -40.03 91.05 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.69 -40.49 88.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.813 . . . . 0.0 109.056 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -74.29 -42.24 59.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.78 -49.15 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.126 -0.984 . . . . 0.0 109.314 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.27 -40.3 89.88 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.05 -55.73 28.66 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.107 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.0 tp -65.9 -39.18 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.237 . . . . 0.0 109.797 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.8 mt-30 -66.99 -39.35 87.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.0 . . . . 0.0 109.256 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.76 93.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.995 -1.065 . . . . 0.0 109.721 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.06 -47.87 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.0 110.348 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -101.23 -61.26 1.39 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.401 -0.812 . . . . 0.0 109.899 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.85 179.61 35.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 145.12 24.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -1.162 . . . . 0.0 109.683 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.578 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -84.15 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.961 -1.087 . . . . 0.0 109.519 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.61 -9.14 59.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -83.17 148.91 27.18 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 p -98.21 -5.71 32.78 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.502 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 68.2 m80 -127.72 122.51 33.08 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.87 153.98 23.7 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.176 -0.952 . . . . 0.0 109.889 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 p -130.93 157.46 42.89 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -144.26 162.52 36.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -144.42 124.53 13.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.238 -0.914 . . . . 0.0 110.055 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 93.1 mt -86.77 113.59 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 77.3 tt0 -62.68 -41.15 98.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.95 154.73 24.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -95.9 142.4 28.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -70.05 138.57 87.42 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.174 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.28 -13.07 38.29 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.739 0.959 . . . . 0.0 111.37 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.59 -40.42 91.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.0 149.39 68.31 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.65 -178.72 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.209 0.753 . . . . 0.0 112.038 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 27' ' ' ARG . 21.8 ptt-85 -86.04 -32.12 21.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.303 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.04 86.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.112 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -69.17 -38.96 78.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.76 -39.99 80.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.259 -0.9 . . . . 0.0 109.644 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.87 -40.53 84.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.194 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -60.27 -48.8 80.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.69 84.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.949 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.93 -40.6 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.171 -0.955 . . . . 0.0 109.851 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -69.89 -39.44 76.26 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 108.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.19 -39.81 93.95 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.39 90.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 109.736 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.9 -40.45 93.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.823 -1.173 . . . . 0.0 109.073 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.12 -41.45 92.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.13 -45.82 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.403 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -74.09 -42.83 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 t -63.55 -37.96 89.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.345 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -60.16 -23.57 64.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.552 -0.718 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.54 7.63 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.957 -1.09 . . . . 0.0 110.457 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 p -145.67 151.95 47.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -72.12 4.2 3.45 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.821 1.014 . . . . 0.0 112.097 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.21 152.0 44.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.0 109.775 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 44.9 p -127.08 150.13 49.61 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.03 158.29 34.1 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 110.489 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 m -153.89 127.91 8.96 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.967 0.889 . . . . 0.0 110.291 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.76 140.74 31.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.674 -0.641 . . . . 0.0 109.681 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 141.88 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.33 -0.856 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -95.02 -6.99 40.99 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.179 -0.951 . . . . 0.0 110.69 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -149.5 155.33 40.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.919 -1.113 . . . . 0.0 109.545 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.37 160.6 33.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.68 130.96 35.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -1.124 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.7 170.02 9.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.089 -1.007 . . . . 0.0 109.79 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.08 -40.08 88.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 109.712 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.92 120.42 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.517 -0.739 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.4 mmm -98.77 129.61 45.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.349 -0.844 . . . . 0.0 109.498 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -112.42 130.32 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -147.19 156.88 43.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.995 -1.065 . . . . 0.0 110.226 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.0 133.15 53.49 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.62 160.09 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 O-C-N 121.006 -1.059 . . . . 0.0 111.395 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -124.73 138.32 54.29 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.2 -146.2 4.12 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.86 130.86 42.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.792 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.501 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -131.25 43.54 3.07 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 55.69 58.18 4.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.685 . . . . 0.0 110.139 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.501 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 17.7 p-10 -141.17 171.58 13.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 0.0 109.126 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -91.25 10.65 26.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 109.73 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 t -141.0 71.67 28.35 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.103 -0.998 . . . . 0.0 109.903 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.37 141.98 32.69 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.108 1.206 . . . . 0.0 112.12 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.5 153.79 33.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.604 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.83 75.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.93 -164.55 17.2 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -55.86 -17.99 20.39 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.796 0.998 . . . . 0.0 111.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -179.02 49.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.1 -164.87 35.54 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -74.77 155.79 37.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.132 -1.216 . . . . 0.0 109.428 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 mt -93.09 -19.7 21.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.141 -0.975 . . . . 0.0 109.272 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.94 169.79 8.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.012 -1.055 . . . . 0.0 109.37 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -163.03 179.96 7.16 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.646 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.83 170.94 16.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.621 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -98.64 158.1 15.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.354 -0.841 . . . . 0.0 109.589 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -57.06 145.94 62.88 Favored Pre-proline 0 N--CA 1.485 1.311 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.16 104.22 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 120.371 0.714 . . . . 0.0 111.62 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.05 171.23 37.91 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.3 -175.63 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.039 1.159 . . . . 0.0 112.024 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.96 -127.09 40.19 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -80.05 -11.13 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.24 . . . . 0.0 109.252 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.92 142.36 46.34 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.09 -21.84 32.22 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.3 150.25 46.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.286 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.03 125.94 19.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 108.749 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -105.87 150.06 25.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.534 -0.729 . . . . 0.0 109.554 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.13 140.05 51.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.77 119.26 10.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.057 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -99.48 -3.32 33.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.361 -0.837 . . . . 0.0 109.354 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.26 -18.56 60.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.833 . . . . 0.0 109.677 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -98.15 159.78 14.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.24 -0.913 . . . . 0.0 108.905 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.8 ttm-85 -89.39 119.59 29.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.25 -0.906 . . . . 0.0 109.691 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.74 145.34 25.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.345 -0.847 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 69.6 p -122.49 160.97 24.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -108.41 30.43 6.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.56 -0.712 . . . . 0.0 109.102 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -148.64 -165.0 2.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.09 -1.006 . . . . 0.0 110.269 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -82.25 28.98 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -73.7 -169.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.134 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.81 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 111.656 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -87.14 153.51 21.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.972 -1.08 . . . . 0.0 110.547 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -143.7 97.59 3.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.187 -0.946 . . . . 0.0 108.55 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.51 -45.95 92.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.364 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.56 -39.85 85.38 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.84 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.488 ' NH1' HD22 ' A' ' 135' ' ' LEU . 1.9 tpm_? -60.0 -43.37 95.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.27 -39.63 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.785 . . . . 0.0 108.89 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.96 84.49 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.37 -0.831 . . . . 0.0 109.164 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.63 -46.66 62.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.85 -41.37 91.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.5 mt -63.77 -39.72 94.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.78 -40.38 80.12 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -66.36 -35.46 80.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 108.328 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.4 t -69.96 -25.32 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.26 -0.03 50.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 109.07 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.19 12.08 66.1 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.813 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.79 128.58 33.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.461 . . . . 0.0 108.979 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.2 m -88.34 170.12 11.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.428 -0.795 . . . . 0.0 109.671 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -66.12 149.0 50.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 t -124.67 161.49 26.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.3 p -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.51 127.37 32.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.047 . . . . 0.0 108.732 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.88 -40.08 81.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.527 -0.733 . . . . 0.0 110.212 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.26 1.41 70.54 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.616 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.01 139.96 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.716 -1.461 . . . . 0.0 109.695 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.488 HD22 ' NH1' ' A' ' 114' ' ' ARG . 88.3 mt -69.02 -29.3 67.45 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 109.274 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 77.3 mmm -74.3 55.23 0.6 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.424 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.8 t80 -69.29 139.49 89.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.8 -3.9 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 CA-C-N 119.832 0.976 . . . . 0.0 112.543 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -162.84 170.91 17.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 109.311 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.6 t80 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 120.715 -1.24 . . . . 0.0 109.06 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.42 HG13 HH21 ' A' ' 114' ' ' ARG . 98.4 t . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.35 0.595 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -146.95 151.81 37.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.408 -0.807 . . . . 0.0 109.207 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.14 149.58 38.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.03 150.26 21.08 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -58.4 -40.08 81.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.835 -1.166 . . . . 0.0 109.035 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.84 -37.74 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.785 -1.197 . . . . 0.0 108.448 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -74.69 -39.93 61.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.99 -49.86 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.095 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.67 -39.78 95.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.963 . . . . 0.0 110.512 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.18 -51.02 47.56 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.93 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -67.81 -38.9 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.401 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 91.6 mt-30 -65.68 -39.75 91.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.685 -1.259 . . . . 0.0 109.315 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.04 95.2 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.782 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.34 -49.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.84 -63.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.094 -1.004 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.09 -165.5 33.25 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.478 HH11 ' HG2' ' A' ' 162' ' ' ARG . 35.3 mtt-85 -96.17 139.85 31.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.451 -1.029 . . . . 0.0 109.261 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.492 1.66 0 O-C-N 120.762 -1.211 . . . . 0.0 108.425 179.503 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.163 0.506 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -85.91 122.01 29.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 108.523 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.85 -12.58 55.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.159 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -82.97 152.44 25.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.705 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 p -96.6 -4.59 40.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.921 . . . . 0.0 109.112 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -125.35 135.41 52.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.69 158.35 43.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.39 -0.819 . . . . 0.0 109.537 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.7 p -128.43 154.08 46.42 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.48 159.97 41.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -149.45 130.35 14.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.084 -1.01 . . . . 0.0 110.176 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 92.8 mt -87.44 115.2 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.88 -40.11 91.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -160.09 151.87 20.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.075 . . . . 0.0 110.26 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -98.87 135.65 40.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.379 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 t -71.2 144.08 89.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.947 . . . . 0.0 108.987 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -66.03 -11.25 30.26 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.704 0.936 . . . . 0.0 112.035 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.13 -39.93 87.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 109.957 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -137.59 150.21 67.51 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.193 -0.942 . . . . 0.0 108.951 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.35 -177.34 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.706 0.937 . . . . 0.0 111.924 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -88.99 -37.04 15.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 0.0 109.938 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.44 83.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.95 -39.01 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 109.617 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.68 -39.95 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -41.59 92.75 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.075 -1.016 . . . . 0.0 109.077 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.59 -46.38 90.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.98 90.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 0.0 109.775 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.31 -40.16 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -39.92 75.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.997 . . . . 0.0 108.682 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.06 -39.97 91.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.31 84.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.938 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.11 -39.95 87.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.965 -1.085 . . . . 0.0 108.786 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.12 -40.28 89.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 110.093 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.12 -47.02 87.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.871 -1.143 . . . . 0.0 109.644 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -71.78 -41.72 67.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.493 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.21 -38.17 81.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.552 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.28 7.73 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 p -145.79 150.0 41.5 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.893 -1.13 . . . . 0.0 109.215 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.13 6.47 1.77 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.693 0.929 . . . . 0.0 111.899 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.93 154.06 42.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.13 -0.981 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.8 p -133.3 149.99 51.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.533 -0.73 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.88 156.24 43.99 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.468 -0.77 . . . . 0.0 109.965 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 m -155.38 132.43 10.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.755 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -78.3 145.66 35.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.96 134.98 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.447 -0.783 . . . . 0.0 109.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -93.07 -0.93 56.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.037 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -152.89 158.63 42.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 109.666 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.6 168.11 30.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.88 149.33 29.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -1.175 . . . . 0.0 109.127 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 151.93 25.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.437 -0.79 . . . . 0.0 109.108 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.286 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -116.56 116.06 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.47 137.52 39.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.46 127.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.1 p -149.58 161.36 42.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 110.207 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.14 139.97 46.07 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.72 167.14 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.198 -0.939 . . . . 0.0 110.739 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.76 146.79 49.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.629 -0.67 . . . . 0.0 110.194 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.52 -150.19 0.87 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -60.07 136.88 58.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.087 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 25.1 p-80 -137.48 54.23 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.82 54.14 8.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.592 -0.693 . . . . 0.0 110.035 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.9 t0 -147.31 162.14 39.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.5 m120 -89.7 9.0 28.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 109.775 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.7 m -134.55 70.58 72.01 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.412 -0.805 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.5 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 120.879 1.053 . . . . 0.0 112.051 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -77.62 141.44 39.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -103.54 62.07 0.77 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.413 -0.804 . . . . 0.0 109.179 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.92 54.82 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -55.91 -14.11 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.023 1.149 . . . . 0.0 111.914 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.18 -178.54 50.83 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.28 -158.8 42.34 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 80' ' ' ASN . 48.0 p-10 -74.33 147.61 42.09 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -1.137 . . . . 0.0 109.478 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -94.66 -15.85 23.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.89 160.12 8.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.05 -1.031 . . . . 0.0 109.286 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.18 -178.7 6.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.286 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.39 168.17 20.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 109.869 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.75 164.46 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.38 -0.825 . . . . 0.0 109.94 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.07 149.88 72.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.838 . . . . 0.0 109.553 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.26 103.47 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 120.689 0.926 . . . . 0.0 111.806 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.03 166.01 38.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.14 -172.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.984 1.123 . . . . 0.0 111.647 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.99 -132.96 49.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -79.92 -10.26 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -1.043 . . . . 0.0 109.946 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.99 144.21 39.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -18.15 32.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -67.12 124.26 22.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.283 . . . . 0.0 109.995 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.89 128.33 53.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.522 -0.736 . . . . 0.0 109.329 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -110.98 135.56 51.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -116.52 137.36 52.23 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.493 -0.754 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.5 122.59 17.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -100.4 0.38 39.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -74.56 -18.66 60.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.904 -1.122 . . . . 0.0 109.93 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.31 162.29 13.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -0.83 . . . . 0.0 109.479 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -87.74 121.43 30.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 0.0 109.28 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.19 147.07 23.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.359 -0.838 . . . . 0.0 110.174 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.0 p -125.56 168.77 13.21 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.43 31.82 6.21 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.59 HD21 ' CZ ' ' A' ' 108' ' ' ARG . 4.7 p30 -149.85 -164.84 2.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.889 . . . . 0.0 109.953 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -86.4 29.22 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.33 -0.856 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.59 ' CZ ' HD21 ' A' ' 106' ' ' ASN . 97.0 mtt180 -76.11 -159.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -40.36 -59.94 1.2 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.53 -0.731 . . . . 0.0 111.53 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -129.78 130.09 44.93 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.048 -1.032 . . . . 0.0 110.388 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -98.58 112.01 24.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.268 -0.895 . . . . 0.0 109.297 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 0.0 110.084 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.94 -42.54 94.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.176 -0.952 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 114' ' ' ARG . 29.5 ttt-85 -60.1 -40.05 88.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 109.332 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.07 -40.06 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.271 -0.893 . . . . 0.0 109.539 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.61 93.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 108.866 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.46 94.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -67.38 -44.4 79.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.776 . . . . 0.0 110.517 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.07 -39.99 87.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.971 -1.081 . . . . 0.0 108.855 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.46 -37.03 84.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.05 -40.89 75.68 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -63.1 -40.12 96.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -1.17 . . . . 0.0 108.634 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -71.61 -23.52 61.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.97 -3.14 58.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -0.941 . . . . 0.0 108.865 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.43 64.3 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.81 127.35 34.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.076 -1.249 . . . . 0.0 109.756 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -88.66 170.04 11.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.453 -0.779 . . . . 0.0 109.752 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -67.5 152.98 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.113 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.8 t -125.15 163.6 22.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.556 -0.715 . . . . 0.0 109.392 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -101.62 6.64 42.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.352 -0.843 . . . . 0.0 110.047 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.97 126.62 32.72 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.186 0.993 . . . . 0.0 109.867 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.3 pt -59.0 -30.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.394 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.46 -3.34 90.57 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.252 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.92 139.15 33.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.352 . . . . 0.0 109.142 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.349 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.8 mtp -75.65 58.6 1.08 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -70.39 134.82 86.67 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -45.74 -63.08 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 120.409 1.182 . . . . 0.0 110.857 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.9 p -94.17 177.01 6.1 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 t80 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.58 -1.325 . . . . 0.0 109.106 179.692 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -145.02 154.46 42.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 109.062 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.42 148.24 37.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.924 -1.11 . . . . 0.0 108.89 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.36 148.45 22.11 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -55.83 -38.35 69.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.194 -0.942 . . . . 0.0 108.686 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -53.97 -39.52 66.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.163 -0.96 . . . . 0.0 108.547 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 156' ' ' ILE . 85.5 m-20 -73.0 -40.01 65.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 109.029 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.47 -50.52 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -39.99 93.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.108 -0.995 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.71 -54.15 7.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.089 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -62.02 -39.91 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.863 -1.375 . . . . 0.0 110.147 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 109.247 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.94 -43.37 95.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.725 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.01 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.512 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 -60.68 1.48 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.58 -178.92 35.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -95.02 140.74 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -1.221 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 HG23 ' A' ' 159' ' ' ILE . 85.6 mtm180 . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.48 118.83 23.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.57 -9.98 59.55 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.317 -0.865 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.5 145.2 26.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.074 . . . . 0.0 110.16 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -92.13 -4.04 54.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -129.92 139.78 51.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.21 161.09 34.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.886 0.85 . . . . 0.0 109.52 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.1 p -127.01 157.07 40.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -144.49 157.55 44.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.156 -0.965 . . . . 0.0 109.339 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -151.06 133.09 15.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.15 118.92 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.62 -40.27 80.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.964 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -161.67 150.9 16.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.644 -1.285 . . . . 0.0 110.955 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.18 133.66 38.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.706 . . . . 0.0 109.558 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 t -70.05 142.56 90.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.3 -8.94 24.39 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.38 0.814 . . . . 0.0 111.398 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.93 -39.59 86.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.3 mt -139.52 152.34 68.62 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.86 -176.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 CA-C-N 119.168 0.739 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -86.87 -34.69 19.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.969 -1.082 . . . . 0.0 109.302 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.89 86.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -69.37 -39.63 77.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -0.834 . . . . 0.0 109.6 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 -47.36 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.159 -0.963 . . . . 0.0 109.045 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -60.28 -40.53 90.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.484 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 85.7 t60 -59.19 -47.55 84.91 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.674 -0.642 . . . . 0.0 109.777 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.2 -39.18 81.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.484 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.18 -38.32 74.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.788 -1.195 . . . . 0.0 110.064 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.94 -42.15 97.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.987 -1.071 . . . . 0.0 110.262 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.484 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 36.9 mttm -64.6 -39.83 94.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.71 76.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -60.8 -43.36 98.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -60.09 -41.46 92.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.93 -43.61 94.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.729 -1.232 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.7 m95 -73.49 -42.33 61.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.905 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t -68.3 -35.39 77.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.041 -1.037 . . . . 0.0 110.517 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -57.81 -28.9 64.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.271 -0.893 . . . . 0.0 111.673 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.92 10.4 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.934 -1.104 . . . . 0.0 111.062 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -144.49 149.9 45.71 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.001 -1.062 . . . . 0.0 109.126 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.18 5.29 2.75 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 120.81 1.007 . . . . 0.0 112.181 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.81 155.44 40.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.905 -1.122 . . . . 0.0 109.268 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 p -131.55 142.33 49.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.394 -0.816 . . . . 0.0 108.8 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.29 153.29 36.6 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.367 -0.833 . . . . 0.0 109.467 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.2 m -153.18 132.31 12.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.804 . . . . 0.0 109.861 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -77.44 139.39 39.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.7 136.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.631 -0.668 . . . . 0.0 109.452 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -96.62 -2.21 45.26 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 110.021 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -149.86 152.27 34.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.41 168.65 45.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -79.95 132.03 35.95 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.564 -0.963 . . . . 0.0 109.461 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.67 149.74 20.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 108.965 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.84 -39.86 86.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.39 -0.819 . . . . 0.0 109.118 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -118.22 119.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.7 mmm -101.14 128.95 46.99 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.13 -0.981 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.04 126.42 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.3 p -149.98 159.71 44.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.781 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.19 137.77 50.96 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.09 162.7 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.42 -0.8 . . . . 0.0 111.626 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -130.43 145.3 51.8 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.813 -0.554 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.18 -146.81 0.64 Allowed Glycine 0 N--CA 1.495 2.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.034 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -72.49 128.95 37.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.615 -0.933 . . . . 0.0 109.165 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.55 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 3.9 p-80 -128.18 54.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.558 -0.714 . . . . 0.0 109.855 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 69' ' ' ARG . 52.4 mtm-85 56.62 50.02 13.52 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.482 -0.762 . . . . 0.0 110.06 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -139.83 163.11 33.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -89.42 14.61 10.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.217 -0.927 . . . . 0.0 109.906 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -140.61 68.62 31.03 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.099 -1.0 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.62 148.22 65.49 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.656 1.571 . . . . 0.0 112.74 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -73.79 149.83 41.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.596 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -124.69 74.43 1.34 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.837 -0.539 . . . . 0.0 109.645 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.94 -174.93 48.2 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.9 -13.64 39.03 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 120.839 1.026 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -174.03 43.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.02 -159.21 31.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -73.73 135.36 43.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.284 -1.127 . . . . 0.0 109.42 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.88 -10.81 43.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.695 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.79 161.35 5.89 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -161.63 116.92 2.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.706 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.74 172.83 8.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -104.57 157.08 17.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.78 147.48 78.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 108.571 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.58 104.37 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.628 0.885 . . . . 0.0 112.587 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.07 170.91 33.85 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -69.82 165.42 31.08 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.226 1.284 . . . . 0.0 112.196 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.61 -121.68 15.48 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.061 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.41 -12.98 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -1.04 . . . . 0.0 109.846 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.04 44.71 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 -8.48 78.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -65.06 128.05 34.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.012 -1.287 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.77 115.57 29.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -98.46 135.79 39.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.283 -0.886 . . . . 0.0 109.244 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.29 134.32 54.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.98 117.2 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.015 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -97.36 -0.34 46.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.365 -0.834 . . . . 0.0 109.046 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -74.77 -20.87 59.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -100.76 159.21 15.37 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.281 -0.887 . . . . 0.0 108.965 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 102' ' ' ARG . 18.7 ttt-85 -87.14 123.4 32.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -89.29 145.17 25.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.653 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.9 p -129.79 169.24 15.39 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.356 -0.84 . . . . 0.0 109.633 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.23 28.81 8.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.592 -0.693 . . . . 0.0 110.159 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 18.0 p30 -152.0 -167.01 2.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.033 . . . . 0.0 109.952 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -71.12 22.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.358 -0.839 . . . . 0.0 110.686 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 106' ' ' ASN . 29.2 mmt180 -75.8 -160.39 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 54.3 mp0 -31.77 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.0 -0.437 . . . . 0.0 111.987 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -129.04 151.07 50.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.319 -0.863 . . . . 0.0 110.758 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 75.8 m-20 -99.25 114.33 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.25 -41.14 92.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.481 -0.762 . . . . 0.0 110.145 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -59.83 -42.06 92.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.0 110.618 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.85 -39.87 86.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.842 -1.161 . . . . 0.0 109.678 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 53.6 t -71.69 -39.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.16 90.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.839 -1.163 . . . . 0.0 108.769 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.69 95.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.569 -0.707 . . . . 0.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -69.18 -50.02 51.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.708 . . . . 0.0 110.335 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -58.6 -40.04 82.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.706 -1.246 . . . . 0.0 109.986 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.7 -39.93 93.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.018 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.25 94.49 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -63.61 -37.77 88.6 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 108.971 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.1 p -69.68 -21.8 63.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.006 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.07 -1.29 57.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.302 -0.874 . . . . 0.0 109.431 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.06 16.92 66.23 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.043 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.64 131.29 34.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.838 -1.389 . . . . 0.0 109.382 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.8 m -88.72 169.1 11.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -67.87 157.47 34.81 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.484 -0.76 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -127.95 164.07 23.11 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.439 -0.788 . . . . 0.0 109.318 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.2 p -102.58 8.94 39.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 110.008 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -83.79 127.65 33.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -0.911 . . . . 0.0 109.291 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.06 -30.02 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 110.319 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.29 0.74 88.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.54 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.77 34.88 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.324 . . . . 0.0 110.463 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.11 -28.47 65.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 109.602 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 86.0 mmm -74.99 52.64 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -70.33 128.97 90.88 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.61 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -48.91 -66.98 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.114 0 CA-C-N 120.483 1.208 . . . . 0.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.5 m -89.64 176.28 6.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.042 -1.036 . . . . 0.0 108.877 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 48.4 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 -179.659 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -145.55 159.94 42.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.65 142.31 42.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.88 165.7 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.24 -38.62 87.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -58.69 -40.66 84.22 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -75.3 -41.01 57.96 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.16 -53.25 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.075 -1.015 . . . . 0.0 109.894 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.78 -39.97 95.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.22 -63.26 5.48 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.758 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.4 tp -60.6 -40.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.888 -1.36 . . . . 0.0 110.26 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.9 mt-30 -64.37 -39.71 94.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.249 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.25 93.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.873 -1.142 . . . . 0.0 109.626 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.407 HG23 HH11 ' A' ' 8' ' ' ARG . 93.7 mt -60.08 -50.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.057 . . . . 0.0 109.119 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.5 -67.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.918 -1.114 . . . . 0.0 109.215 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.47 177.87 37.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -86.14 149.05 25.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.085 -1.244 . . . . 0.0 108.724 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 108.915 179.653 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -83.21 130.0 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.164 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -82.42 -13.79 56.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.277 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -83.78 151.53 25.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.011 -1.056 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 p -97.44 -7.32 31.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.21 -0.932 . . . . 0.0 108.662 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.548 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 31.1 m-70 -121.51 122.28 39.37 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.509 HD12 ' CE2' ' A' ' 49' ' ' PHE . 66.2 mt -110.02 156.35 20.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -126.73 152.74 46.42 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.76 159.51 42.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 108.949 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.3 ttm180 -150.29 130.72 13.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -87.38 120.02 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 108.544 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.98 -40.09 87.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -160.78 149.98 16.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.875 -1.14 . . . . 0.0 109.988 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.22 132.22 43.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -68.67 143.45 95.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.828 -1.17 . . . . 0.0 109.161 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.11 -6.23 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 120.657 0.905 . . . . 0.0 111.774 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.19 -40.18 89.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.765 . . . . 0.0 109.767 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.595 HD13 ' CG ' ' A' ' 105' ' ' ASN . 54.7 mt -138.84 150.03 64.02 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.307 -0.871 . . . . 0.0 108.724 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.01 178.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 CA-C-N 119.247 0.767 . . . . 0.0 111.501 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -87.94 -38.71 15.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.993 -1.067 . . . . 0.0 109.546 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.28 92.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.008 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.12 -39.71 75.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 110.095 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.28 -43.6 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.055 . . . . 0.0 109.299 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.77 -39.37 80.81 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.598 ' CE1' ' HZ1' ' A' ' 36' ' ' LYS . 68.1 t60 -57.24 -47.49 81.23 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.555 -0.715 . . . . 0.0 109.175 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.25 -0.906 . . . . 0.0 110.308 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.07 -39.46 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.725 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.89 -41.64 95.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.948 . . . . 0.0 109.901 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.598 ' HZ1' ' CE1' ' A' ' 32' ' ' HIS . 21.5 mttp -62.5 -38.0 88.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 109.955 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.7 84.76 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.701 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -61.39 -41.08 96.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.29 -42.2 95.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.171 -0.955 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -59.94 -43.45 94.98 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.878 -1.139 . . . . 0.0 110.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.73 -41.61 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.3 t -68.25 -36.19 79.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -60.0 -19.19 51.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 0.0 110.242 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.2 m -112.29 1.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 p -144.56 150.24 46.64 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.0 109.421 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.27 7.66 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.936 1.091 . . . . 0.0 112.122 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.41 151.78 42.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.117 -0.99 . . . . 0.0 109.839 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.548 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 64.5 p -129.79 149.97 51.3 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.509 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -128.26 153.63 46.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.483 -0.76 . . . . 0.0 109.405 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.1 m -153.0 134.99 14.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.03 131.6 36.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.649 -0.657 . . . . 0.0 109.437 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 14.7 m -119.67 130.69 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -96.0 -8.78 32.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.128 -0.982 . . . . 0.0 108.994 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 99.2 mt-10 -143.81 152.12 40.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 95.64 179.53 36.29 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -83.18 133.48 35.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.848 -1.384 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 131.03 45.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -59.87 -43.73 94.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.93 120.08 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.573 -0.704 . . . . 0.0 109.814 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 mtt -99.87 130.36 46.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.153 -0.967 . . . . 0.0 109.873 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.73 126.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 p -150.73 160.79 43.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.14 139.8 41.0 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.12 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.344 -0.848 . . . . 0.0 111.08 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 66' ' ' GLY . 83.3 mtm180 -131.35 143.8 50.76 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.737 -0.602 . . . . 0.0 109.423 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 42.65 -147.4 0.68 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -67.12 130.72 44.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -1.024 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.54 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -133.85 56.16 1.86 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.434 -0.791 . . . . 0.0 109.522 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 mtm-85 58.69 49.29 10.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.807 -0.558 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.4 m-20 -142.76 165.69 26.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.216 -0.928 . . . . 0.0 109.641 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -92.99 9.14 36.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.336 -0.853 . . . . 0.0 109.417 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.7 m -133.93 71.57 73.71 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.28 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.2 152.01 80.26 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 120.868 1.045 . . . . 0.0 111.547 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -76.81 147.66 37.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -109.49 75.04 0.92 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.39 -160.67 9.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.82 -15.66 22.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.957 1.104 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.96 -179.56 45.78 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -164.62 37.31 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -75.32 147.38 40.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -1.065 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 mt -92.71 -18.85 22.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 110.296 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.28 161.6 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 0.0 109.681 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.2 -179.81 6.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.697 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.52 167.42 21.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.142 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -101.14 135.22 42.96 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.272 -0.893 . . . . 0.0 109.784 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.01 150.04 71.51 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -41.76 120.97 1.54 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 120.706 0.937 . . . . 0.0 112.037 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 -169.28 21.29 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -76.4 117.43 4.59 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.564 1.51 . . . . 0.0 113.519 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.3 -111.49 3.35 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.451 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.29 -13.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.992 . . . . 0.0 110.888 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.87 133.12 51.26 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.927 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.3 77.76 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 121.459 -1.024 . . . . 0.0 111.009 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.38 129.75 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.736 -1.449 . . . . 0.0 110.436 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.44 129.1 46.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.31 -0.869 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -115.17 132.9 56.46 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.496 -0.752 . . . . 0.0 109.122 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -118.01 131.93 56.43 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -64.83 126.09 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -100.3 0.63 40.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 110.059 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.44 -20.01 60.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.027 -1.046 . . . . 0.0 109.679 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.13 158.36 15.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 102' ' ' ARG . 23.5 ttt-85 -87.49 114.63 24.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -89.59 150.72 22.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.73 . . . . 0.0 109.993 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.3 p -126.3 164.38 21.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.595 ' CG ' HD13 ' A' ' 25' ' ' LEU . 91.5 m-20 -108.53 32.1 5.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.073 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.615 HD22 ' CD ' ' A' ' 108' ' ' ARG . 15.5 p30 -149.43 -164.98 2.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -0.964 . . . . 0.0 110.379 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -84.83 28.34 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.615 ' CD ' HD22 ' A' ' 106' ' ' ASN . 60.0 mtp180 -76.67 -164.07 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 110.498 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -43.64 -59.96 1.97 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.555 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.29 121.85 43.21 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.178 -0.951 . . . . 0.0 109.804 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -99.99 116.06 31.15 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.09 -39.91 87.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.231 . . . . 0.0 109.976 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -59.91 -41.91 92.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 112.226 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 114' ' ' ARG . 10.4 ptt-85 -59.99 -41.3 91.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.313 -1.492 . . . . 0.0 109.97 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.4 -39.25 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.227 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.1 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.81 94.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.99 -1.069 . . . . 0.0 108.95 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.87 -49.27 54.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -58.97 -40.17 83.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 109.595 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.08 -39.81 95.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 109.742 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.22 -40.04 95.31 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -61.59 -39.16 90.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -1.196 . . . . 0.0 108.519 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.0 m -70.14 -26.22 63.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.767 . . . . 0.0 109.14 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.82 -3.94 57.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.577 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.22 60.54 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -80.82 129.05 34.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.227 . . . . 0.0 108.889 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -88.35 169.69 11.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.72 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -68.89 156.96 37.55 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 108.865 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -125.86 163.42 22.95 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -105.08 13.48 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.392 -0.818 . . . . 0.0 109.715 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 61.6 t0 -84.65 130.89 34.66 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.313 -0.867 . . . . 0.0 108.889 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.05 -38.37 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.039 -1.038 . . . . 0.0 110.313 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -80.12 1.53 79.83 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.246 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.96 128.62 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.626 -1.514 . . . . 0.0 109.471 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 147' ' ' GLN . 95.9 mt -67.56 -26.31 66.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.223 -0.923 . . . . 0.0 108.858 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.2 mmm -72.37 46.29 0.14 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -69.84 127.88 92.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 108.892 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.63 -64.86 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.557 1.235 . . . . 0.0 111.766 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -85.86 169.29 13.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.383 -0.823 . . . . 0.0 109.651 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 120.94 -1.1 . . . . 0.0 108.897 179.338 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.257 0.551 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.411 ' O ' HD11 ' A' ' 135' ' ' LEU . 49.8 mt-30 -144.97 150.0 36.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.241 -0.912 . . . . 0.0 109.066 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.14 143.88 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 108.962 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.51 163.71 12.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.29 -0.881 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -60.05 -40.18 88.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.98 -1.075 . . . . 0.0 108.759 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.74 -40.04 86.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.834 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.87 -40.08 65.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.042 -1.036 . . . . 0.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.11 -50.16 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.877 . . . . 0.0 109.716 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.88 -40.02 91.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.183 -0.948 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.13 -54.05 41.19 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.343 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -68.59 -39.09 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.882 -1.363 . . . . 0.0 110.039 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -63.69 -39.47 94.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.86 95.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.87 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 0.0 109.919 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -95.86 -67.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.047 . . . . 0.0 109.346 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.21 -173.4 40.2 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.51 142.27 27.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 108.963 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.302 -1.475 0 O-C-N 121.132 -0.98 . . . . 0.0 109.387 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.96 122.44 27.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.021 -1.049 . . . . 0.0 108.344 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -83.04 -9.81 59.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -83.73 150.72 25.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -96.87 -3.15 42.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 63.9 m80 -127.97 138.61 52.68 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.9 mt -133.29 158.65 42.42 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -130.2 155.6 45.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.21 157.45 44.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 0.0 108.536 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.543 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.4 ttm180 -150.09 133.63 16.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.97 116.9 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.843 -1.16 . . . . 0.0 108.399 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' SD ' ' A' ' 60' ' ' MET . 99.0 mt-10 -68.25 -38.34 81.7 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.798 . . . . 0.0 111.06 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 21' ' ' TYR . 44.1 t30 -154.56 139.75 17.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.0 109.847 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.405 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 95.4 m-85 -93.86 142.28 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.74 . . . . 0.0 109.345 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -74.13 136.56 75.96 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.95 -11.55 31.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.788 0.96 . . . . 0.0 111.841 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.815 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.5 mt -133.74 151.2 76.62 Favored Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.44 -178.76 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.396 0.82 . . . . 0.0 111.911 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -86.53 -33.57 20.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 109.922 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.04 92.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.048 -1.033 . . . . 0.0 110.402 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.97 -38.94 76.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.275 -0.89 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.08 -41.89 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.133 -0.979 . . . . 0.0 108.922 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -40.22 88.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.004 -1.06 . . . . 0.0 110.045 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 75.7 t60 -60.57 -45.3 94.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.53 81.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.946 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -69.86 -36.83 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -0.816 . . . . 0.0 109.842 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -64.72 -45.64 85.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 109.669 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 35.9 mttm -62.45 -36.95 84.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.992 -1.067 . . . . 0.0 110.256 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.21 -50.01 75.37 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.221 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -60.78 -41.28 95.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 109.364 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 97.8 mt-30 -61.76 -40.21 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.731 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.06 -40.09 88.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.96 . . . . 0.0 109.573 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -73.42 -43.47 60.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 110.347 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -69.26 -30.45 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 19.1 m120 -59.35 -31.96 69.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 8.58 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.146 -0.971 . . . . 0.0 110.894 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 12.4 p -147.74 150.52 36.6 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.732 -1.23 . . . . 0.0 109.732 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.49 5.68 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.117 1.211 . . . . 0.0 112.356 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.3 156.31 39.46 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.096 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 73.9 p -137.74 147.74 45.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 0.0 109.089 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.7 m-85 -128.56 158.19 39.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -154.96 139.2 16.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.57 135.68 37.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 29.4 m -129.44 131.61 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.524 -0.735 . . . . 0.0 109.771 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t -102.51 -2.65 28.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.098 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' C ' HH22 ' A' ' 17' ' ' ARG . 96.8 mt-10 -140.72 152.51 45.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 86.8 177.71 49.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -83.81 134.58 34.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.169 -1.195 . . . . 0.0 109.881 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.93 135.18 41.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.361 -0.837 . . . . 0.0 109.287 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.41 -41.69 94.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.07 116.52 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.559 -0.713 . . . . 0.0 110.232 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.471 ' SD ' ' OE2' ' A' ' 19' ' ' GLU . 34.9 mtt -103.33 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -121.75 127.96 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.628 -0.67 . . . . 0.0 109.201 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.8 p -145.34 153.44 41.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.09 141.06 36.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.1 170.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.005 -1.059 . . . . 0.0 110.733 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.01 139.85 50.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.394 0.616 . . . . 0.0 110.408 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.02 -144.08 0.64 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.6 t0 -62.84 136.66 57.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.672 -0.899 . . . . 0.0 110.042 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.41 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -139.89 52.98 1.68 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HG2' ' NH1' ' A' ' 69' ' ' ARG . 56.8 mtt-85 53.24 55.14 9.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 33.9 t0 -145.13 162.18 37.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.213 -0.929 . . . . 0.0 109.217 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 72.0 m-20 -89.58 8.87 29.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.113 -0.992 . . . . 0.0 109.1 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -134.64 69.4 72.25 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.452 -0.78 . . . . 0.0 109.23 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -72.34 148.01 48.25 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.7 1.6 . . . . 0.0 112.581 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -78.13 137.03 37.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -0.826 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -104.71 66.49 0.78 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.95 -171.0 48.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.76 -9.47 1.21 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.775 0.983 . . . . 0.0 112.176 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 -178.15 46.61 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.52 -167.3 53.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -72.76 156.92 38.43 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.165 -1.197 . . . . 0.0 109.666 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.67 -19.25 22.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.86 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.69 163.8 10.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.037 -1.04 . . . . 0.0 108.752 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.42 -175.52 5.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.104 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.44 172.37 13.47 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.144 -0.972 . . . . 0.0 109.643 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.83 158.96 15.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.348 -0.845 . . . . 0.0 109.409 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.91 149.13 81.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.49 103.64 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.496 0.798 . . . . 0.0 112.149 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.43 171.61 35.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.1 -177.95 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.971 1.114 . . . . 0.0 111.758 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.91 -127.49 43.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -78.44 -7.23 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.293 -1.122 . . . . 0.0 110.24 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 142.4 47.74 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -14.8 61.15 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -67.95 157.91 33.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -1.229 . . . . 0.0 109.9 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.83 118.18 8.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 109.851 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -98.54 144.68 27.59 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.124 -0.985 . . . . 0.0 110.698 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 19.1 m-85 -119.93 137.55 53.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.21 121.02 13.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -97.81 -2.72 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -76.09 -19.27 58.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.83 158.92 15.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.804 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -87.16 117.59 26.01 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.86 147.44 23.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.532 -0.73 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.5 p -130.08 161.07 31.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -108.06 31.06 5.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.736 . . . . 0.0 109.547 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.3 p30 -149.95 -164.99 2.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.945 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 43.1 t80 -80.87 32.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.082 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -76.01 -163.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.962 . . . . 0.0 109.918 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -49.69 -59.0 4.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.537 -0.727 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.42 129.89 55.67 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.994 -1.066 . . . . 0.0 110.949 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 98.1 m-20 -101.97 107.15 18.2 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.238 -0.914 . . . . 0.0 108.542 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.79 -41.48 87.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 111.055 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.474 ' CE1' HG11 ' A' ' 146' ' ' VAL . 23.3 t-160 -59.9 -41.55 91.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.994 -1.067 . . . . 0.0 109.945 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.452 ' NH2' ' CE1' ' A' ' 140' ' ' TYR . 45.3 ttp180 -60.24 -40.28 89.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.45 -39.57 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.21 82.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 0.0 109.215 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.93 78.95 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 109.701 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.16 -49.85 53.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 78.6 mt-10 -59.83 -40.54 88.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.48 -38.7 90.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 108.897 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.26 -41.14 86.35 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -63.7 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.264 . . . . 0.0 108.635 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.0 m -70.48 -25.1 63.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.7 mt -83.13 -1.94 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.5 76.76 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.85 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.08 130.65 35.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.808 -1.407 . . . . 0.0 109.279 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.2 m -88.03 173.53 8.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.3 156.49 37.61 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.803 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -130.32 158.15 40.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -100.08 7.29 44.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.863 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -78.61 132.2 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 133' ' ' GLY . 20.1 tt -60.4 -38.25 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 111.257 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -79.8 -1.61 87.32 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.339 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 129.49 35.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.806 -1.409 . . . . 0.0 109.49 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.43 -26.58 65.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.033 -1.042 . . . . 0.0 109.065 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.1 mmm -73.89 50.06 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.578 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' C ' ' H ' ' A' ' 139' ' ' SER . 18.3 t80 -68.08 135.81 91.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.85 14.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 CA-C-N 120.289 1.139 . . . . 0.0 112.569 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 137' ' ' TYR . 79.5 p -163.98 172.52 13.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 109.76 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CE1' ' NH2' ' A' ' 114' ' ' ARG . 58.3 t80 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.392 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 113' ' ' HIS . 81.6 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.541 0.686 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -147.0 143.46 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.42 136.44 40.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.61 166.44 12.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.04 -39.19 85.09 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.81 -42.34 93.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.346 -0.846 . . . . 0.0 108.995 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -72.22 -43.12 64.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.569 -0.707 . . . . 0.0 109.822 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -49.99 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.012 -1.055 . . . . 0.0 109.369 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.76 -39.29 93.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.4 -51.54 53.79 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.261 -0.899 . . . . 0.0 111.393 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 157' ' ' GLN . 8.9 tp -69.26 -38.48 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.676 -1.485 . . . . 0.0 109.547 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.9 mt-30 -65.77 -38.65 89.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.088 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.24 94.83 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 0.0 109.278 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.09 -51.21 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.51 -65.31 0.97 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.29 179.28 34.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -86.6 156.42 20.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -1.146 . . . . 0.0 108.639 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--N 1.3 -1.553 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.669 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -80.27 115.7 19.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.349 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.63 -10.41 57.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.85 . . . . 0.0 109.597 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.97 149.51 28.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.139 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.46 -3.69 49.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.523 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 88.6 m-70 -127.37 139.32 52.94 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 49' ' ' PHE . 86.5 mt -130.34 153.04 49.1 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.23 -0.919 . . . . 0.0 108.961 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.9 p -126.23 154.41 43.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -142.4 160.0 41.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -148.46 129.99 14.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.219 -0.926 . . . . 0.0 109.801 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.72 118.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.88 -40.22 94.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -163.66 154.26 15.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.812 -1.18 . . . . 0.0 110.404 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -98.78 138.19 36.29 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.259 -0.901 . . . . 0.0 108.901 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 t -71.85 145.95 89.95 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.349 -0.845 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.1 -14.62 45.21 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.442 0.836 . . . . 0.0 111.786 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 -39.86 88.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -135.62 150.18 71.29 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.5 Cg_endo -67.83 -173.34 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.493 0.855 . . . . 0.0 111.847 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 ptt-85 -88.16 -37.45 16.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.842 . . . . 0.0 110.443 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.01 89.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.923 -1.111 . . . . 0.0 109.516 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.28 -39.8 74.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 26' ' ' PRO . 65.6 t -70.46 -47.09 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 109.931 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.7 t0 -60.02 -41.11 91.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.501 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -60.05 -45.72 91.92 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 0.0 109.13 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.03 83.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.21 -40.45 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.907 . . . . 0.0 110.077 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.9 tt0 -69.88 -38.79 76.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.52 -40.09 90.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.37 98.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.885 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' ' CD2' ' A' ' 49' ' ' PHE . 26.4 m-85 -60.0 -40.18 88.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.163 . . . . 0.0 109.72 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 4.1 mp0 -60.11 -40.02 88.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.839 -1.163 . . . . 0.0 109.633 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.1 -40.58 90.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.876 -1.14 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -74.91 -44.04 50.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.2 t -69.42 -34.8 75.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.241 -0.912 . . . . 0.0 110.493 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -56.91 -28.09 61.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 110.107 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 45' ' ' THR . 30.0 m -110.82 5.28 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.379 -0.826 . . . . 0.0 110.694 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' NE2' ' A' ' 157' ' ' GLN . 41.9 p -141.42 146.14 40.94 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.58 7.81 0.87 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.813 1.009 . . . . 0.0 111.702 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.71 156.87 37.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.917 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.523 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 22.2 p -134.55 151.67 51.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -130.89 150.9 51.84 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.326 -0.858 . . . . 0.0 110.291 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -155.8 135.22 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.253 -0.904 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -77.04 146.57 37.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.71 135.36 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.56 -0.712 . . . . 0.0 109.155 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -97.54 -4.2 38.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 109.841 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.4 150.44 36.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.073 -1.017 . . . . 0.0 109.364 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.44 169.62 40.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.649 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 4.7 pm0 -81.3 152.93 27.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -1.174 . . . . 0.0 109.19 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.31 155.45 21.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.36 -0.837 . . . . 0.0 108.91 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.02 -40.28 88.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.687 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.36 116.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.375 -0.828 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp -99.97 134.4 42.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.867 . . . . 0.0 109.38 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.85 129.18 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.525 -0.734 . . . . 0.0 109.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.8 p -147.3 155.94 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.11 139.31 39.97 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.88 162.48 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.36 -0.838 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -129.1 134.56 48.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.725 -0.609 . . . . 0.0 109.886 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.94 -136.42 3.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -70.41 124.45 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.54 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -138.11 66.65 1.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.518 -0.739 . . . . 0.0 109.786 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.3 mtm-85 56.98 48.54 15.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.88 155.2 44.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 108.751 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.61 8.45 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.6 m -137.93 75.39 42.22 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.299 -0.876 . . . . 0.0 109.524 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.74 163.59 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.307 1.338 . . . . 0.0 112.533 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -78.73 151.8 31.89 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.655 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -104.69 67.85 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.71 -167.12 21.04 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -58.1 -15.24 22.08 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.233 1.288 . . . . 0.0 111.919 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.54 -179.95 47.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.11 -163.65 34.67 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 121.042 -1.27 . . . . 0.0 110.163 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -74.54 150.33 39.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.491 -1.005 . . . . 0.0 109.525 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.36 -11.91 36.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.087 -1.008 . . . . 0.0 109.816 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.82 174.98 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.005 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.62 121.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.96 -1.087 . . . . 0.0 110.38 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.01 170.47 11.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.692 -0.63 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -106.5 149.48 27.06 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -58.8 149.07 66.13 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.199 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.67 102.73 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.792 0.995 . . . . 0.0 112.135 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 179.24 36.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.78 -177.62 3.26 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.443 1.429 . . . . 0.0 112.787 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.07 -120.72 23.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.89 -13.58 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.482 -1.01 . . . . 0.0 110.388 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.87 146.06 39.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.28 -18.63 35.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.58 161.69 22.56 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -1.113 . . . . 0.0 109.692 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.4 122.93 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -102.8 134.05 46.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.03 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.59 131.35 56.72 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -63.8 118.79 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -100.25 0.78 40.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.249 -0.907 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -74.05 -16.06 61.05 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.44 156.32 18.03 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -84.72 117.45 23.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 108.977 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.14 148.56 25.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 26.7 p -128.2 165.31 20.7 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.494 -0.754 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -117.02 29.14 8.09 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.766 HD22 ' NE ' ' A' ' 108' ' ' ARG . 26.9 p30 -146.33 -161.42 1.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.199 -0.938 . . . . 0.0 109.739 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -83.01 31.69 0.43 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.766 ' NE ' HD22 ' A' ' 106' ' ' ASN . 65.8 mtm180 -76.34 -162.7 0.26 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.823 -1.173 . . . . 0.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.72 -56.99 14.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 111.866 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 94.2 m-85 -106.87 128.69 54.51 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.948 -1.095 . . . . 0.0 111.176 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -101.2 115.34 30.26 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.97 -40.03 75.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.982 . . . . 0.0 111.053 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -60.36 -44.58 95.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.774 -1.204 . . . . 0.0 111.249 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -59.95 -42.38 93.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.746 -1.221 . . . . 0.0 109.682 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.92 -40.92 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.073 -1.017 . . . . 0.0 108.771 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -42.56 94.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.104 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.7 93.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.647 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.522 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 7.2 t60 -69.65 -40.16 76.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.878 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.02 -40.88 90.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.044 -1.035 . . . . 0.0 108.886 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.97 -40.01 96.42 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.74 -40.07 92.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.522 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 14.1 m-70 -64.28 -37.49 87.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.035 -1.274 . . . . 0.0 108.509 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -70.01 -24.29 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.24 1.2 49.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.58 15.76 77.25 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.5 128.0 32.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.899 -1.353 . . . . 0.0 109.016 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.3 m -87.59 174.32 8.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -69.17 159.82 32.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.626 -0.671 . . . . 0.0 110.466 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -125.24 162.32 24.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.609 -0.682 . . . . 0.0 109.576 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -99.79 1.27 42.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.308 -0.87 . . . . 0.0 109.324 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 48.7 t0 -82.14 116.15 21.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.195 0.998 . . . . 0.0 108.971 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.97 -24.66 30.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.329 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.22 -4.1 88.39 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.88 144.62 29.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -1.221 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 87.0 mt -61.01 -35.26 76.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 72.0 mmm -70.37 54.82 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 109.666 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.3 t80 -70.14 132.38 88.24 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -45.5 -57.11 2.31 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.392 1.176 . . . . 0.0 111.165 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -100.68 175.8 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.7 t80 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 120.836 -1.165 . . . . 0.0 110.475 -179.405 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.138 0.494 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -149.28 152.36 35.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.234 -0.917 . . . . 0.0 108.623 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.96 145.12 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.924 -1.11 . . . . 0.0 108.812 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.77 163.7 14.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.099 -1.001 . . . . 0.0 109.45 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 109.211 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -59.17 -40.69 86.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.802 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -72.54 -40.24 66.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 109.889 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.8 -49.81 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.127 -0.983 . . . . 0.0 109.602 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.88 -39.91 91.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.959 -1.088 . . . . 0.0 109.962 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.63 -54.09 24.46 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.974 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -63.67 -39.87 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.735 -1.45 . . . . 0.0 109.621 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.953 ' NE2' HG22 ' A' ' 45' ' ' THR . 15.9 mm-40 -67.85 -36.89 81.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.4 94.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.793 -1.192 . . . . 0.0 109.381 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.19 -49.79 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.209 -0.932 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.95 -61.33 1.38 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.203 -0.935 . . . . 0.0 110.092 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.42 -175.97 41.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.5 mtt-85 -93.25 140.12 29.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -1.035 . . . . 0.0 109.551 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.47 ' N ' ' OE1' ' A' ' 157' ' ' GLN . 30.1 m . . . . . 0 C--N 1.301 -1.54 0 C-N-CA 119.503 -0.879 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 8' ' ' ARG . 51.7 mtm-85 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.25 0.547 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -79.86 123.85 28.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.71 -9.93 58.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.088 -1.007 . . . . 0.0 110.517 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -85.77 148.08 26.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 109.973 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 p -95.8 -4.12 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.502 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 90.0 m-70 -121.58 129.34 52.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.21 155.56 43.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.493 -0.754 . . . . 0.0 109.869 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -128.33 151.41 49.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.411 -0.805 . . . . 0.0 109.6 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -142.2 160.58 39.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.358 -0.839 . . . . 0.0 109.803 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -150.69 134.37 16.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.301 -0.875 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.42 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 81.7 mt -87.73 119.61 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.8 -39.77 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -160.21 155.35 24.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.377 -0.827 . . . . 0.0 109.519 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -100.22 131.19 46.3 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 t -70.55 141.41 87.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.806 -1.184 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -65.75 -6.22 13.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.578 0.885 . . . . 0.0 111.544 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -60.19 -40.17 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -140.49 151.32 63.52 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.35 179.51 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.475 0.848 . . . . 0.0 111.338 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -85.77 -35.78 20.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.158 -0.964 . . . . 0.0 109.357 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.32 75.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.027 -1.045 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.55 -40.05 70.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.771 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.11 -40.57 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.015 . . . . 0.0 109.623 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.57 -42.87 93.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 109.189 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.37 -42.34 95.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.812 . . . . 0.0 108.911 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.41 95.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -0.834 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.74 -40.09 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 108.643 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.06 -40.76 74.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -60.04 -35.04 74.24 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.271 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HA ' ' HE1' ' A' ' 113' ' ' HIS . . . -68.32 -45.84 71.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -60.2 -40.32 89.65 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.869 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.08 -40.3 89.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 110.176 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 40' ' ' LEU . 83.4 mt -59.93 -43.03 95.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.505 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -73.2 -40.29 64.87 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 110.131 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.6 t -67.96 -35.25 78.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.723 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.71 -34.44 69.46 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 110.182 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 45' ' ' THR . 30.5 m -107.97 10.7 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.965 -1.084 . . . . 0.0 111.558 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 HG23 ' A' ' 44' ' ' VAL . 66.6 p -145.34 148.45 37.61 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 120.757 -1.214 . . . . 0.0 109.634 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.57 9.68 0.92 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.823 1.016 . . . . 0.0 112.187 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.35 158.22 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 109.457 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 67.5 p -136.22 149.87 48.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.21 157.04 43.57 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.414 -0.803 . . . . 0.0 110.241 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.09 126.69 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 63.4 tttp -74.46 138.97 43.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.178 -0.951 . . . . 0.0 108.923 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.58 135.06 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 t -97.99 -1.4 42.77 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.23 -0.919 . . . . 0.0 110.587 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.9 158.41 43.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.093 . . . . 0.0 109.259 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 173.17 46.27 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -79.02 137.89 37.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.241 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.47 139.82 32.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 108.939 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.18 -41.65 93.33 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.7 mt -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mtt -105.48 132.09 52.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.563 -0.711 . . . . 0.0 109.753 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.7 131.27 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.1 p -146.61 159.55 43.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -110.55 139.42 45.81 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.43 168.7 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.271 -0.893 . . . . 0.0 111.229 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 66' ' ' GLY . 80.8 mtm180 -131.94 140.53 49.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.799 -0.563 . . . . 0.0 109.655 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 41.55 -144.25 0.79 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.28 136.69 55.31 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.931 . . . . 0.0 108.957 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.616 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.5 p-80 -138.32 50.59 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 0.0 109.726 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 57.6 50.01 11.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.717 -0.614 . . . . 0.0 110.053 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.537 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 77.8 m-20 -137.05 167.57 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.31 -0.869 . . . . 0.0 109.24 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -88.94 10.0 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 108.998 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.5 m -138.11 73.19 45.33 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -72.0 146.35 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.837 1.025 . . . . 0.0 111.612 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.86 149.21 31.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.062 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -128.17 74.16 1.53 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.29 173.72 46.58 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -50.91 -12.21 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.304 1.336 . . . . 0.0 112.438 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.72 177.23 44.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -157.31 28.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -75.98 145.57 40.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -1.135 . . . . 0.0 109.531 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.12 -15.62 29.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 108.707 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.91 170.39 6.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 109.152 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -161.41 176.38 11.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.914 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.17 168.86 18.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.123 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -105.07 142.27 35.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.757 . . . . 0.0 109.732 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.73 149.01 81.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.03 -1.044 . . . . 0.0 109.062 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.92 109.86 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.701 0.934 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.34 -179.72 29.03 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.46 141.48 20.09 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 120.997 1.131 . . . . 0.0 112.812 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.99 -125.39 7.19 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.285 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.64 -9.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.84 -0.8 . . . . 0.0 110.203 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.31 139.76 48.17 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.74 -13.28 63.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -66.78 160.15 26.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.906 -1.35 . . . . 0.0 110.035 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.12 116.57 6.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -0.851 . . . . 0.0 109.058 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -98.77 153.29 18.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 21.0 m-85 -121.87 140.45 52.38 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -65.75 120.77 13.6 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -99.52 -7.54 25.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.637 -0.664 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -75.69 -12.61 60.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -105.07 149.92 25.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.194 -0.941 . . . . 0.0 108.788 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -83.33 122.09 28.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 109.493 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -89.22 152.56 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.54 -0.725 . . . . 0.0 110.026 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.8 p -120.96 169.49 10.42 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -109.68 27.39 9.62 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.451 HD22 ' HG3' ' A' ' 108' ' ' ARG . 12.2 p30 -149.04 -165.02 2.17 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.815 . . . . 0.0 110.209 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.1 t80 -84.54 33.87 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.917 0.865 . . . . 0.0 109.989 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.451 ' HG3' HD22 ' A' ' 106' ' ' ASN . 24.2 mmt-85 -76.76 -162.46 0.27 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.831 -1.168 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -55.02 -57.65 10.86 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.697 -0.627 . . . . 0.0 110.995 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -97.27 118.75 34.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -109.2 106.13 15.87 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.05 -44.18 69.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.865 -0.522 . . . . 0.0 110.044 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.531 ' HE1' ' HA ' ' A' ' 37' ' ' ALA . 3.3 t60 -60.5 -47.38 86.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -60.07 -40.79 90.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -70.29 -39.26 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.149 -0.969 . . . . 0.0 108.763 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.9 -43.97 94.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.953 -1.092 . . . . 0.0 109.488 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.08 78.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.107 -0.995 . . . . 0.0 109.208 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 135' ' ' LEU . 3.8 t60 -69.95 -50.61 40.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.427 -0.795 . . . . 0.0 110.29 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.2 mt-10 -58.95 -41.5 87.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.914 -1.117 . . . . 0.0 109.153 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.75 -40.44 97.27 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.948 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.48 -41.98 82.46 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -65.42 -34.42 78.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.034 -1.274 . . . . 0.0 108.452 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.3 p -68.42 -19.44 64.59 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.71 -2.63 58.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.65 20.36 56.38 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.47 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.9 137.64 35.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.507 -1.584 . . . . 0.0 108.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -87.0 164.37 16.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -67.27 151.83 46.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.7 t -124.83 168.76 12.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.694 -0.629 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.5 p -107.42 9.98 29.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.449 -0.782 . . . . 0.0 109.951 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.11 130.37 35.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.032 -1.042 . . . . 0.0 109.771 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.4 -40.7 84.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 111.36 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.38 -5.12 85.37 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 121.094 -1.003 . . . . 0.0 110.747 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.69 130.26 35.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.811 -1.405 . . . . 0.0 109.889 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.491 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 93.9 mt -63.33 -22.96 67.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.3 mmt -70.54 35.86 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.693 -0.629 . . . . 0.0 109.627 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.4 t80 -70.71 128.94 90.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.014 -1.053 . . . . 0.0 108.925 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -52.8 -66.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.844 1.337 . . . . 0.0 111.765 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.5 p -82.65 173.94 11.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.96 . . . . 0.0 110.405 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.963 178.969 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.8 t . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -143.6 157.46 44.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.068 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.6 145.03 43.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.037 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 161.53 14.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.247 -0.908 . . . . 0.0 109.633 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -60.14 -42.51 95.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -58.38 -41.03 83.9 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.571 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.37 -42.08 62.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.837 -1.164 . . . . 0.0 109.48 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.71 -49.97 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 108.772 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.18 -40.27 93.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 109.868 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.51 -55.34 29.46 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.484 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.4 tp -67.56 -39.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.246 . . . . 0.0 110.561 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -67.56 -41.5 84.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.063 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.02 94.78 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.8 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.63 -0.669 . . . . 0.0 109.718 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.08 -66.84 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.8 -175.83 36.6 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -86.95 149.7 24.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -0.999 . . . . 0.0 109.231 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 0.0 110.41 -179.294 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 8' ' ' ARG . 40.6 mtm-85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -83.79 122.59 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.037 -1.039 . . . . 0.0 109.936 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 47.6 mp0 -75.15 -30.17 60.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.387 -0.82 . . . . 0.0 109.763 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -81.58 154.51 26.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 p -98.25 -4.5 35.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.897 . . . . 0.0 109.214 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.435 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 82.5 m-70 -111.58 131.58 55.15 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -134.19 157.99 44.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 p -124.2 155.63 38.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.346 -0.846 . . . . 0.0 108.824 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.47 158.64 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -154.31 134.98 13.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.23 123.74 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 0.0 108.831 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.46 -40.25 85.34 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.023 -1.048 . . . . 0.0 111.343 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -160.28 159.15 31.02 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.81 -1.182 . . . . 0.0 109.861 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -102.51 139.78 37.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 142.19 63.43 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.23 -11.7 32.41 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 CA-C-N 119.457 0.842 . . . . 0.0 112.188 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.26 -38.94 85.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' ND2' ' A' ' 105' ' ' ASN . 90.3 mt -134.73 153.47 78.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -60.69 -179.95 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 CA-C-N 119.461 0.843 . . . . 0.0 111.428 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 33.3 ptt180 -87.91 -35.48 17.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.91 -37.57 79.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 110.258 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.82 -34.83 60.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.84 . . . . 0.0 111.034 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.17 -49.82 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.77 -1.207 . . . . 0.0 109.965 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 12.3 p-10 -60.03 -37.08 78.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.751 -1.218 . . . . 0.0 109.62 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -59.13 -48.6 81.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.908 -1.12 . . . . 0.0 109.406 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.68 91.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.055 -1.028 . . . . 0.0 109.612 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.5 mm -72.28 -31.02 37.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.324 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -66.65 -41.65 87.87 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.07 -28.78 65.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.857 -1.152 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.59 -48.18 80.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.913 -1.117 . . . . 0.0 109.007 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.6 m-85 -62.67 -40.43 97.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.686 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -43.52 95.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.099 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.61 -43.95 93.57 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.82 -1.175 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.422 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.3 m95 -70.34 -40.8 73.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.275 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.4 t -69.5 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 110.579 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -59.72 -27.37 66.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.968 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.62 9.56 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 O-C-N 120.971 -1.081 . . . . 0.0 110.492 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 22.5 p -149.19 150.49 32.0 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.926 -1.109 . . . . 0.0 109.658 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -69.68 9.33 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.643 0.895 . . . . 0.0 111.533 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.27 151.18 44.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.225 -0.922 . . . . 0.0 109.068 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.435 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 71.2 p -134.66 148.53 50.38 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 96.6 m-85 -129.9 155.45 46.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.8 m -154.69 134.52 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.455 -0.778 . . . . 0.0 109.534 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -77.34 145.93 37.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.16 132.81 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.642 -0.662 . . . . 0.0 109.733 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 t -96.74 -9.16 29.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -141.9 156.34 45.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 108.878 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.9 171.46 47.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.33 134.82 35.64 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.667 -0.902 . . . . 0.0 109.767 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.86 143.67 26.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.946 -1.096 . . . . 0.0 109.282 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -40.67 89.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.85 119.09 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.521 -0.737 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.9 mtt -103.38 135.86 44.21 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.021 -1.049 . . . . 0.0 109.807 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.45 130.87 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.3 p -149.98 156.1 41.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.752 -1.218 . . . . 0.0 110.708 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.6 138.44 45.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.37 164.46 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.228 -0.92 . . . . 0.0 111.304 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -134.3 145.54 49.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.81 -147.03 2.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -73.77 125.72 28.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.45 -1.03 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -127.62 53.69 1.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 69' ' ' ARG . 61.1 mtt-85 56.61 50.03 13.54 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -139.18 158.36 44.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.19 -0.944 . . . . 0.0 109.658 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -89.12 10.47 21.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 109.751 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -137.81 72.51 48.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.12 146.64 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 120.843 1.029 . . . . 0.0 112.26 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD2' ' OD2' ' A' ' 98' ' ' ASP . 90.5 m-85 -76.26 148.47 37.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.368 -0.833 . . . . 0.0 108.987 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -132.57 72.88 1.5 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.382 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.27 -170.21 42.64 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.01 -16.25 54.49 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.197 1.264 . . . . 0.0 111.727 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.15 49.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.66 -165.97 46.71 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.4 142.1 41.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' OE2' ' A' ' 101' ' ' GLU . 50.9 mt -90.79 -12.36 36.67 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.61 157.33 8.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.362 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.61 177.76 10.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.315 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.78 161.73 23.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -92.71 156.03 17.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.11 149.78 65.46 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.377 -0.827 . . . . 0.0 108.967 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -59.17 106.87 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.61 0.873 . . . . 0.0 111.984 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.2 176.93 38.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -69.2 173.06 11.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.318 1.345 . . . . 0.0 112.029 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.75 14.45 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -83.93 -11.79 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -1.066 . . . . 0.0 109.841 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 140.03 38.02 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.28 -20.33 34.36 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.77 128.75 37.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.028 -1.277 . . . . 0.0 110.717 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.34 24.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.773 . . . . 0.0 109.09 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -130.07 132.44 46.17 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.5 136.4 54.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.385 -0.822 . . . . 0.0 110.095 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.438 ' OD2' ' CD2' ' A' ' 74' ' ' PHE . 13.9 t0 -65.77 124.31 22.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.291 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -101.18 0.27 37.31 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.68 -15.21 60.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.048 -1.032 . . . . 0.0 110.068 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.4 ' OE2' HD22 ' A' ' 81' ' ' LEU . 99.9 mt-10 -106.93 164.23 12.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -88.34 118.37 27.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.116 -0.99 . . . . 0.0 109.902 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.97 148.65 23.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.108 -0.995 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.5 p -124.94 173.53 8.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.529 -0.732 . . . . 0.0 109.666 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.417 ' ND2' HD22 ' A' ' 25' ' ' LEU . 83.9 m-20 -112.34 23.63 13.42 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.401 0.62 . . . . 0.0 109.445 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.73 HD22 ' HD2' ' A' ' 108' ' ' ARG . 19.8 p30 -147.27 -165.0 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -87.87 20.88 2.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.73 ' HD2' HD22 ' A' ' 106' ' ' ASN . 96.1 mtt180 -75.83 -165.73 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.283 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' ARG . 72.5 mm-40 -11.16 -69.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 123.023 0.529 . . . . 0.0 112.41 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -131.8 128.83 39.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -89.9 108.7 19.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 108.627 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.18 -40.16 78.27 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.451 ' ND1' ' C ' ' A' ' 113' ' ' HIS . 17.8 t-80 -59.98 -46.45 89.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.788 -1.195 . . . . 0.0 110.067 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -60.22 -41.91 94.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.004 -1.06 . . . . 0.0 110.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.75 -41.13 79.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.853 -1.154 . . . . 0.0 108.85 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.92 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.82 91.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 33.8 t60 -70.31 -39.97 74.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.989 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -58.66 -40.01 82.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.177 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.0 -39.74 95.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.56 -42.05 65.64 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 7.7 m-70 -62.26 -36.63 82.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.987 -1.302 . . . . 0.0 108.411 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.9 t -69.22 -24.49 64.02 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.6 -4.87 58.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 0.0 109.436 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.03 15.97 58.48 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.91 129.1 34.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.016 -1.285 . . . . 0.0 109.716 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.499 ' O ' ' SD ' ' A' ' 136' ' ' MET . 68.5 m -87.79 165.52 15.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 109.276 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -66.04 160.6 23.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.093 . . . . 0.0 108.788 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -127.21 166.22 18.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.44 -0.788 . . . . 0.0 109.405 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.3 p -100.53 7.32 44.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.336 -0.853 . . . . 0.0 108.988 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -83.26 116.44 22.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.53 -27.86 41.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.577 -0.702 . . . . 0.0 110.422 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.96 -5.76 89.48 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.298 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.45 156.08 24.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.284 . . . . 0.0 109.79 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 89.6 mt -69.6 -29.53 67.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.764 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 127' ' ' SER . 5.6 mtt -74.0 61.95 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.85 126.92 92.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -47.98 -71.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.485 1.209 . . . . 0.0 110.835 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.5 p -94.44 170.15 9.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 108.982 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.0 t80 . . . . . 0 C--N 1.298 -1.659 0 O-C-N 121.062 -1.024 . . . . 0.0 108.511 179.258 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.382 0.61 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -144.78 154.94 43.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.82 145.78 34.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.4 156.24 18.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 109.524 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.16 -39.74 87.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 109.039 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 56.8 t0 -57.93 -39.63 78.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.506 -0.746 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 156' ' ' ILE . 96.1 m-20 -76.34 -40.71 50.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.952 -1.092 . . . . 0.0 109.519 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.5 -50.12 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.256 -0.902 . . . . 0.0 109.265 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.02 -40.06 90.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.085 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.99 -51.63 38.29 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.3 tp -65.75 -40.2 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.008 -1.289 . . . . 0.0 109.486 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.1 mt-30 -65.29 -39.68 92.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.289 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.15 92.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.056 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.72 -49.98 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.057 . . . . 0.0 109.819 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.827 -1.17 . . . . 0.0 109.574 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.23 -165.96 33.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.57 138.64 33.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -1.21 . . . . 0.0 109.849 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -81.3 120.93 25.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.0 109.017 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.74 -14.82 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.69 149.26 27.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.736 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -94.49 -4.61 47.82 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -129.15 141.33 51.21 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -131.99 159.91 37.38 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.2 -0.938 . . . . 0.0 109.883 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.5 p -127.9 155.1 44.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.454 -0.779 . . . . 0.0 109.51 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.58 157.97 43.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -148.49 137.67 21.82 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.236 -0.915 . . . . 0.0 110.066 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.15 119.96 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.5 tt0 -64.98 -39.98 94.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.078 . . . . 0.0 110.365 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.8 m-20 -158.62 151.15 21.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.981 -1.074 . . . . 0.0 109.784 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.13 134.11 40.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 108.978 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -70.1 135.84 87.12 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -66.54 -10.66 28.65 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.769 0.953 . . . . 0.0 111.848 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.12 149.99 74.24 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.83 -177.77 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 CA-C-N 119.485 0.852 . . . . 0.0 111.429 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -87.26 -29.9 21.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.021 -1.049 . . . . 0.0 109.757 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.87 88.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.9 -39.14 76.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.89 -40.9 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.418 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.95 -43.18 95.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.995 . . . . 0.0 109.011 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -59.99 -43.59 95.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.209 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.36 77.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -70.13 -40.06 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.377 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.09 -39.9 75.27 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 109.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.61 88.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -60.1 -39.79 87.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.432 HE21 ' HG2' ' A' ' 35' ' ' GLU . 77.5 mt-30 -59.34 -43.43 92.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.968 -1.082 . . . . 0.0 109.638 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.93 -44.36 97.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.407 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.1 m95 -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.984 -1.072 . . . . 0.0 110.322 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 t -69.81 -39.84 76.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.87 -18.09 54.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.168 -0.958 . . . . 0.0 111.115 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.02 4.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.15 -0.969 . . . . 0.0 109.775 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.516 ' N ' ' OG ' ' A' ' 163' ' ' SER . 6.5 p -146.44 151.18 42.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.231 -0.918 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -69.32 4.82 1.79 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.823 1.015 . . . . 0.0 111.7 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.85 150.16 46.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 p -129.85 149.37 51.61 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.01 157.6 37.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.427 -0.796 . . . . 0.0 109.683 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.06 129.14 8.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.935 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -76.39 138.02 40.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 m -121.12 133.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.466 -0.771 . . . . 0.0 109.354 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -97.77 -0.07 45.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -143.26 150.17 38.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.182 -0.949 . . . . 0.0 109.658 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 165.07 30.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -81.58 137.81 35.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -1.1 . . . . 0.0 109.308 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.0 151.85 21.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.98 -42.91 95.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.858 . . . . 0.0 109.717 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -104.39 109.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.404 -0.81 . . . . 0.0 109.397 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtp -101.94 136.76 41.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.286 -0.884 . . . . 0.0 109.684 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.77 132.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.66 -0.65 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.5 p -147.02 150.46 35.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.24 140.45 38.37 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 109.254 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.7 168.82 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -131.88 138.47 48.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.672 -0.642 . . . . 0.0 109.372 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.65 -151.35 1.11 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.3 t0 -65.24 134.89 54.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.615 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.0 p-80 -132.55 51.26 2.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.725 . . . . 0.0 109.627 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 61.9 mtp180 57.38 53.31 7.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.642 -0.661 . . . . 0.0 110.627 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 92.5 m-20 -142.27 169.99 16.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -89.43 9.49 26.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -138.9 72.42 40.92 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.15 152.31 31.03 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.33 1.353 . . . . 0.0 112.017 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -77.81 137.46 38.43 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.268 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -102.23 68.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.0 109.478 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 178.42 39.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.25 -21.03 6.34 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.252 1.301 . . . . 0.0 112.325 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.63 -178.84 45.09 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.02 -153.35 24.52 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -76.81 142.28 40.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -1.118 . . . . 0.0 109.807 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.3 mt -91.53 -15.16 29.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.99 174.86 4.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 108.9 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 2.6 p80 -161.96 117.34 1.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.197 . . . . 0.0 110.428 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.0 171.11 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.12 148.64 70.6 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 0.0 109.353 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.59 108.21 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 120.598 0.865 . . . . 0.0 111.738 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.62 171.26 41.49 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.976 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -65.93 171.61 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.228 1.286 . . . . 0.0 111.548 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.84 -125.94 16.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.14 -6.79 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.363 -1.081 . . . . 0.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.53 141.59 48.0 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.72 -16.27 54.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.76 163.46 21.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -1.074 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.09 117.73 8.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -0.776 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -101.35 135.55 42.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.453 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.1 m-85 -116.85 129.05 55.83 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' GLU . 62.3 t0 -68.06 128.75 37.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.248 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 69.5 tt0 -100.01 2.53 43.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.278 -0.888 . . . . 0.0 109.418 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.13 -16.78 60.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 54.0 mp0 -94.44 155.62 16.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.075 -1.016 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -85.16 115.12 22.76 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.59 145.46 25.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.105 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.9 p -120.31 171.51 8.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.11 26.08 9.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -151.0 -166.98 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -90.7 32.69 0.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.286 -0.884 . . . . 0.0 110.52 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 9.0 mtp-105 -75.57 -156.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.841 -1.162 . . . . 0.0 109.652 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -36.86 -59.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.714 -0.616 . . . . 0.0 111.379 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.0 m-85 -123.09 128.96 50.83 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.079 -1.013 . . . . 0.0 110.249 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -108.52 110.37 21.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.381 -0.825 . . . . 0.0 109.186 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.4 -41.12 96.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.184 -0.947 . . . . 0.0 110.41 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 110.362 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -59.94 -41.16 91.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.047 -1.033 . . . . 0.0 109.944 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.9 -40.19 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 109.541 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.18 94.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.948 . . . . 0.0 108.992 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.33 83.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.448 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 4.8 t60 -69.98 -48.31 58.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.955 . . . . 0.0 109.609 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 82.8 mt-10 -59.95 -40.01 87.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.6 mt -62.88 -39.8 95.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.257 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.65 -41.45 82.28 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.448 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 19.9 m-70 -64.87 -39.17 93.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.8 p -69.99 -21.4 63.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.587 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.93 -3.24 59.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 0.0 109.219 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 9.86 60.85 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.64 124.58 30.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.103 -1.234 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 65.4 m -87.96 171.08 10.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.287 -0.883 . . . . 0.0 109.723 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.5 153.0 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.8 t -126.61 168.93 13.65 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.0 109.391 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.3 p -102.85 9.53 38.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -0.813 . . . . 0.0 109.561 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -82.47 123.86 29.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.519 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.71 -31.46 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.374 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.62 -4.3 90.19 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.652 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.11 129.77 35.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.858 -1.377 . . . . 0.0 109.404 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.92 -24.94 67.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 108.967 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.9 mmm -73.17 46.98 0.19 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.421 -0.799 . . . . 0.0 109.651 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -69.76 129.95 90.71 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -48.4 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 120.343 1.158 . . . . 0.0 111.78 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.5 p -86.62 171.9 10.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.143 -0.973 . . . . 0.0 109.524 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.269 0.557 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.47 157.16 44.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 108.913 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.407 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.0 mt -75.85 149.93 37.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.104 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.88 158.57 15.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -60.01 -39.48 85.95 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 108.809 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -57.82 -41.44 82.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.957 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.23 -40.35 62.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.147 . . . . 0.0 110.081 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.36 -50.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.93 -40.12 92.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.57 -55.2 24.29 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.397 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.01 -39.99 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.839 -1.389 . . . . 0.0 109.815 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.8 mt-30 -64.92 -38.5 91.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.681 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.13 92.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.16 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.97 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -98.1 -72.77 0.64 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.42 -0.8 . . . . 0.0 109.564 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.21 -165.06 35.24 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -91.47 139.88 30.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.98 . . . . 0.0 109.694 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 45' ' ' THR . 16.6 m . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 109.094 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 8' ' ' ARG . 54.0 mtt-85 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.51 117.52 21.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.724 -1.235 . . . . 0.0 108.64 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -82.93 -10.5 58.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -84.44 149.55 25.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -96.06 -4.42 43.02 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -126.76 141.24 51.89 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.7 mt -135.74 158.33 44.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -129.39 154.03 47.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -141.39 160.59 39.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.442 -0.786 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -147.17 132.54 18.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.163 -0.961 . . . . 0.0 110.095 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.68 120.62 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.07 -40.16 94.27 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.988 -1.07 . . . . 0.0 109.839 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -160.19 157.14 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.082 -1.011 . . . . 0.0 109.741 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.71 136.83 40.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 109.196 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 t -68.5 141.22 92.99 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.004 . . . . 0.0 109.0 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.72 -10.81 29.47 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 119.5 0.857 . . . . 0.0 112.146 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.44 HD13 ' ND2' ' A' ' 105' ' ' ASN . 65.0 mt -135.47 151.33 74.46 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.71 -178.7 0.57 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 120.64 0.894 . . . . 0.0 111.257 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -86.72 -35.94 18.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.184 -0.948 . . . . 0.0 110.046 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.11 73.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.97 -39.9 75.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.29 -42.26 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.88 -40.38 88.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.02 -1.05 . . . . 0.0 108.911 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.83 -48.69 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.579 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.4 92.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.585 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.22 -43.24 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 109.937 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.36 -39.76 77.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.205 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -61.15 -39.88 91.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.18 87.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 109.993 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.8 m-85 -60.13 -39.99 88.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.05 . . . . 0.0 109.316 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -59.96 -41.06 91.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.168 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.13 -41.11 91.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -72.3 -40.02 67.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.35 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.26 -37.23 77.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 0.0 110.089 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -57.85 -21.76 44.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.209 -0.932 . . . . 0.0 110.743 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.93 5.66 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.3 p -147.0 150.38 38.54 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 120.975 -1.078 . . . . 0.0 109.534 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.12 5.3 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.688 0.925 . . . . 0.0 110.997 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.86 160.3 33.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.462 -0.774 . . . . 0.0 110.073 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 p -139.36 153.83 47.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.5 m-85 -130.02 152.02 49.93 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.515 -0.741 . . . . 0.0 109.585 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.3 m -153.31 131.32 11.79 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.283 -0.886 . . . . 0.0 110.33 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -79.5 139.11 37.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.54 136.1 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.346 -0.846 . . . . 0.0 108.842 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -96.89 -8.59 30.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.126 -0.984 . . . . 0.0 110.011 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -145.51 159.97 42.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 109.586 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 172.22 44.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.16 146.27 31.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -1.222 . . . . 0.0 109.494 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.77 145.72 33.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.65 -0.656 . . . . 0.0 109.422 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -117.27 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.497 -0.752 . . . . 0.0 108.978 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.1 mmm -100.09 122.05 42.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.271 -0.893 . . . . 0.0 109.778 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -112.1 129.77 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.254 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.6 p -149.81 161.5 42.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.137 -0.977 . . . . 0.0 109.676 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -109.01 138.39 45.43 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.365 -0.835 . . . . 0.0 110.692 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -133.11 145.45 50.72 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.41 -140.54 4.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -77.74 134.6 38.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.366 -1.079 . . . . 0.0 110.184 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.6 p-80 -136.46 64.55 1.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.525 -0.734 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 69' ' ' ARG . 18.8 mtt-85 54.48 47.48 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.411 -0.806 . . . . 0.0 110.091 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 91.7 m-20 -141.52 165.05 28.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -95.61 9.92 38.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.342 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 67.86 73.59 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.547 -0.721 . . . . 0.0 109.723 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.61 147.29 86.18 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.044 1.162 . . . . 0.0 112.488 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.65 145.44 34.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -138.25 79.92 1.77 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.64 173.37 36.57 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.41 -7.35 19.94 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.147 1.231 . . . . 0.0 111.676 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.88 174.44 47.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.45 -160.54 31.77 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -76.51 144.66 39.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -1.097 . . . . 0.0 109.586 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.93 -15.43 29.8 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.99 -1.069 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.89 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -0.965 . . . . 0.0 108.926 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.14 121.2 3.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.801 -1.187 . . . . 0.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.17 172.63 10.39 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.284 0.564 . . . . 0.0 109.693 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -113.58 147.86 37.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -59.91 149.01 75.1 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.34 112.46 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.811 1.008 . . . . 0.0 112.197 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.52 172.9 43.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -73.27 161.61 42.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.352 1.368 . . . . 0.0 112.29 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.63 -119.5 5.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.66 -11.39 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.171 . . . . 0.0 109.857 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.28 144.39 47.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.06 -15.55 48.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -67.36 162.11 23.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.89 120.46 12.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.275 -0.891 . . . . 0.0 109.099 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -104.75 134.13 48.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.271 -0.893 . . . . 0.0 110.785 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.93 130.91 57.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 56.5 t0 -67.19 123.91 21.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 99' ' ' GLU . 13.9 tp10 -102.11 0.32 34.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.508 -0.745 . . . . 0.0 109.622 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 96.5 m-20 -73.88 -19.56 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 108.886 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.51 155.7 17.7 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 102' ' ' ARG . 32.1 ttt-85 -86.03 121.59 28.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.02 148.71 24.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.5 p -127.11 156.57 41.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.358 -0.839 . . . . 0.0 109.9 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.44 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -107.36 30.95 5.78 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -148.43 -164.99 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -84.31 33.87 0.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.57 -163.37 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.405 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -54.17 -59.32 4.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.398 -0.814 . . . . 0.0 111.935 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.36 130.01 54.84 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.138 -0.976 . . . . 0.0 110.755 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -102.82 117.85 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.21 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.11 -49.34 67.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -59.86 -40.29 88.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 111.508 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.01 -41.27 91.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.686 -1.259 . . . . 0.0 109.611 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.96 -40.01 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 108.645 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.99 89.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.533 -0.73 . . . . 0.0 109.35 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.41 93.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.198 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -69.98 -46.61 64.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -59.13 -40.51 85.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.005 -1.059 . . . . 0.0 109.556 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.62 -35.71 81.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 108.819 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.77 -40.46 96.66 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -66.93 -38.27 85.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.589 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.0 p -69.5 -23.13 63.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.237 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.89 -2.3 58.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.186 -0.946 . . . . 0.0 109.143 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.49 65.66 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.69 128.29 34.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.339 . . . . 0.0 108.714 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.74 173.8 8.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 109.954 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -67.15 158.51 31.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -127.75 156.67 42.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.54 -0.725 . . . . 0.0 109.59 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.4 p -100.98 8.4 43.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.539 -0.726 . . . . 0.0 109.708 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -81.0 130.04 34.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 109.257 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.98 -39.79 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.331 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.41 72.6 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.238 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.53 137.87 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.686 -1.479 . . . . 0.0 109.146 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.16 -25.17 66.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -0.807 . . . . 0.0 109.021 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 66.5 mmm -74.09 62.04 0.88 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.394 -0.816 . . . . 0.0 109.043 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.1 129.44 87.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 108.852 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -48.21 -59.9 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.404 1.18 . . . . 0.0 111.829 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 t -102.98 173.25 6.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 120.808 -1.183 . . . . 0.0 109.0 179.751 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.04 0.448 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -150.03 154.17 37.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 109.049 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.78 146.96 39.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 108.954 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.4 161.47 14.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.475 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.26 -39.92 88.49 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.0 -41.53 87.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -74.08 -40.09 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.14 -50.16 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.61 -39.87 89.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.12 -60.94 7.51 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.777 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.2 tp -60.25 -39.93 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.341 . . . . 0.0 109.274 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.5 mt-30 -65.73 -38.09 88.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 109.035 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.95 95.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.69 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.2 -50.12 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.194 -0.941 . . . . 0.0 109.2 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -96.96 -71.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 109.578 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.94 -177.57 38.96 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.56 146.42 24.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.356 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 8' ' ' ARG . 36.6 mtt-85 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.262 0.554 . . . . 0.0 109.892 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.1 126.03 30.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.173 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.35 -12.99 53.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 110.103 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -81.66 153.62 26.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.6 p -97.42 -6.28 34.31 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.302 -0.874 . . . . 0.0 108.82 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -126.64 143.78 51.12 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.2 159.58 39.76 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.194 -0.941 . . . . 0.0 109.859 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.5 p -127.54 152.98 46.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -142.86 156.11 44.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.722 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.8 ttt-85 -150.21 131.8 14.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 0.0 109.86 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.96 118.47 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.59 -40.05 95.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 0.0 110.735 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -162.5 153.15 17.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.953 -1.092 . . . . 0.0 109.901 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.62 136.53 38.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.86 139.58 88.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.002 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -66.92 -14.05 42.26 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.614 0.898 . . . . 0.0 111.588 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.14 -38.19 82.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.352 -0.842 . . . . 0.0 109.037 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -134.74 149.96 72.15 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.03 -176.96 0.69 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.643 0.896 . . . . 0.0 111.859 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -87.29 -35.34 18.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 109.613 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.1 82.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.09 -40.1 75.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.007 . . . . 0.0 109.773 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.35 -46.08 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.682 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -59.62 -39.99 86.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.782 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -59.93 -46.9 87.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.813 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.4 92.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.206 -0.934 . . . . 0.0 109.827 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.47 -36.87 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 108.657 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.06 -39.96 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.15 -39.91 88.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.82 -1.175 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.54 72.92 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.368 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -62.94 -40.21 96.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.037 -1.04 . . . . 0.0 110.196 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.19 -44.81 94.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.962 -1.086 . . . . 0.0 109.623 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.1 -44.12 95.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.247 -0.908 . . . . 0.0 111.016 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.12 -41.83 73.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.681 -1.262 . . . . 0.0 109.802 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t -69.86 -30.57 68.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 110.359 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -59.88 -34.36 73.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 111.152 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 45' ' ' THR . 32.9 m -110.01 11.02 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.103 -0.998 . . . . 0.0 111.168 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.488 HG23 HG23 ' A' ' 44' ' ' VAL . 65.0 p -140.91 148.15 51.09 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.898 -1.126 . . . . 0.0 109.367 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.69 9.12 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.572 0.848 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.88 156.42 37.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.5 p -135.39 149.86 49.76 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.4 156.66 40.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.316 -0.865 . . . . 0.0 109.962 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -154.39 131.19 10.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -77.02 143.74 39.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.454 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 134.51 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.2 t -97.25 -4.08 39.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.13 159.06 43.57 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.911 -1.118 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.03 173.07 34.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -81.06 151.15 28.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 108.898 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.33 153.54 23.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.382 -0.824 . . . . 0.0 109.206 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.85 -40.94 90.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.93 119.46 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.642 -0.661 . . . . 0.0 109.389 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.1 mtp -103.82 131.38 51.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.409 -0.807 . . . . 0.0 108.867 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.88 129.38 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -150.52 159.69 44.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.19 137.27 44.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.01 160.09 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 0.0 111.169 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -128.71 137.81 51.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.775 -0.578 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.25 -141.57 3.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.72 126.96 31.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -1.054 . . . . 0.0 109.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -133.65 55.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.616 -0.677 . . . . 0.0 109.345 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 50.9 mtt-85 54.98 52.27 12.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 109.761 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.4 161.28 37.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.99 9.43 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.775 . . . . 0.0 110.379 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.5 t -139.74 72.91 35.21 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 109.106 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.31 152.06 79.76 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.234 1.289 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -77.79 150.33 34.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -129.65 72.42 1.48 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.545 -0.722 . . . . 0.0 109.824 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.11 170.47 38.17 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.5 Cg_endo -65.2 -24.72 58.35 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.366 1.377 . . . . 0.0 112.046 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.62 -177.98 46.7 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.8 -137.68 14.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.783 HD22 ' HB3' ' A' ' 83' ' ' HIS . 59.2 t-20 -76.02 122.15 23.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -1.009 . . . . 0.0 109.83 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 -17.52 26.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.009 -1.057 . . . . 0.0 109.993 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.07 160.42 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.783 ' HB3' HD22 ' A' ' 80' ' ' ASN . 0.7 OUTLIER -160.88 179.99 8.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.946 -1.097 . . . . 0.0 110.269 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.52 173.32 12.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 109.765 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.25 146.87 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 3.9 mp0 -59.72 146.99 79.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.901 -1.125 . . . . 0.0 108.397 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -51.04 113.32 1.05 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 120.498 0.799 . . . . 0.0 112.646 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.43 -178.3 34.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.05 176.84 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.246 1.298 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.32 -121.55 24.58 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.216 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -78.8 -10.45 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.577 -0.955 . . . . 0.0 110.284 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.37 151.39 13.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.24 -19.17 32.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.06 157.0 36.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -1.098 . . . . 0.0 110.6 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HB1' ' OE1' ' A' ' 119' ' ' GLU . . . -146.67 122.95 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -102.07 146.0 28.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.858 . . . . 0.0 110.667 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.548 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 16.1 m-85 -117.49 138.31 51.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.444 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 7.9 t70 -65.9 118.39 9.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.032 -1.042 . . . . 0.0 108.599 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -97.9 -1.44 42.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 110.052 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.39 -18.61 59.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 77' ' ' PRO . 95.9 mt-10 -97.63 158.1 15.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 109.202 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -86.53 115.14 23.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.97 -1.081 . . . . 0.0 109.703 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 93.3 m95 -90.12 148.5 22.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -127.97 159.4 35.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.437 -0.79 . . . . 0.0 109.115 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -113.73 30.26 7.38 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.429 HD22 ' HG3' ' A' ' 108' ' ' ARG . 30.0 p30 -147.58 -164.4 2.0 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.062 . . . . 0.0 110.722 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 90.7 t80 -73.72 25.68 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.703 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.429 ' HG3' HD22 ' A' ' 106' ' ' ASN . 26.9 mmt180 -76.1 -168.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.612 -1.305 . . . . 0.0 109.904 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.52 -57.74 10.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 112.208 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -99.5 118.57 36.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.685 -1.26 . . . . 0.0 111.431 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -99.48 116.52 31.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.339 -0.851 . . . . 0.0 109.475 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 tp -63.53 -38.45 91.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.428 -0.795 . . . . 0.0 109.688 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG11 ' A' ' 146' ' ' VAL . 13.1 t-80 -59.78 -39.96 86.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 111.16 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 114' ' ' ARG . 7.2 tpt180 -59.4 -43.87 92.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.848 -1.157 . . . . 0.0 109.857 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.77 -39.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.062 -1.024 . . . . 0.0 109.525 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.9 92.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.79 93.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.837 . . . . 0.0 109.617 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.428 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 5.3 t60 -69.89 -46.3 65.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.846 . . . . 0.0 110.882 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.548 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 80.5 mt-10 -59.86 -40.46 88.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.748 -1.22 . . . . 0.0 109.329 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.258 -0.901 . . . . 0.0 108.572 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.27 78.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.428 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 36.7 m-70 -65.05 -37.89 89.05 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -1.191 . . . . 0.0 108.716 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.0 p -70.27 -24.74 63.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.52 -2.99 58.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.151 -0.968 . . . . 0.0 108.821 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.77 15.79 62.72 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -82.9 130.16 35.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 m -88.25 169.97 11.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -68.57 156.6 37.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.386 -0.821 . . . . 0.0 109.114 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.6 t -131.96 160.84 34.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.85 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.1 p -99.54 6.81 45.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.329 -0.857 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 59.8 t0 -79.91 131.09 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 96.6 mt -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.459 -0.775 . . . . 0.0 109.988 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.38 -2.74 68.74 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.183 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.95 131.69 34.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.75 -1.441 . . . . 0.0 109.8 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.01 -29.87 67.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.0 mmm -75.59 53.95 0.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.186 -0.947 . . . . 0.0 109.732 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.2 140.27 87.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 4.03 1.01 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 119.949 1.017 . . . . 0.0 111.636 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.2 p -156.95 177.53 11.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.625 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.5 t80 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 120.838 -1.164 . . . . 0.0 110.001 -179.894 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 113' ' ' HIS . 73.8 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.328 0.585 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -142.54 151.5 41.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.345 -0.847 . . . . 0.0 108.92 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.64 147.85 39.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.119 -0.988 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.94 153.27 19.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.03 -39.33 78.11 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -53.58 -39.98 65.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.145 -0.972 . . . . 0.0 108.484 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -72.76 -39.95 66.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.279 -0.888 . . . . 0.0 108.701 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.42 -50.2 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 0.0 108.769 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.6 -40.05 93.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.76 -55.75 13.37 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.756 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -63.11 -40.19 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.923 -1.34 . . . . 0.0 109.616 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.8 mt-30 -69.6 -38.83 77.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.25 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.57 94.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.112 -0.992 . . . . 0.0 109.38 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.56 -50.06 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.602 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.28 -173.52 40.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -89.06 148.25 23.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.894 -179.871 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.158 0.504 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -82.17 124.15 29.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.01 . . . . 0.0 108.852 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -84.31 -14.01 50.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -87.3 147.34 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 110.317 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.6 p -94.64 -4.72 47.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.221 -0.924 . . . . 0.0 108.808 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 66.9 m80 -120.69 133.3 55.36 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt -131.8 156.33 46.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.143 -0.973 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -128.58 155.64 44.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.421 -0.799 . . . . 0.0 109.511 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -147.01 161.33 41.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -149.0 133.96 18.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.403 -0.811 . . . . 0.0 109.973 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.8 mt -89.9 118.52 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 93.4 mt-10 -65.94 -41.32 91.44 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.074 -1.016 . . . . 0.0 109.842 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 70.8 m-20 -158.14 158.0 33.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.04 134.45 44.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -68.89 138.02 90.18 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.801 -1.187 . . . . 0.0 108.648 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -66.09 -8.2 19.4 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.659 0.914 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.98 -39.86 87.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 mt -136.89 148.19 62.13 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -58.47 -177.94 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.646 0.897 . . . . 0.0 111.576 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -86.47 -33.72 20.29 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 0.0 109.614 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.51 89.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.905 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.44 -39.55 74.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -0.929 . . . . 0.0 110.016 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.55 -40.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 108.962 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.41 -43.1 93.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.16 -45.06 94.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.258 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.26 88.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.4 -42.87 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.07 -40.68 74.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.855 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -61.01 -40.1 92.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 108.921 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.14 94.64 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.317 -0.864 . . . . 0.0 110.122 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -61.35 -40.17 93.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.766 -1.209 . . . . 0.0 109.398 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -60.56 -42.25 96.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.42 ' CH2' HD22 ' A' ' 148' ' ' LEU . 90.7 m95 -73.69 -42.51 61.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.037 . . . . 0.0 110.21 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -66.73 -37.97 85.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 110.35 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -57.8 -22.91 49.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.497 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.34 7.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -145.72 149.49 40.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.014 -1.054 . . . . 0.0 109.184 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.92 7.47 1.31 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.615 0.877 . . . . 0.0 111.79 178.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.05 154.98 41.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 43.9 p -133.85 150.05 51.37 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -125.74 159.43 32.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.7 m -154.41 126.63 7.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.38 136.87 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.95 135.11 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.466 -0.771 . . . . 0.0 109.172 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 t -98.21 -4.33 35.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 0.0 110.624 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -142.38 155.36 45.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.893 -1.129 . . . . 0.0 110.111 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 177.39 50.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -82.26 143.48 31.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 108.965 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.77 150.89 25.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.8 -40.38 88.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 108.978 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.4 mt -119.61 118.87 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.717 . . . . 0.0 109.259 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.1 mmm -99.62 130.77 45.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.863 . . . . 0.0 108.878 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.45 130.72 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 160.31 43.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.97 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.7 139.18 42.65 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.58 160.45 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.03 -1.043 . . . . 0.0 111.223 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -129.5 136.69 50.18 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.596 0.712 . . . . 0.0 110.118 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.15 -141.86 2.98 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.76 130.5 43.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -1.053 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -138.18 53.3 1.82 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 109.803 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 53.61 59.64 4.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 108.912 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.95 160.39 43.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.048 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -89.37 9.44 26.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.175 -0.953 . . . . 0.0 109.733 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -136.47 71.06 59.99 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 109.367 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -68.42 144.89 63.24 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.061 1.174 . . . . 0.0 112.018 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -76.93 143.78 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.05 70.33 0.9 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.314 -0.866 . . . . 0.0 108.717 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.27 -165.98 42.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.93 -13.23 8.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.17 1.246 . . . . 0.0 112.597 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.42 -177.98 39.99 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.42 -158.12 28.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.87 149.89 39.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.407 -1.054 . . . . 0.0 109.286 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.35 -20.58 19.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.05 -1.032 . . . . 0.0 109.596 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.96 168.62 5.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 108.582 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.29 122.91 1.31 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.541 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.78 168.48 13.46 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.408 0.623 . . . . 0.0 109.408 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.08 153.72 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -59.58 145.36 82.93 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.007 -1.058 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.31 101.44 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 120.441 0.76 . . . . 0.0 111.709 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.64 174.87 35.75 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.28 -179.81 3.42 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 120.878 1.052 . . . . 0.0 111.203 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.47 -127.16 39.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -73.8 -14.33 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.382 -1.069 . . . . 0.0 110.28 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.41 139.45 48.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -16.63 60.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -67.78 160.25 28.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.74 120.86 10.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.052 -1.03 . . . . 0.0 109.227 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -104.31 136.66 43.49 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.664 -0.648 . . . . 0.0 110.427 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -115.81 136.7 52.8 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.667 -0.645 . . . . 0.0 109.615 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.82 118.97 10.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.027 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -99.58 -0.6 40.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 108.778 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.36 -13.04 60.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -105.58 152.17 23.42 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -89.53 120.07 30.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.178 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -84.13 153.5 23.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 -179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.7 p -117.76 164.69 14.62 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.523 0.677 . . . . 0.0 109.621 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.88 28.88 5.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.03 -165.04 2.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.796 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.66 34.04 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.48 -0.762 . . . . 0.0 109.8 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -76.23 -164.32 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -47.72 -57.56 5.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.835 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.91 149.83 23.14 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.727 -1.233 . . . . 0.0 110.767 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -148.36 91.25 1.88 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.0 109.032 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -60.03 -39.83 87.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.195 -0.941 . . . . 0.0 110.818 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.15 -41.22 92.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.732 -1.23 . . . . 0.0 109.773 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.04 -43.0 95.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.955 -1.091 . . . . 0.0 109.759 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.9 t -69.85 -40.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.365 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.69 89.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 108.877 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -68.98 -42.77 76.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 109.847 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.139 -0.976 . . . . 0.0 108.765 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.3 -39.14 93.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.26 85.34 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -65.75 -35.57 81.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.239 . . . . 0.0 108.804 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.8 m -71.65 -28.72 63.95 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 109.892 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.66 -2.54 56.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.84 11.84 67.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -82.27 129.54 34.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.83 -1.394 . . . . 0.0 109.042 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.0 m -88.72 169.93 11.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.873 . . . . 0.0 109.228 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.42 158.97 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.466 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.8 t -124.46 164.65 19.27 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.1 p -99.35 9.67 42.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.032 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -84.84 127.17 34.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.9 -37.33 71.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.507 -0.746 . . . . 0.0 110.598 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.09 1.14 85.99 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 120.981 -1.075 . . . . 0.0 111.45 -178.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.88 138.74 33.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.517 -1.578 . . . . 0.0 109.406 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.52 -29.72 67.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.9 . . . . 0.0 109.679 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.56 54.52 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.6 t80 -71.29 136.69 84.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.871 -1.143 . . . . 0.0 108.643 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.17 9.25 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.908 1.003 . . . . 0.0 112.061 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 36.6 t -164.29 175.89 9.65 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.6 t80 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.221 -179.991 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -146.94 149.7 33.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 108.997 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.42 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.5 mt -75.05 142.69 43.72 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.458 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.0 164.28 13.15 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -59.81 -39.34 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -58.43 -40.96 83.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -74.5 -40.48 61.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.81 -50.24 81.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.132 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.25 -40.23 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.439 178.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -56.66 -61.09 7.88 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -63.48 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.3 . . . . 0.0 110.26 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -63.76 -39.67 94.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.807 -1.183 . . . . 0.0 109.495 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.39 92.75 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.52 -49.01 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -99.48 -62.2 1.27 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.216 -0.928 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.74 -176.47 34.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 148.66 24.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.024 -1.28 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 -179.786 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -80.29 126.38 31.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 108.706 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.9 -10.06 59.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 109.724 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -79.58 150.09 31.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.9 p -96.74 -3.99 41.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -129.52 138.69 51.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.48 159.97 37.83 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.15 -0.969 . . . . 0.0 110.776 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -126.2 154.04 43.82 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.59 0.709 . . . . 0.0 109.144 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -143.5 156.18 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 109.422 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.4 ttt-85 -149.57 132.25 15.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 109.432 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.425 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 94.3 mt -89.25 121.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.87 -39.67 93.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.114 -0.991 . . . . 0.0 110.226 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -161.55 156.7 23.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -102.02 139.45 37.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.63 -0.669 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 22' ' ' THR . 1.7 t -74.03 145.81 84.07 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.53 -11.8 33.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.919 1.079 . . . . 0.0 111.518 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.1 -40.02 88.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.6 mt -139.06 151.6 68.23 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.186 -0.946 . . . . 0.0 108.523 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -62.94 -175.27 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 CA-C-N 119.392 0.819 . . . . 0.0 111.93 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.41 -38.85 13.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.18 84.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.53 -39.13 77.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.616 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.97 -42.01 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.02 . . . . 0.0 109.168 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -59.3 -40.48 86.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 108.781 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -60.01 -46.37 89.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.847 . . . . 0.0 109.362 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.0 -39.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.192 -0.942 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.57 -41.56 88.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -60.72 -40.62 92.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.942 -1.099 . . . . 0.0 110.415 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.46 85.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.944 -1.098 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.23 -40.51 96.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.947 -1.096 . . . . 0.0 109.368 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.58 -43.28 97.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.223 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.75 -42.75 93.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.96 . . . . 0.0 110.265 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -70.44 -40.5 73.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.889 -1.132 . . . . 0.0 109.734 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 t -69.77 -32.41 70.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.792 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.02 -33.38 68.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.113 -0.992 . . . . 0.0 111.089 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.44 10.98 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 110.461 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.9 p -146.55 150.36 40.06 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 120.883 -1.135 . . . . 0.0 109.654 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.49 1.44 4.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.744 0.962 . . . . 0.0 111.467 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.01 153.1 44.37 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.406 -0.809 . . . . 0.0 109.275 -179.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.8 p -133.13 149.94 52.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -128.2 149.52 50.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.446 -0.784 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -152.92 133.09 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.425 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 62.7 tttp -75.64 144.47 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.732 . . . . 0.0 109.786 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.4 136.58 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t -95.76 -1.47 49.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -145.96 157.18 43.89 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.969 -1.082 . . . . 0.0 109.228 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.78 159.03 13.36 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.07 137.39 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.529 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.15 149.75 22.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.473 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.33 -40.96 92.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.511 -0.743 . . . . 0.0 109.253 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.26 111.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.9 134.93 43.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.59 131.39 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.7 p -149.52 160.66 43.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -0.96 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.81 138.56 46.01 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.3 165.57 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 110.798 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -139.7 153.41 47.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.564 -0.71 . . . . 0.0 110.001 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.81 -148.68 0.38 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.3 130.91 45.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -1.08 . . . . 0.0 108.86 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 9.1 p-80 -136.38 57.08 1.79 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.611 -0.681 . . . . 0.0 109.899 -178.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 53.82 53.71 10.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.131 -0.981 . . . . 0.0 109.932 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' SER . 12.0 t70 -144.75 159.28 43.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.7 m-20 -89.65 9.54 26.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.29 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 70.0 m -136.81 73.24 54.08 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.437 -0.789 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.05 155.82 58.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.04 1.16 . . . . 0.0 112.232 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.47 150.24 34.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.508 -0.745 . . . . 0.0 109.154 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.25 77.55 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.15 -172.42 11.56 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -55.8 -14.42 10.69 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.414 1.41 . . . . 0.0 112.417 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.0 178.21 41.96 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 -153.39 26.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.413 -1.051 . . . . 0.0 110.533 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -72.62 136.68 45.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.946 -0.738 . . . . 0.0 110.25 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -94.3 -19.91 20.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.5 159.06 9.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.925 -1.109 . . . . 0.0 110.045 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -163.06 -179.85 7.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.396 -0.815 . . . . 0.0 109.814 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.47 167.78 19.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.237 -0.915 . . . . 0.0 109.429 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -97.83 153.54 18.23 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.978 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -58.64 149.32 63.05 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 104.59 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 120.723 0.949 . . . . 0.0 111.655 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.68 -179.76 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.87 1.047 . . . . 0.0 111.434 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.06 -123.1 31.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.58 -10.05 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.948 . . . . 0.0 110.218 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.26 139.78 47.45 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.001 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.62 -15.97 52.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 127.37 31.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.857 -1.378 . . . . 0.0 110.093 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.73 127.36 47.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -111.21 138.6 47.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.3 -0.875 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.99 134.44 55.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.671 -0.643 . . . . 0.0 109.652 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 46.2 t0 -67.88 120.09 13.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.57 1.28 43.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -74.56 -19.71 60.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.003 -1.061 . . . . 0.0 109.388 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.317 -0.864 . . . . 0.0 108.96 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 102' ' ' ARG . 28.5 ttt-85 -85.85 120.08 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 108.701 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.448 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 92.8 m95 -89.52 146.64 24.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.805 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.2 p -123.18 161.16 25.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.22 29.44 7.8 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.733 HD22 ' NE ' ' A' ' 108' ' ' ARG . 14.7 p30 -149.03 -164.99 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -80.68 31.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.956 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.733 ' NE ' HD22 ' A' ' 106' ' ' ASN . 61.2 mtm180 -74.57 -166.62 0.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.739 -1.226 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -48.74 -58.49 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.661 -0.649 . . . . 0.0 111.704 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -107.52 129.8 54.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.971 -1.081 . . . . 0.0 110.975 -178.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -102.48 112.67 25.5 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.37 -41.4 76.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.31 -0.869 . . . . 0.0 111.207 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.74 -41.33 90.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.81 -1.181 . . . . 0.0 109.528 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.8 -43.45 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.464 -0.772 . . . . 0.0 110.257 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.93 -39.79 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.189 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.1 92.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.225 -0.922 . . . . 0.0 109.067 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.66 92.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.612 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.74 -49.2 66.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 108.892 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 42.5 mt-10 -59.75 -41.44 91.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.76 -37.36 86.31 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 108.231 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.52 -41.88 89.35 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -64.2 -35.91 82.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 108.388 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.6 m -69.03 -26.46 65.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.628 -0.67 . . . . 0.0 109.413 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.36 -4.3 59.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.61 61.62 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.22 128.53 34.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.069 -1.253 . . . . 0.0 109.457 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.7 m -88.6 173.0 8.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 109.701 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -68.29 157.03 36.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -0.854 . . . . 0.0 109.014 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.7 t -125.01 164.4 20.24 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 64.5 p -97.41 4.34 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 109.318 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -82.07 124.95 30.28 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.949 -1.095 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.3 -39.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 110.387 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 5.65 51.91 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.356 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 142.75 30.42 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.65 -1.5 . . . . 0.0 109.292 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 137' ' ' TYR . 99.0 mt -59.78 -39.48 85.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 109.44 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 31.1 mtp -71.1 67.85 0.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.473 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.5 t80 -71.69 124.89 91.6 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.11 -1.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 CA-C-N 120.488 1.21 . . . . 0.0 113.008 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 50.3 m -167.75 166.96 13.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.071 -1.018 . . . . 0.0 108.486 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.688 -1.258 . . . . 0.0 108.84 179.662 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 121.426 0.632 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -148.73 159.44 44.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.806 . . . . 0.0 109.093 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.72 144.49 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.014 -1.054 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 163.16 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.013 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.95 -40.18 88.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -59.63 -41.37 90.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.264 -0.898 . . . . 0.0 109.835 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.24 -40.32 64.75 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.089 -1.007 . . . . 0.0 109.408 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.94 -49.96 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -64.87 -39.76 94.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.559 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.92 -54.72 26.31 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.067 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.43 -38.56 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.996 -1.296 . . . . 0.0 109.377 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -68.05 -34.92 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.106 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.16 88.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.34 -50.56 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.099 -1.001 . . . . 0.0 108.911 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -97.84 -73.69 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.72 . . . . 0.0 109.255 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.49 -169.34 37.74 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.1 mtm-85 -92.28 144.61 25.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.287 . . . . 0.0 109.707 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.487 1.417 0 O-C-N 121.254 -0.904 . . . . 0.0 108.914 -179.834 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -83.8 127.28 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.953 -1.092 . . . . 0.0 108.408 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.18 -10.78 59.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.272 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.466 ' CD ' ' H ' ' A' ' 11' ' ' GLN . 9.8 mp0 -85.79 149.49 25.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.755 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -94.46 -4.12 48.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 108.623 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.44 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 33.7 m-70 -128.88 141.53 51.25 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.9 mt -130.27 153.76 48.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.388 -0.82 . . . . 0.0 109.675 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 p -125.29 155.8 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -144.61 159.91 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -149.29 133.14 17.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.88 120.05 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -65.86 -40.09 91.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.069 -1.019 . . . . 0.0 110.04 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -159.95 155.34 25.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.017 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -99.69 136.83 39.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 t -67.7 139.21 93.64 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.15 -0.968 . . . . 0.0 108.628 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.55 -13.96 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 CA-C-N 119.561 0.879 . . . . 0.0 112.196 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.23 -40.21 89.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 110.393 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.84 149.37 70.41 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.14 -175.92 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 119.304 0.787 . . . . 0.0 111.831 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 15.9 ptm180 -87.38 -32.27 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -56.96 -44.86 83.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 110.15 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.05 -39.8 54.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.011 -1.056 . . . . 0.0 110.159 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.41 -49.51 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 111.179 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 42.3 p-10 -58.98 -39.24 81.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.67 -1.269 . . . . 0.0 109.402 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.4 t60 -59.82 -43.3 94.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 0.0 108.86 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.26 91.5 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.25 -42.63 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -69.99 -39.12 76.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.052 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.31 -40.12 89.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.95 90.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.601 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.5 m-85 -60.08 -40.14 88.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 109.025 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.03 -43.01 95.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.1 -43.95 95.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.703 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -71.2 -42.3 69.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.659 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.2 t -67.75 -32.53 73.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 110.834 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.22 -35.0 72.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 110.72 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.87 14.92 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.283 -0.885 . . . . 0.0 111.122 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 62.2 p -144.66 147.34 35.5 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.833 -1.167 . . . . 0.0 109.139 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.9 6.3 1.75 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.623 0.882 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -72.57 163.76 27.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.227 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 33.3 p -138.89 151.34 46.88 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.96 149.97 52.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.632 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -155.04 129.81 9.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -77.93 142.08 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.405 -0.81 . . . . 0.0 109.922 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.42 134.85 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -97.13 -4.99 38.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.94 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -142.76 151.04 40.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.096 -1.003 . . . . 0.0 109.747 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.63 169.53 42.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.06 146.44 30.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -1.154 . . . . 0.0 109.025 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.79 157.08 18.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.41 -0.806 . . . . 0.0 109.209 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.93 118.09 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.412 -0.805 . . . . 0.0 109.581 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -98.57 128.11 44.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -110.68 129.94 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.4 p -148.41 155.11 40.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.94 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -104.72 139.14 39.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.6 160.09 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.344 -0.847 . . . . 0.0 110.754 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.32 142.46 50.82 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.682 -0.636 . . . . 0.0 109.442 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.79 -140.99 5.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -78.65 128.08 32.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -1.035 . . . . 0.0 109.285 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.588 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.6 p-80 -126.04 56.9 1.4 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 109.872 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 31.1 mmt180 56.4 47.82 18.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.544 -0.723 . . . . 0.0 109.997 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.2 m-20 -138.83 162.89 33.66 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.387 -0.82 . . . . 0.0 108.877 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -89.97 8.76 30.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.942 . . . . 0.0 110.333 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -136.04 73.35 59.02 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -70.02 155.84 64.11 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.164 1.243 . . . . 0.0 112.188 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.91 150.36 32.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -121.94 75.02 1.18 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.546 -0.721 . . . . 0.0 109.438 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.14 -171.27 7.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -53.05 -8.97 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.26 1.307 . . . . 0.0 112.784 -179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.27 46.81 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.83 -171.22 55.09 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -73.83 151.41 40.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.298 -1.119 . . . . 0.0 109.234 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 mt -91.01 -12.53 35.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.984 -1.073 . . . . 0.0 109.72 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.37 163.3 12.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.42 -179.6 7.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -0.817 . . . . 0.0 109.033 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.21 168.98 18.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.99 156.66 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -59.09 150.04 64.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.58 101.38 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 CA-C-N 119.083 0.708 . . . . 0.0 111.398 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.42 175.88 35.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 179.85 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.801 1.001 . . . . 0.0 111.667 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.47 -130.55 40.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -78.83 -7.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -1.19 . . . . 0.0 109.245 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.01 137.35 49.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.21 -15.63 52.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -67.91 124.64 23.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.884 -1.362 . . . . 0.0 109.964 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.13 149.87 21.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -132.9 132.5 42.12 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.427 -0.795 . . . . 0.0 109.668 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.78 135.38 54.09 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.407 -0.808 . . . . 0.0 109.914 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.466 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 56.7 t0 -67.58 121.83 16.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 108.935 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -98.98 0.02 43.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.358 -0.839 . . . . 0.0 109.834 -179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.36 -17.97 60.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.793 -1.192 . . . . 0.0 109.508 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.85 157.82 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -84.42 118.72 24.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.026 -1.047 . . . . 0.0 109.381 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.466 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 97.8 m95 -88.24 147.2 24.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.365 -0.834 . . . . 0.0 109.818 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.7 p -129.51 157.21 42.66 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.83 31.49 5.97 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -145.91 -164.16 1.9 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -178.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.77 30.85 0.36 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 110.21 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 12.9 mmt-85 -76.28 -164.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.92 -56.84 17.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 111.313 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -104.68 119.14 38.29 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.987 -1.07 . . . . 0.0 110.385 -178.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 79.2 m-20 -96.33 112.2 24.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.331 -0.856 . . . . 0.0 110.665 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.962 -1.086 . . . . 0.0 109.71 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 135' ' ' LEU . 20.3 tpt180 -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 -179.265 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.03 -39.39 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.198 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.37 85.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.951 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 109.511 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -69.98 -48.26 58.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 109.737 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.4 -40.19 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.541 -1.349 . . . . 0.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.48 -31.64 72.94 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.94 -39.64 95.83 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -66.59 -34.49 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -1.082 . . . . 0.0 109.037 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -69.64 -23.24 63.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.225 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.92 -4.94 58.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 109.221 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.91 16.7 59.22 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.35 131.11 35.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.927 -1.337 . . . . 0.0 109.809 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.5 m -88.41 171.56 10.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.989 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -68.59 159.15 32.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.3 t -125.08 157.41 36.35 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.53 -0.731 . . . . 0.0 109.461 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -99.89 3.82 44.73 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.43 126.9 32.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -39.99 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.66 -178.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.37 -1.06 49.89 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.047 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.95 33.15 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.682 -1.481 . . . . 0.0 109.38 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.449 ' CD2' ' NH1' ' A' ' 114' ' ' ARG . 93.6 mt -66.47 -34.43 77.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.776 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 37.7 mtp -75.15 64.95 1.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.945 . . . . 0.0 110.297 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.8 t80 -72.63 137.51 80.39 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 108.859 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.83 7.09 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 119.926 1.009 . . . . 0.0 112.127 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 137' ' ' TYR . 31.1 p -159.0 174.67 14.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 108.704 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.795 -1.19 . . . . 0.0 110.118 -179.629 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.373 0.606 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -148.9 159.0 44.59 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.09 139.85 41.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.963 -1.086 . . . . 0.0 108.765 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.55 164.88 13.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -40.51 89.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.0 -40.08 79.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.187 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.9 -40.9 60.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 109.829 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.06 -50.01 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.103 -0.998 . . . . 0.0 109.57 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.63 -40.01 95.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 110.153 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.15 -55.28 24.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.429 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -67.35 -40.0 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.89 -1.359 . . . . 0.0 110.227 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.8 mt-30 -68.89 -40.1 79.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 0.0 110.085 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.73 94.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.035 -1.041 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.43 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -96.77 -67.82 0.83 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.194 -0.941 . . . . 0.0 109.855 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.1 179.43 38.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.83 148.5 23.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.112 -1.228 . . . . 0.0 109.098 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.623 -179.583 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 124' ' ' LEU . 23.9 mmm180 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.91 122.74 28.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.006 -1.059 . . . . 0.0 108.543 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 58.7 mp0 -84.28 -11.53 56.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 109.905 -179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.42 144.52 29.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 109.211 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -91.67 -3.27 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.141 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.556 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.4 m-70 -126.64 142.13 51.63 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.46 156.87 48.0 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.208 -0.933 . . . . 0.0 109.929 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -130.49 154.79 47.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -141.84 159.84 41.41 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -147.09 137.22 23.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.157 -0.964 . . . . 0.0 109.949 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -88.14 119.04 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.513 -0.742 . . . . 0.0 109.025 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -69.9 -39.81 75.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -163.41 150.58 12.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.822 -1.174 . . . . 0.0 110.806 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.81 130.8 44.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.669 -0.644 . . . . 0.0 109.629 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -75.39 145.83 80.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.02 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.2 -9.67 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 CA-C-N 119.452 0.84 . . . . 0.0 111.956 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.96 -40.19 88.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.165 -0.959 . . . . 0.0 109.517 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.8 mt -140.07 151.24 64.53 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 108.952 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.2 Cg_endo -61.75 -175.07 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.805 1.004 . . . . 0.0 112.038 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -88.7 -36.91 15.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.614 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -44.0 91.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.413 -0.804 . . . . 0.0 109.519 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.04 -39.92 75.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.08 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 26' ' ' PRO . 74.8 t -69.85 -40.72 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.672 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -60.15 -40.36 89.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.984 -1.073 . . . . 0.0 108.949 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.86 -45.19 93.26 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.69 89.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mm -72.29 -43.1 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.08 -1.012 . . . . 0.0 109.597 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.53 -39.76 81.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.79 -39.81 90.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 110.25 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.77 83.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.961 -1.087 . . . . 0.0 110.166 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -60.18 -39.69 87.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.996 -1.065 . . . . 0.0 109.032 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.73 -40.18 87.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.925 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.97 -44.96 94.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.001 -1.062 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.479 ' CH2' HD22 ' A' ' 148' ' ' LEU . 93.3 m95 -75.12 -41.81 57.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.226 -0.921 . . . . 0.0 111.132 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -66.77 -38.42 86.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 110.119 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -60.24 -15.87 28.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 111.044 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.71 2.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.96 -1.088 . . . . 0.0 110.504 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.401 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 13.1 p -145.49 150.57 44.5 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.054 . . . . 0.0 108.899 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.93 8.15 0.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.673 0.915 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.15 153.42 41.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.556 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 29.2 p -130.34 147.47 52.05 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.27 154.65 45.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.655 . . . . 0.0 109.462 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 m -155.64 133.58 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.486 -0.758 . . . . 0.0 109.87 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.0 135.35 36.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.43 130.72 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.477 -0.765 . . . . 0.0 108.955 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -95.63 0.11 52.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.092 -1.005 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.14 152.78 41.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.35 179.46 51.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.359 -1.083 . . . . 0.0 110.505 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.42 136.95 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.05 -40.21 88.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.212 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -121.52 120.39 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.556 -0.715 . . . . 0.0 109.401 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.9 mtt -100.84 139.19 36.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.38 131.3 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.6 p -151.01 156.11 40.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.119 -0.988 . . . . 0.0 109.949 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -104.35 138.65 40.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.06 160.03 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 O-C-N 121.061 -1.024 . . . . 0.0 110.674 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' CB ' ' A' ' 65' ' ' ARG . 11.5 mtp-105 -129.16 139.79 51.78 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.336 0.589 . . . . 0.0 110.087 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.98 -137.43 2.79 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -73.58 128.43 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.978 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 21.8 p-80 -137.97 65.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 53.21 53.51 11.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -142.69 161.6 37.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 109.106 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.91 9.73 41.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.3 m -138.61 69.68 45.13 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.425 -0.797 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.7 156.05 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.034 1.156 . . . . 0.0 112.292 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -76.6 140.59 41.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -101.76 60.24 0.87 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.545 -0.722 . . . . 0.0 109.613 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.3 179.33 50.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -50.09 -12.22 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.336 1.357 . . . . 0.0 111.927 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.23 178.52 41.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.25 -153.97 25.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 47.4 p-10 -75.16 149.65 38.95 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.353 -1.086 . . . . 0.0 109.415 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.13 -18.02 23.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.649 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.16 167.38 7.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -160.1 173.59 15.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.961 -1.087 . . . . 0.0 109.66 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.41 164.31 22.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.124 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.08 152.24 18.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.179 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -59.71 151.18 63.87 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 109.289 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -53.22 104.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 120.718 0.945 . . . . 0.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.92 174.62 34.56 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.0 172.56 15.23 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.069 1.18 . . . . 0.0 111.699 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.02 -125.33 18.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.82 -10.95 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.567 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.36 148.98 28.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.42 -20.65 10.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.01 151.43 47.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.275 . . . . 0.0 109.236 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.58 123.63 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 0.0 108.78 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -100.89 143.07 31.48 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.635 0.731 . . . . 0.0 110.793 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.4 m-85 -113.85 131.29 56.31 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -65.78 118.45 9.64 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.852 -1.155 . . . . 0.0 108.778 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -99.13 0.74 44.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.18 -16.88 60.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.821 -1.174 . . . . 0.0 109.754 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -101.22 159.16 15.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 109.444 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -85.53 121.13 27.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.228 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.94 147.59 23.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.373 -0.83 . . . . 0.0 109.97 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.5 p -129.89 164.21 24.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.491 -0.756 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -110.33 32.5 5.12 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -149.03 -164.94 2.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 109.371 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -88.72 25.12 1.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 110.019 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -76.71 -161.45 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 110.032 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.0 mt-10 -24.42 -68.7 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -137.27 144.02 42.49 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.967 -1.083 . . . . 0.0 109.912 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -105.02 119.4 38.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.757 . . . . 0.0 109.4 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.88 -40.78 97.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.41 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -59.94 -41.57 92.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.084 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.55 -44.96 93.08 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.082 -1.012 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.03 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.27 92.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.03 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.53 84.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 108.884 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.78 -46.4 62.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.838 . . . . 0.0 109.943 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 64.3 mt-10 -59.89 -40.59 89.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.721 -1.237 . . . . 0.0 109.489 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.15 -38.4 91.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.278 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.92 86.88 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.19 -26.81 64.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.267 . . . . 0.0 109.302 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.6 p -71.06 -22.21 62.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.073 -1.017 . . . . 0.0 108.399 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 89.6 mt -85.57 -8.73 58.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.361 -0.837 . . . . 0.0 109.14 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.88 19.28 48.13 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.666 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.93 142.1 32.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.84 -1.388 . . . . 0.0 108.947 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.9 m -87.71 168.39 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.015 -1.053 . . . . 0.0 109.479 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -67.92 153.0 44.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.405 -0.809 . . . . 0.0 109.412 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.5 t -124.11 154.54 39.85 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.1 p -99.99 10.83 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.286 -0.884 . . . . 0.0 109.829 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.5 t0 -83.53 132.91 34.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.925 -1.109 . . . . 0.0 110.143 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 91.8 mt -60.24 -40.04 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.12 -5.72 81.38 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.546 -178.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.55 128.88 34.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.935 -1.333 . . . . 0.0 109.486 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.4 mt -64.31 -25.36 68.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.571 -0.706 . . . . 0.0 109.275 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 47.0 mmm -74.18 45.16 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.115 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.6 t80 -69.55 129.94 91.03 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 108.7 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -46.28 -62.52 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.192 1.104 . . . . 0.0 111.702 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 t -96.97 172.42 7.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 108.819 179.706 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.9 t . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.295 0.569 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -148.63 151.04 34.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 109.056 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.479 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.0 mt -76.52 142.9 40.72 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.859 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 162.93 13.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 108.735 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -59.83 -40.39 88.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 0.0 109.434 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -58.9 -40.14 83.57 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.521 -0.737 . . . . 0.0 109.642 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.22 -40.87 64.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.095 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.22 -52.81 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.43 -40.13 96.33 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.854 -1.154 . . . . 0.0 110.096 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.8 -55.43 29.86 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.611 -178.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -65.61 -39.96 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.977 -1.308 . . . . 0.0 110.582 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.6 mt-30 -65.64 -39.82 91.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.821 -1.175 . . . . 0.0 109.346 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.59 -44.6 89.87 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.65 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -49.97 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 109.646 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -93.28 -70.1 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.66 -178.66 39.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.94 142.58 27.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.401 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 69.2 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.824 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -83.12 119.83 25.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.976 -1.078 . . . . 0.0 108.5 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.6 -9.97 59.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 109.5 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -80.3 145.08 32.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.81 -8.87 36.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.494 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 93.5 m-70 -123.22 119.86 31.44 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.08 165.41 12.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.499 -0.751 . . . . 0.0 109.253 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -129.58 155.46 45.77 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -144.13 159.21 43.03 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.144 -0.972 . . . . 0.0 109.078 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' O ' ' A' ' 53' ' ' SER . 70.7 ttt180 -148.76 131.19 15.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.061 -1.024 . . . . 0.0 110.608 -178.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.51 116.81 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.22 -42.96 99.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 110.268 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -162.15 160.85 27.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.0 110.19 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.58 136.64 40.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.602 -0.686 . . . . 0.0 109.333 179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -74.97 142.32 76.11 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.975 . . . . 0.0 108.97 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -61.11 -10.88 16.46 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 CA-C-N 119.527 0.867 . . . . 0.0 111.825 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.89 -40.1 87.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.0 mt -139.04 151.17 67.4 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.69 -171.35 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 119.475 0.848 . . . . 0.0 111.914 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 27' ' ' ARG . 7.1 ptm180 -87.96 -35.43 17.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.57 94.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 109.978 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.02 -39.72 75.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.2 -43.24 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.924 -1.11 . . . . 0.0 109.286 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -59.93 -50.04 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.15 91.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.206 -0.933 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -70.01 -39.82 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 110.159 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.57 -41.23 93.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.019 -1.05 . . . . 0.0 109.844 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -62.42 -40.02 95.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.728 -1.233 . . . . 0.0 110.037 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.66 64.13 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.102 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -62.36 -42.51 99.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.842 -1.161 . . . . 0.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mm-40 -60.3 -42.09 94.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.132 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.61 -41.66 90.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 109.91 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -72.79 -40.48 65.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.84 -1.163 . . . . 0.0 109.644 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 t -69.37 -32.97 72.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 110.593 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 17.0 m120 -59.3 -26.1 64.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.234 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.86 7.9 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.238 -0.914 . . . . 0.0 110.668 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -145.95 150.56 42.83 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.883 -1.136 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.62 2.73 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.912 1.075 . . . . 0.0 111.538 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.04 151.62 44.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.265 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.494 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.8 p -137.16 147.01 45.65 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -121.18 120.24 34.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.6 m -96.0 132.48 41.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.465 -0.772 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 128.48 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 108.871 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.2 m -127.41 129.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.427 -0.796 . . . . 0.0 108.859 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.494 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 40.3 t -99.49 0.29 42.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.9 158.63 43.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.138 -0.976 . . . . 0.0 109.639 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.92 170.4 38.4 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -82.62 130.27 35.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -1.152 . . . . 0.0 109.206 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.67 155.11 17.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -59.98 -39.9 87.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.803 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.9 mt -118.92 120.0 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.7 mmm -99.13 128.6 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.62 126.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.4 p -148.42 157.53 43.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.994 -1.066 . . . . 0.0 110.356 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -107.35 136.85 46.46 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.1 160.38 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.167 -0.958 . . . . 0.0 111.42 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 142.79 49.08 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.26 -147.65 2.59 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.52 128.74 37.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.436 -1.038 . . . . 0.0 109.745 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p-80 -135.97 58.68 1.74 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.43 -0.794 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 69' ' ' ARG . 59.6 mtt-85 55.56 52.92 10.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.485 -0.76 . . . . 0.0 110.426 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.0 p-10 -144.17 160.96 40.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.05 -1.031 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -92.48 12.37 23.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.071 -1.018 . . . . 0.0 110.022 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.6 m -139.37 69.76 39.69 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 109.563 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -70.19 148.65 62.77 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.927 1.085 . . . . 0.0 112.153 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.01 150.03 37.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -125.14 73.97 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.424 -0.798 . . . . 0.0 109.506 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.78 167.41 42.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -54.42 -16.34 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.334 1.356 . . . . 0.0 111.984 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 175.63 40.23 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.99 -151.25 19.99 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -75.99 141.05 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -1.201 . . . . 0.0 109.475 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.6 mt -93.91 -19.69 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.044 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.53 160.54 11.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.903 -1.123 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -160.18 -179.81 8.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.55 167.69 21.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.509 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.65 149.33 21.35 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.09 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -59.96 149.39 73.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -46.88 115.82 1.43 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 120.533 0.822 . . . . 0.0 112.084 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.96 173.9 42.26 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.37 173.95 12.93 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-N 118.157 0.978 . . . . 0.0 111.419 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.19 -120.75 22.27 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.85 -7.35 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.173 -1.192 . . . . 0.0 110.214 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.24 134.25 52.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.5 -11.38 70.19 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.0 124.94 24.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.272 . . . . 0.0 110.068 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.74 126.12 45.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.474 -0.766 . . . . 0.0 109.606 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -107.96 136.85 46.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.563 -0.711 . . . . 0.0 109.627 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -117.33 130.73 56.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.657 -0.652 . . . . 0.0 109.241 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.32 121.55 15.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 109.48 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -100.41 3.75 43.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.381 -0.824 . . . . 0.0 110.17 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -73.73 -18.16 61.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 109.175 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.47 158.43 16.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 108.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -86.9 125.02 33.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.943 . . . . 0.0 109.52 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.49 147.17 23.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.356 -0.84 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.3 p -129.68 158.86 38.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.535 -0.728 . . . . 0.0 109.741 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.03 29.97 7.15 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 15.8 p30 -144.99 -160.5 1.14 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.832 . . . . 0.0 109.447 -178.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -87.97 15.41 7.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.198 -0.939 . . . . 0.0 110.531 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.5 mtt180 -76.47 -167.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.809 -1.182 . . . . 0.0 109.981 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 108' ' ' ARG . 93.9 mt-10 -4.51 -87.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.02 151.68 51.6 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 110.084 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.457 HD21 ' HD2' ' A' ' 114' ' ' ARG . 77.5 m-20 -98.41 115.14 27.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.883 . . . . 0.0 109.391 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.45 -39.22 93.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.008 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -59.06 -42.42 90.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.973 -1.079 . . . . 0.0 109.542 -179.295 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' HD2' HD21 ' A' ' 111' ' ' ASN . 0.7 OUTLIER -59.9 -39.6 85.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.978 -1.076 . . . . 0.0 109.181 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.51 -40.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.05 92.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.024 . . . . 0.0 109.184 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.4 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.995 -1.066 . . . . 0.0 108.716 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -70.38 -48.8 54.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.68 -42.72 93.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.666 -1.271 . . . . 0.0 110.028 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -39.8 93.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.098 . . . . 0.0 108.701 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.97 88.96 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -65.59 -37.47 86.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -1.191 . . . . 0.0 109.171 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -69.86 -20.77 63.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.211 -0.93 . . . . 0.0 108.554 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.25 -0.97 57.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.225 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.43 66.68 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.635 179.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.86 128.68 34.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.896 -1.356 . . . . 0.0 109.082 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -87.97 170.37 11.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.361 -0.837 . . . . 0.0 109.5 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -65.85 155.12 37.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.5 t -125.3 153.71 42.84 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.0 p -99.52 9.87 42.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -82.36 128.37 34.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 108.874 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.04 -40.13 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.22 -2.19 66.16 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.254 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.28 141.19 32.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.712 -1.463 . . . . 0.0 109.201 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.42 -27.84 65.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 29.9 mtp -74.19 52.08 0.45 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.846 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' SER . 22.2 t80 -70.45 137.6 86.23 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -53.32 -1.99 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 119.828 0.974 . . . . 0.0 112.498 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' TYR . 81.4 p -159.94 174.75 13.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.938 -1.101 . . . . 0.0 110.502 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 0.0 109.676 -179.811 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.408 0.623 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -146.9 156.95 43.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.3 mt -75.97 146.63 39.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.883 -1.136 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.46 153.31 19.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.401 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -57.04 -39.94 75.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -53.08 -40.15 63.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.918 -1.114 . . . . 0.0 108.945 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.76 -39.67 66.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.32 -48.03 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.62 -40.09 90.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.727 -1.233 . . . . 0.0 110.514 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -51.46 44.59 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.162 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -66.62 -40.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.874 -1.368 . . . . 0.0 109.767 -179.262 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.3 mt-30 -66.08 -39.97 90.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.09 95.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.032 -1.042 . . . . 0.0 109.814 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -50.13 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.33 -65.41 0.96 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.121 -0.987 . . . . 0.0 109.421 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.34 -170.21 33.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.04 142.87 27.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.111 -1.229 . . . . 0.0 109.303 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.012 -1.055 . . . . 0.0 109.002 179.816 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.08 120.91 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 108.82 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.0 -10.01 58.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.37 148.65 29.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.275 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -95.86 -6.07 40.18 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.083 -1.011 . . . . 0.0 108.866 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 15.0 m-70 -130.62 132.57 45.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.238 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' CE1' ' A' ' 49' ' ' PHE . 66.4 mt -121.77 156.03 34.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.7 p -125.7 153.57 43.7 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -144.78 161.06 40.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.77 132.45 13.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.869 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.59 120.03 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -64.96 -40.01 94.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -160.37 150.39 18.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.898 -1.126 . . . . 0.0 109.768 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.25 140.33 30.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . 9.0 t -70.7 137.24 85.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 109.642 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.75 -14.59 45.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.815 0.97 . . . . 0.0 111.792 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.99 -40.1 88.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.2 mt -135.05 149.1 69.37 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.05 -174.01 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 120.545 0.83 . . . . 0.0 112.031 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.43 -36.16 16.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.872 . . . . 0.0 109.739 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.99 -41.18 77.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 108.89 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -39.98 75.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.435 -0.79 . . . . 0.0 109.628 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.04 -43.83 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.982 . . . . 0.0 109.021 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.98 -39.93 87.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.337 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.583 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 57.6 t-80 -59.97 -50.05 75.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.75 89.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 110.763 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.8 mm -70.05 -38.43 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.123 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.38 -41.3 96.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.007 -1.058 . . . . 0.0 109.776 -178.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.583 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 32.7 mttp -64.76 -37.58 88.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 109.994 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.947 -1.096 . . . . 0.0 109.322 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.88 -41.44 97.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 109.02 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.07 -41.53 92.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.831 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.92 -41.8 92.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.018 -1.051 . . . . 0.0 109.621 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -74.57 -40.49 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.04 -1.037 . . . . 0.0 109.946 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -69.86 -35.27 74.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.106 -0.996 . . . . 0.0 110.42 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -57.31 -31.4 65.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 110.435 -178.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.533 HG23 HG23 ' A' ' 45' ' ' THR . 34.3 m -109.53 9.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.308 -0.87 . . . . 0.0 110.208 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 44' ' ' VAL . 72.9 p -140.94 144.91 37.13 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.234 -0.916 . . . . 0.0 108.983 178.719 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.9 2.99 3.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.563 0.842 . . . . 0.0 111.226 178.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.21 153.61 42.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 62.6 p -130.39 143.1 50.56 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.448 ' CE1' HD12 ' A' ' 14' ' ' LEU . 90.4 m-85 -119.16 151.68 37.89 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.515 -0.741 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.9 m -153.34 131.71 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.49 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -77.19 144.88 38.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.439 -0.788 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.53 135.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.496 -0.753 . . . . 0.0 109.072 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -95.36 -6.86 40.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -150.18 159.57 44.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.032 -1.042 . . . . 0.0 109.411 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.14 176.42 51.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -83.81 139.04 32.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -1.096 . . . . 0.0 109.495 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.58 143.79 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.319 -0.863 . . . . 0.0 109.138 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -59.95 -40.09 87.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.011 -1.056 . . . . 0.0 109.348 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.01 118.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.7 mtt -102.45 133.3 47.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.239 -0.913 . . . . 0.0 109.579 179.108 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.25 128.33 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.1 p -147.36 153.13 39.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -101.87 138.54 38.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.24 164.86 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.189 -0.944 . . . . 0.0 110.535 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.8 mtm-85 -139.96 142.45 36.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.67 5.39 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.291 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -70.04 127.25 32.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -1.074 . . . . 0.0 109.71 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 19.4 p-80 -136.94 62.29 1.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 69' ' ' ARG . 4.2 mmt-85 56.17 49.99 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.74 . . . . 0.0 109.304 -179.624 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.0 t0 -142.55 148.13 37.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 51.6 p-10 -89.48 9.73 25.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.064 -1.023 . . . . 0.0 109.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -136.24 73.14 58.17 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.555 -0.716 . . . . 0.0 109.161 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.85 166.44 26.36 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.252 1.301 . . . . 0.0 112.207 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -77.95 149.33 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 10.6 t0 -101.88 65.38 1.0 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.278 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.46 170.11 46.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.7 -16.26 29.95 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 120.903 1.069 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.42 -175.78 43.28 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.05 17.21 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.159 -1.2 . . . . 0.0 110.102 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 82' ' ' ALA . 13.7 t-20 -73.83 123.8 24.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.452 -1.028 . . . . 0.0 109.591 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.36 -14.32 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.128 -0.983 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -169.01 158.45 8.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.911 -1.118 . . . . 0.0 109.737 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.14 -178.8 6.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.059 -1.025 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.2 178.49 8.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.92 -178.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -104.33 157.4 17.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.656 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -59.99 149.59 73.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.14 103.99 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.601 0.867 . . . . 0.0 112.286 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.92 168.11 34.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.68 -178.42 1.57 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.045 1.163 . . . . 0.0 111.737 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.18 -123.18 30.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 tt -79.99 -12.8 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.949 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.11 144.18 48.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.52 -16.4 53.67 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -66.9 157.36 33.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -1.215 . . . . 0.0 109.366 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.88 17.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.188 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -102.17 136.06 42.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.75 . . . . 0.0 109.59 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -114.14 129.65 56.62 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.76 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.19 117.8 9.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.181 -0.95 . . . . 0.0 109.126 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -97.7 1.89 49.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 0.0 109.306 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.76 -17.68 61.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 0.0 108.447 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -97.49 158.51 15.44 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.632 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -85.58 120.58 27.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.928 -1.108 . . . . 0.0 108.962 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -90.51 140.0 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 109.539 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.9 p -125.29 170.0 11.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.559 -0.713 . . . . 0.0 109.691 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.37 28.76 8.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.617 HD22 ' HD2' ' A' ' 108' ' ' ARG . 11.9 p30 -148.58 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -86.95 27.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 110.643 -178.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.617 ' HD2' HD22 ' A' ' 106' ' ' ASN . 99.2 mtt180 -75.84 -158.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.659 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ARG . 96.1 mt-10 -32.47 -62.99 0.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.976 -0.453 . . . . 0.0 111.732 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -136.04 141.38 44.3 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.118 -0.989 . . . . 0.0 110.219 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -98.96 116.75 31.91 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.98 -43.84 94.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -59.99 -41.0 91.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.624 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -59.97 -43.3 95.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.029 -1.044 . . . . 0.0 110.109 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -69.99 -40.0 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.961 -1.087 . . . . 0.0 108.807 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.71 87.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.01 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.81 92.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.419 ' CD2' ' NE2' ' A' ' 122' ' ' HIS . 3.6 t-160 -69.01 -48.06 63.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 108.949 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.23 -42.59 91.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.903 -1.123 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.67 -40.01 95.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 109.46 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.98 84.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.419 ' NE2' ' CD2' ' A' ' 118' ' ' HIS . 24.3 m-70 -63.46 -36.97 85.52 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -1.1 . . . . 0.0 108.738 179.242 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.9 m -68.81 -26.54 65.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 109.127 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.58 -2.61 54.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 108.469 179.251 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.01 10.61 66.22 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.81 126.88 31.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.372 . . . . 0.0 109.178 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.7 m -88.07 174.26 8.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.798 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -67.08 157.14 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.4 t -131.37 159.68 37.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.0 p -101.72 11.8 38.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 56.8 t0 -80.1 132.93 36.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.007 -1.058 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 95.9 mt -60.04 -40.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.431 -0.793 . . . . 0.0 111.253 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.14 81.98 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.908 -1.12 . . . . 0.0 111.157 -178.442 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.93 136.82 34.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.656 -1.496 . . . . 0.0 109.776 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 91.2 mt -70.02 -29.88 67.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.445 -0.784 . . . . 0.0 109.267 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mmm -71.43 51.0 0.17 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 -178.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.2 t80 -70.0 137.22 87.24 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -64.85 10.22 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 119.871 0.99 . . . . 0.0 111.7 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.2 t -160.02 175.65 12.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 108.833 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.9 t80 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 120.664 -1.273 . . . . 0.0 109.662 -179.817 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.536 0.684 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.27 160.19 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.42 147.62 45.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.848 -1.157 . . . . 0.0 109.308 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.38 149.56 21.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.12 -39.91 72.95 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -54.84 -39.84 68.98 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -73.93 -39.95 63.43 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -0.817 . . . . 0.0 109.33 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.4 mm -62.58 -51.23 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.391 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.13 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.405 -0.809 . . . . 0.0 110.955 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -51.42 38.17 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.259 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.59 -39.96 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.935 -1.332 . . . . 0.0 110.295 -178.857 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.4 mt-30 -67.38 -39.94 85.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.309 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.77 94.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.892 -1.13 . . . . 0.0 108.976 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.02 -50.04 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -96.6 -73.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.45 -171.51 35.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 162' ' ' ARG . 38.1 mtt-85 -85.51 156.27 20.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -1.125 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 -179.693 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -82.16 129.99 34.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.26 -13.43 57.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.886 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -81.84 149.36 28.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 109.58 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.6 p -96.57 -7.47 34.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.936 . . . . 0.0 108.847 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.526 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 64.0 m-70 -130.03 144.2 51.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.17 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.9 mt -134.24 157.6 45.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.18 -0.95 . . . . 0.0 109.802 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.0 p -127.77 155.57 43.83 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -142.5 159.84 41.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 0.0 109.497 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.404 HH12 ' HA ' ' A' ' 19' ' ' GLU . 40.2 ttt-85 -148.1 130.12 15.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 110.082 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.33 119.81 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.342 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 78.0 tt0 -66.89 -39.92 87.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.1 m-20 -157.55 150.03 22.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.979 -1.076 . . . . 0.0 110.082 -179.43 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.16 135.16 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 t -68.59 141.75 93.35 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.232 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.81 -12.66 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.674 0.916 . . . . 0.0 111.832 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -136.28 149.55 68.22 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 121.255 -0.903 . . . . 0.0 108.848 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -59.61 -179.99 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.214 0.755 . . . . 0.0 111.744 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -86.46 -33.01 20.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.12 81.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.84 -39.91 76.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.36 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.35 -42.83 81.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.03 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.05 87.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.405 ' O ' ' N ' ' A' ' 36' ' ' LYS . 86.3 t60 -60.02 -49.7 76.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.18 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.01 90.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.406 -0.809 . . . . 0.0 109.88 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.61 -44.59 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.292 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.23 -40.15 74.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.5 tttt -62.64 -39.68 94.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.07 90.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 31.1 m-85 -59.87 -40.31 88.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.112 . . . . 0.0 109.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.11 -40.67 90.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.0 -43.31 95.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.009 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.97 -41.76 64.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.183 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.5 t -70.14 -26.49 63.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.248 -0.907 . . . . 0.0 110.521 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -60.07 -36.03 76.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 110.852 -178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 45' ' ' THR . 16.7 m -109.92 13.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.061 -1.024 . . . . 0.0 110.403 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.553 HG23 HG23 ' A' ' 44' ' ' VAL . 72.0 p -141.2 146.81 44.55 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.997 -1.064 . . . . 0.0 109.257 179.082 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.19 5.57 2.62 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.579 0.853 . . . . 0.0 111.414 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.84 153.39 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 0.0 109.866 -179.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.526 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 38.2 p -130.91 148.01 52.62 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 98.1 m-85 -126.52 149.76 49.19 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.3 m -153.33 132.06 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 0.0 109.835 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -79.62 142.03 35.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.413 -0.804 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.55 135.85 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -96.67 -3.14 43.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 0.0 110.011 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.67 152.55 41.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.028 -1.045 . . . . 0.0 109.647 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.31 166.99 33.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -82.91 139.52 33.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -1.156 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.64 160.44 14.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 108.983 179.736 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.97 -39.76 86.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.178 -0.952 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.85 120.02 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.485 0.659 . . . . 0.0 109.932 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -99.86 122.13 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.01 129.98 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.417 -0.802 . . . . 0.0 109.052 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -149.05 153.94 38.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.025 -1.047 . . . . 0.0 110.295 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -104.37 138.04 41.38 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.0 170.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.112 -0.993 . . . . 0.0 111.101 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -134.43 143.57 47.63 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.667 -0.646 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.44 -146.68 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -67.17 128.69 37.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.994 . . . . 0.0 109.597 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.495 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -135.97 58.49 1.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.06 52.2 10.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.588 -0.695 . . . . 0.0 109.341 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.495 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 18.9 p-10 -142.43 160.02 41.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 109.072 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -91.14 10.04 28.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.279 -0.888 . . . . 0.0 109.705 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -137.07 74.34 49.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.326 -0.859 . . . . 0.0 109.845 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.53 148.85 48.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.081 1.188 . . . . 0.0 111.405 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -75.88 139.98 41.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.276 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.86 61.04 0.97 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 109.351 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 -176.72 53.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -55.07 -13.55 6.84 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.158 1.238 . . . . 0.0 112.079 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 170.32 34.62 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -150.63 19.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -77.89 142.04 38.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -1.108 . . . . 0.0 109.862 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.5 mt -89.89 -16.6 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.197 -0.94 . . . . 0.0 108.953 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.01 166.96 9.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.932 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.59 -178.44 6.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.839 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.16 170.55 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.396 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.21 153.87 19.56 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.4 -0.813 . . . . 0.0 109.532 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -60.72 151.1 73.53 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.423 -0.798 . . . . 0.0 109.337 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 108.45 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.726 0.951 . . . . 0.0 112.402 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.67 165.19 34.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.04 161.92 40.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.108 1.206 . . . . 0.0 111.997 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.54 -126.65 7.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.51 -13.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 109.8 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.46 141.29 47.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.06 -15.23 60.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.38 159.21 31.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -1.193 . . . . 0.0 109.708 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.99 122.85 12.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.301 -0.874 . . . . 0.0 109.171 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -104.68 148.32 26.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.0 110.465 -179.201 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.3 m-85 -115.22 135.51 54.1 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.246 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 19.7 t0 -67.19 116.67 8.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -95.76 -0.25 51.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -178.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 94.3 m-20 -75.72 -17.33 59.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.84 -1.163 . . . . 0.0 110.095 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -102.2 159.8 15.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 102' ' ' ARG . 35.7 ttm-85 -88.29 120.35 29.57 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.051 -1.03 . . . . 0.0 109.365 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -88.33 148.52 24.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.8 p -124.9 161.12 27.28 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.531 -0.731 . . . . 0.0 109.742 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -112.8 31.46 6.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -148.18 -164.9 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -0.881 . . . . 0.0 109.976 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -79.93 30.64 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.148 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 108' ' ' ARG . 48.9 mtt-85 -76.63 -164.48 0.42 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 52.5 mp0 -60.04 -58.3 9.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 112.552 -177.613 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -106.1 121.63 44.54 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.975 -1.078 . . . . 0.0 111.349 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -104.19 117.28 33.87 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.14 -40.17 90.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.1 -41.32 92.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 114' ' ' ARG . 4.4 mmt-85 -60.15 -39.98 88.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.28 -41.12 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.064 -1.022 . . . . 0.0 109.826 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.11 95.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.93 87.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -69.2 -46.16 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 94.4 mt-10 -59.1 -40.21 84.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.763 -1.211 . . . . 0.0 109.889 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.28 -39.94 92.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.088 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.77 97.16 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -65.3 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.161 -1.199 . . . . 0.0 108.803 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.3 p -70.04 -24.31 63.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 108.813 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.89 -3.43 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.43 13.31 76.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.7 132.66 35.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.884 -1.363 . . . . 0.0 108.942 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -87.91 173.04 9.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 109.793 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.62 159.3 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -127.88 162.57 26.4 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.0 p -100.12 2.8 43.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.019 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -82.3 128.81 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.09 -31.58 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.476 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.14 -0.72 77.87 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.272 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.309 . . . . 0.0 109.346 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.68 -27.55 66.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.7 mmm -74.11 44.43 0.19 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.421 -0.8 . . . . 0.0 109.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.05 134.71 87.44 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 -179.576 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -50.62 -62.11 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 120.055 1.055 . . . . 0.0 111.536 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -81.71 175.38 10.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.815 . . . . 0.0 109.135 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.4 t80 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 109.725 -179.883 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.432 0.634 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -140.57 150.74 44.03 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.11 147.44 40.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 109.012 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.1 162.98 14.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.07 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.98 -40.17 88.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 109.002 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.39 -40.78 87.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.44 -40.15 62.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.12 -52.25 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.226 -0.921 . . . . 0.0 109.166 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.59 -40.1 90.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.051 -1.031 . . . . 0.0 109.476 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.05 11.38 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.793 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -63.4 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.339 . . . . 0.0 109.798 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.3 mt-30 -67.2 -39.93 86.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 0.0 109.717 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.54 92.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.077 -1.014 . . . . 0.0 109.273 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.0 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.751 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -97.57 -69.98 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.14 -0.975 . . . . 0.0 109.325 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.59 -169.18 33.9 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -86.22 157.66 19.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -1.177 . . . . 0.0 109.838 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.25 -0.906 . . . . 0.0 108.921 179.515 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -84.48 120.03 25.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.004 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 55.3 mp0 -82.69 -9.87 59.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.99 155.76 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 0.0 110.299 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.4 p -98.92 -4.5 32.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 48.2 m80 -129.96 141.72 50.73 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 49' ' ' PHE . 69.0 mt -133.39 156.06 48.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.251 -0.905 . . . . 0.0 109.27 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 153.98 45.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.398 -0.813 . . . . 0.0 109.185 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -146.16 162.25 38.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.323 -0.86 . . . . 0.0 109.206 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -147.92 129.88 15.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.37 120.15 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.35 -40.12 89.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 110.422 -178.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -163.27 154.84 17.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.877 -1.139 . . . . 0.0 110.478 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.36 136.4 40.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -70.79 143.05 88.93 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.106 -0.996 . . . . 0.0 109.36 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.85 -11.08 25.15 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.603 0.869 . . . . 0.0 111.749 179.61 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.0 -39.93 87.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.947 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.8 mt -139.55 150.58 64.04 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.371 -0.831 . . . . 0.0 109.044 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.94 -177.04 0.3 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.622 0.881 . . . . 0.0 112.015 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.6 ptt180 -87.03 -33.23 19.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.39 -39.98 81.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.63 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.24 -39.97 59.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -50.04 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.0 111.261 -178.574 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 29.6 p-10 -59.16 -39.03 81.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.76 -1.213 . . . . 0.0 108.948 -179.399 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.412 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.8 t60 -59.73 -49.17 78.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.185 179.01 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.14 87.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 110.165 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.09 -40.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.229 -0.919 . . . . 0.0 109.857 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.07 -39.75 86.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.23 -39.8 87.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 109.29 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.33 95.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.09 -1.006 . . . . 0.0 109.498 -179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -60.02 -39.94 87.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.864 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -60.0 -40.03 87.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.369 -0.832 . . . . 0.0 109.827 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 40' ' ' LEU . 90.2 mt -60.03 -42.96 95.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.055 -1.028 . . . . 0.0 109.709 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -71.65 -40.11 69.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 109.702 -179.48 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 t -69.79 -33.7 72.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.03 -23.06 63.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 111.06 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 m -112.74 3.33 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.166 -0.959 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 9.2 p -148.63 151.37 35.67 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.861 -1.149 . . . . 0.0 109.586 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.99 8.88 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.657 0.905 . . . . 0.0 111.975 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.15 150.01 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.543 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -137.26 153.75 50.27 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.452 -0.78 . . . . 0.0 109.033 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 14' ' ' LEU . 96.5 m-85 -130.01 158.93 38.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.492 -0.755 . . . . 0.0 110.109 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -154.88 126.69 7.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.864 . . . . 0.0 109.984 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.82 143.92 37.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.333 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.76 139.53 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -95.28 -11.2 28.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.165 -0.959 . . . . 0.0 110.097 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -147.59 158.16 43.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.964 -1.085 . . . . 0.0 109.546 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.93 170.83 47.65 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.595 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 5.5 pm0 -80.0 163.96 23.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.41 151.86 51.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -0.752 . . . . 0.0 109.757 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.11 -39.87 87.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.483 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.67 119.85 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.704 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.1 mmm -100.59 128.73 46.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.2 mt -119.13 129.92 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.468 -0.77 . . . . 0.0 109.722 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.7 p -149.74 159.92 43.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.172 -0.955 . . . . 0.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.56 138.37 44.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.14 161.54 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.162 -0.961 . . . . 0.0 111.25 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.92 142.78 50.83 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.717 -0.614 . . . . 0.0 109.786 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.99 -143.52 1.45 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.1 t0 -71.33 130.73 42.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.984 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.416 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.8 p-80 -133.11 53.59 2.01 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.5 -0.75 . . . . 0.0 109.835 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 54.04 50.98 15.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 109.386 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 10.4 t70 -140.03 165.88 26.14 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 26.1 m120 -89.15 9.36 25.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.11 -0.994 . . . . 0.0 109.946 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -135.57 71.43 65.41 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.833 . . . . 0.0 109.635 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.76 141.1 70.57 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 120.937 1.091 . . . . 0.0 111.986 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -75.2 141.33 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -110.74 74.28 0.87 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.784 . . . . 0.0 109.312 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.26 -178.62 6.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.56 -18.78 4.16 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.186 1.257 . . . . 0.0 112.044 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.22 175.06 55.03 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -160.46 29.29 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -75.03 160.12 30.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -1.114 . . . . 0.0 109.681 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 mt -93.64 -20.97 19.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.24 -0.912 . . . . 0.0 109.774 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.59 174.75 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.043 -1.036 . . . . 0.0 109.724 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.04 175.81 10.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 108.943 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.4 167.7 21.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.629 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.78 148.9 24.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.483 -0.76 . . . . 0.0 109.106 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -59.99 149.81 72.3 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.059 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.28 120.58 8.44 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.781 0.987 . . . . 0.0 112.16 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.53 174.9 47.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.81 172.95 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.211 1.274 . . . . 0.0 112.105 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.35 -124.83 16.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.09 -9.13 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -1.043 . . . . 0.0 110.002 -179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.78 143.9 35.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.18 -18.25 46.34 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.07 152.84 45.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.118 -1.225 . . . . 0.0 109.914 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.27 121.42 10.14 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -102.92 141.5 35.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.42 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.8 m-85 -113.8 136.57 52.71 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -65.71 115.6 6.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -98.43 -1.04 42.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.496 -0.752 . . . . 0.0 109.442 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.14 -20.23 59.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.976 -1.078 . . . . 0.0 109.557 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.31 159.55 14.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 108.84 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -87.23 122.43 31.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.932 . . . . 0.0 109.682 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.18 150.01 22.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.892 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.8 p -127.56 159.64 33.99 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.542 -0.724 . . . . 0.0 109.347 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -109.39 29.47 7.52 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.532 -0.73 . . . . 0.0 109.587 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -148.82 -165.01 2.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.217 -0.927 . . . . 0.0 109.655 -179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.72 34.73 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 0.0 110.644 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -76.85 -165.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.392 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.38 -56.59 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.589 -0.694 . . . . 0.0 111.432 -178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 104' ' ' THR . 91.5 m-85 -100.33 119.79 38.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.052 -1.03 . . . . 0.0 110.756 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -103.35 107.3 18.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.385 -0.822 . . . . 0.0 109.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.38 -44.16 97.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 110.09 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -59.91 -43.43 94.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 114' ' ' ARG . 13.7 ttt-85 -59.95 -43.32 95.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.892 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.96 -40.03 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.15 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.56 92.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.27 90.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.28 -45.87 68.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 71.4 mt-10 -59.84 -40.14 87.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.94 -1.1 . . . . 0.0 109.142 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.58 -40.05 90.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 108.894 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.79 -41.92 84.44 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -64.65 -38.98 92.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -1.201 . . . . 0.0 108.835 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.3 p -70.02 -21.47 63.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.344 -0.847 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.86 -0.61 56.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 108.966 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.93 8.93 78.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.2 127.36 32.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.032 -1.275 . . . . 0.0 108.791 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -88.05 175.46 7.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.327 -0.858 . . . . 0.0 109.687 -179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -67.53 159.88 28.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -133.25 163.63 28.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.538 -0.727 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -100.89 7.45 43.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.65 122.01 27.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 108.788 179.574 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.24 -30.82 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.188 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.48 -5.74 89.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.464 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.77 132.08 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.995 -1.297 . . . . 0.0 109.505 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -68.91 -24.64 64.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.1 mmm -73.21 38.63 0.09 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.791 -178.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.9 t80 -69.32 129.72 91.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.965 . . . . 0.0 108.671 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -47.59 -67.51 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.3 1.143 . . . . 0.0 111.863 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 98.0 p -81.88 169.42 16.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.949 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.401 0.619 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.91 154.26 46.04 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 63.4 mt -74.93 146.04 42.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.969 -1.082 . . . . 0.0 109.11 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.07 156.89 16.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 109.092 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.77 -38.89 79.5 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -55.08 -40.11 70.01 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.072 -1.018 . . . . 0.0 108.624 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.7 -39.96 69.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.23 -49.94 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.659 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.99 -39.98 91.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.837 -1.164 . . . . 0.0 110.339 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.74 -54.43 9.91 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.137 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.7 tp -61.89 -40.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.299 . . . . 0.0 110.038 -179.008 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -65.86 -40.04 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.941 -1.099 . . . . 0.0 109.387 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.926 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -50.07 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 110.51 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -100.47 -61.04 1.42 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.171 -0.955 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.7 -176.93 34.69 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -90.93 149.43 21.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.426 -1.043 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 108.685 179.682 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 8' ' ' ARG . 22.6 mtt-85 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -83.75 120.63 26.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.285 -0.885 . . . . 0.0 109.527 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.95 -10.11 58.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 109.109 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.94 150.11 30.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 -179.475 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -97.0 -4.89 38.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.523 -0.735 . . . . 0.0 109.442 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -130.01 139.99 50.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.78 157.61 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.403 -0.811 . . . . 0.0 109.654 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -127.0 155.19 43.59 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.619 -0.676 . . . . 0.0 109.188 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.98 157.91 43.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.009 -1.057 . . . . 0.0 109.266 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.428 HH21 ' CE ' ' A' ' 60' ' ' MET . 42.3 ttp180 -147.33 128.86 15.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.166 -0.959 . . . . 0.0 109.954 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.0 mt -85.41 123.71 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -62.3 -40.76 97.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -178.019 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -162.22 151.84 16.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.304 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -97.54 135.94 38.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.378 -0.827 . . . . 0.0 109.27 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 t -73.41 144.92 84.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.752 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.89 -15.09 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 CA-C-N 119.203 0.751 . . . . 0.0 111.046 179.012 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.49 -40.07 93.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.525 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.4 mt -135.13 150.32 72.58 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.009 -1.057 . . . . 0.0 109.337 -178.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.39 179.82 2.75 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 CA-C-N 119.158 0.735 . . . . 0.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -85.54 -36.13 20.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.924 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.78 84.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.21 -40.03 74.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.85 -44.33 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.443 -179.229 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.54 89.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 108.719 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.87 -47.87 84.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.312 -0.867 . . . . 0.0 109.499 179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.47 89.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.143 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.58 -40.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -70.26 -40.0 74.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.609 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.29 95.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 108.609 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CE1' ' CD1' ' A' ' 49' ' ' PHE . 33.8 m-85 -61.21 -39.59 90.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 109.881 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -58.9 -40.93 85.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.2 -41.24 92.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.034 -1.041 . . . . 0.0 109.317 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -72.39 -40.0 67.57 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.68 -28.47 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.442 -0.786 . . . . 0.0 110.254 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -59.85 -35.14 74.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 110.766 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.405 ' C ' ' HG ' ' A' ' 163' ' ' SER . 2.9 m -108.52 5.63 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.278 -0.889 . . . . 0.0 110.985 -178.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.3 p -140.03 148.63 55.61 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 120.897 -1.127 . . . . 0.0 108.625 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.73 6.4 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.407 1.404 . . . . 0.0 112.389 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.16 157.92 35.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.367 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 p -135.79 147.71 48.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.482 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 95.9 m-85 -128.72 148.7 50.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.725 -0.609 . . . . 0.0 109.65 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -154.35 134.92 13.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -76.06 146.58 39.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.25 135.17 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.369 -0.832 . . . . 0.0 108.978 179.19 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -97.54 -5.89 34.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 110.052 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -142.67 156.67 45.08 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.07 -1.019 . . . . 0.0 109.565 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 167.59 25.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -78.37 148.03 33.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.932 . . . . 0.0 109.272 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.59 148.38 30.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -0.776 . . . . 0.0 108.913 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.45 -40.35 90.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.34 118.89 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.428 ' CE ' HH21 ' A' ' 17' ' ' ARG . 89.7 mmm -101.2 122.19 43.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -111.79 130.05 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.625 -0.672 . . . . 0.0 109.524 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.6 p -147.39 155.5 42.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -105.28 140.2 38.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.57 160.29 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 121.901 0.858 . . . . 0.0 111.188 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.3 mtm-85 -131.96 135.44 46.58 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.72 -138.66 13.88 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -77.37 129.09 35.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.561 -0.964 . . . . 0.0 110.243 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 19.1 p-80 -131.58 47.46 2.53 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.409 -0.807 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 56.04 59.35 3.78 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.1 p-10 -142.72 163.1 33.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.066 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.53 9.19 30.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.172 -0.955 . . . . 0.0 109.233 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 t -140.08 69.51 34.95 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.414 -0.804 . . . . 0.0 109.012 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.67 148.68 42.22 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.364 1.376 . . . . 0.0 112.083 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -79.25 151.12 31.34 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -134.93 76.36 1.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.428 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.83 -179.18 39.73 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -70.73 -15.6 33.46 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.194 1.262 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.04 -174.89 50.5 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.04 -158.38 36.38 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -75.06 143.78 43.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -1.023 . . . . 0.0 109.25 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.32 -16.0 32.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 109.0 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.54 175.67 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.264 -0.898 . . . . 0.0 108.937 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -163.01 120.25 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.914 -1.116 . . . . 0.0 110.629 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.45 168.11 16.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -109.61 143.93 38.63 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -59.47 145.95 80.94 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -58.36 127.28 24.16 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 119.249 0.768 . . . . 0.0 112.306 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.27 178.12 43.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.57 -177.86 3.87 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.359 1.373 . . . . 0.0 112.524 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.75 -123.7 33.52 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.14 -13.74 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.49 -1.006 . . . . 0.0 109.782 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.01 138.77 38.21 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.249 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -13.93 63.5 Favored Glycine 0 N--CA 1.497 2.702 0 O-C-N 121.231 -1.158 . . . . 0.0 110.546 179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.79 162.81 25.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.955 -1.321 . . . . 0.0 109.768 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.5 120.76 11.55 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -105.15 133.45 49.9 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.241 -0.912 . . . . 0.0 110.272 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.508 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 43.8 m-85 -114.65 129.75 56.72 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.356 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -67.53 120.72 14.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 108.968 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -99.4 6.5 46.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.308 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.47 -20.16 60.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 0.0 109.737 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -104.23 160.07 15.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 102' ' ' ARG . 33.2 ttt-85 -84.11 119.16 24.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.138 -0.976 . . . . 0.0 110.147 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -88.8 148.95 23.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.497 -0.752 . . . . 0.0 109.269 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 41.6 p -123.23 167.96 13.06 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.476 -0.765 . . . . 0.0 109.306 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -104.66 23.82 12.75 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -148.98 -165.0 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.657 -0.652 . . . . 0.0 109.805 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -90.88 27.0 1.92 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.231 -0.918 . . . . 0.0 110.911 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.0 mtt-85 -76.47 -157.14 0.08 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.837 -1.165 . . . . 0.0 109.442 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 108' ' ' ARG . 64.4 mm-40 -24.31 -65.4 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.202 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.4 m-85 -130.12 132.05 45.95 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.978 -1.076 . . . . 0.0 109.786 -179.455 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -95.99 113.83 25.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.204 -0.935 . . . . 0.0 109.701 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.25 -40.27 77.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -59.63 -42.9 93.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.958 -1.089 . . . . 0.0 109.988 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 114' ' ' ARG . 25.3 ttt-85 -59.7 -41.52 90.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.27 -39.67 77.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.77 92.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.328 -0.858 . . . . 0.0 108.926 179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.16 85.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.0 109.162 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 4.3 t60 -69.72 -50.1 46.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 73.4 mt-10 -59.95 -40.1 87.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.962 -1.086 . . . . 0.0 110.278 -178.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 58.2 mt -62.12 -39.88 94.04 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 108.828 179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.52 95.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 12.2 m-70 -61.93 -38.73 89.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.067 -1.255 . . . . 0.0 107.778 178.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.5 m -69.65 -24.31 63.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.1 -0.27 51.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 108.852 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.99 13.97 65.5 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.361 -0.923 . . . . 0.0 110.889 178.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.56 124.58 30.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.088 -1.243 . . . . 0.0 108.887 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -88.67 167.28 13.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.998 -1.064 . . . . 0.0 109.1 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 122' ' ' HIS . 80.9 m80 -68.58 152.36 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 t -126.44 169.69 12.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.473 -0.767 . . . . 0.0 108.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.3 p -98.94 1.02 45.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.398 -0.814 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -79.06 119.3 21.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.04 -40.44 83.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 -179.464 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.77 27.87 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.01 -1.057 . . . . 0.0 111.007 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.1 23.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.852 -1.381 . . . . 0.0 109.159 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 85.1 mt -68.19 -23.89 64.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 108.885 178.743 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.564 ' SD ' ' N ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -74.52 62.24 1.0 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.57 -0.706 . . . . 0.0 109.911 -179.262 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 139' ' ' SER . 1.8 t80 -71.19 123.95 90.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -51.11 -2.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 CA-C-N 120.459 1.2 . . . . 0.0 113.546 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 137' ' ' TYR . 58.3 m -163.05 174.55 12.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 0.0 109.074 179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.2 t80 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.903 . . . . 0.0 108.92 179.626 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.315 0.578 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -142.58 157.87 44.26 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.54 145.92 47.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.018 -1.051 . . . . 0.0 108.868 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.07 162.91 13.68 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.21 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.14 -40.19 88.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.193 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.22 -41.67 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.712 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -71.68 -40.78 69.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.76 -49.78 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.781 . . . . 0.0 109.298 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.67 -39.91 88.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.894 -1.129 . . . . 0.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -52.72 34.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.32 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -1.212 . . . . 0.0 109.669 -179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.28 -39.65 92.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.198 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.79 92.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.389 -0.819 . . . . 0.0 110.033 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.97 -47.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.92 -1.112 . . . . 0.0 109.478 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.41 -64.91 1.01 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.299 -0.876 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.91 -169.82 35.94 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -92.11 145.44 24.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.023 -1.281 . . . . 0.0 108.7 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 42.2 m . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.223 -0.923 . . . . 0.0 109.962 -178.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -83.13 118.71 23.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -85.26 -10.65 56.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.287 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.73 150.9 25.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.323 -179.175 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.7 p -96.19 -3.8 43.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -128.85 141.67 51.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 160.05 39.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.244 -0.91 . . . . 0.0 109.784 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 p -127.94 157.18 41.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -146.1 159.94 42.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.416 -0.802 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -150.4 133.87 16.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.2 mt -89.49 118.57 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.4 mt-10 -66.8 -40.13 87.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.531 -178.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.2 m-20 -155.95 152.71 28.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.119 -0.988 . . . . 0.0 109.849 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -101.4 131.98 47.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -68.75 138.26 90.61 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.993 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.47 -8.95 18.5 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.596 0.891 . . . . 0.0 112.052 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.1 -39.97 88.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.004 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -135.73 149.06 67.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.13 -175.44 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.63 0.886 . . . . 0.0 111.696 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -90.01 -37.23 14.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -45.85 85.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.823 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.54 -39.83 73.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.72 -45.58 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -59.95 -40.11 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.184 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -60.12 -42.52 94.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.74 90.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.46 -36.89 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -65.71 -42.03 91.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.739 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.6 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.836 -1.165 . . . . 0.0 109.82 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.95 75.66 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 39.4 m-85 -61.69 -40.96 96.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.918 -1.114 . . . . 0.0 108.78 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.24 -42.03 94.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 0.0 110.356 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.79 -40.6 88.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.067 . . . . 0.0 110.116 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -73.0 -40.04 65.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.822 -1.174 . . . . 0.0 109.186 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 t -70.04 -26.48 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 110.25 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.92 -35.97 76.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.377 -0.827 . . . . 0.0 110.68 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 45' ' ' THR . 33.7 m -108.54 10.26 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 44' ' ' VAL . 65.9 p -141.05 147.25 46.93 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.301 -0.875 . . . . 0.0 109.306 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.78 6.29 2.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.9 1.067 . . . . 0.0 112.067 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.32 155.9 40.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.813 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.8 p -134.54 149.85 50.69 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 91.8 m-85 -125.98 155.13 41.88 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.468 -0.77 . . . . 0.0 109.433 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.5 m -151.65 137.25 17.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.36 137.02 37.82 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -121.57 134.34 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.362 -0.836 . . . . 0.0 109.16 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 t -97.47 -6.02 34.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.344 -0.848 . . . . 0.0 110.624 -179.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -144.19 153.32 41.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.83 165.57 33.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -81.09 147.3 30.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -1.17 . . . . 0.0 108.972 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.77 17.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.73 -38.66 82.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.196 -0.94 . . . . 0.0 108.946 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -116.4 118.3 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.673 0.749 . . . . 0.0 109.833 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.43 129.64 46.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.335 -0.853 . . . . 0.0 109.737 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.46 130.63 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.1 p -148.43 161.2 42.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.0 -1.062 . . . . 0.0 110.582 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.08 140.01 48.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 173.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.134 -0.979 . . . . 0.0 111.003 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -138.15 141.93 40.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.518 -0.739 . . . . 0.0 110.481 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.49 -140.09 2.24 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.57 130.33 40.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.425 -1.044 . . . . 0.0 109.421 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.516 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 12.1 p-80 -136.91 60.44 1.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.519 -0.738 . . . . 0.0 110.315 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 52.45 51.16 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.543 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 72' ' ' SER . 11.9 t70 -144.36 160.09 41.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.219 -0.926 . . . . 0.0 109.337 -179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.96 9.89 23.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 108.74 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 40.3 t -134.17 73.78 69.08 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.537 -0.727 . . . . 0.0 109.318 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.77 145.08 45.27 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.057 1.171 . . . . 0.0 111.88 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.2 142.56 45.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.103 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -102.42 65.63 0.95 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.299 -0.876 . . . . 0.0 109.665 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.3 -166.6 41.39 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.09 -20.02 17.65 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.226 1.284 . . . . 0.0 111.998 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.69 173.77 43.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.38 -163.73 26.53 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -73.9 152.31 40.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.419 -1.048 . . . . 0.0 109.974 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -91.86 -17.0 25.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.03 171.26 7.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.432 -0.793 . . . . 0.0 109.053 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.56 121.97 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.7 173.3 9.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.616 -0.678 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.65 158.54 17.96 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.591 -0.693 . . . . 0.0 109.241 179.235 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -58.82 145.8 77.6 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.135 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.09 96.5 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.776 0.984 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.91 173.49 36.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.318 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -65.1 -174.1 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.92 1.08 . . . . 0.0 111.705 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.38 -134.11 50.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.24 -12.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -1.124 . . . . 0.0 110.313 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.88 144.22 44.68 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.7 -12.67 66.43 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.38 160.83 28.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -1.156 . . . . 0.0 109.979 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.72 115.56 9.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -100.13 142.53 31.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -122.04 134.88 54.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.557 -0.715 . . . . 0.0 109.275 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.8 119.46 13.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -95.14 -0.27 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.83 -18.46 60.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 109.781 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 162.58 13.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.228 -0.92 . . . . 0.0 108.927 179.073 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -87.21 119.15 27.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -87.44 140.12 29.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.038 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 54.3 p -128.78 166.33 19.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.495 -0.753 . . . . 0.0 109.735 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.73 31.05 6.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.62 -0.675 . . . . 0.0 109.258 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.514 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 17.5 p30 -148.46 -162.73 1.62 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -81.11 34.24 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.423 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 108' ' ' ARG . 10.6 mmt-85 -76.77 -166.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.129 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -50.27 -57.14 8.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.596 -0.69 . . . . 0.0 111.991 -178.549 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.3 m-85 -119.94 140.16 51.34 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.136 -0.977 . . . . 0.0 111.494 -177.333 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 21.4 m120 -108.32 118.49 36.9 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.99 -42.01 85.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.18 -0.95 . . . . 0.0 110.682 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -59.95 -42.09 93.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.054 -1.029 . . . . 0.0 110.935 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -59.84 -40.87 89.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 109.968 -178.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 62.6 t -70.33 -40.09 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 108.789 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.23 80.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.004 -1.06 . . . . 0.0 108.943 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.06 -35.01 79.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.956 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -69.99 -56.22 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.857 -1.152 . . . . 0.0 109.948 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 7.0 mp0 -57.73 -39.92 78.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.951 -1.093 . . . . 0.0 109.677 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.94 -39.74 90.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.276 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.86 95.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -63.47 -33.66 76.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -1.091 . . . . 0.0 108.8 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -68.83 -25.31 64.59 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.4 mt -84.58 -6.27 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 0.0 109.431 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.14 19.53 52.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.354 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.37 134.81 34.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.866 -1.373 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.8 m -87.55 168.29 13.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.4 159.14 32.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.9 t -132.35 157.82 43.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.072 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 10.15 41.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.312 -0.867 . . . . 0.0 109.883 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -82.04 128.51 34.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.76 -27.67 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 110.463 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.15 -4.79 88.04 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.413 -179.234 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.35 132.34 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.671 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.84 -27.46 65.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 109.421 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.6 mtp -75.72 45.39 0.32 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.826 -179.347 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -69.94 135.54 87.52 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -47.07 -68.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 119.861 0.986 . . . . 0.0 112.545 179.11 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -85.14 174.05 9.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.017 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.9 t80 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.921 179.748 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.118 0.485 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.88 153.98 41.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.259 -0.9 . . . . 0.0 109.478 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.06 149.46 39.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 108.71 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.76 161.32 14.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -60.03 -39.82 87.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.564 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -58.59 -40.34 82.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.482 -0.761 . . . . 0.0 109.706 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.55 -40.14 66.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.747 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.81 -49.69 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.67 -40.21 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.182 -0.949 . . . . 0.0 109.868 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -57.53 12.76 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.911 -178.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -60.15 -39.98 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.308 . . . . 0.0 109.941 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -63.13 -39.58 95.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.028 -1.045 . . . . 0.0 109.175 179.399 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.57 94.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.22 -52.06 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.743 -1.223 . . . . 0.0 109.392 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -96.1 -70.9 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.11 -170.07 39.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -92.98 141.72 28.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -1.156 . . . . 0.0 109.721 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.16 -39.95 88.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.965 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 61.7 p -91.78 142.0 28.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.37 -0.831 . . . . 0.0 108.912 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -83.21 102.56 11.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.991 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.02 86.36 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.096 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 3' ' ' THR . 10.3 m120 -150.19 66.61 7.95 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 120.41 -1.641 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -78.1 144.41 21.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.404 1.402 . . . . 0.0 112.246 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 -87.18 167.37 14.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -81.7 119.63 24.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.038 -1.039 . . . . 0.0 108.68 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -82.43 -11.5 58.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.68 151.03 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.81 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.4 p -94.81 -3.99 47.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -129.2 144.02 51.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -133.39 158.5 42.88 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.39 -0.819 . . . . 0.0 109.91 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.3 p -128.71 150.02 50.45 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.18 159.41 42.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 0.0 109.578 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -150.7 130.5 13.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.0 109.74 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.21 122.54 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.309 -0.87 . . . . 0.0 108.858 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.83 -40.08 83.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.477 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -161.74 159.45 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.857 -1.152 . . . . 0.0 110.212 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -100.12 138.19 37.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -69.53 139.77 89.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 108.983 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -66.31 -12.13 34.33 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.601 0.893 . . . . 0.0 111.309 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.02 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.387 -0.821 . . . . 0.0 108.976 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -138.04 149.93 65.56 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.88 -170.97 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 120.795 0.997 . . . . 0.0 112.094 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' NH2' ' OD2' ' A' ' 31' ' ' ASP . 6.6 ptm180 -88.51 -31.81 18.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.11 -47.38 78.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.975 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.96 -43.96 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -0.976 . . . . 0.0 110.092 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 87.3 m-20 -59.28 -41.68 89.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.12 . . . . 0.0 109.267 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -60.06 -49.03 79.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.46 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.4 92.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.29 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.05 -40.05 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 0.0 109.725 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.16 -41.02 74.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.818 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.73 -39.74 92.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -46.18 86.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.074 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.884 -1.135 . . . . 0.0 109.261 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.412 HE21 ' HG2' ' A' ' 35' ' ' GLU . 80.3 mt-30 -60.01 -41.2 91.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 110.232 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -41.39 91.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.022 -1.049 . . . . 0.0 109.889 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -72.57 -42.29 64.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.335 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -69.93 -30.82 68.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 110.249 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.61 -31.99 68.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 111.168 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 33.3 m -110.03 9.99 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.084 -1.01 . . . . 0.0 111.009 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 70.4 p -143.25 148.28 43.88 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 120.925 -1.109 . . . . 0.0 109.292 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.78 10.5 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 120.64 0.894 . . . . 0.0 111.196 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.58 151.5 44.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.515 -0.741 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 p -129.8 140.91 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.64 157.7 27.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.571 -0.705 . . . . 0.0 109.38 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -154.59 125.74 7.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 109.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -78.38 133.53 37.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.373 -0.83 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.9 135.89 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.579 -0.701 . . . . 0.0 109.261 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -96.22 -2.0 47.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 109.994 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -146.35 156.39 43.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.966 -1.084 . . . . 0.0 109.587 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.98 164.52 34.05 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -80.45 131.48 35.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.291 . . . . 0.0 108.594 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.81 155.19 16.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.22 -0.925 . . . . 0.0 109.846 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 109.602 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -120.01 113.06 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.44 -0.788 . . . . 0.0 109.062 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.03 133.6 44.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.113 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.7 mt -116.04 130.03 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.557 -0.714 . . . . 0.0 109.334 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.1 p -150.15 155.17 39.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.39 137.67 41.18 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.78 160.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.264 -0.897 . . . . 0.0 111.264 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -130.51 143.47 50.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.318 0.58 . . . . 0.0 109.528 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.88 -142.74 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -76.49 130.14 37.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.482 -1.01 . . . . 0.0 110.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.583 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.2 p-80 -130.56 54.14 1.91 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 57.45 49.99 12.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 109.818 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 8.4 m-20 -142.79 162.0 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 0.0 109.033 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -90.46 9.66 28.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.631 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.7 71.62 64.25 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.997 -1.064 . . . . 0.0 110.668 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.47 149.92 56.92 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.201 1.268 . . . . 0.0 111.828 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -77.45 142.98 38.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.592 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -108.01 65.5 0.64 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.45 -0.781 . . . . 0.0 109.353 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.44 -167.54 54.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.97 -8.52 4.75 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.2 1.267 . . . . 0.0 112.079 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.14 176.48 42.18 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 -164.27 41.17 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.575 ' HB3' HG12 ' A' ' 173' ' ' CGS . 8.7 p-10 -75.27 159.65 31.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.219 -1.165 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.67 -18.18 21.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.363 -0.836 . . . . 0.0 109.851 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.34 169.41 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.965 . . . . 0.0 108.872 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.6 177.75 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.081 . . . . 0.0 109.799 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.3 177.91 7.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.325 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.67 154.65 21.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.512 -0.743 . . . . 0.0 109.281 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 5.1 mp0 -58.59 149.99 59.04 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.182 -0.949 . . . . 0.0 108.802 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -60.72 107.42 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.575 0.85 . . . . 0.0 112.047 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.11 173.24 41.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.59 176.98 2.44 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.091 1.194 . . . . 0.0 112.121 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.11 -131.93 33.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.51 -12.72 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -1.062 . . . . 0.0 109.788 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.38 142.94 42.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.29 -21.49 37.49 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.52 153.35 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -1.17 . . . . 0.0 109.946 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.64 122.69 10.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 109.062 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -104.89 152.13 23.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.459 -0.776 . . . . 0.0 110.11 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 20.8 m-85 -119.91 139.64 52.1 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -66.55 119.81 12.33 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -98.51 2.3 47.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.55 -22.38 59.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.156 -0.965 . . . . 0.0 109.752 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -100.69 155.31 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.271 -0.893 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -85.21 128.07 34.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.031 -1.043 . . . . 0.0 109.251 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -89.6 145.86 24.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 109.785 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.1 p -129.87 166.41 20.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.576 -0.703 . . . . 0.0 109.708 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.41 30.3 6.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.555 -0.715 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 4.7 p30 -150.02 -164.24 1.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 31.76 0.43 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 108' ' ' ARG . 44.7 mtt-85 -75.91 -157.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.602 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -39.78 -59.66 1.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 111.389 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -135.08 151.21 50.53 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 67.1 m-20 -103.59 115.04 29.77 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.13 -43.92 90.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.053 -1.029 . . . . 0.0 110.736 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -60.01 -42.32 94.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 0.0 110.239 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.567 HH12 ' N ' ' A' ' 143' ' ' SER . 69.9 ttt180 -59.91 -40.53 89.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.997 . . . . 0.0 109.796 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 79.7 t -70.82 -41.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.996 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.93 92.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.018 -1.051 . . . . 0.0 109.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.75 88.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 0.0 109.204 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.452 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 6.5 t60 -68.33 -44.7 74.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.414 -0.804 . . . . 0.0 109.72 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 74.7 mt-10 -60.03 -39.93 87.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 109.437 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.69 -40.01 90.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 108.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.87 -41.84 84.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.27 -39.95 93.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 108.701 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.6 m -70.19 -27.27 64.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.82 -1.53 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.171 -0.955 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.12 9.93 69.67 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.28 123.61 30.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.939 -1.33 . . . . 0.0 109.181 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.9 m -88.2 176.23 7.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.97 155.38 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -131.17 168.38 17.56 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.1 p -101.82 10.52 39.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.379 -0.826 . . . . 0.0 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.43 129.52 34.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.33 -40.02 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 110.641 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 0.19 77.54 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.985 -1.103 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 129.52 34.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.655 -1.497 . . . . 0.0 109.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 137' ' ' TYR . 88.0 mt -69.21 -24.28 64.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -71.44 45.58 0.11 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 135' ' ' LEU . 5.4 t80 -70.03 129.78 90.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.44 ' O ' ' HC1' ' A' ' 173' ' ' CGS . 21.5 Cg_exo -48.57 -71.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.192 1.104 . . . . 0.0 112.091 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.4 p -80.92 170.0 16.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 109.597 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.54 135.88 33.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 109.197 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.492 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.0 p -146.71 171.82 14.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.296 -0.878 . . . . 0.0 109.321 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -95.77 115.86 28.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.567 ' N ' HH12 ' A' ' 114' ' ' ARG . 70.0 p -104.18 166.75 10.2 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -68.05 -120.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -80.45 156.92 26.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 109.208 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.4 t -86.39 104.81 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.949 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -146.43 152.29 38.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.079 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.52 142.98 42.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 109.043 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 166.57 12.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.178 -0.951 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.371 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -59.9 -40.3 88.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.517 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -73.07 -40.05 65.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 0.0 109.522 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.05 -50.07 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.76 -39.87 93.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.988 -1.07 . . . . 0.0 109.866 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.45 -57.49 19.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.222 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -65.99 -40.08 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.793 -1.416 . . . . 0.0 110.007 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.09 -39.95 90.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.88 96.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.01 -50.06 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.895 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -99.56 -64.86 1.0 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.5 -179.11 38.78 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -89.97 149.87 22.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -1.197 . . . . 0.0 109.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.43 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 21.5 m -73.38 89.67 1.63 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -76.57 33.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.729 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 163' ' ' SER . 81.3 m-20 -154.46 72.75 6.13 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.46 54.35 4.88 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.517 1.478 . . . . 0.0 112.015 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 t -89.93 110.16 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.032 -1.042 . . . . 0.0 109.397 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 55.8 mt-30 -64.35 -60.42 8.63 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 168' ' ' GLN . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.319 0 CA-C-N 120.398 1.178 . . . . 0.0 112.347 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.575 HG12 ' HB3' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.101 0.477 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.66 -82.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.0 109.449 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 p -98.67 138.79 35.34 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.193 -0.942 . . . . 0.0 109.721 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.97 145.94 39.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.103 -0.998 . . . . 0.0 109.1 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 -145.16 33.85 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -81.37 149.2 64.82 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.263 -1.14 . . . . 0.0 109.113 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -61.28 157.25 41.25 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.623 0.882 . . . . 0.0 112.131 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 8' ' ' ARG . 43.7 mtt-85 -146.21 163.02 36.74 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.744 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -82.41 120.44 25.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.061 -1.024 . . . . 0.0 109.591 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -83.87 -13.89 52.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 109.598 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.98 149.22 28.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.912 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -95.03 -3.9 47.49 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 67.0 m80 -125.3 134.49 52.23 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.9 151.48 50.42 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.872 . . . . 0.0 109.221 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -120.97 155.91 33.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 109.221 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -145.19 159.22 43.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -150.77 133.81 16.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.089 -1.007 . . . . 0.0 110.07 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.5 mt -90.84 120.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.96 -40.11 91.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.991 -1.068 . . . . 0.0 110.882 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.9 149.58 14.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.713 -1.242 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -95.22 132.85 39.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -71.05 143.23 88.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.691 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.72 -9.91 24.6 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.789 0.993 . . . . 0.0 112.625 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.97 -39.97 87.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.086 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -137.83 149.69 65.27 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.64 179.8 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.667 0.911 . . . . 0.0 111.916 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -86.58 -31.43 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.71 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -70.42 -40.07 74.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 110.499 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -40.82 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.546 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.02 -40.46 89.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.34 -45.04 94.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.342 -0.849 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.81 91.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.31 -40.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.695 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -69.92 -40.1 75.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.415 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -61.82 -40.01 93.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.292 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.63 91.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.035 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -60.47 -40.21 90.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.918 -1.114 . . . . 0.0 108.881 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -59.97 -41.47 92.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.792 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.32 -41.3 93.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.104 -0.997 . . . . 0.0 110.458 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -74.76 -42.11 58.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.985 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -68.71 -34.8 76.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 110.407 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.27 -32.24 69.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.269 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.616 HG23 HG23 ' A' ' 45' ' ' THR . 17.3 m -109.79 11.7 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.049 -1.032 . . . . 0.0 110.761 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 44' ' ' VAL . 52.0 p -143.01 149.27 48.62 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.911 -1.118 . . . . 0.0 109.472 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -73.68 3.88 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.538 0.826 . . . . 0.0 111.723 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 157.88 37.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 109.657 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.478 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.6 p -133.41 151.77 51.85 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.19 154.36 46.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.536 -0.727 . . . . 0.0 109.619 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.2 m -154.01 131.15 11.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -77.87 135.59 37.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.765 . . . . 0.0 109.082 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.17 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.313 -0.867 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 t -99.1 11.66 38.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.482 -0.761 . . . . 0.0 109.835 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.07 153.7 42.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.076 -1.015 . . . . 0.0 109.183 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 168.32 1.44 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -82.05 147.49 29.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 109.011 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.35 160.01 14.78 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.15 -40.06 88.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.34 119.32 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.396 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.1 mtp -103.58 134.3 47.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.523 -0.736 . . . . 0.0 109.767 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -119.68 126.83 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 0.0 109.283 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.9 p -149.69 156.09 41.29 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -103.13 140.78 36.89 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 68' ' ' HIS . 26.1 m -138.95 169.77 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 120.945 -1.097 . . . . 0.0 110.818 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -138.08 149.26 45.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.713 -0.617 . . . . 0.0 110.147 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.91 -146.52 2.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -70.07 129.97 40.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -1.08 . . . . 0.0 110.296 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.1 p-80 -137.98 55.82 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.699 -0.626 . . . . 0.0 109.39 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 85.0 mtm180 57.24 48.96 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 109.79 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -142.47 158.25 43.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.347 -0.845 . . . . 0.0 109.156 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.96 8.61 34.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -134.5 72.48 69.96 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.342 -0.849 . . . . 0.0 109.752 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.95 148.46 35.54 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.312 1.341 . . . . 0.0 112.682 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -76.4 146.19 38.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.776 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.57 75.2 1.53 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.153 -0.967 . . . . 0.0 110.123 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 -178.75 44.15 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.67 -6.4 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 120.746 0.964 . . . . 0.0 110.999 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.25 43.89 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.69 -173.74 47.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.57 ' CG ' HG12 ' A' ' 173' ' ' CGS . 80.1 m-20 -73.28 151.13 41.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -1.146 . . . . 0.0 109.089 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt -90.91 -13.39 33.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.24 163.41 8.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 108.909 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.46 179.72 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.836 -1.165 . . . . 0.0 110.211 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.83 174.13 10.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.4 155.72 17.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.376 -0.827 . . . . 0.0 108.995 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -59.56 149.02 72.56 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.279 -0.888 . . . . 0.0 108.836 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.97 100.19 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 120.503 0.802 . . . . 0.0 111.842 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 171.75 35.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.94 -169.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.422 1.415 . . . . 0.0 112.144 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.2 -131.38 51.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.03 -9.99 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -1.014 . . . . 0.0 109.796 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.94 147.33 26.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -23.01 36.19 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 121.268 -1.136 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -67.45 154.89 40.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.352 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.1 123.08 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -105.15 147.54 27.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.368 -0.833 . . . . 0.0 110.283 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -119.72 133.96 55.42 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -66.9 122.33 17.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.143 -0.973 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -95.94 -2.62 46.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.032 -1.043 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -76.07 -13.85 60.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.959 -1.088 . . . . 0.0 109.238 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -93.84 152.68 18.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -0.811 . . . . 0.0 109.107 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -86.5 115.07 23.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 108.704 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -91.97 144.6 25.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 110.125 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 p -129.35 174.13 9.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.2 22.38 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.416 -0.803 . . . . 0.0 109.492 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.741 HD22 ' NE ' ' A' ' 108' ' ' ARG . 20.1 p30 -151.02 -166.4 2.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -0.921 . . . . 0.0 109.887 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.76 29.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.201 -0.937 . . . . 0.0 110.621 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.741 ' NE ' HD22 ' A' ' 106' ' ' ASN . 45.6 mtt-85 -76.16 -159.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.025 . . . . 0.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 108' ' ' ARG . 77.8 mm-40 -32.16 -60.4 0.27 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.815 -0.553 . . . . 0.0 111.819 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -137.92 139.08 39.61 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.089 -1.007 . . . . 0.0 110.041 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -105.9 119.53 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.354 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.8 tp -67.25 -39.93 86.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 0.0 110.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.07 -42.68 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 141' ' ' THR . 60.7 mtp180 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.603 -1.311 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.45 -39.78 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.902 -1.124 . . . . 0.0 109.595 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.6 93.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.46 94.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.034 -1.042 . . . . 0.0 109.891 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.05 -47.31 68.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.97 -39.95 75.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 109.493 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.53 -39.52 91.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 108.798 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.11 90.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -62.69 -40.01 95.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -1.232 . . . . 0.0 109.369 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -70.93 -23.49 62.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.236 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.39 -3.82 58.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.161 -0.962 . . . . 0.0 109.044 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.65 16.79 72.29 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.918 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.57 129.17 34.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.876 -1.367 . . . . 0.0 108.95 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 m -88.06 168.66 12.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.038 . . . . 0.0 109.54 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.73 159.99 31.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.6 t -130.22 168.84 16.21 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -103.05 10.06 38.23 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.316 -0.865 . . . . 0.0 109.618 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.39 128.5 33.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.06 -1.025 . . . . 0.0 109.176 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -40.09 81.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.586 -0.696 . . . . 0.0 110.55 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.57 1.61 65.98 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.601 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 136.48 34.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.614 -1.521 . . . . 0.0 109.61 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.1 -26.38 64.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.4 mmm -75.23 52.12 0.57 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.0 t80 -70.17 137.25 86.86 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.954 . . . . 0.0 109.087 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.91 4.63 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 CA-C-N 119.847 0.981 . . . . 0.0 112.184 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.8 p -160.18 176.17 12.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.172 -0.955 . . . . 0.0 109.354 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.499 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 64.4 t80 -87.34 128.35 35.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.835 -1.166 . . . . 0.0 109.452 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.532 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 35.0 p -153.55 -171.38 3.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.422 -0.799 . . . . 0.0 109.099 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -141.03 148.46 40.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 t -176.56 122.43 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.57 -167.69 0.16 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -82.32 169.77 16.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 0.0 109.605 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.18 108.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -0.977 . . . . 0.0 109.281 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -144.57 160.2 41.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.439 -0.788 . . . . 0.0 108.89 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.24 141.05 45.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 109.354 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.19 156.43 16.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -56.61 -39.04 72.89 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.056 -1.027 . . . . 0.0 108.801 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -55.33 -39.99 70.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.83 -40.02 63.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.174 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.86 -51.35 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.0 109.034 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.17 -40.17 96.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.775 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.07 -53.32 41.15 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.309 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -69.02 -39.69 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.912 -1.346 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.6 mt-30 -67.18 -37.97 84.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 109.172 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.9 -50.19 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.793 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -95.31 -69.96 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.16 -0.963 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.61 -168.56 36.12 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 162' ' ' ARG . 30.6 mtm-85 -87.8 150.28 23.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -1.087 . . . . 0.0 108.714 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 165' ' ' ASN . 13.8 m -71.13 90.92 0.89 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 108.793 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.07 34.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.68 -0.638 . . . . 0.0 109.769 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 163' ' ' SER . 17.2 m120 -152.35 73.91 7.48 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.15 -0.969 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.16 61.41 7.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.526 1.484 . . . . 0.0 111.806 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 m -84.2 135.31 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.875 -1.141 . . . . 0.0 109.358 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -115.28 149.8 43.36 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 C-N-CA 120.824 1.016 . . . . 0.0 112.269 179.779 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.57 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.02 133.22 47.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.322 -0.861 . . . . 0.0 109.224 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.8 p -94.72 129.68 41.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 109.326 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.56 131.38 38.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.185 -0.947 . . . . 0.0 109.967 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.03 -59.76 0.51 Allowed Glycine 0 N--CA 1.501 3.024 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -151.92 72.81 7.94 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.133 -1.216 . . . . 0.0 109.595 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -59.76 107.84 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 120.996 1.131 . . . . 0.0 111.929 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -86.47 169.15 13.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -81.71 125.93 31.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.239 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.7 -16.8 53.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 0.0 109.145 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -82.47 147.44 28.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.2 p -96.08 -4.87 42.12 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -123.38 130.01 52.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.52 150.53 40.09 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -125.63 154.92 41.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.47 159.61 41.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.252 -0.905 . . . . 0.0 109.78 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -148.99 130.31 14.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.385 -0.822 . . . . 0.0 109.318 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.42 127.07 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 108.728 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.88 -40.04 83.61 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -162.91 155.33 18.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.976 -1.077 . . . . 0.0 109.976 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.63 136.32 40.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t -70.49 141.66 88.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.29 -12.65 31.45 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 CA-C-N 119.413 0.826 . . . . 0.0 111.697 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.2 -39.93 88.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 110.5 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -138.38 149.58 63.56 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.062 -1.024 . . . . 0.0 108.39 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.68 -175.93 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.52 0.814 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -85.69 -33.25 21.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.65 74.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.344 -0.847 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.97 -39.99 72.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.13 -42.68 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 109.495 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.6 -44.48 93.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.201 -0.937 . . . . 0.0 109.111 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.21 -46.41 89.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -72.34 -41.05 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.844 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 86.7 tt0 -70.05 -40.89 74.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.966 -1.084 . . . . 0.0 109.751 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -61.35 -35.81 78.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 108.809 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.68 92.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.223 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.2 m-85 -60.19 -40.62 90.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.768 -1.208 . . . . 0.0 109.707 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.479 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -60.69 -39.81 89.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.052 -1.03 . . . . 0.0 110.506 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.67 -46.15 89.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.881 -1.137 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.405 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.6 m95 -71.32 -40.28 70.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.606 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -67.14 -39.16 86.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 111.301 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -56.33 -29.9 61.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.44 11.76 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.867 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.1 p -144.8 150.06 45.17 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.968 -1.083 . . . . 0.0 109.007 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.66 2.22 4.86 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.569 0.846 . . . . 0.0 111.962 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.1 mt -70.74 147.89 48.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.0 p -125.53 149.81 47.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 96.8 m-85 -126.21 152.29 46.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.8 m -153.23 129.92 10.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.899 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -77.08 144.22 38.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.543 -0.723 . . . . 0.0 109.54 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.6 135.4 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 t -95.45 -9.46 32.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -144.23 158.32 43.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.66 172.87 49.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.01 160.88 25.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.592 -0.946 . . . . 0.0 108.958 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.94 52.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.03 -40.6 89.91 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 110.558 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.64 119.91 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.3 mtp -102.22 131.6 48.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -0.798 . . . . 0.0 109.481 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -111.62 131.72 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -145.54 160.1 42.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.092 -1.005 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -116.96 136.65 52.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.23 160.01 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.296 -0.877 . . . . 0.0 110.601 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -126.75 137.14 53.19 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.77 -149.51 1.63 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -66.5 130.29 42.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -1.085 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.522 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.2 p-80 -130.89 47.57 2.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.687 -0.633 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 64.6 mtp180 59.54 51.83 6.19 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.161 0.505 . . . . 0.0 109.912 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.522 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 7.5 m-20 -137.67 167.72 21.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.383 -0.823 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -90.69 8.8 32.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 m -137.0 71.88 55.07 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.802 . . . . 0.0 109.133 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.54 146.55 55.67 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 121.184 1.256 . . . . 0.0 111.697 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.68 148.69 36.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -106.27 70.75 0.85 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.438 -0.789 . . . . 0.0 109.423 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.11 -157.58 2.52 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.28 -19.53 17.08 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 118.571 1.185 . . . . 0.0 112.179 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.2 -177.47 41.9 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.56 -166.93 38.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.669 ' OD1' HG12 ' A' ' 173' ' ' CGS . 83.2 m-20 -72.02 152.02 42.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -1.132 . . . . 0.0 109.845 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.68 -18.01 23.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.62 165.3 8.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -162.85 -179.31 6.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.48 166.47 22.64 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -95.8 159.71 14.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 109.937 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -57.25 150.95 39.43 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.534 -0.729 . . . . 0.0 109.241 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -62.02 104.82 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.501 0.801 . . . . 0.0 112.198 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 174.61 37.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.89 171.57 15.45 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.868 1.045 . . . . 0.0 112.318 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 -126.72 17.38 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -73.88 -13.22 15.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.338 -1.095 . . . . 0.0 109.258 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 144.0 45.48 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.58 18.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.97 126.08 28.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.301 . . . . 0.0 110.197 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.74 129.92 51.18 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -102.46 142.54 33.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.288 -0.883 . . . . 0.0 109.833 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -120.18 136.88 54.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.718 -0.614 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.19 121.15 17.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 109.652 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -97.79 -4.53 36.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.55 -16.02 59.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.02 -1.05 . . . . 0.0 109.135 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -93.24 158.24 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.9 ttm-85 -87.9 115.11 25.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 108.796 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.66 139.83 30.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.5 p -127.54 166.66 17.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.473 -0.767 . . . . 0.0 109.644 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -111.45 33.28 4.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -151.75 -165.97 2.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -84.89 32.01 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.95 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -76.14 -161.66 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.1 -59.23 3.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 111.59 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -121.31 132.25 54.68 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.099 -1.001 . . . . 0.0 111.143 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.13 124.27 49.45 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.98 -39.8 75.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -58.46 -45.33 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 111.224 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 87.4 mtt180 -60.2 -44.27 95.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.28 . . . . 0.0 110.526 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.48 -41.05 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.019 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.16 93.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.061 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.22 86.34 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.46 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 56.0 t60 -70.06 -41.59 73.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 110.072 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -58.25 -42.06 85.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.058 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.42 -40.09 93.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 108.942 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.29 -40.08 83.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -66.12 -34.91 79.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -1.206 . . . . 0.0 109.106 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.0 t -69.09 -29.05 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.57 -4.99 57.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.5 19.14 57.41 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.073 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.25 130.11 34.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.823 -1.398 . . . . 0.0 109.094 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 m -86.98 167.47 14.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 109.106 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -63.88 159.75 19.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -128.05 166.82 17.69 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.615 -0.678 . . . . 0.0 109.418 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -107.75 9.1 29.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 11.7 t70 -81.73 129.24 34.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.09 -39.47 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -74.75 -3.22 66.82 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.048 -1.033 . . . . 0.0 111.475 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 137.21 33.54 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.714 -1.462 . . . . 0.0 110.428 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.53 -27.55 65.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 0.0 108.961 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.46 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.0 mtp -76.64 58.67 1.42 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.864 . . . . 0.0 109.865 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -71.83 132.15 85.24 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.33 -68.18 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.211 0 CA-C-N 120.198 1.106 . . . . 0.0 111.057 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.0 p -86.33 175.29 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.42 -0.8 . . . . 0.0 109.773 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.63 126.14 31.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 41.3 p -148.63 153.7 38.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.58 119.93 24.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 109.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.8 t -90.02 -73.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 109.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.444 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 154.64 -110.79 0.46 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -80.05 141.7 35.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 108.439 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.2 t -86.46 105.45 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 110.385 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.49 150.55 39.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 143.72 40.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.825 -1.172 . . . . 0.0 109.298 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.84 156.43 19.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.04 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.75 -40.06 86.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 48.6 t0 -58.76 -40.34 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.75 -40.2 66.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.585 -1.322 . . . . 0.0 109.205 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.51 -48.13 88.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.923 -1.111 . . . . 0.0 110.473 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.94 38.17 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 121.037 -1.039 . . . . 0.0 111.619 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.28 -38.75 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.83 -1.394 . . . . 0.0 109.549 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -64.41 -39.95 94.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 108.57 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.99 97.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.0 109.293 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.38 -50.09 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.037 -1.039 . . . . 0.0 109.593 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -100.66 -67.79 0.84 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.352 -0.843 . . . . 0.0 109.144 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.29 -169.77 34.91 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.11 152.33 22.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.243 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 m -73.12 76.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -95.24 88.48 5.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -155.02 83.19 3.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.331 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -79.44 51.89 4.06 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.837 1.025 . . . . 0.0 112.322 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.45 137.8 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -126.16 79.17 70.06 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 C-N-CA 120.833 1.022 . . . . 0.0 112.14 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.669 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.15 -53.44 57.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 108.696 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.6 p -100.73 146.1 27.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.16 132.91 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 0.0 108.766 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.74 -143.25 42.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -85.15 145.11 42.32 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.121 -1.223 . . . . 0.0 108.326 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 106.75 1.42 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 CA-C-N 119.758 0.949 . . . . 0.0 112.138 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.118 -0.989 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -84.36 124.87 31.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.323 -0.861 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.71 -12.68 59.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.884 -1.135 . . . . 0.0 110.63 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 19.2 pt20 -86.86 155.96 20.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.88 -1.138 . . . . 0.0 109.428 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -96.58 -4.2 41.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.071 -1.018 . . . . 0.0 109.672 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -117.75 130.94 56.62 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 HE21 ' A' ' 11' ' ' GLN . 73.2 mt -118.95 154.21 33.37 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.3 p -128.92 153.17 47.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.272 -0.892 . . . . 0.0 108.698 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.16 162.07 37.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.079 -1.013 . . . . 0.0 109.49 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 17' ' ' ARG . 16.6 ttt-85 -146.98 136.77 23.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 0.0 110.395 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.585 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 86.1 mt -89.33 111.47 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.6 tp10 -64.58 -38.78 92.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.486 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 61.5 m-80 -156.64 146.49 20.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.099 . . . . 0.0 110.264 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.76 138.98 32.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR . 9.7 t -70.01 134.95 87.43 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.085 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -64.11 -13.73 39.44 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 120.017 1.042 . . . . 0.0 111.533 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.873 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.2 mt -134.75 149.57 71.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.69 -175.53 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 120.708 0.938 . . . . 0.0 111.978 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -88.16 -35.58 17.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.12 79.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.566 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.12 -39.98 68.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.204 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.6 t -68.9 -40.84 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.142 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -40.11 88.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 108.824 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -56.7 -50.38 72.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 109.426 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.51 92.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 110.333 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.0 mm -69.94 -39.09 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.083 -1.011 . . . . 0.0 109.762 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.29 -41.44 89.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -63.28 -39.92 95.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.962 -1.087 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.88 75.72 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.803 -1.185 . . . . 0.0 109.206 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 38.1 m-85 -60.97 -40.78 94.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 109.159 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 19.2 mm100 -60.27 -43.23 96.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.97 -41.42 91.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.964 -1.085 . . . . 0.0 110.28 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.5 m95 -74.28 -41.28 61.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.704 -1.247 . . . . 0.0 110.028 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.1 -30.41 69.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 85.0 m-20 -58.82 -32.91 69.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.282 -0.886 . . . . 0.0 111.22 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.55 8.26 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.3 p -143.83 148.87 44.25 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.915 -1.116 . . . . 0.0 109.843 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.66 6.58 1.55 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.015 1.143 . . . . 0.0 111.655 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.7 mt -70.24 152.25 44.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.382 -0.823 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.0 p -130.31 150.92 51.33 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 95.3 m-85 -125.86 157.15 38.34 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.5 -0.75 . . . . 0.0 109.952 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.7 m -154.89 126.98 7.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.392 -0.817 . . . . 0.0 109.866 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.585 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 64.2 tttp -81.37 139.73 35.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 136.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.477 -0.764 . . . . 0.0 109.012 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -95.3 -0.75 52.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.116 -0.99 . . . . 0.0 109.148 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -149.36 159.21 44.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.391 -0.818 . . . . 0.0 109.419 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.25 164.69 36.58 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.41 139.24 39.65 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -1.166 . . . . 0.0 108.075 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.34 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 109.439 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 93.5 m-20 -60.17 -40.71 90.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.462 -0.774 . . . . 0.0 110.006 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.03 118.56 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.83 123.58 45.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 108.956 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -113.04 129.96 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.471 -0.768 . . . . 0.0 109.035 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -146.34 152.61 39.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 109.728 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.58 138.12 40.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.1 162.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.984 . . . . 0.0 110.818 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.11 152.63 51.92 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.39 -151.74 0.62 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.49 130.2 41.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.957 . . . . 0.0 110.392 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 17.3 p-80 -135.63 49.27 2.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.493 -0.754 . . . . 0.0 109.073 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 55.07 56.95 5.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.5 t0 -142.52 160.28 40.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.326 -0.859 . . . . 0.0 108.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 50.5 t30 -88.93 7.53 34.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.084 -1.01 . . . . 0.0 110.047 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 72.4 m -136.11 71.24 62.06 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.0 108.925 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 144.29 75.88 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 120.919 1.079 . . . . 0.0 111.9 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.52 147.97 37.42 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.405 -0.809 . . . . 0.0 109.432 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -128.72 77.1 1.76 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.557 -0.714 . . . . 0.0 109.659 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.19 -174.27 26.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.42 -5.15 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.105 1.203 . . . . 0.0 112.392 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.76 179.19 44.29 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.81 -165.94 49.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.493 ' CG ' HG12 ' A' ' 173' ' ' CGS . 81.8 m-20 -72.45 151.05 42.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.967 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.3 mt -91.08 -17.56 26.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.42 164.67 8.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.016 -1.053 . . . . 0.0 109.85 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -160.37 177.32 10.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.266 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.87 174.7 9.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.201 -0.937 . . . . 0.0 109.766 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -109.05 153.26 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.645 -0.659 . . . . 0.0 109.897 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.93 151.57 64.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -58.01 104.85 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 120.956 1.104 . . . . 0.0 112.196 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.22 171.41 37.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.81 173.06 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.466 1.444 . . . . 0.0 111.81 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 -127.72 29.44 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.451 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.19 -7.1 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.604 -0.939 . . . . 0.0 110.234 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.31 47.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.3 -21.52 28.03 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 121.246 -1.149 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.33 156.1 35.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -1.197 . . . . 0.0 110.69 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 121.51 11.49 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.6 142.89 29.61 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.211 -0.931 . . . . 0.0 110.88 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.512 ' CE2' ' OE1' ' A' ' 119' ' ' GLU . 26.6 m-85 -119.96 134.59 55.2 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.73 116.58 8.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.493 -0.755 . . . . 0.0 109.025 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -99.58 2.26 44.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.14 -14.85 60.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.57 161.86 13.32 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.5 117.82 26.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -93.1 149.5 21.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.749 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.8 p -127.56 166.58 17.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.62 31.41 6.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.621 -0.674 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.466 HD22 ' HG3' ' A' ' 108' ' ' ARG . 14.4 p30 -149.91 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.088 -1.007 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 53.3 t80 -81.11 33.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.466 ' HG3' HD22 ' A' ' 106' ' ' ASN . 18.2 mmm180 -76.58 -165.91 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.071 -1.018 . . . . 0.0 110.351 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -59.66 -56.99 14.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 0.0 111.794 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -93.62 125.14 38.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 110.223 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -104.42 104.57 14.46 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -70.02 -39.99 75.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -59.63 -47.43 85.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.908 -1.12 . . . . 0.0 110.781 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 110.548 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 59.5 t -69.76 -41.54 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.876 -1.14 . . . . 0.0 109.608 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.6 86.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.04 92.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.077 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.515 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 5.6 t60 -68.32 -43.93 76.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 110.726 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.512 ' OE1' ' CE2' ' A' ' 97' ' ' PHE . 5.5 mp0 -59.51 -40.69 87.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.597 -1.315 . . . . 0.0 109.633 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.12 -39.99 92.09 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.971 -1.081 . . . . 0.0 108.45 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.06 -41.97 98.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -64.2 -36.21 83.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.019 -1.283 . . . . 0.0 108.653 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.4 t -69.96 -22.79 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.346 -0.846 . . . . 0.0 108.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.82 -3.75 58.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.09 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.11 21.27 55.66 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 120.401 -0.905 . . . . 0.0 110.932 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.72 135.92 34.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.38 . . . . 0.0 109.684 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.1 m -88.74 166.87 13.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.375 -0.828 . . . . 0.0 110.145 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -68.01 161.94 25.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.5 t -125.7 160.96 28.37 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.41 -0.806 . . . . 0.0 109.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 82.5 p -99.99 9.39 42.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.7 t0 -83.3 130.18 35.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt -62.01 -40.42 87.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 111.12 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.14 65.87 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.959 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.34 130.09 35.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.746 -1.444 . . . . 0.0 109.498 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.12 -34.34 73.38 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.9 mmm -72.31 44.95 0.12 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.793 -0.567 . . . . 0.0 110.894 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -69.29 139.95 90.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.6 -55.84 3.61 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 120.216 1.113 . . . . 0.0 111.484 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 140' ' ' TYR . 9.3 t -100.34 176.12 5.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.408 ' N ' ' OG ' ' A' ' 139' ' ' SER . 65.0 t80 -82.88 147.23 28.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 109.37 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -142.18 130.33 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.249 -0.907 . . . . 0.0 109.689 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.37 -40.22 93.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.961 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.7 p -73.28 162.84 28.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.635 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 121.85 124.48 3.04 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.4 t0 -83.17 158.07 22.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -1.134 . . . . 0.0 109.425 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.532 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 57.6 t -84.22 76.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.476 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -150.41 149.44 30.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.426 HD22 ' CH2' ' A' ' 41' ' ' TRP . 69.4 mt -76.79 148.77 36.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.693 -1.254 . . . . 0.0 109.225 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.02 159.72 15.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.052 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 108.914 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -58.19 -40.0 80.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.257 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.23 -41.83 60.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.31 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.17 -49.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.852 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.813 -1.179 . . . . 0.0 109.259 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -57.89 16.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.95 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -64.55 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.86 -1.376 . . . . 0.0 110.08 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.74 -40.05 88.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.004 . . . . 0.0 109.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.32 96.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 109.674 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.87 -50.23 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.95 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.35 -64.25 1.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.271 -0.893 . . . . 0.0 109.752 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.03 170.9 30.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 162' ' ' ARG . 46.4 mtt-85 -90.24 138.01 31.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.0 109.373 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.8 m -74.81 87.52 2.25 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -92.25 116.65 29.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.47 -0.769 . . . . 0.0 109.885 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -158.21 146.14 13.8 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -78.69 19.22 0.88 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 119.847 0.981 . . . . 0.0 111.698 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.6 p -94.58 131.13 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -69.97 149.45 96.38 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.176 -0.953 . . . . 0.0 108.917 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 C-N-CA 120.755 0.97 . . . . 0.0 112.025 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.608 ' CY ' HG13 ' A' ' 173' ' ' CGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.7 mp -60.05 -40.72 90.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.371 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.0 p -94.32 162.81 13.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.069 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -71.91 131.5 43.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.24 -0.913 . . . . 0.0 108.963 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.2 -152.21 50.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -84.59 147.99 50.77 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -1.172 . . . . 0.0 108.294 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.74 93.65 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.352 0.804 . . . . 0.0 112.088 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -144.84 155.46 43.49 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -84.07 133.38 34.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 108.993 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.56 -36.6 60.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.043 -1.035 . . . . 0.0 110.377 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.413 HE21 HD23 ' A' ' 14' ' ' LEU . 20.3 pt20 -80.01 155.29 27.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.02 -1.05 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -95.18 -2.73 49.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -111.62 135.51 52.11 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD23 HE21 ' A' ' 11' ' ' GLN . 68.5 mt -134.48 159.92 39.63 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.211 -0.93 . . . . 0.0 109.515 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.2 p -130.91 152.9 49.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.615 -0.678 . . . . 0.0 109.24 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.49 158.41 43.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.469 HH12 ' HA ' ' A' ' 54' ' ' GLU . 69.6 ttt180 -150.73 137.06 18.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 0.0 109.244 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.67 122.09 42.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.53 -40.11 95.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.618 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -160.01 158.43 30.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.293 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.54 133.98 44.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.366 -0.834 . . . . 0.0 109.28 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -70.99 143.66 89.2 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.95 -10.85 24.44 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 CA-C-N 119.728 0.938 . . . . 0.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.17 -40.04 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.893 . . . . 0.0 110.263 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.7 mt -139.54 150.12 62.42 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.4 Cg_endo -60.46 -174.77 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 120.77 0.98 . . . . 0.0 112.331 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -89.45 -37.13 15.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.96 94.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -71.36 -37.43 71.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.879 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' PRO . 51.7 t -69.7 -40.45 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -59.98 -41.68 92.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.557 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -60.45 -45.27 94.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.536 -0.727 . . . . 0.0 109.32 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.75 -44.98 93.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.157 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.33 -41.74 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.584 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.95 -39.7 75.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.014 -1.054 . . . . 0.0 109.927 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.99 -39.3 85.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.34 94.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 109.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.9 m-85 -60.95 -39.77 90.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.077 -1.014 . . . . 0.0 109.381 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.85 -39.89 86.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 40' ' ' LEU . 91.0 mt -60.08 -42.17 94.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -71.35 -42.92 67.9 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.353 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.8 t -69.86 -25.23 63.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.404 -0.81 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.083 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 45' ' ' THR . 19.6 m -109.33 10.88 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.164 -0.96 . . . . 0.0 110.873 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.639 HG23 HG23 ' A' ' 44' ' ' VAL . 38.1 p -139.95 143.3 33.81 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.002 -1.061 . . . . 0.0 109.505 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.47 13.49 0.44 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.182 1.254 . . . . 0.0 111.746 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.66 160.54 32.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 108.893 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 p -137.22 149.2 47.03 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.4 154.25 47.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.761 -0.587 . . . . 0.0 109.536 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -153.08 130.05 11.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 109.748 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -81.77 139.87 34.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.14 139.65 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.5 t -99.89 -6.32 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.368 -0.832 . . . . 0.0 110.238 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.5 mt-10 -144.48 156.79 44.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.157 -0.964 . . . . 0.0 108.772 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 169.9 39.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -84.63 139.44 32.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -1.204 . . . . 0.0 109.655 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.2 156.1 17.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.64 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.1 -39.59 86.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.869 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.94 118.6 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.323 -0.86 . . . . 0.0 109.437 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.7 mmm -100.38 133.77 44.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 108.949 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.1 130.72 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.568 -0.708 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.0 p -149.76 167.73 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.588 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.33 137.65 51.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.72 159.84 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.278 -0.889 . . . . 0.0 110.841 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -125.29 135.35 52.4 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.14 -130.65 4.53 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -81.02 129.82 34.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -1.101 . . . . 0.0 109.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 29.4 p-80 -136.44 51.21 2.01 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.41 54.99 5.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.771 -0.581 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.3 p-10 -141.01 170.21 16.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.047 -1.033 . . . . 0.0 109.457 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -91.92 9.64 32.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 t -140.52 74.95 27.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -71.27 139.09 34.41 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.533 1.488 . . . . 0.0 112.17 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.76 148.14 36.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.105 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -133.27 77.19 1.72 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.563 -0.711 . . . . 0.0 109.819 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.52 177.28 42.93 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.065 -1.022 . . . . 0.0 110.747 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -68.83 -23.04 35.73 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.501 1.467 . . . . 0.0 112.312 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.79 -177.56 51.08 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.64 -153.39 27.24 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -74.57 144.11 44.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.85 -19.93 19.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.43 170.66 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 0.0 109.429 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.57 179.33 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 109.976 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.97 170.0 17.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.71 154.5 19.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.699 . . . . 0.0 109.452 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -60.07 150.54 69.95 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.228 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.44 102.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.563 0.842 . . . . 0.0 111.957 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.18 171.24 33.38 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.83 169.83 15.39 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.033 1.155 . . . . 0.0 111.966 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.98 -123.18 14.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -77.81 -13.1 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.027 . . . . 0.0 109.587 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.08 140.54 44.69 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.59 -17.22 50.59 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -66.26 158.32 29.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.323 -1.104 . . . . 0.0 109.757 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 118.97 6.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.171 -0.956 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.36 145.87 28.34 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.5 -0.75 . . . . 0.0 110.832 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 24.6 m-85 -116.19 139.11 50.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.758 -0.589 . . . . 0.0 109.679 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.85 118.79 10.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 108.489 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -97.38 -1.03 45.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 109.769 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.29 -20.03 59.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.049 -1.032 . . . . 0.0 109.542 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -98.04 162.34 13.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.7 121.33 29.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.815 -1.178 . . . . 0.0 109.056 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -89.13 135.45 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 109.522 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 p -128.82 170.06 13.81 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.0 109.473 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -118.71 27.12 9.1 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.573 -0.705 . . . . 0.0 110.172 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.593 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 37.0 p-10 -151.9 -167.02 2.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 0.0 110.538 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -59.97 10.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.312 -0.868 . . . . 0.0 111.6 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.529 ' NE ' HD22 ' A' ' 106' ' ' ASN . 96.4 mtt180 -76.24 166.32 23.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.724 -1.235 . . . . 0.0 110.154 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 108' ' ' ARG . 41.3 mp0 -4.89 -76.9 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -131.74 150.98 51.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.204 -0.935 . . . . 0.0 110.416 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 30.1 m120 -99.36 119.99 38.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 tp -65.3 -40.11 93.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.223 -0.923 . . . . 0.0 110.59 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -59.97 -42.18 93.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.6 t -70.12 -41.57 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.4 91.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.35 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.05 88.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.067 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.422 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 5.9 t60 -66.81 -45.78 77.26 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.355 -0.841 . . . . 0.0 109.643 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.3 mt-10 -59.72 -39.38 84.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 109.304 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.2 -39.64 90.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.998 . . . . 0.0 109.12 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.85 93.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -67.7 -38.48 83.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 0.0 109.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.5 p -70.11 -22.54 63.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.62 -3.35 59.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 109.239 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.97 72.72 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.86 131.23 35.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.345 . . . . 0.0 109.122 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.3 m -88.49 171.34 10.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 109.897 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -66.77 160.02 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.434 -0.791 . . . . 0.0 109.761 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -124.6 168.04 13.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.0 109.137 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.8 p -104.93 3.64 31.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 109.479 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 120.69 26.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.961 . . . . 0.0 109.312 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 tt -55.95 -29.97 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.21 0.74 83.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.681 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.48 135.95 34.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.785 -1.42 . . . . 0.0 109.546 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.14 -27.41 65.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 0.0 108.653 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.8 mmm -79.02 40.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.713 . . . . 0.0 110.033 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -69.88 133.87 88.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 108.982 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.434 ' O ' ' HC1' ' A' ' 173' ' ' CGS . 22.1 Cg_exo -46.91 -67.5 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.805 0.966 . . . . 0.0 112.207 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.5 m -82.63 175.51 10.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -89.64 129.07 36.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.911 -1.118 . . . . 0.0 109.329 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.8 p -150.18 155.3 39.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.968 . . . . 0.0 109.355 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -102.39 127.15 49.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.391 -0.818 . . . . 0.0 108.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.9 p -152.31 100.11 2.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.093 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.53 -166.42 51.23 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -84.79 170.55 13.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -1.128 . . . . 0.0 109.023 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.5 t -82.81 99.35 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -142.28 160.89 39.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.159 -0.963 . . . . 0.0 109.137 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.42 131.74 42.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.029 . . . . 0.0 109.267 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.27 166.45 13.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.541 -0.724 . . . . 0.0 109.157 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.842 . . . . 0.0 108.856 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.35 -39.69 80.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.25 -42.78 59.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.957 -1.089 . . . . 0.0 109.516 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.15 -51.59 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.159 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.4 -39.84 92.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.797 -1.19 . . . . 0.0 110.233 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.44 49.22 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.231 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.19 -37.54 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.305 . . . . 0.0 109.999 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.1 mt-30 -67.59 -40.65 84.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.82 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.09 89.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.131 -0.98 . . . . 0.0 109.484 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.47 -51.04 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.08 . . . . 0.0 109.647 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -98.52 -67.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.097 -1.002 . . . . 0.0 109.953 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.88 -169.25 38.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -96.62 138.49 34.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -1.08 . . . . 0.0 109.243 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 m -73.72 87.03 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.022 -1.049 . . . . 0.0 108.969 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -89.25 102.88 15.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 110.53 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -159.52 137.79 7.57 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.286 -0.884 . . . . 0.0 109.34 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.15 -29.99 4.65 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 119.982 1.029 . . . . 0.0 111.331 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 167' ' ' VAL . 30.8 m -96.34 130.03 45.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.4 148.33 98.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.915 -1.116 . . . . 0.0 109.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 117.93 -0.946 . . . . 0.0 111.416 179.19 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.434 ' HC1' ' O ' ' A' ' 138' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.92 -39.97 95.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 108.926 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.1 p -94.53 159.83 14.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.329 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.45 134.9 42.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.88 -154.9 34.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -80.23 139.92 52.69 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.199 -1.177 . . . . 0.0 109.024 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.35 130.97 19.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 119.739 0.943 . . . . 0.0 111.909 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH1' HD13 ' A' ' 159' ' ' ILE . 30.1 mmt180 -91.3 168.99 11.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.957 . . . . 0.0 108.819 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -82.75 120.05 25.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.173 -0.954 . . . . 0.0 109.12 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.71 -12.62 55.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.776 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -83.29 150.63 26.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.2 p -95.69 -4.22 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.226 -0.921 . . . . 0.0 108.975 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.55 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 54.3 m-70 -130.57 144.78 51.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -136.12 158.88 43.34 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.8 p -124.24 155.79 37.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.366 -0.834 . . . . 0.0 109.205 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.97 158.42 43.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.787 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.441 HH21 ' CE ' ' A' ' 60' ' ' MET . 44.0 ttp180 -149.88 130.4 13.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.488 -0.757 . . . . 0.0 109.809 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -90.17 115.77 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.85 -39.73 94.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.473 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -159.46 152.62 22.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.791 -1.193 . . . . 0.0 110.701 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -97.93 135.28 39.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -70.04 138.02 87.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.036 . . . . 0.0 109.869 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.31 -12.5 30.75 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 119.619 0.9 . . . . 0.0 111.818 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.16 -39.43 86.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 109.817 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 105' ' ' ASN . 93.9 mt -138.81 150.47 65.67 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.31 -171.77 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.385 0.723 . . . . 0.0 111.794 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -86.5 -37.36 18.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.24 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.87 -40.74 75.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.295 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -70.23 -42.65 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 108.909 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.105 . . . . 0.0 108.998 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.626 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.84 82.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.22 -39.78 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.32 -47.41 79.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.774 -1.203 . . . . 0.0 109.786 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -64.03 -33.64 76.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.788 -1.195 . . . . 0.0 110.075 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.77 -50.98 71.69 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.813 -1.179 . . . . 0.0 109.025 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.4 -40.0 95.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -59.98 -43.34 95.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.8 -44.35 94.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 0.0 110.505 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.56 -40.07 70.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 109.67 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.9 t -69.81 -38.52 76.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -54.68 -30.57 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.201 -0.937 . . . . 0.0 110.898 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 45' ' ' THR . 35.9 m -106.4 11.14 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.204 -0.935 . . . . 0.0 109.842 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 44' ' ' VAL . 81.4 p -142.08 146.21 39.19 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.97 5.38 2.61 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 120.859 1.039 . . . . 0.0 111.577 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -71.73 162.18 29.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.437 -0.79 . . . . 0.0 109.11 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 24.4 p -137.8 150.78 47.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -125.0 155.73 39.22 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.525 -0.734 . . . . 0.0 109.615 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.9 m -153.77 132.39 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -77.57 140.75 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.624 -0.673 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.85 130.56 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.519 -0.738 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -95.56 -3.39 46.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.31 151.0 35.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.126 -0.984 . . . . 0.0 109.469 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.17 168.54 44.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.89 140.28 35.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -1.168 . . . . 0.0 108.956 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.62 148.58 25.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.64 -43.74 93.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.17 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -111.48 110.56 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 109.555 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.441 ' CE ' HH21 ' A' ' 17' ' ' ARG . 85.8 mtp -102.46 124.81 48.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.11 129.97 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 0.0 109.109 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.8 p -146.75 156.25 43.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.084 -1.01 . . . . 0.0 110.222 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -107.02 135.46 48.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.77 159.99 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 55.0 mtt-85 -123.77 138.93 54.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 109.802 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.36 -139.34 1.24 Allowed Glycine 0 N--CA 1.498 2.802 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.87 122.43 19.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.967 . . . . 0.0 109.427 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -135.17 66.29 1.53 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.431 -0.793 . . . . 0.0 109.866 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 53.69 50.34 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.98 . . . . 0.0 108.61 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 13.9 t0 -141.93 157.83 44.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 109.231 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 27.7 m120 -93.78 8.79 39.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.213 -0.929 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -136.81 74.25 51.89 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.203 -0.936 . . . . 0.0 109.286 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.47 147.32 86.81 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.281 1.32 . . . . 0.0 111.991 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.41 136.91 38.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.068 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -103.23 67.42 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.379 -0.826 . . . . 0.0 109.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.11 -175.02 37.73 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -70.57 -10.67 28.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.061 1.174 . . . . 0.0 111.944 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.33 179.55 40.64 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.06 -146.68 21.32 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.38 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.56 HD22 ' C ' ' A' ' 82' ' ' ALA . 41.7 t30 -73.77 131.89 42.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.47 -1.018 . . . . 0.0 110.292 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.45 -18.23 24.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.061 -1.024 . . . . 0.0 109.157 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.56 ' C ' HD22 ' A' ' 80' ' ' ASN . . . -170.88 164.51 7.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.001 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -161.21 125.47 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.977 -1.077 . . . . 0.0 110.68 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.57 168.26 14.65 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.682 -0.636 . . . . 0.0 109.292 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.02 142.15 35.32 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.41 147.87 56.93 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.939 -1.101 . . . . 0.0 109.334 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.17 123.16 12.58 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.42 0.747 . . . . 0.0 111.65 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -179.34 175.69 47.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -73.95 163.31 37.22 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.857 1.038 . . . . 0.0 111.908 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' GLY . . . 74.05 -147.33 37.79 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 tt -50.14 -8.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -1.07 . . . . 0.0 110.19 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 90' ' ' GLY . . . -60.5 142.27 47.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.79 -16.11 55.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.86 159.62 30.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.395 -1.062 . . . . 0.0 110.125 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.56 124.38 22.6 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -106.02 130.15 54.0 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.394 -0.817 . . . . 0.0 110.443 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.557 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.5 m-85 -114.18 134.33 54.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.561 -0.712 . . . . 0.0 109.611 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 98' ' ' ASP . 57.5 t0 -63.34 119.09 9.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 109.608 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.411 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.9 tt0 -101.13 -1.45 33.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.586 -0.696 . . . . 0.0 109.267 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -75.96 -19.83 58.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -101.82 156.6 17.41 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.476 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 44.4 ttp180 -87.23 125.13 34.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.051 -1.031 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.06 149.85 22.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 0.0 109.86 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.7 p -131.69 169.97 15.43 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.366 -0.833 . . . . 0.0 109.175 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.45 HD21 HD13 ' A' ' 25' ' ' LEU . 82.7 m-20 -111.63 23.93 13.34 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.428 -0.795 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 35.1 p-10 -146.99 -165.0 2.13 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.909 -1.12 . . . . 0.0 109.995 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.74 22.19 0.06 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.128 -0.982 . . . . 0.0 111.51 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.9 mtp180 -76.66 -163.65 0.35 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.646 -1.284 . . . . 0.0 110.059 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.6 mt-10 -25.2 -67.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -141.4 159.17 42.79 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.905 -1.122 . . . . 0.0 110.842 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 68.8 m-80 -107.45 110.93 23.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -41.48 92.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.372 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.91 -46.92 87.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.922 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.33 -39.73 88.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.825 -1.172 . . . . 0.0 110.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.45 -40.21 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.989 -1.069 . . . . 0.0 108.407 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -41.88 91.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.386 -0.822 . . . . 0.0 109.014 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.088 -1.008 . . . . 0.0 109.724 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.5 t-160 -68.22 -51.81 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 109.183 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.557 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 57.9 mt-10 -58.48 -40.97 84.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -63.4 -39.91 95.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.071 -1.018 . . . . 0.0 109.213 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.39 -38.66 93.74 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -64.21 -35.94 82.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 108.698 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.5 m -69.55 -25.47 64.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 108.726 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.03 -0.68 56.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.31 13.6 70.6 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.842 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.6 128.96 34.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.488 . . . . 0.0 108.919 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.14 170.96 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.607 -0.683 . . . . 0.0 109.703 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.95 156.36 37.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.862 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.4 t -124.97 165.04 18.85 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.1 p -102.04 0.89 35.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.456 -0.777 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -78.33 128.13 33.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.9 tt -58.71 -29.28 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.0 110.497 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.82 3.28 84.14 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.474 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.87 128.92 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.941 -1.329 . . . . 0.0 109.775 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 -31.79 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.453 -0.78 . . . . 0.0 109.146 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 36.4 mtp -74.42 47.76 0.31 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.99 130.92 91.14 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.0 108.948 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -45.63 -68.17 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 CA-C-N 119.99 1.032 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.2 p -80.15 171.02 15.63 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.138 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -82.83 130.31 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 108.881 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 59.5 p -149.81 170.25 19.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -92.08 136.47 33.15 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.162 -0.962 . . . . 0.0 109.546 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.5 p -101.09 1.07 38.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.388 -0.82 . . . . 0.0 109.746 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.72 -42.78 1.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -152.45 149.79 28.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.079 -1.248 . . . . 0.0 109.165 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 25.4 t -86.57 100.24 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 109.645 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -148.45 150.9 34.29 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.3 mt -75.24 147.95 39.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 0.0 109.017 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.16 158.42 16.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 109.06 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -60.04 -40.42 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.735 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.8 t0 -58.98 -40.2 84.1 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -74.27 -39.99 62.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.475 HG22 ' NE2' ' A' ' 157' ' ' GLN . 96.9 mt -63.42 -50.03 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.96 -39.95 96.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.91 21.61 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.771 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -60.06 -39.54 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.852 -1.381 . . . . 0.0 109.659 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 33.1 mt-30 -66.13 -37.53 85.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 108.972 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.28 96.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.443 HD13 ' NH1' ' A' ' 8' ' ' ARG . 96.8 mt -62.27 -48.44 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.08 -67.79 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.98 -178.12 37.94 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -88.76 150.61 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.427 -1.043 . . . . 0.0 109.296 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.2 m -74.2 85.38 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.044 -1.035 . . . . 0.0 109.043 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -96.77 111.36 23.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -157.21 74.51 4.34 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.82 40.95 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.622 1.548 . . . . 0.0 112.404 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 167' ' ' VAL . 2.3 m -89.49 118.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 109.691 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -127.91 78.28 75.37 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 121.159 1.24 . . . . 0.0 112.135 179.693 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.488 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.082 0.468 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.66 141.35 51.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.069 -1.02 . . . . 0.0 109.431 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.9 p -99.27 -138.87 0.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 109.675 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.61 ' C ' ' H ' ' A' ' 6' ' ' ASN . 86.2 tt0 -69.4 154.73 41.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.605 -0.685 . . . . 0.0 109.167 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.09 19.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.338 -0.851 . . . . 0.0 111.087 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.61 ' H ' ' C ' ' A' ' 4' ' ' GLU . 25.2 m120 -149.42 69.84 9.65 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.671 -1.488 . . . . 0.0 109.411 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -61.15 149.96 86.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.23 1.287 . . . . 0.0 112.636 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.4 159.05 43.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -0.793 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -84.13 130.13 34.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -0.867 . . . . 0.0 108.846 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.51 -32.96 62.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.959 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -82.36 153.34 25.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 0.0 109.685 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -93.92 -4.09 50.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.228 -0.92 . . . . 0.0 108.669 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -108.33 130.63 55.19 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.416 HD12 ' CE1' ' A' ' 49' ' ' PHE . 82.3 mt -126.28 152.42 46.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.474 -0.766 . . . . 0.0 109.486 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 p -124.04 150.45 44.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.488 -0.758 . . . . 0.0 109.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -144.63 161.38 39.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 109.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -151.32 133.62 15.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.415 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.35 116.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.34 -39.34 92.27 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.727 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -159.82 147.39 16.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.655 -1.278 . . . . 0.0 110.508 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.15 134.19 41.54 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -71.45 145.83 90.87 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.793 -1.192 . . . . 0.0 108.572 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.27 -8.62 19.24 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 119.391 0.818 . . . . 0.0 112.015 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.88 -39.91 86.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 mt -135.88 153.16 76.93 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.5 Cg_endo -66.26 -176.56 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.389 0.818 . . . . 0.0 111.001 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.0 -38.83 15.18 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.967 -1.083 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.25 93.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.16 -39.14 72.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 26' ' ' PRO . 54.3 t -67.15 -39.51 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 44.3 t0 -59.71 -40.45 87.98 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.526 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -60.17 -45.46 93.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 109.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.35 92.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 109.205 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -71.82 -40.19 68.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.494 -0.754 . . . . 0.0 110.042 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.15 -39.64 78.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -61.89 -39.87 93.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.786 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.12 93.66 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.308 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -59.92 -39.02 84.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.005 -1.059 . . . . 0.0 108.779 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.492 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.71 -45.63 91.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 109.678 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.2 m95 -74.69 -45.29 45.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -65.1 -37.41 87.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.843 . . . . 0.0 110.822 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.34 -23.34 64.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.543 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.81 7.19 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.413 -0.804 . . . . 0.0 110.71 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.42 ' N ' ' OG ' ' A' ' 163' ' ' SER . 11.3 p -145.31 150.06 43.4 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.109 -0.994 . . . . 0.0 109.101 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -72.11 9.51 1.1 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.451 0.767 . . . . 0.0 111.684 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.12 150.0 42.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.307 -0.871 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.9 p -130.25 148.2 52.06 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 14' ' ' LEU . 97.3 m-85 -128.02 153.44 46.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.699 -0.625 . . . . 0.0 109.891 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -155.28 133.05 11.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.199 -0.938 . . . . 0.0 110.017 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.22 144.59 40.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.16 135.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -98.69 -4.38 33.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.739 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -144.22 147.78 34.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.04 172.12 48.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -82.59 149.74 27.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 109.331 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.44 152.26 24.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.55 -0.719 . . . . 0.0 109.102 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.1 -44.84 94.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.342 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -114.05 112.21 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.755 0.788 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.5 mtp -99.06 131.17 45.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.69 129.19 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.6 p -153.12 159.81 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.4 140.24 46.15 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.86 167.62 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.37 -0.831 . . . . 0.0 111.055 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.43 138.98 40.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.0 109.601 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.23 -139.82 10.7 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -73.39 129.04 37.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -1.004 . . . . 0.0 110.095 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.4 p-80 -133.0 60.83 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.256 -0.902 . . . . 0.0 109.619 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 57.66 47.26 16.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.469 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 93.3 m-20 -141.73 163.73 32.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.58 -0.7 . . . . 0.0 109.454 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -96.0 9.59 40.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.316 -0.865 . . . . 0.0 109.776 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -134.04 73.0 71.33 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.341 -0.849 . . . . 0.0 109.599 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -64.31 158.97 45.99 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.986 1.124 . . . . 0.0 112.143 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.79 152.03 31.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -110.36 67.88 0.65 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.525 -0.735 . . . . 0.0 109.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.85 -170.99 31.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.27 -16.78 23.53 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.323 1.349 . . . . 0.0 112.701 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.32 -175.25 46.27 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.16 -150.54 27.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.565 ' CG ' HG12 ' A' ' 173' ' ' CGS . 88.0 m-20 -77.27 144.17 38.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.432 -1.04 . . . . 0.0 109.485 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.76 -18.33 25.15 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.954 -1.091 . . . . 0.0 109.067 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.16 166.06 9.04 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.352 -0.842 . . . . 0.0 108.83 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 83' ' ' HIS . 2.8 p80 -162.5 114.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.962 -1.086 . . . . 0.0 110.346 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.61 173.46 9.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -109.23 160.8 15.82 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -58.11 148.33 61.84 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.021 -1.049 . . . . 0.0 109.242 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.61 103.66 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.773 0.982 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -169.01 169.57 41.94 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -173.32 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.141 1.227 . . . . 0.0 112.81 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.43 -126.41 42.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -82.44 -8.43 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -1.057 . . . . 0.0 110.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.1 138.76 48.59 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.63 63.23 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.198 -1.177 . . . . 0.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.94 130.15 41.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.962 -1.317 . . . . 0.0 110.491 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.89 116.15 31.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.165 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -100.86 132.71 46.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.072 -1.017 . . . . 0.0 109.834 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.51 131.26 55.53 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.392 -0.818 . . . . 0.0 109.902 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.6 127.27 31.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.395 -0.815 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.64 3.98 42.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.104 -0.997 . . . . 0.0 109.97 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.38 -20.04 60.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.022 -1.049 . . . . 0.0 109.334 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -101.91 157.36 16.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 108.804 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -86.35 125.77 33.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 108.625 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -91.11 140.35 29.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.1 p -129.23 163.27 25.98 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -108.66 31.31 5.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.466 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -148.55 -164.99 2.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 109.855 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.54 28.26 0.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -76.56 -163.56 0.34 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -43.63 -60.97 1.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 111.909 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.2 m-85 -125.73 135.49 52.13 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.617 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -103.1 117.16 33.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.98 -41.7 96.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.844 -1.16 . . . . 0.0 109.76 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.43 -49.58 77.0 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.728 -0.608 . . . . 0.0 112.458 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -59.73 -42.91 94.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.232 -1.542 . . . . 0.0 110.453 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.29 -39.79 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.094 -1.004 . . . . 0.0 109.426 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.92 86.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.345 -0.847 . . . . 0.0 109.089 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.44 90.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.026 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.588 ' ND1' ' SD ' ' A' ' 136' ' ' MET . 3.2 t60 -68.13 -42.45 80.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.907 -1.12 . . . . 0.0 110.223 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -57.71 -40.13 78.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 109.329 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.69 -39.92 90.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.994 -1.066 . . . . 0.0 109.177 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.28 -38.21 77.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -66.61 -34.76 78.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.082 -1.246 . . . . 0.0 109.305 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -70.21 -23.97 63.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.12 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.96 -5.63 58.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 108.771 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.96 58.16 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.03 131.47 35.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.117 -1.226 . . . . 0.0 108.707 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.7 m -87.18 169.86 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.091 -1.005 . . . . 0.0 109.511 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.52 161.73 27.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.513 -0.742 . . . . 0.0 109.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.5 t -126.96 166.16 18.05 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -102.31 11.33 38.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 51.9 t0 -83.1 130.33 35.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 109.882 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.75 -39.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.722 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.63 73.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.367 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -83.98 132.52 34.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.548 . . . . 0.0 109.222 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.14 -24.13 64.05 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.588 ' SD ' ' ND1' ' A' ' 118' ' ' HIS . 59.5 mmm -72.44 48.84 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.767 -0.583 . . . . 0.0 110.153 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 139' ' ' SER . 13.7 t80 -71.39 137.16 83.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.861 -1.149 . . . . 0.0 109.198 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.63 18.81 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.037 1.049 . . . . 0.0 111.844 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 137' ' ' TYR . 22.2 t -166.5 176.67 7.19 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.531 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 66.9 t80 -83.53 117.82 23.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.644 -1.285 . . . . 0.0 110.436 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.6 p -150.21 176.52 10.78 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.49 154.28 42.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -129.8 -24.39 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.48 -0.763 . . . . 0.0 109.309 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 166.61 -124.83 1.26 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -80.35 169.98 17.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -1.068 . . . . 0.0 109.163 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.76 103.75 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.023 -1.048 . . . . 0.0 109.261 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -142.46 150.49 40.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 108.653 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 41' ' ' TRP . 97.1 mt -73.49 145.43 45.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.058 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.17 156.8 17.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.449 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.94 -39.9 87.12 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.24 -40.4 85.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.461 -0.775 . . . . 0.0 109.255 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.63 -41.14 65.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.53 -46.48 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.192 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.54 -40.22 93.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.89 -1.131 . . . . 0.0 110.431 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.64 -58.19 15.11 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.731 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -63.91 -41.29 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.114 -1.227 . . . . 0.0 110.344 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -66.33 -40.32 89.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.823 -1.173 . . . . 0.0 110.386 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.42 93.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.956 -1.09 . . . . 0.0 109.65 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -50.31 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 108.969 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.98 -74.02 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.196 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.99 -176.07 35.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 162' ' ' ARG . 57.6 mtt-85 -83.86 151.94 24.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.063 . . . . 0.0 109.441 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 45' ' ' THR . 5.8 m -73.35 82.51 1.41 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -99.53 125.85 45.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.433 -0.792 . . . . 0.0 110.124 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -152.36 143.47 15.81 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.171 -0.955 . . . . 0.0 108.88 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.77 108.42 2.09 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 119.624 0.902 . . . . 0.0 111.655 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.95 134.38 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.335 -0.853 . . . . 0.0 109.942 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -71.23 148.81 94.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 108.682 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.488 1.152 0 C-N-CA 120.699 0.933 . . . . 0.0 112.03 179.338 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.565 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.28 -40.09 92.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.5 p -91.62 152.65 20.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.632 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -73.42 142.94 46.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.91 -161.78 35.06 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.96 137.29 53.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.884 -1.363 . . . . 0.0 108.565 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -67.8 -178.45 1.63 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 CA-C-N 119.694 0.927 . . . . 0.0 111.676 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.62 160.83 39.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 87' ' ' PRO . 99.0 m95 -84.79 114.46 22.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.854 -1.154 . . . . 0.0 109.094 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.57 -9.87 48.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 109.505 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -80.94 150.76 28.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.757 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 p -96.6 -5.05 40.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -123.97 131.74 53.61 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.6 mt -132.88 149.73 52.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -125.29 154.65 41.4 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.302 -0.874 . . . . 0.0 109.446 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.89 159.53 42.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 109.311 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 17' ' ' ARG . 37.7 ttt-85 -148.8 134.04 18.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -89.79 123.26 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.22 -0.925 . . . . 0.0 108.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -41.57 84.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.515 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -162.28 151.04 15.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.858 -1.151 . . . . 0.0 110.23 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -96.94 138.4 34.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.85 144.18 85.25 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 109.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.45 -12.02 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.614 0.876 . . . . 0.0 112.018 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.15 -40.34 89.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.077 -1.014 . . . . 0.0 110.196 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.0 mt -135.73 151.24 73.87 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -65.58 -177.51 0.72 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.468 0.846 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -85.85 -35.51 20.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -43.23 90.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.43 -39.58 77.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 0.0 110.401 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.0 -40.0 87.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.824 -1.172 . . . . 0.0 109.422 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.48 -46.45 90.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.61 95.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.155 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.95 -40.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.717 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.83 -40.3 75.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.045 -1.034 . . . . 0.0 109.974 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -61.0 -40.87 95.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.98 87.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.962 -1.086 . . . . 0.0 109.259 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 30.4 m-85 -60.0 -40.6 89.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.856 -1.152 . . . . 0.0 109.496 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -59.95 -40.47 89.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 110.363 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.0 -45.14 93.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.015 -1.053 . . . . 0.0 110.039 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -71.75 -39.89 69.71 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.462 -0.774 . . . . 0.0 109.502 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 t -68.58 -30.63 69.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -0.85 . . . . 0.0 109.766 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -59.81 -37.51 79.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -106.96 10.31 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.217 -0.927 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -138.33 149.32 62.76 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.03 -1.044 . . . . 0.0 108.597 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.41 7.3 2.68 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.335 0.798 . . . . 0.0 110.529 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.4 157.88 36.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.701 -0.624 . . . . 0.0 109.753 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -137.4 151.99 49.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -130.78 155.87 45.94 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -154.33 132.75 11.98 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -81.64 137.02 35.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.324 -0.86 . . . . 0.0 110.032 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.26 132.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.7 t -94.7 0.94 55.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.045 -1.034 . . . . 0.0 109.594 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.3 157.71 44.12 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.22 -0.925 . . . . 0.0 109.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.76 167.31 8.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.03 160.38 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.264 . . . . 0.0 108.705 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.7 158.6 27.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 109.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.35 -39.65 83.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.298 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.23 120.0 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 109.53 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.0 mtp -101.12 135.93 41.79 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.192 -0.942 . . . . 0.0 109.419 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.84 126.94 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -148.03 155.19 41.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.65 139.03 40.86 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.22 163.09 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.503 -0.748 . . . . 0.0 110.773 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 61.4 mtt-85 -131.25 132.69 44.79 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.378 0.609 . . . . 0.0 110.023 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.3 -135.97 7.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -71.54 125.92 28.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.3 p-80 -134.03 49.77 2.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.325 -0.859 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 69' ' ' ARG . 52.8 mtt-85 58.41 53.09 6.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.643 -0.66 . . . . 0.0 111.109 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.536 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.4 m-20 -139.35 163.29 32.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.358 -0.838 . . . . 0.0 108.898 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -90.06 9.3 28.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.6 m -139.67 71.61 36.86 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.349 -0.844 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.91 159.27 41.86 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.154 1.236 . . . . 0.0 112.142 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.64 147.21 37.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.616 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.94 62.33 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.482 -0.761 . . . . 0.0 109.117 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.73 -166.01 53.4 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -54.19 -22.36 25.59 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.304 1.336 . . . . 0.0 112.636 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.0 177.79 48.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.03 -165.18 26.56 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.517 ' HB3' HG12 ' A' ' 173' ' ' CGS . 40.8 p-10 -75.07 150.41 38.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.288 -1.125 . . . . 0.0 109.94 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -91.45 -13.26 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.57 167.33 9.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.046 -1.034 . . . . 0.0 109.893 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.98 179.91 7.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -166.38 169.33 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -98.04 156.88 16.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -58.48 149.65 59.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.146 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.411 ' HB3' ' NE1' ' A' ' 9' ' ' TRP . 7.5 Cg_endo -58.69 103.12 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 120.428 0.752 . . . . 0.0 111.792 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.29 172.88 37.62 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.22 177.32 6.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.321 1.347 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.54 -125.35 31.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.27 -9.54 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.193 . . . . 0.0 110.041 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.65 135.94 47.03 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.1 -16.83 59.58 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.491 -1.005 . . . . 0.0 110.709 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.64 121.76 15.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.913 -1.345 . . . . 0.0 110.636 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.17 131.81 45.9 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -112.74 135.0 53.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.501 -0.749 . . . . 0.0 109.294 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.8 m-85 -114.73 130.97 56.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.374 -0.829 . . . . 0.0 110.087 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' OD2' ' OE2' ' A' ' 101' ' ' GLU . 62.4 t0 -69.32 122.59 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -99.57 4.47 45.86 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.027 -1.046 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -73.5 -15.28 61.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.713 -1.242 . . . . 0.0 109.128 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 56.4 mp0 -102.64 152.66 20.93 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -85.71 119.4 26.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.93 -1.106 . . . . 0.0 108.777 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.53 150.28 24.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 p -129.82 163.09 27.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -113.9 34.86 4.37 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.473 ' OD1' ' CG ' ' A' ' 108' ' ' ARG . 4.6 p30 -150.18 -165.02 2.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.0 109.99 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.25 31.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.305 -0.872 . . . . 0.0 109.764 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.473 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.9 mmt-85 -76.82 -165.09 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -0.999 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.0 -58.25 9.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.731 . . . . 0.0 112.203 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -101.12 121.85 42.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.052 -1.03 . . . . 0.0 110.984 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -108.69 110.95 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.77 -44.67 96.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.11 -0.994 . . . . 0.0 111.122 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.081 . . . . 0.0 110.713 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.693 ' NH1' HOM2 ' A' ' 173' ' ' CGS . 43.9 ttt-85 -59.17 -46.68 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 109.738 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.516 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 72.1 t -70.12 -40.4 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.165 -0.96 . . . . 0.0 109.535 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.08 91.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.955 -1.091 . . . . 0.0 109.575 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.13 95.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.8 . . . . 0.0 109.813 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.439 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 48.6 t60 -69.77 -40.79 75.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.16 -40.14 88.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.812 -1.18 . . . . 0.0 109.075 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.19 -39.97 88.38 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.65 -42.4 67.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -63.24 -39.33 94.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.241 -1.152 . . . . 0.0 108.549 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.8 p -70.14 -22.93 62.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.232 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.22 -2.63 58.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.144 -0.973 . . . . 0.0 109.385 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.41 73.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.22 131.42 35.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.03 -1.276 . . . . 0.0 108.804 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.0 m -88.1 170.56 10.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.03 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -66.07 158.66 27.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 108.705 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -129.88 158.72 38.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.42 -0.8 . . . . 0.0 109.224 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -102.94 13.83 33.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -84.13 130.91 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -42.91 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.66 0.32 65.57 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.235 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.69 139.2 32.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.676 -1.485 . . . . 0.0 108.928 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.74 -27.61 66.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 108.895 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.439 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 28.7 mtp -75.75 60.86 1.34 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 0.0 109.489 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.7 t80 -68.31 137.49 91.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.46 5.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.985 1.03 . . . . 0.0 112.1 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 137' ' ' TYR . 57.6 p -158.78 173.75 16.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.965 -1.084 . . . . 0.0 109.501 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -85.9 134.8 33.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.4 p -151.05 170.26 19.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.398 -0.814 . . . . 0.0 109.093 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 37.9 p90 -96.87 123.17 40.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.8 m -107.04 147.43 29.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.327 -0.858 . . . . 0.0 109.747 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.88 -89.07 0.13 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -88.43 135.3 33.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -1.229 . . . . 0.0 108.984 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 t -88.23 104.29 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.851 -1.156 . . . . 0.0 109.436 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -141.29 150.28 42.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 0.0 109.61 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.7 139.66 45.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 168.88 10.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.99 -40.7 90.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.581 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.53 -40.44 87.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.505 -0.747 . . . . 0.0 109.748 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -75.24 -42.56 55.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 109.263 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.79 -50.63 74.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.451 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.22 -39.37 90.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.16 . . . . 0.0 110.02 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.38 -56.37 20.3 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.72 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -64.38 -40.85 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.4 mt-30 -65.22 -39.09 92.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.029 -1.044 . . . . 0.0 110.108 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.41 88.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.81 -1.182 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.37 -49.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.044 -1.035 . . . . 0.0 109.527 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -97.28 -67.6 0.84 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.474 -0.766 . . . . 0.0 109.833 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.87 179.66 39.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.72 134.29 34.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -1.115 . . . . 0.0 109.421 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.5 m -76.73 80.79 3.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -99.08 79.61 2.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.354 -0.842 . . . . 0.0 109.964 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.775 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 3.7 m-80 -157.91 -37.03 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.034 -1.041 . . . . 0.0 111.924 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.775 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 17.2 Cg_endo -86.42 79.07 1.93 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.322 1.151 . . . . 0.0 112.682 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 167' ' ' VAL . 17.4 m -87.72 119.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.82 -1.175 . . . . 0.0 108.766 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -71.21 150.63 94.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.048 -1.032 . . . . 0.0 110.114 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 CA-C-O 117.932 -0.945 . . . . 0.0 112.128 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.693 HOM2 ' NH1' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.363 0.601 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.36 137.73 53.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.4 p -89.8 166.02 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -0.86 . . . . 0.0 109.315 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -75.09 131.74 40.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.021 -1.049 . . . . 0.0 109.024 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.96 -174.53 54.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -82.98 147.28 53.94 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 108.558 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.9 118.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.643 0.895 . . . . 0.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -144.94 156.96 44.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -84.87 124.11 31.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.38 -0.825 . . . . 0.0 109.6 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -87.55 -6.78 58.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.82 150.44 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -95.09 -6.29 42.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -130.03 139.8 50.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -132.8 157.98 43.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.535 -0.728 . . . . 0.0 109.332 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -127.99 153.56 46.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.94 158.42 43.63 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.225 -0.922 . . . . 0.0 109.922 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -146.99 134.61 21.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.014 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.86 112.35 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.2 tt0 -63.63 -39.82 95.32 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 0.0 110.392 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 83.1 m-20 -155.29 142.45 19.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.949 -1.094 . . . . 0.0 110.479 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.01 137.06 32.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -69.34 136.99 88.79 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -66.83 -9.37 24.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.691 0.925 . . . . 0.0 110.909 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.28 -40.11 89.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.762 -0.586 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -136.24 149.87 69.23 Favored Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -178.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.107 0 CA-C-N 119.353 0.805 . . . . 0.0 111.443 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -31.69 18.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.71 87.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.895 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.92 -40.01 65.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.792 . . . . 0.0 110.7 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.05 -44.32 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -58.58 -44.8 89.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.298 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -59.64 -41.94 91.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.047 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.2 82.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.875 -1.14 . . . . 0.0 109.729 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.1 -39.26 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 0.0 109.684 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.14 -39.68 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.067 -1.021 . . . . 0.0 109.432 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -63.3 -40.04 96.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.738 -1.226 . . . . 0.0 110.695 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.89 71.43 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.691 -1.255 . . . . 0.0 109.45 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 37.8 m-85 -60.31 -43.96 95.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.547 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -60.04 -42.76 95.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.93 -40.29 88.39 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.839 -1.163 . . . . 0.0 110.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -74.42 -40.21 62.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.479 -1.388 . . . . 0.0 109.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.56 -27.24 66.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.587 -0.696 . . . . 0.0 110.061 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -38.85 84.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 111.252 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 22.9 m -109.84 13.46 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.22 -0.925 . . . . 0.0 110.77 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 72.1 p -141.34 148.42 50.88 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.2 -0.938 . . . . 0.0 108.879 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.06 6.17 2.27 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 119.573 0.883 . . . . 0.0 111.982 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.28 151.72 42.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.159 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 p -131.75 149.19 52.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 96.7 m-85 -129.21 156.04 44.58 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.274 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.8 m -154.66 128.83 8.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.669 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -78.53 139.3 38.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.36 136.82 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 t -97.81 -2.92 39.9 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.051 -1.03 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -145.61 155.28 42.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.815 -1.178 . . . . 0.0 109.528 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.58 173.46 44.91 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.0 158.7 26.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -1.207 . . . . 0.0 109.391 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.02 152.22 41.15 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.46 -0.775 . . . . 0.0 109.134 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -60.03 -40.6 89.89 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -119.83 119.04 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mtp -101.28 127.66 47.79 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.858 . . . . 0.0 109.646 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -109.88 131.13 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.415 -0.803 . . . . 0.0 109.251 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.6 p -146.86 160.0 42.84 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.849 0.833 . . . . 0.0 110.091 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.26 139.28 47.93 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.26 167.25 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -139.3 144.78 38.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 0.0 110.248 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.85 -149.6 2.29 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -71.77 128.83 37.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.277 -1.131 . . . . 0.0 109.565 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 11.3 p-80 -130.83 60.19 1.65 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.379 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 53.36 54.67 9.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.944 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.7 p-10 -142.77 169.44 17.56 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.157 -0.964 . . . . 0.0 109.35 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.86 9.04 41.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.319 -0.863 . . . . 0.0 109.236 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -137.17 70.97 55.28 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 0.0 109.579 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.24 145.69 73.21 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 120.716 0.944 . . . . 0.0 111.496 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -74.74 144.7 43.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 72.67 0.84 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.02 -166.71 54.51 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -66.81 -10.14 27.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.186 1.257 . . . . 0.0 111.72 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.6 170.22 26.6 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.04 -151.11 19.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.589 ' CG ' HG12 ' A' ' 173' ' ' CGS . 98.0 m-20 -73.58 142.58 46.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -1.081 . . . . 0.0 109.64 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.89 -16.23 26.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.072 -1.017 . . . . 0.0 109.23 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.62 171.48 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -163.27 121.12 1.93 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.802 -1.186 . . . . 0.0 109.76 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.53 162.02 21.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.723 -0.611 . . . . 0.0 109.854 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -107.76 146.64 31.9 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -59.78 146.05 82.22 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.948 -1.095 . . . . 0.0 108.616 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.65 125.75 20.04 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.849 0.982 . . . . 0.0 112.122 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.27 174.51 44.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.96 -177.55 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.115 1.21 . . . . 0.0 112.093 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.32 -128.88 48.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -78.91 -4.14 6.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.43 -1.041 . . . . 0.0 109.838 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.99 132.45 50.81 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.1 52.12 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -68.75 160.02 31.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.0 122.28 21.63 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -99.12 136.21 39.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.409 -0.807 . . . . 0.0 110.867 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.8 m-85 -116.16 131.41 56.95 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.43 121.83 17.15 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.077 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -100.15 -0.46 38.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.155 -0.965 . . . . 0.0 109.868 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -72.93 -15.67 61.57 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.962 -1.086 . . . . 0.0 109.877 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 159.96 15.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.38 -0.825 . . . . 0.0 108.871 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.409 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.3 ttp180 -89.25 122.23 32.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.085 -1.009 . . . . 0.0 109.596 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -89.22 151.7 22.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 110.106 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 59.1 p -125.95 160.32 30.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.507 -0.746 . . . . 0.0 109.56 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.99 29.27 7.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.533 -0.729 . . . . 0.0 109.987 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -148.67 -165.02 2.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.486 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -81.04 30.81 0.32 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.945 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -75.65 -175.06 2.75 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.033 -1.042 . . . . 0.0 109.228 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 55.5 mp0 -47.4 -59.77 2.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.828 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 79.7 m-85 -83.62 152.5 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.86 -1.15 . . . . 0.0 110.92 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -140.89 90.24 2.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.99 -46.44 89.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.139 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.07 -45.77 91.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.0 109.985 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.427 ' HG2' HOM1 ' A' ' 173' ' ' CGS . 45.8 ttp180 -59.4 -40.31 86.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.009 -1.057 . . . . 0.0 108.798 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.633 HG22 HOM3 ' A' ' 173' ' ' CGS . 53.6 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.262 -0.899 . . . . 0.0 109.319 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.84 -40.56 84.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 109.144 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.63 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 109.085 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.7 t-160 -68.69 -50.33 51.84 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.5 mt-10 -57.49 -41.96 81.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.877 -1.139 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.86 -37.88 88.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.896 -1.127 . . . . 0.0 109.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.59 92.28 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -64.79 -37.33 87.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.266 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -69.92 -22.68 63.17 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.48 -1.91 57.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.16 59.82 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.25 132.16 35.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.361 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.3 m -87.54 163.8 16.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.457 -0.777 . . . . 0.0 110.169 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -65.81 157.94 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.633 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -130.3 167.44 18.5 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -106.6 10.63 31.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.744 . . . . 0.0 109.148 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.67 120.12 24.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.87 -28.81 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.828 . . . . 0.0 110.798 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.56 -6.89 88.81 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.699 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.11 133.15 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.271 . . . . 0.0 109.868 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.72 -24.65 67.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 84.2 mmm -74.71 56.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.958 . . . . 0.0 109.33 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.5 t80 -70.11 137.42 87.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 108.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.33 7.23 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 120.098 1.071 . . . . 0.0 112.743 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.5 p -161.67 169.69 21.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 109' ' ' GLU . 49.3 t80 -87.13 133.12 33.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.216 -0.927 . . . . 0.0 109.788 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.7 p -145.82 145.74 30.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -66.18 -28.11 68.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.017 -1.052 . . . . 0.0 109.55 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.6 m -77.06 142.12 39.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.958 . . . . 0.0 109.811 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.22 113.79 1.09 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 60.4 t0 -85.08 156.19 21.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -1.189 . . . . 0.0 109.108 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.565 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 93.7 t -84.41 83.41 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 109.713 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -148.93 147.22 28.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 109.01 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.0 mt -78.55 133.85 37.31 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.14 166.33 13.03 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -60.78 -40.03 91.05 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.69 -40.49 88.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.813 . . . . 0.0 109.056 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -74.29 -42.24 59.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.78 -49.15 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.126 -0.984 . . . . 0.0 109.314 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.27 -40.3 89.88 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.05 -55.73 28.66 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.107 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.0 tp -65.9 -39.18 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.237 . . . . 0.0 109.797 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.8 mt-30 -66.99 -39.35 87.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.0 . . . . 0.0 109.256 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.76 93.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.995 -1.065 . . . . 0.0 109.721 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.06 -47.87 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.0 110.348 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -101.23 -61.26 1.39 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.401 -0.812 . . . . 0.0 109.899 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.85 179.61 35.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 145.12 24.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -1.162 . . . . 0.0 109.683 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m -73.05 88.74 1.42 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -92.17 103.0 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -152.36 155.94 33.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.286 -0.884 . . . . 0.0 109.119 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.29 72.02 6.47 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 120.699 0.933 . . . . 0.0 111.111 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.76 133.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.423 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -69.79 148.06 96.41 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 108.946 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 C-N-CA 120.763 0.975 . . . . 0.0 112.118 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.633 HOM3 HG22 ' A' ' 115' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 2' ' ' LEU . 7.6 p . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.602 ' N ' HG13 ' A' ' 1' ' ' VAL . 33.4 tp -90.09 -3.86 57.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -85.66 127.14 34.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.79 -1.193 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -75.61 139.39 42.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.659 -0.651 . . . . 0.0 109.518 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.83 -60.09 0.47 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -153.46 72.34 6.8 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.166 -1.196 . . . . 0.0 109.945 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.87 106.78 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.918 1.079 . . . . 0.0 112.313 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -87.61 161.34 17.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.036 -1.04 . . . . 0.0 109.065 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -84.15 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.961 -1.087 . . . . 0.0 109.519 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.61 -9.14 59.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -83.17 148.91 27.18 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 p -98.21 -5.71 32.78 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.502 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 68.2 m80 -127.72 122.51 33.08 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.87 153.98 23.7 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.176 -0.952 . . . . 0.0 109.889 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 p -130.93 157.46 42.89 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -144.26 162.52 36.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -144.42 124.53 13.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.238 -0.914 . . . . 0.0 110.055 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 93.1 mt -86.77 113.59 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 77.3 tt0 -62.68 -41.15 98.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.95 154.73 24.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -95.9 142.4 28.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -70.05 138.57 87.42 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.174 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.28 -13.07 38.29 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.739 0.959 . . . . 0.0 111.37 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.59 -40.42 91.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.0 149.39 68.31 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.65 -178.72 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.209 0.753 . . . . 0.0 112.038 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 27' ' ' ARG . 21.8 ptt-85 -86.04 -32.12 21.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.303 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.04 86.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.112 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -69.17 -38.96 78.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.76 -39.99 80.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.259 -0.9 . . . . 0.0 109.644 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.87 -40.53 84.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.194 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -60.27 -48.8 80.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.69 84.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.949 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.93 -40.6 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.171 -0.955 . . . . 0.0 109.851 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -69.89 -39.44 76.26 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 108.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.19 -39.81 93.95 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.39 90.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 109.736 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.9 -40.45 93.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.823 -1.173 . . . . 0.0 109.073 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.12 -41.45 92.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.13 -45.82 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.403 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -74.09 -42.83 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 t -63.55 -37.96 89.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.345 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -60.16 -23.57 64.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.552 -0.718 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.54 7.63 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.957 -1.09 . . . . 0.0 110.457 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 p -145.67 151.95 47.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -72.12 4.2 3.45 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.821 1.014 . . . . 0.0 112.097 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.21 152.0 44.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.0 109.775 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 44.9 p -127.08 150.13 49.61 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.03 158.29 34.1 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 110.489 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 m -153.89 127.91 8.96 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.967 0.889 . . . . 0.0 110.291 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.76 140.74 31.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.674 -0.641 . . . . 0.0 109.681 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 141.88 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.33 -0.856 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -95.02 -6.99 40.99 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.179 -0.951 . . . . 0.0 110.69 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -149.5 155.33 40.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.919 -1.113 . . . . 0.0 109.545 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.37 160.6 33.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.68 130.96 35.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -1.124 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.7 170.02 9.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.089 -1.007 . . . . 0.0 109.79 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.08 -40.08 88.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 109.712 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.92 120.42 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.517 -0.739 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.4 mmm -98.77 129.61 45.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.349 -0.844 . . . . 0.0 109.498 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -112.42 130.32 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -147.19 156.88 43.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.995 -1.065 . . . . 0.0 110.226 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.0 133.15 53.49 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.62 160.09 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 O-C-N 121.006 -1.059 . . . . 0.0 111.395 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -124.73 138.32 54.29 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.2 -146.2 4.12 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.86 130.86 42.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.792 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.501 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -131.25 43.54 3.07 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 55.69 58.18 4.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.685 . . . . 0.0 110.139 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.501 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 17.7 p-10 -141.17 171.58 13.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 0.0 109.126 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -91.25 10.65 26.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 109.73 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 t -141.0 71.67 28.35 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.103 -0.998 . . . . 0.0 109.903 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.37 141.98 32.69 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.108 1.206 . . . . 0.0 112.12 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.5 153.79 33.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.604 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.83 75.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.93 -164.55 17.2 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -55.86 -17.99 20.39 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.796 0.998 . . . . 0.0 111.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -179.02 49.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.1 -164.87 35.54 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.528 ' HB3' HG12 ' A' ' 173' ' ' CGS . 43.5 p-10 -74.77 155.79 37.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.132 -1.216 . . . . 0.0 109.428 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 mt -93.09 -19.7 21.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.141 -0.975 . . . . 0.0 109.272 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.94 169.79 8.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.012 -1.055 . . . . 0.0 109.37 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -163.03 179.96 7.16 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.646 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.83 170.94 16.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.621 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -98.64 158.1 15.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.354 -0.841 . . . . 0.0 109.589 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -57.06 145.94 62.88 Favored Pre-proline 0 N--CA 1.485 1.311 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.16 104.22 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 120.371 0.714 . . . . 0.0 111.62 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.05 171.23 37.91 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.3 -175.63 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.039 1.159 . . . . 0.0 112.024 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.96 -127.09 40.19 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -80.05 -11.13 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.24 . . . . 0.0 109.252 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.92 142.36 46.34 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.09 -21.84 32.22 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.3 150.25 46.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.286 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.03 125.94 19.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 108.749 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -105.87 150.06 25.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.534 -0.729 . . . . 0.0 109.554 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.13 140.05 51.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.77 119.26 10.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.057 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -99.48 -3.32 33.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.361 -0.837 . . . . 0.0 109.354 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.26 -18.56 60.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.833 . . . . 0.0 109.677 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -98.15 159.78 14.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.24 -0.913 . . . . 0.0 108.905 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.8 ttm-85 -89.39 119.59 29.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.25 -0.906 . . . . 0.0 109.691 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.74 145.34 25.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.345 -0.847 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 69.6 p -122.49 160.97 24.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -108.41 30.43 6.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.56 -0.712 . . . . 0.0 109.102 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -148.64 -165.0 2.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.09 -1.006 . . . . 0.0 110.269 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -82.25 28.98 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -73.7 -169.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.134 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.81 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 111.656 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -87.14 153.51 21.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.972 -1.08 . . . . 0.0 110.547 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -143.7 97.59 3.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.187 -0.946 . . . . 0.0 108.55 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.51 -45.95 92.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.364 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.56 -39.85 85.38 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.84 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.488 ' NH1' HD22 ' A' ' 135' ' ' LEU . 1.9 tpm_? -60.0 -43.37 95.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.27 -39.63 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.785 . . . . 0.0 108.89 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.96 84.49 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.37 -0.831 . . . . 0.0 109.164 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.49 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 4.5 t60 -70.63 -46.66 62.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.85 -41.37 91.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.5 mt -63.77 -39.72 94.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.78 -40.38 80.12 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -66.36 -35.46 80.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 108.328 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.4 t -69.96 -25.32 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.26 -0.03 50.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 109.07 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.19 12.08 66.1 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.813 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.79 128.58 33.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.461 . . . . 0.0 108.979 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.2 m -88.34 170.12 11.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.428 -0.795 . . . . 0.0 109.671 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -66.12 149.0 50.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 t -124.67 161.49 26.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.3 p -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.51 127.37 32.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.047 . . . . 0.0 108.732 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.88 -40.08 81.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.527 -0.733 . . . . 0.0 110.212 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.26 1.41 70.54 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.616 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.01 139.96 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.716 -1.461 . . . . 0.0 109.695 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.488 HD22 ' NH1' ' A' ' 114' ' ' ARG . 88.3 mt -69.02 -29.3 67.45 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 109.274 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 77.3 mmm -74.3 55.23 0.6 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.424 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.8 t80 -69.29 139.49 89.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.8 -3.9 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 CA-C-N 119.832 0.976 . . . . 0.0 112.543 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -162.84 170.91 17.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 109.311 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.45 ' O ' HG23 ' A' ' 141' ' ' THR . 65.6 t80 -84.95 101.58 12.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.715 -1.24 . . . . 0.0 109.06 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 140' ' ' TYR . 28.1 p -155.12 8.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 109.598 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -98.01 123.99 42.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.174 -0.953 . . . . 0.0 110.041 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.4 m -119.94 135.22 54.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.509 -0.744 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.16 -159.04 32.09 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.618 -1.277 . . . . 0.0 109.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 49.4 t0 -81.06 152.2 28.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -1.003 . . . . 0.0 108.967 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.522 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 98.4 t -83.01 96.92 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 0.0 109.703 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -146.95 151.81 37.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.408 -0.807 . . . . 0.0 109.207 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.14 149.58 38.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.03 150.26 21.08 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -58.4 -40.08 81.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.835 -1.166 . . . . 0.0 109.035 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.84 -37.74 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.785 -1.197 . . . . 0.0 108.448 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -74.69 -39.93 61.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.99 -49.86 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.095 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.67 -39.78 95.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.963 . . . . 0.0 110.512 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.18 -51.02 47.56 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.93 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -67.81 -38.9 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.401 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 91.6 mt-30 -65.68 -39.75 91.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.685 -1.259 . . . . 0.0 109.315 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.04 95.2 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.782 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.34 -49.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.84 -63.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.094 -1.004 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.09 -165.5 33.25 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.3 mtt-85 -96.17 139.85 31.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.451 -1.029 . . . . 0.0 109.261 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.7 m -75.55 88.58 2.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.762 -1.211 . . . . 0.0 108.425 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.06 77.43 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 108.752 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -156.63 76.44 4.37 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 121.496 -0.752 . . . . 0.0 109.16 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -81.19 93.12 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.542 1.495 . . . . 0.0 112.453 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.6 t -149.43 124.5 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -67.69 149.67 98.18 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.175 -0.953 . . . . 0.0 108.77 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 117.91 -0.954 . . . . 0.0 111.99 -179.488 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.528 HG12 ' HB3' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.5 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -76.98 138.24 39.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 109.647 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 80.2 p -94.05 129.73 40.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -81.21 104.91 12.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.85 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.75 78.56 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.022 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.42 ' O ' ' OG1' ' A' ' 3' ' ' THR . 76.2 m-20 -152.87 70.05 7.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 120.683 -1.48 . . . . 0.0 110.692 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -78.15 101.3 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.386 1.391 . . . . 0.0 111.803 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -145.8 154.16 41.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.031 -1.043 . . . . 0.0 109.696 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -85.91 122.01 29.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 108.523 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.85 -12.58 55.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.159 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -82.97 152.44 25.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.705 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 p -96.6 -4.59 40.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.921 . . . . 0.0 109.112 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -125.35 135.41 52.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.69 158.35 43.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.39 -0.819 . . . . 0.0 109.537 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.7 p -128.43 154.08 46.42 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.48 159.97 41.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -149.45 130.35 14.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.084 -1.01 . . . . 0.0 110.176 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 92.8 mt -87.44 115.2 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.88 -40.11 91.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -160.09 151.87 20.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.075 . . . . 0.0 110.26 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -98.87 135.65 40.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.379 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 t -71.2 144.08 89.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.947 . . . . 0.0 108.987 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -66.03 -11.25 30.26 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.704 0.936 . . . . 0.0 112.035 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.13 -39.93 87.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 109.957 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -137.59 150.21 67.51 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.193 -0.942 . . . . 0.0 108.951 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.35 -177.34 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.706 0.937 . . . . 0.0 111.924 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -88.99 -37.04 15.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 0.0 109.938 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.44 83.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.95 -39.01 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 109.617 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.68 -39.95 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -41.59 92.75 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.075 -1.016 . . . . 0.0 109.077 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.59 -46.38 90.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.98 90.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 0.0 109.775 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.31 -40.16 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -39.92 75.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.997 . . . . 0.0 108.682 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.06 -39.97 91.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.31 84.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.938 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.11 -39.95 87.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.965 -1.085 . . . . 0.0 108.786 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.12 -40.28 89.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 110.093 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.12 -47.02 87.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.871 -1.143 . . . . 0.0 109.644 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -71.78 -41.72 67.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.493 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.21 -38.17 81.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.552 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.28 7.73 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 p -145.79 150.0 41.5 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.893 -1.13 . . . . 0.0 109.215 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.13 6.47 1.77 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.693 0.929 . . . . 0.0 111.899 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.93 154.06 42.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.13 -0.981 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.8 p -133.3 149.99 51.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.533 -0.73 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.88 156.24 43.99 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.468 -0.77 . . . . 0.0 109.965 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 m -155.38 132.43 10.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.755 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -78.3 145.66 35.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.96 134.98 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.447 -0.783 . . . . 0.0 109.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -93.07 -0.93 56.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.037 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -152.89 158.63 42.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 109.666 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.6 168.11 30.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -80.88 149.33 29.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -1.175 . . . . 0.0 109.127 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 151.93 25.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.437 -0.79 . . . . 0.0 109.108 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.286 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -116.56 116.06 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.47 137.52 39.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.46 127.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.1 p -149.58 161.36 42.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 110.207 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.14 139.97 46.07 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.72 167.14 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.198 -0.939 . . . . 0.0 110.739 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.76 146.79 49.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.629 -0.67 . . . . 0.0 110.194 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.52 -150.19 0.87 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -60.07 136.88 58.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.087 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 25.1 p-80 -137.48 54.23 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.82 54.14 8.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.592 -0.693 . . . . 0.0 110.035 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.9 t0 -147.31 162.14 39.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.5 m120 -89.7 9.0 28.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 109.775 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.7 m -134.55 70.58 72.01 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.412 -0.805 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.5 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 120.879 1.053 . . . . 0.0 112.051 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -77.62 141.44 39.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -103.54 62.07 0.77 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.413 -0.804 . . . . 0.0 109.179 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.92 54.82 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -55.91 -14.11 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.023 1.149 . . . . 0.0 111.914 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.18 -178.54 50.83 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.28 -158.8 42.34 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.534 ' HB3' HG12 ' A' ' 173' ' ' CGS . 48.0 p-10 -74.33 147.61 42.09 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -1.137 . . . . 0.0 109.478 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -94.66 -15.85 23.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.89 160.12 8.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.05 -1.031 . . . . 0.0 109.286 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.18 -178.7 6.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.286 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.39 168.17 20.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 109.869 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.75 164.46 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.38 -0.825 . . . . 0.0 109.94 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.07 149.88 72.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.838 . . . . 0.0 109.553 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.26 103.47 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 120.689 0.926 . . . . 0.0 111.806 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.03 166.01 38.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.14 -172.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.984 1.123 . . . . 0.0 111.647 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.99 -132.96 49.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -79.92 -10.26 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -1.043 . . . . 0.0 109.946 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.99 144.21 39.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -18.15 32.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -67.12 124.26 22.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.283 . . . . 0.0 109.995 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.89 128.33 53.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.522 -0.736 . . . . 0.0 109.329 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -110.98 135.56 51.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -116.52 137.36 52.23 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.493 -0.754 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.5 122.59 17.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -100.4 0.38 39.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -74.56 -18.66 60.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.904 -1.122 . . . . 0.0 109.93 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.31 162.29 13.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -0.83 . . . . 0.0 109.479 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -87.74 121.43 30.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 0.0 109.28 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.19 147.07 23.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.359 -0.838 . . . . 0.0 110.174 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.0 p -125.56 168.77 13.21 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.43 31.82 6.21 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.59 HD21 ' CZ ' ' A' ' 108' ' ' ARG . 4.7 p30 -149.85 -164.84 2.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.889 . . . . 0.0 109.953 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -86.4 29.22 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.33 -0.856 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.59 ' CZ ' HD21 ' A' ' 106' ' ' ASN . 97.0 mtt180 -76.11 -159.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -40.36 -59.94 1.2 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.53 -0.731 . . . . 0.0 111.53 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -129.78 130.09 44.93 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.048 -1.032 . . . . 0.0 110.388 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -98.58 112.01 24.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.268 -0.895 . . . . 0.0 109.297 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 0.0 110.084 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.94 -42.54 94.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.176 -0.952 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.503 ' NH1' HOM1 ' A' ' 173' ' ' CGS . 29.5 ttt-85 -60.1 -40.05 88.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 109.332 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.07 -40.06 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.271 -0.893 . . . . 0.0 109.539 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.61 93.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 108.866 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.46 94.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.63 ' ND1' HOM2 ' A' ' 173' ' ' CGS . 28.5 t60 -67.38 -44.4 79.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.776 . . . . 0.0 110.517 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.07 -39.99 87.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.971 -1.081 . . . . 0.0 108.855 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.46 -37.03 84.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.05 -40.89 75.68 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -63.1 -40.12 96.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -1.17 . . . . 0.0 108.634 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -71.61 -23.52 61.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.97 -3.14 58.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -0.941 . . . . 0.0 108.865 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.43 64.3 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.81 127.35 34.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.076 -1.249 . . . . 0.0 109.756 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -88.66 170.04 11.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.453 -0.779 . . . . 0.0 109.752 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -67.5 152.98 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.113 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.8 t -125.15 163.6 22.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.556 -0.715 . . . . 0.0 109.392 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -101.62 6.64 42.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.352 -0.843 . . . . 0.0 110.047 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.97 126.62 32.72 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.186 0.993 . . . . 0.0 109.867 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.3 pt -59.0 -30.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.394 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.46 -3.34 90.57 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.252 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.92 139.15 33.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.352 . . . . 0.0 109.142 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.349 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.458 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 34.8 mtp -75.65 58.6 1.08 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -70.39 134.82 86.67 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.408 ' O ' ' HC1' ' A' ' 173' ' ' CGS . 22.8 Cg_exo -45.74 -63.08 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 120.409 1.182 . . . . 0.0 110.857 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.9 p -94.17 177.01 6.1 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 69.6 t80 -84.94 139.23 31.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.58 -1.325 . . . . 0.0 109.106 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.8 p -146.78 167.22 24.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.56 124.94 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.449 -0.782 . . . . 0.0 109.597 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -106.93 -22.83 12.55 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.376 -0.827 . . . . 0.0 109.93 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' O ' ' OD1' ' A' ' 145' ' ' ASP . . . 74.58 -16.51 3.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 144' ' ' GLY . 71.0 m-20 -153.7 122.36 6.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.893 -1.357 . . . . 0.0 109.815 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.8 t -87.7 105.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -145.02 154.46 42.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 109.062 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.42 148.24 37.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.924 -1.11 . . . . 0.0 108.89 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.36 148.45 22.11 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -55.83 -38.35 69.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.194 -0.942 . . . . 0.0 108.686 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -53.97 -39.52 66.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.163 -0.96 . . . . 0.0 108.547 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 156' ' ' ILE . 85.5 m-20 -73.0 -40.01 65.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 109.029 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.47 -50.52 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -39.99 93.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.108 -0.995 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.71 -54.15 7.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.089 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -62.02 -39.91 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.863 -1.375 . . . . 0.0 110.147 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 109.247 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.94 -43.37 95.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.725 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.01 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.512 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 -60.68 1.48 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.58 -178.92 35.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -95.02 140.74 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -1.221 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 165' ' ' ASN . 75.0 m -74.82 90.16 2.36 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.44 76.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 163' ' ' SER . 52.6 m-20 -152.48 156.44 33.42 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.11 95.4 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.492 0.795 . . . . 0.0 111.783 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.2 t -85.81 137.84 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.253 -0.904 . . . . 0.0 109.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -71.3 148.03 93.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 108.894 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 117.98 -0.925 . . . . 0.0 111.974 179.628 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.63 HOM2 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.042 0.449 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.1 -49.52 77.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.054 -1.029 . . . . 0.0 108.955 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.2 p -95.3 157.18 16.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.455 -0.778 . . . . 0.0 110.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -72.95 138.72 46.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.23 -146.92 33.85 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -79.83 147.31 66.24 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.232 -1.158 . . . . 0.0 109.099 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.94 -175.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 120.688 0.926 . . . . 0.0 112.292 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 HG23 ' A' ' 159' ' ' ILE . 85.6 mtm180 -147.15 163.57 35.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.302 -0.874 . . . . 0.0 109.467 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.48 118.83 23.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.57 -9.98 59.55 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.317 -0.865 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.5 145.2 26.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.074 . . . . 0.0 110.16 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -92.13 -4.04 54.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -129.92 139.78 51.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.21 161.09 34.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.886 0.85 . . . . 0.0 109.52 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.1 p -127.01 157.07 40.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -144.49 157.55 44.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.156 -0.965 . . . . 0.0 109.339 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -151.06 133.09 15.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.15 118.92 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.62 -40.27 80.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.964 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -161.67 150.9 16.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.644 -1.285 . . . . 0.0 110.955 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.18 133.66 38.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.706 . . . . 0.0 109.558 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 t -70.05 142.56 90.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.3 -8.94 24.39 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.38 0.814 . . . . 0.0 111.398 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.93 -39.59 86.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.3 mt -139.52 152.34 68.62 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.86 -176.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 CA-C-N 119.168 0.739 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -86.87 -34.69 19.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.969 -1.082 . . . . 0.0 109.302 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.89 86.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -69.37 -39.63 77.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -0.834 . . . . 0.0 109.6 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 -47.36 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.159 -0.963 . . . . 0.0 109.045 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -60.28 -40.53 90.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.484 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 85.7 t60 -59.19 -47.55 84.91 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.674 -0.642 . . . . 0.0 109.777 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.2 -39.18 81.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.484 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.18 -38.32 74.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.788 -1.195 . . . . 0.0 110.064 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.94 -42.15 97.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.987 -1.071 . . . . 0.0 110.262 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.484 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 36.9 mttm -64.6 -39.83 94.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.71 76.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -60.8 -43.36 98.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -60.09 -41.46 92.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.93 -43.61 94.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.729 -1.232 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.7 m95 -73.49 -42.33 61.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.905 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t -68.3 -35.39 77.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.041 -1.037 . . . . 0.0 110.517 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -57.81 -28.9 64.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.271 -0.893 . . . . 0.0 111.673 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.92 10.4 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.934 -1.104 . . . . 0.0 111.062 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -144.49 149.9 45.71 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.001 -1.062 . . . . 0.0 109.126 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.18 5.29 2.75 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 120.81 1.007 . . . . 0.0 112.181 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.81 155.44 40.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.905 -1.122 . . . . 0.0 109.268 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 p -131.55 142.33 49.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.394 -0.816 . . . . 0.0 108.8 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.29 153.29 36.6 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.367 -0.833 . . . . 0.0 109.467 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.2 m -153.18 132.31 12.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.804 . . . . 0.0 109.861 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -77.44 139.39 39.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.7 136.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.631 -0.668 . . . . 0.0 109.452 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -96.62 -2.21 45.26 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 110.021 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -149.86 152.27 34.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.41 168.65 45.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -79.95 132.03 35.95 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.564 -0.963 . . . . 0.0 109.461 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.67 149.74 20.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 108.965 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.84 -39.86 86.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.39 -0.819 . . . . 0.0 109.118 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -118.22 119.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.7 mmm -101.14 128.95 46.99 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.13 -0.981 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.04 126.42 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.3 p -149.98 159.71 44.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.781 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.19 137.77 50.96 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.09 162.7 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.42 -0.8 . . . . 0.0 111.626 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -130.43 145.3 51.8 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.813 -0.554 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.18 -146.81 0.64 Allowed Glycine 0 N--CA 1.495 2.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.034 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -72.49 128.95 37.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.615 -0.933 . . . . 0.0 109.165 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.55 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.9 p-80 -128.18 54.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.558 -0.714 . . . . 0.0 109.855 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 69' ' ' ARG . 52.4 mtm-85 56.62 50.02 13.52 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.482 -0.762 . . . . 0.0 110.06 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -139.83 163.11 33.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -89.42 14.61 10.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.217 -0.927 . . . . 0.0 109.906 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -140.61 68.62 31.03 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.099 -1.0 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.62 148.22 65.49 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.656 1.571 . . . . 0.0 112.74 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -73.79 149.83 41.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.596 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -124.69 74.43 1.34 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.837 -0.539 . . . . 0.0 109.645 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.94 -174.93 48.2 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.9 -13.64 39.03 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 120.839 1.026 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -174.03 43.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.02 -159.21 31.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' HG12 ' A' ' 173' ' ' CGS . 40.6 m-80 -73.73 135.36 43.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.284 -1.127 . . . . 0.0 109.42 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.88 -10.81 43.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.695 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.79 161.35 5.89 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -161.63 116.92 2.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.706 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.74 172.83 8.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -104.57 157.08 17.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.78 147.48 78.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 108.571 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.58 104.37 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.628 0.885 . . . . 0.0 112.587 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.07 170.91 33.85 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -69.82 165.42 31.08 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.226 1.284 . . . . 0.0 112.196 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.61 -121.68 15.48 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.061 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.41 -12.98 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -1.04 . . . . 0.0 109.846 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.04 44.71 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 -8.48 78.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -65.06 128.05 34.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.012 -1.287 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.77 115.57 29.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -98.46 135.79 39.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.283 -0.886 . . . . 0.0 109.244 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.29 134.32 54.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.98 117.2 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.015 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -97.36 -0.34 46.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.365 -0.834 . . . . 0.0 109.046 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -74.77 -20.87 59.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -100.76 159.21 15.37 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.281 -0.887 . . . . 0.0 108.965 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 102' ' ' ARG . 18.7 ttt-85 -87.14 123.4 32.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -89.29 145.17 25.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.653 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.9 p -129.79 169.24 15.39 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.356 -0.84 . . . . 0.0 109.633 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.23 28.81 8.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.592 -0.693 . . . . 0.0 110.159 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 18.0 p30 -152.0 -167.01 2.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.033 . . . . 0.0 109.952 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -71.12 22.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.358 -0.839 . . . . 0.0 110.686 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 106' ' ' ASN . 29.2 mmt180 -75.8 -160.39 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 54.3 mp0 -31.77 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.0 -0.437 . . . . 0.0 111.987 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -129.04 151.07 50.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.319 -0.863 . . . . 0.0 110.758 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 75.8 m-20 -99.25 114.33 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.25 -41.14 92.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.481 -0.762 . . . . 0.0 110.145 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -59.83 -42.06 92.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.0 110.618 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.566 HH12 ' N ' ' A' ' 143' ' ' SER . 62.8 ttt180 -59.85 -39.87 86.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.842 -1.161 . . . . 0.0 109.678 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 53.6 t -71.69 -39.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.16 90.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.839 -1.163 . . . . 0.0 108.769 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.69 95.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.569 -0.707 . . . . 0.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.456 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.8 t-160 -69.18 -50.02 51.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.708 . . . . 0.0 110.335 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -58.6 -40.04 82.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.706 -1.246 . . . . 0.0 109.986 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.7 -39.93 93.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.018 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.25 94.49 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -63.61 -37.77 88.6 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 108.971 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.1 p -69.68 -21.8 63.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.006 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.07 -1.29 57.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.302 -0.874 . . . . 0.0 109.431 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.06 16.92 66.23 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.043 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.64 131.29 34.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.838 -1.389 . . . . 0.0 109.382 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.8 m -88.72 169.1 11.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -67.87 157.47 34.81 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.484 -0.76 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -127.95 164.07 23.11 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.439 -0.788 . . . . 0.0 109.318 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.2 p -102.58 8.94 39.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 110.008 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -83.79 127.65 33.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -0.911 . . . . 0.0 109.291 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.06 -30.02 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 110.319 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.29 0.74 88.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.54 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.77 34.88 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.324 . . . . 0.0 110.463 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.11 -28.47 65.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 109.602 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 86.0 mmm -74.99 52.64 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CD2' ' OG1' ' A' ' 141' ' ' THR . 2.7 t80 -70.33 128.97 90.88 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.61 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -48.91 -66.98 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.114 0 CA-C-N 120.483 1.208 . . . . 0.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.5 m -89.64 176.28 6.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.042 -1.036 . . . . 0.0 108.877 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.544 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 48.4 t80 -85.83 128.3 34.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 75.1 p -149.69 161.84 41.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -79.13 125.53 29.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.566 ' N ' HH12 ' A' ' 114' ' ' ARG . 49.7 p -111.41 12.58 21.52 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.736 -0.603 . . . . 0.0 109.449 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.9 -125.78 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -79.98 146.55 31.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.044 -1.268 . . . . 0.0 108.798 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.69 107.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.351 -0.843 . . . . 0.0 109.852 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -145.55 159.94 42.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.65 142.31 42.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.88 165.7 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.24 -38.62 87.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -58.69 -40.66 84.22 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -75.3 -41.01 57.96 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.16 -53.25 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.075 -1.015 . . . . 0.0 109.894 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.78 -39.97 95.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.22 -63.26 5.48 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.758 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.4 tp -60.6 -40.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.888 -1.36 . . . . 0.0 110.26 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.9 mt-30 -64.37 -39.71 94.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.249 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.25 93.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.873 -1.142 . . . . 0.0 109.626 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.407 HG23 HH11 ' A' ' 8' ' ' ARG . 93.7 mt -60.08 -50.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.057 . . . . 0.0 109.119 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.5 -67.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.918 -1.114 . . . . 0.0 109.215 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.47 177.87 37.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -86.14 149.05 25.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.085 -1.244 . . . . 0.0 108.724 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.5 m -72.75 85.06 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 108.915 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -78.2 54.54 1.38 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.062 -1.024 . . . . 0.0 109.211 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -151.68 73.39 8.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -80.29 35.35 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.29 1.327 . . . . 0.0 111.783 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.0 121.08 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.487 -0.758 . . . . 0.0 109.285 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.17 147.17 79.49 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 0.0 108.637 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 118.162 -0.849 . . . . 0.0 112.356 -179.406 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.544 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.5 mt -100.49 130.49 46.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.188 -0.945 . . . . 0.0 109.525 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.4 p -99.74 124.78 45.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -78.31 129.1 34.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 0.0 109.713 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.1 -66.14 0.58 Allowed Glycine 0 N--CA 1.5 2.962 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -155.55 77.09 4.82 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.257 . . . . 0.0 110.236 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -48.05 125.96 12.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.129 1.219 . . . . 0.0 112.837 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -91.34 161.43 15.02 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.583 -0.698 . . . . 0.0 109.576 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -83.21 130.0 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.164 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -82.42 -13.79 56.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.277 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -83.78 151.53 25.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.011 -1.056 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 p -97.44 -7.32 31.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.21 -0.932 . . . . 0.0 108.662 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.548 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 31.1 m-70 -121.51 122.28 39.37 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.509 HD12 ' CE2' ' A' ' 49' ' ' PHE . 66.2 mt -110.02 156.35 20.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -126.73 152.74 46.42 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.76 159.51 42.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 108.949 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.3 ttm180 -150.29 130.72 13.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -87.38 120.02 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 108.544 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.98 -40.09 87.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -160.78 149.98 16.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.875 -1.14 . . . . 0.0 109.988 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.22 132.22 43.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -68.67 143.45 95.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.828 -1.17 . . . . 0.0 109.161 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.11 -6.23 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 120.657 0.905 . . . . 0.0 111.774 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.19 -40.18 89.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.765 . . . . 0.0 109.767 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.595 HD13 ' CG ' ' A' ' 105' ' ' ASN . 54.7 mt -138.84 150.03 64.02 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.307 -0.871 . . . . 0.0 108.724 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.01 178.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 CA-C-N 119.247 0.767 . . . . 0.0 111.501 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -87.94 -38.71 15.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.993 -1.067 . . . . 0.0 109.546 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.28 92.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.008 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.12 -39.71 75.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 110.095 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.28 -43.6 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.055 . . . . 0.0 109.299 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.77 -39.37 80.81 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.598 ' CE1' ' HZ1' ' A' ' 36' ' ' LYS . 68.1 t60 -57.24 -47.49 81.23 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.555 -0.715 . . . . 0.0 109.175 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.25 -0.906 . . . . 0.0 110.308 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.07 -39.46 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.725 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.89 -41.64 95.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.948 . . . . 0.0 109.901 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.598 ' HZ1' ' CE1' ' A' ' 32' ' ' HIS . 21.5 mttp -62.5 -38.0 88.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 109.955 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.7 84.76 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.701 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -61.39 -41.08 96.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.29 -42.2 95.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.171 -0.955 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -59.94 -43.45 94.98 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.878 -1.139 . . . . 0.0 110.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.73 -41.61 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.3 t -68.25 -36.19 79.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -60.0 -19.19 51.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 0.0 110.242 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.2 m -112.29 1.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 p -144.56 150.24 46.64 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.0 109.421 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.27 7.66 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.936 1.091 . . . . 0.0 112.122 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.41 151.78 42.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.117 -0.99 . . . . 0.0 109.839 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.548 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 64.5 p -129.79 149.97 51.3 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.509 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -128.26 153.63 46.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.483 -0.76 . . . . 0.0 109.405 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.1 m -153.0 134.99 14.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.03 131.6 36.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.649 -0.657 . . . . 0.0 109.437 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 14.7 m -119.67 130.69 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -96.0 -8.78 32.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.128 -0.982 . . . . 0.0 108.994 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 99.2 mt-10 -143.81 152.12 40.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 95.64 179.53 36.29 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -83.18 133.48 35.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.848 -1.384 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 131.03 45.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -59.87 -43.73 94.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.93 120.08 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.573 -0.704 . . . . 0.0 109.814 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 mtt -99.87 130.36 46.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.153 -0.967 . . . . 0.0 109.873 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.73 126.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 p -150.73 160.79 43.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.14 139.8 41.0 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.12 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.344 -0.848 . . . . 0.0 111.08 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 66' ' ' GLY . 83.3 mtm180 -131.35 143.8 50.76 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.737 -0.602 . . . . 0.0 109.423 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 42.65 -147.4 0.68 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -67.12 130.72 44.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -1.024 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.54 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -133.85 56.16 1.86 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.434 -0.791 . . . . 0.0 109.522 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 mtm-85 58.69 49.29 10.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.807 -0.558 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.4 m-20 -142.76 165.69 26.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.216 -0.928 . . . . 0.0 109.641 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -92.99 9.14 36.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.336 -0.853 . . . . 0.0 109.417 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.7 m -133.93 71.57 73.71 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.28 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.2 152.01 80.26 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 120.868 1.045 . . . . 0.0 111.547 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -76.81 147.66 37.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -109.49 75.04 0.92 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.39 -160.67 9.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.82 -15.66 22.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.957 1.104 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.96 -179.56 45.78 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -164.62 37.31 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.32 147.38 40.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -1.065 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 mt -92.71 -18.85 22.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 110.296 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.28 161.6 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 0.0 109.681 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.2 -179.81 6.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.697 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.52 167.42 21.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.142 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -101.14 135.22 42.96 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.272 -0.893 . . . . 0.0 109.784 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.01 150.04 71.51 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -41.76 120.97 1.54 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 120.706 0.937 . . . . 0.0 112.037 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 -169.28 21.29 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -76.4 117.43 4.59 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.564 1.51 . . . . 0.0 113.519 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.3 -111.49 3.35 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.451 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.29 -13.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.992 . . . . 0.0 110.888 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.87 133.12 51.26 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.927 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.3 77.76 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 121.459 -1.024 . . . . 0.0 111.009 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.38 129.75 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.736 -1.449 . . . . 0.0 110.436 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.44 129.1 46.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.31 -0.869 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -115.17 132.9 56.46 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.496 -0.752 . . . . 0.0 109.122 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -118.01 131.93 56.43 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -64.83 126.09 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -100.3 0.63 40.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 110.059 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.44 -20.01 60.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.027 -1.046 . . . . 0.0 109.679 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.13 158.36 15.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 102' ' ' ARG . 23.5 ttt-85 -87.49 114.63 24.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -89.59 150.72 22.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.73 . . . . 0.0 109.993 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.3 p -126.3 164.38 21.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.595 ' CG ' HD13 ' A' ' 25' ' ' LEU . 91.5 m-20 -108.53 32.1 5.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.073 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.615 HD22 ' CD ' ' A' ' 108' ' ' ARG . 15.5 p30 -149.43 -164.98 2.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -0.964 . . . . 0.0 110.379 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -84.83 28.34 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.615 ' CD ' HD22 ' A' ' 106' ' ' ASN . 60.0 mtp180 -76.67 -164.07 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 110.498 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -43.64 -59.96 1.97 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.555 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.29 121.85 43.21 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.178 -0.951 . . . . 0.0 109.804 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -99.99 116.06 31.15 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.09 -39.91 87.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.231 . . . . 0.0 109.976 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -59.91 -41.91 92.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 112.226 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 114' ' ' ARG . 10.4 ptt-85 -59.99 -41.3 91.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.313 -1.492 . . . . 0.0 109.97 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.4 -39.25 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.227 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.1 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.81 94.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.99 -1.069 . . . . 0.0 108.95 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.69 ' HD1' HOM2 ' A' ' 173' ' ' CGS . 3.6 t-160 -69.87 -49.27 54.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -58.97 -40.17 83.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 109.595 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.08 -39.81 95.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 109.742 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.22 -40.04 95.31 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -61.59 -39.16 90.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -1.196 . . . . 0.0 108.519 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.0 m -70.14 -26.22 63.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.767 . . . . 0.0 109.14 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.82 -3.94 57.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.577 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.22 60.54 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -80.82 129.05 34.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.227 . . . . 0.0 108.889 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -88.35 169.69 11.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.72 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -68.89 156.96 37.55 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 108.865 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -125.86 163.42 22.95 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -105.08 13.48 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.392 -0.818 . . . . 0.0 109.715 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 61.6 t0 -84.65 130.89 34.66 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.313 -0.867 . . . . 0.0 108.889 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.05 -38.37 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.039 -1.038 . . . . 0.0 110.313 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -80.12 1.53 79.83 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.246 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.96 128.62 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.626 -1.514 . . . . 0.0 109.471 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 147' ' ' GLN . 95.9 mt -67.56 -26.31 66.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.223 -0.923 . . . . 0.0 108.858 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.2 mmm -72.37 46.29 0.14 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -69.84 127.88 92.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 108.892 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.63 -64.86 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.557 1.235 . . . . 0.0 111.766 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -85.86 169.29 13.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.383 -0.823 . . . . 0.0 109.651 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 66.3 t80 -85.61 136.54 33.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.94 -1.1 . . . . 0.0 108.897 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.1 p -147.6 167.39 24.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.281 -0.887 . . . . 0.0 108.878 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.22 137.83 55.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 108.719 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 85.5 p -139.91 155.15 47.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -92.04 -126.33 3.79 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -80.72 160.04 25.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.71 111.72 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.987 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.411 ' O ' HD11 ' A' ' 135' ' ' LEU . 49.8 mt-30 -144.97 150.0 36.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.241 -0.912 . . . . 0.0 109.066 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.14 143.88 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 108.962 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.51 163.71 12.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.29 -0.881 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -60.05 -40.18 88.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.98 -1.075 . . . . 0.0 108.759 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.74 -40.04 86.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.834 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.87 -40.08 65.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.042 -1.036 . . . . 0.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.11 -50.16 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.877 . . . . 0.0 109.716 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.88 -40.02 91.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.183 -0.948 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.13 -54.05 41.19 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.343 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -68.59 -39.09 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.882 -1.363 . . . . 0.0 110.039 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -63.69 -39.47 94.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.86 95.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.87 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 0.0 109.919 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -95.86 -67.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.047 . . . . 0.0 109.346 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.21 -173.4 40.2 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.51 142.27 27.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 108.963 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.5 m -76.36 85.59 3.13 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.132 -0.98 . . . . 0.0 109.387 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -93.58 101.17 13.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.315 -0.866 . . . . 0.0 109.099 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -159.08 155.52 24.39 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.63 68.77 8.0 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 CA-C-N 119.546 0.874 . . . . 0.0 111.363 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 t -87.16 133.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 108.959 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -122.98 80.69 50.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.654 -0.654 . . . . 0.0 109.384 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 120.8 1.0 . . . . 0.0 111.882 -179.594 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.69 HOM2 ' HD1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 2' ' ' LEU . 7.2 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' N ' HG13 ' A' ' 1' ' ' VAL . 90.6 mt -60.3 -40.47 90.62 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.1 p -99.67 127.64 45.78 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.086 -1.009 . . . . 0.0 109.701 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.64 133.05 38.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.318 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.41 -87.1 0.21 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -152.18 76.66 7.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.928 . . . . 0.0 108.794 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.48 -166.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.246 1.297 . . . . 0.0 113.18 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -91.88 172.19 8.62 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.96 122.44 27.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.021 -1.049 . . . . 0.0 108.344 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -83.04 -9.81 59.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -83.73 150.72 25.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -96.87 -3.15 42.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 63.9 m80 -127.97 138.61 52.68 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.9 mt -133.29 158.65 42.42 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -130.2 155.6 45.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.21 157.45 44.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 0.0 108.536 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.4 ttm180 -150.09 133.63 16.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.97 116.9 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.843 -1.16 . . . . 0.0 108.399 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' SD ' ' A' ' 60' ' ' MET . 99.0 mt-10 -68.25 -38.34 81.7 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.798 . . . . 0.0 111.06 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 21' ' ' TYR . 44.1 t30 -154.56 139.75 17.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.0 109.847 -178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.405 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 95.4 m-85 -93.86 142.28 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.74 . . . . 0.0 109.345 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -74.13 136.56 75.96 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.95 -11.55 31.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.788 0.96 . . . . 0.0 111.841 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.815 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.5 mt -133.74 151.2 76.62 Favored Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.44 -178.76 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.396 0.82 . . . . 0.0 111.911 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -86.53 -33.57 20.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 109.922 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.04 92.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.048 -1.033 . . . . 0.0 110.402 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.97 -38.94 76.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.275 -0.89 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.08 -41.89 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.133 -0.979 . . . . 0.0 108.922 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -40.22 88.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.004 -1.06 . . . . 0.0 110.045 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 75.7 t60 -60.57 -45.3 94.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.53 81.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.946 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -69.86 -36.83 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -0.816 . . . . 0.0 109.842 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -64.72 -45.64 85.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 109.669 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 35.9 mttm -62.45 -36.95 84.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.992 -1.067 . . . . 0.0 110.256 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.21 -50.01 75.37 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.221 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -60.78 -41.28 95.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 109.364 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 97.8 mt-30 -61.76 -40.21 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.731 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.06 -40.09 88.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.96 . . . . 0.0 109.573 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -73.42 -43.47 60.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 110.347 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -69.26 -30.45 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 19.1 m120 -59.35 -31.96 69.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 8.58 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.146 -0.971 . . . . 0.0 110.894 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 12.4 p -147.74 150.52 36.6 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.732 -1.23 . . . . 0.0 109.732 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.49 5.68 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.117 1.211 . . . . 0.0 112.356 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.3 156.31 39.46 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.096 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 73.9 p -137.74 147.74 45.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 0.0 109.089 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.7 m-85 -128.56 158.19 39.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -154.96 139.2 16.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.57 135.68 37.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 29.4 m -129.44 131.61 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.524 -0.735 . . . . 0.0 109.771 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t -102.51 -2.65 28.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.098 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' C ' HH22 ' A' ' 17' ' ' ARG . 96.8 mt-10 -140.72 152.51 45.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 86.8 177.71 49.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -83.81 134.58 34.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.169 -1.195 . . . . 0.0 109.881 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.93 135.18 41.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.361 -0.837 . . . . 0.0 109.287 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.41 -41.69 94.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.07 116.52 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.559 -0.713 . . . . 0.0 110.232 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.471 ' SD ' ' OE2' ' A' ' 19' ' ' GLU . 34.9 mtt -103.33 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -121.75 127.96 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.628 -0.67 . . . . 0.0 109.201 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.8 p -145.34 153.44 41.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.09 141.06 36.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.1 170.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.005 -1.059 . . . . 0.0 110.733 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.01 139.85 50.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.394 0.616 . . . . 0.0 110.408 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.02 -144.08 0.64 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.6 t0 -62.84 136.66 57.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.672 -0.899 . . . . 0.0 110.042 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.41 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -139.89 52.98 1.68 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HG2' ' NH1' ' A' ' 69' ' ' ARG . 56.8 mtt-85 53.24 55.14 9.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 33.9 t0 -145.13 162.18 37.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.213 -0.929 . . . . 0.0 109.217 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 72.0 m-20 -89.58 8.87 29.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.113 -0.992 . . . . 0.0 109.1 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -134.64 69.4 72.25 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.452 -0.78 . . . . 0.0 109.23 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -72.34 148.01 48.25 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.7 1.6 . . . . 0.0 112.581 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -78.13 137.03 37.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -0.826 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -104.71 66.49 0.78 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.95 -171.0 48.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.76 -9.47 1.21 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.775 0.983 . . . . 0.0 112.176 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 -178.15 46.61 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.52 -167.3 53.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.575 ' HB3' HG12 ' A' ' 173' ' ' CGS . 10.0 p-10 -72.76 156.92 38.43 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.165 -1.197 . . . . 0.0 109.666 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.67 -19.25 22.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.86 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.69 163.8 10.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.037 -1.04 . . . . 0.0 108.752 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.42 -175.52 5.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.104 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.44 172.37 13.47 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.144 -0.972 . . . . 0.0 109.643 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.83 158.96 15.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.348 -0.845 . . . . 0.0 109.409 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.91 149.13 81.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.49 103.64 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.496 0.798 . . . . 0.0 112.149 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.43 171.61 35.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.1 -177.95 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.971 1.114 . . . . 0.0 111.758 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.91 -127.49 43.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -78.44 -7.23 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.293 -1.122 . . . . 0.0 110.24 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 142.4 47.74 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -14.8 61.15 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -67.95 157.91 33.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -1.229 . . . . 0.0 109.9 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.83 118.18 8.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 109.851 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -98.54 144.68 27.59 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.124 -0.985 . . . . 0.0 110.698 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 19.1 m-85 -119.93 137.55 53.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.21 121.02 13.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -97.81 -2.72 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -76.09 -19.27 58.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.83 158.92 15.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.804 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -87.16 117.59 26.01 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.86 147.44 23.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.532 -0.73 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.5 p -130.08 161.07 31.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -108.06 31.06 5.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.736 . . . . 0.0 109.547 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.3 p30 -149.95 -164.99 2.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.945 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 43.1 t80 -80.87 32.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.082 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -76.01 -163.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.962 . . . . 0.0 109.918 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -49.69 -59.0 4.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.537 -0.727 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.42 129.89 55.67 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.994 -1.066 . . . . 0.0 110.949 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 98.1 m-20 -101.97 107.15 18.2 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.238 -0.914 . . . . 0.0 108.542 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.79 -41.48 87.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 111.055 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.474 ' CE1' HG11 ' A' ' 146' ' ' VAL . 23.3 t-160 -59.9 -41.55 91.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.994 -1.067 . . . . 0.0 109.945 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.452 ' NH2' ' CE1' ' A' ' 140' ' ' TYR . 45.3 ttp180 -60.24 -40.28 89.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.45 -39.57 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.21 82.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 0.0 109.215 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.93 78.95 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 109.701 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.4 ' ND1' ' O27' ' A' ' 173' ' ' CGS . 3.6 t-160 -69.16 -49.85 53.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 78.6 mt-10 -59.83 -40.54 88.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.48 -38.7 90.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 108.897 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.26 -41.14 86.35 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -63.7 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.264 . . . . 0.0 108.635 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.0 m -70.48 -25.1 63.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.7 mt -83.13 -1.94 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.5 76.76 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.85 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.08 130.65 35.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.808 -1.407 . . . . 0.0 109.279 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.2 m -88.03 173.53 8.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.3 156.49 37.61 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.803 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -130.32 158.15 40.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -100.08 7.29 44.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.863 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -78.61 132.2 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 133' ' ' GLY . 20.1 tt -60.4 -38.25 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 111.257 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -79.8 -1.61 87.32 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.339 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 129.49 35.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.806 -1.409 . . . . 0.0 109.49 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.43 -26.58 65.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.033 -1.042 . . . . 0.0 109.065 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.1 mmm -73.89 50.06 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.578 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' C ' ' H ' ' A' ' 139' ' ' SER . 18.3 t80 -68.08 135.81 91.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.85 14.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 CA-C-N 120.289 1.139 . . . . 0.0 112.569 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 137' ' ' TYR . 79.5 p -163.98 172.52 13.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 109.76 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CE1' ' NH2' ' A' ' 114' ' ' ARG . 58.3 t80 -83.37 143.8 30.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.392 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.0 p -141.91 136.93 30.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.207 -0.933 . . . . 0.0 109.584 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -69.02 -29.51 67.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 t -98.83 129.44 45.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.025 -1.047 . . . . 0.0 109.928 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.24 112.27 0.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.78 156.24 25.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -1.181 . . . . 0.0 108.646 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 113' ' ' HIS . 81.6 t -85.06 88.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -147.0 143.46 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.42 136.44 40.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.61 166.44 12.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.04 -39.19 85.09 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.81 -42.34 93.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.346 -0.846 . . . . 0.0 108.995 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -72.22 -43.12 64.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.569 -0.707 . . . . 0.0 109.822 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -49.99 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.012 -1.055 . . . . 0.0 109.369 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.76 -39.29 93.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.4 -51.54 53.79 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.261 -0.899 . . . . 0.0 111.393 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 157' ' ' GLN . 8.9 tp -69.26 -38.48 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.676 -1.485 . . . . 0.0 109.547 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.9 mt-30 -65.77 -38.65 89.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.088 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.24 94.83 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 0.0 109.278 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.09 -51.21 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.51 -65.31 0.97 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.29 179.28 34.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -86.6 156.42 20.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -1.146 . . . . 0.0 108.639 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 m -74.89 84.43 2.21 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -81.26 34.53 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.656 -0.653 . . . . 0.0 109.837 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -154.16 75.53 5.96 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.805 . . . . 0.0 108.902 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -82.1 74.17 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.674 1.583 . . . . 0.0 111.541 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.09 131.73 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -126.04 80.15 68.26 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 120.912 1.075 . . . . 0.0 112.184 -179.042 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.575 HG12 ' HB3' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.342 0.591 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.1 mm? -78.01 158.74 29.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.2 p -89.63 156.2 18.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.196 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -72.18 136.71 46.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.48 -169.32 53.52 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -82.64 149.86 61.52 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.218 -1.166 . . . . 0.0 109.361 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.69 -168.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 120.493 0.796 . . . . 0.0 111.916 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -141.33 164.35 30.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.867 . . . . 0.0 108.722 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -80.27 115.7 19.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.349 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.63 -10.41 57.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.85 . . . . 0.0 109.597 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.97 149.51 28.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.139 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.46 -3.69 49.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.523 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 88.6 m-70 -127.37 139.32 52.94 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 49' ' ' PHE . 86.5 mt -130.34 153.04 49.1 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.23 -0.919 . . . . 0.0 108.961 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.9 p -126.23 154.41 43.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -142.4 160.0 41.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -148.46 129.99 14.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.219 -0.926 . . . . 0.0 109.801 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.72 118.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.88 -40.22 94.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -163.66 154.26 15.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.812 -1.18 . . . . 0.0 110.404 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -98.78 138.19 36.29 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.259 -0.901 . . . . 0.0 108.901 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 t -71.85 145.95 89.95 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.349 -0.845 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.1 -14.62 45.21 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.442 0.836 . . . . 0.0 111.786 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 -39.86 88.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.8 mt -135.62 150.18 71.29 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.5 Cg_endo -67.83 -173.34 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.493 0.855 . . . . 0.0 111.847 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 ptt-85 -88.16 -37.45 16.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.842 . . . . 0.0 110.443 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.01 89.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.923 -1.111 . . . . 0.0 109.516 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.28 -39.8 74.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 26' ' ' PRO . 65.6 t -70.46 -47.09 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 109.931 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.7 t0 -60.02 -41.11 91.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.501 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -60.05 -45.72 91.92 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 0.0 109.13 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.03 83.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.21 -40.45 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.907 . . . . 0.0 110.077 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.9 tt0 -69.88 -38.79 76.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.52 -40.09 90.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.37 98.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.885 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' ' CD2' ' A' ' 49' ' ' PHE . 26.4 m-85 -60.0 -40.18 88.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.163 . . . . 0.0 109.72 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 4.1 mp0 -60.11 -40.02 88.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.839 -1.163 . . . . 0.0 109.633 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.1 -40.58 90.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.876 -1.14 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -74.91 -44.04 50.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.2 t -69.42 -34.8 75.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.241 -0.912 . . . . 0.0 110.493 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -56.91 -28.09 61.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 110.107 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 45' ' ' THR . 30.0 m -110.82 5.28 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.379 -0.826 . . . . 0.0 110.694 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' NE2' ' A' ' 157' ' ' GLN . 41.9 p -141.42 146.14 40.94 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.58 7.81 0.87 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.813 1.009 . . . . 0.0 111.702 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.71 156.87 37.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.917 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.523 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 22.2 p -134.55 151.67 51.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -130.89 150.9 51.84 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.326 -0.858 . . . . 0.0 110.291 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -155.8 135.22 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.253 -0.904 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -77.04 146.57 37.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.71 135.36 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.56 -0.712 . . . . 0.0 109.155 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -97.54 -4.2 38.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 109.841 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.4 150.44 36.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.073 -1.017 . . . . 0.0 109.364 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.44 169.62 40.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.649 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 4.7 pm0 -81.3 152.93 27.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -1.174 . . . . 0.0 109.19 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.31 155.45 21.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.36 -0.837 . . . . 0.0 108.91 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.02 -40.28 88.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.687 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.36 116.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.375 -0.828 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp -99.97 134.4 42.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.867 . . . . 0.0 109.38 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.85 129.18 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.525 -0.734 . . . . 0.0 109.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.8 p -147.3 155.94 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.11 139.31 39.97 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.88 162.48 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.36 -0.838 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -129.1 134.56 48.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.725 -0.609 . . . . 0.0 109.886 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.94 -136.42 3.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -70.41 124.45 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.54 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -138.11 66.65 1.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.518 -0.739 . . . . 0.0 109.786 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.3 mtm-85 56.98 48.54 15.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.88 155.2 44.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 108.751 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.61 8.45 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.6 m -137.93 75.39 42.22 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.299 -0.876 . . . . 0.0 109.524 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.74 163.59 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.307 1.338 . . . . 0.0 112.533 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -78.73 151.8 31.89 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.655 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -104.69 67.85 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.71 -167.12 21.04 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -58.1 -15.24 22.08 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.233 1.288 . . . . 0.0 111.919 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.54 -179.95 47.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.11 -163.65 34.67 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 121.042 -1.27 . . . . 0.0 110.163 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -74.54 150.33 39.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.491 -1.005 . . . . 0.0 109.525 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.36 -11.91 36.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.087 -1.008 . . . . 0.0 109.816 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.82 174.98 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.005 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.62 121.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.96 -1.087 . . . . 0.0 110.38 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.01 170.47 11.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.692 -0.63 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -106.5 149.48 27.06 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.8 149.07 66.13 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.199 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.67 102.73 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.792 0.995 . . . . 0.0 112.135 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 179.24 36.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.78 -177.62 3.26 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.443 1.429 . . . . 0.0 112.787 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.07 -120.72 23.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.89 -13.58 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.482 -1.01 . . . . 0.0 110.388 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.87 146.06 39.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.28 -18.63 35.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.58 161.69 22.56 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -1.113 . . . . 0.0 109.692 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.4 122.93 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -102.8 134.05 46.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.03 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.59 131.35 56.72 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -63.8 118.79 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -100.25 0.78 40.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.249 -0.907 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -74.05 -16.06 61.05 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.44 156.32 18.03 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -84.72 117.45 23.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 108.977 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.14 148.56 25.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 26.7 p -128.2 165.31 20.7 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.494 -0.754 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -117.02 29.14 8.09 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.766 HD22 ' NE ' ' A' ' 108' ' ' ARG . 26.9 p30 -146.33 -161.42 1.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.199 -0.938 . . . . 0.0 109.739 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -83.01 31.69 0.43 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.766 ' NE ' HD22 ' A' ' 106' ' ' ASN . 65.8 mtm180 -76.34 -162.7 0.26 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.823 -1.173 . . . . 0.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.72 -56.99 14.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 111.866 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 94.2 m-85 -106.87 128.69 54.51 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.948 -1.095 . . . . 0.0 111.176 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -101.2 115.34 30.26 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.97 -40.03 75.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.982 . . . . 0.0 111.053 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -60.36 -44.58 95.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.774 -1.204 . . . . 0.0 111.249 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -59.95 -42.38 93.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.746 -1.221 . . . . 0.0 109.682 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.92 -40.92 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.073 -1.017 . . . . 0.0 108.771 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -42.56 94.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.104 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.7 93.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.647 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.468 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 7.2 t60 -69.65 -40.16 76.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.878 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.02 -40.88 90.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.044 -1.035 . . . . 0.0 108.886 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.97 -40.01 96.42 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.74 -40.07 92.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -64.28 -37.49 87.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.035 -1.274 . . . . 0.0 108.509 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -70.01 -24.29 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.24 1.2 49.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.58 15.76 77.25 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.5 128.0 32.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.899 -1.353 . . . . 0.0 109.016 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.3 m -87.59 174.32 8.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -69.17 159.82 32.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.626 -0.671 . . . . 0.0 110.466 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -125.24 162.32 24.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.609 -0.682 . . . . 0.0 109.576 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -99.79 1.27 42.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.308 -0.87 . . . . 0.0 109.324 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 48.7 t0 -82.14 116.15 21.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.195 0.998 . . . . 0.0 108.971 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.97 -24.66 30.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.329 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.22 -4.1 88.39 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.88 144.62 29.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -1.221 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 87.0 mt -61.01 -35.26 76.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 72.0 mmm -70.37 54.82 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 109.666 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.3 t80 -70.14 132.38 88.24 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -45.5 -57.11 2.31 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.392 1.176 . . . . 0.0 111.165 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -100.68 175.8 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.483 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 65.7 t80 -84.93 125.69 32.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.836 -1.165 . . . . 0.0 110.475 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.2 p -149.01 160.02 43.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.38 -0.825 . . . . 0.0 109.297 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 28.7 p90 -99.98 120.49 39.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.8 t -88.32 -75.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 108.624 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -173.74 -103.76 0.17 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 33.3 p-10 -86.7 156.91 19.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -1.17 . . . . 0.0 108.804 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.48 105.47 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -149.28 152.36 35.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.234 -0.917 . . . . 0.0 108.623 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.96 145.12 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.924 -1.11 . . . . 0.0 108.812 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.77 163.7 14.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.099 -1.001 . . . . 0.0 109.45 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 109.211 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -59.17 -40.69 86.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.802 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -72.54 -40.24 66.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 109.889 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.8 -49.81 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.127 -0.983 . . . . 0.0 109.602 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.88 -39.91 91.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.959 -1.088 . . . . 0.0 109.962 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.63 -54.09 24.46 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.974 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -63.67 -39.87 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.735 -1.45 . . . . 0.0 109.621 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.953 ' NE2' HG22 ' A' ' 45' ' ' THR . 15.9 mm-40 -67.85 -36.89 81.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.4 94.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.793 -1.192 . . . . 0.0 109.381 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.19 -49.79 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.209 -0.932 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.95 -61.33 1.38 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.203 -0.935 . . . . 0.0 110.092 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.42 -175.97 41.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.5 mtt-85 -93.25 140.12 29.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -1.035 . . . . 0.0 109.551 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 165' ' ' ASN . 30.1 m -69.83 92.7 0.7 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.503 -0.879 . . . . 0.0 108.656 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -63.19 34.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.625 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' A' ' 163' ' ' SER . 22.6 m120 -153.19 74.02 6.84 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.418 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -80.22 73.58 5.95 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.551 1.501 . . . . 0.0 112.217 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 58.9 t -89.99 121.97 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.39 -0.818 . . . . 0.0 108.991 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -67.4 151.48 97.11 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 108.977 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 120.805 1.003 . . . . 0.0 112.261 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 1.3 mm? -59.98 -48.61 81.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.88 -1.138 . . . . 0.0 108.326 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.4 p -101.07 133.03 46.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.459 -0.776 . . . . 0.0 109.096 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -78.75 117.13 19.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.121 -0.987 . . . . 0.0 109.242 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.1 -92.82 0.21 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -150.69 87.53 4.76 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.15 -1.206 . . . . 0.0 109.771 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -56.03 111.28 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.148 1.232 . . . . 0.0 113.235 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 8' ' ' ARG . 51.7 mtm-85 -94.86 164.76 12.78 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.739 -0.601 . . . . 0.0 110.363 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -79.86 123.85 28.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.71 -9.93 58.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.088 -1.007 . . . . 0.0 110.517 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -85.77 148.08 26.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 109.973 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 p -95.8 -4.12 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.502 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 90.0 m-70 -121.58 129.34 52.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.21 155.56 43.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.493 -0.754 . . . . 0.0 109.869 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -128.33 151.41 49.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.411 -0.805 . . . . 0.0 109.6 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -142.2 160.58 39.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.358 -0.839 . . . . 0.0 109.803 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -150.69 134.37 16.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.301 -0.875 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.42 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 81.7 mt -87.73 119.61 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.8 -39.77 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -160.21 155.35 24.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.377 -0.827 . . . . 0.0 109.519 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -100.22 131.19 46.3 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 t -70.55 141.41 87.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.806 -1.184 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -65.75 -6.22 13.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.578 0.885 . . . . 0.0 111.544 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -60.19 -40.17 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -140.49 151.32 63.52 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.35 179.51 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.475 0.848 . . . . 0.0 111.338 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -85.77 -35.78 20.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.158 -0.964 . . . . 0.0 109.357 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.32 75.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.027 -1.045 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.55 -40.05 70.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.771 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.11 -40.57 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.015 . . . . 0.0 109.623 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.57 -42.87 93.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 109.189 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.37 -42.34 95.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.812 . . . . 0.0 108.911 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.41 95.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -0.834 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.74 -40.09 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 108.643 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.06 -40.76 74.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -60.04 -35.04 74.24 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.271 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HA ' ' HE1' ' A' ' 113' ' ' HIS . . . -68.32 -45.84 71.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -60.2 -40.32 89.65 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.869 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -60.08 -40.3 89.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 110.176 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 40' ' ' LEU . 83.4 mt -59.93 -43.03 95.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.505 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -73.2 -40.29 64.87 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 110.131 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.6 t -67.96 -35.25 78.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.723 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.71 -34.44 69.46 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 110.182 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 45' ' ' THR . 30.5 m -107.97 10.7 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.965 -1.084 . . . . 0.0 111.558 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 HG23 ' A' ' 44' ' ' VAL . 66.6 p -145.34 148.45 37.61 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 120.757 -1.214 . . . . 0.0 109.634 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.57 9.68 0.92 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.823 1.016 . . . . 0.0 112.187 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.35 158.22 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 109.457 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 67.5 p -136.22 149.87 48.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.21 157.04 43.57 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.414 -0.803 . . . . 0.0 110.241 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.09 126.69 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 63.4 tttp -74.46 138.97 43.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.178 -0.951 . . . . 0.0 108.923 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.58 135.06 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 t -97.99 -1.4 42.77 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.23 -0.919 . . . . 0.0 110.587 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.9 158.41 43.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.093 . . . . 0.0 109.259 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 173.17 46.27 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -79.02 137.89 37.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.241 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.47 139.82 32.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 108.939 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.18 -41.65 93.33 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.7 mt -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mtt -105.48 132.09 52.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.563 -0.711 . . . . 0.0 109.753 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.7 131.27 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.1 p -146.61 159.55 43.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -110.55 139.42 45.81 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.43 168.7 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.271 -0.893 . . . . 0.0 111.229 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 66' ' ' GLY . 80.8 mtm180 -131.94 140.53 49.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.799 -0.563 . . . . 0.0 109.655 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 41.55 -144.25 0.79 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.28 136.69 55.31 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.931 . . . . 0.0 108.957 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.616 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.5 p-80 -138.32 50.59 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 0.0 109.726 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 57.6 50.01 11.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.717 -0.614 . . . . 0.0 110.053 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 77.8 m-20 -137.05 167.57 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.31 -0.869 . . . . 0.0 109.24 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -88.94 10.0 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 108.998 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.5 m -138.11 73.19 45.33 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -72.0 146.35 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.837 1.025 . . . . 0.0 111.612 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.86 149.21 31.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.062 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -128.17 74.16 1.53 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.29 173.72 46.58 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -50.91 -12.21 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.304 1.336 . . . . 0.0 112.438 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.72 177.23 44.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -157.31 28.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.62 ' CG ' HG12 ' A' ' 173' ' ' CGS . 72.4 m-20 -75.98 145.57 40.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -1.135 . . . . 0.0 109.531 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.12 -15.62 29.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 108.707 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.91 170.39 6.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 109.152 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -161.41 176.38 11.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.914 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.17 168.86 18.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.123 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -105.07 142.27 35.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.757 . . . . 0.0 109.732 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.73 149.01 81.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.03 -1.044 . . . . 0.0 109.062 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.92 109.86 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.701 0.934 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.34 -179.72 29.03 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.46 141.48 20.09 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 120.997 1.131 . . . . 0.0 112.812 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.99 -125.39 7.19 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.285 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.64 -9.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.84 -0.8 . . . . 0.0 110.203 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.31 139.76 48.17 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.74 -13.28 63.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -66.78 160.15 26.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.906 -1.35 . . . . 0.0 110.035 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.12 116.57 6.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -0.851 . . . . 0.0 109.058 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -98.77 153.29 18.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 21.0 m-85 -121.87 140.45 52.38 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -65.75 120.77 13.6 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -99.52 -7.54 25.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.637 -0.664 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -75.69 -12.61 60.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -105.07 149.92 25.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.194 -0.941 . . . . 0.0 108.788 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -83.33 122.09 28.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 109.493 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -89.22 152.56 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.54 -0.725 . . . . 0.0 110.026 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.8 p -120.96 169.49 10.42 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -109.68 27.39 9.62 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.451 HD22 ' HG3' ' A' ' 108' ' ' ARG . 12.2 p30 -149.04 -165.02 2.17 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.815 . . . . 0.0 110.209 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.1 t80 -84.54 33.87 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.917 0.865 . . . . 0.0 109.989 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.451 ' HG3' HD22 ' A' ' 106' ' ' ASN . 24.2 mmt-85 -76.76 -162.46 0.27 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.831 -1.168 . . . . 0.0 110.005 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -55.02 -57.65 10.86 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.697 -0.627 . . . . 0.0 110.995 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -97.27 118.75 34.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -109.2 106.13 15.87 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.05 -44.18 69.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.865 -0.522 . . . . 0.0 110.044 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.531 ' HE1' ' HA ' ' A' ' 37' ' ' ALA . 3.3 t60 -60.5 -47.38 86.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -60.07 -40.79 90.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -70.29 -39.26 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.149 -0.969 . . . . 0.0 108.763 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.9 -43.97 94.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.953 -1.092 . . . . 0.0 109.488 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.08 78.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.107 -0.995 . . . . 0.0 109.208 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.519 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.8 t60 -69.95 -50.61 40.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.427 -0.795 . . . . 0.0 110.29 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.2 mt-10 -58.95 -41.5 87.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.914 -1.117 . . . . 0.0 109.153 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.75 -40.44 97.27 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.948 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.48 -41.98 82.46 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -65.42 -34.42 78.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.034 -1.274 . . . . 0.0 108.452 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.3 p -68.42 -19.44 64.59 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.71 -2.63 58.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.65 20.36 56.38 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.47 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.9 137.64 35.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.507 -1.584 . . . . 0.0 108.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -87.0 164.37 16.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -67.27 151.83 46.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.7 t -124.83 168.76 12.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.694 -0.629 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.5 p -107.42 9.98 29.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.449 -0.782 . . . . 0.0 109.951 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.11 130.37 35.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.032 -1.042 . . . . 0.0 109.771 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.4 -40.7 84.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 111.36 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.38 -5.12 85.37 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 121.094 -1.003 . . . . 0.0 110.747 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.69 130.26 35.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.811 -1.405 . . . . 0.0 109.889 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.491 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 93.9 mt -63.33 -22.96 67.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.3 mmt -70.54 35.86 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.693 -0.629 . . . . 0.0 109.627 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.4 t80 -70.71 128.94 90.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.014 -1.053 . . . . 0.0 108.925 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -52.8 -66.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.844 1.337 . . . . 0.0 111.765 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.5 p -82.65 173.94 11.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.96 . . . . 0.0 110.405 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -81.2 130.54 35.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.963 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -152.01 -169.48 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 54.7 p90 -97.22 133.33 42.0 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 81.3 p -114.0 14.71 18.46 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.541 -0.724 . . . . 0.0 109.39 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.56 -119.34 13.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -83.72 153.93 23.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -1.233 . . . . 0.0 109.966 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.16 90.72 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 109.138 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -143.6 157.46 44.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.068 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.6 145.03 43.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.037 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 161.53 14.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.247 -0.908 . . . . 0.0 109.633 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -60.14 -42.51 95.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -58.38 -41.03 83.9 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.571 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.37 -42.08 62.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.837 -1.164 . . . . 0.0 109.48 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.71 -49.97 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 108.772 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.18 -40.27 93.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 109.868 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.51 -55.34 29.46 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.484 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.4 tp -67.56 -39.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.246 . . . . 0.0 110.561 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 90.7 mt-30 -67.56 -41.5 84.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.063 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.02 94.78 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.8 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.63 -0.669 . . . . 0.0 109.718 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.08 -66.84 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.8 -175.83 36.6 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -86.95 149.7 24.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -0.999 . . . . 0.0 109.231 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.3 m -77.21 64.89 2.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 0.0 110.41 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -96.28 131.08 43.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 108.839 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.835 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 52.0 m-20 -156.69 -34.87 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.497 -0.752 . . . . 0.0 111.846 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.835 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 24.2 Cg_endo -87.09 86.15 0.78 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 CA-C-N 120.571 1.24 . . . . 0.0 112.002 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 167' ' ' VAL . 0.5 OUTLIER -87.85 117.89 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.182 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.646 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 0.1 OUTLIER -75.59 -35.04 1.69 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.074 -1.016 . . . . 0.0 111.236 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 5.5 Cg_exo . . . . . 0 N--CA 1.486 1.063 0 CA-C-N 119.72 0.936 . . . . 0.0 111.403 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.62 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.0 tp -152.41 66.05 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.216 -0.928 . . . . 0.0 109.268 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.1 p -93.73 -179.38 4.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 0.0 109.822 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -70.49 140.45 51.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.892 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.06 -142.91 38.65 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -80.97 146.11 58.53 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.163 -1.198 . . . . 0.0 108.305 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.39 162.75 13.92 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 120.748 0.965 . . . . 0.0 112.516 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 8' ' ' ARG . 40.6 mtm-85 -148.39 156.48 42.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -83.79 122.59 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.037 -1.039 . . . . 0.0 109.936 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 47.6 mp0 -75.15 -30.17 60.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.387 -0.82 . . . . 0.0 109.763 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -81.58 154.51 26.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 p -98.25 -4.5 35.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.897 . . . . 0.0 109.214 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 82.5 m-70 -111.58 131.58 55.15 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -134.19 157.99 44.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 p -124.2 155.63 38.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.346 -0.846 . . . . 0.0 108.824 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.47 158.64 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -154.31 134.98 13.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.23 123.74 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 0.0 108.831 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.46 -40.25 85.34 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.023 -1.048 . . . . 0.0 111.343 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -160.28 159.15 31.02 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.81 -1.182 . . . . 0.0 109.861 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -102.51 139.78 37.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 142.19 63.43 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.23 -11.7 32.41 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 CA-C-N 119.457 0.842 . . . . 0.0 112.188 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.26 -38.94 85.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' ND2' ' A' ' 105' ' ' ASN . 90.3 mt -134.73 153.47 78.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -60.69 -179.95 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 CA-C-N 119.461 0.843 . . . . 0.0 111.428 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 33.3 ptt180 -87.91 -35.48 17.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.91 -37.57 79.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 110.258 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.82 -34.83 60.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.84 . . . . 0.0 111.034 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.17 -49.82 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.77 -1.207 . . . . 0.0 109.965 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 12.3 p-10 -60.03 -37.08 78.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.751 -1.218 . . . . 0.0 109.62 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -59.13 -48.6 81.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.908 -1.12 . . . . 0.0 109.406 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.68 91.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.055 -1.028 . . . . 0.0 109.612 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.5 mm -72.28 -31.02 37.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.324 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -66.65 -41.65 87.87 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.07 -28.78 65.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.857 -1.152 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.59 -48.18 80.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.913 -1.117 . . . . 0.0 109.007 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.6 m-85 -62.67 -40.43 97.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.686 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -60.12 -43.52 95.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.099 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.61 -43.95 93.57 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.82 -1.175 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.422 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.3 m95 -70.34 -40.8 73.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.275 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.4 t -69.5 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 110.579 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -59.72 -27.37 66.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.968 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.62 9.56 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 O-C-N 120.971 -1.081 . . . . 0.0 110.492 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 22.5 p -149.19 150.49 32.0 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.926 -1.109 . . . . 0.0 109.658 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -69.68 9.33 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.643 0.895 . . . . 0.0 111.533 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.27 151.18 44.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.225 -0.922 . . . . 0.0 109.068 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.435 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 71.2 p -134.66 148.53 50.38 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 96.6 m-85 -129.9 155.45 46.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.8 m -154.69 134.52 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.455 -0.778 . . . . 0.0 109.534 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -77.34 145.93 37.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.16 132.81 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.642 -0.662 . . . . 0.0 109.733 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 t -96.74 -9.16 29.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -141.9 156.34 45.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 108.878 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.9 171.46 47.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.33 134.82 35.64 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.667 -0.902 . . . . 0.0 109.767 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.86 143.67 26.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.946 -1.096 . . . . 0.0 109.282 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -40.67 89.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.85 119.09 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.521 -0.737 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.9 mtt -103.38 135.86 44.21 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.021 -1.049 . . . . 0.0 109.807 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.45 130.87 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.3 p -149.98 156.1 41.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.752 -1.218 . . . . 0.0 110.708 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.6 138.44 45.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.37 164.46 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.228 -0.92 . . . . 0.0 111.304 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -134.3 145.54 49.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.81 -147.03 2.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -73.77 125.72 28.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.45 -1.03 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -127.62 53.69 1.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 69' ' ' ARG . 61.1 mtt-85 56.61 50.03 13.54 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -139.18 158.36 44.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.19 -0.944 . . . . 0.0 109.658 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -89.12 10.47 21.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 109.751 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -137.81 72.51 48.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.12 146.64 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 120.843 1.029 . . . . 0.0 112.26 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD2' ' OD2' ' A' ' 98' ' ' ASP . 90.5 m-85 -76.26 148.47 37.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.368 -0.833 . . . . 0.0 108.987 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -132.57 72.88 1.5 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.382 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.27 -170.21 42.64 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.01 -16.25 54.49 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.197 1.264 . . . . 0.0 111.727 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.15 49.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.66 -165.97 46.71 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.736 ' CG ' HG12 ' A' ' 173' ' ' CGS . 97.1 m-20 -76.4 142.1 41.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' OE2' ' A' ' 101' ' ' GLU . 50.9 mt -90.79 -12.36 36.67 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.61 157.33 8.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.362 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.61 177.76 10.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.315 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.78 161.73 23.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -92.71 156.03 17.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.11 149.78 65.46 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.377 -0.827 . . . . 0.0 108.967 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -59.17 106.87 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.61 0.873 . . . . 0.0 111.984 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.2 176.93 38.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -69.2 173.06 11.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.318 1.345 . . . . 0.0 112.029 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.75 14.45 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -83.93 -11.79 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -1.066 . . . . 0.0 109.841 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 140.03 38.02 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.28 -20.33 34.36 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.77 128.75 37.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.028 -1.277 . . . . 0.0 110.717 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.34 24.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.773 . . . . 0.0 109.09 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -130.07 132.44 46.17 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.5 136.4 54.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.385 -0.822 . . . . 0.0 110.095 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.438 ' OD2' ' CD2' ' A' ' 74' ' ' PHE . 13.9 t0 -65.77 124.31 22.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.291 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -101.18 0.27 37.31 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.68 -15.21 60.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.048 -1.032 . . . . 0.0 110.068 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' OE2' HD22 ' A' ' 81' ' ' LEU . 99.9 mt-10 -106.93 164.23 12.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -88.34 118.37 27.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.116 -0.99 . . . . 0.0 109.902 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.97 148.65 23.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.108 -0.995 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.5 p -124.94 173.53 8.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.529 -0.732 . . . . 0.0 109.666 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' ND2' HD22 ' A' ' 25' ' ' LEU . 83.9 m-20 -112.34 23.63 13.42 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.401 0.62 . . . . 0.0 109.445 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.73 HD22 ' HD2' ' A' ' 108' ' ' ARG . 19.8 p30 -147.27 -165.0 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -87.87 20.88 2.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.73 ' HD2' HD22 ' A' ' 106' ' ' ASN . 96.1 mtt180 -75.83 -165.73 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.283 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' ARG . 72.5 mm-40 -11.16 -69.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 123.023 0.529 . . . . 0.0 112.41 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -131.8 128.83 39.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -89.9 108.7 19.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 108.627 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.18 -40.16 78.27 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.451 ' ND1' ' C ' ' A' ' 113' ' ' HIS . 17.8 t-80 -59.98 -46.45 89.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.788 -1.195 . . . . 0.0 110.067 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -60.22 -41.91 94.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.004 -1.06 . . . . 0.0 110.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.75 -41.13 79.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.853 -1.154 . . . . 0.0 108.85 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.92 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.82 91.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.441 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 33.8 t60 -70.31 -39.97 74.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.989 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -58.66 -40.01 82.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.177 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.0 -39.74 95.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.56 -42.05 65.64 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -62.26 -36.63 82.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.987 -1.302 . . . . 0.0 108.411 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.9 t -69.22 -24.49 64.02 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.6 -4.87 58.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 0.0 109.436 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.03 15.97 58.48 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.91 129.1 34.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.016 -1.285 . . . . 0.0 109.716 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.499 ' O ' ' SD ' ' A' ' 136' ' ' MET . 68.5 m -87.79 165.52 15.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 109.276 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -66.04 160.6 23.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.093 . . . . 0.0 108.788 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -127.21 166.22 18.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.44 -0.788 . . . . 0.0 109.405 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.3 p -100.53 7.32 44.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.336 -0.853 . . . . 0.0 108.988 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -83.26 116.44 22.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.53 -27.86 41.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.577 -0.702 . . . . 0.0 110.422 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.96 -5.76 89.48 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.298 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.45 156.08 24.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.284 . . . . 0.0 109.79 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 89.6 mt -69.6 -29.53 67.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.764 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 127' ' ' SER . 5.6 mtt -74.0 61.95 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.85 126.92 92.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -47.98 -71.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.485 1.209 . . . . 0.0 110.835 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.5 p -94.44 170.15 9.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 108.982 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -84.61 137.62 33.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.062 -1.024 . . . . 0.0 108.511 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.7 p -148.6 -141.91 0.12 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.119 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -57.83 139.28 54.47 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.994 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.8 m -101.2 120.18 39.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.256 -0.903 . . . . 0.0 109.088 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.47 -153.62 27.84 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 42.3 t0 -80.85 154.1 27.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -1.204 . . . . 0.0 109.726 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.543 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 51.8 t -84.82 98.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 109.681 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -144.78 154.94 43.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.82 145.78 34.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.4 156.24 18.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 109.524 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.16 -39.74 87.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 109.039 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 56.8 t0 -57.93 -39.63 78.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.506 -0.746 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 156' ' ' ILE . 96.1 m-20 -76.34 -40.71 50.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.952 -1.092 . . . . 0.0 109.519 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.5 -50.12 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.256 -0.902 . . . . 0.0 109.265 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.02 -40.06 90.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.085 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.99 -51.63 38.29 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.3 tp -65.75 -40.2 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.008 -1.289 . . . . 0.0 109.486 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.1 mt-30 -65.29 -39.68 92.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.289 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.15 92.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.056 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.72 -49.98 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.057 . . . . 0.0 109.819 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.827 -1.17 . . . . 0.0 109.574 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.23 -165.96 33.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.57 138.64 33.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -1.21 . . . . 0.0 109.849 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.4 m -75.05 84.45 2.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.17 112.65 24.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.775 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 14.7 m120 -156.59 -35.01 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.003 -1.061 . . . . 0.0 112.66 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.775 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 8.0 Cg_endo -80.41 48.59 2.93 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 CA-C-N 120.88 1.35 . . . . 0.0 111.201 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.75 125.44 41.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.552 -0.718 . . . . 0.0 109.384 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.509 HE22 ' C ' ' A' ' 166' ' ' PRO . 24.2 mp0 -124.6 79.26 62.56 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 0.0 109.101 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.492 1.434 0 C-N-CA 120.783 0.989 . . . . 0.0 112.714 -179.719 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.736 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.0 mp -60.86 -39.99 91.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.777 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.1 p -93.69 163.51 13.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -72.21 141.61 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.099 -1.0 . . . . 0.0 109.289 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.91 -161.85 43.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.77 138.41 46.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.122 -1.222 . . . . 0.0 108.631 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.35 -171.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 119.795 0.963 . . . . 0.0 112.144 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -144.37 161.25 39.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.366 -0.834 . . . . 0.0 108.784 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -81.3 120.93 25.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.0 109.017 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.74 -14.82 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.69 149.26 27.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.736 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -94.49 -4.61 47.82 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -129.15 141.33 51.21 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -131.99 159.91 37.38 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.2 -0.938 . . . . 0.0 109.883 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.5 p -127.9 155.1 44.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.454 -0.779 . . . . 0.0 109.51 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.58 157.97 43.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -148.49 137.67 21.82 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.236 -0.915 . . . . 0.0 110.066 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.15 119.96 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.5 tt0 -64.98 -39.98 94.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.078 . . . . 0.0 110.365 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.8 m-20 -158.62 151.15 21.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.981 -1.074 . . . . 0.0 109.784 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.13 134.11 40.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 108.978 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -70.1 135.84 87.12 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -66.54 -10.66 28.65 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.769 0.953 . . . . 0.0 111.848 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.12 149.99 74.24 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.83 -177.77 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 CA-C-N 119.485 0.852 . . . . 0.0 111.429 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -87.26 -29.9 21.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.021 -1.049 . . . . 0.0 109.757 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.87 88.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.9 -39.14 76.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.89 -40.9 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.418 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.95 -43.18 95.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.995 . . . . 0.0 109.011 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -59.99 -43.59 95.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.209 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.36 77.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -70.13 -40.06 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.377 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.09 -39.9 75.27 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 109.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.61 88.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -60.1 -39.79 87.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.432 HE21 ' HG2' ' A' ' 35' ' ' GLU . 77.5 mt-30 -59.34 -43.43 92.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.968 -1.082 . . . . 0.0 109.638 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.93 -44.36 97.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.407 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.1 m95 -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.984 -1.072 . . . . 0.0 110.322 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 t -69.81 -39.84 76.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.87 -18.09 54.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.168 -0.958 . . . . 0.0 111.115 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.02 4.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.15 -0.969 . . . . 0.0 109.775 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.516 ' N ' ' OG ' ' A' ' 163' ' ' SER . 6.5 p -146.44 151.18 42.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.231 -0.918 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -69.32 4.82 1.79 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.823 1.015 . . . . 0.0 111.7 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.85 150.16 46.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 p -129.85 149.37 51.61 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.01 157.6 37.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.427 -0.796 . . . . 0.0 109.683 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.06 129.14 8.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.935 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -76.39 138.02 40.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 m -121.12 133.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.466 -0.771 . . . . 0.0 109.354 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -97.77 -0.07 45.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -143.26 150.17 38.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.182 -0.949 . . . . 0.0 109.658 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 165.07 30.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -81.58 137.81 35.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -1.1 . . . . 0.0 109.308 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.0 151.85 21.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.98 -42.91 95.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.858 . . . . 0.0 109.717 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -104.39 109.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.404 -0.81 . . . . 0.0 109.397 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtp -101.94 136.76 41.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.286 -0.884 . . . . 0.0 109.684 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.77 132.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.66 -0.65 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.5 p -147.02 150.46 35.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.24 140.45 38.37 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 109.254 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.7 168.82 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -131.88 138.47 48.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.672 -0.642 . . . . 0.0 109.372 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.65 -151.35 1.11 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.3 t0 -65.24 134.89 54.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.615 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.0 p-80 -132.55 51.26 2.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.725 . . . . 0.0 109.627 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 61.9 mtp180 57.38 53.31 7.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.642 -0.661 . . . . 0.0 110.627 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 92.5 m-20 -142.27 169.99 16.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -89.43 9.49 26.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -138.9 72.42 40.92 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.15 152.31 31.03 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.33 1.353 . . . . 0.0 112.017 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -77.81 137.46 38.43 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.268 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -102.23 68.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.0 109.478 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 178.42 39.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.25 -21.03 6.34 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.252 1.301 . . . . 0.0 112.325 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.63 -178.84 45.09 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.02 -153.35 24.52 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.721 ' OD1' HG12 ' A' ' 173' ' ' CGS . 96.4 m-20 -76.81 142.28 40.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -1.118 . . . . 0.0 109.807 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.3 mt -91.53 -15.16 29.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.99 174.86 4.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 108.9 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 2.6 p80 -161.96 117.34 1.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.197 . . . . 0.0 110.428 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.0 171.11 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.12 148.64 70.6 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 0.0 109.353 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.59 108.21 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 120.598 0.865 . . . . 0.0 111.738 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.62 171.26 41.49 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.976 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -65.93 171.61 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.228 1.286 . . . . 0.0 111.548 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.84 -125.94 16.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.14 -6.79 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.363 -1.081 . . . . 0.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.53 141.59 48.0 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.72 -16.27 54.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.76 163.46 21.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -1.074 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.09 117.73 8.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -0.776 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -101.35 135.55 42.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.453 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.1 m-85 -116.85 129.05 55.83 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' GLU . 62.3 t0 -68.06 128.75 37.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.248 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 69.5 tt0 -100.01 2.53 43.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.278 -0.888 . . . . 0.0 109.418 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.13 -16.78 60.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 54.0 mp0 -94.44 155.62 16.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.075 -1.016 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -85.16 115.12 22.76 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.59 145.46 25.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.105 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.9 p -120.31 171.51 8.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.11 26.08 9.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -151.0 -166.98 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -90.7 32.69 0.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.286 -0.884 . . . . 0.0 110.52 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 9.0 mtp-105 -75.57 -156.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.841 -1.162 . . . . 0.0 109.652 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -36.86 -59.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.714 -0.616 . . . . 0.0 111.379 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.0 m-85 -123.09 128.96 50.83 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.079 -1.013 . . . . 0.0 110.249 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -108.52 110.37 21.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.381 -0.825 . . . . 0.0 109.186 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.4 -41.12 96.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.184 -0.947 . . . . 0.0 110.41 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 110.362 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 141' ' ' THR . 70.4 ttt180 -59.94 -41.16 91.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.047 -1.033 . . . . 0.0 109.944 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.9 -40.19 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 109.541 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.18 94.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.948 . . . . 0.0 108.992 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.33 83.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -69.98 -48.31 58.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.955 . . . . 0.0 109.609 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 82.8 mt-10 -59.95 -40.01 87.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.6 mt -62.88 -39.8 95.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.257 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.65 -41.45 82.28 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -64.87 -39.17 93.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.8 p -69.99 -21.4 63.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.587 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.93 -3.24 59.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 0.0 109.219 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 9.86 60.85 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.64 124.58 30.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.103 -1.234 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 65.4 m -87.96 171.08 10.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.287 -0.883 . . . . 0.0 109.723 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.5 153.0 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.8 t -126.61 168.93 13.65 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.0 109.391 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.3 p -102.85 9.53 38.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -0.813 . . . . 0.0 109.561 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -82.47 123.86 29.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.519 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.71 -31.46 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.374 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.62 -4.3 90.19 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.652 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.11 129.77 35.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.858 -1.377 . . . . 0.0 109.404 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.92 -24.94 67.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 108.967 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.9 mmm -73.17 46.98 0.19 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.421 -0.799 . . . . 0.0 109.651 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -69.76 129.95 90.71 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -48.4 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 120.343 1.158 . . . . 0.0 111.78 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.5 p -86.62 171.9 10.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -85.15 138.29 32.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.143 -0.973 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.521 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 80.8 p -147.55 165.1 31.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -74.37 135.94 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.0 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.421 ' CB ' ' NH1' ' A' ' 114' ' ' ARG . 14.0 t -127.83 140.13 52.22 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.521 -0.737 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.43 -101.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.51 139.46 31.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.144 -1.209 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.8 t -86.99 111.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -0.957 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.47 157.16 44.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 108.913 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.407 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.0 mt -75.85 149.93 37.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.104 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.88 158.57 15.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -60.01 -39.48 85.95 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 108.809 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -57.82 -41.44 82.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.957 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.23 -40.35 62.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.147 . . . . 0.0 110.081 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.36 -50.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.93 -40.12 92.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.57 -55.2 24.29 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.397 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.01 -39.99 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.839 -1.389 . . . . 0.0 109.815 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.8 mt-30 -64.92 -38.5 91.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.681 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.13 92.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.16 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.97 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -98.1 -72.77 0.64 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.42 -0.8 . . . . 0.0 109.564 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.21 -165.06 35.24 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -91.47 139.88 30.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.98 . . . . 0.0 109.694 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 45' ' ' THR . 16.6 m -76.26 84.58 3.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 109.094 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -97.25 123.81 41.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.838 . . . . 0.0 109.333 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -152.5 150.17 24.37 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.88 103.6 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 120.677 0.918 . . . . 0.0 111.976 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.18 123.77 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 0.0 109.635 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.91 149.91 92.68 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.221 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.49 1.311 0 CA-C-O 117.957 -0.935 . . . . 0.0 111.92 179.592 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.721 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.51 -41.46 97.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.285 -0.884 . . . . 0.0 108.939 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 p -130.24 139.74 50.76 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.694 -0.629 . . . . 0.0 109.318 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -75.16 130.0 38.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.3 -138.84 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -82.78 146.04 51.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -1.092 . . . . 0.0 109.107 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.92 171.94 6.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.527 0.818 . . . . 0.0 111.802 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 8' ' ' ARG . 54.0 mtt-85 -87.57 -176.73 5.68 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.51 117.52 21.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.724 -1.235 . . . . 0.0 108.64 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -82.93 -10.5 58.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -84.44 149.55 25.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -96.06 -4.42 43.02 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -126.76 141.24 51.89 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.7 mt -135.74 158.33 44.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -129.39 154.03 47.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -141.39 160.59 39.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.442 -0.786 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -147.17 132.54 18.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.163 -0.961 . . . . 0.0 110.095 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.68 120.62 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.07 -40.16 94.27 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.988 -1.07 . . . . 0.0 109.839 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -160.19 157.14 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.082 -1.011 . . . . 0.0 109.741 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.71 136.83 40.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 109.196 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 t -68.5 141.22 92.99 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.004 . . . . 0.0 109.0 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.72 -10.81 29.47 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 119.5 0.857 . . . . 0.0 112.146 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.44 HD13 ' ND2' ' A' ' 105' ' ' ASN . 65.0 mt -135.47 151.33 74.46 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.71 -178.7 0.57 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 120.64 0.894 . . . . 0.0 111.257 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -86.72 -35.94 18.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.184 -0.948 . . . . 0.0 110.046 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.11 73.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.97 -39.9 75.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.29 -42.26 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.88 -40.38 88.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.02 -1.05 . . . . 0.0 108.911 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.83 -48.69 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.579 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.4 92.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.585 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.22 -43.24 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 109.937 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.36 -39.76 77.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.205 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -61.15 -39.88 91.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.18 87.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 109.993 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.8 m-85 -60.13 -39.99 88.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.05 . . . . 0.0 109.316 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -59.96 -41.06 91.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.168 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.13 -41.11 91.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -72.3 -40.02 67.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.35 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.26 -37.23 77.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 0.0 110.089 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -57.85 -21.76 44.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.209 -0.932 . . . . 0.0 110.743 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.93 5.66 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.3 p -147.0 150.38 38.54 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 120.975 -1.078 . . . . 0.0 109.534 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.12 5.3 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.688 0.925 . . . . 0.0 110.997 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.86 160.3 33.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.462 -0.774 . . . . 0.0 110.073 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 p -139.36 153.83 47.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.5 m-85 -130.02 152.02 49.93 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.515 -0.741 . . . . 0.0 109.585 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.3 m -153.31 131.32 11.79 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.283 -0.886 . . . . 0.0 110.33 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -79.5 139.11 37.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.54 136.1 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.346 -0.846 . . . . 0.0 108.842 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -96.89 -8.59 30.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.126 -0.984 . . . . 0.0 110.011 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -145.51 159.97 42.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 109.586 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 172.22 44.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.16 146.27 31.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -1.222 . . . . 0.0 109.494 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.77 145.72 33.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.65 -0.656 . . . . 0.0 109.422 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -117.27 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.497 -0.752 . . . . 0.0 108.978 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.1 mmm -100.09 122.05 42.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.271 -0.893 . . . . 0.0 109.778 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -112.1 129.77 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.254 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.6 p -149.81 161.5 42.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.137 -0.977 . . . . 0.0 109.676 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -109.01 138.39 45.43 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.365 -0.835 . . . . 0.0 110.692 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -133.11 145.45 50.72 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.41 -140.54 4.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -77.74 134.6 38.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.366 -1.079 . . . . 0.0 110.184 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.6 p-80 -136.46 64.55 1.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.525 -0.734 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 69' ' ' ARG . 18.8 mtt-85 54.48 47.48 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.411 -0.806 . . . . 0.0 110.091 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 91.7 m-20 -141.52 165.05 28.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -95.61 9.92 38.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.342 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 67.86 73.59 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.547 -0.721 . . . . 0.0 109.723 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.61 147.29 86.18 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.044 1.162 . . . . 0.0 112.488 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.65 145.44 34.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -138.25 79.92 1.77 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.64 173.37 36.57 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.41 -7.35 19.94 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.147 1.231 . . . . 0.0 111.676 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.88 174.44 47.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.45 -160.54 31.77 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.528 ' CG ' HG12 ' A' ' 173' ' ' CGS . 81.9 m-20 -76.51 144.66 39.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -1.097 . . . . 0.0 109.586 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.93 -15.43 29.8 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.99 -1.069 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.89 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -0.965 . . . . 0.0 108.926 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.14 121.2 3.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.801 -1.187 . . . . 0.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.17 172.63 10.39 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.284 0.564 . . . . 0.0 109.693 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -113.58 147.86 37.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -59.91 149.01 75.1 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.34 112.46 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.811 1.008 . . . . 0.0 112.197 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.52 172.9 43.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -73.27 161.61 42.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.352 1.368 . . . . 0.0 112.29 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.63 -119.5 5.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.66 -11.39 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.171 . . . . 0.0 109.857 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.28 144.39 47.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.06 -15.55 48.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -67.36 162.11 23.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.89 120.46 12.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.275 -0.891 . . . . 0.0 109.099 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -104.75 134.13 48.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.271 -0.893 . . . . 0.0 110.785 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.93 130.91 57.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 56.5 t0 -67.19 123.91 21.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 99' ' ' GLU . 13.9 tp10 -102.11 0.32 34.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.508 -0.745 . . . . 0.0 109.622 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 96.5 m-20 -73.88 -19.56 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 108.886 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.51 155.7 17.7 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 102' ' ' ARG . 32.1 ttt-85 -86.03 121.59 28.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.02 148.71 24.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.5 p -127.11 156.57 41.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.358 -0.839 . . . . 0.0 109.9 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.44 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -107.36 30.95 5.78 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -148.43 -164.99 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -84.31 33.87 0.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.57 -163.37 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.405 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -54.17 -59.32 4.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.398 -0.814 . . . . 0.0 111.935 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.36 130.01 54.84 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.138 -0.976 . . . . 0.0 110.755 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -102.82 117.85 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.21 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.11 -49.34 67.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -59.86 -40.29 88.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 111.508 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 28.1 mmt180 -60.01 -41.27 91.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.686 -1.259 . . . . 0.0 109.611 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.96 -40.01 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 108.645 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.99 89.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.533 -0.73 . . . . 0.0 109.35 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.41 93.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.198 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.3 t-160 -69.98 -46.61 64.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -59.13 -40.51 85.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.005 -1.059 . . . . 0.0 109.556 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.62 -35.71 81.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 108.819 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.77 -40.46 96.66 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -66.93 -38.27 85.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.589 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.0 p -69.5 -23.13 63.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.237 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.89 -2.3 58.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.186 -0.946 . . . . 0.0 109.143 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.49 65.66 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.69 128.29 34.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.339 . . . . 0.0 108.714 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.74 173.8 8.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 109.954 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -67.15 158.51 31.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -127.75 156.67 42.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.54 -0.725 . . . . 0.0 109.59 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.4 p -100.98 8.4 43.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.539 -0.726 . . . . 0.0 109.708 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -81.0 130.04 34.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 109.257 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.98 -39.79 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.331 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.41 72.6 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.238 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.53 137.87 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.686 -1.479 . . . . 0.0 109.146 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.16 -25.17 66.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -0.807 . . . . 0.0 109.021 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 66.5 mmm -74.09 62.04 0.88 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.394 -0.816 . . . . 0.0 109.043 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.1 129.44 87.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 108.852 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -48.21 -59.9 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.404 1.18 . . . . 0.0 111.829 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 t -102.98 173.25 6.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.451 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 74.1 t80 -85.77 138.81 31.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.808 -1.183 . . . . 0.0 109.0 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 p -154.03 -171.87 4.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 109.905 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 44.3 p90 -61.44 130.18 44.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.1 p -92.81 156.64 16.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.522 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . -104.82 -127.62 6.04 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' C ' ' NH2' ' A' ' 114' ' ' ARG . 36.6 p-10 -85.06 152.17 23.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.072 -1.252 . . . . 0.0 108.7 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.21 89.74 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.105 . . . . 0.0 109.927 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -150.03 154.17 37.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 109.049 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.78 146.96 39.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 108.954 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.4 161.47 14.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.475 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.26 -39.92 88.49 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.0 -41.53 87.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -74.08 -40.09 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.14 -50.16 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.61 -39.87 89.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.12 -60.94 7.51 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.777 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.2 tp -60.25 -39.93 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.341 . . . . 0.0 109.274 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.5 mt-30 -65.73 -38.09 88.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 109.035 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.95 95.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.69 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.2 -50.12 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.194 -0.941 . . . . 0.0 109.2 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -96.96 -71.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 109.578 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.94 -177.57 38.96 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.56 146.42 24.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.3 m -76.41 77.54 3.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -100.3 125.06 46.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.451 -0.78 . . . . 0.0 109.494 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -154.5 75.48 5.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.022 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -83.29 52.57 3.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.368 1.379 . . . . 0.0 111.373 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.9 126.82 41.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 108.886 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -125.94 79.65 68.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 109.544 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo . . . . . 0 N--CA 1.491 1.333 0 CA-C-O 117.949 -0.938 . . . . 0.0 112.11 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.528 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.265 0.555 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.2 mp -60.05 -40.08 88.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 0.0 109.557 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.9 p -91.66 160.19 15.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 109.886 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -75.83 130.06 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.16 -168.28 44.53 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 149.77 70.3 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.143 -1.21 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.73 128.71 25.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 CA-C-N 119.33 0.796 . . . . 0.0 111.399 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 8' ' ' ARG . 36.6 mtt-85 -91.55 166.1 13.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.1 126.03 30.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.173 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.35 -12.99 53.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 110.103 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -81.66 153.62 26.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.6 p -97.42 -6.28 34.31 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.302 -0.874 . . . . 0.0 108.82 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -126.64 143.78 51.12 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.2 159.58 39.76 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.194 -0.941 . . . . 0.0 109.859 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.5 p -127.54 152.98 46.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -142.86 156.11 44.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.722 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.8 ttt-85 -150.21 131.8 14.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 0.0 109.86 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.96 118.47 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.59 -40.05 95.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 0.0 110.735 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -162.5 153.15 17.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.953 -1.092 . . . . 0.0 109.901 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.62 136.53 38.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.86 139.58 88.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.002 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -66.92 -14.05 42.26 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.614 0.898 . . . . 0.0 111.588 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.14 -38.19 82.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.352 -0.842 . . . . 0.0 109.037 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -134.74 149.96 72.15 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.03 -176.96 0.69 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.643 0.896 . . . . 0.0 111.859 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -87.29 -35.34 18.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 109.613 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.1 82.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.09 -40.1 75.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.007 . . . . 0.0 109.773 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.35 -46.08 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.682 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -59.62 -39.99 86.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.782 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -59.93 -46.9 87.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.813 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.4 92.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.206 -0.934 . . . . 0.0 109.827 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.47 -36.87 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 108.657 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.06 -39.96 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.15 -39.91 88.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.82 -1.175 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.54 72.92 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.368 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -62.94 -40.21 96.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.037 -1.04 . . . . 0.0 110.196 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.19 -44.81 94.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.962 -1.086 . . . . 0.0 109.623 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.1 -44.12 95.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.247 -0.908 . . . . 0.0 111.016 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.12 -41.83 73.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.681 -1.262 . . . . 0.0 109.802 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t -69.86 -30.57 68.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 110.359 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 -59.88 -34.36 73.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 111.152 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 45' ' ' THR . 32.9 m -110.01 11.02 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.103 -0.998 . . . . 0.0 111.168 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.488 HG23 HG23 ' A' ' 44' ' ' VAL . 65.0 p -140.91 148.15 51.09 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.898 -1.126 . . . . 0.0 109.367 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.69 9.12 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.572 0.848 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.88 156.42 37.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.5 p -135.39 149.86 49.76 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.4 156.66 40.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.316 -0.865 . . . . 0.0 109.962 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -154.39 131.19 10.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -77.02 143.74 39.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.454 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 134.51 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.2 t -97.25 -4.08 39.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.13 159.06 43.57 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.911 -1.118 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.03 173.07 34.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -81.06 151.15 28.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 108.898 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.33 153.54 23.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.382 -0.824 . . . . 0.0 109.206 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.85 -40.94 90.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.93 119.46 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.642 -0.661 . . . . 0.0 109.389 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.1 mtp -103.82 131.38 51.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.409 -0.807 . . . . 0.0 108.867 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.88 129.38 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -150.52 159.69 44.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.19 137.27 44.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.01 160.09 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 0.0 111.169 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -128.71 137.81 51.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.775 -0.578 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.25 -141.57 3.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.72 126.96 31.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -1.054 . . . . 0.0 109.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -133.65 55.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.616 -0.677 . . . . 0.0 109.345 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 50.9 mtt-85 54.98 52.27 12.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 109.761 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.4 161.28 37.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.99 9.43 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.775 . . . . 0.0 110.379 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.5 t -139.74 72.91 35.21 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 109.106 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.31 152.06 79.76 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.234 1.289 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -77.79 150.33 34.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -129.65 72.42 1.48 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.545 -0.722 . . . . 0.0 109.824 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.11 170.47 38.17 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.5 Cg_endo -65.2 -24.72 58.35 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.366 1.377 . . . . 0.0 112.046 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.62 -177.98 46.7 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.8 -137.68 14.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.783 HD22 ' HB3' ' A' ' 83' ' ' HIS . 59.2 t-20 -76.02 122.15 23.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -1.009 . . . . 0.0 109.83 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.7 mt -90.61 -17.52 26.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.009 -1.057 . . . . 0.0 109.993 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 173' ' ' CGS . . . -170.07 160.42 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.783 ' HB3' HD22 ' A' ' 80' ' ' ASN . 0.7 OUTLIER -160.88 179.99 8.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.946 -1.097 . . . . 0.0 110.269 179.644 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.52 173.32 12.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 109.765 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.25 146.87 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 3.9 mp0 -59.72 146.99 79.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.901 -1.125 . . . . 0.0 108.397 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -51.04 113.32 1.05 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 120.498 0.799 . . . . 0.0 112.646 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.43 -178.3 34.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.05 176.84 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.246 1.298 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.32 -121.55 24.58 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.216 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -78.8 -10.45 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.577 -0.955 . . . . 0.0 110.284 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.37 151.39 13.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.24 -19.17 32.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.06 157.0 36.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -1.098 . . . . 0.0 110.6 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HB1' ' OE1' ' A' ' 119' ' ' GLU . . . -146.67 122.95 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -102.07 146.0 28.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.858 . . . . 0.0 110.667 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.548 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 16.1 m-85 -117.49 138.31 51.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.444 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 7.9 t70 -65.9 118.39 9.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.032 -1.042 . . . . 0.0 108.599 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -97.9 -1.44 42.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 110.052 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.39 -18.61 59.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 77' ' ' PRO . 95.9 mt-10 -97.63 158.1 15.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 109.202 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -86.53 115.14 23.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.97 -1.081 . . . . 0.0 109.703 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 93.3 m95 -90.12 148.5 22.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -127.97 159.4 35.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.437 -0.79 . . . . 0.0 109.115 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -113.73 30.26 7.38 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.429 HD22 ' HG3' ' A' ' 108' ' ' ARG . 30.0 p30 -147.58 -164.4 2.0 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.062 . . . . 0.0 110.722 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 90.7 t80 -73.72 25.68 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.703 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.429 ' HG3' HD22 ' A' ' 106' ' ' ASN . 26.9 mmt180 -76.1 -168.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.612 -1.305 . . . . 0.0 109.904 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.52 -57.74 10.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 112.208 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -99.5 118.57 36.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.685 -1.26 . . . . 0.0 111.431 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -99.48 116.52 31.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.339 -0.851 . . . . 0.0 109.475 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 tp -63.53 -38.45 91.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.428 -0.795 . . . . 0.0 109.688 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG11 ' A' ' 146' ' ' VAL . 13.1 t-80 -59.78 -39.96 86.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 111.16 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 114' ' ' ARG . 7.2 tpt180 -59.4 -43.87 92.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.848 -1.157 . . . . 0.0 109.857 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.77 -39.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.062 -1.024 . . . . 0.0 109.525 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.9 92.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.79 93.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.837 . . . . 0.0 109.617 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.664 ' ND1' HOM2 ' A' ' 173' ' ' CGS . 5.3 t60 -69.89 -46.3 65.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.846 . . . . 0.0 110.882 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.548 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 80.5 mt-10 -59.86 -40.46 88.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.748 -1.22 . . . . 0.0 109.329 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.258 -0.901 . . . . 0.0 108.572 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.27 78.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -65.05 -37.89 89.05 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -1.191 . . . . 0.0 108.716 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.0 p -70.27 -24.74 63.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.52 -2.99 58.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.151 -0.968 . . . . 0.0 108.821 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.77 15.79 62.72 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -82.9 130.16 35.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 m -88.25 169.97 11.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -68.57 156.6 37.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.386 -0.821 . . . . 0.0 109.114 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.6 t -131.96 160.84 34.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.85 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.1 p -99.54 6.81 45.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.329 -0.857 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 59.8 t0 -79.91 131.09 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 96.6 mt -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.459 -0.775 . . . . 0.0 109.988 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.38 -2.74 68.74 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.183 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.95 131.69 34.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.75 -1.441 . . . . 0.0 109.8 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.01 -29.87 67.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.0 mmm -75.59 53.95 0.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.186 -0.947 . . . . 0.0 109.732 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.2 140.27 87.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 4.03 1.01 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 119.949 1.017 . . . . 0.0 111.636 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.2 p -156.95 177.53 11.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.625 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.495 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 84.5 t80 -90.71 135.73 33.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.838 -1.164 . . . . 0.0 110.001 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.2 p -149.74 169.3 21.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -76.66 123.25 25.86 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.259 -0.901 . . . . 0.0 109.046 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.1 m -118.93 132.42 56.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.748 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.48 -112.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 48.9 t0 -82.75 152.28 25.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.136 . . . . 0.0 108.974 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.551 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.8 t -86.37 107.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.427 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -142.54 151.5 41.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.345 -0.847 . . . . 0.0 108.92 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.64 147.85 39.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.119 -0.988 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.94 153.27 19.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.03 -39.33 78.11 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -53.58 -39.98 65.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.145 -0.972 . . . . 0.0 108.484 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -72.76 -39.95 66.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.279 -0.888 . . . . 0.0 108.701 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.42 -50.2 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 0.0 108.769 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.6 -40.05 93.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.76 -55.75 13.37 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.756 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -63.11 -40.19 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.923 -1.34 . . . . 0.0 109.616 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.8 mt-30 -69.6 -38.83 77.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.25 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.57 94.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.112 -0.992 . . . . 0.0 109.38 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.56 -50.06 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.602 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.28 -173.52 40.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -89.06 148.25 23.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m -73.96 88.72 1.87 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -82.51 33.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.515 -0.74 . . . . 0.0 109.245 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -153.45 72.61 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.338 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.32 68.32 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.552 1.501 . . . . 0.0 111.598 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -85.58 134.9 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -71.5 149.11 93.49 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 118.112 -0.87 . . . . 0.0 111.8 179.168 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.664 HOM2 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.1 mp -60.82 -40.69 93.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 p -92.21 162.6 14.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.49 130.52 39.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.54 -169.06 54.68 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.22 148.39 67.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.896 -1.355 . . . . 0.0 109.194 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.63 152.81 71.3 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 120.635 0.89 . . . . 0.0 111.82 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -149.0 159.2 44.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -82.17 124.15 29.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.01 . . . . 0.0 108.852 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -84.31 -14.01 50.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -87.3 147.34 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 110.317 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.6 p -94.64 -4.72 47.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.221 -0.924 . . . . 0.0 108.808 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 66.9 m80 -120.69 133.3 55.36 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt -131.8 156.33 46.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.143 -0.973 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -128.58 155.64 44.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.421 -0.799 . . . . 0.0 109.511 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -147.01 161.33 41.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -149.0 133.96 18.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.403 -0.811 . . . . 0.0 109.973 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.8 mt -89.9 118.52 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 93.4 mt-10 -65.94 -41.32 91.44 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.074 -1.016 . . . . 0.0 109.842 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 70.8 m-20 -158.14 158.0 33.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.04 134.45 44.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -68.89 138.02 90.18 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.801 -1.187 . . . . 0.0 108.648 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -66.09 -8.2 19.4 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.659 0.914 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.98 -39.86 87.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 mt -136.89 148.19 62.13 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -58.47 -177.94 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.646 0.897 . . . . 0.0 111.576 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -86.47 -33.72 20.29 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 0.0 109.614 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.51 89.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.905 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.44 -39.55 74.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -0.929 . . . . 0.0 110.016 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.55 -40.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 108.962 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.41 -43.1 93.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.16 -45.06 94.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.258 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.26 88.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.4 -42.87 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.07 -40.68 74.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.855 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -61.01 -40.1 92.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 108.921 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.14 94.64 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.317 -0.864 . . . . 0.0 110.122 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -61.35 -40.17 93.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.766 -1.209 . . . . 0.0 109.398 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -60.56 -42.25 96.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.42 ' CH2' HD22 ' A' ' 148' ' ' LEU . 90.7 m95 -73.69 -42.51 61.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.037 . . . . 0.0 110.21 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -66.73 -37.97 85.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 110.35 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -57.8 -22.91 49.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.497 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.34 7.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -145.72 149.49 40.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.014 -1.054 . . . . 0.0 109.184 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.92 7.47 1.31 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.615 0.877 . . . . 0.0 111.79 178.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.05 154.98 41.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 43.9 p -133.85 150.05 51.37 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -125.74 159.43 32.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.7 m -154.41 126.63 7.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.38 136.87 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.95 135.11 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.466 -0.771 . . . . 0.0 109.172 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 t -98.21 -4.33 35.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 0.0 110.624 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -142.38 155.36 45.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.893 -1.129 . . . . 0.0 110.111 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 177.39 50.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -82.26 143.48 31.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 108.965 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.77 150.89 25.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.8 -40.38 88.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 108.978 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.4 mt -119.61 118.87 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.717 . . . . 0.0 109.259 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.1 mmm -99.62 130.77 45.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.863 . . . . 0.0 108.878 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.45 130.72 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 160.31 43.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.97 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.7 139.18 42.65 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.58 160.45 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.03 -1.043 . . . . 0.0 111.223 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -129.5 136.69 50.18 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.596 0.712 . . . . 0.0 110.118 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.15 -141.86 2.98 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.76 130.5 43.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -1.053 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -138.18 53.3 1.82 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 109.803 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 53.61 59.64 4.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 108.912 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.95 160.39 43.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.048 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -89.37 9.44 26.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.175 -0.953 . . . . 0.0 109.733 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -136.47 71.06 59.99 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 109.367 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -68.42 144.89 63.24 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.061 1.174 . . . . 0.0 112.018 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -76.93 143.78 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.05 70.33 0.9 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.314 -0.866 . . . . 0.0 108.717 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.27 -165.98 42.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.93 -13.23 8.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.17 1.246 . . . . 0.0 112.597 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.42 -177.98 39.99 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.42 -158.12 28.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.698 ' CG ' HG12 ' A' ' 173' ' ' CGS . 96.6 m-20 -74.87 149.89 39.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.407 -1.054 . . . . 0.0 109.286 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.35 -20.58 19.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.05 -1.032 . . . . 0.0 109.596 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.96 168.62 5.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 108.582 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.29 122.91 1.31 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.541 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.78 168.48 13.46 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.408 0.623 . . . . 0.0 109.408 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.08 153.72 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -59.58 145.36 82.93 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.007 -1.058 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.31 101.44 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 120.441 0.76 . . . . 0.0 111.709 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.64 174.87 35.75 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.28 -179.81 3.42 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 120.878 1.052 . . . . 0.0 111.203 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.47 -127.16 39.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -73.8 -14.33 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.382 -1.069 . . . . 0.0 110.28 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.41 139.45 48.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -16.63 60.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -67.78 160.25 28.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.74 120.86 10.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.052 -1.03 . . . . 0.0 109.227 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -104.31 136.66 43.49 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.664 -0.648 . . . . 0.0 110.427 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -115.81 136.7 52.8 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.667 -0.645 . . . . 0.0 109.615 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.82 118.97 10.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.027 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -99.58 -0.6 40.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 108.778 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.36 -13.04 60.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -105.58 152.17 23.42 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -89.53 120.07 30.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.178 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -84.13 153.5 23.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 -179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.7 p -117.76 164.69 14.62 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.523 0.677 . . . . 0.0 109.621 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.88 28.88 5.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.03 -165.04 2.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.796 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.66 34.04 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.48 -0.762 . . . . 0.0 109.8 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -76.23 -164.32 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -47.72 -57.56 5.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.835 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.91 149.83 23.14 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.727 -1.233 . . . . 0.0 110.767 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -148.36 91.25 1.88 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.0 109.032 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -60.03 -39.83 87.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.195 -0.941 . . . . 0.0 110.818 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.15 -41.22 92.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.732 -1.23 . . . . 0.0 109.773 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.04 -43.0 95.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.955 -1.091 . . . . 0.0 109.759 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.9 t -69.85 -40.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.365 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.69 89.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 108.877 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.446 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 6.2 t60 -68.98 -42.77 76.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 109.847 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.139 -0.976 . . . . 0.0 108.765 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.3 -39.14 93.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.26 85.34 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -65.75 -35.57 81.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.239 . . . . 0.0 108.804 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.8 m -71.65 -28.72 63.95 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 109.892 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.66 -2.54 56.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.84 11.84 67.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -82.27 129.54 34.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.83 -1.394 . . . . 0.0 109.042 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.0 m -88.72 169.93 11.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.873 . . . . 0.0 109.228 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.42 158.97 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.466 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.8 t -124.46 164.65 19.27 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.1 p -99.35 9.67 42.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.032 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -84.84 127.17 34.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.9 -37.33 71.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.507 -0.746 . . . . 0.0 110.598 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.09 1.14 85.99 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 120.981 -1.075 . . . . 0.0 111.45 -178.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.88 138.74 33.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.517 -1.578 . . . . 0.0 109.406 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.52 -29.72 67.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.9 . . . . 0.0 109.679 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.56 54.52 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.6 t80 -71.29 136.69 84.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.871 -1.143 . . . . 0.0 108.643 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.17 9.25 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.908 1.003 . . . . 0.0 112.061 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 36.6 t -164.29 175.89 9.65 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE1' ' O ' ' A' ' 141' ' ' THR . 53.6 t80 -82.26 154.86 25.16 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.221 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.518 ' O ' ' CE1' ' A' ' 140' ' ' TYR . 60.1 p -150.05 -175.47 5.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.426 -0.796 . . . . 0.0 109.499 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -60.07 150.62 28.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 109.749 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.8 p -72.68 160.19 32.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.329 -0.857 . . . . 0.0 109.565 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.51 -152.51 6.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -83.65 132.96 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.92 -1.341 . . . . 0.0 109.584 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.82 98.64 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.807 . . . . 0.0 109.199 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -146.94 149.7 33.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 108.997 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.42 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.5 mt -75.05 142.69 43.72 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.458 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.0 164.28 13.15 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -59.81 -39.34 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -58.43 -40.96 83.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -74.5 -40.48 61.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.81 -50.24 81.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.132 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.25 -40.23 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.439 178.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -56.66 -61.09 7.88 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -63.48 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.3 . . . . 0.0 110.26 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.5 mt-30 -63.76 -39.67 94.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.807 -1.183 . . . . 0.0 109.495 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.39 92.75 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.52 -49.01 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -99.48 -62.2 1.27 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.216 -0.928 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.74 -176.47 34.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 148.66 24.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.024 -1.28 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.1 m -74.96 67.42 1.68 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.52 99.94 10.61 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -156.33 78.91 4.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -80.46 41.02 1.06 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 120.905 1.07 . . . . 0.0 111.482 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.7 m -85.75 135.62 24.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -74.62 149.34 86.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 N--CA 1.491 1.353 0 CA-C-O 118.014 -0.911 . . . . 0.0 112.466 -179.871 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.698 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.746 HD22 ' H ' ' A' ' 2' ' ' LEU . 2.7 mm? -62.6 -41.97 99.29 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 38.2 p -100.48 143.26 30.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 110.202 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -80.38 95.57 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.811 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 23.47 77.39 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.367 178.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' OG1' ' A' ' 3' ' ' THR . 7.9 m120 -154.37 69.45 6.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.56 -1.553 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -60.22 152.15 68.3 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.097 1.198 . . . . 0.0 111.789 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -142.44 150.81 41.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -80.29 126.38 31.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 108.706 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.9 -10.06 59.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 109.724 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -79.58 150.09 31.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.9 p -96.74 -3.99 41.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -129.52 138.69 51.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.48 159.97 37.83 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.15 -0.969 . . . . 0.0 110.776 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -126.2 154.04 43.82 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.59 0.709 . . . . 0.0 109.144 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -143.5 156.18 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 109.422 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.4 ttt-85 -149.57 132.25 15.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 109.432 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.425 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 94.3 mt -89.25 121.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.87 -39.67 93.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.114 -0.991 . . . . 0.0 110.226 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -161.55 156.7 23.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -102.02 139.45 37.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.63 -0.669 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 22' ' ' THR . 1.7 t -74.03 145.81 84.07 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.53 -11.8 33.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.919 1.079 . . . . 0.0 111.518 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.1 -40.02 88.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.6 mt -139.06 151.6 68.23 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.186 -0.946 . . . . 0.0 108.523 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -62.94 -175.27 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 CA-C-N 119.392 0.819 . . . . 0.0 111.93 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.41 -38.85 13.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.18 84.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.53 -39.13 77.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.616 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.97 -42.01 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.02 . . . . 0.0 109.168 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -59.3 -40.48 86.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 108.781 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -60.01 -46.37 89.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.847 . . . . 0.0 109.362 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.0 -39.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.192 -0.942 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.57 -41.56 88.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -60.72 -40.62 92.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.942 -1.099 . . . . 0.0 110.415 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.46 85.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.944 -1.098 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.23 -40.51 96.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.947 -1.096 . . . . 0.0 109.368 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.58 -43.28 97.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.223 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.75 -42.75 93.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.96 . . . . 0.0 110.265 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -70.44 -40.5 73.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.889 -1.132 . . . . 0.0 109.734 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 t -69.77 -32.41 70.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.792 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.02 -33.38 68.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.113 -0.992 . . . . 0.0 111.089 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.44 10.98 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 110.461 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.9 p -146.55 150.36 40.06 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 120.883 -1.135 . . . . 0.0 109.654 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.49 1.44 4.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.744 0.962 . . . . 0.0 111.467 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.01 153.1 44.37 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.406 -0.809 . . . . 0.0 109.275 -179.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.8 p -133.13 149.94 52.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -128.2 149.52 50.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.446 -0.784 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -152.92 133.09 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 62.7 tttp -75.64 144.47 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.732 . . . . 0.0 109.786 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.4 136.58 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t -95.76 -1.47 49.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -145.96 157.18 43.89 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.969 -1.082 . . . . 0.0 109.228 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.78 159.03 13.36 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.07 137.39 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.529 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.15 149.75 22.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.473 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.33 -40.96 92.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.511 -0.743 . . . . 0.0 109.253 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.26 111.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.9 134.93 43.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.59 131.39 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.7 p -149.52 160.66 43.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -0.96 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.81 138.56 46.01 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.3 165.57 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 110.798 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -139.7 153.41 47.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.564 -0.71 . . . . 0.0 110.001 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.81 -148.68 0.38 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.3 130.91 45.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -1.08 . . . . 0.0 108.86 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 9.1 p-80 -136.38 57.08 1.79 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.611 -0.681 . . . . 0.0 109.899 -178.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 53.82 53.71 10.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.131 -0.981 . . . . 0.0 109.932 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' SER . 12.0 t70 -144.75 159.28 43.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.7 m-20 -89.65 9.54 26.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.29 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 70.0 m -136.81 73.24 54.08 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.437 -0.789 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.05 155.82 58.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.04 1.16 . . . . 0.0 112.232 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.47 150.24 34.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.508 -0.745 . . . . 0.0 109.154 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.25 77.55 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.15 -172.42 11.56 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -55.8 -14.42 10.69 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.414 1.41 . . . . 0.0 112.417 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.0 178.21 41.96 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 -153.39 26.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.413 -1.051 . . . . 0.0 110.533 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.522 HD21 ' C ' ' A' ' 82' ' ' ALA . 9.0 t30 -72.62 136.68 45.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.946 -0.738 . . . . 0.0 110.25 -179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -94.3 -19.91 20.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.522 ' C ' HD21 ' A' ' 80' ' ' ASN . . . -168.5 159.06 9.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.925 -1.109 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.06 -179.85 7.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.396 -0.815 . . . . 0.0 109.814 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.47 167.78 19.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.237 -0.915 . . . . 0.0 109.429 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -97.83 153.54 18.23 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.978 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -58.64 149.32 63.05 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 104.59 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 120.723 0.949 . . . . 0.0 111.655 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.68 -179.76 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.87 1.047 . . . . 0.0 111.434 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.06 -123.1 31.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.58 -10.05 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.948 . . . . 0.0 110.218 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.26 139.78 47.45 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.001 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.62 -15.97 52.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 127.37 31.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.857 -1.378 . . . . 0.0 110.093 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.73 127.36 47.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -111.21 138.6 47.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.3 -0.875 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.99 134.44 55.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.671 -0.643 . . . . 0.0 109.652 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 46.2 t0 -67.88 120.09 13.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.57 1.28 43.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -74.56 -19.71 60.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.003 -1.061 . . . . 0.0 109.388 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.317 -0.864 . . . . 0.0 108.96 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 102' ' ' ARG . 28.5 ttt-85 -85.85 120.08 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 108.701 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.448 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 92.8 m95 -89.52 146.64 24.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.805 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.2 p -123.18 161.16 25.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.22 29.44 7.8 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.733 HD22 ' NE ' ' A' ' 108' ' ' ARG . 14.7 p30 -149.03 -164.99 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -80.68 31.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.956 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.733 ' NE ' HD22 ' A' ' 106' ' ' ASN . 61.2 mtm180 -74.57 -166.62 0.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.739 -1.226 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -48.74 -58.49 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.661 -0.649 . . . . 0.0 111.704 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -107.52 129.8 54.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.971 -1.081 . . . . 0.0 110.975 -178.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -102.48 112.67 25.5 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.37 -41.4 76.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.31 -0.869 . . . . 0.0 111.207 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.74 -41.33 90.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.81 -1.181 . . . . 0.0 109.528 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.407 HH11 ' HB2' ' A' ' 143' ' ' SER . 71.7 ttt180 -59.8 -43.45 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.464 -0.772 . . . . 0.0 110.257 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.93 -39.79 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.189 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.1 92.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.225 -0.922 . . . . 0.0 109.067 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.66 92.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.612 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.503 ' ND1' HOM2 ' A' ' 173' ' ' CGS . 3.6 t-160 -66.74 -49.2 66.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 108.892 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 42.5 mt-10 -59.75 -41.44 91.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.76 -37.36 86.31 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 108.231 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.52 -41.88 89.35 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -64.2 -35.91 82.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 108.388 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.6 m -69.03 -26.46 65.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.628 -0.67 . . . . 0.0 109.413 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.36 -4.3 59.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.61 61.62 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.22 128.53 34.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.069 -1.253 . . . . 0.0 109.457 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.7 m -88.6 173.0 8.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 109.701 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 118' ' ' HIS . 66.1 m170 -68.29 157.03 36.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -0.854 . . . . 0.0 109.014 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.7 t -125.01 164.4 20.24 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 64.5 p -97.41 4.34 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 109.318 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -82.07 124.95 30.28 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.949 -1.095 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.3 -39.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 110.387 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 5.65 51.91 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.356 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 142.75 30.42 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.65 -1.5 . . . . 0.0 109.292 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 137' ' ' TYR . 99.0 mt -59.78 -39.48 85.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 109.44 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 31.1 mtp -71.1 67.85 0.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.473 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.5 t80 -71.69 124.89 91.6 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.11 -1.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 CA-C-N 120.488 1.21 . . . . 0.0 113.008 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 50.3 m -167.75 166.96 13.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.071 -1.018 . . . . 0.0 108.486 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.66 136.85 33.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.688 -1.258 . . . . 0.0 108.84 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -148.57 -162.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 108.863 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.45 131.9 51.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.137 -0.977 . . . . 0.0 109.159 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.407 ' HB2' HH11 ' A' ' 114' ' ' ARG . 39.5 t -105.34 125.93 51.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 109.949 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -102.45 -125.44 5.63 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -81.8 135.44 35.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.055 -1.262 . . . . 0.0 109.044 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t -89.62 108.43 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.969 -1.082 . . . . 0.0 109.458 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -148.73 159.44 44.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.806 . . . . 0.0 109.093 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.72 144.49 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.014 -1.054 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 163.16 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.013 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.95 -40.18 88.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -59.63 -41.37 90.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.264 -0.898 . . . . 0.0 109.835 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.24 -40.32 64.75 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.089 -1.007 . . . . 0.0 109.408 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.94 -49.96 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -64.87 -39.76 94.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.559 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.92 -54.72 26.31 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.067 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.43 -38.56 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.996 -1.296 . . . . 0.0 109.377 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -68.05 -34.92 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.106 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.16 88.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.34 -50.56 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.099 -1.001 . . . . 0.0 108.911 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -97.84 -73.69 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.72 . . . . 0.0 109.255 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.49 -169.34 37.74 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.1 mtm-85 -92.28 144.61 25.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.287 . . . . 0.0 109.707 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.8 m -73.63 85.11 1.6 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.254 -0.904 . . . . 0.0 108.914 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -94.94 34.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.31 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -147.4 72.05 11.85 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 0.0 109.947 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -83.17 49.11 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.62 1.547 . . . . 0.0 111.318 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 167' ' ' VAL . 3.3 m -88.2 134.95 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.349 -0.844 . . . . 0.0 109.511 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -72.77 148.9 90.12 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 108.95 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 118.023 -0.907 . . . . 0.0 111.708 179.879 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.503 HOM2 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.303 0.573 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.89 -39.93 91.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.816 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.4 p -137.8 160.02 40.42 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.225 -0.922 . . . . 0.0 109.94 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 6' ' ' ASN . 75.9 tt0 -73.03 169.5 16.85 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.49 20.35 0.05 OUTLIER Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.607 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 4' ' ' GLU . 20.5 m120 -150.25 67.82 8.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.302 . . . . 0.0 108.772 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.0 160.76 32.41 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.357 1.371 . . . . 0.0 112.795 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -145.53 151.71 38.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.428 -0.795 . . . . 0.0 109.007 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -83.8 127.28 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.953 -1.092 . . . . 0.0 108.408 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.18 -10.78 59.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.272 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.466 ' CD ' ' H ' ' A' ' 11' ' ' GLN . 9.8 mp0 -85.79 149.49 25.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.755 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -94.46 -4.12 48.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 108.623 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.44 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 33.7 m-70 -128.88 141.53 51.25 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.9 mt -130.27 153.76 48.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.388 -0.82 . . . . 0.0 109.675 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 p -125.29 155.8 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -144.61 159.91 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -149.29 133.14 17.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.88 120.05 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -65.86 -40.09 91.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.069 -1.019 . . . . 0.0 110.04 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -159.95 155.34 25.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.017 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -99.69 136.83 39.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 t -67.7 139.21 93.64 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.15 -0.968 . . . . 0.0 108.628 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.55 -13.96 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 CA-C-N 119.561 0.879 . . . . 0.0 112.196 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.23 -40.21 89.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 110.393 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.84 149.37 70.41 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.14 -175.92 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 119.304 0.787 . . . . 0.0 111.831 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 15.9 ptm180 -87.38 -32.27 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -56.96 -44.86 83.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 110.15 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.05 -39.8 54.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.011 -1.056 . . . . 0.0 110.159 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.41 -49.51 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 111.179 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 42.3 p-10 -58.98 -39.24 81.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.67 -1.269 . . . . 0.0 109.402 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.4 t60 -59.82 -43.3 94.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 0.0 108.86 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.26 91.5 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.25 -42.63 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -69.99 -39.12 76.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.052 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.31 -40.12 89.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.95 90.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.601 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.5 m-85 -60.08 -40.14 88.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 109.025 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.03 -43.01 95.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.1 -43.95 95.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.703 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -71.2 -42.3 69.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.659 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.2 t -67.75 -32.53 73.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 110.834 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.22 -35.0 72.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 110.72 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.87 14.92 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.283 -0.885 . . . . 0.0 111.122 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 62.2 p -144.66 147.34 35.5 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.833 -1.167 . . . . 0.0 109.139 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.9 6.3 1.75 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.623 0.882 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -72.57 163.76 27.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.227 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 33.3 p -138.89 151.34 46.88 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.96 149.97 52.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.632 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -155.04 129.81 9.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -77.93 142.08 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.405 -0.81 . . . . 0.0 109.922 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.42 134.85 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -97.13 -4.99 38.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.94 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -142.76 151.04 40.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.096 -1.003 . . . . 0.0 109.747 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.63 169.53 42.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.06 146.44 30.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -1.154 . . . . 0.0 109.025 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.79 157.08 18.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.41 -0.806 . . . . 0.0 109.209 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.93 118.09 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.412 -0.805 . . . . 0.0 109.581 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -98.57 128.11 44.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -110.68 129.94 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.4 p -148.41 155.11 40.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.94 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -104.72 139.14 39.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.6 160.09 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.344 -0.847 . . . . 0.0 110.754 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.32 142.46 50.82 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.682 -0.636 . . . . 0.0 109.442 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.79 -140.99 5.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -78.65 128.08 32.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -1.035 . . . . 0.0 109.285 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.588 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.6 p-80 -126.04 56.9 1.4 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 109.872 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 31.1 mmt180 56.4 47.82 18.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.544 -0.723 . . . . 0.0 109.997 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.2 m-20 -138.83 162.89 33.66 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.387 -0.82 . . . . 0.0 108.877 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -89.97 8.76 30.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.942 . . . . 0.0 110.333 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -136.04 73.35 59.02 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -70.02 155.84 64.11 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.164 1.243 . . . . 0.0 112.188 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.91 150.36 32.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -121.94 75.02 1.18 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.546 -0.721 . . . . 0.0 109.438 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.14 -171.27 7.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -53.05 -8.97 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.26 1.307 . . . . 0.0 112.784 -179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.27 46.81 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.83 -171.22 55.09 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -73.83 151.41 40.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.298 -1.119 . . . . 0.0 109.234 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 mt -91.01 -12.53 35.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.984 -1.073 . . . . 0.0 109.72 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.37 163.3 12.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.42 -179.6 7.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -0.817 . . . . 0.0 109.033 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.21 168.98 18.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.99 156.66 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -59.09 150.04 64.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.58 101.38 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 CA-C-N 119.083 0.708 . . . . 0.0 111.398 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.42 175.88 35.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 179.85 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.801 1.001 . . . . 0.0 111.667 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.47 -130.55 40.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -78.83 -7.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -1.19 . . . . 0.0 109.245 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.01 137.35 49.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.21 -15.63 52.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -67.91 124.64 23.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.884 -1.362 . . . . 0.0 109.964 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.13 149.87 21.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -132.9 132.5 42.12 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.427 -0.795 . . . . 0.0 109.668 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.78 135.38 54.09 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.407 -0.808 . . . . 0.0 109.914 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.466 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 56.7 t0 -67.58 121.83 16.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 108.935 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -98.98 0.02 43.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.358 -0.839 . . . . 0.0 109.834 -179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.36 -17.97 60.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.793 -1.192 . . . . 0.0 109.508 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.85 157.82 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -84.42 118.72 24.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.026 -1.047 . . . . 0.0 109.381 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.466 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 97.8 m95 -88.24 147.2 24.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.365 -0.834 . . . . 0.0 109.818 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.7 p -129.51 157.21 42.66 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.83 31.49 5.97 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -145.91 -164.16 1.9 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -178.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.77 30.85 0.36 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 110.21 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 12.9 mmt-85 -76.28 -164.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.92 -56.84 17.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 111.313 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -104.68 119.14 38.29 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.987 -1.07 . . . . 0.0 110.385 -178.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 79.2 m-20 -96.33 112.2 24.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.331 -0.856 . . . . 0.0 110.665 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.962 -1.086 . . . . 0.0 109.71 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 135' ' ' LEU . 20.3 tpt180 -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 -179.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.415 HG13 ' HD1' ' A' ' 173' ' ' CGS . 82.6 t -70.03 -39.39 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.198 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.37 85.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.951 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 109.511 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.44 ' HB2' HOM2 ' A' ' 173' ' ' CGS . 5.3 t-160 -69.98 -48.26 58.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.4 -40.19 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.541 -1.349 . . . . 0.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.48 -31.64 72.94 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.94 -39.64 95.83 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -66.59 -34.49 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -1.082 . . . . 0.0 109.037 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -69.64 -23.24 63.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.225 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.92 -4.94 58.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 109.221 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.91 16.7 59.22 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.35 131.11 35.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.927 -1.337 . . . . 0.0 109.809 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.5 m -88.41 171.56 10.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.989 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -68.59 159.15 32.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.3 t -125.08 157.41 36.35 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.53 -0.731 . . . . 0.0 109.461 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -99.89 3.82 44.73 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.43 126.9 32.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -39.99 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.66 -178.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.37 -1.06 49.89 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.047 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.95 33.15 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.682 -1.481 . . . . 0.0 109.38 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.449 ' CD2' ' NH1' ' A' ' 114' ' ' ARG . 93.6 mt -66.47 -34.43 77.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.776 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 37.7 mtp -75.15 64.95 1.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.945 . . . . 0.0 110.297 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.8 t80 -72.63 137.51 80.39 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 108.859 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.83 7.09 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 119.926 1.009 . . . . 0.0 112.127 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 137' ' ' TYR . 31.1 p -159.0 174.67 14.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 108.704 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.533 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 58.7 t80 -87.45 121.28 29.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.795 -1.19 . . . . 0.0 110.118 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -149.18 160.01 43.74 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 52.0 p90 -99.66 126.29 45.66 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.0 109.077 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 92.2 p -109.8 18.35 20.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.567 -0.708 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.08 -116.42 4.21 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.97 140.39 36.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -1.138 . . . . 0.0 109.849 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.46 117.84 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -148.9 159.0 44.59 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.09 139.85 41.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.963 -1.086 . . . . 0.0 108.765 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.55 164.88 13.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -40.51 89.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.0 -40.08 79.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.187 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.9 -40.9 60.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 109.829 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.06 -50.01 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.103 -0.998 . . . . 0.0 109.57 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.63 -40.01 95.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 110.153 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.15 -55.28 24.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.429 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -67.35 -40.0 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.89 -1.359 . . . . 0.0 110.227 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.8 mt-30 -68.89 -40.1 79.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 0.0 110.085 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.73 94.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.035 -1.041 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.43 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -96.77 -67.82 0.83 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.194 -0.941 . . . . 0.0 109.855 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.1 179.43 38.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.83 148.5 23.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.112 -1.228 . . . . 0.0 109.098 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.5 m -71.64 85.32 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.623 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.37 34.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.784 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -151.76 72.19 8.07 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -81.76 46.94 2.36 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.512 1.475 . . . . 0.0 111.835 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 167' ' ' VAL . 6.4 m -86.24 141.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -72.45 149.48 91.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 117.962 -0.932 . . . . 0.0 112.19 179.471 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.533 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.288 0.566 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.2 mp -60.09 -41.53 92.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 0.0 109.576 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.5 p -90.88 158.19 16.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -71.43 137.48 48.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.049 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.49 -154.72 51.78 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -82.21 148.55 60.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.255 . . . . 0.0 109.242 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.7 132.38 37.39 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.518 0.812 . . . . 0.0 111.638 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 124' ' ' LEU . 23.9 mmm180 -89.44 158.95 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.947 . . . . 0.0 108.692 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.91 122.74 28.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.006 -1.059 . . . . 0.0 108.543 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 58.7 mp0 -84.28 -11.53 56.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 109.905 -179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.42 144.52 29.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 109.211 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -91.67 -3.27 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.556 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.4 m-70 -126.64 142.13 51.63 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.46 156.87 48.0 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.208 -0.933 . . . . 0.0 109.929 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -130.49 154.79 47.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -141.84 159.84 41.41 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -147.09 137.22 23.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.157 -0.964 . . . . 0.0 109.949 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -88.14 119.04 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.513 -0.742 . . . . 0.0 109.025 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -69.9 -39.81 75.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -163.41 150.58 12.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.822 -1.174 . . . . 0.0 110.806 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.81 130.8 44.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.669 -0.644 . . . . 0.0 109.629 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -75.39 145.83 80.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.02 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.2 -9.67 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 CA-C-N 119.452 0.84 . . . . 0.0 111.956 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.96 -40.19 88.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.165 -0.959 . . . . 0.0 109.517 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.8 mt -140.07 151.24 64.53 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 108.952 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.2 Cg_endo -61.75 -175.07 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.805 1.004 . . . . 0.0 112.038 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -88.7 -36.91 15.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.614 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -44.0 91.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.413 -0.804 . . . . 0.0 109.519 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.04 -39.92 75.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.08 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 26' ' ' PRO . 74.8 t -69.85 -40.72 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.672 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -60.15 -40.36 89.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.984 -1.073 . . . . 0.0 108.949 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.86 -45.19 93.26 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.69 89.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mm -72.29 -43.1 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.08 -1.012 . . . . 0.0 109.597 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.53 -39.76 81.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.79 -39.81 90.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 110.25 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.77 83.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.961 -1.087 . . . . 0.0 110.166 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -60.18 -39.69 87.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.996 -1.065 . . . . 0.0 109.032 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.73 -40.18 87.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.925 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.97 -44.96 94.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.001 -1.062 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.479 ' CH2' HD22 ' A' ' 148' ' ' LEU . 93.3 m95 -75.12 -41.81 57.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.226 -0.921 . . . . 0.0 111.132 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -66.77 -38.42 86.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 110.119 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -60.24 -15.87 28.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 111.044 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.71 2.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.96 -1.088 . . . . 0.0 110.504 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 13.1 p -145.49 150.57 44.5 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.054 . . . . 0.0 108.899 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.93 8.15 0.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.673 0.915 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.15 153.42 41.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.556 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 29.2 p -130.34 147.47 52.05 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.27 154.65 45.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.655 . . . . 0.0 109.462 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 m -155.64 133.58 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.486 -0.758 . . . . 0.0 109.87 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.0 135.35 36.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.43 130.72 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.477 -0.765 . . . . 0.0 108.955 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -95.63 0.11 52.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.092 -1.005 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.14 152.78 41.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.35 179.46 51.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.359 -1.083 . . . . 0.0 110.505 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.42 136.95 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.05 -40.21 88.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.212 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -121.52 120.39 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.556 -0.715 . . . . 0.0 109.401 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.9 mtt -100.84 139.19 36.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.38 131.3 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.6 p -151.01 156.11 40.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.119 -0.988 . . . . 0.0 109.949 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -104.35 138.65 40.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.06 160.03 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 O-C-N 121.061 -1.024 . . . . 0.0 110.674 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' CB ' ' A' ' 65' ' ' ARG . 11.5 mtp-105 -129.16 139.79 51.78 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.336 0.589 . . . . 0.0 110.087 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.98 -137.43 2.79 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -73.58 128.43 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.978 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 21.8 p-80 -137.97 65.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 53.21 53.51 11.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -142.69 161.6 37.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 109.106 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.91 9.73 41.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.3 m -138.61 69.68 45.13 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.425 -0.797 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.7 156.05 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.034 1.156 . . . . 0.0 112.292 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -76.6 140.59 41.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -101.76 60.24 0.87 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.545 -0.722 . . . . 0.0 109.613 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.3 179.33 50.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -50.09 -12.22 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.336 1.357 . . . . 0.0 111.927 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.23 178.52 41.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.25 -153.97 25.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.579 ' CB ' HG12 ' A' ' 173' ' ' CGS . 47.4 p-10 -75.16 149.65 38.95 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.353 -1.086 . . . . 0.0 109.415 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.13 -18.02 23.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.649 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.16 167.38 7.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -160.1 173.59 15.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.961 -1.087 . . . . 0.0 109.66 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.41 164.31 22.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.124 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.08 152.24 18.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.179 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -59.71 151.18 63.87 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 109.289 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -53.22 104.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 120.718 0.945 . . . . 0.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.92 174.62 34.56 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.0 172.56 15.23 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.069 1.18 . . . . 0.0 111.699 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.02 -125.33 18.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.82 -10.95 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.567 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.36 148.98 28.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.42 -20.65 10.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.01 151.43 47.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.275 . . . . 0.0 109.236 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.58 123.63 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 0.0 108.78 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -100.89 143.07 31.48 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.635 0.731 . . . . 0.0 110.793 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.4 m-85 -113.85 131.29 56.31 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -65.78 118.45 9.64 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.852 -1.155 . . . . 0.0 108.778 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -99.13 0.74 44.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.18 -16.88 60.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.821 -1.174 . . . . 0.0 109.754 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -101.22 159.16 15.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 109.444 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -85.53 121.13 27.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.228 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.94 147.59 23.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.373 -0.83 . . . . 0.0 109.97 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.5 p -129.89 164.21 24.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.491 -0.756 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -110.33 32.5 5.12 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -149.03 -164.94 2.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 109.371 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -88.72 25.12 1.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 110.019 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -76.71 -161.45 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 110.032 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.0 mt-10 -24.42 -68.7 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -137.27 144.02 42.49 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.967 -1.083 . . . . 0.0 109.912 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -105.02 119.4 38.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.757 . . . . 0.0 109.4 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.88 -40.78 97.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.41 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -59.94 -41.57 92.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.084 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.55 -44.96 93.08 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.082 -1.012 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.03 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.27 92.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.03 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.53 84.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 108.884 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.428 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 4.3 t60 -70.78 -46.4 62.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.838 . . . . 0.0 109.943 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 64.3 mt-10 -59.89 -40.59 89.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.721 -1.237 . . . . 0.0 109.489 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.15 -38.4 91.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.278 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.92 86.88 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.19 -26.81 64.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.267 . . . . 0.0 109.302 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.6 p -71.06 -22.21 62.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.073 -1.017 . . . . 0.0 108.399 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 89.6 mt -85.57 -8.73 58.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.361 -0.837 . . . . 0.0 109.14 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.88 19.28 48.13 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.666 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.93 142.1 32.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.84 -1.388 . . . . 0.0 108.947 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.9 m -87.71 168.39 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.015 -1.053 . . . . 0.0 109.479 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -67.92 153.0 44.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.405 -0.809 . . . . 0.0 109.412 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.5 t -124.11 154.54 39.85 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.1 p -99.99 10.83 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.286 -0.884 . . . . 0.0 109.829 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.5 t0 -83.53 132.91 34.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.925 -1.109 . . . . 0.0 110.143 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 91.8 mt -60.24 -40.04 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.12 -5.72 81.38 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.546 -178.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.55 128.88 34.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.935 -1.333 . . . . 0.0 109.486 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.4 mt -64.31 -25.36 68.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.571 -0.706 . . . . 0.0 109.275 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 47.0 mmm -74.18 45.16 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.115 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.6 t80 -69.55 129.94 91.03 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 108.7 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.473 ' O ' ' HC2' ' A' ' 173' ' ' CGS . 17.9 Cg_exo -46.28 -62.52 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.192 1.104 . . . . 0.0 111.702 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 t -96.97 172.42 7.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -85.11 147.06 26.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 108.819 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -134.35 137.99 44.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.503 -0.748 . . . . 0.0 109.272 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -61.9 -44.09 97.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -80.17 163.76 23.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.188 -0.945 . . . . 0.0 110.474 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 114.99 119.6 3.33 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -82.79 165.53 19.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.122 . . . . 0.0 109.194 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.78 90.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -148.63 151.04 34.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 109.056 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.479 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.0 mt -76.52 142.9 40.72 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.859 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 162.93 13.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 108.735 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -59.83 -40.39 88.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 0.0 109.434 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -58.9 -40.14 83.57 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.521 -0.737 . . . . 0.0 109.642 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.22 -40.87 64.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.095 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.22 -52.81 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.43 -40.13 96.33 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.854 -1.154 . . . . 0.0 110.096 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.8 -55.43 29.86 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.611 -178.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -65.61 -39.96 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.977 -1.308 . . . . 0.0 110.582 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.6 mt-30 -65.64 -39.82 91.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.821 -1.175 . . . . 0.0 109.346 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.59 -44.6 89.87 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.65 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -49.97 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 109.646 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -93.28 -70.1 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.66 -178.66 39.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.94 142.58 27.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.401 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 69.2 m -72.96 84.88 1.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.824 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -89.66 112.96 24.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -153.83 75.28 6.24 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.18 -0.95 . . . . 0.0 109.778 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -82.57 47.37 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.558 1.506 . . . . 0.0 112.151 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.37 131.91 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 0.0 110.072 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -70.06 148.36 96.03 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.213 -0.929 . . . . 0.0 108.66 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo . . . . . 0 N--CA 1.491 1.352 0 CA-C-O 118.082 -0.883 . . . . 0.0 112.352 179.892 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.579 HG12 ' CB ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.76 123.0 41.51 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.208 -0.932 . . . . 0.0 109.021 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.9 p -94.23 148.03 22.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 110.041 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -74.19 139.56 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.483 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.45 -147.41 19.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -84.0 122.53 76.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -1.178 . . . . 0.0 108.989 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -69.92 106.13 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.058 1.057 . . . . 0.0 112.338 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -92.74 161.7 14.43 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -83.12 119.83 25.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.976 -1.078 . . . . 0.0 108.5 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.6 -9.97 59.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 109.5 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -80.3 145.08 32.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.81 -8.87 36.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.494 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 93.5 m-70 -123.22 119.86 31.44 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.08 165.41 12.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.499 -0.751 . . . . 0.0 109.253 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -129.58 155.46 45.77 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -144.13 159.21 43.03 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.144 -0.972 . . . . 0.0 109.078 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' O ' ' A' ' 53' ' ' SER . 70.7 ttt180 -148.76 131.19 15.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.061 -1.024 . . . . 0.0 110.608 -178.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.51 116.81 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.22 -42.96 99.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 110.268 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -162.15 160.85 27.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.0 110.19 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.58 136.64 40.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.602 -0.686 . . . . 0.0 109.333 179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -74.97 142.32 76.11 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.975 . . . . 0.0 108.97 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -61.11 -10.88 16.46 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 CA-C-N 119.527 0.867 . . . . 0.0 111.825 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.89 -40.1 87.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.0 mt -139.04 151.17 67.4 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.69 -171.35 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 119.475 0.848 . . . . 0.0 111.914 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 27' ' ' ARG . 7.1 ptm180 -87.96 -35.43 17.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.57 94.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 109.978 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.02 -39.72 75.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.2 -43.24 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.924 -1.11 . . . . 0.0 109.286 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -59.93 -50.04 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.15 91.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.206 -0.933 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -70.01 -39.82 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 110.159 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.57 -41.23 93.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.019 -1.05 . . . . 0.0 109.844 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -62.42 -40.02 95.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.728 -1.233 . . . . 0.0 110.037 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.66 64.13 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -62.36 -42.51 99.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.842 -1.161 . . . . 0.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mm-40 -60.3 -42.09 94.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.132 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.61 -41.66 90.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 109.91 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -72.79 -40.48 65.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.84 -1.163 . . . . 0.0 109.644 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 t -69.37 -32.97 72.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 110.593 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 17.0 m120 -59.3 -26.1 64.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.234 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.86 7.9 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.238 -0.914 . . . . 0.0 110.668 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -145.95 150.56 42.83 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.883 -1.136 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.62 2.73 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.912 1.075 . . . . 0.0 111.538 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.04 151.62 44.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.265 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.494 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.8 p -137.16 147.01 45.65 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -121.18 120.24 34.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.6 m -96.0 132.48 41.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.465 -0.772 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 128.48 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 108.871 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 52' ' ' VAL . 19.2 m -127.41 129.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.427 -0.796 . . . . 0.0 108.859 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.494 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 40.3 t -99.49 0.29 42.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.9 158.63 43.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.138 -0.976 . . . . 0.0 109.639 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.92 170.4 38.4 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -82.62 130.27 35.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -1.152 . . . . 0.0 109.206 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.67 155.11 17.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -59.98 -39.9 87.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.803 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.9 mt -118.92 120.0 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.7 mmm -99.13 128.6 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.62 126.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.4 p -148.42 157.53 43.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.994 -1.066 . . . . 0.0 110.356 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -107.35 136.85 46.46 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.1 160.38 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.167 -0.958 . . . . 0.0 111.42 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 142.79 49.08 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.26 -147.65 2.59 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.52 128.74 37.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.436 -1.038 . . . . 0.0 109.745 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p-80 -135.97 58.68 1.74 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.43 -0.794 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 69' ' ' ARG . 59.6 mtt-85 55.56 52.92 10.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.485 -0.76 . . . . 0.0 110.426 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.0 p-10 -144.17 160.96 40.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.05 -1.031 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -92.48 12.37 23.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.071 -1.018 . . . . 0.0 110.022 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.6 m -139.37 69.76 39.69 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 109.563 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -70.19 148.65 62.77 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.927 1.085 . . . . 0.0 112.153 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.01 150.03 37.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -125.14 73.97 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.424 -0.798 . . . . 0.0 109.506 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.78 167.41 42.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -54.42 -16.34 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.334 1.356 . . . . 0.0 111.984 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 175.63 40.23 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.99 -151.25 19.99 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.485 ' OD1' HG12 ' A' ' 173' ' ' CGS . 80.4 m-20 -75.99 141.05 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -1.201 . . . . 0.0 109.475 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.6 mt -93.91 -19.69 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.044 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.53 160.54 11.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.903 -1.123 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -160.18 -179.81 8.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.55 167.69 21.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.509 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.65 149.33 21.35 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.09 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -59.96 149.39 73.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -46.88 115.82 1.43 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 120.533 0.822 . . . . 0.0 112.084 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.96 173.9 42.26 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.37 173.95 12.93 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-N 118.157 0.978 . . . . 0.0 111.419 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.19 -120.75 22.27 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.85 -7.35 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.173 -1.192 . . . . 0.0 110.214 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.24 134.25 52.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.5 -11.38 70.19 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.0 124.94 24.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.272 . . . . 0.0 110.068 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.74 126.12 45.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.474 -0.766 . . . . 0.0 109.606 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -107.96 136.85 46.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.563 -0.711 . . . . 0.0 109.627 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -117.33 130.73 56.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.657 -0.652 . . . . 0.0 109.241 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.32 121.55 15.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 109.48 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -100.41 3.75 43.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.381 -0.824 . . . . 0.0 110.17 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -73.73 -18.16 61.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 109.175 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.47 158.43 16.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 108.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -86.9 125.02 33.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.943 . . . . 0.0 109.52 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.49 147.17 23.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.356 -0.84 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.3 p -129.68 158.86 38.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.535 -0.728 . . . . 0.0 109.741 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.03 29.97 7.15 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 15.8 p30 -144.99 -160.5 1.14 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.832 . . . . 0.0 109.447 -178.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -87.97 15.41 7.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.198 -0.939 . . . . 0.0 110.531 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.5 mtt180 -76.47 -167.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.809 -1.182 . . . . 0.0 109.981 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 108' ' ' ARG . 93.9 mt-10 -4.51 -87.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.02 151.68 51.6 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 110.084 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.457 HD21 ' HD2' ' A' ' 114' ' ' ARG . 77.5 m-20 -98.41 115.14 27.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.883 . . . . 0.0 109.391 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.45 -39.22 93.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.008 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -59.06 -42.42 90.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.973 -1.079 . . . . 0.0 109.542 -179.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' HD2' HD21 ' A' ' 111' ' ' ASN . 0.7 OUTLIER -59.9 -39.6 85.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.978 -1.076 . . . . 0.0 109.181 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 82.1 t -68.51 -40.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.05 92.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.024 . . . . 0.0 109.184 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.4 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.995 -1.066 . . . . 0.0 108.716 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -70.38 -48.8 54.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.68 -42.72 93.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.666 -1.271 . . . . 0.0 110.028 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -39.8 93.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.098 . . . . 0.0 108.701 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.97 88.96 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -65.59 -37.47 86.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -1.191 . . . . 0.0 109.171 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -69.86 -20.77 63.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.211 -0.93 . . . . 0.0 108.554 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.25 -0.97 57.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.225 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.43 66.68 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.635 179.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.86 128.68 34.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.896 -1.356 . . . . 0.0 109.082 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -87.97 170.37 11.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.361 -0.837 . . . . 0.0 109.5 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -65.85 155.12 37.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.5 t -125.3 153.71 42.84 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.0 p -99.52 9.87 42.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -82.36 128.37 34.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 108.874 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.04 -40.13 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.22 -2.19 66.16 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.254 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.28 141.19 32.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.712 -1.463 . . . . 0.0 109.201 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.42 -27.84 65.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 29.9 mtp -74.19 52.08 0.45 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.846 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' SER . 22.2 t80 -70.45 137.6 86.23 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -53.32 -1.99 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 119.828 0.974 . . . . 0.0 112.498 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' TYR . 81.4 p -159.94 174.75 13.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.938 -1.101 . . . . 0.0 110.502 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -86.95 137.76 32.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 0.0 109.676 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.3 p -146.88 159.69 43.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -65.68 139.76 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.847 . . . . 0.0 109.327 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -138.37 144.13 40.14 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.286 -0.884 . . . . 0.0 109.883 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.51 -114.14 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.2 t0 -82.01 154.71 25.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -1.186 . . . . 0.0 109.026 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.52 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 86.0 t -89.6 108.02 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.101 -179.502 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -146.9 156.95 43.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.3 mt -75.97 146.63 39.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.883 -1.136 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.46 153.31 19.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.401 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -57.04 -39.94 75.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -53.08 -40.15 63.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.918 -1.114 . . . . 0.0 108.945 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.76 -39.67 66.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.32 -48.03 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.62 -40.09 90.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.727 -1.233 . . . . 0.0 110.514 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -51.46 44.59 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.162 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -66.62 -40.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.874 -1.368 . . . . 0.0 109.767 -179.262 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.3 mt-30 -66.08 -39.97 90.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.09 95.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.032 -1.042 . . . . 0.0 109.814 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -50.13 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.33 -65.41 0.96 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.121 -0.987 . . . . 0.0 109.421 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.34 -170.21 33.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.438 ' NH2' ' OE1' ' A' ' 164' ' ' GLN . 84.8 mtm180 -91.04 142.87 27.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.111 -1.229 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.4 m -73.33 78.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.012 -1.055 . . . . 0.0 109.002 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.438 ' OE1' ' NH2' ' A' ' 162' ' ' ARG . 22.1 mt-30 -100.48 116.58 32.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -155.8 140.67 12.14 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -79.92 41.99 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.023 1.044 . . . . 0.0 112.008 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 88.8 t -90.51 120.23 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.403 -0.811 . . . . 0.0 109.861 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' PRO . 32.5 mt-30 -69.99 150.39 96.29 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 168' ' ' GLN . 20.8 Cg_exo . . . . . 0 N--CA 1.489 1.216 0 CA-C-O 117.958 -0.934 . . . . 0.0 112.227 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.485 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.99 -44.24 94.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 p -145.61 -152.46 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 6' ' ' ASN . 83.3 tt0 -73.2 159.38 33.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.356 -0.84 . . . . 0.0 109.035 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.41 10.28 0.3 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 4' ' ' GLU . 15.9 m120 -145.38 72.61 14.32 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 108.731 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -69.05 -171.24 0.4 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.019 1.146 . . . . 0.0 112.483 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -141.52 170.01 16.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.08 120.91 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 108.82 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.0 -10.01 58.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.37 148.65 29.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.275 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -95.86 -6.07 40.18 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.083 -1.011 . . . . 0.0 108.866 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 15.0 m-70 -130.62 132.57 45.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.238 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' CE1' ' A' ' 49' ' ' PHE . 66.4 mt -121.77 156.03 34.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.7 p -125.7 153.57 43.7 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -144.78 161.06 40.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.77 132.45 13.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.869 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.59 120.03 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -64.96 -40.01 94.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -160.37 150.39 18.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.898 -1.126 . . . . 0.0 109.768 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.25 140.33 30.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . 9.0 t -70.7 137.24 85.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 109.642 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.75 -14.59 45.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.815 0.97 . . . . 0.0 111.792 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.99 -40.1 88.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.2 mt -135.05 149.1 69.37 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.05 -174.01 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 120.545 0.83 . . . . 0.0 112.031 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.43 -36.16 16.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.872 . . . . 0.0 109.739 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.99 -41.18 77.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 108.89 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -39.98 75.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.435 -0.79 . . . . 0.0 109.628 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.04 -43.83 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.982 . . . . 0.0 109.021 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.98 -39.93 87.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.337 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.583 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 57.6 t-80 -59.97 -50.05 75.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.75 89.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 110.763 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.8 mm -70.05 -38.43 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.123 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.38 -41.3 96.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.007 -1.058 . . . . 0.0 109.776 -178.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.583 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 32.7 mttp -64.76 -37.58 88.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 109.994 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.947 -1.096 . . . . 0.0 109.322 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.88 -41.44 97.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 109.02 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.07 -41.53 92.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.831 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.92 -41.8 92.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.018 -1.051 . . . . 0.0 109.621 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -74.57 -40.49 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.04 -1.037 . . . . 0.0 109.946 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -69.86 -35.27 74.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.106 -0.996 . . . . 0.0 110.42 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -57.31 -31.4 65.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 110.435 -178.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.533 HG23 HG23 ' A' ' 45' ' ' THR . 34.3 m -109.53 9.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.308 -0.87 . . . . 0.0 110.208 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 44' ' ' VAL . 72.9 p -140.94 144.91 37.13 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.234 -0.916 . . . . 0.0 108.983 178.719 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.9 2.99 3.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.563 0.842 . . . . 0.0 111.226 178.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.21 153.61 42.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 62.6 p -130.39 143.1 50.56 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.448 ' CE1' HD12 ' A' ' 14' ' ' LEU . 90.4 m-85 -119.16 151.68 37.89 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.515 -0.741 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.9 m -153.34 131.71 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.49 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -77.19 144.88 38.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.439 -0.788 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.53 135.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.496 -0.753 . . . . 0.0 109.072 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -95.36 -6.86 40.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -150.18 159.57 44.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.032 -1.042 . . . . 0.0 109.411 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.14 176.42 51.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -83.81 139.04 32.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -1.096 . . . . 0.0 109.495 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.58 143.79 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.319 -0.863 . . . . 0.0 109.138 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -59.95 -40.09 87.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.011 -1.056 . . . . 0.0 109.348 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.01 118.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.7 mtt -102.45 133.3 47.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.239 -0.913 . . . . 0.0 109.579 179.108 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.25 128.33 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.1 p -147.36 153.13 39.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -101.87 138.54 38.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.24 164.86 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.189 -0.944 . . . . 0.0 110.535 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.8 mtm-85 -139.96 142.45 36.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.67 5.39 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -70.04 127.25 32.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -1.074 . . . . 0.0 109.71 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 19.4 p-80 -136.94 62.29 1.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 69' ' ' ARG . 4.2 mmt-85 56.17 49.99 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.74 . . . . 0.0 109.304 -179.624 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.0 t0 -142.55 148.13 37.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 51.6 p-10 -89.48 9.73 25.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.064 -1.023 . . . . 0.0 109.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -136.24 73.14 58.17 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.555 -0.716 . . . . 0.0 109.161 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.85 166.44 26.36 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.252 1.301 . . . . 0.0 112.207 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -77.95 149.33 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 10.6 t0 -101.88 65.38 1.0 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.278 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.46 170.11 46.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.7 -16.26 29.95 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 120.903 1.069 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.42 -175.78 43.28 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.05 17.21 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.159 -1.2 . . . . 0.0 110.102 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.526 ' OD1' HG12 ' A' ' 173' ' ' CGS . 30.0 t30 -73.83 123.8 24.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.452 -1.028 . . . . 0.0 109.591 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.36 -14.32 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.128 -0.983 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.01 158.45 8.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.911 -1.118 . . . . 0.0 109.737 -179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.14 -178.8 6.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.059 -1.025 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.2 178.49 8.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.92 -178.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -104.33 157.4 17.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.656 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -59.99 149.59 73.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.14 103.99 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.601 0.867 . . . . 0.0 112.286 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.92 168.11 34.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.68 -178.42 1.57 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.045 1.163 . . . . 0.0 111.737 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.18 -123.18 30.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 tt -79.99 -12.8 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.949 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.11 144.18 48.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.52 -16.4 53.67 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -66.9 157.36 33.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -1.215 . . . . 0.0 109.366 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.88 17.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.188 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -102.17 136.06 42.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.75 . . . . 0.0 109.59 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -114.14 129.65 56.62 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.76 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.19 117.8 9.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.181 -0.95 . . . . 0.0 109.126 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -97.7 1.89 49.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 0.0 109.306 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.76 -17.68 61.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 0.0 108.447 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -97.49 158.51 15.44 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.632 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -85.58 120.58 27.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.928 -1.108 . . . . 0.0 108.962 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -90.51 140.0 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 109.539 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.9 p -125.29 170.0 11.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.559 -0.713 . . . . 0.0 109.691 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.37 28.76 8.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.617 HD22 ' HD2' ' A' ' 108' ' ' ARG . 11.9 p30 -148.58 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.63 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -86.95 27.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 110.643 -178.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.617 ' HD2' HD22 ' A' ' 106' ' ' ASN . 99.2 mtt180 -75.84 -158.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.659 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ARG . 96.1 mt-10 -32.47 -62.99 0.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.976 -0.453 . . . . 0.0 111.732 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -136.04 141.38 44.3 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.118 -0.989 . . . . 0.0 110.219 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -98.96 116.75 31.91 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.98 -43.84 94.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -59.99 -41.0 91.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.624 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -59.97 -43.3 95.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.029 -1.044 . . . . 0.0 110.109 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -69.99 -40.0 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.961 -1.087 . . . . 0.0 108.807 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.71 87.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.01 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.81 92.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.454 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.6 t-160 -69.01 -48.06 63.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 108.949 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.23 -42.59 91.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.903 -1.123 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.67 -40.01 95.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 109.46 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.98 84.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -63.46 -36.97 85.52 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -1.1 . . . . 0.0 108.738 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.9 m -68.81 -26.54 65.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 109.127 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.58 -2.61 54.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 108.469 179.251 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.01 10.61 66.22 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.81 126.88 31.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.372 . . . . 0.0 109.178 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.7 m -88.07 174.26 8.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.798 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -67.08 157.14 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.4 t -131.37 159.68 37.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.0 p -101.72 11.8 38.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 56.8 t0 -80.1 132.93 36.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.007 -1.058 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 95.9 mt -60.04 -40.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.431 -0.793 . . . . 0.0 111.253 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.14 81.98 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.908 -1.12 . . . . 0.0 111.157 -178.442 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.93 136.82 34.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.656 -1.496 . . . . 0.0 109.776 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 91.2 mt -70.02 -29.88 67.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.445 -0.784 . . . . 0.0 109.267 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mmm -71.43 51.0 0.17 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 -178.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.2 t80 -70.0 137.22 87.24 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -64.85 10.22 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 119.871 0.99 . . . . 0.0 111.7 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.2 t -160.02 175.65 12.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 108.833 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.542 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 65.9 t80 -86.55 119.95 27.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.664 -1.273 . . . . 0.0 109.662 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 69.5 p -150.09 164.0 36.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -134.23 149.88 51.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.38 -0.825 . . . . 0.0 109.166 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -147.32 -1.83 0.62 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.05 -148.58 12.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -80.6 164.92 22.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 108.994 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.41 110.03 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.081 -1.012 . . . . 0.0 109.605 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.27 160.19 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.42 147.62 45.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.848 -1.157 . . . . 0.0 109.308 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.38 149.56 21.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.12 -39.91 72.95 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -54.84 -39.84 68.98 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -73.93 -39.95 63.43 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -0.817 . . . . 0.0 109.33 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.4 mm -62.58 -51.23 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.391 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.13 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.405 -0.809 . . . . 0.0 110.955 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -51.42 38.17 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.259 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.59 -39.96 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.935 -1.332 . . . . 0.0 110.295 -178.857 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.4 mt-30 -67.38 -39.94 85.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.309 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.77 94.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.892 -1.13 . . . . 0.0 108.976 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.02 -50.04 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -96.6 -73.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.45 -171.51 35.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 162' ' ' ARG . 38.1 mtt-85 -85.51 156.27 20.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -1.125 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.5 m -71.38 85.05 0.81 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.55 35.44 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.384 -0.823 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -146.4 112.67 4.37 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 168' ' ' GLN . 29.1 Cg_endo -77.72 135.96 14.83 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.024 1.044 . . . . 0.0 112.15 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.9 t -86.05 146.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.599 -0.688 . . . . 0.0 109.731 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 166' ' ' PRO . 25.8 mp0 -125.02 78.8 66.02 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.49 1.305 0 C-N-CA 120.793 0.995 . . . . 0.0 112.039 -179.462 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.542 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.16 -43.72 95.56 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.4 p -142.26 -150.14 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 6' ' ' ASN . 88.3 tt0 -72.66 153.4 41.23 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.209 -0.932 . . . . 0.0 109.002 179.717 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.34 7.08 0.24 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 4' ' ' GLU . 72.2 m-80 -145.39 75.45 13.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.143 -1.21 . . . . 0.0 108.726 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -59.1 148.57 84.94 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.784 0.989 . . . . 0.0 111.642 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.47 160.02 41.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.313 -0.867 . . . . 0.0 109.017 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -82.16 129.99 34.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.26 -13.43 57.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.886 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -81.84 149.36 28.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 109.58 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.6 p -96.57 -7.47 34.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.936 . . . . 0.0 108.847 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.526 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 64.0 m-70 -130.03 144.2 51.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.17 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.9 mt -134.24 157.6 45.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.18 -0.95 . . . . 0.0 109.802 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.0 p -127.77 155.57 43.83 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -142.5 159.84 41.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 0.0 109.497 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.404 HH12 ' HA ' ' A' ' 19' ' ' GLU . 40.2 ttt-85 -148.1 130.12 15.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 110.082 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.33 119.81 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.342 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 78.0 tt0 -66.89 -39.92 87.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.1 m-20 -157.55 150.03 22.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.979 -1.076 . . . . 0.0 110.082 -179.43 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.16 135.16 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 t -68.59 141.75 93.35 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.232 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.81 -12.66 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.674 0.916 . . . . 0.0 111.832 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -136.28 149.55 68.22 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 121.255 -0.903 . . . . 0.0 108.848 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -59.61 -179.99 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.214 0.755 . . . . 0.0 111.744 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -86.46 -33.01 20.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.12 81.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.84 -39.91 76.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.36 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.35 -42.83 81.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.03 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.05 87.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.405 ' O ' ' N ' ' A' ' 36' ' ' LYS . 86.3 t60 -60.02 -49.7 76.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.18 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.01 90.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.406 -0.809 . . . . 0.0 109.88 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.61 -44.59 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.292 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.23 -40.15 74.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.5 tttt -62.64 -39.68 94.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.07 90.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 31.1 m-85 -59.87 -40.31 88.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.112 . . . . 0.0 109.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.11 -40.67 90.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.0 -43.31 95.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.009 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.97 -41.76 64.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.183 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.5 t -70.14 -26.49 63.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.248 -0.907 . . . . 0.0 110.521 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -60.07 -36.03 76.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 110.852 -178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 45' ' ' THR . 16.7 m -109.92 13.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.061 -1.024 . . . . 0.0 110.403 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.553 HG23 HG23 ' A' ' 44' ' ' VAL . 72.0 p -141.2 146.81 44.55 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.997 -1.064 . . . . 0.0 109.257 179.082 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.19 5.57 2.62 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.579 0.853 . . . . 0.0 111.414 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.84 153.39 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 0.0 109.866 -179.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.526 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 38.2 p -130.91 148.01 52.62 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 98.1 m-85 -126.52 149.76 49.19 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.3 m -153.33 132.06 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 0.0 109.835 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -79.62 142.03 35.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.413 -0.804 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.55 135.85 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -96.67 -3.14 43.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 0.0 110.011 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.67 152.55 41.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.028 -1.045 . . . . 0.0 109.647 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.31 166.99 33.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -82.91 139.52 33.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -1.156 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.64 160.44 14.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 108.983 179.736 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.97 -39.76 86.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.178 -0.952 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.85 120.02 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.485 0.659 . . . . 0.0 109.932 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -99.86 122.13 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.01 129.98 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.417 -0.802 . . . . 0.0 109.052 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -149.05 153.94 38.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.025 -1.047 . . . . 0.0 110.295 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -104.37 138.04 41.38 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.0 170.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.112 -0.993 . . . . 0.0 111.101 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -134.43 143.57 47.63 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.667 -0.646 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.44 -146.68 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -67.17 128.69 37.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.994 . . . . 0.0 109.597 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.495 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -135.97 58.49 1.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.06 52.2 10.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.588 -0.695 . . . . 0.0 109.341 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.495 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 18.9 p-10 -142.43 160.02 41.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 109.072 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -91.14 10.04 28.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.279 -0.888 . . . . 0.0 109.705 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -137.07 74.34 49.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.326 -0.859 . . . . 0.0 109.845 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.53 148.85 48.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.081 1.188 . . . . 0.0 111.405 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -75.88 139.98 41.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.276 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.86 61.04 0.97 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 109.351 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 -176.72 53.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -55.07 -13.55 6.84 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.158 1.238 . . . . 0.0 112.079 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 170.32 34.62 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -150.63 19.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.723 ' OD1' HG12 ' A' ' 173' ' ' CGS . 97.9 m-20 -77.89 142.04 38.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -1.108 . . . . 0.0 109.862 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.5 mt -89.89 -16.6 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.197 -0.94 . . . . 0.0 108.953 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.01 166.96 9.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.932 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.59 -178.44 6.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.839 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.16 170.55 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.396 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.21 153.87 19.56 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.4 -0.813 . . . . 0.0 109.532 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -60.72 151.1 73.53 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.423 -0.798 . . . . 0.0 109.337 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 108.45 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.726 0.951 . . . . 0.0 112.402 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.67 165.19 34.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.04 161.92 40.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.108 1.206 . . . . 0.0 111.997 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.54 -126.65 7.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.51 -13.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 109.8 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.46 141.29 47.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.06 -15.23 60.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.38 159.21 31.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -1.193 . . . . 0.0 109.708 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.99 122.85 12.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.301 -0.874 . . . . 0.0 109.171 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -104.68 148.32 26.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.0 110.465 -179.201 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.3 m-85 -115.22 135.51 54.1 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.246 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 19.7 t0 -67.19 116.67 8.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -95.76 -0.25 51.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -178.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 94.3 m-20 -75.72 -17.33 59.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.84 -1.163 . . . . 0.0 110.095 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -102.2 159.8 15.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 102' ' ' ARG . 35.7 ttm-85 -88.29 120.35 29.57 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.051 -1.03 . . . . 0.0 109.365 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -88.33 148.52 24.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.8 p -124.9 161.12 27.28 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.531 -0.731 . . . . 0.0 109.742 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -112.8 31.46 6.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -148.18 -164.9 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -0.881 . . . . 0.0 109.976 -178.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -79.93 30.64 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 108' ' ' ARG . 48.9 mtt-85 -76.63 -164.48 0.42 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 52.5 mp0 -60.04 -58.3 9.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 112.552 -177.613 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -106.1 121.63 44.54 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.975 -1.078 . . . . 0.0 111.349 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -104.19 117.28 33.87 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.14 -40.17 90.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.1 -41.32 92.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 114' ' ' ARG . 4.4 mmt-85 -60.15 -39.98 88.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 88.0 t -70.28 -41.12 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.064 -1.022 . . . . 0.0 109.826 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.11 95.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.93 87.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.4 t-160 -69.2 -46.16 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 94.4 mt-10 -59.1 -40.21 84.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.763 -1.211 . . . . 0.0 109.889 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.28 -39.94 92.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.088 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.77 97.16 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -65.3 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.161 -1.199 . . . . 0.0 108.803 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.3 p -70.04 -24.31 63.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 108.813 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.89 -3.43 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.43 13.31 76.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.7 132.66 35.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.884 -1.363 . . . . 0.0 108.942 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -87.91 173.04 9.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 109.793 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.62 159.3 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -127.88 162.57 26.4 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.0 p -100.12 2.8 43.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.019 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -82.3 128.81 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.09 -31.58 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.476 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.14 -0.72 77.87 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.272 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.309 . . . . 0.0 109.346 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.68 -27.55 66.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.7 mmm -74.11 44.43 0.19 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.421 -0.8 . . . . 0.0 109.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.05 134.71 87.44 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 -179.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -50.62 -62.11 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 120.055 1.055 . . . . 0.0 111.536 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -81.71 175.38 10.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.815 . . . . 0.0 109.135 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.99 128.77 34.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 109.725 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.4 p -149.43 175.0 11.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.455 -0.778 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -130.75 149.74 52.25 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.42 -0.8 . . . . 0.0 109.606 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.2 p -126.13 23.13 7.15 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.626 -0.672 . . . . 0.0 109.229 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.67 -109.91 3.31 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 42.5 t0 -81.76 155.11 25.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.124 179.833 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.515 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 60.9 t -88.66 110.04 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -140.57 150.74 44.03 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.11 147.44 40.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 109.012 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.1 162.98 14.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.07 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.98 -40.17 88.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 109.002 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.39 -40.78 87.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.44 -40.15 62.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.12 -52.25 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.226 -0.921 . . . . 0.0 109.166 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.59 -40.1 90.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.051 -1.031 . . . . 0.0 109.476 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.05 11.38 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.793 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -63.4 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.339 . . . . 0.0 109.798 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.3 mt-30 -67.2 -39.93 86.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 0.0 109.717 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.54 92.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.077 -1.014 . . . . 0.0 109.273 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.0 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.751 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -97.57 -69.98 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.14 -0.975 . . . . 0.0 109.325 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.59 -169.18 33.9 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -86.22 157.66 19.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -1.177 . . . . 0.0 109.838 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 165' ' ' ASN . 37.3 m -73.72 80.94 1.56 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.25 -0.906 . . . . 0.0 108.921 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -80.87 35.14 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 163' ' ' SER . 68.2 m-80 -145.55 85.71 7.74 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.269 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.65 63.45 8.77 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.119 1.213 . . . . 0.0 111.83 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.4 p -150.3 131.57 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 109.283 179.743 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -71.17 150.32 94.54 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.965 . . . . 0.0 109.169 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 120.825 1.017 . . . . 0.0 111.868 179.974 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.723 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.62 138.88 33.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.331 -0.855 . . . . 0.0 109.091 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.8 p -92.62 160.15 15.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.252 -0.905 . . . . 0.0 109.461 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -71.95 137.71 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 108.799 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.33 -159.68 48.89 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -80.01 148.93 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.26 . . . . 0.0 108.79 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.99 -178.62 2.13 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.647 0.898 . . . . 0.0 112.027 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -145.03 156.95 44.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 108.824 179.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -84.48 120.03 25.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.004 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 55.3 mp0 -82.69 -9.87 59.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.99 155.76 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 0.0 110.299 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.4 p -98.92 -4.5 32.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 48.2 m80 -129.96 141.72 50.73 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 49' ' ' PHE . 69.0 mt -133.39 156.06 48.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.251 -0.905 . . . . 0.0 109.27 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 153.98 45.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.398 -0.813 . . . . 0.0 109.185 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -146.16 162.25 38.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.323 -0.86 . . . . 0.0 109.206 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -147.92 129.88 15.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.37 120.15 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.35 -40.12 89.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 110.422 -178.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -163.27 154.84 17.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.877 -1.139 . . . . 0.0 110.478 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.36 136.4 40.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -70.79 143.05 88.93 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.106 -0.996 . . . . 0.0 109.36 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.85 -11.08 25.15 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.603 0.869 . . . . 0.0 111.749 179.61 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.0 -39.93 87.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.947 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.8 mt -139.55 150.58 64.04 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.371 -0.831 . . . . 0.0 109.044 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.94 -177.04 0.3 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.622 0.881 . . . . 0.0 112.015 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.6 ptt180 -87.03 -33.23 19.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.39 -39.98 81.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.63 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.24 -39.97 59.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -50.04 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.0 111.261 -178.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 29.6 p-10 -59.16 -39.03 81.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.76 -1.213 . . . . 0.0 108.948 -179.399 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.8 t60 -59.73 -49.17 78.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.185 179.01 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.14 87.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 110.165 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.09 -40.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.229 -0.919 . . . . 0.0 109.857 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.07 -39.75 86.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.23 -39.8 87.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 109.29 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.33 95.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.09 -1.006 . . . . 0.0 109.498 -179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -60.02 -39.94 87.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.864 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -60.0 -40.03 87.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.369 -0.832 . . . . 0.0 109.827 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 40' ' ' LEU . 90.2 mt -60.03 -42.96 95.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.055 -1.028 . . . . 0.0 109.709 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -71.65 -40.11 69.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 109.702 -179.48 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 t -69.79 -33.7 72.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.03 -23.06 63.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 111.06 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 m -112.74 3.33 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.166 -0.959 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 9.2 p -148.63 151.37 35.67 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.861 -1.149 . . . . 0.0 109.586 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.99 8.88 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.657 0.905 . . . . 0.0 111.975 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.15 150.01 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.543 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -137.26 153.75 50.27 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.452 -0.78 . . . . 0.0 109.033 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 14' ' ' LEU . 96.5 m-85 -130.01 158.93 38.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.492 -0.755 . . . . 0.0 110.109 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -154.88 126.69 7.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.864 . . . . 0.0 109.984 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.82 143.92 37.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.333 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.76 139.53 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -95.28 -11.2 28.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.165 -0.959 . . . . 0.0 110.097 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -147.59 158.16 43.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.964 -1.085 . . . . 0.0 109.546 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.93 170.83 47.65 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.595 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 5.5 pm0 -80.0 163.96 23.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.41 151.86 51.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -0.752 . . . . 0.0 109.757 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.11 -39.87 87.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.483 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.67 119.85 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.704 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.1 mmm -100.59 128.73 46.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.2 mt -119.13 129.92 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.468 -0.77 . . . . 0.0 109.722 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.7 p -149.74 159.92 43.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.172 -0.955 . . . . 0.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.56 138.37 44.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.14 161.54 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.162 -0.961 . . . . 0.0 111.25 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.92 142.78 50.83 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.717 -0.614 . . . . 0.0 109.786 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.99 -143.52 1.45 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.1 t0 -71.33 130.73 42.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.984 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.416 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.8 p-80 -133.11 53.59 2.01 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.5 -0.75 . . . . 0.0 109.835 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 54.04 50.98 15.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 109.386 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 10.4 t70 -140.03 165.88 26.14 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 26.1 m120 -89.15 9.36 25.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.11 -0.994 . . . . 0.0 109.946 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -135.57 71.43 65.41 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.833 . . . . 0.0 109.635 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.76 141.1 70.57 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 120.937 1.091 . . . . 0.0 111.986 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -75.2 141.33 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -110.74 74.28 0.87 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.784 . . . . 0.0 109.312 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.26 -178.62 6.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.56 -18.78 4.16 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.186 1.257 . . . . 0.0 112.044 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.22 175.06 55.03 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -160.46 29.29 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -75.03 160.12 30.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -1.114 . . . . 0.0 109.681 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 mt -93.64 -20.97 19.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.24 -0.912 . . . . 0.0 109.774 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.59 174.75 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.043 -1.036 . . . . 0.0 109.724 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.04 175.81 10.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 108.943 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.4 167.7 21.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.629 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.78 148.9 24.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.483 -0.76 . . . . 0.0 109.106 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -59.99 149.81 72.3 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.059 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.28 120.58 8.44 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.781 0.987 . . . . 0.0 112.16 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.53 174.9 47.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.81 172.95 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.211 1.274 . . . . 0.0 112.105 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.35 -124.83 16.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.09 -9.13 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -1.043 . . . . 0.0 110.002 -179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.78 143.9 35.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.18 -18.25 46.34 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.07 152.84 45.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.118 -1.225 . . . . 0.0 109.914 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.27 121.42 10.14 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -102.92 141.5 35.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.42 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.8 m-85 -113.8 136.57 52.71 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -65.71 115.6 6.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -98.43 -1.04 42.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.496 -0.752 . . . . 0.0 109.442 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.14 -20.23 59.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.976 -1.078 . . . . 0.0 109.557 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.31 159.55 14.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 108.84 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -87.23 122.43 31.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.932 . . . . 0.0 109.682 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.18 150.01 22.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.892 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.8 p -127.56 159.64 33.99 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.542 -0.724 . . . . 0.0 109.347 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -109.39 29.47 7.52 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.532 -0.73 . . . . 0.0 109.587 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -148.82 -165.01 2.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.217 -0.927 . . . . 0.0 109.655 -179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.72 34.73 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 0.0 110.644 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -76.85 -165.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.392 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.38 -56.59 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.589 -0.694 . . . . 0.0 111.432 -178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 104' ' ' THR . 91.5 m-85 -100.33 119.79 38.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.052 -1.03 . . . . 0.0 110.756 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -103.35 107.3 18.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.385 -0.822 . . . . 0.0 109.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.38 -44.16 97.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 110.09 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -59.91 -43.43 94.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 114' ' ' ARG . 13.7 ttt-85 -59.95 -43.32 95.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.892 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.477 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 69.9 t -69.96 -40.03 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.15 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.56 92.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.27 90.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.456 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 5.8 t60 -69.28 -45.87 68.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 71.4 mt-10 -59.84 -40.14 87.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.94 -1.1 . . . . 0.0 109.142 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.58 -40.05 90.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 108.894 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.79 -41.92 84.44 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -64.65 -38.98 92.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -1.201 . . . . 0.0 108.835 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.3 p -70.02 -21.47 63.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.344 -0.847 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.86 -0.61 56.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 108.966 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.93 8.93 78.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.2 127.36 32.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.032 -1.275 . . . . 0.0 108.791 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -88.05 175.46 7.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.327 -0.858 . . . . 0.0 109.687 -179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -67.53 159.88 28.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -133.25 163.63 28.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.538 -0.727 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -100.89 7.45 43.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.65 122.01 27.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 108.788 179.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.24 -30.82 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.188 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.48 -5.74 89.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.464 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.77 132.08 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.995 -1.297 . . . . 0.0 109.505 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -68.91 -24.64 64.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.1 mmm -73.21 38.63 0.09 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.791 -178.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.9 t80 -69.32 129.72 91.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.965 . . . . 0.0 108.671 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -47.59 -67.51 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.3 1.143 . . . . 0.0 111.863 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 98.0 p -81.88 169.42 16.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -87.37 139.54 30.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.2 p -147.51 160.63 42.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -72.92 149.51 43.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.812 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.3 p -152.87 160.08 43.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.277 -0.89 . . . . 0.0 109.579 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.88 -122.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.43 158.85 23.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 109.626 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.4 t -86.97 108.59 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 109.849 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.91 154.26 46.04 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 63.4 mt -74.93 146.04 42.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.969 -1.082 . . . . 0.0 109.11 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.07 156.89 16.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 109.092 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.77 -38.89 79.5 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -55.08 -40.11 70.01 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.072 -1.018 . . . . 0.0 108.624 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.7 -39.96 69.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.23 -49.94 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.659 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.99 -39.98 91.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.837 -1.164 . . . . 0.0 110.339 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.74 -54.43 9.91 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.137 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.7 tp -61.89 -40.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.299 . . . . 0.0 110.038 -179.008 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -65.86 -40.04 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.941 -1.099 . . . . 0.0 109.387 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.926 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -50.07 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 110.51 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -100.47 -61.04 1.42 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.171 -0.955 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.7 -176.93 34.69 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -90.93 149.43 21.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.426 -1.043 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.1 m -73.7 83.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 108.685 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.37 34.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 0.0 109.431 -179.634 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -143.54 72.32 17.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 109.324 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.99 58.07 5.64 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.653 1.569 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 82.5 t -87.04 118.5 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.36 -179.766 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -76.63 148.69 80.08 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 118.018 -0.909 . . . . 0.0 112.057 179.877 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.477 HOM3 ' HA ' ' A' ' 115' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.213 0.53 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.32 -40.2 89.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.05 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.5 p -96.5 139.69 32.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.805 . . . . 0.0 108.997 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.12 134.47 38.7 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.931 -1.106 . . . . 0.0 108.986 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.69 -94.96 0.65 Allowed Glycine 0 N--CA 1.502 3.097 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.462 ' ND2' ' OE1' ' A' ' 86' ' ' GLN . 68.5 m-80 -153.45 83.52 4.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.347 -1.09 . . . . 0.0 109.966 -179.257 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -52.22 161.25 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 120.85 1.033 . . . . 0.0 111.998 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 8' ' ' ARG . 22.6 mtt-85 -88.97 179.29 6.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.954 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -83.75 120.63 26.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.285 -0.885 . . . . 0.0 109.527 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.95 -10.11 58.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 109.109 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.94 150.11 30.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 -179.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -97.0 -4.89 38.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.523 -0.735 . . . . 0.0 109.442 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -130.01 139.99 50.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.78 157.61 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.403 -0.811 . . . . 0.0 109.654 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -127.0 155.19 43.59 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.619 -0.676 . . . . 0.0 109.188 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.98 157.91 43.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.009 -1.057 . . . . 0.0 109.266 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.428 HH21 ' CE ' ' A' ' 60' ' ' MET . 42.3 ttp180 -147.33 128.86 15.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.166 -0.959 . . . . 0.0 109.954 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.0 mt -85.41 123.71 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -62.3 -40.76 97.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -178.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -162.22 151.84 16.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.304 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -97.54 135.94 38.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.378 -0.827 . . . . 0.0 109.27 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 t -73.41 144.92 84.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.752 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.89 -15.09 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 CA-C-N 119.203 0.751 . . . . 0.0 111.046 179.012 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.49 -40.07 93.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.525 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.4 mt -135.13 150.32 72.58 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.009 -1.057 . . . . 0.0 109.337 -178.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.39 179.82 2.75 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 CA-C-N 119.158 0.735 . . . . 0.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -85.54 -36.13 20.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.924 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.78 84.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.21 -40.03 74.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.85 -44.33 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.443 -179.229 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.54 89.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 108.719 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.87 -47.87 84.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.312 -0.867 . . . . 0.0 109.499 179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.47 89.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.143 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.58 -40.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -70.26 -40.0 74.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.609 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.29 95.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 108.609 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CE1' ' CD1' ' A' ' 49' ' ' PHE . 33.8 m-85 -61.21 -39.59 90.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 109.881 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -58.9 -40.93 85.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.2 -41.24 92.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.034 -1.041 . . . . 0.0 109.317 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -72.39 -40.0 67.57 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.68 -28.47 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.442 -0.786 . . . . 0.0 110.254 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -59.85 -35.14 74.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 110.766 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.405 ' C ' ' HG ' ' A' ' 163' ' ' SER . 2.9 m -108.52 5.63 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.278 -0.889 . . . . 0.0 110.985 -178.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.3 p -140.03 148.63 55.61 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 120.897 -1.127 . . . . 0.0 108.625 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.73 6.4 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.407 1.404 . . . . 0.0 112.389 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.16 157.92 35.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.367 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 p -135.79 147.71 48.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.482 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 95.9 m-85 -128.72 148.7 50.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.725 -0.609 . . . . 0.0 109.65 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -154.35 134.92 13.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -76.06 146.58 39.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.25 135.17 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.369 -0.832 . . . . 0.0 108.978 179.19 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -97.54 -5.89 34.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 110.052 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -142.67 156.67 45.08 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.07 -1.019 . . . . 0.0 109.565 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 167.59 25.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -78.37 148.03 33.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.932 . . . . 0.0 109.272 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.59 148.38 30.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -0.776 . . . . 0.0 108.913 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.45 -40.35 90.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.34 118.89 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.428 ' CE ' HH21 ' A' ' 17' ' ' ARG . 89.7 mmm -101.2 122.19 43.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -111.79 130.05 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.625 -0.672 . . . . 0.0 109.524 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.6 p -147.39 155.5 42.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -105.28 140.2 38.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.57 160.29 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 121.901 0.858 . . . . 0.0 111.188 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.3 mtm-85 -131.96 135.44 46.58 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.72 -138.66 13.88 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -77.37 129.09 35.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.561 -0.964 . . . . 0.0 110.243 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 19.1 p-80 -131.58 47.46 2.53 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.409 -0.807 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 56.04 59.35 3.78 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.1 p-10 -142.72 163.1 33.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.066 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.53 9.19 30.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.172 -0.955 . . . . 0.0 109.233 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 t -140.08 69.51 34.95 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.414 -0.804 . . . . 0.0 109.012 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.67 148.68 42.22 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.364 1.376 . . . . 0.0 112.083 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -79.25 151.12 31.34 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -134.93 76.36 1.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.428 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.83 -179.18 39.73 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -70.73 -15.6 33.46 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.194 1.262 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.04 -174.89 50.5 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.04 -158.38 36.38 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.581 ' CG ' HG12 ' A' ' 173' ' ' CGS . 79.2 m-20 -75.06 143.78 43.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -1.023 . . . . 0.0 109.25 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.32 -16.0 32.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 109.0 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.54 175.67 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.264 -0.898 . . . . 0.0 108.937 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -163.01 120.25 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.914 -1.116 . . . . 0.0 110.629 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.45 168.11 16.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -109.61 143.93 38.63 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.462 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 80.3 mt-30 -59.47 145.95 80.94 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -58.36 127.28 24.16 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 119.249 0.768 . . . . 0.0 112.306 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.27 178.12 43.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.57 -177.86 3.87 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.359 1.373 . . . . 0.0 112.524 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.75 -123.7 33.52 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.14 -13.74 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.49 -1.006 . . . . 0.0 109.782 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.01 138.77 38.21 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.249 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -13.93 63.5 Favored Glycine 0 N--CA 1.497 2.702 0 O-C-N 121.231 -1.158 . . . . 0.0 110.546 179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.79 162.81 25.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.955 -1.321 . . . . 0.0 109.768 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.5 120.76 11.55 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -105.15 133.45 49.9 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.241 -0.912 . . . . 0.0 110.272 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.508 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 43.8 m-85 -114.65 129.75 56.72 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.356 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -67.53 120.72 14.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 108.968 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -99.4 6.5 46.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.308 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.47 -20.16 60.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 0.0 109.737 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -104.23 160.07 15.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 102' ' ' ARG . 33.2 ttt-85 -84.11 119.16 24.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.138 -0.976 . . . . 0.0 110.147 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -88.8 148.95 23.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.497 -0.752 . . . . 0.0 109.269 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 41.6 p -123.23 167.96 13.06 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.476 -0.765 . . . . 0.0 109.306 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -104.66 23.82 12.75 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -148.98 -165.0 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.657 -0.652 . . . . 0.0 109.805 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -90.88 27.0 1.92 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.231 -0.918 . . . . 0.0 110.911 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.0 mtt-85 -76.47 -157.14 0.08 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.837 -1.165 . . . . 0.0 109.442 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 108' ' ' ARG . 64.4 mm-40 -24.31 -65.4 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.202 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.4 m-85 -130.12 132.05 45.95 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.978 -1.076 . . . . 0.0 109.786 -179.455 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -95.99 113.83 25.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.204 -0.935 . . . . 0.0 109.701 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.25 -40.27 77.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -59.63 -42.9 93.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.958 -1.089 . . . . 0.0 109.988 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.675 ' NH1' HOM1 ' A' ' 173' ' ' CGS . 25.3 ttt-85 -59.7 -41.52 90.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.27 -39.67 77.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.77 92.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.328 -0.858 . . . . 0.0 108.926 179.55 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.16 85.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.0 109.162 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.521 ' HD1' HOM2 ' A' ' 173' ' ' CGS . 4.3 t60 -69.72 -50.1 46.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 73.4 mt-10 -59.95 -40.1 87.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.962 -1.086 . . . . 0.0 110.278 -178.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 58.2 mt -62.12 -39.88 94.04 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 108.828 179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.52 95.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 128' ' ' HIS . 12.2 m-70 -61.93 -38.73 89.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.067 -1.255 . . . . 0.0 107.778 178.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.5 m -69.65 -24.31 63.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.1 -0.27 51.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 108.852 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.99 13.97 65.5 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.361 -0.923 . . . . 0.0 110.889 178.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.56 124.58 30.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.088 -1.243 . . . . 0.0 108.887 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -88.67 167.28 13.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.998 -1.064 . . . . 0.0 109.1 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 122' ' ' HIS . 80.9 m80 -68.58 152.36 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 t -126.44 169.69 12.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.473 -0.767 . . . . 0.0 108.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.3 p -98.94 1.02 45.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.398 -0.814 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -79.06 119.3 21.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.04 -40.44 83.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 -179.464 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.77 27.87 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.01 -1.057 . . . . 0.0 111.007 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.1 23.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.852 -1.381 . . . . 0.0 109.159 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 85.1 mt -68.19 -23.89 64.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 108.885 178.743 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.564 ' SD ' ' N ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -74.52 62.24 1.0 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.57 -0.706 . . . . 0.0 109.911 -179.262 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 139' ' ' SER . 1.8 t80 -71.19 123.95 90.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -51.11 -2.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 CA-C-N 120.459 1.2 . . . . 0.0 113.546 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 137' ' ' TYR . 58.3 m -163.05 174.55 12.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 0.0 109.074 179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 93.2 t80 -86.43 129.68 34.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.903 . . . . 0.0 108.92 179.626 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.4 p -153.01 168.66 25.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.127 -0.983 . . . . 0.0 110.036 -179.466 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.07 125.81 25.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.612 -0.68 . . . . 0.0 110.077 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 144' ' ' GLY . 51.0 m -129.66 142.69 50.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.449 -0.782 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -63.76 -126.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.8 155.59 25.34 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.842 -1.387 . . . . 0.0 109.213 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.26 110.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.456 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -142.58 157.87 44.26 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.54 145.92 47.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.018 -1.051 . . . . 0.0 108.868 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.07 162.91 13.68 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.21 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.14 -40.19 88.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.193 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.22 -41.67 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.712 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -71.68 -40.78 69.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.76 -49.78 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.781 . . . . 0.0 109.298 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.67 -39.91 88.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.894 -1.129 . . . . 0.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -52.72 34.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.32 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -1.212 . . . . 0.0 109.669 -179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.28 -39.65 92.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.198 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.79 92.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.389 -0.819 . . . . 0.0 110.033 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.97 -47.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.92 -1.112 . . . . 0.0 109.478 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.41 -64.91 1.01 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.299 -0.876 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.91 -169.82 35.94 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -92.11 145.44 24.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.023 -1.281 . . . . 0.0 108.7 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 42.2 m -71.42 87.39 0.87 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.223 -0.923 . . . . 0.0 109.962 -178.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -86.96 93.4 9.33 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -155.35 96.63 2.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.684 -0.635 . . . . 0.0 109.785 -178.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -80.04 57.45 6.51 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 CA-C-N 119.425 0.83 . . . . 0.0 111.807 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.2 t -142.83 130.57 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.502 ' CD ' ' H ' ' A' ' 168' ' ' GLN . 1.8 mp0 -67.35 148.39 98.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.861 -1.149 . . . . 0.0 108.759 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.492 1.408 0 CA-C-O 118.063 -0.891 . . . . 0.0 112.525 -179.509 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.675 HOM1 ' NH1' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.29 -42.9 96.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 108.857 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.3 p -96.35 124.53 40.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 109.565 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.51 116.66 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.323 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.18 -98.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -142.47 81.32 13.79 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.336 -1.097 . . . . 0.0 109.551 -179.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -73.28 -171.37 0.8 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.079 1.186 . . . . 0.0 112.582 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -90.15 -179.14 5.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.747 . . . . 0.0 109.291 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -83.13 118.71 23.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -85.26 -10.65 56.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.287 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.73 150.9 25.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.323 -179.175 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.7 p -96.19 -3.8 43.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -128.85 141.67 51.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 160.05 39.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.244 -0.91 . . . . 0.0 109.784 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 p -127.94 157.18 41.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -146.1 159.94 42.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.416 -0.802 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -150.4 133.87 16.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.2 mt -89.49 118.57 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.4 mt-10 -66.8 -40.13 87.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.531 -178.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.2 m-20 -155.95 152.71 28.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.119 -0.988 . . . . 0.0 109.849 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -101.4 131.98 47.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -68.75 138.26 90.61 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.993 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.47 -8.95 18.5 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.596 0.891 . . . . 0.0 112.052 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.1 -39.97 88.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.004 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -135.73 149.06 67.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.13 -175.44 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.63 0.886 . . . . 0.0 111.696 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -90.01 -37.23 14.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -45.85 85.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.823 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.54 -39.83 73.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.72 -45.58 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -59.95 -40.11 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.184 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -60.12 -42.52 94.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.74 90.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.46 -36.89 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -65.71 -42.03 91.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.739 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.6 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.836 -1.165 . . . . 0.0 109.82 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.95 75.66 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 39.4 m-85 -61.69 -40.96 96.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.918 -1.114 . . . . 0.0 108.78 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.24 -42.03 94.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 0.0 110.356 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.79 -40.6 88.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.067 . . . . 0.0 110.116 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -73.0 -40.04 65.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.822 -1.174 . . . . 0.0 109.186 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 t -70.04 -26.48 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 110.25 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.92 -35.97 76.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.377 -0.827 . . . . 0.0 110.68 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 45' ' ' THR . 33.7 m -108.54 10.26 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 44' ' ' VAL . 65.9 p -141.05 147.25 46.93 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.301 -0.875 . . . . 0.0 109.306 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.78 6.29 2.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.9 1.067 . . . . 0.0 112.067 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.32 155.9 40.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.813 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.8 p -134.54 149.85 50.69 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 91.8 m-85 -125.98 155.13 41.88 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.468 -0.77 . . . . 0.0 109.433 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.5 m -151.65 137.25 17.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.36 137.02 37.82 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -121.57 134.34 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.362 -0.836 . . . . 0.0 109.16 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 t -97.47 -6.02 34.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.344 -0.848 . . . . 0.0 110.624 -179.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -144.19 153.32 41.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.83 165.57 33.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -81.09 147.3 30.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -1.17 . . . . 0.0 108.972 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.77 17.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.73 -38.66 82.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.196 -0.94 . . . . 0.0 108.946 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -116.4 118.3 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.673 0.749 . . . . 0.0 109.833 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.43 129.64 46.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.335 -0.853 . . . . 0.0 109.737 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.46 130.63 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.1 p -148.43 161.2 42.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.0 -1.062 . . . . 0.0 110.582 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.08 140.01 48.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 173.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.134 -0.979 . . . . 0.0 111.003 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -138.15 141.93 40.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.518 -0.739 . . . . 0.0 110.481 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.49 -140.09 2.24 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.57 130.33 40.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.425 -1.044 . . . . 0.0 109.421 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.516 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 12.1 p-80 -136.91 60.44 1.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.519 -0.738 . . . . 0.0 110.315 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 52.45 51.16 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.543 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 72' ' ' SER . 11.9 t70 -144.36 160.09 41.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.219 -0.926 . . . . 0.0 109.337 -179.794 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.96 9.89 23.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 108.74 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 40.3 t -134.17 73.78 69.08 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.537 -0.727 . . . . 0.0 109.318 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.77 145.08 45.27 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.057 1.171 . . . . 0.0 111.88 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.2 142.56 45.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.103 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -102.42 65.63 0.95 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.299 -0.876 . . . . 0.0 109.665 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.3 -166.6 41.39 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.09 -20.02 17.65 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.226 1.284 . . . . 0.0 111.998 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.69 173.77 43.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.38 -163.73 26.53 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' HG12 ' A' ' 173' ' ' CGS . 28.6 p-10 -73.9 152.31 40.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.419 -1.048 . . . . 0.0 109.974 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -91.86 -17.0 25.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.03 171.26 7.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.432 -0.793 . . . . 0.0 109.053 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.56 121.97 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.7 173.3 9.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.616 -0.678 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.65 158.54 17.96 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.591 -0.693 . . . . 0.0 109.241 179.235 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -58.82 145.8 77.6 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.135 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.09 96.5 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.776 0.984 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.91 173.49 36.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.318 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -65.1 -174.1 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.92 1.08 . . . . 0.0 111.705 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.38 -134.11 50.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.24 -12.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -1.124 . . . . 0.0 110.313 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.88 144.22 44.68 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.7 -12.67 66.43 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.38 160.83 28.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -1.156 . . . . 0.0 109.979 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.72 115.56 9.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -100.13 142.53 31.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -122.04 134.88 54.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.557 -0.715 . . . . 0.0 109.275 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.8 119.46 13.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -95.14 -0.27 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.83 -18.46 60.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 109.781 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 162.58 13.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.228 -0.92 . . . . 0.0 108.927 179.073 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -87.21 119.15 27.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -87.44 140.12 29.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.038 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 54.3 p -128.78 166.33 19.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.495 -0.753 . . . . 0.0 109.735 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.73 31.05 6.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.62 -0.675 . . . . 0.0 109.258 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.514 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 17.5 p30 -148.46 -162.73 1.62 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -81.11 34.24 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.423 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 108' ' ' ARG . 10.6 mmt-85 -76.77 -166.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.129 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -50.27 -57.14 8.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.596 -0.69 . . . . 0.0 111.991 -178.549 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.3 m-85 -119.94 140.16 51.34 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.136 -0.977 . . . . 0.0 111.494 -177.333 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 21.4 m120 -108.32 118.49 36.9 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.99 -42.01 85.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.18 -0.95 . . . . 0.0 110.682 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -59.95 -42.09 93.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.054 -1.029 . . . . 0.0 110.935 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.559 ' NH1' ' H ' ' A' ' 143' ' ' SER . 82.8 mtt180 -59.84 -40.87 89.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 109.968 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 62.6 t -70.33 -40.09 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 108.789 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.23 80.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.004 -1.06 . . . . 0.0 108.943 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.06 -35.01 79.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.956 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.456 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.5 t-160 -69.99 -56.22 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.857 -1.152 . . . . 0.0 109.948 -179.479 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 7.0 mp0 -57.73 -39.92 78.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.951 -1.093 . . . . 0.0 109.677 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.94 -39.74 90.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.276 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.86 95.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -63.47 -33.66 76.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -1.091 . . . . 0.0 108.8 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -68.83 -25.31 64.59 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.4 mt -84.58 -6.27 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 0.0 109.431 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.14 19.53 52.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.37 134.81 34.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.866 -1.373 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.8 m -87.55 168.29 13.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.4 159.14 32.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.9 t -132.35 157.82 43.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.072 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 10.15 41.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.312 -0.867 . . . . 0.0 109.883 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -82.04 128.51 34.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.76 -27.67 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 110.463 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.15 -4.79 88.04 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.413 -179.234 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.35 132.34 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.671 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.84 -27.46 65.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 109.421 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.6 mtp -75.72 45.39 0.32 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.826 -179.347 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -69.94 135.54 87.52 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -47.07 -68.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 119.861 0.986 . . . . 0.0 112.545 179.11 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -85.14 174.05 9.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.017 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -84.59 136.62 33.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.921 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.7 p -145.76 159.46 43.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.182 -0.948 . . . . 0.0 109.444 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.13 127.37 32.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.559 ' H ' ' NH1' ' A' ' 114' ' ' ARG . 32.0 t -117.05 122.7 44.93 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.491 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.1 -95.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.71 141.51 31.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -1.133 . . . . 0.0 109.718 -179.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t -89.12 107.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.248 -0.907 . . . . 0.0 109.737 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.88 153.98 41.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.259 -0.9 . . . . 0.0 109.478 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.06 149.46 39.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 108.71 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.76 161.32 14.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -60.03 -39.82 87.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.564 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -58.59 -40.34 82.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.482 -0.761 . . . . 0.0 109.706 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.55 -40.14 66.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.747 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.81 -49.69 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.67 -40.21 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.182 -0.949 . . . . 0.0 109.868 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -57.53 12.76 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.911 -178.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -60.15 -39.98 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.308 . . . . 0.0 109.941 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -63.13 -39.58 95.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.028 -1.045 . . . . 0.0 109.175 179.399 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.57 94.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.22 -52.06 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.743 -1.223 . . . . 0.0 109.392 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -96.1 -70.9 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.11 -170.07 39.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -92.98 141.72 28.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -1.156 . . . . 0.0 109.721 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.7 m -75.11 85.29 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -98.41 91.85 5.39 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.23 -0.919 . . . . 0.0 109.635 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -157.5 153.17 22.55 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.069 -1.02 . . . . 0.0 109.257 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -79.03 91.58 1.19 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.584 0.887 . . . . 0.0 111.553 178.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.5 m -85.28 139.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 110.28 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 12.5 mm100 -63.28 -58.79 14.23 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 111.029 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 168' ' ' GLN . 1.1 Cg_endo . . . . . 0 N--CA 1.493 1.494 0 CA-C-N 120.255 1.127 . . . . 0.0 112.107 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 173' ' ' CGS . . . . . 0.511 ' C5 ' HG13 ' A' ' 173' ' ' CGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -81.7 119.63 24.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.038 -1.039 . . . . 0.0 108.68 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -82.43 -11.5 58.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.68 151.03 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.81 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.4 p -94.81 -3.99 47.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -129.2 144.02 51.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -133.39 158.5 42.88 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.39 -0.819 . . . . 0.0 109.91 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.3 p -128.71 150.02 50.45 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.18 159.41 42.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 0.0 109.578 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -150.7 130.5 13.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.0 109.74 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.21 122.54 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.309 -0.87 . . . . 0.0 108.858 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.83 -40.08 83.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.477 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -161.74 159.45 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.857 -1.152 . . . . 0.0 110.212 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -100.12 138.19 37.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -69.53 139.77 89.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 108.983 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -66.31 -12.13 34.33 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.601 0.893 . . . . 0.0 111.309 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.02 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.387 -0.821 . . . . 0.0 108.976 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -138.04 149.93 65.56 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.88 -170.97 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 120.795 0.997 . . . . 0.0 112.094 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' NH2' ' OD2' ' A' ' 31' ' ' ASP . 6.6 ptm180 -88.51 -31.81 18.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.11 -47.38 78.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.975 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.96 -43.96 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -0.976 . . . . 0.0 110.092 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 87.3 m-20 -59.28 -41.68 89.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.12 . . . . 0.0 109.267 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -60.06 -49.03 79.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.46 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.4 92.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.29 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.05 -40.05 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 0.0 109.725 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.16 -41.02 74.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.818 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.73 -39.74 92.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -46.18 86.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.074 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.884 -1.135 . . . . 0.0 109.261 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.412 HE21 ' HG2' ' A' ' 35' ' ' GLU . 80.3 mt-30 -60.01 -41.2 91.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 110.232 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -41.39 91.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.022 -1.049 . . . . 0.0 109.889 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -72.57 -42.29 64.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.335 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -69.93 -30.82 68.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 110.249 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.61 -31.99 68.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 111.168 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 33.3 m -110.03 9.99 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.084 -1.01 . . . . 0.0 111.009 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 70.4 p -143.25 148.28 43.88 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 120.925 -1.109 . . . . 0.0 109.292 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.78 10.5 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 120.64 0.894 . . . . 0.0 111.196 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.58 151.5 44.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.515 -0.741 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 p -129.8 140.91 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.64 157.7 27.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.571 -0.705 . . . . 0.0 109.38 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -154.59 125.74 7.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 109.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -78.38 133.53 37.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.373 -0.83 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.9 135.89 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.579 -0.701 . . . . 0.0 109.261 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -96.22 -2.0 47.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 109.994 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -146.35 156.39 43.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.966 -1.084 . . . . 0.0 109.587 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.98 164.52 34.05 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -80.45 131.48 35.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.291 . . . . 0.0 108.594 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.81 155.19 16.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.22 -0.925 . . . . 0.0 109.846 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 109.602 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -120.01 113.06 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.44 -0.788 . . . . 0.0 109.062 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.03 133.6 44.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.113 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.7 mt -116.04 130.03 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.557 -0.714 . . . . 0.0 109.334 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.1 p -150.15 155.17 39.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.39 137.67 41.18 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.78 160.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.264 -0.897 . . . . 0.0 111.264 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -130.51 143.47 50.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.318 0.58 . . . . 0.0 109.528 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.88 -142.74 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -76.49 130.14 37.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.482 -1.01 . . . . 0.0 110.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.583 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.2 p-80 -130.56 54.14 1.91 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 57.45 49.99 12.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 109.818 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 8.4 m-20 -142.79 162.0 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 0.0 109.033 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -90.46 9.66 28.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.631 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.7 71.62 64.25 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.997 -1.064 . . . . 0.0 110.668 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.47 149.92 56.92 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.201 1.268 . . . . 0.0 111.828 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -77.45 142.98 38.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.592 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -108.01 65.5 0.64 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.45 -0.781 . . . . 0.0 109.353 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.44 -167.54 54.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.97 -8.52 4.75 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.2 1.267 . . . . 0.0 112.079 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.14 176.48 42.18 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 -164.27 41.17 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.49 ' H ' HD22 ' A' ' 80' ' ' ASN . 3.0 p30 -75.27 159.65 31.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.219 -1.165 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.67 -18.18 21.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.363 -0.836 . . . . 0.0 109.851 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.34 169.41 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.965 . . . . 0.0 108.872 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.6 177.75 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.081 . . . . 0.0 109.799 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.3 177.91 7.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.325 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.67 154.65 21.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.512 -0.743 . . . . 0.0 109.281 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.7 mp0 -58.59 149.99 59.04 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.182 -0.949 . . . . 0.0 108.802 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -60.72 107.42 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.575 0.85 . . . . 0.0 112.047 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.11 173.24 41.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.59 176.98 2.44 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.091 1.194 . . . . 0.0 112.121 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.11 -131.93 33.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.51 -12.72 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -1.062 . . . . 0.0 109.788 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.38 142.94 42.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.29 -21.49 37.49 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.52 153.35 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -1.17 . . . . 0.0 109.946 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.64 122.69 10.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 109.062 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -104.89 152.13 23.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.459 -0.776 . . . . 0.0 110.11 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 20.8 m-85 -119.91 139.64 52.1 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -66.55 119.81 12.33 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -98.51 2.3 47.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.55 -22.38 59.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.156 -0.965 . . . . 0.0 109.752 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -100.69 155.31 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.271 -0.893 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -85.21 128.07 34.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.031 -1.043 . . . . 0.0 109.251 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -89.6 145.86 24.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 109.785 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.1 p -129.87 166.41 20.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.576 -0.703 . . . . 0.0 109.708 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.41 30.3 6.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.555 -0.715 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 4.7 p30 -150.02 -164.24 1.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 31.76 0.43 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 108' ' ' ARG . 44.7 mtt-85 -75.91 -157.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.602 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -39.78 -59.66 1.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 111.389 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -135.08 151.21 50.53 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 67.1 m-20 -103.59 115.04 29.77 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.13 -43.92 90.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.053 -1.029 . . . . 0.0 110.736 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -60.01 -42.32 94.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 0.0 110.239 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -59.91 -40.53 89.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.997 . . . . 0.0 109.796 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.7 t -70.82 -41.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.996 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.93 92.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.018 -1.051 . . . . 0.0 109.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.75 88.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 0.0 109.204 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -68.33 -44.7 74.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.414 -0.804 . . . . 0.0 109.72 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 74.7 mt-10 -60.03 -39.93 87.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 109.437 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.69 -40.01 90.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 108.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.87 -41.84 84.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.27 -39.95 93.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 108.701 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.6 m -70.19 -27.27 64.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.82 -1.53 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.171 -0.955 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.12 9.93 69.67 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.28 123.61 30.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.939 -1.33 . . . . 0.0 109.181 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.9 m -88.2 176.23 7.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.97 155.38 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -131.17 168.38 17.56 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.1 p -101.82 10.52 39.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.379 -0.826 . . . . 0.0 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.43 129.52 34.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.33 -40.02 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 110.641 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 0.19 77.54 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.985 -1.103 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 129.52 34.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.655 -1.497 . . . . 0.0 109.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 137' ' ' TYR . 88.0 mt -69.21 -24.28 64.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -71.44 45.58 0.11 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 135' ' ' LEU . 5.4 t80 -70.03 129.78 90.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -48.57 -71.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.192 1.104 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.4 p -80.92 170.0 16.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 109.597 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.8 t80 . . . . . 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 109.197 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.417 0.627 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -146.43 152.29 38.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.079 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.52 142.98 42.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 109.043 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 166.57 12.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.178 -0.951 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.371 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -59.9 -40.3 88.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.517 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -73.07 -40.05 65.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 0.0 109.522 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.05 -50.07 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.76 -39.87 93.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.988 -1.07 . . . . 0.0 109.866 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.45 -57.49 19.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.222 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -65.99 -40.08 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.793 -1.416 . . . . 0.0 110.007 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.1 mt-30 -66.09 -39.95 90.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.88 96.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.01 -50.06 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.895 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -99.56 -64.86 1.0 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.5 -179.11 38.78 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -89.97 149.87 22.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -1.197 . . . . 0.0 109.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.43 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 21.5 m . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 8' ' ' ARG . 43.7 mtt-85 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -82.41 120.44 25.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.061 -1.024 . . . . 0.0 109.591 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -83.87 -13.89 52.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 109.598 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.98 149.22 28.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.912 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -95.03 -3.9 47.49 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 67.0 m80 -125.3 134.49 52.23 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.9 151.48 50.42 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.872 . . . . 0.0 109.221 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -120.97 155.91 33.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 109.221 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -145.19 159.22 43.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -150.77 133.81 16.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.089 -1.007 . . . . 0.0 110.07 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.5 mt -90.84 120.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.96 -40.11 91.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.991 -1.068 . . . . 0.0 110.882 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.9 149.58 14.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.713 -1.242 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -95.22 132.85 39.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -71.05 143.23 88.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.691 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.72 -9.91 24.6 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.789 0.993 . . . . 0.0 112.625 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.97 -39.97 87.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.086 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -137.83 149.69 65.27 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.64 179.8 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.667 0.911 . . . . 0.0 111.916 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -86.58 -31.43 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.71 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -70.42 -40.07 74.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 110.499 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -40.82 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.546 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.02 -40.46 89.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.34 -45.04 94.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.342 -0.849 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.81 91.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.31 -40.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.695 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -69.92 -40.1 75.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.415 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -61.82 -40.01 93.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.292 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.63 91.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.035 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -60.47 -40.21 90.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.918 -1.114 . . . . 0.0 108.881 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -59.97 -41.47 92.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.792 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.32 -41.3 93.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.104 -0.997 . . . . 0.0 110.458 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -74.76 -42.11 58.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.985 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -68.71 -34.8 76.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 110.407 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.27 -32.24 69.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.269 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.616 HG23 HG23 ' A' ' 45' ' ' THR . 17.3 m -109.79 11.7 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.049 -1.032 . . . . 0.0 110.761 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 44' ' ' VAL . 52.0 p -143.01 149.27 48.62 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.911 -1.118 . . . . 0.0 109.472 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -73.68 3.88 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.538 0.826 . . . . 0.0 111.723 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 157.88 37.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 109.657 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.478 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.6 p -133.41 151.77 51.85 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.19 154.36 46.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.536 -0.727 . . . . 0.0 109.619 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.2 m -154.01 131.15 11.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -77.87 135.59 37.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.765 . . . . 0.0 109.082 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.17 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.313 -0.867 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 t -99.1 11.66 38.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.482 -0.761 . . . . 0.0 109.835 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.07 153.7 42.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.076 -1.015 . . . . 0.0 109.183 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 168.32 1.44 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -82.05 147.49 29.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 109.011 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.35 160.01 14.78 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.15 -40.06 88.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.34 119.32 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.396 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.1 mtp -103.58 134.3 47.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.523 -0.736 . . . . 0.0 109.767 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -119.68 126.83 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 0.0 109.283 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.9 p -149.69 156.09 41.29 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -103.13 140.78 36.89 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 68' ' ' HIS . 26.1 m -138.95 169.77 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 120.945 -1.097 . . . . 0.0 110.818 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -138.08 149.26 45.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.713 -0.617 . . . . 0.0 110.147 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.91 -146.52 2.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -70.07 129.97 40.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -1.08 . . . . 0.0 110.296 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.1 p-80 -137.98 55.82 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.699 -0.626 . . . . 0.0 109.39 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 85.0 mtm180 57.24 48.96 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 109.79 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -142.47 158.25 43.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.347 -0.845 . . . . 0.0 109.156 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -90.96 8.61 34.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -134.5 72.48 69.96 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.342 -0.849 . . . . 0.0 109.752 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.95 148.46 35.54 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.312 1.341 . . . . 0.0 112.682 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -76.4 146.19 38.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.776 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.57 75.2 1.53 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.153 -0.967 . . . . 0.0 110.123 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 -178.75 44.15 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.67 -6.4 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 120.746 0.964 . . . . 0.0 110.999 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.25 43.89 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.69 -173.74 47.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -73.28 151.13 41.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -1.146 . . . . 0.0 109.089 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt -90.91 -13.39 33.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.24 163.41 8.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 108.909 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.46 179.72 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.836 -1.165 . . . . 0.0 110.211 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.83 174.13 10.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.4 155.72 17.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.376 -0.827 . . . . 0.0 108.995 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -59.56 149.02 72.56 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.279 -0.888 . . . . 0.0 108.836 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.97 100.19 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 120.503 0.802 . . . . 0.0 111.842 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 171.75 35.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.94 -169.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.422 1.415 . . . . 0.0 112.144 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.2 -131.38 51.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.03 -9.99 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -1.014 . . . . 0.0 109.796 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.94 147.33 26.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -23.01 36.19 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 121.268 -1.136 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -67.45 154.89 40.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.352 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.1 123.08 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -105.15 147.54 27.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.368 -0.833 . . . . 0.0 110.283 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -119.72 133.96 55.42 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -66.9 122.33 17.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.143 -0.973 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -95.94 -2.62 46.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.032 -1.043 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -76.07 -13.85 60.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.959 -1.088 . . . . 0.0 109.238 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -93.84 152.68 18.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -0.811 . . . . 0.0 109.107 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -86.5 115.07 23.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 108.704 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -91.97 144.6 25.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 110.125 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 p -129.35 174.13 9.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.2 22.38 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.416 -0.803 . . . . 0.0 109.492 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.651 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.02 -166.4 2.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -0.921 . . . . 0.0 109.887 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.76 29.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.201 -0.937 . . . . 0.0 110.621 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 109' ' ' GLU . 45.6 mtt-85 -76.16 -159.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.025 . . . . 0.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 108' ' ' ARG . 77.8 mm-40 -32.16 -60.4 0.27 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.815 -0.553 . . . . 0.0 111.819 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -137.92 139.08 39.61 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.089 -1.007 . . . . 0.0 110.041 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.53 HD22 ' N ' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -105.9 119.53 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.354 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 111' ' ' ASN . 64.8 tp -67.25 -39.93 86.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 0.0 110.632 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -60.07 -42.68 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.603 -1.311 . . . . 0.0 110.325 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.45 -39.78 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.902 -1.124 . . . . 0.0 109.595 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.6 93.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.46 94.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.034 -1.042 . . . . 0.0 109.891 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.05 -47.31 68.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.97 -39.95 75.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 109.493 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.53 -39.52 91.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 108.798 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.11 90.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -62.69 -40.01 95.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -1.232 . . . . 0.0 109.369 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -70.93 -23.49 62.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.236 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.39 -3.82 58.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.161 -0.962 . . . . 0.0 109.044 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.65 16.79 72.29 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.918 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.57 129.17 34.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.876 -1.367 . . . . 0.0 108.95 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 m -88.06 168.66 12.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.038 . . . . 0.0 109.54 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.73 159.99 31.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.6 t -130.22 168.84 16.21 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -103.05 10.06 38.23 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.316 -0.865 . . . . 0.0 109.618 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.39 128.5 33.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.06 -1.025 . . . . 0.0 109.176 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -40.09 81.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.586 -0.696 . . . . 0.0 110.55 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.57 1.61 65.98 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.601 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 136.48 34.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.614 -1.521 . . . . 0.0 109.61 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.1 -26.38 64.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.4 mmm -75.23 52.12 0.57 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.0 t80 -70.17 137.25 86.86 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.954 . . . . 0.0 109.087 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.91 4.63 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 CA-C-N 119.847 0.981 . . . . 0.0 112.184 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.8 p -160.18 176.17 12.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.172 -0.955 . . . . 0.0 109.354 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.4 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 120.835 -1.166 . . . . 0.0 109.452 -179.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -144.57 160.2 41.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.439 -0.788 . . . . 0.0 108.89 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.24 141.05 45.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 109.354 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.19 156.43 16.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -56.61 -39.04 72.89 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.056 -1.027 . . . . 0.0 108.801 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -55.33 -39.99 70.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.83 -40.02 63.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.174 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.86 -51.35 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.0 109.034 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.17 -40.17 96.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.775 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.07 -53.32 41.15 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.309 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -69.02 -39.69 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.912 -1.346 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.9 mt-30 -67.18 -37.97 84.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 109.172 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.9 -50.19 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.793 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -95.31 -69.96 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.16 -0.963 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.61 -168.56 36.12 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 162' ' ' ARG . 30.6 mtm-85 -87.8 150.28 23.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -1.087 . . . . 0.0 108.714 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 C--N 1.301 -1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 108.793 -179.713 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -81.71 125.93 31.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.239 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.7 -16.8 53.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 0.0 109.145 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -82.47 147.44 28.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.2 p -96.08 -4.87 42.12 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -123.38 130.01 52.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.52 150.53 40.09 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -125.63 154.92 41.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.47 159.61 41.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.252 -0.905 . . . . 0.0 109.78 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -148.99 130.31 14.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.385 -0.822 . . . . 0.0 109.318 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.42 127.07 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 108.728 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.88 -40.04 83.61 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -162.91 155.33 18.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.976 -1.077 . . . . 0.0 109.976 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.63 136.32 40.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t -70.49 141.66 88.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.29 -12.65 31.45 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 CA-C-N 119.413 0.826 . . . . 0.0 111.697 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.2 -39.93 88.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 110.5 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -138.38 149.58 63.56 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.062 -1.024 . . . . 0.0 108.39 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.68 -175.93 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.52 0.814 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -85.69 -33.25 21.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.65 74.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.344 -0.847 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.97 -39.99 72.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.13 -42.68 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 109.495 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.6 -44.48 93.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.201 -0.937 . . . . 0.0 109.111 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.21 -46.41 89.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -72.34 -41.05 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.844 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 86.7 tt0 -70.05 -40.89 74.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.966 -1.084 . . . . 0.0 109.751 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -61.35 -35.81 78.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 108.809 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.68 92.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.223 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.2 m-85 -60.19 -40.62 90.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.768 -1.208 . . . . 0.0 109.707 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.479 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -60.69 -39.81 89.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.052 -1.03 . . . . 0.0 110.506 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.67 -46.15 89.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.881 -1.137 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.405 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.6 m95 -71.32 -40.28 70.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.606 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -67.14 -39.16 86.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 111.301 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -56.33 -29.9 61.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.44 11.76 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.867 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.1 p -144.8 150.06 45.17 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.968 -1.083 . . . . 0.0 109.007 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.66 2.22 4.86 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.569 0.846 . . . . 0.0 111.962 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.1 mt -70.74 147.89 48.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.0 p -125.53 149.81 47.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 96.8 m-85 -126.21 152.29 46.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.8 m -153.23 129.92 10.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.899 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -77.08 144.22 38.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.543 -0.723 . . . . 0.0 109.54 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.6 135.4 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 t -95.45 -9.46 32.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -144.23 158.32 43.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.66 172.87 49.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.01 160.88 25.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.592 -0.946 . . . . 0.0 108.958 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.94 52.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.03 -40.6 89.91 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 110.558 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.64 119.91 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.3 mtp -102.22 131.6 48.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -0.798 . . . . 0.0 109.481 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -111.62 131.72 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -145.54 160.1 42.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.092 -1.005 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -116.96 136.65 52.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.23 160.01 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.296 -0.877 . . . . 0.0 110.601 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -126.75 137.14 53.19 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.77 -149.51 1.63 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -66.5 130.29 42.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -1.085 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.522 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.2 p-80 -130.89 47.57 2.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.687 -0.633 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 64.6 mtp180 59.54 51.83 6.19 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.161 0.505 . . . . 0.0 109.912 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.522 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 7.5 m-20 -137.67 167.72 21.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.383 -0.823 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -90.69 8.8 32.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 m -137.0 71.88 55.07 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.802 . . . . 0.0 109.133 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.54 146.55 55.67 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 121.184 1.256 . . . . 0.0 111.697 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.68 148.69 36.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -106.27 70.75 0.85 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.438 -0.789 . . . . 0.0 109.423 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.11 -157.58 2.52 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.28 -19.53 17.08 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 118.571 1.185 . . . . 0.0 112.179 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.2 -177.47 41.9 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.56 -166.93 38.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -72.02 152.02 42.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -1.132 . . . . 0.0 109.845 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.68 -18.01 23.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.62 165.3 8.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -162.85 -179.31 6.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.48 166.47 22.64 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -95.8 159.71 14.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 109.937 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.25 150.95 39.43 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.534 -0.729 . . . . 0.0 109.241 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -62.02 104.82 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.501 0.801 . . . . 0.0 112.198 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 174.61 37.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.89 171.57 15.45 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.868 1.045 . . . . 0.0 112.318 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 -126.72 17.38 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -73.88 -13.22 15.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.338 -1.095 . . . . 0.0 109.258 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 144.0 45.48 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.58 18.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.97 126.08 28.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.301 . . . . 0.0 110.197 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.74 129.92 51.18 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -102.46 142.54 33.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.288 -0.883 . . . . 0.0 109.833 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -120.18 136.88 54.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.718 -0.614 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.19 121.15 17.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 109.652 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -97.79 -4.53 36.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.55 -16.02 59.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.02 -1.05 . . . . 0.0 109.135 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -93.24 158.24 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.9 ttm-85 -87.9 115.11 25.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 108.796 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.66 139.83 30.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.5 p -127.54 166.66 17.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.473 -0.767 . . . . 0.0 109.644 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -111.45 33.28 4.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -151.75 -165.97 2.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -84.89 32.01 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.95 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -76.14 -161.66 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.1 -59.23 3.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 111.59 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -121.31 132.25 54.68 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.099 -1.001 . . . . 0.0 111.143 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.13 124.27 49.45 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.98 -39.8 75.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -58.46 -45.33 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 111.224 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.2 -44.27 95.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.28 . . . . 0.0 110.526 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.48 -41.05 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.019 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.16 93.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.061 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.22 86.34 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.647 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 56.0 t60 -70.06 -41.59 73.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 110.072 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -58.25 -42.06 85.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.058 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.42 -40.09 93.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 108.942 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.29 -40.08 83.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.647 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 20.5 m-70 -66.12 -34.91 79.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -1.206 . . . . 0.0 109.106 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.0 t -69.09 -29.05 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.57 -4.99 57.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.5 19.14 57.41 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.073 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.25 130.11 34.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.823 -1.398 . . . . 0.0 109.094 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 m -86.98 167.47 14.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 109.106 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -63.88 159.75 19.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -128.05 166.82 17.69 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.615 -0.678 . . . . 0.0 109.418 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -107.75 9.1 29.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 11.7 t70 -81.73 129.24 34.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.09 -39.47 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -74.75 -3.22 66.82 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.048 -1.033 . . . . 0.0 111.475 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 137.21 33.54 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.714 -1.462 . . . . 0.0 110.428 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.53 -27.55 65.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 0.0 108.961 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 40.0 mtp -76.64 58.67 1.42 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.864 . . . . 0.0 109.865 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -71.83 132.15 85.24 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.33 -68.18 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.211 0 CA-C-N 120.198 1.106 . . . . 0.0 111.057 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.0 p -86.33 175.29 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.42 -0.8 . . . . 0.0 109.773 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 108.444 179.271 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.436 0.636 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.49 150.55 39.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 143.72 40.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.825 -1.172 . . . . 0.0 109.298 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.84 156.43 19.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.04 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.75 -40.06 86.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' OD1' ' C ' ' A' ' 151' ' ' ASP . 48.6 t0 -58.76 -40.34 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.75 -40.2 66.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.585 -1.322 . . . . 0.0 109.205 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.51 -48.13 88.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.923 -1.111 . . . . 0.0 110.473 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.94 38.17 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 121.037 -1.039 . . . . 0.0 111.619 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.28 -38.75 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.83 -1.394 . . . . 0.0 109.549 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -64.41 -39.95 94.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 108.57 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.99 97.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.0 109.293 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.38 -50.09 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.037 -1.039 . . . . 0.0 109.593 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -100.66 -67.79 0.84 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.352 -0.843 . . . . 0.0 109.144 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.29 -169.77 34.91 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.11 152.33 22.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.243 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.402 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 . . . . . 0 N--CA 1.501 2.105 0 CA-C-O 121.452 0.644 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -84.36 124.87 31.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.323 -0.861 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.71 -12.68 59.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.884 -1.135 . . . . 0.0 110.63 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 19.2 pt20 -86.86 155.96 20.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.88 -1.138 . . . . 0.0 109.428 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -96.58 -4.2 41.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.071 -1.018 . . . . 0.0 109.672 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.3 m170 -117.75 130.94 56.62 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 HE21 ' A' ' 11' ' ' GLN . 73.2 mt -118.95 154.21 33.37 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.3 p -128.92 153.17 47.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.272 -0.892 . . . . 0.0 108.698 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.16 162.07 37.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.079 -1.013 . . . . 0.0 109.49 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 17' ' ' ARG . 16.6 ttt-85 -146.98 136.77 23.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 0.0 110.395 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 86.1 mt -89.33 111.47 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.6 tp10 -64.58 -38.78 92.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.486 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 61.5 m-80 -156.64 146.49 20.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.099 . . . . 0.0 110.264 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.76 138.98 32.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR . 9.7 t -70.01 134.95 87.43 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.085 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -64.11 -13.73 39.44 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 120.017 1.042 . . . . 0.0 111.533 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.873 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.2 mt -134.75 149.57 71.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.69 -175.53 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 120.708 0.938 . . . . 0.0 111.978 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -88.16 -35.58 17.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.12 79.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.566 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.12 -39.98 68.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.204 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.6 t -68.9 -40.84 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.142 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -40.11 88.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 108.824 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -56.7 -50.38 72.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 109.426 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.51 92.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 110.333 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.0 mm -69.94 -39.09 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.083 -1.011 . . . . 0.0 109.762 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.29 -41.44 89.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -63.28 -39.92 95.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.962 -1.087 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.88 75.72 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.803 -1.185 . . . . 0.0 109.206 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 38.1 m-85 -60.97 -40.78 94.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 109.159 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 19.2 mm100 -60.27 -43.23 96.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.97 -41.42 91.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.964 -1.085 . . . . 0.0 110.28 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.5 m95 -74.28 -41.28 61.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.704 -1.247 . . . . 0.0 110.028 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.1 -30.41 69.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 6.2 m120 -58.82 -32.91 69.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.282 -0.886 . . . . 0.0 111.22 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.55 8.26 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.3 p -143.83 148.87 44.25 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.915 -1.116 . . . . 0.0 109.843 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.66 6.58 1.55 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.015 1.143 . . . . 0.0 111.655 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.7 mt -70.24 152.25 44.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.382 -0.823 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.0 p -130.31 150.92 51.33 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 95.3 m-85 -125.86 157.15 38.34 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.5 -0.75 . . . . 0.0 109.952 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.7 m -154.89 126.98 7.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.392 -0.817 . . . . 0.0 109.866 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.585 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 64.2 tttp -81.37 139.73 35.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 136.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.477 -0.764 . . . . 0.0 109.012 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -95.3 -0.75 52.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.116 -0.99 . . . . 0.0 109.148 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -149.36 159.21 44.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.391 -0.818 . . . . 0.0 109.419 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.25 164.69 36.58 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.41 139.24 39.65 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -1.166 . . . . 0.0 108.075 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.34 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 109.439 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 93.5 m-20 -60.17 -40.71 90.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.462 -0.774 . . . . 0.0 110.006 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.03 118.56 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.83 123.58 45.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 108.956 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -113.04 129.96 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.471 -0.768 . . . . 0.0 109.035 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -146.34 152.61 39.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 109.728 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.58 138.12 40.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.1 162.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.984 . . . . 0.0 110.818 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.11 152.63 51.92 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.39 -151.74 0.62 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.49 130.2 41.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.957 . . . . 0.0 110.392 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 17.3 p-80 -135.63 49.27 2.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.493 -0.754 . . . . 0.0 109.073 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 55.07 56.95 5.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.5 t0 -142.52 160.28 40.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.326 -0.859 . . . . 0.0 108.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 50.5 t30 -88.93 7.53 34.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.084 -1.01 . . . . 0.0 110.047 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 72.4 m -136.11 71.24 62.06 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.0 108.925 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 144.29 75.88 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 120.919 1.079 . . . . 0.0 111.9 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.52 147.97 37.42 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.405 -0.809 . . . . 0.0 109.432 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -128.72 77.1 1.76 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.557 -0.714 . . . . 0.0 109.659 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.19 -174.27 26.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.42 -5.15 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.105 1.203 . . . . 0.0 112.392 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.76 179.19 44.29 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.81 -165.94 49.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.45 151.05 42.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.967 . . . . 0.0 109.412 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.3 mt -91.08 -17.56 26.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.42 164.67 8.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.016 -1.053 . . . . 0.0 109.85 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -160.37 177.32 10.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.266 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.87 174.7 9.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.201 -0.937 . . . . 0.0 109.766 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -109.05 153.26 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.645 -0.659 . . . . 0.0 109.897 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.93 151.57 64.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -58.01 104.85 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 120.956 1.104 . . . . 0.0 112.196 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.22 171.41 37.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.81 173.06 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.466 1.444 . . . . 0.0 111.81 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 -127.72 29.44 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.451 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.19 -7.1 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.604 -0.939 . . . . 0.0 110.234 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.31 47.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.3 -21.52 28.03 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 121.246 -1.149 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.33 156.1 35.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -1.197 . . . . 0.0 110.69 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 121.51 11.49 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.6 142.89 29.61 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.211 -0.931 . . . . 0.0 110.88 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.512 ' CE2' ' OE1' ' A' ' 119' ' ' GLU . 26.6 m-85 -119.96 134.59 55.2 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.73 116.58 8.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.493 -0.755 . . . . 0.0 109.025 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -99.58 2.26 44.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.14 -14.85 60.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.57 161.86 13.32 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.5 117.82 26.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -93.1 149.5 21.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.749 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.429 ' HB ' HD21 ' A' ' 106' ' ' ASN . 56.8 p -127.56 166.58 17.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.62 31.41 6.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.621 -0.674 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.57 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.91 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.088 -1.007 . . . . 0.0 109.896 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 53.3 t80 -81.11 33.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.508 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 18.2 mmm180 -76.58 -165.91 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.071 -1.018 . . . . 0.0 110.351 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -59.66 -56.99 14.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 0.0 111.794 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -93.62 125.14 38.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 110.223 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -104.42 104.57 14.46 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -70.02 -39.99 75.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -59.63 -47.43 85.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.908 -1.12 . . . . 0.0 110.781 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 110.548 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 59.5 t -69.76 -41.54 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.876 -1.14 . . . . 0.0 109.608 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.6 86.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.04 92.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.077 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.755 ' HE2' ' CE1' ' A' ' 122' ' ' HIS . 5.6 t60 -68.32 -43.93 76.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 110.726 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.512 ' OE1' ' CE2' ' A' ' 97' ' ' PHE . 5.5 mp0 -59.51 -40.69 87.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.597 -1.315 . . . . 0.0 109.633 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.12 -39.99 92.09 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.971 -1.081 . . . . 0.0 108.45 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.06 -41.97 98.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.755 ' CE1' ' HE2' ' A' ' 118' ' ' HIS . 4.2 m-70 -64.2 -36.21 83.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.019 -1.283 . . . . 0.0 108.653 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.4 t -69.96 -22.79 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.346 -0.846 . . . . 0.0 108.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.82 -3.75 58.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.09 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.11 21.27 55.66 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 120.401 -0.905 . . . . 0.0 110.932 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.72 135.92 34.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.38 . . . . 0.0 109.684 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.1 m -88.74 166.87 13.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.375 -0.828 . . . . 0.0 110.145 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -68.01 161.94 25.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.5 t -125.7 160.96 28.37 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.41 -0.806 . . . . 0.0 109.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 82.5 p -99.99 9.39 42.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.7 t0 -83.3 130.18 35.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt -62.01 -40.42 87.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 111.12 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.14 65.87 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.959 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.34 130.09 35.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.746 -1.444 . . . . 0.0 109.498 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.12 -34.34 73.38 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.9 mmm -72.31 44.95 0.12 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.793 -0.567 . . . . 0.0 110.894 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -69.29 139.95 90.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.6 -55.84 3.61 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 120.216 1.113 . . . . 0.0 111.484 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 140' ' ' TYR . 9.3 t -100.34 176.12 5.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.408 ' N ' ' OG ' ' A' ' 139' ' ' SER . 65.0 t80 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 109.37 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.429 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 57.6 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.55 0.69 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -150.41 149.44 30.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.426 HD22 ' CH2' ' A' ' 41' ' ' TRP . 69.4 mt -76.79 148.77 36.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.693 -1.254 . . . . 0.0 109.225 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.02 159.72 15.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.052 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 108.914 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -58.19 -40.0 80.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.257 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.23 -41.83 60.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.31 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.17 -49.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.852 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.813 -1.179 . . . . 0.0 109.259 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -57.89 16.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.95 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -64.55 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.86 -1.376 . . . . 0.0 110.08 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.74 -40.05 88.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.004 . . . . 0.0 109.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.32 96.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 109.674 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.87 -50.23 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.95 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.35 -64.25 1.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.271 -0.893 . . . . 0.0 109.752 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.03 170.9 30.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 162' ' ' ARG . 46.4 mtt-85 -90.24 138.01 31.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.0 109.373 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 C--N 1.303 -1.452 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.461 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -84.07 133.38 34.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 108.993 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.56 -36.6 60.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.043 -1.035 . . . . 0.0 110.377 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.413 HE21 HD23 ' A' ' 14' ' ' LEU . 20.3 pt20 -80.01 155.29 27.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.02 -1.05 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -95.18 -2.73 49.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -111.62 135.51 52.11 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD23 HE21 ' A' ' 11' ' ' GLN . 68.5 mt -134.48 159.92 39.63 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.211 -0.93 . . . . 0.0 109.515 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.2 p -130.91 152.9 49.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.615 -0.678 . . . . 0.0 109.24 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.49 158.41 43.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.469 HH12 ' HA ' ' A' ' 54' ' ' GLU . 69.6 ttt180 -150.73 137.06 18.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 0.0 109.244 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.67 122.09 42.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.53 -40.11 95.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.618 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -160.01 158.43 30.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.293 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.54 133.98 44.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.366 -0.834 . . . . 0.0 109.28 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -70.99 143.66 89.2 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.95 -10.85 24.44 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 CA-C-N 119.728 0.938 . . . . 0.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.17 -40.04 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.893 . . . . 0.0 110.263 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.7 mt -139.54 150.12 62.42 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.4 Cg_endo -60.46 -174.77 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 120.77 0.98 . . . . 0.0 112.331 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -89.45 -37.13 15.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.96 94.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -71.36 -37.43 71.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.879 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' PRO . 51.7 t -69.7 -40.45 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -59.98 -41.68 92.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.557 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -60.45 -45.27 94.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.536 -0.727 . . . . 0.0 109.32 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.75 -44.98 93.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.157 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.33 -41.74 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.584 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.95 -39.7 75.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.014 -1.054 . . . . 0.0 109.927 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.99 -39.3 85.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.34 94.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 109.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.9 m-85 -60.95 -39.77 90.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.077 -1.014 . . . . 0.0 109.381 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.85 -39.89 86.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 40' ' ' LEU . 91.0 mt -60.08 -42.17 94.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -71.35 -42.92 67.9 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.353 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.8 t -69.86 -25.23 63.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.404 -0.81 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.083 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 45' ' ' THR . 19.6 m -109.33 10.88 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.164 -0.96 . . . . 0.0 110.873 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.639 HG23 HG23 ' A' ' 44' ' ' VAL . 38.1 p -139.95 143.3 33.81 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.002 -1.061 . . . . 0.0 109.505 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.47 13.49 0.44 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.182 1.254 . . . . 0.0 111.746 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.66 160.54 32.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 108.893 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 p -137.22 149.2 47.03 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.4 154.25 47.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.761 -0.587 . . . . 0.0 109.536 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -153.08 130.05 11.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 109.748 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -81.77 139.87 34.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.14 139.65 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.5 t -99.89 -6.32 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.368 -0.832 . . . . 0.0 110.238 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.5 mt-10 -144.48 156.79 44.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.157 -0.964 . . . . 0.0 108.772 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 169.9 39.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -84.63 139.44 32.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -1.204 . . . . 0.0 109.655 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.2 156.1 17.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.64 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.1 -39.59 86.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.869 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.94 118.6 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.323 -0.86 . . . . 0.0 109.437 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.7 mmm -100.38 133.77 44.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 108.949 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.1 130.72 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.568 -0.708 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.0 p -149.76 167.73 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.588 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.33 137.65 51.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.72 159.84 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.278 -0.889 . . . . 0.0 110.841 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -125.29 135.35 52.4 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.14 -130.65 4.53 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -81.02 129.82 34.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -1.101 . . . . 0.0 109.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 29.4 p-80 -136.44 51.21 2.01 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.41 54.99 5.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.771 -0.581 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.3 p-10 -141.01 170.21 16.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.047 -1.033 . . . . 0.0 109.457 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -91.92 9.64 32.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 t -140.52 74.95 27.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -71.27 139.09 34.41 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.533 1.488 . . . . 0.0 112.17 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.76 148.14 36.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.105 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -133.27 77.19 1.72 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.563 -0.711 . . . . 0.0 109.819 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.52 177.28 42.93 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.065 -1.022 . . . . 0.0 110.747 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -68.83 -23.04 35.73 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.501 1.467 . . . . 0.0 112.312 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.79 -177.56 51.08 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.64 -153.39 27.24 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.57 144.11 44.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.85 -19.93 19.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.43 170.66 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 0.0 109.429 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.57 179.33 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 109.976 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.97 170.0 17.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.71 154.5 19.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.699 . . . . 0.0 109.452 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -60.07 150.54 69.95 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.228 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.44 102.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.563 0.842 . . . . 0.0 111.957 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.18 171.24 33.38 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.83 169.83 15.39 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.033 1.155 . . . . 0.0 111.966 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.98 -123.18 14.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -77.81 -13.1 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.027 . . . . 0.0 109.587 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.08 140.54 44.69 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.59 -17.22 50.59 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -66.26 158.32 29.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.323 -1.104 . . . . 0.0 109.757 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 118.97 6.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.171 -0.956 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.36 145.87 28.34 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.5 -0.75 . . . . 0.0 110.832 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 24.6 m-85 -116.19 139.11 50.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.758 -0.589 . . . . 0.0 109.679 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.85 118.79 10.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 108.489 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -97.38 -1.03 45.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 109.769 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.29 -20.03 59.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.049 -1.032 . . . . 0.0 109.542 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -98.04 162.34 13.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.7 121.33 29.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.815 -1.178 . . . . 0.0 109.056 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -89.13 135.45 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 109.522 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 p -128.82 170.06 13.81 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.0 109.473 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -118.71 27.12 9.1 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.573 -0.705 . . . . 0.0 110.172 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.774 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.9 -167.02 2.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 0.0 110.538 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -59.97 10.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.312 -0.868 . . . . 0.0 111.6 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 106' ' ' ASN . 96.4 mtt180 -76.24 166.32 23.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.724 -1.235 . . . . 0.0 110.154 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 108' ' ' ARG . 41.3 mp0 -4.89 -76.9 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -131.74 150.98 51.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.204 -0.935 . . . . 0.0 110.416 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 82.5 m-20 -99.36 119.99 38.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 tp -65.3 -40.11 93.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.223 -0.923 . . . . 0.0 110.59 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -59.97 -42.18 93.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.6 t -70.12 -41.57 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.4 91.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.35 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.05 88.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.067 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 5.9 t60 -66.81 -45.78 77.26 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.355 -0.841 . . . . 0.0 109.643 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.3 mt-10 -59.72 -39.38 84.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 109.304 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.2 -39.64 90.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.998 . . . . 0.0 109.12 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.85 93.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.524 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 7.6 m-70 -67.7 -38.48 83.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 0.0 109.022 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.5 p -70.11 -22.54 63.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.62 -3.35 59.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 109.239 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.97 72.72 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.86 131.23 35.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.345 . . . . 0.0 109.122 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.3 m -88.49 171.34 10.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 109.897 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -66.77 160.02 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.434 -0.791 . . . . 0.0 109.761 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -124.6 168.04 13.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.0 109.137 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.8 p -104.93 3.64 31.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 109.479 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 120.69 26.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.961 . . . . 0.0 109.312 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 tt -55.95 -29.97 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.21 0.74 83.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.681 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.48 135.95 34.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.785 -1.42 . . . . 0.0 109.546 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.14 -27.41 65.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 0.0 108.653 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.8 mmm -79.02 40.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.713 . . . . 0.0 110.033 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -69.88 133.87 88.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 108.982 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -46.91 -67.5 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.805 0.966 . . . . 0.0 112.207 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.5 m -82.63 175.51 10.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.7 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.911 -1.118 . . . . 0.0 109.329 -179.874 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.5 t . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -142.28 160.89 39.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.159 -0.963 . . . . 0.0 109.137 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.42 131.74 42.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.029 . . . . 0.0 109.267 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.27 166.45 13.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.541 -0.724 . . . . 0.0 109.157 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.842 . . . . 0.0 108.856 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.35 -39.69 80.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.25 -42.78 59.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.957 -1.089 . . . . 0.0 109.516 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.15 -51.59 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.159 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.4 -39.84 92.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.797 -1.19 . . . . 0.0 110.233 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.44 49.22 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.231 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.19 -37.54 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.305 . . . . 0.0 109.999 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.1 mt-30 -67.59 -40.65 84.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.82 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.09 89.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.131 -0.98 . . . . 0.0 109.484 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.47 -51.04 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.08 . . . . 0.0 109.647 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -98.52 -67.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.097 -1.002 . . . . 0.0 109.953 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.88 -169.25 38.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -96.62 138.49 34.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -1.08 . . . . 0.0 109.243 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--N 1.303 -1.419 0 O-C-N 121.022 -1.049 . . . . 0.0 108.969 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH1' HD13 ' A' ' 159' ' ' ILE . 30.1 mmt180 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -82.75 120.05 25.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.173 -0.954 . . . . 0.0 109.12 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.71 -12.62 55.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.776 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -83.29 150.63 26.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.2 p -95.69 -4.22 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.226 -0.921 . . . . 0.0 108.975 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.55 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 54.3 m-70 -130.57 144.78 51.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -136.12 158.88 43.34 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.8 p -124.24 155.79 37.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.366 -0.834 . . . . 0.0 109.205 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.97 158.42 43.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.787 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.441 HH21 ' CE ' ' A' ' 60' ' ' MET . 44.0 ttp180 -149.88 130.4 13.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.488 -0.757 . . . . 0.0 109.809 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -90.17 115.77 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.85 -39.73 94.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.473 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -159.46 152.62 22.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.791 -1.193 . . . . 0.0 110.701 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -97.93 135.28 39.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -70.04 138.02 87.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.036 . . . . 0.0 109.869 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.31 -12.5 30.75 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 119.619 0.9 . . . . 0.0 111.818 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.16 -39.43 86.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 109.817 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 105' ' ' ASN . 93.9 mt -138.81 150.47 65.67 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.31 -171.77 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.385 0.723 . . . . 0.0 111.794 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -86.5 -37.36 18.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.24 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.87 -40.74 75.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.295 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -70.23 -42.65 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 108.909 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.105 . . . . 0.0 108.998 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 45.9 t60 -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.626 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.84 82.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.22 -39.78 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.32 -47.41 79.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.774 -1.203 . . . . 0.0 109.786 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 36.1 mttp -64.03 -33.64 76.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.788 -1.195 . . . . 0.0 110.075 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.77 -50.98 71.69 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.813 -1.179 . . . . 0.0 109.025 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.4 -40.0 95.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -59.98 -43.34 95.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.8 -44.35 94.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 0.0 110.505 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.56 -40.07 70.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 109.67 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.9 t -69.81 -38.52 76.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.68 -30.57 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.201 -0.937 . . . . 0.0 110.898 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 45' ' ' THR . 35.9 m -106.4 11.14 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.204 -0.935 . . . . 0.0 109.842 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 44' ' ' VAL . 81.4 p -142.08 146.21 39.19 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.97 5.38 2.61 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 120.859 1.039 . . . . 0.0 111.577 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -71.73 162.18 29.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.437 -0.79 . . . . 0.0 109.11 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 24.4 p -137.8 150.78 47.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -125.0 155.73 39.22 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.525 -0.734 . . . . 0.0 109.615 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.9 m -153.77 132.39 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -77.57 140.75 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.624 -0.673 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.85 130.56 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.519 -0.738 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -95.56 -3.39 46.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.31 151.0 35.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.126 -0.984 . . . . 0.0 109.469 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.17 168.54 44.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.89 140.28 35.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -1.168 . . . . 0.0 108.956 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.62 148.58 25.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.64 -43.74 93.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.17 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -111.48 110.56 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 109.555 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.441 ' CE ' HH21 ' A' ' 17' ' ' ARG . 85.8 mtp -102.46 124.81 48.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.11 129.97 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 0.0 109.109 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.8 p -146.75 156.25 43.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.084 -1.01 . . . . 0.0 110.222 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -107.02 135.46 48.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.77 159.99 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 55.0 mtt-85 -123.77 138.93 54.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 109.802 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.36 -139.34 1.24 Allowed Glycine 0 N--CA 1.498 2.802 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.87 122.43 19.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.967 . . . . 0.0 109.427 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -135.17 66.29 1.53 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.431 -0.793 . . . . 0.0 109.866 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 53.69 50.34 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.98 . . . . 0.0 108.61 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 13.9 t0 -141.93 157.83 44.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 109.231 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 27.7 m120 -93.78 8.79 39.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.213 -0.929 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -136.81 74.25 51.89 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.203 -0.936 . . . . 0.0 109.286 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.47 147.32 86.81 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.281 1.32 . . . . 0.0 111.991 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.41 136.91 38.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.068 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -103.23 67.42 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.379 -0.826 . . . . 0.0 109.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.11 -175.02 37.73 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -70.57 -10.67 28.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.061 1.174 . . . . 0.0 111.944 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.33 179.55 40.64 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.06 -146.68 21.32 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.38 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 82' ' ' ALA . 13.1 t-20 -73.77 131.89 42.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.47 -1.018 . . . . 0.0 110.292 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.45 -18.23 24.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.061 -1.024 . . . . 0.0 109.157 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.88 164.51 7.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.001 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -161.21 125.47 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.977 -1.077 . . . . 0.0 110.68 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.57 168.26 14.65 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.682 -0.636 . . . . 0.0 109.292 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.02 142.15 35.32 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.41 147.87 56.93 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.939 -1.101 . . . . 0.0 109.334 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.17 123.16 12.58 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.42 0.747 . . . . 0.0 111.65 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -179.34 175.69 47.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -73.95 163.31 37.22 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.857 1.038 . . . . 0.0 111.908 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' GLY . . . 74.05 -147.33 37.79 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 tt -50.14 -8.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -1.07 . . . . 0.0 110.19 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 90' ' ' GLY . . . -60.5 142.27 47.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.79 -16.11 55.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.86 159.62 30.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.395 -1.062 . . . . 0.0 110.125 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.56 124.38 22.6 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -106.02 130.15 54.0 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.394 -0.817 . . . . 0.0 110.443 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.557 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.5 m-85 -114.18 134.33 54.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.561 -0.712 . . . . 0.0 109.611 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 98' ' ' ASP . 57.5 t0 -63.34 119.09 9.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 109.608 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.411 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.9 tt0 -101.13 -1.45 33.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.586 -0.696 . . . . 0.0 109.267 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -75.96 -19.83 58.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -101.82 156.6 17.41 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.476 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 44.4 ttp180 -87.23 125.13 34.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.051 -1.031 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.06 149.85 22.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 0.0 109.86 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.7 p -131.69 169.97 15.43 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.366 -0.833 . . . . 0.0 109.175 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.45 HD21 HD13 ' A' ' 25' ' ' LEU . 82.7 m-20 -111.63 23.93 13.34 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.428 -0.795 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.703 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.99 -165.0 2.13 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.909 -1.12 . . . . 0.0 109.995 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.74 22.19 0.06 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.128 -0.982 . . . . 0.0 111.51 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.9 mtp180 -76.66 -163.65 0.35 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.646 -1.284 . . . . 0.0 110.059 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.6 mt-10 -25.2 -67.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -141.4 159.17 42.79 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.905 -1.122 . . . . 0.0 110.842 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 68.8 m-80 -107.45 110.93 23.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -41.48 92.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.372 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.91 -46.92 87.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.922 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.33 -39.73 88.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.825 -1.172 . . . . 0.0 110.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.45 -40.21 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.989 -1.069 . . . . 0.0 108.407 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -41.88 91.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.386 -0.822 . . . . 0.0 109.014 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.088 -1.008 . . . . 0.0 109.724 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.22 -51.81 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 109.183 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.557 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 57.9 mt-10 -58.48 -40.97 84.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -63.4 -39.91 95.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.071 -1.018 . . . . 0.0 109.213 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.39 -38.66 93.74 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -64.21 -35.94 82.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 108.698 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.5 m -69.55 -25.47 64.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 108.726 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.03 -0.68 56.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.31 13.6 70.6 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.842 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.6 128.96 34.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.488 . . . . 0.0 108.919 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.14 170.96 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.607 -0.683 . . . . 0.0 109.703 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.95 156.36 37.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.862 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.4 t -124.97 165.04 18.85 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.1 p -102.04 0.89 35.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.456 -0.777 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -78.33 128.13 33.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.9 tt -58.71 -29.28 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.0 110.497 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.82 3.28 84.14 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.474 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.87 128.92 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.941 -1.329 . . . . 0.0 109.775 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 -31.79 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.453 -0.78 . . . . 0.0 109.146 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 36.4 mtp -74.42 47.76 0.31 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.99 130.92 91.14 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.0 108.948 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -45.63 -68.17 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 CA-C-N 119.99 1.032 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.2 p -80.15 171.02 15.63 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.138 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.6 t80 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 108.881 179.732 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 25.4 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.503 0.668 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -148.45 150.9 34.29 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.3 mt -75.24 147.95 39.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 0.0 109.017 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.16 158.42 16.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 109.06 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -60.04 -40.42 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.735 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.8 t0 -58.98 -40.2 84.1 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -74.27 -39.99 62.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.475 HG22 ' NE2' ' A' ' 157' ' ' GLN . 96.9 mt -63.42 -50.03 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.96 -39.95 96.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.91 21.61 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.771 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -60.06 -39.54 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.852 -1.381 . . . . 0.0 109.659 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 33.1 mt-30 -66.13 -37.53 85.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 108.972 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.28 96.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.443 HD13 ' NH1' ' A' ' 8' ' ' ARG . 96.8 mt -62.27 -48.44 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.08 -67.79 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.98 -178.12 37.94 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -88.76 150.61 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.427 -1.043 . . . . 0.0 109.296 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.044 -1.035 . . . . 0.0 109.043 179.666 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -84.13 130.13 34.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -0.867 . . . . 0.0 108.846 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.51 -32.96 62.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.959 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.53 HE21 HD23 ' A' ' 14' ' ' LEU . 15.0 pt20 -82.36 153.34 25.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 0.0 109.685 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -93.92 -4.09 50.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.228 -0.92 . . . . 0.0 108.669 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -108.33 130.63 55.19 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.53 HD23 HE21 ' A' ' 11' ' ' GLN . 82.3 mt -126.28 152.42 46.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.474 -0.766 . . . . 0.0 109.486 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 p -124.04 150.45 44.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.488 -0.758 . . . . 0.0 109.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -144.63 161.38 39.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 109.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -151.32 133.62 15.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.415 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.35 116.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.34 -39.34 92.27 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.727 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -159.82 147.39 16.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.655 -1.278 . . . . 0.0 110.508 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.15 134.19 41.54 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -71.45 145.83 90.87 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.793 -1.192 . . . . 0.0 108.572 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.27 -8.62 19.24 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 119.391 0.818 . . . . 0.0 112.015 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.88 -39.91 86.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 mt -135.88 153.16 76.93 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.5 Cg_endo -66.26 -176.56 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.389 0.818 . . . . 0.0 111.001 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.0 -38.83 15.18 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.967 -1.083 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.25 93.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.16 -39.14 72.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 26' ' ' PRO . 54.3 t -67.15 -39.51 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 44.3 t0 -59.71 -40.45 87.98 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.526 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -60.17 -45.46 93.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 109.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.35 92.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 109.205 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -71.82 -40.19 68.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.494 -0.754 . . . . 0.0 110.042 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.15 -39.64 78.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -61.89 -39.87 93.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.786 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.12 93.66 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.308 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -59.92 -39.02 84.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.005 -1.059 . . . . 0.0 108.779 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.492 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.71 -45.63 91.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 109.678 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.2 m95 -74.69 -45.29 45.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -65.1 -37.41 87.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.843 . . . . 0.0 110.822 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.34 -23.34 64.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.543 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.81 7.19 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.413 -0.804 . . . . 0.0 110.71 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.42 ' N ' ' OG ' ' A' ' 163' ' ' SER . 11.3 p -145.31 150.06 43.4 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.109 -0.994 . . . . 0.0 109.101 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -72.11 9.51 1.1 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.451 0.767 . . . . 0.0 111.684 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.12 150.0 42.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.307 -0.871 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.9 p -130.25 148.2 52.06 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 14' ' ' LEU . 97.3 m-85 -128.02 153.44 46.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.699 -0.625 . . . . 0.0 109.891 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -155.28 133.05 11.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.199 -0.938 . . . . 0.0 110.017 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.22 144.59 40.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.16 135.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -98.69 -4.38 33.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.739 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -144.22 147.78 34.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.04 172.12 48.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -82.59 149.74 27.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 109.331 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.44 152.26 24.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.55 -0.719 . . . . 0.0 109.102 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.1 -44.84 94.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.342 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -114.05 112.21 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.755 0.788 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.5 mtp -99.06 131.17 45.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.69 129.19 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.6 p -153.12 159.81 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.4 140.24 46.15 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.86 167.62 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.37 -0.831 . . . . 0.0 111.055 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.43 138.98 40.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.0 109.601 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.23 -139.82 10.7 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -73.39 129.04 37.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -1.004 . . . . 0.0 110.095 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 3.4 p-80 -133.0 60.83 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.256 -0.902 . . . . 0.0 109.619 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 57.66 47.26 16.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.469 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 93.3 m-20 -141.73 163.73 32.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.58 -0.7 . . . . 0.0 109.454 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -96.0 9.59 40.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.316 -0.865 . . . . 0.0 109.776 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -134.04 73.0 71.33 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.341 -0.849 . . . . 0.0 109.599 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -64.31 158.97 45.99 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.986 1.124 . . . . 0.0 112.143 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.79 152.03 31.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -110.36 67.88 0.65 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.525 -0.735 . . . . 0.0 109.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.85 -170.99 31.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.27 -16.78 23.53 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.323 1.349 . . . . 0.0 112.701 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.32 -175.25 46.27 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.16 -150.54 27.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -77.27 144.17 38.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.432 -1.04 . . . . 0.0 109.485 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.76 -18.33 25.15 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.954 -1.091 . . . . 0.0 109.067 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.16 166.06 9.04 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.352 -0.842 . . . . 0.0 108.83 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 83' ' ' HIS . 2.8 p80 -162.5 114.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.962 -1.086 . . . . 0.0 110.346 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.61 173.46 9.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -109.23 160.8 15.82 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -58.11 148.33 61.84 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.021 -1.049 . . . . 0.0 109.242 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.61 103.66 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.773 0.982 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -169.01 169.57 41.94 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -173.32 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.141 1.227 . . . . 0.0 112.81 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.43 -126.41 42.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -82.44 -8.43 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -1.057 . . . . 0.0 110.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.1 138.76 48.59 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.63 63.23 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.198 -1.177 . . . . 0.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.94 130.15 41.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.962 -1.317 . . . . 0.0 110.491 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.89 116.15 31.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.165 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -100.86 132.71 46.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.072 -1.017 . . . . 0.0 109.834 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.51 131.26 55.53 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.392 -0.818 . . . . 0.0 109.902 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.6 127.27 31.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.395 -0.815 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.64 3.98 42.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.104 -0.997 . . . . 0.0 109.97 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.38 -20.04 60.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.022 -1.049 . . . . 0.0 109.334 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -101.91 157.36 16.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 108.804 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -86.35 125.77 33.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 108.625 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -91.11 140.35 29.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.1 p -129.23 163.27 25.98 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -108.66 31.31 5.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.466 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -148.55 -164.99 2.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 109.855 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.54 28.26 0.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -76.56 -163.56 0.34 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -43.63 -60.97 1.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 111.909 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.2 m-85 -125.73 135.49 52.13 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.617 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -103.1 117.16 33.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.98 -41.7 96.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.844 -1.16 . . . . 0.0 109.76 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.43 -49.58 77.0 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.728 -0.608 . . . . 0.0 112.458 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -59.73 -42.91 94.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.232 -1.542 . . . . 0.0 110.453 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.29 -39.79 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.094 -1.004 . . . . 0.0 109.426 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.92 86.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.345 -0.847 . . . . 0.0 109.089 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.44 90.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.026 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.588 ' ND1' ' SD ' ' A' ' 136' ' ' MET . 3.2 t60 -68.13 -42.45 80.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.907 -1.12 . . . . 0.0 110.223 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -57.71 -40.13 78.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 109.329 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.69 -39.92 90.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.994 -1.066 . . . . 0.0 109.177 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.28 -38.21 77.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' NE2' ' CE1' ' A' ' 118' ' ' HIS . 47.8 m-70 -66.61 -34.76 78.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.082 -1.246 . . . . 0.0 109.305 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -70.21 -23.97 63.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.12 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.96 -5.63 58.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 108.771 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.96 58.16 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.03 131.47 35.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.117 -1.226 . . . . 0.0 108.707 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.7 m -87.18 169.86 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.091 -1.005 . . . . 0.0 109.511 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.52 161.73 27.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.513 -0.742 . . . . 0.0 109.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.5 t -126.96 166.16 18.05 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -102.31 11.33 38.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 51.9 t0 -83.1 130.33 35.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 109.882 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.75 -39.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.722 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.63 73.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.367 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -83.98 132.52 34.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.548 . . . . 0.0 109.222 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.14 -24.13 64.05 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.588 ' SD ' ' ND1' ' A' ' 118' ' ' HIS . 59.5 mmm -72.44 48.84 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.767 -0.583 . . . . 0.0 110.153 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 139' ' ' SER . 13.7 t80 -71.39 137.16 83.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.861 -1.149 . . . . 0.0 109.198 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.63 18.81 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.037 1.049 . . . . 0.0 111.844 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 137' ' ' TYR . 22.2 t -166.5 176.67 7.19 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.9 t80 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 120.644 -1.285 . . . . 0.0 110.436 -179.16 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.2 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -142.46 150.49 40.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 108.653 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 41' ' ' TRP . 97.1 mt -73.49 145.43 45.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.058 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.17 156.8 17.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.449 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.94 -39.9 87.12 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.24 -40.4 85.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.461 -0.775 . . . . 0.0 109.255 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.63 -41.14 65.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.412 HG22 ' NE2' ' A' ' 157' ' ' GLN . 93.1 mt -63.53 -46.48 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.192 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.54 -40.22 93.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.89 -1.131 . . . . 0.0 110.431 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.64 -58.19 15.11 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.731 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -63.91 -41.29 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.114 -1.227 . . . . 0.0 110.344 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.33 -40.32 89.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.823 -1.173 . . . . 0.0 110.386 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.42 93.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.956 -1.09 . . . . 0.0 109.65 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -50.31 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 108.969 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.98 -74.02 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.196 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.99 -176.07 35.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 162' ' ' ARG . 57.6 mtt-85 -83.86 151.94 24.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.063 . . . . 0.0 109.441 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 45' ' ' THR . 5.8 m . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 87' ' ' PRO . 99.0 m95 -84.79 114.46 22.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.854 -1.154 . . . . 0.0 109.094 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.57 -9.87 48.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 109.505 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -80.94 150.76 28.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.757 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 p -96.6 -5.05 40.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -123.97 131.74 53.61 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.6 mt -132.88 149.73 52.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -125.29 154.65 41.4 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.302 -0.874 . . . . 0.0 109.446 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.89 159.53 42.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 109.311 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 17' ' ' ARG . 37.7 ttt-85 -148.8 134.04 18.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -89.79 123.26 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.22 -0.925 . . . . 0.0 108.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -41.57 84.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.515 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -162.28 151.04 15.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.858 -1.151 . . . . 0.0 110.23 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -96.94 138.4 34.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.85 144.18 85.25 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 109.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.45 -12.02 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.614 0.876 . . . . 0.0 112.018 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.15 -40.34 89.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.077 -1.014 . . . . 0.0 110.196 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.0 mt -135.73 151.24 73.87 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -65.58 -177.51 0.72 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.468 0.846 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -85.85 -35.51 20.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -43.23 90.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.43 -39.58 77.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 0.0 110.401 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.0 -40.0 87.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.824 -1.172 . . . . 0.0 109.422 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.48 -46.45 90.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.61 95.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.155 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.95 -40.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.717 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.83 -40.3 75.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.045 -1.034 . . . . 0.0 109.974 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -61.0 -40.87 95.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.98 87.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.962 -1.086 . . . . 0.0 109.259 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 30.4 m-85 -60.0 -40.6 89.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.856 -1.152 . . . . 0.0 109.496 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -59.95 -40.47 89.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 110.363 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.0 -45.14 93.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.015 -1.053 . . . . 0.0 110.039 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -71.75 -39.89 69.71 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.462 -0.774 . . . . 0.0 109.502 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 t -68.58 -30.63 69.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -0.85 . . . . 0.0 109.766 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -59.81 -37.51 79.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -106.96 10.31 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.217 -0.927 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -138.33 149.32 62.76 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.03 -1.044 . . . . 0.0 108.597 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.41 7.3 2.68 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.335 0.798 . . . . 0.0 110.529 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.4 157.88 36.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.701 -0.624 . . . . 0.0 109.753 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -137.4 151.99 49.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -130.78 155.87 45.94 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -154.33 132.75 11.98 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -81.64 137.02 35.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.324 -0.86 . . . . 0.0 110.032 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.26 132.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.7 t -94.7 0.94 55.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.045 -1.034 . . . . 0.0 109.594 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.3 157.71 44.12 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.22 -0.925 . . . . 0.0 109.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.76 167.31 8.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.03 160.38 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.264 . . . . 0.0 108.705 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.7 158.6 27.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 109.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.35 -39.65 83.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.298 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.23 120.0 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 109.53 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.0 mtp -101.12 135.93 41.79 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.192 -0.942 . . . . 0.0 109.419 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.84 126.94 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -148.03 155.19 41.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.65 139.03 40.86 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.22 163.09 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.503 -0.748 . . . . 0.0 110.773 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 61.4 mtt-85 -131.25 132.69 44.79 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.378 0.609 . . . . 0.0 110.023 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.3 -135.97 7.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -71.54 125.92 28.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.3 p-80 -134.03 49.77 2.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.325 -0.859 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 69' ' ' ARG . 52.8 mtt-85 58.41 53.09 6.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.643 -0.66 . . . . 0.0 111.109 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.536 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.4 m-20 -139.35 163.29 32.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.358 -0.838 . . . . 0.0 108.898 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -90.06 9.3 28.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.6 m -139.67 71.61 36.86 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.349 -0.844 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.91 159.27 41.86 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.154 1.236 . . . . 0.0 112.142 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.64 147.21 37.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.616 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.94 62.33 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.482 -0.761 . . . . 0.0 109.117 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.73 -166.01 53.4 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -54.19 -22.36 25.59 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.304 1.336 . . . . 0.0 112.636 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.0 177.79 48.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.03 -165.18 26.56 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.71 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -75.07 150.41 38.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.288 -1.125 . . . . 0.0 109.94 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -91.45 -13.26 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.57 167.33 9.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.046 -1.034 . . . . 0.0 109.893 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.98 179.91 7.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -166.38 169.33 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -98.04 156.88 16.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -58.48 149.65 59.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.146 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.411 ' HB3' ' NE1' ' A' ' 9' ' ' TRP . 7.5 Cg_endo -58.69 103.12 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 120.428 0.752 . . . . 0.0 111.792 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.29 172.88 37.62 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.22 177.32 6.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.321 1.347 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.54 -125.35 31.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.27 -9.54 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.193 . . . . 0.0 110.041 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.65 135.94 47.03 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.1 -16.83 59.58 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.491 -1.005 . . . . 0.0 110.709 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.64 121.76 15.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.913 -1.345 . . . . 0.0 110.636 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.17 131.81 45.9 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -112.74 135.0 53.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.501 -0.749 . . . . 0.0 109.294 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.8 m-85 -114.73 130.97 56.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.374 -0.829 . . . . 0.0 110.087 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.412 ' OD2' ' OE2' ' A' ' 101' ' ' GLU . 62.4 t0 -69.32 122.59 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -99.57 4.47 45.86 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.027 -1.046 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -73.5 -15.28 61.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.713 -1.242 . . . . 0.0 109.128 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 56.4 mp0 -102.64 152.66 20.93 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -85.71 119.4 26.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.93 -1.106 . . . . 0.0 108.777 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.53 150.28 24.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 p -129.82 163.09 27.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -113.9 34.86 4.37 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -150.18 -165.02 2.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.0 109.99 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.25 31.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.305 -0.872 . . . . 0.0 109.764 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.473 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.9 mmt-85 -76.82 -165.09 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -0.999 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.0 -58.25 9.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.731 . . . . 0.0 112.203 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -101.12 121.85 42.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.052 -1.03 . . . . 0.0 110.984 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 9.3 m120 -108.69 110.95 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.77 -44.67 96.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.11 -0.994 . . . . 0.0 111.122 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.081 . . . . 0.0 110.713 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -59.17 -46.68 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 109.738 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.1 t -70.12 -40.4 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.165 -0.96 . . . . 0.0 109.535 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.08 91.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.955 -1.091 . . . . 0.0 109.575 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.13 95.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.8 . . . . 0.0 109.813 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.407 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 48.6 t60 -69.77 -40.79 75.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.16 -40.14 88.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.812 -1.18 . . . . 0.0 109.075 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.19 -39.97 88.38 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.65 -42.4 67.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.407 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 61.9 m-70 -63.24 -39.33 94.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.241 -1.152 . . . . 0.0 108.549 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.8 p -70.14 -22.93 62.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.232 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.22 -2.63 58.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.144 -0.973 . . . . 0.0 109.385 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.41 73.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.22 131.42 35.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.03 -1.276 . . . . 0.0 108.804 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.0 m -88.1 170.56 10.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.03 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -66.07 158.66 27.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 108.705 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -129.88 158.72 38.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.42 -0.8 . . . . 0.0 109.224 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -102.94 13.83 33.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -84.13 130.91 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -42.91 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.66 0.32 65.57 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.235 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.69 139.2 32.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.676 -1.485 . . . . 0.0 108.928 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.74 -27.61 66.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 108.895 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 28.7 mtp -75.75 60.86 1.34 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 0.0 109.489 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.7 t80 -68.31 137.49 91.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.46 5.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.985 1.03 . . . . 0.0 112.1 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 137' ' ' TYR . 57.6 p -158.78 173.75 16.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.965 -1.084 . . . . 0.0 109.501 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.512 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -141.29 150.28 42.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 0.0 109.61 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.7 139.66 45.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 168.88 10.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.99 -40.7 90.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.581 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.53 -40.44 87.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.505 -0.747 . . . . 0.0 109.748 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -75.24 -42.56 55.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 109.263 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.79 -50.63 74.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.451 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.22 -39.37 90.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.16 . . . . 0.0 110.02 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.38 -56.37 20.3 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.72 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -64.38 -40.85 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.8 mt-30 -65.22 -39.09 92.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.029 -1.044 . . . . 0.0 110.108 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.41 88.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.81 -1.182 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.37 -49.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.044 -1.035 . . . . 0.0 109.527 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -97.28 -67.6 0.84 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.474 -0.766 . . . . 0.0 109.833 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.87 179.66 39.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.72 134.29 34.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -1.115 . . . . 0.0 109.421 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.799 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -84.87 124.11 31.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.38 -0.825 . . . . 0.0 109.6 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -87.55 -6.78 58.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.82 150.44 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -95.09 -6.29 42.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -130.03 139.8 50.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -132.8 157.98 43.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.535 -0.728 . . . . 0.0 109.332 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -127.99 153.56 46.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.94 158.42 43.63 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.225 -0.922 . . . . 0.0 109.922 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -146.99 134.61 21.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.014 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.86 112.35 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.2 tt0 -63.63 -39.82 95.32 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 0.0 110.392 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 83.1 m-20 -155.29 142.45 19.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.949 -1.094 . . . . 0.0 110.479 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.01 137.06 32.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -69.34 136.99 88.79 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -66.83 -9.37 24.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.691 0.925 . . . . 0.0 110.909 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.28 -40.11 89.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.762 -0.586 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -136.24 149.87 69.23 Favored Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -178.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.107 0 CA-C-N 119.353 0.805 . . . . 0.0 111.443 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -31.69 18.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.71 87.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.895 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.92 -40.01 65.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.792 . . . . 0.0 110.7 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.05 -44.32 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -58.58 -44.8 89.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.298 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -59.64 -41.94 91.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.047 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.2 82.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.875 -1.14 . . . . 0.0 109.729 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.1 -39.26 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 0.0 109.684 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.14 -39.68 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.067 -1.021 . . . . 0.0 109.432 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -63.3 -40.04 96.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.738 -1.226 . . . . 0.0 110.695 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.89 71.43 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.691 -1.255 . . . . 0.0 109.45 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 37.8 m-85 -60.31 -43.96 95.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.547 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -60.04 -42.76 95.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.93 -40.29 88.39 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.839 -1.163 . . . . 0.0 110.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -74.42 -40.21 62.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.479 -1.388 . . . . 0.0 109.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.56 -27.24 66.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.587 -0.696 . . . . 0.0 110.061 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -38.85 84.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 111.252 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 22.9 m -109.84 13.46 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.22 -0.925 . . . . 0.0 110.77 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 72.1 p -141.34 148.42 50.88 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.2 -0.938 . . . . 0.0 108.879 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.06 6.17 2.27 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 119.573 0.883 . . . . 0.0 111.982 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.28 151.72 42.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.159 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 p -131.75 149.19 52.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 96.7 m-85 -129.21 156.04 44.58 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.274 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.8 m -154.66 128.83 8.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.669 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -78.53 139.3 38.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.36 136.82 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 t -97.81 -2.92 39.9 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.051 -1.03 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -145.61 155.28 42.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.815 -1.178 . . . . 0.0 109.528 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.58 173.46 44.91 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.0 158.7 26.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -1.207 . . . . 0.0 109.391 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.02 152.22 41.15 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.46 -0.775 . . . . 0.0 109.134 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -60.03 -40.6 89.89 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -119.83 119.04 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mtp -101.28 127.66 47.79 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.858 . . . . 0.0 109.646 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -109.88 131.13 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.415 -0.803 . . . . 0.0 109.251 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.6 p -146.86 160.0 42.84 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.849 0.833 . . . . 0.0 110.091 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.26 139.28 47.93 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.26 167.25 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -139.3 144.78 38.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 0.0 110.248 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.85 -149.6 2.29 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -71.77 128.83 37.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.277 -1.131 . . . . 0.0 109.565 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 11.3 p-80 -130.83 60.19 1.65 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.379 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 53.36 54.67 9.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.944 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.7 p-10 -142.77 169.44 17.56 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.157 -0.964 . . . . 0.0 109.35 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.86 9.04 41.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.319 -0.863 . . . . 0.0 109.236 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -137.17 70.97 55.28 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 0.0 109.579 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.24 145.69 73.21 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 120.716 0.944 . . . . 0.0 111.496 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -74.74 144.7 43.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 72.67 0.84 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.02 -166.71 54.51 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -66.81 -10.14 27.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.186 1.257 . . . . 0.0 111.72 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.6 170.22 26.6 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.04 -151.11 19.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -73.58 142.58 46.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -1.081 . . . . 0.0 109.64 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.89 -16.23 26.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.072 -1.017 . . . . 0.0 109.23 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.62 171.48 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -163.27 121.12 1.93 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.802 -1.186 . . . . 0.0 109.76 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.53 162.02 21.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.723 -0.611 . . . . 0.0 109.854 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -107.76 146.64 31.9 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -59.78 146.05 82.22 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.948 -1.095 . . . . 0.0 108.616 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.65 125.75 20.04 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.849 0.982 . . . . 0.0 112.122 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.27 174.51 44.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.96 -177.55 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.115 1.21 . . . . 0.0 112.093 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.32 -128.88 48.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -78.91 -4.14 6.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.43 -1.041 . . . . 0.0 109.838 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.99 132.45 50.81 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.1 52.12 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -68.75 160.02 31.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.0 122.28 21.63 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -99.12 136.21 39.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.409 -0.807 . . . . 0.0 110.867 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.8 m-85 -116.16 131.41 56.95 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.43 121.83 17.15 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.077 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -100.15 -0.46 38.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.155 -0.965 . . . . 0.0 109.868 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -72.93 -15.67 61.57 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.962 -1.086 . . . . 0.0 109.877 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 159.96 15.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.38 -0.825 . . . . 0.0 108.871 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.409 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.3 ttp180 -89.25 122.23 32.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.085 -1.009 . . . . 0.0 109.596 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -89.22 151.7 22.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 110.106 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 59.1 p -125.95 160.32 30.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.507 -0.746 . . . . 0.0 109.56 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.99 29.27 7.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.533 -0.729 . . . . 0.0 109.987 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' ND2' ' CG ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -148.67 -165.02 2.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.486 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -81.04 30.81 0.32 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.945 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.492 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 17.0 mmm180 -75.65 -175.06 2.75 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.033 -1.042 . . . . 0.0 109.228 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 55.5 mp0 -47.4 -59.77 2.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.828 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 79.7 m-85 -83.62 152.5 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.86 -1.15 . . . . 0.0 110.92 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -140.89 90.24 2.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.99 -46.44 89.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.139 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -60.07 -45.77 91.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.0 109.985 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -59.4 -40.31 86.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.009 -1.057 . . . . 0.0 108.798 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.262 -0.899 . . . . 0.0 109.319 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.84 -40.56 84.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 109.144 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.63 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 109.085 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -68.69 -50.33 51.84 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.5 mt-10 -57.49 -41.96 81.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.877 -1.139 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.86 -37.88 88.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.896 -1.127 . . . . 0.0 109.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.59 92.28 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -64.79 -37.33 87.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.266 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -69.92 -22.68 63.17 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.48 -1.91 57.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.16 59.82 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.25 132.16 35.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.361 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.3 m -87.54 163.8 16.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.457 -0.777 . . . . 0.0 110.169 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -65.81 157.94 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.633 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -130.3 167.44 18.5 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -106.6 10.63 31.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.744 . . . . 0.0 109.148 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.67 120.12 24.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.87 -28.81 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.828 . . . . 0.0 110.798 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.56 -6.89 88.81 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.699 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.11 133.15 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.271 . . . . 0.0 109.868 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.72 -24.65 67.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 84.2 mmm -74.71 56.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.958 . . . . 0.0 109.33 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.5 t80 -70.11 137.42 87.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 108.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.33 7.23 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 120.098 1.071 . . . . 0.0 112.743 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.5 p -161.67 169.69 21.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 109' ' ' GLU . 49.3 t80 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.216 -0.927 . . . . 0.0 109.788 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.428 0.632 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -148.93 147.22 28.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 109.01 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.0 mt -78.55 133.85 37.31 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.14 166.33 13.03 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -60.78 -40.03 91.05 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.69 -40.49 88.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.813 . . . . 0.0 109.056 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -74.29 -42.24 59.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.78 -49.15 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.126 -0.984 . . . . 0.0 109.314 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.27 -40.3 89.88 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.05 -55.73 28.66 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.107 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.0 tp -65.9 -39.18 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.237 . . . . 0.0 109.797 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.8 mt-30 -66.99 -39.35 87.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.0 . . . . 0.0 109.256 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.76 93.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.995 -1.065 . . . . 0.0 109.721 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.06 -47.87 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.0 110.348 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -101.23 -61.26 1.39 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.401 -0.812 . . . . 0.0 109.899 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.85 179.61 35.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 145.12 24.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -1.162 . . . . 0.0 109.683 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.578 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -84.15 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.961 -1.087 . . . . 0.0 109.519 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.61 -9.14 59.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -83.17 148.91 27.18 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 p -98.21 -5.71 32.78 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.502 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 68.2 m80 -127.72 122.51 33.08 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.87 153.98 23.7 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.176 -0.952 . . . . 0.0 109.889 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 p -130.93 157.46 42.89 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -144.26 162.52 36.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -144.42 124.53 13.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.238 -0.914 . . . . 0.0 110.055 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 93.1 mt -86.77 113.59 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 77.3 tt0 -62.68 -41.15 98.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.95 154.73 24.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -95.9 142.4 28.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -70.05 138.57 87.42 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.174 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.28 -13.07 38.29 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.739 0.959 . . . . 0.0 111.37 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.59 -40.42 91.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.415 HD22 ' ND2' ' A' ' 105' ' ' ASN . 26.3 mt -136.0 149.39 68.31 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.65 -178.72 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.209 0.753 . . . . 0.0 112.038 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 27' ' ' ARG . 21.8 ptt-85 -86.04 -32.12 21.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.303 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.04 86.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.112 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -69.17 -38.96 78.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.76 -39.99 80.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.259 -0.9 . . . . 0.0 109.644 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.87 -40.53 84.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.194 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -60.27 -48.8 80.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.69 84.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.949 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.93 -40.6 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.171 -0.955 . . . . 0.0 109.851 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -69.89 -39.44 76.26 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 108.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.19 -39.81 93.95 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.39 90.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 109.736 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.9 -40.45 93.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.823 -1.173 . . . . 0.0 109.073 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.12 -41.45 92.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.13 -45.82 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.403 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -74.09 -42.83 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 t -63.55 -37.96 89.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.345 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -60.16 -23.57 64.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.552 -0.718 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.54 7.63 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.957 -1.09 . . . . 0.0 110.457 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 p -145.67 151.95 47.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -72.12 4.2 3.45 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.821 1.014 . . . . 0.0 112.097 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.21 152.0 44.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.0 109.775 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 44.9 p -127.08 150.13 49.61 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.03 158.29 34.1 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 110.489 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 m -153.89 127.91 8.96 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.967 0.889 . . . . 0.0 110.291 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.76 140.74 31.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.674 -0.641 . . . . 0.0 109.681 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 141.88 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.33 -0.856 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -95.02 -6.99 40.99 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.179 -0.951 . . . . 0.0 110.69 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -149.5 155.33 40.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.919 -1.113 . . . . 0.0 109.545 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.37 160.6 33.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.68 130.96 35.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -1.124 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.7 170.02 9.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.089 -1.007 . . . . 0.0 109.79 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.08 -40.08 88.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 109.712 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.92 120.42 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.517 -0.739 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.4 mmm -98.77 129.61 45.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.349 -0.844 . . . . 0.0 109.498 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -112.42 130.32 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -147.19 156.88 43.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.995 -1.065 . . . . 0.0 110.226 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.0 133.15 53.49 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.62 160.09 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 O-C-N 121.006 -1.059 . . . . 0.0 111.395 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -124.73 138.32 54.29 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.2 -146.2 4.12 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.86 130.86 42.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.792 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.501 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -131.25 43.54 3.07 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 55.69 58.18 4.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.685 . . . . 0.0 110.139 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.501 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 17.7 p-10 -141.17 171.58 13.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 0.0 109.126 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -91.25 10.65 26.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 109.73 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 t -141.0 71.67 28.35 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.103 -0.998 . . . . 0.0 109.903 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.37 141.98 32.69 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.108 1.206 . . . . 0.0 112.12 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.5 153.79 33.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.604 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.83 75.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.93 -164.55 17.2 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -55.86 -17.99 20.39 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.796 0.998 . . . . 0.0 111.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -179.02 49.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.1 -164.87 35.54 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.5 p-10 -74.77 155.79 37.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.132 -1.216 . . . . 0.0 109.428 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 mt -93.09 -19.7 21.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.141 -0.975 . . . . 0.0 109.272 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.94 169.79 8.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.012 -1.055 . . . . 0.0 109.37 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -163.03 179.96 7.16 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.646 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.83 170.94 16.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.621 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -98.64 158.1 15.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.354 -0.841 . . . . 0.0 109.589 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -57.06 145.94 62.88 Favored Pre-proline 0 N--CA 1.485 1.311 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.16 104.22 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 120.371 0.714 . . . . 0.0 111.62 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.05 171.23 37.91 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.3 -175.63 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.039 1.159 . . . . 0.0 112.024 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.96 -127.09 40.19 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -80.05 -11.13 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.24 . . . . 0.0 109.252 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.92 142.36 46.34 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.09 -21.84 32.22 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.3 150.25 46.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.286 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.03 125.94 19.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 108.749 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -105.87 150.06 25.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.534 -0.729 . . . . 0.0 109.554 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.13 140.05 51.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.77 119.26 10.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.057 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -99.48 -3.32 33.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.361 -0.837 . . . . 0.0 109.354 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.26 -18.56 60.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.833 . . . . 0.0 109.677 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -98.15 159.78 14.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.24 -0.913 . . . . 0.0 108.905 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.8 ttm-85 -89.39 119.59 29.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.25 -0.906 . . . . 0.0 109.691 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.74 145.34 25.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.345 -0.847 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 69.6 p -122.49 160.97 24.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.415 ' ND2' HD22 ' A' ' 25' ' ' LEU . 80.2 m-20 -108.41 30.43 6.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.56 -0.712 . . . . 0.0 109.102 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -148.64 -165.0 2.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.09 -1.006 . . . . 0.0 110.269 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -82.25 28.98 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -73.7 -169.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.134 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.81 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 111.656 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -87.14 153.51 21.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.972 -1.08 . . . . 0.0 110.547 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -143.7 97.59 3.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.187 -0.946 . . . . 0.0 108.55 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.51 -45.95 92.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.364 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.56 -39.85 85.38 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.84 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.488 ' NH1' HD22 ' A' ' 135' ' ' LEU . 1.9 tpm_? -60.0 -43.37 95.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.27 -39.63 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.785 . . . . 0.0 108.89 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.96 84.49 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.37 -0.831 . . . . 0.0 109.164 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.63 -46.66 62.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.528 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.85 -41.37 91.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.5 mt -63.77 -39.72 94.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.78 -40.38 80.12 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -66.36 -35.46 80.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 108.328 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.4 t -69.96 -25.32 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.26 -0.03 50.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 109.07 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.19 12.08 66.1 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.813 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.79 128.58 33.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.461 . . . . 0.0 108.979 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.2 m -88.34 170.12 11.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.428 -0.795 . . . . 0.0 109.671 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -66.12 149.0 50.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 t -124.67 161.49 26.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.3 p -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.51 127.37 32.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.047 . . . . 0.0 108.732 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.88 -40.08 81.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.527 -0.733 . . . . 0.0 110.212 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.26 1.41 70.54 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.616 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.01 139.96 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.716 -1.461 . . . . 0.0 109.695 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.488 HD22 ' NH1' ' A' ' 114' ' ' ARG . 88.3 mt -69.02 -29.3 67.45 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 109.274 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 77.3 mmm -74.3 55.23 0.6 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.424 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.8 t80 -69.29 139.49 89.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.8 -3.9 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 CA-C-N 119.832 0.976 . . . . 0.0 112.543 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -162.84 170.91 17.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 109.311 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.6 t80 . . . . . 0 N--CA 1.488 1.462 0 O-C-N 120.715 -1.24 . . . . 0.0 109.06 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.42 HG13 HH21 ' A' ' 114' ' ' ARG . 98.4 t . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.35 0.595 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -146.95 151.81 37.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.408 -0.807 . . . . 0.0 109.207 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.14 149.58 38.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.03 150.26 21.08 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -58.4 -40.08 81.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.835 -1.166 . . . . 0.0 109.035 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.84 -37.74 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.785 -1.197 . . . . 0.0 108.448 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -74.69 -39.93 61.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.99 -49.86 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.095 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.67 -39.78 95.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.963 . . . . 0.0 110.512 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.18 -51.02 47.56 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.93 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -67.81 -38.9 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.401 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.4 mt-30 -65.68 -39.75 91.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.685 -1.259 . . . . 0.0 109.315 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.04 95.2 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.782 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.34 -49.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.84 -63.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.094 -1.004 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.09 -165.5 33.25 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.478 HH11 ' HG2' ' A' ' 162' ' ' ARG . 35.3 mtt-85 -96.17 139.85 31.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.451 -1.029 . . . . 0.0 109.261 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.492 1.66 0 O-C-N 120.762 -1.211 . . . . 0.0 108.425 179.503 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 121.163 0.506 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -85.91 122.01 29.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 108.523 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.85 -12.58 55.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.159 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -82.97 152.44 25.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.705 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 p -96.6 -4.59 40.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.921 . . . . 0.0 109.112 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.499 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 77.2 m80 -125.35 135.41 52.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.69 158.35 43.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.39 -0.819 . . . . 0.0 109.537 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.7 p -128.43 154.08 46.42 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.48 159.97 41.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -149.45 130.35 14.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.084 -1.01 . . . . 0.0 110.176 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 92.8 mt -87.44 115.2 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.88 -40.11 91.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -160.09 151.87 20.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.075 . . . . 0.0 110.26 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -98.87 135.65 40.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.379 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 t -71.2 144.08 89.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.947 . . . . 0.0 108.987 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -66.03 -11.25 30.26 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.704 0.936 . . . . 0.0 112.035 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.13 -39.93 87.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 109.957 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -137.59 150.21 67.51 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.193 -0.942 . . . . 0.0 108.951 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.35 -177.34 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.706 0.937 . . . . 0.0 111.924 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -88.99 -37.04 15.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 0.0 109.938 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.44 83.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.95 -39.01 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 109.617 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.68 -39.95 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -41.59 92.75 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.075 -1.016 . . . . 0.0 109.077 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.59 -46.38 90.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.98 90.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 0.0 109.775 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.31 -40.16 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -39.92 75.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.997 . . . . 0.0 108.682 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.06 -39.97 91.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.31 84.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.938 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.11 -39.95 87.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.965 -1.085 . . . . 0.0 108.786 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.12 -40.28 89.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 110.093 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.12 -47.02 87.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.871 -1.143 . . . . 0.0 109.644 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -71.78 -41.72 67.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.493 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.21 -38.17 81.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.552 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.28 7.73 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 p -145.79 150.0 41.5 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.893 -1.13 . . . . 0.0 109.215 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.13 6.47 1.77 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.693 0.929 . . . . 0.0 111.899 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.93 154.06 42.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.13 -0.981 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.499 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.8 p -133.3 149.99 51.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.533 -0.73 . . . . 0.0 109.333 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.88 156.24 43.99 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.468 -0.77 . . . . 0.0 109.965 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 m -155.38 132.43 10.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.755 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -78.3 145.66 35.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.96 134.98 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.447 -0.783 . . . . 0.0 109.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -93.07 -0.93 56.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.037 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -152.89 158.63 42.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 109.666 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.6 168.11 30.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.88 149.33 29.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -1.175 . . . . 0.0 109.127 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 151.93 25.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.437 -0.79 . . . . 0.0 109.108 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.286 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -116.56 116.06 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.47 137.52 39.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.46 127.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.1 p -149.58 161.36 42.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 110.207 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.14 139.97 46.07 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.72 167.14 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.198 -0.939 . . . . 0.0 110.739 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.76 146.79 49.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.629 -0.67 . . . . 0.0 110.194 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.52 -150.19 0.87 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -60.07 136.88 58.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.087 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 25.1 p-80 -137.48 54.23 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.82 54.14 8.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.592 -0.693 . . . . 0.0 110.035 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.9 t0 -147.31 162.14 39.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.5 m120 -89.7 9.0 28.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 109.775 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.7 m -134.55 70.58 72.01 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.412 -0.805 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.5 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 120.879 1.053 . . . . 0.0 112.051 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -77.62 141.44 39.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -103.54 62.07 0.77 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.413 -0.804 . . . . 0.0 109.179 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.92 54.82 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -55.91 -14.11 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.023 1.149 . . . . 0.0 111.914 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.18 -178.54 50.83 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.28 -158.8 42.34 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 80' ' ' ASN . 48.0 p-10 -74.33 147.61 42.09 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -1.137 . . . . 0.0 109.478 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -94.66 -15.85 23.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.89 160.12 8.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.05 -1.031 . . . . 0.0 109.286 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.18 -178.7 6.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.286 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.39 168.17 20.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 109.869 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.75 164.46 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.38 -0.825 . . . . 0.0 109.94 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.07 149.88 72.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.838 . . . . 0.0 109.553 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.26 103.47 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 120.689 0.926 . . . . 0.0 111.806 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.03 166.01 38.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.14 -172.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.984 1.123 . . . . 0.0 111.647 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.99 -132.96 49.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -79.92 -10.26 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -1.043 . . . . 0.0 109.946 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.99 144.21 39.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -18.15 32.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -67.12 124.26 22.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.283 . . . . 0.0 109.995 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.89 128.33 53.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.522 -0.736 . . . . 0.0 109.329 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -110.98 135.56 51.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -116.52 137.36 52.23 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.493 -0.754 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.5 122.59 17.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -100.4 0.38 39.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -74.56 -18.66 60.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.904 -1.122 . . . . 0.0 109.93 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.31 162.29 13.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -0.83 . . . . 0.0 109.479 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -87.74 121.43 30.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 0.0 109.28 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.19 147.07 23.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.359 -0.838 . . . . 0.0 110.174 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.0 p -125.56 168.77 13.21 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.43 31.82 6.21 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.59 HD21 ' CZ ' ' A' ' 108' ' ' ARG . 4.7 p30 -149.85 -164.84 2.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.889 . . . . 0.0 109.953 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -86.4 29.22 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.33 -0.856 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.59 ' CZ ' HD21 ' A' ' 106' ' ' ASN . 97.0 mtt180 -76.11 -159.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -40.36 -59.94 1.2 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.53 -0.731 . . . . 0.0 111.53 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -129.78 130.09 44.93 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.048 -1.032 . . . . 0.0 110.388 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -98.58 112.01 24.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.268 -0.895 . . . . 0.0 109.297 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 0.0 110.084 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.94 -42.54 94.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.176 -0.952 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.436 HH11 ' HG2' ' A' ' 114' ' ' ARG . 29.5 ttt-85 -60.1 -40.05 88.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 109.332 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.07 -40.06 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.271 -0.893 . . . . 0.0 109.539 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.61 93.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 108.866 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.46 94.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -67.38 -44.4 79.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.776 . . . . 0.0 110.517 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.07 -39.99 87.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.971 -1.081 . . . . 0.0 108.855 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.46 -37.03 84.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.05 -40.89 75.68 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -63.1 -40.12 96.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -1.17 . . . . 0.0 108.634 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -71.61 -23.52 61.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.97 -3.14 58.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -0.941 . . . . 0.0 108.865 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.43 64.3 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.81 127.35 34.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.076 -1.249 . . . . 0.0 109.756 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -88.66 170.04 11.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.453 -0.779 . . . . 0.0 109.752 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -67.5 152.98 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.113 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.8 t -125.15 163.6 22.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.556 -0.715 . . . . 0.0 109.392 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -101.62 6.64 42.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.352 -0.843 . . . . 0.0 110.047 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.97 126.62 32.72 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.186 0.993 . . . . 0.0 109.867 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.3 pt -59.0 -30.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.394 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.46 -3.34 90.57 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.252 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.92 139.15 33.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.352 . . . . 0.0 109.142 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.349 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.8 mtp -75.65 58.6 1.08 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -70.39 134.82 86.67 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -45.74 -63.08 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 120.409 1.182 . . . . 0.0 110.857 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.9 p -94.17 177.01 6.1 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.6 t80 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.58 -1.325 . . . . 0.0 109.106 179.692 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -145.02 154.46 42.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 109.062 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.42 148.24 37.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.924 -1.11 . . . . 0.0 108.89 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.36 148.45 22.11 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -55.83 -38.35 69.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.194 -0.942 . . . . 0.0 108.686 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -53.97 -39.52 66.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.163 -0.96 . . . . 0.0 108.547 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 156' ' ' ILE . 85.5 m-20 -73.0 -40.01 65.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 109.029 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.47 -50.52 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -39.99 93.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.108 -0.995 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.71 -54.15 7.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.089 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -62.02 -39.91 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.863 -1.375 . . . . 0.0 110.147 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 109.247 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.94 -43.37 95.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.725 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.01 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.512 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 -60.68 1.48 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.58 -178.92 35.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -95.02 140.74 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -1.221 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.0 m . . . . . 0 C--N 1.301 -1.504 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 HG23 ' A' ' 159' ' ' ILE . 85.6 mtm180 . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.48 118.83 23.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.57 -9.98 59.55 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.317 -0.865 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.5 145.2 26.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.074 . . . . 0.0 110.16 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -92.13 -4.04 54.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -129.92 139.78 51.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.21 161.09 34.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.886 0.85 . . . . 0.0 109.52 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.1 p -127.01 157.07 40.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -144.49 157.55 44.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.156 -0.965 . . . . 0.0 109.339 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -151.06 133.09 15.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.15 118.92 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.62 -40.27 80.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.964 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -161.67 150.9 16.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.644 -1.285 . . . . 0.0 110.955 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.18 133.66 38.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.706 . . . . 0.0 109.558 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 t -70.05 142.56 90.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.3 -8.94 24.39 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.38 0.814 . . . . 0.0 111.398 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.93 -39.59 86.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.3 mt -139.52 152.34 68.62 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.86 -176.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 CA-C-N 119.168 0.739 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -86.87 -34.69 19.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.969 -1.082 . . . . 0.0 109.302 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.89 86.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -69.37 -39.63 77.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -0.834 . . . . 0.0 109.6 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 -47.36 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.159 -0.963 . . . . 0.0 109.045 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -60.28 -40.53 90.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.484 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 85.7 t60 -59.19 -47.55 84.91 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.674 -0.642 . . . . 0.0 109.777 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.2 -39.18 81.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.484 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.18 -38.32 74.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.788 -1.195 . . . . 0.0 110.064 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.94 -42.15 97.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.987 -1.071 . . . . 0.0 110.262 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.484 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 36.9 mttm -64.6 -39.83 94.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.71 76.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -60.8 -43.36 98.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -60.09 -41.46 92.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.93 -43.61 94.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.729 -1.232 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.7 m95 -73.49 -42.33 61.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.905 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t -68.3 -35.39 77.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.041 -1.037 . . . . 0.0 110.517 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.81 -28.9 64.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.271 -0.893 . . . . 0.0 111.673 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.92 10.4 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.934 -1.104 . . . . 0.0 111.062 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -144.49 149.9 45.71 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.001 -1.062 . . . . 0.0 109.126 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.18 5.29 2.75 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 120.81 1.007 . . . . 0.0 112.181 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.81 155.44 40.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.905 -1.122 . . . . 0.0 109.268 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 p -131.55 142.33 49.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.394 -0.816 . . . . 0.0 108.8 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.29 153.29 36.6 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.367 -0.833 . . . . 0.0 109.467 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.2 m -153.18 132.31 12.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.804 . . . . 0.0 109.861 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -77.44 139.39 39.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.7 136.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.631 -0.668 . . . . 0.0 109.452 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -96.62 -2.21 45.26 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 110.021 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -149.86 152.27 34.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.41 168.65 45.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -79.95 132.03 35.95 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.564 -0.963 . . . . 0.0 109.461 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.67 149.74 20.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 108.965 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.84 -39.86 86.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.39 -0.819 . . . . 0.0 109.118 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -118.22 119.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.7 mmm -101.14 128.95 46.99 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.13 -0.981 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.04 126.42 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.3 p -149.98 159.71 44.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.781 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.19 137.77 50.96 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.09 162.7 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.42 -0.8 . . . . 0.0 111.626 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -130.43 145.3 51.8 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.813 -0.554 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.18 -146.81 0.64 Allowed Glycine 0 N--CA 1.495 2.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.034 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -72.49 128.95 37.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.615 -0.933 . . . . 0.0 109.165 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.55 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.9 p-80 -128.18 54.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.558 -0.714 . . . . 0.0 109.855 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 69' ' ' ARG . 52.4 mtm-85 56.62 50.02 13.52 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.482 -0.762 . . . . 0.0 110.06 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -139.83 163.11 33.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -89.42 14.61 10.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.217 -0.927 . . . . 0.0 109.906 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -140.61 68.62 31.03 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.099 -1.0 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.62 148.22 65.49 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.656 1.571 . . . . 0.0 112.74 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -73.79 149.83 41.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.596 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -124.69 74.43 1.34 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.837 -0.539 . . . . 0.0 109.645 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.94 -174.93 48.2 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.9 -13.64 39.03 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 120.839 1.026 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -174.03 43.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.02 -159.21 31.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -73.73 135.36 43.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.284 -1.127 . . . . 0.0 109.42 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.88 -10.81 43.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.695 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.79 161.35 5.89 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -161.63 116.92 2.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.706 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.74 172.83 8.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -104.57 157.08 17.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.78 147.48 78.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 108.571 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.58 104.37 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.628 0.885 . . . . 0.0 112.587 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.07 170.91 33.85 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -69.82 165.42 31.08 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.226 1.284 . . . . 0.0 112.196 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.61 -121.68 15.48 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.061 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.41 -12.98 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -1.04 . . . . 0.0 109.846 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.04 44.71 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 -8.48 78.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -65.06 128.05 34.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.012 -1.287 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.77 115.57 29.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -98.46 135.79 39.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.283 -0.886 . . . . 0.0 109.244 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.29 134.32 54.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.98 117.2 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.015 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -97.36 -0.34 46.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.365 -0.834 . . . . 0.0 109.046 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -74.77 -20.87 59.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -100.76 159.21 15.37 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.281 -0.887 . . . . 0.0 108.965 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 102' ' ' ARG . 18.7 ttt-85 -87.14 123.4 32.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -89.29 145.17 25.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.653 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.9 p -129.79 169.24 15.39 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.356 -0.84 . . . . 0.0 109.633 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.23 28.81 8.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.592 -0.693 . . . . 0.0 110.159 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.626 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -152.0 -167.01 2.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.033 . . . . 0.0 109.952 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -71.12 22.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.358 -0.839 . . . . 0.0 110.686 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.5 ' CG ' HD21 ' A' ' 106' ' ' ASN . 29.2 mmt180 -75.8 -160.39 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 54.3 mp0 -31.77 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.0 -0.437 . . . . 0.0 111.987 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -129.04 151.07 50.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.319 -0.863 . . . . 0.0 110.758 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 75.8 m-20 -99.25 114.33 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.25 -41.14 92.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.481 -0.762 . . . . 0.0 110.145 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -59.83 -42.06 92.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.0 110.618 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -59.85 -39.87 86.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.842 -1.161 . . . . 0.0 109.678 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 53.6 t -71.69 -39.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.16 90.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.839 -1.163 . . . . 0.0 108.769 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.69 95.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.569 -0.707 . . . . 0.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -69.18 -50.02 51.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.708 . . . . 0.0 110.335 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -58.6 -40.04 82.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.706 -1.246 . . . . 0.0 109.986 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.7 -39.93 93.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.018 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.25 94.49 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -63.61 -37.77 88.6 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 108.971 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.1 p -69.68 -21.8 63.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.006 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.07 -1.29 57.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.302 -0.874 . . . . 0.0 109.431 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.06 16.92 66.23 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.043 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.64 131.29 34.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.838 -1.389 . . . . 0.0 109.382 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.8 m -88.72 169.1 11.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -67.87 157.47 34.81 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.484 -0.76 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -127.95 164.07 23.11 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.439 -0.788 . . . . 0.0 109.318 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.2 p -102.58 8.94 39.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 110.008 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -83.79 127.65 33.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -0.911 . . . . 0.0 109.291 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.06 -30.02 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 110.319 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.29 0.74 88.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.54 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.77 34.88 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.324 . . . . 0.0 110.463 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.11 -28.47 65.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 109.602 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 86.0 mmm -74.99 52.64 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -70.33 128.97 90.88 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.61 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -48.91 -66.98 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.114 0 CA-C-N 120.483 1.208 . . . . 0.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.5 m -89.64 176.28 6.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.042 -1.036 . . . . 0.0 108.877 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 48.4 t80 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 -179.659 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.352 0.596 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -145.55 159.94 42.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.65 142.31 42.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.88 165.7 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.24 -38.62 87.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -58.69 -40.66 84.22 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -75.3 -41.01 57.96 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.16 -53.25 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.075 -1.015 . . . . 0.0 109.894 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.78 -39.97 95.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.22 -63.26 5.48 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.758 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.4 tp -60.6 -40.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.888 -1.36 . . . . 0.0 110.26 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.9 mt-30 -64.37 -39.71 94.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.249 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.25 93.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.873 -1.142 . . . . 0.0 109.626 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.407 HG23 HH11 ' A' ' 8' ' ' ARG . 93.7 mt -60.08 -50.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.057 . . . . 0.0 109.119 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.5 -67.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.918 -1.114 . . . . 0.0 109.215 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.47 177.87 37.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -86.14 149.05 25.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.085 -1.244 . . . . 0.0 108.724 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 108.915 179.653 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 . . . . . 0 N--CA 1.496 1.857 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -83.21 130.0 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.164 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -82.42 -13.79 56.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.277 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -83.78 151.53 25.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.011 -1.056 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 p -97.44 -7.32 31.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.21 -0.932 . . . . 0.0 108.662 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.548 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 31.1 m-70 -121.51 122.28 39.37 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.509 HD12 ' CE2' ' A' ' 49' ' ' PHE . 66.2 mt -110.02 156.35 20.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -126.73 152.74 46.42 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.76 159.51 42.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 108.949 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.3 ttm180 -150.29 130.72 13.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -87.38 120.02 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 108.544 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.98 -40.09 87.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -160.78 149.98 16.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.875 -1.14 . . . . 0.0 109.988 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.22 132.22 43.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -68.67 143.45 95.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.828 -1.17 . . . . 0.0 109.161 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.11 -6.23 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 120.657 0.905 . . . . 0.0 111.774 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.19 -40.18 89.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.765 . . . . 0.0 109.767 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.595 HD13 ' CG ' ' A' ' 105' ' ' ASN . 54.7 mt -138.84 150.03 64.02 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.307 -0.871 . . . . 0.0 108.724 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.01 178.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 CA-C-N 119.247 0.767 . . . . 0.0 111.501 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -87.94 -38.71 15.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.993 -1.067 . . . . 0.0 109.546 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.28 92.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.008 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.12 -39.71 75.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 110.095 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.28 -43.6 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.055 . . . . 0.0 109.299 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.77 -39.37 80.81 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.598 ' CE1' ' HZ1' ' A' ' 36' ' ' LYS . 68.1 t60 -57.24 -47.49 81.23 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.555 -0.715 . . . . 0.0 109.175 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.25 -0.906 . . . . 0.0 110.308 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.07 -39.46 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.725 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.89 -41.64 95.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.948 . . . . 0.0 109.901 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.598 ' HZ1' ' CE1' ' A' ' 32' ' ' HIS . 21.5 mttp -62.5 -38.0 88.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 109.955 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.7 84.76 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.701 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -61.39 -41.08 96.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.29 -42.2 95.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.171 -0.955 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -59.94 -43.45 94.98 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.878 -1.139 . . . . 0.0 110.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.73 -41.61 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.3 t -68.25 -36.19 79.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -60.0 -19.19 51.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 0.0 110.242 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.2 m -112.29 1.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 p -144.56 150.24 46.64 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.0 109.421 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.27 7.66 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.936 1.091 . . . . 0.0 112.122 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.41 151.78 42.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.117 -0.99 . . . . 0.0 109.839 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.548 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 64.5 p -129.79 149.97 51.3 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.509 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -128.26 153.63 46.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.483 -0.76 . . . . 0.0 109.405 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.1 m -153.0 134.99 14.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.03 131.6 36.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.649 -0.657 . . . . 0.0 109.437 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 14.7 m -119.67 130.69 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -96.0 -8.78 32.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.128 -0.982 . . . . 0.0 108.994 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 99.2 mt-10 -143.81 152.12 40.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 95.64 179.53 36.29 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.18 133.48 35.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.848 -1.384 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 131.03 45.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -59.87 -43.73 94.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.93 120.08 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.573 -0.704 . . . . 0.0 109.814 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 mtt -99.87 130.36 46.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.153 -0.967 . . . . 0.0 109.873 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.73 126.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 p -150.73 160.79 43.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.14 139.8 41.0 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.12 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.344 -0.848 . . . . 0.0 111.08 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 66' ' ' GLY . 83.3 mtm180 -131.35 143.8 50.76 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.737 -0.602 . . . . 0.0 109.423 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 42.65 -147.4 0.68 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -67.12 130.72 44.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -1.024 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.54 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -133.85 56.16 1.86 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.434 -0.791 . . . . 0.0 109.522 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 mtm-85 58.69 49.29 10.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.807 -0.558 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.4 m-20 -142.76 165.69 26.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.216 -0.928 . . . . 0.0 109.641 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -92.99 9.14 36.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.336 -0.853 . . . . 0.0 109.417 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.7 m -133.93 71.57 73.71 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.28 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.2 152.01 80.26 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 120.868 1.045 . . . . 0.0 111.547 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -76.81 147.66 37.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -109.49 75.04 0.92 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.39 -160.67 9.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.82 -15.66 22.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.957 1.104 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.96 -179.56 45.78 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -164.62 37.31 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -75.32 147.38 40.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -1.065 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 mt -92.71 -18.85 22.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 110.296 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.28 161.6 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 0.0 109.681 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.2 -179.81 6.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.697 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.52 167.42 21.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.142 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -101.14 135.22 42.96 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.272 -0.893 . . . . 0.0 109.784 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -60.01 150.04 71.51 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -41.76 120.97 1.54 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 120.706 0.937 . . . . 0.0 112.037 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 -169.28 21.29 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -76.4 117.43 4.59 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.564 1.51 . . . . 0.0 113.519 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.3 -111.49 3.35 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.451 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.29 -13.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.992 . . . . 0.0 110.888 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.87 133.12 51.26 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.927 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.3 77.76 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 121.459 -1.024 . . . . 0.0 111.009 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.38 129.75 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.736 -1.449 . . . . 0.0 110.436 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.44 129.1 46.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.31 -0.869 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -115.17 132.9 56.46 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.496 -0.752 . . . . 0.0 109.122 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -118.01 131.93 56.43 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -64.83 126.09 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -100.3 0.63 40.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 110.059 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.44 -20.01 60.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.027 -1.046 . . . . 0.0 109.679 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.13 158.36 15.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 102' ' ' ARG . 23.5 ttt-85 -87.49 114.63 24.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -89.59 150.72 22.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.73 . . . . 0.0 109.993 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.3 p -126.3 164.38 21.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.595 ' CG ' HD13 ' A' ' 25' ' ' LEU . 91.5 m-20 -108.53 32.1 5.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.073 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.479 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.43 -164.98 2.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -0.964 . . . . 0.0 110.379 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -84.83 28.34 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -76.67 -164.07 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 110.498 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -43.64 -59.96 1.97 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.555 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.29 121.85 43.21 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.178 -0.951 . . . . 0.0 109.804 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.99 116.06 31.15 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.09 -39.91 87.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.231 . . . . 0.0 109.976 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -59.91 -41.91 92.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 112.226 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 114' ' ' ARG . 10.4 ptt-85 -59.99 -41.3 91.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.313 -1.492 . . . . 0.0 109.97 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.4 -39.25 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.227 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.1 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.81 94.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.99 -1.069 . . . . 0.0 108.95 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.87 -49.27 54.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -58.97 -40.17 83.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 109.595 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.08 -39.81 95.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 109.742 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.22 -40.04 95.31 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -61.59 -39.16 90.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -1.196 . . . . 0.0 108.519 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.0 m -70.14 -26.22 63.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.767 . . . . 0.0 109.14 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.82 -3.94 57.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.577 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.22 60.54 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -80.82 129.05 34.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.227 . . . . 0.0 108.889 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -88.35 169.69 11.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.72 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -68.89 156.96 37.55 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 108.865 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -125.86 163.42 22.95 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -105.08 13.48 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.392 -0.818 . . . . 0.0 109.715 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 61.6 t0 -84.65 130.89 34.66 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.313 -0.867 . . . . 0.0 108.889 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.05 -38.37 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.039 -1.038 . . . . 0.0 110.313 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -80.12 1.53 79.83 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.246 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.96 128.62 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.626 -1.514 . . . . 0.0 109.471 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 147' ' ' GLN . 95.9 mt -67.56 -26.31 66.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.223 -0.923 . . . . 0.0 108.858 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.2 mmm -72.37 46.29 0.14 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -69.84 127.88 92.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 108.892 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.63 -64.86 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.557 1.235 . . . . 0.0 111.766 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -85.86 169.29 13.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.383 -0.823 . . . . 0.0 109.651 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 120.94 -1.1 . . . . 0.0 108.897 179.338 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.257 0.551 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.411 ' O ' HD11 ' A' ' 135' ' ' LEU . 49.8 mt-30 -144.97 150.0 36.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.241 -0.912 . . . . 0.0 109.066 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.14 143.88 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 108.962 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.51 163.71 12.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.29 -0.881 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -60.05 -40.18 88.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.98 -1.075 . . . . 0.0 108.759 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.74 -40.04 86.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.834 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.87 -40.08 65.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.042 -1.036 . . . . 0.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.11 -50.16 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.877 . . . . 0.0 109.716 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.88 -40.02 91.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.183 -0.948 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.13 -54.05 41.19 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.343 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -68.59 -39.09 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.882 -1.363 . . . . 0.0 110.039 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -63.69 -39.47 94.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.86 95.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.87 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 0.0 109.919 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -95.86 -67.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.047 . . . . 0.0 109.346 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.21 -173.4 40.2 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.51 142.27 27.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 108.963 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.302 -1.475 0 O-C-N 121.132 -0.98 . . . . 0.0 109.387 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.96 122.44 27.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.021 -1.049 . . . . 0.0 108.344 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -83.04 -9.81 59.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -83.73 150.72 25.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -96.87 -3.15 42.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 63.9 m80 -127.97 138.61 52.68 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.9 mt -133.29 158.65 42.42 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -130.2 155.6 45.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.21 157.45 44.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 0.0 108.536 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.543 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.4 ttm180 -150.09 133.63 16.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.97 116.9 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.843 -1.16 . . . . 0.0 108.399 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' SD ' ' A' ' 60' ' ' MET . 99.0 mt-10 -68.25 -38.34 81.7 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.798 . . . . 0.0 111.06 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.699 HD22 ' H ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -154.56 139.75 17.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.0 109.847 -178.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.699 ' H ' HD22 ' A' ' 20' ' ' ASN . 95.4 m-85 -93.86 142.28 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.74 . . . . 0.0 109.345 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -74.13 136.56 75.96 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.95 -11.55 31.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.788 0.96 . . . . 0.0 111.841 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.815 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.5 mt -133.74 151.2 76.62 Favored Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.44 -178.76 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.396 0.82 . . . . 0.0 111.911 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -86.53 -33.57 20.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 109.922 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.04 92.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.048 -1.033 . . . . 0.0 110.402 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.97 -38.94 76.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.275 -0.89 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.08 -41.89 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.133 -0.979 . . . . 0.0 108.922 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -40.22 88.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.004 -1.06 . . . . 0.0 110.045 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 75.7 t60 -60.57 -45.3 94.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.53 81.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.946 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -69.86 -36.83 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -0.816 . . . . 0.0 109.842 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -64.72 -45.64 85.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 109.669 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 35.9 mttm -62.45 -36.95 84.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.992 -1.067 . . . . 0.0 110.256 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.21 -50.01 75.37 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.221 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -60.78 -41.28 95.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 109.364 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 97.8 mt-30 -61.76 -40.21 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.731 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.06 -40.09 88.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.96 . . . . 0.0 109.573 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -73.42 -43.47 60.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 110.347 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -69.26 -30.45 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 19.1 m120 -59.35 -31.96 69.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 8.58 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.146 -0.971 . . . . 0.0 110.894 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 12.4 p -147.74 150.52 36.6 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.732 -1.23 . . . . 0.0 109.732 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.49 5.68 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.117 1.211 . . . . 0.0 112.356 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.3 156.31 39.46 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.096 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 73.9 p -137.74 147.74 45.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 0.0 109.089 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.7 m-85 -128.56 158.19 39.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -154.96 139.2 16.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.57 135.68 37.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 29.4 m -129.44 131.61 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.524 -0.735 . . . . 0.0 109.771 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t -102.51 -2.65 28.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.098 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' C ' HH22 ' A' ' 17' ' ' ARG . 96.8 mt-10 -140.72 152.51 45.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 86.8 177.71 49.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -83.81 134.58 34.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.169 -1.195 . . . . 0.0 109.881 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.93 135.18 41.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.361 -0.837 . . . . 0.0 109.287 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.41 -41.69 94.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.07 116.52 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.559 -0.713 . . . . 0.0 110.232 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.471 ' SD ' ' OE2' ' A' ' 19' ' ' GLU . 34.9 mtt -103.33 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -121.75 127.96 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.628 -0.67 . . . . 0.0 109.201 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.8 p -145.34 153.44 41.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.09 141.06 36.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.1 170.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.005 -1.059 . . . . 0.0 110.733 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.01 139.85 50.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.394 0.616 . . . . 0.0 110.408 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.02 -144.08 0.64 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.6 t0 -62.84 136.66 57.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.672 -0.899 . . . . 0.0 110.042 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.41 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -139.89 52.98 1.68 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HG2' ' NH1' ' A' ' 69' ' ' ARG . 56.8 mtt-85 53.24 55.14 9.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 33.9 t0 -145.13 162.18 37.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.213 -0.929 . . . . 0.0 109.217 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 5.5 m120 -89.58 8.87 29.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.113 -0.992 . . . . 0.0 109.1 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -134.64 69.4 72.25 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.452 -0.78 . . . . 0.0 109.23 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -72.34 148.01 48.25 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.7 1.6 . . . . 0.0 112.581 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -78.13 137.03 37.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -0.826 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -104.71 66.49 0.78 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.95 -171.0 48.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.76 -9.47 1.21 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.775 0.983 . . . . 0.0 112.176 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 -178.15 46.61 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.52 -167.3 53.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.53 ' H ' HD22 ' A' ' 80' ' ' ASN . 2.4 p30 -72.76 156.92 38.43 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.165 -1.197 . . . . 0.0 109.666 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.67 -19.25 22.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.86 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.69 163.8 10.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.037 -1.04 . . . . 0.0 108.752 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.42 -175.52 5.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.104 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.44 172.37 13.47 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.144 -0.972 . . . . 0.0 109.643 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.83 158.96 15.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.348 -0.845 . . . . 0.0 109.409 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.91 149.13 81.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.49 103.64 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.496 0.798 . . . . 0.0 112.149 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.43 171.61 35.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.1 -177.95 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.971 1.114 . . . . 0.0 111.758 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.91 -127.49 43.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -78.44 -7.23 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.293 -1.122 . . . . 0.0 110.24 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 142.4 47.74 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -14.8 61.15 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -67.95 157.91 33.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -1.229 . . . . 0.0 109.9 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.83 118.18 8.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 109.851 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -98.54 144.68 27.59 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.124 -0.985 . . . . 0.0 110.698 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.478 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 19.1 m-85 -119.93 137.55 53.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.21 121.02 13.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -97.81 -2.72 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -76.09 -19.27 58.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.83 158.92 15.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.804 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -87.16 117.59 26.01 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.86 147.44 23.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.532 -0.73 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.5 p -130.08 161.07 31.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -108.06 31.06 5.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.736 . . . . 0.0 109.547 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.3 p30 -149.95 -164.99 2.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.945 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 43.1 t80 -80.87 32.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.082 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -76.01 -163.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.962 . . . . 0.0 109.918 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -49.69 -59.0 4.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.537 -0.727 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.42 129.89 55.67 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.994 -1.066 . . . . 0.0 110.949 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 98.1 m-20 -101.97 107.15 18.2 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.238 -0.914 . . . . 0.0 108.542 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.79 -41.48 87.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 111.055 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.474 ' CE1' HG11 ' A' ' 146' ' ' VAL . 23.3 t-160 -59.9 -41.55 91.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.994 -1.067 . . . . 0.0 109.945 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.452 ' NH2' ' CE1' ' A' ' 140' ' ' TYR . 45.3 ttp180 -60.24 -40.28 89.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.45 -39.57 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.21 82.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 0.0 109.215 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.93 78.95 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 109.701 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.16 -49.85 53.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 78.6 mt-10 -59.83 -40.54 88.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.48 -38.7 90.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 108.897 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.26 -41.14 86.35 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -63.7 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.264 . . . . 0.0 108.635 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.0 m -70.48 -25.1 63.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.7 mt -83.13 -1.94 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.5 76.76 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.85 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.08 130.65 35.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.808 -1.407 . . . . 0.0 109.279 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.2 m -88.03 173.53 8.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.3 156.49 37.61 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.803 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -130.32 158.15 40.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -100.08 7.29 44.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.863 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -78.61 132.2 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 133' ' ' GLY . 20.1 tt -60.4 -38.25 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 111.257 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -79.8 -1.61 87.32 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.339 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 129.49 35.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.806 -1.409 . . . . 0.0 109.49 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.43 -26.58 65.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.033 -1.042 . . . . 0.0 109.065 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.1 mmm -73.89 50.06 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.578 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' C ' ' H ' ' A' ' 139' ' ' SER . 18.3 t80 -68.08 135.81 91.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.85 14.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 CA-C-N 120.289 1.139 . . . . 0.0 112.569 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 137' ' ' TYR . 79.5 p -163.98 172.52 13.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 109.76 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CE1' ' NH2' ' A' ' 114' ' ' ARG . 58.3 t80 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.392 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 113' ' ' HIS . 81.6 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.541 0.686 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -147.0 143.46 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.42 136.44 40.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.61 166.44 12.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.04 -39.19 85.09 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.81 -42.34 93.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.346 -0.846 . . . . 0.0 108.995 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -72.22 -43.12 64.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.569 -0.707 . . . . 0.0 109.822 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -49.99 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.012 -1.055 . . . . 0.0 109.369 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.76 -39.29 93.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.4 -51.54 53.79 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.261 -0.899 . . . . 0.0 111.393 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 157' ' ' GLN . 8.9 tp -69.26 -38.48 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.676 -1.485 . . . . 0.0 109.547 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.9 mt-30 -65.77 -38.65 89.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.088 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.24 94.83 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 0.0 109.278 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.09 -51.21 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.51 -65.31 0.97 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.29 179.28 34.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -86.6 156.42 20.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -1.146 . . . . 0.0 108.639 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--N 1.3 -1.553 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.669 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -80.27 115.7 19.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.349 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.63 -10.41 57.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.85 . . . . 0.0 109.597 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.97 149.51 28.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.139 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.46 -3.69 49.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.523 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 88.6 m-70 -127.37 139.32 52.94 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 49' ' ' PHE . 86.5 mt -130.34 153.04 49.1 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.23 -0.919 . . . . 0.0 108.961 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.9 p -126.23 154.41 43.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -142.4 160.0 41.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -148.46 129.99 14.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.219 -0.926 . . . . 0.0 109.801 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.72 118.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.88 -40.22 94.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -163.66 154.26 15.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.812 -1.18 . . . . 0.0 110.404 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -98.78 138.19 36.29 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.259 -0.901 . . . . 0.0 108.901 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 t -71.85 145.95 89.95 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.349 -0.845 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.1 -14.62 45.21 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.442 0.836 . . . . 0.0 111.786 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 -39.86 88.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.442 HD13 ' ND2' ' A' ' 105' ' ' ASN . 44.8 mt -135.62 150.18 71.29 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.5 Cg_endo -67.83 -173.34 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.493 0.855 . . . . 0.0 111.847 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 ptt-85 -88.16 -37.45 16.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.842 . . . . 0.0 110.443 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.01 89.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.923 -1.111 . . . . 0.0 109.516 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.28 -39.8 74.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 26' ' ' PRO . 65.6 t -70.46 -47.09 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 109.931 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.7 t0 -60.02 -41.11 91.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.501 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -60.05 -45.72 91.92 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 0.0 109.13 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.03 83.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.21 -40.45 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.907 . . . . 0.0 110.077 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.9 tt0 -69.88 -38.79 76.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.52 -40.09 90.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.37 98.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.885 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' ' CD2' ' A' ' 49' ' ' PHE . 26.4 m-85 -60.0 -40.18 88.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.163 . . . . 0.0 109.72 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 4.1 mp0 -60.11 -40.02 88.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.839 -1.163 . . . . 0.0 109.633 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.1 -40.58 90.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.876 -1.14 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -74.91 -44.04 50.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.2 t -69.42 -34.8 75.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.241 -0.912 . . . . 0.0 110.493 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -56.91 -28.09 61.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 110.107 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 45' ' ' THR . 30.0 m -110.82 5.28 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.379 -0.826 . . . . 0.0 110.694 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' NE2' ' A' ' 157' ' ' GLN . 41.9 p -141.42 146.14 40.94 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.58 7.81 0.87 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.813 1.009 . . . . 0.0 111.702 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.71 156.87 37.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.917 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.523 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 22.2 p -134.55 151.67 51.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -130.89 150.9 51.84 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.326 -0.858 . . . . 0.0 110.291 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -155.8 135.22 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.253 -0.904 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -77.04 146.57 37.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.71 135.36 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.56 -0.712 . . . . 0.0 109.155 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -97.54 -4.2 38.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 109.841 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.4 150.44 36.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.073 -1.017 . . . . 0.0 109.364 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.44 169.62 40.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.649 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 4.7 pm0 -81.3 152.93 27.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -1.174 . . . . 0.0 109.19 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.31 155.45 21.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.36 -0.837 . . . . 0.0 108.91 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.02 -40.28 88.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.687 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.36 116.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.375 -0.828 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp -99.97 134.4 42.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.867 . . . . 0.0 109.38 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.85 129.18 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.525 -0.734 . . . . 0.0 109.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.8 p -147.3 155.94 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.11 139.31 39.97 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.88 162.48 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.36 -0.838 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -129.1 134.56 48.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.725 -0.609 . . . . 0.0 109.886 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.94 -136.42 3.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -70.41 124.45 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.54 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -138.11 66.65 1.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.518 -0.739 . . . . 0.0 109.786 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.3 mtm-85 56.98 48.54 15.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.88 155.2 44.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 108.751 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.61 8.45 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.6 m -137.93 75.39 42.22 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.299 -0.876 . . . . 0.0 109.524 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.74 163.59 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.307 1.338 . . . . 0.0 112.533 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -78.73 151.8 31.89 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.655 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -104.69 67.85 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.71 -167.12 21.04 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -58.1 -15.24 22.08 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.233 1.288 . . . . 0.0 111.919 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.54 -179.95 47.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.11 -163.65 34.67 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 121.042 -1.27 . . . . 0.0 110.163 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -74.54 150.33 39.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.491 -1.005 . . . . 0.0 109.525 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.36 -11.91 36.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.087 -1.008 . . . . 0.0 109.816 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.82 174.98 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.005 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.62 121.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.96 -1.087 . . . . 0.0 110.38 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.01 170.47 11.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.692 -0.63 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -106.5 149.48 27.06 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -58.8 149.07 66.13 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.199 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.67 102.73 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.792 0.995 . . . . 0.0 112.135 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 179.24 36.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.78 -177.62 3.26 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.443 1.429 . . . . 0.0 112.787 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.07 -120.72 23.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.89 -13.58 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.482 -1.01 . . . . 0.0 110.388 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.87 146.06 39.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.28 -18.63 35.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.58 161.69 22.56 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -1.113 . . . . 0.0 109.692 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.4 122.93 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -102.8 134.05 46.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.03 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.59 131.35 56.72 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -63.8 118.79 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -100.25 0.78 40.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.249 -0.907 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -74.05 -16.06 61.05 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.44 156.32 18.03 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -84.72 117.45 23.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 108.977 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.14 148.56 25.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 26.7 p -128.2 165.31 20.7 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.494 -0.754 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 25' ' ' LEU . 84.9 m-20 -117.02 29.14 8.09 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.749 ' ND2' ' HE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -146.33 -161.42 1.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.199 -0.938 . . . . 0.0 109.739 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -83.01 31.69 0.43 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.749 ' HE ' ' ND2' ' A' ' 106' ' ' ASN . 65.8 mtm180 -76.34 -162.7 0.26 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.823 -1.173 . . . . 0.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.72 -56.99 14.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 111.866 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 94.2 m-85 -106.87 128.69 54.51 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.948 -1.095 . . . . 0.0 111.176 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -101.2 115.34 30.26 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.97 -40.03 75.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.982 . . . . 0.0 111.053 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -60.36 -44.58 95.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.774 -1.204 . . . . 0.0 111.249 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -59.95 -42.38 93.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.746 -1.221 . . . . 0.0 109.682 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.92 -40.92 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.073 -1.017 . . . . 0.0 108.771 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -42.56 94.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.104 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.7 93.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.647 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.522 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 7.2 t60 -69.65 -40.16 76.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.878 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.02 -40.88 90.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.044 -1.035 . . . . 0.0 108.886 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.97 -40.01 96.42 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.74 -40.07 92.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.522 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 14.1 m-70 -64.28 -37.49 87.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.035 -1.274 . . . . 0.0 108.509 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -70.01 -24.29 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.24 1.2 49.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.58 15.76 77.25 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.5 128.0 32.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.899 -1.353 . . . . 0.0 109.016 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.3 m -87.59 174.32 8.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -69.17 159.82 32.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.626 -0.671 . . . . 0.0 110.466 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -125.24 162.32 24.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.609 -0.682 . . . . 0.0 109.576 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -99.79 1.27 42.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.308 -0.87 . . . . 0.0 109.324 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 48.7 t0 -82.14 116.15 21.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.195 0.998 . . . . 0.0 108.971 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.97 -24.66 30.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.329 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.22 -4.1 88.39 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.88 144.62 29.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -1.221 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 87.0 mt -61.01 -35.26 76.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 72.0 mmm -70.37 54.82 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 109.666 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.3 t80 -70.14 132.38 88.24 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -45.5 -57.11 2.31 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.392 1.176 . . . . 0.0 111.165 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -100.68 175.8 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.7 t80 . . . . . 0 N--CA 1.498 1.954 0 O-C-N 120.836 -1.165 . . . . 0.0 110.475 -179.405 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.138 0.494 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -149.28 152.36 35.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.234 -0.917 . . . . 0.0 108.623 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.96 145.12 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.924 -1.11 . . . . 0.0 108.812 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.77 163.7 14.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.099 -1.001 . . . . 0.0 109.45 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 109.211 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -59.17 -40.69 86.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.802 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -72.54 -40.24 66.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 109.889 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.8 -49.81 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.127 -0.983 . . . . 0.0 109.602 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.88 -39.91 91.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.959 -1.088 . . . . 0.0 109.962 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.63 -54.09 24.46 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.974 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -63.67 -39.87 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.735 -1.45 . . . . 0.0 109.621 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.953 ' NE2' HG22 ' A' ' 45' ' ' THR . 15.9 mm-40 -67.85 -36.89 81.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.4 94.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.793 -1.192 . . . . 0.0 109.381 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.19 -49.79 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.209 -0.932 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.95 -61.33 1.38 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.203 -0.935 . . . . 0.0 110.092 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.42 -175.97 41.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.5 mtt-85 -93.25 140.12 29.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -1.035 . . . . 0.0 109.551 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.47 ' N ' ' OE1' ' A' ' 157' ' ' GLN . 30.1 m . . . . . 0 C--N 1.301 -1.54 0 C-N-CA 119.503 -0.879 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 8' ' ' ARG . 51.7 mtm-85 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.25 0.547 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -79.86 123.85 28.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.71 -9.93 58.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.088 -1.007 . . . . 0.0 110.517 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -85.77 148.08 26.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 109.973 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 p -95.8 -4.12 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.502 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 90.0 m-70 -121.58 129.34 52.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.21 155.56 43.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.493 -0.754 . . . . 0.0 109.869 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -128.33 151.41 49.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.411 -0.805 . . . . 0.0 109.6 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -142.2 160.58 39.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.358 -0.839 . . . . 0.0 109.803 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -150.69 134.37 16.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.301 -0.875 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.42 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 81.7 mt -87.73 119.61 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.8 -39.77 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -160.21 155.35 24.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.377 -0.827 . . . . 0.0 109.519 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -100.22 131.19 46.3 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 t -70.55 141.41 87.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.806 -1.184 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -65.75 -6.22 13.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.578 0.885 . . . . 0.0 111.544 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -60.19 -40.17 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -140.49 151.32 63.52 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.35 179.51 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.475 0.848 . . . . 0.0 111.338 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -85.77 -35.78 20.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.158 -0.964 . . . . 0.0 109.357 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.32 75.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.027 -1.045 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.55 -40.05 70.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.771 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.11 -40.57 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.015 . . . . 0.0 109.623 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.57 -42.87 93.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 109.189 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.37 -42.34 95.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.812 . . . . 0.0 108.911 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.41 95.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -0.834 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.74 -40.09 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 108.643 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.06 -40.76 74.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -60.04 -35.04 74.24 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.271 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.32 -45.84 71.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -60.2 -40.32 89.65 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.869 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -60.08 -40.3 89.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 110.176 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 40' ' ' LEU . 83.4 mt -59.93 -43.03 95.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.505 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -73.2 -40.29 64.87 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 110.131 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.6 t -67.96 -35.25 78.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.723 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.71 -34.44 69.46 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 110.182 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 45' ' ' THR . 30.5 m -107.97 10.7 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.965 -1.084 . . . . 0.0 111.558 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 HG23 ' A' ' 44' ' ' VAL . 66.6 p -145.34 148.45 37.61 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 120.757 -1.214 . . . . 0.0 109.634 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.57 9.68 0.92 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.823 1.016 . . . . 0.0 112.187 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.35 158.22 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 109.457 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 67.5 p -136.22 149.87 48.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.21 157.04 43.57 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.414 -0.803 . . . . 0.0 110.241 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.09 126.69 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 63.4 tttp -74.46 138.97 43.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.178 -0.951 . . . . 0.0 108.923 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.58 135.06 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 t -97.99 -1.4 42.77 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.23 -0.919 . . . . 0.0 110.587 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.9 158.41 43.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.093 . . . . 0.0 109.259 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 173.17 46.27 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -79.02 137.89 37.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.241 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.47 139.82 32.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 108.939 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.18 -41.65 93.33 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.7 mt -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mtt -105.48 132.09 52.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.563 -0.711 . . . . 0.0 109.753 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.7 131.27 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.1 p -146.61 159.55 43.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -110.55 139.42 45.81 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.43 168.7 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.271 -0.893 . . . . 0.0 111.229 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 66' ' ' GLY . 80.8 mtm180 -131.94 140.53 49.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.799 -0.563 . . . . 0.0 109.655 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 41.55 -144.25 0.79 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.28 136.69 55.31 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.931 . . . . 0.0 108.957 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.616 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.5 p-80 -138.32 50.59 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 0.0 109.726 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 57.6 50.01 11.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.717 -0.614 . . . . 0.0 110.053 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.537 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 77.8 m-20 -137.05 167.57 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.31 -0.869 . . . . 0.0 109.24 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -88.94 10.0 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 108.998 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.5 m -138.11 73.19 45.33 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -72.0 146.35 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.837 1.025 . . . . 0.0 111.612 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.86 149.21 31.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.062 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -128.17 74.16 1.53 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.29 173.72 46.58 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -50.91 -12.21 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.304 1.336 . . . . 0.0 112.438 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.72 177.23 44.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -157.31 28.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -75.98 145.57 40.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -1.135 . . . . 0.0 109.531 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.12 -15.62 29.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 108.707 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.91 170.39 6.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 109.152 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -161.41 176.38 11.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.914 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.17 168.86 18.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.123 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -105.07 142.27 35.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.757 . . . . 0.0 109.732 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.73 149.01 81.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.03 -1.044 . . . . 0.0 109.062 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.92 109.86 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.701 0.934 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.34 -179.72 29.03 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.46 141.48 20.09 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 120.997 1.131 . . . . 0.0 112.812 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.99 -125.39 7.19 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.285 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.64 -9.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.84 -0.8 . . . . 0.0 110.203 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.31 139.76 48.17 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.74 -13.28 63.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -66.78 160.15 26.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.906 -1.35 . . . . 0.0 110.035 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.12 116.57 6.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -0.851 . . . . 0.0 109.058 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -98.77 153.29 18.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 21.0 m-85 -121.87 140.45 52.38 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -65.75 120.77 13.6 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -99.52 -7.54 25.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.637 -0.664 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -75.69 -12.61 60.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -105.07 149.92 25.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.194 -0.941 . . . . 0.0 108.788 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -83.33 122.09 28.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 109.493 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -89.22 152.56 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.54 -0.725 . . . . 0.0 110.026 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HD21 ' A' ' 106' ' ' ASN . 30.8 p -120.96 169.49 10.42 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -109.68 27.39 9.62 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.645 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.04 -165.02 2.17 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.815 . . . . 0.0 110.209 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.1 t80 -84.54 33.87 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.917 0.865 . . . . 0.0 109.989 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.2 mmt-85 -76.76 -162.46 0.27 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.831 -1.168 . . . . 0.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -55.02 -57.65 10.86 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.697 -0.627 . . . . 0.0 110.995 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -97.27 118.75 34.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -109.2 106.13 15.87 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.05 -44.18 69.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.865 -0.522 . . . . 0.0 110.044 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -60.5 -47.38 86.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -60.07 -40.79 90.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -70.29 -39.26 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.149 -0.969 . . . . 0.0 108.763 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.9 -43.97 94.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.953 -1.092 . . . . 0.0 109.488 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.08 78.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.107 -0.995 . . . . 0.0 109.208 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 135' ' ' LEU . 3.8 t60 -69.95 -50.61 40.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.427 -0.795 . . . . 0.0 110.29 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.2 mt-10 -58.95 -41.5 87.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.914 -1.117 . . . . 0.0 109.153 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.75 -40.44 97.27 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.948 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.48 -41.98 82.46 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -65.42 -34.42 78.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.034 -1.274 . . . . 0.0 108.452 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.3 p -68.42 -19.44 64.59 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.71 -2.63 58.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.65 20.36 56.38 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.47 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.9 137.64 35.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.507 -1.584 . . . . 0.0 108.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -87.0 164.37 16.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -67.27 151.83 46.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.7 t -124.83 168.76 12.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.694 -0.629 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.5 p -107.42 9.98 29.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.449 -0.782 . . . . 0.0 109.951 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.11 130.37 35.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.032 -1.042 . . . . 0.0 109.771 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.4 -40.7 84.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 111.36 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.38 -5.12 85.37 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 121.094 -1.003 . . . . 0.0 110.747 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.69 130.26 35.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.811 -1.405 . . . . 0.0 109.889 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.491 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 93.9 mt -63.33 -22.96 67.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.3 mmt -70.54 35.86 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.693 -0.629 . . . . 0.0 109.627 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.4 t80 -70.71 128.94 90.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.014 -1.053 . . . . 0.0 108.925 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -52.8 -66.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.844 1.337 . . . . 0.0 111.765 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.5 p -82.65 173.94 11.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.96 . . . . 0.0 110.405 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.963 178.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.8 t . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -143.6 157.46 44.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.068 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.6 145.03 43.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.037 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 161.53 14.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.247 -0.908 . . . . 0.0 109.633 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -60.14 -42.51 95.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -58.38 -41.03 83.9 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.571 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.37 -42.08 62.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.837 -1.164 . . . . 0.0 109.48 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.71 -49.97 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 108.772 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.18 -40.27 93.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 109.868 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.51 -55.34 29.46 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.484 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.4 tp -67.56 -39.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.246 . . . . 0.0 110.561 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -67.56 -41.5 84.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.063 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.02 94.78 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.8 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.63 -0.669 . . . . 0.0 109.718 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.08 -66.84 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.8 -175.83 36.6 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -86.95 149.7 24.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -0.999 . . . . 0.0 109.231 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 0.0 110.41 -179.294 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 8' ' ' ARG . 40.6 mtm-85 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -83.79 122.59 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.037 -1.039 . . . . 0.0 109.936 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 47.6 mp0 -75.15 -30.17 60.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.387 -0.82 . . . . 0.0 109.763 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -81.58 154.51 26.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 p -98.25 -4.5 35.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.897 . . . . 0.0 109.214 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.435 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 82.5 m-70 -111.58 131.58 55.15 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -134.19 157.99 44.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 p -124.2 155.63 38.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.346 -0.846 . . . . 0.0 108.824 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.47 158.64 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -154.31 134.98 13.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.23 123.74 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 0.0 108.831 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.46 -40.25 85.34 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.023 -1.048 . . . . 0.0 111.343 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -160.28 159.15 31.02 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.81 -1.182 . . . . 0.0 109.861 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -102.51 139.78 37.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 142.19 63.43 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.23 -11.7 32.41 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 CA-C-N 119.457 0.842 . . . . 0.0 112.188 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.26 -38.94 85.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' ND2' ' A' ' 105' ' ' ASN . 90.3 mt -134.73 153.47 78.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -60.69 -179.95 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 CA-C-N 119.461 0.843 . . . . 0.0 111.428 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 33.3 ptt180 -87.91 -35.48 17.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.91 -37.57 79.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 110.258 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.82 -34.83 60.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.84 . . . . 0.0 111.034 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.17 -49.82 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.77 -1.207 . . . . 0.0 109.965 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 12.3 p-10 -60.03 -37.08 78.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.751 -1.218 . . . . 0.0 109.62 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -59.13 -48.6 81.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.908 -1.12 . . . . 0.0 109.406 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.68 91.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.055 -1.028 . . . . 0.0 109.612 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.5 mm -72.28 -31.02 37.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.324 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -66.65 -41.65 87.87 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.07 -28.78 65.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.857 -1.152 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.59 -48.18 80.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.913 -1.117 . . . . 0.0 109.007 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.6 m-85 -62.67 -40.43 97.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.686 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.12 -43.52 95.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.099 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.61 -43.95 93.57 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.82 -1.175 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.422 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.3 m95 -70.34 -40.8 73.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.275 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.4 t -69.5 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 110.579 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -59.72 -27.37 66.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.968 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.62 9.56 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 O-C-N 120.971 -1.081 . . . . 0.0 110.492 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 22.5 p -149.19 150.49 32.0 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.926 -1.109 . . . . 0.0 109.658 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -69.68 9.33 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.643 0.895 . . . . 0.0 111.533 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.27 151.18 44.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.225 -0.922 . . . . 0.0 109.068 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.435 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 71.2 p -134.66 148.53 50.38 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 96.6 m-85 -129.9 155.45 46.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.8 m -154.69 134.52 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.455 -0.778 . . . . 0.0 109.534 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -77.34 145.93 37.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.16 132.81 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.642 -0.662 . . . . 0.0 109.733 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 t -96.74 -9.16 29.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -141.9 156.34 45.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 108.878 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.9 171.46 47.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.33 134.82 35.64 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.667 -0.902 . . . . 0.0 109.767 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.86 143.67 26.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.946 -1.096 . . . . 0.0 109.282 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -40.67 89.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.85 119.09 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.521 -0.737 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.9 mtt -103.38 135.86 44.21 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.021 -1.049 . . . . 0.0 109.807 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.45 130.87 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.3 p -149.98 156.1 41.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.752 -1.218 . . . . 0.0 110.708 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.6 138.44 45.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.37 164.46 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.228 -0.92 . . . . 0.0 111.304 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -134.3 145.54 49.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.81 -147.03 2.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -73.77 125.72 28.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.45 -1.03 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -127.62 53.69 1.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 69' ' ' ARG . 61.1 mtt-85 56.61 50.03 13.54 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -139.18 158.36 44.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.19 -0.944 . . . . 0.0 109.658 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -89.12 10.47 21.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 109.751 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -137.81 72.51 48.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.12 146.64 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 120.843 1.029 . . . . 0.0 112.26 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD2' ' OD2' ' A' ' 98' ' ' ASP . 90.5 m-85 -76.26 148.47 37.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.368 -0.833 . . . . 0.0 108.987 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -132.57 72.88 1.5 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.382 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.27 -170.21 42.64 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.01 -16.25 54.49 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.197 1.264 . . . . 0.0 111.727 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.15 49.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.66 -165.97 46.71 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -76.4 142.1 41.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' OE2' ' A' ' 101' ' ' GLU . 50.9 mt -90.79 -12.36 36.67 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.61 157.33 8.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.362 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.61 177.76 10.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.315 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.78 161.73 23.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -92.71 156.03 17.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.11 149.78 65.46 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.377 -0.827 . . . . 0.0 108.967 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -59.17 106.87 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.61 0.873 . . . . 0.0 111.984 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.2 176.93 38.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -69.2 173.06 11.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.318 1.345 . . . . 0.0 112.029 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.75 14.45 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -83.93 -11.79 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -1.066 . . . . 0.0 109.841 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 140.03 38.02 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.28 -20.33 34.36 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.77 128.75 37.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.028 -1.277 . . . . 0.0 110.717 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.34 24.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.773 . . . . 0.0 109.09 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -130.07 132.44 46.17 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.5 136.4 54.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.385 -0.822 . . . . 0.0 110.095 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.438 ' OD2' ' CD2' ' A' ' 74' ' ' PHE . 13.9 t0 -65.77 124.31 22.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.291 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -101.18 0.27 37.31 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.68 -15.21 60.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.048 -1.032 . . . . 0.0 110.068 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.4 ' OE2' HD22 ' A' ' 81' ' ' LEU . 99.9 mt-10 -106.93 164.23 12.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -88.34 118.37 27.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.116 -0.99 . . . . 0.0 109.902 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.97 148.65 23.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.108 -0.995 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.5 p -124.94 173.53 8.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.529 -0.732 . . . . 0.0 109.666 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.417 ' ND2' HD22 ' A' ' 25' ' ' LEU . 83.9 m-20 -112.34 23.63 13.42 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.401 0.62 . . . . 0.0 109.445 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -147.27 -165.0 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -87.87 20.88 2.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 109' ' ' GLU . 96.1 mtt180 -75.83 -165.73 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.283 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' ARG . 72.5 mm-40 -11.16 -69.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 123.023 0.529 . . . . 0.0 112.41 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -131.8 128.83 39.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -89.9 108.7 19.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 108.627 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.18 -40.16 78.27 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.451 ' ND1' ' C ' ' A' ' 113' ' ' HIS . 17.8 t-80 -59.98 -46.45 89.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.788 -1.195 . . . . 0.0 110.067 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -60.22 -41.91 94.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.004 -1.06 . . . . 0.0 110.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.75 -41.13 79.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.853 -1.154 . . . . 0.0 108.85 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.92 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.82 91.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 33.8 t60 -70.31 -39.97 74.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.989 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -58.66 -40.01 82.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.177 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.0 -39.74 95.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.56 -42.05 65.64 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 7.7 m-70 -62.26 -36.63 82.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.987 -1.302 . . . . 0.0 108.411 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.9 t -69.22 -24.49 64.02 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.6 -4.87 58.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 0.0 109.436 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.03 15.97 58.48 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.91 129.1 34.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.016 -1.285 . . . . 0.0 109.716 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.499 ' O ' ' SD ' ' A' ' 136' ' ' MET . 68.5 m -87.79 165.52 15.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 109.276 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -66.04 160.6 23.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.093 . . . . 0.0 108.788 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -127.21 166.22 18.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.44 -0.788 . . . . 0.0 109.405 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.3 p -100.53 7.32 44.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.336 -0.853 . . . . 0.0 108.988 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -83.26 116.44 22.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.53 -27.86 41.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.577 -0.702 . . . . 0.0 110.422 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.96 -5.76 89.48 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.298 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.45 156.08 24.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.284 . . . . 0.0 109.79 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 89.6 mt -69.6 -29.53 67.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.764 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 127' ' ' SER . 5.6 mtt -74.0 61.95 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.85 126.92 92.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -47.98 -71.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.485 1.209 . . . . 0.0 110.835 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.5 p -94.44 170.15 9.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 108.982 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.0 t80 . . . . . 0 C--N 1.298 -1.659 0 O-C-N 121.062 -1.024 . . . . 0.0 108.511 179.258 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.382 0.61 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -144.78 154.94 43.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.82 145.78 34.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.4 156.24 18.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 109.524 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.16 -39.74 87.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 109.039 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 56.8 t0 -57.93 -39.63 78.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.506 -0.746 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 156' ' ' ILE . 96.1 m-20 -76.34 -40.71 50.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.952 -1.092 . . . . 0.0 109.519 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.5 -50.12 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.256 -0.902 . . . . 0.0 109.265 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.02 -40.06 90.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.085 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.99 -51.63 38.29 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.3 tp -65.75 -40.2 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.008 -1.289 . . . . 0.0 109.486 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.1 mt-30 -65.29 -39.68 92.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.289 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.15 92.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.056 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.72 -49.98 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.057 . . . . 0.0 109.819 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.827 -1.17 . . . . 0.0 109.574 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.23 -165.96 33.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.57 138.64 33.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -1.21 . . . . 0.0 109.849 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -81.3 120.93 25.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.0 109.017 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.74 -14.82 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.69 149.26 27.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.736 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -94.49 -4.61 47.82 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -129.15 141.33 51.21 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -131.99 159.91 37.38 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.2 -0.938 . . . . 0.0 109.883 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.5 p -127.9 155.1 44.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.454 -0.779 . . . . 0.0 109.51 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.58 157.97 43.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -148.49 137.67 21.82 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.236 -0.915 . . . . 0.0 110.066 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.15 119.96 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.5 tt0 -64.98 -39.98 94.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.078 . . . . 0.0 110.365 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.8 m-20 -158.62 151.15 21.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.981 -1.074 . . . . 0.0 109.784 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.13 134.11 40.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 108.978 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -70.1 135.84 87.12 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -66.54 -10.66 28.65 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.769 0.953 . . . . 0.0 111.848 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.12 149.99 74.24 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.83 -177.77 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 CA-C-N 119.485 0.852 . . . . 0.0 111.429 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -87.26 -29.9 21.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.021 -1.049 . . . . 0.0 109.757 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.87 88.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.9 -39.14 76.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.89 -40.9 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.418 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.95 -43.18 95.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.995 . . . . 0.0 109.011 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -59.99 -43.59 95.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.209 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.36 77.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -70.13 -40.06 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.377 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.09 -39.9 75.27 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 109.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.61 88.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -60.1 -39.79 87.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.432 HE21 ' HG2' ' A' ' 35' ' ' GLU . 77.5 mt-30 -59.34 -43.43 92.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.968 -1.082 . . . . 0.0 109.638 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.93 -44.36 97.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.407 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.1 m95 -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.984 -1.072 . . . . 0.0 110.322 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 t -69.81 -39.84 76.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.87 -18.09 54.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.168 -0.958 . . . . 0.0 111.115 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.02 4.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.15 -0.969 . . . . 0.0 109.775 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.516 ' N ' ' OG ' ' A' ' 163' ' ' SER . 6.5 p -146.44 151.18 42.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.231 -0.918 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -69.32 4.82 1.79 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.823 1.015 . . . . 0.0 111.7 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.85 150.16 46.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 p -129.85 149.37 51.61 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.01 157.6 37.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.427 -0.796 . . . . 0.0 109.683 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.06 129.14 8.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.935 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -76.39 138.02 40.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 m -121.12 133.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.466 -0.771 . . . . 0.0 109.354 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -97.77 -0.07 45.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -143.26 150.17 38.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.182 -0.949 . . . . 0.0 109.658 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 165.07 30.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -81.58 137.81 35.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -1.1 . . . . 0.0 109.308 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.0 151.85 21.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.98 -42.91 95.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.858 . . . . 0.0 109.717 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -104.39 109.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.404 -0.81 . . . . 0.0 109.397 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtp -101.94 136.76 41.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.286 -0.884 . . . . 0.0 109.684 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.77 132.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.66 -0.65 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.5 p -147.02 150.46 35.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.24 140.45 38.37 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 109.254 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.7 168.82 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -131.88 138.47 48.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.672 -0.642 . . . . 0.0 109.372 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.65 -151.35 1.11 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.3 t0 -65.24 134.89 54.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.615 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.0 p-80 -132.55 51.26 2.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.725 . . . . 0.0 109.627 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 61.9 mtp180 57.38 53.31 7.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.642 -0.661 . . . . 0.0 110.627 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 92.5 m-20 -142.27 169.99 16.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -89.43 9.49 26.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -138.9 72.42 40.92 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.15 152.31 31.03 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.33 1.353 . . . . 0.0 112.017 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -77.81 137.46 38.43 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.268 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -102.23 68.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.0 109.478 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 178.42 39.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.25 -21.03 6.34 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.252 1.301 . . . . 0.0 112.325 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.63 -178.84 45.09 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.02 -153.35 24.52 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -76.81 142.28 40.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -1.118 . . . . 0.0 109.807 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.3 mt -91.53 -15.16 29.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.99 174.86 4.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 108.9 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 2.6 p80 -161.96 117.34 1.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.197 . . . . 0.0 110.428 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.0 171.11 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.12 148.64 70.6 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 0.0 109.353 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.59 108.21 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 120.598 0.865 . . . . 0.0 111.738 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.62 171.26 41.49 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.976 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -65.93 171.61 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.228 1.286 . . . . 0.0 111.548 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.84 -125.94 16.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.14 -6.79 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.363 -1.081 . . . . 0.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.53 141.59 48.0 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.72 -16.27 54.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.76 163.46 21.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -1.074 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.09 117.73 8.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -0.776 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -101.35 135.55 42.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.453 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.1 m-85 -116.85 129.05 55.83 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' GLU . 62.3 t0 -68.06 128.75 37.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.248 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 69.5 tt0 -100.01 2.53 43.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.278 -0.888 . . . . 0.0 109.418 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.13 -16.78 60.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 54.0 mp0 -94.44 155.62 16.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.075 -1.016 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -85.16 115.12 22.76 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.59 145.46 25.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.105 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.9 p -120.31 171.51 8.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.11 26.08 9.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -151.0 -166.98 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -90.7 32.69 0.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.286 -0.884 . . . . 0.0 110.52 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 9.0 mtp-105 -75.57 -156.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.841 -1.162 . . . . 0.0 109.652 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -36.86 -59.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.714 -0.616 . . . . 0.0 111.379 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.0 m-85 -123.09 128.96 50.83 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.079 -1.013 . . . . 0.0 110.249 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -108.52 110.37 21.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.381 -0.825 . . . . 0.0 109.186 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.4 -41.12 96.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.184 -0.947 . . . . 0.0 110.41 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 110.362 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -59.94 -41.16 91.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.047 -1.033 . . . . 0.0 109.944 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.9 -40.19 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 109.541 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.18 94.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.948 . . . . 0.0 108.992 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.33 83.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.448 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 4.8 t60 -69.98 -48.31 58.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.955 . . . . 0.0 109.609 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 82.8 mt-10 -59.95 -40.01 87.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.6 mt -62.88 -39.8 95.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.257 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.65 -41.45 82.28 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.448 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 19.9 m-70 -64.87 -39.17 93.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.8 p -69.99 -21.4 63.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.587 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.93 -3.24 59.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 0.0 109.219 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 9.86 60.85 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.64 124.58 30.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.103 -1.234 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 65.4 m -87.96 171.08 10.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.287 -0.883 . . . . 0.0 109.723 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.5 153.0 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.8 t -126.61 168.93 13.65 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.0 109.391 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.3 p -102.85 9.53 38.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -0.813 . . . . 0.0 109.561 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -82.47 123.86 29.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.519 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.71 -31.46 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.374 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.62 -4.3 90.19 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.652 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.11 129.77 35.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.858 -1.377 . . . . 0.0 109.404 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.92 -24.94 67.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 108.967 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.9 mmm -73.17 46.98 0.19 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.421 -0.799 . . . . 0.0 109.651 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -69.76 129.95 90.71 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -48.4 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 120.343 1.158 . . . . 0.0 111.78 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.5 p -86.62 171.9 10.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.143 -0.973 . . . . 0.0 109.524 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.269 0.557 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.47 157.16 44.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 108.913 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.407 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.0 mt -75.85 149.93 37.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.104 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.88 158.57 15.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -60.01 -39.48 85.95 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 108.809 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -57.82 -41.44 82.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.957 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.23 -40.35 62.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.147 . . . . 0.0 110.081 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.36 -50.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.93 -40.12 92.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.57 -55.2 24.29 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.397 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.01 -39.99 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.839 -1.389 . . . . 0.0 109.815 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.8 mt-30 -64.92 -38.5 91.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.681 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.13 92.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.16 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.97 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -98.1 -72.77 0.64 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.42 -0.8 . . . . 0.0 109.564 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.21 -165.06 35.24 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -91.47 139.88 30.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.98 . . . . 0.0 109.694 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 45' ' ' THR . 16.6 m . . . . . 0 N--CA 1.488 1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 109.094 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 8' ' ' ARG . 54.0 mtt-85 . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.51 117.52 21.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.724 -1.235 . . . . 0.0 108.64 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -82.93 -10.5 58.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -84.44 149.55 25.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -96.06 -4.42 43.02 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -126.76 141.24 51.89 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.7 mt -135.74 158.33 44.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -129.39 154.03 47.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -141.39 160.59 39.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.442 -0.786 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -147.17 132.54 18.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.163 -0.961 . . . . 0.0 110.095 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.68 120.62 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.07 -40.16 94.27 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.988 -1.07 . . . . 0.0 109.839 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -160.19 157.14 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.082 -1.011 . . . . 0.0 109.741 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.71 136.83 40.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 109.196 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 t -68.5 141.22 92.99 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.004 . . . . 0.0 109.0 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.72 -10.81 29.47 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 119.5 0.857 . . . . 0.0 112.146 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.44 HD13 ' ND2' ' A' ' 105' ' ' ASN . 65.0 mt -135.47 151.33 74.46 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.71 -178.7 0.57 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 120.64 0.894 . . . . 0.0 111.257 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -86.72 -35.94 18.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.184 -0.948 . . . . 0.0 110.046 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.11 73.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.97 -39.9 75.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.29 -42.26 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.88 -40.38 88.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.02 -1.05 . . . . 0.0 108.911 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.83 -48.69 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.579 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.4 92.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.585 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.22 -43.24 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 109.937 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.36 -39.76 77.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.205 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -61.15 -39.88 91.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.18 87.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 109.993 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.8 m-85 -60.13 -39.99 88.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.05 . . . . 0.0 109.316 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -59.96 -41.06 91.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.168 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.13 -41.11 91.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -72.3 -40.02 67.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.35 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.26 -37.23 77.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 0.0 110.089 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -57.85 -21.76 44.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.209 -0.932 . . . . 0.0 110.743 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.93 5.66 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.3 p -147.0 150.38 38.54 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 120.975 -1.078 . . . . 0.0 109.534 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.12 5.3 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.688 0.925 . . . . 0.0 110.997 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.86 160.3 33.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.462 -0.774 . . . . 0.0 110.073 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 p -139.36 153.83 47.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.5 m-85 -130.02 152.02 49.93 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.515 -0.741 . . . . 0.0 109.585 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.3 m -153.31 131.32 11.79 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.283 -0.886 . . . . 0.0 110.33 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -79.5 139.11 37.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.54 136.1 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.346 -0.846 . . . . 0.0 108.842 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -96.89 -8.59 30.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.126 -0.984 . . . . 0.0 110.011 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -145.51 159.97 42.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 109.586 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 172.22 44.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.16 146.27 31.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -1.222 . . . . 0.0 109.494 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.77 145.72 33.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.65 -0.656 . . . . 0.0 109.422 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -117.27 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.497 -0.752 . . . . 0.0 108.978 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.1 mmm -100.09 122.05 42.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.271 -0.893 . . . . 0.0 109.778 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -112.1 129.77 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.254 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.6 p -149.81 161.5 42.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.137 -0.977 . . . . 0.0 109.676 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -109.01 138.39 45.43 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.365 -0.835 . . . . 0.0 110.692 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -133.11 145.45 50.72 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.41 -140.54 4.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -77.74 134.6 38.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.366 -1.079 . . . . 0.0 110.184 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.525 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.6 p-80 -136.46 64.55 1.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.525 -0.734 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 69' ' ' ARG . 18.8 mtt-85 54.48 47.48 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.411 -0.806 . . . . 0.0 110.091 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 91.7 m-20 -141.52 165.05 28.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -95.61 9.92 38.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.342 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 67.86 73.59 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.547 -0.721 . . . . 0.0 109.723 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.61 147.29 86.18 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.044 1.162 . . . . 0.0 112.488 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.65 145.44 34.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -138.25 79.92 1.77 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.64 173.37 36.57 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.41 -7.35 19.94 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.147 1.231 . . . . 0.0 111.676 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.88 174.44 47.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.45 -160.54 31.77 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -76.51 144.66 39.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -1.097 . . . . 0.0 109.586 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.93 -15.43 29.8 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.99 -1.069 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.89 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -0.965 . . . . 0.0 108.926 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.14 121.2 3.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.801 -1.187 . . . . 0.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.17 172.63 10.39 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.284 0.564 . . . . 0.0 109.693 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -113.58 147.86 37.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -59.91 149.01 75.1 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.34 112.46 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.811 1.008 . . . . 0.0 112.197 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.52 172.9 43.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -73.27 161.61 42.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.352 1.368 . . . . 0.0 112.29 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.63 -119.5 5.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.66 -11.39 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.171 . . . . 0.0 109.857 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.28 144.39 47.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.06 -15.55 48.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -67.36 162.11 23.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.89 120.46 12.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.275 -0.891 . . . . 0.0 109.099 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -104.75 134.13 48.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.271 -0.893 . . . . 0.0 110.785 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.93 130.91 57.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 56.5 t0 -67.19 123.91 21.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 99' ' ' GLU . 13.9 tp10 -102.11 0.32 34.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.508 -0.745 . . . . 0.0 109.622 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 96.5 m-20 -73.88 -19.56 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 108.886 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.51 155.7 17.7 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 102' ' ' ARG . 32.1 ttt-85 -86.03 121.59 28.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.02 148.71 24.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.5 p -127.11 156.57 41.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.358 -0.839 . . . . 0.0 109.9 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.44 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -107.36 30.95 5.78 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -148.43 -164.99 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -84.31 33.87 0.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.57 -163.37 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.405 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -54.17 -59.32 4.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.398 -0.814 . . . . 0.0 111.935 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.36 130.01 54.84 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.138 -0.976 . . . . 0.0 110.755 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -102.82 117.85 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.21 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.11 -49.34 67.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -59.86 -40.29 88.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 111.508 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.01 -41.27 91.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.686 -1.259 . . . . 0.0 109.611 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.96 -40.01 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 108.645 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.99 89.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.533 -0.73 . . . . 0.0 109.35 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.41 93.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.198 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -69.98 -46.61 64.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 0.0 109.552 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -59.13 -40.51 85.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.005 -1.059 . . . . 0.0 109.556 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.62 -35.71 81.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 108.819 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.77 -40.46 96.66 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -66.93 -38.27 85.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.589 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.0 p -69.5 -23.13 63.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.237 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.89 -2.3 58.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.186 -0.946 . . . . 0.0 109.143 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.49 65.66 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.69 128.29 34.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.339 . . . . 0.0 108.714 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.74 173.8 8.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 109.954 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -67.15 158.51 31.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -127.75 156.67 42.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.54 -0.725 . . . . 0.0 109.59 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.4 p -100.98 8.4 43.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.539 -0.726 . . . . 0.0 109.708 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -81.0 130.04 34.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 109.257 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.98 -39.79 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.331 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.41 72.6 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.238 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.53 137.87 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.686 -1.479 . . . . 0.0 109.146 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.16 -25.17 66.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -0.807 . . . . 0.0 109.021 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 66.5 mmm -74.09 62.04 0.88 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.394 -0.816 . . . . 0.0 109.043 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.1 129.44 87.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 108.852 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -48.21 -59.9 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.404 1.18 . . . . 0.0 111.829 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 t -102.98 173.25 6.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 74.1 t80 . . . . . 0 N--CA 1.497 1.91 0 O-C-N 120.808 -1.183 . . . . 0.0 109.0 179.751 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.04 0.448 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -150.03 154.17 37.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 109.049 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.78 146.96 39.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 108.954 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.4 161.47 14.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.475 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.26 -39.92 88.49 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.0 -41.53 87.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -74.08 -40.09 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.14 -50.16 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.61 -39.87 89.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.12 -60.94 7.51 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.777 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.2 tp -60.25 -39.93 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.341 . . . . 0.0 109.274 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.5 mt-30 -65.73 -38.09 88.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 109.035 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.95 95.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.69 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.2 -50.12 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.194 -0.941 . . . . 0.0 109.2 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -96.96 -71.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 109.578 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.94 -177.57 38.96 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.56 146.42 24.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.356 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 8' ' ' ARG . 36.6 mtt-85 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.262 0.554 . . . . 0.0 109.892 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.1 126.03 30.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.173 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.35 -12.99 53.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 110.103 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -81.66 153.62 26.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.6 p -97.42 -6.28 34.31 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.302 -0.874 . . . . 0.0 108.82 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 34.1 m170 -126.64 143.78 51.12 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.2 159.58 39.76 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.194 -0.941 . . . . 0.0 109.859 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.5 p -127.54 152.98 46.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -142.86 156.11 44.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.722 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.8 ttt-85 -150.21 131.8 14.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 0.0 109.86 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.96 118.47 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.59 -40.05 95.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 0.0 110.735 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -162.5 153.15 17.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.953 -1.092 . . . . 0.0 109.901 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.62 136.53 38.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.86 139.58 88.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.002 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -66.92 -14.05 42.26 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.614 0.898 . . . . 0.0 111.588 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.14 -38.19 82.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.352 -0.842 . . . . 0.0 109.037 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -134.74 149.96 72.15 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.03 -176.96 0.69 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.643 0.896 . . . . 0.0 111.859 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -87.29 -35.34 18.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 109.613 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.1 82.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.09 -40.1 75.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.007 . . . . 0.0 109.773 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.35 -46.08 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.682 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -59.62 -39.99 86.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.782 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -59.93 -46.9 87.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.813 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.4 92.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.206 -0.934 . . . . 0.0 109.827 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.47 -36.87 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 108.657 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.06 -39.96 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.15 -39.91 88.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.82 -1.175 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.54 72.92 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.368 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -62.94 -40.21 96.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.037 -1.04 . . . . 0.0 110.196 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.19 -44.81 94.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.962 -1.086 . . . . 0.0 109.623 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.1 -44.12 95.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.247 -0.908 . . . . 0.0 111.016 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.12 -41.83 73.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.681 -1.262 . . . . 0.0 109.802 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t -69.86 -30.57 68.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 110.359 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.88 -34.36 73.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 111.152 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 45' ' ' THR . 32.9 m -110.01 11.02 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.103 -0.998 . . . . 0.0 111.168 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.488 HG23 HG23 ' A' ' 44' ' ' VAL . 65.0 p -140.91 148.15 51.09 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.898 -1.126 . . . . 0.0 109.367 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.69 9.12 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.572 0.848 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.88 156.42 37.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 30.5 p -135.39 149.86 49.76 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.4 156.66 40.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.316 -0.865 . . . . 0.0 109.962 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -154.39 131.19 10.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -77.02 143.74 39.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.454 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 134.51 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.2 t -97.25 -4.08 39.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.13 159.06 43.57 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.911 -1.118 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.03 173.07 34.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -81.06 151.15 28.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 108.898 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.33 153.54 23.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.382 -0.824 . . . . 0.0 109.206 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.85 -40.94 90.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.93 119.46 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.642 -0.661 . . . . 0.0 109.389 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.1 mtp -103.82 131.38 51.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.409 -0.807 . . . . 0.0 108.867 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.88 129.38 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -150.52 159.69 44.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.19 137.27 44.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.01 160.09 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 0.0 111.169 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -128.71 137.81 51.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.775 -0.578 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.25 -141.57 3.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.72 126.96 31.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -1.054 . . . . 0.0 109.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -133.65 55.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.616 -0.677 . . . . 0.0 109.345 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 50.9 mtt-85 54.98 52.27 12.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 109.761 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.4 161.28 37.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.99 9.43 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.775 . . . . 0.0 110.379 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.5 t -139.74 72.91 35.21 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 109.106 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.31 152.06 79.76 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.234 1.289 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -77.79 150.33 34.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -129.65 72.42 1.48 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.545 -0.722 . . . . 0.0 109.824 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.11 170.47 38.17 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.5 Cg_endo -65.2 -24.72 58.35 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.366 1.377 . . . . 0.0 112.046 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.62 -177.98 46.7 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.8 -137.68 14.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -76.02 122.15 23.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -1.009 . . . . 0.0 109.83 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 80' ' ' ASN . 63.7 mt -90.61 -17.52 26.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.009 -1.057 . . . . 0.0 109.993 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.605 ' H ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.07 160.42 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.88 179.99 8.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.946 -1.097 . . . . 0.0 110.269 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.52 173.32 12.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 109.765 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.25 146.87 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 3.9 mp0 -59.72 146.99 79.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.901 -1.125 . . . . 0.0 108.397 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -51.04 113.32 1.05 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 120.498 0.799 . . . . 0.0 112.646 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.43 -178.3 34.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.05 176.84 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.246 1.298 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.32 -121.55 24.58 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.216 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -78.8 -10.45 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.577 -0.955 . . . . 0.0 110.284 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.37 151.39 13.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.24 -19.17 32.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.06 157.0 36.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -1.098 . . . . 0.0 110.6 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HB1' ' OE1' ' A' ' 119' ' ' GLU . . . -146.67 122.95 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -102.07 146.0 28.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.858 . . . . 0.0 110.667 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.548 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 16.1 m-85 -117.49 138.31 51.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.444 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 7.9 t70 -65.9 118.39 9.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.032 -1.042 . . . . 0.0 108.599 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -97.9 -1.44 42.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 110.052 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.39 -18.61 59.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 77' ' ' PRO . 95.9 mt-10 -97.63 158.1 15.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 109.202 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -86.53 115.14 23.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.97 -1.081 . . . . 0.0 109.703 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 93.3 m95 -90.12 148.5 22.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -127.97 159.4 35.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.437 -0.79 . . . . 0.0 109.115 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -113.73 30.26 7.38 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.709 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -147.58 -164.4 2.0 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.062 . . . . 0.0 110.722 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 90.7 t80 -73.72 25.68 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.703 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.536 ' CG ' HD21 ' A' ' 106' ' ' ASN . 26.9 mmt180 -76.1 -168.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.612 -1.305 . . . . 0.0 109.904 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.52 -57.74 10.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 112.208 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -99.5 118.57 36.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.685 -1.26 . . . . 0.0 111.431 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.48 116.52 31.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.339 -0.851 . . . . 0.0 109.475 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 tp -63.53 -38.45 91.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.428 -0.795 . . . . 0.0 109.688 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG11 ' A' ' 146' ' ' VAL . 13.1 t-80 -59.78 -39.96 86.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 111.16 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 114' ' ' ARG . 7.2 tpt180 -59.4 -43.87 92.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.848 -1.157 . . . . 0.0 109.857 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.77 -39.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.062 -1.024 . . . . 0.0 109.525 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.9 92.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.79 93.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.837 . . . . 0.0 109.617 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.428 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 5.3 t60 -69.89 -46.3 65.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.846 . . . . 0.0 110.882 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.548 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 80.5 mt-10 -59.86 -40.46 88.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.748 -1.22 . . . . 0.0 109.329 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.258 -0.901 . . . . 0.0 108.572 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.27 78.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.428 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 36.7 m-70 -65.05 -37.89 89.05 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -1.191 . . . . 0.0 108.716 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.0 p -70.27 -24.74 63.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.52 -2.99 58.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.151 -0.968 . . . . 0.0 108.821 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.77 15.79 62.72 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -82.9 130.16 35.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 m -88.25 169.97 11.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -68.57 156.6 37.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.386 -0.821 . . . . 0.0 109.114 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.6 t -131.96 160.84 34.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.85 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.1 p -99.54 6.81 45.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.329 -0.857 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 59.8 t0 -79.91 131.09 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 96.6 mt -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.459 -0.775 . . . . 0.0 109.988 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.38 -2.74 68.74 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.183 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.95 131.69 34.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.75 -1.441 . . . . 0.0 109.8 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.01 -29.87 67.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.0 mmm -75.59 53.95 0.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.186 -0.947 . . . . 0.0 109.732 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.2 140.27 87.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 4.03 1.01 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 119.949 1.017 . . . . 0.0 111.636 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.2 p -156.95 177.53 11.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.625 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.5 t80 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 120.838 -1.164 . . . . 0.0 110.001 -179.894 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.443 HG11 ' CE1' ' A' ' 113' ' ' HIS . 73.8 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.328 0.585 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -142.54 151.5 41.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.345 -0.847 . . . . 0.0 108.92 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.64 147.85 39.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.119 -0.988 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.94 153.27 19.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.03 -39.33 78.11 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -53.58 -39.98 65.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.145 -0.972 . . . . 0.0 108.484 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -72.76 -39.95 66.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.279 -0.888 . . . . 0.0 108.701 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.42 -50.2 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 0.0 108.769 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.6 -40.05 93.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.76 -55.75 13.37 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.756 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -63.11 -40.19 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.923 -1.34 . . . . 0.0 109.616 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -69.6 -38.83 77.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.25 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.57 94.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.112 -0.992 . . . . 0.0 109.38 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.56 -50.06 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.602 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.28 -173.52 40.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -89.06 148.25 23.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 C--N 1.301 -1.518 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.894 -179.871 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.158 0.504 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -82.17 124.15 29.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.01 . . . . 0.0 108.852 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -84.31 -14.01 50.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -87.3 147.34 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 110.317 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.6 p -94.64 -4.72 47.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.221 -0.924 . . . . 0.0 108.808 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 66.9 m80 -120.69 133.3 55.36 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt -131.8 156.33 46.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.143 -0.973 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -128.58 155.64 44.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.421 -0.799 . . . . 0.0 109.511 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -147.01 161.33 41.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -149.0 133.96 18.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.403 -0.811 . . . . 0.0 109.973 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.8 mt -89.9 118.52 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 93.4 mt-10 -65.94 -41.32 91.44 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.074 -1.016 . . . . 0.0 109.842 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 70.8 m-20 -158.14 158.0 33.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.04 134.45 44.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -68.89 138.02 90.18 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.801 -1.187 . . . . 0.0 108.648 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -66.09 -8.2 19.4 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.659 0.914 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.98 -39.86 87.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 mt -136.89 148.19 62.13 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -58.47 -177.94 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.646 0.897 . . . . 0.0 111.576 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -86.47 -33.72 20.29 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 0.0 109.614 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.51 89.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.905 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.44 -39.55 74.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -0.929 . . . . 0.0 110.016 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.55 -40.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 108.962 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.41 -43.1 93.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.16 -45.06 94.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.258 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.26 88.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.4 -42.87 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.07 -40.68 74.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.855 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -61.01 -40.1 92.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 108.921 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.14 94.64 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.317 -0.864 . . . . 0.0 110.122 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -61.35 -40.17 93.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.766 -1.209 . . . . 0.0 109.398 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -60.56 -42.25 96.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.42 ' CH2' HD22 ' A' ' 148' ' ' LEU . 90.7 m95 -73.69 -42.51 61.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.037 . . . . 0.0 110.21 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -66.73 -37.97 85.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 110.35 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -57.8 -22.91 49.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.497 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.34 7.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -145.72 149.49 40.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.014 -1.054 . . . . 0.0 109.184 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.92 7.47 1.31 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.615 0.877 . . . . 0.0 111.79 178.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.05 154.98 41.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 43.9 p -133.85 150.05 51.37 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -125.74 159.43 32.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.7 m -154.41 126.63 7.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.38 136.87 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.95 135.11 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.466 -0.771 . . . . 0.0 109.172 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 t -98.21 -4.33 35.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 0.0 110.624 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -142.38 155.36 45.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.893 -1.129 . . . . 0.0 110.111 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 177.39 50.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -82.26 143.48 31.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 108.965 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.77 150.89 25.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.8 -40.38 88.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 108.978 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.4 mt -119.61 118.87 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.717 . . . . 0.0 109.259 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.1 mmm -99.62 130.77 45.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.863 . . . . 0.0 108.878 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.45 130.72 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 160.31 43.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.97 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.7 139.18 42.65 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.58 160.45 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.03 -1.043 . . . . 0.0 111.223 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -129.5 136.69 50.18 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.596 0.712 . . . . 0.0 110.118 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.15 -141.86 2.98 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.76 130.5 43.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -1.053 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -138.18 53.3 1.82 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 109.803 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 53.61 59.64 4.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 108.912 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.95 160.39 43.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.048 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -89.37 9.44 26.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.175 -0.953 . . . . 0.0 109.733 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -136.47 71.06 59.99 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 109.367 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -68.42 144.89 63.24 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.061 1.174 . . . . 0.0 112.018 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -76.93 143.78 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.05 70.33 0.9 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.314 -0.866 . . . . 0.0 108.717 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.27 -165.98 42.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.93 -13.23 8.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.17 1.246 . . . . 0.0 112.597 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.42 -177.98 39.99 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.42 -158.12 28.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.87 149.89 39.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.407 -1.054 . . . . 0.0 109.286 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.35 -20.58 19.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.05 -1.032 . . . . 0.0 109.596 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.96 168.62 5.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 108.582 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.29 122.91 1.31 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.541 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.78 168.48 13.46 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.408 0.623 . . . . 0.0 109.408 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.08 153.72 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -59.58 145.36 82.93 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.007 -1.058 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.31 101.44 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 120.441 0.76 . . . . 0.0 111.709 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.64 174.87 35.75 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.28 -179.81 3.42 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 120.878 1.052 . . . . 0.0 111.203 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.47 -127.16 39.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -73.8 -14.33 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.382 -1.069 . . . . 0.0 110.28 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.41 139.45 48.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -16.63 60.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -67.78 160.25 28.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.74 120.86 10.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.052 -1.03 . . . . 0.0 109.227 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -104.31 136.66 43.49 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.664 -0.648 . . . . 0.0 110.427 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -115.81 136.7 52.8 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.667 -0.645 . . . . 0.0 109.615 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.82 118.97 10.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.027 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -99.58 -0.6 40.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 108.778 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.36 -13.04 60.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -105.58 152.17 23.42 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -89.53 120.07 30.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.178 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -84.13 153.5 23.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 -179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.7 p -117.76 164.69 14.62 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.523 0.677 . . . . 0.0 109.621 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.88 28.88 5.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.03 -165.04 2.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.796 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.66 34.04 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.48 -0.762 . . . . 0.0 109.8 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -76.23 -164.32 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -47.72 -57.56 5.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.835 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.91 149.83 23.14 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.727 -1.233 . . . . 0.0 110.767 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -148.36 91.25 1.88 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.0 109.032 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -60.03 -39.83 87.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.195 -0.941 . . . . 0.0 110.818 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.15 -41.22 92.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.732 -1.23 . . . . 0.0 109.773 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.04 -43.0 95.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.955 -1.091 . . . . 0.0 109.759 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.9 t -69.85 -40.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.365 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.69 89.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 108.877 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -68.98 -42.77 76.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 109.847 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.139 -0.976 . . . . 0.0 108.765 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.3 -39.14 93.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.26 85.34 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -65.75 -35.57 81.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.239 . . . . 0.0 108.804 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.8 m -71.65 -28.72 63.95 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 109.892 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.66 -2.54 56.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.84 11.84 67.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -82.27 129.54 34.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.83 -1.394 . . . . 0.0 109.042 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.0 m -88.72 169.93 11.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.873 . . . . 0.0 109.228 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.42 158.97 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.466 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.8 t -124.46 164.65 19.27 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.1 p -99.35 9.67 42.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.032 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -84.84 127.17 34.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.9 -37.33 71.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.507 -0.746 . . . . 0.0 110.598 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.09 1.14 85.99 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 120.981 -1.075 . . . . 0.0 111.45 -178.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.88 138.74 33.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.517 -1.578 . . . . 0.0 109.406 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.52 -29.72 67.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.9 . . . . 0.0 109.679 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.56 54.52 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.6 t80 -71.29 136.69 84.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.871 -1.143 . . . . 0.0 108.643 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.17 9.25 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.908 1.003 . . . . 0.0 112.061 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 36.6 t -164.29 175.89 9.65 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.6 t80 . . . . . 0 C--N 1.3 -1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.221 -179.991 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -146.94 149.7 33.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 108.997 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.42 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.5 mt -75.05 142.69 43.72 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.458 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.0 164.28 13.15 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -59.81 -39.34 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -58.43 -40.96 83.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -74.5 -40.48 61.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.81 -50.24 81.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.132 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.25 -40.23 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.439 178.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -56.66 -61.09 7.88 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -63.48 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.3 . . . . 0.0 110.26 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.2 mt-30 -63.76 -39.67 94.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.807 -1.183 . . . . 0.0 109.495 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.39 92.75 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.52 -49.01 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -99.48 -62.2 1.27 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.216 -0.928 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.74 -176.47 34.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 148.66 24.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.024 -1.28 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 -179.786 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -80.29 126.38 31.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 108.706 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.9 -10.06 59.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 109.724 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -79.58 150.09 31.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.9 p -96.74 -3.99 41.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -129.52 138.69 51.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.48 159.97 37.83 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.15 -0.969 . . . . 0.0 110.776 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -126.2 154.04 43.82 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.59 0.709 . . . . 0.0 109.144 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -143.5 156.18 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 109.422 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.4 ttt-85 -149.57 132.25 15.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 109.432 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.425 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 94.3 mt -89.25 121.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.87 -39.67 93.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.114 -0.991 . . . . 0.0 110.226 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -161.55 156.7 23.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -102.02 139.45 37.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.63 -0.669 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 22' ' ' THR . 1.7 t -74.03 145.81 84.07 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.53 -11.8 33.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.919 1.079 . . . . 0.0 111.518 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.1 -40.02 88.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.6 mt -139.06 151.6 68.23 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.186 -0.946 . . . . 0.0 108.523 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -62.94 -175.27 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 CA-C-N 119.392 0.819 . . . . 0.0 111.93 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.41 -38.85 13.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.18 84.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.53 -39.13 77.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.616 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.97 -42.01 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.02 . . . . 0.0 109.168 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -59.3 -40.48 86.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 108.781 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -60.01 -46.37 89.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.847 . . . . 0.0 109.362 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.0 -39.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.192 -0.942 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.57 -41.56 88.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -60.72 -40.62 92.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.942 -1.099 . . . . 0.0 110.415 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.46 85.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.944 -1.098 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.23 -40.51 96.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.947 -1.096 . . . . 0.0 109.368 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.58 -43.28 97.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.223 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.75 -42.75 93.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.96 . . . . 0.0 110.265 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -70.44 -40.5 73.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.889 -1.132 . . . . 0.0 109.734 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 t -69.77 -32.41 70.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.792 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.02 -33.38 68.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.113 -0.992 . . . . 0.0 111.089 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.44 10.98 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 110.461 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.9 p -146.55 150.36 40.06 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 120.883 -1.135 . . . . 0.0 109.654 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.49 1.44 4.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.744 0.962 . . . . 0.0 111.467 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.01 153.1 44.37 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.406 -0.809 . . . . 0.0 109.275 -179.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.8 p -133.13 149.94 52.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -128.2 149.52 50.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.446 -0.784 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -152.92 133.09 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.425 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 62.7 tttp -75.64 144.47 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.732 . . . . 0.0 109.786 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.4 136.58 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t -95.76 -1.47 49.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -145.96 157.18 43.89 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.969 -1.082 . . . . 0.0 109.228 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.78 159.03 13.36 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.07 137.39 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.529 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.15 149.75 22.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.473 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.33 -40.96 92.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.511 -0.743 . . . . 0.0 109.253 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.26 111.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.9 134.93 43.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.59 131.39 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.7 p -149.52 160.66 43.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -0.96 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.81 138.56 46.01 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.3 165.57 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 110.798 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -139.7 153.41 47.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.564 -0.71 . . . . 0.0 110.001 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.81 -148.68 0.38 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.3 130.91 45.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -1.08 . . . . 0.0 108.86 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 9.1 p-80 -136.38 57.08 1.79 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.611 -0.681 . . . . 0.0 109.899 -178.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 53.82 53.71 10.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.131 -0.981 . . . . 0.0 109.932 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' SER . 12.0 t70 -144.75 159.28 43.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.7 m-20 -89.65 9.54 26.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.29 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 70.0 m -136.81 73.24 54.08 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.437 -0.789 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.05 155.82 58.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.04 1.16 . . . . 0.0 112.232 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.47 150.24 34.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.508 -0.745 . . . . 0.0 109.154 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.25 77.55 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.15 -172.42 11.56 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -55.8 -14.42 10.69 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.414 1.41 . . . . 0.0 112.417 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.0 178.21 41.96 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 -153.39 26.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.413 -1.051 . . . . 0.0 110.533 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.522 HD21 ' C ' ' A' ' 82' ' ' ALA . 9.0 t30 -72.62 136.68 45.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.946 -0.738 . . . . 0.0 110.25 -179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -94.3 -19.91 20.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.522 ' C ' HD21 ' A' ' 80' ' ' ASN . . . -168.5 159.06 9.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.925 -1.109 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.06 -179.85 7.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.396 -0.815 . . . . 0.0 109.814 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.47 167.78 19.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.237 -0.915 . . . . 0.0 109.429 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -97.83 153.54 18.23 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.978 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -58.64 149.32 63.05 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 104.59 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 120.723 0.949 . . . . 0.0 111.655 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.68 -179.76 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.87 1.047 . . . . 0.0 111.434 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.06 -123.1 31.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.58 -10.05 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.948 . . . . 0.0 110.218 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.26 139.78 47.45 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.001 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.62 -15.97 52.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 127.37 31.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.857 -1.378 . . . . 0.0 110.093 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.73 127.36 47.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -111.21 138.6 47.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.3 -0.875 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.99 134.44 55.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.671 -0.643 . . . . 0.0 109.652 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 46.2 t0 -67.88 120.09 13.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.57 1.28 43.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -74.56 -19.71 60.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.003 -1.061 . . . . 0.0 109.388 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.317 -0.864 . . . . 0.0 108.96 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 102' ' ' ARG . 28.5 ttt-85 -85.85 120.08 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 108.701 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.448 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 92.8 m95 -89.52 146.64 24.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.805 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.2 p -123.18 161.16 25.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.22 29.44 7.8 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.764 HD21 ' HE ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -149.03 -164.99 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -80.68 31.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.956 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.764 ' HE ' HD21 ' A' ' 106' ' ' ASN . 61.2 mtm180 -74.57 -166.62 0.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.739 -1.226 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -48.74 -58.49 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.661 -0.649 . . . . 0.0 111.704 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -107.52 129.8 54.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.971 -1.081 . . . . 0.0 110.975 -178.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -102.48 112.67 25.5 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.37 -41.4 76.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.31 -0.869 . . . . 0.0 111.207 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.74 -41.33 90.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.81 -1.181 . . . . 0.0 109.528 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -59.8 -43.45 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.464 -0.772 . . . . 0.0 110.257 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.93 -39.79 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.189 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.1 92.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.225 -0.922 . . . . 0.0 109.067 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.66 92.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.612 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -66.74 -49.2 66.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 108.892 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 42.5 mt-10 -59.75 -41.44 91.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.76 -37.36 86.31 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 108.231 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.52 -41.88 89.35 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -64.2 -35.91 82.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 108.388 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.6 m -69.03 -26.46 65.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.628 -0.67 . . . . 0.0 109.413 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.36 -4.3 59.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.61 61.62 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.22 128.53 34.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.069 -1.253 . . . . 0.0 109.457 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.7 m -88.6 173.0 8.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 109.701 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -68.29 157.03 36.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -0.854 . . . . 0.0 109.014 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.7 t -125.01 164.4 20.24 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 64.5 p -97.41 4.34 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 109.318 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -82.07 124.95 30.28 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.949 -1.095 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.3 -39.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 110.387 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 5.65 51.91 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.356 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 142.75 30.42 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.65 -1.5 . . . . 0.0 109.292 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 137' ' ' TYR . 99.0 mt -59.78 -39.48 85.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 109.44 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 31.1 mtp -71.1 67.85 0.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.473 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.5 t80 -71.69 124.89 91.6 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.11 -1.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 CA-C-N 120.488 1.21 . . . . 0.0 113.008 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 50.3 m -167.75 166.96 13.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.071 -1.018 . . . . 0.0 108.486 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.688 -1.258 . . . . 0.0 108.84 179.662 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 121.426 0.632 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -148.73 159.44 44.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.806 . . . . 0.0 109.093 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.72 144.49 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.014 -1.054 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 163.16 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.013 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.95 -40.18 88.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -59.63 -41.37 90.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.264 -0.898 . . . . 0.0 109.835 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.24 -40.32 64.75 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.089 -1.007 . . . . 0.0 109.408 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.94 -49.96 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -64.87 -39.76 94.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.559 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.92 -54.72 26.31 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.067 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.43 -38.56 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.996 -1.296 . . . . 0.0 109.377 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -68.05 -34.92 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.106 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.16 88.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.34 -50.56 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.099 -1.001 . . . . 0.0 108.911 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -97.84 -73.69 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.72 . . . . 0.0 109.255 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.49 -169.34 37.74 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.1 mtm-85 -92.28 144.61 25.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.287 . . . . 0.0 109.707 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.487 1.417 0 O-C-N 121.254 -0.904 . . . . 0.0 108.914 -179.834 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -83.8 127.28 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.953 -1.092 . . . . 0.0 108.408 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.18 -10.78 59.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.272 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.466 ' CD ' ' H ' ' A' ' 11' ' ' GLN . 9.8 mp0 -85.79 149.49 25.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.755 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -94.46 -4.12 48.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 108.623 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.44 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 33.7 m-70 -128.88 141.53 51.25 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.9 mt -130.27 153.76 48.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.388 -0.82 . . . . 0.0 109.675 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 p -125.29 155.8 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -144.61 159.91 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -149.29 133.14 17.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.88 120.05 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -65.86 -40.09 91.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.069 -1.019 . . . . 0.0 110.04 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -159.95 155.34 25.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.017 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -99.69 136.83 39.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 t -67.7 139.21 93.64 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.15 -0.968 . . . . 0.0 108.628 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.55 -13.96 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 CA-C-N 119.561 0.879 . . . . 0.0 112.196 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.23 -40.21 89.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 110.393 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.84 149.37 70.41 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.14 -175.92 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 119.304 0.787 . . . . 0.0 111.831 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 15.9 ptm180 -87.38 -32.27 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -56.96 -44.86 83.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 110.15 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.05 -39.8 54.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.011 -1.056 . . . . 0.0 110.159 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.41 -49.51 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 111.179 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 42.3 p-10 -58.98 -39.24 81.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.67 -1.269 . . . . 0.0 109.402 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.4 t60 -59.82 -43.3 94.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 0.0 108.86 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.26 91.5 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.25 -42.63 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -69.99 -39.12 76.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.052 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.31 -40.12 89.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.95 90.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.601 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.5 m-85 -60.08 -40.14 88.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 109.025 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.03 -43.01 95.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.1 -43.95 95.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.703 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -71.2 -42.3 69.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.659 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.2 t -67.75 -32.53 73.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 110.834 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.22 -35.0 72.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 110.72 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.87 14.92 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.283 -0.885 . . . . 0.0 111.122 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 62.2 p -144.66 147.34 35.5 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.833 -1.167 . . . . 0.0 109.139 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.9 6.3 1.75 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.623 0.882 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -72.57 163.76 27.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.227 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 33.3 p -138.89 151.34 46.88 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.96 149.97 52.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.632 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -155.04 129.81 9.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -77.93 142.08 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.405 -0.81 . . . . 0.0 109.922 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.42 134.85 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -97.13 -4.99 38.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.94 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -142.76 151.04 40.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.096 -1.003 . . . . 0.0 109.747 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.63 169.53 42.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.06 146.44 30.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -1.154 . . . . 0.0 109.025 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.79 157.08 18.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.41 -0.806 . . . . 0.0 109.209 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.93 118.09 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.412 -0.805 . . . . 0.0 109.581 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -98.57 128.11 44.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -110.68 129.94 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.4 p -148.41 155.11 40.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.94 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -104.72 139.14 39.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.6 160.09 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.344 -0.847 . . . . 0.0 110.754 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.32 142.46 50.82 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.682 -0.636 . . . . 0.0 109.442 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.79 -140.99 5.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -78.65 128.08 32.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -1.035 . . . . 0.0 109.285 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.588 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.6 p-80 -126.04 56.9 1.4 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 109.872 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 31.1 mmt180 56.4 47.82 18.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.544 -0.723 . . . . 0.0 109.997 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.2 m-20 -138.83 162.89 33.66 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.387 -0.82 . . . . 0.0 108.877 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -89.97 8.76 30.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.942 . . . . 0.0 110.333 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -136.04 73.35 59.02 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -70.02 155.84 64.11 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.164 1.243 . . . . 0.0 112.188 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.91 150.36 32.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -121.94 75.02 1.18 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.546 -0.721 . . . . 0.0 109.438 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.14 -171.27 7.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -53.05 -8.97 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.26 1.307 . . . . 0.0 112.784 -179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.27 46.81 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.83 -171.22 55.09 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -73.83 151.41 40.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.298 -1.119 . . . . 0.0 109.234 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 mt -91.01 -12.53 35.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.984 -1.073 . . . . 0.0 109.72 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.37 163.3 12.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.42 -179.6 7.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -0.817 . . . . 0.0 109.033 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.21 168.98 18.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.99 156.66 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -59.09 150.04 64.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.58 101.38 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 CA-C-N 119.083 0.708 . . . . 0.0 111.398 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.42 175.88 35.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 179.85 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.801 1.001 . . . . 0.0 111.667 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.47 -130.55 40.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -78.83 -7.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -1.19 . . . . 0.0 109.245 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.01 137.35 49.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.21 -15.63 52.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -67.91 124.64 23.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.884 -1.362 . . . . 0.0 109.964 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.13 149.87 21.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -132.9 132.5 42.12 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.427 -0.795 . . . . 0.0 109.668 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.78 135.38 54.09 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.407 -0.808 . . . . 0.0 109.914 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.466 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 56.7 t0 -67.58 121.83 16.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 108.935 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -98.98 0.02 43.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.358 -0.839 . . . . 0.0 109.834 -179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.36 -17.97 60.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.793 -1.192 . . . . 0.0 109.508 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.85 157.82 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -84.42 118.72 24.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.026 -1.047 . . . . 0.0 109.381 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.466 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 97.8 m95 -88.24 147.2 24.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.365 -0.834 . . . . 0.0 109.818 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.7 p -129.51 157.21 42.66 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.83 31.49 5.97 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -145.91 -164.16 1.9 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -178.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.77 30.85 0.36 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 110.21 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 12.9 mmt-85 -76.28 -164.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.92 -56.84 17.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 111.313 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -104.68 119.14 38.29 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.987 -1.07 . . . . 0.0 110.385 -178.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 79.2 m-20 -96.33 112.2 24.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.331 -0.856 . . . . 0.0 110.665 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.962 -1.086 . . . . 0.0 109.71 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 135' ' ' LEU . 20.3 tpt180 -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 -179.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.6 t -70.03 -39.39 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.198 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.37 85.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.951 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 109.511 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -69.98 -48.26 58.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 109.737 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.4 -40.19 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.541 -1.349 . . . . 0.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.48 -31.64 72.94 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.94 -39.64 95.83 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -66.59 -34.49 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -1.082 . . . . 0.0 109.037 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -69.64 -23.24 63.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.225 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.92 -4.94 58.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 109.221 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.91 16.7 59.22 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.35 131.11 35.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.927 -1.337 . . . . 0.0 109.809 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.5 m -88.41 171.56 10.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.989 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -68.59 159.15 32.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.3 t -125.08 157.41 36.35 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.53 -0.731 . . . . 0.0 109.461 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -99.89 3.82 44.73 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.43 126.9 32.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -39.99 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.66 -178.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.37 -1.06 49.89 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.047 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.95 33.15 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.682 -1.481 . . . . 0.0 109.38 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.449 ' CD2' ' NH1' ' A' ' 114' ' ' ARG . 93.6 mt -66.47 -34.43 77.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.776 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 37.7 mtp -75.15 64.95 1.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.945 . . . . 0.0 110.297 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.8 t80 -72.63 137.51 80.39 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 108.859 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.83 7.09 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 119.926 1.009 . . . . 0.0 112.127 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 137' ' ' TYR . 31.1 p -159.0 174.67 14.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 108.704 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.795 -1.19 . . . . 0.0 110.118 -179.629 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.487 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 39.7 t . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.373 0.606 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 99.9 mm-40 -148.9 159.0 44.59 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.09 139.85 41.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.963 -1.086 . . . . 0.0 108.765 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.55 164.88 13.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -40.51 89.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.0 -40.08 79.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.187 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.9 -40.9 60.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 109.829 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.06 -50.01 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.103 -0.998 . . . . 0.0 109.57 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.63 -40.01 95.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 110.153 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.15 -55.28 24.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.429 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -67.35 -40.0 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.89 -1.359 . . . . 0.0 110.227 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.8 mt-30 -68.89 -40.1 79.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 0.0 110.085 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.73 94.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.035 -1.041 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.43 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -96.77 -67.82 0.83 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.194 -0.941 . . . . 0.0 109.855 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.1 179.43 38.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.83 148.5 23.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.112 -1.228 . . . . 0.0 109.098 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.623 -179.583 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 124' ' ' LEU . 23.9 mmm180 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.91 122.74 28.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.006 -1.059 . . . . 0.0 108.543 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 58.7 mp0 -84.28 -11.53 56.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 109.905 -179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.42 144.52 29.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 109.211 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -91.67 -3.27 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.556 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.4 m-70 -126.64 142.13 51.63 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.46 156.87 48.0 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.208 -0.933 . . . . 0.0 109.929 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -130.49 154.79 47.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -141.84 159.84 41.41 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -147.09 137.22 23.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.157 -0.964 . . . . 0.0 109.949 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -88.14 119.04 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.513 -0.742 . . . . 0.0 109.025 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -69.9 -39.81 75.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -163.41 150.58 12.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.822 -1.174 . . . . 0.0 110.806 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.81 130.8 44.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.669 -0.644 . . . . 0.0 109.629 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -75.39 145.83 80.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.02 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.2 -9.67 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 CA-C-N 119.452 0.84 . . . . 0.0 111.956 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.96 -40.19 88.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.165 -0.959 . . . . 0.0 109.517 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.8 mt -140.07 151.24 64.53 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 108.952 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.2 Cg_endo -61.75 -175.07 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.805 1.004 . . . . 0.0 112.038 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -88.7 -36.91 15.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.614 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -44.0 91.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.413 -0.804 . . . . 0.0 109.519 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.04 -39.92 75.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.08 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 26' ' ' PRO . 74.8 t -69.85 -40.72 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.672 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -60.15 -40.36 89.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.984 -1.073 . . . . 0.0 108.949 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.86 -45.19 93.26 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.69 89.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mm -72.29 -43.1 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.08 -1.012 . . . . 0.0 109.597 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.53 -39.76 81.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.79 -39.81 90.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 110.25 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.77 83.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.961 -1.087 . . . . 0.0 110.166 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -60.18 -39.69 87.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.996 -1.065 . . . . 0.0 109.032 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.73 -40.18 87.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.925 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.97 -44.96 94.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.001 -1.062 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.479 ' CH2' HD22 ' A' ' 148' ' ' LEU . 93.3 m95 -75.12 -41.81 57.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.226 -0.921 . . . . 0.0 111.132 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -66.77 -38.42 86.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 110.119 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.24 -15.87 28.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 111.044 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.71 2.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.96 -1.088 . . . . 0.0 110.504 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.401 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 13.1 p -145.49 150.57 44.5 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.054 . . . . 0.0 108.899 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.93 8.15 0.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.673 0.915 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.15 153.42 41.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.556 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 29.2 p -130.34 147.47 52.05 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.27 154.65 45.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.655 . . . . 0.0 109.462 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 m -155.64 133.58 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.486 -0.758 . . . . 0.0 109.87 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.0 135.35 36.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.43 130.72 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.477 -0.765 . . . . 0.0 108.955 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -95.63 0.11 52.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.092 -1.005 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.14 152.78 41.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.35 179.46 51.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.359 -1.083 . . . . 0.0 110.505 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.42 136.95 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.05 -40.21 88.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.212 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -121.52 120.39 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.556 -0.715 . . . . 0.0 109.401 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.9 mtt -100.84 139.19 36.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.38 131.3 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.6 p -151.01 156.11 40.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.119 -0.988 . . . . 0.0 109.949 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -104.35 138.65 40.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.06 160.03 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 O-C-N 121.061 -1.024 . . . . 0.0 110.674 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' CB ' ' A' ' 65' ' ' ARG . 11.5 mtp-105 -129.16 139.79 51.78 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.336 0.589 . . . . 0.0 110.087 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.98 -137.43 2.79 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -73.58 128.43 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.978 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 21.8 p-80 -137.97 65.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 53.21 53.51 11.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -142.69 161.6 37.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 109.106 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.91 9.73 41.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.3 m -138.61 69.68 45.13 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.425 -0.797 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.7 156.05 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.034 1.156 . . . . 0.0 112.292 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -76.6 140.59 41.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -101.76 60.24 0.87 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.545 -0.722 . . . . 0.0 109.613 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.3 179.33 50.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -50.09 -12.22 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.336 1.357 . . . . 0.0 111.927 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.23 178.52 41.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.25 -153.97 25.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 47.4 p-10 -75.16 149.65 38.95 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.353 -1.086 . . . . 0.0 109.415 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.13 -18.02 23.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.649 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.16 167.38 7.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -160.1 173.59 15.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.961 -1.087 . . . . 0.0 109.66 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.41 164.31 22.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.124 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.08 152.24 18.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.179 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -59.71 151.18 63.87 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 109.289 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -53.22 104.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 120.718 0.945 . . . . 0.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.92 174.62 34.56 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.0 172.56 15.23 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.069 1.18 . . . . 0.0 111.699 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.02 -125.33 18.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.82 -10.95 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.567 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.36 148.98 28.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.42 -20.65 10.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.01 151.43 47.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.275 . . . . 0.0 109.236 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.58 123.63 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 0.0 108.78 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -100.89 143.07 31.48 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.635 0.731 . . . . 0.0 110.793 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.4 m-85 -113.85 131.29 56.31 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -65.78 118.45 9.64 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.852 -1.155 . . . . 0.0 108.778 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -99.13 0.74 44.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.18 -16.88 60.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.821 -1.174 . . . . 0.0 109.754 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -101.22 159.16 15.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 109.444 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -85.53 121.13 27.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.228 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.94 147.59 23.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.373 -0.83 . . . . 0.0 109.97 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.5 p -129.89 164.21 24.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.491 -0.756 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -110.33 32.5 5.12 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -149.03 -164.94 2.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 109.371 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -88.72 25.12 1.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 110.019 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -76.71 -161.45 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 110.032 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.0 mt-10 -24.42 -68.7 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -137.27 144.02 42.49 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.967 -1.083 . . . . 0.0 109.912 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -105.02 119.4 38.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.757 . . . . 0.0 109.4 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.88 -40.78 97.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.41 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -59.94 -41.57 92.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.084 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.55 -44.96 93.08 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.082 -1.012 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.03 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.27 92.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.03 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.53 84.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 108.884 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -70.78 -46.4 62.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.838 . . . . 0.0 109.943 -179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 64.3 mt-10 -59.89 -40.59 89.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.721 -1.237 . . . . 0.0 109.489 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.15 -38.4 91.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.278 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.92 86.88 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.19 -26.81 64.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.267 . . . . 0.0 109.302 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.6 p -71.06 -22.21 62.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.073 -1.017 . . . . 0.0 108.399 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 89.6 mt -85.57 -8.73 58.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.361 -0.837 . . . . 0.0 109.14 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.88 19.28 48.13 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.666 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.93 142.1 32.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.84 -1.388 . . . . 0.0 108.947 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.9 m -87.71 168.39 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.015 -1.053 . . . . 0.0 109.479 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -67.92 153.0 44.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.405 -0.809 . . . . 0.0 109.412 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.5 t -124.11 154.54 39.85 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.1 p -99.99 10.83 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.286 -0.884 . . . . 0.0 109.829 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.5 t0 -83.53 132.91 34.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.925 -1.109 . . . . 0.0 110.143 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 91.8 mt -60.24 -40.04 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.12 -5.72 81.38 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.546 -178.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.55 128.88 34.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.935 -1.333 . . . . 0.0 109.486 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.4 mt -64.31 -25.36 68.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.571 -0.706 . . . . 0.0 109.275 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 47.0 mmm -74.18 45.16 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.115 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.6 t80 -69.55 129.94 91.03 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 108.7 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -46.28 -62.52 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.192 1.104 . . . . 0.0 111.702 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 t -96.97 172.42 7.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 108.819 179.706 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.9 t . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.295 0.569 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -148.63 151.04 34.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 109.056 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.479 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.0 mt -76.52 142.9 40.72 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.859 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 162.93 13.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 108.735 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -59.83 -40.39 88.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 0.0 109.434 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -58.9 -40.14 83.57 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.521 -0.737 . . . . 0.0 109.642 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.22 -40.87 64.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.095 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.22 -52.81 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.43 -40.13 96.33 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.854 -1.154 . . . . 0.0 110.096 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.8 -55.43 29.86 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.611 -178.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -65.61 -39.96 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.977 -1.308 . . . . 0.0 110.582 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.6 mt-30 -65.64 -39.82 91.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.821 -1.175 . . . . 0.0 109.346 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.59 -44.6 89.87 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.65 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -49.97 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 109.646 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -93.28 -70.1 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.66 -178.66 39.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.94 142.58 27.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.401 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 69.2 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.824 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -83.12 119.83 25.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.976 -1.078 . . . . 0.0 108.5 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.6 -9.97 59.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 109.5 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -80.3 145.08 32.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.81 -8.87 36.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.494 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 93.5 m-70 -123.22 119.86 31.44 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.08 165.41 12.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.499 -0.751 . . . . 0.0 109.253 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -129.58 155.46 45.77 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -144.13 159.21 43.03 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.144 -0.972 . . . . 0.0 109.078 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' O ' ' A' ' 53' ' ' SER . 70.7 ttt180 -148.76 131.19 15.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.061 -1.024 . . . . 0.0 110.608 -178.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.51 116.81 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.22 -42.96 99.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 110.268 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -162.15 160.85 27.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.0 110.19 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.58 136.64 40.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.602 -0.686 . . . . 0.0 109.333 179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -74.97 142.32 76.11 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.975 . . . . 0.0 108.97 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -61.11 -10.88 16.46 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 CA-C-N 119.527 0.867 . . . . 0.0 111.825 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.89 -40.1 87.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.0 mt -139.04 151.17 67.4 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.69 -171.35 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 119.475 0.848 . . . . 0.0 111.914 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 27' ' ' ARG . 7.1 ptm180 -87.96 -35.43 17.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.57 94.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 109.978 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.02 -39.72 75.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.2 -43.24 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.924 -1.11 . . . . 0.0 109.286 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -59.93 -50.04 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.15 91.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.206 -0.933 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -70.01 -39.82 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 110.159 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.57 -41.23 93.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.019 -1.05 . . . . 0.0 109.844 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -62.42 -40.02 95.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.728 -1.233 . . . . 0.0 110.037 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.66 64.13 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -62.36 -42.51 99.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.842 -1.161 . . . . 0.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mm-40 -60.3 -42.09 94.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.132 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.61 -41.66 90.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 109.91 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -72.79 -40.48 65.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.84 -1.163 . . . . 0.0 109.644 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 t -69.37 -32.97 72.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 110.593 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 17.0 m120 -59.3 -26.1 64.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.234 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.86 7.9 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.238 -0.914 . . . . 0.0 110.668 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -145.95 150.56 42.83 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.883 -1.136 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.62 2.73 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.912 1.075 . . . . 0.0 111.538 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.04 151.62 44.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.265 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.494 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.8 p -137.16 147.01 45.65 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -121.18 120.24 34.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.6 m -96.0 132.48 41.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.465 -0.772 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 128.48 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 108.871 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 52' ' ' VAL . 19.2 m -127.41 129.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.427 -0.796 . . . . 0.0 108.859 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.494 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 40.3 t -99.49 0.29 42.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.9 158.63 43.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.138 -0.976 . . . . 0.0 109.639 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.92 170.4 38.4 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -82.62 130.27 35.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -1.152 . . . . 0.0 109.206 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.67 155.11 17.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -59.98 -39.9 87.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.803 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.9 mt -118.92 120.0 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.7 mmm -99.13 128.6 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.62 126.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.4 p -148.42 157.53 43.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.994 -1.066 . . . . 0.0 110.356 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -107.35 136.85 46.46 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.1 160.38 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.167 -0.958 . . . . 0.0 111.42 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 142.79 49.08 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.26 -147.65 2.59 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.52 128.74 37.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.436 -1.038 . . . . 0.0 109.745 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p-80 -135.97 58.68 1.74 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.43 -0.794 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 69' ' ' ARG . 59.6 mtt-85 55.56 52.92 10.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.485 -0.76 . . . . 0.0 110.426 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.0 p-10 -144.17 160.96 40.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.05 -1.031 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -92.48 12.37 23.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.071 -1.018 . . . . 0.0 110.022 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.6 m -139.37 69.76 39.69 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 109.563 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -70.19 148.65 62.77 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.927 1.085 . . . . 0.0 112.153 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.01 150.03 37.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -125.14 73.97 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.424 -0.798 . . . . 0.0 109.506 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.78 167.41 42.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -54.42 -16.34 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.334 1.356 . . . . 0.0 111.984 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 175.63 40.23 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.99 -151.25 19.99 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -75.99 141.05 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -1.201 . . . . 0.0 109.475 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.6 mt -93.91 -19.69 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.044 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.53 160.54 11.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.903 -1.123 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -160.18 -179.81 8.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.55 167.69 21.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.509 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.65 149.33 21.35 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.09 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -59.96 149.39 73.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -46.88 115.82 1.43 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 120.533 0.822 . . . . 0.0 112.084 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.96 173.9 42.26 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.37 173.95 12.93 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-N 118.157 0.978 . . . . 0.0 111.419 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.19 -120.75 22.27 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.85 -7.35 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.173 -1.192 . . . . 0.0 110.214 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.24 134.25 52.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.5 -11.38 70.19 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.0 124.94 24.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.272 . . . . 0.0 110.068 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.74 126.12 45.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.474 -0.766 . . . . 0.0 109.606 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -107.96 136.85 46.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.563 -0.711 . . . . 0.0 109.627 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -117.33 130.73 56.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.657 -0.652 . . . . 0.0 109.241 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.32 121.55 15.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 109.48 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -100.41 3.75 43.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.381 -0.824 . . . . 0.0 110.17 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -73.73 -18.16 61.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 109.175 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.47 158.43 16.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 108.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -86.9 125.02 33.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.943 . . . . 0.0 109.52 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.49 147.17 23.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.356 -0.84 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.3 p -129.68 158.86 38.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.535 -0.728 . . . . 0.0 109.741 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.03 29.97 7.15 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.554 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 15.8 p30 -144.99 -160.5 1.14 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.832 . . . . 0.0 109.447 -178.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -87.97 15.41 7.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.198 -0.939 . . . . 0.0 110.531 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.5 mtt180 -76.47 -167.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.809 -1.182 . . . . 0.0 109.981 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 108' ' ' ARG . 93.9 mt-10 -4.51 -87.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.02 151.68 51.6 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 110.084 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 5.5 m120 -98.41 115.14 27.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.883 . . . . 0.0 109.391 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.45 -39.22 93.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.008 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -59.06 -42.42 90.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.973 -1.079 . . . . 0.0 109.542 -179.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.9 -39.6 85.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.978 -1.076 . . . . 0.0 109.181 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.51 -40.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.05 92.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.024 . . . . 0.0 109.184 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.4 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.995 -1.066 . . . . 0.0 108.716 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -70.38 -48.8 54.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.68 -42.72 93.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.666 -1.271 . . . . 0.0 110.028 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -39.8 93.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.098 . . . . 0.0 108.701 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.97 88.96 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -65.59 -37.47 86.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -1.191 . . . . 0.0 109.171 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -69.86 -20.77 63.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.211 -0.93 . . . . 0.0 108.554 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.25 -0.97 57.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.43 66.68 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.635 179.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.86 128.68 34.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.896 -1.356 . . . . 0.0 109.082 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -87.97 170.37 11.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.361 -0.837 . . . . 0.0 109.5 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -65.85 155.12 37.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.5 t -125.3 153.71 42.84 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.0 p -99.52 9.87 42.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -82.36 128.37 34.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 108.874 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.04 -40.13 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.22 -2.19 66.16 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.254 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.28 141.19 32.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.712 -1.463 . . . . 0.0 109.201 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.42 -27.84 65.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 29.9 mtp -74.19 52.08 0.45 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.846 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' SER . 22.2 t80 -70.45 137.6 86.23 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -53.32 -1.99 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 119.828 0.974 . . . . 0.0 112.498 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' TYR . 81.4 p -159.94 174.75 13.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.938 -1.101 . . . . 0.0 110.502 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 0.0 109.676 -179.811 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.408 0.623 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -146.9 156.95 43.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.3 mt -75.97 146.63 39.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.883 -1.136 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.46 153.31 19.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.401 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -57.04 -39.94 75.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -53.08 -40.15 63.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.918 -1.114 . . . . 0.0 108.945 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.76 -39.67 66.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.32 -48.03 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.62 -40.09 90.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.727 -1.233 . . . . 0.0 110.514 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -51.46 44.59 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.162 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -66.62 -40.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.874 -1.368 . . . . 0.0 109.767 -179.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.3 mt-30 -66.08 -39.97 90.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.09 95.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.032 -1.042 . . . . 0.0 109.814 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -50.13 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.33 -65.41 0.96 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.121 -0.987 . . . . 0.0 109.421 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.34 -170.21 33.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -91.04 142.87 27.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.111 -1.229 . . . . 0.0 109.303 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.012 -1.055 . . . . 0.0 109.002 179.816 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.08 120.91 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 108.82 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.0 -10.01 58.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.37 148.65 29.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.275 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -95.86 -6.07 40.18 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.083 -1.011 . . . . 0.0 108.866 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 15.0 m-70 -130.62 132.57 45.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.238 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' CE1' ' A' ' 49' ' ' PHE . 66.4 mt -121.77 156.03 34.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.7 p -125.7 153.57 43.7 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -144.78 161.06 40.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.77 132.45 13.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.869 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.59 120.03 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -64.96 -40.01 94.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -160.37 150.39 18.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.898 -1.126 . . . . 0.0 109.768 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.25 140.33 30.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . 9.0 t -70.7 137.24 85.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 109.642 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.75 -14.59 45.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.815 0.97 . . . . 0.0 111.792 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.99 -40.1 88.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.2 mt -135.05 149.1 69.37 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.05 -174.01 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 120.545 0.83 . . . . 0.0 112.031 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.43 -36.16 16.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.872 . . . . 0.0 109.739 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.99 -41.18 77.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 108.89 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -39.98 75.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.435 -0.79 . . . . 0.0 109.628 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.04 -43.83 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.982 . . . . 0.0 109.021 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.98 -39.93 87.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.337 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.622 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 59.9 t60 -59.97 -50.05 75.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.75 89.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 110.763 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.8 mm -70.05 -38.43 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.123 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.38 -41.3 96.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.007 -1.058 . . . . 0.0 109.776 -178.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.622 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 32.7 mttp -64.76 -37.58 88.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 109.994 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.947 -1.096 . . . . 0.0 109.322 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.88 -41.44 97.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 109.02 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.07 -41.53 92.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.831 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.92 -41.8 92.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.018 -1.051 . . . . 0.0 109.621 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -74.57 -40.49 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.04 -1.037 . . . . 0.0 109.946 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -69.86 -35.27 74.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.106 -0.996 . . . . 0.0 110.42 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.31 -31.4 65.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 110.435 -178.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.533 HG23 HG23 ' A' ' 45' ' ' THR . 34.3 m -109.53 9.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.308 -0.87 . . . . 0.0 110.208 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 44' ' ' VAL . 72.9 p -140.94 144.91 37.13 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.234 -0.916 . . . . 0.0 108.983 178.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.9 2.99 3.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.563 0.842 . . . . 0.0 111.226 178.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.21 153.61 42.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 62.6 p -130.39 143.1 50.56 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.448 ' CE1' HD12 ' A' ' 14' ' ' LEU . 90.4 m-85 -119.16 151.68 37.89 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.515 -0.741 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.9 m -153.34 131.71 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.49 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -77.19 144.88 38.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.439 -0.788 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.53 135.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.496 -0.753 . . . . 0.0 109.072 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -95.36 -6.86 40.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -150.18 159.57 44.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.032 -1.042 . . . . 0.0 109.411 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.14 176.42 51.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -83.81 139.04 32.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -1.096 . . . . 0.0 109.495 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.58 143.79 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.319 -0.863 . . . . 0.0 109.138 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -59.95 -40.09 87.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.011 -1.056 . . . . 0.0 109.348 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.01 118.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.7 mtt -102.45 133.3 47.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.239 -0.913 . . . . 0.0 109.579 179.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.25 128.33 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.1 p -147.36 153.13 39.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -101.87 138.54 38.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.24 164.86 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.189 -0.944 . . . . 0.0 110.535 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.8 mtm-85 -139.96 142.45 36.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.67 5.39 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -70.04 127.25 32.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -1.074 . . . . 0.0 109.71 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 19.4 p-80 -136.94 62.29 1.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 69' ' ' ARG . 4.2 mmt-85 56.17 49.99 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.74 . . . . 0.0 109.304 -179.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.0 t0 -142.55 148.13 37.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 51.6 p-10 -89.48 9.73 25.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.064 -1.023 . . . . 0.0 109.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -136.24 73.14 58.17 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.555 -0.716 . . . . 0.0 109.161 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.85 166.44 26.36 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.252 1.301 . . . . 0.0 112.207 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -77.95 149.33 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 10.6 t0 -101.88 65.38 1.0 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.278 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.46 170.11 46.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.7 -16.26 29.95 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 120.903 1.069 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.42 -175.78 43.28 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.05 17.21 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.159 -1.2 . . . . 0.0 110.102 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 82' ' ' ALA . 13.7 t-20 -73.83 123.8 24.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.452 -1.028 . . . . 0.0 109.591 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.36 -14.32 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.128 -0.983 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -169.01 158.45 8.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.911 -1.118 . . . . 0.0 109.737 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.14 -178.8 6.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.059 -1.025 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.2 178.49 8.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.92 -178.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -104.33 157.4 17.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.656 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -59.99 149.59 73.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.14 103.99 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.601 0.867 . . . . 0.0 112.286 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.92 168.11 34.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.68 -178.42 1.57 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.045 1.163 . . . . 0.0 111.737 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.18 -123.18 30.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 tt -79.99 -12.8 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.949 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.11 144.18 48.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.52 -16.4 53.67 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -66.9 157.36 33.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -1.215 . . . . 0.0 109.366 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.88 17.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.188 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -102.17 136.06 42.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.75 . . . . 0.0 109.59 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -114.14 129.65 56.62 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.76 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.19 117.8 9.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.181 -0.95 . . . . 0.0 109.126 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -97.7 1.89 49.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 0.0 109.306 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.76 -17.68 61.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 0.0 108.447 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -97.49 158.51 15.44 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.632 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -85.58 120.58 27.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.928 -1.108 . . . . 0.0 108.962 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -90.51 140.0 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 109.539 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.9 p -125.29 170.0 11.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.559 -0.713 . . . . 0.0 109.691 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.37 28.76 8.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.478 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -148.58 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.63 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -86.95 27.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 110.643 -178.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -75.84 -158.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.659 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ARG . 96.1 mt-10 -32.47 -62.99 0.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.976 -0.453 . . . . 0.0 111.732 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -136.04 141.38 44.3 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.118 -0.989 . . . . 0.0 110.219 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -98.96 116.75 31.91 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.98 -43.84 94.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -59.99 -41.0 91.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.624 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -59.97 -43.3 95.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.029 -1.044 . . . . 0.0 110.109 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -69.99 -40.0 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.961 -1.087 . . . . 0.0 108.807 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.71 87.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.01 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.81 92.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.419 ' CD2' ' NE2' ' A' ' 122' ' ' HIS . 3.6 t-160 -69.01 -48.06 63.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 108.949 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.23 -42.59 91.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.903 -1.123 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.67 -40.01 95.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 109.46 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.98 84.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.419 ' NE2' ' CD2' ' A' ' 118' ' ' HIS . 24.3 m-70 -63.46 -36.97 85.52 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -1.1 . . . . 0.0 108.738 179.242 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.9 m -68.81 -26.54 65.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 109.127 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.58 -2.61 54.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 108.469 179.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.01 10.61 66.22 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.81 126.88 31.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.372 . . . . 0.0 109.178 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.7 m -88.07 174.26 8.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.798 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -67.08 157.14 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.4 t -131.37 159.68 37.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.0 p -101.72 11.8 38.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 56.8 t0 -80.1 132.93 36.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.007 -1.058 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 95.9 mt -60.04 -40.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.431 -0.793 . . . . 0.0 111.253 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.14 81.98 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.908 -1.12 . . . . 0.0 111.157 -178.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.93 136.82 34.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.656 -1.496 . . . . 0.0 109.776 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 91.2 mt -70.02 -29.88 67.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.445 -0.784 . . . . 0.0 109.267 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mmm -71.43 51.0 0.17 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 -178.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.2 t80 -70.0 137.22 87.24 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -64.85 10.22 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 119.871 0.99 . . . . 0.0 111.7 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.2 t -160.02 175.65 12.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 108.833 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.9 t80 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 120.664 -1.273 . . . . 0.0 109.662 -179.817 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.536 0.684 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.27 160.19 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.42 147.62 45.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.848 -1.157 . . . . 0.0 109.308 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.38 149.56 21.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.12 -39.91 72.95 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -54.84 -39.84 68.98 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -73.93 -39.95 63.43 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -0.817 . . . . 0.0 109.33 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.4 mm -62.58 -51.23 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.391 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.13 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.405 -0.809 . . . . 0.0 110.955 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -51.42 38.17 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.259 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.59 -39.96 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.935 -1.332 . . . . 0.0 110.295 -178.857 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.4 mt-30 -67.38 -39.94 85.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.309 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.77 94.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.892 -1.13 . . . . 0.0 108.976 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.02 -50.04 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -96.6 -73.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.45 -171.51 35.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 162' ' ' ARG . 38.1 mtt-85 -85.51 156.27 20.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -1.125 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 -179.693 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -82.16 129.99 34.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.26 -13.43 57.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.886 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -81.84 149.36 28.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 109.58 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.6 p -96.57 -7.47 34.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.936 . . . . 0.0 108.847 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.526 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 64.0 m-70 -130.03 144.2 51.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.17 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.9 mt -134.24 157.6 45.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.18 -0.95 . . . . 0.0 109.802 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.0 p -127.77 155.57 43.83 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -142.5 159.84 41.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 0.0 109.497 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.404 HH12 ' HA ' ' A' ' 19' ' ' GLU . 40.2 ttt-85 -148.1 130.12 15.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 110.082 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.33 119.81 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 78.0 tt0 -66.89 -39.92 87.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.1 m-20 -157.55 150.03 22.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.979 -1.076 . . . . 0.0 110.082 -179.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.16 135.16 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 t -68.59 141.75 93.35 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.232 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.81 -12.66 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.674 0.916 . . . . 0.0 111.832 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -136.28 149.55 68.22 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 121.255 -0.903 . . . . 0.0 108.848 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -59.61 -179.99 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.214 0.755 . . . . 0.0 111.744 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -86.46 -33.01 20.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.12 81.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.84 -39.91 76.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.36 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.35 -42.83 81.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.03 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.05 87.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.405 ' O ' ' N ' ' A' ' 36' ' ' LYS . 86.3 t60 -60.02 -49.7 76.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.18 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.01 90.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.406 -0.809 . . . . 0.0 109.88 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.61 -44.59 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.292 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.23 -40.15 74.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.5 tttt -62.64 -39.68 94.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.07 90.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 31.1 m-85 -59.87 -40.31 88.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.112 . . . . 0.0 109.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.11 -40.67 90.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.0 -43.31 95.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.009 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.97 -41.76 64.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.183 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.5 t -70.14 -26.49 63.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.248 -0.907 . . . . 0.0 110.521 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -60.07 -36.03 76.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 110.852 -178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 45' ' ' THR . 16.7 m -109.92 13.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.061 -1.024 . . . . 0.0 110.403 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.553 HG23 HG23 ' A' ' 44' ' ' VAL . 72.0 p -141.2 146.81 44.55 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.997 -1.064 . . . . 0.0 109.257 179.082 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.19 5.57 2.62 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.579 0.853 . . . . 0.0 111.414 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.84 153.39 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 0.0 109.866 -179.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.526 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 38.2 p -130.91 148.01 52.62 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 98.1 m-85 -126.52 149.76 49.19 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.3 m -153.33 132.06 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 0.0 109.835 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -79.62 142.03 35.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.413 -0.804 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.55 135.85 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -96.67 -3.14 43.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 0.0 110.011 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.67 152.55 41.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.028 -1.045 . . . . 0.0 109.647 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.31 166.99 33.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -82.91 139.52 33.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -1.156 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.64 160.44 14.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 108.983 179.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.97 -39.76 86.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.178 -0.952 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.85 120.02 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.485 0.659 . . . . 0.0 109.932 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -99.86 122.13 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.01 129.98 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.417 -0.802 . . . . 0.0 109.052 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -149.05 153.94 38.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.025 -1.047 . . . . 0.0 110.295 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -104.37 138.04 41.38 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.0 170.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.112 -0.993 . . . . 0.0 111.101 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -134.43 143.57 47.63 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.667 -0.646 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.44 -146.68 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -67.17 128.69 37.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.994 . . . . 0.0 109.597 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.495 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -135.97 58.49 1.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.06 52.2 10.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.588 -0.695 . . . . 0.0 109.341 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.495 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 18.9 p-10 -142.43 160.02 41.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 109.072 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -91.14 10.04 28.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.279 -0.888 . . . . 0.0 109.705 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -137.07 74.34 49.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.326 -0.859 . . . . 0.0 109.845 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.53 148.85 48.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.081 1.188 . . . . 0.0 111.405 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -75.88 139.98 41.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.276 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.86 61.04 0.97 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 109.351 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 -176.72 53.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -55.07 -13.55 6.84 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.158 1.238 . . . . 0.0 112.079 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 170.32 34.62 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -150.63 19.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -77.89 142.04 38.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -1.108 . . . . 0.0 109.862 -179.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.5 mt -89.89 -16.6 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.197 -0.94 . . . . 0.0 108.953 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.01 166.96 9.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.932 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.59 -178.44 6.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.839 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.16 170.55 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.396 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.21 153.87 19.56 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.4 -0.813 . . . . 0.0 109.532 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -60.72 151.1 73.53 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.423 -0.798 . . . . 0.0 109.337 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 108.45 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.726 0.951 . . . . 0.0 112.402 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.67 165.19 34.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.04 161.92 40.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.108 1.206 . . . . 0.0 111.997 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.54 -126.65 7.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.51 -13.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 109.8 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.46 141.29 47.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.06 -15.23 60.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.38 159.21 31.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -1.193 . . . . 0.0 109.708 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.99 122.85 12.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.301 -0.874 . . . . 0.0 109.171 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -104.68 148.32 26.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.0 110.465 -179.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.3 m-85 -115.22 135.51 54.1 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.246 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 19.7 t0 -67.19 116.67 8.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -95.76 -0.25 51.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -178.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 94.3 m-20 -75.72 -17.33 59.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.84 -1.163 . . . . 0.0 110.095 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -102.2 159.8 15.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 102' ' ' ARG . 35.7 ttm-85 -88.29 120.35 29.57 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.051 -1.03 . . . . 0.0 109.365 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -88.33 148.52 24.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.8 p -124.9 161.12 27.28 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.531 -0.731 . . . . 0.0 109.742 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -112.8 31.46 6.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -148.18 -164.9 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -0.881 . . . . 0.0 109.976 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -79.93 30.64 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 108' ' ' ARG . 48.9 mtt-85 -76.63 -164.48 0.42 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 52.5 mp0 -60.04 -58.3 9.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 112.552 -177.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -106.1 121.63 44.54 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.975 -1.078 . . . . 0.0 111.349 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 4.6 m120 -104.19 117.28 33.87 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.14 -40.17 90.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -60.1 -41.32 92.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 114' ' ' ARG . 4.4 mmt-85 -60.15 -39.98 88.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.28 -41.12 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.064 -1.022 . . . . 0.0 109.826 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.11 95.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.93 87.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -69.2 -46.16 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 94.4 mt-10 -59.1 -40.21 84.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.763 -1.211 . . . . 0.0 109.889 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.28 -39.94 92.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.088 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.77 97.16 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -65.3 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.161 -1.199 . . . . 0.0 108.803 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.3 p -70.04 -24.31 63.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 108.813 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.89 -3.43 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.43 13.31 76.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.7 132.66 35.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.884 -1.363 . . . . 0.0 108.942 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -87.91 173.04 9.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 109.793 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.62 159.3 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -127.88 162.57 26.4 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.0 p -100.12 2.8 43.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.019 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -82.3 128.81 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.09 -31.58 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.476 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.14 -0.72 77.87 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.272 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.309 . . . . 0.0 109.346 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.68 -27.55 66.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.7 mmm -74.11 44.43 0.19 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.421 -0.8 . . . . 0.0 109.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.05 134.71 87.44 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 -179.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -50.62 -62.11 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 120.055 1.055 . . . . 0.0 111.536 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -81.71 175.38 10.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.815 . . . . 0.0 109.135 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.4 t80 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 109.725 -179.883 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.432 0.634 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -140.57 150.74 44.03 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.11 147.44 40.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 109.012 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.1 162.98 14.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.07 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.98 -40.17 88.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 109.002 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.39 -40.78 87.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.44 -40.15 62.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.12 -52.25 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.226 -0.921 . . . . 0.0 109.166 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.59 -40.1 90.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.051 -1.031 . . . . 0.0 109.476 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.05 11.38 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.793 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -63.4 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.339 . . . . 0.0 109.798 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.3 mt-30 -67.2 -39.93 86.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 0.0 109.717 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.54 92.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.077 -1.014 . . . . 0.0 109.273 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.0 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.751 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -97.57 -69.98 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.14 -0.975 . . . . 0.0 109.325 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.59 -169.18 33.9 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -86.22 157.66 19.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -1.177 . . . . 0.0 109.838 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.25 -0.906 . . . . 0.0 108.921 179.515 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -84.48 120.03 25.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.004 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 55.3 mp0 -82.69 -9.87 59.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.99 155.76 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 0.0 110.299 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.4 p -98.92 -4.5 32.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 48.2 m80 -129.96 141.72 50.73 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 49' ' ' PHE . 69.0 mt -133.39 156.06 48.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.251 -0.905 . . . . 0.0 109.27 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 153.98 45.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.398 -0.813 . . . . 0.0 109.185 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -146.16 162.25 38.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.323 -0.86 . . . . 0.0 109.206 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -147.92 129.88 15.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.37 120.15 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.35 -40.12 89.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 110.422 -178.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -163.27 154.84 17.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.877 -1.139 . . . . 0.0 110.478 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.36 136.4 40.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -70.79 143.05 88.93 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.106 -0.996 . . . . 0.0 109.36 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.85 -11.08 25.15 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.603 0.869 . . . . 0.0 111.749 179.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.0 -39.93 87.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.947 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD13 ' ND2' ' A' ' 105' ' ' ASN . 95.8 mt -139.55 150.58 64.04 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.371 -0.831 . . . . 0.0 109.044 -179.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.94 -177.04 0.3 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.622 0.881 . . . . 0.0 112.015 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.6 ptt180 -87.03 -33.23 19.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.39 -39.98 81.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.63 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.24 -39.97 59.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -50.04 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.0 111.261 -178.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 29.6 p-10 -59.16 -39.03 81.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.76 -1.213 . . . . 0.0 108.948 -179.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.412 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.8 t60 -59.73 -49.17 78.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.185 179.01 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.14 87.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 110.165 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.09 -40.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.229 -0.919 . . . . 0.0 109.857 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.07 -39.75 86.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.23 -39.8 87.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 109.29 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.33 95.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.09 -1.006 . . . . 0.0 109.498 -179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -60.02 -39.94 87.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.864 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -60.0 -40.03 87.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.369 -0.832 . . . . 0.0 109.827 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 40' ' ' LEU . 90.2 mt -60.03 -42.96 95.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.055 -1.028 . . . . 0.0 109.709 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -71.65 -40.11 69.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 109.702 -179.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 t -69.79 -33.7 72.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.03 -23.06 63.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 111.06 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 m -112.74 3.33 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.166 -0.959 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 9.2 p -148.63 151.37 35.67 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.861 -1.149 . . . . 0.0 109.586 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.99 8.88 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.657 0.905 . . . . 0.0 111.975 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.15 150.01 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.543 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -137.26 153.75 50.27 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.452 -0.78 . . . . 0.0 109.033 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 14' ' ' LEU . 96.5 m-85 -130.01 158.93 38.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.492 -0.755 . . . . 0.0 110.109 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -154.88 126.69 7.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.864 . . . . 0.0 109.984 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.82 143.92 37.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.333 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.76 139.53 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -95.28 -11.2 28.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.165 -0.959 . . . . 0.0 110.097 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -147.59 158.16 43.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.964 -1.085 . . . . 0.0 109.546 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.93 170.83 47.65 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.595 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 5.5 pm0 -80.0 163.96 23.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.41 151.86 51.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -0.752 . . . . 0.0 109.757 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.11 -39.87 87.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.483 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.67 119.85 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.704 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.1 mmm -100.59 128.73 46.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.2 mt -119.13 129.92 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.468 -0.77 . . . . 0.0 109.722 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.7 p -149.74 159.92 43.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.172 -0.955 . . . . 0.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.56 138.37 44.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.14 161.54 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.162 -0.961 . . . . 0.0 111.25 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.92 142.78 50.83 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.717 -0.614 . . . . 0.0 109.786 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.99 -143.52 1.45 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.1 t0 -71.33 130.73 42.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.984 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.416 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.8 p-80 -133.11 53.59 2.01 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.5 -0.75 . . . . 0.0 109.835 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 54.04 50.98 15.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 109.386 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 10.4 t70 -140.03 165.88 26.14 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 26.1 m120 -89.15 9.36 25.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.11 -0.994 . . . . 0.0 109.946 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -135.57 71.43 65.41 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.833 . . . . 0.0 109.635 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.76 141.1 70.57 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 120.937 1.091 . . . . 0.0 111.986 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -75.2 141.33 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -110.74 74.28 0.87 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.784 . . . . 0.0 109.312 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.26 -178.62 6.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.56 -18.78 4.16 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.186 1.257 . . . . 0.0 112.044 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.22 175.06 55.03 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -160.46 29.29 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -75.03 160.12 30.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -1.114 . . . . 0.0 109.681 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 mt -93.64 -20.97 19.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.24 -0.912 . . . . 0.0 109.774 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.59 174.75 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.043 -1.036 . . . . 0.0 109.724 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.04 175.81 10.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 108.943 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.4 167.7 21.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.629 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.78 148.9 24.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.483 -0.76 . . . . 0.0 109.106 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -59.99 149.81 72.3 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.059 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.28 120.58 8.44 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.781 0.987 . . . . 0.0 112.16 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.53 174.9 47.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.81 172.95 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.211 1.274 . . . . 0.0 112.105 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.35 -124.83 16.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.09 -9.13 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -1.043 . . . . 0.0 110.002 -179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.78 143.9 35.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.18 -18.25 46.34 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.07 152.84 45.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.118 -1.225 . . . . 0.0 109.914 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.27 121.42 10.14 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -102.92 141.5 35.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.42 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.8 m-85 -113.8 136.57 52.71 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -65.71 115.6 6.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -98.43 -1.04 42.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.496 -0.752 . . . . 0.0 109.442 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.14 -20.23 59.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.976 -1.078 . . . . 0.0 109.557 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.31 159.55 14.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 108.84 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -87.23 122.43 31.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.932 . . . . 0.0 109.682 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.18 150.01 22.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.892 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.8 p -127.56 159.64 33.99 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.542 -0.724 . . . . 0.0 109.347 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.462 ' ND2' HD13 ' A' ' 25' ' ' LEU . 83.3 m-20 -109.39 29.47 7.52 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.532 -0.73 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.685 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.82 -165.01 2.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.217 -0.927 . . . . 0.0 109.655 -179.802 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.72 34.73 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 0.0 110.644 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.548 ' CG ' HD21 ' A' ' 106' ' ' ASN . 26.1 mmt180 -76.85 -165.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.392 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.38 -56.59 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.589 -0.694 . . . . 0.0 111.432 -178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 104' ' ' THR . 91.5 m-85 -100.33 119.79 38.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.052 -1.03 . . . . 0.0 110.756 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -103.35 107.3 18.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.385 -0.822 . . . . 0.0 109.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.38 -44.16 97.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 110.09 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -59.91 -43.43 94.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 114' ' ' ARG . 13.7 ttt-85 -59.95 -43.32 95.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.892 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.9 t -69.96 -40.03 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.15 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.56 92.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.27 90.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.28 -45.87 68.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 71.4 mt-10 -59.84 -40.14 87.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.94 -1.1 . . . . 0.0 109.142 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.58 -40.05 90.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 108.894 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.79 -41.92 84.44 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -64.65 -38.98 92.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -1.201 . . . . 0.0 108.835 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.3 p -70.02 -21.47 63.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.344 -0.847 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.86 -0.61 56.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 108.966 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.93 8.93 78.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.2 127.36 32.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.032 -1.275 . . . . 0.0 108.791 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -88.05 175.46 7.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.327 -0.858 . . . . 0.0 109.687 -179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -67.53 159.88 28.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -133.25 163.63 28.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.538 -0.727 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -100.89 7.45 43.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.65 122.01 27.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 108.788 179.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.24 -30.82 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.48 -5.74 89.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.464 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.77 132.08 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.995 -1.297 . . . . 0.0 109.505 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -68.91 -24.64 64.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.1 mmm -73.21 38.63 0.09 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.791 -178.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.9 t80 -69.32 129.72 91.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.965 . . . . 0.0 108.671 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -47.59 -67.51 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.3 1.143 . . . . 0.0 111.863 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 98.0 p -81.88 169.42 16.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.949 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.401 0.619 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.91 154.26 46.04 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 63.4 mt -74.93 146.04 42.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.969 -1.082 . . . . 0.0 109.11 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.07 156.89 16.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 109.092 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.77 -38.89 79.5 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -55.08 -40.11 70.01 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.072 -1.018 . . . . 0.0 108.624 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.7 -39.96 69.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.23 -49.94 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.659 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.99 -39.98 91.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.837 -1.164 . . . . 0.0 110.339 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.74 -54.43 9.91 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.137 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.7 tp -61.89 -40.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.299 . . . . 0.0 110.038 -179.008 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -65.86 -40.04 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.941 -1.099 . . . . 0.0 109.387 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.926 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -50.07 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 110.51 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -100.47 -61.04 1.42 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.171 -0.955 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.7 -176.93 34.69 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -90.93 149.43 21.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.426 -1.043 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 108.685 179.682 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 8' ' ' ARG . 22.6 mtt-85 . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -83.75 120.63 26.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.285 -0.885 . . . . 0.0 109.527 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.95 -10.11 58.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 109.109 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.94 150.11 30.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 -179.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -97.0 -4.89 38.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.523 -0.735 . . . . 0.0 109.442 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -130.01 139.99 50.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.78 157.61 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.403 -0.811 . . . . 0.0 109.654 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -127.0 155.19 43.59 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.619 -0.676 . . . . 0.0 109.188 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.98 157.91 43.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.009 -1.057 . . . . 0.0 109.266 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.428 HH21 ' CE ' ' A' ' 60' ' ' MET . 42.3 ttp180 -147.33 128.86 15.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.166 -0.959 . . . . 0.0 109.954 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.0 mt -85.41 123.71 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -62.3 -40.76 97.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -178.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -162.22 151.84 16.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.304 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -97.54 135.94 38.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.378 -0.827 . . . . 0.0 109.27 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 t -73.41 144.92 84.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.752 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.89 -15.09 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 CA-C-N 119.203 0.751 . . . . 0.0 111.046 179.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.49 -40.07 93.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.4 mt -135.13 150.32 72.58 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.009 -1.057 . . . . 0.0 109.337 -178.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.39 179.82 2.75 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 CA-C-N 119.158 0.735 . . . . 0.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -85.54 -36.13 20.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.924 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.78 84.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.21 -40.03 74.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.85 -44.33 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.443 -179.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.54 89.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 108.719 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.87 -47.87 84.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.312 -0.867 . . . . 0.0 109.499 179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.47 89.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.143 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.58 -40.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.404 ' HG2' HE21 ' A' ' 39' ' ' GLN . 87.8 tt0 -70.26 -40.0 74.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.609 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.29 95.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 108.609 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CE1' ' CD1' ' A' ' 49' ' ' PHE . 33.8 m-85 -61.21 -39.59 90.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 109.881 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.404 HE21 ' HG2' ' A' ' 35' ' ' GLU . 76.3 mt-30 -58.9 -40.93 85.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.514 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.2 -41.24 92.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.034 -1.041 . . . . 0.0 109.317 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -72.39 -40.0 67.57 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.68 -28.47 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.442 -0.786 . . . . 0.0 110.254 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -59.85 -35.14 74.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 110.766 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.405 ' C ' ' HG ' ' A' ' 163' ' ' SER . 2.9 m -108.52 5.63 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.278 -0.889 . . . . 0.0 110.985 -178.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.3 p -140.03 148.63 55.61 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 120.897 -1.127 . . . . 0.0 108.625 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.73 6.4 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.407 1.404 . . . . 0.0 112.389 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.16 157.92 35.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.367 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 p -135.79 147.71 48.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.482 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 95.9 m-85 -128.72 148.7 50.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.725 -0.609 . . . . 0.0 109.65 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -154.35 134.92 13.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -76.06 146.58 39.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.25 135.17 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.369 -0.832 . . . . 0.0 108.978 179.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -97.54 -5.89 34.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 110.052 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -142.67 156.67 45.08 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.07 -1.019 . . . . 0.0 109.565 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 167.59 25.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -78.37 148.03 33.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.932 . . . . 0.0 109.272 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.59 148.38 30.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -0.776 . . . . 0.0 108.913 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.45 -40.35 90.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.34 118.89 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.428 ' CE ' HH21 ' A' ' 17' ' ' ARG . 89.7 mmm -101.2 122.19 43.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -111.79 130.05 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.625 -0.672 . . . . 0.0 109.524 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.6 p -147.39 155.5 42.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -105.28 140.2 38.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.57 160.29 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 121.901 0.858 . . . . 0.0 111.188 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.3 mtm-85 -131.96 135.44 46.58 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.72 -138.66 13.88 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -77.37 129.09 35.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.561 -0.964 . . . . 0.0 110.243 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 19.1 p-80 -131.58 47.46 2.53 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.409 -0.807 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 56.04 59.35 3.78 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.1 p-10 -142.72 163.1 33.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.066 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.53 9.19 30.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.172 -0.955 . . . . 0.0 109.233 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 t -140.08 69.51 34.95 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.414 -0.804 . . . . 0.0 109.012 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.67 148.68 42.22 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.364 1.376 . . . . 0.0 112.083 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -79.25 151.12 31.34 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -134.93 76.36 1.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.428 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.83 -179.18 39.73 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -70.73 -15.6 33.46 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.194 1.262 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.04 -174.89 50.5 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.04 -158.38 36.38 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -75.06 143.78 43.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -1.023 . . . . 0.0 109.25 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.32 -16.0 32.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 109.0 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.54 175.67 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.264 -0.898 . . . . 0.0 108.937 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -163.01 120.25 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.914 -1.116 . . . . 0.0 110.629 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.45 168.11 16.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -109.61 143.93 38.63 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -59.47 145.95 80.94 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -58.36 127.28 24.16 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 119.249 0.768 . . . . 0.0 112.306 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.27 178.12 43.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.57 -177.86 3.87 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.359 1.373 . . . . 0.0 112.524 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.75 -123.7 33.52 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.14 -13.74 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.49 -1.006 . . . . 0.0 109.782 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.01 138.77 38.21 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.249 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -13.93 63.5 Favored Glycine 0 N--CA 1.497 2.702 0 O-C-N 121.231 -1.158 . . . . 0.0 110.546 179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.79 162.81 25.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.955 -1.321 . . . . 0.0 109.768 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.5 120.76 11.55 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -105.15 133.45 49.9 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.241 -0.912 . . . . 0.0 110.272 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.508 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 43.8 m-85 -114.65 129.75 56.72 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -67.53 120.72 14.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 108.968 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -99.4 6.5 46.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.308 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.47 -20.16 60.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 0.0 109.737 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -104.23 160.07 15.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 102' ' ' ARG . 33.2 ttt-85 -84.11 119.16 24.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.138 -0.976 . . . . 0.0 110.147 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -88.8 148.95 23.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.497 -0.752 . . . . 0.0 109.269 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 41.6 p -123.23 167.96 13.06 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.476 -0.765 . . . . 0.0 109.306 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -104.66 23.82 12.75 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -148.98 -165.0 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.657 -0.652 . . . . 0.0 109.805 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -90.88 27.0 1.92 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.231 -0.918 . . . . 0.0 110.911 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.0 mtt-85 -76.47 -157.14 0.08 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.837 -1.165 . . . . 0.0 109.442 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 108' ' ' ARG . 64.4 mm-40 -24.31 -65.4 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.4 m-85 -130.12 132.05 45.95 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.978 -1.076 . . . . 0.0 109.786 -179.455 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -95.99 113.83 25.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.204 -0.935 . . . . 0.0 109.701 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.25 -40.27 77.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -59.63 -42.9 93.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.958 -1.089 . . . . 0.0 109.988 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 114' ' ' ARG . 25.3 ttt-85 -59.7 -41.52 90.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.27 -39.67 77.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.77 92.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.328 -0.858 . . . . 0.0 108.926 179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.16 85.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.0 109.162 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 122' ' ' HIS . 4.3 t60 -69.72 -50.1 46.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 73.4 mt-10 -59.95 -40.1 87.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.962 -1.086 . . . . 0.0 110.278 -178.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 58.2 mt -62.12 -39.88 94.04 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 108.828 179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.52 95.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 118' ' ' HIS . 12.2 m-70 -61.93 -38.73 89.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.067 -1.255 . . . . 0.0 107.778 178.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.5 m -69.65 -24.31 63.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.1 -0.27 51.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 108.852 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.99 13.97 65.5 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.361 -0.923 . . . . 0.0 110.889 178.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.56 124.58 30.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.088 -1.243 . . . . 0.0 108.887 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -88.67 167.28 13.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.998 -1.064 . . . . 0.0 109.1 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 122' ' ' HIS . 80.9 m80 -68.58 152.36 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 t -126.44 169.69 12.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.473 -0.767 . . . . 0.0 108.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.3 p -98.94 1.02 45.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.398 -0.814 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -79.06 119.3 21.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.04 -40.44 83.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 -179.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.77 27.87 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.01 -1.057 . . . . 0.0 111.007 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.1 23.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.852 -1.381 . . . . 0.0 109.159 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 85.1 mt -68.19 -23.89 64.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 108.885 178.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.564 ' SD ' ' N ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -74.52 62.24 1.0 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.57 -0.706 . . . . 0.0 109.911 -179.262 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 139' ' ' SER . 1.8 t80 -71.19 123.95 90.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -51.11 -2.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 CA-C-N 120.459 1.2 . . . . 0.0 113.546 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 137' ' ' TYR . 58.3 m -163.05 174.55 12.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 0.0 109.074 179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 93.2 t80 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.903 . . . . 0.0 108.92 179.626 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.315 0.578 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -142.58 157.87 44.26 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.54 145.92 47.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.018 -1.051 . . . . 0.0 108.868 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.07 162.91 13.68 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.21 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.14 -40.19 88.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.22 -41.67 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -71.68 -40.78 69.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.76 -49.78 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.781 . . . . 0.0 109.298 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.67 -39.91 88.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.894 -1.129 . . . . 0.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -52.72 34.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.32 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -1.212 . . . . 0.0 109.669 -179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.28 -39.65 92.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.198 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.79 92.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.389 -0.819 . . . . 0.0 110.033 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.97 -47.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.92 -1.112 . . . . 0.0 109.478 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.41 -64.91 1.01 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.299 -0.876 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.91 -169.82 35.94 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -92.11 145.44 24.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.023 -1.281 . . . . 0.0 108.7 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 42.2 m . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.223 -0.923 . . . . 0.0 109.962 -178.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -83.13 118.71 23.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -85.26 -10.65 56.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.287 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.73 150.9 25.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.323 -179.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.7 p -96.19 -3.8 43.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -128.85 141.67 51.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 160.05 39.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.244 -0.91 . . . . 0.0 109.784 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 p -127.94 157.18 41.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -146.1 159.94 42.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.416 -0.802 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -150.4 133.87 16.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.2 mt -89.49 118.57 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.4 mt-10 -66.8 -40.13 87.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.531 -178.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.2 m-20 -155.95 152.71 28.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.119 -0.988 . . . . 0.0 109.849 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -101.4 131.98 47.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -68.75 138.26 90.61 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.993 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.47 -8.95 18.5 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.596 0.891 . . . . 0.0 112.052 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.1 -39.97 88.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.004 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -135.73 149.06 67.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.13 -175.44 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.63 0.886 . . . . 0.0 111.696 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -90.01 -37.23 14.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -45.85 85.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.823 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.54 -39.83 73.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.72 -45.58 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -59.95 -40.11 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.184 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -60.12 -42.52 94.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.74 90.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.46 -36.89 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -65.71 -42.03 91.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.739 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.6 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.836 -1.165 . . . . 0.0 109.82 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.95 75.66 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 39.4 m-85 -61.69 -40.96 96.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.918 -1.114 . . . . 0.0 108.78 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.24 -42.03 94.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 0.0 110.356 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.79 -40.6 88.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.067 . . . . 0.0 110.116 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -73.0 -40.04 65.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.822 -1.174 . . . . 0.0 109.186 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 t -70.04 -26.48 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 110.25 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.92 -35.97 76.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.377 -0.827 . . . . 0.0 110.68 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 45' ' ' THR . 33.7 m -108.54 10.26 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 44' ' ' VAL . 65.9 p -141.05 147.25 46.93 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.301 -0.875 . . . . 0.0 109.306 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.78 6.29 2.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.9 1.067 . . . . 0.0 112.067 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.32 155.9 40.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.813 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.8 p -134.54 149.85 50.69 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 91.8 m-85 -125.98 155.13 41.88 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.468 -0.77 . . . . 0.0 109.433 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.5 m -151.65 137.25 17.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.36 137.02 37.82 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -121.57 134.34 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.362 -0.836 . . . . 0.0 109.16 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 t -97.47 -6.02 34.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.344 -0.848 . . . . 0.0 110.624 -179.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -144.19 153.32 41.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.83 165.57 33.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -81.09 147.3 30.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -1.17 . . . . 0.0 108.972 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.77 17.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.73 -38.66 82.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.196 -0.94 . . . . 0.0 108.946 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -116.4 118.3 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.673 0.749 . . . . 0.0 109.833 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.43 129.64 46.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.335 -0.853 . . . . 0.0 109.737 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.46 130.63 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.1 p -148.43 161.2 42.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.0 -1.062 . . . . 0.0 110.582 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.08 140.01 48.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 173.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.134 -0.979 . . . . 0.0 111.003 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -138.15 141.93 40.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.518 -0.739 . . . . 0.0 110.481 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.49 -140.09 2.24 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.57 130.33 40.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.425 -1.044 . . . . 0.0 109.421 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.516 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 12.1 p-80 -136.91 60.44 1.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.519 -0.738 . . . . 0.0 110.315 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 52.45 51.16 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.543 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 72' ' ' SER . 11.9 t70 -144.36 160.09 41.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.219 -0.926 . . . . 0.0 109.337 -179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -88.96 9.89 23.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 108.74 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 40.3 t -134.17 73.78 69.08 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.537 -0.727 . . . . 0.0 109.318 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.77 145.08 45.27 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.057 1.171 . . . . 0.0 111.88 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.2 142.56 45.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.103 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -102.42 65.63 0.95 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.299 -0.876 . . . . 0.0 109.665 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.3 -166.6 41.39 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.09 -20.02 17.65 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.226 1.284 . . . . 0.0 111.998 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.69 173.77 43.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.38 -163.73 26.53 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -73.9 152.31 40.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.419 -1.048 . . . . 0.0 109.974 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -91.86 -17.0 25.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.03 171.26 7.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.432 -0.793 . . . . 0.0 109.053 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.56 121.97 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.7 173.3 9.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.616 -0.678 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.65 158.54 17.96 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.591 -0.693 . . . . 0.0 109.241 179.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -58.82 145.8 77.6 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.135 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.09 96.5 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.776 0.984 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.91 173.49 36.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -65.1 -174.1 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.92 1.08 . . . . 0.0 111.705 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.38 -134.11 50.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.24 -12.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -1.124 . . . . 0.0 110.313 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.88 144.22 44.68 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.7 -12.67 66.43 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.38 160.83 28.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -1.156 . . . . 0.0 109.979 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.72 115.56 9.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -100.13 142.53 31.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -122.04 134.88 54.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.557 -0.715 . . . . 0.0 109.275 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.8 119.46 13.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -95.14 -0.27 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.83 -18.46 60.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 109.781 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 162.58 13.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.228 -0.92 . . . . 0.0 108.927 179.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -87.21 119.15 27.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -87.44 140.12 29.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.038 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 54.3 p -128.78 166.33 19.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.495 -0.753 . . . . 0.0 109.735 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.73 31.05 6.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.62 -0.675 . . . . 0.0 109.258 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.554 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -148.46 -162.73 1.62 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.956 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -81.11 34.24 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.423 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.503 ' CG ' HD21 ' A' ' 106' ' ' ASN . 10.6 mmt-85 -76.77 -166.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.129 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -50.27 -57.14 8.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.596 -0.69 . . . . 0.0 111.991 -178.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.3 m-85 -119.94 140.16 51.34 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.136 -0.977 . . . . 0.0 111.494 -177.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 21.4 m120 -108.32 118.49 36.9 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.99 -42.01 85.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.18 -0.95 . . . . 0.0 110.682 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -59.95 -42.09 93.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.054 -1.029 . . . . 0.0 110.935 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -59.84 -40.87 89.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 109.968 -178.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 62.6 t -70.33 -40.09 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 108.789 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.23 80.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.004 -1.06 . . . . 0.0 108.943 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.06 -35.01 79.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.956 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -69.99 -56.22 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.857 -1.152 . . . . 0.0 109.948 -179.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 7.0 mp0 -57.73 -39.92 78.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.951 -1.093 . . . . 0.0 109.677 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.94 -39.74 90.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.276 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.86 95.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -63.47 -33.66 76.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -1.091 . . . . 0.0 108.8 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -68.83 -25.31 64.59 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.4 mt -84.58 -6.27 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 0.0 109.431 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.14 19.53 52.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.37 134.81 34.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.866 -1.373 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.8 m -87.55 168.29 13.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.4 159.14 32.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.9 t -132.35 157.82 43.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.072 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 10.15 41.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.312 -0.867 . . . . 0.0 109.883 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -82.04 128.51 34.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.76 -27.67 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 110.463 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.15 -4.79 88.04 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.413 -179.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.35 132.34 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.671 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.84 -27.46 65.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 109.421 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.6 mtp -75.72 45.39 0.32 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.826 -179.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -69.94 135.54 87.52 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -47.07 -68.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 119.861 0.986 . . . . 0.0 112.545 179.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -85.14 174.05 9.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.017 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.9 t80 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.921 179.748 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.118 0.485 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.88 153.98 41.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.259 -0.9 . . . . 0.0 109.478 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.06 149.46 39.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 108.71 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.76 161.32 14.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -60.03 -39.82 87.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -58.59 -40.34 82.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.482 -0.761 . . . . 0.0 109.706 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.55 -40.14 66.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.747 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.81 -49.69 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.67 -40.21 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.182 -0.949 . . . . 0.0 109.868 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -57.53 12.76 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.911 -178.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -60.15 -39.98 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.308 . . . . 0.0 109.941 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -63.13 -39.58 95.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.028 -1.045 . . . . 0.0 109.175 179.399 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.57 94.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.22 -52.06 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.743 -1.223 . . . . 0.0 109.392 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -96.1 -70.9 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.11 -170.07 39.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -92.98 141.72 28.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -1.156 . . . . 0.0 109.721 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.1 mt -60.16 -39.95 88.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 108.965 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 61.7 p -91.78 142.0 28.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.37 -0.831 . . . . 0.0 108.912 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -83.21 102.56 11.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.991 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.02 86.36 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.096 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.453 ' O ' ' OG1' ' A' ' 3' ' ' THR . 10.3 m120 -150.19 66.61 7.95 Favored Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 120.41 -1.641 . . . . 0.0 110.212 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -78.1 144.41 21.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.404 1.402 . . . . 0.0 112.246 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 43.6 mtm-85 -87.18 167.37 14.2 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -81.7 119.63 24.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.038 -1.039 . . . . 0.0 108.68 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -82.43 -11.5 58.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.894 . . . . 0.0 109.734 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -84.68 151.03 24.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.81 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.4 p -94.81 -3.99 47.97 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -129.2 144.02 51.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -133.39 158.5 42.88 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.39 -0.819 . . . . 0.0 109.91 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.3 p -128.71 150.02 50.45 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.18 159.41 42.29 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.317 -0.864 . . . . 0.0 109.578 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -150.7 130.5 13.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.264 -0.898 . . . . 0.0 109.74 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.0 mt -87.21 122.54 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.309 -0.87 . . . . 0.0 108.858 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.83 -40.08 83.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.477 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -161.74 159.45 27.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.857 -1.152 . . . . 0.0 110.212 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -100.12 138.19 37.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 0.0 109.155 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.1 t -69.53 139.77 89.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 108.983 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -66.31 -12.13 34.33 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 CA-C-N 119.601 0.893 . . . . 0.0 111.309 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.0 -40.02 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.387 -0.821 . . . . 0.0 108.976 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 70.7 mt -138.04 149.93 65.56 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.88 -170.97 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 120.795 0.997 . . . . 0.0 112.094 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' NH2' ' OD2' ' A' ' 31' ' ' ASP . 6.6 ptm180 -88.51 -31.81 18.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.301 -0.874 . . . . 0.0 109.596 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.11 -47.38 78.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.823 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.975 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.96 -43.96 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.139 -0.976 . . . . 0.0 110.092 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.402 ' OD2' ' NH2' ' A' ' 27' ' ' ARG . 87.3 m-20 -59.28 -41.68 89.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.908 -1.12 . . . . 0.0 109.267 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -60.06 -49.03 79.26 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.326 -0.859 . . . . 0.0 109.46 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.4 92.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 110.29 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.05 -40.05 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.16 -0.962 . . . . 0.0 109.725 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.16 -41.02 74.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.135 -0.978 . . . . 0.0 109.818 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.73 -39.74 92.61 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -46.18 86.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 0.0 110.074 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -60.0 -40.03 87.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.884 -1.135 . . . . 0.0 109.261 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.412 HE21 ' HG2' ' A' ' 35' ' ' GLU . 80.3 mt-30 -60.01 -41.2 91.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 0.0 110.232 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -41.39 91.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.022 -1.049 . . . . 0.0 109.889 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -72.57 -42.29 64.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 110.335 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 t -69.93 -30.82 68.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.23 -0.919 . . . . 0.0 110.249 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -58.61 -31.99 68.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 111.168 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 33.3 m -110.03 9.99 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 O-C-N 121.084 -1.01 . . . . 0.0 111.009 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 70.4 p -143.25 148.28 43.88 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 120.925 -1.109 . . . . 0.0 109.292 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.78 10.5 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 120.64 0.894 . . . . 0.0 111.196 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.58 151.5 44.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.515 -0.741 . . . . 0.0 109.842 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 p -129.8 140.91 50.94 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.64 157.7 27.93 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.571 -0.705 . . . . 0.0 109.38 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.9 m -154.59 125.74 7.27 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.233 -0.917 . . . . 0.0 109.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -78.38 133.53 37.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.373 -0.83 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.9 135.89 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.579 -0.701 . . . . 0.0 109.261 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -96.22 -2.0 47.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.316 -0.865 . . . . 0.0 109.994 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -146.35 156.39 43.3 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.966 -1.084 . . . . 0.0 109.587 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.98 164.52 34.05 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -80.45 131.48 35.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.006 -1.291 . . . . 0.0 108.594 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.81 155.19 16.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.22 -0.925 . . . . 0.0 109.846 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -59.96 -40.05 87.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.306 -0.871 . . . . 0.0 109.602 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -120.01 113.06 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.44 -0.788 . . . . 0.0 109.062 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.3 mtp -100.03 133.6 44.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.425 -0.797 . . . . 0.0 109.113 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.7 mt -116.04 130.03 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.557 -0.714 . . . . 0.0 109.334 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.1 p -150.15 155.17 39.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 110.19 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -103.39 137.67 41.18 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.78 160.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.264 -0.897 . . . . 0.0 111.264 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -130.51 143.47 50.78 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.318 0.58 . . . . 0.0 109.528 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.88 -142.74 3.21 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -76.49 130.14 37.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.482 -1.01 . . . . 0.0 110.037 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.583 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.2 p-80 -130.56 54.14 1.91 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 57.45 49.99 12.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 109.818 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 8.4 m-20 -142.79 162.0 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.437 -0.789 . . . . 0.0 109.033 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -90.46 9.66 28.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.249 -0.907 . . . . 0.0 110.631 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.7 71.62 64.25 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 120.997 -1.064 . . . . 0.0 110.668 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.47 149.92 56.92 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.201 1.268 . . . . 0.0 111.828 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -77.45 142.98 38.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.905 . . . . 0.0 109.592 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -108.01 65.5 0.64 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.45 -0.781 . . . . 0.0 109.353 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.44 -167.54 54.27 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -57.97 -8.52 4.75 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.2 1.267 . . . . 0.0 112.079 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.14 176.48 42.18 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.67 -164.27 41.17 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.575 ' HB3' HG12 ' A' ' 173' ' ' CGS . 3.0 p30 -75.27 159.65 31.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.219 -1.165 . . . . 0.0 109.786 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.67 -18.18 21.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.363 -0.836 . . . . 0.0 109.851 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.34 169.41 9.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.157 -0.965 . . . . 0.0 108.872 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.6 177.75 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.971 -1.081 . . . . 0.0 109.799 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.3 177.91 7.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.325 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.67 154.65 21.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.512 -0.743 . . . . 0.0 109.281 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 86' ' ' GLN . 3.7 mp0 -58.59 149.99 59.04 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.182 -0.949 . . . . 0.0 108.802 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -60.72 107.42 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 120.575 0.85 . . . . 0.0 112.047 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.11 173.24 41.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.59 176.98 2.44 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.091 1.194 . . . . 0.0 112.121 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.11 -131.93 33.42 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 tt -73.51 -12.72 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -1.062 . . . . 0.0 109.788 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.38 142.94 42.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.29 -21.49 37.49 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -67.52 153.35 43.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.212 -1.17 . . . . 0.0 109.946 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.64 122.69 10.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 109.062 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -104.89 152.13 23.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.459 -0.776 . . . . 0.0 110.11 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 20.8 m-85 -119.91 139.64 52.1 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -66.55 119.81 12.33 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -98.51 2.3 47.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.55 -22.38 59.03 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.156 -0.965 . . . . 0.0 109.752 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -100.69 155.31 17.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.271 -0.893 . . . . 0.0 108.8 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -85.21 128.07 34.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.031 -1.043 . . . . 0.0 109.251 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -89.6 145.86 24.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.395 -0.816 . . . . 0.0 109.785 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.1 p -129.87 166.41 20.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.576 -0.703 . . . . 0.0 109.708 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -110.41 30.3 6.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.555 -0.715 . . . . 0.0 109.505 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 4.7 p30 -150.02 -164.24 1.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.188 -0.945 . . . . 0.0 109.767 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 31.76 0.43 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.244 -0.91 . . . . 0.0 110.066 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 108' ' ' ARG . 44.7 mtt-85 -75.91 -157.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.602 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -39.78 -59.66 1.13 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.747 . . . . 0.0 111.389 -178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -135.08 151.21 50.53 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.983 -1.073 . . . . 0.0 110.408 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 67.1 m-20 -103.59 115.04 29.77 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.13 -43.92 90.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.053 -1.029 . . . . 0.0 110.736 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -60.01 -42.32 94.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.07 -1.019 . . . . 0.0 110.239 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.567 HH12 ' N ' ' A' ' 143' ' ' SER . 69.9 ttt180 -59.91 -40.53 89.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.104 -0.997 . . . . 0.0 109.796 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 79.7 t -70.82 -41.99 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.996 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.93 92.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.018 -1.051 . . . . 0.0 109.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.75 88.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.461 -0.774 . . . . 0.0 109.204 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.452 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 6.5 t60 -68.33 -44.7 74.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.414 -0.804 . . . . 0.0 109.72 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.524 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 74.7 mt-10 -60.03 -39.93 87.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.041 -1.037 . . . . 0.0 109.437 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.69 -40.01 90.58 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.244 -0.91 . . . . 0.0 108.586 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.87 -41.84 84.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -65.27 -39.95 93.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 108.701 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.6 m -70.19 -27.27 64.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.82 -1.53 54.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.171 -0.955 . . . . 0.0 109.467 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.12 9.93 69.67 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.5 mt -84.28 123.61 30.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.939 -1.33 . . . . 0.0 109.181 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.9 m -88.2 176.23 7.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.291 -0.881 . . . . 0.0 109.792 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.97 155.38 38.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -131.17 168.38 17.56 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.492 -0.755 . . . . 0.0 109.305 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.1 p -101.82 10.52 39.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.379 -0.826 . . . . 0.0 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.43 129.52 34.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -0.877 . . . . 0.0 109.793 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.33 -40.02 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 110.641 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 0.19 77.54 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.985 -1.103 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 129.52 34.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.655 -1.497 . . . . 0.0 109.283 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 137' ' ' TYR . 88.0 mt -69.21 -24.28 64.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.409 -0.807 . . . . 0.0 109.374 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 92.8 mmm -71.44 45.58 0.11 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.546 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 135' ' ' LEU . 5.4 t80 -70.03 129.78 90.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.056 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.44 ' O ' ' HC1' ' A' ' 173' ' ' CGS . 21.5 Cg_exo -48.57 -71.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.192 1.104 . . . . 0.0 112.091 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.4 p -80.92 170.0 16.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 109.597 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.54 135.88 33.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.126 -0.984 . . . . 0.0 109.197 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.492 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 51.0 p -146.71 171.82 14.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.296 -0.878 . . . . 0.0 109.321 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -95.77 115.86 28.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.216 -0.928 . . . . 0.0 109.837 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.567 ' N ' HH12 ' A' ' 114' ' ' ARG . 70.0 p -104.18 166.75 10.2 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 0.0 109.299 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -68.05 -120.26 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -80.45 156.92 26.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.061 -1.258 . . . . 0.0 109.208 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.4 t -86.39 104.81 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.949 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -146.43 152.29 38.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.363 -0.836 . . . . 0.0 109.079 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.52 142.98 42.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.107 -0.995 . . . . 0.0 109.043 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 166.57 12.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.178 -0.951 . . . . 0.0 109.549 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.371 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -59.9 -40.3 88.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 109.517 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -73.07 -40.05 65.37 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.092 -1.005 . . . . 0.0 109.522 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.05 -50.07 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.701 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -61.76 -39.87 93.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.988 -1.07 . . . . 0.0 109.866 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.45 -57.49 19.34 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.222 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.433 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -65.99 -40.08 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.793 -1.416 . . . . 0.0 110.007 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.1 mt-30 -66.09 -39.95 90.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.36 -43.88 96.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.328 -0.857 . . . . 0.0 109.749 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.4 mt -60.01 -50.06 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.287 -0.883 . . . . 0.0 109.895 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -99.56 -64.86 1.0 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.5 -179.11 38.78 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -89.97 149.87 22.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -1.197 . . . . 0.0 109.382 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.43 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 21.5 m -73.38 89.67 1.63 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.5 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 95.5 mt-30 -76.57 33.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.729 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 23.6 m120 -154.46 72.75 6.13 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 109.208 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.46 54.35 4.88 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.517 1.478 . . . . 0.0 112.015 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.9 t -89.93 110.16 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.032 -1.042 . . . . 0.0 109.397 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.413 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 55.8 mt-30 -64.35 -60.42 8.63 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 111.143 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 168' ' ' GLN . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.319 0 CA-C-N 120.398 1.178 . . . . 0.0 112.347 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.575 HG12 ' HB3' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.101 0.477 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 91.2 mt -56.66 -82.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.0 109.449 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.3 p -98.67 138.79 35.34 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.193 -0.942 . . . . 0.0 109.721 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.97 145.94 39.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.103 -0.998 . . . . 0.0 109.1 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 -145.16 33.85 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.408 HD22 ' N ' ' A' ' 6' ' ' ASN . 1.6 m120 -81.37 149.2 64.82 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.263 -1.14 . . . . 0.0 109.113 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -61.28 157.25 41.25 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.623 0.882 . . . . 0.0 112.131 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.438 HH11 ' HG2' ' A' ' 8' ' ' ARG . 43.7 mtt-85 -146.21 163.02 36.74 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 108.744 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -82.41 120.44 25.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.061 -1.024 . . . . 0.0 109.591 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -83.87 -13.89 52.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 109.598 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.98 149.22 28.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.146 -0.971 . . . . 0.0 109.912 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -95.03 -3.9 47.49 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 67.0 m80 -125.3 134.49 52.23 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 76.1 mt -129.9 151.48 50.42 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.304 -0.872 . . . . 0.0 109.221 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -120.97 155.91 33.25 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.519 -0.738 . . . . 0.0 109.221 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -145.19 159.22 43.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 109.497 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -150.77 133.81 16.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.089 -1.007 . . . . 0.0 110.07 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.5 mt -90.84 120.05 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.96 -40.11 91.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.991 -1.068 . . . . 0.0 110.882 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.9 149.58 14.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.713 -1.242 . . . . 0.0 110.454 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -95.22 132.85 39.74 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -71.05 143.23 88.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.691 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.72 -9.91 24.6 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 120.789 0.993 . . . . 0.0 112.625 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.97 -39.97 87.49 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.086 . . . . 0.0 109.429 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.5 mt -137.83 149.69 65.27 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.64 179.8 0.63 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 120.667 0.911 . . . . 0.0 111.916 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -86.58 -31.43 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.301 -0.874 . . . . 0.0 109.178 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.71 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.836 . . . . 0.0 109.484 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -70.42 -40.07 74.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.45 -0.781 . . . . 0.0 110.499 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.6 t -70.46 -40.82 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.546 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -60.02 -40.46 89.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.34 -45.04 94.85 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.342 -0.849 . . . . 0.0 108.739 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.81 91.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.534 -0.729 . . . . 0.0 110.182 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.1 mm -70.31 -40.11 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.27 -0.894 . . . . 0.0 109.695 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -69.92 -40.1 75.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.415 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -61.82 -40.01 93.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 110.292 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.77 -41.63 91.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.137 -0.977 . . . . 0.0 110.035 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -60.47 -40.21 90.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.918 -1.114 . . . . 0.0 108.881 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -59.97 -41.47 92.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.792 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.32 -41.3 93.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.104 -0.997 . . . . 0.0 110.458 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -74.76 -42.11 58.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 109.985 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -68.71 -34.8 76.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 110.407 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.27 -32.24 69.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.373 -0.829 . . . . 0.0 111.269 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.616 HG23 HG23 ' A' ' 45' ' ' THR . 17.3 m -109.79 11.7 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.049 -1.032 . . . . 0.0 110.761 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 44' ' ' VAL . 52.0 p -143.01 149.27 48.62 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.911 -1.118 . . . . 0.0 109.472 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -73.68 3.88 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.538 0.826 . . . . 0.0 111.723 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.8 mt -71.69 157.88 37.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.852 . . . . 0.0 109.657 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.478 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.6 p -133.41 151.77 51.85 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -129.19 154.36 46.84 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.536 -0.727 . . . . 0.0 109.619 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.2 m -154.01 131.15 11.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.246 -0.909 . . . . 0.0 110.165 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -77.87 135.59 37.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.475 -0.765 . . . . 0.0 109.082 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -120.17 130.28 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.313 -0.867 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.5 t -99.1 11.66 38.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.482 -0.761 . . . . 0.0 109.835 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -144.07 153.7 42.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.076 -1.015 . . . . 0.0 109.183 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 168.32 1.44 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -82.05 147.49 29.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 109.011 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -101.35 160.01 14.78 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.313 -0.867 . . . . 0.0 110.226 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -60.15 -40.06 88.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.379 -0.826 . . . . 0.0 109.638 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.34 119.32 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.396 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.1 mtp -103.58 134.3 47.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.523 -0.736 . . . . 0.0 109.767 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -119.68 126.83 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 0.0 109.283 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.9 p -149.69 156.09 41.29 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.225 -0.922 . . . . 0.0 110.086 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -103.13 140.78 36.89 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 68' ' ' HIS . 26.1 m -138.95 169.77 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 120.945 -1.097 . . . . 0.0 110.818 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -138.08 149.26 45.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.713 -0.617 . . . . 0.0 110.147 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.91 -146.52 2.72 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -70.07 129.97 40.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -1.08 . . . . 0.0 110.296 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 11.1 p-80 -137.98 55.82 1.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.699 -0.626 . . . . 0.0 109.39 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 85.0 mtm180 57.24 48.96 14.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.578 -0.701 . . . . 0.0 109.79 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -142.47 158.25 43.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.347 -0.845 . . . . 0.0 109.156 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -90.96 8.61 34.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.195 -0.941 . . . . 0.0 109.941 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.7 m -134.5 72.48 69.96 Favored Pre-proline 0 N--CA 1.501 2.112 0 O-C-N 121.342 -0.849 . . . . 0.0 109.752 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.95 148.46 35.54 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.312 1.341 . . . . 0.0 112.682 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -76.4 146.19 38.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.776 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -136.57 75.2 1.53 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.153 -0.967 . . . . 0.0 110.123 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.72 -178.75 44.15 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.67 -6.4 8.9 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 120.746 0.964 . . . . 0.0 110.999 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.25 43.89 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.69 -173.74 47.67 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.57 ' CG ' HG12 ' A' ' 173' ' ' CGS . 80.1 m-20 -73.28 151.13 41.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -1.146 . . . . 0.0 109.089 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.5 mt -90.91 -13.39 33.65 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.24 163.41 8.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 108.909 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -161.46 179.72 8.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.836 -1.165 . . . . 0.0 110.211 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.83 174.13 10.97 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 0.0 109.486 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -101.4 155.72 17.89 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.376 -0.827 . . . . 0.0 108.995 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -59.56 149.02 72.56 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.279 -0.888 . . . . 0.0 108.836 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.97 100.19 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 120.503 0.802 . . . . 0.0 111.842 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.41 171.75 35.93 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -61.94 -169.62 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.422 1.415 . . . . 0.0 112.144 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.2 -131.38 51.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -80.03 -9.99 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.477 -1.014 . . . . 0.0 109.796 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.94 147.33 26.08 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -23.01 36.19 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 121.268 -1.136 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -67.45 154.89 40.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.352 . . . . 0.0 109.752 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.1 123.08 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -105.15 147.54 27.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.368 -0.833 . . . . 0.0 110.283 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -119.72 133.96 55.42 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -66.9 122.33 17.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.143 -0.973 . . . . 0.0 109.561 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -95.94 -2.62 46.74 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.032 -1.043 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -76.07 -13.85 60.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.959 -1.088 . . . . 0.0 109.238 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -93.84 152.68 18.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.403 -0.811 . . . . 0.0 109.107 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -86.5 115.07 23.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 108.704 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -91.97 144.6 25.29 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.818 . . . . 0.0 110.125 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.8 p -129.35 174.13 9.9 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -104.2 22.38 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.416 -0.803 . . . . 0.0 109.492 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.651 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.02 -166.4 2.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -0.921 . . . . 0.0 109.887 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.76 29.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.201 -0.937 . . . . 0.0 110.621 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.447 ' O ' ' C ' ' A' ' 109' ' ' GLU . 45.6 mtt-85 -76.16 -159.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.025 . . . . 0.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 108' ' ' ARG . 77.8 mm-40 -32.16 -60.4 0.27 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.815 -0.553 . . . . 0.0 111.819 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -137.92 139.08 39.61 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.089 -1.007 . . . . 0.0 110.041 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.53 HD22 ' N ' ' A' ' 112' ' ' LEU . 0.7 OUTLIER -105.9 119.53 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.5 -0.75 . . . . 0.0 109.354 179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 111' ' ' ASN . 64.8 tp -67.25 -39.93 86.21 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 0.0 110.632 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -60.07 -42.68 95.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 141' ' ' THR . 60.7 mtp180 -60.11 -40.04 88.3 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.603 -1.311 . . . . 0.0 110.325 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.45 -39.78 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.902 -1.124 . . . . 0.0 109.595 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.54 -43.6 93.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.46 94.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.034 -1.042 . . . . 0.0 109.891 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -68.05 -47.31 68.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -56.97 -39.95 75.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 109.493 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 87.3 mt -61.53 -39.52 91.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 108.798 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.08 -40.11 90.89 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -62.69 -40.01 95.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -1.232 . . . . 0.0 109.369 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -70.93 -23.49 62.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.236 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.39 -3.82 58.53 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.161 -0.962 . . . . 0.0 109.044 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.65 16.79 72.29 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.918 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.57 129.17 34.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.876 -1.367 . . . . 0.0 108.95 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.3 m -88.06 168.66 12.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.038 . . . . 0.0 109.54 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -68.73 159.99 31.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.6 t -130.22 168.84 16.21 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -103.05 10.06 38.23 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.316 -0.865 . . . . 0.0 109.618 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -80.39 128.5 33.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.06 -1.025 . . . . 0.0 109.176 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -40.09 81.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.586 -0.696 . . . . 0.0 110.55 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.57 1.61 65.98 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.976 -1.107 . . . . 0.0 111.601 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 136.48 34.52 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.614 -1.521 . . . . 0.0 109.61 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.1 -26.38 64.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 90.4 mmm -75.23 52.12 0.57 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.0 t80 -70.17 137.25 86.86 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.173 -0.954 . . . . 0.0 109.087 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.91 4.63 0.28 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 CA-C-N 119.847 0.981 . . . . 0.0 112.184 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.8 p -160.18 176.17 12.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.172 -0.955 . . . . 0.0 109.354 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.499 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 64.4 t80 -87.34 128.35 35.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.835 -1.166 . . . . 0.0 109.452 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.532 ' O ' ' NH2' ' A' ' 114' ' ' ARG . 35.0 p -153.55 -171.38 3.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.422 -0.799 . . . . 0.0 109.099 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -141.03 148.46 40.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.261 -0.899 . . . . 0.0 109.549 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.7 t -176.56 122.43 0.15 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.57 -167.69 0.16 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -82.32 169.77 16.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 0.0 109.605 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.18 108.33 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -0.977 . . . . 0.0 109.281 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -144.57 160.2 41.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.439 -0.788 . . . . 0.0 108.89 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.24 141.05 45.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.085 -1.009 . . . . 0.0 109.354 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.19 156.43 16.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -56.61 -39.04 72.89 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.056 -1.027 . . . . 0.0 108.801 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -55.33 -39.99 70.66 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.83 -40.02 63.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.174 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.86 -51.35 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.94 -1.1 . . . . 0.0 109.034 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.17 -40.17 96.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.338 -0.851 . . . . 0.0 110.775 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.07 -53.32 41.15 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.309 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -69.02 -39.69 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.912 -1.346 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.9 mt-30 -67.18 -37.97 84.6 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -0.99 . . . . 0.0 109.172 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.41 89.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -59.9 -50.19 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.115 -0.991 . . . . 0.0 109.793 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -95.31 -69.96 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.16 -0.963 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.61 -168.56 36.12 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 162' ' ' ARG . 30.6 mtm-85 -87.8 150.28 23.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -1.087 . . . . 0.0 108.714 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 165' ' ' ASN . 13.8 m -71.13 90.92 0.89 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 108.793 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.07 34.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.68 -0.638 . . . . 0.0 109.769 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 163' ' ' SER . 17.2 m120 -152.35 73.91 7.48 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.15 -0.969 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.16 61.41 7.3 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.526 1.484 . . . . 0.0 111.806 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 m -84.2 135.31 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.875 -1.141 . . . . 0.0 109.358 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -115.28 149.8 43.36 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 C-N-CA 120.824 1.016 . . . . 0.0 112.269 179.779 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.57 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.02 133.22 47.17 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.322 -0.861 . . . . 0.0 109.224 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 43.8 p -94.72 129.68 41.54 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.994 -1.066 . . . . 0.0 109.326 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.56 131.38 38.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.185 -0.947 . . . . 0.0 109.967 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.03 -59.76 0.51 Allowed Glycine 0 N--CA 1.501 3.024 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -151.92 72.81 7.94 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.133 -1.216 . . . . 0.0 109.595 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -59.76 107.84 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 120.996 1.131 . . . . 0.0 111.929 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -86.47 169.15 13.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.198 -0.939 . . . . 0.0 109.029 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -81.71 125.93 31.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 0.0 109.239 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -80.7 -16.8 53.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.1 -1.0 . . . . 0.0 109.145 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -82.47 147.44 28.71 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.186 -0.946 . . . . 0.0 109.682 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.2 p -96.08 -4.87 42.12 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -123.38 130.01 52.11 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.52 150.53 40.09 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.3 p -125.63 154.92 41.59 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.47 159.61 41.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.252 -0.905 . . . . 0.0 109.78 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -148.99 130.31 14.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.385 -0.822 . . . . 0.0 109.318 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.42 127.07 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.203 -0.936 . . . . 0.0 108.728 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.88 -40.04 83.61 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.278 -0.889 . . . . 0.0 110.159 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -162.91 155.33 18.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.976 -1.077 . . . . 0.0 109.976 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.63 136.32 40.68 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.0 t -70.49 141.66 88.29 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.949 -1.094 . . . . 0.0 109.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.29 -12.65 31.45 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 CA-C-N 119.413 0.826 . . . . 0.0 111.697 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.2 -39.93 88.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 110.5 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.4 mt -138.38 149.58 63.56 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.062 -1.024 . . . . 0.0 108.39 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.68 -175.93 0.51 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 120.52 0.814 . . . . 0.0 112.0 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -85.69 -33.25 21.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 109.555 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.66 -48.65 74.68 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.344 -0.847 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.97 -39.99 72.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 110.08 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.13 -42.68 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 109.495 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -59.6 -44.48 93.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.201 -0.937 . . . . 0.0 109.111 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.21 -46.41 89.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 0.0 109.937 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.56 92.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -72.34 -41.05 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.844 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 86.7 tt0 -70.05 -40.89 74.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.966 -1.084 . . . . 0.0 109.751 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -61.35 -35.81 78.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 108.809 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.87 -44.68 92.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.332 -0.855 . . . . 0.0 110.223 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.2 m-85 -60.19 -40.62 90.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.768 -1.208 . . . . 0.0 109.707 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.479 ' NE2' ' N ' ' A' ' 39' ' ' GLN . 0.4 OUTLIER -60.69 -39.81 89.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.052 -1.03 . . . . 0.0 110.506 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -59.67 -46.15 89.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.881 -1.137 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.405 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.6 m95 -71.32 -40.28 70.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.147 -0.971 . . . . 0.0 109.606 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.4 t -67.14 -39.16 86.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.335 -0.853 . . . . 0.0 111.301 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -56.33 -29.9 61.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 111.17 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.4 m -109.44 11.76 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.169 -0.957 . . . . 0.0 110.867 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 25.1 p -144.8 150.06 45.17 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.968 -1.083 . . . . 0.0 109.007 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -71.66 2.22 4.86 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 120.569 0.846 . . . . 0.0 111.962 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 64.1 mt -70.74 147.89 48.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 109.096 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.0 p -125.53 149.81 47.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 96.8 m-85 -126.21 152.29 46.25 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.8 m -153.23 129.92 10.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.868 . . . . 0.0 109.899 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -77.08 144.22 38.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.543 -0.723 . . . . 0.0 109.54 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.6 135.4 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.5 t -95.45 -9.46 32.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -144.23 158.32 43.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.276 -0.89 . . . . 0.0 109.48 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.66 172.87 49.31 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.01 160.88 25.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.592 -0.946 . . . . 0.0 108.958 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.94 52.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.03 -40.6 89.91 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.519 -0.738 . . . . 0.0 110.558 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.4 mt -119.64 119.91 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.3 mtp -102.22 131.6 48.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.423 -0.798 . . . . 0.0 109.481 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.3 mt -111.62 131.72 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.2 p -145.54 160.1 42.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.092 -1.005 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -116.96 136.65 52.78 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.23 160.01 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.296 -0.877 . . . . 0.0 110.601 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -126.75 137.14 53.19 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.77 -149.51 1.63 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -66.5 130.29 42.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -1.085 . . . . 0.0 109.585 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.522 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 20.2 p-80 -130.89 47.57 2.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.687 -0.633 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 64.6 mtp180 59.54 51.83 6.19 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.161 0.505 . . . . 0.0 109.912 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.522 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 7.5 m-20 -137.67 167.72 21.12 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.383 -0.823 . . . . 0.0 109.749 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -90.69 8.8 32.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 m -137.0 71.88 55.07 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.418 -0.802 . . . . 0.0 109.133 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -70.54 146.55 55.67 Favored 'Trans proline' 0 N--CA 1.488 1.171 0 C-N-CA 121.184 1.256 . . . . 0.0 111.697 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -76.68 148.69 36.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.328 -0.858 . . . . 0.0 109.615 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -106.27 70.75 0.85 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.438 -0.789 . . . . 0.0 109.423 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 51.11 -157.58 2.52 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.28 -19.53 17.08 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 118.571 1.185 . . . . 0.0 112.179 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.2 -177.47 41.9 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.56 -166.93 38.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.815 ' ND2' HG12 ' A' ' 173' ' ' CGS . 19.3 m120 -72.02 152.02 42.75 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.275 -1.132 . . . . 0.0 109.845 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.9 mt -92.68 -18.01 23.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.312 -0.868 . . . . 0.0 109.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.62 165.3 8.3 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -162.85 -179.31 6.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.48 166.47 22.64 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -95.8 159.71 14.84 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.251 -0.906 . . . . 0.0 109.937 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.25 150.95 39.43 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.534 -0.729 . . . . 0.0 109.241 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -62.02 104.82 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 120.501 0.801 . . . . 0.0 112.198 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 174.61 37.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -70.89 171.57 15.45 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 120.868 1.045 . . . . 0.0 112.318 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.03 -126.72 17.38 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -73.88 -13.22 15.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.338 -1.095 . . . . 0.0 109.258 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.17 144.0 45.48 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.58 18.17 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -66.97 126.08 28.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.301 . . . . 0.0 110.197 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.74 129.92 51.18 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -102.46 142.54 33.49 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.288 -0.883 . . . . 0.0 109.833 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -120.18 136.88 54.48 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.718 -0.614 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.19 121.15 17.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 109.652 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -97.79 -4.53 36.74 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.092 -1.005 . . . . 0.0 109.718 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.55 -16.02 59.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.02 -1.05 . . . . 0.0 109.135 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -93.24 158.24 15.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 102' ' ' ARG . 40.9 ttm-85 -87.9 115.11 25.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.871 . . . . 0.0 108.796 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -89.66 139.83 30.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.185 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.5 p -127.54 166.66 17.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.473 -0.767 . . . . 0.0 109.644 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -111.45 33.28 4.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -151.75 -165.97 2.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.21 -0.931 . . . . 0.0 110.227 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -84.89 32.01 0.54 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.392 -0.817 . . . . 0.0 109.95 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -76.14 -161.66 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.219 -0.925 . . . . 0.0 110.116 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.1 -59.23 3.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 111.59 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -121.31 132.25 54.68 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.099 -1.001 . . . . 0.0 111.143 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.13 124.27 49.45 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.98 -39.8 75.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -58.46 -45.33 88.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 111.224 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 87.4 mtt180 -60.2 -44.27 95.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.28 . . . . 0.0 110.526 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.48 -41.05 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.986 -1.071 . . . . 0.0 110.019 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -42.16 93.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.061 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -37.22 86.34 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.46 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 56.0 t60 -70.06 -41.59 73.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 110.072 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -58.25 -42.06 85.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.118 -0.989 . . . . 0.0 109.058 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.42 -40.09 93.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.095 -1.003 . . . . 0.0 108.942 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.29 -40.08 83.94 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -66.12 -34.91 79.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -1.206 . . . . 0.0 109.106 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.0 t -69.09 -29.05 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.153 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.2 mt -81.57 -4.99 57.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.5 19.14 57.41 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.073 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.25 130.11 34.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.823 -1.398 . . . . 0.0 109.094 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.7 m -86.98 167.47 14.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.293 -0.879 . . . . 0.0 109.106 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -63.88 159.75 19.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -128.05 166.82 17.69 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.615 -0.678 . . . . 0.0 109.418 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 44.2 p -107.75 9.1 29.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 11.7 t70 -81.73 129.24 34.65 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.217 -0.927 . . . . 0.0 109.871 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.3 mt -60.09 -39.47 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -74.75 -3.22 66.82 Favored Glycine 0 N--CA 1.496 2.673 0 O-C-N 121.048 -1.033 . . . . 0.0 111.475 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.36 137.21 33.54 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.714 -1.462 . . . . 0.0 110.428 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.53 -27.55 65.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 0.0 108.961 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.46 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 40.0 mtp -76.64 58.67 1.42 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.864 . . . . 0.0 109.865 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -71.83 132.15 85.24 Favored Pre-proline 0 N--CA 1.487 1.41 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -46.33 -68.18 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.211 0 CA-C-N 120.198 1.106 . . . . 0.0 111.057 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.0 p -86.33 175.29 8.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.42 -0.8 . . . . 0.0 109.773 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -82.63 126.14 31.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 108.444 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 41.3 p -148.63 153.7 38.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -82.58 119.93 24.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.121 -0.987 . . . . 0.0 109.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.8 t -90.02 -73.04 0.53 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.388 -0.82 . . . . 0.0 109.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.444 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . 154.64 -110.79 0.46 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -80.05 141.7 35.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -1.195 . . . . 0.0 108.439 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.2 t -86.46 105.45 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 110.385 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -143.49 150.55 39.11 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 83.7 mt -76.31 143.72 40.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.825 -1.172 . . . . 0.0 109.298 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.84 156.43 19.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.04 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.75 -40.06 86.88 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 48.6 t0 -58.76 -40.34 83.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.75 -40.2 66.22 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.585 -1.322 . . . . 0.0 109.205 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.51 -48.13 88.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.434 -0.791 . . . . 0.0 109.911 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.79 -40.29 94.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.923 -1.111 . . . . 0.0 110.473 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.68 -52.94 38.17 Favored Glycine 0 N--CA 1.496 2.7 0 O-C-N 121.037 -1.039 . . . . 0.0 111.619 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.28 -38.75 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 120.83 -1.394 . . . . 0.0 109.549 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.9 mt-30 -64.41 -39.95 94.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.11 -0.994 . . . . 0.0 108.57 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.99 97.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.0 109.293 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 92.8 mt -60.38 -50.09 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.037 -1.039 . . . . 0.0 109.593 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -100.66 -67.79 0.84 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.352 -0.843 . . . . 0.0 109.144 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.29 -169.77 34.91 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.11 152.33 22.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.086 -1.243 . . . . 0.0 109.758 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 37.5 m -73.12 76.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 0.0 109.809 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -95.24 88.48 5.17 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -155.02 83.19 3.88 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.331 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -79.44 51.89 4.06 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 120.837 1.025 . . . . 0.0 112.322 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.45 137.8 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -126.16 79.17 70.06 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.493 1.445 0 C-N-CA 120.833 1.022 . . . . 0.0 112.14 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.815 HG12 ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.15 -53.44 57.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 108.696 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 63.6 p -100.73 146.1 27.65 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -72.16 132.91 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 0.0 108.766 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.74 -143.25 42.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -85.15 145.11 42.32 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.121 -1.223 . . . . 0.0 108.326 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.16 106.75 1.42 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 CA-C-N 119.758 0.949 . . . . 0.0 112.138 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.118 -0.989 . . . . 0.0 110.077 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -84.36 124.87 31.76 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.323 -0.861 . . . . 0.0 109.095 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.71 -12.68 59.43 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.884 -1.135 . . . . 0.0 110.63 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.527 ' NE2' ' OD2' ' A' ' 58' ' ' ASP . 19.2 pt20 -86.86 155.96 20.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.88 -1.138 . . . . 0.0 109.428 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -96.58 -4.2 41.64 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.071 -1.018 . . . . 0.0 109.672 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 40.3 m170 -117.75 130.94 56.62 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 HE21 ' A' ' 11' ' ' GLN . 73.2 mt -118.95 154.21 33.37 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.346 -0.846 . . . . 0.0 109.443 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.3 p -128.92 153.17 47.77 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.272 -0.892 . . . . 0.0 108.698 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.16 162.07 37.97 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.079 -1.013 . . . . 0.0 109.49 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 17' ' ' ARG . 16.6 ttt-85 -146.98 136.77 23.12 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 0.0 110.395 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.585 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 86.1 mt -89.33 111.47 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.6 tp10 -64.58 -38.78 92.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.334 -0.854 . . . . 0.0 110.486 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 61.5 m-80 -156.64 146.49 20.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.941 -1.099 . . . . 0.0 110.264 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.76 138.98 32.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 109.464 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR . 9.7 t -70.01 134.95 87.43 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.085 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -64.11 -13.73 39.44 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 120.017 1.042 . . . . 0.0 111.533 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.96 -40.02 87.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.873 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.2 mt -134.75 149.57 71.08 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.69 -175.53 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 120.708 0.938 . . . . 0.0 111.978 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -88.16 -35.58 17.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.12 79.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.348 -0.845 . . . . 0.0 109.566 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -72.12 -39.98 68.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 110.204 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.6 t -68.9 -40.84 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 109.142 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -60.04 -40.11 88.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 108.824 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -56.7 -50.38 72.31 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.564 -0.71 . . . . 0.0 109.426 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.51 92.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 110.333 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.0 mm -69.94 -39.09 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.083 -1.011 . . . . 0.0 109.762 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.29 -41.44 89.78 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -63.28 -39.92 95.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.962 -1.087 . . . . 0.0 110.676 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.88 75.72 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.803 -1.185 . . . . 0.0 109.206 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 38.1 m-85 -60.97 -40.78 94.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.082 -1.011 . . . . 0.0 109.159 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.409 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 19.2 mm100 -60.27 -43.23 96.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.97 -41.42 91.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.964 -1.085 . . . . 0.0 110.28 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.426 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.5 m95 -74.28 -41.28 61.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.704 -1.247 . . . . 0.0 110.028 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.1 -30.41 69.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 6.2 m120 -58.82 -32.91 69.81 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.282 -0.886 . . . . 0.0 111.22 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.55 8.26 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.3 p -143.83 148.87 44.25 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.915 -1.116 . . . . 0.0 109.843 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.66 6.58 1.55 Allowed 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.015 1.143 . . . . 0.0 111.655 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.7 mt -70.24 152.25 44.43 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.382 -0.823 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.0 p -130.31 150.92 51.33 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 95.3 m-85 -125.86 157.15 38.34 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.5 -0.75 . . . . 0.0 109.952 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.7 m -154.89 126.98 7.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.392 -0.817 . . . . 0.0 109.866 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.585 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 64.2 tttp -81.37 139.73 35.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.342 -0.849 . . . . 0.0 109.913 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.45 136.29 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.477 -0.764 . . . . 0.0 109.012 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.1 t -95.3 -0.75 52.52 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.116 -0.99 . . . . 0.0 109.148 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -149.36 159.21 44.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.391 -0.818 . . . . 0.0 109.419 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.25 164.69 36.58 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -77.41 139.24 39.65 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.218 -1.166 . . . . 0.0 108.075 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.34 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.43 -0.794 . . . . 0.0 109.439 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' OD2' ' NE2' ' A' ' 11' ' ' GLN . 93.5 m-20 -60.17 -40.71 90.9 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.462 -0.774 . . . . 0.0 110.006 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.03 118.56 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.83 123.58 45.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.329 -0.857 . . . . 0.0 108.956 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.6 mt -113.04 129.96 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.471 -0.768 . . . . 0.0 109.035 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -146.34 152.61 39.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 109.728 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.58 138.12 40.7 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.1 162.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.125 -0.984 . . . . 0.0 110.818 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.11 152.63 51.92 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.39 -151.74 0.62 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -69.49 130.2 41.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.957 . . . . 0.0 110.392 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 17.3 p-80 -135.63 49.27 2.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.493 -0.754 . . . . 0.0 109.073 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 55.07 56.95 5.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.5 -0.75 . . . . 0.0 109.723 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.5 t0 -142.52 160.28 40.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.326 -0.859 . . . . 0.0 108.756 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 50.5 t30 -88.93 7.53 34.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.084 -1.01 . . . . 0.0 110.047 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 72.4 m -136.11 71.24 62.06 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.394 -0.816 . . . . 0.0 108.925 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.96 144.29 75.88 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 120.919 1.079 . . . . 0.0 111.9 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.52 147.97 37.42 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.405 -0.809 . . . . 0.0 109.432 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -128.72 77.1 1.76 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.557 -0.714 . . . . 0.0 109.659 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.19 -174.27 26.91 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.42 -5.15 2.13 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.105 1.203 . . . . 0.0 112.392 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.76 179.19 44.29 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.81 -165.94 49.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.493 ' CG ' HG12 ' A' ' 173' ' ' CGS . 22.0 m120 -72.45 151.05 42.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.967 . . . . 0.0 109.412 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.3 mt -91.08 -17.56 26.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.121 -0.987 . . . . 0.0 109.554 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.42 164.67 8.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.016 -1.053 . . . . 0.0 109.85 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -160.37 177.32 10.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.266 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -165.87 174.7 9.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.201 -0.937 . . . . 0.0 109.766 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -109.05 153.26 23.89 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.645 -0.659 . . . . 0.0 109.897 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.93 151.57 64.0 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -58.01 104.85 0.18 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 120.956 1.104 . . . . 0.0 112.196 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.22 171.41 37.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.81 173.06 5.06 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.466 1.444 . . . . 0.0 111.81 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.44 -127.72 29.44 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.451 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.6 tt -78.19 -7.1 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.604 -0.939 . . . . 0.0 110.234 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.2 143.31 47.5 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.3 -21.52 28.03 Favored Glycine 0 N--CA 1.497 2.706 0 O-C-N 121.246 -1.149 . . . . 0.0 110.243 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -66.33 156.1 35.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -1.197 . . . . 0.0 110.69 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.36 121.51 11.49 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.446 -0.784 . . . . 0.0 109.563 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.6 142.89 29.61 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.211 -0.931 . . . . 0.0 110.88 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.512 ' CE2' ' OE1' ' A' ' 119' ' ' GLU . 26.6 m-85 -119.96 134.59 55.2 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.73 116.58 8.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.493 -0.755 . . . . 0.0 109.025 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -99.58 2.26 44.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.14 -14.85 60.16 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.296 -0.877 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -100.57 161.86 13.32 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.391 -0.818 . . . . 0.0 110.146 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.5 117.82 26.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.669 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -93.1 149.5 21.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 0.0 109.749 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.429 ' HB ' HD21 ' A' ' 106' ' ' ASN . 56.8 p -127.56 166.58 17.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.521 -0.737 . . . . 0.0 109.388 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.62 31.41 6.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.621 -0.674 . . . . 0.0 109.449 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.57 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.91 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.088 -1.007 . . . . 0.0 109.896 -179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.521 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 53.3 t80 -81.11 33.38 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.508 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 18.2 mmm180 -76.58 -165.91 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.071 -1.018 . . . . 0.0 110.351 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -59.66 -56.99 14.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 0.0 111.794 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -93.62 125.14 38.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 110.223 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -104.42 104.57 14.46 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 tp -70.02 -39.99 75.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 110.436 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -59.63 -47.43 85.64 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.908 -1.12 . . . . 0.0 110.781 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.06 -39.86 87.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 110.548 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 59.5 t -69.76 -41.54 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.876 -1.14 . . . . 0.0 109.608 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.08 -38.6 86.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.04 92.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.077 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.515 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 5.6 t60 -68.32 -43.93 76.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 110.726 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.512 ' OE1' ' CE2' ' A' ' 97' ' ' PHE . 5.5 mp0 -59.51 -40.69 87.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.597 -1.315 . . . . 0.0 109.633 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.12 -39.99 92.09 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.971 -1.081 . . . . 0.0 108.45 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.06 -41.97 98.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -64.2 -36.21 83.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.019 -1.283 . . . . 0.0 108.653 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.4 t -69.96 -22.79 63.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.346 -0.846 . . . . 0.0 108.738 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.2 mt -87.82 -3.75 58.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.09 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.11 21.27 55.66 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 120.401 -0.905 . . . . 0.0 110.932 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.72 135.92 34.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.855 -1.38 . . . . 0.0 109.684 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.1 m -88.74 166.87 13.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.375 -0.828 . . . . 0.0 110.145 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -68.01 161.94 25.56 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.5 t -125.7 160.96 28.37 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.41 -0.806 . . . . 0.0 109.192 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 82.5 p -99.99 9.39 42.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.7 t0 -83.3 130.18 35.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.244 -0.91 . . . . 0.0 109.442 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.417 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 85.4 mt -62.01 -40.42 87.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.18 -0.95 . . . . 0.0 111.12 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.93 2.14 65.87 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.959 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.34 130.09 35.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.746 -1.444 . . . . 0.0 109.498 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.12 -34.34 73.38 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 93.9 mmm -72.31 44.95 0.12 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.793 -0.567 . . . . 0.0 110.894 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -69.29 139.95 90.07 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -47.6 -55.84 3.61 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 CA-C-N 120.216 1.113 . . . . 0.0 111.484 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.408 ' OG ' ' N ' ' A' ' 140' ' ' TYR . 9.3 t -100.34 176.12 5.47 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.712 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.408 ' N ' ' OG ' ' A' ' 139' ' ' SER . 65.0 t80 -82.88 147.23 28.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.123 -0.986 . . . . 0.0 109.37 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.7 p -142.18 130.33 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.249 -0.907 . . . . 0.0 109.689 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -61.37 -40.22 93.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.961 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.7 p -73.28 162.84 28.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.635 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 121.85 124.48 3.04 Favored Glycine 0 N--CA 1.502 3.071 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 33.4 t0 -83.17 158.07 22.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -1.134 . . . . 0.0 109.425 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.532 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 57.6 t -84.22 76.08 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.476 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -150.41 149.44 30.05 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.426 HD22 ' CH2' ' A' ' 41' ' ' TRP . 69.4 mt -76.79 148.77 36.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.693 -1.254 . . . . 0.0 109.225 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.02 159.72 15.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.827 . . . . 0.0 110.052 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.68 -39.93 86.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 108.914 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -58.19 -40.0 80.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.087 -1.008 . . . . 0.0 109.257 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -74.23 -41.83 60.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.034 -1.041 . . . . 0.0 110.31 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.17 -49.42 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.852 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.813 -1.179 . . . . 0.0 109.259 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.13 -57.89 16.27 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.95 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -64.55 -39.82 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.86 -1.376 . . . . 0.0 110.08 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.4 mt-30 -66.74 -40.05 88.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.004 . . . . 0.0 109.863 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.65 -44.32 96.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.0 109.674 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.87 -50.23 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.95 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -97.35 -64.25 1.06 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.271 -0.893 . . . . 0.0 109.752 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.03 170.9 30.61 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.431 ' HG2' HH11 ' A' ' 162' ' ' ARG . 46.4 mtt-85 -90.24 138.01 31.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -1.128 . . . . 0.0 109.373 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 41.8 m -74.81 87.52 2.25 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -92.25 116.65 29.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.47 -0.769 . . . . 0.0 109.885 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -158.21 146.14 13.8 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -78.69 19.22 0.88 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 119.847 0.981 . . . . 0.0 111.698 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.6 p -94.58 131.13 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -69.97 149.45 96.38 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.176 -0.953 . . . . 0.0 108.917 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 C-N-CA 120.755 0.97 . . . . 0.0 112.025 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.608 ' CY ' HG13 ' A' ' 173' ' ' CGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.7 mp -60.05 -40.72 90.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.371 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.0 p -94.32 162.81 13.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.155 -0.966 . . . . 0.0 109.069 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -71.91 131.5 43.07 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.24 -0.913 . . . . 0.0 108.963 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.2 -152.21 50.79 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -84.59 147.99 50.77 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -1.172 . . . . 0.0 108.294 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -62.74 93.65 0.14 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.352 0.804 . . . . 0.0 112.088 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -144.84 155.46 43.49 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -84.07 133.38 34.65 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 108.993 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.56 -36.6 60.37 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.043 -1.035 . . . . 0.0 110.377 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.413 HE21 HD23 ' A' ' 14' ' ' LEU . 20.3 pt20 -80.01 155.29 27.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.02 -1.05 . . . . 0.0 109.657 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -95.18 -2.73 49.14 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -111.62 135.51 52.11 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD23 HE21 ' A' ' 11' ' ' GLN . 68.5 mt -134.48 159.92 39.63 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.211 -0.93 . . . . 0.0 109.515 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 76.2 p -130.91 152.9 49.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.615 -0.678 . . . . 0.0 109.24 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -144.49 158.41 43.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.292 -0.88 . . . . 0.0 109.651 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.469 HH12 ' HA ' ' A' ' 54' ' ' GLU . 69.6 ttt180 -150.73 137.06 18.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.476 -0.765 . . . . 0.0 109.244 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 95.9 mt -91.67 122.09 42.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.53 -40.11 95.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.618 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -160.01 158.43 30.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.293 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.54 133.98 44.17 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.366 -0.834 . . . . 0.0 109.28 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.6 t -70.99 143.66 89.2 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.95 -10.85 24.44 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 CA-C-N 119.728 0.938 . . . . 0.0 111.807 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.17 -40.04 88.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.893 . . . . 0.0 110.263 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.7 mt -139.54 150.12 62.42 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.396 -0.815 . . . . 0.0 108.998 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.4 Cg_endo -60.46 -174.77 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 120.77 0.98 . . . . 0.0 112.331 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -89.45 -37.13 15.02 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.84 -43.96 94.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.012 -1.055 . . . . 0.0 109.923 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -71.36 -37.43 71.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.267 -0.896 . . . . 0.0 109.879 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' PRO . 51.7 t -69.7 -40.45 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.622 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -59.98 -41.68 92.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.056 -1.057 . . . . 0.0 108.557 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -60.45 -45.27 94.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.536 -0.727 . . . . 0.0 109.32 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.75 -44.98 93.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.157 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.8 mm -72.33 -41.74 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 0.0 109.584 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.95 -39.7 75.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.014 -1.054 . . . . 0.0 109.927 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -59.99 -39.3 85.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 109.516 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.34 94.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.899 -1.126 . . . . 0.0 109.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.9 m-85 -60.95 -39.77 90.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.077 -1.014 . . . . 0.0 109.381 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -59.85 -39.89 86.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.516 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 40' ' ' LEU . 91.0 mt -60.08 -42.17 94.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.0 -1.063 . . . . 0.0 109.537 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -71.35 -42.92 67.9 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.353 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.8 t -69.86 -25.23 63.63 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.404 -0.81 . . . . 0.0 110.472 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -60.15 -39.48 86.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.083 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 45' ' ' THR . 19.6 m -109.33 10.88 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.164 -0.96 . . . . 0.0 110.873 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.639 HG23 HG23 ' A' ' 44' ' ' VAL . 38.1 p -139.95 143.3 33.81 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.002 -1.061 . . . . 0.0 109.505 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.47 13.49 0.44 Allowed 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.182 1.254 . . . . 0.0 111.746 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.66 160.54 32.07 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 108.893 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 p -137.22 149.2 47.03 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.4 154.25 47.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.761 -0.587 . . . . 0.0 109.536 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 23.9 m -153.08 130.05 11.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 0.0 109.748 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -81.77 139.87 34.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -0.805 . . . . 0.0 109.266 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.14 139.65 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.5 t -99.89 -6.32 26.92 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.368 -0.832 . . . . 0.0 110.238 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.5 mt-10 -144.48 156.79 44.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.157 -0.964 . . . . 0.0 108.772 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 169.9 39.78 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -84.63 139.44 32.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.153 -1.204 . . . . 0.0 109.655 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.2 156.1 17.78 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.455 -0.778 . . . . 0.0 109.64 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.1 -39.59 86.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.348 -0.845 . . . . 0.0 109.869 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.94 118.6 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.323 -0.86 . . . . 0.0 109.437 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.7 mmm -100.38 133.77 44.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.388 -0.82 . . . . 0.0 108.949 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.1 130.72 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.568 -0.708 . . . . 0.0 109.549 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.0 p -149.76 167.73 25.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.039 -1.038 . . . . 0.0 110.588 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -115.33 137.65 51.81 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.72 159.84 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.278 -0.889 . . . . 0.0 110.841 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -125.29 135.35 52.4 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.14 -130.65 4.53 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -81.02 129.82 34.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -1.101 . . . . 0.0 109.537 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 29.4 p-80 -136.44 51.21 2.01 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 58.41 54.99 5.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.771 -0.581 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.3 p-10 -141.01 170.21 16.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.047 -1.033 . . . . 0.0 109.457 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -91.92 9.64 32.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 109.511 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 t -140.52 74.95 27.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.577 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -71.27 139.09 34.41 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.533 1.488 . . . . 0.0 112.17 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.76 148.14 36.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 109.105 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -133.27 77.19 1.72 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.563 -0.711 . . . . 0.0 109.819 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.52 177.28 42.93 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 121.065 -1.022 . . . . 0.0 110.747 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -68.83 -23.04 35.73 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.501 1.467 . . . . 0.0 112.312 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.79 -177.56 51.08 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.64 -153.39 27.24 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.57 144.11 44.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.401 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.85 -19.93 19.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.43 170.66 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.838 -1.164 . . . . 0.0 109.429 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -161.57 179.33 8.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.0 109.976 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.97 170.0 17.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.312 -0.868 . . . . 0.0 109.719 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -104.71 154.5 19.9 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.699 . . . . 0.0 109.452 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -60.07 150.54 69.95 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.228 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.44 102.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.563 0.842 . . . . 0.0 111.957 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.18 171.24 33.38 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -67.83 169.83 15.39 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.033 1.155 . . . . 0.0 111.966 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.98 -123.18 14.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -77.81 -13.1 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.027 . . . . 0.0 109.587 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.08 140.54 44.69 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.59 -17.22 50.59 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -66.26 158.32 29.24 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.323 -1.104 . . . . 0.0 109.757 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.46 118.97 6.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.171 -0.956 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.36 145.87 28.34 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.5 -0.75 . . . . 0.0 110.832 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.495 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 24.6 m-85 -116.19 139.11 50.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.758 -0.589 . . . . 0.0 109.679 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.85 118.79 10.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 108.489 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -97.38 -1.03 45.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.488 -0.758 . . . . 0.0 109.769 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -75.29 -20.03 59.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.049 -1.032 . . . . 0.0 109.542 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -98.04 162.34 13.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.242 -0.911 . . . . 0.0 108.833 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.7 121.33 29.99 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.815 -1.178 . . . . 0.0 109.056 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -89.13 135.45 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 0.0 109.522 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.4 p -128.82 170.06 13.81 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.441 -0.787 . . . . 0.0 109.473 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -118.71 27.12 9.1 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.573 -0.705 . . . . 0.0 110.172 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.774 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -151.9 -167.02 2.66 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 0.0 110.538 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -59.97 10.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.312 -0.868 . . . . 0.0 111.6 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 106' ' ' ASN . 96.4 mtt180 -76.24 166.32 23.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.724 -1.235 . . . . 0.0 110.154 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 108' ' ' ARG . 41.3 mp0 -4.89 -76.9 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -131.74 150.98 51.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.204 -0.935 . . . . 0.0 110.416 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 82.5 m-20 -99.36 119.99 38.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.2 tp -65.3 -40.11 93.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.223 -0.923 . . . . 0.0 110.59 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -59.97 -42.18 93.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 79.6 t -70.12 -41.57 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.4 91.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.35 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.05 88.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.067 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.422 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 5.9 t60 -66.81 -45.78 77.26 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.355 -0.841 . . . . 0.0 109.643 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 85.3 mt-10 -59.72 -39.38 84.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 109.304 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.2 -39.64 90.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.104 -0.998 . . . . 0.0 109.12 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.07 -38.85 93.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -67.7 -38.48 83.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 0.0 109.022 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.5 p -70.11 -22.54 63.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 108.997 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.62 -3.35 59.02 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 109.239 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.81 11.97 72.72 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.86 131.23 35.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.345 . . . . 0.0 109.122 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 53.3 m -88.49 171.34 10.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.295 -0.878 . . . . 0.0 109.897 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -66.77 160.02 26.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.434 -0.791 . . . . 0.0 109.761 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.2 t -124.6 168.04 13.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.0 109.137 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.8 p -104.93 3.64 31.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.743 . . . . 0.0 109.479 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -84.24 120.69 26.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.961 . . . . 0.0 109.312 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.5 tt -55.95 -29.97 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.21 0.74 83.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.681 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.48 135.95 34.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.785 -1.42 . . . . 0.0 109.546 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.14 -27.41 65.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.219 -0.925 . . . . 0.0 108.653 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.8 mmm -79.02 40.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.713 . . . . 0.0 110.033 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -69.88 133.87 88.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 108.982 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.434 ' O ' ' HC1' ' A' ' 173' ' ' CGS . 22.1 Cg_exo -46.91 -67.5 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.805 0.966 . . . . 0.0 112.207 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.5 m -82.63 175.51 10.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -89.64 129.07 36.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.911 -1.118 . . . . 0.0 109.329 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 77.8 p -150.18 155.3 39.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.968 . . . . 0.0 109.355 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -102.39 127.15 49.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.391 -0.818 . . . . 0.0 108.997 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.9 p -152.31 100.11 2.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.972 -1.08 . . . . 0.0 110.093 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.53 -166.42 51.23 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -84.79 170.55 13.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -1.128 . . . . 0.0 109.023 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 69.5 t -82.81 99.35 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.034 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -142.28 160.89 39.36 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.159 -0.963 . . . . 0.0 109.137 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.42 131.74 42.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.029 . . . . 0.0 109.267 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.27 166.45 13.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.541 -0.724 . . . . 0.0 109.157 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.352 -0.842 . . . . 0.0 108.856 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -58.35 -39.69 80.2 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.25 -42.78 59.11 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.957 -1.089 . . . . 0.0 109.516 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.15 -51.59 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.159 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.4 -39.84 92.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.797 -1.19 . . . . 0.0 110.233 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.42 -52.44 49.22 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.231 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.19 -37.54 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.982 -1.305 . . . . 0.0 109.999 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.1 mt-30 -67.59 -40.65 84.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.82 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.09 89.55 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.131 -0.98 . . . . 0.0 109.484 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.47 -51.04 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.973 -1.08 . . . . 0.0 109.647 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -98.52 -67.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.097 -1.002 . . . . 0.0 109.953 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 163.88 -169.25 38.75 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -96.62 138.49 34.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -1.08 . . . . 0.0 109.243 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.9 m -73.72 87.03 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.022 -1.049 . . . . 0.0 108.969 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -89.25 102.88 15.54 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.524 -0.735 . . . . 0.0 110.53 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -159.52 137.79 7.57 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.286 -0.884 . . . . 0.0 109.34 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -77.15 -29.99 4.65 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 CA-C-N 119.982 1.029 . . . . 0.0 111.331 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 167' ' ' VAL . 30.8 m -96.34 130.03 45.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -67.4 148.33 98.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 120.915 -1.116 . . . . 0.0 109.012 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo . . . . . 0 N--CA 1.492 1.418 0 CA-C-O 117.93 -0.946 . . . . 0.0 111.416 179.19 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.434 ' HC1' ' O ' ' A' ' 138' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.92 -39.97 95.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.428 -0.795 . . . . 0.0 108.926 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.1 p -94.53 159.83 14.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.567 -0.708 . . . . 0.0 109.329 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -74.45 134.9 42.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -0.961 . . . . 0.0 109.602 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.88 -154.9 34.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -80.23 139.92 52.69 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.199 -1.177 . . . . 0.0 109.024 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.35 130.97 19.48 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 CA-C-N 119.739 0.943 . . . . 0.0 111.909 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH1' HD13 ' A' ' 159' ' ' ILE . 30.1 mmt180 -91.3 168.99 11.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.957 . . . . 0.0 108.819 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -82.75 120.05 25.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.173 -0.954 . . . . 0.0 109.12 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.71 -12.62 55.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.776 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -83.29 150.63 26.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.491 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.2 p -95.69 -4.22 44.64 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.226 -0.921 . . . . 0.0 108.975 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.55 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 54.3 m-70 -130.57 144.78 51.64 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -136.12 158.88 43.34 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.8 p -124.24 155.79 37.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.366 -0.834 . . . . 0.0 109.205 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -141.97 158.42 43.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.787 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.441 HH21 ' CE ' ' A' ' 60' ' ' MET . 44.0 ttp180 -149.88 130.4 13.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.488 -0.757 . . . . 0.0 109.809 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.8 mt -90.17 115.77 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.85 -39.73 94.03 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 110.473 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -159.46 152.62 22.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.791 -1.193 . . . . 0.0 110.701 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -97.93 135.28 39.88 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -70.04 138.02 87.34 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.036 . . . . 0.0 109.869 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.31 -12.5 30.75 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 CA-C-N 119.619 0.9 . . . . 0.0 111.818 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -60.16 -39.43 86.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.356 -0.84 . . . . 0.0 109.817 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 105' ' ' ASN . 93.9 mt -138.81 150.47 65.67 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -62.31 -171.77 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.385 0.723 . . . . 0.0 111.794 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -86.5 -37.36 18.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 109.453 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.24 76.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.87 -40.74 75.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.295 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.9 t -70.23 -42.65 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.183 -0.948 . . . . 0.0 108.909 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.03 -39.91 87.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.105 . . . . 0.0 108.998 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.589 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 45.9 t60 -60.06 -50.03 75.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.35 -0.844 . . . . 0.0 109.626 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.39 -47.84 82.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.21 -0.931 . . . . 0.0 110.166 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.22 -39.78 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.472 -0.768 . . . . 0.0 110.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -64.32 -47.41 79.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.774 -1.203 . . . . 0.0 109.786 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 36.1 mttp -64.03 -33.64 76.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.788 -1.195 . . . . 0.0 110.075 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.77 -50.98 71.69 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.813 -1.179 . . . . 0.0 109.025 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.4 -40.0 95.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.812 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -59.98 -43.34 95.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.996 -1.065 . . . . 0.0 109.86 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.8 -44.35 94.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 0.0 110.505 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -71.56 -40.07 70.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 109.67 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.9 t -69.81 -38.52 76.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -54.68 -30.57 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.201 -0.937 . . . . 0.0 110.898 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 HG23 ' A' ' 45' ' ' THR . 35.9 m -106.4 11.14 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.204 -0.935 . . . . 0.0 109.842 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.539 HG23 HG23 ' A' ' 44' ' ' VAL . 81.4 p -142.08 146.21 39.19 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.97 5.38 2.61 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 120.859 1.039 . . . . 0.0 111.577 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.0 mt -71.73 162.18 29.85 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.437 -0.79 . . . . 0.0 109.11 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.55 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 24.4 p -137.8 150.78 47.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -125.0 155.73 39.22 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.525 -0.734 . . . . 0.0 109.615 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.9 m -153.77 132.39 12.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.417 -0.802 . . . . 0.0 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -77.57 140.75 39.75 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.624 -0.673 . . . . 0.0 110.247 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.85 130.56 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.519 -0.738 . . . . 0.0 109.148 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -95.56 -3.39 46.57 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -147.31 151.0 35.86 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.126 -0.984 . . . . 0.0 109.469 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.17 168.54 44.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -80.89 140.28 35.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -1.168 . . . . 0.0 108.956 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -103.62 148.58 25.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.502 -0.749 . . . . 0.0 109.272 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.64 -43.74 93.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.17 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.9 mt -111.48 110.56 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 109.555 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.441 ' CE ' HH21 ' A' ' 17' ' ' ARG . 85.8 mtp -102.46 124.81 48.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.324 -0.86 . . . . 0.0 109.386 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.11 129.97 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 0.0 109.109 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.8 p -146.75 156.25 43.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.084 -1.01 . . . . 0.0 110.222 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -107.02 135.46 48.54 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.77 159.99 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.399 0 O-C-N 121.244 -0.91 . . . . 0.0 111.523 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 99' ' ' GLU . 55.0 mtt-85 -123.77 138.93 54.43 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.628 -0.67 . . . . 0.0 109.802 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.36 -139.34 1.24 Allowed Glycine 0 N--CA 1.498 2.802 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -70.87 122.43 19.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.556 -0.967 . . . . 0.0 109.427 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -135.17 66.29 1.53 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.431 -0.793 . . . . 0.0 109.866 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 53.69 50.34 17.29 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.98 . . . . 0.0 108.61 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 13.9 t0 -141.93 157.83 44.5 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.414 -0.804 . . . . 0.0 109.231 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 27.7 m120 -93.78 8.79 39.75 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.213 -0.929 . . . . 0.0 110.708 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -136.81 74.25 51.89 Favored Pre-proline 0 N--CA 1.5 2.072 0 O-C-N 121.203 -0.936 . . . . 0.0 109.286 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.47 147.32 86.81 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.281 1.32 . . . . 0.0 111.991 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -77.41 136.91 38.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.127 -0.983 . . . . 0.0 109.068 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -103.23 67.42 0.93 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.379 -0.826 . . . . 0.0 109.894 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.11 -175.02 37.73 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -70.57 -10.67 28.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.061 1.174 . . . . 0.0 111.944 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -92.33 179.55 40.64 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.06 -146.68 21.32 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 121.245 -1.15 . . . . 0.0 110.38 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.637 ' ND2' ' HA ' ' A' ' 173' ' ' CGS . 13.1 t-20 -73.77 131.89 42.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.47 -1.018 . . . . 0.0 110.292 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.45 -18.23 24.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.061 -1.024 . . . . 0.0 109.157 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.88 164.51 7.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.001 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -161.21 125.47 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.977 -1.077 . . . . 0.0 110.68 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.57 168.26 14.65 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.682 -0.636 . . . . 0.0 109.292 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.02 142.15 35.32 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -57.41 147.87 56.93 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.939 -1.101 . . . . 0.0 109.334 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.17 123.16 12.58 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 120.42 0.747 . . . . 0.0 111.65 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -179.34 175.69 47.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -73.95 163.31 37.22 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.857 1.038 . . . . 0.0 111.908 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' GLY . . . 74.05 -147.33 37.79 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 tt -50.14 -8.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.381 -1.07 . . . . 0.0 110.19 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 90' ' ' GLY . . . -60.5 142.27 47.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.79 -16.11 55.55 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.86 159.62 30.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.395 -1.062 . . . . 0.0 110.125 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.56 124.38 22.6 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -106.02 130.15 54.0 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.394 -0.817 . . . . 0.0 110.443 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.557 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.5 m-85 -114.18 134.33 54.98 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.561 -0.712 . . . . 0.0 109.611 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' OD1' ' C ' ' A' ' 98' ' ' ASP . 57.5 t0 -63.34 119.09 9.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.823 . . . . 0.0 109.608 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.411 ' O ' ' NH1' ' A' ' 65' ' ' ARG . 45.9 tt0 -101.13 -1.45 33.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.586 -0.696 . . . . 0.0 109.267 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -75.96 -19.83 58.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 109.895 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -101.82 156.6 17.41 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.476 ' NH2' ' NH2' ' A' ' 108' ' ' ARG . 44.4 ttp180 -87.23 125.13 34.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.051 -1.031 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.06 149.85 22.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 0.0 109.86 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.7 p -131.69 169.97 15.43 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.366 -0.833 . . . . 0.0 109.175 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.45 HD21 HD13 ' A' ' 25' ' ' LEU . 82.7 m-20 -111.63 23.93 13.34 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.428 -0.795 . . . . 0.0 110.039 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.703 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -146.99 -165.0 2.13 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.909 -1.12 . . . . 0.0 109.995 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.74 22.19 0.06 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.128 -0.982 . . . . 0.0 111.51 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.479 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.9 mtp180 -76.66 -163.65 0.35 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.646 -1.284 . . . . 0.0 110.059 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.6 mt-10 -25.2 -67.61 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -141.4 159.17 42.79 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.905 -1.122 . . . . 0.0 110.842 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 68.8 m-80 -107.45 110.93 23.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.03 -41.48 92.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 0.0 110.372 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -59.91 -46.92 87.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.295 -0.878 . . . . 0.0 110.922 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.33 -39.73 88.14 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.825 -1.172 . . . . 0.0 110.36 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.45 -40.21 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.989 -1.069 . . . . 0.0 108.407 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.63 -41.88 91.47 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.386 -0.822 . . . . 0.0 109.014 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.088 -1.008 . . . . 0.0 109.724 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.5 t-160 -68.22 -51.81 41.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 109.183 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.557 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 57.9 mt-10 -58.48 -40.97 84.19 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.557 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -63.4 -39.91 95.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.071 -1.018 . . . . 0.0 109.213 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.39 -38.66 93.74 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -64.21 -35.94 82.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -1.108 . . . . 0.0 108.698 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.5 m -69.55 -25.47 64.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 108.726 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.03 -0.68 56.14 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.31 13.6 70.6 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 120.115 -1.041 . . . . 0.0 110.842 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.6 128.96 34.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.671 -1.488 . . . . 0.0 108.919 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.14 170.96 11.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.607 -0.683 . . . . 0.0 109.703 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -67.95 156.36 37.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.862 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.4 t -124.97 165.04 18.85 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.45 -0.781 . . . . 0.0 109.512 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.1 p -102.04 0.89 35.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.456 -0.777 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -78.33 128.13 33.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.9 tt -58.71 -29.28 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.0 110.497 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.82 3.28 84.14 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.474 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.87 128.92 34.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.941 -1.329 . . . . 0.0 109.775 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.64 -31.79 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.453 -0.78 . . . . 0.0 109.146 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 36.4 mtp -74.42 47.76 0.31 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.99 130.92 91.14 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.0 108.948 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -45.63 -68.17 0.1 Allowed 'Trans proline' 0 N--CA 1.489 1.234 0 CA-C-N 119.99 1.032 . . . . 0.0 111.643 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.2 p -80.15 171.02 15.63 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.138 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -82.83 130.31 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.24 -0.913 . . . . 0.0 108.881 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 59.5 p -149.81 170.25 19.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.259 -0.9 . . . . 0.0 109.328 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -92.08 136.47 33.15 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.162 -0.962 . . . . 0.0 109.546 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.5 p -101.09 1.07 38.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.388 -0.82 . . . . 0.0 109.746 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.72 -42.78 1.32 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -152.45 149.79 28.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.079 -1.248 . . . . 0.0 109.165 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 25.4 t -86.57 100.24 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 109.645 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 97.6 mm-40 -148.45 150.9 34.29 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.3 mt -75.24 147.95 39.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.128 -0.983 . . . . 0.0 109.017 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.16 158.42 16.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 0.0 109.06 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -60.04 -40.42 89.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.735 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.409 ' C ' ' OD1' ' A' ' 151' ' ' ASP . 42.8 t0 -58.98 -40.2 84.1 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.545 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -74.27 -39.99 62.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 109.571 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.475 HG22 ' NE2' ' A' ' 157' ' ' GLN . 96.9 mt -63.42 -50.03 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.96 -39.95 96.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.91 21.61 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.771 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -60.06 -39.54 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.852 -1.381 . . . . 0.0 109.659 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 33.1 mt-30 -66.13 -37.53 85.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 108.972 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.51 -42.28 96.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 110.123 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.443 HD13 ' NH1' ' A' ' 8' ' ' ARG . 96.8 mt -62.27 -48.44 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 109.279 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -101.08 -67.79 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 109.39 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.98 -178.12 37.94 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -88.76 150.61 22.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.427 -1.043 . . . . 0.0 109.296 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.2 m -74.2 85.38 1.89 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.044 -1.035 . . . . 0.0 109.043 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -96.77 111.36 23.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.255 -0.903 . . . . 0.0 109.723 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -157.21 74.51 4.34 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.82 40.95 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.622 1.548 . . . . 0.0 112.404 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 167' ' ' VAL . 2.3 m -89.49 118.76 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 109.691 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -127.91 78.28 75.37 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 121.159 1.24 . . . . 0.0 112.135 179.693 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.637 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 91.1 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.082 0.468 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.66 141.35 51.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.069 -1.02 . . . . 0.0 109.431 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.9 p -99.27 -138.87 0.31 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.302 -0.874 . . . . 0.0 109.675 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.61 ' C ' ' H ' ' A' ' 6' ' ' ASN . 86.2 tt0 -69.4 154.73 41.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.605 -0.685 . . . . 0.0 109.167 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.09 19.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.471 0 O-C-N 121.338 -0.851 . . . . 0.0 111.087 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.61 ' H ' ' C ' ' A' ' 4' ' ' GLU . 25.2 m120 -149.42 69.84 9.65 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.671 -1.488 . . . . 0.0 109.411 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -61.15 149.96 86.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.23 1.287 . . . . 0.0 112.636 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -146.4 159.05 43.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.431 -0.793 . . . . 0.0 109.073 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -84.13 130.13 34.86 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.313 -0.867 . . . . 0.0 108.846 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.51 -32.96 62.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.959 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.53 HE21 HD23 ' A' ' 14' ' ' LEU . 15.0 pt20 -82.36 153.34 25.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.144 -0.972 . . . . 0.0 109.685 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -93.92 -4.09 50.49 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.228 -0.92 . . . . 0.0 108.669 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -108.33 130.63 55.19 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.53 HD23 HE21 ' A' ' 11' ' ' GLN . 82.3 mt -126.28 152.42 46.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.474 -0.766 . . . . 0.0 109.486 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 p -124.04 150.45 44.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.488 -0.758 . . . . 0.0 109.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -144.63 161.38 39.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 109.915 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -151.32 133.62 15.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.415 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.35 116.97 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.34 -39.34 92.27 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.422 -0.799 . . . . 0.0 110.727 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -159.82 147.39 16.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.655 -1.278 . . . . 0.0 110.508 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.15 134.19 41.54 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -71.45 145.83 90.87 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.793 -1.192 . . . . 0.0 108.572 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -65.27 -8.62 19.24 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 CA-C-N 119.391 0.818 . . . . 0.0 112.015 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -59.88 -39.91 86.9 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.591 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.9 mt -135.88 153.16 76.93 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.5 Cg_endo -66.26 -176.56 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 119.389 0.818 . . . . 0.0 111.001 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.0 -38.83 15.18 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.967 -1.083 . . . . 0.0 110.06 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.25 93.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.07 -1.019 . . . . 0.0 110.348 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.16 -39.14 72.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.821 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 26' ' ' PRO . 54.3 t -67.15 -39.51 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.411 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 44.3 t0 -59.71 -40.45 87.98 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.154 -1.019 . . . . 0.0 108.526 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -60.17 -45.46 93.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 109.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.35 92.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.214 -0.929 . . . . 0.0 109.205 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -71.82 -40.19 68.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.494 -0.754 . . . . 0.0 110.042 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.15 -39.64 78.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -61.89 -39.87 93.46 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.786 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.12 93.66 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.049 -1.032 . . . . 0.0 110.308 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -59.92 -39.02 84.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.005 -1.059 . . . . 0.0 108.779 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.492 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.71 -45.63 91.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.199 -0.938 . . . . 0.0 109.678 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 148' ' ' LEU . 94.2 m95 -74.69 -45.29 45.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.0 t -65.1 -37.41 87.41 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.352 -0.843 . . . . 0.0 110.822 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -60.34 -23.34 64.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 110.543 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.1 m -111.81 7.19 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.413 -0.804 . . . . 0.0 110.71 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.42 ' N ' ' OG ' ' A' ' 163' ' ' SER . 11.3 p -145.31 150.06 43.4 Favored Pre-proline 0 N--CA 1.502 2.152 0 O-C-N 121.109 -0.994 . . . . 0.0 109.101 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -72.11 9.51 1.1 Allowed 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.451 0.767 . . . . 0.0 111.684 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.12 150.0 42.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.307 -0.871 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.9 p -130.25 148.2 52.06 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 14' ' ' LEU . 97.3 m-85 -128.02 153.44 46.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.699 -0.625 . . . . 0.0 109.891 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.0 m -155.28 133.05 11.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.199 -0.938 . . . . 0.0 110.017 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -76.22 144.59 40.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.16 135.85 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.7 t -98.69 -4.38 33.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.517 -0.739 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -144.22 147.78 34.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.085 -1.009 . . . . 0.0 110.08 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.04 172.12 48.25 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -82.59 149.74 27.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -1.131 . . . . 0.0 109.331 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.44 152.26 24.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.55 -0.719 . . . . 0.0 109.102 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.1 -44.84 94.54 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.204 -0.935 . . . . 0.0 109.342 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.2 mt -114.05 112.21 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.755 0.788 . . . . 0.0 109.122 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 82.5 mtp -99.06 131.17 45.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 109.657 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.69 129.19 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 86.6 p -153.12 159.81 42.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.906 -1.121 . . . . 0.0 110.385 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -111.4 140.24 46.15 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.86 167.62 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.37 -0.831 . . . . 0.0 111.055 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -137.43 138.98 40.37 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.0 109.601 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.23 -139.82 10.7 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -73.39 129.04 37.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -1.004 . . . . 0.0 110.095 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.4 p-80 -133.0 60.83 1.69 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.256 -0.902 . . . . 0.0 109.619 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 57.66 47.26 16.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.601 -0.687 . . . . 0.0 109.469 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 93.3 m-20 -141.73 163.73 32.12 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.58 -0.7 . . . . 0.0 109.454 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -96.0 9.59 40.23 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.316 -0.865 . . . . 0.0 109.776 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -134.04 73.0 71.33 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.341 -0.849 . . . . 0.0 109.599 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -64.31 158.97 45.99 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.986 1.124 . . . . 0.0 112.143 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -78.79 152.03 31.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -110.36 67.88 0.65 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.525 -0.735 . . . . 0.0 109.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.85 -170.99 31.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.27 -16.78 23.53 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.323 1.349 . . . . 0.0 112.701 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.32 -175.25 46.27 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.16 -150.54 27.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.565 ' CG ' HG12 ' A' ' 173' ' ' CGS . 88.0 m-20 -77.27 144.17 38.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.432 -1.04 . . . . 0.0 109.485 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -90.76 -18.33 25.15 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.954 -1.091 . . . . 0.0 109.067 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.16 166.06 9.04 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.352 -0.842 . . . . 0.0 108.83 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 83' ' ' HIS . 2.8 p80 -162.5 114.99 1.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.962 -1.086 . . . . 0.0 110.346 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.61 173.46 9.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -109.23 160.8 15.82 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -58.11 148.33 61.84 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.021 -1.049 . . . . 0.0 109.242 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -60.61 103.66 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 120.773 0.982 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -169.01 169.57 41.94 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.67 -173.32 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.141 1.227 . . . . 0.0 112.81 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.43 -126.41 42.37 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.2 tt -82.44 -8.43 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.403 -1.057 . . . . 0.0 110.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.1 138.76 48.59 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.38 -13.63 63.23 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.198 -1.177 . . . . 0.0 110.689 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.94 130.15 41.96 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.962 -1.317 . . . . 0.0 110.491 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.89 116.15 31.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.497 -0.752 . . . . 0.0 109.165 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 m170 -100.86 132.71 46.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.072 -1.017 . . . . 0.0 109.834 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -119.51 131.26 55.53 Favored 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.392 -0.818 . . . . 0.0 109.902 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -65.6 127.27 31.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.395 -0.815 . . . . 0.0 109.792 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.64 3.98 42.93 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.104 -0.997 . . . . 0.0 109.97 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -74.38 -20.04 60.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.022 -1.049 . . . . 0.0 109.334 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -101.91 157.36 16.91 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 0.0 108.804 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -86.35 125.77 33.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 108.625 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -91.11 140.35 29.9 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 76.1 p -129.23 163.27 25.98 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -108.66 31.31 5.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.572 -0.705 . . . . 0.0 109.466 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -148.55 -164.99 2.15 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.272 -0.893 . . . . 0.0 109.855 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.54 28.26 0.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.47 -0.769 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -76.56 -163.56 0.34 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -43.63 -60.97 1.54 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 111.909 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.407 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.2 m-85 -125.73 135.49 52.13 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.617 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -103.1 117.16 33.94 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.98 -41.7 96.96 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.844 -1.16 . . . . 0.0 109.76 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -60.43 -49.58 77.0 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.728 -0.608 . . . . 0.0 112.458 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -59.73 -42.91 94.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.232 -1.542 . . . . 0.0 110.453 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.5 t -70.29 -39.79 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.094 -1.004 . . . . 0.0 109.426 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.92 86.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.345 -0.847 . . . . 0.0 109.089 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.44 90.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.237 -0.914 . . . . 0.0 110.026 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.588 ' ND1' ' SD ' ' A' ' 136' ' ' MET . 3.2 t60 -68.13 -42.45 80.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.907 -1.12 . . . . 0.0 110.223 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -57.71 -40.13 78.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.779 -1.201 . . . . 0.0 109.329 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.69 -39.92 90.27 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.994 -1.066 . . . . 0.0 109.177 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.28 -38.21 77.1 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -66.61 -34.76 78.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.082 -1.246 . . . . 0.0 109.305 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.1 p -70.21 -23.97 63.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.907 -1.12 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -81.96 -5.63 58.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 108.771 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.96 58.16 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -82.03 131.47 35.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.117 -1.226 . . . . 0.0 108.707 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.7 m -87.18 169.86 11.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.091 -1.005 . . . . 0.0 109.511 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -68.52 161.73 27.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.513 -0.742 . . . . 0.0 109.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.5 t -126.96 166.16 18.05 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -102.31 11.33 38.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 51.9 t0 -83.1 130.33 35.11 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 109.882 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.75 -39.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.395 -0.816 . . . . 0.0 109.722 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.23 0.63 73.46 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.998 -1.096 . . . . 0.0 111.367 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -83.98 132.52 34.74 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.548 . . . . 0.0 109.222 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.14 -24.13 64.05 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.588 ' SD ' ' ND1' ' A' ' 118' ' ' HIS . 59.5 mmm -72.44 48.84 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.767 -0.583 . . . . 0.0 110.153 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 139' ' ' SER . 13.7 t80 -71.39 137.16 83.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.861 -1.149 . . . . 0.0 109.198 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -68.63 18.81 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 CA-C-N 120.037 1.049 . . . . 0.0 111.844 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 137' ' ' TYR . 22.2 t -166.5 176.67 7.19 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.531 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 66.9 t80 -83.53 117.82 23.38 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.644 -1.285 . . . . 0.0 110.436 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.6 p -150.21 176.52 10.78 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.49 154.28 42.75 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 8.2 m -129.8 -24.39 2.7 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.48 -0.763 . . . . 0.0 109.309 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 166.61 -124.83 1.26 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -80.35 169.98 17.0 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -1.068 . . . . 0.0 109.163 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.76 103.75 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.023 -1.048 . . . . 0.0 109.261 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -142.46 150.49 40.61 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.289 -0.882 . . . . 0.0 108.653 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 41' ' ' TRP . 97.1 mt -73.49 145.43 45.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.166 -0.959 . . . . 0.0 109.058 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.17 156.8 17.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.348 -0.845 . . . . 0.0 109.449 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.94 -39.9 87.12 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -59.24 -40.4 85.81 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.461 -0.775 . . . . 0.0 109.255 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.63 -41.14 65.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.412 HG22 ' NE2' ' A' ' 157' ' ' GLN . 93.1 mt -63.53 -46.48 94.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.192 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -61.54 -40.22 93.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.89 -1.131 . . . . 0.0 110.431 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.64 -58.19 15.11 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.731 -178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.2 tp -63.91 -41.29 92.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.114 -1.227 . . . . 0.0 110.344 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.33 -40.32 89.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.823 -1.173 . . . . 0.0 110.386 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.42 93.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.956 -1.09 . . . . 0.0 109.65 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -50.31 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.144 -0.972 . . . . 0.0 108.969 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.98 -74.02 0.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 109.196 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.99 -176.07 35.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.42 ' HG2' HH11 ' A' ' 162' ' ' ARG . 57.6 mtt-85 -83.86 151.94 24.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.063 . . . . 0.0 109.441 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 45' ' ' THR . 5.8 m -73.35 82.51 1.41 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.281 -0.887 . . . . 0.0 109.458 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -99.53 125.85 45.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.433 -0.792 . . . . 0.0 110.124 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -152.36 143.47 15.81 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.171 -0.955 . . . . 0.0 108.88 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.77 108.42 2.09 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 CA-C-N 119.624 0.902 . . . . 0.0 111.655 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 p -88.95 134.38 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.335 -0.853 . . . . 0.0 109.942 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -71.23 148.81 94.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 108.682 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 N--CA 1.488 1.152 0 C-N-CA 120.699 0.933 . . . . 0.0 112.03 179.338 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.565 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.28 -40.09 92.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.144 -0.973 . . . . 0.0 109.59 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.5 p -91.62 152.65 20.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.632 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -73.42 142.94 46.92 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 109.548 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.91 -161.78 35.06 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.96 137.29 53.74 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.884 -1.363 . . . . 0.0 108.565 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -67.8 -178.45 1.63 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 CA-C-N 119.694 0.927 . . . . 0.0 111.676 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.62 160.83 39.36 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 87' ' ' PRO . 99.0 m95 -84.79 114.46 22.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.854 -1.154 . . . . 0.0 109.094 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.57 -9.87 48.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.915 . . . . 0.0 109.505 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -80.94 150.76 28.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.35 -0.844 . . . . 0.0 109.757 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.6 p -96.6 -5.05 40.0 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 0.0 109.173 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -123.97 131.74 53.61 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.6 mt -132.88 149.73 52.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.7 p -125.29 154.65 41.4 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.302 -0.874 . . . . 0.0 109.446 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -142.89 159.53 42.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 109.311 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 17' ' ' ARG . 37.7 ttt-85 -148.8 134.04 18.37 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.279 -0.888 . . . . 0.0 109.468 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -89.79 123.26 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.22 -0.925 . . . . 0.0 108.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -67.36 -41.57 84.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.043 . . . . 0.0 110.515 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -162.28 151.04 15.07 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.858 -1.151 . . . . 0.0 110.23 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -96.94 138.4 34.54 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.365 -0.834 . . . . 0.0 109.293 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.8 t -72.85 144.18 85.25 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.033 -1.042 . . . . 0.0 109.285 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -65.45 -12.02 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.614 0.876 . . . . 0.0 112.018 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.15 -40.34 89.52 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.077 -1.014 . . . . 0.0 110.196 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 53.0 mt -135.73 151.24 73.87 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -65.58 -177.51 0.72 Allowed 'Trans proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.468 0.846 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -85.85 -35.51 20.57 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.8 -43.23 90.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.972 -1.08 . . . . 0.0 109.73 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.43 -39.58 77.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.378 -0.826 . . . . 0.0 110.401 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -60.0 -40.0 87.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.824 -1.172 . . . . 0.0 109.422 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.48 -46.45 90.04 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.652 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.61 95.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.155 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.95 -40.17 76.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.717 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -69.83 -40.3 75.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.045 -1.034 . . . . 0.0 109.974 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -61.0 -40.87 95.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 109.777 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.69 -46.98 87.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.962 -1.086 . . . . 0.0 109.259 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 30.4 m-85 -60.0 -40.6 89.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.856 -1.152 . . . . 0.0 109.496 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -59.95 -40.47 89.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.093 -1.005 . . . . 0.0 110.363 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.0 -45.14 93.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.015 -1.053 . . . . 0.0 110.039 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -71.75 -39.89 69.71 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.462 -0.774 . . . . 0.0 109.502 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 t -68.58 -30.63 69.43 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -0.85 . . . . 0.0 109.766 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -59.81 -37.51 79.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 110.605 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -106.96 10.31 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.217 -0.927 . . . . 0.0 110.874 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -138.33 149.32 62.76 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.03 -1.044 . . . . 0.0 108.597 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.41 7.3 2.68 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-N 119.335 0.798 . . . . 0.0 110.529 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.4 157.88 36.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.701 -0.624 . . . . 0.0 109.753 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -137.4 151.99 49.15 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.0 m-85 -130.78 155.87 45.94 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.322 -0.861 . . . . 0.0 110.412 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.3 m -154.33 132.75 11.98 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -81.64 137.02 35.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.324 -0.86 . . . . 0.0 110.032 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.26 132.09 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.7 t -94.7 0.94 55.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.045 -1.034 . . . . 0.0 109.594 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -144.3 157.71 44.12 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.22 -0.925 . . . . 0.0 109.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.76 167.31 8.78 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.03 160.38 25.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.264 . . . . 0.0 108.705 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.7 158.6 27.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.524 -0.735 . . . . 0.0 109.147 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.35 -39.65 83.9 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.298 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.23 120.0 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.555 -0.716 . . . . 0.0 109.53 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.0 mtp -101.12 135.93 41.79 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.192 -0.942 . . . . 0.0 109.419 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.84 126.94 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.2 p -148.03 155.19 41.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -105.65 139.03 40.86 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.22 163.09 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.503 -0.748 . . . . 0.0 110.773 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HG2' ' NH1' ' A' ' 65' ' ' ARG . 61.4 mtt-85 -131.25 132.69 44.79 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.378 0.609 . . . . 0.0 110.023 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.3 -135.97 7.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -71.54 125.92 28.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 109.8 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 7.3 p-80 -134.03 49.77 2.24 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.325 -0.859 . . . . 0.0 109.67 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 69' ' ' ARG . 52.8 mtt-85 58.41 53.09 6.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.643 -0.66 . . . . 0.0 111.109 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.536 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 88.4 m-20 -139.35 163.29 32.88 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.358 -0.838 . . . . 0.0 108.898 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -90.06 9.3 28.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.935 . . . . 0.0 109.137 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.6 m -139.67 71.61 36.86 Favored Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.349 -0.844 . . . . 0.0 109.689 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.91 159.27 41.86 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.154 1.236 . . . . 0.0 112.142 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -76.64 147.21 37.68 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.616 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -102.94 62.33 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.482 -0.761 . . . . 0.0 109.117 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.73 -166.01 53.4 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -54.19 -22.36 25.59 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.304 1.336 . . . . 0.0 112.636 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.0 177.79 48.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.03 -165.18 26.56 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.71 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -75.07 150.41 38.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.288 -1.125 . . . . 0.0 109.94 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.2 mt -91.45 -13.26 32.58 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.57 167.33 9.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.046 -1.034 . . . . 0.0 109.893 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.98 179.91 7.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 109.638 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -166.38 169.33 14.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -98.04 156.88 16.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.481 -0.762 . . . . 0.0 108.99 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -58.48 149.65 59.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.146 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.411 ' HB3' ' NE1' ' A' ' 9' ' ' TRP . 7.5 Cg_endo -58.69 103.12 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.146 0 C-N-CA 120.428 0.752 . . . . 0.0 111.792 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.29 172.88 37.62 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -70.22 177.32 6.02 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.321 1.347 . . . . 0.0 111.673 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.54 -125.35 31.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.5 tt -79.27 -9.54 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.173 -1.193 . . . . 0.0 110.041 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.65 135.94 47.03 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.1 -16.83 59.58 Favored Glycine 0 N--CA 1.497 2.712 0 O-C-N 121.491 -1.005 . . . . 0.0 110.709 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.64 121.76 15.24 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.913 -1.345 . . . . 0.0 110.636 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.17 131.81 45.9 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -112.74 135.0 53.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.501 -0.749 . . . . 0.0 109.294 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.525 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 38.8 m-85 -114.73 130.97 56.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.374 -0.829 . . . . 0.0 110.087 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' OD2' ' OE2' ' A' ' 101' ' ' GLU . 62.4 t0 -69.32 122.59 19.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -99.57 4.47 45.86 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.027 -1.046 . . . . 0.0 109.408 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -73.5 -15.28 61.32 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.713 -1.242 . . . . 0.0 109.128 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 56.4 mp0 -102.64 152.66 20.93 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -85.71 119.4 26.0 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.93 -1.106 . . . . 0.0 108.777 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -85.53 150.28 24.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 0.0 110.322 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 34.4 p -129.82 163.09 27.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -113.9 34.86 4.37 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.483 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -150.18 -165.02 2.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.357 -0.839 . . . . 0.0 109.99 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.25 31.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.305 -0.872 . . . . 0.0 109.764 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.473 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 11.9 mmt-85 -76.82 -165.09 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.101 -0.999 . . . . 0.0 110.019 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.0 -58.25 9.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.531 -0.731 . . . . 0.0 112.203 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -101.12 121.85 42.54 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.052 -1.03 . . . . 0.0 110.984 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 9.3 m120 -108.69 110.95 22.49 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.9 tp -61.77 -44.67 96.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.11 -0.994 . . . . 0.0 111.122 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -59.94 -40.07 87.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.081 . . . . 0.0 110.713 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.693 ' NH1' HOM2 ' A' ' 173' ' ' CGS . 43.9 ttt-85 -59.17 -46.68 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 109.738 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.516 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 72.1 t -70.12 -40.4 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.165 -0.96 . . . . 0.0 109.535 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.08 91.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.955 -1.091 . . . . 0.0 109.575 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.13 95.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.421 -0.8 . . . . 0.0 109.813 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.439 ' HD1' ' HA ' ' A' ' 136' ' ' MET . 48.6 t60 -69.77 -40.79 75.86 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 110.124 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 76.6 mt-10 -60.16 -40.14 88.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.812 -1.18 . . . . 0.0 109.075 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.19 -39.97 88.38 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.65 -42.4 67.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -63.24 -39.33 94.32 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.241 -1.152 . . . . 0.0 108.549 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.8 p -70.14 -22.93 62.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.232 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.22 -2.63 58.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.144 -0.973 . . . . 0.0 109.385 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.57 14.41 73.52 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.0 mt -81.22 131.42 35.29 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.03 -1.276 . . . . 0.0 108.804 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.0 m -88.1 170.56 10.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 109.03 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -66.07 158.66 27.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.098 -1.001 . . . . 0.0 108.705 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.6 t -129.88 158.72 38.72 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.42 -0.8 . . . . 0.0 109.224 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.8 p -102.94 13.83 33.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -84.13 130.91 34.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.04 -42.91 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 110.72 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.66 0.32 65.57 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.235 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.69 139.2 32.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.676 -1.485 . . . . 0.0 108.928 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.74 -27.61 66.07 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 108.895 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.439 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 28.7 mtp -75.75 60.86 1.34 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.449 -0.782 . . . . 0.0 109.489 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.7 t80 -68.31 137.49 91.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -57.46 5.19 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 CA-C-N 119.985 1.03 . . . . 0.0 112.1 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 137' ' ' TYR . 57.6 p -158.78 173.75 16.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.965 -1.084 . . . . 0.0 109.501 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -85.9 134.8 33.87 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 67.4 p -151.05 170.26 19.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.398 -0.814 . . . . 0.0 109.093 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.513 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 37.9 p90 -96.87 123.17 40.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.8 m -107.04 147.43 29.96 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.327 -0.858 . . . . 0.0 109.747 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.88 -89.07 0.13 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -88.43 135.3 33.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.11 -1.229 . . . . 0.0 108.984 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 t -88.23 104.29 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.851 -1.156 . . . . 0.0 109.436 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -141.29 150.28 42.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.17 -0.956 . . . . 0.0 109.61 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 79.2 mt -73.7 139.66 45.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 0.0 109.066 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 168.88 10.82 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.313 -0.867 . . . . 0.0 110.172 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.99 -40.7 90.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.293 -0.879 . . . . 0.0 109.581 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -59.53 -40.44 87.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.505 -0.747 . . . . 0.0 109.748 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -75.24 -42.56 55.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.026 -1.046 . . . . 0.0 109.263 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 91.0 mt -64.79 -50.63 74.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 109.451 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -61.22 -39.37 90.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.844 -1.16 . . . . 0.0 110.02 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.38 -56.37 20.3 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.72 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.5 tp -64.38 -40.85 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -1.203 . . . . 0.0 109.88 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.8 mt-30 -65.22 -39.09 92.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.029 -1.044 . . . . 0.0 110.108 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.41 88.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.81 -1.182 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.37 -49.34 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.044 -1.035 . . . . 0.0 109.527 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -97.28 -67.6 0.84 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.474 -0.766 . . . . 0.0 109.833 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.87 179.66 39.0 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -91.72 134.29 34.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -1.115 . . . . 0.0 109.421 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.5 m -76.73 80.79 3.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.431 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -99.08 79.61 2.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.354 -0.842 . . . . 0.0 109.964 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.775 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 3.7 m-80 -157.91 -37.03 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.169 0 O-C-N 121.034 -1.041 . . . . 0.0 111.924 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.775 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 17.2 Cg_endo -86.42 79.07 1.93 Allowed 'Trans proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.322 1.151 . . . . 0.0 112.682 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 167' ' ' VAL . 17.4 m -87.72 119.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.82 -1.175 . . . . 0.0 108.766 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -71.21 150.63 94.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.048 -1.032 . . . . 0.0 110.114 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 CA-C-O 117.932 -0.945 . . . . 0.0 112.128 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.693 HOM2 ' NH1' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.363 0.601 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 52.8 tp -69.36 137.73 53.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.4 p -89.8 166.02 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.323 -0.86 . . . . 0.0 109.315 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -75.09 131.74 40.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.021 -1.049 . . . . 0.0 109.024 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.96 -174.53 54.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -82.98 147.28 53.94 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 108.558 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -63.9 118.63 5.56 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 120.643 0.895 . . . . 0.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -144.94 156.96 44.27 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.231 -0.918 . . . . 0.0 109.292 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -84.87 124.11 31.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.38 -0.825 . . . . 0.0 109.6 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -87.55 -6.78 58.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -80.82 150.44 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.243 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.6 p -95.09 -6.29 42.35 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.427 -0.795 . . . . 0.0 109.267 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -130.03 139.8 50.95 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.4 mt -132.8 157.98 43.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.535 -0.728 . . . . 0.0 109.332 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -127.99 153.56 46.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 108.707 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -142.94 158.42 43.63 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.225 -0.922 . . . . 0.0 109.922 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -146.99 134.61 21.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.396 -0.815 . . . . 0.0 110.014 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 90.1 mt -87.86 112.35 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.447 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 88.2 tt0 -63.63 -39.82 95.32 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 0.0 110.392 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 83.1 m-20 -155.29 142.45 19.31 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.949 -1.094 . . . . 0.0 110.479 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.01 137.06 32.67 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -69.34 136.99 88.79 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -66.83 -9.37 24.46 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 CA-C-N 119.691 0.925 . . . . 0.0 110.909 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.28 -40.11 89.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.762 -0.586 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.0 mt -136.24 149.87 69.23 Favored Pre-proline 0 N--CA 1.501 2.098 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.68 -178.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.487 1.107 0 CA-C-N 119.353 0.805 . . . . 0.0 111.443 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.38 -31.69 18.74 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.71 87.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.895 . . . . 0.0 109.22 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.92 -40.01 65.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.792 . . . . 0.0 110.7 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -71.05 -44.32 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.854 -1.154 . . . . 0.0 109.811 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -58.58 -44.8 89.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.298 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -59.64 -41.94 91.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.047 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.2 82.06 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.875 -1.14 . . . . 0.0 109.729 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mm -70.1 -39.26 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -0.936 . . . . 0.0 109.684 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.14 -39.68 93.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.067 -1.021 . . . . 0.0 109.432 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -63.3 -40.04 96.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.738 -1.226 . . . . 0.0 110.695 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.08 -50.89 71.43 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.691 -1.255 . . . . 0.0 109.45 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 37.8 m-85 -60.31 -43.96 95.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -0.935 . . . . 0.0 109.547 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -60.04 -42.76 95.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.089 -1.007 . . . . 0.0 110.232 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.93 -40.29 88.39 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.839 -1.163 . . . . 0.0 110.327 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -74.42 -40.21 62.13 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.479 -1.388 . . . . 0.0 109.28 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -67.56 -27.24 66.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.587 -0.696 . . . . 0.0 110.061 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.07 -38.85 84.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 111.252 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG23 ' A' ' 45' ' ' THR . 22.9 m -109.84 13.46 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 121.22 -0.925 . . . . 0.0 110.77 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.561 HG23 HG23 ' A' ' 44' ' ' VAL . 72.1 p -141.34 148.42 50.88 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.2 -0.938 . . . . 0.0 108.879 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.06 6.17 2.27 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 CA-C-N 119.573 0.883 . . . . 0.0 111.982 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.28 151.72 42.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.951 . . . . 0.0 110.159 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.0 p -131.75 149.19 52.55 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 96.7 m-85 -129.21 156.04 44.58 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.274 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.8 m -154.66 128.83 8.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.368 -0.832 . . . . 0.0 109.669 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -78.53 139.3 38.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.36 136.82 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.3 t -97.81 -2.92 39.9 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.051 -1.03 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -145.61 155.28 42.93 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.815 -1.178 . . . . 0.0 109.528 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.58 173.46 44.91 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -80.0 158.7 26.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.149 -1.207 . . . . 0.0 109.391 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -123.02 152.22 41.15 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.46 -0.775 . . . . 0.0 109.134 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -60.03 -40.6 89.89 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -119.83 119.04 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.0 mtp -101.28 127.66 47.79 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.858 . . . . 0.0 109.646 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -109.88 131.13 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.415 -0.803 . . . . 0.0 109.251 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.6 p -146.86 160.0 42.84 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.849 0.833 . . . . 0.0 110.091 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.26 139.28 47.93 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.26 167.25 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -139.3 144.78 38.48 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 0.0 110.248 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.85 -149.6 2.29 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -71.77 128.83 37.05 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.277 -1.131 . . . . 0.0 109.565 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 11.3 p-80 -130.83 60.19 1.65 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.555 -0.716 . . . . 0.0 109.379 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 53.36 54.67 9.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.944 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.7 p-10 -142.77 169.44 17.56 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.157 -0.964 . . . . 0.0 109.35 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -95.86 9.04 41.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.319 -0.863 . . . . 0.0 109.236 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.0 m -137.17 70.97 55.28 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 0.0 109.579 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.24 145.69 73.21 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 120.716 0.944 . . . . 0.0 111.496 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -74.74 144.7 43.52 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 72.67 0.84 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.02 -166.71 54.51 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -66.81 -10.14 27.19 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.186 1.257 . . . . 0.0 111.72 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.6 170.22 26.6 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.04 -151.11 19.84 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.589 ' CG ' HG12 ' A' ' 173' ' ' CGS . 98.0 m-20 -73.58 142.58 46.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -1.081 . . . . 0.0 109.64 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.89 -16.23 26.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.072 -1.017 . . . . 0.0 109.23 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.62 171.48 4.51 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -163.27 121.12 1.93 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.802 -1.186 . . . . 0.0 109.76 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.53 162.02 21.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.723 -0.611 . . . . 0.0 109.854 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -107.76 146.64 31.9 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -59.78 146.05 82.22 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.948 -1.095 . . . . 0.0 108.616 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -56.65 125.75 20.04 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 CA-C-N 119.849 0.982 . . . . 0.0 112.122 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.27 174.51 44.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.96 -177.55 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.115 1.21 . . . . 0.0 112.093 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.32 -128.88 48.52 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -78.91 -4.14 6.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.43 -1.041 . . . . 0.0 109.838 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.99 132.45 50.81 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.1 52.12 Favored Glycine 0 N--CA 1.498 2.775 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -68.75 160.02 31.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.0 122.28 21.63 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.403 -0.811 . . . . 0.0 109.132 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -99.12 136.21 39.41 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.409 -0.807 . . . . 0.0 110.867 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.8 m-85 -116.16 131.41 56.95 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -68.43 121.83 17.15 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.077 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -100.15 -0.46 38.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.155 -0.965 . . . . 0.0 109.868 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -72.93 -15.67 61.57 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.962 -1.086 . . . . 0.0 109.877 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -103.27 159.96 15.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.38 -0.825 . . . . 0.0 108.871 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.409 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.3 ttp180 -89.25 122.23 32.31 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.085 -1.009 . . . . 0.0 109.596 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -89.22 151.7 22.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.382 -0.824 . . . . 0.0 110.106 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 59.1 p -125.95 160.32 30.29 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.507 -0.746 . . . . 0.0 109.56 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -108.99 29.27 7.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.533 -0.729 . . . . 0.0 109.987 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' ND2' ' CG ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -148.67 -165.02 2.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.04 . . . . 0.0 109.486 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -81.04 30.81 0.32 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.189 -0.945 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.492 ' CG ' ' ND2' ' A' ' 106' ' ' ASN . 17.0 mmm180 -75.65 -175.06 2.75 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.033 -1.042 . . . . 0.0 109.228 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.607 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 55.5 mp0 -47.4 -59.77 2.98 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.828 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 104' ' ' THR . 79.7 m-85 -83.62 152.5 24.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.86 -1.15 . . . . 0.0 110.92 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -140.89 90.24 2.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.99 -46.44 89.44 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.233 -0.917 . . . . 0.0 110.139 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -60.07 -45.77 91.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.995 -1.066 . . . . 0.0 109.985 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.427 ' HG2' HOM1 ' A' ' 173' ' ' CGS . 45.8 ttp180 -59.4 -40.31 86.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.009 -1.057 . . . . 0.0 108.798 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.633 HG22 HOM3 ' A' ' 173' ' ' CGS . 53.6 t -70.03 -40.0 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.262 -0.899 . . . . 0.0 109.319 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.84 -40.56 84.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.953 -1.092 . . . . 0.0 109.144 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.63 96.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.95 -1.094 . . . . 0.0 109.085 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.7 t-160 -68.69 -50.33 51.84 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.5 mt-10 -57.49 -41.96 81.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.877 -1.139 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.86 -37.88 88.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.896 -1.127 . . . . 0.0 109.22 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.84 -43.59 92.28 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -64.79 -37.33 87.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.266 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -69.92 -22.68 63.17 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.48 -1.91 57.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.16 59.82 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.25 132.16 35.06 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.886 -1.361 . . . . 0.0 109.762 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.3 m -87.54 163.8 16.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.457 -0.777 . . . . 0.0 110.169 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -65.81 157.94 29.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -0.859 . . . . 0.0 109.633 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 t -130.3 167.44 18.5 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.8 p -106.6 10.63 31.07 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.744 . . . . 0.0 109.148 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.67 120.12 24.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 17.6 tt -58.87 -28.81 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.376 -0.828 . . . . 0.0 110.798 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.56 -6.89 88.81 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.699 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.11 133.15 34.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.271 . . . . 0.0 109.868 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.72 -24.65 67.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.366 -0.834 . . . . 0.0 109.576 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 84.2 mmm -74.71 56.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.168 -0.958 . . . . 0.0 109.33 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.5 t80 -70.11 137.42 87.02 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 108.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.33 7.23 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.651 0 CA-C-N 120.098 1.071 . . . . 0.0 112.743 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 137' ' ' TYR . 80.5 p -161.67 169.69 21.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.571 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 109' ' ' GLU . 49.3 t80 -87.13 133.12 33.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.216 -0.927 . . . . 0.0 109.788 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.7 p -145.82 145.74 30.89 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -66.18 -28.11 68.52 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.017 -1.052 . . . . 0.0 109.55 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.6 m -77.06 142.12 39.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.168 -0.958 . . . . 0.0 109.811 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.22 113.79 1.09 Allowed Glycine 0 N--CA 1.499 2.855 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 60.4 t0 -85.08 156.19 21.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -1.189 . . . . 0.0 109.108 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.565 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 93.7 t -84.41 83.41 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.912 -1.117 . . . . 0.0 109.713 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -148.93 147.22 28.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.114 -0.991 . . . . 0.0 109.01 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 82.0 mt -78.55 133.85 37.31 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.14 166.33 13.03 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -60.78 -40.03 91.05 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.69 -40.49 88.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.4 -0.813 . . . . 0.0 109.056 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -74.29 -42.24 59.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.78 -49.15 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.126 -0.984 . . . . 0.0 109.314 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.27 -40.3 89.88 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 110.452 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.05 -55.73 28.66 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.107 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.0 tp -65.9 -39.18 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.237 . . . . 0.0 109.797 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.8 mt-30 -66.99 -39.35 87.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.0 . . . . 0.0 109.256 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.76 93.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.995 -1.065 . . . . 0.0 109.721 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.6 mt -63.06 -47.87 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.925 -1.109 . . . . 0.0 110.348 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -101.23 -61.26 1.39 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.401 -0.812 . . . . 0.0 109.899 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.85 179.61 35.71 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -92.66 145.12 24.66 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -1.162 . . . . 0.0 109.683 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m -73.05 88.74 1.42 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -92.17 103.0 15.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 109.821 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -152.36 155.94 33.3 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.286 -0.884 . . . . 0.0 109.119 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -78.29 72.02 6.47 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 120.699 0.933 . . . . 0.0 111.111 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -85.76 133.91 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.423 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -69.79 148.06 96.41 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 108.946 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 C-N-CA 120.763 0.975 . . . . 0.0 112.118 179.601 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.633 HOM3 HG22 ' A' ' 115' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 2' ' ' LEU . 7.6 p . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.602 ' N ' HG13 ' A' ' 1' ' ' VAL . 33.4 tp -90.09 -3.86 57.68 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.175 -0.953 . . . . 0.0 109.147 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -85.66 127.14 34.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.79 -1.193 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -75.61 139.39 42.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.659 -0.651 . . . . 0.0 109.518 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.83 -60.09 0.47 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -153.46 72.34 6.8 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.166 -1.196 . . . . 0.0 109.945 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.87 106.78 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.918 1.079 . . . . 0.0 112.313 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -87.61 161.34 17.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.036 -1.04 . . . . 0.0 109.065 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -84.15 128.0 34.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.961 -1.087 . . . . 0.0 109.519 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -81.61 -9.14 59.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 0.0 110.003 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -83.17 148.91 27.18 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.137 -0.977 . . . . 0.0 109.98 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.3 p -98.21 -5.71 32.78 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.502 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 68.2 m80 -127.72 122.51 33.08 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -109.87 153.98 23.7 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.176 -0.952 . . . . 0.0 109.889 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.9 p -130.93 157.46 42.89 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -144.26 162.52 36.17 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -144.42 124.53 13.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.238 -0.914 . . . . 0.0 110.055 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 93.1 mt -86.77 113.59 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 77.3 tt0 -62.68 -41.15 98.94 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.24 -0.913 . . . . 0.0 109.527 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 81.8 m-20 -159.95 154.73 24.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -95.9 142.4 28.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -70.05 138.57 87.42 Favored Pre-proline 0 C--N 1.301 -1.508 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.174 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -66.28 -13.07 38.29 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.739 0.959 . . . . 0.0 111.37 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.59 -40.42 91.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.415 HD22 ' ND2' ' A' ' 105' ' ' ASN . 26.3 mt -136.0 149.39 68.31 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.65 -178.72 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 CA-C-N 119.209 0.753 . . . . 0.0 112.038 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 27' ' ' ARG . 21.8 ptt-85 -86.04 -32.12 21.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.303 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.04 86.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.112 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -69.17 -38.96 78.97 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.181 -0.949 . . . . 0.0 109.825 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.76 -39.99 80.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.259 -0.9 . . . . 0.0 109.644 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -58.87 -40.53 84.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.194 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -60.27 -48.8 80.18 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.107 -0.996 . . . . 0.0 109.141 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.69 84.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.581 -0.699 . . . . 0.0 109.949 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.6 mm -69.93 -40.6 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.171 -0.955 . . . . 0.0 109.851 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -69.89 -39.44 76.26 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 108.985 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -62.19 -39.81 93.95 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.183 -0.948 . . . . 0.0 110.158 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.51 -45.39 90.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 109.736 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -60.9 -40.45 93.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.823 -1.173 . . . . 0.0 109.073 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.12 -41.45 92.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.13 -45.82 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.403 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -74.09 -42.83 59.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 t -63.55 -37.96 89.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.345 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -60.16 -23.57 64.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.552 -0.718 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.54 7.63 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.957 -1.09 . . . . 0.0 110.457 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 p -145.67 151.95 47.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -72.12 4.2 3.45 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.821 1.014 . . . . 0.0 112.097 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -70.21 152.0 44.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.043 . . . . 0.0 109.775 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 44.9 p -127.08 150.13 49.61 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -125.03 158.29 34.1 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 110.489 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.0 m -153.89 127.91 8.96 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.967 0.889 . . . . 0.0 110.291 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -83.76 140.74 31.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.674 -0.641 . . . . 0.0 109.681 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.7 141.88 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.33 -0.856 . . . . 0.0 108.828 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.1 t -95.02 -6.99 40.99 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.179 -0.951 . . . . 0.0 110.69 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -149.5 155.33 40.2 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.919 -1.113 . . . . 0.0 109.545 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.37 160.6 33.25 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -80.68 130.96 35.39 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.289 -1.124 . . . . 0.0 109.501 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.7 170.02 9.75 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.089 -1.007 . . . . 0.0 109.79 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.08 -40.08 88.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.33 -0.856 . . . . 0.0 109.712 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.92 120.42 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.517 -0.739 . . . . 0.0 109.35 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 99.4 mmm -98.77 129.61 45.2 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.349 -0.844 . . . . 0.0 109.498 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.7 mt -112.42 130.32 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.2 p -147.19 156.88 43.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.995 -1.065 . . . . 0.0 110.226 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -110.0 133.15 53.49 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.62 160.09 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 O-C-N 121.006 -1.059 . . . . 0.0 111.395 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -124.73 138.32 54.29 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.444 0.64 . . . . 0.0 109.849 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 47.2 -146.2 4.12 Favored Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -70.86 130.86 42.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.421 -1.046 . . . . 0.0 109.792 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.501 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -131.25 43.54 3.07 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 55.69 58.18 4.7 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.685 . . . . 0.0 110.139 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.501 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 17.7 p-10 -141.17 171.58 13.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 0.0 109.126 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -91.25 10.65 26.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.123 -0.986 . . . . 0.0 109.73 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 t -141.0 71.67 28.35 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.103 -0.998 . . . . 0.0 109.903 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.37 141.98 32.69 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.108 1.206 . . . . 0.0 112.12 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -77.5 153.79 33.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.604 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -117.83 75.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.93 -164.55 17.2 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -55.86 -17.99 20.39 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 120.796 0.998 . . . . 0.0 111.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.29 -179.02 49.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.1 -164.87 35.54 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.528 ' HB3' HG12 ' A' ' 173' ' ' CGS . 43.5 p-10 -74.77 155.79 37.25 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.132 -1.216 . . . . 0.0 109.428 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.4 mt -93.09 -19.7 21.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.141 -0.975 . . . . 0.0 109.272 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.94 169.79 8.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.012 -1.055 . . . . 0.0 109.37 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -163.03 179.96 7.16 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.646 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.83 170.94 16.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.621 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -98.64 158.1 15.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.354 -0.841 . . . . 0.0 109.589 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -57.06 145.94 62.88 Favored Pre-proline 0 N--CA 1.485 1.311 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -59.16 104.22 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 120.371 0.714 . . . . 0.0 111.62 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.05 171.23 37.91 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.3 -175.63 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.039 1.159 . . . . 0.0 112.024 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.96 -127.09 40.19 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -80.05 -11.13 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.092 -1.24 . . . . 0.0 109.252 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.92 142.36 46.34 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.09 -21.84 32.22 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -64.3 150.25 46.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.013 -1.286 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.03 125.94 19.58 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.284 -0.885 . . . . 0.0 108.749 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -105.87 150.06 25.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.534 -0.729 . . . . 0.0 109.554 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -120.13 140.05 51.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -65.77 119.26 10.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 0.0 109.057 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -99.48 -3.32 33.85 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.361 -0.837 . . . . 0.0 109.354 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -75.26 -18.56 60.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.833 . . . . 0.0 109.677 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -98.15 159.78 14.72 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.24 -0.913 . . . . 0.0 108.905 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.416 ' O ' ' CD2' ' A' ' 110' ' ' TYR . 46.8 ttm-85 -89.39 119.59 29.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.25 -0.906 . . . . 0.0 109.691 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -88.74 145.34 25.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.345 -0.847 . . . . 0.0 110.188 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 69.6 p -122.49 160.97 24.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.563 -0.711 . . . . 0.0 109.237 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.415 ' ND2' HD22 ' A' ' 25' ' ' LEU . 80.2 m-20 -108.41 30.43 6.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.56 -0.712 . . . . 0.0 109.102 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -148.64 -165.0 2.16 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.09 -1.006 . . . . 0.0 110.269 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -82.25 28.98 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -73.7 -169.42 0.71 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.134 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.81 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.533 -0.73 . . . . 0.0 111.656 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' O ' ' OG1' ' A' ' 104' ' ' THR . 92.6 m-85 -87.14 153.51 21.45 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.972 -1.08 . . . . 0.0 110.547 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -143.7 97.59 3.09 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.187 -0.946 . . . . 0.0 108.55 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.2 tp -61.51 -45.95 92.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 110.364 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.56 -39.85 85.38 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.84 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.488 ' NH1' HD22 ' A' ' 135' ' ' LEU . 1.9 tpm_? -60.0 -43.37 95.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 110.016 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.5 t -69.27 -39.63 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -0.785 . . . . 0.0 108.89 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.96 84.49 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.37 -0.831 . . . . 0.0 109.164 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.49 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 4.5 t60 -70.63 -46.66 62.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.181 -0.949 . . . . 0.0 109.528 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.85 -41.37 91.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.08 -1.013 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.5 mt -63.77 -39.72 94.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.039 -1.038 . . . . 0.0 109.554 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.78 -40.38 80.12 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -66.36 -35.46 80.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -1.12 . . . . 0.0 108.328 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.4 t -69.96 -25.32 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.26 -0.03 50.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.303 -0.873 . . . . 0.0 109.07 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.19 12.08 66.1 Favored Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.813 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.79 128.58 33.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.717 -1.461 . . . . 0.0 108.979 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.2 m -88.34 170.12 11.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.428 -0.795 . . . . 0.0 109.671 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -66.12 149.0 50.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 0.0 109.383 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.7 t -124.67 161.49 26.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.388 -0.82 . . . . 0.0 109.519 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 73.3 p -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.378 -0.826 . . . . 0.0 109.936 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.51 127.37 32.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.026 -1.047 . . . . 0.0 108.732 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.88 -40.08 81.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.527 -0.733 . . . . 0.0 110.212 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.26 1.41 70.54 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.616 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.01 139.96 32.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.716 -1.461 . . . . 0.0 109.695 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.488 HD22 ' NH1' ' A' ' 114' ' ' ARG . 88.3 mt -69.02 -29.3 67.45 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.228 -0.92 . . . . 0.0 109.274 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 77.3 mmm -74.3 55.23 0.6 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.424 ' C ' ' H ' ' A' ' 139' ' ' SER . 16.8 t80 -69.29 139.49 89.78 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -53.8 -3.9 0.21 Allowed 'Trans proline' 0 N--CA 1.496 1.661 0 CA-C-N 119.832 0.976 . . . . 0.0 112.543 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 137' ' ' TYR . 92.2 p -162.84 170.91 17.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 109.311 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.45 ' O ' HG23 ' A' ' 141' ' ' THR . 65.6 t80 -84.95 101.58 12.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.715 -1.24 . . . . 0.0 109.06 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 140' ' ' TYR . 28.1 p -155.12 8.99 0.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 109.598 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -98.01 123.99 42.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.174 -0.953 . . . . 0.0 110.041 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.4 m -119.94 135.22 54.98 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.509 -0.744 . . . . 0.0 109.737 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 165.16 -159.04 32.09 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.618 -1.277 . . . . 0.0 109.925 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 49.4 t0 -81.06 152.2 28.0 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.494 -1.003 . . . . 0.0 108.967 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.522 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 98.4 t -83.01 96.92 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 0.0 109.703 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -146.95 151.81 37.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.408 -0.807 . . . . 0.0 109.207 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.1 mt -75.14 149.58 38.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.094 -1.004 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.03 150.26 21.08 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -58.4 -40.08 81.45 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.835 -1.166 . . . . 0.0 109.035 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.84 -37.74 60.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.785 -1.197 . . . . 0.0 108.448 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -74.69 -39.93 61.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.233 -0.917 . . . . 0.0 109.305 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.2 mm -60.99 -49.86 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.936 . . . . 0.0 109.095 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -63.67 -39.78 95.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.158 -0.963 . . . . 0.0 110.512 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.18 -51.02 47.56 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 120.892 -1.13 . . . . 0.0 110.93 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.415 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -67.81 -38.9 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.204 -1.174 . . . . 0.0 110.401 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 25.4 mt-30 -65.68 -39.75 91.64 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.685 -1.259 . . . . 0.0 109.315 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.04 95.2 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.782 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.34 -49.62 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.329 -0.857 . . . . 0.0 110.313 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -99.84 -63.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.094 -1.004 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.09 -165.5 33.25 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.478 ' HG2' HH11 ' A' ' 162' ' ' ARG . 35.3 mtt-85 -96.17 139.85 31.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.451 -1.029 . . . . 0.0 109.261 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.7 m -75.55 88.58 2.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.762 -1.211 . . . . 0.0 108.425 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.06 77.43 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 108.752 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -156.63 76.44 4.37 Favored Pre-proline 0 C--N 1.302 -1.485 0 O-C-N 121.496 -0.752 . . . . 0.0 109.16 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -81.19 93.12 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 121.542 1.495 . . . . 0.0 112.453 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.6 t -149.43 124.5 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -67.69 149.67 98.18 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.175 -0.953 . . . . 0.0 108.77 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 117.91 -0.954 . . . . 0.0 111.99 -179.488 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.528 HG12 ' HB3' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 95.5 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.0 tp -76.98 138.24 39.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 109.647 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 80.2 p -94.05 129.73 40.47 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.307 -0.871 . . . . 0.0 109.18 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -81.21 104.91 12.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.85 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.75 78.56 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.022 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.42 ' O ' ' OG1' ' A' ' 3' ' ' THR . 76.2 m-20 -152.87 70.05 7.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 120.683 -1.48 . . . . 0.0 110.692 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -78.15 101.3 1.46 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 121.386 1.391 . . . . 0.0 111.803 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -145.8 154.16 41.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.031 -1.043 . . . . 0.0 109.696 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -85.91 122.01 29.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.21 -0.931 . . . . 0.0 108.523 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -83.85 -12.58 55.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.0 110.159 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -82.97 152.44 25.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.705 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.2 p -96.6 -4.59 40.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.227 -0.921 . . . . 0.0 109.112 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.499 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 77.2 m80 -125.35 135.41 52.41 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.3 mt -133.69 158.35 43.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.39 -0.819 . . . . 0.0 109.537 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.7 p -128.43 154.08 46.42 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.48 159.97 41.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.448 -0.783 . . . . 0.0 108.934 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -149.45 130.35 14.27 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.084 -1.01 . . . . 0.0 110.176 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 92.8 mt -87.44 115.2 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.88 -40.11 91.3 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.249 -0.907 . . . . 0.0 110.335 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -160.09 151.87 20.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.979 -1.075 . . . . 0.0 110.26 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -98.87 135.65 40.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.386 -0.821 . . . . 0.0 109.379 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 t -71.2 144.08 89.24 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.947 . . . . 0.0 108.987 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -66.03 -11.25 30.26 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 120.704 0.936 . . . . 0.0 112.035 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.13 -39.93 87.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 109.957 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.8 mt -137.59 150.21 67.51 Favored Pre-proline 0 N--CA 1.502 2.133 0 O-C-N 121.193 -0.942 . . . . 0.0 108.951 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.35 -177.34 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.706 0.937 . . . . 0.0 111.924 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.3 ptt-85 -88.99 -37.04 15.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.909 . . . . 0.0 109.938 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.44 83.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.95 -39.01 76.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.138 -0.976 . . . . 0.0 109.617 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.68 -39.95 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.07 -41.59 92.75 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.075 -1.016 . . . . 0.0 109.077 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -60.59 -46.38 90.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.98 90.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 0.0 109.775 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -70.31 -40.16 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -69.88 -39.92 75.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.104 -0.997 . . . . 0.0 108.682 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.06 -39.97 91.88 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.548 -0.72 . . . . 0.0 109.62 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -47.31 84.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.938 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -60.11 -39.95 87.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.965 -1.085 . . . . 0.0 108.786 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -60.12 -40.28 89.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 110.093 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.12 -47.02 87.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.871 -1.143 . . . . 0.0 109.644 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -71.78 -41.72 67.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.493 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -68.21 -38.17 81.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.487 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -58.2 -24.58 59.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.552 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.6 m -110.28 7.73 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 p -145.79 150.0 41.5 Favored Pre-proline 0 N--CA 1.502 2.128 0 O-C-N 120.893 -1.13 . . . . 0.0 109.215 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.13 6.47 1.77 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 120.693 0.929 . . . . 0.0 111.899 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.93 154.06 42.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.13 -0.981 . . . . 0.0 109.779 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.499 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 74.8 p -133.3 149.99 51.9 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.533 -0.73 . . . . 0.0 109.333 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -128.88 156.24 43.99 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.468 -0.77 . . . . 0.0 109.965 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 m -155.38 132.43 10.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.755 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -78.3 145.66 35.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.913 . . . . 0.0 109.394 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.96 134.98 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.447 -0.783 . . . . 0.0 109.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -93.07 -0.93 56.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.344 -0.847 . . . . 0.0 110.037 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -152.89 158.63 42.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.008 -1.058 . . . . 0.0 109.666 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.6 168.11 30.43 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.88 149.33 29.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.203 -1.175 . . . . 0.0 109.127 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.76 151.93 25.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.437 -0.79 . . . . 0.0 109.108 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.01 -40.03 87.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -0.894 . . . . 0.0 109.286 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.5 mt -116.56 116.06 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.47 137.52 39.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.258 -0.901 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -119.46 127.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.1 p -149.58 161.36 42.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 110.207 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.14 139.97 46.07 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.0 m -135.72 167.14 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.198 -0.939 . . . . 0.0 110.739 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -134.76 146.79 49.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.629 -0.67 . . . . 0.0 110.194 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.52 -150.19 0.87 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 57.0 t0 -60.07 136.88 58.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -1.087 . . . . 0.0 109.473 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 25.1 p-80 -137.48 54.23 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.714 . . . . 0.0 109.466 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 55.82 54.14 8.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.592 -0.693 . . . . 0.0 110.035 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 44.9 t0 -147.31 162.14 39.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.265 -0.897 . . . . 0.0 109.178 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 24.5 m120 -89.7 9.0 28.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.17 -0.956 . . . . 0.0 109.775 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.7 m -134.55 70.58 72.01 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.412 -0.805 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.5 153.62 77.39 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 120.879 1.053 . . . . 0.0 112.051 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -77.62 141.44 39.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.128 -0.982 . . . . 0.0 109.476 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -103.54 62.07 0.77 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.413 -0.804 . . . . 0.0 109.179 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.92 54.82 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -55.91 -14.11 10.34 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 121.023 1.149 . . . . 0.0 111.914 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.18 -178.54 50.83 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.28 -158.8 42.34 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.534 ' HB3' HG12 ' A' ' 173' ' ' CGS . 48.0 p-10 -74.33 147.61 42.09 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.267 -1.137 . . . . 0.0 109.478 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.0 mt -94.66 -15.85 23.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.14 -0.975 . . . . 0.0 110.032 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.89 160.12 8.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.05 -1.031 . . . . 0.0 109.286 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.18 -178.7 6.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.224 -0.923 . . . . 0.0 109.286 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.39 168.17 20.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 109.869 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -96.75 164.46 12.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.38 -0.825 . . . . 0.0 109.94 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.07 149.88 72.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.36 -0.838 . . . . 0.0 109.553 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -65.26 103.47 0.53 Allowed 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 120.689 0.926 . . . . 0.0 111.806 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.03 166.01 38.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.14 -172.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 120.984 1.123 . . . . 0.0 111.647 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.99 -132.96 49.3 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.0 tt -79.92 -10.26 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -1.043 . . . . 0.0 109.946 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.99 144.21 39.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -18.15 32.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -67.12 124.26 22.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.283 . . . . 0.0 109.995 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.89 128.33 53.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.522 -0.736 . . . . 0.0 109.329 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -110.98 135.56 51.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -116.52 137.36 52.23 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.493 -0.754 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -66.5 122.59 17.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.322 -0.861 . . . . 0.0 109.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -100.4 0.38 39.74 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -74.56 -18.66 60.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.904 -1.122 . . . . 0.0 109.93 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -103.31 162.29 13.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.372 -0.83 . . . . 0.0 109.479 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -87.74 121.43 30.15 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 0.0 109.28 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.19 147.07 23.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.359 -0.838 . . . . 0.0 110.174 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.0 p -125.56 168.77 13.21 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.612 -0.68 . . . . 0.0 109.445 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.43 31.82 6.21 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.59 HD21 ' CZ ' ' A' ' 108' ' ' ARG . 4.7 p30 -149.85 -164.84 2.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -0.889 . . . . 0.0 109.953 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -86.4 29.22 0.78 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.33 -0.856 . . . . 0.0 109.811 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.59 ' CZ ' HD21 ' A' ' 106' ' ' ASN . 97.0 mtt180 -76.11 -159.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.949 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -40.36 -59.94 1.2 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.53 -0.731 . . . . 0.0 111.53 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -129.78 130.09 44.93 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.048 -1.032 . . . . 0.0 110.388 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -98.58 112.01 24.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.268 -0.895 . . . . 0.0 109.297 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.51 -40.18 95.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.246 -0.909 . . . . 0.0 110.084 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -59.94 -42.54 94.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.176 -0.952 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.503 ' NH1' HOM1 ' A' ' 173' ' ' CGS . 29.5 ttt-85 -60.1 -40.05 88.29 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 109.332 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.07 -40.06 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.271 -0.893 . . . . 0.0 109.539 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.64 -42.61 93.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 108.866 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.46 94.53 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.252 -0.905 . . . . 0.0 108.887 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.63 ' ND1' HOM2 ' A' ' 173' ' ' CGS . 28.5 t60 -67.38 -44.4 79.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.459 -0.776 . . . . 0.0 110.517 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -60.07 -39.99 87.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.971 -1.081 . . . . 0.0 108.855 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.46 -37.03 84.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.05 -40.89 75.68 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -63.1 -40.12 96.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -1.17 . . . . 0.0 108.634 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -71.61 -23.52 61.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.97 -3.14 58.65 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.195 -0.941 . . . . 0.0 108.865 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.42 16.43 64.3 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.1 mt -84.81 127.35 34.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.076 -1.249 . . . . 0.0 109.756 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.8 m -88.66 170.04 11.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.453 -0.779 . . . . 0.0 109.752 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -67.5 152.98 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.113 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.8 t -125.15 163.6 22.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.556 -0.715 . . . . 0.0 109.392 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.3 p -101.62 6.64 42.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.352 -0.843 . . . . 0.0 110.047 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.97 126.62 32.72 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.186 0.993 . . . . 0.0 109.867 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.3 pt -59.0 -30.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.394 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.46 -3.34 90.57 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.252 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.92 139.15 33.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.352 . . . . 0.0 109.142 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.13 -29.79 67.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.349 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.458 ' HA ' ' HD1' ' A' ' 118' ' ' HIS . 34.8 mtp -75.65 58.6 1.08 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.177 -0.952 . . . . 0.0 110.352 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -70.39 134.82 86.67 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.408 ' O ' ' HC1' ' A' ' 173' ' ' CGS . 22.8 Cg_exo -45.74 -63.08 0.36 Allowed 'Trans proline' 0 N--CA 1.487 1.12 0 CA-C-N 120.409 1.182 . . . . 0.0 110.857 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.9 p -94.17 177.01 6.1 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 69.6 t80 -84.94 139.23 31.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.58 -1.325 . . . . 0.0 109.106 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 33.8 p -146.78 167.22 24.4 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.143 -0.973 . . . . 0.0 109.843 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.56 124.94 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.449 -0.782 . . . . 0.0 109.597 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.2 m -106.93 -22.83 12.55 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.376 -0.827 . . . . 0.0 109.93 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' O ' ' OD1' ' A' ' 145' ' ' ASP . . . 74.58 -16.51 3.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 144' ' ' GLY . 71.0 m-20 -153.7 122.36 6.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.893 -1.357 . . . . 0.0 109.815 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 88.8 t -87.7 105.96 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -145.02 154.46 42.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 109.062 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 61.1 mt -76.42 148.24 37.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.924 -1.11 . . . . 0.0 108.89 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.36 148.45 22.11 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -55.83 -38.35 69.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.194 -0.942 . . . . 0.0 108.686 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -53.97 -39.52 66.07 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.163 -0.96 . . . . 0.0 108.547 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 156' ' ' ILE . 85.5 m-20 -73.0 -40.01 65.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.261 -0.899 . . . . 0.0 109.029 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.47 -50.52 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.318 -0.864 . . . . 0.0 109.743 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.6 -39.99 93.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.108 -0.995 . . . . 0.0 110.65 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.71 -54.15 7.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.089 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -62.02 -39.91 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.863 -1.375 . . . . 0.0 110.147 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.0 mt-30 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 109.247 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.94 -43.37 95.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.725 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.01 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.512 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -100.3 -60.68 1.48 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.58 -178.92 35.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -95.02 140.74 29.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -1.221 . . . . 0.0 109.623 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 165' ' ' ASN . 75.0 m -74.82 90.16 2.36 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.44 76.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 163' ' ' SER . 52.6 m-20 -152.48 156.44 33.42 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -76.11 95.4 1.03 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 120.492 0.795 . . . . 0.0 111.783 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.2 t -85.81 137.84 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.253 -0.904 . . . . 0.0 109.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -71.3 148.03 93.42 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 108.894 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 117.98 -0.925 . . . . 0.0 111.974 179.628 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.63 HOM2 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.042 0.449 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.8 mt -60.1 -49.52 77.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.054 -1.029 . . . . 0.0 108.955 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 37.2 p -95.3 157.18 16.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.455 -0.778 . . . . 0.0 110.215 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -72.95 138.72 46.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.23 -146.92 33.85 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -79.83 147.31 66.24 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.232 -1.158 . . . . 0.0 109.099 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.94 -175.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 120.688 0.926 . . . . 0.0 112.292 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 HG23 ' A' ' 159' ' ' ILE . 85.6 mtm180 -147.15 163.57 35.91 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.302 -0.874 . . . . 0.0 109.467 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.48 118.83 23.52 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -81.57 -9.98 59.55 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.317 -0.865 . . . . 0.0 109.537 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -86.5 145.2 26.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.981 -1.074 . . . . 0.0 110.16 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.4 p -92.13 -4.04 54.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -129.92 139.78 51.06 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.21 161.09 34.26 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.886 0.85 . . . . 0.0 109.52 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.1 p -127.01 157.07 40.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -144.49 157.55 44.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.156 -0.965 . . . . 0.0 109.339 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 40.1 ttt-85 -151.06 133.09 15.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 0.0 109.478 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.9 mt -89.15 118.92 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.62 -40.27 80.44 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.964 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -161.67 150.9 16.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.644 -1.285 . . . . 0.0 110.955 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -95.18 133.66 38.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.571 -0.706 . . . . 0.0 109.558 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.4 t -70.05 142.56 90.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.514 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -68.3 -8.94 24.39 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.38 0.814 . . . . 0.0 111.398 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.93 -39.59 86.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.812 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.3 mt -139.52 152.34 68.62 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -56.86 -176.65 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 CA-C-N 119.168 0.739 . . . . 0.0 111.225 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -86.87 -34.69 19.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.969 -1.082 . . . . 0.0 109.302 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.05 -45.89 86.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.194 -0.941 . . . . 0.0 110.253 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -69.37 -39.63 77.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -0.834 . . . . 0.0 109.6 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -70.49 -47.36 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.159 -0.963 . . . . 0.0 109.045 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -60.28 -40.53 90.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.484 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 85.7 t60 -59.19 -47.55 84.91 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.674 -0.642 . . . . 0.0 109.777 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.2 -39.18 81.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.212 -0.93 . . . . 0.0 109.484 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.18 -38.32 74.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.788 -1.195 . . . . 0.0 110.064 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.94 -42.15 97.41 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.987 -1.071 . . . . 0.0 110.262 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.484 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 36.9 mttm -64.6 -39.83 94.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 109.998 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.96 -49.71 76.59 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.602 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -60.8 -43.36 98.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.114 -0.991 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -60.09 -41.46 92.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.93 -43.61 94.82 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.729 -1.232 . . . . 0.0 110.269 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.423 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.7 m95 -73.49 -42.33 61.97 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.905 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.2 t -68.3 -35.39 77.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.041 -1.037 . . . . 0.0 110.517 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.81 -28.9 64.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.271 -0.893 . . . . 0.0 111.673 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 m -108.92 10.4 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.934 -1.104 . . . . 0.0 111.062 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 7.8 p -144.49 149.9 45.71 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.001 -1.062 . . . . 0.0 109.126 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.18 5.29 2.75 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 120.81 1.007 . . . . 0.0 112.181 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.81 155.44 40.78 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.905 -1.122 . . . . 0.0 109.268 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 p -131.55 142.33 49.9 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.394 -0.816 . . . . 0.0 108.8 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.29 153.29 36.6 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.367 -0.833 . . . . 0.0 109.467 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.2 m -153.18 132.31 12.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.413 -0.804 . . . . 0.0 109.861 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -77.44 139.39 39.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.342 -0.849 . . . . 0.0 109.824 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.7 136.26 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.631 -0.668 . . . . 0.0 109.452 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -96.62 -2.21 45.26 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 0.0 110.021 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -149.86 152.27 34.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.41 168.65 45.06 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -79.95 132.03 35.95 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.564 -0.963 . . . . 0.0 109.461 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.67 149.74 20.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 108.965 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -59.84 -39.86 86.57 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.39 -0.819 . . . . 0.0 109.118 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.5 mt -118.22 119.69 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.7 mmm -101.14 128.95 46.99 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.13 -0.981 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.04 126.42 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 84.3 p -149.98 159.71 44.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 110.781 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -113.19 137.77 50.96 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.09 162.7 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 O-C-N 121.42 -0.8 . . . . 0.0 111.626 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -130.43 145.3 51.8 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.813 -0.554 . . . . 0.0 109.726 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.18 -146.81 0.64 Allowed Glycine 0 N--CA 1.495 2.591 0 O-C-N 121.159 -0.963 . . . . 0.0 111.034 178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -72.49 128.95 37.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.615 -0.933 . . . . 0.0 109.165 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.55 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.9 p-80 -128.18 54.57 1.72 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.558 -0.714 . . . . 0.0 109.855 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 69' ' ' ARG . 52.4 mtm-85 56.62 50.02 13.52 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.482 -0.762 . . . . 0.0 110.06 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 87.7 m-20 -139.83 163.11 33.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.318 -0.864 . . . . 0.0 109.317 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -89.42 14.61 10.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.217 -0.927 . . . . 0.0 109.906 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -140.61 68.62 31.03 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.099 -1.0 . . . . 0.0 109.974 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -69.62 148.22 65.49 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.656 1.571 . . . . 0.0 112.74 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -73.79 149.83 41.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.596 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -124.69 74.43 1.34 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.837 -0.539 . . . . 0.0 109.645 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.94 -174.93 48.2 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.9 -13.64 39.03 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 120.839 1.026 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.26 -174.03 43.5 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.02 -159.21 31.12 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.569 ' ND2' HG12 ' A' ' 173' ' ' CGS . 21.2 m120 -73.73 135.36 43.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.284 -1.127 . . . . 0.0 109.42 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.88 -10.81 43.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.415 -0.803 . . . . 0.0 109.695 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.79 161.35 5.89 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -161.63 116.92 2.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.706 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.74 172.83 8.95 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -104.57 157.08 17.42 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -59.78 147.48 78.52 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.114 -0.991 . . . . 0.0 108.571 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.58 104.37 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 120.628 0.885 . . . . 0.0 112.587 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.07 170.91 33.85 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -69.82 165.42 31.08 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.226 1.284 . . . . 0.0 112.196 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.61 -121.68 15.48 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.061 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.3 tt -72.41 -12.98 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.432 -1.04 . . . . 0.0 109.846 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.04 44.71 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 -8.48 78.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -65.06 128.05 34.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.012 -1.287 . . . . 0.0 109.288 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.77 115.57 29.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 109.584 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -98.46 135.79 39.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.283 -0.886 . . . . 0.0 109.244 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.29 134.32 54.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -65.98 117.2 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.015 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -97.36 -0.34 46.57 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.365 -0.834 . . . . 0.0 109.046 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -74.77 -20.87 59.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.849 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -100.76 159.21 15.37 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.281 -0.887 . . . . 0.0 108.965 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 102' ' ' ARG . 18.7 ttt-85 -87.14 123.4 32.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -89.29 145.17 25.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.272 -0.892 . . . . 0.0 109.653 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.9 p -129.79 169.24 15.39 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.356 -0.84 . . . . 0.0 109.633 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.23 28.81 8.49 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.592 -0.693 . . . . 0.0 110.159 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.626 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -152.0 -167.01 2.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.048 -1.033 . . . . 0.0 109.952 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -71.12 22.39 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.358 -0.839 . . . . 0.0 110.686 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.5 ' CG ' HD21 ' A' ' 106' ' ' ASN . 29.2 mmt180 -75.8 -160.39 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.816 -1.177 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 109' ' ' GLU . 54.3 mp0 -31.77 -78.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 122.0 -0.437 . . . . 0.0 111.987 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -129.04 151.07 50.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.319 -0.863 . . . . 0.0 110.758 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 75.8 m-20 -99.25 114.33 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 tp -60.25 -41.14 92.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.481 -0.762 . . . . 0.0 110.145 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -59.83 -42.06 92.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.0 110.618 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.566 HH12 ' N ' ' A' ' 143' ' ' SER . 62.8 ttt180 -59.85 -39.87 86.65 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.842 -1.161 . . . . 0.0 109.678 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 53.6 t -71.69 -39.37 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 109.793 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.16 90.18 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.839 -1.163 . . . . 0.0 108.769 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.92 -39.69 95.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.569 -0.707 . . . . 0.0 110.001 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.456 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.8 t-160 -69.18 -50.02 51.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.708 . . . . 0.0 110.335 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 115' ' ' VAL . 0.5 OUTLIER -58.6 -40.04 82.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.706 -1.246 . . . . 0.0 109.986 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.5 mt -61.7 -39.93 93.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.018 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.25 94.49 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -63.61 -37.77 88.6 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 108.971 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.1 p -69.68 -21.8 63.48 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.242 -0.911 . . . . 0.0 109.006 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.07 -1.29 57.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.302 -0.874 . . . . 0.0 109.431 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.06 16.92 66.23 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.043 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.64 131.29 34.61 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.838 -1.389 . . . . 0.0 109.382 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.8 m -88.72 169.1 11.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.572 -0.705 . . . . 0.0 110.272 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -67.87 157.47 34.81 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.484 -0.76 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.8 t -127.95 164.07 23.11 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.439 -0.788 . . . . 0.0 109.318 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 72.2 p -102.58 8.94 39.69 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 110.008 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -83.79 127.65 33.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.242 -0.911 . . . . 0.0 109.291 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.3 tt -59.06 -30.02 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 110.319 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.29 0.74 88.62 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.54 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.5 133.77 34.88 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.324 . . . . 0.0 110.463 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.11 -28.47 65.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 109.602 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 86.0 mmm -74.99 52.64 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.381 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.4 ' CD2' ' OG1' ' A' ' 141' ' ' THR . 2.7 t80 -70.33 128.97 90.88 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.61 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -48.91 -66.98 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.114 0 CA-C-N 120.483 1.208 . . . . 0.0 110.793 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.5 m -89.64 176.28 6.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.042 -1.036 . . . . 0.0 108.877 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.544 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 48.4 t80 -85.83 128.3 34.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.008 . . . . 0.0 109.881 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.507 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 75.1 p -149.69 161.84 41.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -79.13 125.53 29.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.101 -1.0 . . . . 0.0 109.622 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.566 ' N ' HH12 ' A' ' 114' ' ' ARG . 49.7 p -111.41 12.58 21.52 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.736 -0.603 . . . . 0.0 109.449 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.9 -125.78 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -79.98 146.55 31.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.044 -1.268 . . . . 0.0 108.798 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.69 107.67 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.351 -0.843 . . . . 0.0 109.852 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -145.55 159.94 42.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.65 142.31 42.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.987 -1.071 . . . . 0.0 109.663 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.88 165.7 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -61.24 -38.62 87.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -58.69 -40.66 84.22 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.417 -0.802 . . . . 0.0 109.309 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -75.3 -41.01 57.96 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 0.0 109.718 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.16 -53.25 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.075 -1.015 . . . . 0.0 109.894 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.78 -39.97 95.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.22 -63.26 5.48 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.129 -1.034 . . . . 0.0 110.758 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.4 tp -60.6 -40.52 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.888 -1.36 . . . . 0.0 110.26 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.9 mt-30 -64.37 -39.71 94.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.249 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.87 -42.25 93.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.873 -1.142 . . . . 0.0 109.626 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.407 HG23 HH11 ' A' ' 8' ' ' ARG . 93.7 mt -60.08 -50.11 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.057 . . . . 0.0 109.119 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.5 -67.74 0.83 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.918 -1.114 . . . . 0.0 109.215 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.47 177.87 37.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -86.14 149.05 25.4 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.085 -1.244 . . . . 0.0 108.724 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.5 m -72.75 85.06 1.21 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 108.915 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -78.2 54.54 1.38 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.062 -1.024 . . . . 0.0 109.211 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -151.68 73.39 8.07 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.327 -0.858 . . . . 0.0 109.977 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -80.29 35.35 0.57 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.29 1.327 . . . . 0.0 111.783 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 60.1 t -90.0 121.08 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.487 -0.758 . . . . 0.0 109.285 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -76.17 147.17 79.49 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 0.0 108.637 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo . . . . . 0 N--CA 1.491 1.345 0 CA-C-O 118.162 -0.849 . . . . 0.0 112.356 -179.406 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.569 HG12 ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.5 mt -100.49 130.49 46.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.188 -0.945 . . . . 0.0 109.525 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.4 p -99.74 124.78 45.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.17 -0.956 . . . . 0.0 109.365 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -78.31 129.1 34.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 0.0 109.713 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.1 -66.14 0.58 Allowed Glycine 0 N--CA 1.5 2.962 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -155.55 77.09 4.82 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.062 -1.257 . . . . 0.0 110.236 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -48.05 125.96 12.51 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.129 1.219 . . . . 0.0 112.837 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -91.34 161.43 15.02 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.583 -0.698 . . . . 0.0 109.576 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -83.21 130.0 35.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.164 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -82.42 -13.79 56.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 0.0 110.277 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -83.78 151.53 25.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.011 -1.056 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.7 p -97.44 -7.32 31.91 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.21 -0.932 . . . . 0.0 108.662 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.548 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 31.1 m-70 -121.51 122.28 39.37 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.509 HD12 ' CE2' ' A' ' 49' ' ' PHE . 66.2 mt -110.02 156.35 20.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.308 -0.87 . . . . 0.0 109.774 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -126.73 152.74 46.42 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -143.76 159.51 42.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.162 -0.961 . . . . 0.0 108.949 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.3 ttm180 -150.29 130.72 13.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.6 mt -87.38 120.02 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.945 . . . . 0.0 108.544 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.98 -40.09 87.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.214 -0.929 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -160.78 149.98 16.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.875 -1.14 . . . . 0.0 109.988 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -97.22 132.22 43.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -68.67 143.45 95.06 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 120.828 -1.17 . . . . 0.0 109.161 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.11 -6.23 14.1 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 120.657 0.905 . . . . 0.0 111.774 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.19 -40.18 89.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.765 . . . . 0.0 109.767 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.595 HD13 ' CG ' ' A' ' 105' ' ' ASN . 54.7 mt -138.84 150.03 64.02 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.307 -0.871 . . . . 0.0 108.724 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.01 178.15 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.212 0 CA-C-N 119.247 0.767 . . . . 0.0 111.501 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -87.94 -38.71 15.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.993 -1.067 . . . . 0.0 109.546 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.28 92.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 110.008 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.12 -39.71 75.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 110.095 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.28 -43.6 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.011 -1.055 . . . . 0.0 109.299 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -58.77 -39.37 80.81 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.598 ' CE1' ' HZ1' ' A' ' 36' ' ' LYS . 68.1 t60 -57.24 -47.49 81.23 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.555 -0.715 . . . . 0.0 109.175 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -40.11 88.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.25 -0.906 . . . . 0.0 110.308 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mm -70.07 -39.46 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 109.725 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.89 -41.64 95.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.948 . . . . 0.0 109.901 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.598 ' HZ1' ' CE1' ' A' ' 32' ' ' HIS . 21.5 mttp -62.5 -38.0 88.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 109.955 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.7 84.76 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.701 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -61.39 -41.08 96.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 109.194 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -60.29 -42.2 95.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.171 -0.955 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.3 mt -59.94 -43.45 94.98 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.878 -1.139 . . . . 0.0 110.251 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -72.73 -41.61 65.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.526 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.3 t -68.25 -36.19 79.08 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -60.0 -19.19 51.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 0.0 110.242 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.2 m -112.29 1.14 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 O-C-N 121.291 -0.881 . . . . 0.0 110.256 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 p -144.56 150.24 46.64 Favored Pre-proline 0 N--CA 1.5 2.036 0 O-C-N 121.006 -1.059 . . . . 0.0 109.421 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -69.27 7.66 0.81 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.936 1.091 . . . . 0.0 112.122 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.41 151.78 42.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.117 -0.99 . . . . 0.0 109.839 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.548 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 64.5 p -129.79 149.97 51.3 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.509 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -128.26 153.63 46.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.483 -0.76 . . . . 0.0 109.405 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.1 m -153.0 134.99 14.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 0.0 110.099 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.03 131.6 36.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.649 -0.657 . . . . 0.0 109.437 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 14.7 m -119.67 130.69 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -96.0 -8.78 32.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.128 -0.982 . . . . 0.0 108.994 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' C ' ' NH2' ' A' ' 17' ' ' ARG . 99.2 mt-10 -143.81 152.12 40.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.439 -0.788 . . . . 0.0 109.103 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 95.64 179.53 36.29 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -83.18 133.48 35.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.848 -1.384 . . . . 0.0 109.834 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 131.03 45.4 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -59.87 -43.73 94.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.067 -1.021 . . . . 0.0 109.954 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.93 120.08 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.573 -0.704 . . . . 0.0 109.814 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 mtt -99.87 130.36 46.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.153 -0.967 . . . . 0.0 109.873 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.73 126.43 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.8 p -150.73 160.79 43.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.046 -1.034 . . . . 0.0 110.383 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -107.14 139.8 41.0 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.12 160.0 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.344 -0.848 . . . . 0.0 111.08 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 66' ' ' GLY . 83.3 mtm180 -131.35 143.8 50.76 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.737 -0.602 . . . . 0.0 109.423 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 42.65 -147.4 0.68 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -67.12 130.72 44.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.459 -1.024 . . . . 0.0 109.462 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.54 ' CD2' ' OD2' ' A' ' 70' ' ' ASP . 6.3 p-80 -133.85 56.16 1.86 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.434 -0.791 . . . . 0.0 109.522 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 42.5 mtm-85 58.69 49.29 10.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.807 -0.558 . . . . 0.0 110.293 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 96.4 m-20 -142.76 165.69 26.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.216 -0.928 . . . . 0.0 109.641 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -92.99 9.14 36.95 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.336 -0.853 . . . . 0.0 109.417 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 53.7 m -133.93 71.57 73.71 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.36 -0.837 . . . . 0.0 110.28 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.2 152.01 80.26 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 120.868 1.045 . . . . 0.0 111.547 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -76.81 147.66 37.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.883 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -109.49 75.04 0.92 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.462 -0.774 . . . . 0.0 109.225 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.39 -160.67 9.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.82 -15.66 22.45 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 120.957 1.104 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.96 -179.56 45.78 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.98 -164.62 37.31 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.533 ' ND2' HG12 ' A' ' 173' ' ' CGS . 32.6 m120 -75.32 147.38 40.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.39 -1.065 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.4 mt -92.71 -18.85 22.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 110.296 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.28 161.6 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 0.0 109.681 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -164.2 -179.81 6.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.697 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.52 167.42 21.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.142 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -101.14 135.22 42.96 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.272 -0.893 . . . . 0.0 109.784 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -60.01 150.04 71.51 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -41.76 120.97 1.54 Allowed 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 120.706 0.937 . . . . 0.0 112.037 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.81 -169.28 21.29 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -76.4 117.43 4.59 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.564 1.51 . . . . 0.0 113.519 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.3 -111.49 3.35 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.451 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 18.6 tt -51.29 -13.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.513 -0.992 . . . . 0.0 110.888 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.87 133.12 51.26 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.927 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.3 77.76 Favored Glycine 0 N--CA 1.497 2.738 0 O-C-N 121.459 -1.024 . . . . 0.0 111.009 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.38 129.75 40.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.736 -1.449 . . . . 0.0 110.436 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.44 129.1 46.36 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.31 -0.869 . . . . 0.0 109.074 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -115.17 132.9 56.46 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.496 -0.752 . . . . 0.0 109.122 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -118.01 131.93 56.43 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.362 -0.836 . . . . 0.0 109.348 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -64.83 126.09 26.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -100.3 0.63 40.52 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 110.059 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -74.44 -20.01 60.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.027 -1.046 . . . . 0.0 109.679 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.13 158.36 15.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.461 HH11 ' HG2' ' A' ' 102' ' ' ARG . 23.5 ttt-85 -87.49 114.63 24.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -89.59 150.72 22.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.533 -0.73 . . . . 0.0 109.993 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.3 p -126.3 164.38 21.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.595 ' CG ' HD13 ' A' ' 25' ' ' LEU . 91.5 m-20 -108.53 32.1 5.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.434 -0.791 . . . . 0.0 109.073 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.479 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -149.43 -164.98 2.15 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.158 -0.964 . . . . 0.0 110.379 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -84.83 28.34 0.69 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.458 -0.776 . . . . 0.0 110.805 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -76.67 -164.07 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.881 -1.137 . . . . 0.0 110.498 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -43.64 -59.96 1.97 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.615 -0.678 . . . . 0.0 111.555 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.29 121.85 43.21 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.178 -0.951 . . . . 0.0 109.804 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.99 116.06 31.15 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.2 tp -60.09 -39.91 87.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.231 . . . . 0.0 109.976 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.5 t-160 -59.91 -41.91 92.73 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 112.226 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 114' ' ' ARG . 10.4 ptt-85 -59.99 -41.3 91.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.313 -1.492 . . . . 0.0 109.97 -178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.8 t -70.4 -39.25 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.243 -0.91 . . . . 0.0 109.227 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.1 87.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.007 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.81 94.9 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.99 -1.069 . . . . 0.0 108.95 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.69 ' HD1' HOM2 ' A' ' 173' ' ' CGS . 3.6 t-160 -69.87 -49.27 54.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -58.97 -40.17 83.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 109.595 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.08 -39.81 95.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 109.742 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.22 -40.04 95.31 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -61.59 -39.16 90.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -1.196 . . . . 0.0 108.519 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.0 m -70.14 -26.22 63.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.767 . . . . 0.0 109.14 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.82 -3.94 57.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.577 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.22 60.54 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -80.82 129.05 34.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.227 . . . . 0.0 108.889 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -88.35 169.69 11.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.72 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -68.89 156.96 37.55 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 108.865 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.7 t -125.86 163.42 22.95 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 80.5 p -105.08 13.48 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.392 -0.818 . . . . 0.0 109.715 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 61.6 t0 -84.65 130.89 34.66 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.313 -0.867 . . . . 0.0 108.889 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 133' ' ' GLY . 19.9 tt -60.05 -38.37 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.039 -1.038 . . . . 0.0 110.313 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -80.12 1.53 79.83 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.246 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.96 128.62 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.626 -1.514 . . . . 0.0 109.471 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 147' ' ' GLN . 95.9 mt -67.56 -26.31 66.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.223 -0.923 . . . . 0.0 108.858 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 95.2 mmm -72.37 46.29 0.14 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -69.84 127.88 92.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 108.892 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.63 -64.86 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 120.557 1.235 . . . . 0.0 111.766 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 84.8 p -85.86 169.29 13.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.383 -0.823 . . . . 0.0 109.651 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.461 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 66.3 t80 -85.61 136.54 33.34 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.94 -1.1 . . . . 0.0 108.897 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 70.1 p -147.6 167.39 24.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.281 -0.887 . . . . 0.0 108.878 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.22 137.83 55.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 108.719 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 85.5 p -139.91 155.15 47.32 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -92.04 -126.33 3.79 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -80.72 160.04 25.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.353 -1.087 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 36.4 t -86.71 111.72 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 0.0 109.987 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.411 ' O ' HD11 ' A' ' 135' ' ' LEU . 49.8 mt-30 -144.97 150.0 36.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.241 -0.912 . . . . 0.0 109.066 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 66.6 mt -76.14 143.88 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 108.962 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.51 163.71 12.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.29 -0.881 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -60.05 -40.18 88.52 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.98 -1.075 . . . . 0.0 108.759 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -59.74 -40.04 86.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.834 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -72.87 -40.08 65.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.042 -1.036 . . . . 0.0 109.602 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.7 mt -63.11 -50.16 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.877 . . . . 0.0 109.716 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -60.88 -40.02 91.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.183 -0.948 . . . . 0.0 109.951 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.13 -54.05 41.19 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.343 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 10.2 tp -68.59 -39.09 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.882 -1.363 . . . . 0.0 110.039 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 161' ' ' GLY . 95.7 mt-30 -63.69 -39.47 94.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.22 -0.925 . . . . 0.0 109.126 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.86 95.21 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.444 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.87 -50.07 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 0.0 109.919 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -95.86 -67.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.047 . . . . 0.0 109.346 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.21 -173.4 40.2 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.51 142.27 27.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 108.963 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.5 m -76.36 85.59 3.13 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.132 -0.98 . . . . 0.0 109.387 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -93.58 101.17 13.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.315 -0.866 . . . . 0.0 109.099 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -159.08 155.52 24.39 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.63 68.77 8.0 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 CA-C-N 119.546 0.874 . . . . 0.0 111.363 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 t -87.16 133.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 108.959 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -122.98 80.69 50.69 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.654 -0.654 . . . . 0.0 109.384 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 120.8 1.0 . . . . 0.0 111.882 -179.594 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.69 HOM2 ' HD1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 2' ' ' LEU . 7.2 p . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' N ' HG13 ' A' ' 1' ' ' VAL . 90.6 mt -60.3 -40.47 90.62 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 0.0 109.663 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.1 p -99.67 127.64 45.78 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.086 -1.009 . . . . 0.0 109.701 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.64 133.05 38.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.465 -0.772 . . . . 0.0 109.318 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 138.41 -87.1 0.21 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -152.18 76.66 7.03 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.623 -0.928 . . . . 0.0 108.794 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.48 -166.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.246 1.297 . . . . 0.0 113.18 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -91.88 172.19 8.62 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.96 122.44 27.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.021 -1.049 . . . . 0.0 108.344 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -83.04 -9.81 59.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.201 -0.937 . . . . 0.0 110.29 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -83.73 150.72 25.64 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -96.87 -3.15 42.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 63.9 m80 -127.97 138.61 52.68 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.9 mt -133.29 158.65 42.42 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 74.8 p -130.2 155.6 45.98 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -143.21 157.45 44.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 0.0 108.536 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' NH2' ' O ' ' A' ' 55' ' ' GLY . 39.4 ttm180 -150.09 133.63 16.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.008 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.0 mt -87.97 116.9 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.843 -1.16 . . . . 0.0 108.399 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' SD ' ' A' ' 60' ' ' MET . 99.0 mt-10 -68.25 -38.34 81.7 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.798 . . . . 0.0 111.06 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.699 HD22 ' H ' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -154.56 139.75 17.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.017 -1.052 . . . . 0.0 109.847 -178.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.699 ' H ' HD22 ' A' ' 20' ' ' ASN . 95.4 m-85 -93.86 142.28 27.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.517 -0.74 . . . . 0.0 109.345 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 t -74.13 136.56 75.96 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -65.95 -11.55 31.44 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.788 0.96 . . . . 0.0 111.841 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.379 -0.826 . . . . 0.0 109.815 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.5 mt -133.74 151.2 76.62 Favored Pre-proline 0 N--CA 1.501 2.092 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.44 -178.76 0.29 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 119.396 0.82 . . . . 0.0 111.911 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.3 ptt-85 -86.53 -33.57 20.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 109.922 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.04 92.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.048 -1.033 . . . . 0.0 110.402 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.97 -38.94 76.24 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.275 -0.89 . . . . 0.0 109.94 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.08 -41.89 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.133 -0.979 . . . . 0.0 108.922 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.04 -40.22 88.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.004 -1.06 . . . . 0.0 110.045 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' A' ' 36' ' ' LYS . 75.7 t60 -60.57 -45.3 94.43 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.231 -0.918 . . . . 0.0 109.33 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.6 -48.53 81.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.946 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.7 mm -69.86 -36.83 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -0.816 . . . . 0.0 109.842 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -64.72 -45.64 85.64 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.283 -0.885 . . . . 0.0 109.669 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 32' ' ' HIS . 35.9 mttm -62.45 -36.95 84.05 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.992 -1.067 . . . . 0.0 110.256 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.21 -50.01 75.37 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.517 -1.273 . . . . 0.0 109.221 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.3 m-85 -60.78 -41.28 95.24 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 109.364 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 97.8 mt-30 -61.76 -40.21 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.731 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.06 -40.09 88.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.165 -0.96 . . . . 0.0 109.573 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.1 m95 -73.42 -43.47 60.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.922 -1.111 . . . . 0.0 110.347 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -69.26 -30.45 68.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 110.52 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 39' ' ' GLN . 19.1 m120 -59.35 -31.96 69.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 110.612 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.08 8.58 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.146 -0.971 . . . . 0.0 110.894 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 12.4 p -147.74 150.52 36.6 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 120.732 -1.23 . . . . 0.0 109.732 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -66.49 5.68 0.68 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.117 1.211 . . . . 0.0 112.356 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.3 156.31 39.46 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.096 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 73.9 p -137.74 147.74 45.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 0.0 109.089 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 98.7 m-85 -128.56 158.19 39.14 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.626 -0.671 . . . . 0.0 109.593 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.6 m -154.96 139.2 16.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.393 -0.817 . . . . 0.0 110.431 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.57 135.68 37.34 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.424 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 29.4 m -129.44 131.61 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.524 -0.735 . . . . 0.0 109.771 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t -102.51 -2.65 28.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.453 -0.779 . . . . 0.0 110.098 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' C ' HH22 ' A' ' 17' ' ' ARG . 96.8 mt-10 -140.72 152.51 45.36 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.543 ' O ' ' NH2' ' A' ' 17' ' ' ARG . . . 86.8 177.71 49.25 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -83.81 134.58 34.71 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.169 -1.195 . . . . 0.0 109.881 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.93 135.18 41.74 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.361 -0.837 . . . . 0.0 109.287 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.41 -41.69 94.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 110.069 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.07 116.52 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.559 -0.713 . . . . 0.0 110.232 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.471 ' SD ' ' OE2' ' A' ' 19' ' ' GLU . 34.9 mtt -103.33 140.45 37.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.27 -0.893 . . . . 0.0 109.491 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -121.75 127.96 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.628 -0.67 . . . . 0.0 109.201 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.8 p -145.34 153.44 41.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.146 -0.971 . . . . 0.0 110.494 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.09 141.06 36.47 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.1 170.37 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.005 -1.059 . . . . 0.0 110.733 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -131.01 139.85 50.04 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.394 0.616 . . . . 0.0 110.408 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.02 -144.08 0.64 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.6 t0 -62.84 136.66 57.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.672 -0.899 . . . . 0.0 110.042 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.41 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 20.5 p-80 -139.89 52.98 1.68 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HG2' ' NH1' ' A' ' 69' ' ' ARG . 56.8 mtt-85 53.24 55.14 9.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 33.9 t0 -145.13 162.18 37.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.213 -0.929 . . . . 0.0 109.217 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.539 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 5.5 m120 -89.58 8.87 29.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.113 -0.992 . . . . 0.0 109.1 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.3 m -134.64 69.4 72.25 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.452 -0.78 . . . . 0.0 109.23 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -72.34 148.01 48.25 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.7 1.6 . . . . 0.0 112.581 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -78.13 137.03 37.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -0.826 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -104.71 66.49 0.78 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.189 -0.944 . . . . 0.0 109.768 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.95 -171.0 48.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -53.76 -9.47 1.21 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.775 0.983 . . . . 0.0 112.176 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 -178.15 46.61 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.52 -167.3 53.88 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.575 ' HB3' HG12 ' A' ' 173' ' ' CGS . 2.4 p30 -72.76 156.92 38.43 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.165 -1.197 . . . . 0.0 109.666 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.67 -19.25 22.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.86 . . . . 0.0 109.326 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.69 163.8 10.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.037 -1.04 . . . . 0.0 108.752 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.42 -175.52 5.07 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.986 -1.071 . . . . 0.0 109.104 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.44 172.37 13.47 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.144 -0.972 . . . . 0.0 109.643 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.83 158.96 15.74 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.348 -0.845 . . . . 0.0 109.409 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.91 149.13 81.94 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.49 103.64 0.19 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 120.496 0.798 . . . . 0.0 112.149 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.43 171.61 35.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.1 -177.95 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.971 1.114 . . . . 0.0 111.758 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.91 -127.49 43.12 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 tt -78.44 -7.23 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.293 -1.122 . . . . 0.0 110.24 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -62.72 142.4 47.74 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -14.8 61.15 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -67.95 157.91 33.97 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -1.229 . . . . 0.0 109.9 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.83 118.18 8.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.471 -0.768 . . . . 0.0 109.851 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -98.54 144.68 27.59 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.124 -0.985 . . . . 0.0 110.698 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.478 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 19.1 m-85 -119.93 137.55 53.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -64.21 121.02 13.25 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -97.81 -2.72 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -76.09 -19.27 58.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -97.83 158.92 15.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.804 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -87.16 117.59 26.01 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -90.86 147.44 23.16 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.532 -0.73 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 81.5 p -130.08 161.07 31.85 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -108.06 31.06 5.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.523 -0.736 . . . . 0.0 109.547 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.439 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.3 p30 -149.95 -164.99 2.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.335 -0.853 . . . . 0.0 109.945 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 43.1 t80 -80.87 32.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.082 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -76.01 -163.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.962 . . . . 0.0 109.918 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -49.69 -59.0 4.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.537 -0.727 . . . . 0.0 111.762 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.42 129.89 55.67 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 120.994 -1.066 . . . . 0.0 110.949 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 98.1 m-20 -101.97 107.15 18.2 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.238 -0.914 . . . . 0.0 108.542 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.79 -41.48 87.56 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 111.055 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.474 ' CE1' HG11 ' A' ' 146' ' ' VAL . 23.3 t-160 -59.9 -41.55 91.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.994 -1.067 . . . . 0.0 109.945 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.452 ' NH2' ' CE1' ' A' ' 140' ' ' TYR . 45.3 ttp180 -60.24 -40.28 89.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.884 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.45 -39.57 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.148 -0.97 . . . . 0.0 109.648 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.21 82.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 0.0 109.215 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.93 78.95 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.08 -1.013 . . . . 0.0 109.701 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.4 ' ND1' ' O27' ' A' ' 173' ' ' CGS . 3.6 t-160 -69.16 -49.85 53.1 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.478 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 78.6 mt-10 -59.83 -40.54 88.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.48 -38.7 90.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 108.897 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.26 -41.14 86.35 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -63.7 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.05 -1.264 . . . . 0.0 108.635 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.0 m -70.48 -25.1 63.01 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.7 mt -83.13 -1.94 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.5 76.76 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.85 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.8 mt -81.08 130.65 35.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.808 -1.407 . . . . 0.0 109.279 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.2 m -88.03 173.53 8.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.445 -0.784 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -68.3 156.49 37.61 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 109.803 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.7 t -130.32 158.15 40.6 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.6 p -100.08 7.29 44.75 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.863 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -78.61 132.2 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 133' ' ' GLY . 20.1 tt -60.4 -38.25 77.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.511 -0.743 . . . . 0.0 111.257 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 132' ' ' ILE . . . -79.8 -1.61 87.32 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.339 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.19 129.49 35.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.806 -1.409 . . . . 0.0 109.49 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.43 -26.58 65.59 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.033 -1.042 . . . . 0.0 109.065 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 87.1 mmm -73.89 50.06 0.34 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.578 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' C ' ' H ' ' A' ' 139' ' ' SER . 18.3 t80 -68.08 135.81 91.7 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.85 14.45 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 CA-C-N 120.289 1.139 . . . . 0.0 112.569 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 137' ' ' TYR . 79.5 p -163.98 172.52 13.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.051 -1.031 . . . . 0.0 109.76 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' CE1' ' NH2' ' A' ' 114' ' ' ARG . 58.3 t80 -83.37 143.8 30.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 109.392 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.0 p -141.91 136.93 30.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.207 -0.933 . . . . 0.0 109.584 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -69.02 -29.51 67.7 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 30.3 t -98.83 129.44 45.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.025 -1.047 . . . . 0.0 109.928 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.24 112.27 0.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.78 156.24 25.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -1.181 . . . . 0.0 108.646 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.474 HG11 ' CE1' ' A' ' 113' ' ' HIS . 81.6 t -85.06 88.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -147.0 143.46 28.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.42 136.44 40.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.61 166.44 12.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -60.04 -39.19 85.09 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -59.81 -42.34 93.24 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.346 -0.846 . . . . 0.0 108.995 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -72.22 -43.12 64.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.569 -0.707 . . . . 0.0 109.822 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.78 -49.99 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.012 -1.055 . . . . 0.0 109.369 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.76 -39.29 93.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.4 -51.54 53.79 Favored Glycine 0 N--CA 1.492 2.421 0 O-C-N 121.261 -0.899 . . . . 0.0 111.393 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 157' ' ' GLN . 8.9 tp -69.26 -38.48 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.676 -1.485 . . . . 0.0 109.547 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 161' ' ' GLY . 92.9 mt-30 -65.77 -38.65 89.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.96 -1.088 . . . . 0.0 109.469 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.24 94.83 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.934 -1.104 . . . . 0.0 109.278 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.09 -51.21 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.644 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.51 -65.31 0.97 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.16 -0.962 . . . . 0.0 110.41 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 160.29 179.28 34.96 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -86.6 156.42 20.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -1.146 . . . . 0.0 108.639 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 m -74.89 84.43 2.21 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -81.26 34.53 0.37 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.656 -0.653 . . . . 0.0 109.837 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -154.16 75.53 5.96 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.413 -0.805 . . . . 0.0 108.902 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -82.1 74.17 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.674 1.583 . . . . 0.0 111.541 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.09 131.73 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 108.794 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -126.04 80.15 68.26 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 120.912 1.075 . . . . 0.0 112.184 -179.042 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.575 HG12 ' HB3' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.342 0.591 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.1 mm? -78.01 158.74 29.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 109.5 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 77.2 p -89.63 156.2 18.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.196 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -72.18 136.71 46.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 108.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.48 -169.32 53.52 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -82.64 149.86 61.52 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.218 -1.166 . . . . 0.0 109.361 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.69 -168.29 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 120.493 0.796 . . . . 0.0 111.916 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -141.33 164.35 30.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.867 . . . . 0.0 108.722 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -80.27 115.7 19.95 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.349 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.63 -10.41 57.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.339 -0.85 . . . . 0.0 109.597 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -81.97 149.51 28.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.955 . . . . 0.0 110.139 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.46 -3.69 49.58 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.523 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 88.6 m-70 -127.37 139.32 52.94 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.434 HD12 ' CE2' ' A' ' 49' ' ' PHE . 86.5 mt -130.34 153.04 49.1 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.23 -0.919 . . . . 0.0 108.961 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.9 p -126.23 154.41 43.37 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -142.4 160.0 41.13 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.364 -0.835 . . . . 0.0 109.688 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -148.46 129.99 14.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.219 -0.926 . . . . 0.0 109.801 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.72 118.23 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.88 -40.22 94.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -163.66 154.26 15.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.812 -1.18 . . . . 0.0 110.404 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -98.78 138.19 36.29 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.259 -0.901 . . . . 0.0 108.901 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 t -71.85 145.95 89.95 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.349 -0.845 . . . . 0.0 109.253 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -66.1 -14.62 45.21 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 CA-C-N 119.442 0.836 . . . . 0.0 111.786 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 -39.86 88.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.295 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.442 HD13 ' ND2' ' A' ' 105' ' ' ASN . 44.8 mt -135.62 150.18 71.29 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 17.5 Cg_endo -67.83 -173.34 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 CA-C-N 119.493 0.855 . . . . 0.0 111.847 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 ptt-85 -88.16 -37.45 16.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.842 . . . . 0.0 110.443 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.0 -42.01 89.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.923 -1.111 . . . . 0.0 109.516 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -70.28 -39.8 74.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 26' ' ' PRO . 65.6 t -70.46 -47.09 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 109.931 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.7 t0 -60.02 -41.11 91.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 109.501 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -60.05 -45.72 91.92 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 0.0 109.13 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -48.03 83.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.752 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.21 -40.45 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.248 -0.907 . . . . 0.0 110.077 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 85.9 tt0 -69.88 -38.79 76.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.095 -1.003 . . . . 0.0 109.369 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.52 -40.09 90.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 109.751 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.37 98.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.885 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.408 ' CE1' ' CD2' ' A' ' 49' ' ' PHE . 26.4 m-85 -60.0 -40.18 88.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.163 . . . . 0.0 109.72 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' ' O ' ' A' ' 35' ' ' GLU . 4.1 mp0 -60.11 -40.02 88.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.839 -1.163 . . . . 0.0 109.633 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -60.1 -40.58 90.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.876 -1.14 . . . . 0.0 109.565 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -74.91 -44.04 50.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.275 -0.891 . . . . 0.0 110.257 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 43.2 t -69.42 -34.8 75.0 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.241 -0.912 . . . . 0.0 110.493 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -56.91 -28.09 61.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.988 . . . . 0.0 110.107 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 45' ' ' THR . 30.0 m -110.82 5.28 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.379 -0.826 . . . . 0.0 110.694 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.953 HG22 ' NE2' ' A' ' 157' ' ' GLN . 41.9 p -141.42 146.14 40.94 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 121.078 -1.014 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -69.58 7.81 0.87 Allowed 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 120.813 1.009 . . . . 0.0 111.702 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.71 156.87 37.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.917 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.523 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 22.2 p -134.55 151.67 51.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 14' ' ' LEU . 96.1 m-85 -130.89 150.9 51.84 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.326 -0.858 . . . . 0.0 110.291 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.7 m -155.8 135.22 12.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.253 -0.904 . . . . 0.0 110.483 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -77.04 146.57 37.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.517 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.5 m -120.71 135.36 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.56 -0.712 . . . . 0.0 109.155 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.0 t -97.54 -4.2 38.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.298 -0.876 . . . . 0.0 109.841 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -145.4 150.44 36.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.073 -1.017 . . . . 0.0 109.364 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.44 169.62 40.56 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.649 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 4.7 pm0 -81.3 152.93 27.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -1.174 . . . . 0.0 109.19 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.31 155.45 21.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.36 -0.837 . . . . 0.0 108.91 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.02 -40.28 88.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.687 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -120.36 116.38 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.375 -0.828 . . . . 0.0 109.324 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp -99.97 134.4 42.93 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.867 . . . . 0.0 109.38 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.5 mt -119.85 129.18 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.525 -0.734 . . . . 0.0 109.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 69.8 p -147.3 155.94 42.48 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 109.803 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -105.11 139.31 39.97 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.88 162.48 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.36 -0.838 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -129.1 134.56 48.13 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.725 -0.609 . . . . 0.0 109.886 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.94 -136.42 3.99 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -70.41 124.45 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.555 -0.968 . . . . 0.0 109.54 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -138.11 66.65 1.43 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.518 -0.739 . . . . 0.0 109.786 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 50.3 mtm-85 56.98 48.54 15.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 0.0 109.423 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.88 155.2 44.71 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.351 -0.843 . . . . 0.0 108.751 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -91.61 8.45 36.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.871 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.6 m -137.93 75.39 42.22 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.299 -0.876 . . . . 0.0 109.524 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -63.74 163.59 24.2 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.307 1.338 . . . . 0.0 112.533 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -78.73 151.8 31.89 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.354 -0.841 . . . . 0.0 109.655 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -104.69 67.85 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 0.0 109.706 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 62.71 -167.12 21.04 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -58.1 -15.24 22.08 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.233 1.288 . . . . 0.0 111.919 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.54 -179.95 47.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.11 -163.65 34.67 Favored Glycine 0 N--CA 1.493 2.478 0 O-C-N 121.042 -1.27 . . . . 0.0 110.163 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -74.54 150.33 39.82 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.491 -1.005 . . . . 0.0 109.525 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.36 -11.91 36.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.087 -1.008 . . . . 0.0 109.816 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -172.82 174.98 3.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.141 -0.975 . . . . 0.0 109.005 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.62 121.7 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.96 -1.087 . . . . 0.0 110.38 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.01 170.47 11.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.692 -0.63 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -106.5 149.48 27.06 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -58.8 149.07 66.13 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 109.199 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.67 102.73 0.3 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.792 0.995 . . . . 0.0 112.135 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.68 179.24 36.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.78 -177.62 3.26 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.443 1.429 . . . . 0.0 112.787 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.07 -120.72 23.95 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.8 tt -75.89 -13.58 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.482 -1.01 . . . . 0.0 110.388 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.87 146.06 39.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.28 -18.63 35.87 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.58 161.69 22.56 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -1.113 . . . . 0.0 109.692 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.4 122.93 15.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -102.8 134.05 46.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.546 -0.721 . . . . 0.0 110.03 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.59 131.35 56.72 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -63.8 118.79 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.332 -0.855 . . . . 0.0 108.967 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -100.25 0.78 40.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.249 -0.907 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -74.05 -16.06 61.05 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.068 -1.02 . . . . 0.0 109.052 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.44 156.32 18.03 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -84.72 117.45 23.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.92 . . . . 0.0 108.977 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.14 148.56 25.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 26.7 p -128.2 165.31 20.7 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.494 -0.754 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 25' ' ' LEU . 84.9 m-20 -117.02 29.14 8.09 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.749 ' ND2' ' HE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -146.33 -161.42 1.31 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.199 -0.938 . . . . 0.0 109.739 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -83.01 31.69 0.43 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.844 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.749 ' HE ' ' ND2' ' A' ' 106' ' ' ASN . 65.8 mtm180 -76.34 -162.7 0.26 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.823 -1.173 . . . . 0.0 109.947 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.72 -56.99 14.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.309 -0.869 . . . . 0.0 111.866 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.449 ' O ' ' OG1' ' A' ' 104' ' ' THR . 94.2 m-85 -106.87 128.69 54.51 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.948 -1.095 . . . . 0.0 111.176 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -101.2 115.34 30.26 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.97 -40.03 75.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.128 -0.982 . . . . 0.0 111.053 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -60.36 -44.58 95.43 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.774 -1.204 . . . . 0.0 111.249 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -59.95 -42.38 93.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.746 -1.221 . . . . 0.0 109.682 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.92 -40.92 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.073 -1.017 . . . . 0.0 108.771 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -42.56 94.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.104 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.7 93.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.434 -0.791 . . . . 0.0 109.647 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.468 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 7.2 t60 -69.65 -40.16 76.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.878 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -60.02 -40.88 90.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.044 -1.035 . . . . 0.0 108.886 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.97 -40.01 96.42 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.388 -0.82 . . . . 0.0 109.005 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.74 -40.07 92.24 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -64.28 -37.49 87.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.035 -1.274 . . . . 0.0 108.509 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -70.01 -24.29 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.035 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -85.24 1.2 49.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 80.58 15.76 77.25 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.5 mt -79.5 128.0 32.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.899 -1.353 . . . . 0.0 109.016 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.3 m -87.59 174.32 8.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 109.969 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -69.17 159.82 32.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.626 -0.671 . . . . 0.0 110.466 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -125.24 162.32 24.97 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.609 -0.682 . . . . 0.0 109.576 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 69.8 p -99.79 1.27 42.99 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.308 -0.87 . . . . 0.0 109.324 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 133' ' ' GLY . 48.7 t0 -82.14 116.15 21.57 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.195 0.998 . . . . 0.0 108.971 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.0 pt -59.97 -24.66 30.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.329 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 131' ' ' ASP . . . -84.22 -4.1 88.39 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.88 144.62 29.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -1.221 . . . . 0.0 109.773 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 87.0 mt -61.01 -35.26 76.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.436 -0.79 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 72.0 mmm -70.37 54.82 0.15 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.253 -0.904 . . . . 0.0 109.666 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 135' ' ' LEU . 7.3 t80 -70.14 132.38 88.24 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -45.5 -57.11 2.31 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 CA-C-N 120.392 1.176 . . . . 0.0 111.165 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -100.68 175.8 5.53 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.483 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 65.7 t80 -84.93 125.69 32.88 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.836 -1.165 . . . . 0.0 110.475 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.2 p -149.01 160.02 43.69 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.38 -0.825 . . . . 0.0 109.297 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 28.7 p90 -99.98 120.49 39.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.39 -0.819 . . . . 0.0 109.347 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 7.8 t -88.32 -75.4 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 108.624 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -173.74 -103.76 0.17 Allowed Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 33.3 p-10 -86.7 156.91 19.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.21 -1.17 . . . . 0.0 108.804 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.48 105.47 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.163 -0.961 . . . . 0.0 110.142 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -149.28 152.36 35.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.234 -0.917 . . . . 0.0 108.623 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.96 145.12 40.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.924 -1.11 . . . . 0.0 108.812 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.77 163.7 14.36 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.099 -1.001 . . . . 0.0 109.45 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -59.95 -40.12 87.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.446 -0.784 . . . . 0.0 109.211 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -59.17 -40.69 86.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.802 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -72.54 -40.24 66.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.836 -1.165 . . . . 0.0 109.889 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.8 -49.81 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.127 -0.983 . . . . 0.0 109.602 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.88 -39.91 91.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.959 -1.088 . . . . 0.0 109.962 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.63 -54.09 24.46 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.974 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.6 tp -63.67 -39.87 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.735 -1.45 . . . . 0.0 109.621 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.953 ' NE2' HG22 ' A' ' 45' ' ' THR . 15.9 mm-40 -67.85 -36.89 81.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 108.991 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.4 94.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.793 -1.192 . . . . 0.0 109.381 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.19 -49.79 82.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.209 -0.932 . . . . 0.0 109.852 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -98.95 -61.33 1.38 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.203 -0.935 . . . . 0.0 110.092 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.42 -175.97 41.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 162' ' ' ARG . 52.5 mtt-85 -93.25 140.12 29.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.44 -1.035 . . . . 0.0 109.551 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 165' ' ' ASN . 30.1 m -69.83 92.7 0.7 Allowed 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.503 -0.879 . . . . 0.0 108.656 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -63.19 34.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.567 -0.708 . . . . 0.0 110.625 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' A' ' 163' ' ' SER . 22.6 m120 -153.19 74.02 6.84 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.97 -1.081 . . . . 0.0 108.418 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -80.22 73.58 5.95 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.551 1.501 . . . . 0.0 112.217 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 58.9 t -89.99 121.97 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.39 -0.818 . . . . 0.0 108.991 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -67.4 151.48 97.11 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 108.977 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 120.805 1.003 . . . . 0.0 112.261 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 1.3 mm? -59.98 -48.61 81.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.88 -1.138 . . . . 0.0 108.326 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.4 p -101.07 133.03 46.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.459 -0.776 . . . . 0.0 109.096 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -78.75 117.13 19.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.121 -0.987 . . . . 0.0 109.242 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.1 -92.82 0.21 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -150.69 87.53 4.76 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.15 -1.206 . . . . 0.0 109.771 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -56.03 111.28 0.73 Allowed 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.148 1.232 . . . . 0.0 113.235 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 8' ' ' ARG . 51.7 mtm-85 -94.86 164.76 12.78 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.739 -0.601 . . . . 0.0 110.363 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -79.86 123.85 28.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -83.71 -9.93 58.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.088 -1.007 . . . . 0.0 110.517 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -85.77 148.08 26.01 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 0.0 109.973 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 p -95.8 -4.12 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.502 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 90.0 m-70 -121.58 129.34 52.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.8 mt -127.21 155.56 43.23 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.493 -0.754 . . . . 0.0 109.869 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.2 p -128.33 151.41 49.35 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.411 -0.805 . . . . 0.0 109.6 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -142.2 160.58 39.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.358 -0.839 . . . . 0.0 109.803 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -150.69 134.37 16.54 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.301 -0.875 . . . . 0.0 109.972 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.42 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 81.7 mt -87.73 119.61 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -63.8 -39.77 95.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -160.21 155.35 24.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.377 -0.827 . . . . 0.0 109.519 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -100.22 131.19 46.3 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.186 -0.946 . . . . 0.0 109.304 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 t -70.55 141.41 87.87 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.806 -1.184 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -65.75 -6.22 13.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 CA-C-N 119.578 0.885 . . . . 0.0 111.544 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -60.19 -40.17 89.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.405 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -140.49 151.32 63.52 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -61.35 179.51 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 CA-C-N 119.475 0.848 . . . . 0.0 111.338 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -85.77 -35.78 20.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.158 -0.964 . . . . 0.0 109.357 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.32 75.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.027 -1.045 . . . . 0.0 109.319 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -71.55 -40.05 70.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.35 -0.844 . . . . 0.0 110.771 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.11 -40.57 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.075 -1.015 . . . . 0.0 109.623 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.57 -42.87 93.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 109.189 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -60.37 -42.34 95.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.402 -0.812 . . . . 0.0 108.911 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.41 95.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -0.834 . . . . 0.0 110.196 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.74 -40.09 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.181 -0.949 . . . . 0.0 108.643 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.06 -40.76 74.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.476 -0.765 . . . . 0.0 109.062 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -60.04 -35.04 74.24 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.271 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.32 -45.84 71.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -60.2 -40.32 89.65 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.261 -0.899 . . . . 0.0 109.869 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -60.08 -40.3 89.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.032 . . . . 0.0 110.176 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 40' ' ' LEU . 83.4 mt -59.93 -43.03 95.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.505 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -73.2 -40.29 64.87 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 110.131 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.6 t -67.96 -35.25 78.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.564 -0.71 . . . . 0.0 109.723 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -57.71 -34.44 69.46 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.519 -0.738 . . . . 0.0 110.182 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 45' ' ' THR . 30.5 m -107.97 10.7 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.965 -1.084 . . . . 0.0 111.558 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 HG23 ' A' ' 44' ' ' VAL . 66.6 p -145.34 148.45 37.61 Favored Pre-proline 0 N--CA 1.505 2.315 0 O-C-N 120.757 -1.214 . . . . 0.0 109.634 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.57 9.68 0.92 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.823 1.016 . . . . 0.0 112.187 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.6 mt -71.35 158.22 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.14 -0.975 . . . . 0.0 109.457 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.502 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 67.5 p -136.22 149.87 48.73 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -130.21 157.04 43.57 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.414 -0.803 . . . . 0.0 110.241 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.09 126.69 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 0.0 110.075 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 63.4 tttp -74.46 138.97 43.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.178 -0.951 . . . . 0.0 108.923 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.58 135.06 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 t -97.99 -1.4 42.77 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.23 -0.919 . . . . 0.0 110.587 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.9 158.41 43.64 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.952 -1.093 . . . . 0.0 109.259 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 173.17 46.27 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -79.02 137.89 37.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.241 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.47 139.82 32.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 108.939 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.18 -41.65 93.33 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.7 mt -119.77 119.93 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 20.6 mtt -105.48 132.09 52.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.563 -0.711 . . . . 0.0 109.753 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.7 131.27 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.1 p -146.61 159.55 43.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -110.55 139.42 45.81 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.43 168.7 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 121.271 -0.893 . . . . 0.0 111.229 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 66' ' ' GLY . 80.8 mtm180 -131.94 140.53 49.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.799 -0.563 . . . . 0.0 109.655 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 65' ' ' ARG . . . 41.55 -144.25 0.79 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -67.28 136.69 55.31 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.618 -0.931 . . . . 0.0 108.957 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.616 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 3.5 p-80 -138.32 50.59 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.414 -0.804 . . . . 0.0 109.726 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 57.6 50.01 11.66 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.717 -0.614 . . . . 0.0 110.053 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 77.8 m-20 -137.05 167.57 21.27 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.31 -0.869 . . . . 0.0 109.24 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -88.94 10.0 22.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 108.998 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.5 m -138.11 73.19 45.33 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.481 -0.762 . . . . 0.0 109.68 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -72.0 146.35 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.837 1.025 . . . . 0.0 111.612 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.86 149.21 31.04 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.856 . . . . 0.0 109.062 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -128.17 74.16 1.53 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.302 -0.874 . . . . 0.0 109.067 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.29 173.72 46.58 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -50.91 -12.21 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 121.304 1.336 . . . . 0.0 112.438 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.72 177.23 44.96 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -157.31 28.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.62 ' CG ' HG12 ' A' ' 173' ' ' CGS . 7.8 m120 -75.98 145.57 40.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -1.135 . . . . 0.0 109.531 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.12 -15.62 29.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 0.0 108.707 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.91 170.39 6.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.259 -0.901 . . . . 0.0 109.152 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -161.41 176.38 11.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 0.0 109.914 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.17 168.86 18.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.521 -0.737 . . . . 0.0 109.123 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -105.07 142.27 35.15 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.488 -0.757 . . . . 0.0 109.732 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -60.73 149.01 81.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.03 -1.044 . . . . 0.0 109.062 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.92 109.86 0.14 Allowed 'Trans proline' 0 N--CA 1.488 1.16 0 C-N-CA 120.701 0.934 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.34 -179.72 29.03 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.46 141.48 20.09 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 120.997 1.131 . . . . 0.0 112.812 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.99 -125.39 7.19 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.264 -0.969 . . . . 0.0 111.285 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -57.64 -9.59 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.84 -0.8 . . . . 0.0 110.203 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.31 139.76 48.17 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.74 -13.28 63.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -66.78 160.15 26.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.906 -1.35 . . . . 0.0 110.035 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.12 116.57 6.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -0.851 . . . . 0.0 109.058 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -98.77 153.29 18.86 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.519 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 21.0 m-85 -121.87 140.45 52.38 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -65.75 120.77 13.6 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -99.52 -7.54 25.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.637 -0.664 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -75.69 -12.61 60.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.066 -1.021 . . . . 0.0 109.822 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -105.07 149.92 25.43 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.194 -0.941 . . . . 0.0 108.788 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -83.33 122.09 28.0 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.098 -1.001 . . . . 0.0 109.493 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -89.22 152.56 21.52 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.54 -0.725 . . . . 0.0 110.026 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HD21 ' A' ' 106' ' ' ASN . 30.8 p -120.96 169.49 10.42 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -109.68 27.39 9.62 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.645 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -149.04 -165.02 2.17 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.815 . . . . 0.0 110.209 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 85.1 t80 -84.54 33.87 0.52 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.917 0.865 . . . . 0.0 109.989 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.2 mmt-85 -76.76 -162.46 0.27 Allowed 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.831 -1.168 . . . . 0.0 110.005 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -55.02 -57.65 10.86 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.697 -0.627 . . . . 0.0 110.995 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -97.27 118.75 34.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -109.2 106.13 15.87 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.05 -44.18 69.69 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.865 -0.522 . . . . 0.0 110.044 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -60.5 -47.38 86.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -60.07 -40.79 90.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.1 t -70.29 -39.26 76.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.149 -0.969 . . . . 0.0 108.763 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.9 -43.97 94.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.953 -1.092 . . . . 0.0 109.488 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.91 -37.08 78.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.107 -0.995 . . . . 0.0 109.208 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.519 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.8 t60 -69.95 -50.61 40.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.427 -0.795 . . . . 0.0 110.29 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.519 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 68.2 mt-10 -58.95 -41.5 87.59 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.914 -1.117 . . . . 0.0 109.153 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.75 -40.44 97.27 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.948 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.48 -41.98 82.46 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -65.42 -34.42 78.26 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.034 -1.274 . . . . 0.0 108.452 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 37.3 p -68.42 -19.44 64.59 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.71 -2.63 58.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.65 20.36 56.38 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.47 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.1 mt -81.9 137.64 35.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.507 -1.584 . . . . 0.0 108.867 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 68.2 m -87.0 164.37 16.53 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -67.27 151.83 46.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.7 t -124.83 168.76 12.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.694 -0.629 . . . . 0.0 109.552 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 81.5 p -107.42 9.98 29.61 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.449 -0.782 . . . . 0.0 109.951 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -82.11 130.37 35.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.032 -1.042 . . . . 0.0 109.771 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.4 -40.7 84.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 111.36 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.38 -5.12 85.37 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 121.094 -1.003 . . . . 0.0 110.747 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.69 130.26 35.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.811 -1.405 . . . . 0.0 109.889 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.491 ' O ' ' ND1' ' A' ' 118' ' ' HIS . 93.9 mt -63.33 -22.96 67.2 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.3 mmt -70.54 35.86 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.693 -0.629 . . . . 0.0 109.627 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.4 t80 -70.71 128.94 90.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.014 -1.053 . . . . 0.0 108.925 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -52.8 -66.95 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 CA-C-N 120.844 1.337 . . . . 0.0 111.765 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.5 p -82.65 173.94 11.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.163 -0.96 . . . . 0.0 110.405 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -81.2 130.54 35.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.444 -0.785 . . . . 0.0 108.963 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 p -152.01 -169.48 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 54.7 p90 -97.22 133.33 42.0 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.247 -0.908 . . . . 0.0 109.505 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 81.3 p -114.0 14.71 18.46 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.541 -0.724 . . . . 0.0 109.39 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.56 -119.34 13.72 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -83.72 153.93 23.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.104 -1.233 . . . . 0.0 109.966 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 86.8 t -85.16 90.72 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 0.0 109.138 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -143.6 157.46 44.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.068 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.6 145.03 43.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 109.037 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.26 161.53 14.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.247 -0.908 . . . . 0.0 109.633 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -60.14 -42.51 95.0 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -58.38 -41.03 83.9 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.571 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -73.37 -42.08 62.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.837 -1.164 . . . . 0.0 109.48 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.71 -49.97 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 108.772 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.18 -40.27 93.29 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.984 -1.072 . . . . 0.0 109.868 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.51 -55.34 29.46 Favored Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.484 -178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.4 tp -67.56 -39.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.246 . . . . 0.0 110.561 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -67.56 -41.5 84.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.998 -1.063 . . . . 0.0 109.689 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.02 94.78 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.8 -48.98 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.63 -0.669 . . . . 0.0 109.718 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.08 -66.84 0.88 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.33 -0.856 . . . . 0.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.8 -175.83 36.6 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -86.95 149.7 24.6 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -0.999 . . . . 0.0 109.231 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.3 m -77.21 64.89 2.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.135 -0.978 . . . . 0.0 110.41 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -96.28 131.08 43.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 108.839 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.835 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 52.0 m-20 -156.69 -34.87 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.497 -0.752 . . . . 0.0 111.846 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.835 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 24.2 Cg_endo -87.09 86.15 0.78 Allowed 'Trans proline' 0 N--CA 1.486 1.04 0 CA-C-N 120.571 1.24 . . . . 0.0 112.002 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 167' ' ' VAL . 0.5 OUTLIER -87.85 117.89 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.378 -0.826 . . . . 0.0 109.182 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.646 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 0.1 OUTLIER -75.59 -35.04 1.69 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.074 -1.016 . . . . 0.0 111.236 179.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 168' ' ' GLN . 5.5 Cg_exo . . . . . 0 N--CA 1.486 1.063 0 CA-C-N 119.72 0.936 . . . . 0.0 111.403 -179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.62 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 27.0 tp -152.41 66.05 0.82 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.216 -0.928 . . . . 0.0 109.268 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.1 p -93.73 -179.38 4.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.268 -0.895 . . . . 0.0 109.822 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -70.49 140.45 51.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.892 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.06 -142.91 38.65 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -80.97 146.11 58.53 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.163 -1.198 . . . . 0.0 108.305 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.39 162.75 13.92 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 120.748 0.965 . . . . 0.0 112.516 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 8' ' ' ARG . 40.6 mtm-85 -148.39 156.48 42.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -83.79 122.59 28.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.037 -1.039 . . . . 0.0 109.936 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 47.6 mp0 -75.15 -30.17 60.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.387 -0.82 . . . . 0.0 109.763 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -81.58 154.51 26.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.107 -0.996 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.5 p -98.25 -4.5 35.11 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.264 -0.897 . . . . 0.0 109.214 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 82.5 m-70 -111.58 131.58 55.15 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.4 mt -134.19 157.99 44.83 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 p -124.2 155.63 38.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.346 -0.846 . . . . 0.0 108.824 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.47 158.64 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -154.31 134.98 13.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.23 123.74 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 0.0 108.831 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.46 -40.25 85.34 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.023 -1.048 . . . . 0.0 111.343 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -160.28 159.15 31.02 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.81 -1.182 . . . . 0.0 109.861 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -102.51 139.78 37.66 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.277 -0.89 . . . . 0.0 109.508 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 t -78.16 142.19 63.43 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.285 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -66.23 -11.7 32.41 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 CA-C-N 119.457 0.842 . . . . 0.0 112.188 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.26 -38.94 85.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 0.0 109.243 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' ND2' ' A' ' 105' ' ' ASN . 90.3 mt -134.73 153.47 78.88 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -60.69 -179.95 0.31 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 CA-C-N 119.461 0.843 . . . . 0.0 111.428 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 33.3 ptt180 -87.91 -35.48 17.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -59.91 -37.57 79.81 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.292 -0.88 . . . . 0.0 110.258 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.82 -34.83 60.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.357 -0.84 . . . . 0.0 111.034 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.17 -49.82 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.77 -1.207 . . . . 0.0 109.965 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 12.3 p-10 -60.03 -37.08 78.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.751 -1.218 . . . . 0.0 109.62 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -59.13 -48.6 81.01 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.908 -1.12 . . . . 0.0 109.406 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.67 -41.68 91.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.055 -1.028 . . . . 0.0 109.612 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.5 mm -72.28 -31.02 37.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.324 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -66.65 -41.65 87.87 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.862 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.07 -28.78 65.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.857 -1.152 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.59 -48.18 80.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.913 -1.117 . . . . 0.0 109.007 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.485 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 39.6 m-85 -62.67 -40.43 97.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.182 -0.949 . . . . 0.0 109.686 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -60.12 -43.52 95.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.099 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -59.61 -43.95 93.57 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.82 -1.175 . . . . 0.0 110.055 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.422 ' O ' ' OG1' ' A' ' 45' ' ' THR . 92.3 m95 -70.34 -40.8 73.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.969 -1.092 . . . . 0.0 109.275 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.4 t -69.5 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 110.579 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -59.72 -27.37 66.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.968 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -110.62 9.56 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 O-C-N 120.971 -1.081 . . . . 0.0 110.492 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 22.5 p -149.19 150.49 32.0 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 120.926 -1.109 . . . . 0.0 109.658 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -69.68 9.33 0.59 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.643 0.895 . . . . 0.0 111.533 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.27 151.18 44.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.225 -0.922 . . . . 0.0 109.068 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.435 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 71.2 p -134.66 148.53 50.38 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 96.6 m-85 -129.9 155.45 46.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.404 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.8 m -154.69 134.52 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.455 -0.778 . . . . 0.0 109.534 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -77.34 145.93 37.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.16 132.81 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 121.642 -0.662 . . . . 0.0 109.733 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.6 t -96.74 -9.16 29.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 0.0 109.937 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -141.9 156.34 45.51 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.226 -0.921 . . . . 0.0 108.878 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.9 171.46 47.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -81.33 134.82 35.64 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.667 -0.902 . . . . 0.0 109.767 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -91.86 143.67 26.27 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.946 -1.096 . . . . 0.0 109.282 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -40.67 89.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.044 -1.035 . . . . 0.0 109.449 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.85 119.09 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.521 -0.737 . . . . 0.0 109.204 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 35.9 mtt -103.38 135.86 44.21 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.021 -1.049 . . . . 0.0 109.807 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.45 130.87 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.3 p -149.98 156.1 41.12 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.752 -1.218 . . . . 0.0 110.708 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -109.6 138.44 45.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.37 164.46 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.228 -0.92 . . . . 0.0 111.304 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -134.3 145.54 49.15 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.81 -147.03 2.44 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -73.77 125.72 28.76 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.45 -1.03 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -127.62 53.69 1.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 69' ' ' ARG . 61.1 mtt-85 56.61 50.03 13.54 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -139.18 158.36 44.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.19 -0.944 . . . . 0.0 109.658 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -89.12 10.47 21.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 109.751 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.1 m -137.81 72.51 48.4 Favored Pre-proline 0 N--CA 1.497 1.911 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -75.12 146.64 32.47 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 120.843 1.029 . . . . 0.0 112.26 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.438 ' CD2' ' OD2' ' A' ' 98' ' ' ASP . 90.5 m-85 -76.26 148.47 37.57 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.368 -0.833 . . . . 0.0 108.987 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -132.57 72.88 1.5 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.452 -0.78 . . . . 0.0 109.382 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.27 -170.21 42.64 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -65.01 -16.25 54.49 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 121.197 1.264 . . . . 0.0 111.727 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.15 49.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.66 -165.97 46.71 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.736 ' CG ' HG12 ' A' ' 173' ' ' CGS . 97.1 m-20 -76.4 142.1 41.22 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD22 ' OE2' ' A' ' 101' ' ' GLU . 50.9 mt -90.79 -12.36 36.67 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.61 157.33 8.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.362 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -160.61 177.76 10.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.315 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.78 161.73 23.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -92.71 156.03 17.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.11 149.78 65.46 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.377 -0.827 . . . . 0.0 108.967 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -59.17 106.87 0.32 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.61 0.873 . . . . 0.0 111.984 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -162.2 176.93 38.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -69.2 173.06 11.02 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.318 1.345 . . . . 0.0 112.029 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.75 14.45 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.8 tt -83.93 -11.79 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.387 -1.066 . . . . 0.0 109.841 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.58 140.03 38.02 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.28 -20.33 34.36 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.77 128.75 37.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.028 -1.277 . . . . 0.0 110.717 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.53 145.34 24.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.773 . . . . 0.0 109.09 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -130.07 132.44 46.17 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.5 136.4 54.78 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.385 -0.822 . . . . 0.0 110.095 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.438 ' OD2' ' CD2' ' A' ' 74' ' ' PHE . 13.9 t0 -65.77 124.31 22.1 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.291 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -101.18 0.27 37.31 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.319 -0.863 . . . . 0.0 110.098 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.68 -15.21 60.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.048 -1.032 . . . . 0.0 110.068 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' OE2' HD22 ' A' ' 81' ' ' LEU . 99.9 mt-10 -106.93 164.23 12.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -88.34 118.37 27.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.116 -0.99 . . . . 0.0 109.902 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -88.97 148.65 23.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.108 -0.995 . . . . 0.0 109.51 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.5 p -124.94 173.53 8.59 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.529 -0.732 . . . . 0.0 109.666 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' ND2' HD22 ' A' ' 25' ' ' LEU . 83.9 m-20 -112.34 23.63 13.42 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.401 0.62 . . . . 0.0 109.445 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -147.27 -165.0 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 109.317 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -87.87 20.88 2.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.051 -1.031 . . . . 0.0 110.38 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.523 ' O ' ' C ' ' A' ' 109' ' ' GLU . 96.1 mtt180 -75.83 -165.73 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.283 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 108' ' ' ARG . 72.5 mm-40 -11.16 -69.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 123.023 0.529 . . . . 0.0 112.41 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -131.8 128.83 39.58 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -89.9 108.7 19.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 108.627 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -69.18 -40.16 78.27 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.451 ' ND1' ' C ' ' A' ' 113' ' ' HIS . 17.8 t-80 -59.98 -46.45 89.4 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.788 -1.195 . . . . 0.0 110.067 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -60.22 -41.91 94.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.004 -1.06 . . . . 0.0 110.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.75 -41.13 79.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.853 -1.154 . . . . 0.0 108.85 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.92 90.92 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 0.0 108.799 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.82 91.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.441 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 33.8 t60 -70.31 -39.97 74.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 0.0 109.989 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -58.66 -40.01 82.26 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 109.177 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.0 -39.74 95.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -53.56 -42.05 65.64 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -62.26 -36.63 82.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.987 -1.302 . . . . 0.0 108.411 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.9 t -69.22 -24.49 64.02 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.6 -4.87 58.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 0.0 109.436 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.03 15.97 58.48 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.954 -1.091 . . . . 0.0 110.626 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.91 129.1 34.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.016 -1.285 . . . . 0.0 109.716 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.499 ' O ' ' SD ' ' A' ' 136' ' ' MET . 68.5 m -87.79 165.52 15.27 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.117 -0.989 . . . . 0.0 109.276 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -66.04 160.6 23.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.093 . . . . 0.0 108.788 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -127.21 166.22 18.14 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.44 -0.788 . . . . 0.0 109.405 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.3 p -100.53 7.32 44.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.336 -0.853 . . . . 0.0 108.988 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -83.26 116.44 22.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 109.915 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.2 tt -60.53 -27.86 41.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.577 -0.702 . . . . 0.0 110.422 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.96 -5.76 89.48 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.55 -1.309 . . . . 0.0 110.298 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.45 156.08 24.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.284 . . . . 0.0 109.79 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 89.6 mt -69.6 -29.53 67.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.327 -0.858 . . . . 0.0 109.764 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 127' ' ' SER . 5.6 mtt -74.0 61.95 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 110.097 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.85 126.92 92.21 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -47.98 -71.9 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.485 1.209 . . . . 0.0 110.835 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 88.5 p -94.44 170.15 9.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 108.982 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -84.61 137.62 33.18 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.062 -1.024 . . . . 0.0 108.511 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.7 p -148.6 -141.91 0.12 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.119 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -57.83 139.28 54.47 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.994 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.8 m -101.2 120.18 39.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.256 -0.903 . . . . 0.0 109.088 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -99.47 -153.62 27.84 Favored Glycine 0 N--CA 1.499 2.835 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 42.3 t0 -80.85 154.1 27.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -1.204 . . . . 0.0 109.726 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.543 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 51.8 t -84.82 98.13 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 109.681 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -144.78 154.94 43.23 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.82 145.78 34.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.4 156.24 18.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.356 -0.84 . . . . 0.0 109.524 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.16 -39.74 87.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.355 -0.841 . . . . 0.0 109.039 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 151' ' ' ASP . 56.8 t0 -57.93 -39.63 78.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.506 -0.746 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.409 ' O ' HG22 ' A' ' 156' ' ' ILE . 96.1 m-20 -76.34 -40.71 50.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.952 -1.092 . . . . 0.0 109.519 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.5 -50.12 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.256 -0.902 . . . . 0.0 109.265 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -66.02 -40.06 90.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 110.085 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.99 -51.63 38.29 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.3 tp -65.75 -40.2 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.008 -1.289 . . . . 0.0 109.486 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 161' ' ' GLY . 93.1 mt-30 -65.29 -39.68 92.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 109.289 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.15 92.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.056 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.72 -49.98 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.057 . . . . 0.0 109.819 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -97.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.827 -1.17 . . . . 0.0 109.574 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.23 -165.96 33.48 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -96.57 138.64 33.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -1.21 . . . . 0.0 109.849 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.4 m -75.05 84.45 2.29 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.17 112.65 24.35 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.775 ' H ' ' CD ' ' A' ' 166' ' ' PRO . 14.7 m120 -156.59 -35.01 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.003 -1.061 . . . . 0.0 112.66 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.775 ' CD ' ' H ' ' A' ' 165' ' ' ASN . 8.0 Cg_endo -80.41 48.59 2.93 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 CA-C-N 120.88 1.35 . . . . 0.0 111.201 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.75 125.44 41.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.552 -0.718 . . . . 0.0 109.384 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.509 HE22 ' C ' ' A' ' 166' ' ' PRO . 24.2 mp0 -124.6 79.26 62.56 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 0.0 109.101 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.492 1.434 0 C-N-CA 120.783 0.989 . . . . 0.0 112.714 -179.719 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.736 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 2' ' ' LEU . 8.0 mp -60.86 -39.99 91.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.777 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.1 p -93.69 163.51 13.51 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -72.21 141.61 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.099 -1.0 . . . . 0.0 109.289 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.91 -161.85 43.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -81.77 138.41 46.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.122 -1.222 . . . . 0.0 108.631 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.35 -171.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 119.795 0.963 . . . . 0.0 112.144 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -144.37 161.25 39.47 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.366 -0.834 . . . . 0.0 108.784 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -81.3 120.93 25.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.0 109.017 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -83.74 -14.82 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 109.693 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -82.69 149.26 27.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.736 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.7 p -94.49 -4.61 47.82 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -129.15 141.33 51.21 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.2 mt -131.99 159.91 37.38 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.2 -0.938 . . . . 0.0 109.883 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.5 p -127.9 155.1 44.72 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.454 -0.779 . . . . 0.0 109.51 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -145.58 157.97 43.91 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -148.49 137.67 21.82 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.236 -0.915 . . . . 0.0 110.066 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.9 mt -89.15 119.96 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 85.5 tt0 -64.98 -39.98 94.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.078 . . . . 0.0 110.365 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.8 m-20 -158.62 151.15 21.89 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.981 -1.074 . . . . 0.0 109.784 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.13 134.11 40.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.409 -0.807 . . . . 0.0 108.978 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 t -70.1 135.84 87.12 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.699 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -66.54 -10.66 28.65 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.769 0.953 . . . . 0.0 111.848 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 mt -133.12 149.99 74.24 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -61.83 -177.77 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.384 0 CA-C-N 119.485 0.852 . . . . 0.0 111.429 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -87.26 -29.9 21.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.021 -1.049 . . . . 0.0 109.757 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -43.87 88.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.037 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -69.9 -39.14 76.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.89 -40.9 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.902 . . . . 0.0 109.418 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.95 -43.18 95.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.995 . . . . 0.0 109.011 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -59.99 -43.59 95.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.209 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.36 77.96 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.409 -0.807 . . . . 0.0 109.927 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.4 mm -70.13 -40.06 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.377 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HG2' HE21 ' A' ' 39' ' ' GLN . 86.1 tt0 -70.09 -39.9 75.27 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.162 -0.961 . . . . 0.0 109.264 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -60.65 -39.93 90.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.0 109.852 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 -44.61 88.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.073 -1.017 . . . . 0.0 109.846 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -60.1 -39.79 87.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 0.0 109.363 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.432 HE21 ' HG2' ' A' ' 35' ' ' GLU . 77.5 mt-30 -59.34 -43.43 92.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.968 -1.082 . . . . 0.0 109.638 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.93 -44.36 97.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.485 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.407 ' CH2' HD22 ' A' ' 148' ' ' LEU . 92.1 m95 -75.34 -40.0 58.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.984 -1.072 . . . . 0.0 110.322 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 t -69.81 -39.84 76.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.87 -18.09 54.07 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.168 -0.958 . . . . 0.0 111.115 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.02 4.04 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.15 -0.969 . . . . 0.0 109.775 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.516 ' N ' ' OG ' ' A' ' 163' ' ' SER . 6.5 p -146.44 151.18 42.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.231 -0.918 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -69.32 4.82 1.79 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.823 1.015 . . . . 0.0 111.7 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -70.85 150.16 46.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.4 p -129.85 149.37 51.61 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -126.01 157.6 37.47 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.427 -0.796 . . . . 0.0 109.683 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.9 m -155.06 129.14 8.83 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.935 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -76.39 138.02 40.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 m -121.12 133.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.466 -0.771 . . . . 0.0 109.354 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.3 t -97.77 -0.07 45.96 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.261 -0.899 . . . . 0.0 109.734 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -143.26 150.17 38.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.182 -0.949 . . . . 0.0 109.658 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 165.07 30.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -81.58 137.81 35.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -1.1 . . . . 0.0 109.308 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.0 151.85 21.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.98 -42.91 95.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.858 . . . . 0.0 109.717 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -104.39 109.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.404 -0.81 . . . . 0.0 109.397 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.6 mtp -101.94 136.76 41.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.286 -0.884 . . . . 0.0 109.684 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -123.77 132.16 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.66 -0.65 . . . . 0.0 109.574 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.5 p -147.02 150.46 35.14 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 109.724 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -105.24 140.45 38.37 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.491 -0.755 . . . . 0.0 109.254 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.7 168.82 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.191 -0.943 . . . . 0.0 110.596 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -131.88 138.47 48.44 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.672 -0.642 . . . . 0.0 109.372 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.65 -151.35 1.11 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 61.3 t0 -65.24 134.89 54.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.615 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.0 p-80 -132.55 51.26 2.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.725 . . . . 0.0 109.627 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 61.9 mtp180 57.38 53.31 7.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.642 -0.661 . . . . 0.0 110.627 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 92.5 m-20 -142.27 169.99 16.54 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.25 -0.906 . . . . 0.0 109.858 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -89.43 9.49 26.15 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -138.9 72.42 40.92 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -77.15 152.31 31.03 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.33 1.353 . . . . 0.0 112.017 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -77.81 137.46 38.43 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.268 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -102.23 68.4 1.09 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.0 109.478 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 74.31 178.42 39.19 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.25 -21.03 6.34 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.252 1.301 . . . . 0.0 112.325 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.63 -178.84 45.09 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.02 -153.35 24.52 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.721 ' OD1' HG12 ' A' ' 173' ' ' CGS . 96.4 m-20 -76.81 142.28 40.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -1.118 . . . . 0.0 109.807 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.3 mt -91.53 -15.16 29.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.303 -0.873 . . . . 0.0 109.354 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.99 174.86 4.58 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 108.9 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 83' ' ' HIS . 2.6 p80 -161.96 117.34 1.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.785 -1.197 . . . . 0.0 110.428 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.0 171.11 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -119.77 145.16 46.83 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.12 148.64 70.6 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.096 -1.003 . . . . 0.0 109.353 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -60.59 108.21 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 120.598 0.865 . . . . 0.0 111.738 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.62 171.26 41.49 Favored Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.467 -1.349 . . . . 0.0 109.976 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -65.93 171.61 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.228 1.286 . . . . 0.0 111.548 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.84 -125.94 16.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.5 tt -80.14 -6.79 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.363 -1.081 . . . . 0.0 110.336 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.53 141.59 48.0 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.72 -16.27 54.85 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -67.76 163.46 21.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.373 -1.074 . . . . 0.0 110.248 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.09 117.73 8.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.458 -0.776 . . . . 0.0 109.34 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -101.35 135.55 42.66 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.34 -0.85 . . . . 0.0 110.453 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.538 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 40.1 m-85 -116.85 129.05 55.83 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' GLU . 62.3 t0 -68.06 128.75 37.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.248 179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 69.5 tt0 -100.01 2.53 43.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.278 -0.888 . . . . 0.0 109.418 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -75.13 -16.78 60.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.156 -0.965 . . . . 0.0 110.377 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 54.0 mp0 -94.44 155.62 16.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.075 -1.016 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -85.16 115.12 22.76 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -88.59 145.46 25.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 110.105 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 72.9 p -120.31 171.51 8.46 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -105.11 26.08 9.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.487 -0.758 . . . . 0.0 109.297 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -151.0 -166.98 2.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.573 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -90.7 32.69 0.96 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.286 -0.884 . . . . 0.0 110.52 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 9.0 mtp-105 -75.57 -156.07 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.841 -1.162 . . . . 0.0 109.652 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 108' ' ' ARG . 98.3 mt-10 -36.86 -59.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.714 -0.616 . . . . 0.0 111.379 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.445 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.0 m-85 -123.09 128.96 50.83 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.079 -1.013 . . . . 0.0 110.249 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -108.52 110.37 21.85 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.381 -0.825 . . . . 0.0 109.186 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.4 -41.12 96.64 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.184 -0.947 . . . . 0.0 110.41 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -59.97 -41.17 91.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 110.362 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 141' ' ' THR . 70.4 ttt180 -59.94 -41.16 91.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.047 -1.033 . . . . 0.0 109.944 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.9 -40.19 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.097 -1.002 . . . . 0.0 109.541 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -42.18 94.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.948 . . . . 0.0 108.992 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.24 -36.33 83.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.296 -0.877 . . . . 0.0 109.837 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -69.98 -48.31 58.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.955 . . . . 0.0 109.609 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.538 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 82.8 mt-10 -59.95 -40.01 87.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.174 -0.954 . . . . 0.0 109.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.6 mt -62.88 -39.8 95.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.419 -0.801 . . . . 0.0 109.257 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.65 -41.45 82.28 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -64.87 -39.17 93.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.304 -1.115 . . . . 0.0 108.744 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 90.8 p -69.99 -21.4 63.23 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.432 -0.792 . . . . 0.0 109.587 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.2 mt -86.93 -3.24 59.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 0.0 109.219 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 9.86 60.85 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.64 124.58 30.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.103 -1.234 . . . . 0.0 109.469 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 65.4 m -87.96 171.08 10.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.287 -0.883 . . . . 0.0 109.723 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -66.5 153.0 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.534 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.8 t -126.61 168.93 13.65 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.583 -0.698 . . . . 0.0 109.391 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.3 p -102.85 9.53 38.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -0.813 . . . . 0.0 109.561 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -82.47 123.86 29.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.232 -0.917 . . . . 0.0 109.519 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.71 -31.46 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 110.374 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.62 -4.3 90.19 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.652 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.11 129.77 35.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.858 -1.377 . . . . 0.0 109.404 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.92 -24.94 67.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 108.967 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 85.9 mmm -73.17 46.98 0.19 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.421 -0.799 . . . . 0.0 109.651 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -69.76 129.95 90.71 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -48.4 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 120.343 1.158 . . . . 0.0 111.78 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.5 p -86.62 171.9 10.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -85.15 138.29 32.48 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.143 -0.973 . . . . 0.0 109.524 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.521 ' O ' ' NH1' ' A' ' 114' ' ' ARG . 80.8 p -147.55 165.1 31.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.343 -0.848 . . . . 0.0 109.235 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -74.37 135.94 42.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.0 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.421 ' CB ' ' NH1' ' A' ' 114' ' ' ARG . 14.0 t -127.83 140.13 52.22 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.521 -0.737 . . . . 0.0 109.847 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.43 -101.86 0.08 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.51 139.46 31.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.144 -1.209 . . . . 0.0 109.628 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.8 t -86.99 111.17 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.169 -0.957 . . . . 0.0 109.544 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -144.47 157.16 44.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 108.913 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.407 HD22 ' CH2' ' A' ' 41' ' ' TRP . 88.0 mt -75.85 149.93 37.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.104 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.88 158.57 15.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -60.01 -39.48 85.95 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 108.809 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -57.82 -41.44 82.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.957 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -74.23 -40.35 62.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.147 . . . . 0.0 110.081 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.36 -50.03 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.93 -40.12 92.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.57 -55.2 24.29 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.397 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.01 -39.99 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.839 -1.389 . . . . 0.0 109.815 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.8 mt-30 -64.92 -38.5 91.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.681 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.13 92.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.16 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.97 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -98.1 -72.77 0.64 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.42 -0.8 . . . . 0.0 109.564 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 161.21 -165.06 35.24 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 162' ' ' ARG . 0.4 OUTLIER -91.47 139.88 30.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.98 . . . . 0.0 109.694 -179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 45' ' ' THR . 16.6 m -76.26 84.58 3.06 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 109.094 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -97.25 123.81 41.16 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.36 -0.838 . . . . 0.0 109.333 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -152.5 150.17 24.37 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -78.88 103.6 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 120.677 0.918 . . . . 0.0 111.976 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.6 t -89.18 123.77 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 0.0 109.635 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.91 149.91 92.68 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.221 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.49 1.311 0 CA-C-O 117.957 -0.935 . . . . 0.0 111.92 179.592 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.721 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.51 -41.46 97.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.285 -0.884 . . . . 0.0 108.939 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.1 p -130.24 139.74 50.76 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.694 -0.629 . . . . 0.0 109.318 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -75.16 130.0 38.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.167 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.3 -138.84 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -82.78 146.04 51.75 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.344 -1.092 . . . . 0.0 109.107 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.92 171.94 6.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.527 0.818 . . . . 0.0 111.802 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HG2' ' A' ' 8' ' ' ARG . 54.0 mtt-85 -87.57 -176.73 5.68 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.51 117.52 21.31 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.724 -1.235 . . . . 0.0 108.64 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -82.93 -10.5 58.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.538 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -84.44 149.55 25.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 110.118 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -96.06 -4.42 43.02 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -126.76 141.24 51.89 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.7 mt -135.74 158.33 44.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.9 p -129.39 154.03 47.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.607 -0.683 . . . . 0.0 109.465 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -141.39 160.59 39.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.442 -0.786 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -147.17 132.54 18.56 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.163 -0.961 . . . . 0.0 110.095 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.68 120.62 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.07 -40.16 94.27 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.988 -1.07 . . . . 0.0 109.839 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -160.19 157.14 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.082 -1.011 . . . . 0.0 109.741 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.71 136.83 40.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 109.196 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 t -68.5 141.22 92.99 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.094 -1.004 . . . . 0.0 109.0 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.72 -10.81 29.47 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 119.5 0.857 . . . . 0.0 112.146 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -59.95 -40.0 87.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.44 HD13 ' ND2' ' A' ' 105' ' ' ASN . 65.0 mt -135.47 151.33 74.46 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -63.71 -178.7 0.57 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 120.64 0.894 . . . . 0.0 111.257 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -86.72 -35.94 18.96 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.184 -0.948 . . . . 0.0 110.046 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.31 -42.11 73.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.11 -0.994 . . . . 0.0 109.552 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -69.97 -39.9 75.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.29 -42.26 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -59.88 -40.38 88.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.02 -1.05 . . . . 0.0 108.911 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.83 -48.69 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.579 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.4 92.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.453 -0.779 . . . . 0.0 110.585 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -71.22 -43.24 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.954 -1.091 . . . . 0.0 109.937 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.36 -39.76 77.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.237 -0.914 . . . . 0.0 109.205 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -61.15 -39.88 91.75 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.32 -46.18 87.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.988 -1.07 . . . . 0.0 109.993 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 35.8 m-85 -60.13 -39.99 88.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.021 -1.05 . . . . 0.0 109.316 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -59.96 -41.06 91.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.168 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.13 -41.11 91.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.619 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -72.3 -40.02 67.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 109.35 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -69.26 -37.23 77.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 0.0 110.089 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -57.85 -21.76 44.35 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.209 -0.932 . . . . 0.0 110.743 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.93 5.66 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.3 p -147.0 150.38 38.54 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 120.975 -1.078 . . . . 0.0 109.534 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -68.12 5.3 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.688 0.925 . . . . 0.0 110.997 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.86 160.3 33.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.462 -0.774 . . . . 0.0 110.073 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 p -139.36 153.83 47.75 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.5 m-85 -130.02 152.02 49.93 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.515 -0.741 . . . . 0.0 109.585 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 18.3 m -153.31 131.32 11.79 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.283 -0.886 . . . . 0.0 110.33 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -79.5 139.11 37.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 109.58 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.6 m -117.54 136.1 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 121.346 -0.846 . . . . 0.0 108.842 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -96.89 -8.59 30.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.126 -0.984 . . . . 0.0 110.011 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -145.51 159.97 42.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 109.586 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.51 172.22 44.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -80.16 146.27 31.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -1.222 . . . . 0.0 109.494 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.77 145.72 33.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.65 -0.656 . . . . 0.0 109.422 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.02 -39.98 87.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.337 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 87.5 mt -117.27 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.497 -0.752 . . . . 0.0 108.978 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.1 mmm -100.09 122.05 42.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.271 -0.893 . . . . 0.0 109.778 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.8 mt -112.1 129.77 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.254 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.6 p -149.81 161.5 42.13 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.137 -0.977 . . . . 0.0 109.676 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -109.01 138.39 45.43 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.1 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.365 -0.835 . . . . 0.0 110.692 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -133.11 145.45 50.72 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.41 -140.54 4.99 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -77.74 134.6 38.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.366 -1.079 . . . . 0.0 110.184 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.525 ' NE2' ' OD2' ' A' ' 70' ' ' ASP . 9.6 p-80 -136.46 64.55 1.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.525 -0.734 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 69' ' ' ARG . 18.8 mtt-85 54.48 47.48 22.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.411 -0.806 . . . . 0.0 110.091 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.525 ' OD2' ' NE2' ' A' ' 68' ' ' HIS . 91.7 m-20 -141.52 165.05 28.58 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.34 -0.85 . . . . 0.0 109.781 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -95.61 9.92 38.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.342 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 67.86 73.59 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.547 -0.721 . . . . 0.0 109.723 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -65.61 147.29 86.18 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.044 1.162 . . . . 0.0 112.488 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -78.65 145.44 34.62 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -138.25 79.92 1.77 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 109.826 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.64 173.37 36.57 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.41 -7.35 19.94 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.147 1.231 . . . . 0.0 111.676 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.88 174.44 47.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.45 -160.54 31.77 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.528 ' CG ' HG12 ' A' ' 173' ' ' CGS . 81.9 m-20 -76.51 144.66 39.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -1.097 . . . . 0.0 109.586 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.93 -15.43 29.8 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.99 -1.069 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.8 163.89 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -0.965 . . . . 0.0 108.926 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -159.14 121.2 3.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.801 -1.187 . . . . 0.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.17 172.63 10.39 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.284 0.564 . . . . 0.0 109.693 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -113.58 147.86 37.24 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -59.91 149.01 75.1 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.08 -1.012 . . . . 0.0 109.232 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -60.34 112.46 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.811 1.008 . . . . 0.0 112.197 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.52 172.9 43.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -73.27 161.61 42.46 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.352 1.368 . . . . 0.0 112.29 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.63 -119.5 5.12 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.66 -11.39 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.171 . . . . 0.0 109.857 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.28 144.39 47.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.06 -15.55 48.1 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -67.36 162.11 23.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -1.192 . . . . 0.0 109.699 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.89 120.46 12.5 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.275 -0.891 . . . . 0.0 109.099 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -104.75 134.13 48.41 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.271 -0.893 . . . . 0.0 110.785 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.93 130.91 57.0 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 56.5 t0 -67.19 123.91 21.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.03 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 99' ' ' GLU . 13.9 tp10 -102.11 0.32 34.62 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.508 -0.745 . . . . 0.0 109.622 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 96.5 m-20 -73.88 -19.56 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 108.886 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.51 155.7 17.7 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 102' ' ' ARG . 32.1 ttt-85 -86.03 121.59 28.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.992 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.02 148.71 24.39 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.455 -0.778 . . . . 0.0 109.539 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.5 p -127.11 156.57 41.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.358 -0.839 . . . . 0.0 109.9 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.44 ' ND2' HD13 ' A' ' 25' ' ' LEU . 94.2 m-20 -107.36 30.95 5.78 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -148.43 -164.99 2.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 109.765 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -84.31 33.87 0.51 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.397 -0.814 . . . . 0.0 109.945 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.57 -163.37 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.227 -0.921 . . . . 0.0 110.405 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -54.17 -59.32 4.81 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.398 -0.814 . . . . 0.0 111.935 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -107.36 130.01 54.84 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.138 -0.976 . . . . 0.0 110.755 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -102.82 117.85 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.599 -0.688 . . . . 0.0 109.21 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -66.11 -49.34 67.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 111.051 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -59.86 -40.29 88.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 111.508 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.522 ' NH2' ' O ' ' A' ' 144' ' ' GLY . 28.1 mmt180 -60.01 -41.27 91.77 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.686 -1.259 . . . . 0.0 109.611 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -69.96 -40.01 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 108.645 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.99 89.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.533 -0.73 . . . . 0.0 109.35 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.41 93.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.198 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.472 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.3 t-160 -69.98 -46.61 64.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 0.0 109.552 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -59.13 -40.51 85.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.005 -1.059 . . . . 0.0 109.556 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.62 -35.71 81.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 108.819 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.77 -40.46 96.66 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -66.93 -38.27 85.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.366 -1.079 . . . . 0.0 109.589 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 88.0 p -69.5 -23.13 63.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.237 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -86.89 -2.3 58.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.186 -0.946 . . . . 0.0 109.143 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.54 14.49 65.66 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.69 128.29 34.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.924 -1.339 . . . . 0.0 108.714 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.9 m -87.74 173.8 8.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 109.954 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -67.15 158.51 31.06 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.278 -0.889 . . . . 0.0 110.019 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.1 t -127.75 156.67 42.08 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.54 -0.725 . . . . 0.0 109.59 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 70.4 p -100.98 8.4 43.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.539 -0.726 . . . . 0.0 109.708 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -81.0 130.04 34.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.215 -0.928 . . . . 0.0 109.257 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.98 -39.79 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 0.0 110.331 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.63 1.41 72.6 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.238 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.53 137.87 34.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.686 -1.479 . . . . 0.0 109.146 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.16 -25.17 66.03 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.41 -0.807 . . . . 0.0 109.021 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 66.5 mmm -74.09 62.04 0.88 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.394 -0.816 . . . . 0.0 109.043 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -72.1 129.44 87.79 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.409 -0.807 . . . . 0.0 108.852 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -48.21 -59.9 1.07 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.404 1.18 . . . . 0.0 111.829 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 14.1 t -102.98 173.25 6.39 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.334 -0.854 . . . . 0.0 109.589 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.451 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 74.1 t80 -85.77 138.81 31.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.808 -1.183 . . . . 0.0 109.0 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 p -154.03 -171.87 4.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 109.905 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' CD1' ' O ' ' A' ' 142' ' ' PHE . 44.3 p90 -61.44 130.18 44.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.1 p -92.81 156.64 16.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 0.0 109.864 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.522 ' O ' ' NH2' ' A' ' 114' ' ' ARG . . . -104.82 -127.62 6.04 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' C ' ' NH2' ' A' ' 114' ' ' ARG . 36.6 p-10 -85.06 152.17 23.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.072 -1.252 . . . . 0.0 108.7 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 84.3 t -85.21 89.74 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.932 -1.105 . . . . 0.0 109.927 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -150.03 154.17 37.71 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.181 -0.949 . . . . 0.0 109.049 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.78 146.96 39.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.982 -1.074 . . . . 0.0 108.954 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.4 161.47 14.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.475 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -60.26 -39.92 88.49 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.0 -41.53 87.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -74.08 -40.09 63.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 110.007 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.14 -50.16 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.017 -1.052 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -60.61 -39.87 89.78 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.918 -1.114 . . . . 0.0 109.734 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -61.12 -60.94 7.51 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 120.295 -0.955 . . . . 0.0 110.777 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.2 tp -60.25 -39.93 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.341 . . . . 0.0 109.274 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.544 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.5 mt-30 -65.73 -38.09 88.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.094 -1.004 . . . . 0.0 109.035 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.95 95.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.69 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.2 -50.12 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.194 -0.941 . . . . 0.0 109.2 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -96.96 -71.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.327 -0.858 . . . . 0.0 109.578 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.94 -177.57 38.96 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.56 146.42 24.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -1.223 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.3 m -76.41 77.54 3.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.209 -0.932 . . . . 0.0 108.699 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.508 ' O ' ' ND2' ' A' ' 165' ' ' ASN . 95.4 mm-40 -100.3 125.06 46.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.451 -0.78 . . . . 0.0 109.494 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 164' ' ' GLN . 28.4 m120 -154.5 75.48 5.75 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.83 . . . . 0.0 109.022 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -83.29 52.57 3.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.368 1.379 . . . . 0.0 111.373 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.9 126.82 41.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 108.886 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -125.94 79.65 68.55 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.58 -0.7 . . . . 0.0 109.544 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo . . . . . 0 N--CA 1.491 1.333 0 CA-C-O 117.949 -0.938 . . . . 0.0 112.11 -179.97 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.528 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.265 0.555 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.2 mp -60.05 -40.08 88.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 0.0 109.557 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.9 p -91.66 160.19 15.49 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.252 -0.905 . . . . 0.0 109.886 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -75.83 130.06 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.16 -168.28 44.53 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 149.77 70.3 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.143 -1.21 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.73 128.71 25.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 CA-C-N 119.33 0.796 . . . . 0.0 111.399 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 8' ' ' ARG . 36.6 mtt-85 -91.55 166.1 13.01 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.26 -0.9 . . . . 0.0 109.892 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.1 126.03 30.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.186 -0.946 . . . . 0.0 109.173 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.35 -12.99 53.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 110.103 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -81.66 153.62 26.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.6 p -97.42 -6.28 34.31 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.302 -0.874 . . . . 0.0 108.82 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 34.1 m170 -126.64 143.78 51.12 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -133.2 159.58 39.76 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.194 -0.941 . . . . 0.0 109.859 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 73.5 p -127.54 152.98 46.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -142.86 156.11 44.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.722 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.8 ttt-85 -150.21 131.8 14.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 0.0 109.86 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -89.96 118.47 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.59 -40.05 95.96 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 0.0 110.735 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -162.5 153.15 17.06 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.953 -1.092 . . . . 0.0 109.901 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -98.62 136.53 38.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -69.86 139.58 88.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.128 -0.983 . . . . 0.0 109.002 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -66.92 -14.05 42.26 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 CA-C-N 119.614 0.898 . . . . 0.0 111.588 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.14 -38.19 82.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.352 -0.842 . . . . 0.0 109.037 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -134.74 149.96 72.15 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.03 -176.96 0.69 Allowed 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.643 0.896 . . . . 0.0 111.859 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -87.29 -35.34 18.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 109.613 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.1 82.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.18 -0.95 . . . . 0.0 109.538 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -70.09 -40.1 75.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.007 . . . . 0.0 109.773 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -71.35 -46.08 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.682 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -59.62 -39.99 86.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.094 -1.003 . . . . 0.0 108.782 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -59.93 -46.9 87.89 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.353 -0.842 . . . . 0.0 109.813 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.4 92.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.206 -0.934 . . . . 0.0 109.827 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mm -69.47 -36.87 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.065 -1.022 . . . . 0.0 108.657 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.06 -39.96 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -60.15 -39.91 88.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.82 -1.175 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.05 -50.54 72.92 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.368 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -62.94 -40.21 96.94 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.037 -1.04 . . . . 0.0 110.196 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.19 -44.81 94.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.962 -1.086 . . . . 0.0 109.623 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.1 -44.12 95.06 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.247 -0.908 . . . . 0.0 111.016 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -70.12 -41.83 73.45 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.681 -1.262 . . . . 0.0 109.802 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.8 t -69.86 -30.57 68.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.305 -0.872 . . . . 0.0 110.359 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -59.88 -34.36 73.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 0.0 111.152 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.488 HG23 HG23 ' A' ' 45' ' ' THR . 32.9 m -110.01 11.02 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 O-C-N 121.103 -0.998 . . . . 0.0 111.168 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.488 HG23 HG23 ' A' ' 44' ' ' VAL . 65.0 p -140.91 148.15 51.09 Favored Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 120.898 -1.126 . . . . 0.0 109.367 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -69.69 9.12 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.572 0.848 . . . . 0.0 111.967 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.88 156.42 37.71 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.445 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 30.5 p -135.39 149.86 49.76 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.4 156.66 40.21 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.316 -0.865 . . . . 0.0 109.962 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.9 m -154.39 131.19 10.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.0 109.803 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -77.02 143.74 39.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.454 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -122.42 134.51 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.2 t -97.25 -4.08 39.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 0.0 110.454 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -145.13 159.06 43.57 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.911 -1.118 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.03 173.07 34.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -81.06 151.15 28.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -1.149 . . . . 0.0 108.898 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.33 153.54 23.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.382 -0.824 . . . . 0.0 109.206 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -59.85 -40.94 90.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 82.5 mt -119.93 119.46 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.642 -0.661 . . . . 0.0 109.389 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.1 mtp -103.82 131.38 51.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.409 -0.807 . . . . 0.0 108.867 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.88 129.38 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.495 -0.753 . . . . 0.0 109.493 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.9 p -150.52 159.69 44.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.184 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.19 137.27 44.43 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.01 160.09 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.212 -0.93 . . . . 0.0 111.169 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -128.71 137.81 51.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.775 -0.578 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.25 -141.57 3.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -71.72 126.96 31.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.409 -1.054 . . . . 0.0 109.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -133.65 55.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.616 -0.677 . . . . 0.0 109.345 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 69' ' ' ARG . 50.9 mtt-85 54.98 52.27 12.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.503 -0.748 . . . . 0.0 109.761 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.4 161.28 37.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -90.99 9.43 30.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.459 -0.775 . . . . 0.0 110.379 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.5 t -139.74 72.91 35.21 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.234 -0.916 . . . . 0.0 109.106 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.31 152.06 79.76 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.234 1.289 . . . . 0.0 112.278 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -77.79 150.33 34.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.81 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -129.65 72.42 1.48 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.545 -0.722 . . . . 0.0 109.824 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.11 170.47 38.17 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' O ' ' OE2' ' A' ' 101' ' ' GLU . 10.5 Cg_endo -65.2 -24.72 58.35 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.366 1.377 . . . . 0.0 112.046 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.62 -177.98 46.7 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.8 -137.68 14.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.605 ' ND2' ' H ' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -76.02 122.15 23.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.485 -1.009 . . . . 0.0 109.83 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 80' ' ' ASN . 63.7 mt -90.61 -17.52 26.77 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.009 -1.057 . . . . 0.0 109.993 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.605 ' H ' ' ND2' ' A' ' 80' ' ' ASN . . . -170.07 160.42 8.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.085 -1.009 . . . . 0.0 109.273 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.88 179.99 8.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.946 -1.097 . . . . 0.0 110.269 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.52 173.32 12.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.38 -0.825 . . . . 0.0 109.765 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.25 146.87 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 3.9 mp0 -59.72 146.99 79.59 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.901 -1.125 . . . . 0.0 108.397 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -51.04 113.32 1.05 Allowed 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 120.498 0.799 . . . . 0.0 112.646 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.43 -178.3 34.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.05 176.84 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.246 1.298 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.32 -121.55 24.58 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.676 -0.774 . . . . 0.0 111.216 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -78.8 -10.45 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.577 -0.955 . . . . 0.0 110.284 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.37 151.39 13.89 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.24 -19.17 32.63 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.06 157.0 36.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -1.098 . . . . 0.0 110.6 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HB1' ' OE1' ' A' ' 119' ' ' GLU . . . -146.67 122.95 10.92 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -102.07 146.0 28.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.858 . . . . 0.0 110.667 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.548 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 16.1 m-85 -117.49 138.31 51.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.444 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 7.9 t70 -65.9 118.39 9.64 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.032 -1.042 . . . . 0.0 108.599 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -97.9 -1.44 42.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.202 -0.936 . . . . 0.0 110.052 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -75.39 -18.61 59.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.202 -0.936 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 77' ' ' PRO . 95.9 mt-10 -97.63 158.1 15.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.468 -0.77 . . . . 0.0 109.202 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -86.53 115.14 23.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.97 -1.081 . . . . 0.0 109.703 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 93.3 m95 -90.12 148.5 22.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.489 -0.757 . . . . 0.0 109.471 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 20.1 p -127.97 159.4 35.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.437 -0.79 . . . . 0.0 109.115 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -113.73 30.26 7.38 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.709 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -147.58 -164.4 2.0 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.002 -1.062 . . . . 0.0 110.722 -178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 90.7 t80 -73.72 25.68 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.661 -0.649 . . . . 0.0 110.703 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.536 ' CG ' HD21 ' A' ' 106' ' ' ASN . 26.9 mmt180 -76.1 -168.06 0.86 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.612 -1.305 . . . . 0.0 109.904 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -62.52 -57.74 10.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 0.0 112.208 -177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -99.5 118.57 36.37 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.685 -1.26 . . . . 0.0 111.431 -177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.48 116.52 31.81 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.339 -0.851 . . . . 0.0 109.475 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.5 tp -63.53 -38.45 91.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.428 -0.795 . . . . 0.0 109.688 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.443 ' CE1' HG11 ' A' ' 146' ' ' VAL . 13.1 t-80 -59.78 -39.96 86.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 111.16 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.41 HH11 ' HG2' ' A' ' 114' ' ' ARG . 7.2 tpt180 -59.4 -43.87 92.89 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.848 -1.157 . . . . 0.0 109.857 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.77 -39.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.062 -1.024 . . . . 0.0 109.525 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.21 -44.9 92.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.79 93.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.362 -0.837 . . . . 0.0 109.617 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.664 ' ND1' HOM2 ' A' ' 173' ' ' CGS . 5.3 t60 -69.89 -46.3 65.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.846 . . . . 0.0 110.882 -178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.548 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 80.5 mt-10 -59.86 -40.46 88.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.748 -1.22 . . . . 0.0 109.329 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.1 mt -61.57 -39.53 91.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.258 -0.901 . . . . 0.0 108.572 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.66 -40.27 78.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -65.05 -37.89 89.05 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.176 -1.191 . . . . 0.0 108.716 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.0 p -70.27 -24.74 63.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.572 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.52 -2.99 58.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.151 -0.968 . . . . 0.0 108.821 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.77 15.79 62.72 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -82.9 130.16 35.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.571 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.3 m -88.25 169.97 11.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -68.57 156.6 37.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.386 -0.821 . . . . 0.0 109.114 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 36.6 t -131.96 160.84 34.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.85 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 36.1 p -99.54 6.81 45.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.329 -0.857 . . . . 0.0 109.685 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 59.8 t0 -79.91 131.09 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.056 -1.027 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.406 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 96.6 mt -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.459 -0.775 . . . . 0.0 109.988 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.38 -2.74 68.74 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.183 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.95 131.69 34.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.75 -1.441 . . . . 0.0 109.8 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 mt -70.01 -29.87 67.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 89.0 mmm -75.59 53.95 0.74 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.186 -0.947 . . . . 0.0 109.732 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.2 140.27 87.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -65.84 4.03 1.01 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 CA-C-N 119.949 1.017 . . . . 0.0 111.636 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.2 p -156.95 177.53 11.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 109.625 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.495 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 84.5 t80 -90.71 135.73 33.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.838 -1.164 . . . . 0.0 110.001 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 49.2 p -149.74 169.3 21.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.333 -0.855 . . . . 0.0 109.539 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -76.66 123.25 25.86 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.259 -0.901 . . . . 0.0 109.046 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 52.1 m -118.93 132.42 56.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.748 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.48 -112.58 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 48.9 t0 -82.75 152.28 25.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -1.136 . . . . 0.0 108.974 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.551 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.8 t -86.37 107.4 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.907 . . . . 0.0 109.427 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -142.54 151.5 41.67 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.345 -0.847 . . . . 0.0 108.92 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.64 147.85 39.19 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.119 -0.988 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.94 153.27 19.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -58.03 -39.33 78.11 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -53.58 -39.98 65.28 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.145 -0.972 . . . . 0.0 108.484 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -72.76 -39.95 66.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.279 -0.888 . . . . 0.0 108.701 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.42 -50.2 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 0.0 108.769 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -61.6 -40.05 93.42 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.381 -0.824 . . . . 0.0 109.57 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.76 -55.75 13.37 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.756 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.1 tp -63.11 -40.19 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.923 -1.34 . . . . 0.0 109.616 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.533 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.2 mt-30 -69.6 -38.83 77.45 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.25 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.57 94.59 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.112 -0.992 . . . . 0.0 109.38 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.56 -50.06 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -96.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.358 -0.839 . . . . 0.0 109.602 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.28 -173.52 40.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.44 ' HB2' HE21 ' A' ' 164' ' ' GLN . 97.6 mtt180 -89.06 148.25 23.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -1.113 . . . . 0.0 109.36 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 73.3 m -73.96 88.72 1.87 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 162' ' ' ARG . 93.8 mm-40 -82.51 33.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.515 -0.74 . . . . 0.0 109.245 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -153.45 72.61 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.338 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -82.32 68.32 7.8 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.552 1.501 . . . . 0.0 111.598 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.8 p -85.58 134.9 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -71.5 149.11 93.49 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 CA-C-O 118.112 -0.87 . . . . 0.0 111.8 179.168 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.664 HOM2 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.1 mp -60.82 -40.69 93.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 p -92.21 162.6 14.24 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.49 130.52 39.76 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.54 -169.06 54.68 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.906 -1.677 . . . . 0.0 108.906 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -80.22 148.39 67.11 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.896 -1.355 . . . . 0.0 109.194 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.63 152.81 71.3 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 120.635 0.89 . . . . 0.0 111.82 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -149.0 159.2 44.44 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.893 -1.129 . . . . 0.0 109.786 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -82.17 124.15 29.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.01 . . . . 0.0 108.852 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -84.31 -14.01 50.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.13 -0.981 . . . . 0.0 109.649 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -87.3 147.34 25.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 110.317 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.6 p -94.64 -4.72 47.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.221 -0.924 . . . . 0.0 108.808 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 66.9 m80 -120.69 133.3 55.36 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.7 mt -131.8 156.33 46.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.143 -0.973 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -128.58 155.64 44.61 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.421 -0.799 . . . . 0.0 109.511 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -147.01 161.33 41.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.453 -0.779 . . . . 0.0 109.507 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -149.0 133.96 18.07 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.403 -0.811 . . . . 0.0 109.973 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.8 mt -89.9 118.52 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 93.4 mt-10 -65.94 -41.32 91.44 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.074 -1.016 . . . . 0.0 109.842 -179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 70.8 m-20 -158.14 158.0 33.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.275 -0.891 . . . . 0.0 110.126 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -101.04 134.45 44.02 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.9 t -68.89 138.02 90.18 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.801 -1.187 . . . . 0.0 108.648 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -66.09 -8.2 19.4 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.659 0.914 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.98 -39.86 87.13 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 mt -136.89 148.19 62.13 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -58.47 -177.94 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.646 0.897 . . . . 0.0 111.576 179.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -86.47 -33.72 20.29 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.004 -1.06 . . . . 0.0 109.614 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.51 89.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.163 -0.961 . . . . 0.0 109.905 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -70.44 -39.55 74.29 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.214 -0.929 . . . . 0.0 110.016 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.55 -40.09 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 108.962 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.41 -43.1 93.06 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.16 -45.06 94.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.258 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.26 88.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.4 -42.87 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.59 -179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.07 -40.68 74.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.888 . . . . 0.0 109.855 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -61.01 -40.1 92.28 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 108.921 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.26 -45.14 94.64 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.317 -0.864 . . . . 0.0 110.122 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -61.35 -40.17 93.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.766 -1.209 . . . . 0.0 109.398 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -60.56 -42.25 96.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.37 -45.29 94.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.142 -0.974 . . . . 0.0 110.135 -179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.42 ' CH2' HD22 ' A' ' 148' ' ' LEU . 90.7 m95 -73.69 -42.51 61.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.041 -1.037 . . . . 0.0 110.21 -179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.7 t -66.73 -37.97 85.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 110.35 -178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -57.8 -22.91 49.91 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.497 -178.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.34 7.68 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.252 -0.905 . . . . 0.0 110.315 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -145.72 149.49 40.09 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.014 -1.054 . . . . 0.0 109.184 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -70.92 7.47 1.31 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.615 0.877 . . . . 0.0 111.79 178.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.05 154.98 41.25 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.256 -0.903 . . . . 0.0 109.833 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 43.9 p -133.85 150.05 51.37 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -125.74 159.43 32.36 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.399 -0.813 . . . . 0.0 110.295 -178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.7 m -154.41 126.63 7.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.524 -0.735 . . . . 0.0 109.963 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -80.38 136.87 36.46 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.271 -0.893 . . . . 0.0 110.204 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.95 135.11 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.466 -0.771 . . . . 0.0 109.172 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 t -98.21 -4.33 35.64 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.38 -0.825 . . . . 0.0 110.624 -179.359 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -142.38 155.36 45.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.893 -1.129 . . . . 0.0 110.111 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 177.39 50.61 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -82.26 143.48 31.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 108.965 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.77 150.89 25.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.368 -0.832 . . . . 0.0 109.002 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -59.8 -40.38 88.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 108.978 -179.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.4 mt -119.61 118.87 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.717 . . . . 0.0 109.259 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.1 mmm -99.62 130.77 45.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.863 . . . . 0.0 108.878 179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -117.45 130.72 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.6 p -149.28 160.31 43.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.97 -179.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -107.7 139.18 42.65 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.58 160.45 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 121.03 -1.043 . . . . 0.0 111.223 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -129.5 136.69 50.18 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.596 0.712 . . . . 0.0 110.118 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.15 -141.86 2.98 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.76 130.5 43.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -1.053 . . . . 0.0 109.385 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -138.18 53.3 1.82 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 109.803 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 53.61 59.64 4.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.194 -0.941 . . . . 0.0 108.912 -179.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -148.95 160.39 43.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.441 -0.787 . . . . 0.0 109.048 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -89.37 9.44 26.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.175 -0.953 . . . . 0.0 109.733 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -136.47 71.06 59.99 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.377 -0.827 . . . . 0.0 109.367 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -68.42 144.89 63.24 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.061 1.174 . . . . 0.0 112.018 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -76.93 143.78 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.138 -0.976 . . . . 0.0 109.61 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -105.05 70.33 0.9 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.314 -0.866 . . . . 0.0 108.717 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.27 -165.98 42.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.93 -13.23 8.5 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.17 1.246 . . . . 0.0 112.597 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -93.42 -177.98 39.99 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.42 -158.12 28.48 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.698 ' CG ' HG12 ' A' ' 173' ' ' CGS . 96.6 m-20 -74.87 149.89 39.38 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.407 -1.054 . . . . 0.0 109.286 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.35 -20.58 19.02 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.05 -1.032 . . . . 0.0 109.596 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.96 168.62 5.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 108.582 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -166.29 122.91 1.31 Allowed 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.541 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.78 168.48 13.46 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.408 0.623 . . . . 0.0 109.408 179.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -106.08 153.72 21.66 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -59.58 145.36 82.93 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.007 -1.058 . . . . 0.0 108.777 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.31 101.44 0.29 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 120.441 0.76 . . . . 0.0 111.709 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.64 174.87 35.75 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -70.28 -179.81 3.42 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 120.878 1.052 . . . . 0.0 111.203 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.47 -127.16 39.19 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -73.8 -14.33 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.382 -1.069 . . . . 0.0 110.28 -179.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.41 139.45 48.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -16.63 60.29 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -67.78 160.25 28.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -1.176 . . . . 0.0 109.367 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -144.74 120.86 10.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.052 -1.03 . . . . 0.0 109.227 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -104.31 136.66 43.49 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.664 -0.648 . . . . 0.0 110.427 -178.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -115.81 136.7 52.8 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.667 -0.645 . . . . 0.0 109.615 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -65.82 118.97 10.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.367 -0.833 . . . . 0.0 109.027 179.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -99.58 -0.6 40.1 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 108.778 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -75.36 -13.04 60.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -105.58 152.17 23.42 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -89.53 120.07 30.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.133 -0.979 . . . . 0.0 109.178 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -84.13 153.5 23.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 -179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 80.7 p -117.76 164.69 14.62 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.523 0.677 . . . . 0.0 109.621 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.88 28.88 5.79 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -150.03 -165.04 2.17 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.796 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -92.66 34.04 1.1 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.48 -0.762 . . . . 0.0 109.8 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -76.23 -164.32 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -47.72 -57.56 5.4 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.402 -0.811 . . . . 0.0 110.835 -178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.91 149.83 23.14 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.727 -1.233 . . . . 0.0 110.767 -178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -148.36 91.25 1.88 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.0 109.032 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.3 tp -60.03 -39.83 87.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.195 -0.941 . . . . 0.0 110.818 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -60.15 -41.22 92.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.732 -1.23 . . . . 0.0 109.773 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -60.04 -43.0 95.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.955 -1.091 . . . . 0.0 109.759 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 83.9 t -69.85 -40.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.365 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.57 -43.69 89.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.161 -0.962 . . . . 0.0 108.877 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.446 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 6.2 t60 -68.98 -42.77 76.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 0.0 109.847 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.32 -40.41 86.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.139 -0.976 . . . . 0.0 108.765 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.3 -39.14 93.74 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.344 -0.848 . . . . 0.0 109.373 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.26 85.34 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -65.75 -35.57 81.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.239 . . . . 0.0 108.804 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 59.8 m -71.65 -28.72 63.95 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.54 -0.725 . . . . 0.0 109.892 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.66 -2.54 56.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.164 -0.96 . . . . 0.0 109.37 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.84 11.84 67.32 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.4 mt -82.27 129.54 34.88 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.83 -1.394 . . . . 0.0 109.042 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 56.0 m -88.72 169.93 11.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.873 . . . . 0.0 109.228 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -64.42 158.97 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.119 -0.988 . . . . 0.0 108.466 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.8 t -124.46 164.65 19.27 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 76.1 p -99.35 9.67 42.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.319 -0.863 . . . . 0.0 110.032 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -84.84 127.17 34.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.502 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.9 -37.33 71.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.507 -0.746 . . . . 0.0 110.598 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.09 1.14 85.99 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 120.981 -1.075 . . . . 0.0 111.45 -178.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.88 138.74 33.78 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.517 -1.578 . . . . 0.0 109.406 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.52 -29.72 67.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.9 . . . . 0.0 109.679 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.1 mmm -74.56 54.52 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.675 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.6 t80 -71.29 136.69 84.12 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.871 -1.143 . . . . 0.0 108.643 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.17 9.25 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.908 1.003 . . . . 0.0 112.061 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 36.6 t -164.29 175.89 9.65 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.518 ' CE1' ' O ' ' A' ' 141' ' ' THR . 53.6 t80 -82.26 154.86 25.16 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.221 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.518 ' O ' ' CE1' ' A' ' 140' ' ' TYR . 60.1 p -150.05 -175.47 5.07 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.426 -0.796 . . . . 0.0 109.499 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -60.07 150.62 28.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.027 -1.045 . . . . 0.0 109.749 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.8 p -72.68 160.19 32.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.329 -0.857 . . . . 0.0 109.565 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -163.51 -152.51 6.9 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -83.65 132.96 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.92 -1.341 . . . . 0.0 109.584 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t -85.82 98.64 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.807 . . . . 0.0 109.199 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -146.94 149.7 33.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 108.997 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.42 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.5 mt -75.05 142.69 43.72 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.458 178.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.0 164.28 13.15 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.377 -0.827 . . . . 0.0 109.12 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -59.81 -39.34 84.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.273 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -58.43 -40.96 83.97 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -74.5 -40.48 61.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -0.887 . . . . 0.0 110.232 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 93.0 mt -61.81 -50.24 81.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.132 -179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -62.25 -40.23 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.439 178.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -56.66 -61.09 7.88 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -63.48 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.99 -1.3 . . . . 0.0 110.26 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 161' ' ' GLY . 26.2 mt-30 -63.76 -39.67 94.85 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.807 -1.183 . . . . 0.0 109.495 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.39 92.75 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 109.727 -179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.6 mt -60.52 -49.01 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.002 . . . . 0.0 110.167 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -99.48 -62.2 1.27 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.216 -0.928 . . . . 0.0 110.263 -179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.74 -176.47 34.03 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -87.76 148.66 24.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.024 -1.28 . . . . 0.0 109.267 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.1 m -74.96 67.42 1.68 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.843 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.52 99.94 10.61 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -156.33 78.91 4.07 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -80.46 41.02 1.06 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 120.905 1.07 . . . . 0.0 111.482 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.7 m -85.75 135.62 24.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -74.62 149.34 86.04 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 N--CA 1.491 1.353 0 CA-C-O 118.014 -0.911 . . . . 0.0 112.466 -179.871 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.698 HG12 ' CG ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.746 HD22 ' H ' ' A' ' 2' ' ' LEU . 2.7 mm? -62.6 -41.97 99.29 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 6' ' ' ASN . 38.2 p -100.48 143.26 30.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 110.202 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -80.38 95.57 6.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.811 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 23.47 77.39 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.367 178.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' O ' ' OG1' ' A' ' 3' ' ' THR . 7.9 m120 -154.37 69.45 6.04 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 120.56 -1.553 . . . . 0.0 110.308 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -60.22 152.15 68.3 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.097 1.198 . . . . 0.0 111.789 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -142.44 150.81 41.09 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -80.29 126.38 31.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.982 -1.074 . . . . 0.0 108.706 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -82.9 -10.06 59.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.361 -0.837 . . . . 0.0 109.724 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -79.58 150.09 31.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 109.664 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.9 p -96.74 -3.99 41.44 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -129.52 138.69 51.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.48 159.97 37.83 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.15 -0.969 . . . . 0.0 110.776 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.0 p -126.2 154.04 43.82 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.59 0.709 . . . . 0.0 109.144 179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.1 p90 -143.5 156.18 44.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.31 -0.869 . . . . 0.0 109.422 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 17' ' ' ARG . 35.4 ttt-85 -149.57 132.25 15.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 109.432 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.425 ' H ' ' NZ ' ' A' ' 51' ' ' LYS . 94.3 mt -89.25 121.05 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.188 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -64.87 -39.67 93.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.114 -0.991 . . . . 0.0 110.226 -178.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -161.55 156.7 23.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 110.255 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -102.02 139.45 37.63 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.63 -0.669 . . . . 0.0 109.425 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 22' ' ' THR . 1.7 t -74.03 145.81 84.07 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -67.53 -11.8 33.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 120.919 1.079 . . . . 0.0 111.518 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.1 -40.02 88.2 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.527 -0.733 . . . . 0.0 110.119 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 52.6 mt -139.06 151.6 68.23 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 121.186 -0.946 . . . . 0.0 108.523 -179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -62.94 -175.27 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 CA-C-N 119.392 0.819 . . . . 0.0 111.93 179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.41 -38.85 13.01 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.3 -0.875 . . . . 0.0 110.363 -179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -45.18 84.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.609 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -69.53 -39.13 77.69 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.397 -0.814 . . . . 0.0 109.616 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.97 -42.01 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.02 . . . . 0.0 109.168 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -59.3 -40.48 86.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 108.781 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -60.01 -46.37 89.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.007 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.847 . . . . 0.0 109.362 179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.0 -39.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.192 -0.942 . . . . 0.0 109.591 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.57 -41.56 88.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.8 mttt -60.72 -40.62 92.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.942 -1.099 . . . . 0.0 110.415 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.46 85.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.944 -1.098 . . . . 0.0 109.208 -179.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -62.23 -40.51 96.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.947 -1.096 . . . . 0.0 109.368 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -60.58 -43.28 97.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 110.223 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.4 mt -59.75 -42.75 93.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.96 . . . . 0.0 110.265 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -70.44 -40.5 73.73 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.889 -1.132 . . . . 0.0 109.734 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 t -69.77 -32.41 70.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.792 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.02 -33.38 68.89 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.113 -0.992 . . . . 0.0 111.089 -178.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.44 10.98 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.028 -1.045 . . . . 0.0 110.461 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.9 p -146.55 150.36 40.06 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 120.883 -1.135 . . . . 0.0 109.654 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.49 1.44 4.92 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.744 0.962 . . . . 0.0 111.467 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.01 153.1 44.37 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.406 -0.809 . . . . 0.0 109.275 -179.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.8 p -133.13 149.94 52.07 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -128.2 149.52 50.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.446 -0.784 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 94.5 m -152.92 133.09 13.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 109.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' NZ ' ' H ' ' A' ' 18' ' ' ILE . 62.7 tttp -75.64 144.47 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.53 -0.732 . . . . 0.0 109.786 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.4 136.58 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t -95.76 -1.47 49.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.328 -178.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -145.96 157.18 43.89 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.969 -1.082 . . . . 0.0 109.228 179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.78 159.03 13.36 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -79.07 137.39 37.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.13 -1.217 . . . . 0.0 109.529 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.15 149.75 22.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 109.473 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.33 -40.96 92.48 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.511 -0.743 . . . . 0.0 109.253 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.26 111.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.9 134.93 43.15 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.59 131.39 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 79.7 p -149.52 160.66 43.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.165 -0.96 . . . . 0.0 109.987 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.81 138.56 46.01 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.3 165.57 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 110.798 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -139.7 153.41 47.24 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.564 -0.71 . . . . 0.0 110.001 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.81 -148.68 0.38 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -64.3 130.91 45.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -1.08 . . . . 0.0 108.86 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.521 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 9.1 p-80 -136.38 57.08 1.79 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.611 -0.681 . . . . 0.0 109.899 -178.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 53.82 53.71 10.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.131 -0.981 . . . . 0.0 109.932 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' SER . 12.0 t70 -144.75 159.28 43.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 98.7 m-20 -89.65 9.54 26.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.29 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 70.0 m -136.81 73.24 54.08 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.437 -0.789 . . . . 0.0 109.858 179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -63.05 155.82 58.59 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.04 1.16 . . . . 0.0 112.232 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -77.47 150.24 34.94 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.508 -0.745 . . . . 0.0 109.154 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.25 77.55 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.15 -172.42 11.56 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -55.8 -14.42 10.69 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.414 1.41 . . . . 0.0 112.417 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.0 178.21 41.96 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 -153.39 26.84 Favored Glycine 0 N--CA 1.492 2.391 0 O-C-N 121.413 -1.051 . . . . 0.0 110.533 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.522 HD21 ' C ' ' A' ' 82' ' ' ALA . 9.0 t30 -72.62 136.68 45.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.946 -0.738 . . . . 0.0 110.25 -179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.2 mt -94.3 -19.91 20.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 109.887 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.522 ' C ' HD21 ' A' ' 80' ' ' ASN . . . -168.5 159.06 9.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.925 -1.109 . . . . 0.0 110.045 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -163.06 -179.85 7.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.396 -0.815 . . . . 0.0 109.814 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.47 167.78 19.13 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.237 -0.915 . . . . 0.0 109.429 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -97.83 153.54 18.23 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.978 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -58.64 149.32 63.05 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.186 -0.946 . . . . 0.0 109.63 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.92 104.59 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 120.723 0.949 . . . . 0.0 111.655 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -63.68 -179.76 0.79 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 120.87 1.047 . . . . 0.0 111.434 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 61.06 -123.1 31.66 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 179.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.3 tt -82.58 -10.05 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.589 -0.948 . . . . 0.0 110.218 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.26 139.78 47.45 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.001 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.62 -15.97 52.17 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -64.97 127.37 31.32 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.857 -1.378 . . . . 0.0 110.093 -179.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.73 127.36 47.18 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -111.21 138.6 47.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.3 -0.875 . . . . 0.0 109.934 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.517 ' CE2' ' OE2' ' A' ' 119' ' ' GLU . 30.9 m-85 -119.99 134.44 55.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.671 -0.643 . . . . 0.0 109.652 179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.448 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 46.2 t0 -67.88 120.09 13.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -99.57 1.28 43.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.129 -0.982 . . . . 0.0 109.427 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -74.56 -19.71 60.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.003 -1.061 . . . . 0.0 109.388 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.317 -0.864 . . . . 0.0 108.96 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 102' ' ' ARG . 28.5 ttt-85 -85.85 120.08 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.063 -1.023 . . . . 0.0 108.701 179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.448 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 92.8 m95 -89.52 146.64 24.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.805 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 34.2 p -123.18 161.16 25.02 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.494 -0.754 . . . . 0.0 109.339 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.22 29.44 7.8 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.764 HD21 ' HE ' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -149.03 -164.99 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.752 179.917 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -80.68 31.58 0.3 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.278 -0.889 . . . . 0.0 110.956 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.764 ' HE ' HD21 ' A' ' 106' ' ' ASN . 61.2 mtm180 -74.57 -166.62 0.46 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.739 -1.226 . . . . 0.0 109.723 179.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -48.74 -58.49 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.661 -0.649 . . . . 0.0 111.704 -178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.434 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.9 m-85 -107.52 129.8 54.93 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.971 -1.081 . . . . 0.0 110.975 -178.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -102.48 112.67 25.5 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.37 -41.4 76.6 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.31 -0.869 . . . . 0.0 111.207 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -59.74 -41.33 90.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.81 -1.181 . . . . 0.0 109.528 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.407 HH11 ' HB2' ' A' ' 143' ' ' SER . 71.7 ttt180 -59.8 -43.45 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.464 -0.772 . . . . 0.0 110.257 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.1 t -69.93 -39.79 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.189 -179.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.1 92.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.225 -0.922 . . . . 0.0 109.067 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.66 92.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.72 . . . . 0.0 109.612 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.503 ' ND1' HOM2 ' A' ' 173' ' ' CGS . 3.6 t-160 -66.74 -49.2 66.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 108.892 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.517 ' OE2' ' CE2' ' A' ' 97' ' ' PHE . 42.5 mt-10 -59.75 -41.44 91.02 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.13 -0.981 . . . . 0.0 110.079 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.76 -37.36 86.31 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.826 -1.171 . . . . 0.0 108.231 178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.52 -41.88 89.35 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -64.2 -35.91 82.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -1.149 . . . . 0.0 108.388 178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.6 m -69.03 -26.46 65.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.628 -0.67 . . . . 0.0 109.413 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.36 -4.3 59.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.133 -0.979 . . . . 0.0 109.354 179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.39 14.61 61.62 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.22 128.53 34.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.069 -1.253 . . . . 0.0 109.457 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.7 m -88.6 173.0 8.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.342 -0.848 . . . . 0.0 109.701 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 118' ' ' HIS . 66.1 m170 -68.29 157.03 36.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.334 -0.854 . . . . 0.0 109.014 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.7 t -125.01 164.4 20.24 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 64.5 p -97.41 4.34 50.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 109.318 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -82.07 124.95 30.28 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.949 -1.095 . . . . 0.0 109.674 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 95.7 mt -60.3 -39.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.409 -0.807 . . . . 0.0 110.387 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -77.83 5.65 51.91 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.356 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 142.75 30.42 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.65 -1.5 . . . . 0.0 109.292 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 137' ' ' TYR . 99.0 mt -59.78 -39.48 85.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 0.0 109.44 179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 31.1 mtp -71.1 67.85 0.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.473 -179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 139' ' ' SER . 1.5 t80 -71.69 124.89 91.6 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -52.11 -1.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.498 1.752 0 CA-C-N 120.488 1.21 . . . . 0.0 113.008 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 137' ' ' TYR . 50.3 m -167.75 166.96 13.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.071 -1.018 . . . . 0.0 108.486 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -85.66 136.85 33.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.688 -1.258 . . . . 0.0 108.84 179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 65.5 p -148.57 -162.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.247 -0.908 . . . . 0.0 108.863 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.45 131.9 51.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.137 -0.977 . . . . 0.0 109.159 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.407 ' HB2' HH11 ' A' ' 114' ' ' ARG . 39.5 t -105.34 125.93 51.53 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.346 -0.846 . . . . 0.0 109.949 -179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -102.45 -125.44 5.63 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -81.8 135.44 35.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.055 -1.262 . . . . 0.0 109.044 179.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t -89.62 108.43 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.969 -1.082 . . . . 0.0 109.458 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -148.73 159.44 44.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.411 -0.806 . . . . 0.0 109.093 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.72 144.49 43.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.014 -1.054 . . . . 0.0 108.821 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.79 163.16 13.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.193 -0.942 . . . . 0.0 109.013 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.95 -40.18 88.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 108.889 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -59.63 -41.37 90.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.264 -0.898 . . . . 0.0 109.835 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.24 -40.32 64.75 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.089 -1.007 . . . . 0.0 109.408 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.5 mt -64.94 -49.96 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.692 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -64.87 -39.76 94.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.091 . . . . 0.0 110.559 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.92 -54.72 26.31 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.067 -178.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.43 -38.56 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.996 -1.296 . . . . 0.0 109.377 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.9 mt-30 -68.05 -34.92 77.36 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.055 -1.028 . . . . 0.0 109.106 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.16 88.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.275 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.34 -50.56 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.099 -1.001 . . . . 0.0 108.911 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -97.84 -73.69 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.549 -0.72 . . . . 0.0 109.255 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 162.49 -169.34 37.74 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.1 mtm-85 -92.28 144.61 25.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.012 -1.287 . . . . 0.0 109.707 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.8 m -73.63 85.11 1.6 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.254 -0.904 . . . . 0.0 108.914 -179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -94.94 34.51 1.36 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.495 -0.753 . . . . 0.0 109.31 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -147.4 72.05 11.85 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 0.0 109.947 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -83.17 49.11 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.62 1.547 . . . . 0.0 111.318 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 167' ' ' VAL . 3.3 m -88.2 134.95 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.349 -0.844 . . . . 0.0 109.511 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -72.77 148.9 90.12 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 108.95 -179.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 118.023 -0.907 . . . . 0.0 111.708 179.879 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.503 HOM2 ' ND1' ' A' ' 118' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 121.303 0.573 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.89 -39.93 91.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.816 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.4 p -137.8 160.02 40.42 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.225 -0.922 . . . . 0.0 109.94 -179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 6' ' ' ASN . 75.9 tt0 -73.03 169.5 16.85 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.49 20.35 0.05 OUTLIER Glycine 0 N--CA 1.495 2.585 0 O-C-N 121.037 -1.039 . . . . 0.0 110.607 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 4' ' ' GLU . 20.5 m120 -150.25 67.82 8.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.302 . . . . 0.0 108.772 179.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.0 160.76 32.41 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.357 1.371 . . . . 0.0 112.795 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -145.53 151.71 38.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.428 -0.795 . . . . 0.0 109.007 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -83.8 127.28 33.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.953 -1.092 . . . . 0.0 108.408 179.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.18 -10.78 59.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.025 -1.047 . . . . 0.0 110.272 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.466 ' CD ' ' H ' ' A' ' 11' ' ' GLN . 9.8 mp0 -85.79 149.49 25.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.755 -179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -94.46 -4.12 48.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.208 -0.932 . . . . 0.0 108.623 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.44 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 33.7 m-70 -128.88 141.53 51.25 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.9 mt -130.27 153.76 48.3 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.388 -0.82 . . . . 0.0 109.675 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 p -125.29 155.8 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -144.61 159.91 42.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.6 ttt-85 -149.29 133.14 17.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.294 -0.879 . . . . 0.0 110.099 -179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 88.1 mt -89.88 120.05 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -65.86 -40.09 91.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.069 -1.019 . . . . 0.0 110.04 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -159.95 155.34 25.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.017 . . . . 0.0 109.527 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -99.69 136.83 39.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.469 -0.769 . . . . 0.0 109.343 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 t -67.7 139.21 93.64 Favored Pre-proline 0 N--CA 1.487 1.395 0 O-C-N 121.15 -0.968 . . . . 0.0 108.628 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.55 -13.96 41.69 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 CA-C-N 119.561 0.879 . . . . 0.0 112.196 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -60.23 -40.21 89.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 0.0 110.393 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.84 149.37 70.41 Favored Pre-proline 0 N--CA 1.5 2.071 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -66.14 -175.92 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 CA-C-N 119.304 0.787 . . . . 0.0 111.831 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 15.9 ptm180 -87.38 -32.27 19.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.705 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -56.96 -44.86 83.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 0.0 110.15 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -76.05 -39.8 54.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.011 -1.056 . . . . 0.0 110.159 -179.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.41 -49.51 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.0 111.179 -178.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 32' ' ' HIS . 42.3 p-10 -58.98 -39.24 81.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.67 -1.269 . . . . 0.0 109.402 -179.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.535 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 86.4 t60 -59.82 -43.3 94.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.008 -1.057 . . . . 0.0 108.86 179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -41.26 91.5 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.25 -42.63 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -69.99 -39.12 76.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.052 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.31 -40.12 89.41 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.69 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.95 90.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.015 -1.053 . . . . 0.0 109.601 -179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 49' ' ' PHE . 32.5 m-85 -60.08 -40.14 88.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 109.025 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -60.03 -43.01 95.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 110.031 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.1 -43.95 95.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.703 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 93.7 m95 -71.2 -42.3 69.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.659 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.2 t -67.75 -32.53 73.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.37 -0.831 . . . . 0.0 110.834 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -59.22 -35.0 72.86 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.091 -1.006 . . . . 0.0 110.72 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.87 14.92 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.283 -0.885 . . . . 0.0 111.122 -178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 62.2 p -144.66 147.34 35.5 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 120.833 -1.167 . . . . 0.0 109.139 178.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.9 6.3 1.75 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 120.623 0.882 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -72.57 163.76 27.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.227 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 33.3 p -138.89 151.34 46.88 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 38' ' ' PHE . 97.7 m-85 -130.96 149.97 52.33 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.632 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.6 m -155.04 129.81 9.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 0.0 109.691 -179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -77.93 142.08 38.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.405 -0.81 . . . . 0.0 109.922 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.9 m -123.42 134.85 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t -97.13 -4.99 38.3 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.177 -0.952 . . . . 0.0 109.94 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -142.76 151.04 40.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.096 -1.003 . . . . 0.0 109.747 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.63 169.53 42.66 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -81.06 146.44 30.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -1.154 . . . . 0.0 109.025 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.79 157.08 18.91 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.41 -0.806 . . . . 0.0 109.209 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -59.98 -39.99 87.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.818 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.93 118.09 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.412 -0.805 . . . . 0.0 109.581 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -98.57 128.11 44.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 109.149 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.8 mt -110.68 129.94 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.468 -0.77 . . . . 0.0 109.106 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 90.4 p -148.41 155.11 40.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.94 . . . . 0.0 110.276 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -104.72 139.14 39.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.6 160.09 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.344 -0.847 . . . . 0.0 110.754 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -129.32 142.46 50.82 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.682 -0.636 . . . . 0.0 109.442 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 45.79 -140.99 5.23 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -78.65 128.08 32.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.44 -1.035 . . . . 0.0 109.285 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.588 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 2.6 p-80 -126.04 56.9 1.4 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 109.872 -179.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.436 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 31.1 mmt180 56.4 47.82 18.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.544 -0.723 . . . . 0.0 109.997 179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' ' CD2' ' A' ' 68' ' ' HIS . 98.2 m-20 -138.83 162.89 33.66 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.387 -0.82 . . . . 0.0 108.877 179.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -89.97 8.76 30.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.194 -0.942 . . . . 0.0 110.333 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.5 m -136.04 73.35 59.02 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.186 -0.946 . . . . 0.0 109.789 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -70.02 155.84 64.11 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.164 1.243 . . . . 0.0 112.188 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.91 150.36 32.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -121.94 75.02 1.18 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.546 -0.721 . . . . 0.0 109.438 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 61.14 -171.27 7.94 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -53.05 -8.97 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.26 1.307 . . . . 0.0 112.784 -179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.67 -177.27 46.81 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.83 -171.22 55.09 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -73.83 151.41 40.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.298 -1.119 . . . . 0.0 109.234 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.2 mt -91.01 -12.53 35.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.984 -1.073 . . . . 0.0 109.72 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.37 163.3 12.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -160.42 -179.6 7.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -0.817 . . . . 0.0 109.033 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.21 168.98 18.25 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.086 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.99 156.66 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.36 -0.838 . . . . 0.0 109.31 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -59.09 150.04 64.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 -179.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -61.58 101.38 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.157 0 CA-C-N 119.083 0.708 . . . . 0.0 111.398 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.42 175.88 35.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -68.68 179.85 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.801 1.001 . . . . 0.0 111.667 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.47 -130.55 40.73 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.2 tt -78.83 -7.96 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -1.19 . . . . 0.0 109.245 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.01 137.35 49.94 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.21 -15.63 52.76 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -67.91 124.64 23.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.884 -1.362 . . . . 0.0 109.964 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.13 149.87 21.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -132.9 132.5 42.12 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.427 -0.795 . . . . 0.0 109.668 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -117.78 135.38 54.09 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.407 -0.808 . . . . 0.0 109.914 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.466 ' O ' ' NE1' ' A' ' 103' ' ' TRP . 56.7 t0 -67.58 121.83 16.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.322 -0.861 . . . . 0.0 108.935 179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -98.98 0.02 43.05 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.358 -0.839 . . . . 0.0 109.834 -179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -74.36 -17.97 60.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.793 -1.192 . . . . 0.0 109.508 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.85 157.82 16.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -84.42 118.72 24.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.026 -1.047 . . . . 0.0 109.381 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.466 ' NE1' ' O ' ' A' ' 98' ' ' ASP . 97.8 m95 -88.24 147.2 24.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.365 -0.834 . . . . 0.0 109.818 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 16.7 p -129.51 157.21 42.66 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.83 31.49 5.97 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 5.9 p30 -145.91 -164.16 1.9 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.275 -178.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.77 30.85 0.36 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 110.21 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.442 ' CG ' ' OD1' ' A' ' 106' ' ' ASN . 12.9 mmt-85 -76.28 -164.36 0.38 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.169 -0.957 . . . . 0.0 109.999 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -58.92 -56.84 17.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.419 -0.8 . . . . 0.0 111.313 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -104.68 119.14 38.29 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.987 -1.07 . . . . 0.0 110.385 -178.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 106' ' ' ASN . 79.2 m-20 -96.33 112.2 24.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 179.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.1 tp -64.79 -42.26 95.18 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.331 -0.856 . . . . 0.0 110.665 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -60.05 -40.0 87.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.962 -1.086 . . . . 0.0 109.71 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 135' ' ' LEU . 20.3 tpt180 -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.354 -0.841 . . . . 0.0 109.89 -179.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.415 HG13 ' HD1' ' A' ' 173' ' ' CGS . 82.6 t -70.03 -39.39 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.198 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.76 -43.37 85.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 109.951 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.16 96.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 109.511 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.44 ' HB2' HOM2 ' A' ' 173' ' ' CGS . 5.3 t-160 -69.98 -48.26 58.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 0.0 109.737 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.4 -40.19 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.541 -1.349 . . . . 0.0 109.456 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.48 -31.64 72.94 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.94 -39.64 95.83 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -66.59 -34.49 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -1.082 . . . . 0.0 109.037 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 60.3 p -69.64 -23.24 63.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.225 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.3 mt -87.92 -4.94 58.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.205 -0.935 . . . . 0.0 109.221 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.91 16.7 59.22 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.35 131.11 35.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.927 -1.337 . . . . 0.0 109.809 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 62.5 m -88.41 171.56 10.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 108.989 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -68.59 159.15 32.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.171 -0.956 . . . . 0.0 109.968 -179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.3 t -125.08 157.41 36.35 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.53 -0.731 . . . . 0.0 109.461 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.1 p -99.89 3.82 44.73 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -81.43 126.9 32.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.0 -39.99 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.66 -178.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.37 -1.06 49.89 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.806 -1.187 . . . . 0.0 111.047 -178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.42 140.95 33.15 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.682 -1.481 . . . . 0.0 109.38 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.449 ' CD2' ' NH1' ' A' ' 114' ' ' ARG . 93.6 mt -66.47 -34.43 77.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.0 109.776 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 37.7 mtp -75.15 64.95 1.47 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.945 . . . . 0.0 110.297 -178.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 139' ' ' SER . 17.8 t80 -72.63 137.51 80.39 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 108.859 179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -62.83 7.09 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.603 0 CA-C-N 119.926 1.009 . . . . 0.0 112.127 179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 137' ' ' TYR . 31.1 p -159.0 174.67 14.6 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 108.704 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.533 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 58.7 t80 -87.45 121.28 29.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.795 -1.19 . . . . 0.0 110.118 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 30.4 p -149.18 160.01 43.74 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 142' ' ' PHE . 52.0 p90 -99.66 126.29 45.66 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.0 109.077 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 92.2 p -109.8 18.35 20.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.567 -0.708 . . . . 0.0 109.419 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.08 -116.42 4.21 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -79.97 140.39 36.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.265 -1.138 . . . . 0.0 109.849 -179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.487 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 39.7 t -88.46 117.84 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.438 -0.789 . . . . 0.0 109.536 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.487 ' NE2' ' O ' ' A' ' 146' ' ' VAL . 99.9 mm-40 -148.9 159.0 44.59 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 84.7 mt -76.09 139.85 41.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.963 -1.086 . . . . 0.0 108.765 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.55 164.88 13.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.14 -0.975 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.02 -40.51 89.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.216 -0.927 . . . . 0.0 109.521 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -58.0 -40.08 79.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.187 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -74.9 -40.9 60.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 109.829 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.2 mt -63.06 -50.01 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.103 -0.998 . . . . 0.0 109.57 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -62.63 -40.01 95.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.921 . . . . 0.0 110.153 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.15 -55.28 24.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.429 -178.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.7 tp -67.35 -40.0 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.89 -1.359 . . . . 0.0 110.227 -178.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.8 mt-30 -68.89 -40.1 79.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 0.0 110.085 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.97 -44.73 94.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.035 -1.041 . . . . 0.0 109.646 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.2 -49.43 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -96.77 -67.82 0.83 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.194 -0.941 . . . . 0.0 109.855 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.1 179.43 38.33 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.83 148.5 23.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.112 -1.228 . . . . 0.0 109.098 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.5 m -71.64 85.32 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.909 . . . . 0.0 109.623 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.37 34.14 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.337 -0.852 . . . . 0.0 109.784 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -151.76 72.19 8.07 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -81.76 46.94 2.36 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.512 1.475 . . . . 0.0 111.835 179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 167' ' ' VAL . 6.4 m -86.24 141.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -72.45 149.48 91.19 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.338 -0.851 . . . . 0.0 109.226 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo . . . . . 0 N--CA 1.491 1.355 0 CA-C-O 117.962 -0.932 . . . . 0.0 112.19 179.471 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.533 ' HD2' ' HA ' ' A' ' 140' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.288 0.566 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 2' ' ' LEU . 7.2 mp -60.09 -41.53 92.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 0.0 109.576 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.5 p -90.88 158.19 16.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.0 109.263 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -71.43 137.48 48.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.049 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.49 -154.72 51.78 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -82.21 148.55 60.05 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.255 . . . . 0.0 109.242 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -62.7 132.38 37.39 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 120.518 0.812 . . . . 0.0 111.638 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 124' ' ' LEU . 23.9 mmm180 -89.44 158.95 17.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.184 -0.947 . . . . 0.0 108.692 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -81.91 122.74 28.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.006 -1.059 . . . . 0.0 108.543 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 58.7 mp0 -84.28 -11.53 56.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.304 -0.872 . . . . 0.0 109.905 -179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -83.42 144.52 29.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.006 . . . . 0.0 109.211 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -91.67 -3.27 56.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.556 ' HD1' ' HG1' ' A' ' 48' ' ' THR . 88.4 m-70 -126.64 142.13 51.63 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -136.46 156.87 48.0 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.208 -0.933 . . . . 0.0 109.929 -179.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 p -130.49 154.79 47.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.298 -0.876 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -141.84 159.84 41.41 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -147.09 137.22 23.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.157 -0.964 . . . . 0.0 109.949 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 91.7 mt -88.14 119.04 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.513 -0.742 . . . . 0.0 109.025 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -69.9 -39.81 75.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.36 -179.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -163.41 150.58 12.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.822 -1.174 . . . . 0.0 110.806 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -96.81 130.8 44.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.669 -0.644 . . . . 0.0 109.629 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 t -75.39 145.83 80.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.02 179.555 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -66.2 -9.67 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 CA-C-N 119.452 0.84 . . . . 0.0 111.956 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -59.96 -40.19 88.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.165 -0.959 . . . . 0.0 109.517 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 40.8 mt -140.07 151.24 64.53 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 108.952 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 30' ' ' VAL . 10.2 Cg_endo -61.75 -175.07 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.805 1.004 . . . . 0.0 112.038 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -88.7 -36.91 15.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.195 -0.94 . . . . 0.0 109.614 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.93 -44.0 91.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.413 -0.804 . . . . 0.0 109.519 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.04 -39.92 75.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.08 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 26' ' ' PRO . 74.8 t -69.85 -40.72 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.672 -179.292 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -60.15 -40.36 89.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.984 -1.073 . . . . 0.0 108.949 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -59.86 -45.19 93.26 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.473 -0.767 . . . . 0.0 109.471 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.86 -40.69 89.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mm -72.29 -43.1 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.08 -1.012 . . . . 0.0 109.597 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.53 -39.76 81.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.79 -39.81 90.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.402 -0.811 . . . . 0.0 110.25 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.71 -43.77 83.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.961 -1.087 . . . . 0.0 110.166 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -60.18 -39.69 87.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.996 -1.065 . . . . 0.0 109.032 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -59.73 -40.18 87.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.925 . . . . 0.0 109.472 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.97 -44.96 94.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.001 -1.062 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.479 ' CH2' HD22 ' A' ' 148' ' ' LEU . 93.3 m95 -75.12 -41.81 57.75 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.226 -0.921 . . . . 0.0 111.132 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.0 t -66.77 -38.42 86.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 110.119 -179.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.24 -15.87 28.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 111.044 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.71 2.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.96 -1.088 . . . . 0.0 110.504 -179.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 ' CA ' ' OG ' ' A' ' 163' ' ' SER . 13.1 p -145.49 150.57 44.5 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.054 . . . . 0.0 108.899 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.93 8.15 0.64 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.673 0.915 . . . . 0.0 112.198 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.15 153.42 41.66 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.556 ' HG1' ' HD1' ' A' ' 13' ' ' HIS . 29.2 p -130.34 147.47 52.05 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.27 154.65 45.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.655 . . . . 0.0 109.462 -179.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 m -155.64 133.58 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.486 -0.758 . . . . 0.0 109.87 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.0 135.35 36.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.43 130.72 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.477 -0.765 . . . . 0.0 108.955 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.7 t -95.63 0.11 52.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.092 -1.005 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.14 152.78 41.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.566 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.35 179.46 51.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.359 -1.083 . . . . 0.0 110.505 -179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -102.42 136.95 41.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.05 -40.21 88.64 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.044 -1.035 . . . . 0.0 109.212 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -121.52 120.39 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.556 -0.715 . . . . 0.0 109.401 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.9 mtt -100.84 139.19 36.87 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.056 -1.027 . . . . 0.0 109.564 179.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -123.38 131.3 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 76.6 p -151.01 156.11 40.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.119 -0.988 . . . . 0.0 109.949 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -104.35 138.65 40.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.06 160.03 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.476 0 O-C-N 121.061 -1.024 . . . . 0.0 110.674 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.442 ' NH1' ' CB ' ' A' ' 65' ' ' ARG . 11.5 mtp-105 -129.16 139.79 51.78 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.336 0.589 . . . . 0.0 110.087 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 41.98 -137.43 2.79 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -73.58 128.43 35.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.978 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 21.8 p-80 -137.97 65.12 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.519 -0.738 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 53.21 53.51 11.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.549 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -142.69 161.6 37.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.311 -0.868 . . . . 0.0 109.106 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -96.91 9.73 41.08 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.3 m -138.61 69.68 45.13 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.425 -0.797 . . . . 0.0 109.409 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.7 156.05 45.03 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.034 1.156 . . . . 0.0 112.292 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -76.6 140.59 41.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -101.76 60.24 0.87 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.545 -0.722 . . . . 0.0 109.613 -179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.3 179.33 50.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -50.09 -12.22 0.42 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.336 1.357 . . . . 0.0 111.927 179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.23 178.52 41.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.25 -153.97 25.86 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.579 ' CB ' HG12 ' A' ' 173' ' ' CGS . 47.4 p-10 -75.16 149.65 38.95 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.353 -1.086 . . . . 0.0 109.415 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.13 -18.02 23.08 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.649 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.16 167.38 7.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.764 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -160.1 173.59 15.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.961 -1.087 . . . . 0.0 109.66 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.41 164.31 22.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.487 -0.758 . . . . 0.0 109.124 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.08 152.24 18.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.179 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -59.71 151.18 63.87 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.337 -0.852 . . . . 0.0 109.289 -179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -53.22 104.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 120.718 0.945 . . . . 0.0 112.0 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -156.92 174.62 34.56 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.0 172.56 15.23 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.069 1.18 . . . . 0.0 111.699 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.02 -125.33 18.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.82 -10.95 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -1.116 . . . . 0.0 109.567 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.36 148.98 28.68 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.42 -20.65 10.37 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -68.01 151.43 47.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.275 . . . . 0.0 109.236 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.58 123.63 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 0.0 108.78 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -100.89 143.07 31.48 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.635 0.731 . . . . 0.0 110.793 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.4 m-85 -113.85 131.29 56.31 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -65.78 118.45 9.64 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.852 -1.155 . . . . 0.0 108.778 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -99.13 0.74 44.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 -179.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -74.18 -16.88 60.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.821 -1.174 . . . . 0.0 109.754 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -101.22 159.16 15.48 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.19 -0.944 . . . . 0.0 109.444 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -85.53 121.13 27.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.216 -0.928 . . . . 0.0 109.228 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -89.94 147.59 23.62 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.373 -0.83 . . . . 0.0 109.97 -179.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 52.5 p -129.89 164.21 24.67 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.491 -0.756 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -110.33 32.5 5.12 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -149.03 -164.94 2.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 109.371 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -88.72 25.12 1.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 110.019 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.476 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -76.71 -161.45 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.124 -0.985 . . . . 0.0 110.032 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 108' ' ' ARG . 99.0 mt-10 -24.42 -68.7 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -137.27 144.02 42.49 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.967 -1.083 . . . . 0.0 109.912 -179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -105.02 119.4 38.93 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.488 -0.757 . . . . 0.0 109.4 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 tp -63.88 -40.78 97.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.41 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -59.94 -41.57 92.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.084 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -59.55 -44.96 93.08 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.082 -1.012 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.98 -40.03 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.887 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.07 -41.27 92.01 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.03 . . . . 0.0 108.767 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.53 84.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.209 -0.932 . . . . 0.0 108.884 179.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.428 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 4.3 t60 -70.78 -46.4 62.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.358 -0.838 . . . . 0.0 109.943 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 64.3 mt-10 -59.89 -40.59 89.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.721 -1.237 . . . . 0.0 109.489 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.3 mt -63.15 -38.4 91.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 109.278 179.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.81 -42.92 86.88 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.19 -26.81 64.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.046 -1.267 . . . . 0.0 109.302 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 83.6 p -71.06 -22.21 62.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.073 -1.017 . . . . 0.0 108.399 179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.533 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 89.6 mt -85.57 -8.73 58.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.361 -0.837 . . . . 0.0 109.14 179.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.88 19.28 48.13 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.666 179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.4 mt -81.93 142.1 32.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.84 -1.388 . . . . 0.0 108.947 179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.9 m -87.71 168.39 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.015 -1.053 . . . . 0.0 109.479 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -67.92 153.0 44.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.405 -0.809 . . . . 0.0 109.412 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.5 t -124.11 154.54 39.85 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.1 p -99.99 10.83 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.286 -0.884 . . . . 0.0 109.829 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 132' ' ' ILE . 58.5 t0 -83.53 132.91 34.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.925 -1.109 . . . . 0.0 110.143 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.459 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 91.8 mt -60.24 -40.04 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -76.12 -5.72 81.38 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.546 -178.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.55 128.88 34.86 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.935 -1.333 . . . . 0.0 109.486 179.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 137' ' ' TYR . 95.4 mt -64.31 -25.36 68.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.571 -0.706 . . . . 0.0 109.275 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 47.0 mmm -74.18 45.16 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.115 -179.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.407 ' H ' ' C ' ' A' ' 135' ' ' LEU . 4.6 t80 -69.55 129.94 91.03 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 108.7 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.473 ' O ' ' HC2' ' A' ' 173' ' ' CGS . 17.9 Cg_exo -46.28 -62.52 0.44 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.192 1.104 . . . . 0.0 111.702 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 t -96.97 172.42 7.87 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.42 -0.8 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -85.11 147.06 26.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 108.819 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 71.8 p -134.35 137.99 44.57 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.503 -0.748 . . . . 0.0 109.272 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -61.9 -44.09 97.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.564 -0.71 . . . . 0.0 110.053 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -80.17 163.76 23.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.188 -0.945 . . . . 0.0 110.474 -178.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 114.99 119.6 3.33 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -82.79 165.53 19.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -1.122 . . . . 0.0 109.194 179.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.9 t -87.78 90.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.138 -0.976 . . . . 0.0 109.473 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -148.63 151.04 34.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 109.056 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.479 HD22 ' CH2' ' A' ' 41' ' ' TRP . 93.0 mt -76.52 142.9 40.72 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.859 179.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.11 162.93 13.83 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 108.735 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -59.83 -40.39 88.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 0.0 109.434 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -58.9 -40.14 83.57 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.521 -0.737 . . . . 0.0 109.642 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -73.22 -40.87 64.36 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.095 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.22 -52.81 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 0.0 109.476 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.43 -40.13 96.33 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.854 -1.154 . . . . 0.0 110.096 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.8 -55.43 29.86 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.611 -178.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.1 tp -65.61 -39.96 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.977 -1.308 . . . . 0.0 110.582 -179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.6 mt-30 -65.64 -39.82 91.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.821 -1.175 . . . . 0.0 109.346 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.59 -44.6 89.87 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.65 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.98 -49.97 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.044 -1.035 . . . . 0.0 109.646 179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -93.28 -70.1 0.72 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.272 -0.893 . . . . 0.0 109.847 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 164.66 -178.66 39.76 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.94 142.58 27.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.068 -1.254 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.401 ' OG ' ' CA ' ' A' ' 45' ' ' THR . 69.2 m -72.96 84.88 1.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 109.824 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -89.66 112.96 24.36 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -153.83 75.28 6.24 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.18 -0.95 . . . . 0.0 109.778 -179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -82.57 47.37 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.558 1.506 . . . . 0.0 112.151 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 88.9 t -87.37 131.91 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 0.0 110.072 -179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -70.06 148.36 96.03 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.213 -0.929 . . . . 0.0 108.66 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo . . . . . 0 N--CA 1.491 1.352 0 CA-C-O 118.082 -0.883 . . . . 0.0 112.352 179.892 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.579 HG12 ' CB ' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 tp -97.76 123.0 41.51 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.208 -0.932 . . . . 0.0 109.021 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.9 p -94.23 148.03 22.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.491 -0.755 . . . . 0.0 110.041 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -74.19 139.56 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.483 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.45 -147.41 19.08 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -84.0 122.53 76.02 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -1.178 . . . . 0.0 108.989 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -69.92 106.13 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.058 1.057 . . . . 0.0 112.338 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -92.74 161.7 14.43 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -83.12 119.83 25.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.976 -1.078 . . . . 0.0 108.5 179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.6 -9.97 59.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.129 -0.982 . . . . 0.0 109.5 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -80.3 145.08 32.32 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.18 -0.95 . . . . 0.0 109.335 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.7 p -94.81 -8.87 36.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.494 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 93.5 m-70 -123.22 119.86 31.44 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.08 165.41 12.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.499 -0.751 . . . . 0.0 109.253 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -129.58 155.46 45.77 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -144.13 159.21 43.03 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.144 -0.972 . . . . 0.0 109.078 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' NH2' ' O ' ' A' ' 53' ' ' SER . 70.7 ttt180 -148.76 131.19 15.69 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.061 -1.024 . . . . 0.0 110.608 -178.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.51 116.81 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.22 -42.96 99.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.025 -1.047 . . . . 0.0 110.268 -178.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -162.15 160.85 27.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.831 -1.168 . . . . 0.0 110.19 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.58 136.64 40.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.602 -0.686 . . . . 0.0 109.333 179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 t -74.97 142.32 76.11 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.139 -0.975 . . . . 0.0 108.97 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -61.11 -10.88 16.46 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 CA-C-N 119.527 0.867 . . . . 0.0 111.825 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -59.89 -40.1 87.57 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.0 mt -139.04 151.17 67.4 Favored Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.69 -171.35 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 CA-C-N 119.475 0.848 . . . . 0.0 111.914 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.403 ' HG3' ' NH1' ' A' ' 27' ' ' ARG . 7.1 ptm180 -87.96 -35.43 17.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.06 -42.57 94.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 109.978 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.02 -39.72 75.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.2 -43.24 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.928 . . . . 0.0 109.648 -179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -59.97 -40.03 87.68 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.924 -1.11 . . . . 0.0 109.286 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -59.93 -50.04 75.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.628 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.15 91.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.206 -0.933 . . . . 0.0 109.807 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.9 mm -70.01 -39.82 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.314 -0.866 . . . . 0.0 110.159 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -65.57 -41.23 93.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.019 -1.05 . . . . 0.0 109.844 -178.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -62.42 -40.02 95.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.728 -1.233 . . . . 0.0 110.037 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.66 64.13 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.011 -1.056 . . . . 0.0 109.762 -179.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -62.36 -42.51 99.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.842 -1.161 . . . . 0.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.4 ' O ' ' CG ' ' A' ' 43' ' ' ASN . 95.7 mm-40 -60.3 -42.09 94.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.132 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.7 mt -59.61 -41.66 90.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 109.91 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -72.79 -40.48 65.85 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.84 -1.163 . . . . 0.0 109.644 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 t -69.37 -32.97 72.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 110.593 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' CG ' ' O ' ' A' ' 39' ' ' GLN . 17.0 m120 -59.3 -26.1 64.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.089 -1.007 . . . . 0.0 110.234 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.9 m -109.86 7.9 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.238 -0.914 . . . . 0.0 110.668 -179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.5 p -145.95 150.56 42.83 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 120.883 -1.136 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.62 2.73 3.19 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.912 1.075 . . . . 0.0 111.538 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.8 mt -71.04 151.62 44.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 110.265 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.494 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 29.8 p -137.16 147.01 45.65 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -121.18 120.24 34.67 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.295 -0.878 . . . . 0.0 110.217 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.6 m -96.0 132.48 41.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.465 -0.772 . . . . 0.0 110.19 179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.23 128.48 33.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.131 -0.981 . . . . 0.0 108.871 178.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 52' ' ' VAL . 19.2 m -127.41 129.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.427 -0.796 . . . . 0.0 108.859 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.494 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 40.3 t -99.49 0.29 42.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -143.9 158.63 43.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.138 -0.976 . . . . 0.0 109.639 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.92 170.4 38.4 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -82.62 130.27 35.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -1.152 . . . . 0.0 109.206 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.67 155.11 17.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -59.98 -39.9 87.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.201 -0.937 . . . . 0.0 109.803 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.9 mt -118.92 120.0 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.7 mmm -99.13 128.6 45.29 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -113.62 126.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.4 p -148.42 157.53 43.54 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.994 -1.066 . . . . 0.0 110.356 -179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -107.35 136.85 46.46 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.1 160.38 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.167 -0.958 . . . . 0.0 111.42 -178.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 142.79 49.08 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.26 -147.65 2.59 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -70.52 128.74 37.18 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.436 -1.038 . . . . 0.0 109.745 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p-80 -135.97 58.68 1.74 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.43 -0.794 . . . . 0.0 109.814 -179.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 69' ' ' ARG . 59.6 mtt-85 55.56 52.92 10.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.485 -0.76 . . . . 0.0 110.426 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 23.0 p-10 -144.17 160.96 40.04 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.05 -1.031 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -92.48 12.37 23.09 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.071 -1.018 . . . . 0.0 110.022 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 64.6 m -139.37 69.76 39.69 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.211 -0.931 . . . . 0.0 109.563 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -70.19 148.65 62.77 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.927 1.085 . . . . 0.0 112.153 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -76.01 150.03 37.46 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.905 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -125.14 73.97 1.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.424 -0.798 . . . . 0.0 109.506 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.78 167.41 42.36 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -54.42 -16.34 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.334 1.356 . . . . 0.0 111.984 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 175.63 40.23 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.99 -151.25 19.99 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.641 ' ND2' HG12 ' A' ' 173' ' ' CGS . 16.7 m120 -75.99 141.05 42.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -1.201 . . . . 0.0 109.475 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.6 mt -93.91 -19.69 20.71 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 0.0 110.044 -179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.53 160.54 11.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.903 -1.123 . . . . 0.0 109.735 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -160.18 -179.81 8.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.602 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.55 167.69 21.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 109.509 -179.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -94.65 149.33 21.35 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.214 -0.929 . . . . 0.0 109.09 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -59.96 149.39 73.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.164 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -46.88 115.82 1.43 Allowed 'Trans proline' 0 N--CA 1.487 1.099 0 C-N-CA 120.533 0.822 . . . . 0.0 112.084 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.96 173.9 42.26 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.37 173.95 12.93 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 CA-C-N 118.157 0.978 . . . . 0.0 111.419 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.19 -120.75 22.27 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -80.85 -7.35 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.173 -1.192 . . . . 0.0 110.214 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.24 134.25 52.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.5 -11.38 70.19 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.0 124.94 24.79 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.272 . . . . 0.0 110.068 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.74 126.12 45.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.474 -0.766 . . . . 0.0 109.606 179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -107.96 136.85 46.97 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.563 -0.711 . . . . 0.0 109.627 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -117.33 130.73 56.71 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.657 -0.652 . . . . 0.0 109.241 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -66.32 121.55 15.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.907 . . . . 0.0 109.48 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -100.41 3.75 43.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.381 -0.824 . . . . 0.0 110.17 -179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -73.73 -18.16 61.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.927 -1.108 . . . . 0.0 109.175 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -102.47 158.43 16.22 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 108.94 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -86.9 125.02 33.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.19 -0.943 . . . . 0.0 109.52 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -90.49 147.17 23.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.356 -0.84 . . . . 0.0 109.985 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.3 p -129.68 158.86 38.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.535 -0.728 . . . . 0.0 109.741 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.03 29.97 7.15 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.554 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 15.8 p30 -144.99 -160.5 1.14 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.368 -0.832 . . . . 0.0 109.447 -178.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -87.97 15.41 7.29 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.198 -0.939 . . . . 0.0 110.531 -178.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.5 mtt180 -76.47 -167.85 0.87 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.809 -1.182 . . . . 0.0 109.981 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 108' ' ' ARG . 93.9 mt-10 -4.51 -87.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -132.02 151.68 51.6 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.308 -0.87 . . . . 0.0 110.084 -178.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 5.5 m120 -98.41 115.14 27.87 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.883 . . . . 0.0 109.391 179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.45 -39.22 93.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.349 -0.844 . . . . 0.0 110.008 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -59.06 -42.42 90.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.973 -1.079 . . . . 0.0 109.542 -179.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.9 -39.6 85.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.978 -1.076 . . . . 0.0 109.181 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.441 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 82.1 t -68.51 -40.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.966 . . . . 0.0 109.469 -179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.05 92.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.024 . . . . 0.0 109.184 179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.4 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.995 -1.066 . . . . 0.0 108.716 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -70.38 -48.8 54.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.68 -42.72 93.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.666 -1.271 . . . . 0.0 110.028 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.9 -39.8 93.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.098 . . . . 0.0 108.701 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.97 88.96 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -65.59 -37.47 86.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -1.191 . . . . 0.0 109.171 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 85.2 p -69.86 -20.77 63.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.211 -0.93 . . . . 0.0 108.554 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.25 -0.97 57.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 109.113 179.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.37 11.43 66.68 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.199 -1.001 . . . . 0.0 110.635 179.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.6 mt -81.86 128.68 34.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.896 -1.356 . . . . 0.0 109.082 179.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.5 m -87.97 170.37 11.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.361 -0.837 . . . . 0.0 109.5 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -65.85 155.12 37.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.347 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.5 t -125.3 153.71 42.84 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.0 p -99.52 9.87 42.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.246 -0.909 . . . . 0.0 109.519 -179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -82.36 128.37 34.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 108.874 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.04 -40.13 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -75.22 -2.19 66.16 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.254 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.28 141.19 32.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.712 -1.463 . . . . 0.0 109.201 179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.42 -27.84 65.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 29.9 mtp -74.19 52.08 0.45 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.163 -0.961 . . . . 0.0 109.846 -178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' SER . 22.2 t80 -70.45 137.6 86.23 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.567 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -53.32 -1.99 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 CA-C-N 119.828 0.974 . . . . 0.0 112.498 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' TYR . 81.4 p -159.94 174.75 13.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.938 -1.101 . . . . 0.0 110.502 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -86.95 137.76 32.1 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 0.0 109.676 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.3 p -146.88 159.69 43.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -65.68 139.76 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.847 . . . . 0.0 109.327 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.8 t -138.37 144.13 40.14 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.286 -0.884 . . . . 0.0 109.883 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.51 -114.14 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 44.2 t0 -82.01 154.71 25.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.184 -1.186 . . . . 0.0 109.026 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.52 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 86.0 t -89.6 108.02 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.212 -0.93 . . . . 0.0 110.101 -179.502 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -146.9 156.95 43.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 75.3 mt -75.97 146.63 39.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.883 -1.136 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.46 153.31 19.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.158 -0.964 . . . . 0.0 108.401 179.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -57.04 -39.94 75.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.275 -0.891 . . . . 0.0 109.645 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -53.08 -40.15 63.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.918 -1.114 . . . . 0.0 108.945 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.76 -39.67 66.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.32 -48.03 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 0.0 109.117 -179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.62 -40.09 90.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.727 -1.233 . . . . 0.0 110.514 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -51.46 44.59 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.162 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.3 tp -66.62 -40.02 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.874 -1.368 . . . . 0.0 109.767 -179.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.537 ' O ' ' N ' ' A' ' 161' ' ' GLY . 97.3 mt-30 -66.08 -39.97 90.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.09 95.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.032 -1.042 . . . . 0.0 109.814 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -50.13 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.108 -0.995 . . . . 0.0 109.966 -179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -98.33 -65.41 0.96 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.121 -0.987 . . . . 0.0 109.421 179.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.34 -170.21 33.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.702 ' NH2' HE22 ' A' ' 164' ' ' GLN . 84.8 mtm180 -91.04 142.87 27.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.111 -1.229 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.4 m -73.33 78.16 1.35 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.012 -1.055 . . . . 0.0 109.002 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.702 HE22 ' NH2' ' A' ' 162' ' ' ARG . 96.9 mt-30 -100.48 116.58 32.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.43 -0.794 . . . . 0.0 109.353 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -155.8 140.67 12.14 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -79.92 41.99 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 CA-C-N 120.023 1.044 . . . . 0.0 112.008 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 88.8 t -90.51 120.23 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.403 -0.811 . . . . 0.0 109.861 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 169' ' ' PRO . 32.5 mt-30 -69.99 150.39 96.29 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 168' ' ' GLN . 20.8 Cg_exo . . . . . 0 N--CA 1.489 1.216 0 CA-C-O 117.958 -0.934 . . . . 0.0 112.227 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.641 HG12 ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.99 -44.24 94.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 p -145.61 -152.46 0.43 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 6' ' ' ASN . 83.3 tt0 -73.2 159.38 33.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.356 -0.84 . . . . 0.0 109.035 179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.41 10.28 0.3 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.532 ' H ' ' C ' ' A' ' 4' ' ' GLU . 15.9 m120 -145.38 72.61 14.32 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 108.731 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -69.05 -171.24 0.4 Allowed 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.019 1.146 . . . . 0.0 112.483 -179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -141.52 170.01 16.53 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -80.08 120.91 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 108.82 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.0 -10.01 58.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -81.37 148.65 29.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.275 -179.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -95.86 -6.07 40.18 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.083 -1.011 . . . . 0.0 108.866 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 15.0 m-70 -130.62 132.57 45.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.238 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' CE1' ' A' ' 49' ' ' PHE . 66.4 mt -121.77 156.03 34.03 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 109.512 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 49.7 p -125.7 153.57 43.7 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -144.78 161.06 40.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -152.77 132.45 13.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.869 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 87.7 mt -86.59 120.03 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.375 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -64.96 -40.01 94.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.568 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -160.37 150.39 18.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.898 -1.126 . . . . 0.0 109.768 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.25 140.33 30.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.241 -0.912 . . . . 0.0 109.762 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 22' ' ' THR . 9.0 t -70.7 137.24 85.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 109.642 -179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.75 -14.59 45.4 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 CA-C-N 119.815 0.97 . . . . 0.0 111.792 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -59.99 -40.1 88.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.2 mt -135.05 149.1 69.37 Favored Pre-proline 0 N--CA 1.499 2.011 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -62.05 -174.01 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 120.545 0.83 . . . . 0.0 112.031 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -88.43 -36.16 16.66 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.872 . . . . 0.0 109.739 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.99 -41.18 77.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.072 -1.018 . . . . 0.0 108.89 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -39.98 75.38 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.435 -0.79 . . . . 0.0 109.628 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.04 -43.83 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.128 -0.982 . . . . 0.0 109.021 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.98 -39.93 87.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.337 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.622 ' CE1' ' NZ ' ' A' ' 36' ' ' LYS . 59.9 t60 -59.97 -50.05 75.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.233 -179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.75 89.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.377 -0.827 . . . . 0.0 110.763 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.8 mm -70.05 -38.43 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 110.123 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.38 -41.3 96.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.007 -1.058 . . . . 0.0 109.776 -178.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.622 ' NZ ' ' CE1' ' A' ' 32' ' ' HIS . 32.7 mttp -64.76 -37.58 88.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.95 -1.094 . . . . 0.0 109.994 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.47 81.57 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.947 -1.096 . . . . 0.0 109.322 -179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -61.88 -41.44 97.88 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 109.02 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -60.07 -41.53 92.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.831 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.92 -41.8 92.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.018 -1.051 . . . . 0.0 109.621 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -74.57 -40.49 61.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.04 -1.037 . . . . 0.0 109.946 179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.8 t -69.86 -35.27 74.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.106 -0.996 . . . . 0.0 110.42 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -57.31 -31.4 65.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.246 -0.909 . . . . 0.0 110.435 -178.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.533 HG23 HG23 ' A' ' 45' ' ' THR . 34.3 m -109.53 9.98 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.308 -0.87 . . . . 0.0 110.208 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 44' ' ' VAL . 72.9 p -140.94 144.91 37.13 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.234 -0.916 . . . . 0.0 108.983 178.719 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.9 2.99 3.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.563 0.842 . . . . 0.0 111.226 178.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.21 153.61 42.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.783 . . . . 0.0 109.496 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.522 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 62.6 p -130.39 143.1 50.56 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.448 ' CE1' HD12 ' A' ' 14' ' ' LEU . 90.4 m-85 -119.16 151.68 37.89 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.515 -0.741 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.9 m -153.34 131.71 12.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.359 -0.838 . . . . 0.0 109.49 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -77.19 144.88 38.0 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.439 -0.788 . . . . 0.0 109.513 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.53 135.87 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.496 -0.753 . . . . 0.0 109.072 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -95.36 -6.86 40.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.293 -0.879 . . . . 0.0 110.238 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -150.18 159.57 44.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.032 -1.042 . . . . 0.0 109.411 -179.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.14 176.42 51.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -83.81 139.04 32.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -1.096 . . . . 0.0 109.495 -179.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.58 143.79 30.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.319 -0.863 . . . . 0.0 109.138 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -59.95 -40.09 87.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.011 -1.056 . . . . 0.0 109.348 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.4 mt -120.01 118.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.557 -0.714 . . . . 0.0 109.285 179.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.7 mtt -102.45 133.3 47.62 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.239 -0.913 . . . . 0.0 109.579 179.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.25 128.33 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.1 p -147.36 153.13 39.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -101.87 138.54 38.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.24 164.86 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.189 -0.944 . . . . 0.0 110.535 -178.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.413 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 42.8 mtm-85 -139.96 142.45 36.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 109.579 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.67 5.39 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 179.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -70.04 127.25 32.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -1.074 . . . . 0.0 109.71 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' ND1' ' N ' ' A' ' 68' ' ' HIS . 19.4 p-80 -136.94 62.29 1.6 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 109.097 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 69' ' ' ARG . 4.2 mmt-85 56.17 49.99 14.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.515 -0.74 . . . . 0.0 109.304 -179.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 55.0 t0 -142.55 148.13 37.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 51.6 p-10 -89.48 9.73 25.37 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.064 -1.023 . . . . 0.0 109.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.3 m -136.24 73.14 58.17 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.555 -0.716 . . . . 0.0 109.161 179.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.85 166.44 26.36 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.252 1.301 . . . . 0.0 112.207 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -77.95 149.33 34.17 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.356 -0.84 . . . . 0.0 109.642 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 75' ' ' ASP . 10.6 t0 -101.88 65.38 1.0 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.449 -0.782 . . . . 0.0 109.278 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.46 170.11 46.16 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.7 -16.26 29.95 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 120.903 1.069 . . . . 0.0 111.88 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.42 -175.78 43.28 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.05 17.21 Favored Glycine 0 N--CA 1.492 2.413 0 O-C-N 121.159 -1.2 . . . . 0.0 110.102 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.694 ' ND2' HG12 ' A' ' 173' ' ' CGS . 13.7 t-20 -73.83 123.8 24.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.452 -1.028 . . . . 0.0 109.591 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -88.36 -14.32 38.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.128 -0.983 . . . . 0.0 109.907 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.52 ' O ' ' ND2' ' A' ' 80' ' ' ASN . . . -169.01 158.45 8.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.911 -1.118 . . . . 0.0 109.737 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -162.14 -178.8 6.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.059 -1.025 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.2 178.49 8.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.92 -178.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -104.33 157.4 17.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.776 . . . . 0.0 109.656 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 -59.99 149.59 73.28 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -58.14 103.99 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 120.601 0.867 . . . . 0.0 112.286 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.92 168.11 34.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.68 -178.42 1.57 Allowed 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.045 1.163 . . . . 0.0 111.737 179.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 62.18 -123.18 30.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.0 tt -79.99 -12.8 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.949 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.11 144.18 48.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.52 -16.4 53.67 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -66.9 157.36 33.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -1.215 . . . . 0.0 109.366 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.88 17.32 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.188 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -102.17 136.06 42.67 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.501 -0.75 . . . . 0.0 109.59 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -114.14 129.65 56.62 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.483 -0.76 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.19 117.8 9.0 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.181 -0.95 . . . . 0.0 109.126 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -97.7 1.89 49.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.233 -0.917 . . . . 0.0 109.306 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -73.76 -17.68 61.07 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -0.95 . . . . 0.0 108.447 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.483 ' OE1' ' N ' ' A' ' 101' ' ' GLU . 0.6 OUTLIER -97.49 158.51 15.44 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.632 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -85.58 120.58 27.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.928 -1.108 . . . . 0.0 108.962 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -90.51 140.0 30.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.27 -0.894 . . . . 0.0 109.539 -179.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.9 p -125.29 170.0 11.73 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.559 -0.713 . . . . 0.0 109.691 -179.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -113.37 28.76 8.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.478 ' C ' HD22 ' A' ' 106' ' ' ASN . 0.1 OUTLIER -148.58 -163.72 1.85 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.219 -0.926 . . . . 0.0 109.735 -179.63 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -86.95 27.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.121 -0.987 . . . . 0.0 110.643 -178.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 109' ' ' GLU . 99.2 mtt180 -75.84 -158.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.659 179.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 108' ' ' ARG . 96.1 mt-10 -32.47 -62.99 0.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.976 -0.453 . . . . 0.0 111.732 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -136.04 141.38 44.3 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.118 -0.989 . . . . 0.0 110.219 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -98.96 116.75 31.91 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.98 -43.84 94.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 110.284 -179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -59.99 -41.0 91.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.624 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -59.97 -43.3 95.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.029 -1.044 . . . . 0.0 110.109 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.2 t -69.99 -40.0 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.961 -1.087 . . . . 0.0 108.807 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.71 87.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.01 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.81 92.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.273 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.454 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.6 t-160 -69.01 -48.06 63.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.342 -0.849 . . . . 0.0 108.949 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -59.23 -42.59 91.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.903 -1.123 . . . . 0.0 109.462 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.67 -40.01 95.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 109.46 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.98 84.24 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -63.46 -36.97 85.52 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -1.1 . . . . 0.0 108.738 179.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 65.9 m -68.81 -26.54 65.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.431 -0.793 . . . . 0.0 109.127 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.58 -2.61 54.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 108.469 179.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 89.01 10.61 66.22 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.81 126.88 31.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.372 . . . . 0.0 109.178 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.7 m -88.07 174.26 8.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.798 -179.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -67.08 157.14 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.388 -0.82 . . . . 0.0 109.462 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.4 t -131.37 159.68 37.26 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.844 -179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 75.0 p -101.72 11.8 38.18 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 134' ' ' ALA . 56.8 t0 -80.1 132.93 36.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.007 -1.058 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.413 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 95.9 mt -60.04 -40.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.431 -0.793 . . . . 0.0 111.253 -179.13 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.14 81.98 Favored Glycine 0 N--CA 1.495 2.6 0 O-C-N 120.908 -1.12 . . . . 0.0 111.157 -178.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 131' ' ' ASP . . . -82.93 136.82 34.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.656 -1.496 . . . . 0.0 109.776 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 137' ' ' TYR . 91.2 mt -70.02 -29.88 67.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.445 -0.784 . . . . 0.0 109.267 179.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 70.7 mmm -71.43 51.0 0.17 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 -178.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 139' ' ' SER . 15.2 t80 -70.0 137.22 87.24 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -64.85 10.22 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 119.871 0.99 . . . . 0.0 111.7 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 137' ' ' TYR . 7.2 t -160.02 175.65 12.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.407 -0.808 . . . . 0.0 108.833 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.542 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 65.9 t80 -86.55 119.95 27.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.664 -1.273 . . . . 0.0 109.662 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 69.5 p -150.09 164.0 36.73 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -134.23 149.88 51.0 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.38 -0.825 . . . . 0.0 109.166 179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -147.32 -1.83 0.62 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.214 -0.929 . . . . 0.0 109.314 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.05 -148.58 12.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -80.6 164.92 22.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 108.994 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.41 110.03 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.081 -1.012 . . . . 0.0 109.605 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.27 160.19 41.88 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.42 147.62 45.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.848 -1.157 . . . . 0.0 109.308 -179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.38 149.56 21.34 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.12 -39.91 72.95 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -54.84 -39.84 68.98 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -73.93 -39.95 63.43 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.393 -0.817 . . . . 0.0 109.33 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 34.4 mm -62.58 -51.23 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.038 -1.039 . . . . 0.0 109.391 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.13 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.405 -0.809 . . . . 0.0 110.955 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -51.42 38.17 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.074 -1.06 . . . . 0.0 111.259 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.9 tp -69.59 -39.96 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.935 -1.332 . . . . 0.0 110.295 -178.857 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 161' ' ' GLY . 27.4 mt-30 -67.38 -39.94 85.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.001 -1.062 . . . . 0.0 110.309 -179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.77 94.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.892 -1.13 . . . . 0.0 108.976 179.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.02 -50.04 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 109.437 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -96.6 -73.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 109.437 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 158.45 -171.51 35.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 162' ' ' ARG . 38.1 mtt-85 -85.51 156.27 20.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -1.125 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 75.5 m -71.38 85.05 0.81 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.237 -0.914 . . . . 0.0 109.357 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -93.55 35.44 1.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.384 -0.823 . . . . 0.0 109.42 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -146.4 112.67 4.37 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.484 ' O ' ' NE2' ' A' ' 168' ' ' GLN . 29.1 Cg_endo -77.72 135.96 14.83 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.024 1.044 . . . . 0.0 112.15 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.9 t -86.05 146.27 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.599 -0.688 . . . . 0.0 109.731 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 166' ' ' PRO . 25.8 mp0 -125.02 78.8 66.02 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.49 1.305 0 C-N-CA 120.793 0.995 . . . . 0.0 112.039 -179.462 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.694 HG12 ' ND2' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.3 tp -60.16 -43.72 95.56 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.4 p -142.26 -150.14 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 6' ' ' ASN . 88.3 tt0 -72.66 153.4 41.23 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.209 -0.932 . . . . 0.0 109.002 179.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.34 7.08 0.24 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 4' ' ' GLU . 72.2 m-80 -145.39 75.45 13.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.143 -1.21 . . . . 0.0 108.726 179.466 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -59.1 148.57 84.94 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 120.784 0.989 . . . . 0.0 111.642 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.47 160.02 41.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.313 -0.867 . . . . 0.0 109.017 -179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -82.16 129.99 34.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 108.864 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.26 -13.43 57.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.886 -179.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -81.84 149.36 28.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 109.58 -179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.6 p -96.57 -7.47 34.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.936 . . . . 0.0 108.847 179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.526 ' ND1' ' OG1' ' A' ' 48' ' ' THR . 64.0 m-70 -130.03 144.2 51.21 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.17 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.9 mt -134.24 157.6 45.85 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.18 -0.95 . . . . 0.0 109.802 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.0 p -127.77 155.57 43.83 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -142.5 159.84 41.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.241 -0.912 . . . . 0.0 109.497 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.404 HH12 ' HA ' ' A' ' 19' ' ' GLU . 40.2 ttt-85 -148.1 130.12 15.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.277 -0.889 . . . . 0.0 110.082 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.33 119.81 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 78.0 tt0 -66.89 -39.92 87.6 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 -178.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 79.1 m-20 -157.55 150.03 22.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.979 -1.076 . . . . 0.0 110.082 -179.43 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -98.16 135.16 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.519 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 t -68.59 141.75 93.35 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.232 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.81 -12.66 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.674 0.916 . . . . 0.0 111.832 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.92 -40.03 87.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.865 . . . . 0.0 110.139 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.5 mt -136.28 149.55 68.22 Favored Pre-proline 0 N--CA 1.501 2.087 0 O-C-N 121.255 -0.903 . . . . 0.0 108.848 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -59.61 -179.99 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 119.214 0.755 . . . . 0.0 111.744 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -86.46 -33.01 20.52 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.704 -179.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.91 -41.12 81.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.116 -0.99 . . . . 0.0 109.473 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -69.84 -39.91 76.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.36 179.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.0 t -69.35 -42.83 81.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.03 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.99 -40.05 87.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.405 ' O ' ' N ' ' A' ' 36' ' ' LYS . 86.3 t60 -60.02 -49.7 76.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.37 -0.831 . . . . 0.0 109.18 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.87 -46.01 90.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.406 -0.809 . . . . 0.0 109.88 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.61 -44.59 76.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.292 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.23 -40.15 74.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' HIS . 78.5 tttt -62.64 -39.68 94.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.101 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.14 -45.07 90.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.287 -0.883 . . . . 0.0 109.857 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.519 ' CD1' ' CG ' ' A' ' 49' ' ' PHE . 31.1 m-85 -59.87 -40.31 88.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.922 -1.112 . . . . 0.0 109.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.11 -40.67 90.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.0 -43.31 95.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.009 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.97 -41.76 64.05 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.033 -1.042 . . . . 0.0 110.183 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.5 t -70.14 -26.49 63.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.248 -0.907 . . . . 0.0 110.521 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -60.07 -36.03 76.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.303 -0.873 . . . . 0.0 110.852 -178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 45' ' ' THR . 16.7 m -109.92 13.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.061 -1.024 . . . . 0.0 110.403 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.553 HG23 HG23 ' A' ' 44' ' ' VAL . 72.0 p -141.2 146.81 44.55 Favored Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.997 -1.064 . . . . 0.0 109.257 179.082 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.19 5.57 2.62 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.579 0.853 . . . . 0.0 111.414 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.84 153.39 41.94 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.496 -0.752 . . . . 0.0 109.866 -179.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.526 ' OG1' ' ND1' ' A' ' 13' ' ' HIS . 38.2 p -130.91 148.01 52.62 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CG ' ' CD1' ' A' ' 38' ' ' PHE . 98.1 m-85 -126.52 149.76 49.19 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.3 m -153.33 132.06 12.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 0.0 109.835 -179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -79.62 142.03 35.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.413 -0.804 . . . . 0.0 109.549 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.55 135.85 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -96.67 -3.14 43.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 0.0 110.011 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -143.67 152.55 41.47 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.028 -1.045 . . . . 0.0 109.647 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.31 166.99 33.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -82.91 139.52 33.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -1.156 . . . . 0.0 109.396 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -100.64 160.44 14.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 108.983 179.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.97 -39.76 86.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.178 -0.952 . . . . 0.0 109.528 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.85 120.02 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.485 0.659 . . . . 0.0 109.932 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.4 mmm -99.86 122.13 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.357 -0.84 . . . . 0.0 109.291 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.01 129.98 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.417 -0.802 . . . . 0.0 109.052 179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -149.05 153.94 38.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.025 -1.047 . . . . 0.0 110.295 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -104.37 138.04 41.38 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.0 170.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.337 0 O-C-N 121.112 -0.993 . . . . 0.0 111.101 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -134.43 143.57 47.63 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.667 -0.646 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 40.44 -146.68 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -67.17 128.69 37.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.51 -0.994 . . . . 0.0 109.597 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.495 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 17.6 p-80 -135.97 58.49 1.74 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 56.06 52.2 10.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.588 -0.695 . . . . 0.0 109.341 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.495 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 18.9 p-10 -142.43 160.02 41.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 109.072 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -91.14 10.04 28.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.279 -0.888 . . . . 0.0 109.705 -179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.1 t -137.07 74.34 49.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.326 -0.859 . . . . 0.0 109.845 -179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.53 148.85 48.66 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.081 1.188 . . . . 0.0 111.405 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -75.88 139.98 41.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.276 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -100.86 61.04 0.97 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.315 -0.865 . . . . 0.0 109.351 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.07 -176.72 53.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -55.07 -13.55 6.84 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.158 1.238 . . . . 0.0 112.079 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.91 170.32 34.62 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -150.63 19.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.723 ' OD1' HG12 ' A' ' 173' ' ' CGS . 97.9 m-20 -77.89 142.04 38.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.316 -1.108 . . . . 0.0 109.862 -179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.5 mt -89.89 -16.6 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.197 -0.94 . . . . 0.0 108.953 179.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.01 166.96 9.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 108.932 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.59 -178.44 6.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.171 -0.956 . . . . 0.0 109.839 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.16 170.55 16.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.396 -179.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -102.21 153.87 19.56 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.4 -0.813 . . . . 0.0 109.532 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -60.72 151.1 73.53 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.423 -0.798 . . . . 0.0 109.337 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 108.45 0.33 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.726 0.951 . . . . 0.0 112.402 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.67 165.19 34.98 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.04 161.92 40.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.108 1.206 . . . . 0.0 111.997 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.54 -126.65 7.69 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.1 tt -76.51 -13.0 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 109.8 -179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.46 141.29 47.49 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.06 -15.23 60.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.38 159.21 31.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -1.193 . . . . 0.0 109.708 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.99 122.85 12.7 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.301 -0.874 . . . . 0.0 109.171 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -104.68 148.32 26.69 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.505 -0.747 . . . . 0.0 110.465 -179.201 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.54 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 35.3 m-85 -115.22 135.51 54.1 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.246 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 100' ' ' ASP . 19.7 t0 -67.19 116.67 8.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -95.76 -0.25 51.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.255 -0.903 . . . . 0.0 109.716 -178.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 98' ' ' ASP . 94.3 m-20 -75.72 -17.33 59.96 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.84 -1.163 . . . . 0.0 110.095 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -102.2 159.8 15.08 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 102' ' ' ARG . 35.7 ttm-85 -88.29 120.35 29.57 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.051 -1.03 . . . . 0.0 109.365 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -88.33 148.52 24.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.844 . . . . 0.0 109.604 -179.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.8 p -124.9 161.12 27.28 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.531 -0.731 . . . . 0.0 109.742 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -112.8 31.46 6.36 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 4.6 p30 -148.18 -164.9 2.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.29 -0.881 . . . . 0.0 109.976 -178.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -79.93 30.64 0.26 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 108' ' ' ARG . 48.9 mtt-85 -76.63 -164.48 0.42 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 110.056 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 52.5 mp0 -60.04 -58.3 9.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.514 -0.742 . . . . 0.0 112.552 -177.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -106.1 121.63 44.54 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.975 -1.078 . . . . 0.0 111.349 -177.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 4.6 m120 -104.19 117.28 33.87 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.596 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.14 -40.17 90.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.257 -0.902 . . . . 0.0 110.293 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -60.1 -41.32 92.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 114' ' ' ARG . 4.4 mmt-85 -60.15 -39.98 88.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 88.0 t -70.28 -41.12 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.064 -1.022 . . . . 0.0 109.826 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.11 95.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.526 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.93 87.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.652 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.447 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.4 t-160 -69.2 -46.16 68.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.493 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 94.4 mt-10 -59.1 -40.21 84.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.763 -1.211 . . . . 0.0 109.889 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.6 mt -61.28 -39.94 92.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.088 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.77 97.16 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -65.3 -36.57 84.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.161 -1.199 . . . . 0.0 108.803 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 84.3 p -70.04 -24.31 63.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 108.813 179.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.89 -3.43 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.43 13.31 76.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.7 132.66 35.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.884 -1.363 . . . . 0.0 108.942 179.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 66.0 m -87.91 173.04 9.16 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 109.793 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -67.62 159.3 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.417 -0.802 . . . . 0.0 109.71 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -127.88 162.57 26.4 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 65.0 p -100.12 2.8 43.47 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.019 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -82.3 128.81 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.7 tt -59.09 -31.58 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.476 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.14 -0.72 77.87 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.768 -1.206 . . . . 0.0 110.272 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.975 -1.309 . . . . 0.0 109.346 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.1 mt -67.68 -27.55 66.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 108.817 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 88.7 mmm -74.11 44.43 0.19 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.421 -0.8 . . . . 0.0 109.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.05 134.71 87.44 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.269 -179.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -50.62 -62.11 0.45 Allowed 'Trans proline' 0 N--CA 1.489 1.227 0 CA-C-N 120.055 1.055 . . . . 0.0 111.536 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 82.8 p -81.71 175.38 10.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.395 -0.815 . . . . 0.0 109.135 179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -84.99 128.77 34.77 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 109.725 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.4 p -149.43 175.0 11.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.455 -0.778 . . . . 0.0 109.217 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -130.75 149.74 52.25 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.42 -0.8 . . . . 0.0 109.606 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 79.2 p -126.13 23.13 7.15 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.626 -0.672 . . . . 0.0 109.229 -179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 84.67 -109.91 3.31 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 146' ' ' VAL . 42.5 t0 -81.76 155.11 25.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.093 -1.239 . . . . 0.0 109.124 179.833 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.515 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 60.9 t -88.66 110.04 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.106 -0.996 . . . . 0.0 109.837 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -140.57 150.74 44.03 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.11 147.44 40.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.118 -0.989 . . . . 0.0 109.012 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.1 162.98 14.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.07 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.98 -40.17 88.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.245 -0.909 . . . . 0.0 109.002 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -59.39 -40.78 87.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -74.44 -40.15 62.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.12 -52.25 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.226 -0.921 . . . . 0.0 109.166 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.59 -40.1 90.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.051 -1.031 . . . . 0.0 109.476 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.05 11.38 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 120.178 -1.01 . . . . 0.0 110.793 -179.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.8 tp -63.4 -39.95 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.925 -1.339 . . . . 0.0 109.798 -179.232 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.3 mt-30 -67.2 -39.93 86.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.013 -1.055 . . . . 0.0 109.717 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.22 -43.54 92.31 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.077 -1.014 . . . . 0.0 109.273 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.0 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.751 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -97.57 -69.98 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.14 -0.975 . . . . 0.0 109.325 179.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 156.59 -169.18 33.9 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -86.22 157.66 19.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.199 -1.177 . . . . 0.0 109.838 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 165' ' ' ASN . 37.3 m -73.72 80.94 1.56 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.25 -0.906 . . . . 0.0 108.921 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -80.87 35.14 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 163' ' ' SER . 68.2 m-80 -145.55 85.71 7.74 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.567 -0.708 . . . . 0.0 109.269 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.65 63.45 8.77 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 121.119 1.213 . . . . 0.0 111.83 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.4 p -150.3 131.57 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.218 -0.926 . . . . 0.0 109.283 179.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -71.17 150.32 94.54 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.965 . . . . 0.0 109.169 -179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 N--CA 1.494 1.528 0 C-N-CA 120.825 1.017 . . . . 0.0 111.868 179.974 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.723 HG12 ' OD1' ' A' ' 80' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 76.0 mt -96.62 138.88 33.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.331 -0.855 . . . . 0.0 109.091 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.8 p -92.62 160.15 15.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.252 -0.905 . . . . 0.0 109.461 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -71.95 137.71 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 108.799 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.33 -159.68 48.89 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 -179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -80.01 148.93 69.16 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.26 . . . . 0.0 108.79 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -68.99 -178.62 2.13 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.647 0.898 . . . . 0.0 112.027 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 -145.03 156.95 44.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.338 -0.851 . . . . 0.0 108.824 179.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -84.48 120.03 25.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.004 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 55.3 mp0 -82.69 -9.87 59.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.47 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -79.99 155.76 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.857 . . . . 0.0 110.299 -179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.4 p -98.92 -4.5 32.69 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.543 ' CD2' ' OG1' ' A' ' 48' ' ' THR . 48.2 m80 -129.96 141.72 50.73 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 49' ' ' PHE . 69.0 mt -133.39 156.06 48.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.251 -0.905 . . . . 0.0 109.27 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.3 p -127.44 153.98 45.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.398 -0.813 . . . . 0.0 109.185 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -146.16 162.25 38.41 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.323 -0.86 . . . . 0.0 109.206 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -147.92 129.88 15.33 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.0 mt -87.37 120.15 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.35 -40.12 89.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 110.422 -178.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -163.27 154.84 17.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.877 -1.139 . . . . 0.0 110.478 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -100.36 136.4 40.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -70.79 143.05 88.93 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.106 -0.996 . . . . 0.0 109.36 -179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -63.85 -11.08 25.15 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 120.603 0.869 . . . . 0.0 111.749 179.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.0 -39.93 87.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.339 -0.851 . . . . 0.0 109.947 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD13 ' ND2' ' A' ' 105' ' ' ASN . 95.8 mt -139.55 150.58 64.04 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.371 -0.831 . . . . 0.0 109.044 -179.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.94 -177.04 0.3 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.622 0.881 . . . . 0.0 112.015 179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.44 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 31.6 ptt180 -87.03 -33.23 19.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 0.0 109.434 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASP . . . -58.39 -39.98 81.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 109.63 179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -75.24 -39.97 59.44 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.027 -1.046 . . . . 0.0 110.34 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.43 -50.04 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.0 111.261 -178.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 29.6 p-10 -59.16 -39.03 81.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.76 -1.213 . . . . 0.0 108.948 -179.399 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 84.8 t60 -59.73 -49.17 78.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.179 -0.951 . . . . 0.0 109.185 179.01 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.14 87.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.493 -0.754 . . . . 0.0 110.165 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.09 -40.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.229 -0.919 . . . . 0.0 109.857 -179.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -67.07 -39.75 86.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.11 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -60.23 -39.8 87.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.402 -0.811 . . . . 0.0 109.29 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.33 95.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.09 -1.006 . . . . 0.0 109.498 -179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -60.02 -39.94 87.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.852 -1.155 . . . . 0.0 108.864 179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -60.0 -40.03 87.79 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.369 -0.832 . . . . 0.0 109.827 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 40' ' ' LEU . 90.2 mt -60.03 -42.96 95.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.055 -1.028 . . . . 0.0 109.709 -179.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' O ' ' OG1' ' A' ' 45' ' ' THR . 81.8 m95 -71.65 -40.11 69.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 109.702 -179.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.4 t -69.79 -33.7 72.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.227 -0.921 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -60.03 -23.06 63.39 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.351 -0.843 . . . . 0.0 111.06 -178.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 8.0 m -112.74 3.33 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 121.166 -0.959 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 41' ' ' TRP . 9.2 p -148.63 151.37 35.67 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 120.861 -1.149 . . . . 0.0 109.586 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -67.99 8.88 0.41 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.657 0.905 . . . . 0.0 111.975 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.15 150.01 46.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.543 ' OG1' ' CD2' ' A' ' 13' ' ' HIS . 59.6 p -137.26 153.75 50.27 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.452 -0.78 . . . . 0.0 109.033 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE1' HD12 ' A' ' 14' ' ' LEU . 96.5 m-85 -130.01 158.93 38.22 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.492 -0.755 . . . . 0.0 110.109 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -154.88 126.69 7.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -0.864 . . . . 0.0 109.984 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -77.82 143.92 37.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.333 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.76 139.53 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.9 t -95.28 -11.2 28.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.165 -0.959 . . . . 0.0 110.097 -179.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -147.59 158.16 43.88 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.964 -1.085 . . . . 0.0 109.546 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.93 170.83 47.65 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.595 ' CD ' ' H ' ' A' ' 56' ' ' GLN . 5.5 pm0 -80.0 163.96 23.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 109.402 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.41 151.86 51.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.497 -0.752 . . . . 0.0 109.757 -179.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.11 -39.87 87.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.483 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.6 mt -116.67 119.85 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.704 . . . . 0.0 109.482 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.1 mmm -100.59 128.73 46.55 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.2 mt -119.13 129.92 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.468 -0.77 . . . . 0.0 109.722 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.7 p -149.74 159.92 43.96 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.172 -0.955 . . . . 0.0 110.033 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.56 138.37 44.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.14 161.54 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.162 -0.961 . . . . 0.0 111.25 -178.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -128.92 142.78 50.83 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.717 -0.614 . . . . 0.0 109.786 179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.99 -143.52 1.45 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 68' ' ' HIS . 63.1 t0 -71.33 130.73 42.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.528 -0.984 . . . . 0.0 109.905 -179.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.416 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 19.8 p-80 -133.11 53.59 2.01 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.5 -0.75 . . . . 0.0 109.835 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 54.04 50.98 15.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 109.386 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 10.4 t70 -140.03 165.88 26.14 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 26.1 m120 -89.15 9.36 25.87 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.11 -0.994 . . . . 0.0 109.946 -179.29 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -135.57 71.43 65.41 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.368 -0.833 . . . . 0.0 109.635 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.76 141.1 70.57 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 120.937 1.091 . . . . 0.0 111.986 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -75.2 141.33 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 109.451 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -110.74 74.28 0.87 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.446 -0.784 . . . . 0.0 109.312 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.26 -178.62 6.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -50.56 -18.78 4.16 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.186 1.257 . . . . 0.0 112.044 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.22 175.06 55.03 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.38 -160.46 29.29 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -75.03 160.12 30.9 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -1.114 . . . . 0.0 109.681 -179.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.9 mt -93.64 -20.97 19.68 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.24 -0.912 . . . . 0.0 109.774 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -173.59 174.75 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.043 -1.036 . . . . 0.0 109.724 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -163.04 175.81 10.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.331 -0.856 . . . . 0.0 108.943 179.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.4 167.7 21.33 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.119 -0.988 . . . . 0.0 109.629 -179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -101.78 148.9 24.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.483 -0.76 . . . . 0.0 109.106 -179.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -59.99 149.81 72.3 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.267 -0.896 . . . . 0.0 109.059 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -55.28 120.58 8.44 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 120.781 0.987 . . . . 0.0 112.16 -179.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.53 174.9 47.33 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.81 172.95 10.82 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.211 1.274 . . . . 0.0 112.105 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.35 -124.83 16.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.9 tt -80.09 -9.13 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -1.043 . . . . 0.0 110.002 -179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.78 143.9 35.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.18 -18.25 46.34 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.07 152.84 45.04 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.118 -1.225 . . . . 0.0 109.914 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.27 121.42 10.14 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -102.92 141.5 35.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.46 -0.775 . . . . 0.0 110.42 -179.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.528 ' CZ ' ' OE1' ' A' ' 119' ' ' GLU . 44.8 m-85 -113.8 136.57 52.71 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -65.71 115.6 6.04 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -98.43 -1.04 42.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.496 -0.752 . . . . 0.0 109.442 -179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -75.14 -20.23 59.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.976 -1.078 . . . . 0.0 109.557 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -98.31 159.55 14.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.313 -0.867 . . . . 0.0 108.84 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -87.23 122.43 31.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.208 -0.932 . . . . 0.0 109.682 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -90.18 150.01 22.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.484 -0.76 . . . . 0.0 109.892 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 44.8 p -127.56 159.64 33.99 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.542 -0.724 . . . . 0.0 109.347 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.462 ' ND2' HD13 ' A' ' 25' ' ' LEU . 83.3 m-20 -109.39 29.47 7.52 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.532 -0.73 . . . . 0.0 109.587 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.685 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -148.82 -165.01 2.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.217 -0.927 . . . . 0.0 109.655 -179.802 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -79.72 34.73 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.184 -0.947 . . . . 0.0 110.644 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.548 ' CG ' HD21 ' A' ' 106' ' ' ASN . 26.1 mmt180 -76.85 -165.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.938 -1.101 . . . . 0.0 110.392 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -59.38 -56.59 20.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.589 -0.694 . . . . 0.0 111.432 -178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 104' ' ' THR . 91.5 m-85 -100.33 119.79 38.95 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.052 -1.03 . . . . 0.0 110.756 -178.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -103.35 107.3 18.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.385 -0.822 . . . . 0.0 109.476 179.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.38 -44.16 97.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 110.09 179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -59.91 -43.43 94.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 110.706 -179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 114' ' ' ARG . 13.7 ttt-85 -59.95 -43.32 95.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.892 -178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.477 ' HA ' HOM3 ' A' ' 173' ' ' CGS . 69.9 t -69.96 -40.03 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -0.959 . . . . 0.0 109.15 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.56 92.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.27 90.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.456 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 5.8 t60 -69.28 -45.87 68.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 110.037 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' OE1' ' CZ ' ' A' ' 97' ' ' PHE . 71.4 mt-10 -59.84 -40.14 87.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.94 -1.1 . . . . 0.0 109.142 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.58 -40.05 90.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.118 -0.989 . . . . 0.0 108.894 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -55.79 -41.92 84.44 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -64.65 -38.98 92.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -1.201 . . . . 0.0 108.835 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.3 p -70.02 -21.47 63.19 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.344 -0.847 . . . . 0.0 108.916 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.6 mt -86.86 -0.61 56.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 108.966 179.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 85.93 8.93 78.46 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.1 mt -81.2 127.36 32.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.032 -1.275 . . . . 0.0 108.791 179.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 50.2 m -88.05 175.46 7.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.327 -0.858 . . . . 0.0 109.687 -179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -67.53 159.88 28.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 110.104 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.0 t -133.25 163.63 28.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.538 -0.727 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 74.3 p -100.89 7.45 43.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 109.536 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -81.65 122.01 27.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 108.788 179.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 tt -59.24 -30.82 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 110.355 -179.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.48 -5.74 89.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.464 -178.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.77 132.08 34.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.995 -1.297 . . . . 0.0 109.505 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 137' ' ' TYR . 86.5 mt -68.91 -24.64 64.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 94.1 mmm -73.21 38.63 0.09 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 109.791 -178.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 135' ' ' LEU . 6.9 t80 -69.32 129.72 91.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.965 . . . . 0.0 108.671 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -47.59 -67.51 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.3 1.143 . . . . 0.0 111.863 179.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 98.0 p -81.88 169.42 16.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -87.37 139.54 30.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 82.2 p -147.51 160.63 42.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.218 -0.926 . . . . 0.0 109.398 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -72.92 149.51 43.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.219 -0.926 . . . . 0.0 109.812 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.3 p -152.87 160.08 43.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.277 -0.89 . . . . 0.0 109.579 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.88 -122.34 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -82.43 158.85 23.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.0 109.626 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 31.4 t -86.97 108.59 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 109.849 -179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -140.91 154.26 46.04 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 63.4 mt -74.93 146.04 42.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.969 -1.082 . . . . 0.0 109.11 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.07 156.89 16.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 109.092 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -58.77 -38.89 79.5 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -55.08 -40.11 70.01 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.072 -1.018 . . . . 0.0 108.624 179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.7 -39.96 69.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 108.918 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.23 -49.94 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 109.659 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -60.99 -39.98 91.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.837 -1.164 . . . . 0.0 110.339 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.74 -54.43 9.91 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.137 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 157' ' ' GLN . 9.7 tp -61.89 -40.02 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.299 . . . . 0.0 110.038 -179.008 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 161' ' ' GLY . 96.2 mt-30 -65.86 -40.04 91.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.941 -1.099 . . . . 0.0 109.387 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -44.05 94.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.317 -0.864 . . . . 0.0 109.926 -179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -50.07 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.288 -0.883 . . . . 0.0 110.51 -179.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -100.47 -61.04 1.42 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.171 -0.955 . . . . 0.0 109.751 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 157.7 -176.93 34.69 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -90.93 149.43 21.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.426 -1.043 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.1 m -73.7 83.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.084 -1.01 . . . . 0.0 108.685 179.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -91.37 34.97 0.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 0.0 109.431 -179.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -143.54 72.32 17.51 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 0.0 109.324 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -83.99 58.07 5.64 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.653 1.569 . . . . 0.0 111.549 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 82.5 t -87.04 118.5 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.36 -179.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -76.63 148.69 80.08 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo . . . . . 0 N--CA 1.488 1.19 0 CA-C-O 118.018 -0.909 . . . . 0.0 112.057 179.877 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.477 HOM3 ' HA ' ' A' ' 115' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.213 0.53 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.32 -40.2 89.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.05 179.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 70.5 p -96.5 139.69 32.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.805 . . . . 0.0 108.997 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -77.12 134.47 38.7 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.931 -1.106 . . . . 0.0 108.986 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.69 -94.96 0.65 Allowed Glycine 0 N--CA 1.502 3.097 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.462 ' ND2' ' OE1' ' A' ' 86' ' ' GLN . 68.5 m-80 -153.45 83.52 4.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.347 -1.09 . . . . 0.0 109.966 -179.257 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -52.22 161.25 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 120.85 1.033 . . . . 0.0 111.998 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 8' ' ' ARG . 22.6 mtt-85 -88.97 179.29 6.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.174 -0.954 . . . . 0.0 109.627 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -83.75 120.63 26.26 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.285 -0.885 . . . . 0.0 109.527 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.95 -10.11 58.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.849 -1.157 . . . . 0.0 109.109 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.94 150.11 30.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.095 -179.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -97.0 -4.89 38.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.523 -0.735 . . . . 0.0 109.442 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -130.01 139.99 50.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 69.3 mt -133.78 157.61 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.403 -0.811 . . . . 0.0 109.654 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.2 p -127.0 155.19 43.59 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.619 -0.676 . . . . 0.0 109.188 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.98 157.91 43.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.009 -1.057 . . . . 0.0 109.266 179.864 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.428 HH21 ' CE ' ' A' ' 60' ' ' MET . 42.3 ttp180 -147.33 128.86 15.02 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.166 -0.959 . . . . 0.0 109.954 -179.326 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 85.0 mt -85.41 123.71 39.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -62.3 -40.76 97.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 110.179 -178.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -162.22 151.84 16.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.983 -1.073 . . . . 0.0 110.304 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -97.54 135.94 38.66 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.378 -0.827 . . . . 0.0 109.27 179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 t -73.41 144.92 84.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.212 -0.93 . . . . 0.0 109.752 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.89 -15.09 45.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 CA-C-N 119.203 0.751 . . . . 0.0 111.046 179.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.49 -40.07 93.22 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.4 mt -135.13 150.32 72.58 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.009 -1.057 . . . . 0.0 109.337 -178.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -68.39 179.82 2.75 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 CA-C-N 119.158 0.735 . . . . 0.0 111.939 179.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -85.54 -36.13 20.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.924 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.43 -44.78 84.97 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.418 -0.801 . . . . 0.0 109.83 -179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -70.21 -40.03 74.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.311 -0.868 . . . . 0.0 109.434 -179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.4 t -69.85 -44.33 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.443 -179.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.88 -40.54 89.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 108.719 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -60.87 -47.87 84.42 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.312 -0.867 . . . . 0.0 109.499 179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.47 89.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.143 -179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.58 -40.66 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 109.813 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.404 ' HG2' HE21 ' A' ' 39' ' ' GLN . 87.8 tt0 -70.26 -40.0 74.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 109.609 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.0 -39.85 87.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.213 -0.929 . . . . 0.0 108.778 179.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.29 95.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 108.609 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CE1' ' CD1' ' A' ' 49' ' ' PHE . 33.8 m-85 -61.21 -39.59 90.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.072 -1.017 . . . . 0.0 109.881 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.404 HE21 ' HG2' ' A' ' 35' ' ' GLU . 76.3 mt-30 -58.9 -40.93 85.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.514 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.2 -41.24 92.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.034 -1.041 . . . . 0.0 109.317 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -72.39 -40.0 67.57 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.476 -179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.4 t -69.68 -28.47 65.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.442 -0.786 . . . . 0.0 110.254 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -59.85 -35.14 74.15 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.357 -0.839 . . . . 0.0 110.766 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.405 ' C ' ' HG ' ' A' ' 163' ' ' SER . 2.9 m -108.52 5.63 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.278 -0.889 . . . . 0.0 110.985 -178.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 45.3 p -140.03 148.63 55.61 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 120.897 -1.127 . . . . 0.0 108.625 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.73 6.4 2.42 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.407 1.404 . . . . 0.0 112.389 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.16 157.92 35.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 0.0 109.367 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.6 p -135.79 147.71 48.45 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.482 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 95.9 m-85 -128.72 148.7 50.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.725 -0.609 . . . . 0.0 109.65 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.4 m -154.35 134.92 13.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.116 -0.99 . . . . 0.0 109.765 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -76.06 146.58 39.3 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.358 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.25 135.17 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 O-C-N 121.369 -0.832 . . . . 0.0 108.978 179.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -97.54 -5.89 34.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 110.052 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -142.67 156.67 45.08 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.07 -1.019 . . . . 0.0 109.565 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.25 167.59 25.04 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -78.37 148.03 33.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.616 -0.932 . . . . 0.0 109.272 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.59 148.38 30.42 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -0.776 . . . . 0.0 108.913 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.45 -40.35 90.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.183 -0.948 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -112.34 118.89 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.428 ' CE ' HH21 ' A' ' 17' ' ' ARG . 89.7 mmm -101.2 122.19 43.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.5 mt -111.79 130.05 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.625 -0.672 . . . . 0.0 109.524 179.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.6 p -147.39 155.5 42.02 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.081 -1.012 . . . . 0.0 109.619 179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -105.28 140.2 38.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.57 160.29 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 CA-C-O 121.901 0.858 . . . . 0.0 111.188 -178.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 54.3 mtm-85 -131.96 135.44 46.58 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 48.72 -138.66 13.88 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -77.37 129.09 35.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.561 -0.964 . . . . 0.0 110.243 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 19.1 p-80 -131.58 47.46 2.53 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.409 -0.807 . . . . 0.0 109.772 179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 56.04 59.35 3.78 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.542 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 21.1 p-10 -142.72 163.1 33.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.491 -0.756 . . . . 0.0 109.066 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.53 9.19 30.36 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.172 -0.955 . . . . 0.0 109.233 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.3 t -140.08 69.51 34.95 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.414 -0.804 . . . . 0.0 109.012 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.67 148.68 42.22 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.364 1.376 . . . . 0.0 112.083 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -79.25 151.12 31.34 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.531 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -134.93 76.36 1.62 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 109.428 -179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.83 -179.18 39.73 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -70.73 -15.6 33.46 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 121.194 1.262 . . . . 0.0 112.377 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.04 -174.89 50.5 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.04 -158.38 36.38 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.581 ' CG ' HG12 ' A' ' 173' ' ' CGS . 11.7 m120 -75.06 143.78 43.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -1.023 . . . . 0.0 109.25 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.1 mt -89.32 -16.0 32.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.911 . . . . 0.0 109.0 -179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -171.54 175.67 4.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.264 -0.898 . . . . 0.0 108.937 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -163.01 120.25 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.914 -1.116 . . . . 0.0 110.629 179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.45 168.11 16.83 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -109.61 143.93 38.63 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.165 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.462 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 80.3 mt-30 -59.47 145.95 80.94 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 109.312 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -58.36 127.28 24.16 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 CA-C-N 119.249 0.768 . . . . 0.0 112.306 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.27 178.12 43.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.57 -177.86 3.87 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.359 1.373 . . . . 0.0 112.524 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.75 -123.7 33.52 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.635 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.1 tt -75.14 -13.74 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.49 -1.006 . . . . 0.0 109.782 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -54.01 138.77 38.21 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.249 -179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 -13.93 63.5 Favored Glycine 0 N--CA 1.497 2.702 0 O-C-N 121.231 -1.158 . . . . 0.0 110.546 179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.79 162.81 25.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.955 -1.321 . . . . 0.0 109.768 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.5 120.76 11.55 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -105.15 133.45 49.9 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.241 -0.912 . . . . 0.0 110.272 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.508 ' CE1' ' OE1' ' A' ' 119' ' ' GLU . 43.8 m-85 -114.65 129.75 56.72 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -67.53 120.72 14.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.105 -0.997 . . . . 0.0 108.968 179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -99.4 6.5 46.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.308 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -74.47 -20.16 60.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 0.0 109.737 -179.101 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -104.23 160.07 15.18 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 102' ' ' ARG . 33.2 ttt-85 -84.11 119.16 24.65 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.138 -0.976 . . . . 0.0 110.147 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -88.8 148.95 23.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.497 -0.752 . . . . 0.0 109.269 179.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 41.6 p -123.23 167.96 13.06 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.476 -0.765 . . . . 0.0 109.306 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -104.66 23.82 12.75 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -148.98 -165.0 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.657 -0.652 . . . . 0.0 109.805 -179.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -90.88 27.0 1.92 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.231 -0.918 . . . . 0.0 110.911 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' A' ' 109' ' ' GLU . 56.0 mtt-85 -76.47 -157.14 0.08 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.837 -1.165 . . . . 0.0 109.442 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 108' ' ' ARG . 64.4 mm-40 -24.31 -65.4 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' OG1' ' A' ' 104' ' ' THR . 93.4 m-85 -130.12 132.05 45.95 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.978 -1.076 . . . . 0.0 109.786 -179.455 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -95.99 113.83 25.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.204 -0.935 . . . . 0.0 109.701 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 61.9 tp -69.25 -40.27 77.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -59.63 -42.9 93.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.958 -1.089 . . . . 0.0 109.988 -179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.675 ' NH1' HOM1 ' A' ' 173' ' ' CGS . 25.3 ttt-85 -59.7 -41.52 90.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.0 t -70.27 -39.67 77.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.129 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.77 92.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.328 -0.858 . . . . 0.0 108.926 179.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.16 85.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.0 109.162 179.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.521 ' HD1' HOM2 ' A' ' 173' ' ' CGS . 4.3 t60 -69.72 -50.1 46.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.214 -0.929 . . . . 0.0 109.648 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 97' ' ' PHE . 73.4 mt-10 -59.95 -40.1 87.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.962 -1.086 . . . . 0.0 110.278 -178.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.42 HD22 ' CZ ' ' A' ' 38' ' ' PHE . 58.2 mt -62.12 -39.88 94.04 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 108.828 179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.81 -40.52 95.2 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 128' ' ' HIS . 12.2 m-70 -61.93 -38.73 89.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.067 -1.255 . . . . 0.0 107.778 178.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.5 m -69.65 -24.31 63.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -84.1 -0.27 51.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 108.852 178.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.99 13.97 65.5 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.361 -0.923 . . . . 0.0 110.889 178.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.56 124.58 30.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.088 -1.243 . . . . 0.0 108.887 179.617 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.2 m -88.67 167.28 13.48 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.998 -1.064 . . . . 0.0 109.1 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.501 ' CE1' ' CE1' ' A' ' 122' ' ' HIS . 80.9 m80 -68.58 152.36 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -0.972 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.6 t -126.44 169.69 12.74 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.473 -0.767 . . . . 0.0 108.969 179.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 60.3 p -98.94 1.02 45.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.398 -0.814 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -79.06 119.3 21.99 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.04 -40.44 83.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.154 -0.966 . . . . 0.0 110.298 -179.464 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.49 -3.77 27.87 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 121.01 -1.057 . . . . 0.0 111.007 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.81 154.1 23.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.852 -1.381 . . . . 0.0 109.159 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 135' ' ' LEU . 85.1 mt -68.19 -23.89 64.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.116 -0.99 . . . . 0.0 108.885 178.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.564 ' SD ' ' N ' ' A' ' 136' ' ' MET . 0.0 OUTLIER -74.52 62.24 1.0 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.57 -0.706 . . . . 0.0 109.911 -179.262 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 139' ' ' SER . 1.8 t80 -71.19 123.95 90.19 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -51.11 -2.1 0.05 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 CA-C-N 120.459 1.2 . . . . 0.0 113.546 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 137' ' ' TYR . 58.3 m -163.05 174.55 12.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 0.0 109.074 179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 173' ' ' CGS . 93.2 t80 -86.43 129.68 34.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.903 . . . . 0.0 108.92 179.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.4 p -153.01 168.66 25.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.127 -0.983 . . . . 0.0 110.036 -179.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.07 125.81 25.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.612 -0.68 . . . . 0.0 110.077 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 144' ' ' GLY . 51.0 m -129.66 142.69 50.68 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.449 -0.782 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' SER . . . -63.76 -126.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -81.8 155.59 25.34 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.842 -1.387 . . . . 0.0 109.213 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.26 110.28 20.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.456 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -142.58 157.87 44.26 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 80.3 mt -72.54 145.92 47.12 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.018 -1.051 . . . . 0.0 108.868 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.07 162.91 13.68 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.328 -0.857 . . . . 0.0 109.21 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.14 -40.19 88.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.22 -41.67 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 110.034 179.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -71.68 -40.78 69.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.155 -0.965 . . . . 0.0 109.699 -179.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 77.1 mt -63.76 -49.78 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.781 . . . . 0.0 109.298 179.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.67 -39.91 88.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.894 -1.129 . . . . 0.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.1 -52.72 34.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -64.32 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -1.212 . . . . 0.0 109.669 -179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.9 mt-30 -65.28 -39.65 92.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.865 -1.147 . . . . 0.0 109.198 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -41.79 92.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.389 -0.819 . . . . 0.0 110.033 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.97 -47.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.92 -1.112 . . . . 0.0 109.478 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.41 -64.91 1.01 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.299 -0.876 . . . . 0.0 110.48 -179.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 159.91 -169.82 35.94 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -92.11 145.44 24.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.023 -1.281 . . . . 0.0 108.7 179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 44' ' ' VAL . 42.2 m -71.42 87.39 0.87 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.223 -0.923 . . . . 0.0 109.962 -178.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.417 ' C ' ' ND2' ' A' ' 165' ' ' ASN . 76.8 mt-30 -86.96 93.4 9.33 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.417 ' ND2' ' C ' ' A' ' 164' ' ' GLN . 14.3 m-80 -155.35 96.63 2.44 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.684 -0.635 . . . . 0.0 109.785 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -80.04 57.45 6.51 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 CA-C-N 119.425 0.83 . . . . 0.0 111.807 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.2 t -142.83 130.57 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.58 ' NE2' ' N ' ' A' ' 168' ' ' GLN . 2.5 mp0 -67.35 148.39 98.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.861 -1.149 . . . . 0.0 108.759 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.492 1.408 0 CA-C-O 118.063 -0.891 . . . . 0.0 112.525 -179.509 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.675 HOM1 ' NH1' ' A' ' 114' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.29 -42.9 96.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 108.857 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 62.3 p -96.35 124.53 40.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 109.565 -179.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.51 116.66 20.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.323 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.18 -98.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 179.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -142.47 81.32 13.79 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.336 -1.097 . . . . 0.0 109.551 -179.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -73.28 -171.37 0.8 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.079 1.186 . . . . 0.0 112.582 -179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -90.15 -179.14 5.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.504 -0.747 . . . . 0.0 109.291 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -83.13 118.71 23.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -85.26 -10.65 56.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.212 -0.93 . . . . 0.0 109.287 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -83.73 150.9 25.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.323 -179.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.7 p -96.19 -3.8 43.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -128.85 141.67 51.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 160.05 39.74 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.244 -0.91 . . . . 0.0 109.784 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.5 p -127.94 157.18 41.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -146.1 159.94 42.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.416 -0.802 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -150.4 133.87 16.47 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.261 -0.899 . . . . 0.0 110.196 -179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 94.2 mt -89.49 118.57 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 98.4 mt-10 -66.8 -40.13 87.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.992 -1.068 . . . . 0.0 110.531 -178.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 19' ' ' GLU . 80.2 m-20 -155.95 152.71 28.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.119 -0.988 . . . . 0.0 109.849 -179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -101.4 131.98 47.21 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 t -68.75 138.26 90.61 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.022 -1.049 . . . . 0.0 108.993 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -64.47 -8.95 18.5 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 CA-C-N 119.596 0.891 . . . . 0.0 112.052 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.1 -39.97 88.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.004 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 54.0 mt -135.73 149.06 67.88 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -60.13 -175.44 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 120.63 0.886 . . . . 0.0 111.696 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -90.01 -37.23 14.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 109.845 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.8 -45.85 85.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.111 -0.993 . . . . 0.0 109.823 -179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.54 -39.83 73.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.8 t -69.72 -45.58 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.092 -1.005 . . . . 0.0 109.749 -179.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -59.95 -40.11 87.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.177 -0.952 . . . . 0.0 109.184 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -60.12 -42.52 94.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.362 -0.836 . . . . 0.0 108.974 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.74 90.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.46 -36.89 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -65.71 -42.03 91.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.739 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -62.6 -39.61 94.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.836 -1.165 . . . . 0.0 109.82 179.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.95 75.66 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' CD1' ' CD2' ' A' ' 49' ' ' PHE . 39.4 m-85 -61.69 -40.96 96.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.918 -1.114 . . . . 0.0 108.78 179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -60.24 -42.03 94.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -0.865 . . . . 0.0 110.356 179.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.79 -40.6 88.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.992 -1.067 . . . . 0.0 110.116 -179.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -73.0 -40.04 65.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.822 -1.174 . . . . 0.0 109.186 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.9 t -70.04 -26.48 64.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 110.25 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.92 -35.97 76.03 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.377 -0.827 . . . . 0.0 110.68 -178.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 45' ' ' THR . 33.7 m -108.54 10.26 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.322 -0.861 . . . . 0.0 109.664 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 44' ' ' VAL . 65.9 p -141.05 147.25 46.93 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.301 -0.875 . . . . 0.0 109.306 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.78 6.29 2.1 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 120.9 1.067 . . . . 0.0 112.067 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 72.6 mt -71.32 155.9 40.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.813 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.8 p -134.54 149.85 50.69 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.586 ' CD2' ' CD1' ' A' ' 38' ' ' PHE . 91.8 m-85 -125.98 155.13 41.88 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.468 -0.77 . . . . 0.0 109.433 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 19.5 m -151.65 137.25 17.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.295 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -78.36 137.02 37.82 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.4 m -121.57 134.34 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 121.362 -0.836 . . . . 0.0 109.16 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 t -97.47 -6.02 34.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.344 -0.848 . . . . 0.0 110.624 -179.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -144.19 153.32 41.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.905 -1.122 . . . . 0.0 109.643 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.83 165.57 33.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -81.09 147.3 30.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.211 -1.17 . . . . 0.0 108.972 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.79 156.77 17.98 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -59.73 -38.66 82.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.196 -0.94 . . . . 0.0 108.946 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.7 mt -116.4 118.3 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.673 0.749 . . . . 0.0 109.833 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.4 mmm -100.43 129.64 46.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.335 -0.853 . . . . 0.0 109.737 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.46 130.63 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.51 -0.744 . . . . 0.0 109.274 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.1 p -148.43 161.2 42.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.0 -1.062 . . . . 0.0 110.582 -179.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.08 140.01 48.83 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.81 173.25 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.134 -0.979 . . . . 0.0 111.003 -179.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -138.15 141.93 40.11 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.518 -0.739 . . . . 0.0 110.481 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 42.49 -140.09 2.24 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 178.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -71.57 130.33 40.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.425 -1.044 . . . . 0.0 109.421 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.516 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 12.1 p-80 -136.91 60.44 1.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.519 -0.738 . . . . 0.0 110.315 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 52.45 51.16 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.543 179.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 72' ' ' SER . 11.9 t70 -144.36 160.09 41.61 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.219 -0.926 . . . . 0.0 109.337 -179.794 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -88.96 9.89 23.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 108.74 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 40.3 t -134.17 73.78 69.08 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.537 -0.727 . . . . 0.0 109.318 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.77 145.08 45.27 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.057 1.171 . . . . 0.0 111.88 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.2 142.56 45.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.103 179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -102.42 65.63 0.95 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.299 -0.876 . . . . 0.0 109.665 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 67.3 -166.6 41.39 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -54.09 -20.02 17.65 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.226 1.284 . . . . 0.0 111.998 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -87.69 173.77 43.94 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.38 -163.73 26.53 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' HG12 ' A' ' 173' ' ' CGS . 28.6 p-10 -73.9 152.31 40.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.419 -1.048 . . . . 0.0 109.974 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.8 mt -91.86 -17.0 25.92 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -170.03 171.26 7.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.432 -0.793 . . . . 0.0 109.053 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -162.56 121.97 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.186 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.7 173.3 9.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.616 -0.678 . . . . 0.0 110.474 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -109.65 158.54 17.96 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.591 -0.693 . . . . 0.0 109.241 179.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -58.82 145.8 77.6 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.135 -179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.09 96.5 0.46 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 120.776 0.984 . . . . 0.0 112.909 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -159.91 173.49 36.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.318 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -65.1 -174.1 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 120.92 1.08 . . . . 0.0 111.705 179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.38 -134.11 50.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.5 tt -71.24 -12.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -1.124 . . . . 0.0 110.313 -179.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.88 144.22 44.68 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 89.7 -12.67 66.43 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.38 160.83 28.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -1.156 . . . . 0.0 109.979 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -141.72 115.56 9.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.285 -0.884 . . . . 0.0 109.422 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -100.13 142.53 31.49 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.358 -0.839 . . . . 0.0 110.162 -179.456 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -122.04 134.88 54.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.557 -0.715 . . . . 0.0 109.275 179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -68.8 119.46 13.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.329 -0.857 . . . . 0.0 109.533 179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -95.14 -0.27 53.53 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -73.83 -18.46 60.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 109.781 -179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.04 162.58 13.15 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.228 -0.92 . . . . 0.0 108.927 179.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -87.21 119.15 27.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -87.44 140.12 29.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.038 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 110' ' ' TYR . 54.3 p -128.78 166.33 19.22 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.495 -0.753 . . . . 0.0 109.735 -179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -117.73 31.05 6.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.62 -0.675 . . . . 0.0 109.258 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.554 HD22 ' H ' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -148.46 -162.73 1.62 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 -179.956 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -81.11 34.24 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.905 . . . . 0.0 110.423 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.503 ' CG ' HD21 ' A' ' 106' ' ' ASN . 10.6 mmt-85 -76.77 -166.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.062 -1.024 . . . . 0.0 110.129 179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -50.27 -57.14 8.5 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.596 -0.69 . . . . 0.0 111.991 -178.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' O ' ' OG1' ' A' ' 104' ' ' THR . 96.3 m-85 -119.94 140.16 51.34 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.136 -0.977 . . . . 0.0 111.494 -177.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 106' ' ' ASN . 21.4 m120 -108.32 118.49 36.9 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.5 tp -66.99 -42.01 85.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.18 -0.95 . . . . 0.0 110.682 -179.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -59.95 -42.09 93.3 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.054 -1.029 . . . . 0.0 110.935 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.559 ' NH1' ' H ' ' A' ' 143' ' ' SER . 82.8 mtt180 -59.84 -40.87 89.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 109.968 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.474 ' O ' ' OE1' ' A' ' 119' ' ' GLU . 62.6 t -70.33 -40.09 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 108.789 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.23 80.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.004 -1.06 . . . . 0.0 108.943 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.06 -35.01 79.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.523 -0.736 . . . . 0.0 109.956 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.456 ' CD2' ' O48' ' A' ' 173' ' ' CGS . 3.5 t-160 -69.99 -56.22 7.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.857 -1.152 . . . . 0.0 109.948 -179.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.487 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 7.0 mp0 -57.73 -39.92 78.43 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.951 -1.093 . . . . 0.0 109.677 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.94 -39.74 90.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.966 -1.084 . . . . 0.0 109.276 179.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.65 -39.86 95.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -63.47 -33.66 76.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.346 -1.091 . . . . 0.0 108.8 179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.3 t -68.83 -25.31 64.59 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 98.4 mt -84.58 -6.27 59.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.418 -0.801 . . . . 0.0 109.431 179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 88.14 19.53 52.76 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.5 mt -83.37 134.81 34.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.866 -1.373 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 69.8 m -87.55 168.29 13.19 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.692 -179.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -68.4 159.14 32.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.471 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.9 t -132.35 157.82 43.5 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.532 -0.73 . . . . 0.0 109.072 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 77.6 p -100.84 10.15 41.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.312 -0.867 . . . . 0.0 109.883 -179.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -82.04 128.51 34.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.989 -1.069 . . . . 0.0 109.293 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.76 -27.67 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 110.463 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.15 -4.79 88.04 Favored Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.413 -179.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.35 132.34 35.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.3 . . . . 0.0 109.671 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.84 -27.46 65.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 109.421 179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 39.6 mtp -75.72 45.39 0.32 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.264 -0.898 . . . . 0.0 109.826 -179.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -69.94 135.54 87.52 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -47.07 -68.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 CA-C-N 119.861 0.986 . . . . 0.0 112.545 179.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.1 p -85.14 174.05 9.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.183 -0.948 . . . . 0.0 110.017 -179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -84.59 136.62 33.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.921 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.7 p -145.76 159.46 43.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.182 -0.948 . . . . 0.0 109.444 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.13 127.37 32.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.331 -0.855 . . . . 0.0 109.785 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.559 ' H ' ' NH1' ' A' ' 114' ' ' ARG . 32.0 t -117.05 122.7 44.93 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -52.1 -95.14 0.01 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.71 141.51 31.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.274 -1.133 . . . . 0.0 109.718 -179.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 66.0 t -89.12 107.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.248 -0.907 . . . . 0.0 109.737 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -145.88 153.98 41.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.259 -0.9 . . . . 0.0 109.478 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.06 149.46 39.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.932 . . . . 0.0 108.71 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.76 161.32 14.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.163 -0.961 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -60.03 -39.82 87.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -58.59 -40.34 82.92 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.482 -0.761 . . . . 0.0 109.706 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -72.55 -40.14 66.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.747 -179.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.81 -49.69 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.085 179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -60.67 -40.21 91.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.182 -0.949 . . . . 0.0 109.868 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.46 -57.53 12.76 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 120.196 -1.002 . . . . 0.0 110.911 -178.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 157' ' ' GLN . 10.0 tp -60.15 -39.98 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.308 . . . . 0.0 109.941 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 161' ' ' GLY . 94.5 mt-30 -63.13 -39.58 95.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.028 -1.045 . . . . 0.0 109.175 179.399 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.57 94.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.95 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.22 -52.06 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.743 -1.223 . . . . 0.0 109.392 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -96.1 -70.9 0.7 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 157' ' ' GLN . . . 165.11 -170.07 39.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -92.98 141.72 28.09 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -1.156 . . . . 0.0 109.721 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.7 m -75.11 85.29 2.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -98.41 91.85 5.39 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.23 -0.919 . . . . 0.0 109.635 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -157.5 153.17 22.55 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.069 -1.02 . . . . 0.0 109.257 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -79.03 91.58 1.19 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.584 0.887 . . . . 0.0 111.553 178.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.5 m -85.28 139.16 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 110.28 -179.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' HD2' ' A' ' 169' ' ' PRO . 12.5 mm100 -63.28 -58.79 14.23 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.439 -0.788 . . . . 0.0 111.029 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 168' ' ' GLN . 1.1 Cg_endo . . . . . 0 N--CA 1.493 1.494 0 CA-C-N 120.255 1.127 . . . . 0.0 112.107 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' CGS . . . . . 0.511 ' C5 ' HG13 ' A' ' 173' ' ' CGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_